PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Forte, S; Pagliuca, A; Maniscalchi, ET; Gulino, R; Calabrese, G; Ricci-Vitiani, L; Pallini, R; Signore, M; Parenti, R; De Maria, R; Gulisano, M				Forte, Stefano; Pagliuca, Alfredo; Maniscalchi, Eugenia T.; Gulino, Rosario; Calabrese, Giovanna; Ricci-Vitiani, Lucia; Pallini, Roberto; Signore, Michele; Parenti, Rosalba; De Maria, Ruggero; Gulisano, Massimo			Gene Expression Analysis of PTEN Positive Glioblastoma Stem Cells Identifies DUB3 and Wee1 Modulation in a Cell Differentiation Model	PLOS ONE			English	Article							ALTERED EXPRESSION; CDC25 PHOSPHATASES; CANCER-CELLS; CYCLE ARREST; CARCINOMAS; GROWTH	The term astrocytoma defines a quite heterogeneous group of neoplastic diseases that collectively represent the most frequent brain tumors in humans. Among them, glioblastoma multiforme represents the most malignant form and its associated prognosis is one of the poorest among tumors of the central nervous system. It has been demonstrated that a small population of tumor cells, isolated from the brain neoplastic tissue, can reproduce the parental tumor when transplanted in immunodeficient mouse. These tumor initiating cells are supposed to be involved in cancer development and progression and possess stem cell-like features; like their normal counterpart, these cells remain quiescent until they are committed to differentiation. Many studies have shown that the role of the tumor suppressor protein PTEN in cell cycle progression is fundamental for tumor dynamics: in low grade gliomas, PTEN contributes to maintain cells in G1 while the loss of its activity is frequently observed in high grade gliomas. The mechanisms underlying the above described PTEN activity have been studied in many tumors, but those involved in the maintenance of tumor initiating cells quiescence remain to be investigated in more detail. The aim of the present study is to shed light on the role of PTEN pathway on cell cycle regulation in Glioblastoma stem cells, through a cell differentiation model. Our results suggest the existence of a molecular mechanism,	[Forte, Stefano; Gulino, Rosario; Calabrese, Giovanna] IOM Ric Srl, Viagrande, Italy; [Pagliuca, Alfredo; Ricci-Vitiani, Lucia; Signore, Michele] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy; [Pallini, Roberto] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurosurg, I-00168 Rome, Italy; [Maniscalchi, Eugenia T.; Parenti, Rosalba; Gulisano, Massimo] Univ Catania, Dept Biomed Sci, I-95124 Catania, Italy; [De Maria, Ruggero] Italian Natl Canc Inst Regina Elena, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Officina dei Materiali (IOM-CNR); Istituto Superiore di Sanita (ISS); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Catania	Forte, S (corresponding author), IOM Ric Srl, Viagrande, Italy.	stefano@stefanoforte.it	De Maria, Ruggero/S-6385-2019; PALLINI, Roberto/AAA-3747-2019; Pagliuca, Alfredo/AAI-3689-2020; Parenti, Rosalba/ABC-5780-2020; Ricci Vitiani, Lucia/J-8320-2016; Gulisano, Massimo/F-6609-2012; Pallini, Roberto/AAA-3760-2019; Forte, Stefano/D-3645-2013; Signore, Michele/J-8563-2016; Parenti, Rosalba/AAS-5489-2020	De Maria, Ruggero/0000-0003-2255-0583; PALLINI, Roberto/0000-0002-4611-8827; Parenti, Rosalba/0000-0002-1614-4696; Ricci Vitiani, Lucia/0000-0001-7336-5615; Gulisano, Massimo/0000-0001-8654-1745; Forte, Stefano/0000-0001-5746-7451; Signore, Michele/0000-0002-0262-842X; Calabrese, Giovanna/0000-0003-1937-5403; pagliuca, alfredo/0000-0002-8703-2077; Gulino, Rosario/0000-0002-8067-697X	Associazione Italiana per la Ricerca sul Cancro, AIRC [6326]; Fondi d'Ateneo Linea D1; Progetto FIRB [RBAP10KJC5]	Associazione Italiana per la Ricerca sul Cancro, AIRC(Fondazione AIRC per la ricerca sul cancro); Fondi d'Ateneo Linea D1; Progetto FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB))	This study was supported by Associazione Italiana per la Ricerca sul Cancro, AIRC (Start-up 6326) to LRV, by Fondi d'Ateneo, Linea D1to R. P and by Progetto FIRB RBAP10KJC5. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boutros R, 2007, NAT REV CANCER, V7, P495, DOI 10.1038/nrc2169; Cantley LC, 1999, P NATL ACAD SCI USA, V96, P4240, DOI 10.1073/pnas.96.8.4240; Cheng Y, 1999, J NEUROPATH EXP NEUR, V58, P120, DOI 10.1097/00005072-199902000-00002; Choe GY, 2002, CLIN CANCER RES, V8, P2894; Chow LML, 2006, CANCER LETT, V241, P184, DOI 10.1016/j.canlet.2005.11.042; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Esteller M, 1999, CANCER RES, V59, P793; Furnari FB, 1998, CANCER RES, V58, P5002; GALAKTIONOV K, 1995, SCIENCE, V269, P1575, DOI 10.1126/science.7667636; Hayes SD, 2010, NAT CELL BIOL, V12, P311, DOI 10.1038/ncb2043; Kleihues P, 2000, PATHOLOGY GENETICS T; Koul D, 2008, CANCER BIOL THER, V7, P1321, DOI 10.4161/cbt.7.9.6954; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Newcomb EW, 1998, BRAIN PATHOL, V8, P655, DOI 10.1111/j.1750-3639.1998.tb00191.x; Nishioka K, 2001, BRIT J CANCER, V85, P412, DOI 10.1054/bjoc.2001.1934; Pereg Y, 2010, NAT CELL BIOL, V12, P400, DOI 10.1038/ncb2041; R Core Team, 2013, R LANG ENV STAT COMP; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Ricci-Vitiani L, 2008, CELL DEATH DIFFER, V15, P1491, DOI 10.1038/cdd.2008.72; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Seminario MC, 2003, ONCOGENE, V22, P8195, DOI 10.1038/sj.onc.1206872; Sette G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046891; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; van Duijn PW, 2010, PROSTATE, V70, P135, DOI 10.1002/pros.21045; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang P, 2009, CANCER RES, V69, P8157, DOI 10.1158/0008-5472.CAN-09-1996; Xu XD, 2003, CLIN CANCER RES, V9, P1764	27	9	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81432	10.1371/journal.pone.0081432	http://dx.doi.org/10.1371/journal.pone.0081432			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349068	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800017
J	Kissopoulou, A; Jonasson, J; Lindahl, TL; Osman, A				Kissopoulou, Antheia; Jonasson, Jon; Lindahl, Tomas L.; Osman, Abdimajid			Next Generation Sequencing Analysis of Human Platelet PolyA plus mRNAs and rRNA-Depleted Total RNA	PLOS ONE			English	Article							HUMAN TRANSCRIPTOME; GENE-EXPRESSION; SEQ; TECHNOLOGY; PROTEINS; ISOFORM; LIBRARY; CELL	Background: Platelets are small anucleate cells circulating in the blood vessels where they play a key role in hemostasis and thrombosis. Here, we compared platelet RNA-Seq results obtained from polyA+ mRNA and rRNA-depleted total RNA. Materials and Methods: We used purified, CD45 depleted, human blood platelets collected by apheresis from three male and one female healthy blood donors. The Illumina HiSeq 2000 platform was employed to sequence cDNA converted either from oligo(dT) isolated polyA+ RNA or from rRNA-depleted total RNA. The reads were aligned to the GRCh37 reference assembly with the TopHat/Cufflinks alignment package using Ensembl annotations. A de novo assembly of the platelet transcriptome using the Trinity software package and RSEM was also performed. The bioinformatic tools HTSeq and DESeq from Bioconductor were employed for further statistical analyses of read counts. Results: Consistent with previous findings our data suggests that mitochondrially expressed genes comprise a substantial fraction of the platelet transcriptome. We also identified high transcript levels for protein coding genes related to the cytoskeleton function, chemokine signaling, cell adhesion, aggregation, as well as receptor interaction between cells. Certain transcripts were particularly abundant in platelets compared with other cell and tissue types represented by RNA-Seq data from the Illumina Human Body Map 2.0 project. Irrespective of the different library preparation and sequencing protocols, there was good agreement between samples from the 4 individuals. Eighteen differentially expressed genes were identified in the two sexes at 10% false discovery rate using DESeq. Conclusion: The present data suggests that platelets may have a unique transcriptome profile characterized by a relative over-expression of mitochondrially encoded genes and also of genomic transcripts related to the cytoskeleton function, chemokine signaling and surface components compared with other cell and tissue types. The in vivo functional significance of the non-mitochondrial transcripts remains to be shown.	[Kissopoulou, Antheia; Jonasson, Jon; Lindahl, Tomas L.; Osman, Abdimajid] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Osman, A (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	Majid.Osman@lio.se	Lindahl, Tomas L/H-5150-2012	Lindahl, Tomas L/0000-0003-0174-8152; Osman, Abdimajid/0000-0002-5143-8315	County Council of Ostergotland; Scientific Research Council [VR 521-2012-2729]	County Council of Ostergotland; Scientific Research Council	The County Council of Ostergotland (A. K., J.J. and A.O.) and the Scientific Research Council (T. L., project VR 521-2012-2729) supported this project. Sequencing was performed by the SNP&SEQ Technology Platform, Science for Life Laboratory at Uppsala University, a national infrastructure supported by the Swedish Research Council (VR-RFI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray PF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-1; Bugert P, 2003, THROMB HAEMOSTASIS, V90, P738; Cheung F, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-272; Costa V, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/853916; Dittrich M, 2006, THROMB HAEMOSTASIS, V95, P643, DOI 10.1160/TH05-11-0764; FARBISZEWSKI R, 1968, THROMB DIATH HAEMOST, V19, P578, DOI 10.1055/s-0038-1651237; Gnatenko DV, 2003, BLOOD, V101, P2285, DOI 10.1182/blood-2002-09-2797; Heap GA, 2010, HUM MOL GENET, V19, P122, DOI 10.1093/hmg/ddp473; Hee CS, 2013, IMMUNOGENETICS, V65, P157, DOI 10.1007/s00251-012-0667-4; Katz Y, 2010, NAT METHODS, V7, P1009, DOI 10.1038/NMETH.1528; Kaur H, 2012, BIOL CHEM, V393, P595, DOI 10.1515/hsz-2012-0131; KIEFFER N, 1987, EUR J BIOCHEM, V164, P189, DOI 10.1111/j.1432-1033.1987.tb11010.x; Marguerat S, 2010, CELL MOL LIFE SCI, V67, P569, DOI 10.1007/s00018-009-0180-6; McRedmond JP, 2004, MOL CELL PROTEOMICS, V3, P133, DOI 10.1074/mcp.M300063-MCP200; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Perrin BJ, 2010, CYTOSKELETON, V67, P630, DOI 10.1002/cm.20475; Rowley JW, 2011, BLOOD, V118, pE101, DOI 10.1182/blood-2011-03-339705; Rox JM, 2004, CLIN CHEM, V50, P2271, DOI 10.1373/clinchem.2004.035386; Schenk BI, 2002, J IMMUNOL, V169, P2602, DOI 10.4049/jimmunol.169.5.2602; Schwertz H, 2006, J EXP MED, V203, P2433, DOI 10.1084/jem.20061302; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tynngard N, 2008, TRANSFUSION, V48, P715, DOI 10.1111/j.1537-2995.2007.01610.x; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WICKI AN, 1989, THROMB HAEMOSTASIS, V61, P448; Wilhelm BT, 2009, METHODS, V48, P249, DOI 10.1016/j.ymeth.2009.03.016	27	39	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81809	10.1371/journal.pone.0081809	http://dx.doi.org/10.1371/journal.pone.0081809			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349131	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300052
J	Du, X; Zhang, M; Wei, DT; Li, WF; Zhang, QL; Qiu, J				Du, Xue; Zhang, Meng; Wei, DongTao; Li, Wenfu; Zhang, Qinglin; Qiu, Jiang			The Neural Circuitry of Reward Processing in Complex Social Comparison: Evidence from an Event-Related fMRI Study	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; COMPARISON ORIENTATION; RESPONSES; STRIATUM; BRAIN; DEPRESSION; ANTICIPATION; PREFERENCES; PERFORMANCE; LOSSES	In this study, Functional magnetic resonance imaging (fMRI) was conducted to investigate the mechanisms by which the brain activity in a complex social comparison context. One true subject and two pseudo-subjects were asked to complete a simple number estimate task at the same time which including upward and downward comparisons. Two categories of social comparison rewards (fair and unfair rewards distributions) were mainly presented by comparing the true subject with other two pseudo-subjects. Particularly, there were five conditions of unfair distribution when all the three subjects were correct but received different rewards. Behavioral data indicated that the ability to self-regulate was important in satisfaction judgment when the subject perceived an unfair reward distribution. fMRI data indicated that the interaction between the ventral striatum and the prefrontal cortex was important in self-regulation under specific conditions in complex social comparison, especially under condition of reward processing when there were two different reward values and the subject failed to exhibit upward comparison.	[Du, Xue; Zhang, Meng; Wei, DongTao; Li, Wenfu; Zhang, Qinglin; Qiu, Jiang] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Du, Xue; Zhang, Meng; Wei, DongTao; Li, Wenfu; Zhang, Qinglin; Qiu, Jiang] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Zhang, Meng] Xinxiang Med Univ, Dept Psychol, Xinxiang, Henan, Peoples R China	Southwest University - China; Southwest University - China; Xinxiang Medical University	Zhang, QL (corresponding author), Southwest Univ, Fac Psychol, Chongqing, Peoples R China.	zhangql@swu.edu.cn; qiuj318@swu.edu.cn			National Natural Science Foundation of China [31070900, 31271087]; Program for New Century Excellent Talents in University by the Ministry of Education; Fundamental Research Funds for the Central Universities [SWU1209101]; Key Discipline Fund of National 211 Project [TR201208-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Key Discipline Fund of National 211 Project	This research was supported by the National Natural Science Foundation of China (31070900; 31271087), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Fundamental Research Funds for the Central Universities (SWU1209101) and the Key Discipline Fund of National 211 Project (TR201208-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Bault N, 2011, P NATL ACAD SCI USA, V108, P16044, DOI 10.1073/pnas.1100892108; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Bui KV, 1999, J SOC BEHAV PERS, V14, P569; Buunk B. P., 2013, HLTH COPING WELL BEI; Buunk BP, 2001, J EXP SOC PSYCHOL, V37, P452, DOI 10.1006/jesp.2000.1465; Costa P. T., 1992, PSYCHOL ASSESSMENT R, V396, P653; Cromwell HC, 2005, EXP BRAIN RES, V162, P520, DOI 10.1007/s00221-005-2223-z; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; GIBBONS FX, 1986, J PERS SOC PSYCHOL, V51, P140, DOI 10.1037/0022-3514.51.1.140; Gibbons FX, 2000, PERS SOC PSYCHOL B, V26, P637, DOI 10.1177/0146167200267011; Goel V, 1997, BRAIN, V120, P1805, DOI 10.1093/brain/120.10.1805; Goel V, 2001, NAT NEUROSCI, V4, P237, DOI 10.1038/85076; Goel V, 2000, NEUROIMAGE, V12, P504, DOI 10.1006/nimg.2000.0636; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Haber SN, 2010, NEUROPSYCHOPHARMACOL, V35, P4, DOI 10.1038/npp.2009.129; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kedia G, 2013, NEUROREPORT, V24, P259, DOI 10.1097/WNR.0b013e32835f2069; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Leon MI, 1999, NEURON, V24, P415, DOI 10.1016/S0896-6273(00)80854-5; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mussweiler T, 2004, J EXP SOC PSYCHOL, V40, P689, DOI 10.1016/j.jesp.2004.01.004; O'Doherty JP, 2002, NEURON, V33, P815, DOI 10.1016/S0896-6273(02)00603-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Schultz W, 2000, NAT REV NEUROSCI, V1, P199, DOI 10.1038/35044563; Seymour B, 2007, J NEUROSCI, V27, P4826, DOI 10.1523/JNEUROSCI.0400-07.2007; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; SWALLOW SR, 1988, CLIN PSYCHOL REV, V8, P55, DOI 10.1016/0272-7358(88)90049-9; TABACHNIK N, 1983, J PERS SOC PSYCHOL, V45, P688, DOI 10.1037/0022-3514.45.3.688; Tricomi E, 2010, NATURE, V463, P1089, DOI 10.1038/nature08785; UYLINGS HBM, 1990, PROG BRAIN RES, V85, P31; Van der Zee K, 1998, J PERS SOC PSYCHOL, V75, P801, DOI 10.1037/0022-3514.75.3.801; WILLS TA, 1981, PSYCHOL BULL, V90, P245, DOI 10.1037/0033-2909.90.2.245; Zheng R., 1999, COLL STUDENTS PSYCHO; Zink CF, 2010, J NEUROSCI, V30, P7017, DOI 10.1523/JNEUROSCI.4899-09.2010	41	9	9	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82534	10.1371/journal.pone.0082534	http://dx.doi.org/10.1371/journal.pone.0082534			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340037	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400079
J	Nandety, RS; Kamita, SG; Hammock, BD; Falk, BW				Nandety, Raja Sekhar; Kamita, Shizuo G.; Hammock, Bruce D.; Falk, Bryce W.			Sequencing and De Novo Assembly of the Transcriptome of the Glassy-Winged Sharpshooter (Homalodisca vitripennis)	PLOS ONE			English	Article							RNA INTERFERENCE; TRANSPOSABLE ELEMENTS; GENOME SEQUENCE; EXPRESSION; ANNOTATION; DISCOVERY; MOSQUITO; BLAST2GO; BEETLE	Background: The glassy-winged sharpshooter Homalodisca vitripennis (Hemiptera: Cicadellidae), is a xylem-feeding leafhopper and important vector of the bacterium Xylella fastidiosa; the causal agent of Pierce's disease of grapevines. The functional complexity of the transcriptome of H. vitripennis has not been elucidated thus far. It is a necessary blueprint for an understanding of the development of H. vitripennis and for designing efficient biorational control strategies including those based on RNA interference. Results: Here we elucidate and explore the transcriptome of adult H. vitripennis using high-throughput paired end deep sequencing and de novo assembly. A total of 32,803,656 paired-end reads were obtained with an average transcript length of 624 nucleotides. We assembled 32.9 Mb of the transcriptome of H. vitripennis that spanned across 47,265 loci and 52,708 transcripts. Comparison of our non-redundant database showed that 45% of the deduced proteins of H. vitripennis exhibit identity (e-value <= 1(-5)) with known proteins. We assigned Gene Ontology (GO) terms, Kyoto Encyclopedia of Genes and Genomes (KEGG) annotations, and potential Pfam domains to each transcript isoform. In order to gain insight into the molecular basis of key regulatory genes of H. vitripennis, we characterized predicted proteins involved in the metabolism of juvenile hormone, and biogenesis of small RNAs (Dicer and Piwi sequences) from the transcriptomic sequences. Analysis of transposable element sequences of H. vitripennis indicated that the genome is less expanded in comparison to many other insects with approximately 1% of the transcriptome carrying transposable elements. Conclusions: Our data significantly enhance the molecular resources available for future study and control of this economically important hemipteran. This transcriptional information not only provides a more nuanced understanding of the underlying biological and physiological mechanisms that govern H. vitripennis, but may also lead to the identification of novel targets for biorationally designed control strategies.	[Nandety, Raja Sekhar; Falk, Bryce W.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Kamita, Shizuo G.; Hammock, Bruce D.] Univ Calif Davis, UC Davis Comprehens Canc Res Ctr, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Falk, BW (corresponding author), Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA.	bwfalk@ucdavis.edu		Yan, Zhiyong/0000-0001-8253-0694; Nandety, Raja Sekhar/0000-0002-1129-0790	University of California Pierce's Disease Research Grants Program	University of California Pierce's Disease Research Grants Program	This work was supported by grants awarded to Dr. Bryce W. Falk from the USDA-funded University of California Pierce's Disease Research Grants Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allshire RC, 2008, NAT REV GENET, V9, P923, DOI 10.1038/nrg2466; Asokan R, 2013, B ENTOMOL RES, P1; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Cai YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036599; Cernilogar FM, 2011, NATURE, V480, P391, DOI 10.1038/nature10492; Chenais B, 2012, GENE, V509, P7, DOI 10.1016/j.gene.2012.07.042; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Coates BS, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/604076; Comeault AA, 2012, MOL ECOL RESOUR, V12, P549, DOI 10.1111/j.1755-0998.2012.03121.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Deininger PL, 2003, CURR OPIN GENET DEV, V13, P651, DOI 10.1016/j.gde.2003.10.013; Fedoroff NV, 2012, SCIENCE, V338, P758, DOI 10.1126/science.338.6108.758; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gong ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071564; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Harmoko R, 2013, MOL CELLS; Hartl DL, 2001, GENETICS, V157, P471; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Hull JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055105; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; Jiang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040532; KAMINKER JS, 2002, GENOME BIOL, V0003; Kamita SG, 2013, ARCH INSECT BIOCH PH; Keeling CI, 2012, INSECT BIOCHEM MOLEC, V42, P525, DOI 10.1016/j.ibmb.2012.03.010; Kennerdell JR, 2000, NAT BIOTECHNOL, V18, P896, DOI 10.1038/78531; Kumar P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031347; Li SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047401; Li Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042558, 10.1371/journal.pone.0043023]; Liu FS, 2012, MOL BIOL REP, V39, P1927, DOI 10.1007/s11033-011-0939-3; Liu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045161; Minakuchi C, 2008, FEBS J, V275, P2919, DOI 10.1111/j.1742-4658.2008.06428.x; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Morisseau Christophe, 2007, Curr Protoc Toxicol, VChapter 4, DOI 10.1002/0471140856.tx0423s33; Nandety RS, 2013, VIROLOGY, V442, P12, DOI 10.1016/j.virol.2013.04.005; Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878; Palavesam A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068454; Pauchet Y, 2010, INSECT MOL BIOL, V19, P61, DOI 10.1111/j.1365-2583.2009.00936.x; Pauchet Y, 2009, INSECT BIOCHEM MOLEC, V39, P403, DOI 10.1016/j.ibmb.2009.04.001; Peng X, 2011, INSECT MOL BIOL, V20, P745, DOI 10.1111/j.1365-2583.2011.01104.x; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rosa C, 2012, PEST MANAG SCI, V68, P995, DOI 10.1002/ps.3253; Rosa Cristina, 2010, J RNAi Gene Silencing, V6, P361; Sarkar A, 2003, MOL GENET GENOMICS, V270, P173, DOI 10.1007/s00438-003-0909-0; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shen GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029127; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Sze SH, 2012, INSECT MOL BIOL, V21, P205, DOI 10.1111/j.1365-2583.2011.01127.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whyard S, 2009, INSECT BIOCHEM MOLEC, V39, P824, DOI 10.1016/j.ibmb.2009.09.007; Wuriyanghan H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027736; Xie W, 2012, INT J BIOL SCI, V8, P1142, DOI 10.7150/ijbs.4588; Xu HF, 2006, MOL GENET GENOMICS, V276, P31, DOI 10.1007/s00438-006-0124-x; Xu HE, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat055; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Zhang SZ, 2010, J INSECT PHYSIOL, V56, P1198, DOI 10.1016/j.jinsphys.2010.03.021; Zhu JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032291	64	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81681	10.1371/journal.pone.0081681	http://dx.doi.org/10.1371/journal.pone.0081681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339955	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400031
J	Potlukova, E; Freiberger, T; Limanova, Z; Jiskra, J; Telicka, Z; Bartakova, J; Springer, D; Vitkova, H; Trendelenburg, M				Potlukova, Eliska; Freiberger, Tomas; Limanova, Zdenka; Jiskra, Jan; Telicka, Zdenek; Bartakova, Jana; Springer, Drahomira; Vitkova, Hana; Trendelenburg, Marten			Association between Low Levels of Mannan-Binding Lectin and Markers of Autoimmune Thyroid Disease in Pregnancy	PLOS ONE			English	Article							GENE POLYMORPHISMS; MBL2 GENE; CHILDREN; ASTHMA; DEFICIENCY; GENOTYPES; PREECLAMPSIA; INFECTIONS; C1Q; AGE	Functional deficiency of mannan-binding lectin (MBL) has been associated with adverse pregnancy outcome. Adverse events during pregnancy have also been described in women with autoimmune thyroid diseases (AITD), and thyroid hormones have been shown to influence serum levels of MBL. Therefore, the aim of this study was to analyse the impact of MBL-deficiency on the outcome of pregnancy in relation to the presence of AITD. Almost one year after delivery, we assessed serum MBL levels and MBL2-genotypes in 212 women positively screened for AITD in pregnancy. In 103 of these women, we could also measure MBL levels in frozen serum samples from the 9-12th gestational week, obtaining 96 pairs of MBL values (pregnancy vs. follow-up). As controls, 80 sera of pregnant women screened negatively for AITD were used. MBL2-genotyping was performed using multiplex PCR. Women with thyroid dysfunction and/or thyroid peroxidase antibodies (TPOAb) had lower MBL levels during pregnancy than controls, (3275 vs. 5000 ng/ml, p<0.05). The lowest levels were found in women with elevated thyroid-stimulating hormone (TSH) levels in the absence of TPOAb (2207 ng/ml; p<0.01 as compared to controls). MBL2 genotype distribution did not differ between subgroups. At a median follow-up period of 17 months (range: 3-78 months) after delivery, median MBL level had decreased further to 1923 ng/ml (p<0.0001) without significant changes in TSH. In an explorative survey, functional MBL-deficiency was neither linked to a history of spontaneous abortion, nor other obstetric complications, severe infections throughout life/pregnancy or antibiotics use in pregnancy. In conclusion, hypothyroidism during pregnancy is associated with decreased MBL levels, and the levels decreased further after delivery.	[Potlukova, Eliska; Limanova, Zdenka; Jiskra, Jan; Telicka, Zdenek; Bartakova, Jana; Vitkova, Hana] Univ Hosp Geneva, Dept Med 3, Prague, Czech Republic; [Potlukova, Eliska; Limanova, Zdenka; Jiskra, Jan; Telicka, Zdenek; Bartakova, Jana; Springer, Drahomira; Vitkova, Hana] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Freiberger, Tomas] Ctr Cardiovasc Surg & Transplantat, Mol Genet Lab, Brno, Czech Republic; [Freiberger, Tomas] Ceitec, Brno Univ Technol, Brno, Czech Republic; [Freiberger, Tomas] Masaryk Univ, Fac Med, Brno, Czech Republic; [Springer, Drahomira] Gen Univ Hosp, Inst Clin Biochem & Lab Med, Prague, Czech Republic; [Trendelenburg, Marten] Univ Basel Hosp, Dept Biomed, Clin Immunol Lab, Basel, Switzerland	Charles University Prague; Brno University of Technology; Masaryk University Brno; General University Hospital Prague; University of Basel	Trendelenburg, M (corresponding author), Univ Basel Hosp, Dept Biomed, Clin Immunol Lab, Basel, Switzerland.	marten.trendelenburg@usb.ch	Vitkova, Hana/D-5610-2017; Springer, Drahomira/J-2474-2017; Freiberger, Tomas/D-8421-2011; Jiskra, Jan/M-1894-2017; Limanova, Zdenka/S-5847-2016; Trendelenburg, Marten/AAM-1626-2020	Vitkova, Hana/0000-0002-6342-6303; Springer, Drahomira/0000-0003-4756-0585; Freiberger, Tomas/0000-0001-6532-7053; Jiskra, Jan/0000-0003-0920-4854; Limanova, Zdenka/0000-0003-2233-4012; Trendelenburg, Marten/0000-0001-7036-8386; Bartakova, Jana/0000-0001-5392-7801; Potlukova, Eliska/0000-0003-4790-8860	Research Programme Prvouk 25 of Charles University, Prague, CZ; Swiss National foundation [310030_134900]; CEITEC - Central European Institute of Technology" [CZ.1.05/1.1.00/02.0068]; SuPReMMe [CZ.1.07/2.3.00/20.0045]	Research Programme Prvouk 25 of Charles University, Prague, CZ; Swiss National foundation(Swiss National Science Foundation (SNSF)); CEITEC - Central European Institute of Technology"; SuPReMMe	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EP was supported by the Research Programme Prvouk 25 of Charles University, Prague, CZ. MT is supported by a grant from the Swiss National foundation (310030_134900). TF was supported by the project "CEITEC - Central European Institute of Technology" (CZ.1.05/1.1.00/02.0068) and SuPReMMe (CZ.1.07/2.3.00/20.0045).	Aittoniemi J, 2005, CLIN EXP IMMUNOL, V142, P120, DOI 10.1111/j.1365-2249.2005.02881.x; Carrera MC, 2010, ANN ALLERG ASTHMA IM, V105, P39, DOI 10.1016/j.anai.2010.03.017; Cedzynski M, 2004, CLIN EXP IMMUNOL, V136, P304, DOI 10.1111/j.1365-2249.2004.02453.x; Cedzynski M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/363246; Christiansen OB, 2009, HUM REPROD, V24, P291, DOI 10.1093/humrep/den377; FIDDES J C, 1981, Journal of Molecular and Applied Genetics, V1, P3; Font J, 2007, RHEUMATOLOGY, V46, P76, DOI 10.1093/rheumatology/kel199; Gadjeva M, 2004, MOL IMMUNOL, V41, P113, DOI 10.1016/j.molimm.2004.03.015; GLINOER D, 1990, J CLIN ENDOCR METAB, V71, P276, DOI 10.1210/jcem-71-2-276; Hansen TK, 2001, J CLIN ENDOCR METAB, V86, P5383, DOI 10.1210/jc.86.11.5383; Heitzeneder S, 2012, CLIN IMMUNOL, V143, P22, DOI 10.1016/j.clim.2011.11.002; Kaur S, 2005, J ALLERGY CLIN IMMUN, V116, P1381, DOI 10.1016/j.jaci.2005.08.028; Kaur S, 2006, CURR ALLERGY ASTHM R, V6, P377, DOI 10.1007/s11882-996-0007-6; Kilpatrick DC, 2000, HUM REPROD, V15, P941, DOI 10.1093/humrep/15.4.941; KILPATRICK DC, 1995, HUM REPROD, V10, P2501; Koenig KF, 2012, CLIN IMMUNOL, V144, P80, DOI 10.1016/j.clim.2012.05.002; Limnell V, 2002, CARDIOLOGY, V98, P123, DOI 10.1159/000066313; Nagy A, 2003, J ALLERGY CLIN IMMUN, V112, P729, DOI 10.1016/S0091-6749(03)02010-4; Nauta AJ, 2004, J IMMUNOL, V173, P3044, DOI 10.4049/jimmunol.173.5.3044; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Potlukova E, 2012, J CLIN ENDOCR METAB, V97, P1945, DOI 10.1210/jc.2011-3275; Potlukova E, 2010, CLIN IMMUNOL, V136, P123, DOI 10.1016/j.clim.2010.02.015; Rossner P, 2011, ENVIRON HEALTH PERSP, V119, P265, DOI 10.1289/ehp.1002470; Seelen MA, 2005, RHEUMATOLOGY, V44, P111, DOI 10.1093/rheumatology/keh417; Skalnikova H, 2004, J IMMUNOL METHODS, V295, P139, DOI 10.1016/j.jim.2004.10.007; Sorensen CM, 2006, CLIN EXP IMMUNOL, V145, P173, DOI 10.1111/j.1365-2249.2006.03101.x; Springer D, 2009, EUR J ENDOCRINOL, V160, P791, DOI 10.1530/EJE-08-0890; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Staley KG, 2007, J ALLERGY CLIN IMMUN, V119, P503, DOI 10.1016/j.jaci.2006.09.028; Thiel S, 2006, MOL IMMUNOL, V43, P86, DOI 10.1016/j.molimm.2005.06.018; Thorarinsdottir HK, 2005, SCAND J IMMUNOL, V61, P466, DOI 10.1111/j.1365-3083.2005.01588.x; Uguz A, 2005, PEDIAT ALLERG IMM-UK, V16, P231, DOI 10.1111/j.1399-3038.2005.00258.x; van de Geijn FE, 2008, MOL IMMUNOL, V45, P1514, DOI 10.1016/j.molimm.2007.08.021; van de Geijn FE, 2007, HUM REPROD, V22, P362, DOI 10.1093/humrep/del392; van de Geijn FE, 2007, HUM IMMUNOL, V68, P888, DOI 10.1016/j.humimm.2007.10.002; Vianna P, 2010, AM J REPROD IMMUNOL, V64, P359, DOI 10.1111/j.1600-0897.2010.00846.x; Wang X, 2007, CLIN EXP ALLERGY, V37, P1334, DOI 10.1111/j.1365-2222.2007.02761.x	37	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81755	10.1371/journal.pone.0081755	http://dx.doi.org/10.1371/journal.pone.0081755			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339961	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400037
J	Punsmann, S; Liebers, V; Lotz, A; Bruning, T; Raulf, M				Punsmann, Stefanie; Liebers, Verena; Lotz, Anne; Bruening, Thomas; Raulf, Monika			Ex Vivo Cytokine Release and Pattern Recognition Receptor Expression of Subjects Exposed to Dampness: Pilot Study to Assess the Outcome of Mould Exposure to the Innate Immune System	PLOS ONE			English	Article							DAMAGED BUILDING-MATERIALS; TOLL-LIKE RECEPTOR-2; INFLAMMATORY RESPONSES; ASPERGILLUS-VERSICOLOR; ENDOTOXIN EXPOSURE; ANTIGEN EXPOSURE; BLOOD; CELLS; COMPONENTS; DECTIN-1	In rooms with moisture damage, the indoor air can be enriched with microorganisms causing a variety of symptoms. Due to the highly diverse composition of bioaerosols and the multiple effects on humans, an assessment of the health risk is not sufficiently possible. The aim of this study was to characterize the features of innate immunity using blood from subjects exposed to moisture damage compared to control subjects living in houses without visible moisture damage. We investigated the expression of TLR-2, TLR-4 and dectin-1 on the surface of monocytes from both fresh blood and after in vitro stimulation with the model substances E. coli endotoxin, zymosan A, Pam(3)Cys and Aspergillus versicolor in 25 exposed subjects and 25 control subjects. In vitro stimulation of whole blood with the same components was performed for 20 h and the release of inflammatory mediators IL-8 and IL-1 beta were quantified. In addition to an enhanced number of blood leucocytes, the expression of the receptors TLR-2, TLR-4 and dectin-1 on blood monocytes was significantly enhanced in exposed subjects. In contrast, no different alteration in expression was detected between exposed and control group after in vitro stimulation with the model substances. The release of IL-8 and IL-1 beta after stimulation of whole blood with A. versicolor was increased in subjects exposed to moisture damage. Furthermore, in the exposed subjects the IL-1 beta release was significantly enhanced after in vitro stimulation with E. coli endotoxin (1000 pg/mL). In conclusion, features of the innate immune system (receptor expression and mediator release of monocytes) are altered in subjects exposed to moisture damage which may be a potential explanation for the increased incidence of respiratory health diseases observed in these populations.	[Punsmann, Stefanie; Liebers, Verena; Lotz, Anne; Bruening, Thomas; Raulf, Monika] Inst Ruhr Univ Bochum, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany	Ruhr University Bochum	Punsmann, S (corresponding author), Inst Ruhr Univ Bochum, German Social Accid Insurance, Inst Prevent & Occupat Med, Bochum, Germany.	punsmann@ipa-dguv.de	Brüning, Thomas/G-8120-2015	Brüning, Thomas/0000-0001-9560-5464; Lotz, Anne/0000-0002-8715-0743	Deutsche Bundesstiftung Umwelt, Osnabruck, Germany [20010/090]	Deutsche Bundesstiftung Umwelt, Osnabruck, Germany	SP has a scholarship of the Deutsche Bundesstiftung Umwelt, Osnabruck, Germany www.dbu.de (20010/090). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Andersen B, 2011, APPL ENVIRON MICROB, V77, P4180, DOI 10.1128/AEM.02513-10; Apetrei Natalia Simona, 2010, Roum Arch Microbiol Immunol, V69, P61; Beijer L, 2003, EUR RESPIR J, V21, P317, DOI 10.1183/09031936.03.00283603; Bellanger AP, 2009, LETT APPL MICROBIOL, V49, P260, DOI 10.1111/j.1472-765X.2009.02653.x; Bonfim CV, 2009, MED MYCOL, V47, P722, DOI 10.3109/13693780802641425; Bonlokke JH, 2004, INT ARCH OCC ENV HEA, V77, P136, DOI 10.1007/s00420-003-0479-9; Borm PJA, 1999, INT ARCH OCC ENV HEA, V72, P323, DOI 10.1007/s004200050382; Brown GD, 2001, NATURE, V413, P36, DOI 10.1038/35092620; DICARLO FJ, 1958, SCIENCE, V127, P756, DOI 10.1126/science.127.3301.756-a; Douwes J, 2006, ANN AGR ENV MED, V13, P361; Flo TH, 2001, J LEUKOCYTE BIOL, V69, P474; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Gehring U, 2007, EUR RESPIR J, V29, P1144, DOI 10.1183/09031936.00118806; Goetzl EJ, 2010, FASEB J, V24, P3580, DOI 10.1096/fj.10-160911; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jaresova I, 2007, MICROBES INFECT, V9, P1359, DOI 10.1016/j.micinf.2007.06.009; Karvala K, 2011, INT ARCH OCC ENV HEA, V84, P713, DOI 10.1007/s00420-011-0677-9; Liebers V, 2008, ARCH TOXICOL, V82, P203, DOI 10.1007/s00204-008-0290-1; Liebers V, 2009, INT J HYG ENVIR HEAL, V212, P547, DOI 10.1016/j.ijheh.2009.03.003; Madsen AM, 2006, ANN AGR ENV MED, V13, P81; Noss I, 2010, ANN OCCUP HYG, V54, P651, DOI 10.1093/annhyg/meq026; Park Ju-Hyeong, 2011, Front Biosci (Elite Ed), V3, P757, DOI 10.2741/e284; Park SJ, 2009, CLIN MICROBIOL REV, V22, P535, DOI 10.1128/CMR.00014-09; Punsmann S, 2013, INT J HYG ENVIR HEAL, V216, P402, DOI 10.1016/j.ijheh.2012.11.001; Sahlander K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031646; Sahlander K, 2010, INNATE IMMUN-LONDON, V16, P27, DOI 10.1177/1753425909106317; Sander I, 2008, J IMMUNOL METHODS, V337, P55, DOI 10.1016/j.jim.2008.05.010; Sander I, 2012, J TOXICOL ENV HEAL A, V75, P1185, DOI 10.1080/15287394.2012.707603; Smit LAM, 2009, EUR RESPIR J, V34, P795, DOI 10.1183/09031936.00161908; Suihko ML, 2009, INDOOR AIR, V19, P268, DOI 10.1111/j.1600-0668.2009.00591.x; Sun WK, 2012, EUR J CLIN MICROBIOL, V31, P2755, DOI 10.1007/s10096-012-1624-8; Thorne PS, 2005, AM J RESP CRIT CARE, V172, P1371, DOI 10.1164/rccm.200505-758OC; Tischer C, 2011, EUR RESPIR J, V38, P812, DOI 10.1183/09031936.00184010; Tischer C, 2011, EUR RESPIR J, V37, P1050, DOI 10.1183/09031936.00091210; Willment JA, 2005, EUR J IMMUNOL, V35, P1539, DOI 10.1002/eji.200425725; Wouters IM, 2002, TOXICOL IND HEALTH, V18, P15, DOI 10.1191/0748233702th126oa; Zahradnik E, 2013, ENVIRON SCI-PROC IMP, V15, P1162, DOI 10.1039/c3em30870g; Zahradnik E, 2011, J ENVIRON MONITOR, V13, P2638, DOI 10.1039/c1em10430f; Zhang X, 2012, SCI TOTAL ENVIRON, V430, P75, DOI 10.1016/j.scitotenv.2012.04.040; Zhang Y, 2012, MOL MED REP, V5, P1318, DOI 10.3892/mmr.2012.788	42	8	8	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82734	10.1371/journal.pone.0082734	http://dx.doi.org/10.1371/journal.pone.0082734			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340055	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400092
J	Tomcal, M; Stiffler, N; Barkan, A				Tomcal, Michael; Stiffler, Nicholas; Barkan, Alice			POGs2: A Web Portal to Facilitate Cross-Species Inferences About Protein Architecture and Function in Plants	PLOS ONE			English	Article							COMPARATIVE GENOMICS; DATABASE SEARCH; RESOURCE; ANNOTATION; ALIGNMENT	The Putative orthologous Groups 2 Database (POGs2) (http://pogs.uoregon.edu/) integrates information about the inferred proteomes of four plant species (Arabidopsis thaliana, Zea mays, Orza sativa, and Populus trichocarpa) in a display that facilitates comparisons among orthologs and extrapolation of annotations among species. A single-page view collates key functional data for members of each Putative Orthologous Group (POG): graphical representations of InterPro domains, predicted and established intracellular locations, and imported gene descriptions. The display incorporates POGs predicted by two different algorithms as well as gene trees, allowing users to evaluate the validity of POG memberships. The web interface provides ready access to sequences and alignments of POG members, as well as sequences, alignments, and domain architectures of closely-related paralogs. A simple and flexible search interface permits queries by BLAST and by any combination of gene identifier, keywords, domain names, InterPro identifiers, and intracellular location. The concurrent display of domain architectures for orthologous proteins highlights errors in gene models and false-negatives in domain predictions. The POGs2 layout is also useful for exploring candidate genes identified by transposon tagging, QTL mapping, map-based cloning, and proteomics, and for navigating between orthologous groups that belong to the same gene family.	[Tomcal, Michael; Stiffler, Nicholas; Barkan, Alice] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA	University of Oregon	Barkan, A (corresponding author), Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA.	abarkan@molbio.uoregon.edu	Stiffler, Nicholas/AAX-7639-2020	Stiffler, Nicholas/0000-0001-7685-3673	National Science Foundation [IOS-0922560]; Division Of Integrative Organismal Systems [0922560] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation grant IOS-0922560 to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brown NP, 1998, BIOINFORMATICS, V14, P380, DOI 10.1093/bioinformatics/14.4.380; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Rouard M, 2011, NUCLEIC ACIDS RES, V39, pD1095, DOI 10.1093/nar/gkq811; Sen TZ, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap020; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smits SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012267; Sun Q, 2009, NUCLEIC ACIDS RES, V37, pD969, DOI 10.1093/nar/gkn654; Trachana K, 2011, BIOESSAYS, V33, P769, DOI 10.1002/bies.201100062; Van Bel M, 2012, PLANT PHYSIOL, V158, P590, DOI 10.1104/pp.111.189514; Vilella AJ, 2009, GENOME RES, V19, P327, DOI 10.1101/gr.073585.107; Walker NS, 2007, NUCLEIC ACIDS RES, V35, pD852, DOI 10.1093/nar/gkl795; Williams-Carrier R, 2010, PLANT J, V63, P167, DOI 10.1111/j.1365-313X.2010.04231.x	22	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82569	10.1371/journal.pone.0082569	http://dx.doi.org/10.1371/journal.pone.0082569			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340041	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400082
J	van Soelen, N; du Preez, K; van Wyk, SS; Mandalakas, AM; Enarson, DA; Reid, AJ; Hesseling, AC				van Soelen, Nelda; du Preez, Karen; van Wyk, Susan S.; Mandalakas, Anna M.; Enarson, Don A.; Reid, Anthony J.; Hesseling, Anneke C.			Does an Isoniazid Prophylaxis Register Improve Tuberculosis Contact Management in South African Children?	PLOS ONE			English	Article							PREVENTIVE THERAPY; HOUSEHOLD CONTACTS	Setting: We compared the change in child household contact management of pulmonary tuberculosis (TB) cases before and after the implementation of an isoniazid preventive therapy (IPT) register in an urban clinic setting in Cape Town, South Africa. Objectives: We determined if the presence of an IPT register was associated with an increase in the number of child contacts identified per infectious case and the proportion of identified children who were started on IPT. Design: We reviewed routine programme data on IPT delivery to children during two time periods (May 2008-October 2008 and May 2011-October 2011), before and after the implementation of an IPT register used by routine clinic personnel. Results: Adult TB case demographic and clinical characteristics from the two observation periods were similar. During the post-register period, more child contacts per adult case were identified (0.7 (54 children) vs. 0.3 (24 children)), more of the identified children were started on IPT (54 vs. 4) and 37% of those who started, completed six months of treatment compared to the pre-register period where no adherence information was recorded. Conclusions: After pilot implementation of an IPT register, documented identification of child contacts, IPT initiation and IPT adherence documentation in TB exposed children was improved. Our findings support further exploration of the potential impact of using standardised IPT recording and reporting in routine clinics in high-burden TB settings to improve TB prevention efforts targeted at young children. Future efforts to improve IPT delivery should be systematic and comprehensive in order to support a change in current operational IPT delivery practices in TB programs.	[van Soelen, Nelda; du Preez, Karen; van Wyk, Susan S.; Mandalakas, Anna M.; Enarson, Don A.; Hesseling, Anneke C.] Univ Stellenbosch, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Cape Town, Western Cape, South Africa; [Mandalakas, Anna M.] Baylor Coll Med, Dept Pediat, Sect Retrovirol & Global Hlth, Houston, TX 77030 USA; [Mandalakas, Anna M.] Texas Childrens Hosp, TB Initiat, Houston, TX 77030 USA; [Enarson, Don A.] Int Union TB & Lung Dis, Paris, France; [Reid, Anthony J.] Medecins Sans Frontieres Operat Ctr Brussels, Operat Res Unit, Luxembourg, Luxembourg	Stellenbosch University; Baylor College of Medicine; Baylor College of Medicine	van Soelen, N (corresponding author), Univ Stellenbosch, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Cape Town, Western Cape, South Africa.	neldavs@mweb.co.za			Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, France; Operational Research Unit, Medecins sans Frontieres, Brussels-Luxembourg; Center for International Health, University of Bergen; Department for International Development, UK; I-CATCH grant	Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, France; Operational Research Unit, Medecins sans Frontieres, Brussels-Luxembourg; Center for International Health, University of Bergen; Department for International Development, UK; I-CATCH grant	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, France, and the Operational Research Unit, Medecins sans Frontieres, Brussels-Luxembourg. Additional support for running the course was provided by the Center for International Health, University of Bergen. Funding for the course was from an anonymous donor and the Department for International Development, UK. NVS was also supported as an operational research fellow from the Centre for Operational Research during this period, and the project accessed funding through an I-CATCH grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claessens NJM, 2002, INT J TUBERC LUNG D, V6, P362; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Kruk A, 2008, PEDIATRICS, V121, pE1646, DOI 10.1542/peds.2007-3138; Mandalakas AM, 2013, THORAX, V68, P247, DOI 10.1136/thoraxjnl-2011-200933; Rekha B, 2013, INT J TUBERC LUNG D, V17, P163, DOI 10.5588/ijtld.12.0415; Skinner D, 2013, INT J TUBERC LUNG D, V17, P175, DOI 10.5588/ijtld.12.0230; Smieja M, 2010, ISONIAZID PREVENTING; The National Department of Health, 2009, NAT TUB MAN GUID, P117; Van Wyk SS, 2010, INT J TUBERC LUNG D, V14, P650; van Wyk SS, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-544; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; WHO, 2007, INT J TUBERC LUNG D, V11, P12; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zachariah R, 2003, INT J TUBERC LUNG D, V7, P1033	14	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e80803	10.1371/journal.pone.0080803	http://dx.doi.org/10.1371/journal.pone.0080803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339884	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400007
J	Ghirardi, A; Scotti, L; Zambon, A; Della Vedova, G; D'oro, LC; Lapi, F; Cipriani, F; Caputi, AP; Vaccheri, A; Gregori, D; Gesuita, R; Vestri, A; Staniscia, T; Mazzaglia, G; Corrao, G				Ghirardi, Arianna; Scotti, Lorenza; Zambon, Antonella; Della Vedova, Gianluca; D'oro, Luca Cavalieri; Lapi, Francesco; Cipriani, Francesco; Caputi, Achille P.; Vaccheri, Alberto; Gregori, Dario; Gesuita, Rosaria; Vestri, Annarita; Staniscia, Tommaso; Mazzaglia, Giampiero; Corrao, Giovanni		BEST Investigators	Risk of Severe Upper Gastrointestinal Complications among Oral Bisphosphonate Users	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; SEROTONIN REUPTAKE INHIBITORS; BONE-MINERAL DENSITY; VERTEBRAL FRACTURES; RANDOMIZED-TRIAL; PEPTIC-ULCER; POSTMENOPAUSAL OSTEOPOROSIS; RISEDRONATE TREATMENT; GASTRODUODENAL ULCER; ETIDRONATE THERAPY	Background: Oral bisphosphonates (BPs) are the primary agents for the treatment of osteoporosis. Although BPs are generally well tolerated, serious gastrointestinal adverse events have been observed. Aim: To assess the risk of severe upper gastrointestinal complications (UGIC) among BP users by means of a large study based on a network of Italian healthcare utilization databases. Methods: A nested case-control study was carried out by including 110,220 patients aged 45 years or older who, from 2003 until 2005, were treated with oral BPs. Cases were the 862 patients who experienced the outcome (hospitalization for UGIC) until 2007. Up to 20 controls were randomly selected for each case. Conditional logistic regression model was used to estimate odds ratio (OR) associated with current use of BPs after adjusting for several covariates. A set of sensitivity analyses was performed in order to account for sources of systematic uncertainty. Results: The adjusted OR for current use of BPs with respect to past use was 0.94 (95% Cl 0.81 to 1.08). There was no evidence that this risk changed either with BP type and regimen, or concurrent use of other drugs or previous hospitalizations. Conclusions: No evidence was found that current use of BPs increases the risk of severe upper gastrointestinal complications compared to past use.	[Ghirardi, Arianna; Scotti, Lorenza; Zambon, Antonella; Corrao, Giovanni] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Div Biostat Epidemiol & Publ Hlth, Milan, Italy; [Della Vedova, Gianluca] Univ Milano Bicocca, Dept Informat Syst & Commun, Milan, Italy; [D'oro, Luca Cavalieri] Local Hlth Unit Monza, Operat Unit Epidemiol, Monza, Italy; [Lapi, Francesco; Cipriani, Francesco; Mazzaglia, Giampiero] Reg Agcy Healthcare Serv Tuscany, Dept Epidemiol, Florence, Italy; [Lapi, Francesco] Univ Florence, Dept Preclin & Clin Pharmacol, Florence, Italy; [Lapi, Francesco] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada; [Caputi, Achille P.] Univ Messina, Dept Med & Pharmacol, Messina, Italy; [Vaccheri, Alberto] Univ Bologna, Dept Pharmacol, Reg Ctr Drug Evaluat & Informat CREVIF, Bologna, Italy; [Gregori, Dario] Univ Turin, Dept Publ Hlth & Microbiol, Turin, Italy; [Gesuita, Rosaria] Polytech Univ Marche, Ctr Epidemiol Biostat & Med Informat Technol, Ancona, Italy; [Vestri, Annarita] Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00185 Rome, Italy; [Staniscia, Tommaso] Univ G DAnnunzio, Dept Med & Aging, Chieti, Italy	University of Milano-Bicocca; University of Milano-Bicocca; University of Florence; McGill University; University of Messina; University of Bologna; University of Turin; Marche Polytechnic University; Sapienza University Rome; G d'Annunzio University of Chieti-Pescara	Corrao, G (corresponding author), Univ Milano Bicocca, Dept Stat & Quantitat Methods, Div Biostat Epidemiol & Publ Hlth, Milan, Italy.	giovanni.corrao@unimib.it	Valenti, Marco/F-4818-2015; Scotti, Lorenza/AAB-9544-2019; Della Vedova, Gianluca/AAW-1572-2021; Gesuita, Rosaria/AAU-8863-2020; Gregori, Dario/F-9974-2012	Valenti, Marco/0000-0001-9043-3456; Scotti, Lorenza/0000-0002-3861-9058; Della Vedova, Gianluca/0000-0001-5584-3089; Gregori, Dario/0000-0001-7906-0580; Zambon, Antonella/0000-0001-6443-3858; Cavalieri d'Oro, Luca/0000-0001-7713-1293; Mazzaglia, Giampiero/0000-0003-4933-2148	AIFA - the Italian Medicines Agency (AIFA), Rome, Italy [FARM06R9YY]; Italian Minister for University and Research ('Fondo d'Ateneo per la Ricerca' portion)	AIFA - the Italian Medicines Agency (AIFA), Rome, Italy; Italian Minister for University and Research ('Fondo d'Ateneo per la Ricerca' portion)	This study was almost entirely funded by a research grant from the AIFA - the Italian Medicines Agency (AIFA grant FARM06R9YY), Rome, Italy. Data analyses were performed at the Unit of Biostatistics, Epidemiology and Public Health, Dept. of Statistics and Quantitative Methods, University of Milano-Bicocca with grants from the Italian Minister for University and Research ('Fondo d'Ateneo per la Ricerca' portion, year 2010). No additional external funding received for this study. The fundcrs had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, FED INF PROC STAND P; Bauer DC, 2000, ARCH INTERN MED, V160, P517, DOI 10.1001/archinte.160.4.517; Bjorkhem-Bergman L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010702; Black DM, 1996, LANCET, V348, P1535, DOI 10.1016/S0140-6736(96)07088-2; BOLLINI P, 1992, ARCH INTERN MED, V152, P1289, DOI 10.1001/archinte.152.6.1289; Brumsen C, 2002, J BONE MINER RES, V17, P1057, DOI 10.1359/jbmr.2002.17.6.1057; Cadarette SM, 2009, OSTEOPOROSIS INT, V20, P1735, DOI 10.1007/s00198-009-0871-8; Cattaruzzi C, 1999, J CLIN EPIDEMIOL, V52, P499, DOI 10.1016/S0895-4356(99)00004-9; Chan KM, 2003, B WORLD HEALTH ORGAN, V81, P827; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Coloma PM, 2011, PHARMACOEPIDEM DR S, V20, P1, DOI 10.1002/pds.2053; Cryer B, 2002, MAYO CLIN PROC, V77, P1031, DOI 10.4065/77.10.1031; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Dalton SO, 2003, ARCH INTERN MED, V163, P59, DOI 10.1001/archinte.163.1.59; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Donahue JG, 2002, ARCH INTERN MED, V162, P936, DOI 10.1001/archinte.162.8.936; Etminan M, 2009, ALIMENT PHARM THER, V29, P1188, DOI 10.1111/j.1365-2036.2009.03989.x; Rodriguez LAG, 2011, CIRCULATION, V123, P1108, DOI 10.1161/CIRCULATIONAHA.110.973008; Graham DY, 2002, DIGEST DIS SCI, V47, P1665, DOI 10.1023/A:1016495221567; Harris ST, 1999, JAMA-J AM MED ASSOC, V282, P1344, DOI 10.1001/jama.282.14.1344; HAWKEY CJ, 1990, BMJ-BRIT MED J, V300, P278, DOI 10.1136/bmj.300.6720.278; Henry D, 1996, BRIT MED J, V312, P1563, DOI 10.1136/bmj.312.7046.1563; Hernandez-Diaz S, 2000, ARCH INTERN MED, V160, P2093, DOI 10.1001/archinte.160.14.2093; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Laporte JR, 2004, DRUG SAFETY, V27, P411, DOI 10.2165/00002018-200427060-00005; Lees B, 1996, OSTEOPOROSIS INT, V6, P480, DOI 10.1007/BF01629581; Legault C, 1996, STROKE, V27, P593, DOI 10.1161/01.STR.27.4.593; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; McClung MR, 2004, J BONE MINER RES, V19, P11, DOI 10.1359/JBMR.0301202; Miller RG, 2004, AM J MANAG CARE, V10, pS207; Miyake K, 2009, J GASTROENTEROL, V44, P113, DOI 10.1007/s00535-008-2278-2; Mortensen L, 1998, J CLIN ENDOCR METAB, V83, P396, DOI 10.1210/jc.83.2.396; Ninkovic M, 2002, J HEPATOL, V37, P93, DOI 10.1016/S0168-8278(02)00100-9; Pols HAP, 1999, OSTEOPOROSIS INT, V9, P461, DOI 10.1007/PL00004171; Ramakrishnan K, 2007, AM FAM PHYSICIAN, V76, P1005; Reginster JY, 2000, OSTEOPOROSIS INT, V11, P83, DOI 10.1007/s001980050010; REID IR, 1988, LANCET, V1, P143; REID IR, 1994, J CLIN ENDOCR METAB, V79, P1595, DOI 10.1210/jc.79.6.1595; Rodriguez LAG, 1998, ARCH INTERN MED, V158, P33, DOI 10.1001/archinte.158.1.33; Ryan PJ, 2000, OSTEOPOROSIS INT, V11, P171, DOI 10.1007/PL00004179; Sato Y, 2000, J BONE MINER RES, V15, P2487, DOI 10.1359/jbmr.2000.15.12.2487; Sato Y, 2004, AM J PHYS MED REHAB, V83, P298, DOI 10.1097/01.PHM.0000122877.28631.23; Schelleman H, 2010, AM J MED, V123, P151, DOI 10.1016/j.amjmed.2009.07.020; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P219; Suissa S, 2008, AM J EPIDEMIOL, V168, P329, DOI 10.1093/aje/kwn135; Taggart H, 2002, MAYO CLIN PROC, V77, P262, DOI 10.4065/77.3.262; Tamim H, 2007, PHARMACOEPIDEM DR S, V16, P250, DOI 10.1002/pds.1360; Tata LJ, 2005, ALIMENT PHARM THERAP, V22, P175, DOI 10.1111/j.1365-2036.2005.02543.x; Tonino RP, 2000, J CLIN ENDOCR METAB, V85, P3109, DOI 10.1210/jc.85.9.3109; Udd M, 2007, SCAND J GASTROENTERO, V42, P1395, DOI 10.1080/00365520701478758; van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8; Wallach S, 2000, CALCIFIED TISSUE INT, V67, P277, DOI 10.1007/s002230001146; Weil J, 2000, GUT, V46, P27, DOI 10.1136/gut.46.1.27; Yamaguchi T, 2005, J BONE MINER METAB, V23, P36, DOI 10.1007/s00774-004-0538-7; Zullo A, 2007, DRUG AGING, V24, P815, DOI 10.2165/00002512-200724100-00003	59	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e73159	10.1371/journal.pone.0073159	http://dx.doi.org/10.1371/journal.pone.0073159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24348985	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200001
J	Massaro, M; Sainudiin, R; Merton, D; Briskie, JV; Poole, AM; Hale, ML				Massaro, Melanie; Sainudiin, Raazesh; Merton, Don; Briskie, James V.; Poole, Anthony M.; Hale, Marie L.			Human-Assisted Spread of a Maladaptive Behavior in a Critically Endangered Bird	PLOS ONE			English	Article							EVOLUTION; POPULATIONS; CONSERVATION; HARVEST; EXTINCTION; ABUNDANCE; SELECTION; HISTORY; DRIVEN	Conservation management often focuses on counteracting the adverse effects of human activities on threatened populations. However, conservation measures may unintentionally relax selection by allowing the survival of the not-so-fit, increasing the risk of fixation of maladaptive traits. Here, we report such a case in the critically-endangered Chatham Island black robin (Petroica traversi) which, in 1980, was reduced to a single breeding pair. Following this bottleneck, some females were observed to lay eggs on the rims of their nests. Rim eggs left in place always failed to hatch. To expedite population recovery, rim eggs were repositioned inside nests, yielding viable hatchlings. Repositioning resulted in rapid growth of the black robin population, but by 1989 over 50% of all females were laying rim eggs. We used an exceptional, species-wide pedigree to consider both recessive and dominant models of inheritance over all plausible founder genotype combinations at a biallelic and possibly sex-linked locus. The pattern of rim laying is best fitted as an autosomal dominant Mendelian trait. Using a phenotype permutation test we could also reject the null hypothesis of non-heritability for this trait in favour of our best-fitting model of heritability. Data collected after intervention ceased shows that the frequency of rim laying has strongly declined, and that this trait is maladaptive. This episode yields an important lesson for conservation biology: fixation of maladaptive traits could render small threatened populations completely dependent on humans for reproduction, irreversibly compromising the long term viability of populations humanity seeks to conserve.	[Massaro, Melanie] Charles Sturt Univ, Sch Environm Sci, Albury, NSW, Australia; [Sainudiin, Raazesh] Univ Canterbury, Dept Math & Stat, Christchurch 1, New Zealand; [Merton, Don] Dept Conservat, Natl Off, Wellington, New Zealand; [Briskie, James V.; Poole, Anthony M.; Hale, Marie L.] Univ Canterbury, Sch Biol Sci, Christchurch 1, New Zealand	Charles Sturt University; University of Canterbury; University of Canterbury	Massaro, M (corresponding author), Charles Sturt Univ, Sch Environm Sci, Albury, NSW, Australia.	mmassaro@csu.edu.au	Massaro, Melanie/P-4791-2017	Massaro, Melanie/0000-0001-9039-1268; Poole, Anthony/0000-0001-9940-2824	New Zealand Foundation for Research, Science and Technology fellowship [UOCX0601]; School of Biological Sciences, University of Canterbury; Brian Mason Scientific and Technical Trust; Royal Society of New Zealand Rutherford Discovery Fellowship; Royal Swedish Academy of Sciences through a grant from the Knut and Alice Wallenberg Foundation; Research Chair in Mathematical Models of Biodiversity; French National Museum of Natural History; Centre for Mathematics and its Applications, Ecole Polytechnique, Palaiseau, France	New Zealand Foundation for Research, Science and Technology fellowship(New Zealand Foundation for Research, Science and Technology); School of Biological Sciences, University of Canterbury; Brian Mason Scientific and Technical Trust; Royal Society of New Zealand Rutherford Discovery Fellowship(Royal Society of New Zealand); Royal Swedish Academy of Sciences through a grant from the Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Research Chair in Mathematical Models of Biodiversity; French National Museum of Natural History; Centre for Mathematics and its Applications, Ecole Polytechnique, Palaiseau, France	Research in 2007-09 was funded by a New Zealand Foundation for Research, Science and Technology fellowship (UOCX0601) to MM. Research in 2010 was supported by the School of Biological Sciences, University of Canterbury and in 2011 by a grant from the Brian Mason Scientific and Technical Trust. AMP is supported by a Royal Society of New Zealand Rutherford Discovery Fellowship, and acknowledges past support of the Royal Swedish Academy of Sciences through a grant from the Knut and Alice Wallenberg Foundation. RS is supported by a Research Chair in Mathematical Models of Biodiversity held by Veolia Environment, the French National Museum of Natural History and Centre for Mathematics and its Applications, Ecole Polytechnique, Palaiseau, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2008, TRENDS ECOL EVOL, V23, P327, DOI 10.1016/j.tree.2008.02.008; Allendorf FW, 2009, P NATL ACAD SCI USA, V106, P9987, DOI 10.1073/pnas.0901069106; Anderson CNK, 2008, NATURE, V452, P835, DOI 10.1038/nature06851; Bates D., 2009, LME4 LINEAR MIXED EF; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Butler D., 1992, BLACK ROBIN SAVING W; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Doucet A., 2009, HDB NONLINEAR FILTER, V12, P656; Edeline E, 2007, P NATL ACAD SCI USA, V104, P15799, DOI 10.1073/pnas.0705908104; Ellegren H, 2000, TRENDS ECOL EVOL, V15, P188, DOI 10.1016/S0169-5347(00)01821-8; FLEMING C. A., 1939, EMU, V38, P380; GARBE J. R., 2008, PEDIGRAPH USER MANUA; Goldsmith MR, 2005, ANNU REV ENTOMOL, V50, P71, DOI 10.1146/annurev.ento.50.071803.130456; Hamilton WD, 2001, HOSP COMING NARROW R; Hasstedt SJ, 2005, GENET EPIDEMIOL, V29, P255; Hearn Lafcadio, 1899, GHOSTLY JAPAN; Hendry AP, 2006, P R SOC B, V273, P1887, DOI 10.1098/rspb.2006.3534; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; HUBBELL S, 2001, SHRINKING CAT GENETI; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Koskinen MT, 2002, NATURE, V419, P826, DOI 10.1038/nature01029; LAIKRE L, 1993, CONSERV BIOL, V7, P592, DOI 10.1046/j.1523-1739.1993.07030592.x; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; LANDE R, 1995, CONSERV BIOL, V9, P782, DOI 10.1046/j.1523-1739.1995.09040782.x; Lynch M, 2001, CONSERV GENET, V2, P363, DOI 10.1023/A:1012550620717; Millener PR, 1999, SM C PALEOB, P85; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; R Development Core Team, 2012, R LANG ENV STAT COMP; STEIN W. A., 2022, SAGE MATH SOFTWARE V; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Tennyson A. J. D., 1994, Notornis, V41, P165	31	18	18	1	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e79066	10.1371/journal.pone.0079066	http://dx.doi.org/10.1371/journal.pone.0079066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24348992	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200005
J	Bachasson, D; Wuyam, B; Pepin, JL; Tamisier, R; Levy, P; Verges, S				Bachasson, Damien; Wuyam, Bernard; Pepin, Jean-Louis; Tamisier, Renaud; Levy, Patrick; Verges, Samuel			Quadriceps and Respiratory Muscle Fatigue Following High-Intensity Cycling in COPD Patients	PLOS ONE			English	Article							DIAPHRAGMATIC FATIGUE; ABDOMINAL-MUSCLE; SYMPTOM LIMITATION; EXERCISE; HYPERINFLATION; CONTRACTILITY; ACTIVATION; ENDURANCE; DYSPNEA	Exercise intolerance in COPD seems to combine abnormal ventilatory mechanics, impaired O-2 transport and skeletal muscle dysfunction. However their relatie contribution and their influence on symptoms reported by patients remain to be clarified. In order to clarify the complex interaction between ventilatory and neuromuscular exercise limiting factors and symptoms, we evaluated respiratory muscles and quadriceps contractile fatigue, dynamic hyperinflation and symptoms induced by exhaustive high-intensity cycling in COPD patients. Fifteen gold II-III COPD patients (age = 67 +/- 6 yr; BMI = 26.6 +/- 4.2 kg. m(-2)) performed constant-load cycling test at 80% of their peak workload until exhaustion (9.3 +/- 2.4 min). Before exercise and at exhaustion, potentiated twitch quadriceps strength (Q(tw)), transdiaphragmatic (P-di,P-tw) and gastric (P-ga,P-tw) pressures were evoked by femoral nerve, cervical and thoracic magnetic stimulation, respectively. Changes in operational lung volumes during exercise were assessed via repetitive inspiratory capacity (IC) measurements. Dyspnoea and leg discomfort were measured on visual analog scale. At exhaustion, Q(tw) (-33 +/- 15%, > 15% reduction observed in all patients but two) and P-di,P-tw (-20 +/- 15%, > 15% reduction in 6 patients) were significantly reduced (P<0.05) but not P-ga,P-tw (-6 +/- 10%, > 15% reduction in 3 patients). Percentage reduction in Q(tw) correlated with the percentage reduction in P-di,P-tw (r=0.66; P<0.05). Percentage reductions in P-di,P-tw and P-ga,P-tw negatively correlated with the reduction in IC at exhaustion (r=-0.56 and r=-0.62, respectively; P<0.05). Neither dyspnea nor leg discomfort correlated with the amount of muscle fatigue. In conclusion, high-intensity exercise induces quadriceps, diaphragm and less frequently abdominal contractile fatigue in this group of COPD patients. In addition, the rise in end-expiratory lung volume and diaphragm flattening associated with dynamic hyperinflation in COPD might limit the development of abdominal and diaphragm muscle fatigue. This study underlines that both respiratory and quadriceps fatigue should be considered to understand the complex interplay of factors leading to exercise intolerance in COPD patients.	[Bachasson, Damien; Wuyam, Bernard; Pepin, Jean-Louis; Tamisier, Renaud; Levy, Patrick; Verges, Samuel] Grenoble Alpes Univ, Lab HP2, Grenoble, France; [Bachasson, Damien; Wuyam, Bernard; Pepin, Jean-Louis; Tamisier, Renaud; Levy, Patrick; Verges, Samuel] INSERM, U1042, Grenoble, France; [Bachasson, Damien; Wuyam, Bernard; Pepin, Jean-Louis; Tamisier, Renaud; Levy, Patrick] CHU Grenoble, Grenoble Locomotor Unit, F-38043 Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Verges, S (corresponding author), Grenoble Alpes Univ, Lab HP2, Grenoble, France.	sverges@chu-grenoble.fr	Tamisier, Renaud/M-6858-2014; Bachasson, Damien/ABC-1705-2020; Verges, Samuel/M-7040-2014; Bachasson, Damien/U-4233-2019; LEVY, Patrick/AAX-2802-2020; PEPIN, Jean-Louis/M-6549-2014; Lévy, Patrick/M-6903-2014; wuyam, bernard MF/M-7438-2014	Tamisier, Renaud/0000-0003-1128-6529; Bachasson, Damien/0000-0001-6335-9916; Verges, Samuel/0000-0002-0831-9222; LEVY, Patrick/0000-0003-3174-7935; Lévy, Patrick/0000-0003-3632-1327; Pepin, Jean Louis/0000-0003-3832-2358	scientific council of the association AGIRadom; Societe Pneumologie de Langue Francaise; Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche; French Association for Muscle Dystrophy	scientific council of the association AGIRadom; Societe Pneumologie de Langue Francaise; Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche; French Association for Muscle Dystrophy	The authors thank the scientific council of the association AGIRadom, the Societe Pneumologie de Langue Francaise and the Association Nationale pour les Traitements A Domicile, les Innovations et la Recherche for financial support. DB received a Ph.D. fellowship from the French Association for Muscle Dystrophy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham KA, 2002, J PHYSIOL-LONDON, V541, P653, DOI 10.1113/jphysiol.2001.013462; Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Amann M, 2010, AM J PHYSIOL-REG I, V299, pR314, DOI 10.1152/ajpregu.00183.2010; Bachasson D, 2013, J ELECTROMYOGR KINES, V23, P649, DOI 10.1016/j.jelekin.2012.11.011; Butcher SJ, 2009, EUR RESPIR J, V33, P763, DOI 10.1183/09031936.00014708; Caron MA, 2009, J APPL PHYSIOL, V107, P952, DOI 10.1152/japplphysiol.00194.2009; Decorte N, 2012, SCAND J MED SCI SPOR, V22, P381, DOI 10.1111/j.1600-0838.2010.01167.x; Deschenes D, 2008, J CARDIOPULM REHABIL, V28, P208, DOI 10.1097/01.HCR.0000320074.73846.3b; DeTroyer A, 1997, EUR RESPIR J, V10, P708; Elia D, 2013, RESPIRATION, V85, P220, DOI 10.1159/000338787; FITCH S, 1985, J PHYSIOL-LONDON, V362, P205, DOI 10.1113/jphysiol.1985.sp015671; Froyd C, 2013, J PHYSIOL-LONDON, V591, P1339, DOI 10.1113/jphysiol.2012.245316; Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2018, GLOBAL STRATEGY DIAG; Gosselink R, 2000, J Cardiopulm Rehabil, V20, P353, DOI 10.1097/00008483-200011000-00004; Guenette JA, 2012, EUR RESPIR J, V40, P322, DOI 10.1183/09031936.00157711; HAMNEGARD CH, 1995, EUR RESPIR J, V8, P1532; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hopkinson NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-15; JOHNSON BD, 1993, J PHYSIOL-LONDON, V460, P385, DOI 10.1113/jphysiol.1993.sp019477; KILLIAN KJ, 1992, AM REV RESPIR DIS, V146, P935, DOI 10.1164/ajrccm/146.4.935; Kufel TJ, 2002, MUSCLE NERVE, V25, P438, DOI 10.1002/mus.10047; Laghi F, 1998, J APPL PHYSIOL, V85, P1103, DOI 10.1152/jappl.1998.85.3.1103; Mador MJ, 2000, AM J RESP CRIT CARE, V161, P118; MADOR MJ, 1991, AM REV RESPIR DIS, V143, P462, DOI 10.1164/ajrccm/143.3.462; Mador MJ, 2003, CHEST, V123, P1104, DOI 10.1378/chest.123.4.1104; MADOR MJ, 1994, AM J RESP CRIT CARE, V149, P739, DOI 10.1164/ajrccm.149.3.8118645; MADOR MJ, 1993, AM REV RESPIR DIS, V148, P1571, DOI 10.1164/ajrccm/148.6_Pt_1.1571; Man WDC, 2005, THORAX, V60, P718, DOI 10.1136/thx.2005.040709; McKenzie DK, 2009, J APPL PHYSIOL, V107, P621, DOI 10.1152/japplphysiol.00163.2009; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Donnell DE, 2009, RESP PHYSIOL NEUROBI, V167, P116, DOI 10.1016/j.resp.2009.01.010; O'Donnell DE, 2008, J APPL PHYSIOL, V105, P753, DOI 10.1152/japplphysiol.90336.2008b; Orozco-Levi M, 1999, EUR RESPIR J, V13, P371, DOI 10.1183/09031936.99.13237199; Orozco-Levi M, 2001, AM J RESP CRIT CARE, V164, P1734, DOI 10.1164/ajrccm.164.9.2011150; Ottenheijm CAC, 2006, AM J RESP CRIT CARE, V173, P527, DOI 10.1164/rccm.200507-1056OC; POLKEY MI, 1995, AM J RESP CRIT CARE, V152, P959, DOI 10.1164/ajrccm.152.3.7663810; Saey D, 2003, AM J RESP CRIT CARE, V168, P425, DOI 10.1164/rccm.200208-856OC; Saey D, 2005, AM J RESP CRIT CARE, V171, P1109, DOI 10.1164/rccm.200408-1005OC; SIMILOWSKI T, 1989, J APPL PHYSIOL, V67, P1311, DOI 10.1152/jappl.1989.67.4.1311; van den Borst B, 2013, J APPL PHYSIOL, V114, P1319, DOI 10.1152/japplphysiol.00508.2012; Verges S, 2007, EUR J APPL PHYSIOL, V101, P225, DOI 10.1007/s00421-007-0491-y; Verges S, 2007, AM J PHYSIOL-REG I, V292, pR1246, DOI 10.1152/ajpregu.00409.2006; Verges S, 2006, MUSCLE NERVE, V34, P423, DOI 10.1002/mus.20599; Verges S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-109; Verges S, 2009, J APPL PHYSIOL, V106, P701, DOI 10.1152/japplphysiol.01051.2007; Walker DJ, 2011, RESP PHYSIOL NEUROBI, V176, P14, DOI 10.1016/j.resp.2011.01.009	46	23	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e83432	10.1371/journal.pone.0083432	http://dx.doi.org/10.1371/journal.pone.0083432			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324843	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566700123
J	Nakamura, Y; Ishii, J; Kondo, A				Nakamura, Yasuyuki; Ishii, Jun; Kondo, Akihiko			Bright Fluorescence Monitoring System UtilizingZoanthus sp Green Fluorescent Protein (ZsGreen) for Human G-Protein-Coupled Receptor Signaling in Microbial Yeast Cells	PLOS ONE			English	Article							CLONED SOMATOSTATIN RECEPTORS; SURFACE DISPLAY; GENETIC IMMOBILIZATION; NEUROTENSIN BINDING; NEUROMEDIN-N; IDENTIFICATION; PEPTIDE; EXPRESSION; AGONISTS; TRANSDUCTION	G-protein-coupled receptors (GPCRs) are currently the most important pharmaceutical targets for drug discovery because they regulate a wide variety of physiological processes. Consequently, simple and convenient detection systems for ligands that regulate the function of GPCR have attracted attention as powerful tools for new drug development. We previously developed a yeast-based fluorescence reporter ligand detection system using flow cytometry. However, using this conventional detection system, fluorescence from a cell expressing GFP and responding to a ligand is weak, making detection of these cells by fluorescence microscopy difficult. We here report improvements to the conventional yeast fluorescence reporter assay system resulting in the development of a new highly-sensitive fluorescence reporter assay system with extremely bright fluorescence and high signal-to-noise (S/N) ratio. This new system allowed the easy detection of GPCR signaling in yeast using fluorescence microscopy. Somatostatin receptor and neurotensin receptor (implicated in Alzheimer's disease and Parkinson's disease, respectively) were chosen as human GPCR(s). The facile detection of binding to these receptors by cognate peptide ligands was demonstrated. In addition, we established a highly sensitive ligand detection system using yeast cell surface display technology that is applicable to peptide screening, and demonstrate that the display of various peptide analogs of neurotensin can activate signaling through the neurotensin receptor in yeast cells. Our system could be useful for identifying lead peptides with agonistic activity towards targeted human GPCR(s).	[Nakamura, Yasuyuki; Kondo, Akihiko] Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Kobe, Hyogo 657, Japan; [Ishii, Jun] Kobe Univ, Org Adv Sci & Technol, Kobe, Hyogo 657, Japan	Kobe University; Kobe University	Kondo, A (corresponding author), Kobe Univ, Dept Chem Sci & Engn, Grad Sch Engn, Kobe, Hyogo 657, Japan.	akondo@kobe-u.ac.jp	Ishii, Jun/D-7670-2016; Kondo, Akihiko/A-2130-2015	Ishii, Jun/0000-0003-2568-515X; Nakamura, Yasuyuki/0000-0002-0093-3754	Japan Society for the Promotion of Science; Naito Foundation; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Research Fellowship for Young Scientists from the Japan Society for the Promotion of Science, the Naito Foundation, and Special Coordination Funds for Promoting Science and Technology, Creation of Innovation Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe; iBioK) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2006, NAT METHODS, V3, P609, DOI 10.1038/NMETH899; Akada R, 2006, YEAST, V23, P399, DOI 10.1002/yea.1365; Barroso S, 2000, J BIOL CHEM, V275, P328, DOI 10.1074/jbc.275.1.328; Ben-Shlomo A, 2008, MOL CELL ENDOCRINOL, V286, P192, DOI 10.1016/j.mce.2007.11.024; BISSETTE G, 1976, NATURE, V262, P607, DOI 10.1038/262607a0; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Brachmann CB, 1998, YEAST, V14, P115; Brown AJ, 2000, YEAST, V16, P11, DOI 10.1002/(SICI)1097-0061(20000115)16:1<11::AID-YEA502>3.0.CO;2-K; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Carraway RE, 2006, PEPTIDES, V27, P2445, DOI 10.1016/j.peptides.2006.04.030; Chalon P, 1996, FEBS LETT, V386, P91, DOI 10.1016/0014-5793(96)00397-3; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; ELION EA, 1993, MOL BIOL CELL, V4, P495, DOI 10.1091/mbc.4.5.495; Evans BJ, 2009, METHOD ENZYMOL, V460, P399, DOI 10.1016/S0076-6879(09)05220-3; Feldhaus MJ, 2003, NAT BIOTECHNOL, V21, P163, DOI 10.1038/nbt785; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukuda N, 2007, APPL MICROBIOL BIOT, V76, P151, DOI 10.1007/s00253-007-0977-x; Fukuda N, 2011, ANAL BIOCHEM, V417, P182, DOI 10.1016/j.ab.2011.06.006; Fukutani Y, 2012, BIOTECHNOL BIOENG, V109, P205, DOI 10.1002/bit.23327; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GRANIER C, 1982, EUR J BIOCHEM, V124, P117, DOI 10.1111/j.1432-1033.1982.tb05913.x; Griebel G, 2012, NAT REV DRUG DISCOV, V11, P462, DOI 10.1038/nrd3702; GUDERMANN T, 1995, J MOL MED, V73, P51, DOI 10.1007/BF00270578; Hara K, 2012, J BIOCHEM, V151, P551, DOI 10.1093/jb/mvs027; Hasegawa S, 2009, P NATL ACAD SCI USA, V106, P13832, DOI 10.1073/pnas.0903999106; Iguchi Y, 2010, J BIOCHEM, V147, P875, DOI 10.1093/jb/mvq023; ISHII J, 2013, ANAL BIOCH IN PRESS, DOI DOI 10.1016/J.AB.2013.10.016.IN; Ishii J, 2008, J BIOCHEM, V143, P667, DOI 10.1093/jb/mvn018; Ishii J, 2006, BIOTECHNOL PROGR, V22, P954, DOI 10.1021/bp0601387; Ishii J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037136; Ishii J, 2012, ANAL BIOCHEM, V426, P129, DOI 10.1016/j.ab.2012.04.012; Ishii J, 2010, FEBS J, V277, P1982, DOI 10.1111/j.1742-4658.2010.07625.x; Ishii J, 2009, J BIOCHEM, V145, P701, DOI 10.1093/jb/mvp028; KISLAUSKIS E, 1988, J BIOL CHEM, V263, P4963; Kitabgi P, 2002, CURR OPIN DRUG DI DE, V5, P764; Klein C, 1998, NAT BIOTECHNOL, V16, P1334, DOI 10.1038/4310; Kondo A, 2004, APPL MICROBIOL BIOT, V64, P28, DOI 10.1007/s00253-003-1492-3; Ladds G, 2005, TRENDS BIOTECHNOL, V23, P367, DOI 10.1016/j.tibtech.2005.05.007; LAMBERTS SWJ, 1994, J CLIN ENDOCR METAB, V78, P17, DOI 10.1210/jc.78.1.17; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Mazella J, 2001, CELL SIGNAL, V13, P1, DOI 10.1016/S0898-6568(00)00130-3; Medico E, 2001, NAT BIOTECHNOL, V19, P579, DOI 10.1038/89343; MINAMINO N, 1984, BIOCHEM BIOPH RES CO, V122, P542, DOI 10.1016/S0006-291X(84)80067-4; Murai T, 1997, APPL MICROBIOL BIOT, V48, P499, DOI 10.1007/s002530051086; Nakamura Y, 2001, APPL MICROBIOL BIOT, V57, P500; NAKAMURA Y, 2013, BIOTECHNOL IN PRESS, DOI DOI 10.1002/BIT.25125.IN; Nakamura Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066793; Pepper LR, 2008, COMB CHEM HIGH T SCR, V11, P127; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; RAYNOR K, 1993, MOL PHARMACOL, V44, P385; RAYNOR K, 1993, MOL PHARMACOL, V43, P838; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Sato N, 2002, APPL MICROBIOL BIOT, V60, P469, DOI 10.1007/s00253-002-1121-6; Schimpff RM, 2001, J NEUROL NEUROSUR PS, V70, P784, DOI 10.1136/jnnp.70.6.784; Shibasaki S, 2009, ANAL SCI, V25, P41, DOI 10.2116/analsci.25.41; Stoeckius M, 2009, NAT METHODS, V6, P745, DOI [10.1038/nmeth.1370, 10.1038/NMETH.1370]; TANAKA K, 1990, NEURON, V4, P847, DOI 10.1016/0896-6273(90)90137-5; Togawa S, 2010, J BIOCHEM, V147, P867, DOI 10.1093/jb/mvq022; Ueda M, 2000, BIOTECHNOL ADV, V18, P121, DOI 10.1016/S0734-9750(00)00031-8; Wan CK, 2012, ANAL BIOCHEM, V431, P90, DOI 10.1016/j.ab.2012.08.016; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Yu L, 2008, MOL BIOL CELL, V19, P1739, DOI 10.1091/mbc.E07-08-0757; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	65	20	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82237	10.1371/journal.pone.0082237	http://dx.doi.org/10.1371/journal.pone.0082237			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340008	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100092
J	Pazienza, V; la Torre, A; Baorda, F; Alfarano, M; Chetta, M; Muscarella, LA; Battista, C; Copetti, M; Kotzot, D; Kapelari, K; Al-Abdulrazzaq, D; Perlman, K; Sochett, E; Cole, DEC; Pellegrini, F; Canaff, L; Hendy, GN; D'Agruma, L; Zelante, L; Carella, M; Scillitani, A; Guarnieri, V				Pazienza, Valerio; la Torre, Annamaria; Baorda, Filomena; Alfarano, Michela; Chetta, Massimiliano; Muscarella, Lucia Anna; Battista, Claudia; Copetti, Massimiliano; Kotzot, Dieter; Kapelari, Klaus; Al-Abdulrazzaq, Dalia; Perlman, Kusiel; Sochett, Etienne; Cole, David E. C.; Pellegrini, Fabio; Canaff, Lucie; Hendy, Geoffrey N.; D'Agruma, Leonardo; Zelante, Leopoldo; Carella, Massimo; Scillitani, Alfredo; Guarnieri, Vito			Identification and Functional Characterization of Three NoLS (Nucleolar Localisation Signals) Mutations of the CDC73 Gene	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; GERM-LINE MUTATIONS; HEREDITARY HYPERPARATHYROIDISM; NUCLEAR-LOCALIZATION; HRPT2 GENE; HUMAN PAF1; HPT-JT; PARAFIBROMIN; EXPRESSION; DELETION	Hyperparathyroidism Jaw-Tumour Syndrome (HPT-JT) is characterized by primary hyperparathyroidism (PHPT), maxillary/mandible ossifying fibromas and by parathyroid carcinoma in 15% of cases. Inactivating mutations of the tumour suppressor CDC73/HRPT2 gene have been found in HPT-JT patients and also as genetic determinants of sporadic parathyroid carcinoma/atypical adenomas and, rarely, typical adenomas, in familial PHPT. Here we report the genetic and molecular analysis of the CDC73/HRPT2 gene in three patients affected by PHPT due to atypical and typical parathyroid adenomas, in one case belonging to familial PHPT. Flag-tagged WT and mutant CDC73/HRPT2 proteins were transiently transfected in HEK293 cells and functional assays were performed in order to investigate the effect of the variants on the whole protein expression, nuclear localization and cell overgrowth induction. We identified four CDC73/HRPT2 gene mutations, three germline (c.679_680delAG, p.Val85_Val86del and p.Glu81_Pro84del), one somatic (p.Arg77Pro). In three cases the mutation was located within the Nucleolar Localisation Signals (NoLS). The three NoLS variants led to instability either of the corresponding mutated protein or mRNA or both. When transfected in HEK293 cells, NoLS mutated proteins mislocalized with a predeliction for cytoplasmic or nucleo-cytoplasmic localization and, finally, they resulted in overgrowth, consistent with a dominant negative interfering effect in the presence of the endogenous protein.	[Pazienza, Valerio] IRCCS Casa Sollievo Sofferenza, Gastroenterol, San Giovanni Rotondo, FG, Italy; [la Torre, Annamaria; Muscarella, Lucia Anna; D'Agruma, Leonardo; Zelante, Leopoldo; Carella, Massimo; Guarnieri, Vito] IRCCS Casa Sollievo Sofferenza, Med Genet, San Giovanni Rotondo, FG, Italy; [Chetta, Massimiliano] Mol Stamping Fdn Bruno Kessler, Dept Mol Biol, Povo, TN, Italy; [Battista, Claudia; Scillitani, Alfredo] IRCCS Casa Sollievo Sofferenza, Endocrinol, San Giovanni Rotondo, FG, Italy; [Copetti, Massimiliano] IRCCS Casa Sollievo Sofferenza, Unit Biostat, San Giovanni Rotondo, FG, Italy; [Kotzot, Dieter] Med Univ Innsbruck, Div Human Genet, Dept Med Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Kapelari, Klaus] Med Univ Innsbruck, Clin Dept Pediat, A-6020 Innsbruck, Austria; [Al-Abdulrazzaq, Dalia; Perlman, Kusiel; Sochett, Etienne] Hosp Sick Children, Div Endocrinol, Toronto, ON M5G 1X8, Canada; [Cole, David E. C.] Univ Toronto, Dept Lab Med & Pathobiol Med & Genet, Toronto, ON M5S 1A1, Canada; [Pellegrini, Fabio] Consorzio Mario Negri Sud, Lab Clin Epidemiol Diabet & Chron Dis, Santa Maria Imbaro, CH, Italy; [Canaff, Lucie; Hendy, Geoffrey N.] Royal Victoria Hosp, Calcium Res Lab, Montreal, PQ, Canada; [Canaff, Lucie; Hendy, Geoffrey N.] Royal Victoria Hosp, Hormones & Canc Res Unit, Montreal, PQ H3A 1A1, Canada	IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Fondazione Bruno Kessler; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; Medical University of Innsbruck; Medical University of Innsbruck; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Consorzio Mario Negri Sud; McGill University; Royal Victoria Hospital; McGill University; Royal Victoria Hospital	Guarnieri, V (corresponding author), IRCCS Casa Sollievo Sofferenza, Med Genet, San Giovanni Rotondo, FG, Italy.	v.guarnieri@operapadrepio.it	Copetti, Massimiliano/K-3186-2016; Chetta, Massimiliano/ABC-5896-2021; Guarnieri, Vito/B-8826-2017; Pazienza, Valerio/K-5073-2012; la Torre, Annamaria/B-2717-2017; Muscarella, Lucia Anna/K-5979-2016; COPETTI, MASSIMILIANO/AAG-1473-2021; Scillitani, Alfredo/AAB-8948-2019; Battista, Claudia/AAB-2602-2019; Carella, Massimo/A-2804-2014; Leonardo, D'Agruma/A-4824-2015	Copetti, Massimiliano/0000-0002-7960-5947; Chetta, Massimiliano/0000-0001-6300-0604; Guarnieri, Vito/0000-0002-5500-8558; Pazienza, Valerio/0000-0002-3492-1153; la Torre, Annamaria/0000-0003-4199-1077; Muscarella, Lucia Anna/0000-0002-1866-8151; COPETTI, MASSIMILIANO/0000-0002-7960-5947; Scillitani, Alfredo/0000-0001-9954-4187; Carella, Massimo/0000-0002-6830-6829; la Torre, Annamaria/0000-0002-7017-0879; Leonardo, D'Agruma/0000-0001-8308-8957; Battista, Claudia/0000-0002-0961-926X	Ricerca Oncologica [RF-OGR-2006_416850]; Ricerca Corrente; Italian Ministry of Health; Canadian Institutes of Health Research (CIHR)	Ricerca Oncologica; Ricerca Corrente(Ministry of Health, ItalyMinistry of Health Italy - Ricerca Corrente (MOH-RC)); Italian Ministry of Health(Ministry of Health, Italy); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by: Ricerca Oncologica "RF-OGR-2006_416850" (to AS), Ricerca Corrente 2010 (to VG) funding granted by the Italian Ministry of Health, by the "5x1000" voluntary contributions and by Canadian Institutes of Health Research (CIHR) (to GNH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley KJ, 2007, ONCOGENE, V26, P1213, DOI 10.1038/sj.onc.1209893; Bradley KJ, 2006, CLIN ENDOCRINOL, V64, P299, DOI 10.1111/j.1365-2265.2006.02460.x; Bradley KJ, 2005, J INTERN MED, V257, P18, DOI 10.1111/j.1365-2796.2004.01421.x; Bricaire L, 2013, J CLIN ENDOCR METAB, V98, pE403, DOI 10.1210/jc.2012-2789; Canaff L, 2012, J CLIN ENDOCR METAB, V97, pE282, DOI 10.1210/jc.2011-0241; Carpten JD, 2002, NAT GENET, V32, P676, DOI 10.1038/ng1048; Cascon A, 2011, GENE CHROMOSOME CANC, V50, P922, DOI 10.1002/gcc.20911; Cavaco BM, 2001, QJM-INT J MED, V94, P213, DOI 10.1093/qjmed/94.4.213; Cavaco BM, 2011, ENDOCR PATHOL, V22, P44, DOI 10.1007/s12022-011-9151-1; Cetani F, 2007, ENDOCR-RELAT CANCER, V14, P493, DOI 10.1677/ERC-06-0092; D'Alessandro V, 2008, CELL ONCOL, V30, P291, DOI 10.3233/CLO-2008-0424; Domingues R, 2012, CLIN ENDOCRINOL, V76, P33, DOI 10.1111/j.1365-2265.2011.04184.x; Frank-Raue K, 2011, EUR J ENDOCRINOL, V165, P477, DOI 10.1530/EJE-11-0003; Guarnieri V, 2008, SURGERY, V144, P839, DOI 10.1016/j.surg.2008.08.008; Guarnieri V, 2012, CELL ONCOL, V35, P411, DOI 10.1007/s13402-012-0100-x; Hahn MA, 2007, FEBS LETT, V581, P5070, DOI 10.1016/j.febslet.2007.09.050; Haven CJ, 2000, J CLIN ENDOCR METAB, V85, P1449, DOI 10.1210/jc.85.4.1449; JACKSON CE, 1990, SURGERY, V108, P1006; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lin L, 2008, P NATL ACAD SCI USA, V105, P17420, DOI 10.1073/pnas.0710725105; Lin L, 2007, MOL CANCER RES, V5, P183, DOI 10.1158/1541-7786.MCR-06-0129; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Newey PJ, 2010, HUM MUTAT, V31, P295, DOI 10.1002/humu.21188; Panicker LM, 2010, ENDOCR-RELAT CANCER, V17, P513, DOI 10.1677/ERC-09-0272; Rekik N, 2010, ANN ENDOCRINOL-PARIS, V71, P121, DOI 10.1016/j.ando.2009.09.004; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Scintu M, 2007, CANCER LETT, V254, P298, DOI 10.1016/j.canlet.2007.03.021; Shattuck TM, 2003, NEW ENGL J MED, V349, P1722, DOI 10.1056/NEJMoa031237; Siu WK, 2011, FAM CANCER, V10, P695, DOI 10.1007/s10689-011-9466-6; Starker LF, 2012, HORM CANCER-US, V3, P44, DOI 10.1007/s12672-011-0100-8; Wang O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045567; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Zhang C, 2006, BIOCHEM BIOPH RES CO, V350, P17, DOI 10.1016/j.bbrc.2006.08.169; Zhao J, 2007, ONCOGENE, V26, P3440, DOI 10.1038/sj.onc.1210131	35	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82292	10.1371/journal.pone.0082292	http://dx.doi.org/10.1371/journal.pone.0082292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340015	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100096
J	Zuk, J; Ozernov-Palchik, O; Kim, H; Lakshminarayanan, K; Gabrieli, JDE; Tallal, P; Gaab, N				Zuk, Jennifer; Ozernov-Palchik, Ola; Kim, Heesoo; Lakshminarayanan, Kala; Gabrieli, John D. E.; Tallal, Paula; Gaab, Nadine			Enhanced Syllable Discrimination Thresholds in Musicians	PLOS ONE			English	Article							MUSICAL EXPERTISE; DEVELOPMENTAL DYSLEXIA; BRAIN-STEM; RISE-TIME; SPEECH; PITCH; CHILDREN; LANGUAGE; PERCEPTION; DEFICITS	Speech processing inherently relies on the perception of specific, rapidly changing spectral and temporal acoustic features. Advanced acoustic perception is also integral to musical expertise, and accordingly several studies have demonstrated a significant relationship between musical training and superior processing of various aspects of speech. Speech and music appear to overlap in spectral and temporal features; however, it remains unclear which of these acoustic features, crucial for speech processing, are most closely associated with musical training. The present study examined the perceptual acuity of musicians to the acoustic components of speech necessary for intra-phonemic discrimination of synthetic syllables. We compared musicians and non-musicians on discrimination thresholds of three synthetic speech syllable continua that varied in their spectral and temporal discrimination demands, specifically voice onset time (VOT) and amplitude envelope cues in the temporal domain. Musicians demonstrated superior discrimination only for syllables that required resolution of temporal cues. Furthermore, performance on the temporal syllable continua positively correlated with the length and intensity of musical training. These findings support one potential mechanism by which musical training may selectively enhance speech perception, namely by reinforcing temporal acuity and/or perception of amplitude rise time, and implications for the translation of musical training to long-term linguistic abilities.	[Zuk, Jennifer; Ozernov-Palchik, Ola; Gaab, Nadine] Boston Childrens Hosp, Dev Med Ctr, Labs Cognit Neurosci, Boston, MA USA; [Zuk, Jennifer; Gaab, Nadine] Harvard Univ, Sch Med, Boston, MA USA; [Kim, Heesoo] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Lakshminarayanan, Kala] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [Gabrieli, John D. E.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Gaab, Nadine] Harvard Univ, Grad Sch Educ, Cambridge, MA 02138 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of California System; University of California Berkeley; Rutgers State University Newark; Rutgers State University New Brunswick; Massachusetts Institute of Technology (MIT); Harvard University	Gaab, N (corresponding author), Boston Childrens Hosp, Dev Med Ctr, Labs Cognit Neurosci, Boston, MA USA.	nadine.gaab@childrens.harvard.edu	Gabrieli, John/AAJ-2869-2020; Gaab, Nadine/AAD-9144-2022; Ozernov-Palchik, Ola/R-5622-2018	Zuk, Jennifer/0000-0001-9113-3973; Gaab, Nadine/0000-0002-7548-413X; Ozernov-Palchik, Ola/0000-0003-0055-6642	Grammy Foundation; William F. Milton Funds; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC000038] Funding Source: NIH RePORTER	Grammy Foundation; William F. Milton Funds; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding came from Grammy Foundation and William F. Milton Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, E PRIM VERS 1 0; [Anonymous], 1993, EDUC PSYCHOL-UK, DOI [DOI 10.1080/0144341930130103, 10.1080/0144341930130103]; [Anonymous], 1998, WOODCOCK READING MAS; Anvari SH, 2002, J EXP CHILD PSYCHOL, V83, P111, DOI 10.1016/S0022-0965(02)00124-8; Banai K, 2009, CEREB CORTEX, V19, P2699, DOI 10.1093/cercor/bhp024; BARWICK J, 1989, BRIT J EDUC PSYCHOL, V59, P253, DOI 10.1111/j.2044-8279.1989.tb03097.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Besson M, 2007, RESTOR NEUROL NEUROS, V25, P399; Bhide A, 2013, MIND BRAIN EDUC, V7, P113, DOI 10.1111/mbe.12016; Bidelman GM, 2011, BRAIN COGNITION, V77, P1, DOI 10.1016/j.bandc.2011.07.006; Caclin A, 2005, J ACOUST SOC AM, V118, P471, DOI 10.1121/1.1929229; Chandrasekaran B, 2010, MUSIC PERCEPT, V27, P297, DOI 10.1525/MP.2010.27.4.297; Chobert J, 2012, CEREB CORTEX; Chobert J, 2011, J COGNITIVE NEUROSCI, V23, P3874, DOI 10.1162/jocn_a_00088; CUTLER A, 1994, LINGUA, V92, P81, DOI 10.1016/0024-3841(94)90338-7; Dege F, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00124; Deguchi C, 2012, BRAIN RES, V1455, P75, DOI 10.1016/j.brainres.2012.03.034; Douglas S., 1994, J RES READ, V17, p99?107, DOI [DOI 10.1111/J.1467-9817.1994.TB00057.X, 10.1111/j.1467-9817.1994.tb00057.x]; Dutoit T, 1996, ICSLP 96 - FOURTH INTERNATIONAL CONFERENCE ON SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, VOLS 1-4, P1393, DOI 10.1109/ICSLP.1996.607874; Francois C, 2012, CEREB CORTEX; Fujioka T, 2006, BRAIN, V129, P2593, DOI 10.1093/brain/awl247; Goswami U, 2012, CORTEX; Goswami U, 2011, TRENDS COGN SCI, V15, P3, DOI 10.1016/j.tics.2010.10.001; Goswami U, 2011, DEVELOPMENTAL SCI, V14, P34, DOI 10.1111/j.1467-7687.2010.00955.x; HURWITZ I, 1975, J LEARN DISABIL, V8, P167, DOI 10.1177/002221947500800310; Huss M, 2011, CORTEX, V47, P674, DOI 10.1016/j.cortex.2010.07.010; Jentschke S, 2008, J COGN NEUROSCI; Jentschke S, 2009, NEUROIMAGE, V47, P735, DOI 10.1016/j.neuroimage.2009.04.090; KLATT DH, 1980, J ACOUST SOC AM, V67, P971, DOI 10.1121/1.383940; Koelsch S, 1999, NEUROREPORT, V10, P1309, DOI 10.1097/00001756-199904260-00029; Koelsch S, 2002, PSYCHOPHYSIOLOGY, V39, P657, DOI 10.1017/S0048577202010508; Krumhansl CL, 2000, PSYCHOL BULL, V126, P159, DOI 10.1037/0033-2909.126.1.159; Kujala T, 2001, P NATL ACAD SCI USA, V98, P10509, DOI 10.1073/pnas.181589198; Lakshminarayanan K, 2007, RESTOR NEUROL NEUROS, V25, P263; Lee KM, 2009, J NEUROSCI, V29, P5832, DOI 10.1523/JNEUROSCI.6133-08.2009; Magne C, 2006, J COGNITIVE NEUROSCI, V18, P199, DOI 10.1162/089892906775783660; Marie C, 2011, J COGNITIVE NEUROSCI, V23, P294, DOI 10.1162/jocn.2010.21413; Micheyl C, 2006, HEARING RES, V219, P36, DOI 10.1016/j.heares.2006.05.004; Morais J, 2010, INT J ARTS TECHNOL, V3, P177, DOI 10.1504/IJART.2010.032563; Moreno S, 2009, CEREB CORTEX, V19, P712, DOI 10.1093/cercor/bhn120; Moritz C, 2013, READ WRIT, V26, P739, DOI 10.1007/s11145-012-9389-0; Muneaux M, 2004, NEUROREPORT, V15, P1255, DOI 10.1097/01.wnr.0000127459.31232.c4; Musacchia G, 2008, HEARING RES, V241, P34, DOI 10.1016/j.heares.2008.04.013; Neely ST, 1992, 15 BOYS TOWN NAT RES; Nittrouer S, 2013, J SPEECH LANG HEAR R, V56, P427, DOI 10.1044/1092-4388(2012/12-0075); Overy K, 2003, ANN NY ACAD SCI, V999, P497, DOI 10.1196/annals.1284.060; Overy K, 2003, DYSLEXIA, V9, P18, DOI 10.1002/dys.233; Pantev C, 2001, NEUROREPORT, V12, P169, DOI 10.1097/00001756-200101220-00041; Parbery-Clark A, 2012, NEUROSCIENCE, V219, P111, DOI 10.1016/j.neuroscience.2012.05.042; Parbery-Clark A, 2009, J NEUROSCI, V29, P14100, DOI 10.1523/JNEUROSCI.3256-09.2009; Patel AD, 2012, ANN NY ACAD SCI, V1252, P124, DOI 10.1111/j.1749-6632.2011.06426.x; Patel AD, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00142; Peynircioglu ZF., 2002, J RES READ, V25, P68, DOI [10.1111/1467-9817.00159, DOI 10.1111/1467-9817.00159]; Przybylski L, 2013, NEUROPSYCHOLOGY, V27, P121, DOI 10.1037/a0031277; ROSEN S, 1992, PHILOS T ROY SOC B, V336, P367, DOI 10.1098/rstb.1992.0070; Santos A, 2007, NEUROPSYCHOLOGIA, V45, P1080, DOI 10.1016/j.neuropsychologia.2006.09.010; Schellenberg EG, 2010, PSYCHOL MUSIC, V38, P209, DOI 10.1177/0305735609339473; Schon D, 2004, PSYCHOPHYSIOLOGY, V41, P341, DOI 10.1111/1469-8986.00172.x; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Shipley W. C., 1986, SHIPLEY I LIVING SCA; Slevc LR, 2006, PSYCHOL SCI, V17, P675, DOI 10.1111/j.1467-9280.2006.01765.x; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; SPIEGEL MF, 1984, J ACOUST SOC AM, V76, P1690, DOI 10.1121/1.391605; Standley JM, 1997, MUSIC THERAPY PERSPE, V15, P79, DOI DOI 10.1093/MTP/15.2.79; STEVENS KN, 1980, J ACOUST SOC AM, V68, P836, DOI 10.1121/1.384823; Strait D. L., 2013, CEREB CORTEX; STRONG W, 1967, J ACOUST SOC AM, V41, P277, DOI 10.1121/1.1910337; Swaminathan J, 2012, J NEUROSCI, V32, P1747, DOI 10.1523/JNEUROSCI.4493-11.2012; Tallal P, 2004, NAT REV NEUROSCI, V5, P721, DOI 10.1038/nrn1499; TALLAL P, 1973, NATURE, V241, P468, DOI 10.1038/241468a0; Tallal P, 2006, TRENDS NEUROSCI, V29, P382, DOI 10.1016/j.tins.2006.06.003; Tervaniemi M, 2005, EXP BRAIN RES, V161, P1, DOI 10.1007/s00221-004-2044-5; Tervaniemi M, 2009, EUR J NEUROSCI, V30, P1636, DOI 10.1111/j.1460-9568.2009.06955.x; Thompson WF, 2003, ANN NY ACAD SCI, V999, P530, DOI 10.1196/annals.1284.067; Thomson JM, 2008, J PHYSIOL-PARIS, V102, P120, DOI 10.1016/j.jphysparis.2008.03.007; Thomson JM, 2013, READ WRIT, V26, P139, DOI 10.1007/s11145-012-9359-6; Wolff P.H., 2002, READ WRIT, V15, P179, DOI [10.1023/A:1013880723925, DOI 10.1023/A:1013880723925, 10.1023/a:1013880723925]; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7; Zendel BR, 2009, J COGNITIVE NEUROSCI, V21, P1488, DOI 10.1162/jocn.2009.21140	79	48	49	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80546	10.1371/journal.pone.0080546	http://dx.doi.org/10.1371/journal.pone.0080546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24339875	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100014
J	Zhang, SW; Mercado-Uribe, I; Hanash, S; Liu, J				Zhang, Shiwu; Mercado-Uribe, Imelda; Hanash, Samir; Liu, Jinsong			iTRAQ-Based Proteomic Analysis of Polyploid Giant Cancer Cells and Budding Progeny Cells Reveals Several Distinct Pathways for Ovarian Cancer Development	PLOS ONE			English	Article							HYPOXIA; DEATH; COCL2; P53	Polyploid giant cancer cells (PGCCs) are a morphologically distinct subgroup of human tumor cells with increased nuclear size or multiple nuclei, but they are generally considered unimportant because they are presumed to be nondividing and thus nonviable. We have recently shown that these large cancer cells are not only viable but also can divide asymmetrically and yield progeny cancer cells with cancer stem-like properties via budding division. To further understand the molecular events involved in the regulation of PGCCs and the generation of their progeny cancer cells, we comparatively analyzed the proteomic profiles of PGCCs, PGCCs with budding daughter cells, and regular control cancer cells from the HEY and SKOv3 human ovarian cancer cell lines with and without CoCl2. We used a high-throughput iTRAQ-based proteomic methodology coupled with liquid chromatography-electrospray ionization tandem mass spectroscopy to determine the differentiated regulated proteins. We performed Western blotting and immunohistochemical analyses to validate the differences in the expression patterns of a variety of proteins between PGCCs or budding PGCCs and regular cancer cells identified by iTRAQ approach and also a selected group of proteins from the literature. The differentially regulated proteins included proteins involved in response to hypoxia, stem cell generation, chromatin remodeling, cell-cycle regulation, and invasion and metastasis. In particular, we found that HIF-1alpha and its known target STC1 are upregulated in PGCCs. In addition, we found that a panel of stem cell-regulating factors and epithelial-to-mesenchymal transition regulatory transcription factors were upregulated in budding PGCCs, whereas expression of the histone 1 family of nucleosomal linker proteins was consistently lower in PGCCs than in control cells. Thus, proteomic expression patterns provide valuable insight into the underlying mechanisms of PGCC formation and the relationship between PGCCs and cancer stem cells in patients with ovarian cancers.	[Zhang, Shiwu] Nankai Univ, Affiliated Hosp, Tianjin Union Med Ctr, Dept Pathol, Tianjin 300071, Peoples R China; [Zhang, Shiwu; Mercado-Uribe, Imelda; Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Hanash, Samir] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA	Nankai University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Liu, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA.	jliu@mdanderson.org			Cancer Prevention and Research Institute of Texas (CPRIT) Multi-Investigator Grant; National Institutes of Health [R01CA131183-01A2, IP50CA83639]; NATIONAL CANCER INSTITUTE [R01CA131183, P30CA016672, P50CA083639] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT) Multi-Investigator Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by Cancer Prevention and Research Institute of Texas (CPRIT) Multi-Investigator Grant; National Institutes of Health R01CA131183-01A2; IP50CA83639 (MD Anderson Specialized Programs of Research Excellence [SPORE] in ovarian cancer). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Chaturvedi P, 2013, J CLIN INVEST, V123, P189, DOI 10.1172/JCI64993; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Erenpreisa JA, 2000, CELL BIOL INT, V24, P635, DOI 10.1006/cbir.2000.0558; Erenpreisa J, 2011, CELL BIOL INT, V35, P687, DOI 10.1042/CBI20100762; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hope K, 2011, NAT METHODS, V8, pS36, DOI [10.1038/NMETH.1590, 10.1038/nmeth.1590]; Konopleva M, 2007, CURR DRUG TARGETS, V8, P685, DOI 10.2174/138945007780830827; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Liu GZ, 2010, JNCI-J NATL CANCER I, V102, P812, DOI 10.1093/jnci/djq127; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Piret JP, 2004, EXP CELL RES, V295, P340, DOI 10.1016/j.yexcr.2004.01.024; Piret JP, 2002, ANN NY ACAD SCI, V973, P443, DOI 10.1111/j.1749-6632.2002.tb04680.x; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Vakifahmetoglu H, 2008, CELL DEATH DIFFER, V15, P1153, DOI 10.1038/cdd.2008.47; Vitale I, 2011, CELL DEATH DIFFER, V18, P1403, DOI 10.1038/cdd.2010.145; Vitale I, 2010, EMBO J, V29, P1272, DOI 10.1038/emboj.2010.11; Walen KH, 2006, IN VITRO CELL DEV-AN, V42, P216; Wolberg WH, 1999, CLIN CANCER RES, V5, P3542; Yang G, 2010, CLIN CANCER RES, V16, P3171, DOI 10.1158/1078-0432.CCR-09-3171; Yin XY, 1999, ONCOGENE, V18, P1177, DOI 10.1038/sj.onc.1202410; Zhang S, 2013, ONCOGENE, DOI [10.1038/onc.2013.96, DOI 10.1038/0NC.2013.96.[]; Zhang SW, 2013, CANCER LETT, V333, P205, DOI 10.1016/j.canlet.2013.01.037	29	46	50	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80120	10.1371/journal.pone.0080120	http://dx.doi.org/10.1371/journal.pone.0080120			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24348907	Green Published, Green Submitted, gold			2022-12-27	WOS:000327143800125
J	Liu, SH; Huang, B; Huang, HH; Li, XY; Chen, GC; Zhang, GH; Lin, WT; Guo, D; Wang, J; Yu, ZF; Liu, X; Su, M				Liu, Shuhui; Huang, Bo; Huang, Haihua; Li, Xiaoyun; Chen, Guangcan; Zhang, Guohong; Lin, Wengting; Guo, Dan; Wang, Jie; Yu, Zefeng; Liu, Xi; Su, Min			Patrilineal Background of Esophageal Cancer and Gastric Cardia Cancer Patients in a Chaoshan High-Risk Area in China	PLOS ONE			English	Article							MODERN HUMAN-ORIGIN; SHANXI-PROVINCE; FAMILIAL AGGREGATION; POLYMORPHISMS; POPULATIONS; ASIA	The Taihang Mountain range of north-central China, the Southern region area of Fujian province, and the Chaoshan plain of Guangdong province are 3 major regions in China well known for their high incidence of esophageal cancer (EC). These areas also exhibit high incidences of gastric cardia cancer (GCC). The ancestors of the Chaoshanese, now the major inhabitants in the Chaoshan plain, were from north-central China. We hypothesized that EC and GCC patients in Chaoshan areas share a common ancestry with Taihang Mountain patients. We analyzed 16 East Asian-specific Y-chromosome biallelic markers (single nucleotide polymorphisms; Y-SNPs) and 6 Y-chromosome short tandem repeat (Y-STR) loci in 72 EC and 48 GCC patients from Chaoshan and 49 EC and 63 GCC patients from the Taihang Mountain range. We also compared data for 32 Chaoshan Hakka people and 24 members of the aboriginal She minority who live near the Chaoshan area. Analysis was by frequency distribution and principal component, correlation and hierarchical cluster analysis of Y-SNP. Chaoshan patients were closely related to Taihang Mountain patients, even though they are geographically distant. Y-STR analysis revealed that the 4 patient groups were more closely related with each other than with other groups. Network analysis of the haplogroup O3a3c1-M117 showed a high degree of patient-specific substructure. We suggest that EC and GCC patients from these 2 areas share a similar patrilineal genetic background, which may play an important role in the genetic factor of EC and GCC in these populations.	[Liu, Shuhui; Huang, Bo; Li, Xiaoyun; Zhang, Guohong; Lin, Wengting; Guo, Dan; Wang, Jie; Yu, Zefeng; Liu, Xi; Su, Min] Shantou Univ, Coll Med, Inst Clin Pathol, Shantou, Guangdong, Peoples R China; [Liu, Shuhui; Huang, Bo; Li, Xiaoyun; Zhang, Guohong; Lin, Wengting; Guo, Dan; Wang, Jie; Yu, Zefeng; Liu, Xi; Su, Min] Shantou Univ, Coll Med, Dept Pathol, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Shantou, Guangdong, Peoples R China; [Huang, Haihua] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Pathol, Shantou, Guangdong, Peoples R China; [Chen, Guangcan] Shantou Univ, Coll Med, Affiliated Hosp 1, Dept Gen Surg, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Su, M (corresponding author), Shantou Univ, Coll Med, Inst Clin Pathol, Shantou, Guangdong, Peoples R China.	minsu@stu.edu.cn			NSFC-Guangdong joint fund key project [U1132004]; NSFC [31171226, 81101548]; Guangdong International Cooperative Technical Innovation Platform [gihz1106]; NSF Guangdong Province [S2011020002393]	NSFC-Guangdong joint fund key project; NSFC(National Natural Science Foundation of China (NSFC)); Guangdong International Cooperative Technical Innovation Platform; NSF Guangdong Province	This study was sponsored by NSFC-Guangdong joint fund key project (U1132004), NSFC (31171226, 81101548), Guangdong International Cooperative Technical Innovation Platform (Certificates gihz1106), and NSF Guangdong Province (S2011020002393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Ba H. J., 2007, J FORENSIC MED, V23, P206; Chang-Claude J, 1997, INT J EPIDEMIOL, V26, P1159, DOI 10.1093/ije/26.6.1159; [陈志峰 Chen Zhifeng], 2011, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V38, P57; Feng C. J., 2005, FORENSIC SCI TECHNOL, V3, P23; HU N, 1992, INT J EPIDEMIOL, V21, P877, DOI 10.1093/ije/21.5.877; HU N, 1991, EUR J CANCER, V27, P1336, DOI 10.1016/0277-5379(91)90116-U; Huang HH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011118; Jin L, 2000, NAT REV GENET, V1, P126, DOI 10.1038/35038565; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Ke YH, 2001, SCI CHINA SER C, V44, P225, DOI 10.1007/BF02879329; Kuang J. Z. Z. W., 2005, FORENSIC SCI TECHNOL, V1, P19; Li Hui, 2003, Acta Genetica Sinica, V30, P873; Li XY, 2007, GENOMICS, V90, P474, DOI 10.1016/j.ygeno.2007.06.006; Lin YHL, 2012, KIDNEY BLOOD PRESS R, V35, P305, DOI 10.1159/000336085; PX, 2002, HAKK; SPH, 1999, GUANGD ETHN GROUPS R; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Su M, 2004, WORLD J GASTROENTERO, V10, P2163; Su M, 2007, EUR J EPIDEMIOL, V22, P43, DOI 10.1007/s10654-006-9086-x; Szumilo Justyna, 2009, Pol Merkur Lekarski, V26, P82; TH, 1997, HEADSTR CHAOSH CULT; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Wang WZ, 2010, AM J PHYS ANTHROPOL, V141, P124, DOI 10.1002/ajpa.21124; WANG YP, 1992, CANCER CAUSE CONTROL, V3, P107, DOI 10.1007/BF00051650; Wen B, 2003, SCI CHINA C, V33; Wu W. W., 2005, FORENSIC SCI TECHNOL, V5, P11; Zhao Jian-Min, 2007, Zhonghua Yixue Yichuanxue Zazhi, V24, P94; 陈水琴, 2005, [中国法医学杂志, Chinese Journal of Forensic Medicine], V20, P174	29	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81670	10.1371/journal.pone.0081670	http://dx.doi.org/10.1371/journal.pone.0081670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339953	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400029
J	Shabani, F; Kumar, L				Shabani, Farzin; Kumar, Lalit			Risk Levels of Invasive Fusarium oxysporum f. sp in Areas Suitable for Date Palm (Phoenix dactylifera) Cultivation under Various Climate Change Projections	PLOS ONE			English	Article							POTENTIAL DISTRIBUTION; BIOTIC INTERACTIONS; BAYOUD DISEASE; SP LYCOPERSICI; SP ELAEIDIS; OIL PALM; IMPACT; DIFFERENTIATION; MICROORGANISMS; DISTRIBUTIONS	Global climate model outputs involve uncertainties in prediction, which could be reduced by identifying agreements between the output results of different models, covering all assumptions included in each. Fusarium oxysporum f.sp. is an invasive pathogen that poses risk to date palm cultivation, among other crops. Therefore, in this study, the future distribution of invasive Fusarium oxysporum f.sp., confirmed by CSIRO-Mk3.0 (CS) and MIROC-H (MR) GCMs, was modeled and combined with the future distribution of date palm predicted by the same GCMs, to identify areas suitable for date palm cultivation with different risk levels of invasive Fusarium oxysporum f.sp., for 2030, 2050, 2070 and 2100. Results showed that 40%, 37%, 33% and 28% areas projected to become highly conducive to date palm are under high risk of its lethal fungus, compared with 37%, 39%, 43% and 42% under low risk, for the chosen years respectively. Our study also indicates that areas with marginal risk will be limited to 231, 212, 186 and 172 million hectares by 2030, 2050, 2070 and 2100. The study further demonstrates that CLIMEX outputs refined by a combination of different GCMs results of different species that have symbiosis or parasite relationship, ensure that the predictions become robust, rather than producing hypothetical findings, limited purely to publication.	[Shabani, Farzin; Kumar, Lalit] Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New England	Shabani, F (corresponding author), Univ New England, Sch Environm & Rural Sci, Armidale, NSW, Australia.	fshabani@myune.edu.au	shabani, Farzin/P-1033-2019; Kumar, Lalit/A-6397-2011	shabani, Farzin/0000-0002-5100-8921; Kumar, Lalit/0000-0002-9205-756X				ADAMS RM, 1990, NATURE, V345, P219, DOI 10.1038/345219a0; Anderson RP, 2003, ECOL MODEL, V162, P211, DOI 10.1016/S0304-3800(02)00349-6; Anjani K., 2004, PLANT GENET RESOUR N, V137, P46; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; ASSIGBETSE KB, 1994, PHYTOPATHOLOGY, V84, P622, DOI 10.1094/Phyto-84-622; Barney JN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017222; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bengyella L., 2012, Asian Journal of Plant Pathology, V6, P19, DOI 10.3923/ajppaj.2012.19.24; BENNACEUR M, 1991, PLANT BREEDING, V107, P56, DOI 10.1111/j.1439-0523.1991.tb00528.x; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; BURGESS LW, 1992, MYCOL RES, V96, P780, DOI 10.1016/S0953-7562(09)80448-6; Chakraborty S, 1998, AUSTRALAS PLANT PATH, V27, P15, DOI 10.1071/AP98001; Chakraborty S, 2000, ENVIRON POLLUT, V108, P317, DOI 10.1016/S0269-7491(99)00210-9; Chiew FHS, 2009, 18TH WORLD IMACS CONGRESS AND MODSIM09 INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION, P3907; Coakley SM, 1999, ANNU REV PHYTOPATHOL, V37, P399, DOI 10.1146/annurev.phyto.37.1.399; El Hassni M, 2007, ENVIRON EXP BOT, V59, P224, DOI 10.1016/j.envexpbot.2005.12.008; FEATHER TV, 1989, PLANT DIS, V73, P78, DOI 10.1094/PD-73-0078; Follak S, 2010, WEED RES, V50, P544, DOI 10.1111/j.1365-3180.2010.00802.x; Fravel DR, 1996, PHYTOPATHOLOGY, V86, P236, DOI 10.1094/Phyto-86-236; Ghaemi A., 2011, IRAN AGR RES, V29, P51, DOI [10.22099/iar.2011.136, DOI 10.22099/IAR.2011.136]; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hernandez-Hernandez J, 2010, PHYTOPATHOL MEDITERR, V49, P84; Hirano Yasushi, 2006, Journal of General Plant Pathology, V72, P273, DOI 10.1007/s10327-006-0287-7; Hughes L, 2003, AUSTRAL ECOL, V28, P423, DOI 10.1046/j.1442-9993.2003.01300.x; Intergovernmental Panel on Climate Change, 2022, CLIMATE CHANGE 2022; Kistler HC, 1998, PHYTOPATHOLOGY, V88, P30, DOI 10.1094/PHYTO.1998.88.1.30; Kocmankova E., 2004, AGROCLIMATOLOGICAL M, P1; Kriticos D. J., 2012, Bulletin OEPP, V42, P56, DOI [10.1111/j.1365-2338.2012.02540.x, 10.1111/epp.2540]; Kriticos D. J., 2006, 15th Australian Weeds Conference, Papers and Proceedings, Adelaide, South Australia, 24-28 September 2006: Managing weeds in a changing climate, P27; Kriticos D. J., 2001, Weed risk assessment, P61; Kriticos D. J., 2006, RELEASE NOTES OZCLIM; Kriticos DJ, 2007, J APPL ECOL, V44, P853, DOI 10.1111/j.1365-2664.2007.01331.x; Kriticos DJ, 2012, METHODS ECOL EVOL, V3, P53, DOI 10.1111/j.2041-210X.2011.00134.x; Kriticos DJ, 2010, ECOGRAPHY, V33, P115, DOI 10.1111/j.1600-0587.2009.06042.x; Kriticos DJ, 2009, CLIMATE CHANGE INVAS, P97; Landa BB, 2004, PHYTOPATHOLOGY, V94, P946, DOI 10.1094/PHYTO.2004.94.9.946; Laurence MH, 2012, FUNGAL BIOL-UK, V116, P289, DOI 10.1016/j.funbio.2011.11.011; Lonsdale D, 1996, EFFECTS CLIMATE CHAN, P1; Masutomi Y, 2009, AGR ECOSYST ENVIRON, V131, P281, DOI 10.1016/j.agee.2009.02.004; Mouyna I, 1996, CURR GENET, V30, P174, DOI 10.1007/s002940050117; ORITSEJAFOR JJ, 1986, T BRIT MYCOL SOC, V87, P511, DOI 10.1016/S0007-1536(86)80091-2; Paterson RRM, 2013, CROP PROT, V46, P113, DOI 10.1016/j.cropro.2012.12.023; Pattison RR, 2008, GLOBAL CHANGE BIOL, V14, P813, DOI 10.1111/j.1365-2486.2007.01528.x; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; PODGER FD, 1989, AUST J BOT, V37, P443, DOI 10.1071/BT9890443; ROBINSON PM, 1984, T BRIT MYCOL SOC, V83, P569, DOI 10.1016/S0007-1536(84)80176-X; ROSENZWEIG C, 1994, NATURE, V367, P133, DOI 10.1038/367133a0; Saremi H, 2011, AFR J BIOTECHNOL, V10, P18391, DOI 10.5897/AJB11.2935; Saremi H, 1999, SOIL BIOL BIOCHEM, V31, P941, DOI 10.1016/S0038-0717(99)00001-2; Saremi H., 2000, JIHAD DANESHGAHI, V4, P160; Shabani F, 2014, J AGR SCI-CAMBRIDGE, V152, P543, DOI 10.1017/S0021859613000816; Shabani F., 2013, Journal of Earth Science & Climatic Change, V4, P145; Shabani F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048021; Singh BK, 2010, NAT REV MICROBIOL, V8, P779, DOI 10.1038/nrmicro2439; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Suppiah R, 2007, AUST METEOROL MAG, V56, P131; Sutherland R., 2013, S AFR J SCI, V109, DOI DOI 10.1590/sajs.2013/20120023; Sutherst RW, 2007, GLOBAL CHANGE BIOL, V13, P1843, DOI 10.1111/j.1365-2486.2007.01396.x; Sutherst RW, 2009, BIOL INVASIONS, V11, P1231, DOI 10.1007/s10530-008-9335-x; Sutherst R. W., 2007, CLIMEX VERSION 3 USE, P10; Tantaoui A, 1996, PHYTOPATHOLOGY, V86, P787, DOI 10.1094/Phyto-86-787; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040969; Taylor S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035565; VENDITTI M, 1988, REV INFECT DIS, V10, P653; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Yonow T, 1998, AUST J AGR RES, V49, P935, DOI 10.1071/A97152; Yonow T, 2013, CROP PROT, V44, P18, DOI 10.1016/j.cropro.2012.10.006; Zitter T., 2013, VEGETABLE CROPS	69	29	29	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83404	10.1371/journal.pone.0083404	http://dx.doi.org/10.1371/journal.pone.0083404			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340100	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400133
J	Szekacs, I; Kaszas, N; Grof, P; Erdelyi, K; Szendro, I; Mihalik, B; Pataki, A; Antoni, FA; Madarasz, E				Szekacs, Inna; Kaszas, Nora; Grof, Pal; Erdelyi, Katalin; Szendro, Istvan; Mihalik, Balazs; Pataki, Agnes; Antoni, Ferenc A.; Madarasz, Emilia			Optical Waveguide Lightmode Spectroscopic Techniques for Investigating Membrane-Bound Ion Channel Activities	PLOS ONE			English	Article							LIPID-BILAYER; SURFACE; LIPOSOME; PATTERNS; PROTEIN	Optical waveguide lightmode spectroscopic (OWLS) techniques were probed for monitoring ion permeation through channels incorporated into artificial lipid environment. A novel sensor set-up was developed by depositing liposomes or cell-derived membrane fragments onto hydrophilic polytetrafluoroethylene (PTFE) membrane. The fibrous material of PTFE membrane could entrap lipoid vesicles and the water-filled pores provided environment for the hydrophilic domains of lipid-embedded proteins. The sensor surface was kept clean from the lipid holder PTFE membrane by a water-and ion-permeable polyethylene terephthalate (PET) mesh. The sensor set-up was tested with egg yolk lecithin liposomes containing gramicidin ion channels and with cell-derived membrane fragments enriched in GABA-gated anion channels. The method allowed monitoring the move of Na+ and organic cations through gramicidin channels and detecting the Cl--channel functions of the (alpha(5)beta(2)gamma(2)) GABA(A) receptor in the presence or absence of GABA and the competitive GABA-blocker bicuculline.	[Szekacs, Inna; Madarasz, Emilia] Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary; [Kaszas, Nora; Grof, Pal] Semmelweis Univ, Dept Biophys & Radiat Biol, H-1085 Budapest, Hungary; [Erdelyi, Katalin; Szendro, Istvan] MicroVacuum Ltd, Budapest, Hungary; [Mihalik, Balazs; Pataki, Agnes; Antoni, Ferenc A.] Egis Pharmaceut PLC, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; Servier	Szekacs, I (corresponding author), Hungarian Acad Sci, Inst Expt Med, Budapest, Hungary.	inna.szekacs@gmail.com	Antoni, Ferenc/AAI-7351-2020	Szekacs, Inna/0000-0002-1900-9422	EU FP7 ASMENA Project [CP-FP-214666-2]; Hungarian Scientific Research Fund [OTKA K 106191]; EU FP7 ASMENA Project; Hungarian Scientific Research Fund (OTKA) [TAMOP-4.2.1/B-09, OMFB-00380];  [TAMOP-4.2.1/B-09/1/KMR-2010-0001];  [OMFB-00380/2007]	EU FP7 ASMENA Project; Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EU FP7 ASMENA Project; Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ; 	This work was supported by the EU FP7 ASMENA Project (Grant No.: CP-FP-214666-2) and the grant of Hungarian Scientific Research Fund (OTKA K 106191). N.K. and P.G. were partially supported by TAMOP-4.2.1/B-09/1/KMR-2010-0001 and OMFB-00380/2007. The funders (EU FP7 ASMENA Project, Hungarian Scientific Research Fund (OTKA), TAMOP-4.2.1/B-09 and OMFB-00380) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bally M, 2010, SMALL, V6, P2481, DOI 10.1002/smll.201000644; Baumann MK, 2011, ANAL CHEM, V83, P6267, DOI 10.1021/ac2009178; Birnir B, 2001, J MEMBRANE BIOL, V181, P171, DOI 10.1007/s00232-001-0021-5; Branden M, 2010, BIOPHYS J, V99, P124, DOI 10.1016/j.bpj.2010.03.059; Branden M, 2008, CHEMPHYSCHEM, V9, P2480, DOI 10.1002/cphc.200800614; Cottier K, 2008, APPL PHYS B-LASERS O, V91, P319, DOI 10.1007/s00340-008-2994-6; Erdelyi K., 2007, HDB BIOSENSORS BIOCH, P569; Heimburg T, 2010, BIOPHYS CHEM, V150, P2, DOI 10.1016/j.bpc.2010.02.018; HEMSLEY G, 1991, BIOPHYS J, V59, P901, DOI 10.1016/S0006-3495(91)82303-7; Homola J, 2006, SPRINGER SER CHEM SE, V4, P1, DOI 10.1007/b100321; Horvath R, 2001, APPL PHYS B-LASERS O, V72, P441, DOI 10.1007/s003400100501; Kelkar DA, 2007, BBA-BIOMEMBRANES, V1768, P2011, DOI 10.1016/j.bbamem.2007.05.011; Kosata B, 2006, IUPAC COMPENDIUM CHE, DOI [10.1351/goldbook.L03540, DOI 10.1351/GOLDBOOK.L03540]; Kugler R, 2002, BIOELECTROCHEMISTRY, V56, P175, DOI 10.1016/S1567-5394(02)00031-2; Majd S, 2010, CURR OPIN BIOTECH, V21, P439, DOI 10.1016/j.copbio.2010.05.002; Mashaghi A, 2008, ANAL CHEM, V80, P3666, DOI 10.1021/ac800027s; Moscho A, 1996, P NATL ACAD SCI USA, V93, P11443, DOI 10.1073/pnas.93.21.11443; RAMSDEN JJ, 1993, J STAT PHYS, V73, P853, DOI 10.1007/BF01052813; Sackmann E, 1996, SCIENCE, V271, P43, DOI 10.1126/science.271.5245.43; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Steller L, 2012, ANAL BIOANAL CHEM, V402, P209, DOI 10.1007/s00216-011-5517-y; Sugihara K, 2010, ACS NANO, V4, P5047, DOI 10.1021/nn100773q; Phung T, 2011, BIOSENS BIOELECTRON, V26, P3127, DOI 10.1016/j.bios.2010.12.013; TIEFENTHALER K, 1992, ADV BIOSENSORS, V2, P261; Trummer N, 2001, FRESEN J ANAL CHEM, V371, P21, DOI 10.1007/s002160100929; Voros J, 2002, BIOMATERIALS, V23, P3699, DOI 10.1016/S0142-9612(02)00103-5	26	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81398	10.1371/journal.pone.0081398	http://dx.doi.org/10.1371/journal.pone.0081398			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339925	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000328707400016
J	Zhang, H; Nie, WC; Zhang, X; Zhang, GT; Li, ZQ; Wu, HB; Shi, Q; Chen, Y; Ding, ZJ; Zhou, XP; Yu, RT				Zhang, Hao; Nie, Wenchen; Zhang, Xu; Zhang, Gentang; Li, Zhiqiang; Wu, Huaibing; Shi, Qiong; Chen, Yong; Ding, Zhijun; Zhou, Xiuping; Yu, Rutong			NEDD4-1 Regulates Migration and Invasion of Glioma Cells through CNrasGEF Ubiquitination In Vitro	PLOS ONE			English	Article							E3 LIGASE NEDD4-1; PTEN; PROTEIN; GROWTH; TUMORS; CLASSIFICATION; DEGRADATION; PHOSPHATASE; ENDOCYTOSIS; EXPRESSION	Neuronal precursor cell-expressed developmentally down-regulated 4-1 (NEDD4-1) plays a great role in tumor cell growth, but its function and mechanism in cell invasive behavior are totally unknown. Here we report that NEDD4-1 regulates migration and invasion of malignant glioma cells via triggering ubiquitination of cyclic nucleotide Ras guanine nucleotide exchange factor (CNrasGEF) using cultured glioma cells. NEDD4-1 overexpression promoted cell migration and invasion, while its downregulation specifically inhibited them. However, NEDD4-1 did not affect the proliferation and apoptosis of glioma cells. NEDD4-1 physically interacted with CNrasGEF and promoted its poly-ubiquitination and degradation. Contrary to the effect of NEDD4-1, CNrasGEF downregulation promoted cell migration and invasion, while its overexpression inhibited them. Importantly, downregulation of CNrasGEF facilitated the effect of NEDD4-1-induced cell migration and invasion. Interestingly, aberrant up-regulated NEDD4-1 showed reverse correlation with CNrasGEF protein level but not with its mRNA level in glioma tissues. Combined with the in vitro results, the result of glioma tissues indicated post-translationally modification effect of NEDD4-1 on CNrasGEF. Our study suggests that NEDD4-1 regulates cell migration and invasion through ubiquitination of CNrasGEF in vitro.	[Zhang, Hao; Shi, Qiong; Zhou, Xiuping; Yu, Rutong] Xuzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China; [Shi, Qiong; Zhou, Xiuping; Yu, Rutong] Xuzhou Med Coll, Lab Neurosurg, Xuzhou, Jiangsu, Peoples R China; [Zhang, Hao; Nie, Wenchen; Zhang, Xu; Zhang, Gentang; Li, Zhiqiang; Wu, Huaibing; Chen, Yong; Ding, Zhijun] Xuzhou Med Coll, Grad Sch, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Zhou, XP (corresponding author), Xuzhou Med Coll, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China.	xpzhou@xzmc.edu.cn; yu.rutong@163.com	zhou, xiuping/AAH-6334-2020		National Natural Science Foundation of China [81072072, 81272777]; Natural Science Foundation of Jiangsu Province [BK2011195]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for New Century Excellent Talents in University [NCET-10-0181]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	The project was supported by National Natural Science Foundation of China (No. 81072072; No. 81272777); Natural Science Foundation of Jiangsu Province (No. BK2011195); The Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); and Program for New Century Excellent Talents in University (NCET-10-0181). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2003, CANCER RES, V63, P2300; Amodio N, 2010, AM J PATHOL, V177, P2622, DOI 10.2353/ajpath.2010.091075; Amsen EM, 2006, J BIOL CHEM, V281, P121, DOI 10.1074/jbc.M507595200; Buckner JC, 2007, MAYO CLIN PROC, V82, P1271, DOI 10.4065/82.10.1271; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Chen RH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-81; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Deng Shishan, 2012, Genomics Proteomics & Bioinformatics, V10, P153, DOI 10.1016/j.gpb.2011.12.001; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fouladkou F, 2008, P NATL ACAD SCI USA, V105, P8585, DOI 10.1073/pnas.0803233105; Furnari FB, 1997, P NATL ACAD SCI USA, V94, P12479, DOI 10.1073/pnas.94.23.12479; Huse JT, 2011, GLIA, V59, P1190, DOI 10.1002/glia.21165; Kanemura H, 2009, BIOCHEM BIOPH RES CO, V387, P754, DOI 10.1016/j.bbrc.2009.07.108; Kawabe H, 2010, CELL CYCLE, V9, P2477, DOI 10.4161/cc.9.13.12236; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kim CS, 2011, J KOREAN NEUROSURG S, V50, P157, DOI 10.3340/jkns.2011.50.3.157; Kim SS, 2008, APMIS, V116, P779, DOI 10.1111/j.1600-0463.2008.00999.x; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Kooistra MRH, 2007, J CELL SCI, V120, P17, DOI 10.1242/jcs.03306; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Kwak YD, 2012, J NEUROSCI, V32, P10971, DOI 10.1523/JNEUROSCI.1836-12.2012; Kwak YD, 2010, J BIOL CHEM, V285, P9847, DOI 10.1074/jbc.M109.091637; Lackovic J, 2012, EXP NEUROL, V235, P326, DOI 10.1016/j.expneurol.2012.02.014; Lin Q, 2010, MOL CELL BIOL, V30, P1541, DOI 10.1128/MCB.00013-10; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luo ZG, 2012, AUTOPHAGY, V8, P1677, DOI 10.4161/auto.21484; Onishi M, 2011, BRAIN TUMOR PATHOL, V28, P13, DOI 10.1007/s10014-010-0007-z; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Pham N, 2001, J BIOL CHEM, V276, P46995, DOI 10.1074/jbc.M108373200; Rampling R, 2004, J NEUROL NEUROSUR PS, V75, P24, DOI 10.1136/jnnp.2004.040535; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Rougier JS, 2011, J BIOL CHEM, V286, P8829, DOI 10.1074/jbc.M110.166520; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Simonin A, 2010, J BIOL CHEM, V285, P38293, DOI 10.1074/jbc.M110.115089; Sun Y, 2003, CANCER BIOL THER, V2, P623; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu K, 2011, J BIOL CHEM, V286, P34060, DOI 10.1074/jbc.M111.273045; Yajnik V, 2003, CELL, V112, P673, DOI 10.1016/S0092-8674(03)00155-7; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Yang BL, 2008, NAT IMMUNOL, V9, P1356, DOI 10.1038/ni.1670; Zaro BW, 2011, P NATL ACAD SCI USA, V108, P8146, DOI 10.1073/pnas.1102458108; Zheng N, 2003, STRUCTURE, V11, P5, DOI 10.1016/S0969-2126(02)00940-1; Zhou XP, 2008, P NATL ACAD SCI USA, V105, P17181, DOI 10.1073/pnas.0800846105; Zhou XP, 2013, J MOL NEUROSCI, V50, P78, DOI 10.1007/s12031-012-9864-8; Zhou XP, 2012, J NEURO-ONCOL, V110, P9, DOI 10.1007/s11060-012-0933-1; Zhou XP, 2012, ONCOL REP, V28, P269, DOI 10.3892/or.2012.1796	49	19	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82789	10.1371/journal.pone.0082789	http://dx.doi.org/10.1371/journal.pone.0082789			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340059	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400095
J	Gardner, SN; Hall, BG				Gardner, Shea N.; Hall, Barry G.			When Whole-Genome Alignments Just Won't Work: kSNP v2 Software for Alignment-Free SNP Discovery and Phylogenetics of Hundreds of Microbial Genomes	PLOS ONE			English	Article							TREES; EPIDEMIOLOGY; EVOLUTION	Effective use of rapid and inexpensive whole genome sequencing for microbes requires fast, memory efficient bioinformatics tools for sequence comparison. The kSNP v2 software finds single nucleotide polymorphisms (SNPs) in whole genome data. kSNP v2 has numerous improvements over kSNP v1 including SNP gene annotation; better scaling for draft genomes available as assembled contigs or raw, unassembled reads; a tool to identify the optimal value of k; distribution of packages of executables for Linux and Mac OS X for ease of installation and user-friendly use; and a detailed User Guide. SNP discovery is based on k-mer analysis, and requires no multiple sequence alignment or the selection of a single reference genome. Most target sets with hundreds of genomes complete in minutes to hours. SNP phylogenies are built by maximum likelihood, parsimony, and distance, based on all SNPs, only core SNPs, or SNPs present in some intermediate user-specified fraction of targets. The SNP-based trees that result are consistent with known taxonomy. kSNP v2 can handle many gigabases of sequence in a single run, and if one or more annotated genomes are included in the target set, SNPs are annotated with protein coding and other information (UTRs, etc.) from Genbank file(s). We demonstrate application of kSNP v2 on sets of viral and bacterial genomes, and discuss in detail analysis of a set of 68 finished E. coli and Shigella genomes and a set of the same genomes to which have been added 47 assemblies and four "raw read'' genomes of H104:H4 strains from the recent European E. coli outbreak that resulted in both bloody diarrhea and hemolytic uremic syndrome (HUS), and caused at least 50 deaths.	[Gardner, Shea N.] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA; [Hall, Barry G.] Bellingham Res Inst, Bellingham, WA USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Gardner, SN (corresponding author), Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.	gardner26@llnl.gov			US Department of Homeland Security Science and Technology Directorate [HSHQPM-10-X-00078 P00001, HSHQPM-10-X-00099 P00002]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC52-07NA27344]	US Department of Homeland Security Science and Technology Directorate(United States Department of Homeland Security (DHS)); U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE))	This work was supported by the US Department of Homeland Security Science and Technology Directorate via awards HSHQPM-10-X-00078 P00001 and HSHQPM-10-X-00099 P00002. This work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC52-07NA27344. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039107; Ahmed SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048228; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Gardner SN, 2013, J VIROL METHODS, V193, P112, DOI 10.1016/j.jviromet.2013.04.019; Gardner SN, 2010, J FORENSIC RES, V01, P2, DOI [10.4172/2157-7145.1000107, DOI 10.4172/2157-7145.1000107]; Grad YH, 2012, P NATL ACAD SCI USA, V109, P3065, DOI 10.1073/pnas.1121491109; Hall BG, 2008, MOL BIOL EVOL, V25, P688, DOI 10.1093/molbev/msn008; Hall BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068901; Hall BG, 2005, MOL BIOL EVOL, V22, P792, DOI 10.1093/molbev/msi066; Hao WL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033971; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hysom DA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034560; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Kolaczkowski B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007891; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; McIlroy TM, 1997, SARRAY COLLECTION SU; Mellmann A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022751; NCBI, 2013, E UT; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Rambaut A., 2013, FIGTREE; Salipante SJ, 2011, J CLIN MICROBIOL, V49, P3568, DOI 10.1128/JCM.00919-11; Stamatakis A, 2012, PARSIMONATOR; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446	26	149	150	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81760	10.1371/journal.pone.0081760	http://dx.doi.org/10.1371/journal.pone.0081760			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349125	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200048
J	Horak, J				Horak, Jakub			Effect of Site Level Environmental Variables, Spatial Autocorrelation and Sampling Intensity on Arthropod Communities in an Ancient Temperate Lowland Woodland Area	PLOS ONE			English	Article							SPECIES RICHNESS; HABITAT; MANAGEMENT; LANDSCAPE; BEETLES; CONSERVATION; ECOLOGY; HETEROGENEITY; BIRDS; TRAP	The interaction of arthropods with the environment and the management of their populations is a focus of the ecological agenda. Spatial autocorrelation and under-sampling may generate bias and, when they are ignored, it is hard to determine if results can in any way be trusted. Arthropod communities were studied during two seasons and using two methods: window and panel traps, in an area of ancient temperate lowland woodland of Zebracka (Czech Republic). The composition of arthropod communities was studied focusing on four site level variables (canopy openness, diameter in the breast height and height of tree, and water distance) and finally analysed using two approaches: with and without effects of spatial autocorrelation. I found that the proportion of variance explained by space cannot be ignored (approximate to 20% in both years). Potential bias in analyses of the response of arthropods to site level variables without including spatial co-variables is well illustrated by redundancy analyses. Inclusion of space led to more accurate results, as water distance and tree diameter were significant, showing approximately the same ratio of explained variance and direction in both seasons. Results without spatial co-variables were much more disordered and were difficult to explain. This study showed that neglecting the effects of spatial autocorrelation could lead to wrong conclusions in site level studies and, furthermore, that inclusion of space may lead to more accurate and unambiguous outcomes. Rarefactions showed that lower sampling intensity, when appropriately designed, can produce sufficient results without exploitation of the environment.	Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Forest Protect & Entomol, Prague, Czech Republic	Czech University of Life Sciences Prague	Horak, J (corresponding author), Czech Univ Life Sci Prague, Fac Forestry & Wood Sci, Dept Forest Protect & Entomol, Prague, Czech Republic.	jakub.sruby@gmail.com	Horak, Jakub/C-1050-2011	Horak, Jakub/0000-0003-2049-0599	Ministry of Agriculture of the Czech Republic [QH91097]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by a grant of the Ministry of Agriculture of the Czech Republic (no. QH91097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbaro L, 2007, J BIOGEOGR, V34, P652, DOI 10.1111/j.1365-2699.2006.01656.x; BASSET Y, 1988, J AUST ENTOMOL SOC, V27, P213; Bini LM, 2009, ECOGRAPHY, V32, P193, DOI 10.1111/j.1600-0587.2009.05717.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Buse J, 2007, BIOL CONSERV, V137, P372, DOI 10.1016/j.biocon.2007.02.025; CHAO A, 1984, SCAND J STAT, V11, P265; Collins MD, 2009, ENVIRON ECOL STAT, V16, P89, DOI 10.1007/s10651-007-0051-y; Colwell R.K., 2006, ESTIMATES STAT ESTIM; de Frutos A, 2007, ECOL MODEL, V200, P33, DOI 10.1016/j.ecolmodel.2006.07.007; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; DUTILLEUL P, 1993, OIKOS, V66, P152, DOI 10.2307/3545210; El-Sayed AM, 2006, J ECON ENTOMOL, V99, P1550, DOI 10.1603/0022-0493-99.5.1550; ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Francese JA, 2008, J ECON ENTOMOL, V101, P1831, DOI 10.1603/0022-0493-101.6.1831; Frazer G.W., 1999, GAP LIGHT ANAL GLA V; Fric Z, 2007, BASIC APPL ECOL, V8, P377, DOI 10.1016/j.baae.2006.06.005; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Gotmark F, 2008, J BIOGEOGR, V35, P1062, DOI 10.1111/j.1365-2699.2008.01882.x; Grove SJ, 2002, ANNU REV ECOL SYST, V33, P1, DOI 10.1146/annurev.ecolsys.33.010802.150507; Hawkins BA, 2012, J BIOGEOGR, V39, P1, DOI 10.1111/j.1365-2699.2011.02637.x; Heikkinen RK, 2004, J APPL ECOL, V41, P824, DOI 10.1111/j.0021-8901.2004.00938.x; Horak J, 2013, J INSECT CONSERV, V17, P441, DOI 10.1007/s10841-012-9526-8; Horak J, 2013, J INSECT CONSERV, V17, P307, DOI 10.1007/s10841-012-9511-2; Horak J, 2012, INSECT CONSERV DIVER, V5, P403, DOI 10.1111/j.1752-4598.2011.00173.x; Horak J, 2011, URBAN FOR URBAN GREE, V10, P213, DOI 10.1016/j.ufug.2011.04.002; HOSKING G P, 1979, New Zealand Entomologist, V7, P87; Hradilek Z, 2007, PRIRODOPISNY CASOP A, V56, P193; Koenig WD, 1999, TRENDS ECOL EVOL, V14, P22, DOI 10.1016/S0169-5347(98)01533-X; Kuhn I, 2007, DIVERS DISTRIB, V13, P66, DOI 10.1111/j.1472-4642.2006.00293.x; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Lassau SA, 2005, AUSTRAL ECOL, V30, P179, DOI 10.1111/j.1442-9993.2005.01435.x; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; Leps J, 2003, MULTIVARIATE ANAL EC; Liebhold AM, 2008, ANNU REV ENTOMOL, V53, P387, DOI 10.1146/annurev.ento.52.110405.091401; Okland B, 1996, EUR J ENTOMOL, V93, P195; Okland RH, 1999, J VEG SCI, V10, P131, DOI 10.2307/3237168; Peltanova A, 2012, ACTA MUSEI RICHNOVEN, V19, P12; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; R Core Team, 2018, R LANG ENV STAT COMP; Safar J, 2003, OLOMOUCKO CHRANENA U; Samways MJ, 2007, ANNU REV ENTOMOL, V52, P465, DOI 10.1146/annurev.ento.52.110405.091317; SOUTHWOOD TRE, 1962, BIOL REV, V37, P171, DOI 10.1111/j.1469-185X.1962.tb01609.x; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Titeux N, 2004, J BIOGEOGR, V31, P1841, DOI 10.1111/j.1365-2699.2004.01125.x; TOBLER WR, 1970, ECON GEOGR, V46, P234, DOI 10.2307/143141; Tscharntke T, 2002, ECOL RES, V17, P229, DOI 10.1046/j.1440-1703.2002.00482.x; Vinatier F, 2011, METHODS ECOL EVOL, V2, P11, DOI 10.1111/j.2041-210X.2010.00059.x; WallisDeVries MF, 2004, CONSERV BIOL, V18, P489; Weibull AC, 2003, BIODIVERS CONSERV, V12, P1335, DOI 10.1023/A:1023617117780	52	20	22	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81541	10.1371/journal.pone.0081541	http://dx.doi.org/10.1371/journal.pone.0081541			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349087	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200033
J	Jacobs, AC; Calkins, MJ; Jadhav, A; Dorjsuren, D; Maloney, D; Simeonov, A; Jaruga, P; Dizdaroglu, M; McCullough, AK; Lloyd, RS				Jacobs, Aaron C.; Calkins, Marcus J.; Jadhav, Ajit; Dorjsuren, Dorjbal; Maloney, David; Simeonov, Anton; Jaruga, Pawel; Dizdaroglu, Miral; McCullough, Amanda K.; Lloyd, R. Stephen			Inhibition of DNA Glycosylases via Small Molecule Purine Analogs	PLOS ONE			English	Article							T4 ENDONUCLEASE-V; REPAIR ENZYME; NEIL1 DNA; MODIFIED BASES; DAMAGED DNA; IN-VITRO; EXCISION; PROTEIN; IDENTIFICATION; CELLS	Following the formation of oxidatively-induced DNA damage, several DNA glycosylases are required to initiate repair of the base lesions that are formed. Recently, NEIL1 and other DNA glycosylases, including OGG1 and NTH1 were identified as potential targets in combination chemotherapeutic strategies. The potential therapeutic benefit for the inhibition of DNA glycosylases was validated by demonstrating synthetic lethality with drugs that are commonly used to limit DNA replication through dNTP pool depletion via inhibition of thymidylate synthetase and dihydrofolate reductase. Additionally, NEIL1-associated synthetic lethality has been achieved in combination with Fanconi anemia, group G. As a prelude to the development of strategies to exploit the potential benefits of DNA glycosylase inhibition, it was necessary to develop a reliable high-throughput screening protocol for this class of enzymes. Using NEIL1 as the proof-of-principle glycosylase, a fluorescence-based assay was developed that utilizes incision of site-specifically modified oligodeoxynucleotides to detect enzymatic activity. This assay was miniaturized to a 1536-well format and used to screen small molecule libraries for inhibitors of the combined glycosylase/AP lyase activities. Among the top hits of these screens were several purine analogs, whose postulated presence in the active site of NEIL1 was consistent with the paradigm of NEIL1 recognition and excision of damaged purines. Although a subset of these small molecules could inhibit other DNA glycosylases that excise oxidatively-induced DNA adducts, they could not inhibit a pyrimidine dimer-specific glycosylase.	[Jacobs, Aaron C.; Calkins, Marcus J.; McCullough, Amanda K.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA; [Jadhav, Ajit; Dorjsuren, Dorjbal; Maloney, David; Simeonov, Anton] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Jaruga, Pawel; Dizdaroglu, Miral] NIST, Biomol Measurement Div, Gaithersburg, MD 20899 USA; [McCullough, Amanda K.; Lloyd, R. Stephen] Oregon Hlth & Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA	Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institute of Standards & Technology (NIST) - USA; Oregon Health & Science University	Lloyd, RS (corresponding author), Oregon Hlth & Sci Univ, Ctr Res Occupat & Environm Toxicol, Portland, OR 97201 USA.	lloydst@ohsu.edu	Jaruga, Pawel/M-4378-2015	Jadhav, Ajit/0000-0001-7955-1451; Lloyd, R. Stephen/0000-0001-7273-372X; Jaruga, Pawel/0000-0001-9192-6084	National Institutes of Health [R01 DK75974, P01 CA160032, T32 ES007060]; National Cancer Institute of the National Institutes of Health [T32CA106195]; National Center for Advancing Translational Sciences; Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research [U54MH084681]; NATIONAL CANCER INSTITUTE [T32CA106195, P01CA160032] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIBTR000004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by National Institutes of Health (R01 DK75974, P01 CA160032) to RSL. ACJ was supported by National Institutes of Health (T32 ES007060). Research reported in this publication was also partially supported by the National Cancer Institute of the National Institutes of Health under award number T32CA106195 for MC. Support by the intramural research program of the National Center for Advancing Translational Sciences and the Molecular Libraries Initiative of the National Institutes of Health Roadmap for Medical Research (U54MH084681) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee A, 2005, NATURE, V434, P612, DOI 10.1038/nature03458; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; CARRERAS CW, 1995, ANNU REV BIOCHEM, V64, P721, DOI 10.1146/annurev.bi.64.070195.003445; Chan MK, 2009, DNA REPAIR, V8, P786, DOI 10.1016/j.dnarep.2009.03.001; Dalhus B, 2011, STRUCTURE, V19, P117, DOI 10.1016/j.str.2010.09.023; Dherin C, 1999, NUCLEIC ACIDS RES, V27, P4001, DOI 10.1093/nar/27.20.4001; Dizdaroglu M, 2000, BIOCHEMISTRY-US, V39, P5586, DOI 10.1021/bi9927787; Dizdaroglu M, 1999, BIOCHEMISTRY-US, V38, P243, DOI 10.1021/bi9819071; Dorjsuren D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047974; Dorjsuren D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp641; FITZGERALD GB, 1987, J INVEST DERMATOL, V88, P66, DOI 10.1111/1523-1747.ep12465020; GRUSKIN EA, 1986, J BIOL CHEM, V261, P9607; HARRAP KR, 1989, ADV ENZYME REGUL, V29, P161, DOI 10.1016/0065-2571(89)90099-X; Hazra TK, 2002, P NATL ACAD SCI USA, V99, P3523, DOI 10.1073/pnas.062053799; Jaruga P, 2004, BIOCHEMISTRY-US, V43, P15909, DOI 10.1021/bi048162l; Jaruga P, 2010, BIOCHEMISTRY-US, V49, P1053, DOI 10.1021/bi902161f; Jaruga P, 2008, FREE RADICAL BIO MED, V45, P1601, DOI 10.1016/j.freeradbiomed.2008.09.019; Jiang YL, 2005, J AM CHEM SOC, V127, P17412, DOI 10.1021/ja055846n; Jiang YL, 2006, BIOORGAN MED CHEM, V14, P5666, DOI 10.1016/j.bmc.2006.04.022; Johnson JL, 2011, J INVEST DERMATOL, V131, P753, DOI 10.1038/jid.2010.300; Kennedy RD, 2007, J CLIN INVEST, V117, P1440, DOI 10.1172/JCI31245; Krishnamurthy N, 2008, BIOCHEMISTRY-US, V47, P7137, DOI 10.1021/bi800160s; Krosky DJ, 2006, NUCLEIC ACIDS RES, V34, P5872, DOI 10.1093/nar/gkl747; Kummar S, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-25; Liu MM, 2010, P NATL ACAD SCI USA, V107, P4925, DOI 10.1073/pnas.0908307107; LLOYD RS, 1980, NUCLEIC ACIDS RES, V8, P5113, DOI 10.1093/nar/8.21.5113; Matsumoto N, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq022; McCullough AK, 1998, J BIOL CHEM, V273, P13136, DOI 10.1074/jbc.273.21.13136; McGuire JJ, 2003, CURR PHARM DESIGN, V9, P2593, DOI 10.2174/1381612033453712; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; O'Brien T, 2009, EMBO MOL MED, V1, P297, DOI 10.1002/emmm.200900044; Reddy PT, 2013, J PROTEOME RES, V12, P1049, DOI 10.1021/pr301037t; Rose Michal G, 2002, Clin Colorectal Cancer, V1, P220, DOI 10.3816/CCC.2002.n.003; Roy LM, 2007, J BIOL CHEM, V282, P15790, DOI 10.1074/jbc.M610626200; Sampath H, 2012, FREE RADICAL RES, V46, P460, DOI 10.3109/10715762.2012.655730; Simeonov A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005740; Taricani L, 2010, CELL CYCLE, V9, P4876, DOI 10.4161/cc.9.24.14155; Wilson PM, 2012, MOL CANCER THER, V11, P616, DOI 10.1158/1535-7163.MCT-11-0781; Yamanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045032; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3734, DOI 10.1021/bi062214k	40	32	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81667	10.1371/journal.pone.0081667	http://dx.doi.org/10.1371/journal.pone.0081667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349107	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200041
J	Mohan, S; Das, D; Bauer, RJ; Heroux, A; Zalewski, JK; Heber, S; Dosunmu-Ogunbi, AM; Trakselis, MA; Hildebrand, JD; VanDemark, AP				Mohan, Swarna; Das, Debamitra; Bauer, Robert J.; Heroux, Annie; Zalewski, Jenna K.; Heber, Simone; Dosunmu-Ogunbi, Atinuke M.; Trakselis, Michael A.; Hildebrand, Jeffrey D.; VanDemark, Andrew P.			Structure of a Highly Conserved Domain of Rock1 Required for Shroom-Mediated Regulation of Cell Morphology	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; SMOOTH-MUSCLE MYOSIN; APICAL CONSTRICTION; COILED-COIL; LIGHT-CHAIN; CRYSTAL-STRUCTURE; BINDING PROTEIN; PHOSPHORYLATION; ACTIVATION; MORPHOGENESIS	Rho-associated coiled coil containing protein kinase (Rho-kinase or Rock) is a well-defined determinant of actin organization and dynamics in most animal cells characterized to date. One of the primary effectors of Rock is non-muscle myosin II. Activation of Rock results in increased contractility of myosin II and subsequent changes in actin architecture and cell morphology. The regulation of Rock is thought to occur via autoinhibition of the kinase domain via intramolecular interactions between the N-terminus and the C-terminus of the kinase. This autoinhibited state can be relieved via proteolytic cleavage, binding of lipids to a Pleckstrin Homology domain near the C-terminus, or binding of GTP-bound RhoA to the central coiled-coil region of Rock. Recent work has identified the Shroom family of proteins as an additional regulator of Rock either at the level of cellular distribution or catalytic activity or both. The Shroom-Rock complex is conserved in most animals and is essential for the formation of the neural tube, eye, and gut in vertebrates. To address the mechanism by which Shroom and Rock interact, we have solved the structure of the coiled-coil region of Rock that binds to Shroom proteins. Consistent with other observations, the Shroom binding domain is a parallel coiled-coil dimer. Using biochemical approaches, we have identified a large patch of residues that contribute to Shrm binding. Their orientation suggests that there may be two independent Shrm binding sites on opposing faces of the coiled-coil region of Rock. Finally, we show that the binding surface is essential for Rock colocalization with Shroom and for Shroom-mediated changes in cell morphology.	[Mohan, Swarna; Das, Debamitra; Zalewski, Jenna K.; Heber, Simone; Dosunmu-Ogunbi, Atinuke M.; Hildebrand, Jeffrey D.; VanDemark, Andrew P.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Bauer, Robert J.; Trakselis, Michael A.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Brookhaven National Laboratory	Hildebrand, JD (corresponding author), Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA.	jeffh@pitt.edu; andyv@pitt.edu	Trakselis, Michael/V-3806-2019	VanDemark, Andrew/0000-0003-3424-4831; Trakselis, Michael/0000-0001-7054-8475; Bauer, Robert/0000-0001-6317-6933; Heber, Simone/0000-0002-7702-9798	National Institutes of Health [GM097204]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097204] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the National Institutes of Health (GM097204) to JH and AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amano M, 1999, J BIOL CHEM, V274, P32418, DOI 10.1074/jbc.274.45.32418; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Araki S, 2001, PFLUG ARCH EUR J PHY, V441, P596, DOI 10.1007/s004240000462; Bolinger C, 2010, DEV DYNAM, V239, P2078, DOI 10.1002/dvdy.22326; Chen Z, 2007, BLOOD, V110, P171, DOI 10.1182/blood-2007-02-071589; Chung MI, 2010, DEVELOPMENT, V137, P1339, DOI 10.1242/dev.044610; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dietz ML, 2006, J BIOL CHEM, V281, P20542, DOI 10.1074/jbc.M512463200; Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200; EDELMAN AM, 1990, MOL CELL BIOCHEM, V97, P87; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst S, 2012, DEVELOPMENT, V139, P4571, DOI 10.1242/dev.083253; Fairbank PD, 2006, DEVELOPMENT, V133, P4109, DOI 10.1242/dev.02563; Farber MJ, 2011, MOL BIOL CELL, V22, P795, DOI 10.1091/mbc.E10-06-0505; Feng JH, 1999, J BIOL CHEM, V274, P3744, DOI 10.1074/jbc.274.6.3744; Fischer RS, 2009, CURR BIOL, V19, P260, DOI 10.1016/j.cub.2008.12.045; Fujisawa K, 1996, J BIOL CHEM, V271, P23022, DOI 10.1074/jbc.271.38.23022; Goldschmidt L, 2007, PROTEIN SCI, V16, P1569, DOI 10.1110/ps.072914007; Grosse AS, 2011, DEVELOPMENT, V138, P4423, DOI 10.1242/dev.065789; Hagens O, 2006, HUM GENET, V118, P578, DOI 10.1007/s00439-005-0072-2; Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hildebrand JD, 2005, J CELL SCI, V118, P5191, DOI 10.1242/jcs.02626; Hildebrand JD, 1999, CELL, V99, P485, DOI 10.1016/S0092-8674(00)81537-8; IKEBE M, 1987, J BIOL CHEM, V262, P9569; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jacobs M, 2006, J BIOL CHEM, V281, P260, DOI 10.1074/jbc.M508847200; Lee C, 2009, DEV DYNAM, V238, P1480, DOI 10.1002/dvdy.21942; Leung T, 1996, MOL CELL BIOL, V16, P5313; Maesaki R, 1999, MOL CELL, V4, P793, DOI 10.1016/S1097-2765(00)80389-5; Martin AC, 2010, J CELL BIOL, V188, P735, DOI 10.1083/jcb.200910099; McGeoch AT, 2005, NAT STRUCT MOL BIOL, V12, P756, DOI 10.1038/nsmb974; Mehio W, 2010, BIOINFORMATICS, V26, P2549, DOI 10.1093/bioinformatics/btq490; Mikheikin AL, 2009, NUCLEIC ACIDS RES, V37, P7194, DOI 10.1093/nar/gkp767; Mohan S, 2012, MOL BIOL CELL, V23, P2131, DOI 10.1091/mbc.E11-11-0937; Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Plageman TF, 2011, DEV BIOL; Plageman TF, 2011, DEVELOPMENT, V138, P5177, DOI 10.1242/dev.067868; Plageman TF, 2010, DEVELOPMENT, V137, P405, DOI 10.1242/dev.045369; Rolo A, 2009, DEV BIOL, V327, P327, DOI 10.1016/j.ydbio.2008.12.009; Sawyer JM, 2010, DEV BIOL, V341, P5, DOI 10.1016/j.ydbio.2009.09.009; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Seong KH, 2001, BIOGERONTOLOGY, V2, P271, DOI 10.1023/A:1013249326285; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Shimizu T, 2003, J BIOL CHEM, V278, P46046, DOI 10.1074/jbc.M306458200; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tariq M, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r91; Tu DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018080; TUAZON PT, 1984, J BIOL CHEM, V259, P541; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Tumusiime S, 2009, BIOCHEM BIOPH RES CO, V381, P393, DOI 10.1016/j.bbrc.2009.02.056; Yamaguchi H, 2006, STRUCTURE, V14, P589, DOI 10.1016/j.str.2005.11.024; Yamamoto N, 2009, DEVELOPMENT, V136, P1977, DOI 10.1242/dev.030718	59	12	13	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81075	10.1371/journal.pone.0081075	http://dx.doi.org/10.1371/journal.pone.0081075			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349032	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200016
J	Chia, JC; Yang, CC; Sui, YT; Lin, SY; Juang, RH				Chia, Ju-Chen; Yang, Chien-Chih; Sui, Yu-Ting; Lin, Shin-Yu; Juang, Rong-Huay			Tentative Identification of the Second Substrate Binding Site in Arabidopsis Phytochelatin Synthase	PLOS ONE			English	Article							HEAVY-METAL DETOXIFICATION; GAMMA-GLUTAMYLCYSTEINE; SCHIZOSACCHAROMYCES-POMBE; PI-INTERACTION; HIGHER-PLANTS; CADMIUM; PEPTIDES; PROTEIN; GLUTATHIONE; ACTIVATION	Phytochelatin synthase (PCS) uses the substrates glutathione (GSH, gamma Glu-Cys-Gly) and a cadmium (Cd)-bound GSH (Cd center dot GS(2)) to produce the shortest phytochelatin product (PC2, (gamma Glu-Cys)(2)-Gly) through a ping-pong mechanism. The binding of the 2 substrates to the active site, particularly the second substrate binding site, is not well-understood. In this study, we generated a structural model of the catalytic domain of Arabidopsis AtPCS1 (residues 12-218) by using the crystal structure of the gamma Glu-Cys acyl-enzyme complex of the PCS of the cyanobacterium Nostoc (NsPCS) as a template. The modeled AtPCS1 revealed a cavity in proximity to the first substrate binding site, consisting of 3 loops containing several conserved amino acids including Arg152, Lys185, and Tyr55. Substitutions of these amino acids (R152K, K185R, or double mutation) resulted in the abrogation of enzyme activity, indicating that the arrangement of these 2 positive charges is crucial for the binding of the second substrate. Recombinant AtPCS1s with mutations at Tyr55 showed lower catalytic activities because of reduced affinity (3-fold for Y55W) for the Cd center dot GS(2), further suggesting the role of the cation-p interaction in recognition of the second substrate. Our study results indicate the mechanism for second substrate recognition in PCS. The integrated catalytic mechanism of PCS is further discussed.	[Chia, Ju-Chen; Yang, Chien-Chih; Sui, Yu-Ting; Lin, Shin-Yu; Juang, Rong-Huay] Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 10764, Taiwan	National Taiwan University	Juang, RH (corresponding author), Natl Taiwan Univ, Dept Biochem Sci & Technol, Coll Life Sci, Taipei 10764, Taiwan.	juang@ntu.edu.tw	Hsiao, Wei-Hung/B-9931-2013	Juang, Rong-Huay/0000-0002-9344-0675; Chia, Ju-Chen/0000-0002-7498-5071; YANG, CHIEN-CHIH/0000-0002-6238-2871; LIN, SHIN-YU/0000-0002-0753-2793	National Science Council of the Republic of China [NSC 99-2311-B-002-004-MY3]	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by a grant from the National Science Council of the Republic of China (to RJ; NSC 99-2311-B-002-004-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen JJ, 1997, PHYSIOL PLANTARUM, V101, P165, DOI 10.1034/j.1399-3054.1997.1010122.x; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett CS, 2000, PLANT PHYSIOL, V123, P825, DOI 10.1104/pp.123.3.825; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; GRILL E, 1985, SCIENCE, V230, P674, DOI 10.1126/science.230.4726.674; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; GRILL E, 1986, FEBS LETT, V197, P115, DOI 10.1016/0014-5793(86)80309-X; GRILL E, 1987, P NATL ACAD SCI USA, V84, P439, DOI 10.1073/pnas.84.2.439; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Harada E, 2004, PHYTOCHEMISTRY, V65, P3179, DOI 10.1016/j.phytochem.2004.09.017; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Koide S, 2009, ACS CHEM BIOL, V4, P325, DOI 10.1021/cb800314v; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LOEFFLER S, 1989, FEBS LETT, V258, P42, DOI 10.1016/0014-5793(89)81611-4; Loscos J, 2006, PLANT PHYSIOL, V140, P1213, DOI 10.1104/pp.105.073635; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Maier T, 2003, PLANTA, V218, P300, DOI 10.1007/s00425-003-1091-7; Meyer CL, 2011, PLANTA, V234, P83, DOI 10.1007/s00425-011-1378-z; Ogawa S, 2011, J INORG BIOCHEM, V105, P111, DOI 10.1016/j.jinorgbio.2010.09.011; Rea PA, 2004, PLANT PHYSIOL, V136, P2463, DOI 10.1104/pp.104.048579; Rea PA, 2012, PHYSIOL PLANTARUM, V145, P154, DOI 10.1111/j.1399-3054.2012.01571.x; REESE RN, 1992, PLANT PHYSIOL, V98, P225, DOI 10.1104/pp.98.1.225; Romanyuk ND, 2006, PLANT PHYSIOL, V141, P858, DOI 10.1104/pp.106.082131; Ruotolo R, 2004, J BIOL CHEM, V279, P14686, DOI 10.1074/jbc.M314325200; SALT DE, 1995, PLANT PHYSIOL, V107, P1293, DOI 10.1104/pp.107.4.1293; Singh NJ, 2009, J CHEM THEORY COMPUT, V5, P515, DOI 10.1021/ct800471b; SPEISER DM, 1992, PLANT PHYSIOL, V99, P817, DOI 10.1104/pp.99.3.817; Tsuji N, 2005, PLANTA, V222, P181, DOI 10.1007/s00425-005-1513-9; Tsuji N, 2004, BIOCHEM BIOPH RES CO, V315, P751, DOI 10.1016/j.bbrc.2004.01.122; Vatamaniuk OK, 2001, J BIOL CHEM, V276, P20817, DOI 10.1074/jbc.C100152200; Vatamaniuk OK, 2000, J BIOL CHEM, V275, P31451, DOI 10.1074/jbc.M002997200; Vatamaniuk OK, 1999, P NATL ACAD SCI USA, V96, P7110, DOI 10.1073/pnas.96.12.7110; Vatamaniuk OK, 2004, J BIOL CHEM, V279, P22449, DOI 10.1074/jbc.M313142200; Vestergaard M, 2008, ANAL SCI, V24, P277, DOI 10.2116/analsci.24.277; Vivares D, 2005, P NATL ACAD SCI USA, V102, P18848, DOI 10.1073/pnas.0505833102; VOGELILANGE R, 1990, PLANT PHYSIOL, V92, P1086, DOI 10.1104/pp.92.4.1086; Wang HC, 2009, J AGR FOOD CHEM, V57, P7348, DOI 10.1021/jf9020152; Zenk MH, 1996, GENE, V179, P21, DOI 10.1016/S0378-1119(96)00422-2	39	3	4	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82675	10.1371/journal.pone.0082675	http://dx.doi.org/10.1371/journal.pone.0082675			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340051	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100123
J	Faria, FDEC; Batista, J; Araujo, H				Faria, Fernanda da C. e C.; Batista, Jorge; Araujo, Helder			Stereoscopic Depth Perception Using a Model Based on the Primary Visual Cortex	PLOS ONE			English	Article							BINOCULAR DISPARITY; SPATIAL-FREQUENCY; NEURAL MECHANISMS; CELLS; NEURONS; VISION; SHIFT	This work describes an approach inspired by the primary visual cortex using the stimulus response of the receptive field profiles of binocular cells for disparity computation. Using the energy model based on the mechanism of log-Gabor filters for disparity encodings, we propose a suitable model to consistently represent the complex cells by computing the wide bandwidths of the cortical cells. This way, the model ensures the general neurophysiological findings in the visual cortex (V1), emphasizing the physical disparities and providing a simple selection method for the complex cell response. The results suggest that our proposed approach can achieve better results than a hybrid model with phase-shift and position-shift using position disparity alone.	[Faria, Fernanda da C. e C.; Batista, Jorge; Araujo, Helder] Univ Coimbra, Inst Syst & Robot, Coimbra, Portugal	Universidade de Coimbra	Faria, FDEC (corresponding author), Univ Coimbra, Inst Syst & Robot, Coimbra, Portugal.	fernanda@isr.uc.pt; batista@isr.uc.pt; helder@isr.uc.pt	Batista, Jorge/A-4196-2011; Araujo, Helder/B-3554-2008	Batista, Jorge/0000-0003-2387-5961; Araujo, Helder/0000-0002-9544-424X	Portuguese Foundation for Science and Technology [45430/2008]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	FCCF is supported by a PhD studentship (Grant # 45430/2008) from the Portuguese Foundation for Science and Technology (www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Anderson JS, 2000, J NEUROPHYSIOL, V84, P909, DOI 10.1152/jn.2000.84.2.909; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Chen YH, 2004, NEURAL COMPUT, V16, P1545, DOI 10.1162/089976604774201596; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; DAUGMAN JG, 1985, J OPT SOC AM A, V2, P1160, DOI 10.1364/JOSAA.2.001160; DEVALOIS RL, 1982, VISION RES, V22, P545, DOI 10.1016/0042-6989(82)90113-4; Faria FDEC, 2010, IFIP ADV INF COMM TE, V314, P351; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; Fischer S, 2007, INT J COMPUT VISION, V75, P231, DOI 10.1007/s11263-006-0026-8; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Haefner RM, 2008, NEURON, V57, P147, DOI 10.1016/j.neuron.2007.10.042; Hirschmuller H, 2007, IEEE COMP SOC C COMP; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kovesi P., 1999, VIDERE J COMPUT VIS, V1, P1; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; Ning QA, 1997, NEURON, V18, P359, DOI 10.1016/S0896-6273(00)81238-6; Ohzawa I, 1998, CURR OPIN NEUROBIOL, V8, P509, DOI 10.1016/S0959-4388(98)80039-1; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; Ohzawa I, 1996, J NEUROPHYSIOL, V75, P1779, DOI 10.1152/jn.1996.75.5.1779; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Parker AJ, 2007, NAT REV NEUROSCI, V8, P379, DOI 10.1038/nrn2131; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; QIAN N, 1994, NEURAL COMPUT, V6, P390, DOI 10.1162/neco.1994.6.3.390; Qian N, 1997, VISION RES, V37, P1811, DOI 10.1016/S0042-6989(96)00331-8; Qian N, 2011, VISION 3D ENV, P11; Read JCA, 2002, VISUAL NEUROSCI, V19, P735, DOI 10.1017/S0952523802196052; Read JCA, 2007, NAT NEUROSCI, V10, P1322, DOI 10.1038/nn1951; Scharstein D, 2002, INT J COMPUT VISION, V47, P7, DOI 10.1023/A:1014573219977; Scharstein D, 2007, IEEE COMP SOC C COMP; Tsang EKC, 2007, ADV NEURAL INFORM PR, P1537	32	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80745	10.1371/journal.pone.0080745	http://dx.doi.org/10.1371/journal.pone.0080745			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339881	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100020
J	Jenkins, Y; Sun, TQ; Markovtsov, V; Foretz, M; Li, W; Nguyen, H; Li, YW; Pan, A; Uy, G; Gross, L; Baltgalvis, K; Yung, SL; Gururaja, T; Kinoshita, T; Owyang, A; Smith, IJ; McCaughey, K; White, K; Godinez, G; Alcantara, R; Choy, C; Ren, H; Basile, R; Sweeny, DJ; Xu, X; Issakani, SD; Carroll, DC; Goff, DA; Shaw, SJ; Singh, R; Boros, LG; Laplante, MA; Marcotte, B; Kohen, R; Viollet, B; Marette, A; Payan, DG; Kinsella, TM; Hitoshi, Y				Jenkins, Yonchu; Sun, Tian-Qiang; Markovtsov, Vadim; Foretz, Marc; Li, Wei; Nguyen, Henry; Li, Yingwu; Pan, Alison; Uy, Gerald; Gross, Lisa; Baltgalvis, Kristen; Yung, Stephanie L.; Gururaja, Tarikere; Kinoshita, Taisei; Owyang, Alexander; Smith, Ira J.; McCaughey, Kelly; White, Kathy; Godinez, Guillermo; Alcantara, Raniel; Choy, Carmen; Ren, Hong; Basile, Rachel; Sweeny, David J.; Xu, Xiang; Issakani, Sarkiz D.; Carroll, David C.; Goff, Dane A.; Shaw, Simon J.; Singh, Rajinder; Boros, Laszlo G.; Laplante, Marc-Andre; Marcotte, Bruno; Kohen, Rita; Viollet, Benoit; Marette, Andre; Payan, Donald G.; Kinsella, Todd M.; Hitoshi, Yasumichi			AMPK Activation through Mitochondrial Regulation Results in Increased Substrate Oxidation and Improved Metabolic Parameters in Models of Diabetes	PLOS ONE			English	Article							PROTEIN-KINASE; FATTY-ACID; INSULIN-RESISTANCE; SKELETAL-MUSCLE; METFORMIN; MECHANISM; PHOSPHORYLATION; DYSFUNCTION; INHIBITION; DELETION	Modulation of mitochondrial function through inhibiting respiratory complex I activates a key sensor of cellular energy status, the 5'-AMP-activated protein kinase (AMPK). Activation of AMPK results in the mobilization of nutrient uptake and catabolism for mitochondrial ATP generation to restore energy homeostasis. How these nutrient pathways are affected in the presence of a potent modulator of mitochondrial function and the role of AMPK activation in these effects remain unclear. We have identified a molecule, named R419, that activates AMPK in vitro via complex I inhibition at much lower concentrations than metformin (IC50 100 nM vs 27 mM, respectively). R419 potently increased myocyte glucose uptake that was dependent on AMPK activation, while its ability to suppress hepatic glucose production in vitro was not. In addition, R419 treatment of mouse primary hepatocytes increased fatty acid oxidation and inhibited lipogenesis in an AMPK-dependent fashion. We have performed an extensive metabolic characterization of its effects in the db/db mouse diabetes model. In vivo metabolite profiling of R419-treated db/db mice showed a clear upregulation of fatty acid oxidation and catabolism of branched chain amino acids. Additionally, analyses performed using both C-13-palmitate and C-13-glucose tracers revealed that R419 induces complete oxidation of both glucose and palmitate to CO2 in skeletal muscle, liver, and adipose tissue, confirming that the compound increases mitochondrial function in vivo. Taken together, our results show that R419 is a potent inhibitor of complex I and modulates mitochondrial function in vitro and in diabetic animals in vivo. R419 may serve as a valuable molecular tool for investigating the impact of modulating mitochondrial function on nutrient metabolism in multiple tissues and on glucose and lipid homeostasis in diabetic animal models.	[Jenkins, Yonchu; Sun, Tian-Qiang; Markovtsov, Vadim; Li, Wei; Nguyen, Henry; Li, Yingwu; Pan, Alison; Uy, Gerald; Gross, Lisa; Baltgalvis, Kristen; Yung, Stephanie L.; Gururaja, Tarikere; Kinoshita, Taisei; Owyang, Alexander; Smith, Ira J.; McCaughey, Kelly; White, Kathy; Godinez, Guillermo; Alcantara, Raniel; Choy, Carmen; Ren, Hong; Basile, Rachel; Sweeny, David J.; Xu, Xiang; Issakani, Sarkiz D.; Carroll, David C.; Goff, Dane A.; Shaw, Simon J.; Singh, Rajinder; Payan, Donald G.; Kinsella, Todd M.; Hitoshi, Yasumichi] Rigel Pharmaceut Inc, San Francisco, CA USA; [Foretz, Marc; Viollet, Benoit] Inst Cochin Genet Mol, INSERM, U1016, F-75014 Paris, France; [Foretz, Marc; Viollet, Benoit] CNRS, UMR8104, Paris, France; [Foretz, Marc; Viollet, Benoit] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Boros, Laszlo G.] SiDMAP LLC, Los Angeles, CA USA; [Boros, Laszlo G.] Harbor UCLA Med Ctr, Dept Pediat, Los Angeles Biomed Res Inst LABIOMED, Torrance, CA 90509 USA; [Laplante, Marc-Andre; Marcotte, Bruno; Kohen, Rita; Marette, Andre] Hop Laval, Fac Med, Dept Med, Cardiol Axis Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Laval University	Hitoshi, Y (corresponding author), Rigel Pharmaceut Inc, San Francisco, CA USA.	yhitoshi@rigel.com	FORETZ, Marc/O-7334-2017; Viollet, Benoit/N-2397-2019; Viollet, Benoit/O-6927-2017	FORETZ, Marc/0000-0001-7017-9032; Viollet, Benoit/0000-0002-0121-0224; Viollet, Benoit/0000-0002-0121-0224; Marette, Andre/0000-0003-3950-5973	Rigel research fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007612] Funding Source: NIH RePORTER	Rigel research fund; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was supported by Rigel research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028981; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Balon TW, 2001, BIOCHEM BIOPH RES CO, V282, P1008, DOI 10.1006/bbrc.2001.4677; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Boros L. G., 2012, METABOLOMICS, V2, P107, DOI DOI 10.4172/2153-0769.1000107; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen LG, 2010, PHARMACOGENET GENOM, V20, P687, DOI 10.1097/FPC.0b013e32833fe789; Colca JR, 2013, CLIN PHARMACOL THER, V93, P352, DOI 10.1038/clpt.2013.10; DeLany JP, 2000, AM J CLIN NUTR, V72, P905; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Frosig C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062338; Galmozzi A, 2013, DIABETES, V62, P732, DOI 10.2337/db12-0548; Gambineri A, 2010, J CLIN ENDOCR METAB, V95, pE204, DOI 10.1210/jc.2010-0145; Guigas B, 2006, DIABETES, V55, P865, DOI 10.2337/diabetes.55.04.06.db05-1178; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; HINSCH W, 1976, EUR J BIOCHEM, V64, P45, DOI 10.1111/j.1432-1033.1976.tb10273.x; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; HUNDAL HS, 1992, ENDOCRINOLOGY, V131, P1165, DOI 10.1210/en.131.3.1165; Hundal RS, 2000, DIABETES, V49, P2063, DOI 10.2337/diabetes.49.12.2063; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lamson Davis W, 2002, Altern Med Rev, V7, P94; Lantier L, 2010, FASEB J, V24, P3555, DOI 10.1096/fj.10-155994; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; MAMER OA, 1976, BIOCHEM J, V160, P417, DOI 10.1042/bj1600417a; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Nies AT, 2009, HEPATOLOGY, V50, P1227, DOI 10.1002/hep.23103; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; PRIPBUUS C, 1992, EUR J BIOCHEM, V209, P291, DOI 10.1111/j.1432-1033.1992.tb17288.x; Quintens R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056719; Reitman ZJ, 2011, P NATL ACAD SCI USA, V108, P3270, DOI 10.1073/pnas.1019393108; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shu Y, 2007, J CLIN INVEST, V117, P1422, DOI 10.1172/JCI30558; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Smith AC, 2005, J PHYSIOL-LONDON, V565, P537, DOI 10.1113/jphysiol.2004.081679; Soeters MR, 2012, METABOLISM, V61, P966, DOI 10.1016/j.metabol.2011.11.009; Sogame Y, 2009, BIOPHARM DRUG DISPOS, V30, P476, DOI 10.1002/bdd.684; Steinberg GR, 2010, J BIOL CHEM, V285, P37198, DOI 10.1074/jbc.M110.102434; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Takei M, 2010, TOXICOL SCI, V118, P643, DOI 10.1093/toxsci/kfq211; Turban S, 2012, J BIOL CHEM, V287, P20088, DOI 10.1074/jbc.M111.330746; Vernochet C, 2012, CELL METAB, V16, P765, DOI 10.1016/j.cmet.2012.10.016; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Wredenberg A, 2006, BIOCHEM BIOPH RES CO, V350, P202, DOI 10.1016/j.bbrc.2006.09.029; Zhang Y, 2012, ACTA PHARM SIN B, V2, P341, DOI 10.1016/j.apsb.2012.06.010; Zheng DH, 2001, J APPL PHYSIOL, V91, P1073, DOI 10.1152/jappl.2001.91.3.1073	55	38	38	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81870	10.1371/journal.pone.0081870	http://dx.doi.org/10.1371/journal.pone.0081870			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339975	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100073
J	Maestre-Reyna, M; Wu, WJ; Wang, AHJ				Maestre-Reyna, Manuel; Wu, Wen-Jin; Wang, Andrew H-J.			Structural Insights into RbmA, a Biofilm Scaffolding Protein of V. Cholerae	PLOS ONE			English	Article							VIBRIO-CHOLERAE; LIPOPOLYSACCHARIDE; IDENTIFICATION; FIELD	V. cholerae can form sessile biofilms associated with abiotic surfaces, cyanobacteria, zoo-plankton, mollusks, or crustaceans. Along with the vibrio polysaccharide, secreted proteins of the rbm gene cluster are key to the biofilm ultrastructure. Here we provide a thorough structural characterization of RbmA, a protein involved in mediating cell-cell and cell-biofilm contacts. We correlate our structural findings with initial ligand specificity screening results, NMR protein-ligand interaction analysis, and complement our results with a full biocomputational study.	[Maestre-Reyna, Manuel; Wu, Wen-Jin; Wang, Andrew H-J.] Acad Sinica, Inst Biol Chem, Taipei, Taiwan	Academia Sinica - Taiwan	Wang, AHJ (corresponding author), Acad Sinica, Inst Biol Chem, Taipei, Taiwan.	ahjwang@gate.sinica.edu.tw	Wu, Wen-Jin/F-9904-2019	Wu, Wen-Jin/0000-0002-7253-5384	Taiwanese national science council (NSC) [NSC 101-2319-B-001-003]	Taiwanese national science council (NSC)	The Taiwanese national science council (NSC) indirectly funded this project via the Core Facility for Protein Structural Analysis (grant #NSC 101-2319-B-001-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absalon C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002210; ALIANSARI A, 1986, CARBOHYD RES, V150, P213, DOI 10.1016/0008-6215(86)80017-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], PYMOL MOL GRAPH SYST; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berk V, 2012, SCIENCE, V337, P236, DOI 10.1126/science.1222981; Bezrukov SM, 2004, BIOPHYS J, V87, P3162, DOI 10.1529/biophysj.104.044453; Borlee BR, 2010, MOL MICROBIOL, V75, P827, DOI 10.1111/j.1365-2958.2009.06991.x; Butler SM, 2005, NAT REV MICROBIOL, V3, P611, DOI 10.1038/nrmicro1207; Case D. A., 2012, AMBER 12; CHOWDHURY TA, 1991, CARBOHYD RES, V215, P303, DOI 10.1016/0008-6215(91)84029-E; COLWELL RR, 1994, ANN NY ACAD SCI, V740, P44, DOI 10.1111/j.1749-6632.1994.tb19852.x; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faruque SM, 2006, P NATL ACAD SCI USA, V103, P6350, DOI 10.1073/pnas.0601277103; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fong JCN, 2010, MICROBIOL-SGM, V156, P2757, DOI 10.1099/mic.0.040196-0; Giglio KM, 2013, J BACTERIOL, V195, P3277, DOI 10.1128/JB.00374-13; Hasan NA, 2012, P NATL ACAD SCI USA, V109, pE2010, DOI 10.1073/pnas.1207359109; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; HERMANSSON K, 1993, CARBOHYD RES, V248, P199, DOI 10.1016/0008-6215(93)84127-R; HISATSUNE K, 1993, BIOCHEM BIOPH RES CO, V196, P1309, DOI 10.1006/bbrc.1993.2395; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISSHIKI Y, 1992, MICROBIOL IMMUNOL, V36, P1201, DOI 10.1111/j.1348-0421.1992.tb02123.x; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; KABIR S, 1983, INFECT IMMUN, V39, P1048, DOI 10.1128/IAI.39.3.1048-1058.1983; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Knirel YA, 1997, EUR J BIOCHEM, V247, P402, DOI 10.1111/j.1432-1033.1997.00402.x; Kulharia M, 2009, J MOL GRAPH MODEL, V28, P297, DOI 10.1016/j.jmgm.2009.08.009; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Maestre-Reyna M, 2012, P NATL ACAD SCI USA, V109, P16864, DOI 10.1073/pnas.1207653109; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Sapay Nicolas, 2013, Methods Mol Biol, V924, P469, DOI 10.1007/978-1-62703-017-5_18; Schachter H, 1992, GLYCOCONJUGATES COMP; Seeliger D, 2010, J COMPUT AID MOL DES, V24, P417, DOI 10.1007/s10822-010-9352-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; TAMPLIN ML, 1990, APPL ENVIRON MICROB, V56, P1977, DOI 10.1128/AEM.56.6.1977-1980.1990; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Veelders M, 2010, P NATL ACAD SCI USA, V107, P22511, DOI 10.1073/pnas.1013210108; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028	45	24	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82458	10.1371/journal.pone.0082458	http://dx.doi.org/10.1371/journal.pone.0082458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340031	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100112
J	Saenz, S; Walschburger, T; Gonzalez, JC; Leon, J; McKenney, B; Kiesecker, J				Saenz, Shirley; Walschburger, Tomas; Carlos Gonzalez, Juan; Leon, Jorge; McKenney, Bruce; Kiesecker, Joseph			Development by Design in Colombia: Making Mitigation Decisions Consistent with Conservation Outcomes	PLOS ONE			English	Article							BIODIVERSITY OFFSETS; IRREPLACEABILITY; VULNERABILITY; REQUIREMENTS; SITES	Mitigation policy and regulatory frameworks are consistent in their strong support for the mitigation hierarchy of: (1) avoiding impacts, (2) minimizing impacts, and then (3) offsetting/compensating for residual impacts. While mitigation frameworks require developers to avoid, minimize and restore biodiversity on-site before considering an offset for residual impacts, there is a lack of quantitative guidance for this decision-making process. What are the criteria for requiring impacts be avoided altogether? Here we examine how conservation planning can guide the application of the mitigation hierarchy to address this issue. In support of the Colombian government's aim to improve siting and mitigation practices for planned development, we examined five pilot projects in landscapes expected to experience significant increases in mining, petroleum and/or infrastructure development. By blending landscape-level conservation planning with application of the mitigation hierarchy, we can proactively identify where proposed development and conservation priorities would be in conflict and where impacts should be avoided. The approach we outline here has been adopted by the Colombian Ministry of Environment and Sustainable Development to guide licensing decisions, avoid piecemeal licensing, and promote mitigation decisions that maintain landscape condition.	[Saenz, Shirley; Walschburger, Tomas] Nature Conservancy, Northern Andes Program, Bogota, Colombia; [Carlos Gonzalez, Juan] Nature Conservancy, Northern Andes Program, Quito, Ecuador; [Leon, Jorge] Nature Conservancy, Latin Amer Program, Cartagena, Colombia; [McKenney, Bruce] Nature Conservancy, Global Conservat Lands Program, Charlottesville, VA USA; [Kiesecker, Joseph] Nature Conservancy, Global Conservat Lands Program, Ft Collins, CO USA	Nature Conservancy; Nature Conservancy; Nature Conservancy	Kiesecker, J (corresponding author), Nature Conservancy, Global Conservat Lands Program, Ft Collins, CO USA.	jkiesecker@TNC.ORG			Colombian Ministry of Environment; Nature Conservancy; World Wildlife Fund; Conservation International	Colombian Ministry of Environment; Nature Conservancy; World Wildlife Fund; Conservation International	Funding was provided by the Colombian Ministry of Environment, The Nature Conservancy, World Wildlife Fund, and Conservation International. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso D., 2008, PRIORIDADES CONSERVA, p20p.; Ardron J. A., 2010, MARXAN GOOD PRACTICE; ARMBRUSTER P, 1993, CONSERV BIOL, V7, P602, DOI 10.1046/j.1523-1739.1993.07030602.x; Ball I., 2000, MARXAN V1 8 2 MARINE; Cabrera E, 2009, CONVENIO ASOCIACIO 0; Ceballos G, 2006, P NATL ACAD SCI USA, V103, P19374, DOI 10.1073/pnas.0609334103; Clare S, 2011, WETL ECOL MANAG, V19, P165, DOI 10.1007/s11273-011-9209-3; Copeland H, 2007, J CONSER PLANNING, V2007, P1; Corzo S, 2008, AREAS PRIORITARIAS C; DNP, 2011, PLAN NAC DES 2010 20; Dobson A, 1996, CONSERVATION BIODIVE, P66; Doncaster CP, 1996, OIKOS, V75, P335, DOI 10.2307/3546261; Environmental Law Institute, 2007, MIT IMP FISH WILDL H; ERWIN TL, 2004, P CALIF ACAD SCI, V0056, P00072; Finer M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002932; Galindo G, 2007, PLANEACIO AMBIENTAL; Galindo G, 2009, PLANIFICACIO ECOREGI; Groves C.R., 2003, DRAFTING CONSERVATIO; Heiner M., 2011, IDENTIFYING CONSERVA; IDEAM IGAC IAvH Invemar Sinchi IIAP, 2007, MAPA ECOSISTEMS CONT; International Energy Agency, 2007, WORLD EN OUTL 2007; Kiesecker Joseph M., 2011, P159; Kiesecker JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017566; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; Leon J, 2010, CONVENIO ASOCIACION; Lovejoy T. E., 1980, Parks, V5, P13; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maron M, 2010, J APPL ECOL, V47, P348, DOI 10.1111/j.1365-2664.2010.01787.x; McKenney BA, 2010, ENVIRON MANAGE, V45, P165, DOI 10.1007/s00267-009-9396-3; NatureServe, 2007, INFONATURA BIRDS MAM; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Osaragi T, 2002, CASA WORKING PAPERS; Parker TA III, 1996, NEOTROPICAL BIRDS EC; Possingham H, 1998, QUANTITATIVE METHODS FOR CONSERVATION BIOLOGY, P291; Prendergast JR, 1999, CONSERV BIOL, V13, P484, DOI 10.1046/j.1523-1739.1999.97428.x; Pressey RL, 1997, BIOL CONSERV, V80, P207, DOI 10.1016/S0006-3207(96)00045-6; Pressey RL, 2001, BIOL CONSERV, V100, P355, DOI 10.1016/S0006-3207(01)00039-8; Pressey RL, 2008, CONSERV BIOL, V22, P1340, DOI 10.1111/j.1523-1739.2008.01032.x; Rodriguez N, 2008, CONVENIO ASOCIACIO 1; Romero M, 2008, CONVENIO ASOCIACION; Rosenfeld AB, 2001, FOOTPRINTS JUNGLE; Saenz S, FRAMEWORK I IN PRESS; Saenz S, 2010, CONVENIO ASOCIACIO 0; SALAFSKY N, 1999, GREATER SUM THEIR PA; The Energy & Biodiversity Initiative, 2003, INTEGRATING BIODIVER; WHITE D, 1992, CARTOGR GEOGR INFORM, V19, P5, DOI 10.1559/152304092783786636; World Bank, 2007, GLOB EC PROSP 2007 M; Zapata P., 2010, METODOLOGI GEN PRESE	49	21	22	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81831	10.1371/journal.pone.0081831	http://dx.doi.org/10.1371/journal.pone.0081831			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339972	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100071
J	Schlegel, PM; Steiert, I; Kotter, I; Muller, CA				Schlegel, Paul Martin; Steiert, Ingeborg; Koetter, Ina; Mueller, Claudia A.			B Cells Contribute to Heterogeneity of IL-17 Producing Cells in Rheumatoid Arthritis and Healthy Controls	PLOS ONE			English	Article							CD4 T-CELLS; ROR-GAMMA-T; HELPER TYPE-1; MAST-CELLS; TH17 CELLS; TGF-BETA; DIFFERENTIATION; INTERLEUKIN-17; SYNOVIUM; DISTINCT	Secretion of the proinflammatory cytokine Interleukin-17A (IL-17A) is the hallmark of a unique lineage of CD4 T cells designated Th17 cells, which may play a crucial role in the pathogenesis of rheumatoid arthritis (RA) and many autoimmune diseases. Recently, IL-17-producing cells other than T cells have been described, including diverse innate immune cells. Here, we show that the cellular sources of IL-17A in RA include a significant number of non-T cells. Multicolour fluorescence analysis of IL-17-expressing peripheral blood mononuclear cells (PBMC) revealed larger proportions of IL-17(+)CD3(-) non-T cells in RA patients than in healthy controls (constitutive, 13.6% vs. 8.4%, and after stimulation with PMA/ionomycin 17.4% vs. 7.9% p < 0.001 in both cases). The source of IL-17 included CD3(-)CD56(+) NK cells, CD3(-)CD14(+) myeloid cells as well as the expected CD3(+)CD4(+) Th17 cells and surprisingly a substantial number of CD3(-)CD19(+) B cells. The presence of IL-17A-expressing B cells was confirmed by specific PCR of peripheral MACS-sorted CD19(+) B cells, as well as by the analysis of different EBV-transformed B cell lines. Here we report for the first time that in addition to Th17 cells and different innate immune cells B cells also contribute to the IL-17A found in RA patients and healthy controls.	[Schlegel, Paul Martin; Steiert, Ingeborg; Mueller, Claudia A.] Univ Hosp, Sect Transplantat Immunol & Immunohematol, Dept 2, Med Clin, Tubingen, Germany; [Schlegel, Paul Martin] Univ Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Koetter, Ina] Univ Hosp, Dept 2, Med Clin, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Schlegel, PM (corresponding author), Univ Hosp, Sect Transplantat Immunol & Immunohematol, Dept 2, Med Clin, Tubingen, Germany.	martin.schlegel@uni-tuebingen.de	Koetter, Ina/O-3121-2019	Koetter, Ina/0000-0002-9262-005X; Schlegel, Martin/0000-0001-7054-9566				Aerts NE, 2010, RHEUMATOLOGY, V49, P2264, DOI 10.1093/rheumatology/keq224; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; Bermejo DA, 2013, NAT IMMUNOL, V14, P514, DOI 10.1038/ni.2569; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BIRD L, 2008, NATURE REV IMMUNOLOG, V8, P324, DOI DOI 10.1038/NRI2325; Bosello S, 2008, J RHEUMATOL, V35, P1256; Capolunghi F, 2008, J IMMUNOL, V180, P800, DOI 10.4049/jimmunol.180.2.800; Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chabaud M, 2001, ARTHRITIS RES, V3, P168, DOI 10.1186/ar294; Chakir J, 2003, J ALLERGY CLIN IMMUN, V111, P1293, DOI 10.1067/mai.2003.1557; Chang Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-43; Chen DY, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3431; Church LD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3152; Colin EM, 2010, ARTHRITIS RHEUM-US, V62, P132, DOI 10.1002/art.25043; Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741; Duddy ME, 2004, J IMMUNOL, V172, P3422, DOI 10.4049/jimmunol.172.6.3422; Flores-Borja F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005407; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Gavanescu I, 2008, P NATL ACAD SCI USA, V105, P13009, DOI 10.1073/pnas.0806874105; Genovese MC, 2013, ANN RHEUM DIS, V72, P1461, DOI 10.1136/annrheumdis-2012-202775; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hitchon CA, 2011, CURR OPIN RHEUMATOL, V23, P352, DOI 10.1097/BOR.0b013e3283477b7b; HOCHBERG MC, 1992, ARTHRITIS RHEUM, V35, P498, DOI 10.1002/art.1780350502; Hoshino A, 2008, J AUTOIMMUN, V31, P79, DOI 10.1016/j.jaut.2008.03.006; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Korhonen R, 2010, BASIC CLIN PHARMACOL, V106, P13, DOI 10.1111/j.1742-7843.2009.00452.x; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Lam QLK, 2008, P NATL ACAD SCI USA, V105, P14993, DOI 10.1073/pnas.0806044105; Leon B, 2013, NAT IMMUNOL, V14, P419, DOI 10.1038/ni.2593; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Liu XL, 2009, CLIN IMMUNOL, V131, P333, DOI 10.1016/j.clim.2008.12.007; Lubberts E, 2005, ARTHRITIS RES THER, V7, P29, DOI 10.1186/ar1478; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Marston B, 2010, CURR OPIN RHEUMATOL, V22, P307, DOI 10.1097/BOR.0b013e3283369cb8; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Michel ML, 2007, J EXP MED, V204, P995, DOI 10.1084/jem.20061551; Miranda-Carus ME, 2006, ARTHRITIS RHEUM-US, V54, P1151, DOI 10.1002/art.21731; Morbach H, 2010, CLIN EXP IMMUNOL, V162, P271, DOI 10.1111/j.1365-2249.2010.04206.x; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; O'Neill SK, 2005, J IMMUNOL, V174, P3781, DOI 10.4049/jimmunol.174.6.3781; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; ROUVIER E, 1993, J IMMUNOL, V150, P5445; Shahrara S, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2477; Shen H, 2009, ARTHRITIS RHEUM-US, V60, P1647, DOI 10.1002/art.24568; Souto-Carneiro MM, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2718; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; Szodoray P, 2005, SCAND J IMMUNOL, V62, P421, DOI 10.1111/j.1365-3083.2005.01688.x; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Takemura S, 2001, J IMMUNOL, V167, P4710, DOI 10.4049/jimmunol.167.8.4710; Umemura M, 2007, J IMMUNOL, V178, P3786, DOI 10.4049/jimmunol.178.6.3786; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; WEYAND CM, 1987, J IMMUNOL, V138, P1351; Wilson CL, 2012, IMMUNOLOGY, V135, P344, DOI 10.1111/j.1365-2567.2011.03548.x; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Yamada H, 2008, ANN RHEUM DIS, V67, P1299, DOI 10.1136/ard.2007.080341; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832	63	37	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82580	10.1371/journal.pone.0082580	http://dx.doi.org/10.1371/journal.pone.0082580			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340045	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100120
J	Schreiber, R; Bellinazzi, VR; Sposito, AC; Mill, JG; Krieger, JE; Pereira, AC; Nadruz, W				Schreiber, Roberto; Bellinazzi, Vera Regina; Sposito, Andrei C.; Mill, Jose G.; Krieger, Jose E.; Pereira, Alexandre C.; Nadruz, Wilson, Jr.			Influence of the C242T Polymorphism of the p22-phox Gene (CYBA) on the Interaction between Urinary Sodium Excretion and Blood Pressure in an Urban Brazilian Population	PLOS ONE			English	Article							SALT SENSITIVITY; OXIDATIVE STRESS; NADPH OXIDASES; ASSOCIATION; P22(PHOX); HYPERTENSION; P22PHOX; SYSTEM	Background: Reactive oxygen species are implicated in the physiopathogenesis of salt-induced hypertension and the C242T polymorphism of the p22-phox gene has been associated with higher superoxide production. This study investigated the impact of this polymorphism on the relationship between urinary sodium excretion (USE) and blood pressure levels in an urban Brazilian population. Methods: We cross-sectionally evaluated 1,298 subjects from the city of Vitoria-ES, located in the Southeast region of Brazil, by clinical history, physical examination, anthropometry, analysis of laboratory parameters, USE measurement and p22-phox C242T polymorphism genotyping. Results: No significant differences in studied parameters were detected between the studied genotype groups (CC vs. CT+TT). Systolic blood pressure exhibited significant correlation with USE only in T allele carriers (r = 0.166; p<0.001), while diastolic blood pressure and hypertension status correlated with USE in both genotypes albeit more weakly in subjects with CC genotype (r=0.098; p=0.021 and r=0.105; p=0.013, respectively) than in T carriers (r=0.236; p<0.001 and r=0.213; p<0.001, respectively). Regression analyses adjusted for confounding factors showed that USE remained independently associated with systolic (p<0.001) and diastolic blood pressure (p<0.001) and hypertension status (p = 0.004) only in T allele carriers. Finally, higher diastolic and systolic blood pressure levels were detected in T allele carriers than in CC genotype individuals in the highest tertile of USE. Conclusions: The p22-phox 242T allele is associated with higher blood pressure levels among subjects with higher USE in an urban Brazilian population.	[Schreiber, Roberto; Bellinazzi, Vera Regina; Sposito, Andrei C.; Nadruz, Wilson, Jr.] Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil; [Mill, Jose G.] Univ Fed Espirito Santo, Dept Physiol Sci, Vitoria, Brazil; [Krieger, Jose E.; Pereira, Alexandre C.] Univ Sao Paulo, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Federal do Espirito Santo; Universidade de Sao Paulo	Nadruz, W (corresponding author), Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil.	wilnj@fcm.unicamp.br	Pereira, Alexandre/HHN-1038-2022; Nadruz, Wilson/I-3643-2013; Sposito, Andrei C/G-4116-2013	Nadruz, Wilson/0000-0002-0003-5102; Sposito, Andrei C/0000-0001-7127-2052; Krieger, Jose E/0000-0001-5464-1792	FAPESP [2010/16252-0]; CNPq, Brazil [476909/2012-0, 303539/2010-0]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants from FAPESP (2010/16252-0) and CNPq (476909/2012-0 and 303539/2010-0), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; [Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Arcand J, 2011, AM J CLIN NUTR, V93, P535, DOI 10.3945/ajcn.110.004457; Banday AA, 2007, HYPERTENSION, V49, P664, DOI 10.1161/01.HYP.0000255233.56410.20; Bochud M, 2006, J HYPERTENS, V24, P923, DOI 10.1097/01.hjh.0000222763.84605.4a; Cahilly C, 2000, CIRC RES, V86, P391, DOI 10.1161/01.RES.86.4.391; Castejon AM, 2006, J HUM HYPERTENS, V20, P772, DOI 10.1038/sj.jhh.1002057; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Ito D, 2000, STROKE, V31, P936, DOI 10.1161/01.STR.31.4.936; Jose GS, 2008, CLIN SCI, V114, P173, DOI 10.1042/CS20070130; Kim KI, 2007, INT J CARDIOL, V123, P18, DOI 10.1016/j.ijcard.2006.11.105; Kuznetsova T, 2006, J HYPERTENS, V24, P235, DOI 10.1097/01.hjh.0000194115.89356.bd; Li BH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056478; Mill JG, 2012, BRAZ J MED BIOL RES, V45, P799, DOI 10.1590/S0100-879X2012007500114; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Molina MD, 2003, REV SAUDE PUBL, V37, P743, DOI 10.1590/S0034-89102003000600009; Pereira AC, 2001, BRAZ J MED BIOL RES, V34, P1421, DOI 10.1590/S0100-879X2001001100008; Sanada H, 2011, CURR HYPERTENS REP, V13, P55, DOI 10.1007/s11906-010-0167-6; Schreiber R, 2012, DIABETIC MED, V29, pE55, DOI 10.1111/j.1464-5491.2012.03594.x; Schreiber R, 2013, AM J HYPERTENS, V26, P1024, DOI 10.1093/ajh/hpt066; Schreiber R, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-114; Shimo-Nakanishi Y, 2004, ATHEROSCLEROSIS, V175, P109, DOI 10.1016/j.atherosclerosis.2004.01.043; Tian N, 2005, HYPERTENSION, V45, P934, DOI 10.1161/01.HYP.0000160404.08866.5a; Toda N, 2011, J HYPERTENS, V29, P415, DOI 10.1097/HJH.0b013e328341d19e; Wu ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070885; Yokoyama M, 2000, ANN NY ACAD SCI, V902, P241; Zalba G, 2005, ANTIOXID REDOX SIGN, V7, P1327, DOI 10.1089/ars.2005.7.1327	29	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81054	10.1371/journal.pone.0081054	http://dx.doi.org/10.1371/journal.pone.0081054			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339896	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100030
J	Mender, BMW; Stringer, SM				Mender, Bedeho M. W.; Stringer, Simon M.			A Model of Self-Organizing Head-Centered Visual Responses in Primate Parietal Areas	PLOS ONE			English	Article							INVARIANT OBJECT RECOGNITION; SPATIAL LOCATION; TRANSFORMATIONS; GAZE; COORDINATION; NEURONS; SYSTEM; FIELDS	We present a hypothesis for how head-centered visual representations in primate parietal areas could self-organize through visually-guided learning, and test this hypothesis using a neural network model. The model consists of a competitive output layer of neurons that receives afferent synaptic connections from a population of input neurons with eye position gain modulated retinal receptive fields. The synaptic connections in the model are trained with an associative trace learning rule which has the effect of encouraging output neurons to learn to respond to subsets of input patterns that tend to occur close together in time. This network architecture and synaptic learning rule is hypothesized to promote the development of head-centered output neurons during periods of time when the head remains fixed while the eyes move. This hypothesis is demonstrated to be feasible, and each of the core model components described is tested and found to be individually necessary for successful self-organization.	[Mender, Bedeho M. W.; Stringer, Simon M.] Univ Oxford, Dept Expt Psychol, Oxford OX1 3UD, England	University of Oxford	Mender, BMW (corresponding author), Univ Oxford, Dept Expt Psychol, S Parks Rd, Oxford OX1 3UD, England.	bedeho.mender@psy.ox.ac.uk			Norway Scholarship; Lise og Arnfinn Hejes fund in the form of scholarships	Norway Scholarship; Lise og Arnfinn Hejes fund in the form of scholarships	This research was supported in part by the Norway Scholarship to Oxford University and by Lise og Arnfinn Hejes fund in the form of scholarships to B.M.W. Mender. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen R A, 1993, Curr Opin Neurobiol, V3, P171, DOI 10.1016/0959-4388(93)90206-E; ANDERSEN RA, 1989, ANNU REV NEUROSCI, V12, P377, DOI 10.1146/annurev.neuro.12.1.377; ANDERSEN RA, 1985, SCIENCE, V230, P456, DOI 10.1126/science.4048942; ANDERSEN RA, 1990, J NEUROSCI, V10, P1176; ANDERSEN RA, 1983, J NEUROSCI, V3, P532; ANDERSEN RA, 1995, CEREB CORTEX, V5, P457, DOI 10.1093/cercor/5.5.457; [Anonymous], 1998, NEURAL NETWORKS BRAI; Breveglieri R, 2009, LECT NOTES COMPUT SC, V5602, P324, DOI 10.1007/978-3-642-02267-8_35; COLBY CL, 1991, NEUROPSYCHOLOGIA, V29, P517, DOI 10.1016/0028-3932(91)90008-V; Deneve S, 2001, NAT NEUROSCI, V4, P826, DOI 10.1038/90541; Duhamel JR, 1997, NATURE, V389, P845, DOI 10.1038/39865; Dyan P, 2001, THEORETICAL NEUROSCI; Einhauser W, 2007, NETWORK-COMP NEURAL, V18, P267, DOI 10.1080/09548980701671094; Evans BD, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00046; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Freedman EG, 1997, J NEUROPHYSIOL, V77, P2328, DOI 10.1152/jn.1997.77.5.2328; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1993, EXP BRAIN RES, V96, P221; HALLETT PE, 1976, VISION RES, V16, P107, DOI 10.1016/0042-6989(76)90084-5; Hertz J., 1991, INTRO THEORY NEURAL, V1; MAZZONI P, 1991, P NATL ACAD SCI USA, V88, P4433, DOI 10.1073/pnas.88.10.4433; Mullette-Gillman OA, 2005, J NEUROPHYSIOL, V94, P2331, DOI 10.1152/jn.00021.2005; Pouget A, 1997, J COGNITIVE NEUROSCI, V9, P222, DOI 10.1162/jocn.1997.9.2.222; Pouget A, 2002, NAT REV NEUROSCI, V3, P741, DOI 10.1038/nrn914; ROBINSON DA, 1973, KYBERNETIK, V14, P71, DOI 10.1007/BF00288906; Rolls ET, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00035; Rolls ET, 2000, NEURAL COMPUT, V12, P2547, DOI 10.1162/089976600300014845; Royer S, 2003, NATURE, V422, P518, DOI 10.1038/nature01530; Stringer SM, 2002, NEURAL COMPUT, V14, P2585, DOI 10.1162/089976602760407982; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Widrow B, 1960, IRE WESCON, DOI DOI 10.21236/AD0241531; ZIPSER D, 1988, NATURE, V331, P679, DOI 10.1038/331679a0	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81406	10.1371/journal.pone.0081406	http://dx.doi.org/10.1371/journal.pone.0081406			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349064	gold, Green Submitted, Green Published			2022-12-27	WOS:000327947800045
J	Hao, X; Wang, KC; Li, WF; Yang, WJ; Wei, DT; Qiu, J; Zhang, QL				Hao, Xin; Wang, Kangcheng; Li, Wenfu; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang; Zhang, Qinglin			Individual Differences in Brain Structure and Resting Brain Function Underlie Cognitive Styles: Evidence from the Embedded Figures Test	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; VISUAL WORKING-MEMORY; HEMISPHERIC ASYMMETRIES; ASPERGER-SYNDROME; AUTISTIC TRAITS; PERFORMANCE; FMRI; PERCEPTION	Cognitive styles can be characterized as individual differences in the way people perceive, think, solve problems, learn, and relate to others. Field dependence/independence (FDI) is an important and widely studied dimension of cognitive styles. Although functional imaging studies have investigated the brain activation of FDI cognitive styles, the combined structural and functional correlates with individual differences in a large sample have never been investigated. In the present study, we investigated the neural correlates of individual differences in FDI cognitive styles by analyzing the correlations between Embedded Figures Test (EFT) score and structural neuroimaging data [regional gray matter volume (rGMV) was assessed using voxel-based morphometry (VBM)] / functional neuroimaging data [resting-brain functions were measured by amplitude of low-frequency fluctuation (ALFF)] throughout the whole brain. Results showed that the increased rGMV in the left inferior parietal lobule (IPL) was associated with the EFT score, which might be the structural basis of effective local processing. Additionally, a significant positive correlation between ALFF and EFT score was found in the fronto-parietal network, including the left inferior parietal lobule (IPL) and the medial prefrontal cortex (mPFC). We speculated that the left IPL might be associated with superior feature identification, and mPFC might be related to cognitive inhibition of global processing bias. These results suggested that the underlying neuroanatomical and functional bases were linked to the individual differences in FDI cognitive styles and emphasized the important contribution of superior local processing ability and cognitive inhibition to field-independent style.	[Hao, Xin; Wang, Kangcheng; Li, Wenfu; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang; Zhang, Qinglin] Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China; [Hao, Xin; Wang, Kangcheng; Li, Wenfu; Yang, Wenjing; Wei, Dongtao; Qiu, Jiang; Zhang, Qinglin] Southwest Univ, Dept Psychol, Chongqing, Peoples R China	Southwest University - China	Qiu, J (corresponding author), Minist Educ, Key Lab Cognit & Personal SWU, Chongqing, Peoples R China.	qiuj328@swu.edu.cn; zhangql@swu.edu.cn			National Natural Science Foundation of China [31070900, 30800293, 30970892, 31170983]; Program for New Century Excellent Talents in University by the Ministry of Education; Fundamental Research Funds for the Central Universities [SWU1209101]; China Postdoctoral Science Foundation [2012M510098]; Research Funds for Southwest University [SWU09103]; Key Discipline Fund of National 211 Project [NSKD 11007]; postgraduate Innovation Foundation of Science and Technology of Southwest University [kb2011002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University by the Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Funds for Southwest University; Key Discipline Fund of National 211 Project; postgraduate Innovation Foundation of Science and Technology of Southwest University	The research was supported by the National Natural Science Foundation of China (31070900; 30800293; 30970892; 31170983), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, the Fundamental Research Funds for the Central Universities (SWU1209101), China Postdoctoral Science Foundation funded project (2012M510098), the Research Funds for Southwest University (SWU09103), the Key Discipline Fund of National 211 Project (NSKD 11007), the Fundamental Research Funds for the Central Universities (swu1209101), the Program for New Century Excellent Talents in University (2011) by the Ministry of Education, China Postdoctoral Science Foundation funded project (2012M510098), and the postgraduate Innovation Foundation of Science and Technology of Southwest University (kb2011002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RA, 2010, NEUROPSYCHOLOGIA, V48, P374, DOI 10.1016/j.neuropsychologia.2009.09.024; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Baldassarre A, 2012, P NATL ACAD SCI USA, V109, P3516, DOI 10.1073/pnas.1113148109; BaronCohen S, 1997, J COGNITIVE NEUROSCI, V9, P548, DOI 10.1162/jocn.1997.9.4.548; Best CS, 2008, J AUTISM DEV DISORD, V38, P840, DOI 10.1007/s10803-007-0451-8; Boddaert N, 2004, NEUROIMAGE, V23, P364, DOI 10.1016/j.neuroimage.2004.06.016; Bolte S, 2007, J AUTISM DEV DISORD, V37, P243, DOI 10.1007/s10803-006-0165-3; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brass M, 2009, J NEUROSCI, V29, P1766, DOI 10.1523/JNEUROSCI.5259-08.2009; Buckholtz JW, 2012, NEURON, V74, P990, DOI 10.1016/j.neuron.2012.06.002; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cohen MX, 2008, BRAIN RES, V1238, P127, DOI 10.1016/j.brainres.2008.07.114; Constantino JN, 2005, BIOL PSYCHIAT, V57, P655, DOI 10.1016/j.biopsych.2004.12.014; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damarla SR, 2010, AUTISM RES, V3, P273, DOI 10.1002/aur.153; Desco M, 2011, NEUROIMAGE, V57, P281, DOI 10.1016/j.neuroimage.2011.03.063; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; FATERSON HF, 1970, DEV PSYCHOL, V2, P429, DOI 10.1037/h0029167; Fink GR, 1997, BRAIN, V120, P2013, DOI 10.1093/brain/120.11.2013; Fink GR, 1999, NEUROPSYCHOLOGIA, V37, P31; FORD N, 1995, INT J HUM-COMPUT ST, V43, P241, DOI 10.1006/ijhc.1995.1043; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frith U., 1989, AUTISM EXPLAINING EN, V6th; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Goodyear BG, 2009, EXP BRAIN RES, V192, P231, DOI 10.1007/s00221-008-1574-7; Haier Richard J, 2009, BMC Res Notes, V2, P174, DOI 10.1186/1756-0500-2-174; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Happe F, 1999, TRENDS COGN SCI, V3, P216, DOI 10.1016/S1364-6613(99)01318-2; Happe F, 2006, J AUTISM DEV DISORD, V36, P5, DOI 10.1007/s10803-005-0039-0; Harris IM, 2000, BRAIN, V123, P65, DOI 10.1093/brain/123.1.65; Hayes J., 1994, BRIT J MANAGE, V5, P53, DOI [10.1111/j.1467-8551.1994.tb00068.x, DOI 10.1111/j.1467-8551.1994.tb00068.x]; Hazlett HC, 2006, BIOL PSYCHIAT, V59, P1, DOI 10.1016/j.biopsych.2005.06.015; Horst NK, 2012, J NEUROPHYSIOL, V108, P3276, DOI 10.1152/jn.01192.2011; Huang XQ, 2010, NEUROIMAGE, V49, P2901, DOI 10.1016/j.neuroimage.2009.11.072; Jolliffe T, 1997, J CHILD PSYCHOL PSYC, V38, P527, DOI 10.1111/j.1469-7610.1997.tb01539.x; Kennedy DP, 2008, NEUROIMAGE, V39, P1877, DOI 10.1016/j.neuroimage.2007.10.052; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; Kovacs I, 1999, P NATL ACAD SCI USA, V96, P12204, DOI 10.1073/pnas.96.21.12204; Kozhevnikov M, 2007, PSYCHOL BULL, V133, P464, DOI 10.1037/0033-2909.133.3.464; Kunihira Y, 2006, J AUTISM DEV DISORD, V36, P553, DOI 10.1007/s10803-006-0094-1; Landau SM, 2004, NEUROIMAGE, V22, P211, DOI 10.1016/j.neuroimage.2004.01.003; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Lee PS, 2007, NEUROIMAGE, V38, P184, DOI 10.1016/j.neuroimage.2007.07.013; Li D., 1988, PSYCHOL SCI, V4, P27, DOI DOI 10.16719/J.CNKI.1671-6981.1988.04.007; Linden DEJ, 2003, NEUROIMAGE, V20, P1518, DOI 10.1016/j.neuroimage.2003.07.021; Liston C, 2009, P NATL ACAD SCI USA, V106, P912, DOI 10.1073/pnas.0807041106; Liu YN, 2011, NEUROPSYCHOLOGIA, V49, P2105, DOI 10.1016/j.neuropsychologia.2011.04.005; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Losh M, 2007, J CHILD PSYCHOL PSYC, V48, P105, DOI 10.1111/j.1469-7610.2006.01594.x; Lotspeich L, 2004, ARCH GEN PSYCHIAT, V61, P291, DOI 10.1001/archpsyc.61.3.291; Lux S, 2004, NEUROSCIENCE, V124, P113, DOI 10.1016/j.neuroscience.2003.10.044; Manjaly ZM, 2007, NEUROIMAGE, V35, P283, DOI 10.1016/j.neuroimage.2006.11.036; Manjaly ZM, 2003, NEUROIMAGE, V19, P674, DOI 10.1016/S1053-8119(03)00095-8; Martens U, 2013, BRAIN COGNITION, V81, P161, DOI 10.1016/j.bandc.2012.11.005; Martinez A, 1997, NEUROREPORT, V8, P1685, DOI 10.1097/00001756-199705060-00025; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; Milne Elizabeth, 2009, Adv Cogn Psychol, V5, P1, DOI 10.2478/v10053-008-0062-8; Narayanan NS, 2006, NEURON, V52, P921, DOI 10.1016/j.neuron.2006.10.021; Nickl-Jockschat T, 2012, HUM BRAIN MAPP, V33, P1470, DOI 10.1002/hbm.21299; O'Boyle MW, 2005, COGNITIVE BRAIN RES, V25, P583, DOI 10.1016/j.cogbrainres.2005.08.004; OCONNOR KP, 1978, BIOL PSYCHOL, V6, P93, DOI 10.1016/0301-0511(78)90049-2; OLTMAN PK, 1979, NEUROPSYCHOLOGIA, V17, P699, DOI 10.1016/0028-3932(79)90046-0; Pessoa L, 2002, NEURON, V35, P975, DOI 10.1016/S0896-6273(02)00817-6; Raven J.C., 1938, PROGR MATRICES PERCE; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Ridgway GR, 2009, NEUROIMAGE, V44, P99, DOI 10.1016/j.neuroimage.2008.08.045; Ring HA, 1999, BRAIN, V122, P1305, DOI 10.1093/brain/122.7.1305; Russell-Smith SN, 2012, J AUTISM DEV DISORD, V42, P2420, DOI 10.1007/s10803-012-1506-z; SHAH A, 1983, J CHILD PSYCHOL PSYC, V24, P613, DOI 10.1111/j.1469-7610.1983.tb00137.x; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tang YY, 2012, TRENDS COGN SCI, V16, P330, DOI 10.1016/j.tics.2012.05.001; Todd JJ, 2004, NATURE, V428, P751, DOI 10.1038/nature02466; von dem Hagen EAH, 2011, CEREB CORTEX, V21, P493, DOI 10.1093/cercor/bhq062; Walter E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020742; WANG D, 1989, REPORTS PSYCHOL SCI, V5, P23; [王栋 WANG Dong], 2007, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V15, P559; Wanzel KR, 2007, AM J SURG, V193, P507, DOI 10.1016/j.amjsurg.2006.11.011; Weiss MM, 2009, NEUROIMAGE, V44, P1063, DOI 10.1016/j.neuroimage.2008.09.042; Weissman DH, 2005, CEREB CORTEX, V15, P870, DOI 10.1093/cercor/bhh187; Weissman DH, 2003, NEUROIMAGE, V19, P1361, DOI 10.1016/S1053-8119(03)00167-8; Witkin, 1971, MANUAL GROUP EMBEDDE; WITKIN HA, 1967, J PERS SOC PSYCHOL, V7, P291, DOI 10.1037/h0025070; WITKIN HA, 1977, REV EDUC RES, V47, P1; WITKIN HA, 1950, J PERS, V19, P1, DOI 10.1111/j.1467-6494.1950.tb01084.x; WITKIN HA, 1972, PERSONALITY PERCEPTI; XIE J, 1988, COGNITIVE STYLE EXPT, P71222; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; ZHANG LF, 2001, PERSPECTIVES THINKIN; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	97	24	24	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e78089	10.1371/journal.pone.0078089	http://dx.doi.org/10.1371/journal.pone.0078089			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24348991	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200001
J	De Schepper, S; Groeneveld, J; Naafs, BDA; Van Renterghem, C; Hennissen, J; Head, MJ; Louwye, S; Fabian, K				De Schepper, Stijn; Groeneveld, Jeroen; Naafs, B. David A.; Van Renterghem, Cederic; Hennissen, Jan; Head, Martin J.; Louwye, Stephen; Fabian, Karl			Northern Hemisphere Glaciation during the Globally Warm Early Late Pliocene	PLOS ONE			English	Article							SEA-LEVEL; OVERTURNING CIRCULATION; DINOFLAGELLATE CYSTS; ATLANTIC-OCEAN; PLEISTOCENE; RECONSTRUCTION; PRODUCTIVITY; STRATIGRAPHY; CALIBRATION; DELTA-O-18	The early Late Pliocene (3.6 to similar to 3.0 million years ago) is the last extended interval in Earth's history when atmospheric CO2 concentrations were comparable to today's and global climate was warmer. Yet a severe global glaciation during marine isotope stage (MIS) M2 interrupted this phase of global warmth similar to 3.30 million years ago, and is seen as a premature attempt of the climate system to establish an ice-age world. Here we propose a conceptual model for the glaciation and deglaciation of MIS M2 based on geochemical and palynological records from five marine sediment cores along a Caribbean to eastern North Atlantic transect. Our records show that increased Pacific-to-Atlantic flow via the Central American Seaway weakened the North Atlantic Current and attendant northward heat transport prior to MIS M2. The consequent cooling of the northern high latitude oceans permitted expansion of the continental ice sheets during MIS M2, despite near-modern atmospheric CO2 concentrations. Sea level drop during this glaciation halted the inflow of Pacific water to the Atlantic via the Central American Seaway, allowing the build-up of a Caribbean Warm Pool. Once this warm pool was large enough, the Gulf Stream-North Atlantic Current system was reinvigorated, leading to significant northward heat transport that terminated the glaciation. Before and after MIS M2, heat transport via the North Atlantic Current was crucial in maintaining warm climates comparable to those predicted for the end of this century.	[De Schepper, Stijn] Univ Bergen, Dept Earth Sci, Bergen, Norway; [De Schepper, Stijn] Univ Bremen, Dept Geosci, D-28359 Bremen, Germany; [Groeneveld, Jeroen] Univ Bremen, MARUM Ctr Marine Environm Sci, D-28359 Bremen, Germany; [Naafs, B. David A.] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Van Renterghem, Cederic; Louwye, Stephen] Univ Ghent, Res Unit Palaeontol, B-9000 Ghent, Belgium; [Hennissen, Jan; Head, Martin J.] Univ Toronto, Dept Earth Sci, Toronto, ON, Canada; [Head, Martin J.] Brock Univ, Dept Earth Sci, St Catharines, ON L2S 3A1, Canada; [Fabian, Karl] Norwegian Geol Survey, Trondheim, Norway	University of Bergen; University of Bremen; University of Bremen; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; Ghent University; University of Toronto; Brock University; Geological Survey of Norway	De Schepper, S (corresponding author), Univ Bergen, Dept Earth Sci, Bergen, Norway.	smad2@cantab.net	Hennissen, Jan/AAF-4428-2020; Naafs, Bernhard D.A./F-5257-2012; Naafs, Bernhard David/AFV-1912-2022; Fabian, Karl/AAC-8643-2022; Louwye, Stephen/D-3856-2012; Hennissen, Jan A. I./AAT-7729-2020; De Schepper, Stijn/A-2836-2011	Hennissen, Jan/0000-0002-0435-3343; Naafs, Bernhard D.A./0000-0001-5125-6928; Naafs, Bernhard David/0000-0001-5125-6928; Fabian, Karl/0000-0002-3504-3292; Louwye, Stephen/0000-0003-4814-4313; De Schepper, Stijn/0000-0002-6934-0914	Deutsche Forschungsgemeinschaft [SCHE 1665/2-1, SCHE 1665/2-2, NA973/1-1]; University of Bergen; MARUM Student Summer Fellowship; NSERC Canada Discovery Grant; NERC [bgs05002] Funding Source: UKRI; Natural Environment Research Council [bgs05002] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Bergen; MARUM Student Summer Fellowship; NSERC Canada Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by Deutsche Forschungsgemeinschaft grants SCHE 1665/2-1 and SCHE 1665/2-2 (SDS) and NA973/1-1 (BDAN), the University of Bergen (SDS), a MARUM Student Summer Fellowship (CVR), and a NSERC Canada Discovery Grant (MJH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendregt RW, 2011, DEV QUATER SCI, V15, P419, DOI 10.1016/B978-0-444-53447-7.00032-5; Barker S, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2003GC000559; Bartoli G, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002055; Berger WH, 1996, SOUTH ATLANTIC, P363; Bintanja R, 2008, NATURE, V454, P869, DOI 10.1038/nature07158; Born A, 2010, CLIM PAST, V6, P817, DOI 10.5194/cp-6-817-2010; BRASSELL SC, 1986, NATURE, V320, P129, DOI 10.1038/320129a0; Brierley CM, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2009PA001809; Brigham-Grette J, 2013, SCIENCE, V340, P1421, DOI 10.1126/science.1233137; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Carlson AE, 2008, GEOLOGY, V36, P991, DOI 10.1130/G25080A.1; Chapman MR, 2010, PALEOCEANOGRAPHY, V25, DOI 10.1029/2008PA001708; CLEMENT BM, 1987, INITIAL REP DEEP SEA, V94, P635; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; De Schepper S, 2008, J SYST PALAEONTOL, V6, P101, DOI 10.1017/S1477201907002167; De Schepper S, 2011, PALAEOGEOGR PALAEOCL, V309, P17, DOI 10.1016/j.palaeo.2011.04.020; De Schepper S, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001725; Dolan AM, 2011, PALAEOGEOGR PALAEOCL, V309, P98, DOI 10.1016/j.palaeo.2011.03.030; Dowsett HJ, 2012, NAT CLIM CHANGE, V2, P365, DOI [10.1038/NCLIMATE1455, 10.1038/nclimate1455]; Driscoll NW, 1998, SCIENCE, V282, P436, DOI 10.1126/science.282.5388.436; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; Expedition 306 Scientists, 2006, P IODP, V303/306, P1, DOI [DOI 10.2204/I0DP.PR0C.303306.108.2006, 10.2204/iodp.proc.303306.112.2006.]; Eynaud F, 2004, REV PALAEOBOT PALYNO, V128, P55, DOI 10.1016/S0034-6667(03)00112-X; Ganssen GM, 2000, J GEOL SOC LONDON, V157, P693, DOI 10.1144/jgs.157.3.693; Gao CH, 2012, GEOLOGY, V40, P975, DOI 10.1130/G33092.1; Geirsdottir A, 2011, DEV QUATER SCI, V15, P199, DOI 10.1016/B978-0-444-53447-7.00016-7; Greaves M, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2008GC001974; Groeneveld J, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA001940; HARLAND R, 1983, PALAEONTOLOGY, V26, P321; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Haywood AM, 2004, EARTH PLANET SC LETT, V218, P363, DOI 10.1016/S0012-821X(03)00685-X; Hefter J, 2008, ANAL CHEM, V80, P2161, DOI 10.1021/ac702194m; Heslop D, 2011, MAR MICROPALEONTOL, V79, P114, DOI 10.1016/j.marmicro.2011.01.007; Hilgen FJ, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P923, DOI 10.1016/B978-0-444-59425-9.00029-9; Kleiven HF, 2002, PALAEOGEOGR PALAEOCL, V184, P213; Klocker A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021564; Knies J, 2009, QUATERNARY SCI REV, V28, P812, DOI 10.1016/j.quascirev.2008.12.002; Kurschner WM, 1996, MAR MICROPALEONTOL, V27, P299, DOI 10.1016/0377-8398(95)00067-4; Lawrence KT, 2010, EARTH PLANET SC LETT, V300, P329, DOI 10.1016/j.epsl.2010.10.013; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Locarnini R.A., 2006, NOAA ATLAS NESDIS; Lunt DJ, 2008, NATURE, V454, P1102, DOI 10.1038/nature07223; Lunt DJ, 2008, CLIM DYNAM, V30, P1, DOI 10.1007/s00382-007-0265-6; Miller KG, 2012, GEOLOGY, V40, P407, DOI 10.1130/G32869.1; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Moran K, 2006, NATURE, V441, P601, DOI 10.1038/nature04800; Mudelsee M, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001153; Muller PJ, 1998, GEOCHIM COSMOCHIM AC, V62, P1757, DOI 10.1016/S0016-7037(98)00097-0; Naafs BDA, 2012, EARTH PLANET SC LETT, V317, P8, DOI 10.1016/j.epsl.2011.11.026; Naafs BDA, 2010, EARTH PLANET SC LETT, V298, P434, DOI 10.1016/j.epsl.2010.08.023; Naish T, 2009, NATURE, V458, P322, DOI 10.1038/nature07867; Naish TR, 2009, PHILOS T R SOC A, V367, P169, DOI 10.1098/rsta.2008.0223; Nurnberg D, 2000, PALEOCEANOGRAPHY, V15, P124, DOI 10.1029/1999PA000370; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Paillard D., 1996, EOS T AM GEOPHYS UN, V77, P379, DOI 10.1029/96EO00259; Passchier S, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2010PA002061; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; PRAHL FG, 1987, NATURE, V330, P367, DOI 10.1038/330367a0; Radi T, 2008, MAR MICROPALEONTOL, V68, P84, DOI 10.1016/j.marmicro.2008.01.012; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; Raymo ME, 1996, MAR MICROPALEONTOL, V27, P313, DOI 10.1016/0377-8398(95)00048-8; Rochon A., 1999, AM ASS STRATIGR PALY, V35, P146; Ruddiman W.F., 1987, Initial Reports of the Deep Sea Drilling Project, V94, P351; Salzmann U, 2008, GLOBAL ECOL BIOGEOGR, V17, P432, DOI 10.1111/j.1466-8238.2008.00381.x; Sarnthein M, 2009, CLIM PAST, V5, P269, DOI 10.5194/cp-5-269-2009; Schiebel R, 1997, DEEP-SEA RES PT I, V44, P1701, DOI 10.1016/S0967-0637(97)00036-8; Schiebel R, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006841; Schneider B, 2006, EARTH PLANET SC LETT, V246, P367, DOI 10.1016/j.epsl.2006.04.028; Seki O, 2010, EARTH PLANET SC LETT, V292, P201, DOI 10.1016/j.epsl.2010.01.037; Shackleton N.J., 1995, Proceedings of the Ocean Drilling Program Scientific Results, V138, P337, DOI 10.2973/odp.proc.sr.138.117.1995; Shackleton N. J., 1974, COLLOQ INT CENT NATL, V219, P203; SHACKLETON NJ, 1984, INITIAL REP DEEP SEA, V81, P599, DOI 10.2973/dsdp.proc.81.116.1984; STEPH S, 2006, P OC DRILL PROGR SCI, V0202; Steph S, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2004PA001092; STOCKMARR J, 1971, Pollen et Spores, V13, P615; TIEDEMANN R, 1994, PALEOCEANOGRAPHY, V9, P619, DOI 10.1029/94PA00208; TIEDEMANN R, 2006, P OCEAN DRILLING PRO, V0202; Zhang ZS, 2013, CLIM PAST, V9, P1495, DOI 10.5194/cp-9-1495-2013; Zonneveld KAF, 2013, REV PALAEOBOT PALYNO, V191, P1, DOI 10.1016/j.revpalbo.2012.08.003	80	85	85	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81508	10.1371/journal.pone.0081508	http://dx.doi.org/10.1371/journal.pone.0081508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349081	gold, Green Published			2022-12-27	WOS:000328731800021
J	Wang, YJ; Cai, HW; Li, CJ; Jiang, ZW; Wang, L; Song, JG; Xia, JL				Wang, Yongji; Cai, Hongwei; Li, Chanjuan; Jiang, Zhiwei; Wang, Ling; Song, Jiugang; Xia, Jielai			Optimal Caliper Width for Propensity Score Matching of Three Treatment Groups: A Monte Carlo Study	PLOS ONE			English	Article							CAUSAL INFERENCE; BIAS	Propensity score matching is a method to reduce bias in non-randomized and observational studies. Propensity score matching is mainly applied to two treatment groups rather than multiple treatment groups, because some key issues affecting its application to multiple treatment groups remain unsolved, such as the matching distance, the assessment of balance in baseline variables, and the choice of optimal caliper width. The primary objective of this study was to compare propensity score matching methods using different calipers and to choose the optimal caliper width for use with three treatment groups. The authors used caliper widths from 0.1 to 0.8 of the pooled standard deviation of the logit of the propensity score, in increments of 0.1. The balance in baseline variables was assessed by standardized difference. The matching ratio, relative bias, and mean squared error (MSE) of the estimate between groups in different propensity score-matched samples were also reported. The results of Monte Carlo simulations indicate that matching using a caliper width of 0.2 of the pooled standard deviation of the logit of the propensity score affords superior performance in the estimation of treatment effects. This study provides practical solutions for the application of propensity score matching of three treatment groups.	[Wang, Yongji] 309th Hosp Chinese Peoples Liberat Army, Dept Med, Beijing, Peoples R China; [Wang, Yongji; Li, Chanjuan; Jiang, Zhiwei; Wang, Ling; Xia, Jielai] Fourth Mil Med Univ, Dept Hlth Stat, Xian 710032, Shaanxi, Peoples R China; [Cai, Hongwei] Fourth Mil Med Univ, Sch Stomatol, Informat Ctr, Xian 710032, Shaanxi, Peoples R China; [Song, Jiugang] 309th Hosp Chinese Peoples Liberat Army, Dept Gastroenterol, Beijing, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Cai, HW (corresponding author), Fourth Mil Med Univ, Sch Stomatol, Informat Ctr, Xian 710032, Shaanxi, Peoples R China.	hwcai@fmmu.edu.cn; jielaixia@yahoo.com		Cai, Hongwei/0000-0001-9699-7260	National Natural Science Foundation of China [30800952, 81001290]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants 30800952 and 81001290 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2008, STAT MED, V27, P2037, DOI 10.1002/sim.3150; Austin PC, 2007, J THORAC CARDIOV SUR, V134, P1128, DOI 10.1016/j.jtcvs.2007.07.021; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Austin PC, 2009, BIOMETRICAL J, V51, P171, DOI 10.1002/bimj.200810488; COCHRAN WG, 1973, SANKHYA SER A, V35, P417; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Ekundayo OJ, 2010, INT J CARDIOL, V141, P167, DOI 10.1016/j.ijcard.2008.11.195; FLURY BK, 1986, AM STAT, V40, P249, DOI 10.2307/2684560; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Imai K, 2008, J R STAT SOC A STAT, V171, P481, DOI 10.1111/j.1467-985X.2007.00527.x; Imbens GW, 2000, BIOMETRIKA, V87, P706, DOI 10.1093/biomet/87.3.706; Joffe MM, 1999, AM J EPIDEMIOL, V150, P327; Katherine HH, 2002, BIOSTATISTICS, V2, P179; ROSENBAUM PR, 1989, J AM STAT ASSOC, V84, P1024, DOI 10.2307/2290079; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Spreeuwenberg MD, 2010, MED CARE, V48, P166, DOI 10.1097/MLR.0b013e3181c1328f; Wang JX, 2001, PHARMACOEPIDEM DR S, V10, P105, DOI 10.1002/pds.572	19	70	73	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81045	10.1371/journal.pone.0081045	http://dx.doi.org/10.1371/journal.pone.0081045			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349029	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300019
J	Zhao, HW; Lin, J; Wang, XB; Cheng, X; Wang, JY; Hu, BL; Zhang, Y; Zhang, X; Zhu, JH				Zhao, Hai-Wen; Lin, Jie; Wang, Xue-Bao; Cheng, Xing; Wang, Jian-Yong; Hu, Bei-Lei; Zhang, Yan; Zhang, Xiong; Zhu, Jian-Hong			Assessing Plasma Levels of Selenium, Copper, Iron and Zinc in Patients of Parkinson's Disease	PLOS ONE			English	Article							CELL-DEATH PATHWAYS; CEREBROSPINAL-FLUID; SERUM; METALS; URINE; BLOOD; PERFORMANCE; DEFICIENCY; ALZHEIMERS; FERRITIN	Trace elements have been recognized to play an important role in the development of Parkinson's disease (PD). However, it is difficult to precisely identify the relationship between these elements and the progression of PD because of an insufficient number of patients. In this study, quantifications of selenium (Se), copper (Cu), iron (Fe) and zinc (Zn) by atomic absorption spectrophotometry were performed in plasma from 238 PD patients and 302 controls recruited from eastern China, which is so far the largest cohort of PD patients and controls for measuring plasma levels of these elements. We found that plasma Se and Fe concentrations were significantly increased whereas Cu and Zn concentrations decreased in PD patients as compared with controls. Meanwhile, these four elements displayed differential changes with regard to age. Linear and logistic regression analyses revealed that both Fe and Zn were negatively correlated with age in PD patients. Association analysis suggests that lower plasma Se and Fe levels may reduce the risk for PD, whereas lower plasma Zn is probably a PD risk factor. Finally, a model was generated to predict PD patients based on the plasma concentrations of these four trace elements as well as other features such as sex and age, which achieved an accuracy of 80.97 +/- 1.34% using 10-fold cross-validation. In summary, our data provide new insights into the roles of Se, Cu, Fe and Zn in PD progression.	[Zhao, Hai-Wen; Zhu, Jian-Hong] Wenzhou Med Univ, Dept Prevent Med, Wenzhou, Zhejiang, Peoples R China; [Cheng, Xing; Wang, Jian-Yong; Hu, Bei-Lei; Zhang, Xiong; Zhu, Jian-Hong] Wenzhou Med Univ, Affiliated Hosp 2, Dept Geriatr & Neurol, Wenzhou, Zhejiang, Peoples R China; [Wang, Xue-Bao] Wenzhou Med Univ, Analyt & Testing Ctr, Wenzhou, Zhejiang, Peoples R China; [Lin, Jie; Zhang, Yan] Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China; [Lin, Jie] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Zhang, Y (corresponding author), Chinese Acad Sci, Inst Nutr Sci, Key Lab Nutr & Metab, Shanghai, Peoples R China.	yanzhang01@sibs.ac.cn; zhangxiong98@gmail.com; jianhong.zhu@gmail.com	Zhu, Jian-Hong/E-3927-2010; Wang, Jian-Yong/HGC-1081-2022	Zhu, Jian-Hong/0000-0001-9412-8264; 	National Natural Science Foundation of China [31201065, 31171233]; Zhejiang Provincial Natural Science Foundation [LR13H020002, LY13H090011]; Health Bureau of Zhejiang Province [2013ZDA015, 2013RCA040, 2013ZB086]; Chinese Academy of Sciences [2012OHTP10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Health Bureau of Zhejiang Province; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by funding from National Natural Science Foundation of China (31201065 and 31171233), Zhejiang Provincial Natural Science Foundation (LR13H020002 and LY13H090011), Health Bureau of Zhejiang Province (2013ZDA015, 2013RCA040 and 2013ZB086), and Chinese Academy of Sciences (2012OHTP10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi HI, 2012, CLIN LAB, V58, P7; Aguilar MV, 1998, J NEURAL TRANSM, V105, P1245, DOI 10.1007/s007020050127; Ahmed SSSJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011252; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Brewer GJ, 2010, AM J ALZHEIMERS DIS, V25, P572, DOI 10.1177/1533317510382283; Chen CJ, 2006, SCI TOTAL ENVIRON, V367, P448, DOI 10.1016/j.scitotenv.2006.03.004; Cole NB, 2005, J BIOL CHEM, V280, P9678, DOI 10.1074/jbc.M409946200; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; DEXTER DT, 1991, BRAIN, V114, P1953, DOI 10.1093/brain/114.4.1953; Double Kay L, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS52, DOI 10.1016/S1353-8020(11)70018-9; Eggers C, 2011, MOVEMENT DISORD, V26, P416, DOI 10.1002/mds.23468; FOLIN M, 1994, BIOMETALS, V7, P75; Forsleff L, 1999, J ALTERN COMPLEM MED, V5, P57, DOI 10.1089/acm.1999.5.57; Forte G, 2004, J NEURAL TRANSM, V111, P1031, DOI 10.1007/s00702-004-0124-0; Fukushima T, 2011, NEUROEPIDEMIOLOGY, V36, P240, DOI 10.1159/000328253; Jimenez-Jimenez FJ, 1998, J NEURAL TRANSM, V105, P497, DOI 10.1007/s007020050073; JIMENEZJIMENEZ FJ, 1992, J NEUROL SCI, V112, P30; Levy OA, 2009, APOPTOSIS, V14, P478, DOI 10.1007/s10495-008-0309-3; Ling HL, 2011, EUR NEUROL, V66, P123, DOI 10.1159/000330538; Logroscino G, 1997, NEUROLOGY, V49, P714, DOI 10.1212/WNL.49.3.714; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; MANN VM, 1994, ANN NEUROL, V36, P876, DOI 10.1002/ana.410360612; Mariani S, 2013, NEUROBIOL AGING, V34, P632, DOI 10.1016/j.neurobiolaging.2012.05.015; Meyer D., 2012, MISC FUNCTIONS DEP S; Nikam S, 2009, INDIAN J CLIN BIOCHE, V24, P98, DOI 10.1007/s12291-009-0017-y; Oakley AE, 2007, NEUROLOGY, V68, P1820, DOI 10.1212/01.wnl.0000262033.01945.9a; Popescu BFG, 2009, PHYS MED BIOL, V54, P651, DOI 10.1088/0031-9155/54/3/012; Qureshi GA, 2006, J NEURAL TRANSM-SUPP, P229; Saini N, 2010, BIOL CHEM, V391, P513, DOI 10.1515/BC.2010.052; Shahar A, 2010, MOVEMENT DISORD, V25, P1909, DOI 10.1002/mds.23218; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Ward RJ, 2012, CURR MED CHEM, V19, P2760; Yao Z, 2009, ANTIOXID REDOX SIGN, V11, P2135, DOI [10.1089/ars.2009.2624, 10.1089/ARS.2009.2624]; Zhang S, 2010, MECH AGEING DEV, V131, P253, DOI 10.1016/j.mad.2010.02.006	34	72	73	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83060	10.1371/journal.pone.0083060	http://dx.doi.org/10.1371/journal.pone.0083060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340079	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400115
J	Shi, LJ; Liu, LJ; He, TT; Guo, XJ; Yu, ZP; Yin, SK; Wang, J				Shi, Lijuan; Liu, Lijie; He, Tingting; Guo, Xiaojing; Yu, Zhiping; Yin, Shankai; Wang, Jian			Ribbon Synapse Plasticity in the Cochleae of Guinea Pigs after Noise-Induced Silent Damage	PLOS ONE			English	Article							SURFACE AMPA RECEPTORS; INNER HAIR-CELLS; AFFERENT SYNAPSE; HEARING-LOSS; BRAIN-STEM; AGE; RESPONSES; NEURONS; MECHANISMS; EXPRESSION	Noise exposure at low levels or low doses can damage hair cell afferent ribbon synapses without causing permanent threshold shifts. In contrast to reports in the mouse cochleae, initial damage to ribbon synapses in the cochleae of guinea pigs is largely repairable. In the present study, we further investigated the repair process in ribbon synapses in guinea pigs after similar noise exposure. In the control samples, a small portion of afferent synapses lacked synaptic ribbons, suggesting the co-existence of conventional no-ribbon and ribbon synapses. The loss and recovery of hair cell ribbons and postsynaptic densities (PSDs) occurred in parallel, but the recovery was not complete, resulting in a permanent loss of less than 10% synapses. During the repair process, ribbons were temporally separated from the PSDs. A plastic interaction between ribbons and postsynaptic terminals may be involved in the reestablishment of synaptic contact between ribbons and PSDs, as shown by location changes in both structures. Synapse repair was associated with a breakdown in temporal processing, as reflected by poorer responses in the compound action potential (CAP) of auditory nerves to time-stress signals. Thus, deterioration in temporal processing originated from the cochlea. This deterioration developed with the recovery in hearing threshold and ribbon synapse counts, suggesting that the repaired synapses had deficits in temporal processing.	[Shi, Lijuan; Liu, Lijie; He, Tingting; Guo, Xiaojing; Wang, Jian] Southeast Univ, Coll Med, Dept Physiol & Pharmacol, Nanjing, Jiangsu, Peoples R China; [Yu, Zhiping; Wang, Jian] Dalhousie Univ, Sch Human Commun Disorders, Halifax, NS, Canada; [Yin, Shankai] Jiao Tong Univ, Affiliated Hosp 6, Dept Otolaryngol, Shanghai 200030, Peoples R China	Southeast University - China; Dalhousie University; Shanghai Jiao Tong University	Wang, J (corresponding author), Southeast Univ, Coll Med, Dept Physiol & Pharmacol, Nanjing, Jiangsu, Peoples R China.	Jian.Wang@dal.ca	石, 丽娟/M-8204-2016; liu, lijie/AAG-9041-2021	石, 丽娟/0000-0002-3350-303X; liu, lijie/0000-0002-8309-609X; Wang, Jian/0000-0003-3633-6799	Youth Fund of Medical School of Southeast University [Qj2012004]; National Natural Science Foundation of China [81272086]	Youth Fund of Medical School of Southeast University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a Youth Fund of Medical School of Southeast University (Qj2012004) and the grant of National Natural Science Foundation of China (Grant #81272086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURKARD R, 1984, AUDIOLOGY, V23, P85; Chen Z, 2007, NAT NEUROSCI, V10, P1238, DOI 10.1038/nn1974; Chen ZQ, 2009, J NEUROPHYSIOL, V102, P1152, DOI 10.1152/jn.00288.2009; Ding DL, 1999, ANN NY ACAD SCI, V884, P152, DOI 10.1111/j.1749-6632.1999.tb08640.x; Fuchs PA, 2005, J PHYSIOL-LONDON, V566, P7, DOI 10.1113/jphysiol.2004.082214; Fuchs PA, 2003, CURR OPIN NEUROBIOL, V13, P452, DOI 10.1016/S0959-4388(03)00098-9; Gall MD, 2012, J COMP PHYSIOL A, V198, P61, DOI 10.1007/s00359-011-0687-9; Gordon-Salant S, 2005, J REHABIL RES DEV, V42, P9, DOI 10.1682/JRRD.2005.01.0006; Grose JH, 2010, EAR HEARING, V31, P755, DOI 10.1097/AUD.0b013e3181e627e7; Grose JH, 2009, EAR HEARING, V30, P568, DOI 10.1097/AUD.0b013e3181ac128f; Henry KS, 2011, J COMP PHYSIOL A, V197, P351, DOI 10.1007/s00359-010-0619-0; Iguchi F, 2003, NEUROREPORT, V14, P77, DOI 10.1097/00001756-200301200-00015; Jing ZZ, 2013, J NEUROSCI, V33, P4456, DOI 10.1523/JNEUROSCI.3491-12.2013; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049550; Moser T, 2006, J PHYSIOL-LONDON, V576, P55, DOI 10.1113/jphysiol.2006.114835; Moser T, 2006, CELL TISSUE RES, V326, P347, DOI 10.1007/s00441-006-0276-3; Nouvian R, 2006, J MEMBRANE BIOL, V209, P153, DOI 10.1007/s00232-005-0854-4; Parthasarathy A, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00152; Pujol R, 1990, Acta Otolaryngol Suppl, V476, P32; PUJOL R, 1985, HEARING RES, V18, P145, DOI 10.1016/0378-5955(85)90006-1; PUJOL R, 1993, ACTA OTO-LARYNGOL, V113, P330, DOI 10.3109/00016489309135819; Schmitz F, 2009, NEUROSCIENTIST, V15, P611, DOI 10.1177/1073858409340253; Simon H, 2004, J ACOUST SOC AM, V116, P469, DOI 10.1121/1.1760796; Sterling P, 2005, TRENDS NEUROSCI, V28, P20, DOI 10.1016/j.tins.2004.11.009; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Walton JP, 2010, HEARING RES, V264, P63, DOI 10.1016/j.heares.2010.03.002	28	85	95	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81566	10.1371/journal.pone.0081566	http://dx.doi.org/10.1371/journal.pone.0081566			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349090	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200034
J	Wilson, N; Driss, A; Solomon, W; Dickinson-Copeland, C; Salifu, H; Jain, V; Singh, N; Stiles, J				Wilson, Nana; Driss, Adel; Solomon, Wesley; Dickinson-Copeland, Carmen; Salifu, Hassana; Jain, Vidhan; Singh, Neeru; Stiles, Jonathan			CXCL10 Gene Promoter Polymorphism-1447A > G Correlates with Plasma CXCL10 Levels and is Associated with Male Susceptibility to Cerebral Malaria	PLOS ONE			English	Article							T-CELL TRAFFICKING; CHEMOKINE IP-10; IFN-GAMMA; TUBERCULOSIS; CXCR3; EXPRESSION; INFECTIONS; SURVIVAL; BURDEN; MARKER	The risk factors for cerebral malaria (CM) and the wide variation in clinical manifestations of malaria are poorly understood. Recent studies indicate that interferon gamma inducible chemokine, CXCL10, is a strong predictor of both human and experimental cerebral malaria. Increased plasma and cerebrospinal fluid levels of CXCL10 were tightly associated with fatal CM in Indian and Ghanaian patients. In the present study, we hypothesized that in a subset of malaria patients, CM susceptibility is associated with variation in CXCL10 expression. We determined whether polymorphisms in the CXCL10 gene promoter region played a role in the clinical status of malaria patients and addressed the genetic basis of CXCL10 expression during malaria infection. Following extensive bioinformatics analyses, two reported single nucleotide polymorphisms in the CXCL10 promoter (-135G>A [rs56061981) and -1447A>G [rs4508917]) were identified among 66 CM and 69 non-CM Indian patients using PCR-restriction fragment length polymorphism assay. Individuals with the -1447(A/G) genotype were susceptible to CM (adjusted odds ratio [AOR] = 2.60, 95% CI =1.51-5.85, p = 0.021). In addition, individuals with the -1447(A/G) genotype had significantly higher plasma CXCL10 levels than individuals with the -1447(A/A) genotype. Stratifying patients according to gender, the observed association of CM with over expression of CXCL10 were more pronounced in males than in female patients (AOR = 5.47, 95% CI = 1.34-22.29, p = 0.018). Furthermore, -1356>A polymorphism conferred a decreased risk of CM among males (AOR = 0.19, 95% CI = 0.05-0.78, p = 0.021). Polymorphisms in the CXCL10 gene promoter sequence were associated with increased CXCL10 production, which is linked to severity of CM. These results suggest that the -1447A>G polymorphism in CXCL10 gene promoter could be partly responsible for the reported variation underlying severity of CM outcomes particularly in males.	[Wilson, Nana; Driss, Adel; Solomon, Wesley; Dickinson-Copeland, Carmen; Salifu, Hassana; Stiles, Jonathan] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA; [Jain, Vidhan; Singh, Neeru] Reg Med Res Ctr Tribals ICMR, Jabalpur, Madhya Pradesh, India; [Singh, Neeru] Natl Inst Malaria Res Field Unit ICMR, Jabalpur, Madhya Pradesh, India	Morehouse School of Medicine; Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Wilson, N (corresponding author), Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA.	nanaotoo@gmail.com	Stiles, Jonathan K./AFM-1940-2022; Driss, Adel/A-4151-2008; Beletini, Lucimara Fátima F/H-6083-2016; Christ Angotti, Melisa/H-6077-2016; Driss, Adel/X-6772-2019	Stiles, Jonathan Kwamina/0000-0003-0829-1482	National Institutes of Health [NIH/FIC T90-HG004151]; NIH/FIC/NINDS [R21TW006804]; NIH/MBRS/RISE [S06GM08248]; WHO/UNDP/TDR Collaborative Research Grant [A00524]; American Society of Microbiology's Robert D. Watkins Graduate Research Fellowship;  [NIH/NIMHD/8G12 MD007602]; FOGARTY INTERNATIONAL CENTER [R21TW006804] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R90HG004151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058268, S06GM008248] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101, G12MD007602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/FIC/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/MBRS/RISE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WHO/UNDP/TDR Collaborative Research Grant; American Society of Microbiology's Robert D. Watkins Graduate Research Fellowship; ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institutes of Health grant numbers NIH/FIC T90-HG004151 for postdoctoral training in Genomics and Hemoglobinopathies, NIH/FIC/NINDS R21TW006804, NIH/MBRS/RISE S06GM08248 and NIH/NIMHD/8G12 MD007602 awarded to JKS and WHO/UNDP/TDR Collaborative Research Grant (A00524). The support of American Society of Microbiology's Robert D. Watkins Graduate Research Fellowship to Nana Wilson is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029465; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Bihari S, 2012, PEDIATR INFECT DIS J, V31, P1089, DOI 10.1097/INF.0b013e3182611152; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Campino S, 2006, SEMIN IMMUNOL, V18, P411, DOI 10.1016/j.smim.2006.07.011; Deng GH, 2008, GASTROENTEROLOGY, V134, P716, DOI 10.1053/j.gastro.2007.12.044; Dheda K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004689; Dyer KD, 2009, BLOOD, V114, P2649, DOI 10.1182/blood-2009-01-199497; Galimberti D, 2007, EUR J NEUROL, V14, P162, DOI 10.1111/j.1468-1331.2006.01629.x; Hansen DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003045; Holding PA, 1999, T ROY SOC TROP MED H, V93, P529, DOI 10.1016/S0035-9203(99)90368-1; Hoyert D L, 1999, Natl Vital Stat Rep, V47, P1; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jain V, 2008, AM J TROP MED HYG, V79, P636; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Klich Izabela, 2011, Pediatr Endocrinol Diabetes Metab, V17, P10; Lighter J, 2009, INT J TUBERC LUNG D, V13, P731; Lo BKK, 2010, AM J PATHOL, V176, P2435, DOI 10.2353/ajpath.2010.081059; LUSTER AD, 1987, J EXP MED, V166, P1084, DOI 10.1084/jem.166.4.1084; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Manjurano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047463; MARSH K, 1995, NEW ENGL J MED, V332, P1399, DOI 10.1056/NEJM199505253322102; Mihm S, 2003, J MED VIROL, V70, P562, DOI 10.1002/jmv.10431; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; Mishra SK, 2007, ANN TROP MED PARASIT, V101, P187, DOI 10.1179/136485907X157004; Miu J, 2008, J IMMUNOL, V180, P1217, DOI 10.4049/jimmunol.180.2.1217; Moller AP, 1998, AM NAT, V152, P605, DOI 10.1086/286193; Oliver BG, 2012, JAIDS-J ACQ IMM DEF, V61, P287, DOI 10.1097/QAI.0b013e31826445ef; Romagnani P, 2012, CLIN CHIM ACTA, V413, P1364, DOI 10.1016/j.cca.2012.02.009; Sharma VP, 1996, INDIAN J MED RES, V103, P26; Shiraki Y, 2008, FEMS IMMUNOL MED MIC, V54, P122, DOI 10.1111/j.1574-695X.2008.00457.x; Singh Sarman, 2000, Indian Journal of Malariology, V37, P27; Strzelak Agnieszka, 2012, Pol Merkur Lekarski, V33, P342; Sui YJ, 2004, AM J PATHOL, V164, P1557, DOI 10.1016/S0002-9440(10)63714-5; Tang NLS, 2009, CLIN CHIM ACTA, V406, P98, DOI 10.1016/j.cca.2009.06.006; Van den Steen PE, 2008, EUR J IMMUNOL, V38, P1082, DOI 10.1002/eji.200737906; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; vanHensbroek MB, 1996, J INFECT DIS, V174, P1091, DOI 10.1093/infdis/174.5.1091; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; Venturelli E, 2006, NEUROSCI LETT, V404, P217, DOI 10.1016/j.neulet.2006.05.054; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Wilson NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060898; Wilson NO, 2011, DIS MARKERS, V30, P39, DOI [10.1155/2011/828256, 10.3233/DMA-2011-0763]; Zhang B, 2008, J IMMUNOL, V180, P2641, DOI 10.4049/jimmunol.180.4.2641; Zuk M, 1996, INT J PARASITOL, V26, P1009, DOI [10.1016/S0020-7519(96)00086-0, 10.1016/S0020-7519(96)80001-4]	50	27	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81329	10.1371/journal.pone.0081329	http://dx.doi.org/10.1371/journal.pone.0081329			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349056	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200022
J	Cespon, J; Galcio-Alvarez, S; Diaz, F				Cespon, Jesus; Galcio-Alvarez, Santiago; Diaz, Fernando			Electrophysiological Correlates of Amnestic Mild Cognitive Impairment in a Simon Task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ALZHEIMERS-DISEASE; N2PC COMPONENT; VISUAL-SEARCH; ATTENTION; INDIVIDUALS; ELECTROENCEPHALOGRAPHY; ACTIVATION; GENERATION; CONVERSION	Amnestic mild cognitive impairment (aMCI) represents a prodromal stage of Alzheimer's disease (AD), especially when additional cognitive domains are affected (Petersen et al., 2009). Thus, single-domain amnestic MCI (sdaMCI) and multiple-domain-amnestic MCI (mdaMCI) biomarkers are important for enabling early interventions to help slow down progression of the disease. Recording event-related potentials (ERPs) is a non-invasive and inexpensive measure of brain activity associated with cognitive processes, and it is of interest from a clinical point of view. The ERP technique may also be useful for obtaining early sdaMCI and mdaMCI biomarkers because ERPs are sensitive to impairment in processes that are not manifested at behavioral or clinical levels. In the present study, EEG activity was recorded in 25 healthy participants and 30 amnestic MCI patients (17 sdaMCI and 13 mdaMCI) while they performed a Simon task. The ERPs associated with visuospatial (N2 posterior-contralateral - N2pc -) and motor (lateralized readiness potential - LRP -) processes were examined. The N2pc amplitude was smaller in participants with mdaMCI than in healthy participants, which indicated a decline in the correlates of allocation of attentional resources to the target stimulus. In addition, N2pc amplitude proved to be a moderately good biomarker of mdaMCI subtype (0.77 sensitivity, 0.76 specificity). However, the LRP amplitude was smaller in the two MCI groups (sdaMCI and mdaMCI) than in healthy participants, revealing a reduction in the motor resources available to execute the response in sdaMCI and mdaMCI patients. Furthermore, the LRP amplitude proved to be a valid biomarker (0.80 sensitivity, 0.92 specificity) of both amnestic MCI subtypes.	[Cespon, Jesus; Galcio-Alvarez, Santiago; Diaz, Fernando] Univ Santiago de Compostela, Dept Clin Psychol & Biol Psychol, Santiago De Compostela, Galiza, Spain	Universidade de Santiago de Compostela	Cespon, J (corresponding author), Univ Santiago de Compostela, Dept Clin Psychol & Biol Psychol, Santiago De Compostela, Galiza, Spain.	jesus.cespon@usc.es	Cespón, Jesús/D-6943-2017; Díaz, Fernando/C-9217-2011; Galdo-Alvarez, Santiago/D-3954-2011	Cespón, Jesús/0000-0003-2588-7165; Díaz, Fernando/0000-0003-3373-4855; Galdo-Alvarez, Santiago/0000-0002-5242-3203; Cespon, Jesus/0000-0002-4851-3628	Spanish Government: Ministerio de Educacion [Beca FPU AP2007-04362]; Spanish Government: Ministerio de Economia y Competitividad [PSI2010-22224-C03-03]; Galician Government: Conselleria de Economia e Industria [10 PXIB 211070 PR]; Galician Government: Conselleria de Educacion e Ordenacion Universitaria (Axudas para a Consolidacion e Estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia); Modalidade: Grupos con potencial de crecemento [CN 2012/033]	Spanish Government: Ministerio de Educacion; Spanish Government: Ministerio de Economia y Competitividad; Galician Government: Conselleria de Economia e Industria; Galician Government: Conselleria de Educacion e Ordenacion Universitaria (Axudas para a Consolidacion e Estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia); Modalidade: Grupos con potencial de crecemento	This study was financially supported by funds from the Spanish Government: Ministerios de Educacion (Beca FPU AP2007-04362) and Economia y Competitividad (PSI2010-22224-C03-03), and from the Galician Government: Conselleria de Economia e Industria (10 PXIB 211070 PR), and Conselleria de Educacion e Ordenacion Universitaria (Axudas para a Consolidacion e Estruturacion de unidades de investigacion competitivas do sistema universitario de Galicia. Modalidade: Grupos con potencial de crecemento. Ref: CN 2012/033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse EL, 2008, PSYCHOL RES-PSYCH FO, V72, P261, DOI 10.1007/s00426-007-0110-x; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Alescio-Lautier B, 2007, NEUROPSYCHOLOGIA, V45, P1948, DOI 10.1016/j.neuropsychologia.2006.04.033; Ansorge U, 2004, J EXP PSYCHOL HUMAN, V30, P365, DOI 10.1037/0096-1523.30.2.365; Arnaiz E, 2003, ACTA NEUROL SCAND, V107, P34, DOI 10.1034/j.1600-0404.107.s179.7.x; Band GPH, 2000, BIOL PSYCHOL, V51, P201, DOI 10.1016/S0301-0511(99)00038-1; Bargh J. A., 2000, HDB RES METHODS SOCI, P253; Benedet M. J., 1996, EVALUACION CLIN QUEJ; Bennett DA, 2005, NEUROLOGY, V64, P834, DOI 10.1212/01.WNL.0000152982.47274.9E; Bracco L, 2009, NEUROLOGY, V72, P928, DOI 10.1212/01.wnl.0000344153.68679.37; Castel AD, 2007, NEUROPSYCHOLOGY, V21, P170, DOI 10.1037/0894-4105.21.2.170; Cespon J, 2013, PSYCHOPHYSIOLOGY, V50, P743, DOI 10.1111/psyp.12063; Cespon J, 2013, BIOL PSYCHOL, V93, P75, DOI 10.1016/j.biopsycho.2013.01.010; Cespon J, 2012, INT J PSYCHOPHYSIOL, V84, P120, DOI 10.1016/j.ijpsycho.2012.01.019; Cespon J, INT J PSYCH IN PRESS; Davie JE, 2004, NEUROPSYCHOLOGY, V18, P269, DOI 10.1037/0894-4105.18.2.269; DEJONG R, 1990, J EXP PSYCHOL HUMAN, V16, P164, DOI 10.1037/0096-1523.16.1.164; Delis DC., 2000, CALIFORNIA VERBAL LE; Duong A, 2006, NEUROPSYCHOLOGIA, V44, P1928, DOI 10.1016/j.neuropsychologia.2006.01.034; Eimer M, 1996, ELECTROEN CLIN NEURO, V99, P225, DOI 10.1016/0013-4694(96)95711-9; Falkenstein M, 2006, INT J PSYCHOPHYSIOL, V59, P22, DOI 10.1016/j.ijpsycho.2005.08.004; Fischer P, 2007, NEUROLOGY, V68, P288, DOI 10.1212/01.wnl.0000252358.03285.9d; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gallagher D, 2010, INT J GERIATR PSYCH, V25, P1280, DOI 10.1002/gps.2480; Galli G, 2010, ALZHEIMERS DEMENT, V6, P351, DOI 10.1016/j.jalz.2009.05.664; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Grundman M, 2004, ARCH NEUROL-CHICAGO, V61, P59, DOI 10.1001/archneur.61.1.59; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Hickey C, 2009, J COGNITIVE NEUROSCI, V21, P760, DOI 10.1162/jocn.2009.21039; Hilimire MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012677; HOLLAND BS, 1988, PSYCHOL BULL, V104, P145, DOI 10.1037/0033-2909.104.1.145; HOLM S, 1979, SCAND J STAT, V6, P65; Hopf JM, 2000, CEREB CORTEX, V10, P1233, DOI 10.1093/cercor/10.12.1233; Hort J, 2007, P NATL ACAD SCI USA, V104, P4042, DOI 10.1073/pnas.0611314104; Hunderfund AL, 2006, NEUROLOGY, V67, P1764, DOI 10.1212/01.wnl.0000244430.39969.5f; Iachini Ina, 2009, Curr Aging Sci, V2, P43; Ivarez MJ, 1998, TEST APRENDIZAJE VER; Jackson CE, 2008, ALZHEIMERS DEMENT, V4, pS137, DOI 10.1016/j.jalz.2007.10.008; Julkunen P, 2008, J NEUROSCI METH, V172, P270, DOI 10.1016/j.jneumeth.2008.04.021; Juncos-Rabadan O, 2008, ACTA PSYCHOL, V127, P237, DOI 10.1016/j.actpsy.2007.05.003; Juncos-Rabadan O, 2013, INT PSYCHOGERIATR, V25, P627, DOI 10.1017/S1041610212002207; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P240, DOI 10.1111/j.1469-8986.2007.00611.x; Klein RM, 2011, ACTA PSYCHOL, V136, P225, DOI 10.1016/j.actpsy.2010.08.003; Kolev V, 2006, NEUROBIOL AGING, V27, P1719, DOI 10.1016/j.neurobiolaging.2005.09.027; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Leuthold H, 2011, ACTA PSYCHOL, V136, P203, DOI 10.1016/j.actpsy.2010.08.001; Levey A, 2006, CLIN THER, V28, P991, DOI 10.1016/j.clinthera.2006.07.006; Lien MC, 2011, PSYCHOL AGING, V26, P188, DOI 10.1037/a0021073; Lobo A, 1999, MED CLIN-BARCELONA, V112, P767; Lonie JA, 2009, INT J GERIATR PSYCH, V24, P902, DOI 10.1002/gps.2208; Lorenzo-Lopez L, 2011, NEUROPSYCHOLOGIA, V49, P858, DOI 10.1016/j.neuropsychologia.2011.01.015; Lorenzo-Lopez L, 2008, NEUROBIOL AGING, V29, P1101, DOI 10.1016/j.neurobiolaging.2007.02.007; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; LUCK SJ, 1994, J EXP PSYCHOL HUMAN, V20, P1000, DOI 10.1037/0096-1523.20.5.1000; Markesbery WR, 2010, J ALZHEIMERS DIS, V19, P221, DOI 10.3233/JAD-2010-1220; Mora-Simon S, 2012, REV NEUROLOGIA, V54, P303, DOI 10.33588/rn.5405.2011538; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Praamstra P, 2001, J COGNITIVE NEUROSCI, V13, P31, DOI 10.1162/089892901564153; Praamstra P, 2007, J EXP PSYCHOL HUMAN, V33, P497, DOI 10.1037/0096-1523.33.2.497; Proctor RW, 2005, HUM FACTORS, V47, P250, DOI 10.1518/0018720054679425; Rabin LA, 2009, AGING NEUROPSYCHOL C, V16, P357, DOI 10.1080/13825580902825220; Roggeveen AB, 2007, J GERONTOL B-PSYCHOL, V62, pP78, DOI 10.1093/geronb/62.2.P78; Rosano C, 2005, BIOL PSYCHIAT, V57, P761, DOI 10.1016/j.biopsych.2004.12.031; Rossini PM, 2006, NEUROSCIENCE, V143, P793, DOI 10.1016/j.neuroscience.2006.08.049; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; Schwarzenau P, 1998, BEHAV RES METH INS C, V30, P110, DOI 10.3758/BF03209421; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Smith AT, 2001, CEREB CORTEX, V11, P1182, DOI 10.1093/cercor/11.12.1182; Tsutsumi R, 2012, EXP BRAIN RES, V218, P21, DOI 10.1007/s00221-011-2997-0; Vallesi A, 2005, COGNITION, V96, pB33, DOI 10.1016/j.cognition.2004.11.009; Van der Lubbe RHJ, 2002, PSYCHOPHYSIOLOGY, V39, P100, DOI 10.1017/S0048577202001221; Wahlund L. O., 2004, J INTERN MED, V256, P240; Wild-Wall N, 2008, BRAIN RES, V1211, P72, DOI 10.1016/j.brainres.2008.03.025; Wittfoth M, 2009, NEUROIMAGE, V44, P1201, DOI 10.1016/j.neuroimage.2008.09.026; Woodman GF, 1999, NATURE, V400, P867, DOI 10.1038/23698; Woodman GF, 2003, J EXP PSYCHOL HUMAN, V29, P121, DOI 10.1037/0096-1523.29.1.121; Wylie SA, 2007, NEUROPSYCHOLOGIA, V45, P1408, DOI 10.1016/j.neuropsychologia.2006.11.003; Yordanova J, 2004, BRAIN, V127, P351, DOI 10.1093/brain/awh042; Zhang YM, 2007, AGING NEUROPSYCHOL C, V14, P557, DOI 10.1080/13825580600788118	84	26	27	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81506	10.1371/journal.pone.0081506	http://dx.doi.org/10.1371/journal.pone.0081506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339941	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100065
J	Erbe, M; Gredler, B; Seefried, FR; Bapst, B; Simianer, H				Erbe, Malena; Gredler, Birgit; Seefried, Franz Reinhold; Bapst, Beat; Simianer, Henner			A Function Accounting for Training Set Size and Marker Density to Model the Average Accuracy of Genomic Prediction	PLOS ONE			English	Article							BREEDING VALUES; LINKAGE DISEQUILIBRIUM; RELATIONSHIP MATRIX; SELECTION; IMPACT	Prediction of genomic breeding values is of major practical relevance in dairy cattle breeding. Deterministic equations have been suggested to predict the accuracy of genomic breeding values in a given design which are based on training set size, reliability of phenotypes, and the number of independent chromosome segments (Me). The aim of our study was to find a general deterministic equation for the average accuracy of genomic breeding values that also accounts for marker density and can be fitted empirically. Two data sets of similar to 698 Holstein Friesian bulls genotyped with 50 K SNPs and 19332 Brown Swiss bulls genotyped with 50 K SNPs and imputed to,600 K SNPs were available. Different k-fold (k = 2-10, 15, 20) cross-validation scenarios (50 replicates, random assignment) were performed using a genomic BLUP approach. A maximum likelihood approach was used to estimate the parameters of different prediction equations. The highest likelihood was obtained when using a modified form of the deterministic equation of Daetwyler et al. (2010), augmented by a weighting factor (w) based on the assumption that the maximum achievable accuracy is w < 1. The proportion of genetic variance captured by the complete SNP sets (w(2)) was 0.76 to 0.82 for Holstein Friesian and 0.72 to 0.75 for Brown Swiss. When modifying the number of SNPs, w was found to be proportional to the log of the marker density up to a limit which is population and trait specific and was found to be reached with,209000 SNPs in the Brown Swiss population studied.	[Erbe, Malena; Simianer, Henner] Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany; [Gredler, Birgit; Seefried, Franz Reinhold; Bapst, Beat] Qualitas AG, Zug, Switzerland	University of Gottingen	Erbe, M (corresponding author), Univ Gottingen, Dept Anim Sci, Anim Breeding & Genet Grp, Gottingen, Germany.	merbe@gwdg.de	Simianer, Henner/A-6574-2015	Simianer, Henner/0000-0002-7551-3797; Seefried, Franz/0000-0003-4396-2747	German Federal Ministry of Education and Research [0315528C]; Deutsche Forschungsgemeinschaft (DFG) [RTG1644]; European Commission [222623]; Gottingen University	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Gottingen University	This research was funded by the German Federal Ministry of Education and Research within the AgroClustEr 'Synbreed - Synergistic plant and animal breeding' (Funding ID: 0315528C) in association with the Deutsche Forschungsgemeinschaft (DFG) research training group 'Scaling problems in statistics' (RTG1644). The authors gratefully acknowledge co-funding from the European Commission, under the Seventh Framework Program for Research and Technological Development, for the Collaborative Project LowInputBreeds (Grant agreement No 222623). However, the views expressed by the authors do not necessarily reflect the views of the European Commission, nor do they in any way anticipate the Commission's future policy in this area. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors further acknowledge support by the Open Access Publication Funds of the Gottingen University.	Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Daetwyler H. D., 2009, THESIS WAGENINGEN U; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Daetwyler HD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003395; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; Dekkers JCM, 2007, J ANIM BREED GENET, V124, P331, DOI 10.1111/j.1439-0388.2007.00701.x; Erbe M, 2012, J DAIRY SCI, V95, P4114, DOI 10.3168/jds.2011-5019; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Groeneveld E, 2009, GENET MOL RES, V8, P1158, DOI 10.4238/vol8-3gmr648; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes B, 2009, P ASS ADV ANIM BREED, P34; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Legarra A, 2008, GENETICS, V180, P611, DOI 10.1534/genetics.108.088575; Liu ZT, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-19; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Ober U, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002685; PerezEnciso M, 1995, J ANIM BREED GENET, V112, P327, DOI 10.1111/j.1439-0388.1995.tb00574.x; R Development Core Team, 2011, R LANG ENV STAT COMP; Sargolzaei M, 2011, J DAIRY SCI S1, V421; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; SVED J A, 1971, Theoretical Population Biology, V2, P125; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2013, J DAIRY SCI, V96, P668, DOI 10.3168/jds.2012-5702; VanRaden PM, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-7; Wientjes YCJ, 2013, GENETICS, V193, P621, DOI 10.1534/genetics.112.146290	32	40	40	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81046	10.1371/journal.pone.0081046	http://dx.doi.org/10.1371/journal.pone.0081046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339895	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100029
J	Gauger, KJ; Bassa, LM; Hencheyl, EM; Wyman, J; Bentley, B; Brown, M; Shimono, A; Schneider, SS				Gauger, Kelly J.; Bassa, Lotfi M.; Henchey, Elizabeth M.; Wyman, Josephine; Bentley, Brooke; Brown, Melissa; Shimono, Akihiko; Schneider, Sallie S.			Mice Deficient in Sfrp1 Exhibit Increased Adiposity, Dysregulated Glucose Metabolism, and Enhanced Macrophage Infiltration	PLOS ONE			English	Article							DE-NOVO LIPOGENESIS; INGESTED APOPTOTIC CELLS; WNT SIGNALING PATHWAY; DIET-INDUCED OBESITY; GROWTH-FACTOR-BETA; INFLAMMATORY RESPONSE; RHEUMATOID-ARTHRITIS; INSULIN-RESISTANCE; PROSTATE-CANCER; MAMMARY-GLAND	The molecular mechanisms involved in the development of obesity and related complications remain unclear. Wnt signaling plays an important role in preadipocyte differentiation and adipogenesis. The expression of a Wnt antagonist, secreted frizzled related protein 1 (SFRP1), is increased in response to initial weight gain, then levels are reduced under conditions of extreme obesity in both humans and animals. Here we report that loss of Sfrp1 exacerbates weight gain, glucose homeostasis and inflammation in mice in response to diet induced obesity (DIO). Sfrp1(-/-) mice fed a high fat diet (HFD) exhibited an increase in body mass accompanied by increases in body fat percentage, visceral white adipose tissue (WAT) mass, and adipocyte size. Moreover, Sfrp1 deficiency increases the mRNA levels of key de novo lipid synthesis genes (Fasn, Acaca, Acly, Elovl, Scd1) and the transcription factors that regulate their expression (Lxr-a, Srebp1, Chreb, and Nr1h3) in WAT. Fasting glucose levels are elevated, glucose clearance is impaired, hepatic gluconeogenesis regulators are aberrantly upregulated (G6pc and Pck1), and glucose transporters are repressed (Slc2a2 and Slc2a4) in Sfrp1(-/-) mice fed a HFD. Additionally, we observed increased steatosis in the livers of Sfrp1-/-mice. When there is an expansion of adipose tissue there is a sustained inflammatory response accompanied by adipokine dysregulation, which leads to chronic subclinical inflammation. Thus, we assessed the inflammatory state of different tissues and revealed that Sfrp1-/-mice fed a HFD exhibited increased macrophage infiltration and expression of pro-inflammatory markers including IL-6, Nmnat, Tgf-beta 2, and SerpinE1. Our findings demonstrate that the expression of Sfrp1 is a critical factor required for maintaining appropriate cellular signaling in response to the onset of obesity.	[Gauger, Kelly J.; Henchey, Elizabeth M.; Wyman, Josephine; Bentley, Brooke; Schneider, Sallie S.] Baystate Med Ctr, Pioneer Valley Life Sci Inst, Springfield, MA USA; [Gauger, Kelly J.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Bassa, Lotfi M.; Schneider, Sallie S.] Univ Massachusetts, Amherst, MA 01003 USA; [Brown, Melissa] Univ Massachusetts, Dept Nutr, Amherst, MA 01003 USA; [Shimono, Akihiko] TransGeniclnc, Kobe, Hyogo, Japan	Baystate Medical Center; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Schneider, SS (corresponding author), Baystate Med Ctr, Pioneer Valley Life Sci Inst, Springfield, MA USA.	sallie.schneider@bhs.org			Rays of Hope Foundation	Rays of Hope Foundation	This work was funded by the Rays of Hope Foundation (http://foundation.baystatehealth.org/netcommunity/page.aspx?pid=289). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland A, 1997, AM J CLIN NUTR, V65, P1774, DOI 10.1093/ajcn/65.6.1774; Altintas MM, 2011, J LIPID RES, V52, P480, DOI 10.1194/jlr.M011338; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Bafico A, 1999, J BIOL CHEM, V274, P16180, DOI 10.1074/jbc.274.23.16180; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Barandon L, 2011, ARTERIOSCL THROM VAS, V31, pE80, DOI 10.1161/ATVBAHA.111.232280; Bennett CN, 2003, BIOCHEM BIOPH RES CO, V302, P12, DOI 10.1016/S0006-291X(03)00092-5; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Bi TQ, 2011, ONCOL REP, V26, P1251, DOI 10.3892/or.2011.1378; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; BOGDAN C, 1993, ANN NY ACAD SCI, V685, P713, DOI 10.1111/j.1749-6632.1993.tb35934.x; Boudin E, 2012, MOL GENET METAB, V105, P508, DOI 10.1016/j.ymgme.2011.11.189; Bourlier V, 2008, CIRCULATION, V117, P806, DOI 10.1161/CIRCULATIONAHA.107.724096; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195; Caton PW, 2011, DIABETOLOGIA, V54, P3083, DOI 10.1007/s00125-011-2288-0; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dellas C, 2005, THROMB HAEMOSTASIS, V93, P631, DOI 10.1160/TH05-01-0033; Dumont N, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2457; Eissing L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2537; Esteve P, 2011, NAT NEUROSCI, V14, P562, DOI 10.1038/nn.2794; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Fersching DMI, 2012, ANTICANCER RES, V32, P2047; Finch PW, 1997, P NATL ACAD SCI USA, V94, P6770, DOI 10.1073/pnas.94.13.6770; Fiorentino M, 2008, LAB INVEST, V88, P1340, DOI 10.1038/labinvest.2008.97; FONTANA A, 1992, INT ARCH ALLERGY IMM, V99, P1, DOI 10.1159/000236328; Friebe D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019526; Gauger KJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-25; Gauger KJ, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-59; Gauger KJ, 2009, CANCER CELL INT, V9, DOI 10.1186/1475-2867-9-11; Haider DG, 2006, J CLIN ENDOCR METAB, V91, P1578, DOI 10.1210/jc.2005-2248; Haider DG, 2006, J PEDIATR GASTR NUTR, V43, P548, DOI 10.1097/01.mpg.0000235749.50820.b3; Han B, 2005, ONCOL REP, V14, P105; Hausler KD, 2004, J BONE MINER RES, V19, P1873, DOI 10.1359/JBMR.040807; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Kanazawa A, 2004, AM J HUM GENET, V75, P832, DOI 10.1086/425340; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lagathu C, 2010, INT J OBESITY, V34, P1695, DOI 10.1038/ijo.2010.107; Liu HJ, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001249; Liu WZ, 2012, J BIOL CHEM, V287, P7213, DOI 10.1074/jbc.M111.286724; Mahdi T, 2012, CELL METAB, V16, P625, DOI 10.1016/j.cmet.2012.10.009; Martin-Manso G, 2011, ARCH BIOCHEM BIOPHYS, V509, P147, DOI 10.1016/j.abb.2011.03.004; McDonald PP, 1999, J IMMUNOL, V163, P6164; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Mori H, 2012, J CLIN INVEST, V122, P2405, DOI 10.1172/JCI63604; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Nishizuka M, 2008, FEBS LETT, V582, P3201, DOI 10.1016/j.febslet.2008.08.011; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2010, SCIENCE, V329, P454, DOI 10.1126/science.1188280; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pereira CP, 2009, CURR ATHEROSCLER REP, V11, P236, DOI 10.1007/s11883-009-0036-4; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Presumey J, 2013, ANN RHEUM DIS, V72, P1717, DOI 10.1136/annrheumdis-2012-202403; Reddy PS, 2008, CANCER BIOL THER, V7, P663, DOI 10.4161/cbt.7.5.5663; Roberts R, 2009, DIABETOLOGIA, V52, P882, DOI 10.1007/s00125-009-1300-4; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sen M, 2005, RHEUMATOLOGY, V44, P708, DOI 10.1093/rheumatology/keh553; Spinnler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054106; Strable MS, 2010, CRIT REV BIOCHEM MOL, V45, P199, DOI 10.3109/10409231003667500; Stuckenholz C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062470; Turashvili G, 2006, PATHOBIOLOGY, V73, P213, DOI 10.1159/000098207; Vida M, 2013, LIVER INT; Wang B, 2011, ONCOGENE, V30, P907, DOI 10.1038/onc.2010.468; Wang SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056797; Xu X, 2012, EXP THER MED, V4, P1127, DOI 10.3892/etm.2012.734; Yokota Y, 2001, IUBMB LIFE, V51, P207; Yoshino T, 2011, INTERNAL MED, V50, P269, DOI 10.2169/internalmedicine.50.4306	71	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e78320	10.1371/journal.pone.0078320	http://dx.doi.org/10.1371/journal.pone.0078320			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339864	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100002
J	Keglowich, L; Roth, M; Philippova, M; Resink, T; Tjin, G; Oliver, B; Lardinois, D; Dessus-Babus, S; Gosens, R; Haack, KH; Tamm, M; Borger, P				Keglowich, Laura; Roth, Michael; Philippova, Maria; Resink, Therese; Tjin, Gavin; Oliver, Brian; Lardinois, Didier; Dessus-Babus, Sophie; Gosens, Reinoud; Haack, Katrin Hostettler; Tamm, Michael; Borger, Peter			Bronchial Smooth Muscle Cells of Asthmatics Promote Angiogenesis through Elevated Secretion of CXC-Chemokines (ENA-78, GRO-alpha, and IL-8)	PLOS ONE			English	Article							INDUCED SPUTUM; C/EBP-ALPHA; EXPRESSION; AIRWAYS; VEGF; PROLIFERATION; VASCULARITY; ANTAGONISTS; SPHEROIDS; CHILDREN	Background: Airway wall remodelling is a key pathology of asthma. It includes thickening of the airway wall, hypertrophy and hyperplasia of bronchial smooth muscle cells (BSMC), as well as an increased vascularity of the sub-epithelial cell layer. BSMC are known to be the effector cells of bronchoconstriction, but they are increasingly recognized as an important source of inflammatory mediators and angiogenic factors. Objective: To compare the angiogenic potential of BSMC of asthmatic and non-asthmatic patients and to identify asthma-specific angiogenic factors. Methods: Primary BSMC were isolated from human airway tissue of asthmatic and non-asthmatic patients. Conditioned medium (CM) collected from BSMC isolates was tested for angiogenic capacity using the endothelial cell (EC)-spheroid in vitro angiogenesis assay. Angiogenic factors in CM were quantified using a human angiogenesis antibody array and enzyme linked immunosorbent assay. Results: Induction of sprout outgrowth from EC-spheroids by CM of BSMC obtained from asthma patients was increased compared with CM of control BSMC (twofold, p < 0.001). Levels of ENA-78, GRO-alpha and IL-8 were significantly elevated in CM of BSMC from asthma patients (p < 0.05 vs. non-asthmatic patients). SB 265610, a competitive antagonist of chemokine (CXC-motif) receptor 2 (CXCR2), attenuated the increased sprout outgrowth induced by CM of asthma patient-derived BSMC. Conclusions: BSMC isolated from asthma patients exhibit increased angiogenic potential. This effect is mediated through the CXCR2 ligands (ENA78, GRO-alpha and IL-8) produced by BSMC. Implications: CXCR2 ligands may play a decisive role in directing the neovascularization in the sub-epithelial cell layers of the lungs of asthma patients. Counteracting the CXCR2-mediated neovascularization by pharmaceutical compounds may represent a novel strategy to reduce airway remodelling in asthma.	[Keglowich, Laura; Philippova, Maria; Resink, Therese; Haack, Katrin Hostettler; Tamm, Michael; Borger, Peter] Univ Basel, Dept Biomed, Basel, Switzerland; [Roth, Michael; Haack, Katrin Hostettler; Tamm, Michael] Univ Basel Hosp, Dept Pneumol, CH-4031 Basel, Switzerland; [Tjin, Gavin; Oliver, Brian] Univ Sydney, Dept Pharmacol, Sydney Med Sch, Sydney, NSW 2006, Australia; [Tjin, Gavin; Oliver, Brian] Univ Sydney, Woolcock Inst Med Res, Sydney, NSW 2006, Australia; [Lardinois, Didier] Univ Basel Hosp, Dept Thorac Surg, CH-4031 Basel, Switzerland; [Dessus-Babus, Sophie] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Gosens, Reinoud] Univ Groningen, Dept Mol Pharmacol, Groningen, Netherlands	University of Basel; University of Basel; University of Sydney; University of Sydney; Woolcock Institute of Medical Research; University of Basel; Friedrich Miescher Institute for Biomedical Research; University of Groningen	Borger, P (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	pieter.borger@unibas.ch	Oliver, Brian/E-7939-2010; Roth, Michael/H-8657-2019; Borger, Pieter (Peter)/HIR-2495-2022; Filippova, Maria/GXH-7313-2022	Oliver, Brian/0000-0002-7122-9262; Roth, Michael/0000-0002-8139-2821; Hostettler, Katrin/0000-0001-8118-7441; Gosens, Reinoud/0000-0002-5595-152X; Tjin, Gavin/0000-0002-7235-6909; Filippova, Maria/0000-0003-3124-3155	Swiss National Foundation [320030_124905/1]	Swiss National Foundation(Swiss National Science Foundation (SNSF))	This study was supported by a research grant of the Swiss National Foundation (#320030_124905/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman AMO, 2006, CHEST, V129, P266, DOI 10.1378/chest.129.2.266; ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Ahuja SK, 1996, J BIOL CHEM, V271, P20545, DOI 10.1074/jbc.271.34.20545; Ammit AJ, 2007, AM J PHYSIOL-LUNG C, V292, pL199, DOI 10.1152/ajplung.00230.2006; [Anonymous], 2012, GINA REP GLOB STRAT; Asai K, 2003, CLIN EXP ALLERGY, V33, P595, DOI 10.1046/j.1365-2222.2003.01576.x; Asai K, 2002, J ALLERGY CLIN IMMUN, V110, P571, DOI 10.1067/mai.2002.127797; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Bentley J Kelley, 2008, Proc Am Thorac Soc, V5, P89, DOI 10.1513/pats.200705-063VS; Borger P, 2007, J ALLERGY CLIN IMMUN, V119, P98, DOI 10.1016/j.jaci.2006.07.056; Borger P, 2009, J ALLERGY CLIN IMMUN, V123, P639, DOI 10.1016/j.jaci.2008.11.006; Borish L, 2008, ANN ALLERG ASTHMA IM, V101, P1, DOI 10.1016/S1081-1206(10)60826-5; Bradley ME, 2009, BRIT J PHARMACOL, V158, P328, DOI 10.1111/j.1476-5381.2009.00182.x; Chapman RW, 2009, PHARMACOL THERAPEUT, V121, P55, DOI 10.1016/j.pharmthera.2008.10.005; Cox PG, 2004, EUR RESPIR J, V24, P659, DOI 10.1183/09031936.04.00054604; Grainge CL, 2011, NEW ENGL J MED, V364, P2006, DOI 10.1056/NEJMoa1014350; Hakonarson H, 2003, RESP PHYSIOL NEUROBI, V137, P263, DOI 10.1016/S1569-9048(03)00152-6; Hashimoto M, 2005, CHEST, V127, P965, DOI 10.1378/chest.127.3.965; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Hoshino M, 2001, J ALLERGY CLIN IMMUN, V107, P295, DOI 10.1067/mai.2001.111928; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; JOHNSON PRA, 1995, AM J PHYSIOL-LUNG C, V269, pL514, DOI 10.1152/ajplung.1995.269.4.L514; Johnson PRA, 2001, AM J RESP CRIT CARE, V164, P474, DOI 10.1164/ajrccm.164.3.2010109; Keane MP, 2001, AM J RESP CRIT CARE, V164, P2239, DOI 10.1164/ajrccm.164.12.2104106; Keane MP, 1997, J IMMUNOL, V159, P1437; Korff T, 2001, FASEB J, V15, P447, DOI 10.1096/fj.00-0139com; Kristan SS, 2009, CLIN EXP ALLERGY, V39, P354, DOI 10.1111/j.1365-2222.2008.03170.x; Liu Z, 2009, J CELL SCI, V122, P3294, DOI 10.1242/jcs.048942; Lloyd CM, 2007, EUR RESPIR J, V29, P1020, DOI 10.1183/09031936.00150305; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Miglino N, 2011, EUR RESPIR J, V38, P50, DOI 10.1183/09031936.00068010; Miller JD, 2005, CHEST, V127, P1999, DOI 10.1378/chest.127.6.1999; O'Byrne PM, 2012, CLIN EXP ALLERGY, V42, P706, DOI 10.1111/j.1365-2222.2012.03965.x; Oliver BGG, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-71; Philippova M, 2006, ARTERIOSCL THROM VAS, V26, P2222, DOI 10.1161/01.ATV.0000238356.20565.92; Postma Dirkje S, 2006, Proc Am Thorac Soc, V3, P434, DOI 10.1513/pats.200601-006AW; Raidl M, 2007, CELL BIOCHEM BIOPHYS, V49, P98, DOI 10.1007/s12013-007-0043-4; Roth M, 2004, NEW ENGL J MED, V351, P560, DOI 10.1056/NEJMoa021660; Salchow K, 2010, BRIT J PHARMACOL, V159, P1429, DOI 10.1111/j.1476-5381.2009.00623.x; Shifren A, 2011, CHEST, V140, P573, DOI 10.1378/chest.11-1410; Simcock DE, 2008, AM J RESP CRIT CARE, V178, P460, DOI 10.1164/rccm.200707-1046OC; Simcock DE, 2007, AM J RESP CRIT CARE, V176, P146, DOI 10.1164/rccm.200701-042OC; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Tanaka H, 2003, AM J RESP CRIT CARE, V168, P1495, DOI 10.1164/rccm.200306-727OC; Timmins Nicholas E., 2007, V140, P141; Trian T, 2007, J EXP MED, V204, P3173, DOI 10.1084/jem.20070956; Upreti M, 2011, TRANSL ONCOL, V4, P365, DOI 10.1593/tlo.11187; Wei B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039069; Wilson JW, 2006, CURR OPIN ALLERGY CL, V6, P51, DOI 10.1097/01.all.0000200505.54425.47; Woodruff PG, 2004, AM J RESP CRIT CARE, V169, P1001, DOI 10.1164/rccm.200311-1529OC	50	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81494	10.1371/journal.pone.0081494	http://dx.doi.org/10.1371/journal.pone.0081494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339939	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100063
J	Long, WB; Li, Y; Zhou, WJ; Ling, HQ; Zheng, SS				Long, Wenbo; Li, Ye; Zhou, Wenjuan; Ling, Hong-Qing; Zheng, Shusong			Sequence-Based SSR Marker Development and Their Application in Defining the Introgressions of LA0716 (Solanum pennellii) in the Background of cv. M82 (Solanum lycopersicum)	PLOS ONE			English	Article							CULTIVATED TOMATO; LINE POPULATION; LINKAGE MAP; ESCULENTUM; IDENTIFICATION; GENE; EXPRESSION; DIVERSITY; ORTHOLOG; GENOMICS	The introgression lines (ILs) from cv. M82 (Solanum lycopersicum) x LA0716 (S. pennellii) have been proven to be exceptionally useful for genetic analysis and gene cloning. The introgressions were originally defined by RFLP markers at their development. The objectives of this study are to develop polymorphic SSR markers, and to re-define the DNA introgression from LA0716 in the ILs. Tomato sequence data was scanned by software to generate SSR markers. In total, 829 SSRs, which could be robustly amplified by PCR, were developed. Among them, 658 SSRs were dinucleotide repeats, 162 were trinucleotide repeats, and nine were tetranucleotide repeats. The 829 SSRs together with 96 published RFLPs were integrated into the physical linkage map of S. lycopersicum. Introgressions of DNA fragments from LA0716 were re-defined among the 75 ILs using the newly developed SSRs. A specific introgression of DNA fragment from LA0716 was identified in 72 ILs as described previously by RFLP, whereas the specific DNA introgression described previously were not detected in the ILs LA4035, LA4059 and LA4091. The physical location of each investigated DNA introgression was finely determined by SSR mapping. Among the 72 ILs, eight ILs showed a shorter and three ILs (IL3-2, IL12-3 and IL12-3-1) revealed a longer DNA introgression than that framed by RFLPs. Furthermore, 54 previously undefined segments were found in 21 ILs, ranging from 1 to 11 DNA introgressions per IL. Generally, the newly developed SSRs provide additional markers for genetic studies of tomatoes, and the fine definition of DNA introgressions from LA0716 would facilitate the use of the ILs for genetic analysis and gene cloning.	[Long, Wenbo; Li, Ye; Zhou, Wenjuan; Ling, Hong-Qing; Zheng, Shusong] Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS	Ling, HQ (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, State Key Lab Plant Cell & Chromosome Engn, Beijing, Peoples R China.	hqling@genetics.ac.cn; shusong@genetics.ac.cn	Ling, Hong-Qing/ABC-9451-2020		Ministry of Science and Technology of China [2011CB100304]; Ministry of Agriculture of China [2011ZX08009-003-005]; HarvestPlus Challenge Program [8274]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); HarvestPlus Challenge Program	This work was supported by the Ministry of Science and Technology of China (Grant No. 2011CB100304), the Ministry of Agriculture of China (Grant No. 2011ZX08009-003-005) and the HarvestPlus Challenge Program (Agreement #8274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashrafi H, 2009, GENOME, V52, P935, DOI [10.1139/G09-065, 10.1139/g09-065]; Chaib J, 2006, THEOR APPL GENET, V112, P934, DOI 10.1007/s00122-005-0197-7; Chalivendra SC, 2013, J EXP BOT, V64, P265, DOI 10.1093/jxb/ers324; DEHAN K, 1978, IRRIGATION SCI, V1, P71, DOI 10.1007/BF00269009; Di Matteo A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-163; Eshed Y, 1992, THEOR APPL GENET, V83, P1027, DOI 10.1007/BF00232968; ESHED Y, 1995, GENETICS, V141, P1147; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; Finkers R, 2007, THEOR APPL GENET, V114, P1071, DOI 10.1007/s00122-006-0500-2; Frary A, 2005, THEOR APPL GENET, V111, P291, DOI 10.1007/s00122-005-2023-7; Fulton TM, 2002, PLANT CELL, V14, P1457, DOI 10.1105/tpc.010479; Geethanjali S, 2011, EUPHYTICA, V178, P283, DOI 10.1007/s10681-010-0331-8; Geethanjali S, 2010, EUPHYTICA, V173, P85, DOI 10.1007/s10681-010-0125-z; Gur A, 2011, THEOR APPL GENET, V122, P405, DOI 10.1007/s00122-010-1456-9; He C, 2003, THEOR APPL GENET, V106, P363, DOI 10.1007/s00122-002-1076-0; Krieger U, 2010, NAT GENET, V42, P459, DOI 10.1038/ng.550; Li Qiang, 2005, Yichuan, V27, P808; Liedl BE, 1996, SEX PLANT REPROD, V9, P299, DOI 10.1007/BF02152705; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu YS, 2003, PLANT BIOTECHNOL J, V1, P195, DOI 10.1046/j.1467-7652.2003.00018.x; Meng FJ, 2010, AGR SCI CHINA, V9, P1430, DOI 10.1016/S1671-2927(09)60234-0; Ohyama A, 2009, MOL BREEDING, V23, P685, DOI 10.1007/s11032-009-9265-z; Petreikov M, 2006, PLANTA, V224, P1465, DOI 10.1007/s00425-006-0316-y; Pnueli L, 1998, DEVELOPMENT, V125, P1979; RICK CM, 1981, PLANT SYST EVOL, V139, P11, DOI 10.1007/BF00983920; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Shalata A, 1998, PHYSIOL PLANTARUM, V104, P169, DOI 10.1034/j.1399-3054.1998.1040204.x; Shirasawa K, 2010, THEOR APPL GENET, V121, P731, DOI 10.1007/s00122-010-1344-3; Sim SC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0045520, 10.1371/journal.pone.0040563]; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; STEWART CN, 1993, BIOTECHNIQUES, V14, P748; Tam SM, 2005, THEOR APPL GENET, V110, P819, DOI 10.1007/s00122-004-1837-z; TANKSLEY SD, 1992, GENETICS, V132, P1141; Van Schalkwyk A, 2012, THEOR APPL GENET, V124, P947, DOI 10.1007/s00122-011-1759-5; Viquez-Zamora M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-354; Wang Y, 2006, GENETICS, V172, P2529, DOI 10.1534/genetics.106.055772	37	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81091	10.1371/journal.pone.0081091	http://dx.doi.org/10.1371/journal.pone.0081091			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339899	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100034
J	Ha, NS; Truong, QT; Goo, NS; Park, HC				Ngoc San Ha; Quang Tri Truong; Goo, Nam Seo; Park, Hoon Cheol			Biomechanical Properties of Insect Wings: The Stress Stiffening Effects on the Asymmetric Bending of the Allomyrina dichotoma Beetle's Hind Wing	PLOS ONE			English	Article							FUNCTIONAL-MORPHOLOGY; FLEXURAL STIFFNESS; DEFORMATION; MIMICKING	Although the asymmetry in the upward and downward bending of insect wings is well known, the structural origin of this asymmetry is not yet clearly understood. Some researchers have suggested that based on experimental results, the bending asymmetry of insect wings appears to be a consequence of the camber inherent in the wings. Although an experimental approach can reveal this phenomenon, another method is required to reveal the underlying theory behind the experimental results. The finite element method (FEM) is a powerful tool for evaluating experimental measurements and is useful for studying the bending asymmetry of insect wings. Therefore, in this study, the asymmetric bending of the Allomyrina dichotoma beetle's hind wing was investigated through FEM analyses rather than through an experimental approach. The results demonstrated that both the stressed stiffening of the membrane and the camber of the wing affect the bending asymmetry of insect wings. In particular, the chordwise camber increased the rigidity of the wing when a load was applied to the ventral side, while the spanwise camber increased the rigidity of the wing when a load was applied to the dorsal side. These results provide an appropriate explanation of the mechanical behavior of cambered insect wings, including the bending asymmetry behavior, and suggest an appropriate approach for analyzing the structural behavior of insect wings.	[Ngoc San Ha; Quang Tri Truong; Goo, Nam Seo; Park, Hoon Cheol] Konkuk Univ, Dept Adv Technol Fus, Biomimet & Intelligent Microsyst Lab, Seoul, South Korea	Konkuk University	Goo, NS (corresponding author), Konkuk Univ, Dept Adv Technol Fus, Biomimet & Intelligent Microsyst Lab, Seoul, South Korea.	nsgoo@konkuk.ac.kr	San Ha, Ngoc/AAL-1629-2020	San Ha, Ngoc/0000-0003-4718-3935; Park, Hoon Cheol/0000-0002-5070-6189				[Anonymous], 2009, ANSYS US MAN VERS 12; Birch JM, 2001, NATURE, V412, P729, DOI 10.1038/35089071; Combes S. A., 2010, ENCY AEROSPACE ENG; Combes SA, 2003, J EXP BIOL, V206, P2979, DOI 10.1242/jeb.00523; Combes SA, 2003, J EXP BIOL, V206, P2989, DOI 10.1242/jeb.00524; Dickinson MH, 1999, SCIENCE, V284, P1954, DOI 10.1126/science.284.5422.1954; Du G, 2012, J THEOR BIOL, V300, P19, DOI 10.1016/j.jtbi.2012.01.010; Ellington CP, 1996, NATURE, V384, P626, DOI 10.1038/384626a0; Ha NS, 2012, EXP MECH, V52, P1535, DOI 10.1007/s11340-012-9611-7; Ha NS, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046003; Ha NS, 2013, OPT LASER ENG, V51, P560, DOI 10.1016/j.optlaseng.2012.12.012; Haas F, 2000, P ROY SOC B-BIOL SCI, V267, P1375, DOI 10.1098/rspb.2000.1153; Herbert RC, 2000, J EXP BIOL, V203, P2945; Phan HV, 2012, J BIONIC ENG, V9, P391, DOI 10.1016/S1672-6529(11)60134-0; Jin T, 2010, J BIONIC ENG, V7, pS145, DOI 10.1016/S1672-6529(09)60228-6; Jin T, 2009, J BIONIC ENG, V6, P224, DOI 10.1016/S1672-6529(08)60105-5; Johansson LC, 2012, J R SOC INTERFACE, V9, P2745, DOI 10.1098/rsif.2012.0053; Jongerius SR, 2010, EXP MECH, V50, P1323, DOI 10.1007/s11340-010-9411-x; Kesel AB, 1998, COMPUT BIOL MED, V28, P423, DOI 10.1016/S0010-4825(98)00018-3; Le TQ, 2010, J THEOR BIOL, V266, P485, DOI 10.1016/j.jtbi.2010.07.013; Lehmann FO, 2011, J EXP BIOL, V214, P2949, DOI 10.1242/jeb.045351; Nakata T, 2012, P ROY SOC B-BIOL SCI, V279, P722, DOI 10.1098/rspb.2011.1023; NEWMAN DJS, 1986, J EXP BIOL, V125, P361; Nguyen QV, 2010, J BIONIC ENG, V7, P77, DOI 10.1016/S1672-6529(09)60195-5; Sato H, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00199; Song A, 2008, AIAA J, V46, P2096, DOI 10.2514/1.36694; Srygley RB, 2002, NATURE, V420, P660, DOI 10.1038/nature01223; STEPPAN SJ, 2000, J RES LEPIDOPTERA, V35, P61; Truong QT, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/3/036008; Van Truong T, 2012, J BIONIC ENG, V9, P177, DOI 10.1016/S1672-6529(11)60113-3; Wang ZJ, 2000, PHYS REV LETT, V85, P2216, DOI 10.1103/PhysRevLett.85.2216; Watanabe H, 1995, KAW MILL WORKSH TOK; Wootton RJ, 2000, J EXP BIOL, V203, P2921; Wootton RJ, 2003, PHILOS T R SOC B, V358, P1577, DOI 10.1098/rstb.2003.1351; WOOTTON RJ, 1993, J EXP BIOL, V180, P105; WOOTTON RJ, 1992, ANNU REV ENTOMOL, V37, P113, DOI 10.1146/annurev.en.37.010192.000553; Young J, 2009, SCIENCE, V325, P1549, DOI 10.1126/science.1175928; Zheng LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053060	38	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80689	10.1371/journal.pone.0080689	http://dx.doi.org/10.1371/journal.pone.0080689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339878	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100017
J	Brouwer, IA; Geleijnse, JM; Klaasen, VM; Smit, LA; Giltay, EJ; de Goede, J; Heijboer, AC; Kromhout, D; Katan, MB				Brouwer, Ingeborg A.; Geleijnse, Johanna M.; Klaasen, Veronique M.; Smit, Liesbeth A.; Giltay, Erik J.; de Goede, Janette; Heijboer, Annemieke C.; Kromhout, Daan; Katan, Martijn B.			Effect of Alpha Linolenic Acid Supplementation on Serum Prostate Specific Antigen (PSA): Results from the Alpha Omega Trial	PLOS ONE			English	Article							N-3 FATTY-ACIDS; CANCER RISK; DIETARY-FAT; METAANALYSIS; MEN; DISEASE	Background: Alpha linolenic acid (ALA) is the major omega-3 fatty acid in the diet. Evidence on health effects of ALA is not conclusive, but some observational studies found an increased risk of prostate cancer with higher intake of ALA. We examined the effect of ALA supplementation on serum concentrations of prostate-specific antigen (PSA), a biomarker for prostate cancer. Methods: The Alpha Omega Trial (ClinicalTrials.govIdentifier: NCT00127452) was a double-blind, placebo-controlled trial of ALA and the fish fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA) on the recurrence of cardiovascular disease, using a 262 factorial design. Blood was collected at the start and the end of the intervention period. The present analysis included 1622 patients with a history of a myocardial infarction, aged 60-80 years with an initial PSA concentration,4 ng/mL. They received either 2 g per day of ALA or placebo in margarine spreads for 40 months. T-tests and logistic regression were used to assess the effects of ALA supplementation on changes in serum PSA (both continuously and as a dichotomous outcome, cut-off point: >4 ng/mL). Findings: Mean serum PSA increased by 0.42 ng/mL on placebo (n = 815) and by 0.52 ng/mL on ALA (n = 807), a difference of 0.10 (95% confidence interval: 20.02 to 0.22) ng/mL (P = 0.12). The odds ratio for PSA rising above 4 ng/mL on ALA versus placebo was 1.15 (95% CI: 0.84-1.58). Interpretation: An additional amount of 2 g of ALA per day increased PSA by 0.10 ng/mL, but the confidence interval ranged from 20.02 to 0.22 ng/mL and included no effect. Therefore, more studies are needed to establish whether or not ALA intake has a clinically significant effect on PSA or prostate cancer.	[Brouwer, Ingeborg A.; Klaasen, Veronique M.; Smit, Liesbeth A.; Katan, Martijn B.] Vrije Univ Amsterdam, Dept Hlth Sci, Fac Earth & Life Sci, Amsterdam, Netherlands; [Brouwer, Ingeborg A.; Klaasen, Veronique M.; Smit, Liesbeth A.; Katan, Martijn B.] Vrije Univ Amsterdam, EMGO Inst Hlth & Care Res, Fac Earth & Life Sci, Amsterdam, Netherlands; [Geleijnse, Johanna M.; Klaasen, Veronique M.; de Goede, Janette; Kromhout, Daan] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Giltay, Erik J.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Heijboer, Annemieke C.] Vrije Univ Amsterdam Med Ctr, Endocrine Lab, Dept Clin Chem, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Brouwer, IA (corresponding author), Vrije Univ Amsterdam, Dept Hlth Sci, Fac Earth & Life Sci, Amsterdam, Netherlands.	Ingeborg.Brouwer@vu.nl	Geleijnse, Johanna Marianna M/B-5749-2012; Giltay, Erik J./AAL-9948-2021; Katan, Martijn/ABB-6613-2021	Geleijnse, Johanna Marianna M/0000-0001-7638-0589; Heijboer, Annemieke/0000-0002-6712-9955; Brouwer, Ingeborg/0000-0002-8762-382X; Giltay, Erik/0000-0001-8874-2292	Netherlands Heart Foundation; National Institutes of Health (NIH); Unilever Research and Development; Royal Netherlands Academy of Arts and Sciences	Netherlands Heart Foundation(Netherlands Heart Foundation); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Unilever Research and Development(Unilever); Royal Netherlands Academy of Arts and Sciences	Financial support was obtained from The Netherlands Heart Foundation, the National Institutes of Health (NIH), and Unilever Research and Development. The grant of The Netherlands Heart Foundation covered baseline examinations and mortality follow-up. The NIH grant covered mid-term and final examinations and the verification of nonfatal cardiovascular events. Unilever provided an unrestricted grant for distribution of trial margarines to the patients. Martijn B Katan and Daan Kromhout were supported by an Academy Professorship award of the Royal Netherlands Academy of Arts and Sciences. The funding organizations had no role in the design of the study, data collection, data analysis, interpretation, writing of the report, or the decision to submit.	Balk SP, 2003, J CLIN ONCOL, V21, P383, DOI 10.1200/JCO.2003.02.083; Berger AP, 2007, UROLOGY, V69, P134, DOI 10.1016/j.urology.2006.09.018; Brasky TM, 2013, JNCI-J NATL CANCER I, V105, P1132, DOI 10.1093/jnci/djt174; Brouwer IA, 2004, J NUTR, V134, P919, DOI 10.1093/jn/134.4.919; Brouwer IA, 2008, PROSTAG LEUKOTR ESS, V79, P97, DOI 10.1016/j.plefa.2008.09.006; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; Carayol M, 2010, CANCER CAUSE CONTROL, V21, P347, DOI 10.1007/s10552-009-9465-1; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Demark-Wahnefried W, 2008, CANCER EPIDEM BIOMAR, V17, P3577, DOI 10.1158/1055-9965.EPI-08-0008; Elmadfa I, 2009, ANN NUTR METAB, V55, P56, DOI 10.1159/000228996; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; Goyens PL, 2006, AM J CLIN NUTR, V84, P44, DOI 10.1093/ajcn/84.1.44; Hamazaki K, 2006, IN VIVO, V20, P397; Kromhout D, 2013, N ENGL J MED; Larsson SC, 2004, AM J CLIN NUTR, V79, P935; Orsted DD, 2012, EUR UROL, V61, P865, DOI 10.1016/j.eururo.2011.11.007; Pan A, 2012, AM J CLIN NUTR, V96, P1262, DOI 10.3945/ajcn.112.044040; Pandalai PK, 1996, ANTICANCER RES, V16, P815; Pelser C, 2013, CANCER EPIDEM BIOMAR, V22, P697, DOI 10.1158/1055-9965.EPI-12-1196-T; Safarinejad MR, 2012, BR J NUTR, P1; Simon JA, 2009, AM J CLIN NUTR, V89, pS1558, DOI 10.3945/ajcn.2009.26736E; Smith DS, 1997, CANCER, V80, P1852; van Rossum CTM., 2011, 3500500062011 NAT I; Vickers AJ, 2009, NAT REV UROL, V6, P301, DOI 10.1038/nrurol.2009.95	24	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81519	10.1371/journal.pone.0081519	http://dx.doi.org/10.1371/journal.pone.0081519			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349086	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300036
J	Choi, W; Mohler, KJ; Potsaid, B; Lu, CD; Liu, JJ; Jayaraman, V; Cable, AE; Duker, JS; Huber, R; Fujimoto, JG				Choi, WooJhon; Mohler, Kathrin J.; Potsaid, Benjamin; Lu, Chen D.; Liu, Jonathan J.; Jayaraman, Vijaysekhar; Cable, Alex E.; Duker, Jay S.; Huber, Robert; Fujimoto, James G.			Choriocapillaris and Choroidal Microvasculature Imaging with Ultrahigh Speed OCT Angiography	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; HUMAN RETINA; DRUSEN; ANGIOARCHITECTURE; DEGENERATION; MICROSCOPY; DROPOUT; EYES	We demonstrate in vivo choriocapillaris and choroidal microvasculature imaging in normal human subjects using optical coherence tomography (OCT). An ultrahigh speed swept source OCT prototype at 1060 nm wavelengths with a 400 kHz A-scan rate is developed for three-dimensional ultrahigh speed imaging of the posterior eye. OCT angiography is used to image three-dimensional vascular structure without the need for exogenous fluorophores by detecting erythrocyte motion contrast between OCT intensity cross-sectional images acquired rapidly and repeatedly from the same location on the retina. En face OCT angiograms of the choriocapillaris and choroidal vasculature are visualized by acquiring cross-sectional OCT angiograms volumetrically via raster scanning and segmenting the three-dimensional angiographic data at multiple depths below the retinal pigment epithelium (RPE). Fine microvasculature of the choriocapillaris, as well as tightly packed networks of feeding arterioles and draining venules, can be visualized at different en face depths. Panoramic ultra-wide field stitched OCT angiograms of the choriocapillaris spanning similar to 32 mm on the retina show distinct vascular structures at different fundus locations. Isolated smaller fields at the central fovea and similar to 6 mm nasal to the fovea at the depths of the choriocapillaris and Sattler's layer show vasculature structures consistent with established architectural morphology from histological and electron micrograph corrosion casting studies. Choriocapillaris imaging was performed in eight healthy volunteers with OCT angiograms successfully acquired from all subjects. These results demonstrate the feasibility of ultrahigh speed OCT for in vivo dye-free choriocapillaris and choroidal vasculature imaging, in addition to conventional structural imaging.	[Choi, WooJhon; Mohler, Kathrin J.; Potsaid, Benjamin; Lu, Chen D.; Liu, Jonathan J.; Fujimoto, James G.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Choi, WooJhon; Mohler, Kathrin J.; Potsaid, Benjamin; Lu, Chen D.; Liu, Jonathan J.; Fujimoto, James G.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Mohler, Kathrin J.; Huber, Robert] Univ Munich, Lehrstuhl BioMol Opt, Munich, Germany; [Potsaid, Benjamin; Cable, Alex E.] Thorlabs Inc, Adv Imaging Grp, Newton, NJ USA; [Jayaraman, Vijaysekhar] Praevium Res Inc, Santa Barbara, CA USA; [Duker, Jay S.] Tufts Univ, New England Med Ctr, Boston, MA 02111 USA; [Duker, Jay S.] Tufts Univ, Tufts Med Ctr, Boston, MA 02111 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Munich; Tufts Medical Center; Tufts University; Tufts Medical Center; Tufts University	Fujimoto, JG (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.	jgfuji@mit.edu	Jayaraman, Vijaysekhar/GLR-7595-2022; Huber, Robert A/B-9419-2008	Huber, Robert A/0000-0001-9785-6574	National Institute of Health [NIH R01-EY011289-27, R01-EY013178-12, R44-EY022864-01, R01-CA075289-16]; Air Force Office of Scientific Research [AFOSR FA9550-10-1-0551, AFOSR FA9550-12-1-0499]; Samsung Scholarship; NATIONAL CANCER INSTITUTE [R01CA075289] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011289, R01EY013178, R44EY022864] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Samsung Scholarship(Samsung); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by the National Institute of Health (NIH R01-EY011289-27, R01-EY013178-12, R44-EY022864-01, R01-CA075289-16,), Air Force Office of Scientific Research (AFOSR FA9550-10-1-0551, AFOSR FA9550-12-1-0499), and a Samsung Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An L, 2008, OPT EXPRESS, V16, P11438, DOI 10.1364/OE.16.011438; Bhutto I, 2012, MOL ASPECTS MED, V33, P295, DOI 10.1016/j.mam.2012.04.005; Blatter C, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.070505; Braaf B, 2013, BIOMED OPT EXPRESS, V4, P51, DOI 10.1364/BOE.4.000051; Cao JT, 1998, ARCH OPHTHALMOL-CHIC, V116, P589, DOI 10.1001/archopht.116.5.589; Choi W, 2013, OPT LETT, V38, P338, DOI 10.1364/OL.38.000338; Enfield J, 2011, BIOMED OPT EXPRESS, V2, P1184, DOI 10.1364/BOE.2.001184; Fingler J, 2007, OPT EXPRESS, V15, P12636, DOI 10.1364/OE.15.012636; FRIEDMAN E, 1963, ARCH OPHTHALMOL-CHIC, V69, P220; FRYCZKOWSKI AW, 1989, INT OPHTHALMOL, V13, P269, DOI 10.1007/BF02280087; Gerl VB, 2002, INVEST OPHTH VIS SCI, V43, P1104; Kurokawa K, 2012, OPT EXPRESS, V20, P22796, DOI 10.1364/OE.20.022796; Lengyel I, 2004, INVEST OPHTH VIS SCI, V45, P2886, DOI 10.1167/iovs.03-1083; Lutty G, 1999, MOL VIS, V5; Lutty GA, 1997, AM J PATHOL, V151, P707; Makita S, 2006, OPT EXPRESS, V14, P7821, DOI 10.1364/OE.14.007821; Mariampillai A, 2008, OPT LETT, V33, P1530, DOI 10.1364/OL.33.001530; McLeod DS, 2009, INVEST OPHTH VIS SCI, V50, P4982, DOI 10.1167/iovs.09-3639; MCLEOD DS, 1994, INVEST OPHTH VIS SCI, V35, P3799; Motaghiannezam R, 2012, INVEST OPHTH VIS SCI, V53, P2337, DOI 10.1167/iovs.11-7823; Mullins RE, 2011, INVEST OPHTH VIS SCI, V52, P1606, DOI 10.1167/iovs.10-6476; OLVER JM, 1990, EYE, V4, P262, DOI 10.1038/eye.1990.38; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Sarks SH, 1999, BRIT J OPHTHALMOL, V83, P358, DOI 10.1136/bjo.83.3.358; Schmetterer L., 2012, OCULAR BLOOD FLOW; Sohrab M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048631; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Tao YK, 2008, OPT EXPRESS, V16, P12350, DOI 10.1364/OE.16.012350; Vakoc BJ, 2009, NAT MED, V15, P1219, DOI 10.1038/nm.1971; Von Sallmann L, 1961, ARCH OPHTHALMOL-CHIC, V66, P920; YONEYA S, 1987, ARCH OPHTHALMOL-CHIC, V105, P681; Yu LF, 2010, J BIOMED OPT, V15; Yun SH, 2004, OPT EXPRESS, V12, P2977, DOI 10.1364/OPEX.12.002977; ZHANG HR, 1994, PROG RETIN EYE RES, V13, P243, DOI 10.1016/1350-9462(94)90012-4	34	206	209	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81499	10.1371/journal.pone.0081499	http://dx.doi.org/10.1371/journal.pone.0081499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349078	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300031
J	Franklin, AB; VerCauteren, KC; Maguire, H; Cichon, MK; Fischer, JW; Lavelle, MJ; Powell, A; Root, JJ; Scallan, E				Franklin, Alan B.; VerCauteren, Kurt C.; Maguire, Hugh; Cichon, Mary K.; Fischer, Justin W.; Lavelle, Michael J.; Powell, Amber; Root, J. Jeffrey; Scallan, Elaine			Wild Ungulates as Disseminators of Shiga Toxin-Producing Escherichia coli in Urban Areas	PLOS ONE			English	Article							WHITE-TAILED DEER; UNITED-STATES; O157-H7; INFECTIONS; ILLNESS; INTIMIN; STRAINS; GENES	Background: In 2008, children playing on a soccer field in Colorado were sickened with a strain of Shiga toxin-producing Escherichia coli (STEC) O157:H7, which was ultimately linked to feces from wild Rocky Mountain elk. We addressed whether wild cervids were a potential source of STEC infections in humans and whether STEC was ubiquitous throughout wild cervid populations in Colorado. Methodology/Principal Findings: We collected 483 fecal samples from Rocky Mountain elk and mule deer in urban and non-urban areas. Samples testing positive for STEC were higher in urban (11.0%) than non-urban (1.6%) areas. Elk fecal samples in urban areas had a much higher probability of containing STEC, which increased in both urban and non-urban areas as maximum daily temperature increased. Of the STEC-positive samples, 25% contained stx1 strains, 34.3% contained stx2, and 13% contained both stx1 and stx2. Additionally, eaeA genes were detected in 54.1% of the positive samples. Serotypes O103, and O146 were found in elk and deer feces, which also have the potential to cause human illness. Conclusions/Significance: The high incidence of stx2 strains combined with eaeA and E-hyl genes that we found in wild cervid feces is associated with severe human disease, such as hemolytic uremic syndrome. This is of concern because there is a very close physical interface between elk and humans in urban areas that we sampled. In addition, we found a strong relationship between ambient temperature and incidence of STEC in elk feces, suggesting a higher incidence of STEC in elk feces in public areas on warmer days, which in turn may increase the likelihood that people will come in contact with infected feces. These concerns also have implications to other urban areas where high densities of coexisting wild cervids and humans interact on a regular basis.	[Franklin, Alan B.; VerCauteren, Kurt C.; Fischer, Justin W.; Lavelle, Michael J.; Root, J. Jeffrey] USDA, Natl Wildlife Res Ctr, Ft Collins, CO USA; [Maguire, Hugh; Cichon, Mary K.] Colorado Dept Publ Hlth & Environm, Lab Serv Div, Denver, CO USA; [Powell, Amber] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Scallan, Elaine] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA	United States Department of Agriculture (USDA); Colorado Department of Public Health & Environment; National Jewish Health; Colorado School of Public Health	Franklin, AB (corresponding author), USDA, Natl Wildlife Res Ctr, Ft Collins, CO USA.	alan.b.franklin@aphis.usda.gov	Walter, Elaine Scallan/AAG-4278-2020	Fischer, Justin/0000-0002-9472-8945; Franklin, Alan/0000-0001-9491-795X	United States Department of Agriculture	United States Department of Agriculture(United States Department of Agriculture (USDA))	This study was funded by the United States Department of Agriculture. The manuscript was reviewed for general policy statements committing the USDA to action, but otherwise the findings were independently developed by the authors.	Bardiau M, 2010, J APPL MICROBIOL, V109, P2214, DOI 10.1111/j.1365-2672.2010.04855.x; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Bunnell S.D., 2002, N AM ELK ECOLOGY MAN, P701; Chase LC, 2002, WILDLIFE SOC B, V30, P937; de Sablet T, 2008, MICROBIOL-SGM, V154, P176, DOI 10.1099/mic.0.2007/009704-0; Donohue-Rolfe A, 2000, J INFECT DIS, V181, P1825, DOI 10.1086/315421; Fischer JR, 2001, APPL ENVIRON MICROB, V67, P1218, DOI 10.1128/AEM.67.3.1218-1224.2001; Garcia-Sanchez A, 2007, VET MICROBIOL, V121, P373, DOI 10.1016/j.vetmic.2006.12.012; Gilbreath JJ, 2009, APPL ENVIRON MICROB, V75, P862, DOI 10.1128/AEM.01158-08; Grund MD, 2002, J WILDLIFE MANAGE, V66, P123, DOI 10.2307/3802878; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Hale CR, 2012, CLIN INFECT DIS, V54, pS472, DOI 10.1093/cid/cis051; Henderson H, 2008, JAVMA-J AM VET MED A, V232, P848, DOI 10.2460/javma.232.6.848; Hibert F, 2011, EUR J WILDLIFE RES, V57, P495, DOI 10.1007/s10344-010-0458-x; Hoffmann S, 2012, J FOOD PROTECT, V75, P1292, DOI 10.4315/0362-028X.JFP-11-417; HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006; Karmali MA, 2004, J INFECT DIS, V189, P355, DOI 10.1086/381130; Liu D, 2012, 3172012 SAS I; Lubow BC, 2002, J WILDLIFE MANAGE, V66, P757, DOI 10.2307/3803141; Matyas B., 2010, Morbidity and Mortality Weekly Report, V59, P418; Meays CL, 2006, ENVIRON SCI TECHNOL, V40, P5289, DOI 10.1021/es060659q; Mora A, 2012, APPL ENVIRON MICROB, V78, P2578, DOI 10.1128/AEM.07520-11; National Park Service, 2007, FIN ENV IMP STAT ELK; Olsen SJ, 2002, EMERG INFECT DIS, V8, P370, DOI 10.3201/eid0804.000218; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; ProMED, 2011, E COL O157 US 06 OR; ProMED, 2008, E COL O157 ELK DROPP; Reischl U, 2002, J CLIN MICROBIOL, V40, P2555, DOI 10.1128/JCM.40.7.2555-2565.2002; Sanchez S, 2009, VET J, V180, P384, DOI 10.1016/j.tvjl.2008.01.011; Sargeant JM, 1999, J AM VET MED ASSOC, V215, P792; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Untimanon O., 2005, Current Issues in Intestinal Microbiology, V6, P25; Walter WD, 2011, INT J GEOGR INF SCI, V25, P379, DOI 10.1080/13658816.2010.524163	33	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81512	10.1371/journal.pone.0081512	http://dx.doi.org/10.1371/journal.pone.0081512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349083	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300033
J	Obeid, S; Alen, J; Nguyen, VH; Pham, VC; Meuleman, P; Pannecouque, C; Le, TN; Neyts, J; Dehaen, W; Paeshuyse, J				Obeid, Susan; Alen, Jo; Van Hung Nguyen; Van Cuong Pham; Meuleman, Philip; Pannecouque, Christophe; Thanh Nguyen Le; Neyts, Johan; Dehaen, Wim; Paeshuyse, Jan			Artemisinin Analogues as Potent Inhibitors of In Vitro Hepatitis C Virus Replication	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; ARTESUNATE; DERIVATIVES; RESISTANCE; POLYMERASE; EXPRESSION; THERAPY; STRESS; AGENT; HEMIN	We reported previously that Artemisinin (ART), a widely used anti-malarial drug, is an inhibitor of in vitro HCV subgenomic replicon replication. We here demonstrate that ART exerts its antiviral activity also in hepatoma cells infected with full length infectious HCV JFH-1. We identified a number of ART analogues that are up to 10-fold more potent and selective as in vitro inhibitors of HCV replication than ART. The iron donor Hemin only marginally potentiates the anti-HCV activity of ART in HCV-infected cultures. Carbon-centered radicals have been shown to be critical for the anti-malarial activity of ART. We demonstrate that carbon-centered radicals-trapping (the so-called TEMPO) compounds only marginally affect the anti-HCV activity of ART. This provides evidence that carbon-centered radicals are not the main effectors of the anti-HCV activity of the Artemisinin. ART and analogues may possibly exert their anti-HCV activity by the induction of reactive oxygen species (ROS). The combined anti-HCV activity of ART or its analogues with L-N-Acetylcysteine (L-NAC) [a molecule that inhibits ROS generation] was studied. L-NAC significantly reduced the in vitro anti-HCV activity of ART and derivatives. Taken together, the in vitro anti-HCV activity of ART and analogues can, at least in part, be explained by the induction of ROS; carbon-centered radicals may not be important in the anti-HCV effect of these molecules.	[Obeid, Susan; Pannecouque, Christophe; Neyts, Johan; Paeshuyse, Jan] Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium; [Alen, Jo; Dehaen, Wim] Katholieke Univ Leuven, Dept Chem, Louvain, Belgium; [Van Hung Nguyen; Van Cuong Pham; Thanh Nguyen Le] Vietnam Acad Sci & Technol, Inst Marine Biochem, Hanoi, Vietnam; [Meuleman, Philip] Univ Ghent, Dept Clin Chem Microbiol & Immunol, B-9000 Ghent, Belgium	KU Leuven; KU Leuven; Vietnam Academy of Science & Technology (VAST); Ghent University	Neyts, J (corresponding author), Katholieke Univ Leuven, Rega Inst Med Res, Louvain, Belgium.	Johan.Neyts@rega.kuleuven.be	Pannecouque, Christophe/C-2793-2018; Le, Thanh/AAW-5776-2021; Le, Thanh/GRY-4094-2022; Neyts, Johan/U-8267-2017; Meuleman, Philip/H-2899-2013	Pannecouque, Christophe/0000-0002-1254-4473; Le, Thanh/0000-0002-8375-4187; Neyts, Johan/0000-0002-0033-7514; Paeshuyse, Jan/0000-0003-2396-354X; Meuleman, Philip/0000-0001-6821-234X	Research Foundation Flanders-FWO; IWT-SBO project [100042]; KU Leuven grant [GOA/10/014]; Research Foundation Flanders-FWO [G.0728.09N, G.A099.10N]	Research Foundation Flanders-FWO(FWO); IWT-SBO project(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); KU Leuven grant; Research Foundation Flanders-FWO(FWO)	This work was supported by a postdoctoral fellowship from the Research Foundation Flanders-FWO to Jan Paeshuyse, the IWT-SBO project #100042, KU Leuven grant (GOA/10/014) and by grants G.0728.09N and G.A099.10N (NAFOSTED) of the Research Foundation Flanders-FWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony MP, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-316; Arav-Boger R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010370; Birku Y, 2002, ETHIOPIAN MED J, V40, P17; Chen H, 2010, J CANCER RES CLIN, V136, P897, DOI 10.1007/s00432-009-0731-0; Craxi A, 2003, SEMIN LIVER DIS, V23, P35; Delang L, 2010, VIRUSES-BASEL, V2, P826, DOI 10.3390/v2040826; Delgrange D, 2007, J GEN VIROL, V88, P2495, DOI 10.1099/vir.0.82872-0; deVries PJ, 1996, DRUGS, V52, P818, DOI 10.2165/00003495-199652060-00004; Dondorp AM, 2012, J INFECT DIS, V206, P618, DOI 10.1093/infdis/jis389; Efferth T, 2002, J MOL MED-JMM, V80, P233, DOI 10.1007/s00109-001-0300-8; Efferth T, 2008, CLIN INFECT DIS, V47, P804, DOI 10.1086/591195; Fillebeen C, 2005, J BIOL CHEM, V280, P9049, DOI 10.1074/jbc.M412687200; Fillebeen C, 2007, J HEPATOL, V47, P12, DOI 10.1016/j.jhep.2007.01.035; Fillebeen C, 2010, J HEPATOL, V53, P995, DOI 10.1016/j.jhep.2010.04.044; Fried MW, 2011, LIVER INT, V31, P58, DOI 10.1111/j.1478-3231.2010.02410.x; Fugi MA, 2010, ANTIMICROB AGENTS CH, V54, P1042, DOI 10.1128/AAC.01305-09; Gendron K, 2011, NUCLEIC ACIDS RES, V39, P902, DOI 10.1093/nar/gkq885; Kaptein SJF, 2006, ANTIVIR RES, V69, P60, DOI 10.1016/j.antiviral.2005.10.003; Mavakala BK, 2003, CHINESE J CHEM, V21, P1022; McCown MF, 2008, ANTIMICROB AGENTS CH, V52, P1604, DOI 10.1128/AAC.01317-07; Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7; Messori L, 2006, BIOORGAN MED CHEM, V14, P2972, DOI 10.1016/j.bmc.2005.12.038; Moles P, 2010, J PHYS CHEM B, V114, P1163, DOI 10.1021/jp910207z; Nosten F, 2006, BRIT MED J, V333, P45, DOI 10.1136/bmj.333.7557.45; Obeid S, 2011, J ANTIMICROB CHEMOTH, V66, P1287, DOI 10.1093/jac/dkr104; Paeshuyse J, 2006, BIOCHEM BIOPH RES CO, V348, P139, DOI 10.1016/j.bbrc.2006.07.014; Parry J, 2005, SCIENTIST, V19, P39; Pawlotsky JM, 2012, ANTIVIR THER, V17, P1109, DOI 10.3851/IMP2423; Posner GH, 2008, J MED CHEM, V51, P1035, DOI 10.1021/jm701168h; Prichard M N, 1996, Antivir Ther, V1, P9; Romero MR, 2005, ANTIVIR RES, V68, P75, DOI 10.1016/j.antiviral.2005.07.005; Shapira MY, 2008, CLIN INFECT DIS, V46, P1455, DOI 10.1086/587106; Steyn JD, 2011, INT J PHARMACEUT, V414, P260, DOI 10.1016/j.ijpharm.2011.05.003; Stockwin LH, 2009, INT J CANCER, V125, P1266, DOI 10.1002/ijc.24496; Thompson AJ, 2011, CURR OPIN VIROL, V1, P599, DOI 10.1016/j.coviro.2011.10.001; Tschan S, 2012, EXPERT OPIN EMERG DR, V17, P319, DOI 10.1517/14728214.2012.702754; Van Neck T, 2007, MOLECULES, V12, P395, DOI 10.3390/12030395; van Vugt M, 1999, AM J TROP MED HYG, V60, P936, DOI 10.4269/ajtmh.1999.60.936; Vliegen I, 2009, J HEPATOL, V50, P999, DOI 10.1016/j.jhep.2008.12.028; Wohlfarth C, 2009, ACTA PHARMACOL SIN, V30, P25, DOI 10.1038/aps.2008.5; Wright CW, 2010, MOLECULES, V15, P804, DOI 10.3390/molecules15020804; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; ZHENG YW, 1994, J BIOL CHEM, V269, P8857	43	28	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81783	10.1371/journal.pone.0081783	http://dx.doi.org/10.1371/journal.pone.0081783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349127	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300050
J	Bulbulia, J; Osborne, D; Sibley, CG				Bulbulia, Joseph; Osborne, Danny; Sibley, Chris G.			Moral Foundations Predict Religious Orientations in New Zealand	PLOS ONE			English	Article							UNIVERSAL COMPASSION; SACRED VALUES; EVOLUTION; COOPERATION; PSYCHOLOGY; NEIGHBOR; COUNTRY; BELIEF; QUEST	The interplay between religion, morality, and community-making is a core theme across human experience, yet scholars have only recently begun to quantify these links. Drawing on a sample of 1512 self-identified religious - mainly Christian (86.0%) - New Zealanders, we used structural equation modeling to test hypothesized associations between Religious Orientations (Quest, Intrinsic, Extrinsic Personal, Extrinsic Social) and Moral Foundations (Care/Harm, Fairness/Cheating, Loyalty/Betrayal, Authority/Subversion, Sanctity/Degradation). Our results show, for the first time in a comprehensive model, how different ways of valuing communities are associated with different ways of valuing religion.	[Bulbulia, Joseph] Victoria Univ New Zealand, Wellington, New Zealand; [Osborne, Danny; Sibley, Chris G.] Univ Auckland, Dept Psychol, Auckland, New Zealand	University of Auckland	Bulbulia, J (corresponding author), Victoria Univ New Zealand, Wellington, New Zealand.	Joseph.Bulbulia@vuw.ac.nz	Sibley, Chris G/D-2974-2009	Sibley, Chris G/0000-0002-4064-8800; Osborne, Danny/0000-0002-8513-4125; Bulbulia, Joseph/0000-0002-5861-2056	Canadian Social Sciences and Humanities Research Council (SSHRC): "The Evolution of Religion and Morality''; John F. Templeton Foundation: Testing the functional roles of religion in human society [28745]; Victoria University URF Grant [8-3046-108855]; University of Auckland FRDF grant [3624435/9853]; University of Auckland ECREA grants [3626075]	Canadian Social Sciences and Humanities Research Council (SSHRC): "The Evolution of Religion and Morality''; John F. Templeton Foundation: Testing the functional roles of religion in human society; Victoria University URF Grant; University of Auckland FRDF grant; University of Auckland ECREA grants	The Canadian Social Sciences and Humanities Research Council (SSHRC): "The Evolution of Religion and Morality'' and The John F. Templeton Foundation: Testing the functional roles of religion in human society - ID: 28745 supported this study. Victoria University URF Grant (8-3046-108855) supported Joseph Bulbulia. Collection of the New Zealand Attitudes and Values Study 2009 (NZAVS-09) data analyzed in this paper was funded by University of Auckland FRDF (3624435/9853) and ECREA (3626075) grants awarded to Chris Sibley.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorta CS, 2005, HUM NATURE-INT BIOS, V16, P323, DOI 10.1007/s12110-005-1014-3; Allport G. W., 1954, NATURE PREJUDICE; ALLPORT GW, 1967, J PERS SOC PSYCHOL, V5, P432, DOI 10.1037/h0021212; Atran S, 2008, NEGOTIATION J, V24, P221, DOI 10.1111/j.1571-9979.2008.00182.x; Atran Scott, 2010, Biology Theory, V5, P18, DOI 10.1162/BIOT_a_00018; Batson C D, 1993, RELIG INDIVIDUAL SOC; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; Batson CD, 1999, J SCI STUD RELIG, V38, P445, DOI 10.2307/1387605; BATSON CD, 1976, J SCI STUD RELIG, V15, P29, DOI 10.2307/1384312; BATSON CD, 1991, J SCI STUD RELIG, V30, P416, DOI 10.2307/1387277; BATSON CD, 1983, J SCI STUD RELIG, V22, P38, DOI 10.2307/1385590; Batson CD, 2001, J SCI STUD RELIG, V40, P39, DOI 10.1111/0021-8294.00036; Berggren N, 2011, J ECON BEHAV ORGAN, V80, P459, DOI 10.1016/j.jebo.2011.05.002; Boyer P, 2008, ANNU REV ANTHROPOL, V37, P111, DOI 10.1146/annurev.anthro.37.081407.085201; Bulbulia J, 2012, NUMEN-INT REV HIST R, V59, P564, DOI 10.1163/15685276-12341240; Bulbulia J, 2011, RELIGION, V41, P363, DOI 10.1080/0048721X.2011.604508; Cohen AB, 2005, PERS SOC PSYCHOL REV, V9, P48, DOI 10.1207/s15327957pspr0901_4; Fischer R, 2013, HUM NATURE-INT BIOS, V24, P115, DOI 10.1007/s12110-013-9167-y; Gervais WM, 2011, RELIGION, V41, P389, DOI 10.1080/0048721X.2011.604510; Gervais WM, 2008, DO YOU BELIEVE ATHEI; Ginges J, 2007, P NATL ACAD SCI USA, V104, P7357, DOI 10.1073/pnas.0701768104; GORSUCH RL, 1989, J SCI STUD RELIG, V28, P348, DOI 10.2307/1386745; Graham J., 2012, ADV EXPT SO IN PRESS; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hill P. C., 1999, MEASURES RELIG, DOI 10.2307/2402197; Hoge R, 1972, J SCI STUD RELIG, P369; Hoverd W, 2008, NZ SOCIOLOGY, V23, P41; Hoverd W. J., 2010, NZ SOCIOLOGY, V25, P59; Hoverd WJ, 2013, RELIG BRAIN BEHAV, P1; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Iyer R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042366; Kay AC, 2010, J PERS SOC PSYCHOL, V99, P725, DOI 10.1037/a0021140; KIRKPATRICK LA, 1990, J SCI STUD RELIG, V29, P442, DOI 10.2307/1387311; Norenzayan A, 2009, BEHAV BRAIN SCI, V32, P531, DOI 10.1017/S0140525X09991312; Putnam RD., 2000, BOWLING ALONE COLLAP; Sibley C. G., 2012, J COGNITIVE SCI RELI, V1, P29, DOI DOI 10.1558/JCSR.V1I1.29; Sosis R, 2003, CURR ANTHROPOL, V44, P713, DOI 10.1086/379260; Tetlock PE, 2003, TRENDS COGN SCI, V7, P320, DOI 10.1016/S1364-6613(03)00135-9; Wilson D., 2002, DARWINS CATHEDRAL EV; Wilson M, 2013, NEW CARIBB STUD, P1; Wulff DM, 1996, RELIG CLIN PRACTICE, P43; Xygalatas D., 2013, PSYCHOL SCI	45	20	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e80224	10.1371/journal.pone.0080224	http://dx.doi.org/10.1371/journal.pone.0080224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	275VW	24339872	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400003
J	Wu, XF; Xu, R; Ouyang, ZJ; Qian, C; Shen, Y; Wu, XD; Gu, YH; Xu, Q; Sun, Y				Wu, Xue-Feng; Xu, Rui; Ouyang, Zi-Jun; Qian, Cheng; Shen, Yan; Wu, Xu-Dong; Gu, Yan-Hong; Xu, Qiang; Sun, Yang			Beauvericin Ameliorates Experimental Colitis by Inhibiting Activated T Cells via Downregulation of the PI3K/Akt Signaling Pathway	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; INTESTINAL INFLAMMATION; CROHNS-DISEASE; CYTOCHROME-C; KINASE-B; KAPPA-B; INDUCTION; APOPTOSIS; GAMMA; CASPASE-3	Crohn's disease is a common, chronic inflammatory bowel condition characterized by remission and relapse. Accumulating evidence indicates that activated T cells play an important role in this disease. In the present study, we aimed to examine the effect of beauvericin, a natural cyclic peptide, on 2,4,6-trinitrobenzene sulfonic acid (TNBS)-induced colitis in mice, which mimics Crohn's disease. Beauvericin significantly reduced weight loss, diarrhea and mortality, accompanied with notable alleviation of macroscopic and microscopic signs. In addition, this compound decreased serum levels of tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma in a concentration-dependent manner in mice with experimental colitis. These effects of beauvericin are attributed to its inhibition on activated T cells. Flow cytometry and immunoblot assay data showed that beauvericin suppressed T-cell proliferation, activation and IFN-gamma-STAT1-T-bet signaling and subsequently led to apoptosis of activated T cells by suppressing Bcl-2 and phosphorylated Bad as well as increasing cleavage of caspase-3, -9, -12 and PARP. Furthermore, inhibition of PI3K/Akt signaling, which was an upstream regulator of cell activation and survival in activated T cells, contributed to the effect of beauvericin. Overall, these results supported beauvericin as a novel drug candidate for the treatment of colonic inflammation mainly by targeting PI3K/Akt in activated T cells.	[Wu, Xue-Feng; Xu, Rui; Ouyang, Zi-Jun; Qian, Cheng; Shen, Yan; Wu, Xu-Dong; Xu, Qiang; Sun, Yang] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Gu, Yan-Hong] Nanjing Med Univ, Affiliated Hosp 1, Dept Clin Oncol, Nanjing, Jiangsu, Peoples R China	Nanjing University; Nanjing Medical University	Xu, Q (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	molpharm@163.com; yangsun@nju.edu.cn	Qian, Cheng/ACI-6931-2022	Qian, Cheng/0000-0001-7573-3717	National Natural Science Foundation of China [30973546, 90913023, 81173070, 91229109, 81101563]; Natural Science Foundation of Jiangsu Province [BK2011053]; National Science & Technology Major Project [2012ZX09304-001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Science & Technology Major Project	This work was supported by National Natural Science Foundation of China (Nos. 30973546, 90913023, 81173070, 91229109, 81101563), Natural Science Foundation of Jiangsu Province (BK2011053), and National Science & Technology Major Project (No. 2012ZX09304-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Alimonti A, 2010, J CLIN INVEST, V120, P681, DOI 10.1172/JCI40535; APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Atreya R, 2011, GASTROENTEROLOGY, V141, P2026, DOI 10.1053/j.gastro.2011.08.032; Bauer B, 2002, MOL IMMUNOL, V38, P1087, DOI 10.1016/S0161-5890(02)00011-1; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P1559, DOI 10.1111/j.1572-0241.2006.00603.x; Besliu Alina Nicoleta, 2009, Roum Arch Microbiol Immunol, V68, P69; Cenac N, 2002, AM J PATHOL, V161, P1903, DOI 10.1016/S0002-9440(10)64466-5; Chen ML, 2011, IMMUNOL LETT, V140, P81, DOI 10.1016/j.imlet.2011.06.011; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dothel G, 2013, PHARM THER; Factor V, 2001, HEPATOLOGY, V34, P32, DOI 10.1053/jhep.2001.25270; Ficheux AS, 2013, TOXICON, V71, P1, DOI 10.1016/j.toxicon.2013.04.024; Guo WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046018; GUPTA S, 1991, MYCOPATHOLOGIA, V115, P185, DOI 10.1007/BF00462223; Guri AJ, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-60; Hausmann M, 2011, J BIOL CHEM, V286, P26533, DOI 10.1074/jbc.M111.265322; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Indar AA, 2009, WORLD J SURG, V33, P1049, DOI 10.1007/s00268-009-9957-x; Jow GM, 2004, CANCER LETT, V216, P165, DOI 10.1016/j.canlet.2004.06.005; Kaplan DH, 2012, NAT REV IMMUNOL, V12, P114, DOI 10.1038/nri3150; Kim EH, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00020; Kim HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059793; Kuhl AA, 2007, J LEUKOCYTE BIOL, V81, P168, DOI 10.1189/jlb.1105696; Lin HI, 2005, CANCER LETT, V230, P248, DOI 10.1016/j.canlet.2004.12.044; Logrieco A, 1998, APPL ENVIRON MICROB, V64, P3084; LoPiccolo J, 2007, ANTI-CANCER DRUG, V18, P861; Luo QO, 2011, TOXICOL APPL PHARM, V251, P130, DOI 10.1016/j.taap.2010.12.011; Mak Lok Hang, 2010, J Chem Biol, V3, P157, DOI 10.1007/s12154-010-0041-7; Meca G, 2010, TOXICON, V56, P349, DOI 10.1016/j.toxicon.2010.03.022; Monteleone I, 2002, GUT, V50, P60; Moro H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024972; Neurath MF, 2001, TRENDS IMMUNOL, V22, P21, DOI 10.1016/S1471-4906(00)01798-1; OVCHINNIKOV YA, 1971, TETRAHEDRON LETT, P159; Patel RK, 2005, IMMUNOL RES, V31, P47, DOI 10.1385/IR:31:1:47; Peng XD, 2010, J PHARMACOL EXP THER, V332, P46, DOI 10.1124/jpet.109.153494; Ruixue Luo LL, 2012, J SICHUAN TRADITIONA; Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1332, DOI 10.1002/ibd.21238; Sasaki Maiko, 2012, J Signal Transduct, V2012, P704953, DOI 10.1155/2012/704953; Shanahan F, 2000, Gastroenterology, V119, P1166, DOI 10.1016/S0016-5085(00)80035-9; Sheikh SZ, 2010, CURR OPIN GASTROEN, V26, P578, DOI 10.1097/MOG.0b013e32833d4b71; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Tischner D, 2012, J AUTOIMMUN, V38, P59, DOI 10.1016/j.jaut.2011.12.008; Wang QG, 2012, MOLECULES, V17, P2367, DOI 10.3390/molecules17032367; Wejman Jaroslaw, 2006, Polish Journal of Pathology, V57, P113; Wood JE, 2006, J BIOL CHEM, V281, P32385, DOI 10.1074/jbc.M604878200; Wu XF, 2011, PAIN, V152, P2605, DOI 10.1016/j.pain.2011.08.003; Zhan JX, 2007, J NAT PROD, V70, P227, DOI 10.1021/np060394t; Zheng JJ, 2007, J DIGEST DIS, V8, P35, DOI 10.1111/j.1443-9573.2007.00281.x	51	38	41	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83013	10.1371/journal.pone.0083013	http://dx.doi.org/10.1371/journal.pone.0083013			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340073	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400109
J	Kim, HS; Choi, SI; Min, HL; Kim, MA; Kim, WH				Kim, Hee Sung; Choi, Seung Im; Min, Hae Lim; Kim, Min A.; Kim, Woo Ho			Mutation at Intronic Repeats of the Ataxia-Telangiectasia Mutated (ATM) Gene and ATM Protein Loss in Primary Gastric Cancer with Microsatellite Instability	PLOS ONE			English	Article							CELL-LINES; FRAMESHIFT MUTATIONS; PRIMARY TUMORS; EXPRESSION; LYMPHOMA; MRE11; LEUKEMIA; RECEPTOR; REPAIR	Ataxia-telangiectasia mutated (ATM) is a Ser/Thr protein kinase that plays a critical role in DNA damage-induced signaling and initiation of cell cycle checkpoint signaling in response to DNA-damaging agents such as ionizing radiation. We have previously reported the ATM protein loss by immunohistochemistry (IHC) in 16% of human gastric cancer (GC) tissue. We hypothesized that ATM gene intron mutations targeted by microsatellite instability (MSI) cause ATM protein loss in a subset of GC. We studied mononucleotide mutations at the intron of ATM gene, ATM IHC and MSI in GC. Ten human gastric cancer cell lines were studied for the ATM gene mutation at introns, RT-PCR, direct sequencing, and immunohistochemistry. GC tissues of 839 patients were analyzed for MSI and ATM IHC. Among them, 604 cases were analyzed for the ATM mutations at introns preceding exon 6, exon 10 and exon 20. Two human GC cell lines (SNU-1 and -638) showed ATM intron mutations, deletion in RT-PCR and direct sequencing, and ATM protein loss by IHC. The frequencies of ATM mutation, MSI, and ATM protein loss were 12.9% (78/604), 9.2% (81/882) and 15.2% (134/839), respectively. Analysis of associations among MSI, ATM gene mutation, and ATM protein loss revealed highly co-existing ATM gene alterations and MSI. ATM intron mutation and ATM protein loss were detected in 69.3% (52/75) and 53.3% (40/75) of MSI positive GC. MSI positivity and ATM protein loss were present in 68.4% (52/76) and 48.7% (37/76) of GC with ATM intron mutation. ATM mutation and ATM protein loss had characteristics of old age, distal location of tumor, large tumor size, and histologic intestinal type. Our study might be interpreted as that ATM gene mutation at intron might be targeted by MSI and lead to ATM protein loss in a selected group of GC.	[Kim, Hee Sung] Chung Ang Univ, Coll Med, Dept Pathol, Seoul 156756, South Korea; [Choi, Seung Im; Min, Hae Lim; Kim, Min A.; Kim, Woo Ho] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kim, Min A.; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea	Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, WH (corresponding author), Seoul Natl Univ, Canc Res Inst, Seoul, South Korea.	woohokim@snu.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [NRF-2012R1A1A2004648]	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF-2012R1A1A2004648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANG YJ, 2013, J CLIN ONCOL, V31; Bartkova J, 2005, CELL CYCLE, V4, P838, DOI 10.4161/cc.4.6.1742; Calin G, 1998, CANCER RES, V58, P3777; Ejima Y, 2000, INT J CANCER, V86, P262, DOI 10.1002/(SICI)1097-0215(20000415)86:2<262::AID-IJC17>3.3.CO;2-9; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Greene FL, 2009, AJCC CANC STAGING MA; GUO DSX, 2009, MOL CANC THER S, V8, pB42; Ham MF, 2006, CANCER SCI, V97, P226, DOI 10.1111/j.1349-7006.2006.00165.x; Kim HS, 2013, PATHOBIOLOGY, V80, P127, DOI 10.1159/000346034; Kim JW, 2013, INT CONF IT CONVERGE; Kim NG, 2001, CANCER RES, V61, P36; Malkhosyan S, 1996, NATURE, V382, P499, DOI 10.1038/382499a0; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Min A, 2013, MOL CANCER THER, V12, P865, DOI 10.1158/1535-7163.MCT-12-0950; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Souza RF, 1996, NAT GENET, V14, P255, DOI 10.1038/ng1196-255; Stankovic T, 1998, AM J HUM GENET, V62, P334, DOI 10.1086/301706; Tentori L, 2006, FASEB J, V20, P1709, DOI 10.1096/fj.06-5916fje; Waha A, 1998, INT J CANCER, V78, P306, DOI 10.1002/(SICI)1097-0215(19981029)78:3<306::AID-IJC8>3.0.CO;2-Z; Williamson CT, 2010, MOL CANCER THER, V9, P347, DOI 10.1158/1535-7163.MCT-09-0872; Woerner SM, 2010, NUCLEIC ACIDS RES, V38, pD682, DOI 10.1093/nar/gkp839; Yamamoto H, 1997, CANCER RES, V57, P4420; Zhang L, 2004, MUTAT RES-GEN TOX EN, V557, P41, DOI 10.1016/j.mrgentox.2003.09.012	26	15	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82769	10.1371/journal.pone.0082769	http://dx.doi.org/10.1371/journal.pone.0082769			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324828	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566700107
J	Chruscinski, AJ; Singh, H; Chan, SM; Utz, PJ				Chruscinski, Andrzej J.; Singh, Harvir; Chan, Steven M.; Utz, Paul J.			Broad-Scale Phosphoprotein Profiling of Beta Adrenergic Receptor (beta-AR) Signaling Reveals Novel Phosphorylation and Dephosphorylation Events	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CANCER-CELLS; BETA(2)-ADRENERGIC RECEPTOR; TYROSINE KINASE; PHOSPHATASE 1; APOPTOSIS; ACTIVATION; PATHWAYS; EPAC; PKA	beta-adrenergic receptors (beta-ARs) are model G-protein coupled receptors that mediate signal transduction in the sympathetic nervous system. Despite the widespread clinical use of agents that target beta-ARs, the signaling pathways that operate downstream of beta-AR stimulation have not yet been completely elucidated. Here, we utilized a lysate microarray approach to obtain a broad-scale perspective of phosphoprotein signaling downstream of beta-AR. We monitored the time course of phosphorylation states of 54 proteins after beta-AR activation mouse embryonic fibroblast (MEF) cells. In response to stimulation with the non-selective beta-AR agonist isoproterenol, we observed previously described phosphorylation events such as ERK1/2(T202/Y204) and CREB(S133), but also novel phosphorylation events such as Cdc2(Y15) and Pyk2(Y402). All of these events were mediated through cAMP and PKA as they were reproduced by stimulation with the adenylyl cyclase activator forskolin and were blocked by treatment with H89, a PKA inhibitor. In addition, we also observed a number of novel isoproterenol-induced protein dephosphorylation events in target substrates of the PI3K/AKT pathway: GSK3 beta(S9), 4E-BP1(S65), and p70s6k(T389). These dephosphorylations were dependent on cAMP, but were independent of PKA and correlated with reduced PI3K/AKT activity. Isoproterenol stimulation also led to a cAMP-dependent dephosphorylation of PP1 alpha(T320), a modification known to correlate with enhanced activity of this phosphatase. Dephosphorylation of PP1 alpha coincided with the secondary decline in phosphorylation of some PKA-phosphorylated substrates, suggesting that PP1 alpha may act in a feedback loop to return these phosphorylations to baseline. In summary, lysate microarrays are a powerful tool to profile phosphoprotein signaling and have provided a broad-scale perspective of how beta-AR signaling can regulate key pathways involved in cell growth and metabolism.	[Chruscinski, Andrzej J.] Toronto Gen Hosp, Dept Med, Div Cardiol & Heart Transplantat, Toronto, ON M5G 1L7, Canada; [Singh, Harvir] Univ Hawaii, Honolulu, HI 96822 USA; [Chan, Steven M.] Stanford Univ, Dept Med, Div Hematol, Stanford, CA 94305 USA; [Utz, Paul J.] Stanford Univ, Dept Med, Div Rheumatol & Immunol, Stanford, CA 94305 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Hawaii System; Stanford University; Stanford University	Chruscinski, AJ (corresponding author), Toronto Gen Hosp, Dept Med, Div Cardiol & Heart Transplantat, Toronto, ON M5G 1L7, Canada.	andrzej.chruscinski@uhn.on.ca			NIH; Canadian Heart and Stroke Foundation; Donald E. and Delia B. Baxter Foundation; NHLBI [HHSN288201000034C]; NIH [5 U19-AI082719, 5 U19-AI050864, 1 U19-AI090019, 4 U19-AI090019, 5 U19-AI056363]; Alliance for Lupus Research [21858]; Canadian Institutes of Health Research [OR-92141]; FP [261]; European Union [261382]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864, U19AI056363, U19AI090019, U19AI082719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Donald E. and Delia B. Baxter Foundation; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alliance for Lupus Research; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); FP; European Union(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	A.C. was funded by a NIH Ruth Kirschstein postdoctoral fellowship and is currently funded by a research fellowship fron the Canadian Heart and Stroke Foundation. P.J.U. is the recipient of a Donald E. and Delia B. Baxter Foundation Career Development Award, a gift from The Floren Family Trust, a gift from The Ben May Trust and is supported by NHLBI Proteomics Contract-HHSN288201000034C, Proteomics of Inflammatory Immunity and Pulmonary Arterial Hypertension, grants from the NIH (5 U19-AI082719, 5 U19-AI050864, 1 U19-AI090019, 4 U19-AI090019, 5 U19-AI056363), Alliance for Lupus Research, (Grant 21858), Canadian Institutes of Health Research (Grant OR-92141), FP Grant #261, the research leading to these results has received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement [261382]. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt N, 1997, CURR BIOL, V7, P375, DOI 10.1016/S0960-9822(06)00185-0; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Chan SM, 2004, NAT MED, V10, P1390, DOI 10.1038/nm1139; Cheadle C, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-43; Cole SW, 2012, CLIN CANCER RES, V18, P1201, DOI 10.1158/1078-0432.CCR-11-0641; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DIXON RAF, 1986, NATURE, V321, P75, DOI 10.1038/321075a0; Dremier S, 2003, FEBS LETT, V546, P103, DOI 10.1016/S0014-5793(03)00561-1; Duronio V, 1998, CELL SIGNAL, V10, P233, DOI 10.1016/S0898-6568(97)00129-0; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; Feschenko MS, 2002, J PHARMACOL EXP THER, V302, P111, DOI 10.1124/jpet.302.1.111; Friedman J, 2002, MOL PHARMACOL, V62, P1094, DOI 10.1124/mol.62.5.1094; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Frishman WH, 2011, J CLIN HYPERTENS, V13, P649, DOI 10.1111/j.1751-7176.2011.00515.x; Han SJ, 2006, CELL CYCLE, V5, P227, DOI 10.4161/cc.5.3.2395; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Javed U, 2009, CARDIOL REV, V17, P287, DOI 10.1097/CRD.0b013e3181bdf63e; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; Kim S, 2001, J BIOL CHEM, V276, P12864, DOI 10.1074/jbc.M001492200; Kwon YG, 1997, P NATL ACAD SCI USA, V94, P2168, DOI 10.1073/pnas.94.6.2168; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li MT, 2000, MOL CELL BIOL, V20, P9356, DOI 10.1128/MCB.20.24.9356-9363.2000; Meyer AN, 2004, J BIOL CHEM, V279, P28450, DOI 10.1074/jbc.M403335200; Nicolaou P, 2009, FRONT BIOSCI-LANDMRK, V14, P3571, DOI 10.2741/3472; NORBURY C, 1991, EMBO J, V10, P3321, DOI 10.1002/j.1460-2075.1991.tb04896.x; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sastry KSR, 2007, J BIOL CHEM, V282, P14094, DOI 10.1074/jbc.M611370200; Schmidt M, 2007, CURR OPIN PHARMACOL, V7, P193, DOI 10.1016/j.coph.2006.10.004; Sheppard Karen E., 2012, Critical Reviews in Oncogenesis, V17, P69; Sivamani RK, 2009, PLOS MED, V6, P105, DOI 10.1371/journal.pmed.1000012; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang RH, 2001, ONCOGENE, V20, P6111, DOI 10.1038/sj.onc.1204829; Xiang YK, 2011, CIRC RES, V109, P231, DOI 10.1161/CIRCRESAHA.110.231340; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Xiong WC, 1997, J CELL BIOL, V139, P529, DOI 10.1083/jcb.139.2.529; Zheng M, 2005, PHARMACOL THERAPEUT, V108, P257, DOI 10.1016/j.pharmthera.2005.04.006	43	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82164	10.1371/journal.pone.0082164	http://dx.doi.org/10.1371/journal.pone.0082164			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340001	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566100089
J	Freire, JM; Veiga, AS; Conceicao, TM; Kowalczyk, W; Mohana-Borges, R; Andreu, D; Santos, NC; Da Poian, AT; Castanho, MARB				Freire, Joao Miguel; Veiga, Ana Salome; Conceicao, Thais M.; Kowalczyk, Wioleta; Mohana-Borges, Ronaldo; Andreu, David; Santos, Nuno C.; Da Poian, Andrea T.; Castanho, Miguel A. R. B.			Intracellular Nucleic Acid Delivery by the Supercharged Dengue Virus Capsid Protein	PLOS ONE			English	Article							CELL-PENETRATING PEPTIDES; FUNCTIONAL PROTEINS; LIPID-COMPOSITION; DRUG-DELIVERY; IN-VITRO; EFFICACY; BINDING; VECTOR; DRIVEN; NMR	Supercharged proteins are a recently identified class of proteins that have the ability to efficiently deliver functional macromolecules into mammalian cells. They were first developed as bioengineering products, but were later found in the human proteome. In this work, we show that this class of proteins with unusually high net positive charge is frequently found among viral structural proteins, more specifically among capsid proteins. In particular, the capsid proteins of viruses from the Flaviviridae family have all a very high net charge to molecular weight ratio (> + 1.07/kDa), thus qualifying as supercharged proteins. This ubiquity raises the hypothesis that supercharged viral capsid proteins may have biological roles that arise from an intrinsic ability to penetrate cells. Dengue virus capsid protein was selected for a detailed experimental analysis. We showed that this protein is able to deliver functional nucleic acids into mammalian cells. The same result was obtained with two isolated domains of this protein, one of them being able to translocate lipid bilayers independently of endocytic routes. Nucleic acids such as siRNA and plasmids were delivered fully functional into cells. The results raise the possibility that the ability to penetrate cells is part of the native biological functions of some viral capsid proteins.	[Freire, Joao Miguel; Veiga, Ana Salome; Santos, Nuno C.; Castanho, Miguel A. R. B.] Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal; [Conceicao, Thais M.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Kowalczyk, Wioleta; Andreu, David] Pompeu Fabra Univ, Dept Expt & Hlth Sci, Barcelona, Spain; [Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil	Universidade de Lisboa; Universidade Federal do Rio de Janeiro; Pompeu Fabra University; Universidade Federal do Rio de Janeiro	Castanho, MARB (corresponding author), Univ Lisbon, Inst Med Mol, Fac Med, P-1699 Lisbon, Portugal.	macastanho@fm.ul.pt	Kowalczyk, Wioleta/F-5904-2014; Da Poian, Andrea T./V-1699-2019; Borges, Ronaldo S Mohana/C-5575-2013; Andreu, David/I-4359-2014; Miguel Freire, Joao/J-4881-2015; Santos, Nuno/N-7248-2013	Andreu, David/0000-0002-6317-6666; FCCN, Bogus/0000-0003-1034-3552; Castanho, Miguel/0000-0001-7891-7562; Kowalczyk, Wioleta/0000-0001-5180-594X; Miguel Freire, Joao/0000-0002-8674-0813; Santos, Nuno/0000-0002-0580-0475; Veiga, Ana Salome/0000-0002-9892-2243; Da Poian, Andrea/0000-0002-3969-704X; FCCN, Bogus/0000-0001-6282-8004	Fundacao para a Ciencia e Tecnologia - Ministerio da Educacao e Ciencia (FCT-MEC, Portugal) [PTDC/QUI-BIQ/112929/2009]; European Union [FP7-HEALTH-F3-2008-223414]; Spanish Ministry of Economy and Competitiveness [SAF2011-24899]; Generalitat de Catalunya [2009 SGR 492]; Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); National Institute of Science and Technology in Dengue (INCT-Dengue); FCT-MEC [SFRH/BD/70423/2010]	Fundacao para a Ciencia e Tecnologia - Ministerio da Educacao e Ciencia (FCT-MEC, Portugal)(Portuguese Foundation for Science and Technology); European Union(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); National Institute of Science and Technology in Dengue (INCT-Dengue); FCT-MEC(Portuguese Foundation for Science and Technology)	This work was supported by Fundacao para a Ciencia e Tecnologia - Ministerio da Educacao e Ciencia (FCT-MEC, Portugal) [PTDC/QUI-BIQ/112929/2009], by the European Union [projects FP7-PEOPLE IRSES (MEMPEPACROSS) and FP7-HEALTH-F3-2008-223414 (LEISHDRUG)], by the Spanish Ministry of Economy and Competitiveness (SAF2011-24899), the Generalitat de Catalunya (2009 SGR 492), by the Brazilian Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), and the National Institute of Science and Technology in Dengue (INCT-Dengue). JMF also acknowledges FCT-MEC for Ph.D. fellowship SFRH/BD/70423/2010. WK is a fellow in the Juan de la Cierva Program of the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrescia NGA, 2012, ANNU REV BIOCHEM, V81, P795, DOI 10.1146/annurev-biochem-060910-095130; Alves CS, 2010, J BIOL CHEM, V285, P27536, DOI 10.1074/jbc.M110.130955; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; BRECKENRIDGE WC, 1972, BIOCHIM BIOPHYS ACTA, V266, P695, DOI 10.1016/0005-2736(72)90365-3; Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11; Cronican JJ, 2011, CHEM BIOL, V18, P833, DOI 10.1016/j.chembiol.2011.07.003; Cronican JJ, 2010, ACS CHEM BIOL, V5, P747, DOI 10.1021/cb1001153; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Doerr A, 2009, NAT METHODS, V6, P322, DOI 10.1038/nmeth0509-322; Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004; Ferre R, 2009, BIOPHYS J, V96, P1815, DOI [10.1016/j.bpj.2008.11.053, 10.1016/j.bpj.2008.11053]; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Fischer R, 2002, BBA-BIOMEMBRANES, V1564, P365, DOI 10.1016/S0005-2736(02)00471-6; Freire JM, 2013, BIOPOLYMERS, V100, P325, DOI 10.1002/bip.22266; Freire JM, 2013, J PEPT SCI, V19, P182, DOI 10.1002/psc.2477; Gautam A, 2012, DATABASE-OXFORD, DOI 10.1093/database/bas015; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; GREEN M, 1989, CELL, V58, P215, DOI 10.1016/0092-8674(89)90417-0; Hayashi Y, 2011, INT J PHARMACEUT, V419, P308, DOI 10.1016/j.ijpharm.2011.07.038; Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644; HERTZ L, 1988, NEUROCHEM RES, V13, P605, DOI 10.1007/BF00973275; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Hulo C, 2011, NUCLEIC ACIDS RES, V39, pD576, DOI 10.1093/nar/gkq901; Jarver P, 2010, TRENDS PHARMACOL SCI, V31, P528, DOI 10.1016/j.tips.2010.07.006; Kasson PM, 2011, P NATL ACAD SCI USA, V108, P3827, DOI 10.1073/pnas.1101072108; Kler S, 2012, J AM CHEM SOC, V134, P8823, DOI 10.1021/ja2110703; Kobayashi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040422; Lawrence MS, 2007, J AM CHEM SOC, V129, P10110, DOI 10.1021/ja071641y; Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101; Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; McNaughton BR, 2009, P NATL ACAD SCI USA, V106, P6111, DOI 10.1073/pnas.0807883106; Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035; Menger FM, 2005, LANGMUIR, V21, P10336, DOI 10.1021/la0508691; Milletti F, 2012, DRUG DISCOV TODAY, V17, P850, DOI 10.1016/j.drudis.2012.03.002; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Morris MC, 1999, NUCLEIC ACIDS RES, V27, P3510, DOI 10.1093/nar/27.17.3510; Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; NORTON WT, 1975, J NEUROSCI RES, V1, P57, DOI 10.1002/jnr.490010106; Ouzounis CA, 2000, GENOME RES, V10, P568, DOI 10.1101/gr.10.4.568; Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Santos NC, 2002, QUIM NOVA, V25, P1181, DOI 10.1590/S0100-40422002000700019; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248; Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Svensen N, 2012, TRENDS PHARMACOL SCI, V33, P186, DOI 10.1016/j.tips.2012.02.002; Teixeira AP, 2008, NEUROCHEM INT, V52, P478, DOI 10.1016/j.neuint.2007.08.007; Thompson DB, 2012, CHEM BIOL, V19, P831, DOI 10.1016/j.chembiol.2012.06.014; Thompson DB, 2012, METHOD ENZYMOL, V503, P293, DOI 10.1016/B978-0-12-396962-0.00012-4; Timko BP, 2011, ANNU REV MATER RES, V41, P1, DOI 10.1146/annurev-matsci-062910-100359; Torchilin VP, 2008, BIOPOLYMERS, V90, P604, DOI 10.1002/bip.20989; Torchilin VP, 2006, ANNU REV BIOMED ENG, V8, P343, DOI 10.1146/annurev.bioeng.8.061505.095735; Wexler-Cohen Y, 2010, FASEB J, V24, P4196, DOI 10.1096/fj.09-151704; Wilkins MR, 1999, METH MOL B, V112, P531; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270	63	31	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81450	10.1371/journal.pone.0081450	http://dx.doi.org/10.1371/journal.pone.0081450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339931	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100058
J	Gehrke, S; Brueckner, B; Schepky, A; Klein, J; Iwen, A; Bosch, TCG; Wenck, H; Winnefeld, M; Hagemann, S				Gehrke, Sandra; Brueckner, Bodo; Schepky, Andreas; Klein, Johannes; Iwen, Alexander; Bosch, Thomas C. G.; Wenck, Horst; Winnefeld, Marc; Hagemann, Sabine			Epigenetic Regulation of Depot-Specific Gene Expression in Adipose Tissue	PLOS ONE			English	Article							METABOLIC SYNDROME; FAT DISTRIBUTION; ABDOMINAL FAT; VISCERAL FAT; BODY-FAT; METHYLATION; OBESITY; DISEASE; MEN; DNA	In humans, adipose tissue is distributed in subcutaneous abdominal and subcutaneous gluteal depots that comprise a variety of functional differences. Whereas energy storage in gluteal adipose tissue has been shown to mediate a protective effect, an increase of abdominal adipose tissue is associated with metabolic disorders. However, the molecular basis of depot-specific characteristics is not completely understood yet. Using array-based analyses of transcription profiles, we identified a specific set of genes that was differentially expressed between subcutaneous abdominal and gluteal adipose tissue. To investigate the role of epigenetic regulation in depot-specific gene expression, we additionally analyzed genome-wide DNA methylation patterns in abdominal and gluteal depots. By combining both data sets, we identified a highly significant set of depot-specifically expressed genes that appear to be epigenetically regulated. Interestingly, the majority of these genes form part of the homeobox gene family. Moreover, genes involved in fatty acid metabolism were also differentially expressed. Therefore we suppose that changes in gene expression profiles might account for depot-specific differences in lipid composition. Indeed, triglycerides and fatty acids of abdominal adipose tissue were more saturated compared to triglycerides and fatty acids in gluteal adipose tissue. Taken together, our results uncover clear differences between abdominal and gluteal adipose tissue on the gene expression and DNA methylation level as well as in fatty acid composition. Therefore, a detailed molecular characterization of adipose tissue depots will be essential to develop new treatment strategies for metabolic syndrome associated complications.	[Gehrke, Sandra; Schepky, Andreas; Wenck, Horst; Winnefeld, Marc; Hagemann, Sabine] Beiersdorf AG, Res & Dev, Hamburg, Germany; [Klein, Johannes; Iwen, Alexander] Univ Med Ctr Schleswig Holstein, Dept Med 1, Lubeck, Germany; [Bosch, Thomas C. G.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany	Beiersdorf AG; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Hagemann, S (corresponding author), Beiersdorf AG, Res & Dev, Hamburg, Germany.	Sabine.Hagemann@Beiersdorf.com						[Anonymous], 2013, R LANG ENV STAT COMP; Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BJORNTORP P, 1992, ANN MED, V24, P15, DOI 10.3109/07853899209164140; Cantile M, 2003, J CELL PHYSIOL, V194, P225, DOI 10.1002/jcp.10210; Daftary GS, 2006, ENDOCR REV, V27, P331, DOI 10.1210/er.2005-0018; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Despres JP, 2006, ANN MED, V38, P52, DOI 10.1080/07853890500383895; Dusserre E, 2000, BBA-MOL BASIS DIS, V1500, P88, DOI 10.1016/S0925-4439(99)00091-5; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gibson JM, 1996, J CLIN ENDOCR METAB, V81, P860, DOI 10.1210/jc.81.2.860; Goodpaster BH, 1997, DIABETES, V46, P1579, DOI 10.2337/diabetes.46.10.1579; Heald AH, 2006, EXP CLIN ENDOCR DIAB, V114, P371, DOI 10.1055/s-2006-924320; Huang ZH, 2011, METABOLISM, V60, P1692, DOI 10.1016/j.metabol.2011.04.012; Iyer A, 2012, DIABETES, V61, P2320, DOI 10.2337/db11-1179; Karastergiou K, 2013, J CLIN ENDOCR METAB, V98, P362, DOI 10.1210/jc.2012-2953; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Kuk JL, 2006, OBESITY, V14, P336, DOI 10.1038/oby.2006.43; Lopez-Romero P, 2013, PREPROCESSING AGILEN; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Min JL, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002505; Ohta Hiroya, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P302; Rantalainen M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027338; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; Wang XL, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-87	31	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82516	10.1371/journal.pone.0082516	http://dx.doi.org/10.1371/journal.pone.0082516			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340035	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100116
J	Hachmann, JT; Jeong, JH; Grahn, PJ; Mallory, GW; Evertz, LQ; Bieber, AJ; Lobel, DA; Bennet, KE; Lee, KH; Lujan, JL				Hachmann, Jan T.; Jeong, Ju Ho; Grahn, Peter J.; Mallory, Grant W.; Evertz, Loribeth Q.; Bieber, Allan J.; Lobel, Darlene A.; Bennet, Kevin E.; Lee, Kendall H.; Lujan, J. Luis			Large Animal Model for Development of Functional Restoration Paradigms Using Epidural and Intraspinal Stimulation	PLOS ONE			English	Article							SPINAL-CORD; MICROSTIMULATION; MOVEMENT; HINDLIMB	Restoration of movement following spinal cord injury (SCI) has been achieved using electrical stimulation of peripheral nerves and skeletal muscles. However, practical limitations such as the rapid onset of muscle fatigue hinder clinical application of these technologies. Recently, direct stimulation of alpha motor neurons has shown promise for evoking graded, controlled, and sustained muscle contractions in rodent and feline animal models while overcoming some of these limitations. However, small animal models are not optimal for the development of clinical spinal stimulation techniques for functional restoration of movement. Furthermore, variance in surgical procedure, targeting, and electrode implantation techniques can compromise therapeutic outcomes and impede comparison of results across studies. Herein, we present a protocol and large animal model that allow standardized development, testing, and optimization of novel clinical strategies for restoring motor function following spinal cord injury. We tested this protocol using both epidural and intraspinal stimulation in a porcine model of spinal cord injury, but the protocol is suitable for the development of other novel therapeutic strategies. This protocol will help characterize spinal circuits vital for selective activation of motor neuron pools. In turn, this will expedite the development and validation of high-precision therapeutic targeting strategies and stimulation technologies for optimal restoration of motor function in humans.	[Hachmann, Jan T.; Jeong, Ju Ho; Mallory, Grant W.; Bennet, Kevin E.; Lee, Kendall H.; Lujan, J. Luis] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Hachmann, Jan T.; Grahn, Peter J.; Evertz, Loribeth Q.; Bieber, Allan J.] Mayo Clin, Mayo Grad Sch, Rochester, MN USA; [Jeong, Ju Ho] Kosin Univ, Dept Neurosurg, Coll Med, Pusan, South Korea; [Bieber, Allan J.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Lobel, Darlene A.] Cleveland Clin, Dept Neurosurg, Cleveland, OH 44106 USA; [Bennet, Kevin E.] Mayo Clin, Div Engn, Rochester, MN USA; [Lee, Kendall H.; Lujan, J. Luis] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Cleveland Clinic Foundation; Mayo Clinic; Mayo Clinic	Lujan, JL (corresponding author), Mayo Clin, Dept Neurol Surg, Rochester, MN USA.	lujan.luis@mayo.edu	Hachmann, Jan/AFT-4474-2022	Hachmann, Jan/0000-0002-0625-6416	National Institutes of Health [K08 NS 52232, R01 NS 70872]; Grainger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS052232, R01NS070872, R21NS087320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grainger Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (K08 NS 52232 and R01 NS 70872 awards to KHL), The Grainger Foundation, and a gift from Louise Chapman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamford JA, 2005, J PHYSIOL-LONDON, V569, P873, DOI 10.1113/jphysiol.2005.094516; Bamford JA, 2010, BIOMATERIALS, V31, P5552, DOI 10.1016/j.biomaterials.2010.03.051; Busscher I, 2010, EUR SPINE J, V19, P1104, DOI 10.1007/s00586-010-1326-9; Chang SYK, 2013, J NEUROSURGERY; Courtine G, 2009, NAT NEUROSCI, V12, P1333, DOI 10.1038/nn.2401; Grahn PJ, 2013, WIRELESS CO IN PRESS; Harkema S, 2011, LANCET, V377, P1938, DOI 10.1016/S0140-6736(11)60547-3; Holinski BJ, 2011, IEEE ENG MED BIO, P5798, DOI 10.1109/IEMBS.2011.6091435; Jackson A, 2012, NAT REV NEUROL, V8, P690, DOI 10.1038/nrneurol.2012.219; JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Lemay MA, 2001, IEEE T NEUR SYS REH, V9, P12, DOI 10.1109/7333.918272; Lemay MA, 2009, IEEE T NEUR SYS REH, V17, P379, DOI 10.1109/TNSRE.2009.2023295; Mushahwar VK, 2000, EXP NEUROL, V163, P422, DOI 10.1006/exnr.2000.7381; Mushahwar VK, 2000, IEEE T REHABIL ENG, V8, P11, DOI 10.1109/86.830944; Mushahwar VK, 2004, CAN J PHYSIOL PHARM, V82, P702, DOI 10.1139/Y04-079; NICOLOPOULOSSTOURNARAS S, 1983, J COMP NEUROL, V217, P75, DOI 10.1002/cne.902170107; Nishimura Y, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00057; ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209; Saigal R, 2004, IEEE T NEUR SYS REH, V12, P430, DOI 10.1109/TNSRE.2004.837754; Sunshine MD, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036001; Tai C, 1999, IEEE Trans Rehabil Eng, V7, P46, DOI 10.1109/86.750551; Tai CF, 2003, EXP NEUROL, V183, P620, DOI 10.1016/S0014-4886(03)00210-3; van den Brand R, 2012, SCIENCE, V336, P1182, DOI 10.1126/science.1217416; Vanderhorst VGJM, 1997, J COMP NEUROL, V382, P46	25	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81443	10.1371/journal.pone.0081443	http://dx.doi.org/10.1371/journal.pone.0081443			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339929	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100056
J	Jonker, FAM; Calis, JCJ; Phiri, K; Kraaijenhagen, RJ; Brabin, BJ; Faragher, B; Wiegerinck, ET; Tjalsma, H; Swinkels, DW; van Hensbroek, MB				Jonker, Fernkje A. M.; Calis, Job C. J.; Phiri, Kamija; Kraaijenhagen, Rob J.; Brabin, Bernard J.; Faragher, Brian; Wiegerinck, Erwin T.; Tjalsma, Harold; Swinkels, Dorine W.; van Hensbroek, Michael Boele			Low Hepcidin Levels in Severely Anemic Malawian Children with High Incidence of Infectious Diseases and Bone Marrow Iron Deficiency	PLOS ONE			English	Article							TRANSFERRIN RECEPTOR; SERUM HEPCIDIN; EXPRESSION; INFLAMMATION; OVERLOAD; FERRITIN; INSIGHT; LIVER; GENE	Introduction: A reliable diagnostic biomarker of iron status is required for severely anemic children living in malarious areas because presumptive treatment with iron may increase their infection risk if they are not iron deficient. Current biomarkers are limited because they are altered by host inflammation. In this study hepcidin concentrations were assessed in severely anemic children living in a highly malarious area of Malawi and evaluated against bone marrow iron in order to determine the usefulness of hepcidin as a point of care test. Methods: 207 severely anemic children were assessed for levels of hepcidin, ferritin, serum transferrin receptor, erythropoietin, hematological indices, C-reactive protein, interleukin-6, malaria parasites and HIV infection. Deficiency of bone marrow iron stores was graded and erythroblast iron incorporation estimated. Interaction of covariates was assessed by structural-equation-modeling. Results and Conclusion: Hepcidin was a poor predictor of bone marrow iron deficiency (sensitivity 66.7%; specificity 48.5%), and of iron incorporation (sensitivity 54.2%; specificity 61.8%), and therefore would have limitations as a point of care test in this category of children. As upregulation of hepcidin by inflammation and iron status was blunted by erythropoietin in this population, enhanced iron absorption through the low hepcidin values may increase infection risk. Current recommendations to treat all severely anemic children living in malarious areas with iron should therefore be reconsidered.	[Jonker, Fernkje A. M.; Calis, Job C. J.; van Hensbroek, Michael Boele] Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Phiri, Kamija] Coll Med, Dept Community Hlth, Blantyre, Malawi; [Kraaijenhagen, Rob J.] Meander Med Ctr, Lab Clin Chem & Haematol, Amersfoort, Netherlands; [Brabin, Bernard J.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Faragher, Brian] Univ Liverpool, Dept Biostat, Liverpool Sch Trop Med, Liverpool L69 3BX, Merseyside, England; [Wiegerinck, Erwin T.; Tjalsma, Harold; Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Lab Med, Lab Genet Endocrine & Metab Dis, NL-6525 ED Nijmegen, Netherlands; [Tjalsma, Harold; Swinkels, Dorine W.] Hepcidinanal Com, NL-6525 GA Nijmegen, Netherlands	Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Malawi; Meander Medisch Centrum; Liverpool School of Tropical Medicine; University of Liverpool; Liverpool School of Tropical Medicine; University of Liverpool; Radboud University Nijmegen	Jonker, FAM (corresponding author), Univ Amsterdam, Acad Med Ctr, Global Child Hlth Grp, Emma Childrens Hosp, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	femkje.jonker@gmail.com	Girelli, Domenico/B-1183-2008; Swinkels, Dorine W./H-8098-2014; Brabin, Bernard/AAJ-7389-2020	Girelli, Domenico/0000-0001-9684-1899; Swinkels, Dorine W./0000-0002-1040-9446; Boele van Hensbroek, Michael/0000-0003-1907-5427; Brabin, Bernard/0000-0001-6860-2508; Phiri, Kamija/0000-0003-1753-2727	Wellcome Trust [064722]; Nutricia Research Foundation; Stichting Emma Steun; JANIVO Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); Nutricia Research Foundation(Danone Nutricia); Stichting Emma Steun; JANIVO Foundation	This study was supported by a grant (064722) from the Wellcome Trust and by independent grants from the Nutricia Research Foundation, Stichting Emma Steun, and JANIVO Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuckle J. L., 2007, AMOS 6 0 USERS GUIDE; Calis JCJ, 2008, NEW ENGL J MED, V358, P888, DOI 10.1056/NEJMoa072727; Cercamondi CI, 2010, AM J CLIN NUTR, V92, P1385, DOI 10.3945/ajcn.2010.30051; Cherian S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004030; de Mast Q, 2009, BRIT J HAEMATOL, V145, P657, DOI 10.1111/j.1365-2141.2009.07664.x; de Mast Q, 2009, J INFECT DIS, V199, P253, DOI 10.1086/595790; FINCH CA, 1982, NEW ENGL J MED, V306, P1520, DOI 10.1056/NEJM198206243062504; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; GALE E, 1963, J CLIN INVEST, V42, P1076, DOI 10.1172/JCI104793; Galesloot TE, 2011, BLOOD, V117, pE218, DOI 10.1182/blood-2011-02-337907; HASTKA J, 1993, BLOOD, V81, P1200; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Hepcidinanalysis.com, 2012, WCX TOF MS REF VAL S; Hughes DA, 2004, J CLIN PATHOL, V57, P1038, DOI 10.1136/jcp.2003.015834; Jaeggi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057513; Jonker FAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042670; Kemna E, 2005, BLOOD, V106, P1864, DOI 10.1182/blood-2005-03-1159; Kroot JJC, 2011, CLIN CHEM, V57, P1650, DOI 10.1373/clinchem.2009.140053; Kroot JJC, 2010, CLIN CHEM, V56, P1570, DOI 10.1373/clinchem.2010.149187; Nemeth E, 2003, BLOOD, V101, P2461, DOI 10.1182/blood-2002-10-3235; Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Phiri KS, 2009, J CLIN PATHOL, V62, P1103, DOI 10.1136/jcp.2009.066498; Pigeon C, 2001, J BIOL CHEM, V276, P7811, DOI 10.1074/jbc.M008923200; Pinto JP, 2008, BLOOD, V111, P5727, DOI 10.1182/blood-2007-08-106195; Portugal S, 2011, NAT MED, V17, P732, DOI 10.1038/nm.2368; Prentice AM, 2012, BLOOD, V119, P1922, DOI 10.1182/blood-2011-11-391219; Punnonen K, 1997, BLOOD, V89, P1052, DOI 10.1182/blood.V89.3.1052; Ramos E, 2011, HEPATOLOGY, V53, P1333, DOI 10.1002/hep.24178; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Vokurka M, 2011, FOLIA BIOL-PRAGUE, V57, P248; WHO, 1998, WHO GUID US IR SUPPL; WHO, 2006, CONCL REC WHO CONS P; WHO, 2004, ASS IR STAT POP; WHO, 2005, WORLDW PREV AN 1993; WHO, 2001, IRON DEFICIENCY ANAE; Wilkins, 2001, BONE MARROW PATHOLOG	40	27	27	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e78964	10.1371/journal.pone.0078964	http://dx.doi.org/10.1371/journal.pone.0078964			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339866	gold, Green Published, Green Accepted			2022-12-27	WOS:000328566100005
J	Powers, GL; Rajbhandari, P; Solodin, NM; Bickford, B; Alarid, ET				Powers, Ginny L.; Rajbhandari, Prashant; Solodin, Natalia M.; Bickford, Brant; Alarid, Elaine T.			The Proteasome Inhibitor Bortezomib Induces an Inhibitory Chromatin Environment at a Distal Enhancer of the Estrogen Receptor-alpha Gene	PLOS ONE			English	Article							BREAST-CANCER-CELLS; TRANSCRIPTIONAL REGULATION; EXPRESSION; PROMOTER; GATA-3; IDENTIFICATION; DIFFERENTIATION; OSTEOBLASTS; SENSITIVITY; PROTEOLYSIS		[Alarid, Elaine T.] Univ Wisconsin, Dept Oncol, McArdle Labs Canc Res, Madison, WI 53715 USA; Univ Wisconsin, Carbone Comprehens Canc Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Alarid, ET (corresponding author), Univ Wisconsin, Dept Oncol, McArdle Labs Canc Res, Madison, WI 53715 USA.	alarid@oncology.wisc.edu		Rajbhandari, Prashant/0000-0002-8146-3861	NCI NIH HHS [R01 CA159578, P30 CA014520, CA 159578, T32 CA009135] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009135, R01CA159578, P30CA014520] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alarid ET, 2006, MOL ENDOCRINOL, V20, P1972, DOI 10.1210/me.2005-0481; Alarid ET, 1999, MOL ENDOCRINOL, V13, P1522, DOI 10.1210/me.13.9.1522; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; BERKENSTAM A, 1989, MOL ENDOCRINOL, V3, P22, DOI 10.1210/mend-3-1-22; Bernardo GM, 2010, DEVELOPMENT, V137, P2045, DOI 10.1242/dev.043299; Brand H, 2002, ENDOCRINOLOGY, V143, P3397, DOI 10.1210/en.2001-210832; Castles CG, 1997, J STEROID BIOCHEM, V62, P155, DOI 10.1016/S0960-0760(97)00023-X; Cobleigh MA, 2005, CLIN CANCER RES, V11, P8623, DOI 10.1158/1078-0432.CCR-05-0735; DECONINCK EC, 1995, MOL CELL BIOL, V15, P2191; Denger S, 2001, MOL ENDOCRINOL, V15, P2064, DOI 10.1210/me.15.12.2064; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Donaghue C, 1999, MOL ENDOCRINOL, V13, P1934, DOI 10.1210/me.13.11.1934; Drinkwater NR, 2011, STAT PROBLEMS GENETI; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; El Khissiin A, 1999, FEBS LETT, V448, P160, DOI 10.1016/S0014-5793(99)00343-9; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; Fan MY, 2004, MOL ENDOCRINOL, V18, P2603, DOI 10.1210/me.2004-0164; Flouriot G, 1998, MOL ENDOCRINOL, V12, P1939, DOI 10.1210/me.12.12.1939; Fullgrabe J, 2011, ONCOGENE, V30, P3391, DOI 10.1038/onc.2011.121; Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278; Grandien K, 1996, MOL CELL ENDOCRINOL, V116, P207, DOI 10.1016/0303-7207(95)03716-0; GRANDIEN K, 1995, ENDOCRINOLOGY, V136, P2223, DOI 10.1210/en.136.5.2223; Han YQ, 2008, MOL CANCER RES, V6, P1347, DOI 10.1158/1541-7786.MCR-07-2179; Hwang YC, 2013, NUCL ACIDS RES; Kim C, 2011, J CLIN ONCOL, V29, P4160, DOI 10.1200/JCO.2010.32.9615; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Kos M, 2001, MOL ENDOCRINOL, V15, P2057, DOI 10.1210/me.15.12.2057; Kouros-Mehr H, 2008, CANCER CELL, V13, P141, DOI 10.1016/j.ccr.2008.01.011; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Macaluso M, 2003, ONCOGENE, V22, P3511, DOI 10.1038/sj.onc.1206578; McPherson LA, 1999, NUCLEIC ACIDS RES, V27, P4040, DOI 10.1093/nar/27.20.4040; McPherson LA, 1997, P NATL ACAD SCI USA, V94, P4342, DOI 10.1073/pnas.94.9.4342; Nawaz Z, 1999, P NATL ACAD SCI USA, V96, P1858, DOI 10.1073/pnas.96.5.1858; Powers GL, 2010, ONCOGENE, V29, P1509, DOI 10.1038/onc.2009.434; Rao SH, 2001, J IMMUNOL, V167, P4494, DOI 10.4049/jimmunol.167.8.4494; REDDEL RR, 1984, CANCER RES, V44, P2398; Reid G, 2005, ONCOGENE, V24, P4894, DOI 10.1038/sj.onc.1208662; Rose SL, 2006, GYNECOL ONCOL, V102, P319, DOI 10.1016/j.ygyno.2005.12.025; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Sharma D, 2005, MOL ENDOCRINOL, V19, P1740, DOI 10.1210/me.2004-0011; Tang ZQ, 1997, MOL CELL BIOL, V17, P1274, DOI 10.1128/MCB.17.3.1274; Treilleux I, 1997, MOL ENDOCRINOL, V11, P1319, DOI 10.1210/me.11.9.1319; Valley CC, 2008, J MOL ENDOCRINOL, V40, P23, DOI 10.1677/JME-07-0067; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang DQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009853; Woodfield GW, 2009, CLIN CANCER RES, V15, P3672, DOI 10.1158/1078-0432.CCR-08-2343; Yamashita M, 2002, J BIOL CHEM, V277, P42399, DOI 10.1074/jbc.M205876200; Yan L, 2003, CANCER BIOL THER, V2, P552, DOI 10.4161/cbt.2.5.469	49	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81110	10.1371/journal.pone.0081110	http://dx.doi.org/10.1371/journal.pone.0081110			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339902	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100037
J	Kikuchi, M; Ogishima, S; Miyamoto, T; Miyashita, A; Kuwano, R; Nakaya, J; Tanaka, H				Kikuchi, Masataka; Ogishima, Soichi; Miyamoto, Tadashi; Miyashita, Akinori; Kuwano, Ryozo; Nakaya, Jun; Tanaka, Hiroshi			Identification of Unstable Network Modules Reveals Disease Modules Associated with the Progression of Alzheimer's Disease	PLOS ONE			English	Article							NEURONAL GENE-EXPRESSION; BRAIN-REGIONS; NCBI GEO; COMPLEX; PROTEASOME; INO80; TRANSCRIPTOME; POPULATION; PREVALENCE; ALGORITHM	Alzheimer's disease (AD), the most common cause of dementia, is associated with aging, and it leads to neuron death. Deposits of amyloid beta and aberrantly phosphorylated tau protein are known as pathological hallmarks of AD, but the underlying mechanisms have not yet been revealed. A high-throughput gene expression analysis previously showed that differentially expressed genes accompanying the progression of AD were more down-regulated than up-regulated in the later stages of AD. This suggested that the molecular networks and their constituent modules collapsed along with AD progression. In this study, by using gene expression profiles and protein interaction networks (PINs), we identified the PINs expressed in three brain regions: the entorhinal cortex (EC), hippocampus (HIP) and superior frontal gyrus (SFG). Dividing the expressed PINs into modules, we examined the stability of the modules with AD progression and with normal aging. We found that in the AD modules, the constituent proteins, interactions and cellular functions were not maintained between consecutive stages through all brain regions. Interestingly, the modules were collapsed with AD progression, specifically in the EC region. By identifying the modules that were affected by AD pathology, we found the transcriptional regulation-associated modules that interact with the proteasome-associated module via UCHL5 hub protein, which is a deubiquitinating enzyme. Considering PINs as a system made of network modules, we found that the modules relevant to the transcriptional regulation are disrupted in the EC region, which affects the ubiquitin-proteasome system.	[Kikuchi, Masataka; Miyamoto, Tadashi; Tanaka, Hiroshi] Tokyo Med & Dent Univ, Dept Bioinformat, Bunkyo Ku, Tokyo, Japan; [Ogishima, Soichi; Nakaya, Jun; Tanaka, Hiroshi] Tohoku Univ, Dept Bioclin Informat, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan; [Miyashita, Akinori; Kuwano, Ryozo] Niigata Univ, Brain Res Inst, Bioresource Sci Branch, Ctr Bioresources, Niigata, Japan	Tokyo Medical & Dental University (TMDU); Tohoku University; Niigata University	Ogishima, S (corresponding author), Tohoku Univ, Dept Bioclin Informat, Tohoku Med Megabank Org, Sendai, Miyagi 980, Japan.	ogishima@sysmedbio.org			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22700311]	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (22700311) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Berchtold NC, 2008, P NATL ACAD SCI USA, V105, P15605, DOI 10.1073/pnas.0806883105; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bossi A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.17; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Cai Y, 2003, J BIOL CHEM, V278, P42733, DOI 10.1074/jbc.C300389200; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Ding N, 2008, MOL CELL, V31, P347, DOI 10.1016/j.molcel.2008.05.023; Doyon Y, 2004, CURR OPIN GENET DEV, V14, P147, DOI 10.1016/j.gde.2004.02.009; du Boisgueheneuc F, 2006, BRAIN, V129, P3315, DOI 10.1093/brain/awl244; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; EVANS DA, 1989, JAMA-J AM MED ASSOC, V262, P2551, DOI 10.1001/jama.262.18.2551; Graff J, 2012, NATURE, V483, P222, DOI 10.1038/nature10849; Haroutunian V, 2009, NEUROBIOL AGING, V30, P561, DOI 10.1016/j.neurobiolaging.2007.07.021; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027; Jha S, 2009, MOL CELL, V34, P521, DOI 10.1016/j.molcel.2009.05.016; Jin JY, 2005, J BIOL CHEM, V280, P41207, DOI 10.1074/jbc.M509128200; Johnson MB, 2009, NEURON, V62, P494, DOI 10.1016/j.neuron.2009.03.027; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Keller JN, 2000, J NEUROCHEM, V75, P436, DOI 10.1046/j.1471-4159.2000.0750436.x; Lam YA, 2000, P NATL ACAD SCI USA, V97, P9902, DOI 10.1073/pnas.170173897; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Leduc V, 2011, J NEUROSCI METH, V200, P14, DOI 10.1016/j.jneumeth.2011.05.026; Liang WS, 2008, PHYSIOL GENOMICS, V33, P240, DOI 10.1152/physiolgenomics.00242.2007; Liang WS, 2007, PHYSIOL GENOMICS, V28, P311, DOI 10.1152/physiolgenomics.00208.2006; Liu ZP, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-S2-S11; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Miller JA, 2008, J NEUROSCI, V28, P1410, DOI 10.1523/JNEUROSCI.4098-07.2008; Morrison AJ, 2009, NAT REV MOL CELL BIO, V10, P373, DOI 10.1038/nrm2693; Nakamura Y, 2012, HUM MOL GENET, V21, P1099, DOI 10.1093/hmg/ddr539; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Ray M, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-136; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; ROSVALL M, 2008, ARXIV09061405V2; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rump P, 2011, CLIN GENET, V79, P183, DOI 10.1111/j.1399-0004.2010.01449.x; Salminen A, 2011, PROG NEUROBIOL, V93, P99, DOI 10.1016/j.pneurobio.2010.10.006; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stark C, 2011, NUCLEIC ACIDS RES, V39, pD698, DOI 10.1093/nar/gkq1116; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suthana N, 2012, NEW ENGL J MED, V366, P502, DOI 10.1056/NEJMoa1107212; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Yao T, 2008, MOL CELL, V31, P909, DOI 10.1016/j.molcel.2008.08.027; Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024	58	30	30	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e76162	10.1371/journal.pone.0076162	http://dx.doi.org/10.1371/journal.pone.0076162			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24348898	Green Published, gold			2022-12-27	WOS:000327258600003
J	Yeh, FC; Verstynen, TD; Wang, YB; Fernandez-Miranda, JC; Tseng, WYI				Yeh, Fang-Cheng; Verstynen, Timothy D.; Wang, Yibao; Fernandez-Miranda, Juan C.; Tseng, Wen-Yih Isaac			Deterministic Diffusion Fiber Tracking Improved by Quantitative Anisotropy	PLOS ONE			English	Article							WHITE-MATTER; TRACTOGRAPHY; BRAIN; CONNECTIVITY; MRI; TENSOR; SIZE	Diffusion MRI tractography has emerged as a useful and popular tool for mapping connections between brain regions. In this study, we examined the performance of quantitative anisotropy (QA) in facilitating deterministic fiber tracking. Two phantom studies were conducted. The first phantom study examined the susceptibility of fractional anisotropy (FA), generalized factional anisotropy (GFA), and QA to various partial volume effects. The second phantom study examined the spatial resolution of the FA-aided, GFA-aided, and QA-aided tractographies. An in vivo study was conducted to track the arcuate fasciculus, and two neurosurgeons blind to the acquisition and analysis settings were invited to identify false tracks. The performance of QA in assisting fiber tracking was compared with FA, GFA, and anatomical information from T-1-weighted images. Our first phantom study showed that QA is less sensitive to the partial volume effects of crossing fibers and free water, suggesting that it is a robust index. The second phantom study showed that the QA-aided tractography has better resolution than the FA-aided and GFA-aided tractography. Our in vivo study further showed that the QA-aided tractography outperforms the FA-aided, GFA-aided, and anatomy-aided tractographies. In the shell scheme (HARDI), the FA-aided, GFA-aided, and anatomy-aided tractographies have 30.7%, 32.6%, and 24.45% of the false tracks, respectively, while the QA-aided tractography has 16.2%. In the grid scheme (DSI), the FA-aided, GFA-aided, and anatomy-aided tractographies have 12.3%, 9.0%, and 10.93% of the false tracks, respectively, while the QA-aided tractography has 4.43%. The QA-aided deterministic fiber tracking may assist fiber tracking studies and facilitate the advancement of human connectomics.	[Yeh, Fang-Cheng] Carnegie Mellon Univ, Dept Biomed Engn, Pittsburgh, PA 15213 USA; [Verstynen, Timothy D.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Wang, Yibao; Fernandez-Miranda, Juan C.] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Med Ctr, Pittsburgh, PA 15261 USA; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Tseng, Wen-Yih Isaac] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan	Carnegie Mellon University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Taiwan University; National Taiwan University; National Taiwan University Hospital	Tseng, WYI (corresponding author), Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan.	wytseng@ntu.edu.tw	Yeh, Fang-Cheng/E-9698-2012	Yeh, Fang-Cheng/0000-0002-7946-2173; Tseng, Wen-Yih Isaac/0000-0002-2314-6868; Verstynen, Timothy/0000-0003-4720-0336	National Science Council, Taiwan [NSC100-3112-B-002-016, NSC100-2321-B-002-015]; National Health Research Institute, Taiwan [EX101-10145NI]; National Institutes of Health/National Institute of Mental Health, United States of America [U01MH093765]; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Institutes of Health/National Institute of Mental Health, United States of America; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the National Science Council, Taiwan (NSC100-3112-B-002-016, NSC100-2321-B-002-015), National Health Research Institute, Taiwan (EX101-10145NI) and National Institutes of Health/National Institute of Mental Health, United States of America (U01MH093765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander AL, 2001, MAGN RESON MED, V45, P770, DOI 10.1002/mrm.1105; Bach M, 2013, MAGN RESON MED, DOI [10.1002/mrm.24774, DOI 10.1002/MRM.24774.[]; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Ciccarelli O, 2008, LANCET NEUROL, V7, P715, DOI 10.1016/S1474-4422(08)70163-7; Dauguet J, 2007, NEUROIMAGE, V37, P530, DOI 10.1016/j.neuroimage.2007.04.067; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Fernandez-Miranda JC, 2012, NEUROSURGERY, V71, P430, DOI 10.1227/NEU.0b013e3182592faa; Fillard P, 2011, NEUROIMAGE, V56, P220, DOI 10.1016/j.neuroimage.2011.01.032; Fritzsche KH, 2010, NEUROIMAGE, V51, P242, DOI 10.1016/j.neuroimage.2010.02.007; Girard G, 2013, P 21 SCI M; Hagmann P, 2010, P NATL ACAD SCI USA, V107, P19067, DOI 10.1073/pnas.1009073107; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; Hasan KM, 2011, COMPUT BIOL MED, V41, P1062, DOI 10.1016/j.compbiomed.2010.10.008; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jarbo K, 2012, NEUROIMAGE, V59, P1988, DOI 10.1016/j.neuroimage.2011.09.056; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Jbabdi S, 2010, NEUROIMAGE, V49, P247, DOI 10.1016/j.neuroimage.2009.08.039; Kim YB, 2012, NMR BIOMED, V25, P943, DOI 10.1002/nbm.1815; Kuo LW, 2008, NEUROIMAGE, V41, P7, DOI 10.1016/j.neuroimage.2008.02.016; Lo YC, 2011, PSYCHIAT RES-NEUROIM, V192, P60, DOI 10.1016/j.pscychresns.2010.09.008; Metzler-Baddeley C, 2012, NEUROIMAGE, V59, P1394, DOI 10.1016/j.neuroimage.2011.08.043; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Pasternak O, 2009, MAGN RESON MED, V62, P717, DOI 10.1002/mrm.22055; Smith RE, 2012, NEUROIMAGE, V62, P1924, DOI 10.1016/j.neuroimage.2012.06.005; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Takao H, 2011, NEUROIMAGE, V57, P958, DOI 10.1016/j.neuroimage.2011.05.019; Tang PF, 2010, AM J NEURORADIOL, V31, P1023, DOI 10.3174/ajnr.A1981; Tensaouti F, 2011, J MAGN RESON IMAGING, V34, P165, DOI 10.1002/jmri.22584; Toga AW, 2012, NEUROSURGERY, V71, P1, DOI 10.1227/NEU.0b013e318258e9ff; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Verstynen T, 2011, J NEUROPHYSIOL, V105, P336, DOI 10.1152/jn.00698.2010; Wang Y, 2012, CEREB CORTEX; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Williams Ruth, 2010, Lancet Neurol, V9, P238, DOI 10.1016/S1474-4422(10)70046-6; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126	44	525	526	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80713	10.1371/journal.pone.0080713	http://dx.doi.org/10.1371/journal.pone.0080713			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24348913	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000327258600080
J	Metral, M; Blettery, B; Bresciani, JP; Luyat, M; Guerraz, M				Metral, Morgane; Blettery, Baptiste; Bresciani, Jean-Pierre; Luyat, Marion; Guerraz, Michel			Trying to Move Your Unseen Static Arm Modulates Visually-Evoked Kinesthetic Illusion	PLOS ONE			English	Article							VIBRATION-INDUCED ILLUSIONS; POSITION SENSE; MUSCLE-SPINDLES; INTEGRATION; PERCEPTION; RESPONSES; PROPRIOCEPTORS; CONTRACTIONS; INFORMATION; AFFERENTS	Although kinesthesia is known to largely depend on afferent inflow, recent data suggest that central signals originating from volitional control (efferent outflow) could also be involved and interact with the former to build up a coherent percept. Evidence derives from both clinical and experimental observations where vision, which is of primary importance in kinesthesia, was systematically precluded. The purpose of the present experiment was to assess the role of volitional effort in kinesthesia when visual information is available. Participants (n=20) produced isometric contraction (10-20% of maximal voluntary force) of their right arm while their left arm, which image was reflected in a mirror, either was passively moved into flexion/extension by a motorized manipulandum, or remained static. The contraction of the right arm was either congruent with or opposite to the passive displacements of the left arm. Results revealed that in most trials, kinesthetic illusions were visually driven, and their occurrence and intensity were modulated by whether volitional effort was congruent or not with visual signals. These results confirm the impact of volitional effort in kinesthesia and demonstrate for the first time that these signals interact with visual afferents to offer a coherent and unified percept.	[Metral, Morgane; Guerraz, Michel] Univ Savoie, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Chambery, France; [Blettery, Baptiste; Guerraz, Michel] Univ Savoie, Dept Psychol, Chambery, France; [Metral, Morgane; Luyat, Marion] EA 4559, Lab Funct Neurosci & Pathol, Lille, France; [Bresciani, Jean-Pierre] Univ Fribourg, Dept Med, CH-1700 Fribourg, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite de Savoie; Universite de Savoie; Universite de Lille - ISITE; Universite de Lille; University of Fribourg	Guerraz, M (corresponding author), Univ Savoie, CNRS, UMR 5105, Lab Psychol & NeuroCognit, Chambery, France.	Michel.guerraz@univ-savoie.fr	Bresciani, Jean-Pierre/H-4340-2012; Luyat, Marion/HIR-3502-2022	Luyat, Marion/0000-0002-5640-5002; GUERRAZ, Michel/0000-0002-4267-6995; Bresciani, Jean-Pierre/0000-0002-7242-5433				Ansems GE, 2006, J PHYSIOL-LONDON, V576, P445, DOI 10.1113/jphysiol.2006.115097; Bakeman R, 2005, BEHAV RES METHODS, V37, P379, DOI 10.3758/BF03192707; Blanchard C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062475; Blanchard C, 2011, BRAIN RES, V1382, P219, DOI 10.1016/j.brainres.2011.01.066; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bresciani JP, 2008, SPRINGER TRAC ADV RO, V45, P61, DOI 10.1007/978-3-540-79035-8_5; BURKE D, 1978, J PHYSIOL-LONDON, V285, P101, DOI 10.1113/jphysiol.1978.sp012560; EDIN BB, 1990, J NEUROPHYSIOL, V63, P1307, DOI 10.1152/jn.1990.63.6.1307; Gandevia SC, 2006, J PHYSIOL-LONDON, V571, P703, DOI 10.1113/jphysiol.2005.103093; GOODWIN GM, 1972, BRAIN, V95, P705, DOI 10.1093/brain/95.4.705; GREGORY JE, 1988, J NEUROPHYSIOL, V59, P1220, DOI 10.1152/jn.1988.59.4.1220; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219, DOI 10.1113/jphysiol.1991.sp018547; Guerraz M, 2012, NEUROSCIENCE, V223, P258, DOI 10.1016/j.neuroscience.2012.07.059; Guerraz M, 2001, COGNITIVE BRAIN RES, V11, P259, DOI 10.1016/S0926-6410(00)00080-X; HAY JC, 1965, PSYCHON SCI, V2, P215, DOI 10.3758/BF03343413; Holmes NP, 2004, COGN AFFECT BEHAV NE, V4, P193, DOI 10.3758/CABN.4.2.193; Kavounoudias A, 2008, NEUROPSYCHOLOGIA, V46, P567, DOI 10.1016/j.neuropsychologia.2007.10.002; LACKNER JR, 1984, EXP NEUROL, V85, P97, DOI 10.1016/0014-4886(84)90164-X; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; MATTHEWS PBC, 1988, CAN J PHYSIOL PHARM, V66, P430, DOI 10.1139/y88-073; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; Proske U, 2012, PHYSIOL REV, V92, P1651, DOI 10.1152/physrev.00048.2011; Ramachandran VS, 2009, BRAIN, V132, P1693, DOI 10.1093/brain/awp135; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Reichenbach A, 2009, J PHYSIOL-LONDON, V587, P4605, DOI 10.1113/jphysiol.2009.176362; ROTHWELL JC, 1982, BRAIN, V105, P515, DOI 10.1093/brain/105.3.515; Smith JL, 2009, J APPL PHYSIOL, V106, P950, DOI 10.1152/japplphysiol.91365.2008; TEASDALE N, 1993, ACTA PSYCHOL, V82, P179, DOI 10.1016/0001-6918(93)90011-F; Tsuge M, 2012, EXP BRAIN RES, V223, P541, DOI 10.1007/s00221-012-3281-7; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; WANN JP, 1992, EXP BRAIN RES, V91, P162	31	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2013	8	11							e80360	10.1371/journal.pone.0080360	http://dx.doi.org/10.1371/journal.pone.0080360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255EG	24348909	Green Published, gold, Green Submitted			2022-12-27	WOS:000327221600206
J	Becker, M; Caminiti, S; Fiorella, D; Francis, L; Gravino, P; Haklay, M; Hotho, A; Loreto, V; Mueller, J; Ricchiuti, F; Servedio, VDP; Sirbu, A; Tria, F				Becker, Martin; Caminiti, Saverio; Fiorella, Donato; Francis, Louise; Gravino, Pietro; Haklay, Mordechai (Muki); Hotho, Andreas; Loreto, Vittorio; Mueller, Juergen; Ricchiuti, Ferdinando; Servedio, Vito D. P.; Sirbu, Alina; Tria, Francesca			Awareness and Learning in Participatory Noise Sensing	PLOS ONE			English	Article							EXPOSURE	The development of ICT infrastructures has facilitated the emergence of new paradigms for looking at society and the environment over the last few years. Participatory environmental sensing, i.e. directly involving citizens in environmental monitoring, is one example, which is hoped to encourage learning and enhance awareness of environmental issues. In this paper, an analysis of the behaviour of individuals involved in noise sensing is presented. Citizens have been involved in noise measuring activities through the WideNoise smartphone application. This application has been designed to record both objective (noise samples) and subjective (opinions, feelings) data. The application has been open to be used freely by anyone and has been widely employed worldwide. In addition, several test cases have been organised in European countries. Based on the information submitted by users, an analysis of emerging awareness and learning is performed. The data show that changes in the way the environment is perceived after repeated usage of the application do appear. Specifically, users learn how to recognise different noise levels they are exposed to. Additionally, the subjective data collected indicate an increased user involvement in time and a categorisation effect between pleasant and less pleasant environments.	[Loreto, Vittorio; Sirbu, Alina; Tria, Francesca] Inst Sci Interchange Fdn, Complex Networks & Syst Lagrange Lab, Turin, Italy; [Francis, Louise; Haklay, Mordechai (Muki)] UCL, Extreme Citizen Sci Res Grp, Dept Civil Environm & Geomat Engn, London, England; [Becker, Martin; Hotho, Andreas] Univ Wurzburg, Dept Artificial Intelligence & Appl Comp Sci, D-97070 Wurzburg, Germany; [Caminiti, Saverio; Gravino, Pietro; Loreto, Vittorio; Servedio, Vito D. P.] Univ Roma La Sapienza, Dept Phys, I-00185 Rome, Italy; [Fiorella, Donato; Ricchiuti, Ferdinando] CSP Innovaz Nelle ICT, Turin, Italy; [Mueller, Juergen] Univ Kassel, Dept Elect Engn Comp Sci, D-34125 Kassel, Germany; [Becker, Martin; Hotho, Andreas; Mueller, Juergen] Leibniz Univ Hannover, Res Ctr L3S, Hannover, Germany	University of London; University College London; University of Wurzburg; Sapienza University Rome; Universitat Kassel; Leibniz University Hannover	Sirbu, A (corresponding author), Inst Sci Interchange Fdn, Complex Networks & Syst Lagrange Lab, Turin, Italy.	alina.sirbu@isi.it	Servedio, Vito D. P./P-4965-2015; Sirbu, Alina/I-3288-2014; Haklay, Mordechai/AAN-6892-2021	Servedio, Vito D. P./0000-0003-3221-5973; Sirbu, Alina/0000-0002-3947-7143; Haklay, Mordechai/0000-0001-6117-3026; Francis, Louise/0000-0002-8700-6055; Gravino, Pietro/0000-0002-0937-8830	EveryAware project; Future and Emerging Tech-nologies program of the European Commission under the EU RD [IST-265432]; Engineering and Physical Sciences Research Council [EP/I025278/1] Funding Source: researchfish; EPSRC [EP/I025278/1] Funding Source: UKRI	EveryAware project; Future and Emerging Tech-nologies program of the European Commission under the EU RD; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This research has been supported by the EveryAware project funded by the Future and Emerging Tech-nologies program of the European Commission under the EU RD contract IST-265432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander A., 2012, SMARTPHONE USAGE STA; [Anonymous], 2002, OFF J EUR COMMUNITIE, V45, P12; Assembly UG, 1992, AGENDA, V21; Babisch WF, 2005, EPIDEMIOLOGY, V16, P33, DOI 10.1097/01.ede.0000147104.84424.24; Council of the European Communities, 2008, OFF J EUR COMMUN, VL337, P41; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; European Commission, 2005, PROP REG EUR PARL CO; European Environment Agency, 2011, NOISEWATCH MOB APPL; EveryAware Consortium, WIDENOISE APP IOS; EveryAware Consortium, WIDENOISE APP ANDR; EveryAware Consortium, TERMS COND WIDENOISE; Garas A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00402; Haines MM, 2001, INT J EPIDEMIOL, V30, P839, DOI 10.1093/ije/30.4.839; Haklay M, 2008, NOISE MAPPING HELPS; Kephalopoulos, 2011, BURDEN DIS ENV NOISE; Maisonneuve Nicolas, 2010, Information Polity, V15, P51, DOI 10.3233/IP-2010-0200; Noise Nuisance Association, 2012, NOIS NUIS MOB APPL S; Passchier-Vermeer W, 2000, ENVIRON HEALTH PERSP, V108, P123, DOI 10.1289/ehp.00108s1123; Sano Y, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012805; Stevens M, 2012, THESIS VRIJE U BRUSS; World Health Organisation, 2010, HIDD CIT UNM OV HLTH; Zuffc A, 2008, COMMUN ACM, V51, P24, DOI 10.1145/1325555.1325562	22	47	47	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81638	10.1371/journal.pone.0081638	http://dx.doi.org/10.1371/journal.pone.0081638			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349102	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300041
J	Corre, P; Merceron, C; Vignes, C; Sourice, S; Masson, M; Durand, N; Espitalier, F; Pilet, P; Cordonnier, T; Mercier, J; Remy, S; Anegon, I; Weiss, P; Guicheux, J				Corre, Pierre; Merceron, Christophe; Vignes, Caroline; Sourice, Sophie; Masson, Martial; Durand, Nicolas; Espitalier, Florent; Pilet, Paul; Cordonnier, Thomas; Mercier, Jacques; Remy, Severine; Anegon, Ignacio; Weiss, Pierre; Guicheux, Jerome			Determining a Clinically Relevant Strategy for Bone Tissue Engineering: An "All-in-One" Study in Nude Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; CALCIUM-PHOSPHATE CERAMICS; MARROW STROMAL CELLS; GRAFT SUBSTITUTES; OSTEOGENIC DIFFERENTIATION; POROUS CERAMICS; REPAIR; DEFECTS; TRANSPLANTATION; REGENERATION	Purpose: Autologous bone grafting (BG) remains the standard reconstruction strategy for large craniofacial defects. Calcium phosphate (CaP) biomaterials, such as biphasic calcium phosphate (BCP), do not yield consistent results when used alone and must then be combined with cells through bone tissue engineering (BTE). In this context, total bone marrow (TBM) and bone marrow-derived mesenchymal stem cells (MSC) are the primary sources of cellular material used with biomaterials. However, several other BTE strategies exist, including the use of growth factors, various scaffolds, and MSC isolated from different tissues. Thus, clinicians might be unsure as to which method offers patients the most benefit. For this reason, the aim of this study was to compare eight clinically relevant BTE methods in an "all-in-one" study. Methods: We used a transgenic rat strain expressing green fluorescent protein (GFP), from which BG, TBM, and MSC were harvested. Progenitor cells were then mixed with CaP materials and implanted subcutaneously into nude mice. After eight weeks, bone formation was evaluated by histology and scanning electron microscopy, and GFP-expressing cells were tracked with photon fluorescence microscopy. Results/Conclusions: Bone formation was observed in only four groups. These included CaP materials mixed with BG or TBM, in which abundant de novo bone was formed, and BCP mixed with committed cells grown in two-and three-dimensions, which yielded limited bone formation. Fluorescence microscopy revealed that only the TBM and BG groups were positive for GFP expressing-cells, suggesting that these donor cells were still present in the host and contributed to the formation of bone. Since the TBM-based procedure does not require bone harvest or cell culture techniques, but provides abundant de novo bone formation, we recommend consideration of this strategy for clinical applications.	[Corre, Pierre; Merceron, Christophe; Vignes, Caroline; Sourice, Sophie; Masson, Martial; Durand, Nicolas; Espitalier, Florent; Pilet, Paul; Cordonnier, Thomas; Weiss, Pierre; Guicheux, Jerome] Univ Nantes, INSERM, UMR Unite Mixte Rech 791, Ctr Osteoarticular & Dent Tissue Engn, Nantes, France; [Corre, Pierre; Mercier, Jacques] CHU Nantes, Clin Stomatol & Chirurg Maxillofaciale, F-44035 Nantes 01, France; [Durand, Nicolas; Espitalier, Florent] CHU Nantes, Clin Otorhinolaryngol & Chirurg Cervicofaciale, F-44035 Nantes 01, France; [Remy, Severine; Anegon, Ignacio] ITUN, INSERM, UMR 1064, Ctr Rech Transplantat & Immunol & Plate Forme Tra, Nantes, France; [Corre, Pierre; Merceron, Christophe; Vignes, Caroline; Sourice, Sophie; Masson, Martial; Durand, Nicolas; Espitalier, Florent; Pilet, Paul; Cordonnier, Thomas; Mercier, Jacques; Weiss, Pierre; Guicheux, Jerome] Pole Hosp Univ 4, CHU Nantes, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes	Corre, P (corresponding author), Univ Nantes, INSERM, UMR Unite Mixte Rech 791, Ctr Osteoarticular & Dent Tissue Engn, Nantes, France.	pierre.corre@chu-nantes.fr	Weiss, Pierre/P-1372-2014; CORRE, Pierre/P-1307-2014; Anegon, Ignacio/I-7498-2018; guicheux, Jerome/F-7767-2013; Cordonnier, Thomas/L-1402-2015; Espitalier, Florent/P-6582-2014; Paul, Pilet/A-3755-2015; WEISS, Pierre/AAE-9260-2020; Anegon, Ignacio/I-7760-2018	Weiss, Pierre/0000-0002-6159-8590; CORRE, Pierre/0000-0003-4587-2163; guicheux, Jerome/0000-0003-2754-3024; WEISS, Pierre/0000-0002-6159-8590; Cordonnier, Thomas/0000-0002-0166-6870; merceron, christophe/0000-0003-1085-7182				Akahane M, 2008, J TISSUE ENG REGEN M, V2, P196, DOI 10.1002/term.81; Al Ruhaimi KA, 2001, INT J ORAL MAX IMPL, V16, P105; Arinzeh TL, 2005, BIOMATERIALS, V26, P3631, DOI 10.1016/j.biomaterials.2004.09.035; Bansal S, 2009, INDIAN J ORTHOP, V43, P234, DOI 10.4103/0019-5413.49387; Barboza EP, 1999, INT J PERIODONT REST, V19, P601; Bensaid W, 2005, TISSUE ENG, V11, P814, DOI 10.1089/ten.2005.11.814; Boukhechba F, 2011, TISSUE ENG PT A, V17, P2267, DOI [10.1089/ten.TEA.2010.0461, 10.1089/ten.tea.2010.0461]; Bruder SP, 1998, J ORTHOPAED RES, V16, P155, DOI 10.1002/jor.1100160202; BURCHARDT H, 1987, ORTHOP CLIN N AM, V18, P187; Cancedda R, 2003, STEM CELLS, V21, P610, DOI 10.1634/stemcells.21-5-610; Cavagna R, 1999, J LONG-TERM EFF MED, V9, P403; Cordonnier T, 2010, J MATER SCI-MATER M, V21, P981, DOI 10.1007/s10856-009-3916-9; Cordonnier T, 2014, J TISSUE ENG REGEN M, V8, P364, DOI 10.1002/term.1529; Corre P, 2012, REV STOMATOL CHIR, V113, P131, DOI 10.1016/j.stomax.2011.12.012; Corre P, 2011, REV STOMATOL CHIR, V112, P280, DOI 10.1016/j.stomax.2011.08.003; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Daculsi G, 2011, IRBM, V32, P76, DOI 10.1016/j.irbm.2011.01.031; DACULSI G, 1990, J BIOMED MATER RES, V24, P379, DOI 10.1002/jbm.820240309; Deschepper M, 2011, J CELL MOL MED, V15, P1505, DOI 10.1111/j.1582-4934.2010.01138.x; Doi K, 2007, DENT MATER J, V26, P162, DOI 10.4012/dmj.26.162; Dumas A, 2009, J BIOMED MATER RES A, V90A, P1218, DOI 10.1002/jbm.a.32176; Espitalier F, 2009, BIOMATERIALS, V30, P763, DOI 10.1016/j.biomaterials.2008.10.051; Fang DJ, 2007, STEM CELLS, V25, P1021, DOI 10.1634/stemcells.2006-0576; Fellah BH, 2008, BIOMATERIALS, V29, P1177, DOI 10.1016/j.biomaterials.2007.11.034; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; GOSHIMA J, 1991, CLIN ORTHOP RELAT R, P274; GOUIN F, 1995, REV CHIR ORTHOP, V81, P59; Guerado E, 2011, INJURY, V42, pS64, DOI 10.1016/j.injury.2011.06.200; Harris CT, 2004, J BIOMED MATER RES A, V68A, P747, DOI 10.1002/jbm.a.20107; Helm G A, 2001, Neurosurg Focus, V10, pE4; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Johnson KD, 1996, J ORTHOP RES, V14, P351, DOI 10.1002/jor.1100140304; Khanal GP, 2004, INT ORTHOP, V28, P167, DOI 10.1007/s00264-004-0547-0; Kitoh H, 2004, BONE, V35, P892, DOI 10.1016/j.bone.2004.06.013; Kruyt MC, 2004, J ORTHOP RES, V22, P697, DOI 10.1016/j.orthres.2003.10.021; Kruyt MC, 2004, J ORTHOP RES, V22, P544, DOI 10.1016/j.orthres.2003.10.010; Le Douarin N, 1973, Dev Biol, V30, P217, DOI 10.1016/0012-1606(73)90061-4; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Livingston TL, 2003, J MATER SCI-MATER M, V14, P211, DOI 10.1023/A:1022824505404; Magne D, 2004, CONNECT TISSUE RES, V45, P101, DOI 10.1080/03008200490464839; Mankani MH, 2007, EXP HEMATOL, V35, P995, DOI 10.1016/j.exphem.2007.01.051; Marcacci M, 2007, TISSUE ENG, V13, P947, DOI 10.1089/ten.2006.0271; Mastrogiacomo M, 2006, BIOMATERIALS, V27, P3230, DOI 10.1016/j.biomaterials.2006.01.031; Meijer GJ, 2008, BIOMATERIALS, V29, P3053, DOI 10.1016/j.biomaterials.2008.03.012; Mendes SC, 2002, TISSUE ENG, V8, P911, DOI 10.1089/107632702320934010; Merceron C, 2011, CELL TRANSPLANT, V20, P1575, DOI 10.3727/096368910X557191; Morishita T, 2006, ARTIF ORGANS, V30, P115, DOI 10.1111/j.1525-1594.2006.00190.x; Moro-Barrero L, 2007, J SPINAL DISORD TECH, V20, P409, DOI 10.1097/BSD.0b013e318030ca1e; Muschler GF, 1997, J BONE JOINT SURG AM, V79A, P1699, DOI 10.2106/00004623-199711000-00012; OHGUSHI H, 1989, J ORTHOPAED RES, V7, P568, DOI 10.1002/jor.1100070415; Ohgushi H, 2005, BIOMATERIALS, V26, P4654, DOI 10.1016/j.biomaterials.2004.11.055; OHGUSHI H, 1992, J BIOMED MATER RES, V26, P885, DOI 10.1002/jbm.820260705; OHGUSHI H, 1989, ACTA ORTHOP SCAND, V60, P334, DOI 10.3109/17453678909149289; PASSUTI N, 1989, CLIN ORTHOP RELAT R, P169; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pradel W, 2006, ORAL SURG ORAL MED O, V101, P285, DOI 10.1016/j.tripleo.2005.06.001; Quarto R, 2001, NEW ENGL J MED, V344, P385, DOI 10.1056/NEJM200102013440516; Rajan GP, 2006, J TRAUMA, V60, P1322, DOI 10.1097/01.ta.0000195977.18035.40; Remy S, 2010, TRANSGENIC RES, V19, P745, DOI 10.1007/s11248-009-9352-2; Rihn JA, 2010, SPINE, V35, P1629, DOI 10.1097/BRS.0b013e3181d25803; Schubert T, 2011, BIOMATERIALS, V32, P8880, DOI 10.1016/j.biomaterials.2011.08.009; Shayesteh YS, 2008, ORAL SURG ORAL MED O, V106, P203, DOI 10.1016/j.tripleo.2007.12.001; Sohier J, 2010, ACTA BIOMATER, V6, P2932, DOI 10.1016/j.actbio.2010.02.013; Taub PJ, 2009, PLAST RECONSTR SURG, V123, P1178, DOI 10.1097/PRS.0b013e31819f2949; Teodelinda M, 2011, BIOMATERIALS, V32, P3689, DOI 10.1016/j.biomaterials.2011.01.071; Toquet J, 1999, J BIOMED MATER RES, V44, P98, DOI 10.1002/(SICI)1097-4636(199901)44:1<98::AID-JBM11>3.3.CO;2-G; van Gaalen SM, 2010, J BIOMED MATER RES A, V92A, P303, DOI 10.1002/jbm.a.32380	67	12	12	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81599	10.1371/journal.pone.0081599	http://dx.doi.org/10.1371/journal.pone.0081599			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349093	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300038
J	Gong, PP; Xu, XD; Shi, JL; Ni, LC; Huang, QF; Xia, L; Nie, DK; Lu, XJ; Chen, J; Shi, W				Gong, Peipei; Xu, Xide; Shi, Jinlong; Ni, Lanchun; Huang, Qingfeng; Xia, Liang; Nie, Dekang; Lu, Xiaojian; Chen, Jian; Shi, Wei			Phosphorylation of Mitogen- and Stress-Activated Protein Kinase-1 in Astrocytic Inflammation: A Possible Role in Inhibiting Production of Inflammatory Cytokines	PLOS ONE			English	Article							NF-KAPPA-B; CENTRAL-NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; NEURONAL APOPTOSIS; IN-VITRO; MSK1; MICROGLIA; LIPOPOLYSACCHARIDE; MAPK	Purpose: It is generally accepted that inflammation has a role in the progression of many central nervous system (CNS) diseases, although the mechanisms through which this occurs remain unclear. Among mitogen-activated protein kinase (MAPK) targets, mitogen-and stress-activated protein kinase (MSK1) has been thought to be involved in the pathology of inflammatory gene expression. In this study, the roles of MSK1 activation in neuroinflammation were investigated. Methods: The bacterial lipopolysaccharide (LPS)-induced brain injury model was performed on Sprague-Dawley rats. The dynamic expression changes and the cellular location of p-MSK1 in the brain cortex were detected by Western blot and immunofluorescence staining. The synthesis of inflammatory cytokines in astrocytes was detected by enzyme-linked immunosorbent assay (ELISA). Results: Phosphorylated MSK1 (p-MSK1 Thr-581) was induced significantly after intracerebral injection of LPS into the lateral ventricles of the rat brain. Specific upregulation of p-MSK1 in astrocytes was also observed in inflamed cerebral cortex. At 1 day after LPS stimulation, iNOS, TNF alpha expression, and the astrocyte marker glial fibrillary acidic protein (GFAP) were increased significantly. Also, in vitro studies indicated that the upregulation of p-MSK1 (Thr-581) may be involved in the subsequent astrocyte inflammatory process, following LPS challenge. Using an enzyme-linked immunosorbent assay (ELISA), it was confirmed that treatment with LPS in primary astrocytes stimulated the synthesis of inflammatory cytokines, through MAPKs signaling pathways. In cultured primary astrocytes, both knock-down of total MSK1 by small interfering RNAs (siRNA) or specific mutation of Thr-581 resulted in higher production of certain cytokines, such as TNF alpha and IL-6. Conclusions: Collectively, these results suggest that MSK1 phosphorylation is associated with the regulation of LPS-induced brain injury and possibly acts as a negative regulator of inflammation.	[Gong, Peipei; Xu, Xide; Shi, Jinlong; Ni, Lanchun; Huang, Qingfeng; Xia, Liang; Nie, Dekang; Lu, Xiaojian; Chen, Jian; Shi, Wei] Nantong Univ, Dept Neurosurg, Comprehens Surg Lab, Affiliated Hosp, Nantong, Jiangsu, Peoples R China	Nantong University	Chen, J (corresponding author), Nantong Univ, Dept Neurosurg, Comprehens Surg Lab, Affiliated Hosp, Nantong, Jiangsu, Peoples R China.	chenjian1107@126.com; shiwei1107@163.com			National Natural Science Foundation of China [81070992]; Youth Fund of the National Natural Science Foundation of China [81201975]; Natural Science Foundation of Jiangsu province [BK2009156, BK2009161, BK2010169]; Nature Science Foundation of China Ministry of Health [2010-2-025]; Key Project Nature Science Foundation of Jiangsu Colleges and Universities [11KJA310002]; Application Research Project of Nantong City [HS12030]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Grand of Nantong University for innovation talent	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Fund of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Nature Science Foundation of China Ministry of Health; Key Project Nature Science Foundation of Jiangsu Colleges and Universities; Application Research Project of Nantong City; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Grand of Nantong University for innovation talent	This work was supported by the National Natural Science Foundation of China (No. 81070992), the Youth Fund of the National Natural Science Foundation of China (81201975); Natural Science Foundation of Jiangsu province (No. BK2009156, No. BK2009161 and No. BK2010169); Nature Science Foundation of China Ministry of Health (2010-2-025); Key Project Nature Science Foundation of Jiangsu Colleges and Universities (No. 11KJA310002); Application Research Project of Nantong City (Grant No. HS12030); Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); The Grand of Nantong University for innovation talent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan SM, 2000, ANN NY ACAD SCI, V917, P84; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Arthur JSC, 2004, J NEUROSCI, V24, P4324, DOI 10.1523/JNEUROSCI.5227-03.2004; Beck IM, 2008, EMBO J, V27, P1682, DOI 10.1038/emboj.2008.95; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cho IJ, 2009, INFLAMM RES, V58, P863, DOI 10.1007/s00011-009-0057-z; Dambach DM, 2005, CURR TOP MED CHEM, V5, P929, DOI 10.2174/1568026054985911; Darragh J, 2010, BIOCHEM J, V425, P595, DOI 10.1042/BJ20091062; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Degos V, 2010, J NEURAL TRANSM, V117, P1009, DOI 10.1007/s00702-010-0411-x; Dihne M, 2001, BRAIN RES, V902, P178, DOI 10.1016/S0006-8993(01)02378-2; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Gonzalez MC, 2004, NEUROSCIENCE, V127, P251, DOI 10.1016/j.neuroscience.2004.04.057; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Grin'kina NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036475; Hu S, 1997, NEUROCHEM INT, V30, P427, DOI 10.1016/S0197-0186(96)00078-2; Jana M, 2005, FREE RADICAL BIO MED, V38, P655, DOI 10.1016/j.freeradbiomed.2004.11.021; Jellinger K A, 2001, BMC Neurol, V1, P3, DOI 10.1186/1471-2377-1-3; John GR, 2003, NEUROSCIENTIST, V9, P10, DOI 10.1177/1073858402239587; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kim JH, 2012, CELL MOL BIOL, V58, P1780, DOI 10.1170/209; Kim L, 2005, J IMMUNOL, V174, P4178, DOI 10.4049/jimmunol.174.7.4178; Kim YH, 2010, INT IMMUNOPHARMACOL, V10, P1560, DOI 10.1016/j.intimp.2010.09.007; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lu XF, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-46; MacKenzie KF, 2013, MOL CELL BIOL, V33, P1456, DOI 10.1128/MCB.01690-12; McCoy CE, 2005, BIOCHEM J, V387, P507, DOI 10.1042/BJ20041501; Mccoy CE, 2007, BIOCHEM J, V402, P491, DOI 10.1042/BJ20061183; Min KJ, 2006, J NEUROSCI, V26, P1880, DOI 10.1523/JNEUROSCI.3696-05.2006; MUCKE L, 1993, FASEB J, V7, P1226, DOI 10.1096/fasebj.7.13.8405808; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Naqvi S, 2012, BIOCHEM J, V441, P347, DOI 10.1042/BJ20110970; Niranjan R, 2010, FREE RADICAL RES, V44, P1304, DOI 10.3109/10715762.2010.501080; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Oliveira CS, 2008, INT J DEV NEUROSCI, V26, P355, DOI 10.1016/j.ijdevneu.2007.12.007; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pan WW, 2010, J BIOL CHEM, V285, P34348, DOI 10.1074/jbc.M110.109165; PAXINOS G, 1980, J NEUROSCI METH, V3, P129, DOI 10.1016/0165-0270(80)90021-7; Perry VH, 2002, CURR OPIN NEUROL, V15, P349, DOI 10.1097/00019052-200206000-00020; Pierrat B, 1998, J BIOL CHEM, V273, P29661, DOI 10.1074/jbc.273.45.29661; Possel H, 2000, GLIA, V32, P51, DOI 10.1002/1098-1136(200010)32:1<51::AID-GLIA50>3.0.CO;2-4; Smith JA, 2012, BRAIN RES BULL, V87, P10, DOI 10.1016/j.brainresbull.2011.10.004; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Tiedje C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002977; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838	50	9	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81747	10.1371/journal.pone.0081747	http://dx.doi.org/10.1371/journal.pone.0081747			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349124	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300049
J	Lee, HY; Lee, GH; Lee, MR; Kim, HK; Kim, NY; Kim, SH; Lee, YC; Kim, HR; Chae, HJ				Lee, Hwa-Young; Lee, Geum-Hwa; Lee, Mi-Rin; Kim, Hye-Kyung; Kim, Nan-Young; Kim, Seung-Hyun; Lee, Yong-Chul; Kim, Hyung-Ryong; Chae, Han-Jung			Eucommia ulmoides Oliver Extract, Aucubin, and Geniposide Enhance Lysosomal Activity to Regulate ER Stress and Hepatic Lipid Accumulation	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED-PROTEIN RESPONSE; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; SIGNALING PATHWAY; CHO-CELLS; DEGRADATION; APOPTOSIS; TEA; INHIBITION	Eucommia ulmoides Oliver is a natural product widely used as a dietary supplement and medicinal plant. Here, we examined the potential regulatory effects of Eucommia ulmoides Oliver extracts (EUE) on hepatic dyslipidemia and its related mechanisms by in vitro and in vivo studies. EUE and its two active constituents, aucubin and geniposide, inhibited palmitate-induced endoplasmic reticulum (ER) stress, reducing hepatic lipid accumulation through secretion of apolipoprotein B and associated triglycerides and cholesterol in human HepG2 hepatocytes. To determine how EUE diminishes the ER stress response, lysosomal and proteasomal protein degradation activities were analyzed. Although proteasomal activity was not affected, lysosomal enzyme activities including V-ATPase were significantly increased by EUE as well as aucubin and geniposide in HepG2 cells. Treatment with the V-ATPase inhibitor, bafilomycin, reversed the inhibition of ER stress, secretion of apolipoprotein B, and hepatic lipid accumulation induced by EUE or its component, aucubin or geniposide. In addition, EUE was determined to regulate hepatic dyslipidemia by enhancing lysosomal activity and to regulate ER stress in rats fed a high-fat diet. Together, these results suggest that EUE and its active components enhance lysosomal activity, resulting in decreased ER stress and hepatic dyslipidemia.	[Lee, Hwa-Young; Lee, Geum-Hwa; Lee, Mi-Rin; Kim, Hye-Kyung; Chae, Han-Jung] Chonbuk Natl Univ, Dept Pharmacol, Sch Med, Jeonju, Chonbuk, South Korea; [Lee, Hwa-Young; Lee, Geum-Hwa; Lee, Mi-Rin; Kim, Hye-Kyung; Chae, Han-Jung] Chonbuk Natl Univ, Inst Cardiovasc Res, Sch Med, Jeonju, Chonbuk, South Korea; [Kim, Nan-Young; Kim, Seung-Hyun] Yonsei Univ, Yonsei Inst Pharmaceut Sci, Coll Pharm, Inchon, South Korea; [Lee, Yong-Chul] Chonbuk Natl Univ, Dept Internal Med, Sch Med, Jeonju, Chonbuk, South Korea; [Kim, Hyung-Ryong] Wonkwang Univ, Sch Dent, Dept Dent Pharmacol, Iksan, Chonbuk, South Korea	Jeonbuk National University; Jeonbuk National University; Yonsei University; Jeonbuk National University; Wonkwang University	Chae, HJ (corresponding author), Chonbuk Natl Univ, Dept Pharmacol, Sch Med, Jeonju, Chonbuk, South Korea.	hjchae@chonbuk.ac.kr		Chae, Han-Jung/0000-0003-4190-9889	National Research Foundation [2012R1A2A1A3001907, 2008-0062279]; Korea Health Industry Development Institute [A121931-1211-0000200]	National Research Foundation; Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI))	This study was supported by the National Research Foundation (2012R1A2A1A3001907 and 2008-0062279) and Korea Health Industry Development Institute (A121931-1211-0000200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bobrovnikova-Marjon E, 2008, P NATL ACAD SCI USA, V105, P16314, DOI 10.1073/pnas.0808517105; Cao J, 2012, MOL CELL BIOCHEM, V364, P115, DOI 10.1007/s11010-011-1211-9; Carabelli J, 2011, J CELL MOL MED, V15, P1329, DOI 10.1111/j.1582-4934.2010.01128.x; Choi MS, 2008, AM J CHINESE MED, V36, P81, DOI 10.1142/S0192415X08005606; Dunn Winston, 2008, Curr Gastroenterol Rep, V10, P67, DOI 10.1007/s11894-008-0011-1; Farrell GC, 2006, HEPATOLOGY, V43, pS99, DOI 10.1002/hep.20973; Feldstein AE, 2006, AM J PHYSIOL-GASTR L, V290, pG1339, DOI 10.1152/ajpgi.00509.2005; Fisher EA, 2002, J BIOL CHEM, V277, P17377, DOI 10.1074/jbc.R100068200; Foufelle F, 2007, M S-MED SCI, V23, P291, DOI 10.1051/medsci/2007233291; Friedlander R, 2000, NAT CELL BIOL, V2, P379, DOI 10.1038/35017001; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Gentile CL, 2008, J NUTR BIOCHEM, V19, P567, DOI 10.1016/j.jnutbio.2007.10.001; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hsieh CL, 2000, LIFE SCI, V66, P1387, DOI 10.1016/S0024-3205(00)00450-1; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jung TW, 2012, BIOCHEM BIOPH RES CO, V422, P229, DOI 10.1016/j.bbrc.2012.04.129; Kawai A, 2007, AUTOPHAGY, V3, P154, DOI 10.4161/auto.3634; Kharroubi I, 2004, ENDOCRINOLOGY, V145, P5087, DOI 10.1210/en.2004-0478; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lai WL, 2008, EXP CELL RES, V314, P1667, DOI 10.1016/j.yexcr.2008.02.002; Lee GH, 2011, INT J BIOCHEM CELL B, V43, P1469, DOI 10.1016/j.biocel.2011.06.010; Li H, 2009, J AOAC INT, V92, P103; LI ZL, 1983, SCI SIN B-CHEM B A M, V26, P33; Lin J, 2011, J ZHEJIANG UNIV-SC B, V12, P47, DOI 10.1631/jzus.B1000057; Luo LF, 2010, J ETHNOPHARMACOL, V129, P238, DOI 10.1016/j.jep.2010.03.019; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Miura Y, 2001, J NUTR, V131, P27, DOI 10.1093/jn/131.1.27; Nakamura T, 1997, MUTAT RES-GEN TOX EN, V388, P7, DOI 10.1016/S1383-5718(96)00096-4; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Park S, 2011, J HEPATOL, V54, P984, DOI 10.1016/j.jhep.2010.08.019; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Stangl V, 2006, MOL NUTR FOOD RES, V50, P218, DOI 10.1002/mnfr.200500118; Su QZ, 2009, HEPATOLOGY, V50, P77, DOI 10.1002/hep.22960; Temesvari LA, 1996, J CELL SCI, V109, P663; Tsai Yien Che, 2010, Genes Cancer, V1, P764; Zhang Q, 2013, MOLECULES, V18, P1857, DOI 10.3390/molecules18021857	37	19	21	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81349	10.1371/journal.pone.0081349	http://dx.doi.org/10.1371/journal.pone.0081349			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349058	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300026
J	Cao, JP; Zhu, S; Zhou, W; Li, J; Liu, C; Xuan, HQ; Yan, J; Zheng, L; Zhou, LX; Yu, JX; Chen, GQ; Huang, YR; Yu, Z; Feng, LX				Cao, JingPing; Zhu, Shu; Zhou, Wei; Li, Jie; Liu, Chang; Xuan, HanQing; Yan, Jie; Zheng, Lin; Zhou, LiXin; Yu, JianXiu; Chen, GuoQiang; Huang, YiRan; Yu, Zhuo; Feng, LiXin			PLZF Mediates the PTEN/AKT/FOXO3a Signaling in Suppression of Prostate Tumorigenesis	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ZINC-FINGER GENE; SELF-RENEWAL; PROTEIN PLZF; GERM-CELLS; STEM-CELLS; PTEN LOSS; C-MYC; CANCER; EXPRESSION	Promyelocytic leukemia zinc finger (PLZF) protein expression is closely related to the progression of human cancers, including prostate cancer (PCa). However, the according context of a signaling pathway for PLZF to suppress prostate tumorigenesis remains greatly unknown. Here we report that PLZF is a downstream mediator of the PTEN signaling pathway in PCa. We found that PLZF expression is closely correlated with PTEN expression in a cohort of prostate cancer specimens. Interestingly, both PTEN rescue and phosphoinositide 3-kinase (PI3K) inhibitor LY294002 treatment increase the PLZF expression in prostate cancer cell lines. Further, luciferase reporter assay and chromatin immunoprecipitation assay demonstrate that FOXO3a, a transcriptional factor phosphorylated by PI3K/AKT, could directly bind to the promoter of PLZF gene. These results indicate that PTEN regulates PLZF expression by AKT/FOXO3a. Moreover, our animal experiments also demonstrate that PLZF is capable of inhibiting prostate tumorigenesis in vivo. Taken together, our study defines a PTEN/PLZF pathway and would shed new lights for developing therapeutic strategy of prostate cancer.	[Cao, JingPing; Zhu, Shu; Chen, GuoQiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai, Peoples R China; [Cao, JingPing; Zhu, Shu; Chen, GuoQiang] SJTU SM, Shanghai, Peoples R China; [Cao, JingPing; Zhou, Wei; Liu, Chang; Yu, Zhuo; Feng, LiXin] SJTU SM, Inst Med Sci, Lab Germ Cell Res, Shanghai, Peoples R China; [Cao, JingPing; Li, Jie; Chen, GuoQiang] SJTU SM, Chinese Minist Educ, Key Lab Cell Differentiat & Apoptosis, Dept Pathophysiol, Shanghai, Peoples R China; [Xuan, HanQing; Zhou, LiXin; Huang, YiRan] SJTU SM, Renji Hosp, Dept Urol, Shanghai, Peoples R China; [Zheng, Lin] SJTU SM, Dept Pathol, Shanghai, Peoples R China; [Yan, Jie; Yu, JianXiu] SJTU SM, Dept Biochem & Mol Cell Biol, Lab Tumor Suppressor Genes, Shanghai, Peoples R China; [Yan, Jie; Yu, JianXiu] SJTU SM, Dept Biochem & Mol Cell Biol, MiRNAs, Shanghai, Peoples R China; [Feng, LiXin] Georgetown Univ, Med Ctr, Dept Biochem & Mol & Cellular Biol, Washington, DC 20007 USA	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Georgetown University	Yu, Z (corresponding author), SJTU SM, Inst Med Sci, Lab Germ Cell Res, Shanghai, Peoples R China.	yuzhuo78@shsmu.edu.cn; fenglx@shsmu.edu.cn	Zhu, Shu/P-6163-2018; Zhou, Li/GSE-4531-2022	Zhu, Shu/0000-0002-8163-0869; chen, guo qiang/0000-0003-4936-2363; Zhou, Wei/0000-0001-9636-7963	National Key Basic Research and Development Program of China [2012CB966603]; National Natural Science Foundation of China [30870956, 81000049]; 211 program of Shanghai Jiao Tong University School of Medicine; Shanghai Leading Academic Discipline Project [S30201]	National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 211 program of Shanghai Jiao Tong University School of Medicine; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	This work was partially supported by grants from the National Key Basic Research and Development Program of China (2012CB966603), from the National Natural Science Foundation of China (30870956) awarded to Dr. Feng, from the National Natural Science Foundation of China (81000049) awarded to Dr. Yu, from the 211 program of Shanghai Jiao Tong University School of Medicine and Shanghai Leading Academic Discipline Project (S30201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin MB, 2004, GLEASON GRADING PROS, Vxi; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bismar TA, 2011, BJU INT, V107, P477, DOI 10.1111/j.1464-410X.2010.09470.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Cheung M, 2010, ONCOGENE, V29, P1633, DOI 10.1038/onc.2009.455; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538; Filipponi D, 2007, MOL CELL BIOL, V27, P6770, DOI 10.1128/MCB.00479-07; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hobbs RM, 2010, CELL, V142, P468, DOI 10.1016/j.cell.2010.06.041; Hollander MC, 2011, NAT REV CANCER, V11, P289, DOI 10.1038/nrc3037; Hubner A, 2012, P NATL ACAD SCI USA, V109, P12046, DOI 10.1073/pnas.1209660109; Ikeda R, 2005, J BIOL CHEM, V280, P8523, DOI 10.1074/jbc.M409442200; Kikugawa T, 2006, PROSTATE, V66, P1092, DOI 10.1002/pros.20443; Kuijk EW, 2010, STEM CELLS DEV, V19, P979, DOI 10.1089/scd.2009.0276; Li YR, 2011, J PATHOL, V224, P90, DOI 10.1002/path.2855; Lynch RL, 2005, MOL CANCER RES, V3, P163, DOI 10.1158/1541-7786.MCR-04-0163; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Mulholland DJ, 2012, CANCER RES, V72, P1878, DOI 10.1158/0008-5472.CAN-11-3132; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Suliman Bandar Ali, 2012, Front Oncol, V2, P74, DOI 10.3389/fonc.2012.00074; Yeyati PL, 1999, ONCOGENE, V18, P925, DOI 10.1038/sj.onc.1202375; Yoshimoto M, 2006, CANCER GENET CYTOGEN, V169, P128, DOI 10.1016/j.cancergencyto.2006.04.003; Yoshimoto M, 2013, MODERN PATHOL, V26, P435, DOI 10.1038/modpathol.2012.162; Zafarana G, 2012, CANCER-AM CANCER SOC, V118, P4053, DOI 10.1002/cncr.26729; Zhang T, 1999, P NATL ACAD SCI USA, V96, P11422, DOI 10.1073/pnas.96.20.11422; Zhao Y, 2011, J MOL CELL BIOL, V3, P276, DOI 10.1093/jmcb/mjr013	33	58	61	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e77922	10.1371/journal.pone.0077922	http://dx.doi.org/10.1371/journal.pone.0077922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339862	Green Published, gold			2022-12-27	WOS:000328707400001
J	Haisma, EM; Rietveld, MH; de Breij, A; van Dissel, JT; El Ghalbzouri, A; Nibbering, PH				Haisma, Elisabeth M.; Rietveld, Marion H.; de Breij, Anna; van Dissel, Jaap T.; El Ghalbzouri, Abdoelwaheb; Nibbering, Peter H.			Inflammatory and Antimicrobial Responses to Methicillin-Resistant Staphylococcus aureus in an In Vitro Wound Infection Model	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSE; HUMAN SKIN EQUIVALENT; RECONSTRUCTED EPIDERMIS; EXPRESSION; PEPTIDES; KERATINOCYTES; COLONIZATION; FIBROBLASTS; ACTIVATION; CATHELICIDIN	Treatment of patients with burn wound infections may become complicated by the presence of antibiotic resistant bacteria and biofilms. Herein, we demonstrate an in vitro thermal wound infection model using human skin equivalents (HSE) and biofilm-forming methicillin-resistant Staphylococcus aureus (MRSA) for the testing of agents to combat such infections. Application of a liquid nitrogen-cooled metal device on HSE produced reproducible wounds characterized by keratinocyte death, detachment of the epidermal layer from the dermis, and re-epithelialization. Thermal wounding was accompanied by up-regulation of markers for keratinocyte activation, inflammation, and antimicrobial responses. Exposure of thermal wounded HSEs to MRSA resulted in significant numbers of adherent MRSA/HSE after 1 hour, and multiplication of these bacteria over 24-48 hours. Exposure to MRSA enhanced expression of inflammatory mediators such as TLR2 (but not TLR3), IL-6 and IL-8, and antimicrobial proteins human beta-defensin-2, -3 and RNAse7 by thermal wounded as compared to control HSEs. Moreover, locally applied mupirocin effectively reduced MRSA counts on (thermal wounded) HSEs by more than 99.9% within 24 hours. Together, these data indicate that this thermal wound infection model is a promising tool to study the initial phase of wound colonization and infection, and to assess local effects of candidate antimicrobial agents.	[Haisma, Elisabeth M.; de Breij, Anna; van Dissel, Jaap T.; Nibbering, Peter H.] Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands; [Haisma, Elisabeth M.; Rietveld, Marion H.; El Ghalbzouri, Abdoelwaheb] Leiden Univ, Med Ctr, Dept Dermatol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Haisma, EM (corresponding author), Leiden Univ, Med Ctr, Dept Infect Dis, Leiden, Netherlands.	e.m.haisma@lumc.nl			Dutch Burns Foundation (Nederlandse Brandwonden Stichting) [10.106]	Dutch Burns Foundation (Nederlandse Brandwonden Stichting)	This study was supported by the Dutch Burns Foundation (Nederlandse Brandwonden Stichting), project number 10.106; http://www.brandwondenstichting.nl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens K, 2011, J INVEST DERMATOL, V131, P443, DOI 10.1038/jid.2010.289; Auxenfans C, 2009, EUR J DERMATOL, V19, P107, DOI 10.1684/ejd.2008.0573; Babik J, 2008, Acta Chir Plast, V50, P27; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Church D, 2006, CLIN MICROBIOL REV, V19, P403, DOI 10.1128/CMR.19.2.403-434.2006; Croes S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-229; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; de Breij A, 2012, ANTIMICROB AGENTS CH, V56, P2459, DOI 10.1128/AAC.05975-11; El Ghalbzouri A, 2005, J INVEST DERMATOL, V124, P79, DOI 10.1111/j.0022-202X.2004.23549.x; El Ghalbzouri A, 2004, LAB INVEST, V84, P102, DOI 10.1038/labinvest.3700014; El-Ghalbzouri A, 2002, BRIT J DERMATOL, V147, P230, DOI 10.1046/j.1365-2133.2002.04871.x; Erol S, 2004, BURNS, V30, P357, DOI 10.1016/j.burns.2003.12.013; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gauglitz GG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029942; Harder J, 2010, J INVEST DERMATOL, V130, P1355, DOI 10.1038/jid.2009.432; Holland DB, 2008, FEMS MICROBIOL LETT, V279, P110, DOI 10.1111/j.1574-6968.2007.01021.x; Holland DB, 2009, FEMS MICROBIOL LETT, V290, P149, DOI 10.1111/j.1574-6968.2008.01402.x; Ikada Y, 2013, MICROB PATHOG, DOI [10.1016/j.micpath.2012.11.005, DOI 10.1016/J.MICPATH.2012.11.005.]; Kollisch G, 2005, IMMUNOLOGY, V114, P531, DOI 10.1111/j.1365-2567.2005.02122.x; Krishna S, 2012, SEMIN IMMUNOPATHOL, V34, P261, DOI 10.1007/s00281-011-0292-6; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lerebour G, 2004, J APPL MICROBIOL, V97, P7, DOI 10.1111/j.1365-2672.2004.02181.x; Martin JM, 2010, J INVEST DERMATOL, V130, P38, DOI 10.1038/jid.2009.221; Mempel M, 2003, J INVEST DERMATOL, V121, P1389, DOI 10.1111/j.1523-1747.2003.12630.x; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Niyonsaba F, 2006, CRIT REV IMMUNOL, V26, P545, DOI 10.1615/CritRevImmunol.v26.i6.60; Olaru F, 2010, J INVEST DERMATOL, V130, P1866, DOI 10.1038/jid.2010.37; Ouwehand K, 2012, EUR J CELL BIOL, V91, P765, DOI 10.1016/j.ejcb.2012.06.004; Pastar I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056846; Percival SL, 2010, INT WOUND J, V7, P169, DOI 10.1111/j.1742-481X.2010.00668.x; Poindexter BJ, 2006, BURNS, V32, P402, DOI 10.1016/j.burns.2006.01.021; Ponec M, 1997, J INVEST DERMATOL, V109, P348, DOI 10.1111/1523-1747.ep12336024; Ponec M, 2001, SKIN PHARMACOL APPL, V14, P63, DOI 10.1159/000056392; Sasaki T, 2003, BRIT J DERMATOL, V148, P46, DOI 10.1046/j.1365-2133.2003.05017.x; Schauber J, 2008, J INVEST DERMATOL, V128, P816, DOI 10.1038/sj.jid.5701102; Schauber J, 2007, J CLIN INVEST, V117, P803, DOI 10.1172/JCI30142; Shepherd J, 2009, TISSUE ENG PART C-ME, V15, P475, DOI 10.1089/ten.tec.2008.0614; Smiley AK, 2006, BURNS, V32, P135, DOI 10.1016/j.burns.2005.08.017; Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; Wanke I, 2011, J INVEST DERMATOL, V131, P382, DOI 10.1038/jid.2010.328; Werthen M, 2010, APMIS, V118, P156, DOI 10.1111/j.1600-0463.2009.02580.x; Zanger P, 2010, INFECT IMMUN, V78, P3112, DOI 10.1128/IAI.00078-10; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	48	46	47	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82800	10.1371/journal.pone.0082800	http://dx.doi.org/10.1371/journal.pone.0082800			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340061	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400097
J	Mazloom, R; Eftekhari, G; Rahimi, M; Khori, V; Hajizadeh, S; Dehpour, AR; Mani, AR				Mazloom, Roham; Eftekhari, Golnar; Rahimi, Maryam; Khori, Vahid; Hajizadeh, Sohrab; Dehpour, Ahmad R.; Mani, Ali R.			The Role of alpha(7) Nicotinic Acetylcholine Receptor in Modulation of Heart Rate Dynamics in Endotoxemic Rats	PLOS ONE			English	Article							RATE-VARIABILITY; SYSTEMIC INFLAMMATION; STIMULATION; EXPRESSION; PACEMAKER; CYTOKINE; ALPHA-7-NICOTINIC-ACETYLCHOLINE-RECEPTOR; MECHANISMS; SECRETION; SUBUNIT	Previous reports have indicated that artificial stimulation of the vagus nerve reduces systemic inflammation in experimental models of sepsis. This phenomenon is a part of a broader cholinergic anti-inflammatory pathway which activates the vagus nerve to modulate inflammation through activation of alpha7 nicotinic acetylcholine receptors (alpha 7nACHR). Heart rate variability represents the complex interplay between autonomic nervous system and cardiac pacemaker cells. Reduced heart rate variability and increased cardiac cycle regularity is a hallmark of clinical conditions that are associated with systemic inflammation (e.g. endotoxemia and sepsis). The present study was aimed to assess the role of alpha 7nACHR in modulation of heart rate dynamics during systemic inflammation. Systemic inflammation was induced by injection of endotoxin (lipopolysaccharide) in rats. Electrocardiogram and body temperature were recorded in conscious animals using a telemetric system. Linear and non-linear indices of heart rate variability (e. g. sample entropy and fractal-like temporal structure) were assessed. RT-PCR and immunohistochemistry studies showed that alpha 7nACHR is expressed in rat atrium and is mainly localized at the endothelial layer. Systemic administration of an alpha 7nACHR antagonist (methyllycaconitine) did not show a significant effect on body temperature or heart rate dynamics in naive rats. However, alpha 7nACHR blockade could further reduce heart rate variability and elicit a febrile response in endotoxemic rats. Pre-treatment of endotoxemic animals with an alpha 7nACHR agonist (PHA-543613) was unable to modulate heart rate dynamics in endotoxemic rats but could prevent the effect of endotoxin on body temperature within 24 h experiment. Neither methyllycaconitine nor PHA-543613 could affect cardiac beating variability of isolated perfused hearts taken from control or endotoxemic rats. Based on our observations we suggest a tonic role for nicotinic acetylcholine receptors in modulation of heart rate dynamics during systemic inflammation.	[Mazloom, Roham; Eftekhari, Golnar; Hajizadeh, Sohrab; Mani, Ali R.] Tarbiat Modares Univ, Sch Med Sci, Dept Physiol, Tehran, Iran; [Rahimi, Maryam; Dehpour, Ahmad R.] Univ Tehran Med Sci, Sch Med, Dept Pharmacol, Tehran, Iran; [Khori, Vahid] Univ Med Sci, Ischem Disorders Res Ctr, Gorgan, Iran	Tarbiat Modares University; Tehran University of Medical Sciences	Mani, AR (corresponding author), Tarbiat Modares Univ, Sch Med Sci, Dept Physiol, Tehran, Iran.	mani@modares.ac.ir	Mani, Alireza/H-3236-2015; Mazloom, Roham/U-6539-2017; Dehpour, Ahmad Reza/I-6422-2019; Khori, Vahid/G-1197-2017	Mani, Alireza/0000-0003-0830-2022; Mazloom, Roham/0000-0003-4873-1374; Dehpour, Ahmad Reza/0000-0002-8001-5565; Khori, Vahid/0000-0002-4672-9732; hajizadeh, sohrab/0000-0001-7920-6949	Tarbiat Modares University; Golestan University of Medical Sciences	Tarbiat Modares University; Golestan University of Medical Sciences	This study was supported by grants from Tarbiat Modares University and Golestan University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker BA, 2008, BIOORG MED CHEM LETT, V18, P3611, DOI 10.1016/j.bmcl.2008.04.070; Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Alvarez SM, 2007, J ENDOTOXIN RES, V13, P358, DOI 10.1177/0968051907086465; Andersson U, 2012, ANNU REV IMMUNOL, V30, P313, DOI 10.1146/annurev-immunol-020711-075015; Arazi A, 2010, J THEOR BIOL, V267, P426, DOI 10.1016/j.jtbi.2010.08.033; Ates F, 2006, DIGEST DIS SCI, V51, P1614, DOI 10.1007/s10620-006-9073-9; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bravi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045666; Deck J, 2005, PHYSIOL GENOMICS, V22, P86, DOI 10.1152/physiolgenomics.00085.2004; Dietz JR, 2005, CARDIOVASC RES, V68, P8, DOI 10.1016/j.cardiores.2005.06.008; Dvorakova M, 2005, CELL TISSUE RES, V319, P201, DOI 10.1007/s00441-004-1008-1; Ebadi H, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/08/P08014; Fairchild KD, 2009, AM J PHYSIOL-REG I, V297, pR1019, DOI 10.1152/ajpregu.00132.2009; Gholami M, 2012, SHOCK, V37, P219, DOI 10.1097/SHK.0b013e318240b4be; Giebelen IAJ, 2007, SHOCK, V27, P443, DOI 10.1097/01.shk.0000245016.78493.bb; Goble KH, 2011, J NEUROENDOCRINOL, V23, P129, DOI 10.1111/j.1365-2826.2010.02085.x; Goldberger AL, 2002, P NATL ACAD SCI USA, V99, P2466, DOI 10.1073/pnas.012579499; GOLDSTEIN B, 1995, CRIT CARE MED, V23, P1694, DOI 10.1097/00003246-199510000-00014; Gonzalez-Clemente JM, 2007, EUR J ENDOCRINOL, V157, P31, DOI 10.1530/EJE-07-0090; Griffin MP, 2005, PEDIATRICS, V116, P1070, DOI 10.1542/peds.2004-2461; Haddadian Zahra, 2013, Auton Neurosci, V177, P104, DOI 10.1016/j.autneu.2013.02.022; Hajiasgharzadeh K, 2011, EUR J PHARMACOL, V673, P70, DOI 10.1016/j.ejphar.2011.10.013; Hamano R, 2006, SHOCK, V26, P358, DOI 10.1097/01.shk.0000228168.86845.60; Huston JM, 2011, J INTERN MED, V269, P45, DOI 10.1111/j.1365-2796.2010.02321.x; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Kox M, 2011, SHOCK, V36, P5, DOI 10.1097/SHK.0b013e3182168d56; Lake DE, 2002, AM J PHYSIOL-REG I, V283, pR789, DOI 10.1152/ajpregu.00069.2002; LANG CH, 1985, AM J PHYSIOL, V248, pR471, DOI 10.1152/ajpregu.1985.248.4.R471; Li DJ, 2009, J BIOSCI BIOENG, V108, P85, DOI 10.1016/j.jbiosc.2009.03.004; Mabe AM, 2006, CELL TISSUE RES, V326, P57, DOI 10.1007/s00441-006-0215-3; Mani AR, 2006, LIFE SCI, V79, P1593, DOI 10.1016/j.lfs.2006.05.014; Mani AR, 2009, AM J PHYSIOL-GASTR L, V296, pG330, DOI 10.1152/ajpgi.90488.2008; Marrero MB, 2009, BRAIN RES, V1256, P1, DOI 10.1016/j.brainres.2008.11.053; Matthai C, 2006, MOL HUM REPROD, V12, P7, DOI 10.1093/molehr/gah254; Nezic L, 2009, GEN PHYSIOL BIOPHYS, V28, P119; Niskanen JP, 2004, COMPUT METH PROG BIO, V76, P73, DOI 10.1016/j.cmpb.2004.03.004; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PINCUS SM, 1994, MATH BIOSCI, V122, P161, DOI 10.1016/0025-5564(94)90056-6; Ponard JGC, 2007, BIOPHYS J, V92, P3734, DOI 10.1529/biophysj.106.091892; Rago B, 2011, J PHARMACEUT BIOMED, V55, P1201, DOI 10.1016/j.jpba.2011.03.025; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Romanovsky AA, 2005, FRONT BIOSCI-LANDMRK, V10, P2193, DOI 10.2741/1690; Sakata M, 2011, NUCL MED BIOL, V38, P443, DOI 10.1016/j.nucmedbio.2010.09.007; Shen JX, 2009, ACTA PHARMACOL SIN, V30, P673, DOI 10.1038/aps.2009.64; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; TUREK JW, 1995, J NEUROSCI METH, V61, P113, DOI 10.1016/0165-0270(95)00032-P; Tyagi E, 2010, NEUROCHEM INT, V56, P135, DOI 10.1016/j.neuint.2009.09.011; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wessler I, 2008, BRIT J PHARMACOL, V154, P1558, DOI 10.1038/bjp.2008.185; Yoshikawa H, 2006, CLIN EXP IMMUNOL, V146, P116, DOI 10.1111/j.1365-2249.2006.03169.x; Zorn-Pauly K, 2007, SHOCK, V28, P655, DOI 10.1097/shk.0b013e31812386bf	53	20	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82251	10.1371/journal.pone.0082251	http://dx.doi.org/10.1371/journal.pone.0082251			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340009	gold, Green Published			2022-12-27	WOS:000328707400066
J	Sarangthem, V; Cho, EA; Bae, SM; Singh, TD; Kim, SJ; Kim, S; Jeon, WB; Lee, BH; Park, RW				Sarangthem, Vijaya; Cho, Eun A.; Bae, Sang Mun; Singh, Thoudam Debraj; Kim, Sun-Ji; Kim, Soyoun; Jeon, Won Bae; Lee, Byung-Heon; Park, Rang-Woon			Construction and Application of Elastin Like Polypeptide Containing IL-4 Receptor Targeting Peptide	PLOS ONE			English	Article							FREE-ENERGY TRANSDUCTION; PROTEIN-BASED POLYMERS; INTERLEUKIN-4 RECEPTOR; RECOMBINANT PROTEINS; CARCINOMA-CELLS; CANCER-THERAPY; DRUG-DELIVERY; TUMOR-CELLS; EXPRESSION; TEMPERATURE	Various human solid tumors highly express IL-4 receptors which amplify the expression of some of anti-apoptotic proteins, preventing drug-induced cancer cell death. Thus, IL-4 receptor targeted drug delivery can possibly increase the therapeutic efficacy in cancer treatment. Macromolecular carriers with multivalent targeting moieties offered great advantages in cancer therapy as they not only increase the plasma half-life of the drug but also allow delivery of therapeutic drugs to the cancer cells with higher specificity, minimizing the deleterious effects of the drug on normal cells. In this study we designed a library of elastin like polypeptide (ELP) polymers containing tumor targeting AP1 peptide using recursive directional ligation method. AP1 was previously discovered as an atherosclerotic plaque and breast tumor tissue homing peptide using phage display screening method, and it can selectively bind to the interleukin 4 receptor (IL-4R). The fluorescently labeled [AP1-V-12](6), an ELP polymer containing six AP1 enhanced tumor-specific targeting ability and uptake efficiency in H226 and MDA-MB-231 cancer cell lines in vitro. Surface plasmon resonance analysis showed that multivalent presentation of the targeting ligand in the ELP polymer increased the binding affinity towards IL-4 receptor compared to free peptide. The binding of [AP1-V-12](6) to cancer cells was remarkably reduced when IL-4 receptors were blocked by antibody against IL-4 receptor further confirmed its binding. Importantly, the Cy5.5-labeled [AP1-V-12](6) demonstrated excellent homing and longer retention in tumor tissues in MDA-MB-231 xenograft mouse model. Immunohistological studies of tumor tissues further validated the targeting efficiency of [AP1-V-12](6) to tumor tissue. These results indicate that designed [AP1-V-12](6) can serve as a novel carrier for selective delivery of therapeutic drugs to tumors.	[Sarangthem, Vijaya; Cho, Eun A.; Bae, Sang Mun; Kim, Sun-Ji; Kim, Soyoun; Lee, Byung-Heon; Park, Rang-Woon] Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Taegu, South Korea; [Singh, Thoudam Debraj] Kyungpook Natl Univ, Sch Med, Dept Nucl Med, Taegu, South Korea; [Jeon, Won Bae] Daegu Gyeongbuk Inst Sci & Technol, Lab Biochem & Cellular Engn, Div NanoBioTechnol, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Daegu Gyeongbuk Institute of Science & Technology (DGIST)	Park, RW (corresponding author), Kyungpook Natl Univ, Sch Med, Cell & Matrix Res Inst, Dept Biochem & Cell Biol, Taegu, South Korea.	nwpark@knu.ac.kr	Sarangthem, Vijaya/AAX-7421-2020; Kim, Soyoun/Y-1276-2018	SINGH, THOUDAM DEBRAJ/0000-0003-0750-9136; Vijaya Devi, Sarangthem/0000-0002-6924-0307	Ministry of Knowledge Economy (MEK) [RTI04-01-01]; Regional Technology Innovation Program and R&D program of MOTIE/KEIT [10040393]	Ministry of Knowledge Economy (MEK)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Regional Technology Innovation Program and R&D program of MOTIE/KEIT	This research was supported by the Ministry of Knowledge Economy (MEK) by grant no. RTI04-01-01 from the Regional Technology Innovation Program and R&D program of MOTIE/KEIT (10040393, Development and commercialization of molecular diagnostic technologies for lung cancer through clinical validation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AL, 2006, J IMMUNOL, V176, P7456, DOI 10.4049/jimmunol.176.12.7456; Bidwell GL, 2007, BIOCHEM PHARMACOL, V73, P620, DOI 10.1016/j.bcp.2006.10.028; Bidwell GL, 2012, CANCER LETT, V319, P136, DOI 10.1016/j.canlet.2011.12.042; Bidwell GL, 2005, MOL CANCER THER, V4, P1076, DOI 10.1158/1535-7163.MCT-04-0253; Carlson KT, 2004, DESIGN SELECTION, V17; Conticello C, 2004, J IMMUNOL, V172, P5467, DOI 10.4049/jimmunol.172.9.5467; Dreher MR, 2003, J CONTROL RELEASE, V91, P31, DOI 10.1016/S0168-3659(03)00216-5; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Hassouneh W, 2012, BIOMACROMOLECULES, V13, P1598, DOI 10.1021/bm300321n; He XF, 2011, MOL PHARMACEUT, V8, P430, DOI 10.1021/mp100266g; Hong HY, 2008, J CELL MOL MED, V12, P2003, DOI 10.1111/j.1582-4934.2008.00189.x; Husain SR, 1997, MOL MED, V3, P327, DOI 10.1007/BF03401811; Jeon WB, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-61; Jeon WB, 2011, J BIOMED MATER RES A, V97A, P152, DOI 10.1002/jbm.a.33041; Kawakami K, 2000, CANCER RES, V60, P2981; Kawakami M, 2002, CLIN CANCER RES, V8, P3503; Li ZJ, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-S1-S1; Liu S, 2009, MACROMOLECULES, V42, P3, DOI 10.1021/ma801782q; Massodi I, 2005, J CONTROL RELEASE, V108, P396, DOI 10.1016/j.jconrel.2005.08.007; McElroy CA, 2009, STRUCTURE, V17, P54, DOI 10.1016/j.str.2008.10.019; Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n; Meyer DE, 2004, BIOMACROMOLECULES, V5, P846, DOI 10.1021/bm034215n; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; OBIRI NI, 1994, CLIN EXP IMMUNOL, V95, P148; OBIRI NI, 1993, J CLIN INVEST, V91, P88, DOI 10.1172/JCI116205; Park Y, 2008, J CONTROL RELEASE, V128, P217, DOI 10.1016/j.jconrel.2008.03.019; Raucher D, 2001, CANCER RES, V61, P7163; Roca H, 2012, J CELL BIOCHEM, V113, P1569, DOI 10.1002/jcb.24025; Ruoslahti E, 2010, J CELL BIOL, V188, P759, DOI 10.1083/jcb.200910104; Shamji MF, 2008, J CONTROL RELEASE, V129, P179, DOI 10.1016/j.jconrel.2008.04.021; Shamji MF, 2007, ARTHRITIS RHEUM-US, V56, P3650, DOI 10.1002/art.22952; Simnick AJ, 2011, J CONTROL RELEASE, V155, P144, DOI 10.1016/j.jconrel.2011.06.044; Tatham AS, 2000, TRENDS BIOCHEM SCI, V25, P567, DOI 10.1016/S0968-0004(00)01670-4; Todaro M, 2008, CELL DEATH DIFFER, V15, P762, DOI 10.1038/sj.cdd.4402305; Trabbic-Carlson K, 2004, PROTEIN SCI, V13, P3274, DOI 10.1110/ps.04931604; URRY DW, 1991, J BIOACT COMPAT POL, V6, P263, DOI 10.1177/088391159100600306; URRY DW, 1992, PROG BIOPHYS MOL BIO, V57, P23, DOI 10.1016/0079-6107(92)90003-O; URRY DW, 1991, J AM CHEM SOC, V113, P4346, DOI 10.1021/ja00011a057; Urry DW, 1997, J PHYS CHEM B, V101, P11007, DOI 10.1021/jp972167t; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wu XL, 2010, BIOCONJUGATE CHEM, V21, P208, DOI 10.1021/bc9005283; YUAN F, 1995, CANCER RES, V55, P3752	42	29	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81891	10.1371/journal.pone.0081891	http://dx.doi.org/10.1371/journal.pone.0081891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339977	gold, Green Submitted, Green Published			2022-12-27	WOS:000328707400050
J	Zhu, LY; Ji, SC; Shen, Q; Liu, Y; Li, JY; Liu, H				Zhu, Lingyu; Ji, Shengchang; Shen, Qi; Liu, Yuan; Li, Jinyu; Liu, Hao			A Noise Level Prediction Method Based on Electro-Mechanical Frequency Response Function for Capacitors	PLOS ONE			English	Article							AUDIBLE NOISE	The capacitors in high-voltage direct-current (HVDC) converter stations radiate a lot of audible noise which can reach higher than 100 dB. The existing noise level prediction methods are not satisfying enough. In this paper, a new noise level prediction method is proposed based on a frequency response function considering both electrical and mechanical characteristics of capacitors. The electro-mechanical frequency response function (EMFRF) is defined as the frequency domain quotient of the vibration response and the squared capacitor voltage, and it is obtained from impulse current experiment. Under given excitations, the vibration response of the capacitor tank is the product of EMFRF and the square of the given capacitor voltage in frequency domain, and the radiated audible noise is calculated by structure acoustic coupling formulas. The noise level under the same excitations is also measured in laboratory, and the results are compared with the prediction. The comparison proves that the noise prediction method is effective.	[Zhu, Lingyu; Ji, Shengchang; Liu, Yuan; Li, Jinyu; Liu, Hao] Xi An Jiao Tong Univ, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Shaanxi, Peoples R China; [Shen, Qi] Shaoxing Elect Power Bur, Shaoxing, Zhejiang, Peoples R China	Xi'an Jiaotong University	Ji, SC (corresponding author), Xi An Jiao Tong Univ, State Key Lab Elect Insulat & Power Equipment, Xian 710049, Shaanxi, Peoples R China.	jsc@mail.xjtu.edu.cn	Zhu, Lingyu/AAE-6230-2019; Zhu, Lingyu/A-8077-2013	Zhu, Lingyu/0000-0002-0379-4059; Zhu, Lingyu/0000-0002-0379-4059	National Natural Science Foundation of China [51377130]; Specialized Research Fund for the Doctoral Program of Higher Education [201202011100055]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	The authors would like to gratefully acknowledge the financial support of the National Natural Science Foundation of China (Grant No. 51377130) and Specialized Research Fund for the Doctoral Program of Higher Education(No. 201202011100055). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, 6087111997 IEC; [Anonymous], 2003, 37452003 ISO; [Anonymous], 1996, 165391996 GBT; [曹涛 Cao Tao], 2010, [电工技术学报, Transactions of China Electrotechnical Society], V25, P172; COX MD, 1994, IEEE T POWER DELIVER, V9, P856, DOI 10.1109/61.296267; Ji SC, 2010, IEEE T POWER DELIVER, V25, P1866, DOI 10.1109/TPWRD.2010.2047409; SMEDE J, 1995, IEEE T POWER DELIVER, V10, P747, DOI 10.1109/61.400856; William T.T., 1998, THEORY VIBRATION APP; WorkGroup 14.26, 2002, 202 CIGRE; Wu P, 2011, IEEE T POWER DELIVER, V26, P438, DOI 10.1109/TPWRD.2010.2070880	10	5	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81651	10.1371/journal.pone.0081651	http://dx.doi.org/10.1371/journal.pone.0081651			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349105	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200040
J	Bera, A; Zhao, SJ; Cao, L; Chiao, PJ; Freeman, JW				Bera, Alakesh; Zhao, Shujie; Cao, Lin; Chiao, Paul J.; Freeman, James W.			Oncogenic K-Ras and Loss of Smad4 Mediate Invasion by Activating an EGFR/NF-kappa B Axis That Induces Expression of MMP9 and uPA in Human Pancreas Progenitor Cells	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; UROKINASE PLASMINOGEN-ACTIVATOR; FACTOR RECEPTOR; BREAST-CANCER; MATRIX METALLOPROTEINASES; NUCLEAR TRANSLOCATION; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; PROSTATE-CANCER; OVARIAN-CANCER	Activating K-Ras mutations and inactivating mutations of Smad4 are two common genetic alterations that occur in the development and progression of pancreatic ductal adenocarcinomas (PDAC). To further study the individual and combinatorial roles of these two mutations in the pathogenesis of PDAC, immortalized human pancreas nestin postive cells (HPNE) were genetically modified by either expressing oncogenic K-Ras (HPNE/K-Ras), by shRNA knock down of Smad4 (HPNE/ShSmad4) or by creating both alterations in the same cell line (HPNE/K-Ras/ShSmad4). We previously found that expression of oncogenic K-Ras caused an increase in expression of EGFR and loss of Smad4 further enhanced the up regulation in expression of EGFR and that this increase in EGFR was sufficient to induce invasion. Here we further investigated the mechanism that links mutational alterations and EGFR expression with invasion. The increase in EGFR signaling was associated with up regulation of MMP9 and uPA protein and activity. Moreover, the increase in EGFR signaling promoted a nuclear translocation and binding of RelA (p65), a subunit of NF-kappa B, to the promoters of both MMP-9 and uPA. Treatment of HPNE/K-Ras/ShSmad4 cells with an inhibitor of EGFR reduced EGF-mediated NF-kappa B nuclear translocation and inhibitors of either EGFR or NF-kappa B reduced the increase in MMP-9 or uPA expression. In conclusion, this study provides the mechanism of how a combination of oncogenic K-Ras and loss of Smad4 causes invasion and provides the basis for new strategies to inhibit metastases.	[Bera, Alakesh; Zhao, Shujie; Cao, Lin; Freeman, James W.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Med Oncol, San Antonio, TX 78229 USA; [Freeman, James W.] Canc Therapy & Res Ctr S Texas, Expt & Dev Therapeut Program, San Antonio, TX 78229 USA; [Freeman, James W.] Audie L Murphy Mem Vet Adm Med Ctr, Res & Dev, San Antonio, TX USA; [Chiao, Paul J.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; UTMD Anderson Cancer Center	Freeman, JW (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Med Oncol, San Antonio, TX 78229 USA.	freemanjw@uthscsa.edu	Bera, Alakesh/J-5429-2019	Bera, Alakesh/0000-0002-2690-8178	VA merit award; Cancer Center; CPRIT;  [NIH-RO1CA069122];  [NIH-P30CA054174]; NATIONAL CANCER INSTITUTE [R01CA069122, P30CA054174] Funding Source: NIH RePORTER	VA merit award(US Department of Veterans Affairs); Cancer Center; CPRIT; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants to JWF, VA merit award, and NIH-RO1CA069122, and Cancer Center Grant to CTRC, NIH-P30CA054174 provided support for the use of Flow Cytometry Core Facility, UTHSCSA and the Optical Imaging Core, UTHSCSA. The work was also supported by CPRIT postdoctoral fellowship to Dr. AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alfano M, 2003, J LEUKOCYTE BIOL, V74, P750, DOI 10.1189/jlb.0403176; Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bellezza I, 2012, J NUTR BIOCHEM, V23, P1583, DOI 10.1016/j.jnutbio.2011.10.012; Bierie B, 2006, CYTOKINE GROWTH F R, V17, P29, DOI 10.1016/j.cytogfr.2005.09.006; Biswas DK, 2000, P NATL ACAD SCI USA, V97, P8542, DOI 10.1073/pnas.97.15.8542; Bond M, 1998, FEBS LETT, V435, P29, DOI 10.1016/S0014-5793(98)01034-5; Campbell PM, 2007, CANCER RES, V67, P2098, DOI 10.1158/0008-5472.CAN-06-3752; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Duffy MJ, 2002, CLIN CHEM, V48, P1194; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Fridman R, 2003, CANCER METAST REV, V22, P153, DOI 10.1023/A:1023091214123; Fujioka S, 2003, CLIN CANCER RES, V9, P346; Habib AA, 2001, J BIOL CHEM, V276, P8865, DOI 10.1074/jbc.M008458200; HANSEN SK, 1992, EMBO J, V11, P205, DOI 10.1002/j.1460-2075.1992.tb05043.x; Hirota K, 2001, J BIOL CHEM, V276, P25953, DOI 10.1074/jbc.M011021200; Hodge JC, 2003, CANCER RES, V63, P1359; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeong KJ, 2012, ONCOGENE, V31, P4279, DOI 10.1038/onc.2011.595; Jiang T, 2011, CANCER RES, V71, P2183, DOI 10.1158/0008-5472.CAN-10-3626; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kern SE, 2002, CANCER BIOL THER, V1, P607, DOI 10.4161/cbt.307; Kim S, 2009, CELL SIGNAL, V21, P892, DOI 10.1016/j.cellsig.2009.01.034; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; KORC M, 1992, J CLIN INVEST, V90, P1352, DOI 10.1172/JCI116001; KORC M, 1986, P NATL ACAD SCI USA, V83, P5141, DOI 10.1073/pnas.83.14.5141; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Le Page C, 2005, PROSTATE, V65, P130, DOI 10.1002/pros.20234; Lee CW, 2007, AM J PHYSIOL-LUNG C, V292, pL799, DOI 10.1152/ajplung.00311.2006; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Lessard L, 2003, BJU INT, V91, P417, DOI 10.1046/j.1464-410X.2003.04104.x; Lynch Henry T, 2002, J Hepatobiliary Pancreat Surg, V9, P12, DOI 10.1007/s005340200001; MARSHALL BC, 1990, J BIOL CHEM, V265, P8198; McCawley LJ, 1998, J CELL PHYSIOL, V176, P255, DOI 10.1002/(SICI)1097-4652(199808)176:2<255::AID-JCP4>3.0.CO;2-N; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Mori N, 2002, BLOOD, V100, P1828, DOI 10.1182/blood-2002-01-0151; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nishi H, 2003, INT J MOL MED, V11, P49; NOVAK U, 1991, NUCLEIC ACIDS RES, V19, P3389, DOI 10.1093/nar/19.12.3389; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; Poggi A, 2000, EUR J IMMUNOL, V30, P2751, DOI 10.1002/1521-4141(200010)30:10<2751::AID-IMMU2751>3.0.CO;2-L; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Schwingshackl A, 1999, J ALLERGY CLIN IMMUN, V104, P983, DOI 10.1016/S0091-6749(99)70079-5; Sclabas GM, 2003, J GASTROINTEST SURG, V7, P37, DOI 10.1016/S1091-255X(02)00088-4; Shant J, 2009, EXP CELL RES, V315, P432, DOI 10.1016/j.yexcr.2008.11.003; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Shimizu M, 2011, CANCER RES, V71, P277, DOI 10.1158/0008-5472.CAN-10-2523; Sidenius N, 2003, CANCER METAST REV, V22, P205, DOI 10.1023/A:1023099415940; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Stamenkovic I, 2000, SEMIN CANCER BIOL, V10, P415, DOI 10.1006/scbi.2000.0379; Sun L, 1998, ONCOGENE, V16, P2095, DOI 10.1038/sj.onc.1201731; Tao Y, 2012, ONCOL LETT, V3, P1283, DOI 10.3892/ol.2012.667; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Wang WX, 1999, ONCOGENE, V18, P4554, DOI 10.1038/sj.onc.1202833; Wang WX, 1999, CLIN CANCER RES, V5, P119; Xu DQ, 2012, VIRUS RES, V169, P264, DOI 10.1016/j.virusres.2012.07.002; Zhang HT, 2007, J CLIN INVEST, V117, P2051, DOI 10.1172/JCI32278; Zhang TT, 2013, MOLECULES, V18, P845, DOI 10.3390/molecules18010845; Zhao S, 2008, J BIOL CHEM, V283, P11293, DOI 10.1074/jbc.M800154200; Zhao SJ, 2010, INT J CANCER, V127, P2076, DOI 10.1002/ijc.25412; Zhu BS, 2011, WORLD J GASTROENTERO, V17, P478, DOI 10.3748/wjg.v17.i4.478	63	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82282	10.1371/journal.pone.0082282	http://dx.doi.org/10.1371/journal.pone.0082282			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340014	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566100095
J	Chang, XT; Xia, YF; Pan, JH; Meng, QS; Zhao, Y; Yan, XF				Chang, Xiaotian; Xia, Yifang; Pan, Jihong; Meng, Qingsong; Zhao, Yan; Yan, Xinfeng			PADI2 Is Significantly Associated with Rheumatoid Arthritis	PLOS ONE			English	Article							PEPTIDYLARGININE DEIMINASE TYPE-4; CITRULLINATED PROTEINS; ANKYLOSING-SPONDYLITIS; POLYMORPHISMS; GENE; HAPLOTYPE; SUSCEPTIBILITY; ANTIBODIES; SEVERITY; REPLICATION	Citrullination, a posttranslational modification of peptidyl arginine to citrulline, plays an essential role in rheumatoid arthritis (RA). Citrullination is catalyzed by a group of peptidylarginine deiminases (PADs) including PADI 1, 2, 3, 4 and 6. Many studies have indicated that the gene encoding PADI4 is a factor in susceptibility to RA. Some studies have detected PADI2 expression in RA syriovial tissues, suggesting that PADI2 also plays an important role in the disease. This study evaluated the possible association between the PADI2-encoding gene and RA. Seventeen tag SNPs across the PAD locus were genotyped using a custom-designed Illurnina 96-SNP VeraCode microarray. Peripheral blood samples were collected from patients with RA (n =267), ankylosing spondylitis (AS, n =51) and healthy controls (n =160). The results of genotyping were verified using Sequenom MassARRAY in an independent cohort of 307 patients with RA, 324 patients with AS and 509 healthy controls. A western blot analysis was performed using synovial tissue from patients with RA (n =7), osteoarthntis (OA, n =7) and AS (n = 5) to determine the levels of expression of PADI2. A rnicroarray analysis revealed a significant association between three selected PADI2 SNPs (rs2235926, rs2057094, rs2076616) and the presence of RA. The increased susceptibility to RA associated with rs2235926 (OR =1.706733, 95% Cl = [1.576366-1.866587], p =0.000839) and rs2057094 (OR =1.360432, 95% CI = [1.065483-1.869482], p= 0.003291) was further confirmed by the Sequenom MassARRAY. No tag SNPs in the PADI2 focus showed a significant association with AS. Increased expression of PADI2 was detected in RA synovial tissues compared with samples from patients with OA and AS. PADI2 is significantly associated with RA and may be involved in the pathogenesis of the disease	[Chang, Xiaotian; Xia, Yifang; Meng, Qingsong; Yan, Xinfeng] Shandong Univ, Med Res Ctr, Shandong Prov Qianfoshan Hosp, Jinan 250100, Shandong, Peoples R China; [Pan, Jihong; Zhao, Yan] Shandong Acad Med Sci, Med Biotechnol Res Ctr, Jinan, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Chang, XT (corresponding author), Shandong Univ, Med Res Ctr, Shandong Prov Qianfoshan Hosp, Jinan 250100, Shandong, Peoples R China.	changxt@126.com			National Basic Research Program of China [2010CB529105]; National Natural Science Foundation of China (NTFC) [81171990, 81373218]; Provincial Natural Science Foundation of Shandong [ZR 2010CM 1032]; Shandong Taishan Scholarship	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NTFC)(National Natural Science Foundation of China (NSFC)); Provincial Natural Science Foundation of Shandong(Natural Science Foundation of Shandong Province); Shandong Taishan Scholarship	This study was supported by the National Basic Research Program of China (2010CB529105), the National Natural Science Foundation of China (NTFC) (81171990, 81373218), Provincial Natural Science Foundation of Shandong (ZR 2010CM 1032) and the Shandong Taishan Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd-Allah SH, 2012, JOINT BONE SPINE, V79, P124, DOI 10.1016/j.jbspin.2011.07.006; Arandjelovic S, 2012, J IMMUNOL, V189, P4112, DOI 10.4049/jimmunol.1201098; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barton A, 2005, ANN RHEUM DIS, V64, P1311, DOI 10.1136/ard.2004.034173; Bay-Jensen AC, 2013, ARTHRITIS RHEUM-US, V65, P972, DOI 10.1002/art.37843; Bodnar N, 2012, JOINT BONE SPINE, V79, P63, DOI 10.1016/j.jbspin.2011.03.010; Burr ML, 2010, ANN RHEUM DIS, V69, P666, DOI 10.1136/ard.2009.111294; Calabrese R, 2012, MULT SCLER J, V18, P299, DOI 10.1177/1352458511421055; Cantaert T, 2005, ANN RHEUM DIS, V64, P1316, DOI 10.1136/ard.2004.033548; Caponi L, 2005, ANN RHEUM DIS, V64, P587, DOI 10.1136/ard.2004.026831; Chang X, 2005, RHEUMATOLOGY, V44, P40, DOI 10.1093/rheumatology/keh414; Chang XT, 2009, RHEUMATOL INT, V29, P1411, DOI 10.1007/s00296-009-0870-2; Chen R, 2010, SCAND J IMMUNOL, V72, P449, DOI 10.1111/j.1365-3083.2010.02454.x; Chen RW, 2011, RHEUMATOL INT, V31, P1631, DOI 10.1007/s00296-010-1519-x; Ferrari-Lacraz S, 2012, EUR CYTOKINE NETW, V23, P36, DOI 10.1684/ecn.2012.0303; Foster MW, 2004, NAT REV GENET, V5, P467, DOI 10.1038/nrg1351; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Harney SMJ, 2005, RHEUMATOLOGY, V44, P869, DOI 10.1093/rheumatology/keh614; Harris ML, 2008, ARTHRITIS RHEUM-US, V58, P1958, DOI 10.1002/art.23596; Hoppe B, 2004, J MOL MED-JMM, V82, P762, DOI 10.1007/s00109-004-0584-6; Hoppe B, 2009, ANN RHEUM DIS, V68, P898, DOI 10.1136/ard.2008.091983; Hoppe B, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1889; Hou S, 2013, MOD RHEUMATOL, V23, P50, DOI 10.1007/s10165-012-0639-4; Ikari K, 2005, ARTHRITIS RHEUM, V52, P3054, DOI 10.1002/art.21309; Kang CP, 2006, ARTHRITIS RHEUM-US, V54, P90, DOI 10.1002/art.21536; Kochi Y, 2011, ANN RHEUM DIS, V70, P512, DOI 10.1136/ard.2010.130526; Kuna AT, 2012, CLIN CHIM ACTA, V413, P66, DOI 10.1016/j.cca.2011.10.020; Lee HJ, 2010, J BIOL CHEM, V285, P39655, DOI 10.1074/jbc.M110.170290; Lee YH, 2007, RHEUMATOL INT, V27, P827, DOI 10.1007/s00296-007-0320-y; Lee YH, 2012, MOL BIOL REP, V39, P10627, DOI 10.1007/s11033-012-1952-x; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Martinez A, 2005, RHEUMATOLOGY, V44, P1263, DOI 10.1093/rheumatology/kei008; Nakayama-Hamada M, 2005, BIOCHEM BIOPH RES CO, V327, P192, DOI 10.1016/j.bbrc.2004.11.152; Nijenhuis S, 2004, CLIN CHIM ACTA, V350, P17, DOI 10.1016/j.cccn.2004.07.016; Nishimoto K, 2008, ANN RHEUM DIS, V67, P431, DOI 10.1136/ard.2007.071084; Panati K, 2012, GENES GENET SYST, V87, P191, DOI 10.1266/ggs.87.191; Peene I, 2004, INT J IMMUNOPATH PH, V17, P107, DOI 10.1177/039463200401700202; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Poor G, 2007, ANN NY ACAD SCI, V1110, P23, DOI 10.1196/annals.1423.004; Raptopoulou A, 2007, CRIT REV CL LAB SCI, V44, P339, DOI 10.1080/10408360701295623; Sebbag M, 2004, JOINT BONE SPINE, V71, P493, DOI 10.1016/j.jbspin.2004.07.004; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Suzuki A, 2007, ANN NY ACAD SCI, V1108, P323, DOI 10.1196/annals.1422.034; Takata Y, 2008, J HUM GENET, V53, P163, DOI 10.1007/s10038-007-0232-4; Too CL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4093; Vossenaar ER, 2003, ARTHRITIS RHEUM-US, V48, P2489, DOI 10.1002/art.11229; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211	47	21	24	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81259	10.1371/journal.pone.0081259	http://dx.doi.org/10.1371/journal.pone.0081259			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339914	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100046
J	Hall, JA; Vorachek, WR; Stewart, WC; Gorman, ME; Mosher, WD; Pirelli, GJ; Bobe, G				Hall, Jean A.; Vorachek, William R.; Stewart, Whitney C.; Gorman, M. Elena; Mosher, Wayne D.; Pirelli, Gene J.; Bobe, Gerd			Selenium Supplementation Restores Innate and Humoral Immune Responses in Footrot-Affected Sheep	PLOS ONE			English	Article							DICHELOBACTER-NODOSUS; INORGANIC SELENIUM; VITAMIN-E; ANTIGENIC-COMPETITION; OVINE; PATHOGENESIS; DEFICIENCY; EWES; ROT; ASSOCIATION	Dietary selenium (Se) alters whole-blood Se concentrations in sheep, dependent upon Se source and dosage administered, but little is known about effects on immune function. We used footrot (FR) as a disease model to test the effects of supranutritional Se supplementation on immune function. To determine the effect of Se-source (organic Se-yeast, inorganic Na-selenite or Na-selenate) and Se-dosage (1, 3, 5 times FDA-permitted level) on FR severity, 120 ewes with and 120 ewes without FR were drenched weekly for 62 weeks with different Se sources and dosages (30 ewes/treatment group). Innate immunity was evaluated after 62 weeks of supplementation by measuring neutrophil bacterial killing ability. Adaptive immune function was evaluated by immunizing sheep with keyhole limpet hemocyanin (KLH). The antibody titer and delayed-type hypersensitivity skin test to KLH were used to assess humoral immunity and cell-mediated immunity, respectively. At baseline, FR-affected ewes had lower whole-blood and serum-Se concentrations; this difference was not observed after Se supplementation. Se supplementation increased neutrophil bacterial killing percentages in FR-affected sheep to percentages observed in supplemented and non-supplemented healthy sheep. Similarly, Se supplementation increased KLH antibody titers in FR-affected sheep to titers observed in healthy sheep. FR-affected sheep demonstrated suppressed cell-mediated immunity at 24 hours after intradermal KLH challenge, although there was no improvement with Se supplementation. We did not consistently prevent nor improve recovery from FR over the 62 week Se-treatment period. In conclusion, Se supplementation does not prevent FR, but does restore innate and humoral immune functions negatively affected by FR.	[Hall, Jean A.; Vorachek, William R.; Gorman, M. Elena] Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA; [Stewart, Whitney C.; Mosher, Wayne D.; Pirelli, Gene J.; Bobe, Gerd] Oregon State Univ, Coll Agr, Dept Anim & Rangeland Sci, Corvallis, OR 97331 USA; [Bobe, Gerd] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University	Hall, JA (corresponding author), Oregon State Univ, Coll Vet Med, Dept Biomed Sci, Corvallis, OR 97331 USA.	Jean.Hall@oregonstate.edu		Stewart, Whit/0000-0003-1928-0359	USDA CSREES [2008-35204-04624]; Agricultural Research Foundation; Animal Health and Disease Project Formula Funds, Oregon State University, Corvallis, Oregon	USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Agricultural Research Foundation; Animal Health and Disease Project Formula Funds, Oregon State University, Corvallis, Oregon	The work presented in this study was performed at the Department of Biomedical Sciences, College of Veterinary Medicine, Oregon State University, Corvallis, Oregon 97331-4802, USA, and supported in part by USDA CSREES 2008-35204-04624, Agricultural Research Foundation, and Animal Health and Disease Project Formula Funds, Oregon State University, Corvallis, Oregon 97331-2219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett GN, 2011, VET MICROBIOL, V148, P1, DOI 10.1016/j.vetmic.2010.09.003; Bennett G, 2009, ANAEROBE, V15, P173, DOI 10.1016/j.anaerobe.2009.02.002; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; BULGIN MS, 1985, VET MED-US, V80, P105; Cederlof SE, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-4; Curran JE, 2005, NAT GENET, V37, P1234, DOI 10.1038/ng1655; Davis PA, 2006, J ANIM SCI, V84, P660, DOI 10.2527/2006.843660x; Duncan JS, 2012, VET REC, V170, P462, DOI 10.1136/vr.100363; EGERTON JR, 1971, J COMP PATHOL, V81, P179, DOI 10.1016/0021-9975(71)90091-0; EGERTON JR, 1969, J COMP PATHOL, V79, P207, DOI 10.1016/0021-9975(69)90007-3; Hefnawy AE, 2010, SMALL RUMINANT RES, V89, P185, DOI 10.1016/j.smallrumres.2009.12.042; ELLEMAN TC, 1984, FEBS LETT, V173, P103, DOI 10.1016/0014-5793(84)81026-1; Escayg AP, 1997, RES VET SCI, V63, P283, DOI 10.1016/S0034-5288(97)90035-7; Fairweather-Tait SJ, 2010, AM J CLIN NUTR, V91, p1484S, DOI 10.3945/ajcn.2010.28674J; Felix K, 2004, CANCER RES, V64, P2910, DOI 10.1158/0008-5472.CAN-03-2672; Finch JM, 1996, RES VET SCI, V60, P97, DOI 10.1016/S0034-5288(96)90001-6; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Green LE, 2008, VET J, V175, P173, DOI 10.1016/j.tvjl.2007.01.014; Hall JA, 2012, J ANIM SCI, V90, P568, DOI 10.2527/jas.2011-4075; Hall JA, 2011, ANIM FEED SCI TECH, V164, P184, DOI 10.1016/j.anifeedsci.2011.01.009; Hall JA, 2009, J VET INTERN MED, V23, P352, DOI 10.1111/j.1939-1676.2008.0253.x; Hall JA, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-99; Hall JA, 2010, VET IMMUNOL IMMUNOP, V137, P130, DOI 10.1016/j.vetimm.2010.05.002; Heirman I, 2006, FREE RADICAL BIO MED, V40, P285, DOI 10.1016/j.freeradbiomed.2005.08.033; Hugejiletu H, 2013, BIOL TRACE ELEM RES, V154, P28, DOI 10.1007/s12011-013-9716-6; Kaler J, 2010, J VET INTERN MED, V24, P420, DOI 10.1111/j.1939-1676.2009.0450.x; Kennan RM, 2011, VET MICROBIOL, V153, P59, DOI 10.1016/j.vetmic.2011.04.005; Kim KH, 2007, BIOCHEM BIOPH RES CO, V354, P127, DOI 10.1016/j.bbrc.2006.12.183; Kipp AP, 2012, J NUTR BIOCHEM, V23, P1170, DOI 10.1016/j.jnutbio.2011.06.011; KIREMIDJIANSCHUMACHER L, 1987, ENVIRON RES, V42, P277, DOI 10.1016/S0013-9351(87)80194-9; McClure SJ, 2008, PARASITE IMMUNOL, V30, P89, DOI 10.1111/j.1365-3024.2007.00996.x; Mitchell R.K., 2003, FOOTROT ERADICATION; Moustafa ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057389; MUTH OH, 1958, SCIENCE, V128, P1090, DOI 10.1126/science.128.3331.1090; National Research Council, 2007, NUTR REQ SMALL RUM S, DOI [10.17226/11654, DOI 10.17226/11654]; Novoselov SV, 2005, ONCOGENE, V24, P8003, DOI 10.1038/sj.onc.1208940; Qin SY, 2007, BIOL TRACE ELEM RES, V116, P91, DOI 10.1007/BF02685922; RAADSMA HW, 1994, VET IMMUNOL IMMUNOP, V40, P253, DOI 10.1016/0165-2427(94)90024-8; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; ROBERTS DS, 1969, J COMP PATHOL, V79, P217, DOI 10.1016/0021-9975(69)90008-5; Rooke JA, 2004, J AGR SCI-CAMBRIDGE, V142, P253, DOI 10.1017/S0021859604004368; SAMMALKORPI K, 1988, INFECTION, V16, P222, DOI 10.1007/BF01650756; SCHWARTZKOFF CL, 1993, AUST VET J, V70, P123, DOI 10.1111/j.1751-0813.1993.tb06101.x; Steen A, 2008, ACTA VET SCAND, V50, DOI 10.1186/1751-0147-50-7; Stewart WC, 2013, J ANIM SCI, V91, P1791, DOI 10.2527/jas.2012-5377; Stewart WC, 2012, J ANIM SCI, V90, P4536, DOI 10.2527/jas.2011-5019; Taylor JB, 2009, J ANIM SCI, V87, P1828, DOI 10.2527/jas.2008-1534; Tiwary AK, 2006, J VET DIAGN INVEST, V18, P61, DOI 10.1177/104063870601800108; Wander RC, 1997, J NUTR, V127, P1198, DOI 10.1093/jn/127.6.1198; Whanger PD, 2002, J AM COLL NUTR, V21, P223, DOI 10.1080/07315724.2002.10719214; Winter AC, 2009, SMALL RUMINANT RES, V86, P90, DOI 10.1016/j.smallrumres.2009.09.026; WOOLASTON RR, 1993, AUST VET J, V70, P365, DOI 10.1111/j.1751-0813.1993.tb00809.x; Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005	53	24	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82572	10.1371/journal.pone.0082572	http://dx.doi.org/10.1371/journal.pone.0082572			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340044	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566100119
J	Nagarajan, R; Scutari, M				Nagarajan, Radhakrishnan; Scutari, Marco			Impact of Noise on Molecular Network Inference	PLOS ONE			English	Article							MARKOV BLANKET INDUCTION; BAYESIAN NETWORKS; GENE-EXPRESSION; FUNCTIONAL-RELATIONSHIPS; FEATURE-SELECTION; CAUSAL DISCOVERY; LOCAL CAUSAL; MOTIFS	Molecular entities work in concert as a system and mediate phenotypic outcomes and disease states. There has been recent interest in modelling the associations between molecular entities from their observed expression profiles as networks using a battery of algorithms. These networks have proven to be useful abstractions of the underlying pathways and signalling mechanisms. Noise is ubiquitous in molecular data and can have a pronounced effect on the inferred network. Noise can be an outcome of several factors including: inherent stochastic mechanisms at the molecular level, variation in the abundance of molecules, heterogeneity, sensitivity of the biological assay or measurement artefacts prevalent especially in high-throughput settings. The present study investigates the impact of discrepancies in noise variance on pair-wise dependencies, conditional dependencies and constraint-based Bayesian network structure learning algorithms that incorporate conditional independence tests as a part of the learning process. Popular network motifs and fundamental connections, namely: (a) common-effect, (b) three-chain, and (c) coherent type-I feed-forward loop (FFL) are investigated. The choice of these elementary networks can be attributed to their prevalence across more complex networks. Analytical expressions elucidating the impact of discrepancies in noise variance on pairwise dependencies and conditional dependencies for special cases of these motifs are presented. Subsequently, the impact of noise on two popular constraint-based Bayesian network structure learning algorithms such as Grow-Shrink (GS) and Incremental Association Markov Blanket (IAMB) that implicitly incorporate tests for conditional independence is investigated. Finally, the impact of noise on networks inferred from publicly available single cell molecular expression profiles is investigated. While discrepancies in noise variance are overlooked in routine molecular network inference, the results presented clearly elucidate their non-trivial impact on the conclusions that in turn can challenge the biological significance of the findings. The analytical treatment and arguments presented are generic and not restricted to molecular data sets.	[Nagarajan, Radhakrishnan] Univ Kentucky, Div Biomed Informat, Dept Biostat, Lexington, KY 40506 USA; [Scutari, Marco] UCL, UCL Genet Inst, London, England	University of Kentucky; University of London; University College London	Nagarajan, R (corresponding author), Univ Kentucky, Div Biomed Informat, Dept Biostat, Lexington, KY 40506 USA.	rnagarajan@uky.edu			Kentucky Center for Clinical and Translational Science [UL1TR000117]	Kentucky Center for Clinical and Translational Science	RN acknowledges support from Kentucky Center for Clinical and Translational Science, UL1TR000117. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliferis CF, 2010, J MACH LEARN RES, V11, P171; Aliferis CF, 2010, J MACH LEARN RES, V11, P235; [Anonymous], 1997, EXPERT SYSTEMS PROBA; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bonissone P., 1991, P 6 C UNC ART INT, P255; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197; Efron B, 1993, INTRO BOOTSTRAP, DOI [DOI 10.1007/978-1-4899-4541-9, 10.1007/978-1-4899-4541-9]; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Friedman N, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P196; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Jensen FV, 2007, BAYESIAN NETWORKS DE; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; LEE SB, 1995, CURR OPIN CELL BIOL, V7, P183, DOI 10.1016/0955-0674(95)80026-3; Li Y, 2010, TRENDS GENET, V26, P493, DOI 10.1016/j.tig.2010.09.002; Lucas PJF, 2004, ARTIF INTELL MED, V30, P201, DOI 10.1016/j.artmed.2003.11.001; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Margaritis D., 2003, LEARNING BAYESIAN NE; McAdams HH, 1999, TRENDS GENET, V15, P65, DOI 10.1016/S0168-9525(98)01659-X; Meek C., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P403; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Nagarajan R, 2010, FRONT PHYSIOL, V1, P1; Nagarajan R, 2013, BAYESIAN NETWORKS R; Nagarajan R, 2011, METHOD ENZYMOL, P133, DOI [10.1016/S0076-6879(11)87005-9, 10.1016/B978-0-12-381270-4.00005-6]; Nagarajan R, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1555; Nagarajan R, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1119; Okoniewski MJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-276; Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37; Pe'er Dana, 2005, Sci STKE, V2005, ppl4, DOI 10.1126/stke.2812005pl4; Pearl J., 1988, PROBABILISTIC REASON; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Sachs K, 2005, SCIENCE, V308, P523, DOI 10.1126/science.1105809; Scutari M, 2013, ARTIF INTELL MED, V57, P207, DOI 10.1016/j.artmed.2012.12.006; Scutari M, 2010, J STAT SOFTW, V35, P1, DOI 10.18637/jss.v035.i03; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; Spirtes P., 2000, CAUSATION PREDICTION, Vsecond; STEEN HB, 1992, CYTOMETRY, V13, P822, DOI 10.1002/cyto.990130804; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tsamardinos I., 2003, P FLAIRS C, P376; Tsamardinos I, 2003, 0302 DSL DBMI VAND U; Tsamardinos I., 2003, P 9 ACM SIGKDD INT C, P673; Welch CM, 2011, NAT REV MOL CELL BIO, V12, P749, DOI 10.1038/nrm3212	47	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80735	10.1371/journal.pone.0080735	http://dx.doi.org/10.1371/journal.pone.0080735			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339879	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100018
J	Ren, JY; Zhang, J; Xu, N; Han, GP; Geng, Q; Song, JX; Li, SF; Zhao, JQ; Chen, H				Ren, Jingyi; Zhang, Jing; Xu, Ning; Han, Guanping; Geng, Qiang; Song, Junxian; Li, Sufang; Zhao, Jianqing; Chen, Hong			Signature of Circulating MicroRNAs as Potential Biomarkers in Vulnerable Coronary Artery Disease	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MICROPARTICLES CORRELATE; CELLS; EXPRESSION; PLAQUES; MARKERS	Aims: MicroRNAs (miRNAs) play important roles in the pathogenesis of cardiovascular diseases. Circulating miRNAs were recently identified as biomarkers for various physiological and pathological conditions. In this study, we aimed to identify the circulating miRNA fingerprint of vulnerable coronary artery disease (CAD) and explore its potential as a novel biomarker for this disease. Methods and Results: The Taqman low-density miRNA array and coexpression network analyses were used to identify distinct miRNA expression profiles in the plasma of patients with typical unstable angina (UA) and angiographically documented CAD (UA group, n = 13) compared to individuals with non-cardiac chest pain (control group, n = 13). Significantly elevated expression levels of miR-106b/25 cluster, miR-17/92a cluster, miR-21/590-5p family, miR-126*, and miR-451 were observed in UA patients compared to controls. These findings were validated by real-time PCR in another 45 UA patients, 31 stable angina patients, and 37 controls. In addition, miR-106b, miR-25, miR-92a, miR-21, miR-590-5p, miR-126* and miR-451 were upregulated in microparticles (MPs) isolated from the plasma of UA patients (n = 5) compared to controls (n = 5). Using flow cytometry and immunolabeling, we further found that Annexin V+ MPs were increased in the plasma samples of UA patients compared to controls, and the majority of the increased MPs in plasma were shown to be Annexin V+ CD31(+) MPs. The findings suggest that Annexin V+ CD31(+) MPs may contribute to the elevated expression of the selected miRNAs in the circulation of patients with vulnerable CAD. Conclusion: The circulating miRNA signature, consisting of the miR-106b/25 cluster, miR-17/92a cluster, miR-21/590-5p family, miR-126* and miR-451, may be used as a novel biomarker for vulnerable CAD.	[Ren, Jingyi; Zhang, Jing; Han, Guanping; Geng, Qiang; Song, Junxian; Li, Sufang; Chen, Hong] Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China; [Xu, Ning] Karolinska Inst, Dept Med, Stockholm, Sweden; [Zhao, Jianqing] Natl Engn Res Ctr Beijing Biochip Technol, Beijing, Peoples R China	Peking University; Karolinska Institutet	Chen, H (corresponding author), Peking Univ, Peoples Hosp, Dept Cardiol, Beijing 100871, Peoples R China.	chenhongbj@medmail.com.cn	Landén, Ning Xu/AFL-2883-2022	Landén, Ning Xu/0000-0003-4868-3798; Li, Sufang/0000-0002-3904-0881	National Natural Science Foundation of China (NSFC) [81270274]; Beijing Natural Science Foundation [7132225]; Capital Health Research and Development of Special Funds [2011-4022-03]; NSFC [81270276]; Clinical Medicine Research Special Funds from the Chinese Medical Association [09010060161]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Capital Health Research and Development of Special Funds; NSFC(National Natural Science Foundation of China (NSFC)); Clinical Medicine Research Special Funds from the Chinese Medical Association	This project was supported by the National Natural Science Foundation of China (NSFC) (No. 81270274), the Beijing Natural Science Foundation (No. 7132225), and the Capital Health Research and Development of Special Funds (No. 2011-4022-03) for Dr. Chen, and by the NSFC (No. 81270276) and the Clinical Medicine Research Special Funds from the Chinese Medical Association (No. 09010060161) for Dr. Ren. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose JA, 2010, AM J MED, V123, P10, DOI 10.1016/j.amjmed.2009.07.019; Bandres E, 2009, CLIN CANCER RES, V15, P2281, DOI 10.1158/1078-0432.CCR-08-1818; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen WJ, 2012, ATHEROSCLEROSIS, V222, P314, DOI 10.1016/j.atherosclerosis.2012.01.020; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Gabriely G, 2008, MOL CELL BIOL, V28, P5369, DOI 10.1128/MCB.00479-08; Haver VG, 2010, TRENDS CARDIOVAS MED, V20, P65, DOI 10.1016/j.tcm.2010.04.002; Horstman LL, 2004, FRONT BIOSCI-LANDMRK, V9, P1118, DOI 10.2741/1270; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kuchenbauer F, 2011, BLOOD, V118, P3350, DOI 10.1182/blood-2010-10-312454; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; Lutgens E, 2001, CIRC RES, V89, P853, DOI 10.1161/res.89.10.853; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Petrocca F, 2008, CANCER RES, V68, P8191, DOI 10.1158/0008-5472.CAN-08-1768; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Rippe C, 2012, EXP GERONTOL, V47, P45, DOI 10.1016/j.exger.2011.10.004; Schaar JA, 2007, CURR PHARM DESIGN, V13, P995, DOI 10.2174/138161207780487511; Sinning JM, 2011, EUR HEART J, V32, P2034, DOI 10.1093/eurheartj/ehq478; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Sondermeijer BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025946; Tian Y, 2012, INT J ONCOL, V40, P1105, DOI 10.3892/ijo.2011.1306; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Villeneuve LM, 2010, DIABETES, V59, P2904, DOI 10.2337/db10-0208; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Yao R, 2011, CELL MOL IMMUNOL, V8, P486, DOI 10.1038/cmi.2011.22; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595; Zampetaki A, 2012, CARDIOVASC RES, V93, P555, DOI 10.1093/cvr/cvr266; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610	33	141	151	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80738	10.1371/journal.pone.0080738	http://dx.doi.org/10.1371/journal.pone.0080738			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339880	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100019
J	Siddique, YH; Fatima, A; Jyoti, S; Naz, F; Rahul; Khan, W; Singh, BR; Naqvi, AH				Siddique, Yasir Hasan; Fatima, Ambreen; Jyoti, Smita; Naz, Falaq; Rahul; Khan, Wasi; Singh, Braj Raj; Naqvi, Alim Hussain			Evaluation of the Toxic Potential of Graphene Copper Nanocomposite (GCNC) in the Third Instar Larvae of Transgenic Drosophila melanogaster (hsp70-lacZ)Bg(9)	PLOS ONE			English	Article							HSP70 EXPRESSION; OXIDATIVE STRESS; OXIDE; APOPTOSIS; NANOPARTICLES; INDUCTION; EXPOSURE; BIOCOMPATIBILITY; CYTOTOXICITY; GENOTOXICITY	Graphene, a two-dimensional carbon sheet with single-atom thickness, have attracted the scientific world for its potential applications in various field including the biomedical areas. In the present study the graphene copper nanocomposite (GCNC) was synthesized, characterized and evaluated for its toxic potential on third instar larvae of transgenic Drosophila melanogaster (hsp70-lacZ)Bg(9). The synthesized GCNC was analyzed by X-ray diffraction (XRD), scanning/transmission electron microscopy (SEM/TEM), atomic force microscopy (AFM), and fourier transform infrared spectroscopy (FTIR). The GCNC in 0.1% DMSO was sonicated for 10 min and the final concentration of 0.033, 0.099, 0.199 and 3.996 mu g/mu l of diet were established. The third instar larvae were allowed to feed on it separately for 24 and 48 hrs. The hsp70 expression was measured by O-nitrophenyl-beta-D-galactopyranoside assay, tissue damage by trypan blue exclusion test and beta-galactosidase activity was monitored by in situ histochemical beta-galactosidase staining. Oxidative stress was monitored by performing lipid peroxidation assay and total protein estimation. Ethidium bromide/acridine orange staining was performed on midgut cells for apoptotic index and the comet assay was performed for the DNA damage. The results of the present study showed that the exposure of 0.199 and 3.996 mu g/mu l of GCNC were toxic for 24 hr of exposure and for 48 hr of exposure: 0.099, 0.199 and 3.996 mu g/mu l of GCNC was toxic. The dose of 0.033 mu g/mu l of GCNC showed no toxic effects on its exposure to the third instar larvae for 24 hr as well as 48 hrs. This dose can be considered as No Observed Adverse Effect Level (NOAEL).	[Siddique, Yasir Hasan; Fatima, Ambreen; Jyoti, Smita; Naz, Falaq; Rahul] Aligarh Muslim Univ, Dept Zool, Fac Life Sci, Drosophila Transgen Lab,Sect Genet, Aligarh 202002, Uttar Pradesh, India; [Khan, Wasi; Singh, Braj Raj; Naqvi, Alim Hussain] Aligarh Muslim Univ, Dept Appl Phys, ZH Coll Engn & Technol, Ctr Excellence Mat Sci Nano Mat, Aligarh, Uttar Pradesh, India	Aligarh Muslim University; Aligarh Muslim University; Zakir Husain College Of Engineering & Technology	Siddique, YH (corresponding author), Aligarh Muslim Univ, Dept Zool, Fac Life Sci, Drosophila Transgen Lab,Sect Genet, Aligarh 202002, Uttar Pradesh, India.	yasir_hasansiddique@rediffmail.com	siddique, yasir hasan/B-7580-2011					Ahamed M, 2010, BIOCHEM BIOPH RES CO, V396, P578, DOI 10.1016/j.bbrc.2010.04.156; Aillon KL, 2009, ADV DRUG DELIVER REV, V61, P457, DOI 10.1016/j.addr.2009.03.010; Ait-Aissa S, 2000, TOXICOLOGY, V145, P147, DOI 10.1016/S0300-483X(00)00145-1; Benford DJ, 2000, ATLA-ALTERN LAB ANIM, V28, P119, DOI 10.1177/026119290002800104; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao AN, 2010, ADV MATER, V22, P103, DOI 10.1002/adma.200901920; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; Chang YL, 2011, TOXICOL LETT, V200, P201, DOI 10.1016/j.toxlet.2010.11.016; Chowdhuri DK, 2001, J BIOCHEM MOL TOXIC, V15, P173, DOI 10.1002/jbt.15; Chowdhuri DK, 1999, PESTIC BIOCHEM PHYS, V63, P15, DOI 10.1006/pest.1998.2390; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Galaris D, 2002, CRIT REV ONCOL HEMAT, V42, P93, DOI 10.1016/S1040-8428(01)00212-8; Galeone A, 2012, NANOSCALE, V4, P6401, DOI 10.1039/c2nr31826a; Gupta A, 2012, NANOSCALE, V4, P6562, DOI 10.1039/c2nr31891a; Gupta SC, 2007, BBA-GEN SUBJECTS, V1770, P1382, DOI 10.1016/j.bbagen.2007.05.010; Hodgson E, 1974, SURVIVAL TOXIC ENV, P213; Hou JG, 2011, J HAZARD MATER, V192, P1772, DOI 10.1016/j.jhazmat.2011.07.013; HUMMERS WS, 1958, J AM CHEM SOC, V80, P1339, DOI 10.1021/ja01539a017; Kolosnjaj-Tabi J, 2010, ACS NANO, V4, P1481, DOI 10.1021/nn901573w; Krebs RA, 1997, J EXP BIOL, V200, P2007; Krone PH, 2005, METHODS, V35, P176, DOI 10.1016/j.ymeth.2004.08.009; Li BX, 2012, J COLLOID INTERF SCI, V377, P114, DOI 10.1016/j.jcis.2012.03.060; Liao KH, 2011, ACS NANO, V5, P1253, DOI 10.1021/nn1028967; LIS JT, 1983, CELL, V35, P403, DOI 10.1016/0092-8674(83)90173-3; Liu XY, 2009, ENVIRON SCI TECHNOL, V43, P6357, DOI 10.1021/es901079z; Mukhopadhyay I, 2004, MUTAGENESIS, V19, P85, DOI 10.1093/mutage/geh007; Muller J, 2005, TOXICOL APPL PHARM, V207, P221, DOI 10.1016/j.taap.2005.01.008; Nazir A, 2003, BBA-GEN SUBJECTS, V1621, P218, DOI 10.1016/S0304-4165(03)00060-6; Pompa PP, 2011, NANOSCALE, V3, P2889, DOI 10.1039/c1nr10233h; Pragasam V, 2006, BIOMARKERS, V11, P153, DOI 10.1080/13547500500421138; Pumera M, 2009, CHEM REC, V9, P211, DOI 10.1002/tcr.200900008; Rana VK, 2011, MACROMOL MATER ENG, V296, P131, DOI 10.1002/mame.201000307; Renvoize C, 1998, CELL BIOL TOXICOL, V14, P111, DOI 10.1023/A:1007429904664; Ribble D, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-12; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Santos CM, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/39/395101; Sasidharan A, 2011, NANOSCALE, V3, P2461, DOI 10.1039/c1nr10172b; Shen H, 2012, THERANOSTICS, V2, P283, DOI 10.7150/thno.3642; Shin HJ, 2009, ADV FUNCT MATER, V19, P1987, DOI 10.1002/adfm.200900167; Siddique HR, 2007, CHEM-BIOL INTERACT, V169, P171, DOI 10.1016/j.cbi.2007.06.035; Siddique YH, 2012, DOSE-RESPONSE, V10, P1, DOI 10.2203/dose-response.10-002.Siddique; Siddique YH, 2010, EXP TOXICOL PATHOL, V62, P503, DOI 10.1016/j.etp.2009.06.010; Sun WL, 2011, ANAL METHODS-UK, V3, P2472, DOI 10.1039/c1ay05521f; Tully DB, 2000, TOXICOL APPL PHARM, V168, P79, DOI 10.1006/taap.2000.9014; Vales G, 2013, NANOTOXICOLOGY, V7, P462, DOI 10.3109/17435390.2012.689882; Vecchio G, 2012, NANOMED-NANOTECHNOL, V8, P1, DOI 10.1016/j.nano.2011.11.001; Wang K, 2011, NANOSCALE RES LETT, V6, DOI 10.1007/s11671-010-9751-6; Willemse CM, 2011, SENSORS-BASEL, V11, P3970, DOI 10.3390/s110403970; Xu C, 2009, J SOLID STATE CHEM, V182, P2486, DOI 10.1016/j.jssc.2009.07.001; Yan XY, 2012, CHEM COMMUN, V48, P1892, DOI 10.1039/c2cc17537a; Yang XY, 2009, J MATER CHEM, V19, P2710, DOI 10.1039/b821416f; Zhang JL, 2010, CHEM COMMUN, V46, P1112, DOI 10.1039/b917705a; Zhang LM, 2010, SMALL, V6, P537, DOI 10.1002/smll.200901680; Zhang XY, 2011, CARBON, V49, P986, DOI 10.1016/j.carbon.2010.11.005	55	40	40	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80944	10.1371/journal.pone.0080944	http://dx.doi.org/10.1371/journal.pone.0080944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339891	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100026
J	Zhang, X; Guo, J; Fan, SF; Li, YY; Wei, LL; Yang, XY; Jiang, TT; Chen, ZL; Wang, C; Liu, JY; Ping, ZP; Xu, DD; Wang, JX; Li, ZJ; Qiu, YQ; Li, JC				Zhang, Xing; Guo, Jing; Fan, Shufeng; Li, Yanyuan; Wei, Liliang; Yang, Xiuyun; Jiang, Tingting; Chen, Zhongliang; Wang, Chong; Liu, Jiyan; Ping, Zepeng; Xu, Dandan; Wang, Jiaxiong; Li, Zhongjie; Qiu, Yunqing; Li, Ji-Cheng			Screening and Identification of Six Serum microRNAs as Novel Potential Combination Biomarkers for Pulmonary Tuberculosis Diagnosis	PLOS ONE			English	Article							CIRCULATING MICRORNAS; GENE-EXPRESSION; CANCER; MARKERS; PCR	Background: It is very difficult to prevent pulmonary tuberculosis (TB) due to the lack of specific and diagnostic markers, which could lead to a high incidence of pulmonary TB. We screened the differentially expressed serum microRNAs (miRNAs) as potential biomarkers for the diagnosis of pulmonary TB. Methods: In this study, serum miRNAs were screened using the Solexa sequencing method as the potential biomarkers for the diagnosis of pulmonary TB. The stem-loop quantitative reverse-transcription polymerase chain reaction (qRT-PCR) assay was used to verify differentially expressed serum miRNAs. The receiver operating characteristic (ROC) curve and logistic regression model were used to analyze the sensitivity and specificity of the single miRNA and a combination of miRNAs for diagnosis, respectively. Using the predicted target genes, we constructed the regulatory networks of miRNAs and genes that were related to pulmonary TB. Results: The Solexa sequencing data showed that 91 serum miRNAs were differentially expressed in pulmonary TB patients, compared to healthy controls. Following qRT-PCR confirmation, six serum miRNAs (hsa-miR-378, hsa-miR-483-5p, hsa-miR-22, hsa-miR-29c, hsa-miR-101 and hsa-miR-320b) showed significant difference among pulmonary TB patients, healthy controls (P<0.001) and differential diagnosis groups (including patients with pneumonia, lung cancer and chronic obstructive pulmonary disease) (P<0.05). The logistic regression analysis of a combination of six serum miRNAs revealed that the sensitivity and the specificity of TB diagnosis were 95.0% and 91.8% respectively. The miRNAs-gene regulatory networks revealed that several miRNAs may regulate some target genes involved in immune pathways and participate in the pathogenesis of pulmonary TB. Conclusion: Our study suggests that a combination of six serum miRNAs have great potential to serve as non-invasive biomarkers of pulmonary TB.	[Zhang, Xing; Jiang, Tingting; Chen, Zhongliang; Wang, Chong; Liu, Jiyan; Ping, Zepeng; Xu, Dandan; Wang, Jiaxiong; Li, Zhongjie; Li, Ji-Cheng] Zhejiang Univ, Inst Cell Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Guo, Jing; Li, Yanyuan; Qiu, Yunqing] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Fan, Shufeng] Taizhou Hosp, Dept Radiol, Taizhou, Peoples R China; [Wei, Liliang] Sixth Peoples Hosp Shaoxing Zhejiang, Dept Resp Med, Shaoxing, Peoples R China; [Yang, Xiuyun] Tongde Hosp Zhejiang Prov, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Qiu, YQ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	qiuyq@zju.edu.cn; lijichen@zju.edu.cn	Wang, Jiaxiong/AAE-6781-2020	Wang, Jiaxiong/0000-0002-2819-165X	National Special Sci-Tech Projects [2012ZX10005001-006]; National Natural Science Foundation of China [81072724, 81273882]; Ministry of Science and Technology: New Drug Creation of National 12th FiveYear Plan [2011ZX09302-003-03]	National Special Sci-Tech Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology: New Drug Creation of National 12th FiveYear Plan	This work was supported by grants from National Special Sci-Tech Projects (No. 2012ZX10005001-006), National Natural Science Foundation of China (No. 81072724, No. 81273882) and National Science Technology Major Project of the Ministry of Science and Technology: New Drug Creation of National 12th FiveYear Plan (No. 2011ZX09302-003-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agranoff D, 2006, LANCET, V368, P1012, DOI 10.1016/S0140-6736(06)69342-2; [Anonymous], GLOB TUB REP; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Golub JE, 2006, INT J TUBERC LUNG D, V10, P24; Goren Y, 2012, EUR J HEART FAIL, V14, P147, DOI 10.1093/eurjhf/hfr155; Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009; Jay C, 2007, DNA CELL BIOL, V26, P293, DOI 10.1089/dna.2006.0554; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Kong L, 2011, ACTA DIABETOL, V48, P61, DOI 10.1007/s00592-010-0226-0; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Liu HS, 2012, CANCER LETT, V316, P196, DOI 10.1016/j.canlet.2011.10.034; Liu JY, 2011, CLIN CHEM LAB MED, V49, P1727, DOI 10.1515/CCLM.2011.634; Liu YH, 2011, MOL IMMUNOL, V48, P1084, DOI 10.1016/j.molimm.2011.02.001; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; National Technic Steering Group Of The Epidemiological Sampling Survey For Tuberculosis, 2002, Zhonghua Jie He He Hu Xi Za Zhi, V25, P3; Ng EKO, 2009, GUT, V58, P1375, DOI 10.1136/gut.2008.167817; Phillips PPJ, 2010, LANCET INFECT DIS, V10, P69, DOI 10.1016/S1473-3099(09)70256-7; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; Rosman M.D., 1998, FISHMANS PULMONARY D, P2483; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi WT, 2012, J PSYCHIATR RES, V46, P198, DOI 10.1016/j.jpsychires.2011.09.010; Small Peter M, 2009, Kekkaku, V84, P721; Song MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033608; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wang HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038885; Wu J, 2012, HUM IMMUNOL, V73, P31, DOI 10.1016/j.humimm.2011.10.003; Zhao YD, 2008, CANCER INFORM, V6, P9	33	88	100	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81076	10.1371/journal.pone.0081076	http://dx.doi.org/10.1371/journal.pone.0081076			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349033	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100033
J	Ismail, A; Jacquin, L; Haussy, C; Legoupi, J; Perret, S; Gasparini, J				Ismail, Ahmad; Jacquin, Lisa; Haussy, Claudy; Legoupi, Julie; Perret, Samuel; Gasparini, Julien			Food Availability and Maternal Immunization Affect Transfer and Persistence of Maternal Antibodies in Nestling Pigeons	PLOS ONE			English	Article							KITTIWAKE RISSA-TRIDACTYLA; HUMORAL IMMUNE-RESPONSE; BURGDORFERI-SENSU-LATO; OFFSPRING IMMUNITY; COLONIAL SEABIRD; TRANSMISSION; GROWTH; YOUNG; EGGS; MILK	The ability of mothers to transfer antibodies (Abs) to their young and the temporal persistence of maternal Abs in offspring constitute important life-history traits that can impact the evolution of host-parasite interactions. Here, we examined the effects of food availability and parental immunization on the transfer and persistence of maternal antibodies in nestling pigeons (Columba livia). This species can transmit maternal Abs to offspring before hatching through the egg yolk and potentially after hatching through crop milk. However, the role of this postnatal substance in immunity remains elusive. We used a full cross-fostering design to disentangle the effects of food limitation and parental immunization both before and after hatching on the levels and persistence of maternal Abs in chicks. Parents were immunized via injection with keyhole limpet hemocyanin antigens. Using an immunoassay that specifically detected the IgY antibodies that are known to be transmitted via the yolk, we found that the levels of anti-KLH Abs in newly hatched chicks were positively correlated with the levels of anti-KLH Abs in the blood of their biological mothers. However, this correlation was not present between chicks and their foster parents, suggesting limited IgY transfer via crop milk to the chick's bloodstream. Interestingly, biological mothers subjected to food limitation during egg laying transferred significantly fewer specific maternal Abs, which suggests that the transfer of antibodies might be costly for them. In addition, the persistence of maternal Abs in a chick's bloodstream was not affected by food limitation or the foster parents' anti-KLH Ab levels; it was only affected by the initial level of maternal anti-KLH Abs that were present in newly hatched chicks. These results suggest that the maternal transfer of Abs could be costly but that their persistence in an offspring's bloodstream may not necessarily be affected by environmental conditions.	[Ismail, Ahmad; Jacquin, Lisa; Haussy, Claudy; Legoupi, Julie; Gasparini, Julien] Univ Paris 06, CNRS, ENS, Lab Ecol & Evolut UMR 7625, Paris, France; [Jacquin, Lisa] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Jacquin, Lisa] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Perret, Samuel] Ecole Normale Super, CNRS, ENS, UMS 3194,Ctr Ecol Expt & Predict CEREEP Ecotron I, St Pierre Les Nemours, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; McGill University; McGill University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Gasparini, J (corresponding author), Univ Paris 06, CNRS, ENS, Lab Ecol & Evolut UMR 7625, Paris, France.	jgaspari@snv.jussieu.fr	Jacquin, Lisa/H-6878-2019; Gasparini, Julien/J-9263-2012	Jacquin, Lisa/0000-0002-0521-6113; 	Ile-de-France Region (Sustainable Development Network R2DS) [2008-07]; Damascus University (Syria)	Ile-de-France Region (Sustainable Development Network R2DS)(Region Ile-de-France); Damascus University (Syria)	This work was supported by grants from the Ile-de-France Region (Sustainable Development Network R2DS, No. 2008-07, http://www.r2ds-ile-de-france.com/) and Damascus University (Syria). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addison B, 2010, FUNCT ECOL, V24, P824, DOI 10.1111/j.1365-2435.2010.01706.x; Boost M, 2012, P ROY SOC LOND B BIO, V279, P4009, DOI [10.1098/rspb.2012.1073, DOI 10.1098/RSPB.2012.1073]; Boulinier T, 2008, TRENDS ECOL EVOL, V23, P282, DOI 10.1016/j.tree.2007.12.006; DIXON FJ, 1966, J IMMUNOL, V97, P350; Duffy JE, 2002, MAR ENVIRON RES, V54, P559, DOI 10.1016/S0141-1136(02)00176-9; ENGBERG RM, 1992, AVIAN PATHOL, V21, P409, DOI 10.1080/03079459208418859; Eraud C, 2008, J AVIAN BIOL, V39, P247, DOI 10.1111/j.0908-8857.2008.04053.x; Garnier G, MAMM BIOL IN PRESS; Garnier R, 2012, P ROY SOC B-BIOL SCI, V279, P2033, DOI 10.1098/rspb.2011.2277; Gasparini J, 2007, J EVOLUTION BIOL, V20, P874, DOI 10.1111/j.1420-9101.2007.01315.x; Gasparini J, 2006, CAN J ZOOL, V84, P623, DOI 10.1139/Z06-024; Gasparini J, 2002, ECOL LETT, V5, P519, DOI 10.1046/j.1461-0248.2002.00345.x; Gasparini J, 2001, P ROY SOC B-BIOL SCI, V268, P647, DOI 10.1098/rspb.2000.1411; Gasparini J, 2009, J AVIAN BIOL, V40, P271, DOI 10.1111/j.1600-048X.2008.04590.x; Grindstaff JL, 2010, J ORNITHOL, V151, P423, DOI 10.1007/s10336-009-0472-5; Grindstaff JL, 2005, J ANIM ECOL, V74, P1051, DOI 10.1111/j.1365-2656.2005.01002.x; Grindstaff JL, 2003, P ROY SOC B-BIOL SCI, V270, P2309, DOI 10.1098/rspb.2003.2485; HALLIDAY R, 1955, PROC R SOC SER B-BIO, V144, P427, DOI 10.1098/rspb.1955.0068; Hasselquist D, 2001, BEHAV ECOL, V12, P93, DOI 10.1093/oxfordjournals.beheco.a000384; Hasselquist D, 2009, PHILOS T R SOC B, V364, P51, DOI 10.1098/rstb.2008.0137; Hawkins P., 2001, LAB ANIM, V35, P109; Jacquin L, 2012, BEHAV ECOL, V23, P907, DOI 10.1093/beheco/ars055; Jacquin L, 2013, BIOL J LINN SOC, V108, P647, DOI 10.1111/bij.12001; Jacquin L, 2012, FUNCT ECOL, V26, P866, DOI 10.1111/j.1365-2435.2012.01988.x; Johnston RF, 1995, FERAL PIGEONS; JurincicWinkler C, 1995, ANTICANCER RES, V15, P2771; Kallio ER, 2010, P ROY SOC B-BIOL SCI, V277, P3783, DOI 10.1098/rspb.2010.1022; Kilpimaa J, 2007, J EVOLUTION BIOL, V20, P717, DOI 10.1111/j.1420-9101.2006.01239.x; King MO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009639; KOWALCZYK K, 1985, IMMUNOLOGY, V54, P755; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Pihlaja M, 2006, J ANIM ECOL, V75, P1154, DOI 10.1111/j.1365-2656.2006.01136.x; SHETTY S, 1992, J COMP PHYSIOL B, V162, P632, DOI 10.1007/BF00296644; Staszewski V, 2007, J ANIM ECOL, V76, P1215, DOI 10.1111/j.1365-2656.2007.01293.x; Staszewski V, 2010, FUNCT ECOL, V24, P1333, DOI 10.1111/j.1365-2435.2010.01745.x; Van de Perre P, 2003, VACCINE, V21, P3374, DOI 10.1016/S0264-410X(03)00336-0; Zanchi C, 2012, P ROY SOC B-BIOL SCI, V279, P3223, DOI 10.1098/rspb.2012.0493	37	7	7	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79942	10.1371/journal.pone.0079942	http://dx.doi.org/10.1371/journal.pone.0079942			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24348905	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400097
J	Fang, JE; Sun, LQ; Peng, GQ; Xu, J; Zhou, R; Cao, SB; Chen, HC; Song, YF				Fang, Jin'e; Sun, Leqiang; Peng, Guiqing; Xu, Jia; Zhou, Rui; Cao, Shengbo; Chen, Huanchun; Song, Yunfeng			Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280	PLOS ONE			English	Article							ESSENTIAL-HYPERTENSION; DENGUE VIRUS; HEPATITIS-C; WEST-NILE; INFECTION; CILNIDIPINE; VALIDATION; SPREAD	Japanese encephalitis virus (JEV) can cause severe central nervous disease with a high mortality rate. There is no antiviral drug available for JEV-specific treatment. In this study, a cytopathic-effect-based, high-throughput screening assay was developed and applied to screen JEV inhibitors from Library of Pharmacologically Active Compounds 1280. The antiviral effects of three hit compounds including FGIN-1-27, cilnidipine, and niclosamide were evaluated in cells by western blotting, indirect immunofluorescence assay, and plaque reduction assay. A time-of-addition assay proved that all three compounds inhibited JEV at the stage of replication. The EC50s of FGIN-1-27, cilnidipine, and niclosamide were 3.21, 6.52, and 5.80 mu M, respectively, while the selectivity indexes were 38.79, 30.67, and 7.49. FGIN-1-27 and cilnidipine have high efficiency and selectivity against JEV. This study provided two JEV antiviral inhibitors as candidates for treatment of JEV infection.	[Fang, Jin'e; Sun, Leqiang; Peng, Guiqing; Zhou, Rui; Cao, Shengbo; Chen, Huanchun; Song, Yunfeng] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China; [Fang, Jin'e; Sun, Leqiang; Peng, Guiqing; Xu, Jia; Zhou, Rui; Cao, Shengbo; Chen, Huanchun; Song, Yunfeng] Huazhong Agr Univ, Coll Vet Med, Wuhan, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University	Song, YF (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	syf@mail.hzau.edu.cn			973 Project [2010CB530100]; National Natural Science Foundation [30800831]; 863 Program [2011AA10A212]; National Special Research Programs for Non-Profit Trades [201203082]; Fundamental Research Funds for the Central University [2013JC001]; innovative research groups of NSFC in from China [31121004]	973 Project(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); 863 Program(National High Technology Research and Development Program of China); National Special Research Programs for Non-Profit Trades; Fundamental Research Funds for the Central University; innovative research groups of NSFC in from China	This work was supported by the 973 Project (2010CB530100), National Natural Science Foundation (30800831), 863 Program (2011AA10A212), National Special Research Programs for Non-Profit Trades (201203082), Fundamental Research Funds for the Central University (2013JC001) and innovative research groups of NSFC (31121004) in from China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett AD, 2008, ENCY VIROLOGY, P182, DOI DOI 10.1016/B978-012374410-4; Basu A, 2011, J VIROL, V85, P3106, DOI 10.1128/JVI.01456-10; Boguszewska-Chachulska AM, 2004, FEBS LETT, V567, P253, DOI 10.1016/j.febslet.2004.04.072; Botting C, 2012, EXPERT OPIN DRUG DIS, V7, P417, DOI 10.1517/17460441.2012.673579; Chang CC, 2005, J GEN VIROL, V86, P2513, DOI 10.1099/vir.0.81123-0; Chang SJ, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/925830; Che PL, 2009, INT J CLIN EXP MED, V2, P363; Chen Z, 2012, HYBRIDOMA, V31, P137, DOI 10.1089/hyb.2011.0107; Enserink M, 2011, SCIENCE, V332, P159, DOI 10.1126/science.332.6026.159; Gould EA, 2008, ANTIVIR RES, V78, P140, DOI 10.1016/j.antiviral.2007.10.005; Hanna JN, 1999, MED J AUSTRALIA, V170, P533, DOI 10.5694/j.1326-5377.1999.tb127878.x; HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004; IGARASHI A, 1994, MICROBIOL IMMUNOL, V38, P827, DOI 10.1111/j.1348-0421.1994.tb01866.x; Junaid M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036872; KU CC, 1994, J MED VIROL, V44, P122, DOI 10.1002/jmv.1890440204; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P49; MITCHELL CJ, 1993, AM J TROP MED HYG, V48, P585, DOI 10.4269/ajtmh.1993.48.585; Morimoto S, 2007, J HYPERTENS, V25, P2178, DOI 10.1097/HJH.0b013e3282c2fa62; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Noble CG, 2010, ANTIVIR RES, V85, P450, DOI 10.1016/j.antiviral.2009.12.011; Ogura C, 2012, BLOOD PRESSURE, V21, P367, DOI 10.3109/08037051.2012.694200; ROMEO E, 1993, J PHARMACOL EXP THER, V267, P462; ROMEO E, 1992, J PHARMACOL EXP THER, V262, P971; Sebastian L, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-64; Severson WE, 2007, J BIOMOL SCREEN, V12, P33, DOI 10.1177/1087057106296688; Shi Pei-Yong, 2002, Curr Opin Investig Drugs, V3, P1567; Wang LH, 2007, EMERG INFECT DIS, V13, P1123, DOI 10.3201/eid1307.070010; Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002; Xu Guoliang, 2012, Cardiovascular & Hematological Disorders - Drug Targets, V12, P56; Yang KD, 2004, J GEN VIROL, V85, P635, DOI 10.1099/vir.0.19426-0; YU YX, 1988, AM J TROP MED HYG, V39, P214, DOI 10.4269/ajtmh.1988.39.214	32	42	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78425	10.1371/journal.pone.0078425	http://dx.doi.org/10.1371/journal.pone.0078425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24348901	Green Published, gold, Green Submitted			2022-12-27	WOS:000326503400059
J	Diaz-Chavez, ML; Moniodis, J; Madilao, LL; Jancsik, S; Keeling, CI; Barbour, EL; Ghisalberti, EL; Plummer, JA; Jones, CG; Bohlmann, J				Diaz-Chavez, Maria L.; Moniodis, Jessie; Madilao, Lufiani L.; Jancsik, Sharon; Keeling, Christopher I.; Barbour, Elizabeth L.; Ghisalberti, Emilio L.; Plummer, Julie A.; Jones, Christopher G.; Bohlmann, Joerg			Biosynthesis of Sandalwood Oil: Santalum album CYP76F Cytochromes P450 Produce Santalols and Bergamotol	PLOS ONE			English	Article							GERANIOL 10-HYDROXYLASE; FUNCTIONAL EXPRESSION; YEAST; HEARTWOOD; CLONING	Sandalwood oil is one of the world's most highly prized essential oils, appearing in many high-end perfumes and fragrances. Extracted from the mature heartwood of several Santalum species, sandalwood oil is comprised mainly of sesquiterpene olefins and alcohols. Four sesquiterpenols, alpha-, beta-, and epi-beta-santalol and alpha-exo-bergamotol, make up approximately 90% of the oil of Santalum album. These compounds are the hydroxylated analogues of alpha-, beta-, and epi-beta-santalene and alpha-exo-bergamotene. By mining a transcriptome database of S. album for candidate cytochrome P450 genes, we cloned and characterized cDNAs encoding a small family of ten cytochrome P450-dependent monooxygenases annotated as SaCYP76F37v1, SaCYP76F37v2, SaCYP76F38v1, SaCYP76F38v2, SaCYP76F39v1, SaCYP76F39v2, SaCYP76F40, SaCYP76F41, SaCYP76F42, and SaCYP76F43. Nine of these genes were functionally characterized using in vitro assays and yeast in vivo assays to encode santalene/bergamotene oxidases and bergamotene oxidases. These results provide a foundation for production of sandalwood oil for the fragrance industry by means of metabolic engineering, as demonstrated with proof-of-concept formation of santalols and bergamotol in engineered yeast cells, simultaneously addressing conservation challenges by reducing pressure on supply of sandalwood from native forests.	[Diaz-Chavez, Maria L.; Madilao, Lufiani L.; Jancsik, Sharon; Keeling, Christopher I.; Bohlmann, Joerg] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada; [Moniodis, Jessie; Barbour, Elizabeth L.; Plummer, Julie A.; Jones, Christopher G.] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia; [Moniodis, Jessie; Ghisalberti, Emilio L.] Univ Western Australia, Sch Chem & Biochem, Crawley, WA, Australia	University of British Columbia; University of Western Australia; University of Western Australia	Bohlmann, J (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	bohlmann@msl.ubc.ca	Keeling, Christopher I./I-3371-2012	Keeling, Christopher I./0000-0001-7885-8558; Barbour, Elizabeth/0000-0002-3533-2422	Allyix Inc.; Natural Sciences and Engineering Research Council of Canada; Australian Research Council; Forest Products Commission of Western Australia [LP0882690]; UBC Distinguished University Scholar program	Allyix Inc.; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council); Forest Products Commission of Western Australia; UBC Distinguished University Scholar program	Funding for this work was provided by Allyix Inc. (to JB), the Natural Sciences and Engineering Research Council of Canada (to JB), and the Australian Research Council and the Forest Products Commission of Western Australia through Linkage Project LP0882690 (to JAP, ELG, ELB, JB). JB was supported in part by the UBC Distinguished University Scholar program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DR, 1975, PHYTOCHEMISTRY, V14, P1459, DOI 10.1016/S0031-9422(00)98669-2; Baldovini N, 2011, FLAVOUR FRAG J, V26, P7, DOI 10.1002/ffj.2025; Batard Y, 1998, PLANT J, V14, P111, DOI 10.1046/j.1365-313X.1998.00099.x; Braun NA, 2005, J ESSENT OIL RES, V17, P477, DOI 10.1080/10412905.2005.9698969; Brocke C, 2008, CHEM BIODIVERS, V5, P1000, DOI 10.1002/cbdv.200890080; CHRISTENSON PA, 1981, PHYTOCHEMISTRY, V20, P1139, DOI 10.1016/0031-9422(81)83047-6; CHRISTENSON PA, 1980, J ORG CHEM, V45, P3068, DOI 10.1021/jo01303a026; Collu G, 2001, FEBS LETT, V508, P215, DOI 10.1016/S0014-5793(01)03045-9; Daramwar PP, 2012, ANALYST, V137, P4564, DOI 10.1039/c2an35575b; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; GOTOH O, 1992, J BIOL CHEM, V267, P83; Guengerich FP, 2009, NAT PROTOC, V4, P1245, DOI 10.1038/nprot.2009.121; Hamann T, 2007, PROTEIN EXPRES PURIF, V56, P121, DOI 10.1016/j.pep.2007.06.007; Hamberger B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0426; Harbaugh DT, 2007, AM J BOT, V94, P1028, DOI 10.3732/ajb.94.6.1028; Jones CG, 2008, ARCH BIOCHEM BIOPHYS, V477, P121, DOI 10.1016/j.abb.2008.05.008; Jones CG, 2007, J ESSENT OIL RES, V19, P157, DOI 10.1080/10412905.2007.9699250; Jones CG, 2011, J BIOL CHEM, V286, P17445, DOI 10.1074/jbc.M111.231787; Kim TH, 2006, TETRAHEDRON, V62, P6981, DOI 10.1016/j.tet.2006.04.072; Muratore A, 2010, CHEM BIODIVERS, V7, P623, DOI 10.1002/cbdv.200900119; Nelson D. R., 2008, Tropical Plant Biology, V1, P216, DOI 10.1007/s12042-008-9022-1; Nelson D, 2011, PLANT J, V66, P194, DOI 10.1111/j.1365-313X.2011.04529.x; Page T, 2010, CHEM BIODIVERS, V7, P1990, DOI 10.1002/cbdv.200900382; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Sciarrone D, 2011, J CHROMATOGR A, V1218, P5374, DOI 10.1016/j.chroma.2011.07.001; Sung PH, 2011, J AGR FOOD CHEM, V59, P4637, DOI 10.1021/jf200259n; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valder C, 2003, J ESSENT OIL RES, V15, P178, DOI 10.1080/10412905.2003.9712106; Wang Q, 2012, J BIOL CHEM, V287, P6159, DOI 10.1074/jbc.M111.305599; Zerbe P, 2013, PLANT PHYSIOL, V162, P1073, DOI 10.1104/pp.113.218347	32	70	75	6	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2013	8	9							e75053	10.1371/journal.pone.0075053	http://dx.doi.org/10.1371/journal.pone.0075053			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	221YD	24324844	Green Published, gold, Green Submitted			2022-12-27	WOS:000324695900092
J	Orellana-Paucar, AM; Afrikanova, T; Thomas, J; Aibuldinov, YK; Dehaen, W; de Witte, PAM; Esguerra, CV				Orellana-Paucar, Adriana Monserrath; Afrikanova, Tatiana; Thomas, Joice; Aibuldinov, Yelaman K.; Dehaen, Wim; de Witte, Peter A. M.; Esguerra, Camila V.			Insights from Zebrafish and Mouse Models on the Activity and Safety of Ar-Turmerone as a Potential Drug Candidate for the Treatment of Epilepsy	PLOS ONE			English	Article							ANTIEPILEPTIC DRUGS; CURCUMA-LONGA; 6 HZ; RECEPTOR; LEVETIRACETAM; BRAIN; SEIZURES; COMPLEX; BDNF; OIL	In a previous study, we uncovered the anticonvulsant properties of turmeric oil and its sesquiterpenoids (arturmerone, alpha-, beta-turmerone and alpha-atlantone) in both zebrafish and mouse models of chemically-induced seizures using pentylenetetrazole (PTZ). In this follow-up study, we aimed at evaluating the anticonvulsant activity of arturmerone further. A more in-depth anticonvulsant evaluation of ar-turmerone was therefore carried out in the i.v. PTZ and 6-Hz mouse models. The potential toxic effects of ar-turmerone were evaluated using the beam walking test to assess mouse motor function and balance. In addition, determination of the concentration-time profile of arturmerone was carried out for a more extended evaluation of its bioavailability in the mouse brain. Ar-turmerone displayed anticonvulsant properties in both acute seizure models in mice and modulated the expression patterns of two seizure-related genes (c-fos and brain-derived neurotrophic factor [bdnf]) in zebrafish. Importantly, no effects on motor function and balance were observed in mice after treatment with ar-turmerone even after administering a dose 500-fold higher than the effective dose in the 6-Hz model. In addition, quantification of its concentration in mouse brains revealed rapid absorption after i.p. administration, capacity to cross the BBB and long-term brain residence. Hence, our results provide additional information on the anticonvulsant properties of ar-turmerone and support further evaluation towards elucidating its mechanism of action, bioavailability, toxicity and potential clinical application.	[Orellana-Paucar, Adriana Monserrath; Afrikanova, Tatiana; de Witte, Peter A. M.; Esguerra, Camila V.] Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium; [Orellana-Paucar, Adriana Monserrath] Univ Cuenca, Escuela Bioquim & Farm, Fac Ciencias Quim, Cuenca, Ecuador; [Thomas, Joice; Aibuldinov, Yelaman K.; Dehaen, Wim] Univ Leuven, Dept Chem, Lab Mol Design & Synth, Louvain, Belgium	KU Leuven; Universidad de Cuenca; KU Leuven	Esguerra, CV (corresponding author), Univ Leuven, Dept Pharmaceut & Pharmacol Sci, Lab Mol Biodiscovery, Louvain, Belgium.	camila.esguerra@pharm.kuleuven.be	Esguerra, Camila/N-6159-2015; Orellana-Paucar, Adriana/ABA-5933-2020; Aibuldinov, Yelaman K./I-5015-2016; PAUCAR, ADRIANA MONSERRATH ORELLANA/AAT-4512-2020; Esguerra, Camila/D-7657-2014; Thomas, Joice/N-6432-2018	Esguerra, Camila/0000-0002-2271-8094; Orellana-Paucar, Adriana/0000-0003-1460-0990; Esguerra, Camila/0000-0001-7891-1427; Thomas, Joice/0000-0001-5517-4663; Aibuldinov, Yelaman/0000-0001-9143-4581; de Witte, Peter/0000-0002-9989-9567	Vlaamse Interuniversitaire Raad (VLIR) "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" Project	Vlaamse Interuniversitaire Raad (VLIR) "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" Project	AMOP was partially funded through a fellowship from the Vlaamse Interuniversitaire Raad (VLIR) "Pharmacological Characterization of Medicinal Plants from the South of Ecuador" Project. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah JM, 2011, MALAYS J MED SCI, V18, P1; Abou-Khalil Bassel, 2012, Handb Clin Neurol, V108, P723, DOI 10.1016/B978-0-444-52899-5.00024-1; Alam S, 2012, ARCH DIS CHILD, V97, P985, DOI 10.1136/archdischild-2011-301119; Alarcon G., 2012, INTRO EPILEPSY; [Anonymous], 2011, HERBAL MED BIOMOLECU; Antony B, 2008, INDIAN J PHARM SCI, V70, P445, DOI 10.4103/0250-474X.44591; BALLARIN M, 1991, EXP NEUROL, V114, P35, DOI 10.1016/0014-4886(91)90082-N; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Barton ME, 2003, EPILEPSY RES, V56, P17, DOI 10.1016/j.eplepsyres.2003.08.001; Barton ME, 2001, EPILEPSY RES, V47, P217, DOI 10.1016/S0920-1211(01)00302-3; Baxendale S, 2012, DIS MODEL MECH, V5, P773, DOI 10.1242/dmm.010090; Bota Robert G, 2011, Perm J, V15, P80; Brooks SP, 2011, CURR PROTOC MOUSE BI, V2, P37; BROWN WC, 1953, J PHARMACOL EXP THER, V107, P273; Carter RJ, 2001, CURR PROTOC NEUROSCI, V15; Christie W. W., 1993, ADV LIPID METHODOLOG, VII, P195, DOI [10.1192/bjp.112.483.211-a, DOI 10.1192/BJP.112.483.211-A]; Cilio MR, 2009, EPILEPSY RES, V86, P66, DOI 10.1016/j.eplepsyres.2009.05.004; Cohen-Cory S, 2010, DEV NEUROBIOL, V70, P271, DOI 10.1002/dneu.20774; Cramer JA, 2010, EXPERT REV NEUROTHER, V10, P885, DOI 10.1586/ERN.10.71; Das N, 2012, DRUG DISCOV THER, V6, P178, DOI 10.5582/ddt.2012.v6.4.178; Dobrin S, 2012, DM-DIS MON, V58, P708, DOI 10.1016/j.disamonth.2012.08.011; Dogan S, 2011, EUR J GASTROEN HEPAT, V23, P628, DOI 10.1097/MEG.0b013e328346df7a; Du P, 2012, CHINESE MED J-PEKING, V125, P1975, DOI 10.3760/cma.j.issn.0366-6999.2012.11.025; Duncan GE, 2005, EPILEPSY RES, V67, P81, DOI 10.1016/j.eplepsyres.2005.08.009; Eggers C, 2009, SEIZURE-EUR J EPILEP, V18, P716, DOI 10.1016/j.seizure.2009.09.005; Eigner D, 1999, J ETHNOPHARMACOL, V67, P1, DOI 10.1016/S0378-8741(98)00234-7; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Fejerman N, 2012, ARCH ARGENT PEDIATR, V110, P422, DOI [10.5546/aap.2012.421, 10.1590/S0325-00752012000500010]; Gambardella Antonio, 2008, Neuropsychiatr Dis Treat, V4, P33; Gao L, 2013, EPILEPSY RES, V103, P31, DOI 10.1016/j.eplepsyres.2012.06.005; Giardina WJ, 2009, CURR PROTOC PHARM, V45; Godukhin O V, 2009, Neurosci Behav Physiol, V39, P625, DOI 10.1007/s11055-009-9187-6; Guo JM, 2009, FITOTERAPIA, V80, P168, DOI 10.1016/j.fitote.2009.01.003; Hartman AL, 2008, EPILEPSIA, V49, P334, DOI 10.1111/j.1528-1167.2007.01430.x; Hosseini Mahmoud, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1118, DOI 10.3736/jcim20111013; Hutchins-Wolfbrandt A, 2011, ASIAN PAC J CANCER P, V12, P3169; Joshi Jayashree, 2003, J Assoc Physicians India, V51, P1055; Klitgaard H, 1998, EUR J PHARMACOL, V353, P191, DOI 10.1016/S0014-2999(98)00410-5; Li S., 2011, PHARM CROPS, V2, P28, DOI [DOI 10.2174/2210290601102010028, 10.2174/2210290601102010028]; Liju VB, 2013, FOOD CHEM TOXICOL, V53, P52, DOI 10.1016/j.fct.2012.11.027; Loscher W, 2011, EPILEPSIA, V52, P657, DOI 10.1111/j.1528-1167.2011.03024.x; Loscher W, 2009, EUR J PHARMACOL, V610, P1, DOI 10.1016/j.ejphar.2009.03.025; LOSCHER W, 1991, EPILEPSY RES, V8, P171, DOI 10.1016/0920-1211(91)90062-K; Luscher BP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042101; Luong TN, 2011, JOVE-J VIS EXP, DOI 10.3791/2376; Malizia AL, 1996, NEUROPHARMACOLOGY, V35, P1483, DOI 10.1016/S0028-3908(96)00072-X; Mandhane SN, 2007, SEIZURE-EUR J EPILEP, V16, P636, DOI 10.1016/j.seizure.2007.05.005; Mao XY, 2010, NEUROSCI LETT, V486, P150, DOI 10.1016/j.neulet.2010.09.033; Marchetti C, 2011, J ETHNOPHARMACOL, V137, P382, DOI 10.1016/j.jep.2011.05.038; Martinowich K, 2007, NAT NEUROSCI, V10, P1089, DOI 10.1038/nn1971; McNamara JO, 2010, EPILEPSIA, V51, P46, DOI 10.1111/j.1528-1167.2010.02832.x; Mehrotra N, 2009, CHROMATOGRAPHIA, V69, P1077, DOI 10.1365/s10337-009-1007-1; Meldrum B, 2002, EPILEPSY RES, V50, P33, DOI 10.1016/S0920-1211(02)00066-9; Orellana-Paucar AM, 2012, EPILEPSY BEHAV, V24, P14, DOI 10.1016/j.yebeh.2012.02.020; Ng TP, 2006, AM J EPIDEMIOL, V164, P898, DOI 10.1093/aje/kwj267; Ngugi AK, 2010, EPILEPSIA, V51, P883, DOI 10.1111/j.1528-1167.2009.02481.x; Noor NA, 2012, EPILEPSY BEHAV, V24, P199, DOI 10.1016/j.yebeh.2012.03.026; OLSEN RW, 1981, MOL CELL BIOCHEM, V39, P261, DOI 10.1007/BF00232579; Park SP, 2008, J CLIN NEUROL, V4, P99, DOI 10.3988/jcn.2008.4.3.99; Pina-Garza JE, 2009, EPILEPSIA, V50, P1141, DOI 10.1111/j.1528-1167.2008.01981.x; Poulsen FR, 2002, BRAIN RES, V950, P103, DOI 10.1016/S0006-8993(02)03009-3; Prakash P, 2011, THROMB RES, V127, P111, DOI 10.1016/j.thromres.2010.11.007; Rambeck B, 2006, EPILEPSIA, V47, P681, DOI 10.1111/j.1528-1167.2006.00504.x; Reid CA, 2009, PROG NEUROBIOL, V87, P41, DOI 10.1016/j.pneurobio.2008.09.016; Rocamora R, 2006, SEIZURE-EUR J EPILEP, V15, P428, DOI 10.1016/j.seizure.2006.05.012; Rupe H, 1934, HELV CHIM ACTA, V17, P372, DOI 10.1002/hlca.19340170144; Rupe H, 1924, HELV CHIM ACTA, V7, P654, DOI 10.1002/hlca.19240070181; Rupe H, 1909, BER DTSCH CHEM GES, V42, P2515, DOI 10.1002/cber.190904202156; Schachter SC, 2009, NEUROTHERAPEUTICS, V6, P415, DOI 10.1016/j.nurt.2008.12.004; Scher MS, 2006, EPILEPSY RES, V70, pS41, DOI 10.1016/j.eplepsyres.2005.11.020; Schmidt D, 2009, EPILEPSY BEHAV, V15, P56, DOI 10.1016/j.yebeh.2009.02.030; SCHREIBER SS, 1991, NEUROREPORT, V2, P17, DOI 10.1097/00001756-199101000-00004; Stables JP, 1997, CURR PROB E, V12, P191; Stanley JL, 2005, J PSYCHOPHARMACOL, V19, P221, DOI 10.1177/0269881105051524; Sumanont Y, 2006, LIFE SCI, V78, P1884, DOI 10.1016/j.lfs.2005.08.028; Surges Rainer, 2008, Ther Adv Neurol Disord, V1, P13, DOI 10.1177/1756285608094212; Szyndler J, 2009, EPILEPSY BEHAV, V16, P216, DOI 10.1016/j.yebeh.2009.07.030; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Villegas I, 2008, MOL NUTR FOOD RES, V52, P1040, DOI 10.1002/mnfr.200700280; Wang HC, 2006, NEUROCRIT CARE, V5, P71, DOI 10.1385/NCC:5:1:71; WHO, 2005, ATL EP CAR WORLD 200; Wojda E, 2009, EPILEPSY RES, V86, P163, DOI 10.1016/j.eplepsyres.2009.06.003; Yong-Xue S, 2012, J VET PHARMACOL THER, V35, P47, DOI 10.1111/j.1365-2885.2011.01286.x	84	41	41	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81634	10.1371/journal.pone.0081634	http://dx.doi.org/10.1371/journal.pone.0081634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349101	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200012
J	Chawade, A; Lindlof, A; Olsson, B; Olsson, O				Chawade, Aakash; Lindlof, Angelica; Olsson, Bjorn; Olsson, Olof			Global Expression Profiling of Low Temperature Induced Genes in the Chilling Tolerant Japonica Rice Jumli Marshi	PLOS ONE			English	Article							ORYZA-SATIVA L.; HIGH-SALINITY STRESSES; COLD-ACCLIMATION; CBF GENE; TRANSCRIPTION FACTORS; PLASMA-MEMBRANE; ABIOTIC STRESS; ABSCISIC-ACID; ARABIDOPSIS; DROUGHT	Low temperature is a key factor that limits growth and productivity of many important agronomical crops worldwide. Rice (Oryza sativa L.) is negatively affected already at temperatures below + 10 degrees C and is therefore denoted as chilling sensitive. However, chilling tolerant rice cultivars exist and can be commercially cultivated at altitudes up to 3,050 meters with temperatures reaching as low as + 4 degrees C. In this work, the global transcriptional response to cold stress (+ 4 degrees C) was studied in the Nepalese highland variety Jumli Marshi (spp. japonica) and 4,636 genes were identified as significantly differentially expressed within 24 hours of cold stress. Comparison with previously published microarray data from one chilling tolerant and two sensitive rice cultivars identified 182 genes differentially expressed (DE) upon cold stress in all four rice cultivars and 511 genes DE only in the chilling tolerant rice. Promoter analysis of the 182 genes suggests a complex cross-talk between ABRE and CBF regulons. Promoter analysis of the 511 genes identified over-represented ABRE motifs but not DRE motifs, suggesting a role for ABA signaling in cold tolerance. Moreover, 2,101 genes were DE in Jumli Marshi alone. By chromosomal localization analysis, 473 of these cold responsive genes were located within 13 different QTLs previously identified as cold associated.	[Chawade, Aakash; Lindlof, Angelica; Olsson, Olof] CropTailor AB, Lund, Sweden; [Lindlof, Angelica; Olsson, Bjorn] Univ Skovde, Sch Life Sci, Syst Biol Res Ctr, Skovde, Sweden; [Olsson, Olof] Lund Univ, Dept Pure & Appl Biochem, Lund, Sweden	University of Skovde; Lund University	Chawade, A (corresponding author), CropTailor AB, Lund, Sweden.	aakash.chawade@croptailor.com; olof.olsson@tbiokem.lth.se	Chawade, Aakash/G-7750-2011; Olsson, Björn/N-2733-2014	Chawade, Aakash/0000-0002-6500-4139; Olsson, Björn/0000-0001-6254-4335; Olsson, Olof/0000-0003-3962-9183	Swedish Farmers Supply and Crop Marketing Cooperative (SLF) [H0633164-K02]	Swedish Farmers Supply and Crop Marketing Cooperative (SLF)	This work was supported by Swedish Farmers Supply and Crop Marketing Cooperative (SLF) with grant number H0633164-K02. URL: www.slf.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON MD, 1994, PLANT PHYSIOL, V105, P331, DOI 10.1104/pp.105.1.331; Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Bae MS, 2003, PLANT J, V36, P652, DOI 10.1046/j.1365-313X.2003.01907.x; Benedict C, 2006, PLANT PHYSIOL, V141, P1219, DOI 10.1104/pp.106.083527; Bolstad B. M., 2004, LOW LEVEL ANAL HIGH; Brautigam M, 2005, BMC PLANT BIOL, V5, DOI 10.1186/1471-2229-5-18; Caldana C, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-7; Chawade A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029792; Chawade A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-304; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Cooper B, 2003, P NATL ACAD SCI USA, V100, P4945, DOI 10.1073/pnas.0737574100; del Rio LA, 2006, PLANT PHYSIOL, V141, P330, DOI 10.1104/pp.106.078204; DOWGERT MF, 1984, PLANT PHYSIOL, V75, P1139, DOI 10.1104/pp.75.4.1139; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; FOWLER DB, 1979, CROP SCI, V19, P915, DOI 10.2135/cropsci1979.0011183X001900060040x; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Gautam A.K., 2012, ADV TEMPERATE RICE R, P49; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gesch RW, 1999, ENVIRON EXP BOT, V41, P257, DOI 10.1016/S0098-8472(99)00008-8; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Goulas E, 2006, PLANT J, V47, P720, DOI 10.1111/j.1365-313X.2006.02821.x; Hossain Z, 2012, J PROTEOME RES, V11, P37, DOI 10.1021/pr200863r; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Huang GT, 2012, MOL BIOL REP, V39, P969, DOI 10.1007/s11033-011-0823-1; Ito Y, 2006, PLANT CELL PHYSIOL, V47, P141, DOI 10.1093/pcp/pci230; Janska A, 2011, FUNCT INTEGR GENOMIC, V11, P307, DOI 10.1007/s10142-011-0213-8; Joshi BK, 2005, RICE GENE POOL TARAI, V6, P10; Kawamura Y, 2003, PLANT J, V36, P141, DOI 10.1046/j.1365-313X.2003.01864.x; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kornyeyev D, 2003, FUNCT PLANT BIOL, V30, P101, DOI 10.1071/FP02144; Kreps JA, 2002, PLANT PHYSIOL, V130, P2129, DOI 10.1104/pp.008532; Laudencia-Chingcuanco D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-299; Lee BH, 2005, PLANT CELL, V17, P3155, DOI 10.1105/tpc.105.035568; Lindlof A, 2009, BIOINFORMATICS, V25, P1345, DOI 10.1093/bioinformatics/btp172; Maruyama K, 2004, PLANT J, V38, P982, DOI 10.1111/j.1365-313X.2004.02100.x; Matsumura T, 2002, PHYSIOL PLANTARUM, V116, P317, DOI 10.1034/j.1399-3054.2002.1160306.x; Mittal D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040899; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Morris RT, 2008, BIOINFORMATICS, V24, P2915, DOI 10.1093/bioinformatics/btn537; Morsy MR, 2007, J PLANT PHYSIOL, V164, P157, DOI 10.1016/j.jplph.2005.12.004; Navrot N, 2007, PHYSIOL PLANTARUM, V129, P185, DOI 10.1111/j.1399-3054.2006.00777.x; Ni J, 2009, GRAMENE QTL DATABASE, V2009; Oda S, 2010, GENES GENET SYST, V85, P107, DOI 10.1266/ggs.85.107; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Raboin LM, 2010, UPLAND AEROBIC RICE; Rasmusson AG, 2004, ANNU REV PLANT BIOL, V55, P23, DOI 10.1146/annurev.arplant.55.031903.141720; Sapkota S., 2010, NEPAL J SCI TECHNOLO, V11, P57; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Siddiq EA, 2012, AGR RES, V1, P25, DOI 10.1007/s40003-011-0011-5; Skinner JS, 2005, PLANT MOL BIOL, V59, P533, DOI 10.1007/s11103-005-2498-2; Smyth GK., 2005, LIMMA LINEAR MODELS; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Svensson JT, 2006, PLANT PHYSIOL, V141, P257, DOI 10.1104/pp.105.072645; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Wang XL, 2004, DNA SEQUENCE, V15, P180, DOI 10.1080/10425170410001704508; Wang YJ, 2005, J AM SOC HORTIC SCI, V130, P167, DOI 10.21273/JASHS.130.2.167; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Yoshimura K, 2004, PLANT J, V37, P21, DOI 10.1046/j.1365-313X.2003.01930.x; Yun KY, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-16; Zhang F, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-461; Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043274; Zhang X, 2004, PLANT J, V39, P905, DOI 10.1111/j.1365-313X.2004.02176.x; Zhou QY, 2008, PLANT BIOTECHNOL J, V6, P486, DOI 10.1111/j.1467-7652.2008.00336.x	70	39	39	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81729	10.1371/journal.pone.0081729	http://dx.doi.org/10.1371/journal.pone.0081729			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349120	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800024
J	Huang, L; Liu, ZB; Chen, S; Liu, Y; Shao, ZM				Huang, Liang; Liu, Zhebin; Chen, Sheng; Liu, Yin; Shao, Zhiming			A Prognostic Model for Triple-Negative Breast Cancer Patients Based on Node Status, Cathepsin-D and Ki-67 Index	PLOS ONE			English	Article							PATHOLOGICAL COMPLETE RESPONSE; NEOADJUVANT CHEMOTHERAPY; SURVIVAL; EXPRESSION; P53; CARCINOMAS; PATTERNS; SUBTYPES; MARKERS; IMPACT	Objective: The aim of this study was to evaluate clinicopathologic factors that could possibly affect the outcome of patients with triple negative breast cancer and subsequently build a prognostic model to predict patients' outcome. Methods: We retrospectively analyzed clinicopathologic characteristics and outcome of 504 patients diagnosed with triple-negative invasive ductal breast cancer. 185 patients enrolled between 2000 and 2002 were designated to the training set. The variables that had statistically significant correlation with prognosis were combined to build a model. The prognostic value of the model was further validated in the separate validation set containing 319 patients enrolled between 2003 and 2006. Results: The median follow-up duration was 66 months. 174 patients experienced recurrence, and 111 patients died. Positivity for >= 4 lymph nodes, Cathepsin-D positivity, and Ki-67 index >= 20% were independent factors for DFS, while the lymph nodes status and Ki-67 index were the prognostic factors for OS. The prognostic model was established based on the sum of all three factors, where positivity for >= 4 lymph nodes, Cathepsin-D and Ki-67 index >= 20% would individually contribute 1 point to the risk score. The patients in the validation set were assigned to a low-risk group (0 and 1 point) and a high-risk group (2 and 3 points). The external validation analysis also demonstrated that our prognostic model provided the independent high predictive accuracy of recurrence. Conclusion: This model has a considerable clinical value in predicting recurrence, and will help clinicians to design an appropriate level of adjuvant treatment and schedule adequate appointments of surveillance visits.	[Huang, Liang; Liu, Zhebin; Chen, Sheng; Liu, Yin; Shao, Zhiming] Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China; [Huang, Liang; Liu, Zhebin; Chen, Sheng; Liu, Yin; Shao, Zhiming] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Shao, Zhiming] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Shao, ZM (corresponding author), Fudan Univ, Dept Breast Surg, Shanghai Canc Ctr, Inst Canc, Shanghai 200433, Peoples R China.	zhimingshao@yahoo.com			Key Clinical Program of the Ministry of Health; Shanghai United Developing Technology Project of Municipal Hospitals [SHDC12010116]; National Natural Science Foundation of China [30971143, 30972936, 81001169]	Key Clinical Program of the Ministry of Health; Shanghai United Developing Technology Project of Municipal Hospitals; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the Key Clinical Program of the Ministry of Health (2010-2012), the Shanghai United Developing Technology Project of Municipal Hospitals (SHDC12010116), and the National Natural Science Foundation of China (30971143, 30972936, 81001169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albergaria A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-299; Bartholomeusz C, 2012, ONCOLOGIST, V17, P766, DOI 10.1634/theoncologist.2011-0377; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chae BJ, 2009, JPN J CLIN ONCOL, V39, P217, DOI 10.1093/jjco/hyp007; Chen S, 2012, J SURG ONCOL, V105, P577, DOI 10.1002/jso.22140; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Esserman LJ, 2012, J CLIN ONCOL, V30, P3242, DOI 10.1200/JCO.2011.39.2779; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Glikman P, 1997, TUMORI J, V83, P685, DOI 10.1177/030089169708300312; Han JS, 2011, AM J CLIN PATHOL, V135, P230, DOI 10.1309/AJCP9DV3EVZUATFV; Harbeck N, 1998, ANTICANCER RES, V18, P2187; Hernandez-Aya LF, 2011, J CLIN ONCOL, V29, P2628, DOI 10.1200/JCO.2010.32.1877; Hu L, 2008, CANCER RES, V68, P4666, DOI 10.1158/0008-5472.CAN-07-6276; Jacobs TW, 1999, J CLIN ONCOL, V17, P1983, DOI 10.1200/JCO.1999.17.7.1983; KANDALAFT PL, 1993, CANCER, V71, P2756, DOI 10.1002/1097-0142(19930501)71:9<2756::AID-CNCR2820710912>3.0.CO;2-1; Kashiwagi S, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3068; Keam B, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2834; Lee DS, 2011, JPN J CLIN ONCOL, V41, P854, DOI 10.1093/jjco/hyr066; Oakman C, 2010, BREAST, V19, P312, DOI 10.1016/j.breast.2010.03.026; Peng Yan, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P666; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2006, EUR J CANCER, V42, P3149, DOI 10.1016/j.ejca.2006.08.015; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Rhee JY, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-307; Sagulenko V, 2008, CARCINOGENESIS, V29, P1869, DOI 10.1093/carcin/bgn147; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tan DSP, 2008, BREAST CANCER RES TR, V111, P27, DOI 10.1007/s10549-007-9756-8; Tewari M, 2008, SURG ONCOL, V17, P301, DOI 10.1016/j.suronc.2008.03.003; Thike AA, 2010, MODERN PATHOL, V23, P123, DOI 10.1038/modpathol.2009.145	31	10	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83081	10.1371/journal.pone.0083081	http://dx.doi.org/10.1371/journal.pone.0083081			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340082	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400118
J	Tsugawa, S; Ohsaki, H				Tsugawa, Sho; Ohsaki, Hiroyuki			Effectiveness of Link Prediction for Face-to-Face Behavioral Networks	PLOS ONE			English	Article								Research on link prediction for social networks has been actively pursued. In link prediction for a given social network obtained from time-windowed observation, new link formation in the network is predicted from the topology of the obtained network. In contrast, recent advances in sensing technology have made it possible to obtain face-to-face behavioral networks, which are social networks representing face-to-face interactions among people. However, the effectiveness of link prediction techniques for face-to-face behavioral networks has not yet been explored in depth. To clarify this point, here we investigate the accuracy of conventional link prediction techniques for networks obtained from the history of face-to-face interactions among participants at an academic conference. Our findings were (1) that conventional link prediction techniques predict new link formation with a precision of 0.30-0.45 and a recall of 0.10-0.20, (2) that prolonged observation of social networks often degrades the prediction accuracy, (3) that the proposed decaying weight method leads to higher prediction accuracy than can be achieved by observing all records of communication and simply using them unmodified, and (4) that the prediction accuracy for face-to-face behavioral networks is relatively high compared to that for non-social networks, but not as high as for other types of social networks.	[Tsugawa, Sho] Univ Tsukuba, Fac Engn Informat & Syst, Ibaraki, Japan; [Ohsaki, Hiroyuki] Kwansei Gakuin Univ, Sch Sci & Technol, Kobe, Hyogo, Japan	University of Tsukuba; Kwansei Gakuin University	Tsugawa, S (corresponding author), Univ Tsukuba, Fac Engn Informat & Syst, Ibaraki, Japan.	s-tugawa@cs.tsukuba.ac.jp			JSPS KAKENHI [25280030]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number 25280030. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic LA, 2003, SOC NETWORKS, V25, P211, DOI 10.1016/S0378-8733(03)00009-1; [Anonymous], 2002, CONNECTIONS; Backstrom L, 2011, P 4 ACM INT C WEB SE, V11, P635; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Corlette D, 2010, P 21 ACM C HYP HYP H, P135; DAWAH HA, 1995, J ANIM ECOL, V64, P708, DOI 10.2307/5850; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Fire M., 2011, Proceedings of the 2011 IEEE Third International Conference on Privacy, Security, Risk and Trust and IEEE Third International Conference on Social Computing (PASSAT/SocialCom 2011), P73, DOI 10.1109/PASSAT/SocialCom.2011.20; Gallagher B, 2008, P 14 ACM SIGKDD INT, P256; Guimera R, 2009, P NATL ACAD SCI USA, V106, P22073, DOI 10.1073/pnas.0908366106; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HUANG Z., 2006, P 2006 IEEE INT C SY, P1131; Huang Z, 2006, P WORKSH LINK AN DYN; Huss M, 2007, IET SYST BIOL, V1, P280, DOI 10.1049/iet-syb:20060077; Isella L, 2011, J THEOR BIOL, V271, P166, DOI 10.1016/j.jtbi.2010.11.033; Kashima H., 2009, PROC SIAM INT C DATA, P1100, DOI DOI 10.1137/1.9781611972795.94; Kashima H, 2006, IEEE DATA MINING, P340; Kobayashi Y, 2012, THESIS OSAKA U; Liben-Nowell D, 2007, J AM SOC INF SCI TEC, V58, P1019, DOI 10.1002/asi.20591; Lu LY, 2011, PHYSICA A, V390, P1150, DOI 10.1016/j.physa.2010.11.027; Lu LY, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/18001; Murata T, 2007, PROCEEDINGS OF THE IEEE/WIC/ACM INTERNATIONAL CONFERENCE ON WEB INTELLIGENCE, P85, DOI 10.1109/WI.2007.52; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Olguin DO, 2009, IEEE T SYST MAN CY B, V39, P43, DOI 10.1109/TSMCB.2008.2006638; Salton G., 1986, INTRO MODERN INFORM; Scholz C., 2013, P 7 INT AAAI C WEBL; Scholz C, 2012, PROCEEDINGS OF 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON PRIVACY, SECURITY, RISK AND TRUST AND 2012 ASE/IEEE INTERNATIONAL CONFERENCE ON SOCIAL COMPUTING (SOCIALCOM/PASSAT 2012), P312, DOI 10.1109/SocialCom-PASSAT.2012.49; Shetty J., 2004, ENRON EMAIL DATASET; Song H, 2009, PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON MANAGEMENT SCIENCE AND ENGINEERING MANAGEMENT, P322, DOI 10.1145/1644893.1644932; Tsugawa S, 2012, P 2012 JAP IR WORKSH, P98; Tsugawa S, 2011, PROCEEDINGS OF THE 8TH INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTER ENTERTAINMENT TECHNOLOGY (ACE 2011); Tylenda T., 2009, PROC 3 WORKSHOP SOC, DOI [10.1145/1731011.1731020, DOI 10.1145/1731011.1731020]; Viswanath B, 2009, 2ND ACM SIGCOMM WORKSHOP ON ONLINE SOCIAL NETWORKS (WOSN 09), P37; Wang WQ, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/28004; Zhang QM, 2010, INT J MOD PHYS C, V21, P813, DOI 10.1142/S012918311001549X; Zhou T, 2009, EUR PHYS J B, V71, P623, DOI 10.1140/epjb/e2009-00335-8	37	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81727	10.1371/journal.pone.0081727	http://dx.doi.org/10.1371/journal.pone.0081727			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339956	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400032
J	Zhou, ZY; Wan, XY; Cao, JW				Zhou, Zhong-Yin; Wan, Xin-Yue; Cao, Ji-Wang			Dietary Methionine Intake and Risk of Incident Colorectal Cancer: A Meta-Analysis of 8 Prospective Studies Involving 431,029 Participants	PLOS ONE			English	Article							COLON-CANCER; S-ADENOSYLMETHIONINE; FOLATE; ALCOHOL; VITAMIN-B-6; METHYLTHIOADENOSINE; HYPERMETHYLATION; ASSOCIATIONS; INFLAMMATION; POLYMORPHISM	Background: Methionine is one of the key components of one carbon metabolism. Experimental studies indicate that methionine may reduce inflammation-induced colon cancer. However, epidemiologic findings as to whether dietary methionine intake influences colorectal cancer incidence in humans are inconsistent. Objective: To investigate the relationship between dietary methionine intake and risk of colorectal cancer by performing a meta-analysis of prospective studies. Methods: Eligible studies were identified by searching PubMed and Embase and by reviewing the bibliographies of the retrieved publications. The summary risk estimates were computed using both a random- effects and a fixed-effects model. Results: Eight eligible prospective cohort studies involving 431,029 participants and 6,331 colorectal cancer cases were identified. According to the random-effects model, the summary relative risks (RRs) for the highest compared with the lowest intake of methionine were 0.89 (95% confidence interval [CI] = 0.77-1.03) for colorectal cancer, 0.77 (95% CI = 0.64 - 0.92) for colon cancer, and 0.88 (95% CI = 0.55-1.42) for rectal cancer. In the stratified analysis, a significant inverse association between dietary methionine intake and risk of colorectal cancer was observed in studies with longer follow-up time (RR=0.81, 95% CI=0.70-0.95), in Western studies (RR=0.83, 95% CI = 0.73-0.95) and in men (RR = 0.75, 95% CI=0.57-0.99). We found no indication of publication bias. Conclusion: This meta-analysis indicates that dietary methionine intake may be associated with decreased risk of colorectal cancer, especially colon cancer. More prospective studies with long follow-up time are needed to confirm these findings.	[Zhou, Zhong-Yin; Wan, Xin-Yue; Cao, Ji-Wang] Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China	Wuhan University	Zhou, ZY (corresponding author), Wuhan Univ, Dept Gastroenterol, Renmin Hosp, Wuhan 430072, Hubei Province, Peoples R China.	zhou_zhongyin@126.com			Natural Science Foundation of Hubei Province in China [2011CHB025, 2010CHB01701]	Natural Science Foundation of Hubei Province in China(Natural Science Foundation of Hubei Province)	This work was supported in part by the Natural Science Foundation of Hubei Province in China (2011CHB025 and 2010CHB01701). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aldoori Walid H., 1995, Annals of Epidemiology, V5, P221, DOI 10.1016/1047-2797(94)00109-7; Baniyash M, 2006, SEMIN CANCER BIOL, V16, P80, DOI 10.1016/j.semcancer.2005.12.002; Cairns SR, 2010, GUT, V59, P666, DOI 10.1136/gut.2009.179804; Chen J, 1996, CANCER RES, V56, P4862; de Vogel S, 2008, J NUTR, V138, P2372, DOI 10.3945/jn.108.091157; de Vogel S, 2008, CARCINOGENESIS, V29, P1765, DOI 10.1093/carcin/bgn074; de Vogel S, 2011, CANCER CAUSE CONTROL, V22, P1, DOI 10.1007/s10552-010-9659-6; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Flood A, 2002, CANCER CAUSE CONTROL, V13, P551, DOI 10.1023/A:1016330609603; Fuchs CS, 2002, CANCER EPIDEM BIOMAR, V11, P227; GIOVANNUCCI E, 1995, JNCI-J NATL CANCER I, V87, P265, DOI 10.1093/jnci/87.4.265; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P875, DOI 10.1093/jnci/85.11.875; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Harnack L, 2002, NUTR CANCER, V43, P152, DOI 10.1207/S15327914NC432_5; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOFFMAN RM, 1983, BIOCHIM BIOPHYS ACTA, V738, P49, DOI 10.1016/0304-419X(84)90019-2; Ishihara J, 2007, J NUTR, V137, P1808, DOI 10.1093/jn/137.7.1808; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kabat GC, 2008, BRIT J CANCER, V99, P816, DOI 10.1038/sj.bjc.6604540; Kennedy DA, 2011, CANCER EPIDEMIOL, V35, P2, DOI 10.1016/j.canep.2010.11.004; Lee JE, 2011, AM J CLIN NUTR, V93, P817, DOI 10.3945/ajcn.110.007781; Lev R, 1990, ADENOMATOUS POLYPS C; Li TWH, 2012, CARCINOGENESIS, V33, P427, DOI 10.1093/carcin/bgr295; Li TWH, 2009, MOL PHARMACOL, V76, P192, DOI 10.1124/mol.108.054411; Lu SC, 2005, ALCOHOL, V35, P227, DOI 10.1016/j.alcohol.2005.03.011; Main PAE, 2010, AM J CLIN NUTR, V91, P1598, DOI 10.3945/ajcn.2009.29002; Razzak AA, 2012, NUTR CANCER, V64, P899, DOI 10.1080/01635581.2012.714833; Schemhammer ES, 2008, CANCER EPIDEM BIOMAR, V17, P2895, DOI 10.1158/1055-9965.EPI-08-0638; Schernhammer ES, 2008, GASTROENTEROLOGY, V135, P770, DOI 10.1053/j.gastro.2008.06.033; Schernhammer ES, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021102; Schernhammer ES, 2010, GUT, V59, P794, DOI 10.1136/gut.2009.183707; Shrubsole MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1003, DOI 10.1158/1055-9965.EPI-08-1200; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; STERN PH, 1984, J CELL PHYSIOL, V119, P29, DOI 10.1002/jcp.1041190106; Stover PJ, 2009, J NUTR, V139, P2402, DOI 10.3945/jn.109.113670; Ulrich CM, 2005, J NUTR, V135, P2698, DOI 10.1093/jn/135.11.2698; Vidal-Vanaclocha F, 2009, REUMATOL CLIN, V5, P40, DOI 10.1016/j.reuma.2008.12.008; Yu K, 2010, EUR J HUM GENET, V18, P370, DOI 10.1038/ejhg.2009.131	39	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83588	10.1371/journal.pone.0083588	http://dx.doi.org/10.1371/journal.pone.0083588			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340103	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400136
J	Hollmann, M; Miller, I; Hummel, K; Sabitzer, S; Metzler-Zebeli, BU; Razzazi-Fazeli, E; Zebeli, Q				Hollmann, Manfred; Miller, Ingrid; Hummel, Karin; Sabitzer, Sonja; Metzler-Zebeli, Barbara U.; Razzazi-Fazeli, Ebrahim; Zebeli, Qendrim			Downregulation of Cellular Protective Factors of Rumen Epithelium in Goats Fed High Energy Diet	PLOS ONE			English	Article							PROTEIN DISULFIDE-ISOMERASE; SELENIUM-BINDING PROTEIN-1; SUBACUTE RUMINAL ACIDOSIS; PROTEOMIC ANALYSIS; GENE-EXPRESSION; GRAIN DIETS; IDENTIFICATION; ADAPTATION; GEL; PH	Energy-rich diets can challenge metabolic and protective functions of the rumen epithelial cells, but the underlying factors are unclear. This study sought to evaluate proteomic changes of the rumen epithelium in goats fed a low, medium, or high energy diet. Expression of protein changes were compared by two-dimensional differential gel electrophoresis followed by protein identification with matrix assisted laser desorption ionisation tandem time-of-flight mass spectrometry. Of about 2,000 spots commonly detected in all gels, 64 spots were significantly regulated, which were traced back to 24 unique proteins. Interestingly, the expression profiles of several chaperone proteins with important cellular protective functions such as heat shock cognate 71 kDa protein, peroxiredoxin-6, serpin H1, protein disulfide-isomerase, and selenium-binding protein were collectively downregulated in response to high dietary energy supply. Similar regulation patterns were obtained for some other proteins involved in transport or metabolic functions. In contrast, metabolic enzymes like retinal dehydrogenase 1 and ATP synthase subunit beta, mitochondrial precursor were upregulated in response to high energy diet. Lower expressions of chaperone proteins in the rumen epithelial cells in response to high energy supply may suggest that these cells were less protected against the potentially harmful rumen toxic compounds, which might have consequences for rumen and systemic health. Our findings also suggest that energy-rich diets and the resulting acidotic insult may render rumen epithelial cells more vulnerable to cellular damage by attenuating their cell defense system, hence facilitating the impairment of rumen barrier function, typically observed in energy-rich fed ruminants.	[Hollmann, Manfred; Zebeli, Qendrim] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria; [Miller, Ingrid] Vetmeduni Vienna, Dept Biomed Sci, Inst Med Biochem, Vienna, Austria; [Hummel, Karin; Sabitzer, Sonja; Razzazi-Fazeli, Ebrahim] Vetmeduni Vienna, VetCore Facil Res, Vienna, Austria; [Metzler-Zebeli, Barbara U.] Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Clin Swine, Vienna, Austria	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna	Zebeli, Q (corresponding author), Vetmeduni Vienna, Dept Farm Anim & Vet Publ Hlth, Inst Anim Nutr & Funct Plant Cpds, Vienna, Austria.	qendrim.zebeli@vetmeduni.ac.at		Razzazi-Fazeli, Ebrahim/0000-0002-3343-0301; Miller, Ingrid/0000-0002-7192-0109; Zebeli, Qendrim/0000-0001-5188-9004	University of Veterinary Medicine Vienna	University of Veterinary Medicine Vienna	Financial support was provided by profile line start up funding program at the University of Veterinary Medicine Vienna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlZahal O, 2009, J DAIRY SCI, V92, P5697, DOI 10.3168/jds.2009-2220; Ametaj BN, 2010, METABOLOMICS, V6, P583, DOI 10.1007/s11306-010-0227-6; Aschenbach JR, 2011, J ANIM SCI, V89, P1092, DOI 10.2527/jas.2010-3301; Bendixen E, 2011, J PROTEOMICS, V74, P282, DOI 10.1016/j.jprot.2010.11.005; BERGMAN EN, 1990, PHYSIOL REV, V70, P567, DOI 10.1152/physrev.1990.70.2.567; Bhat PV, 1998, FEBS LETT, V426, P260, DOI 10.1016/S0014-5793(98)00355-X; Bjarnadottir SG, 2012, J ANIM SCI, V90, P2035, DOI 10.2527/jas.2011-4721; Bondzio A, 2011, AM J PHYSIOL-GASTR L, V301, pG260, DOI 10.1152/ajpgi.00304.2010; Chan HL, 2005, PROTEOMICS, V5, P2908, DOI 10.1002/pmic.200401300; Dokladny K, 2006, AM J PHYSIOL-GASTR L, V290, pG204, DOI 10.1152/ajpgi.00401.2005; Emmanuel DGV, 2007, J DAIRY SCI, V90, P5552, DOI 10.3168/jds.2007-0257; Flaumenhaft R, 2013, TRENDS CARDIOVAS MED, V23, P264, DOI 10.1016/j.tcm.2013.03.001; Frota-Ruchon A, 2000, CELL TISSUE RES, V302, P397, DOI 10.1007/s004410000281; Gesellschaft fur Ernahrungsphysiologie, 2003, REC SUPPL EN NUTR GO; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Gozho GN, 2006, J DAIRY SCI, V89, P4404, DOI 10.3168/jds.S0022-0302(06)72487-0; Grune T, 2002, ARCH BIOCHEM BIOPHYS, V397, P407, DOI 10.1006/abbi.2001.2719; Gutierrez AM, 2011, VET J, V187, P356, DOI 10.1016/j.tvjl.2009.12.020; Hernandez-Sanabria E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058461; HIRAYOSHI K, 1991, MOL CELL BIOL, V11, P4036, DOI 10.1128/MCB.11.8.4036; Jimenez CR, 2001, CURR PROTOC PROTEIN, DOI [DOI 10.1002/0471140864.PS1604S14, 10.1002/0471140864.ps1604s14]; Katz MS, 2011, J PEDIATR SURG, V46, P357, DOI 10.1016/j.jpedsurg.2010.11.017; Khafipour E, 2011, J DAIRY SCI, V94, P351, DOI 10.3168/jds.2010-3435; Kim SY, 2008, J BIOL CHEM, V283, P33563, DOI 10.1074/jbc.M806578200; Klevenhusen F, 2013, J DAIRY SCI, V96, P2293, DOI 10.3168/jds.2012-6187; Kuzinski J, 2012, AM J PHYSIOL-REG I, V303, pR909, DOI 10.1152/ajpregu.00597.2011; Lettat A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060978; Li TH, 2008, MOL NUTR FOOD RES, V52, P1289, DOI 10.1002/mnfr.200700331; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LYLES MM, 1991, BIOCHEMISTRY-US, V30, P619, DOI 10.1021/bi00217a005; Metzler-Zebeli BU, 2013, J ANIM SCI, V91, P4256, DOI 10.2527/jas.2012-5570; Miller I, 2012, DIFFERENCE GEL ELECT, P378; Osanai M, 2007, MOL PHARMACOL, V71, P250, DOI 10.1124/mol.106.029579; Penner GB, 2011, J ANIM SCI, V89, P1108, DOI 10.2527/jas.2010-3378; Pohl NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007774; Poon IKH, 2010, J LEUKOCYTE BIOL, V88, P559, DOI 10.1189/jlb.0210087; Porat A, 2000, J BIOL CHEM, V275, P14457, DOI 10.1074/jbc.275.19.14457; Rabbani I, 2010, THESIS FREE U BERLIN; SAGA S, 1987, J CELL BIOL, V105, P517, DOI 10.1083/jcb.105.1.517; Saleem F, 2012, J DAIRY SCI, V95, P6606, DOI 10.3168/jds.2012-5403; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Steele MA, 2011, AM J PHYSIOL-REG I, V300, pR1515, DOI 10.1152/ajpregu.00120.2010; Steele MA, 2009, ACTA VET SCAND, V51, DOI 10.1186/1751-0147-51-39; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veluthakal R, 2009, MOL CELL BIOCHEM, V329, P121, DOI 10.1007/s11010-009-0113-6; Vogels MW, 2011, PROTEOMICS, V11, P4477, DOI 10.1002/pmic.201100224; YU RH, 1992, INFECT IMMUN, V60, P2992, DOI 10.1128/IAI.60.7.2992-2994.1992; Zebeli Q, 2008, J DAIRY SCI, V91, P2046, DOI 10.3168/jds.2007-0572; Zebeli Q, 2012, RES VET SCI, V93, P1099, DOI 10.1016/j.rvsc.2012.02.004	49	25	26	4	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81602	10.1371/journal.pone.0081602	http://dx.doi.org/10.1371/journal.pone.0081602			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349094	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200036
J	Dalboge, LS; Almholt, DLC; Neerup, TSR; Vassiliadis, E; Vrang, N; Pedersen, L; Fosgerau, K; Jelsing, J				Dalboge, Louise S.; Almholt, Dorthe L. C.; Neerup, Trine S. R.; Vassiliadis, Efstathios; Vrang, Niels; Pedersen, Lars; Fosgerau, Keld; Jelsing, Jacob			Characterisation of Age-Dependent Beta Cell Dynamics in the Male db/db Mice	PLOS ONE			English	Article							DIABETIC MUTANT MOUSE; FATTY-ACIDS; PANCREATIC-ISLETS; LEPTIN RECEPTOR; MASS; GLUCOSE; APOPTOSIS; OBESITY; DYSFUNCTION; GENE	Aim: To characterise changes in pancreatic beta cell mass during the development of diabetes in untreated male C57BLKS/J db/db mice. Methods: Blood samples were collected from a total of 72 untreated male db/db mice aged 5, 6, 8, 10, 12, 14, 18, 24 and 34 weeks, for measurement of terminal blood glucose, HbA(1c), plasma insulin, and C-peptide. Pancreata were removed for quantification of beta cell mass, islet numbers as well as proliferation and apoptosis by immunohistochemistry and stereology. Results: Total pancreatic beta cell mass increased significantly from 2.1 +/- 0.3 mg in mice aged 5 weeks to a peak value of 4.84 +/- 0.26 mg (P < 0.05) in 12-week-old mice, then gradually decreased to 3.27 +/- 0.44 mg in mice aged 34 weeks. Analysis of islets in the 5-, 10-, and 24-week age groups showed increased beta cell proliferation in the 10-week-old animals whereas a low proliferation is seen in older animals. The expansion in beta cell mass was driven by an increase in mean islet mass as the total number of islets was unchanged in the three groups. Conclusions/Interpretation: The age-dependent beta cell dynamics in male db/db mice has been described from 5-34 weeks of age and at the same time alterations in insulin/glucose homeostasis were assessed. High beta cell proliferation and increased beta cell mass occur in young animals followed by a gradual decline characterised by a low beta cell proliferation in older animals. The expansion of beta cell mass was caused by an increase in mean islet mass and not islet number.	[Dalboge, Louise S.; Vassiliadis, Efstathios; Vrang, Niels; Jelsing, Jacob] Gubra ApS, Dept Histol, Horsholm, Denmark; [Almholt, Dorthe L. C.; Neerup, Trine S. R.; Fosgerau, Keld] Zealand Pharma AS, Dept Res & Dev, Glostrup, Denmark; [Pedersen, Lars] Visiopharm, Dept Stereol, Horsholm, Denmark	Zealand Pharma A/S	Jelsing, J (corresponding author), Gubra ApS, Dept Histol, Horsholm, Denmark.	jacob@gubra.dk	Vassiliadis, Efstathios/E-5450-2011; Vassiliadis, Efstathios/ABC-8546-2020	Dalboge, Louise Schjellerup/0000-0001-7773-6313	Zealand Pharma A/S; Gubra ApS	Zealand Pharma A/S; Gubra ApS	The study was funded by Zealand Pharma A/S and Gubra ApS. The funders Zealand Pharma had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Jacob Jelsing and Niels Vrang are the owners of Gubra ApS and contributed with an unbiased and impartial role in the study design and manuscript revision.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Bernard-Kargar C, 2001, DIABETES, V50, pS30, DOI 10.2337/diabetes.50.2007.S30; Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; Boyce RW, 2010, TOXICOL PATHOL, V38, P1011, DOI 10.1177/0192623310385140; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; CHICK WL, 1970, DIABETOLOGIA, V6, P243, DOI 10.1007/BF01212233; Coleman D L, 1967, Diabetologia, V3, P238, DOI 10.1007/BF01222201; COLEMAN DL, 1978, DIABETOLOGIA, V14, P141, DOI 10.1007/BF00429772; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Koning EJP, 2008, TRENDS PHARMACOL SCI, V29, P218, DOI 10.1016/j.tips.2008.02.001; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Fosgerau K, 2013, DIABETES OBES METAB, V15, P62, DOI 10.1111/j.1463-1326.2012.01676.x; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hanley SC, 2010, ENDOCRINOLOGY, V151, P1462, DOI 10.1210/en.2009-1277; HUMMEL KP, 1972, BIOCHEM GENET, V7, P1, DOI 10.1007/BF00487005; HUMMEL KP, 1966, SCIENCE, V153, P1127, DOI 10.1126/science.153.3740.1127; Jurgens CA, 2011, AM J PATHOL, V178, P2632, DOI 10.1016/j.ajpath.2011.02.036; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kahn SE, 2013, DIABETES CARE, V36, P4, DOI 10.2337/dc12-1526; Kanda Y, 2009, ENDOCR J, V56, P997, DOI 10.1507/endocrj.K09E-028; Kargar C, 2008, DIABETES OBES METAB, V10, P43, DOI 10.1111/j.1463-1326.2008.00940.x; Kawasaki F, 2005, AM J PHYSIOL-ENDOC M, V288, pE510, DOI 10.1152/ajpendo.00128.2004; Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; LEITER EH, 1981, DIABETES, V30, P1029, DOI 10.2337/diabetes.30.12.1029; LIKE AA, 1970, DIABETOLOGIA, V6, P207, DOI 10.1007/BF01212231; Ma ZA, 2012, EXP DIABETES RES, DOI 10.1155/2012/703538; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Maedler K, 2001, DIABETES, V50, P1683, DOI 10.2337/diabetes.50.8.1683; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Medarova Z, 2005, DIABETES, V54, P1780, DOI 10.2337/diabetes.54.6.1780; Meier JJ, 2008, DIABETOLOGIA, V51, P703, DOI 10.1007/s00125-008-0936-9; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Paulsen SJ, 2010, J ANAT, V217, P624, DOI 10.1111/j.1469-7580.2010.01285.x; Piro S, 2002, METABOLISM, V51, P1340, DOI 10.1053/meta.2002.35200; Poitout V, 2008, ENDOCR REV, V29, P351, DOI 10.1210/er.2007-0023; Poitout V, 2010, BBA-MOL CELL BIOL L, V1801, P289, DOI 10.1016/j.bbalip.2009.08.006; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Puff R, 2011, HORM METAB RES, V43, P306, DOI 10.1055/s-0031-1271817; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Saisho Y, 2013, DIABETES CARE, V36, P111, DOI 10.2337/dc12-0421; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Shimoda M, 2011, DIABETOLOGIA, V54, P1098, DOI 10.1007/s00125-011-2069-9; Sone H, 2005, DIABETOLOGIA, V48, P58, DOI 10.1007/s00125-004-1605-2; Steil GM, 2001, AM J PHYSIOL-ENDOC M, V280, pE788, DOI 10.1152/ajpendo.2001.280.5.E788; Teague J, 2011, J PHARMACOL TOX MET, V63, P15, DOI 10.1016/j.vascn.2010.04.001; Topp BB, 2004, DIABETOLOGIA, V47, P1602, DOI 10.1007/s00125-004-1493-5; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; WYSE BM, 1970, DIABETOLOGIA, V6, P268, DOI 10.1007/BF01212237; Xie JL, 2012, CELL MOL LIFE SCI, V69, P1289, DOI 10.1007/s00018-011-0874-4; Yoon KH, 2003, J CLIN ENDOCR METAB, V88, P2300, DOI 10.1210/jc.2002-020735; Zhao ZS, 2012, J BIOL CHEM, V287, P5562, DOI 10.1074/jbc.M111.305359	58	55	55	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82813	10.1371/journal.pone.0082813	http://dx.doi.org/10.1371/journal.pone.0082813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324833	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566700112
J	Arendt, MD; Schwenter, JA; Witherington, BE; Meylan, AB; Saba, VS				Arendt, Michael D.; Schwenter, Jeffrey A.; Witherington, Blair E.; Meylan, Anne B.; Saba, Vincent S.			Historical versus Contemporary Climate Forcing on the Annual Nesting Variability of Loggerhead Sea Turtles in the Northwest Atlantic Ocean	PLOS ONE			English	Article							CARETTA-CARETTA; CATCH RATES; EL-NINO; REMIGRATION INTERVALS; LEATHERBACK TURTLES; EXCLUDER DEVICES; COASTAL WATERS; MARINE TURTLES; POPULATION; ECOLOGY	A recent analysis suggested that historical climate forcing on the oceanic habitat of neonate sea turtles explained two-thirds of interannual variability in contemporary loggerhead (Caretta caretta) sea turtle nest counts in Florida, where nearly 90% of all nesting by this species in the Northwest Atlantic Ocean occurs. Here, we show that associations between annual nest counts and climate conditions decades prior to nest counts and those conditions one year prior to nest counts were not significantly different. Examination of annual nest count and climate data revealed that statistical artifacts influenced the reported 31-year lag association with nest counts. The projected importance of age 31 neophytes to annual nest counts between 2020 and 2043 was modeled using observed nest counts between 1989 and 2012. Assuming consistent survival rates among cohorts for a 5% population growth trajectory and that one third of the mature female population nests annually, the 41% decline in annual nest counts observed during 1998-2007 was not projected for 2029-2038. This finding suggests that annual nest count trends are more influenced by remigrants than neophytes. Projections under the 5% population growth scenario also suggest that the Peninsular Recovery Unit could attain the demographic recovery criteria of 106,100 annual nests by 2027 if nest counts in 2019 are at least comparable to 2012. Because the first year of life represents only 4% of the time elapsed through age 31, cumulative survival at sea across decades explains most cohort variability, and thus, remigrant population size. Pursuant to the U.S. Endangered Species Act, staggered implementation of protection measures for all loggerhead life stages has taken place since the 1970s. We suggest that the 1998-2007 nesting decline represented a lagged perturbation response to historical anthropogenic impacts, and that subsequent nest count increases since 2008 reflect a potential recovery response.	[Arendt, Michael D.; Schwenter, Jeffrey A.] South Carolina Dept Nat Resources, Marine Resources Div, Charleston, SC USA; [Arendt, Michael D.] Univ S Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Witherington, Blair E.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, Melbourne Beach, FL USA; [Meylan, Anne B.] Florida Fish & Wildlife Conservat Commiss, Fish & Wildlife Res Inst, St Petersburg, FL USA; [Saba, Vincent S.] NOAA, Natl Marine Fisheries Serv, Princeton, NJ USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Florida Fish & Wildlife Conservation Commission; Florida Fish & Wildlife Conservation Commission; National Oceanic Atmospheric Admin (NOAA) - USA	Arendt, MD (corresponding author), South Carolina Dept Nat Resources, Marine Resources Div, Charleston, SC USA.	arendtm@dnr.sc.gov	Saba, Vincent/A-3799-2010	Saba, Vincent/0000-0002-2974-4826				Arendt Michael D., 2012, Endangered Species Research, V18, P219, DOI 10.3354/esr00450; Arendt MD, 2012, FISH B-NOAA, V110, P470; Arendt MD, 2012, FISH B-NOAA, V110, P98; Arendt MD, 2012, MAR BIOL, V159, P101, DOI 10.1007/s00227-011-1793-5; Avens L, 2013, CRC MAR BIOL SER, P97; Bjorndal KA, 2013, MAR BIOL, V160, P2711, DOI 10.1007/s00227-013-2264-y; Caut S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001845; Ceriani SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045335; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Conant TA., 2009, LOGGERHEAD SEA TURTL; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; Dahlen MK, 2000, P 18 INT SEA TURTL S, P60; del Monte-Luna P, 2012, J EXP MAR BIOL ECOL, V412, P103, DOI 10.1016/j.jembe.2011.11.005; Delgado C, 2010, MAR BIOL, V157, P979, DOI 10.1007/s00227-009-1378-8; DIAL BE, 1987, HERPETOLOGICA, V43, P307; Ehrhart Llewellyn M., 2007, Florida Scientist, V70, P415; Epperly Sheryan P., 2007, Endangered Species Research, V3, P283, DOI 10.3354/esr00054; Fuentes MMPB, 2011, GLOBAL CHANGE BIOL, V17, P140, DOI 10.1111/j.1365-2486.2010.02192.x; Godfrey MH, 1996, CAN J ZOOL, V74, P267, DOI 10.1139/z96-033; Hamann M, 2003, CRC MAR BIOL SER, P135; Hatase H, 2008, CAN J ZOOL, V86, P595, DOI 10.1139/Z08-035; Hatase H, 2010, MAR BIOL, V157, P1337, DOI 10.1007/s00227-010-1413-9; Hawkes LA, 2007, GLOBAL CHANGE BIOL, V13, P923, DOI 10.1111/j.1365-2486.2007.01320.x; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hays GC, 2000, J THEOR BIOL, V206, P221, DOI 10.1006/jtbi.2000.2116; Hays GC, 2003, GLOBAL CHANGE BIOL, V9, P642, DOI 10.1046/j.1365-2486.2003.00606.x; Heppell SS, 2003, CRC MAR BIOL SER, P275; Huang JP, 1998, GEOPHYS RES LETT, V25, P2707, DOI 10.1029/98GL01936; Judd K, 2000, PHYSICA D, V136, P31, DOI 10.1016/S0167-2789(99)00152-9; Limpus C, 2000, ATMOS OCEAN SCI LIB, V21, P399; Musick JA, 1999, AM FISH S S, V23, P1; National Marine Fisheries Service U.S. Fish Wildlife Service, 2008, REC PLAN NW ATL POP; Pajuelo M, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00220.1; Platt T, 2003, NATURE, V423, P398, DOI 10.1038/423398b; Reina Richard D., 2009, Endangered Species Research, V7, P155, DOI 10.3354/esr00098; Saba VS, 2007, J APPL ECOL, V44, P395, DOI 10.1111/j.1365-2664.2007.01276.x; Saba VS, 2012, NAT CLIM CHANGE, V2, P814, DOI 10.1038/NCLIMATE1582; Salmon M, 1995, COPEIA, P931, DOI 10.2307/1447042; Solow AR, 2002, ECOL LETT, V5, P742, DOI 10.1046/j.1461-0248.2002.00374.x; STANDORA EA, 1985, COPEIA, P711, DOI 10.2307/1444765; Tomillo PS, 2008, CONSERV BIOL, V22, P1216, DOI 10.1111/j.1523-1739.2008.00987.x; Tomillo PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037602; Van Houtan KS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019043; Wallace BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015465; Wallace BP, 2010, CONSERV LETT, V3, P131, DOI 10.1111/j.1755-263X.2010.00105.x; Watson JW, 2005, CAN J FISH AQUAT SCI, V62, P965, DOI 10.1139/F05-004; WIBBELS T, 1991, CAN J ZOOL, V69, P2973, DOI 10.1139/z91-419; Witherington BE, 2002, MAR BIOL, V140, P843, DOI 10.1007/s00227-001-0737-x; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1; Witt MJ, 2010, J EXP BIOL, V213, P901, DOI 10.1242/jeb.038133; Witzell WN, 1999, FISH B-NOAA, V97, P200	52	14	15	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81097	10.1371/journal.pone.0081097	http://dx.doi.org/10.1371/journal.pone.0081097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339901	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100036
J	Cheung, YT; Lim, SR; Ho, HK; Chan, A				Cheung, Yin Ting; Lim, Si Rong; Ho, Han Kiat; Chan, Alexandre			Cytokines as Mediators of Chemotherapy-Associated Cognitive Changes: Current Evidence, Limitations and Directions for Future Research	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; NECROSIS-FACTOR-ALPHA; BLOOD-BRAIN-BARRIER; BREAST-CANCER PATIENTS; OXIDATIVE STRESS; INFLAMMATORY CYTOKINES; ADJUVANT CHEMOTHERAPY; ANTIOXIDANT ENZYMES; INTERFERON-ALPHA; DRUG ADRIAMYCIN	Objectives: While various clinical and pharmacological determinants for chemotherapy-associated cognitive impairment have been identified, conflicting evidence suggests that cytokines might play an intermediary role. The objective of this systematic review was to evaluate the current evidence pertaining to the associations among chemotherapy, cytokines induction and cognitive impairment in cancer patients. Methods: A literature search with PubMed and SciVerse Scopus was conducted in March 2013 to gather relevant articles and abstracts that fulfilled the inclusion and exclusion criteria. This review included studies that had performed objective and/or subjective cognitive assessments and cytokine measurements on defined populations of cancer patients who received chemotherapy. Results: High methodological heterogeneity existed among the selected studies which differed in cancer populations, subject characteristics, cognitive endpoints, types of cytokines tested and their measurement methods. Weak to moderate correlations were observed between IL-1 beta, IL-6, TNF-alpha levels, and different degrees of cognitive impairment. Different types of chemotherapy treatments might lead to varying presentations and severities of cytokine-induced cognitive impairment. Notably, the time concordance between the onset of cytokine induction and occurrence of cognitive impairment was not well elucidated. A number of confounding factors was identified to interfere with the expression levels of cytokines; these confounders included subjects' cancer types, ages, genders, genetics and psychosocial characteristics such as anxiety, depression and fatigue. Conclusion: Although existing studies observed cognitive impairment and cytokine dysregulation in patients who receive chemotherapy, our results suggest that the intermediary role of cytokines in post-chemotherapy cognitive impairment is still controversial and requires further evaluation. A list of methodological recommendations is proposed to harmonize future studies of this subject matter.	[Cheung, Yin Ting; Lim, Si Rong; Ho, Han Kiat; Chan, Alexandre] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Cheung, Yin Ting; Chan, Alexandre] Natl Canc Ctr Singapore, Dept Pharm, Singapore, Singapore	National University of Singapore; National Cancer Centre Singapore (NCCS)	Chan, A (corresponding author), Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore.	phaac@nus.edu.sg	Cheung, Yin Ting/AAT-4384-2021; Chan, Alexandre/D-5035-2016; Cheung, Yin Ting/N-3524-2017	Cheung, Yin Ting/0000-0001-9874-8938; Chan, Alexandre/0000-0003-4391-4219; Cheung, Yin Ting/0000-0001-9874-8938	National University of Singapore [R-148-000-166-112]; National Cancer Centre Singapore [NRFCB12131]	National University of Singapore(National University of Singapore); National Cancer Centre Singapore	This study is financed by research grants awarded by the National University of Singapore (R-148-000-166-112) and the National Cancer Centre Singapore (NRFCB12131). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ahles TA, 2007, NAT REV CANCER, V7, P192, DOI 10.1038/nrc2073; Ahles TA, 2012, J CLIN ONCOL, V30, P3675, DOI 10.1200/JCO.2012.43.0116; Ahles TA, 2010, J CLIN ONCOL, V28, P4434, DOI 10.1200/JCO.2009.27.0827; Aluise CD, 2011, FREE RADICAL BIO MED, V50, P1630, DOI 10.1016/j.freeradbiomed.2011.03.009; Aluise CD, 2010, ADV EXP MED BIOL, V678, P147; Amore M, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/280724; Anthony DC, 1997, BRAIN, V120, P435, DOI 10.1093/brain/120.3.435; Antoni MH, 2009, BRAIN BEHAV IMMUN, V23, P580, DOI 10.1016/j.bbi.2008.09.005; Argyriou AA, 2011, J PAIN SYMPTOM MANAG, V41, P126, DOI 10.1016/j.jpainsymman.2010.04.021; Banks WA, 2002, NEUROIMMUNOMODULAT, V10, P319, DOI 10.1159/000071472; Beauchet O, 2006, EUR J ENDOCRINOL, V155, P773, DOI 10.1530/eje.1.02306; Boykoff N, 2009, J CANC SURVIV, V3, P1; Cheung YT, 2012, ANN ONCOL, V23, P2547, DOI 10.1093/annonc/mds029; Cheung YT, 2012, CRIT REV ONCOL HEMAT, V83, P99, DOI 10.1016/j.critrevonc.2011.09.001; Christie LA, 2012, CLIN CANCER RES, V18, P1954, DOI 10.1158/1078-0432.CCR-11-2000; Cibelli M, 2010, ANN NEUROL, V68, P360, DOI 10.1002/ana.22082; Correa DD, 2008, CANCER J, V14, P396, DOI 10.1097/PPO.0b013e31818d8769; Corsi-Cabrera M, 1999, SLEEP, V22, P181; Das S, 2008, J NEUROSCI RES, V86, P1199, DOI 10.1002/jnr.21585; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Deeken JF, 2007, CLIN CANCER RES, V13, P1663, DOI 10.1158/1078-0432.CCR-06-2854; Dunlop RJ, 2000, J PAIN SYMPTOM MANAG, V20, P214, DOI 10.1016/S0885-3924(00)00199-8; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Foley JJ, 2008, PSYCHOPHARMACOLOGY, V199, P527, DOI 10.1007/s00213-008-1175-y; Fray PJ, 1996, NEUROTOXICOL TERATOL, V18, P499, DOI 10.1016/0892-0362(96)00027-X; Gan HK, 2011, INT J RADIAT ONCOL, V81, P126, DOI 10.1016/j.ijrobp.2010.05.004; Ganz PA, 2003, J CLIN ONCOL, V21, P4184, DOI 10.1200/JCO.2003.04.196; Ganz PA, 2011, J CLIN ONCOL S, V29, p18S; Ganz PA, 2012, INT COGNITION CANC T; Ganz PA, 2013, BRAIN BEHAV IMMUN, V30, pS99, DOI 10.1016/j.bbi.2012.07.015; HAGER K, 1994, NEUROBIOL AGING, V15, P771, DOI 10.1016/0197-4580(94)90066-3; Hurria A, 2007, CANCER INVEST, V25, P373, DOI 10.1080/07357900701506672; Janelsins MC, 2012, SUPPORT CARE CANCER, V20, P831, DOI 10.1007/s00520-011-1158-0; Jim HSL, 2012, J CLIN ONCOL, V30, P3578, DOI 10.1200/JCO.2011.39.5640; Jolliffe I., 2005, SPRINGERLINK PRINCIP, DOI 10.1007/b98835; Joshi G, 2005, FREE RADICAL RES, V39, P1147, DOI 10.1080/10715760500143478; Joshi G, 2010, NEUROSCIENCE, V166, P796, DOI 10.1016/j.neuroscience.2010.01.021; Joshi G, 2007, J NEUROSCI RES, V85, P497, DOI 10.1002/jnr.21158; Kenis G, 2002, INT J NEUROPSYCHOPH, V5, P401, DOI 10.1017/S1461145702003164; Kesler S, 2013, BRAIN BEHAV IMMUN, V30, pS109, DOI 10.1016/j.bbi.2012.05.017; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Knobel H, 2000, J PAIN SYMPTOM MANAG, V19, P446, DOI 10.1016/S0885-3924(00)00144-5; KNOBF MT, 1986, J CLIN ONCOL, V4, P678, DOI 10.1200/JCO.1986.4.5.678; Konsman JP, 2004, J COMP NEUROL, V472, P113, DOI 10.1002/cne.20052; Kronfol Z, 2000, AM J PSYCHIAT, V157, P683, DOI 10.1176/appi.ajp.157.5.683; Lash GE, 2006, J IMMUNOL METHODS, V309, P205, DOI 10.1016/j.jim.2005.12.007; Lee BN, 2004, NEUROIMMUNOMODULAT, V11, P279, DOI 10.1159/000079408; Lee DC, 2005, YONSEI MED J, V46, P471, DOI 10.3349/ymj.2005.46.4.471; Leng SX, 2008, J GERONTOL A-BIOL, V63, P879, DOI 10.1093/gerona/63.8.879; LIcinio J, 1998, SEMIN ONCOL, V25, P30; Long JM, 2011, PHARMACOL BIOCHEM BE, V100, P205, DOI 10.1016/j.pbb.2011.08.012; Lynch MA, 2010, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.006.2009; Madeleine MM, 2011, BREAST CANCER RES TR, V129, P887, DOI 10.1007/s10549-011-1520-4; Malkin CJ, 2004, J CLIN ENDOCR METAB, V89, P3313, DOI 10.1210/jc.2003-031069; Marsland AL, 2008, BIOL PSYCHIAT, V64, P484, DOI 10.1016/j.biopsych.2008.04.016; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; McCarthy ME, 1997, SLEEP, V20, P115, DOI 10.1093/sleep/20.2.115; Meyers CA, 2005, CANCER-AM CANCER SOC, V104, P788, DOI 10.1002/cncr.21234; Miller AH, 2008, J CLIN ONCOL, V26, P971, DOI 10.1200/JCO.2007.10.7805; Minisini A, 2004, LANCET ONCOL, V5, P273, DOI 10.1016/S1470-2045(04)01465-2; Munir F, 2010, J CLIN NURS, V19, P1362, DOI 10.1111/j.1365-2702.2009.03006.x; Myers JS, 2008, ONCOL NURS FORUM, V35, P916, DOI 10.1188/08.ONF.916-920; Myers JS, 2010, ADV EXP MED BIOL, V678, P119; O'Shaughnessy Joyce A, 2003, Clin Breast Cancer, V4 Suppl 2, pS89, DOI 10.3816/CBC.2003.s.021; PETERSON PK, 1994, CLIN INFECT DIS, V19, P1158, DOI 10.1093/clinids/19.6.1158; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Pilcher JJ, 1997, J AM COLL HEALTH, V46, P121, DOI 10.1080/07448489709595597; Pullens MJJ, 2010, PSYCHO-ONCOLOGY, V19, P1127, DOI 10.1002/pon.1673; Purdue MP, 2011, CANCER RES, V71, P4898, DOI 10.1158/0008-5472.CAN-11-0165; Pusztai L, 2004, CYTOKINE, V25, P94, DOI 10.1016/j.cyto.2003.10.004; Raffa RB, 2011, J CLIN PHARM THER, V36, P257, DOI 10.1111/j.1365-2710.2010.01188.x; Raison CL, 2005, CNS DRUGS, V19, P105, DOI 10.2165/00023210-200519020-00002; Reid-Arndt SA, 2010, PSYCHO-ONCOLOGY, V19, P535, DOI 10.1002/pon.1581; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reyes-Gibby CC, 2007, CANCER EPIDEM BIOMAR, V16, P2745, DOI 10.1158/1055-9965.EPI-07-0651; Rich T, 2005, CLIN CANCER RES, V11, P1757, DOI 10.1158/1078-0432.CCR-04-2000; Rothman N, 2006, LANCET ONCOL, V7, P27, DOI 10.1016/S1470-2045(05)70434-4; Sachdeva N, 2007, FRONT BIOSCI-LANDMRK, V12, P4682, DOI 10.2741/2418; Schagen SB, 2002, ANN ONCOL, V13, P1387, DOI 10.1093/annonc/mdf241; Schubert C, 2007, BRAIN BEHAV IMMUN, V21, P413, DOI 10.1016/j.bbi.2006.11.004; Seigers R, 2011, NEUROSCI BIOBEHAV R, V35, P729, DOI 10.1016/j.neubiorev.2010.09.006; Seigers R, 2010, BEHAV BRAIN RES, V207, P265, DOI 10.1016/j.bbr.2009.10.009; Seruga B, 2008, NAT REV CANCER, V8, P887, DOI 10.1038/nrc2507; Shapiro AM, 1999, CLIN NEUROPSYCHOL, V13, P348, DOI 10.1076/clin.13.3.348.1749; Sioka C, 2009, CANCER CHEMOTH PHARM, V63, P761, DOI 10.1007/s00280-008-0876-6; Tangpong J, 2006, NEUROBIOL DIS, V23, P127, DOI 10.1016/j.nbd.2006.02.013; Tangpong J, 2007, J NEUROCHEM, V100, P191, DOI 10.1111/j.1471-4159.2006.04179.x; Unfer TC, 2006, CLIN CHIM ACTA, V369, P73, DOI 10.1016/j.cca.2006.01.006; Vandenbroeck K, 2003, TRENDS PHARMACOL SCI, V24, P284, DOI 10.1016/S0165-6147(03)00131-7; Vardy J, 2008, ANN ONCOL, V19, P623, DOI 10.1093/annonc/mdm500; Vardy J, 2007, J CLIN ONCOL S, V25, p18S; Vardy J, 2012, INT COGNITION CANC T; Vardy J, 2006, CLIN ONCOL, V24, p18S; Vardy J, 2009, CANCER TREAT RES, P387, DOI 10.1007/978-0-387-75115-3_24; Vardy JL, 2009, J CLIN ONCOL S, V27, p15S; Wagner LI, 2009, J SUPPORT ONCOL, V7, pW32, DOI DOI 10.1016/J.JPAINSYMMAN.2014.08.012; Walker EA, 2011, PSYCHOPHARMACOLOGY, V217, P539, DOI 10.1007/s00213-011-2310-8; Wefel JS, 2011, LANCET ONCOL, V12, P703, DOI 10.1016/S1470-2045(10)70294-1; WEI J, 1992, LIFE SCI, V51, P1953, DOI 10.1016/0024-3205(92)90112-3; Wilson CJ, 2002, J AM GERIATR SOC, V50, P2041, DOI 10.1046/j.1532-5415.2002.50619.x; Winocur G, 2012, CLIN CANCER RES, V18, P3112, DOI 10.1158/1078-0432.CCR-12-0060; Yennurajalingam S, 2011, SUPPORT CARE CANCER, V19, pS233	103	59	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81234	10.1371/journal.pone.0081234	http://dx.doi.org/10.1371/journal.pone.0081234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339912	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100044
J	Rich, KM; Denwood, MJ; Stott, AW; Mellor, DJ; Reid, SWJ; Gunn, GJ				Rich, Karl M.; Denwood, Matthew J.; Stott, Alistair W.; Mellor, Dominic J.; Reid, Stuart W. J.; Gunn, George J.			Systems Approaches to Animal Disease Surveillance and Resource Allocation: Methodological Frameworks for Behavioral Analysis	PLOS ONE			English	Article							BOVINE VIRAL DIARRHEA; MODEL; DYNAMICS; PROGRAM; INTERVENTION; ERADICATION; MITIGATION; STRATEGIES; BENEFITS; EVALUATE	While demands for animal disease surveillance systems are growing, there has been little applied research that has examined the interactions between resource allocation, cost-effectiveness, and behavioral considerations of actors throughout the livestock supply chain in a surveillance system context, These interactions are important as feedbacks between surveillance decisions and disease evolution may be modulated by their contextual drivers, influencing the cost-effectiveness of a given surveillance system. This paper identifies a number of key behavioral aspects involved in animal health surveillance systems and reviews some novel methodologies for their analysis. A generic framework or analysis is discussed, with exemplar results provided to demonstrate the utility of such an approach in guiding better disease control and surveillance decisions.	[Rich, Karl M.] Norwegian Inst Int Affairs NUPI, Dept Int Econ, Oslo, Norway; [Denwood, Matthew J.; Mellor, Dominic J.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Vet Med, Glasgow, Lanark, Scotland; [Stott, Alistair W.] Scotlands Rural Coll SRUC, Edinburgh, Midlothian, Scotland; [Reid, Stuart W. J.] Royal Vet Coll, Hatfield, Herts, England; [Gunn, George J.] Scotlands Rural Coll SRUC, Inverness, Scotland	University of Glasgow; Scotland's Rural College; University of London; University of London Royal Veterinary College; Scotland's Rural College	Rich, KM (corresponding author), Norwegian Inst Int Affairs NUPI, Dept Int Econ, Oslo, Norway.	kr@nupi.no		Reid, Stuart/0000-0002-6872-9071; Stott, Alistair/0000-0002-5242-6850	Scottish Government's EPIC program (Centre for Excellence in Epidemiology, Population Health, and Disease Control (EPIC)	Scottish Government's EPIC program (Centre for Excellence in Epidemiology, Population Health, and Disease Control (EPIC)	This work was funded by the Scottish Government's EPIC program (Centre for Excellence in Epidemiology, Population Health, and Disease Control (EPIC)(http://vvww.sruc.ac.uk/epic/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett R, 2010, PREV VET MED, V93, P286, DOI 10.1016/j.prevetmed.2009.11.006; Benschop J, 2008, PREV VET MED, V83, P347, DOI 10.1016/j.prevetmed.2007.09.005; Bogich TL, 2008, J APPL ECOL, V45, P1134, DOI 10.1111/j.1365-2664.2008.01494.x; Cannon RM, 2009, PREV VET MED, V92, P163, DOI 10.1016/j.prevetmed.2009.06.009; Department for Environment Food and Rural Affairs UK, 2011, REV IMPL VET SURV ST; Gilbert WH, 2013, EPIDEMIOL INFECT, P1; Hadorn DC, 2008, VET RES, V39, DOI 10.1051/vetres:2008033; Hasler B, 2012, PREV VET MED, V106, P162, DOI 10.1016/j.prevetmed.2012.01.022; Hasler B, 2012, PREV VET MED, V103, P93, DOI 10.1016/j.prevetmed.2011.09.013; Hasler B, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-225; Hauser CE, 2009, ECOL LETT, V12, P683, DOI 10.1111/j.1461-0248.2009.01323.x; Hoinville LJ, 2013, PREV VET MED, V112, P1, DOI 10.1016/j.prevetmed.2013.06.006; Homer JB, 2006, AM J PUBLIC HEALTH, V96, P452, DOI 10.2105/AJPH.2005.062059; Howe KS, 2012, EPIDEMIOL INFECT, DOI 10:S095026881200060X; Jost CC, 2007, REV SCI TECH OIE, V26, P537, DOI 10.20506/rst.26.3.1765; Klinkenberg D, 2005, PREV VET MED, V67, P19, DOI 10.1016/j.prevetmed.2004.10.003; Mariner JC, 2003, REV SCI TECH OIE, V22, P837, DOI 10.20506/rst.22.3.1439; MILLAR HH, 1995, FISH RES, V23, P345, DOI 10.1016/0165-7836(94)00344-V; Moran D, 2007, PREV VET MED, V80, P193, DOI 10.1016/j.prevetmed.2007.02.009; Noordegraaf AV, 2002, LIVEST PROD SCI, V76, P153, DOI 10.1016/S0301-6226(02)00005-2; Noordegraaf AV, 1998, PREV VET MED, V36, P219, DOI 10.1016/S0167-5877(98)00081-6; Prattley DJ, 2007, PREV VET MED, V81, P56, DOI 10.1016/j.prevetmed.2007.04.009; Regan TJ, 2006, ECOL LETT, V9, P759, DOI 10.1111/j.1461-0248.2006.00920.x; Rich KM, 2008, SYST DYNAM REV, V24, P67, DOI 10.1002/sdr.385; Rich KM, 2011, FOOD POLICY, V36, P214, DOI 10.1016/j.foodpol.2010.11.018; Rich KM, 2007, 2007 AM ASS AGR EC A; Sanson RL, 1997, PREV VET MED, V30, P37, DOI 10.1016/S0167-5877(96)01083-5; Stark K. D., 2006, BMC HEALTH SERV RES, V28, P6, DOI DOI 10.1186/1472-6963-6-20; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Stott AW, 2003, PREV VET MED, V59, P51, DOI 10.1016/S0167-5877(03)00062-X; Tambi EN, 2004, REV SCI TECH OIE, V23, P737; Tebbens RJD, 2009, MANAGE SCI, V55, P650, DOI 10.1287/mnsc.1080.0965; Ulli-Beer S, 2007, ECOL ECON, V62, P727, DOI 10.1016/j.ecolecon.2006.09.017; Weldegebriel HT, 2009, PREV VET MED, V88, P49, DOI 10.1016/j.prevetmed.2008.07.001; Yamamoto T, 2008, PREV VET MED, V86, P57, DOI 10.1016/j.prevetmed.2008.03.004	35	22	22	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e82019	10.1371/journal.pone.0082019	http://dx.doi.org/10.1371/journal.pone.0082019			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24348922	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000327670300067
J	Koch, E; Ristroph, M; Kirkpatrick, M				Koch, Evan; Ristroph, Mickey; Kirkpatrick, Mark			Long Range Linkage Disequilibrium across the Human Genome	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; HAPLOTYPE MAP; ASSOCIATION; CHROMOSOME; REGION; GENE	Long-range linkage disequilibria (LRLD) between sites that are widely separated on chromosomes may suggest that population admixture, epistatic selection, or other evolutionary forces are at work. We quantified patterns of LRLD on a chromosome-wide level in the YRI population of the HapMap dataset of single nucleotide polymorphisms (SNPs). We calculated the disequilibrium between all pairs of SNPs on each chromosome (a total of > 26x10(11) values) and evaluated significance of overall disequilibrium using randomization. The results show an excess of associations between pairs of distant sites (separated by > 0.25 cM) on all of the 22 autosomes. We discuss possible explanations for this observation.	[Koch, Evan; Ristroph, Mickey; Kirkpatrick, Mark] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Kirkpatrick, M (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	kirkp@mail.utexas.edu		Koch, Evan/0000-0002-1124-4559	N.S.F [DEB-0819901]; Miller Institute for Basic Research in Science	N.S.F(National Science Foundation (NSF)); Miller Institute for Basic Research in Science	Funding was from N.S.F. grant DEB-0819901 (www.nsf.gov) and the Miller Institute for Basic Research in Science (millerinstitute.berkeley.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bansal V, 2007, GENOME RES, V17, P219, DOI 10.1101/gr.5774507; Caceres A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-28; Chen GK, 2009, GENOME RES, V19, P136, DOI 10.1101/gr.083634.108; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibson G., 2009, PRIMER GENOME SCI; GOLDING GB, 1984, GENETICS, V108, P257; Hamon SC, 2006, HUM HERED, V61, P87, DOI 10.1159/000093384; HOUWEN RHJ, 1994, NAT GENET, V8, P380, DOI 10.1038/ng1294-380; HUDSON RR, 2001, HDB STAT GENETICS, P309; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lawrence R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-367; LEWONTIN RC, 1960, EVOLUTION, V14, P458, DOI 10.2307/2405995; LEWONTIN RC, 1995, GENETICS, V140, P377; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; MIYASHITA N, 1988, GENETICS, V120, P199; NEI M, 1973, GENETICS, V75, P213; NYSTROMLAHTI M, 1994, P NATL ACAD SCI USA, V91, P6054, DOI 10.1073/pnas.91.13.6054; Peischl S, 2013, HEREDITY IN PRESS; PETERSON AC, 1995, HUM MOL GENET, V4, P887, DOI 10.1093/hmg/4.5.887; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; Price AL, 2008, AM J HUM GENET, V83, P132, DOI 10.1016/j.ajhg.2008.06.005; Rohlfs RV, 2010, AM J HUM GENET, V86, P674, DOI 10.1016/j.ajhg.2010.03.001; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaper E, 2012, GENETICS, V190, P217, DOI 10.1534/genetics.111.134437; Schmegner C, 2005, HUM GENET, V118, P276, DOI 10.1007/s00439-005-0056-2; SLATKIN M, 1994, GENETICS, V137, P331; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; Sved JA, 2011, GENET RES, V93, P285, DOI 10.1017/S0016672311000255; Takano-Shimizu T, 2004, P NATL ACAD SCI USA, V101, P14156, DOI 10.1073/pnas.0401782101; Tenesa A, 2007, GENOME RES, V17, P520, DOI 10.1101/gr.6023607; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; Weir BS, 1990, GENETIC ANAL; Wilson JF, 2000, AM J HUM GENET, V67, P926, DOI 10.1086/303083; Zapata C, 2002, GENETICS, V161, P1539	41	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80754	10.1371/journal.pone.0080754	http://dx.doi.org/10.1371/journal.pone.0080754			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349013	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800008
J	Eyraud, V; Karaki, L; Rahioui, I; Sivignon, C; Da Silva, P; Rahbe, Y; Royer, C; Gressent, F				Eyraud, Vanessa; Karaki, Lamis; Rahioui, Isabelle; Sivignon, Catherine; Da Silva, Pedro; Rahbe, Yvan; Royer, Corinne; Gressent, Frederic			Expression and Biological Activity of the Cystine Knot Bioinsecticide PA1b (Pea Albumin 1 Subunit b)	PLOS ONE			English	Article							CIRCULAR PROTEINS; KALATA B1; PLANTS; SEEDS; BIOSYNTHESIS; OPTIMIZATION; CYCLIZATION; SITOPHILUS; CYCLOTIDES; GENERATION	The PA1b (Pea Albumin 1, subunit b) peptide is an entomotoxin extract from Legume seeds with lethal activity on several insect pests, such as mosquitoes, some aphids and cereal weevils. This 37 amino-acid cysteine-rich peptide has been, until now, obtained by biochemical purification or chemical synthesis. In this paper, we present our results for the transient production of the peptide in Nicotiana benthamiana by agro-infiltration, with a yield of about 35 mg/g of fresh leaves and maximum production 8 days after infiltration. PA1b is part of the PA1 gene which, after post-translational modifications, encodes two peptides (PA1b and PA1a). We show that transforming tobacco with the PA1b cDNA alone does not result in production of the toxin and, in fact, the entire cDNA is necessary, raising the question of the role of PA1a. We constructed a PA1-cassette, allowing for the quick "cut/paste" of different PA1b mutants within a conserved PA1 cDNA. This cassette enabled us to produce the six isoforms of PA1b which exist in pea seeds. Biological tests revealed that all the isoforms display similar activity, with the exception of one which is inactive. The lack of activity in this isoform led us to conclude that the amphiphilic nature of the peptide is necessary for activity. The possible applications of this expression system for other cysteine-rich biomolecules are discussed.	[Eyraud, Vanessa; Karaki, Lamis; Rahioui, Isabelle; Sivignon, Catherine; Da Silva, Pedro; Rahbe, Yvan; Royer, Corinne; Gressent, Frederic] INRA INSA Lyon, BF2I, Villeurbanne, France	INRAE; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Gressent, F (corresponding author), INRA INSA Lyon, BF2I, Villeurbanne, France.	Frederic.Gressent@lyon.inra.fr	Rahbe, Yvan/B-9389-2009	Rahbe, Yvan/0000-0002-0074-4443; GRESSENT, Frederic/0000-0002-7029-8709	Institut National de le Recherche Agronomique (INRA, France); Institut National des Sciences Appliquees (INSA de Lyon, France)	Institut National de le Recherche Agronomique (INRA, France); Institut National des Sciences Appliquees (INSA de Lyon, France)	Funding was provided by Institut National de le Recherche Agronomique (INRA, France) and Institut National des Sciences Appliquees (INSA de Lyon, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batoko H, 2000, PLANT CELL, V12, P2201, DOI 10.1105/tpc.12.11.2201; Chen Q, 2011, HUM VACCINES, V7, P331, DOI 10.4161/hv.7.3.14262; Conlan BF, 2012, J BIOL CHEM, V287, P28037, DOI 10.1074/jbc.M112.347823; Conlan BF, 2010, BIOPOLYMERS, V94, P573, DOI 10.1002/bip.21422; Craik DJ, 2012, TOXINS, V4, P139, DOI 10.3390/toxins4020139; Craik DJ, 2012, EXPERT OPIN DRUG DIS, V7, P179, DOI 10.1517/17460441.2012.661554; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Da Silva Pedro, 2012, BMC Chemical Biology, V12, P3, DOI 10.1186/1472-6769-12-3; Da Silva P, 2010, J BIOL CHEM, V285, P32689, DOI 10.1074/jbc.M110.147199; Da Silva P, 2009, BIOPOLYMERS, V92, P436, DOI 10.1002/bip.21217; Delobel B., 1998, French Patent, Patent No. [9805877, 98 05877]; Eliasen R, 2012, J BIOL CHEM, V287, P40493, DOI 10.1074/jbc.M112.395442; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Gressent F, 2003, EUR J BIOCHEM, V270, P2429, DOI 10.1046/j.1432-1033.2003.03611.x; Gressent F, 2007, J INSECT SCI, V7; Gressent F, 2011, TOXINS, V3, P1502, DOI 10.3390/toxins3121502; HIGGINS TJV, 1986, J BIOL CHEM, V261, P1124; Jouvensal L, 2003, BIOCHEMISTRY-US, V42, P11915, DOI 10.1021/bi034803l; Kolmar H, 2009, CURR OPIN PHARMACOL, V9, P608, DOI 10.1016/j.coph.2009.05.004; Louis S, 2004, PLANT SCI, V167, P705, DOI 10.1016/j.plantsci.2004.04.018; Louis S, 2007, PHYTOCHEMISTRY, V68, P521, DOI 10.1016/j.phytochem.2006.11.032; PERRIN S, 1990, NUCLEIC ACIDS RES, V18, P7433, DOI 10.1093/nar/18.24.7433; Poth AG, 2011, P NATL ACAD SCI USA, V108, P10127, DOI 10.1073/pnas.1103660108; Reinwarth M, 2013, CHEMBIOCHEM, V14, P137, DOI 10.1002/cbic.201200604; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289	27	8	9	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81619	10.1371/journal.pone.0081619	http://dx.doi.org/10.1371/journal.pone.0081619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349099	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300040
J	Flynn, AJ; Marshall, NJ				Flynn, Adrian J.; Marshall, N. Justin			Lanternfish (Myctophidae) Zoogeography off Eastern Australia: A Comparison with Physicochemical Biogeography	PLOS ONE			English	Article							WARM-CORE EDDY; FAMILY MYCTOPHIDAE; MESOPELAGIC FISH; DISTRIBUTION PATTERNS; SPECIES COMPOSITION; OCEANIC WATERS; CURRENT SYSTEM; TASMAN SEA; REGION; SOUTH	In this first attempt to model the distributions of a mesopelagic fish family at this scale in the eastern Australian region (10 degrees S to 57 degrees S), lanternfish species occurrence data spanning a period from 1928 to 2010 were modelled against environmental covariates. This involved: (1) data collation and taxonomic quality checking, (2) classification of trawls into "horizontal'' (presence-absence) and "oblique'' (presence-only) types, and classification of vertical migration patterns using existing literature and the species occurrence database, (3) binomial GAMs using presence-absence data for representative temperate, subtropical and tropical species to examine depth interactions with environmental covariates and refine the selection of environmental layers for presence-only MAXENT models, (4) Presence-only MAXENT modelling using data from all trawls and the reduced environmental layers, and (5) Multivariate analysis (area-wise and species-wise) of the resulting matrix of logistic score by geographic pixel. We test the hypothesis that major fronts in the region (Tasman Front, Subtropical Convergence, Subantarctic Front) represent zoogeographic boundaries. A four-region zoogeographic scheme is hypothesised: Coral Sea region, Subtropical Lower Water region, Subtropical Convergence/South Tasman region and Subantarctic region. The Tasman Front, Subtropical Convergence and Subantarctic Front represented zoogeographic boundaries. An additional boundary at,similar to 25 degrees S (coined the 'Capricorn' boundary) was adopted to delineate the Coral Sea from Subtropical Lower Water regions. Lanternfish zoogeographic regions are congruent with some aspects of two prevailing physicochemical biogeographic schema in the region, but neither of these schema alone accurately predicts lanternfish distributions. As lanternfishes integrate vertical ocean processes, the hypothesised lanternfish zoogeography may represent a useful model for a generalised pelagic biogeography that should be tested for other oceanic groups.	[Flynn, Adrian J.; Marshall, N. Justin] Univ Queensland, Sch Biomed Sci, Queensland Brain Inst, St Lucia, Qld, Australia; [Flynn, Adrian J.] Commonwealth Sci & Ind Res Organisation, Marine & Atmospher Res, Hobart, Tas, Australia; [Flynn, Adrian J.] Museum Victoria, Melbourne, Vic, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Museum Victoria	Flynn, AJ (corresponding author), Fathom Pacific Pty Ltd, Kensington, Vic, Australia.	adrian.flynn@fathompacific.com		Marshall, Justin/0000-0001-9006-6713	University of Queensland; ARC [ARC LP0775179]	University of Queensland(University of Queensland); ARC(Australian Research Council)	A. Flynn's research was supported by The University of Queensland Research Scholarship. A. Flynn's and J. Marshall's research was supported by an ARC-linkage grant to Prof. Justin Marshall (ARC LP0775179) during the time of this study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 1986, SMITHS SEA FISHES; Backus R. H, 1977, Memoirs Sears Fdn mem. Res., V1, P266; Backus R.H., 1986, PELAGIC BIOGEOGRAPHY, P9; BACKUS RH, 1969, MAR BIOL, V3, P87, DOI 10.1007/BF00353427; Barange M, 1998, DEEP-SEA RES PT I, V45, P1663, DOI 10.1016/S0967-0637(98)00037-5; BARNETT MA, 1984, MAR BIOL, V82, P199, DOI 10.1007/BF00394103; Bellido JM, 2008, HYDROBIOLOGIA, V612, P171, DOI 10.1007/s10750-008-9481-2; Benoit-Bird KJ, 2006, MAR ECOL PROG SER, V319, P1, DOI 10.3354/meps319001; Boltovsky D, 1986, UNESCO TECHNICAL PAP, P14; BRANDT SB, 1983, MAR BIOL, V74, P231, DOI 10.1007/BF00403447; BRANDT SB, 1981, MAR ECOL PROG SER, V6, P19, DOI 10.3354/meps006019; Briggs J.C., 1974, CIMAC C SHANGH CHIN, DOI 10.2307/1442613; Briggs JC, 2012, J BIOGEOGR, V39, P12, DOI 10.1111/j.1365-2699.2011.02613.x; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Condie SA, 2006, MAR FRESHWATER RES, V57, P569, DOI 10.1071/MF06009; Cornejo R, 2006, MAR BIOL, V149, P1519, DOI 10.1007/s00227-006-0319-z; Dennis DM, 2001, MAR FRESHWATER RES, V52, P1175, DOI 10.1071/MF01186; Devred E, 2007, MAR ECOL PROG SER, V346, P1, DOI 10.3354/meps07149; Drazen JC, 2011, DEEP-SEA RES PT I, V58, P557, DOI 10.1016/j.dsr.2011.03.002; Ebeling AW, 1962, MELAMPHIDAE 1 SYSTEM; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; ENDEAN R., 1956, AUSTRALIAN JOUR MARINE AND FRESHWATER RES, V7, P88; Eschmeyer WN, CATALOG FISHES; Evseenko SA, 2006, J ICHTHYOLOGY S1, V46, pS110; Evseenko SA, 2008, J ICHTHYOL, V48, P162; Flynn AJ, 2012, DEEP-SEA RES PT I, V69, P113, DOI 10.1016/j.dsr.2012.07.007; Flynn AJ, 2012, MAR FRESHWATER RES, V63, P1255, DOI 10.1071/MF12185; Fock HO, 2009, GLOBAL ECOL BIOGEOGR, V18, P178, DOI 10.1111/j.1466-8238.2008.00435.x; GARTNER JV, 1989, B MAR SCI, V45, P555; Giannoulaki M, 2008, HYDROBIOLOGIA, V612, P225, DOI 10.1007/s10750-008-9498-6; Gibbs RH, 1971, BIOL STUDIES BERMUDA; Gibbs RHJ, 1969, SMITHSON CONTRIBS ZO, V31; GON O, 1990, FISHES SO OCEAN; Gorley C.K., 2006, GETTING STARTED PRIM; GRIFFITHS FB, 1986, DEEP-SEA RES, V33, P1907, DOI 10.1016/0198-0149(86)90085-3; Hallegraeff GM, 1993, MAR FRESHWATER RES, V44, P325; Hamilton LJ, 2006, DEEP-SEA RES PT I, V53, P1989, DOI 10.1016/j.dsr.2006.08.013; Hardman-Mountford NJ, 2008, REMOTE SENS ENVIRON, V112, P3341, DOI 10.1016/j.rse.2008.02.016; Hastie T., 1986, STAT SCI, V1, P297; Hayes D., 2005, COLLATION ANAL OCEAN; Hobday AJ, 2011, DEEP-SEA RES PT II, V58, P734, DOI 10.1016/j.dsr2.2010.10.006; Hooper J, 2005, COLLATION VALIDATION; HULLEY P A, 1989, Cybium, V13, P83; Hulley PA, 2009, CYBIUM, V33, P259; Hulley P. Alexander, 1998, P75; HULLEY PA, 1981, ARCH FISCHEREIWISS, V31, P1; HULLEY PA, 1987, S AFR J MARINE SCI, V5, P597, DOI 10.2989/025776187784522289; HULLEY PA, 1995, S AFR J MARINE SCI, V15, P185; HULLEY PA, 1992, MAR BIOL, V114, P365, DOI 10.1007/BF00350027; JEFFREY S W, 1987, Deep-Sea Research Part A Oceanographic Research Papers, V34, P649, DOI 10.1016/0198-0149(87)90029-X; Johnson R.K., 1974, Archiv FischWiss, V25, P13; Johnson R. K., 1982, FIELDIANA ZOOL, V12, P1; KINZER J, 1993, DEEP-SEA RES PT II, V40, P783, DOI 10.1016/0967-0645(93)90058-U; Koubbi P, 2011, DEEP-SEA RES PT II, V58, P170, DOI 10.1016/j.dsr2.2010.09.007; Last P., 2005, VALIDATION NATL DEME; Lehmann A, 1998, PLANT ECOL, V139, P113, DOI 10.1023/A:1009754417131; Longhurst A.R, 2007, EC GEOGR SEA 2 ED; Longhurst A, 1995, PROG OCEANOGR, V36, P77, DOI 10.1016/0079-6611(95)00015-1; Loots C, 2007, POLAR BIOL, V30, P951, DOI 10.1007/s00300-007-0253-7; Lyne V., 2005, PELAGIC REGIONALISAT; McCartney MS, 1982, J MAR RES, V40, P427; Mcginnis R. F., 1982, ANTARCTIC RES SERIES, V35; McManus MA, 2008, MAR ECOL PROG SER, V365, P91, DOI 10.3354/meps07491; Miller R. G., 1993, HIST ATLAS FISHES AN; NAFPAKTITIS B G, 1978, Natural History Museum of Los Angeles County Science Bulletin, P1; Nafpaktitis B. G., 1969, Bulletin Los Angeles City Museum Sci, VNo. 5, P1; Neira FJ, 2008, FISH OCEANOGR, V17, P281, DOI 10.1111/j.1365-2419.2008.00479.x; O'Hara TD, 2011, CURR BIOL, V21, P226, DOI 10.1016/j.cub.2011.01.002; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; PAKHOMOV EA, 1994, MAR ECOL PROG SER, V111, P155, DOI 10.3354/meps111155; PAXTON J R, 1979, Contributions in Science (Los Angeles), P1; PAXTON JR, 1967, COPEIA, P422; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Revill AT, 2009, MAR BIOL, V156, P1241, DOI 10.1007/s00227-009-1166-5; Ridgway KR, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030393; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Ridgway KR, 2002, J ATMOS OCEAN TECH, V19, P1357, DOI 10.1175/1520-0426(2002)019<1357:OIBFDW>2.0.CO;2; ROBERTSON DA, 1978, NEW ZEAL J MAR FRESH, V12, P295, DOI 10.1080/00288330.1978.9515757; ROBERTSON DA, 1977, DEEP-SEA RES, V24, P849, DOI 10.1016/0146-6291(77)90476-3; Rotschi H., 1967, OCEANOGRAPHY MARINE, V5, P49; Sassa C, 2004, FISH OCEANOGR, V13, P267, DOI 10.1111/j.1365-2419.2004.00289.x; Sassa C, 2002, FISH OCEANOGR, V11, P193, DOI 10.1046/j.1365-2419.2002.00199.x; Schiller A, 2008, PROG OCEANOGR, V76, P334, DOI 10.1016/j.pocean.2008.01.003; Schiller A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036997; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P1005, DOI 10.1175/1520-0485(2001)031<1005:CRAMOA>2.0.CO;2; Sloyan BM, 2001, J PHYS OCEANOGR, V31, P143, DOI 10.1175/1520-0485(2001)031<0143:TSOLOT>2.0.CO;2; Sokolov S, 2002, J MARINE SYST, V37, P151, DOI 10.1016/S0924-7963(02)00200-2; Sokolov S, 2007, J PHYS OCEANOGR, V37, P1394, DOI 10.1175/JPO3111.1; Sokolov S, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005108; STANTON BR, 1981, NEW ZEAL J MAR FRESH, V15, P289, DOI 10.1080/00288330.1981.9515924; Swartzman G, 2008, PROG OCEANOGR, V79, P228, DOI 10.1016/j.pocean.2008.10.021; Tilburg CE, 2001, J PHYS OCEANOGR, V31, P2917, DOI 10.1175/1520-0485(2001)031<2917:TDOTEA>2.0.CO;2; Tsarin S. A, 1996, J ICHTHYOL, V36, P747; Weeks SJ, 2010, CORAL REEFS, V29, P975, DOI 10.1007/s00338-010-0644-z; WHITE BN, 1994, PROG OCEANOGR, V34, P257, DOI 10.1016/0079-6611(94)90012-4; WHITLEY GILBERT P., 1932, AUSTRALIAN NATURALIST, V8, P166; Wienerroither R, 2009, MAR BIOL RES, V5, P328, DOI 10.1080/17451000802478055; Williams A, 1997, MAR BIOL, V130, P259, DOI 10.1007/s002270050246; Wisner R, 1976, TAXONOMY DISTRIBUTIO; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Woodward S. P., 1851, MANUAL MOLLUSCA RUDI; Young JW, 2011, DEEP-SEA RES PT II, V58, P720, DOI 10.1016/j.dsr2.2010.10.005; Zahuranec BJ, 2000, SMITHSON CONTRIBS ZO, V607	106	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80950	10.1371/journal.pone.0080950	http://dx.doi.org/10.1371/journal.pone.0080950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349024	Green Submitted, gold, Green Published			2022-12-27	WOS:000328730300015
J	Ponce, D; Abrao, JMG; Albino, BB; Balbi, AL				Ponce, Daniela; Gera Abrao, Juliana Maria; Albino, Bianca Ballarin; Balbi, Andre Luis			Extended Daily Dialysis in Acute Kidney Injury Patients: Metabolic and Fluid Control and Risk Factors for Death	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; RENAL REPLACEMENT THERAPY; LOW-EFFICIENCY DIALYSIS; INTERMITTENT HEMODIALYSIS; FAILURE; TRIAL; MANAGEMENT	Intermittent hemodialysis (IHD) and continuous renal replacement therapies (CRRT) are used as Acute Kidney Injury (AKI) therapy and have certain advantages and disadvantages. Extended daily dialysis (EDD) has emerged as an alternative to CRRT in the management of hemodynamically unstable AKI patients, mainly in developed countries. Objectives: We hypothesized that EDD is a safe option for AKI treatment and aimed to describe metabolic and fluid control of AKI patients undergoing EDD and identify complications and risk factors associated with death. Study Selection: This is an observational and retrospective study describing introduction of EDD at our institution. A total of 231 hemodynamically unstable AKI patients (noradrenalin dose between 0.3 and 1.0 ucg/kg/min) were assigned to 1367 EDD session. EDD consisted of 6-8 h of HD 6 days a week, with blood flow of 200 ml/min, dialysate flows of 300 ml/min. Data Synthesis: Mean age was 60.6 +/- 15.8 years, 97.4% of patients were in the intensive care unit, and sepsis was the main etiology of AKI (76.2). BUN and creatinine levels stabilized after four sessions at around 38 and 2.4 mg/dl, respectively. Fluid balance decreased progressively and stabilized around zero after five sessions. Weekly delivered Kt/V was 5.94 +/- 0.7. Hypotension and filter clotting occurred in 47.5 and 12.4% of treatment session, respectively. Regarding AKI outcome, 22.5% of patients presented renal function recovery, 5.6% of patients remained on dialysis after 30 days, and 71.9% of patients died. Age and focus abdominal sepsis were identified as risk factors for death. Urine output and negative fluid balance were identified as protective factors. Conclusions: EDD is effective for AKI patients, allowing adequate metabolic and fluid control. Age, focus abdominal sepsis, and lower urine output as well as positive fluid balance after two EDD sessions were associated significantly with death.	[Ponce, Daniela; Gera Abrao, Juliana Maria; Albino, Bianca Ballarin; Balbi, Andre Luis] Univ Sao Paulo State UNESP, Sao Paulo, Brazil	Universidade Estadual Paulista	Ponce, D (corresponding author), Univ Sao Paulo State UNESP, Sao Paulo, Brazil.	dponce@fmb.unesp.br	Ponce, Daniela/Q-4221-2019; Ponce, Daniela/M-8271-2015; Balbi, Andre/AAD-9859-2019; Balbi, André Luis/O-9278-2016	Ponce, Daniela/0000-0002-6178-6938; Ponce, Daniela/0000-0002-6178-6938; Balbi, Andre/0000-0001-8366-5064; Balbi, André Luis/0000-0001-8366-5064				Augustine JJ, 2004, AM J KIDNEY DIS, V44, P1000, DOI 10.1053/j.ajkd.2004.08.022; Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Berbece AN, 2006, KIDNEY INT, V70, P963, DOI 10.1038/sj.ki.5001700; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; Costa e Silva VT, 2013, PLOS ONE; Daugirdas JT, 2007, HDB DIALYSIS, P23; Demirjian SG, 2011, CONTRIB NEPHROL, V174, P242, DOI 10.1159/000329402; DuBois D, 1915, ARCH INTERN MED, V15, P868; Eloot S, 2008, KIDNEY INT, V73, P765, DOI 10.1038/sj.ki.5002750; Faulhaber-Walter R, 2009, NEPHROL DIAL TRANSPL, V24, P2179, DOI 10.1093/ndt/gfp035; Fieghen HE, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-32; Fliser D, 2006, NAT CLIN PRACT NEPHR, V2, P32, DOI 10.1038/ncpneph0060; George J, 2011, PERITON DIALYSIS INT, V31, P422, DOI 10.3747/pdi.2009.00231; Himmelfarb J, 2007, KIDNEY INT, V71, P971, DOI 10.1038/sj.ki.5002224; Himmelfarb J, 2007, NAT CLIN PRACT NEPHR, V3, P120, DOI 10.1038/ncpneph0422; Kielstein JT, 2010, J NEPHROL, V23, P494; Kumar VA, 2000, AM J KIDNEY DIS, V36, P294, DOI 10.1053/ajkd.2000.8973; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Lewis Charmaine A, 2004, Curr Opin Crit Care, V10, P13, DOI 10.1097/00075198-200402000-00003; LIANO F, 1993, NEPHRON, V63, P21, DOI 10.1159/000187139; Lima EQ, 2005, RENAL FAILURE, V27, P547, DOI 10.1080/08860220500198771; Marshall MR, 2004, NEPHROL DIAL TRANSPL, V19, P877, DOI 10.1093/ndt/gfg625; Marshall MR, 2002, AM J KIDNEY DIS, V39, P556, DOI 10.1053/ajkd.2002.31406; Marshall MR, 2001, KIDNEY INT, V60, P777, DOI 10.1046/j.1523-1755.2001.060002777.x; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mehta RL, 2001, KIDNEY INT, V60, P1154, DOI 10.1046/j.1523-1755.2001.0600031154.x; Palevsky PM, 2008, NEW ENGL J MED, V10, P359; Pannu N, 2008, JAMA-J AM MED ASSOC, V299, P793, DOI 10.1001/jama.299.7.793; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Ponce D, 2012, INT J UROL NEPHROL, P1; Ponce D, 2012, CLIN J AM SOC NEPHRO, V7, P887, DOI 10.2215/CJN.11131111; Ponce Daniela, 2011, Adv Perit Dial, V27, P118; Prowle JR, 2010, NAT REV NEPHROL, V6, P107, DOI 10.1038/nrneph.2009.213; Ricci Z, 2006, NEPHROL DIAL TRANSPL, V21, P690, DOI 10.1093/ndt/gfi296; Schiffl H, 2002, NEW ENGL J MED, V346, P305, DOI 10.1056/NEJMoa010877; Schiffl H, 2013, INT UROL NEPHROL, V45, P191, DOI 10.1007/s11255-011-0112-x; Schmidt JJ, 2012, BLOOD PURIFICAT, V34, P246, DOI 10.1159/000342631; Schortgen F, 2000, AM J RESP CRIT CARE, V162, P197, DOI 10.1164/ajrccm.162.1.9907098; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Schwenger V, 2012, CRIT CARE, V16, DOI 10.1186/cc11445; Silva TNV, 2013, INT UROL NEPHROL, V45, P1405, DOI 10.1007/s11255-012-0339-1; Uchino S, 2005, JAMA-J AM MED ASSOC, V294, P813, DOI 10.1001/jama.294.7.813; Uehlinger DE, 2005, NEPHROL DIAL TRANSPL, V20, P1630, DOI 10.1093/ndt/gfh880; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vinsonneau C, 2006, LANCET, V368, P379, DOI 10.1016/S0140-6736(06)69111-3	45	9	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81697	10.1371/journal.pone.0081697	http://dx.doi.org/10.1371/journal.pone.0081697			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349114	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300046
J	Santos-Soto, IJ; Chorna, N; Carballeira, NM; Velez-Bartolomei, JG; Mendez-Merced, AT; Chornyy, AP; de Ortiz, SP				Santos-Soto, Ivan J.; Chorna, Nataliya; Carballeira, Nestor M.; Velez-Bartolomei, Jose G.; Mendez-Merced, Ana T.; Chornyy, Anatoliy P.; de Ortiz, Sandra Pena			Voluntary Running in Young Adult Mice Reduces Anxiety-Like Behavior and Increases the Accumulation of Bioactive Lipids in the Cerebral Cortex	PLOS ONE			English	Article							LONG-TERM POTENTIATION; DSM-IV DISORDERS; PROTEIN-KINASE-C; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; SYNAPTIC PLASTICITY; PHOSPHOLIPID SUPPLEMENTATION; HIPPOCAMPAL NEUROGENESIS; NEUROTROPHIC FACTOR; CEREBELLAR CORTEX	Combinatorial therapies using voluntary exercise and diet supplementation with polyunsaturated fatty acids have synergistic effects benefiting brain function and behavior. Here, we assessed the effects of voluntary exercise on anxiety-like behavior and on total FA accumulation within three brain regions: cortex, hippocampus, and cerebellum of running versus sedentary young adult male C57/BL6J mice. The running group was subjected to one month of voluntary exercise in their home cages, while the sedentary group was kept in their home cages without access to a running wheel. Elevated plus maze (EPM), several behavioral postures and two risk assessment behaviors (RABs) were then measured in both animal groups followed immediately by blood samplings for assessment of corticosterone levels. Brains were then dissected for non-targeted lipidomic analysis of selected brain regions using gas chromatography coupled to mass spectrometry (GC/MS). Results showed that mice in the running group, when examined in the EPM, displayed significantly lower anxiety-like behavior, higher exploratory and risky behaviors, compared to sedentary mice. Notably, we found no differences in blood corticosterone levels between the two groups, suggesting that the different EPM and RAB behaviors were not related to reduced physiological stress in the running mice. Lipidomics analysis revealed a region-specific cortical decrease of the saturated FA: palmitate (C16:0) and a concomitant increase of polyunsaturated FA, arachidonic acid (AA, omega 6-C20:4) and docosahexaenoic acid (DHA, omega 3-C22:6), in running mice compared to sedentary controls. Finally, we found that running mice, as opposed to sedentary animals, showed significantly enhanced cortical expression of phospholipase A2 (PLA(2)) protein, a signaling molecule required in the production of both AA and DHA. In summary, our data support the anxiolytic effects of exercise and provide insights into the molecular processes modulated by exercise that may lead to its beneficial effects on mood.	[Santos-Soto, Ivan J.; Chorna, Nataliya; Velez-Bartolomei, Jose G.; de Ortiz, Sandra Pena] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Chorna, Nataliya; de Ortiz, Sandra Pena] Univ Puerto Rico, Metabol Res Ctr, San Juan, PR 00936 USA; [Carballeira, Nestor M.] Univ Puerto Rico, Dept Chem, San Juan, PR 00936 USA; [Mendez-Merced, Ana T.] Univ Este, Sch Sci & Technol, Carolina, PR USA; [Chornyy, Anatoliy P.] Univ Puerto Rico, High Performance Comp Facil, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico	de Ortiz, SP (corresponding author), Univ Puerto Rico, Dept Biol, Rio Piedras Campus, San Juan, PR 00936 USA.	sandra@hpcf.upr.edu	Meijer, Anna/K-5118-2016; Chorna, Nataliya/AHC-2895-2022	Chorna, Nataliya/0000-0002-7761-6802; Carballeira, Nestor/0000-0001-7404-0505	National Institutes of Health (NIH) [SPO - P20RR016470/8P20GM103475, 5SC1MH086072, SC1GM084708]; UPR-Graduate Dean's Dissertation Fellowship [5R25GM061151]; ATMM [NIH IP20MD003355];  [PBDTP2010-2011]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061151, P20GM103475, SC1GM084708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [SC1MH086072] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPR-Graduate Dean's Dissertation Fellowship; ATMM; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants and fellowships from the National Institutes of Health (NIH): SPO - P20RR016470/8P20GM103475, 5SC1MH086072; NCarballeira - SC1GM084708; IJSS - Graduate Research Fellowship, 5R25GM061151/UPR-Graduate Dean's Dissertation Fellowship, PBDTP2010-2011; and ATMM - NIH IP20MD003355. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Adlard PA, 2005, NEUROBIOL AGING, V26, P511, DOI 10.1016/j.neurobiolaging.2004.05.006; Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Alvares LD, 2008, NEUROBIOL LEARN MEM, V90, P1, DOI 10.1016/j.nlm.2008.01.009; Anderson BJ, 2002, LEARN MEMORY, V9, P1, DOI 10.1101/lm.43402; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Baruch DE, 2004, BEHAV NEUROSCI, V118, P1123, DOI 10.1037/0735-7044.118.5.1123; Binder E, 2004, BEHAV BRAIN RES, V155, P197, DOI 10.1016/j.bbr.2004.04.017; BLACK JE, 1990, P NATL ACAD SCI USA, V87, P5568, DOI 10.1073/pnas.87.14.5568; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cadas H, 1997, J NEUROSCI, V17, P1226; Carrie I, 2000, BRIT J NUTR, V83, P439; Carrie I, 2002, NUTR NEUROSCI, V5, P43, DOI 10.1080/10284150290007074; Carrie I, 2000, J LIPID RES, V41, P473; Chytrova G, 2010, BRAIN RES, V1341, P32, DOI 10.1016/j.brainres.2009.05.018; CLARK MA, 1987, J BIOL CHEM, V262, P4402; Colon-Cesario WI, 2006, LEARN MEMORY, V13, P734, DOI 10.1101/lm.407706; DENNIS EA, 1994, J BIOL CHEM, V269, P13057; Dietrich A, 2004, BRIT J SPORT MED, V38, P536, DOI 10.1136/bjsm.2004.011718; Droste SK, 2003, ENDOCRINOLOGY, V144, P3012, DOI 10.1210/en.2003-0097; Droste SK, 2009, ENDOCRINOLOGY, V150, P4170, DOI 10.1210/en.2009-0402; Duman CH, 2008, BRAIN RES, V1199, P148, DOI 10.1016/j.brainres.2007.12.047; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; FACCI L, 1995, P NATL ACAD SCI USA, V92, P3376, DOI 10.1073/pnas.92.8.3376; Falls WA, 2010, BEHAV BRAIN RES, V207, P321, DOI 10.1016/j.bbr.2009.10.016; Farooqui AA, 2001, NEUROSCIENTIST, V7, P232, DOI 10.1177/107385840100700308; Fediuc S, 2006, J APPL PHYSIOL, V100, P1867, DOI 10.1152/japplphysiol.01416.2005; Fedorova I, 2007, PROSTAG LEUKOTR ESS, V77, P269, DOI 10.1016/j.plefa.2007.10.013; Ferrari PF, 1998, PHYSIOL BEHAV, V63, P821, DOI 10.1016/S0031-9384(97)00544-1; Feuerecker M, 2012, EUR J APPL PHYSIOL, V112, P2777, DOI 10.1007/s00421-011-2237-0; FORDYCE DE, 1993, BRAIN RES, V619, P111, DOI 10.1016/0006-8993(93)91602-O; Fuss J, 2010, EXP NEUROL, V224, P103, DOI 10.1016/j.expneurol.2010.03.016; Garcia-Capdevila S, 2009, BEHAV BRAIN RES, V202, P162, DOI 10.1016/j.bbr.2009.03.020; Gordon JA, 2004, ANNU REV NEUROSCI, V27, P193, DOI 10.1146/annurev.neuro.27.070203.144212; Greenwood BN, 2009, HIPPOCAMPUS, V19, P988, DOI 10.1002/hipo.20534; Greiner RS, 1999, LIPIDS, V34, pS239, DOI 10.1007/BF02562305; Greiner RS, 2001, PHYSIOL BEHAV, V72, P379, DOI 10.1016/S0031-9384(00)00437-6; Harrison FE, 2009, BEHAV BRAIN RES, V198, P247, DOI 10.1016/j.bbr.2008.10.015; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Heyman E, 2012, PSYCHONEUROENDOCRINO, V37, P844, DOI 10.1016/j.psyneuen.2011.09.017; Iwanaga T, 2009, PROG LIPID RES, V48, P117, DOI 10.1016/j.plipres.2009.02.001; Jump DB, 2002, J BIOL CHEM, V277, P8755, DOI 10.1074/jbc.R100062200; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Kleim JA, 2003, NEUROCHEM RES, V28, P1757, DOI 10.1023/A:1026025408742; Kleim JA, 1996, J NEUROSCI, V16, P4529; Kleim JA, 1998, NEUROBIOL LEARN MEM, V69, P274, DOI 10.1006/nlme.1998.3827; Koch M, 2011, NEUROTOX RES, V19, P330, DOI 10.1007/s12640-010-9166-2; Kronenberg G, 2006, NEUROBIOL AGING, V27, P1505, DOI 10.1016/j.neurobiolaging.2005.09.016; Kwak C, 2009, KOREAN J PHYSIOL PHA, V13, P357, DOI 10.4196/kjpp.2009.13.5.357; LAO YA, 1995, J NEUROCHEM, V64, P1808; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Logan Alan C, 2004, Lipids Health Dis, V3, P25; LoVerme J, 2005, LIFE SCI, V77, P1685, DOI 10.1016/j.lfs.2005.05.012; Marszalek JR, 2005, ANNU REV CELL DEV BI, V21, P633, DOI 10.1146/annurev.cellbio.21.122303.120624; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; Moise AM, 2008, PSYCHOPHARMACOLOGY, V200, P333, DOI 10.1007/s00213-008-1209-5; Molteni R, 2002, EUR J NEUROSCI, V16, P1107, DOI 10.1046/j.1460-9568.2002.02158.x; Moriguchi T, 2000, J NEUROCHEM, V75, P2563, DOI 10.1046/j.1471-4159.2000.0752563.x; Moriguchi T, 2003, J NEUROCHEM, V87, P297, DOI 10.1046/j.1471-4159.2003.01966.x; Okaichi Y, 2005, PHYSIOL BEHAV, V84, P617, DOI 10.1016/j.physbeh.2005.02.008; Olson AK, 2006, HIPPOCAMPUS, V16, P250, DOI 10.1002/hipo.20157; Palanza P, 2001, NEUROSCI BIOBEHAV R, V25, P219, DOI 10.1016/S0149-7634(01)00010-0; PELLERIN L, 1991, NEUROCHEM RES, V16, P983, DOI 10.1007/BF00965841; Perez-Acevedo NL, 2006, BEHAV NEUROSCI, V120, P632, DOI 10.1037/0735-7044.120.3.632; Pistis M, 2010, CURR MED CHEM, V17, P1450, DOI 10.2174/092986710790980014; Ploughman M, 2005, NEUROSCIENCE, V136, P991, DOI 10.1016/j.neuroscience.2005.08.037; PYSH JJ, 1979, SCIENCE, V206, P230, DOI 10.1126/science.482938; Raso GM, 2011, J NEUROENDOCRINOL, V23, P591, DOI 10.1111/j.1365-2826.2011.02152.x; Redila VA, 2006, NEUROSCIENCE, V137, P1299, DOI 10.1016/j.neuroscience.2005.10.050; Ren KQ, 2002, J NEUROCHEM, V80, P949, DOI 10.1046/j.0022-3042.2002.00776.x; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; RODGERS RJ, 1993, PHYSIOL BEHAV, V53, P383, DOI 10.1016/0031-9384(93)90222-2; Rodgers RJ, 1997, NEUROSCI BIOBEHAV R, V21, P801, DOI 10.1016/S0149-7634(96)00058-9; Ross BM, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-21; Salam JN, 2009, BEHAV BRAIN RES, V197, P31, DOI 10.1016/j.bbr.2008.07.036; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; SCHAECHTER JD, 1993, J NEUROSCI, V13, P4361; Scherma M, 2008, NEUROPHARMACOLOGY, V54, P129, DOI 10.1016/j.neuropharm.2007.08.011; Sinclair AJ, 2007, ASIA PAC J CLIN NUTR, V16, P391; Soya H, 2007, BIOCHEM BIOPH RES CO, V358, P961, DOI 10.1016/j.bbrc.2007.04.173; Sparling PB, 2003, NEUROREPORT, V14, P2209, DOI 10.1097/00001756-200312020-00015; Stranahan AM, 2007, HIPPOCAMPUS, V17, P1017, DOI 10.1002/hipo.20348; Takeuchi T, 2003, BRAIN RES, V964, P136, DOI 10.1016/S0006-8993(02)04113-6; Tanabe Y, 2004, CLIN EXP PHARMACOL P, V31, P700, DOI 10.1111/j.1440-1681.2004.04068.x; Toni N, 2008, NAT NEUROSCI, V11, P901, DOI 10.1038/nn.2156; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Tsatsoulis A, 2006, ANN NY ACAD SCI, V1083, P196, DOI 10.1196/annals.1367.020; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2006, NEUROSCIENCE, V139, P1221, DOI 10.1016/j.neuroscience.2006.01.062; Vaynman S, 2004, J NEUROSCI RES, V76, P356, DOI 10.1002/jnr.20077; Vaynman SS, 2006, BRAIN RES, V1070, P124, DOI 10.1016/j.brainres.2005.11.062; Wang DV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018739; Wang JP, 2003, LEARN MEMORY, V10, P503, DOI 10.1101/lm.63003; WILLIAMS JH, 1989, NEUROSCI LETT, V107, P301, DOI 10.1016/0304-3940(89)90835-5; Wolf MJ, 1995, FEBS LETT, V377, P358, DOI 10.1016/0014-5793(95)01371-7; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Yu HL, 2011, PHARMACOL REP, V63, P834, DOI 10.1016/S1734-1140(11)70596-5	107	16	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81459	10.1371/journal.pone.0081459	http://dx.doi.org/10.1371/journal.pone.0081459			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349072	gold, Green Published			2022-12-27	WOS:000328730300029
J	Teixeira, MC; Thomaz, SM; Michelan, TS; Mormul, RP; Meurer, T; Fasolli, JVB; Silveira, MJ				Teixeira, Mariana C.; Thomaz, Sidinei M.; Michelan, Thaisa S.; Mormul, Roger P.; Meurer, Thamis; Fasolli, Jose Vitor B.; Silveira, Marcio J.			Incorrect Citations Give Unfair Credit to Review Authors in Ecology Journals	PLOS ONE			English	Review							RATES; INAPPROPRIATE; BIOLOGY; NUMBERS; INDEX	The number of citations that papers receive has become significant in measuring researchers' scientific productivity, and such measurements are important when one seeks career opportunities and research funding. Skewed citation practices can thus have profound effects on academic careers. We investigated (i) how frequently authors misinterpret original information and (ii) how frequently authors inappropriately cite reviews instead of the articles upon which the reviews are based. To reach this aim, we carried a survey of ecology journals indexed in the Web of Science and assessed the appropriateness of citations of review papers. Reviews were significantly more often cited than regular articles. In addition, 22% of citations were inaccurate, and another 15% unfairly gave credit to the review authors for other scientists' ideas. These practices should be stopped, mainly through more open discussion among mentors, researchers and students.	[Teixeira, Mariana C.; Thomaz, Sidinei M.; Michelan, Thaisa S.; Mormul, Roger P.; Meurer, Thamis; Fasolli, Jose Vitor B.; Silveira, Marcio J.] Univ Estadual Maringa, Maringa, Parana, Brazil	Universidade Estadual de Maringa	Teixeira, MC (corresponding author), Univ Estadual Maringa, Maringa, Parana, Brazil.	m_c_teixeira@yahoo.com	Mormul, Roger Paulo/E-7018-2010; Thomaz, Sidinei Magela/A-7331-2013; Michelan, Thaisa S/I-5255-2012; Michelan, Thaisa Sala/HGV-0299-2022	Mormul, Roger Paulo/0000-0001-9020-4784; Michelan, Thaisa S/0000-0001-9416-0758; Michelan, Thaisa Sala/0000-0001-9416-0758; Thomaz, Sidinei M./0000-0002-5236-1364	CAPES; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge Brazilian funding agencies CAPES and CNPq for scholarships to M. C. Teixeira, T. S. Michelan, R. P. Mormul, T. Meurer, J.V.B. Fasoli and M.J. Silveira. S. M. Thomaz receives a Researcher Productivity grant from CNPq and acknowledges this agency for constant funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DW, 2009, RES POLICY, V38, P895, DOI 10.1016/j.respol.2009.02.001; Almeida ECE, 2013, SCIENTOMETR IN PRESS, DOI [10.1007/s11192-013-0967-y, DOI 10.1007/S11192-013-0967-Y]; Borsuk RM., 2009, OPEN ECOLOGY J, V2, P25, DOI [DOI 10.2174/1874213000902010025, 10.2174/1874213000902010025]; Caron DA, 2000, DEEP-SEA RES PT II, V47, P3249, DOI 10.1016/S0967-0645(00)00067-9; Davis M. A., 2009, INVASION BIOL; Drake DC, 2013, HYDROBIOLOGIA, V702, P1, DOI 10.1007/s10750-012-1392-6; ESA, 2013, TYP CONTR EC MON; Eysenbach G, 2006, PLOS BIOL, V4, P692, DOI 10.1371/journal.pbio.0040157; Gavras H, 2002, AM J HYPERTENS, V15, P831, DOI 10.1016/S0895-7061(02)02989-8; Harzing AW, 2002, J ORGAN BEHAV, V23, P127, DOI 10.1002/job.125; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Kelly CD, 2006, TRENDS ECOL EVOL, V21, P167, DOI 10.1016/j.tree.2006.01.005; Leblond M, 2012, SCIENTOMETRICS, V91, P943, DOI 10.1007/s11192-011-0565-9; Lortie CJ, 2013, SCIENTOMETRICS, V94, P675, DOI 10.1007/s11192-012-0822-6; Loyola RD, 2012, TRENDS ECOL EVOL, V27, P585, DOI 10.1016/j.tree.2012.07.016; Neaves W., 2012, NATURE, V488, P121, DOI DOI 10.1038/NJ7409-121A; odd PA, 2007, OIKOS, V116, P1599; Padial AA, 2010, SCIENTOMETRICS, V85, P1, DOI 10.1007/s11192-010-0231-7; Rose JM, 2007, LIMNOL OCEANOGR, V52, P886, DOI 10.4319/lo.2007.52.2.0886; TERBRAAK CJF, 1986, VEGETATIO, V65, P3; Todd PA, 2010, MAR ECOL PROG SER, V408, P299, DOI 10.3354/meps08587; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	22	32	33	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81871	10.1371/journal.pone.0081871	http://dx.doi.org/10.1371/journal.pone.0081871			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349143	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300058
J	Ekman, M; Bhattachariya, A; Dahan, D; Uvelius, B; Albinsson, S; Sward, K				Ekman, Mari; Bhattachariya, Anirban; Dahan, Diana; Uvelius, Bengt; Albinsson, Sebastian; Sward, Karl			Mir-29 Repression in Bladder Outlet Obstruction Contributes to Matrix Remodeling and Altered Stiffness	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; KAPPA-B; URINARY-BLADDER; MICRORNAS; EXPRESSION; SMAD1; DIFFERENTIATION; SUPPRESSION; ACTIVATION; COLLAGEN	Recent work has uncovered a role of the microRNA (miRNA) miR-29 in remodeling of the extracellular matrix. Partial bladder outlet obstruction is a prevalent condition in older men with prostate enlargement that leads to matrix synthesis in the lower urinary tract and increases bladder stiffness. Here we tested the hypothesis that miR-29 is repressed in the bladder in outlet obstruction and that this has an impact on protein synthesis and matrix remodeling leading to increased bladder stiffness. c-Myc, NF-kappa B and SMAD3, all of which repress miR-29, were activated in the rat detrusor following partial bladder outlet obstruction but at different times. c-Myc and NF-kappa B activation occurred early after obstruction, and SMAD3 phosphorylation increased later, with a significant elevation at 6 weeks. c-Myc, NF-kappa B and SMAD3 activation, respectively, correlated with repression of miR-29b and miR-29c at 10 days of obstruction and with repression of miR-29c at 6 weeks. An mRNA microarray analysis showed that the reduction of miR-29 following outlet obstruction was associated with increased levels of miR-29 target mRNAs, including mRNAs for tropoelastin, the matricellular protein Sparc and collagen IV. Outlet obstruction increased protein levels of eight out of eight examined miR-29 targets, including tropoelastin and Sparc. Transfection of human bladder smooth muscle cells with antimiR-29c and miR-29c mimic caused reciprocal changes in target protein levels in vitro. Tamoxifen inducible and smooth muscle-specific deletion of Dicer in mice reduced miR-29 expression and increased tropoelastin and the thickness of the basal lamina surrounding smooth muscle cells in the bladder. It also increased detrusor stiffness independent of outlet obstruction. Taken together, our study supports a model where the combined repressive influences of c-Myc, NF-kappa B and SMAD3 reduce miR-29 in bladder outlet obstruction, and where the resulting drop in miR-29 contributes to matrix remodeling and altered passive mechanical properties of the detrusor.	[Ekman, Mari; Bhattachariya, Anirban; Dahan, Diana; Albinsson, Sebastian; Sward, Karl] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Uvelius, Bengt] Lund Univ, Dept Urol, Lund, Sweden; [Ekman, Mari] Lund Univ, Dept Biol, Lund, Sweden	Lund University; Lund University; Lund University	Sward, K (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	karl.sward@med.lu.se	Albinsson, Sebastian/B-4105-2010; Bhattachariya, Anirban/H-5566-2013	Albinsson, Sebastian/0000-0001-6936-3967; Bhattachariya, Anirban/0000-0002-7687-3786; Uvelius, Bengt/0000-0003-0201-8928; Sward, Karl/0000-0002-7255-5510	Swedish Research Council; Greta and Johan Kock's Foundation; Crafoord Foundation; Medical Faculty at Lund University; Gosta Jonsson's foundation; Olle Engkvist Byggmastare's foundation; Avtal Lakare Forskning; Marie Curie Initial Training Network SmArt from the European Union	Swedish Research Council(Swedish Research CouncilEuropean Commission); Greta and Johan Kock's Foundation; Crafoord Foundation; Medical Faculty at Lund University; Gosta Jonsson's foundation; Olle Engkvist Byggmastare's foundation; Avtal Lakare Forskning; Marie Curie Initial Training Network SmArt from the European Union	This study was financially supported by The Swedish Research Council, The Greta and Johan Kock's Foundation, The Crafoord Foundation, The Medical Faculty at Lund University, Gosta Jonsson's foundation, Olle Engkvist Byggmastare's foundation and Avtal Lakare Forskning. AB is supported by the Marie Curie Initial Training Network SmArt from the European Union. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KJ, 2009, NAT REV UROL, V6, P596, DOI 10.1038/nrurol.2009.201; Albinsson S, 2013, PHARMACOL RES, V75, P28, DOI 10.1016/j.phrs.2013.04.003; Anumanthan G, 2009, J UROLOGY, V182, P1775, DOI 10.1016/j.juro.2009.05.126; Baskin LS, 1996, LAB INVEST, V75, P157; Bradshaw AD, 2009, J CELL COMMUN SIGNAL, V3, P239, DOI 10.1007/s12079-009-0062-6; Chaqour B, 2006, J BIOL CHEM, V281, P20608, DOI 10.1074/jbc.M600214200; Collado A, 2006, J UROLOGY, V176, P2722, DOI 10.1016/j.juro.2006.07.131; CORTIVO R, 1981, BRIT J UROL, V53, P134, DOI 10.1111/j.1464-410X.1981.tb03151.x; Damaser MS, 1996, NEUROUROL URODYNAM, V15, P650, DOI 10.1002/(SICI)1520-6777(1996)15:6<650::AID-NAU6>3.3.CO;2-3; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gheinani AH, 2013, CELL MOL LIFE SCI, V70, P3773, DOI 10.1007/s00018-013-1275-7; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; HAYASHI K, 1987, ATHEROSCLEROSIS, V66, P259, DOI 10.1016/0021-9150(87)90069-4; Heissmeyer V, 1999, EMBO J, V18, P4766, DOI 10.1093/emboj/18.17.4766; Imamura M, 2013, J CELL PHYSIOL, V228, P1819, DOI 10.1002/jcp.24333; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jones JA, 2011, CIRC-CARDIOVASC GENE, V4, P605, DOI 10.1161/CIRCGENETICS.111.960419; Kapinas K, 2009, J CELL BIOCHEM, V108, P216, DOI 10.1002/jcb.22243; KARIM OMA, 1992, AM J PHYSIOL, V263, pR1284, DOI 10.1152/ajpregu.1992.263.6.R1284; Kriegel AJ, 2012, PHYSIOL GENOMICS, V44, P237, DOI 10.1152/physiolgenomics.00141.2011; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu XJ, 1998, CANCER RES, V58, P4752; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Lu LN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027596; Maclejewski CC, 2012, J UROLOGY, V188, P1543, DOI 10.1016/j.juro.2012.03.045; Maegdefessel L, 2012, J CLIN INVEST, V122, P497, DOI 10.1172/JCI61598; MALKOWICZ SB, 1986, J UROLOGY, V136, P1324, DOI 10.1016/S0022-5347(17)45331-6; Martinez I, 2011, CANCER RES, V71, P5370, DOI 10.1158/0008-5472.CAN-11-1044; Martineza I, 2011, P NATL ACAD SCI USA, V108, P522, DOI 10.1073/pnas.1017346108; Merk DR, 2012, CIRC RES, V110, P312, DOI 10.1161/CIRCRESAHA.111.253740; Moustakas A, 2001, J CELL SCI, V114, P4359; NIELSEN KK, 1995, NEUROUROL URODYNAM, V14, P269, DOI 10.1002/nau.1930140308; Ott CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016250; Pannu J, 2007, J BIOL CHEM, V282, P10405, DOI 10.1074/jbc.M611742200; Persson K, 2001, J UROLOGY, V165, P633, DOI 10.1097/00005392-200102000-00086; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Sadegh MK, 2011, BRIT J PHARMACOL, V162, P1156, DOI 10.1111/j.1476-5381.2010.01115.x; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Takahashi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048974; Tuna BG, 2013, J BIOMECH, V46, P1420, DOI 10.1016/j.jbiomech.2013.03.010; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; UVELIUS B, 1991, UROL INT, V47, P245, DOI 10.1159/000282230; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Veerla S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-145; Wrighton KH, 2009, J BIOL CHEM, V284, P9755, DOI 10.1074/jbc.M809223200; Zhang S, 2012, AM J PATHOL, V181, P937, DOI 10.1016/j.ajpath.2012.05.035; Zhang XW, 2012, CANCER CELL, V22, P506, DOI 10.1016/j.ccr.2012.09.003	50	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82308	10.1371/journal.pone.0082308	http://dx.doi.org/10.1371/journal.pone.0082308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340017	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400070
J	Lind, T; Sundqvist, A; Hu, LJ; Pejler, G; Andersson, G; Jacobson, A; Melhus, H				Lind, Thomas; Sundqvist, Anders; Hu, Lijuan; Pejler, Gunnar; Andersson, Goran; Jacobson, Annica; Melhus, Hakan			Vitamin A Is a Negative Regulator of Osteoblast Mineralization	PLOS ONE			English	Article							CELLS IN-VITRO; RETINOIC ACID; OSTEOGENIC DIFFERENTIATION; MESENCHYMAL CELLS; STROMAL CELLS; HYP MICE; BONE; EXPRESSION; DEGRADATION; CYP26B1	An excessive intake of vitamin A has been associated with an increased risk of fractures in humans. In animals, a high vitamin A intake leads to a reduction of long bone diameter and spontaneous fractures. Studies in rodents indicate that the bone thinning is due to increased periosteal bone resorption and reduced radial growth. Whether the latter is a consequence of direct effects on bone or indirect effects on appetite and general growth is unknown. In this study we therefore used pair-feeding and dynamic histomorphometry to investigate the direct effect of a high intake of vitamin A on bone formation in rats. Although there were no differences in body weight or femur length compared to controls, there was an approximately halved bone formation and mineral apposition rate at the femur diaphysis of rats fed vitamin A. To try to clarify the mechanism(s) behind this reduction, we treated primary human osteoblasts and a murine preosteoblastic cell line (MC3T3-E1) with the active metabolite of vitamin A; retinoic acid (RA), a retinoic acid receptor (RAR) antagonist (AGN194310), and a Cyp26 inhibitor (R115866) which blocks endogenous RA catabolism. We found that RA, via RARs, suppressed in vitro mineralization. This was independent of a negative effect on osteoblast proliferation. Alkaline phosphatase and bone gamma carboxyglutamate protein (Bglap, Osteocalcin) were drastically reduced in RA treated cells and RA also reduced the protein levels of Runx2 and Osterix, key transcription factors for progression to a mature osteoblast. Normal osteoblast differentiation involved up regulation of Cyp26b1, the major enzyme responsible for RA degradation, suggesting that a drop in RA signaling is required for osteogenesis analogous to what has been found for chondrogenesis. In addition, RA decreased Phex, an osteoblast/osteocyte protein necessary for mineralization. Taken together, our data indicate that vitamin A is a negative regulator of osteoblast mineralization.	[Lind, Thomas; Sundqvist, Anders; Hu, Lijuan; Jacobson, Annica; Melhus, Hakan] Uppsala Univ, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden; [Pejler, Gunnar] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Andersson, Goran] Karolinska Inst, Karolinska Univ Hosp, Dept Lab Med, Div Pathol, Huddinge, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Karolinska Institutet; Karolinska University Hospital	Lind, T (corresponding author), Uppsala Univ, Clin Pharmacol Sect, Dept Med Sci, Uppsala, Sweden.	thomas.lind@medsci.uu.se		Lind, Thomas/0000-0003-2791-688X; Rasmusson, Annica/0000-0002-7228-7755	Swedish Medical Research Council	Swedish Medical Research Council(Swedish Medical Research Council (SMRC))	This work was supported by The Swedish Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binkley N, 2000, NUTR REV, V58, P138, DOI 10.1111/j.1753-4887.2000.tb01848.x; Candeliere GA, 2001, BONE, V28, P351, DOI 10.1016/S8756-3282(01)00410-0; Cohen-Tanugi A, 1998, DIFFERENTIATION, V63, P115, DOI 10.1046/j.1432-0436.1998.6330115.x; Feskanich D, 2002, JAMA-J AM MED ASSOC, V287, P47, DOI 10.1001/jama.287.1.47; Gericke J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062643; Hoffman LM, 2006, J CELL BIOL, V174, P101, DOI 10.1083/jcb.200604150; Hollberg K, 2002, EXP CELL RES, V279, P227, DOI 10.1006/excr.2002.5612; Hollberg K, 2008, BONE, V42, P1111, DOI 10.1016/j.bone.2008.01.019; Hu LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013305; Iba K, 2001, CELL STRUCT FUNCT, V26, P227, DOI 10.1247/csf.26.227; Inoue A, 1996, BIOCHEM BIOPH RES CO, V228, P182, DOI 10.1006/bbrc.1996.1636; IWAMOTO M, 1994, MICROSC RES TECHNIQ, V28, P483, DOI 10.1002/jemt.1070280604; IWAMOTO M, 1993, EXP CELL RES, V207, P413, DOI 10.1006/excr.1993.1209; Jacobson A, 2004, BIOCHEM BIOPH RES CO, V322, P162, DOI 10.1016/j.bbrc.2004.07.092; James AW, 2010, PLAST RECONSTR SURG, V125, P1352, DOI 10.1097/PRS.0b013e3181d62980; Jimi E, 1996, ENDOCRINOLOGY, V137, P2187; Johansson S, 2002, BONE, V31, P685, DOI 10.1016/S8756-3282(02)00910-9; Jones DC, 2006, SCIENCE, V312, P1223, DOI 10.1126/science.1126313; Jonsson KB, 1999, ACTA ORTHOP SCAND, V70, P365, DOI 10.3109/17453679908997826; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; KINDMARK A, 1993, BIOCHEM BIOPH RES CO, V192, P1367, DOI 10.1006/bbrc.1993.1567; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Laue K, 2011, AM J HUM GENET, V89, P595, DOI 10.1016/j.ajhg.2011.09.015; Lee LMY, 2012, P NATL ACAD SCI USA, V109, P13668, DOI 10.1073/pnas.1200872109; Li XN, 2008, J CELL BIOL, V181, P959, DOI 10.1083/jcb.200711044; Lind T, 2011, BONE, V48, P496, DOI 10.1016/j.bone.2010.10.169; Liu F, 1997, EXP CELL RES, V232, P97, DOI 10.1006/excr.1997.3501; Maclean G, 2009, DEV DYNAM, V238, P732, DOI 10.1002/dvdy.21878; Malladi P, 2006, TISSUE ENG, V12, P2031, DOI 10.1089/ten.2006.12.2031; Martin A, 2012, MOL ENDOCRINOL, V26, P1883, DOI 10.1210/me.2012-1062; Martin A, 2011, FASEB J, V25, P2551, DOI 10.1096/fj.10-177816; Mattinzoli D, 2012, EUR CELLS MATER, V24, P403, DOI 10.22203/eCM.v024a29; Mbalaviele G, 1998, J CELL BIOL, V141, P1467, DOI 10.1083/jcb.141.6.1467; Melhus H, 1998, ANN INTERN MED, V129, P770, DOI 10.7326/0003-4819-129-10-199811150-00003; Michaelsson K, 2003, NEW ENGL J MED, V348, P287, DOI 10.1056/NEJMoa021171; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nuka S, 1997, CELL STRUCT FUNCT, V22, P27, DOI 10.1247/csf.22.27; OHISHI K, 1995, EUR J ENDOCRINOL, V133, P335, DOI 10.1530/eje.0.1330335; PACIFICI M, 1980, EXP CELL RES, V129, P469, DOI 10.1016/0014-4827(80)90517-0; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Prince M, 2001, J CELL BIOCHEM, V80, P424, DOI 10.1002/1097-4644(20010301)80:3<424::AID-JCB160>3.0.CO;2-6; Rashid H, 2012, ASBMR ANN M; Reijntjes S, 2003, GENE EXPR PATTERNS, V3, P621, DOI 10.1016/S1567-133X(03)00112-1; Roforth MM, 2012, J BONE MINER RES, V27, P891, DOI 10.1002/jbmr.1502; Seitz S, 2013, BONE, V53, P231, DOI 10.1016/j.bone.2012.12.009; Sheng NY, 2010, P NATL ACAD SCI USA, V107, P18886, DOI 10.1073/pnas.1009244107; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; SMITH FR, 1976, NEW ENGL J MED, V294, P805, DOI 10.1056/NEJM197604082941503; Song HM, 2005, J CELL PHYSIOL, V202, P255, DOI 10.1002/jcp.20115; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Wan DC, 2007, TISSUE ENG, V13, P1623, DOI 10.1089/ten.2006.0283; Wang W, 2002, J CELL BIOL, V157, P1061, DOI 10.1083/jcb.200203014; WILEY MJ, 1983, TERATOLOGY, V28, P341, DOI 10.1002/tera.1420280306; Wiper-Bergeron N, 2007, MOL ENDOCRINOL, V21, P2124, DOI 10.1210/me.2006-0452; Woo SM, 2011, J BONE MINER RES, V26, P2634, DOI 10.1002/jbmr.465; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Yamashita A, 2005, CLONING STEM CELLS, V7, P232, DOI 10.1089/clo.2005.7.232; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	58	50	51	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82388	10.1371/journal.pone.0082388	http://dx.doi.org/10.1371/journal.pone.0082388			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340023	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400074
J	Meng, J; Zhou, P; Liu, YF; Liu, F; Yi, XL; Liu, SX; Holtappels, G; Bachert, C; Zhang, N				Meng, Juan; Zhou, Peng; Liu, Yafeng; Liu, Feng; Yi, Xuelian; Liu, Shixi; Holtappels, Gabriele; Bachert, Claus; Zhang, Nan			The Development of Nasal Polyp Disease Involves Early Nasal Mucosal Inflammation and Remodelling	PLOS ONE			English	Article							EPITHELIAL-CELLS; MYOFIBROBLAST DIFFERENTIATION; CHRONIC RHINOSINUSITIS; ALTERNATIVE ACTIVATION; COLLAGEN PRODUCTION; GENE-EXPRESSION; TIGHT JUNCTIONS; SINUS DISEASE; FIBRONECTIN; FIBROSIS	Chronic rhinosinusitis with nasal polyps (CRSwNP) is characterized by both a chronic inflammation and tissue remodelling; as indicated by extracellular matrix protein deposition, basement membrane thickening, goblet cell hyperplasia and subepithelial edema, with reduced vessels and glands. Although remodelling is generally considered to be consequence of persistent inflammation, the chronological order and relationship between inflammation and remodelling in polyp development is still not clear. The aim of our study was therefore to investigate the pathological features prevalent in the development of nasal polyps and to elucidate the chronological order and relationship between inflammation and remodelling, by comparing specific markers of inflammation and remodelling in early stage nasal polyps confined to the middle turbinate (refer to as middle turbinate CRSwNP) obtained from 5 CRSwNP patients with bilateral polyposis, mature ethmoidal polyps from 6 CRSwNP patients, and normal nasal mucosal tissue from 6 control subjects. Middle turbinate CRSwNP demonstrated significantly more severe epithelial loss compared to mature ethmoidal polyps and normal nasal mucosa. The epithelial cell junction molecules E-cadherin, ZO-1 and occludin were also expressed in significantly lower amounts in mature ethmoidal polyps compared to healthy mucosa. Middle turbinate CRSwNP were further characterized by significantly increased numbers of subepithelial eosinophils and M2 type macrophages, with a distinct lack of collagen and deposition of fibronectin in polyp part. In contrast, the turbinate area of the middle turbinate CRSwNP was characterized by an increase in TGF-beta activated myofibroblasts expressing alpha-SMA and vimentin, an increase in the number of pSmad2 positive cells, as well as increased deposition of collagen. These findings suggest a complex network of processes in the formation of CRSwNP; including gross epithelial damage and repair reactions, eosinophil and macrophage cell infiltration, and tissue remodelling. Furthermore, remodelling appears to occur in parallel, rather than subsequent to inflammation.	[Meng, Juan; Zhou, Peng; Liu, Yafeng; Liu, Feng; Yi, Xuelian; Liu, Shixi] Sichuan Univ, West China Med Sch, West China Hosp, Dept Otorhinolaryngol, Chengdu, Sichuan, Peoples R China; [Holtappels, Gabriele; Bachert, Claus; Zhang, Nan] Ghent Univ Hosp, Dept Otorhinolaryngol, Upper Airway Res Lab, Ghent, Belgium; [Bachert, Claus] Karolinska Inst, Clintec, Div ENT Dis, Stockholm, Sweden	Sichuan University; Ghent University; Ghent University Hospital; Karolinska Institutet	Liu, SX (corresponding author), Sichuan Univ, West China Med Sch, West China Hosp, Dept Otorhinolaryngol, Chengdu, Sichuan, Peoples R China.	liusx999@163.com	Bachert, Claus/J-8825-2012; Zhang, Nan/AAQ-3944-2020		Flemish Scientific Research Board [A12/5-HB-KH3, G.0436.04]; Global Allergy and Asthma European Network; Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy [IAP P6/35]; European Commission [260895]; National Natural Science Foundation of China [81271058]; Ph.D. Programs Foundation of Ministry of Education of China [20100181110024]	Flemish Scientific Research Board(FWO); Global Allergy and Asthma European Network; Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office); European Commission(European CommissionEuropean Commission Joint Research Centre); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This work was supported by grants to Claus Bachert from the Flemish Scientific Research Board, Nr. A12/5-HB-KH3 and G.0436.04, the Global Allergy and Asthma European Network and the Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy, Nr. IAP P6/35, and from the European Commission's Seventh Framework programme under grant agreement 260895 (PREDICTA) and by grants to SXL from the National Natural Science Foundation of China (grant NO. 81271058) and Ph.D. Programs Foundation of Ministry of Education of China (NO. 20100181110024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANWAR ARE, 1994, IMMUNOLOGY, V82, P222; ANWAR ARF, 1993, J EXP MED, V177, P839, DOI 10.1084/jem.177.3.839; Bachert C, 2000, AM J RHINOL, V14, P279, DOI 10.2500/105065800781329573; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Claeys S, 2005, CLIN EXP ALLERGY, V35, P467, DOI 10.1111/j.1365-2222.2005.02215.x; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Desmouliere A, 2003, LAB INVEST, V83, P1689, DOI 10.1097/01.LAB.0000101911.53973.90; Dutsch-Wicherek M, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-10; Evans SM, 2002, AM J RESP CELL MOL, V27, P446, DOI 10.1165/rcmb.4776; Fairweather D, 2009, J AUTOIMMUN, V33, P222, DOI 10.1016/j.jaut.2009.09.012; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Fokkens W, 2005, ALLERGY, V60, P583, DOI 10.1111/j.1398-9995.2005.00830.x; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Juniantito V, 2012, HISTOL HISTOPATHOL, V27, P515, DOI 10.14670/HH-27.515; Kicic A, 2010, AM J RESP CRIT CARE, V181, P889, DOI 10.1164/rccm.200907-1071OC; Krysko O, 2011, ALLERGY, V66, P396, DOI 10.1111/j.1398-9995.2010.02498.x; Lee HM, 2009, ANN OTO RHINOL LARYN, V118, P721, DOI 10.1177/000348940911801007; Li XY, 2010, J ALLERGY CLIN IMMUN, V125, P1061, DOI 10.1016/j.jaci.2010.02.023; Liu Y, 2000, J CELL SCI, V113, P2363; Malmstrom K, 2013, CURR OPIN ALLERGY CL, V13, P203, DOI 10.1097/ACI.0b013e32835e122c; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Marzioni D, 2001, MOL HUM REPROD, V7, P279, DOI 10.1093/molehr/7.3.279; Moon YM, 2012, INT ARCH ALLERGY IMM, V159, P399, DOI 10.1159/000337658; Moreira RK, 2007, ARCH PATHOL LAB MED, V131, P1728; Nakagawa T, 1998, ACTA OTO-LARYNGOL, P205; Nakagawa T, 1999, LARYNGOSCOPE, V109, P557, DOI 10.1097/00005537-199904000-00007; Norlander T, 1996, LARYNGOSCOPE, V106, P196, DOI 10.1097/00005537-199602000-00017; Park HH, 2010, AM J RHINOL ALLERGY, V24, P348, DOI 10.2500/ajra.2010.24.3520; Payne DNR, 2003, AM J RESP CRIT CARE, V167, P78, DOI 10.1164/rccm.200205-414OC; Polzehl D, 2006, ALLERGY, V61, P1275, DOI 10.1111/j.1398-9995.2006.01132.x; Sawada Norimasa, 2003, Medical Electron Microscopy, V36, P147, DOI 10.1007/s00795-003-0219-y; Serpero L, 2006, IMMUNOL LETT, V105, P61, DOI 10.1016/j.imlet.2006.01.003; SHOJI S, 1990, AM REV RESPIR DIS, V141, P218, DOI 10.1164/ajrccm/141.1.218; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Soyka MB, 2012, J ALLERGY CLIN IMMUN, V130, P1087, DOI 10.1016/j.jaci.2012.05.052; Takabayashi T, 2013, J ALLERGY CLIN IMMUN, V132, P584, DOI 10.1016/j.jaci.2013.02.003; Takabayashi T, 2013, AM J RESP CRIT CARE, V187, P49, DOI 10.1164/rccm.201207-1292OC; TREMBLE P, 1994, MOL BIOL CELL, V5, P439, DOI 10.1091/mbc.5.4.439; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Van Bruaene N, 2012, CLIN EXP ALLERGY, V42, P883, DOI 10.1111/j.1365-2222.2011.03898.x; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Van Bruaene N, 2009, J ALLERGY CLIN IMMUN, V124, P253, DOI 10.1016/j.jaci.2009.04.013; van Dijk A, 2008, CELL TISSUE RES, V332, P289, DOI 10.1007/s00441-008-0573-0; Van Zele T, 2006, ALLERGY, V61, P1280, DOI 10.1111/j.1398-9995.2006.01225.x; Wang JH, 2009, LARYNGOSCOPE, V119, P1406, DOI 10.1002/lary.20498; Wang Qiu-ping, 2006, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V41, P381; Wang XD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039875; Watelet JB, 2004, ALLERGY, V59, P54, DOI 10.1046/j.1398-9995.2003.00364.x; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yeo NK, 2010, LARYNGOSCOPE, V120, P346, DOI 10.1002/lary.20764; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008	57	83	88	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82373	10.1371/journal.pone.0082373	http://dx.doi.org/10.1371/journal.pone.0082373			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340021	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400073
J	Nasereddin, A; Shtayeh, I; Ramlawi, A; Salman, N; Salem, I; Abdeen, Z				Nasereddin, Abedelmajeed; Shtayeh, Issa; Ramlawi, Asad; Salman, Nisreen; Salem, Ibrahim; Abdeen, Ziad			Streptococcus pneumoniae from Palestinian Nasopharyngeal Carriers: Serotype Distribution and Antimicrobial Resistance	PLOS ONE			English	Article							INVASIVE PNEUMOCOCCAL DISEASE; CONJUGATE VACCINE; CHILDREN YOUNGER; CARRIAGE; PREVALENCE; REDUCTION; COUNTRY; ERA; 6C	Infections of Streptococcus pneumoniae in children can be prevented by vaccination; left untreated, they cause high morbidity and fatalities. This study aimed at determining the nasopharyngeal carrier rates, serotype distribution and antimicrobial resistance patterns of S. pneumoniae in healthy Palestinian children under age two prior to the full introduction of the pneumococcal 7-valent conjugate vaccine (PCV7), which was originally introduced into Palestine in a pilot trial in September, 2010. In a cross sectional study, nasopharyngeal specimens were collected from 397 healthy children from different Palestinian districts between the beginning of November 2012 to the end of January 2013. Samples were inoculated into blood agar and suspected colonies were examined by amplifying the pneumococcal-specific autolysin gene using a real-time PCR. Serotypes were identified by a PCR that incorporated different sets of specific primers. Antimicrobial susceptibility was measured by disk diffusion and MIC methods. The resulting carrier rate of Streptococcus pneumoniae was 55.7% (221/397). The main serotypes were PCV7 serotypes 19F (12.2%), 23F (9.0%), 6B (8.6%) and 14 (4%) and PCV13 serotypes 6A (13.6%) and 19A (4.1%). Notably, serotype 6A, not included in the pilot trial (PCV7) vaccine, was the most prevalent. Resistance to more than two drugs was observed for bacteria from 34.1% of the children (72/211) while 22.3% (47/211) carried bacteria were susceptible to all tested antibiotics. All the isolates were sensitive to cefotaxime and vancomycin. Any or all of these might impinge on the type and efficacy of the pneumococcal conjugate vaccines and antibiotics to be used for prevention and treatment of pneumococcal disease in the country.	[Nasereddin, Abedelmajeed; Abdeen, Ziad] Al Quds Univ, Fac Med, Al Quds Nutr & Hlth Res Inst, Abu Deis, West Bank, Palestine; [Shtayeh, Issa; Ramlawi, Asad; Salman, Nisreen; Salem, Ibrahim] Palestinian Minist Hlth, Cent Publ Hlth Lab, Ramallah, Palestine		Nasereddin, A (corresponding author), Al Quds Univ, Fac Med, Al Quds Nutr & Hlth Res Inst, Abu Deis, West Bank, Palestine.	abedn@ekmd.huji.ac.il; ramlawi_asad@hotmail.com	Abdeen, Ziad/AAC-7889-2019; Nasereddin, Abedelmajeed/N-4150-2017	Nasereddin, Abedelmajeed/0000-0001-8162-420X	Arab Company for Drug Industries AMP; Medical Appliances, Palestine	Arab Company for Drug Industries AMP; Medical Appliances, Palestine	The study was funded by The Arab Company for Drug Industries & Medical Appliances, Palestine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullahi O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030787; Al-Yaqoubi Mubarak M, 2011, Oman Med J, V26, P43, DOI 10.5001/omj.2011.11; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P93; Arai S, 2001, MICROBIOL IMMUNOL, V45, P159, DOI 10.1111/j.1348-0421.2001.tb01284.x; Aristegui J, 2007, EUR J CLIN MICROBIOL, V26, P303, DOI 10.1007/s10096-007-0294-4; Bogaert D, 2001, J CLIN MICROBIOL, V39, P3316, DOI 10.1128/JCM.39.9.3316-3320.2001; Borer A, 2001, CLIN INFECT DIS, V33, P436, DOI 10.1086/321888; Brugger SD, 2009, J CLIN MICROBIOL, V47, P1750, DOI 10.1128/JCM.01877-08; Cardozo Déa M., 2006, Braz J Infect Dis, V10, P293, DOI 10.1590/S1413-86702006000400015; Chiu SS, 2001, ANTIMICROB AGENTS CH, V45, P2765, DOI 10.1128/AAC.45.10.2765-2770.2001; CLSI, 2012, M02A11 CLSI; Dagan R, 2002, J INFECT DIS, V185, P927, DOI 10.1086/339525; Dashti AS, 2012, ARCH IRAN MED, V15, P500, DOI 012158/AIM.0012; Factor SH, 2005, EMERG INFECT DIS, V11, P1476, DOI 10.3201/eid1109.040798; Feikin DR, 2002, CLIN INFECT DIS, V35, P547, DOI 10.1086/341896; Harboe ZB, 2008, VACCINE, V26, P3765, DOI 10.1016/j.vaccine.2008.04.040; Hausdorff WP, 2000, CLIN INFECT DIS, V30, P100, DOI 10.1086/313608; Hicks LA, 2007, J INFECT DIS, V196, P1346, DOI 10.1086/521626; Isaacman DJ, 2010, INT J INFECT DIS, V14, pE197, DOI 10.1016/j.ijid.2009.05.010; Jacobs MR, 2008, CLIN INFECT DIS, V47, P1388, DOI 10.1086/592972; Jin P, 2009, J INFECT DIS, V200, P1375, DOI 10.1086/606118; Jin P, 2009, J CLIN MICROBIOL, V47, P2470, DOI 10.1128/JCM.00484-09; Kaltoft MS, 2008, J MICROBIOL METH, V75, P540, DOI 10.1016/j.mimet.2008.08.010; Kamerling JP., 2000, STREPTOCOCCUS PNEUMO, P81; Katsarolis I, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-120; Kattan R, 2011, EMERG INFECT DIS, V17, P94, DOI 10.3201/eid1701.100886; Lin WJ, 2006, DIAGN MICR INFEC DIS, V56, P189, DOI 10.1016/j.diagmicrobio.2006.03.016; Lo Wen-Tsung, 2003, Journal of Microbiology Immunology and Infection, V36, P175; Malfroot A, 2004, CLIN MICROBIOL INFEC, V10, P797, DOI 10.1111/j.1198-743X.2004.00926.x; Marchisio P, 2002, EMERG INFECT DIS, V8, P479; McAvin JC, 2001, J CLIN MICROBIOL, V39, P3446, DOI 10.1128/JCM.39.10.3446-3451.2001; McIntosh EDG, 2011, EXPERT REV VACCINES, V10, P109, DOI 10.1586/ERV.10.145; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Nahm MH, 2009, J INFECT DIS, V199, P320, DOI 10.1086/596064; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ozdemir B, 2008, J INFECTION, V56, P332, DOI 10.1016/j.jinf.2008.02.010; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Pai R, 2005, J CLIN MICROBIOL, V43, P4820, DOI 10.1128/JCM.43.9.4820-4822.2005; Quintero B, 2011, EUR J CLIN MICROBIOL, V30, P7, DOI 10.1007/s10096-010-1044-6; Regev-Yochay G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035061; Sa-Leao R, 2009, CLIN MICROBIOL INFEC, V15, P1002, DOI 10.1111/j.1469-0691.2009.02775.x; Sahni V, 2012, CAN J PUBLIC HEALTH, V103, P29, DOI 10.1007/BF03404065; Scheifele D, 2001, Can J Infect Dis, V12, P241; Shouval DS, 2009, PEDIATR INFECT DIS J, V28, P277, DOI 10.1097/INF.0b013e31818e0e2e; Sjostrom K, 2007, P NATL ACAD SCI USA, V104, P12907, DOI 10.1073/pnas.0705589104	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82047	10.1371/journal.pone.0082047	http://dx.doi.org/10.1371/journal.pone.0082047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339987	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400057
J	Nishijima, T; Gatanaga, H; Komatsu, H; Takano, M; Ogane, M; Ikeda, K; Oka, S				Nishijima, Takeshi; Gatanaga, Hiroyuki; Komatsu, Hirokazu; Takano, Misao; Ogane, Miwa; Ikeda, Kazuko; Oka, Shinichi			High Prevalence of Illicit Drug Use in Men Who Have Sex with Men with HIV-1 Infection in Japan	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FOLLOW-UP; RISK-FACTORS; INJECTION; COHORT	Objective: To examine the prevalence of illicit drug use among men who have sex with men (MSM) with HIV-1 infection in Japan, where the life-time prevalence of illicit drug use in the general population is only 2.9%. Design: A single-center cross-sectional study at a large HIV clinic in Tokyo, which treats approximately 15% of HIV-1 infected patients in Japan. Methods: The prevalence of illicit drug use and the assciation of characteristics and social demographics of the patients with illicit drug use were examined. Patients who visited the clinic for the first time from 2005 to 2010 were enrolled. Relevant variables were collected using a structured interview and from the medical records. Multivariate logistic regression analyses were applied to estimate the odds of association of MSM over non-MSM HIV-infected patients with illicit drug use. Results: 1,196 patients were enrolled. They were mostly Japanese men of relatively young age. Illicit drug use (including injection drugs) was reported by 35% of the patients (by 40% of MSM), and 4% were IDU while 5% were on methamphetamine. 2% of the population was arrested due to illicit drugs. MSM was significantly associated with illicit drug use (adjusted OR = 4.60; 95% CI, 2.88-7.36; p<0.01). Subgroup analysis of the patients stratified by three age groups (<= 30, 31 to 40, and >40) showed that the odds of association of MSM with illicit drug use was the strongest in the youngest age group (<= 30 years: adjusted OR = 7.56; 95% CI, 2.86-20.0; p<0.01), followed by the oldest (>40 years: adjusted OR = 6.15; 95% CI, 2.40-15.8; p<0.01), and the weakest in the group aged 31 to 40 (adjusted OR = 3.39; 95% CI, 1.73-6.63; p<0.01). Conclusions: The prevalence of illicit drug use is high among MSM patients with HIV-1 infection in Japan. Effective intervention for illicit drug use in this population is warranted.	[Nishijima, Takeshi; Gatanaga, Hiroyuki; Takano, Misao; Ogane, Miwa; Ikeda, Kazuko; Oka, Shinichi] Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan; [Nishijima, Takeshi; Gatanaga, Hiroyuki; Oka, Shinichi] Kumamoto Univ, Ctr AIDS Res, Kumamoto, Japan; [Komatsu, Hirokazu] Saku Cent Hosp, Dept Community Care, Nagano, Japan	National Center for Global Health & Medicine - Japan; Kumamoto University	Gatanaga, H (corresponding author), Natl Ctr Global Hlth & Med, AIDS Clin Ctr, Tokyo, Japan.	higatana@acc.ncgm.go.jp		Oka, Shinichi/0000-0002-9283-2167	Japanese Ministry of Health, Labour, and Welfare [H23-AIDS-001]	Japanese Ministry of Health, Labour, and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in Aid for AIDS research from the Japanese Ministry of Health, Labour, and Welfare (H23-AIDS-001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen YMA, 2007, LANCET, V369, P623, DOI 10.1016/S0140-6736(07)60291-8; Forrest DW, 2010, J URBAN HEALTH, V87, P480, DOI 10.1007/s11524-009-9422-z; Giordano TR, 2009, HIV CLIN TRIALS, V10, P299, DOI 10.1310/hct1005-299; HAHN RA, 1989, JAMA-J AM MED ASSOC, V261, P2677, DOI 10.1001/jama.261.18.2677; Hidaka Y, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-239; Horstmann E, 2010, CLIN INFECT DIS, V50, P752, DOI 10.1086/649933; Lankenau SE, 2012, INT J DRUG POLICY, V23, P37, DOI 10.1016/j.drugpo.2011.05.014; Latkin CA, 2001, J SUBST ABUSE, V13, P89, DOI 10.1016/S0899-3289(01)00070-0; Lebouche B, 2006, HIV MED, V7, P140, DOI 10.1111/j.1468-1293.2006.00357.x; LEHMAN JS, 1994, AIDS, V8, P1465, DOI 10.1097/00002030-199410000-00014; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malta M, 2010, AIDS BEHAV, V14, P731, DOI 10.1007/s10461-008-9489-7; Mansergh G, 2006, SEX TRANSM INFECT, V82, P131, DOI 10.1136/sti.2005.017129; Millett GA, 2006, AM J PUBLIC HEALTH, V96, P1007, DOI 10.2105/AJPH.2005.066720; Milloy MJS, 2012, AIDS, V26, P1049, DOI 10.1097/QAD.0b013e32835221cc; Mocroft A, 2008, HIV MED, V9, P261, DOI 10.1111/j.1468-1293.2008.00557.x; Ndiaye B, 2009, ANTIVIR THER, V14, P567; Nishijima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072310; Nishijima T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029977; Pollini RA, 2011, SUBST ABUSE REHABIL, V2, P173, DOI 10.2147/SAR.S24800; Porter K, 2003, LANCET, V362, P1267, DOI 10.1016/S0140-6736(03)14570-9; Qian HZ, 2011, J SUBST ABUSE TREAT, V41, P14, DOI 10.1016/j.jsat.2011.01.007; Rice BD, 2011, SEX TRANSM DIS, V38, P685, DOI 10.1097/OLQ.0b013e318214b92e; Strathdee SA, 1998, JAMA-J AM MED ASSOC, V280, P547, DOI 10.1001/jama.280.6.547; Tominaga M, 2009, SOC PSYCH PSYCH EPID, V44, P777, DOI 10.1007/s00127-009-0499-1; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Wada K, 2011, ANN NY ACAD SCI, V1216, P62, DOI 10.1111/j.1749-6632.2010.05914.x; Weber R, 2009, HIV MED, V10, P407, DOI 10.1111/j.1468-1293.2009.00701.x; Wood E, 2003, J INFECT DIS, V188, P1164, DOI 10.1086/378703; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	30	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81960	10.1371/journal.pone.0081960	http://dx.doi.org/10.1371/journal.pone.0081960			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VW	24339982	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400054
J	Osada, M; Singh, VJ; Wu, KM; Sant'Angelo, DB; Pezzano, M				Osada, Masako; Singh, Varan J.; Wu, Kenmin; Sant'Angelo, Derek B.; Pezzano, Mark			Label Retention Identifies a Multipotent Mesenchymal Stem Cell-Like Population in the Postnatal Thymus	PLOS ONE			English	Article							HUMAN ADIPOSE-TISSUE; EPITHELIAL-CELLS; IN-VITRO; TRANSCRIPTION FACTORS; FIBRIN MICROBEADS; STROMAL CELLS; ADULT MARROW; FETAL LIVER; DIFFERENTIATION; EXPRESSION	Thymic microenvironments are essential for the proper development and selection of T cells critical for a functional and self-tolerant adaptive immune response. While significant turnover occurs, it is unclear whether populations of adult stem cells contribute to the maintenance of postnatal thymic epithelial microenvironments. Here, the slow cycling characteristic of stem cells and their property of label-retention were used to identify a K5-expressing thymic stromal cell population capable of generating clonal cell lines that retain the capacity to differentiate into a number of mesenchymal lineages including adipocytes, chondrocytes and osteoblasts suggesting a mesenchymal stem cell-like phenotype. Using cell surface analysis both culture expanded LRCs and clonal thymic mesenchymal cell lines were found to express Sca1, PDGFR alpha, PDGFR beta, CD29, CD44, CD49F, and CD90 similar to MSCs. Sorted GFP-expressing stroma, that give rise to TMSC lines, contribute to thymic architecture when reaggregated with fetal stroma and transplanted under the kidney capsule of nude mice. Together these results show that the postnatal thymus contains a population of mesenchymal stem cells that can be maintained in culture and suggests they may contribute to the maintenance of functional thymic microenvironments.	[Osada, Masako; Singh, Varan J.; Wu, Kenmin; Pezzano, Mark] CUNY City Coll, Dept Biol, New York, NY 10031 USA; [Sant'Angelo, Derek B.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pediat, Child Hlth Inst New Jersey, New Brunswick, NJ 08903 USA	City University of New York (CUNY) System; City College of New York (CUNY); Rutgers State University New Brunswick; Rutgers State University Medical Center	Pezzano, M (corresponding author), CUNY City Coll, Dept Biol, 138Th St & Convent Ave, New York, NY 10031 USA.	mpezzano@ccny.cuny.edu			National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) [1SC1AI081527, 9SC1AI104994]; NIH NCI [1U54CA137788]; NIH NIAID [R01 AI083988, AI059739]; Robert Wood Johnson Foundation [67038]; National Center for Research Resources [2G12RR03060-26A1]; National Institute on Minority Health and Health Disparities from the National Institutes of Health [8G12MD007603-27]; NATIONAL CANCER INSTITUTE [U54CA137788] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI081527, R01AI059739, R01AI083988, SC1AI104994] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007603] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities from the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by grants from National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) 1SC1AI081527 and 9SC1AI104994, NIH NCI 1U54CA137788 to M. P. D. B. S. was supported by NIH NIAID R01 AI083988 and AI059739 and by the Robert Wood Johnson Foundation (grant #67038) to the Child Health Institute of New Jersey. Infrastructure support for core facilities and technical staff at CCNY was provided by grants from the National Center for Research Resources (2G12RR03060-26A1) and the National Institute on Minority Health and Health Disparities (8G12MD007603-27) from the National Institutes of Health. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi K, 2007, MOL CELL BIOL, V27, P2202, DOI 10.1128/MCB.01908-06; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Baer PC, 2009, CELL PROLIFERAT, V42, P29, DOI 10.1111/j.1365-2184.2008.00572.x; Banas A, 2007, HEPATOLOGY, V46, P219, DOI 10.1002/hep.21704; BARCLAY AN, 1981, J EXP MED, V153, P1666, DOI 10.1084/jem.153.6.1666; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Battula VL, 2010, STEM CELLS, V28, P1435, DOI 10.1002/stem.467; Bennett AR, 2002, IMMUNITY, V16, P803, DOI 10.1016/S1074-7613(02)00321-7; Blackburn CC, 1996, P NATL ACAD SCI USA, V93, P5742, DOI 10.1073/pnas.93.12.5742; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Bowles J, 2003, CYTOGENET GENOME RES, V101, P261, DOI 10.1159/000074346; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brzoska M, 2005, BIOCHEM BIOPH RES CO, V330, P142, DOI 10.1016/j.bbrc.2005.02.141; Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Chai JY, 2010, BIOSCI TRENDS, V4, P130; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Corre J, 2006, J CELL PHYSIOL, V208, P282, DOI 10.1002/jcp.20655; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Fortunel NO, 2003, SCIENCE, V302, P393; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Fukuda K, 2003, BONE MARROW TRANSPL, V32, pS25, DOI 10.1038/sj.bmt.1703940; Gillard GO, 2006, J IMMUNOL, V176, P5815, DOI 10.4049/jimmunol.176.10.5815; Gimble JM, 2003, CURR TOP DEV BIOL, V58, P137, DOI 10.1016/S0070-2153(03)58005-X; Gimble JM, 2003, CYTOTHERAPY, V5, P362, DOI 10.1080/14653240310003026; Gordon J, 2004, NAT IMMUNOL, V5, P546, DOI 10.1038/ni1064; Gotter J, 2004, J EXP MED, V199, P155, DOI 10.1084/jem.20031677; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Gray DHD, 2002, J IMMUNOL METHODS, V260, P15, DOI 10.1016/S0022-1759(01)00493-8; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Itoi M, 2007, INT IMMUNOL, V19, P953, DOI 10.1093/intimm/dxm060; Jenkinson WE, 2007, BLOOD, V109, P954, DOI 10.1182/blood-2006-05-023143; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kasper S, 2009, UROL ONCOL-SEMIN ORI, V27, P301, DOI 10.1016/j.urolonc.2008.12.012; Kassis I, 2006, BONE MARROW TRANSPL, V37, P967, DOI 10.1038/sj.bmt.1705358; Kawamoto H, 1997, INT IMMUNOL, V9, P1011, DOI 10.1093/intimm/9.7.1011; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; Kvell K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010701; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lee CS, 2005, NATURE, V435, P944, DOI 10.1038/nature03649; Lee JH, 2006, BIOCHEM BIOPH RES CO, V341, P882, DOI 10.1016/j.bbrc.2006.01.038; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Liu F, 2007, NAT GENET, V39, P106, DOI 10.1038/ng1932; Long JL, 2010, LARYNGOSCOPE, V120, P125, DOI 10.1002/lary.20719; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morita H, 2004, MOL CELL BIOL, V24, P9736, DOI 10.1128/MCB.24.22.9736-9743.2004; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Nakao N, 2010, AM J PATHOL, V177, P547, DOI 10.2353/ajpath.2010.091042; Nguyen H, 2009, NAT GENET, V41, P1068, DOI 10.1038/ng.431; Okuda A, 1998, EMBO J, V17, P2019, DOI 10.1093/emboj/17.7.2019; Osada M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009062; Parent A. V., 2013, DEV CELL STEM CELL, V13, P219, DOI DOI 10.1016/J.STEM.2013.04.004; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Popa I, 2007, INT IMMUNOL, V19, P1249, DOI 10.1093/intimm/dxm092; Rodriguez LV, 2006, P NATL ACAD SCI USA, V103, P12167, DOI 10.1073/pnas.0604850103; Rossi SW, 2007, EUR J IMMUNOL, V37, P2411, DOI 10.1002/eji.200737275; Rossi SW, 2006, NATURE, V441, P988, DOI 10.1038/nature04813; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Shakib S, 2009, J IMMUNOL, V182, P130, DOI 10.4049/jimmunol.182.1.130; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1993, BLOOD, V82, P3327; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian V, 1998, DIFFERENTIATION, V64, P11, DOI 10.1046/j.1432-0436.1998.6410011.x; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Tateishi K, 2006, CIRCULATION, V114, P266; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; VANDERIJN M, 1989, P NATL ACAD SCI USA, V86, P4634; Wang GS, 2005, P NATL ACAD SCI USA, V102, P186, DOI 10.1073/pnas.0406266102; Welm BE, 2002, DEV BIOL, V245, P42, DOI 10.1006/dbio.2002.0625; Yamamoto Y, 1996, BLOOD, V88, P445, DOI 10.1182/blood.V88.2.445.bloodjournal882445; Yang HW, 2009, J IMMUNOL, V183, P3040, DOI 10.4049/jimmunol.0900562; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Youm YH, 2009, J BIOL CHEM, V284, P7068, DOI 10.1074/jbc.M808302200; Zangi L, 2006, TISSUE ENG, V12, P2343, DOI 10.1089/ten.2006.12.2343; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459; Zou ZM, 2010, EXPERT OPIN BIOL TH, V10, P215, DOI 10.1517/14712590903456011; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	95	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83024	10.1371/journal.pone.0083024	http://dx.doi.org/10.1371/journal.pone.0083024			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340075	Green Published, gold			2022-12-27	WOS:000328707400111
J	Shu, Y; Zhang, H; Kang, T; Zhang, JJ; Yang, Y; Liu, H; Zhang, L				Shu, Yi; Zhang, Hong; Kang, Tao; Zhang, Jun-jian; Yang, Ying; Liu, Hui; Zhang, Lei			PI3K/Akt Signal Pathway Involved in the Cognitive Impairment Caused by Chronic Cerebral Hypoperfusion in Rats	PLOS ONE			English	Article							PHOSPHOINOSITIDE 3-KINASE PATHWAY; CAROTID-ARTERY OCCLUSION; INJURY-INDUCED DECREASE; BLOOD-FLOW; PHOSPHATIDYLINOSITOL 3-KINASE; OBJECT RECOGNITION; GROWTH-FACTOR; SYNAPTIC PLASTICITY; BAD PHOSPHORYLATION; NEURONAL SURVIVAL	Chronic cerebral hypoperfusion (CCH) is a common pathophysiological state that usually occurs in conditions such as vascular dementia and Alzheimer's disease, both of which are characterized by cognitive impairment. In previous studies we found that learning capacity and memory were gradually impaired with CCH, which altered the expression of synaptophysin, microtubule associated protein-2, growth associated protein-43, brain-derived neurotrophic factor, nerve growth factor, N-methyl-D-aspartate receptor subunit 1, cAMP response element-binding protein and tau hyperpho-sphorylation in the hippocampus. However, the molecular basis of cognitive impairment in CCH remains obscure. Here we explore the hypothesis that the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) signal pathway is involved in this type of cognitive impairment. In order to determine if the expression of PI3K, Akt and phosphorylated Akt (p-Akt) proteins are altered at different stages of CCH with differing levels of cognitive impairment. we performed permanent, bilateral occlusion of the common carotid arteries (2-VO) to induce CCH. Adult male SD rats were randomly divided into sham-operated group, 2-VO 1 week group, 2-VO 4 weeks group and 2-VO 8 weeks group. Behavior tests were utilized to assess cognitive abilities, while western blots were utilized to evaluate protein expression. Rats in the 2-VO groups spent less time exploring novel objects than those in the sham-operated group, and the discrimination ratio of the 2-VO 8 weeks group and the sham-operated group were higher than chance (0.50). Escape latencies in the Morris water maze task in the 2-VO 1 week group were longer than those in the sham-operated group on day 4 and day 5, while escape latencies in the 2-VO 4 weeks group were longer than those in the sham-operated group from day 3 to day 5. Escape latencies in 2-VO 8 weeks group were longer than those in the sham-operated group from day 2 to day 5. NE (northeast) square swimming times in the 2-VO 1 week group, 2-VO 4 weeks group and 2-VO 8 weeks group were shorter than that in the sham-operated group. Western blotting showed that the PI3K expression in the 2-VO 1 week group was lower than that in sham-operated group, while p-Akt expression in the 2-VO 8 weeks group was higher than that in the sham-operated group. There was a linear relationship between the PI3K expression and the discrimination ratio, as well as a linear relationship between the PI3K and NE square swimming time. Thus, we propose that the PI3K/Akt signal pathway is an important cell pathway that is associated with the cognitive impairment following CCH.	[Shu, Yi; Zhang, Hong; Kang, Tao; Zhang, Jun-jian; Yang, Ying; Liu, Hui; Zhang, Lei] Wuhan Univ, Zhongnan Hosp, Dept Neurol, Wuhan 430072, Peoples R China	Wuhan University	Zhang, H (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Neurol, Wuhan 430072, Peoples R China.	zhangh9@gmail.com		Liu, Hui/0000-0003-0575-6678	Natural Science Foundation of Hubei Province in China [2009CDA077]; Scientific Research Foundation from Health Department of Hubei Province in China [JX5A04]	Natural Science Foundation of Hubei Province in China(Natural Science Foundation of Hubei Province); Scientific Research Foundation from Health Department of Hubei Province in China	This work was supported by the Key Projects of Natural Science Foundation of Hubei Province (2009CDA077) in China, and the Key Projects of Scientific Research Foundation from Health Department of Hubei Province (JX5A04) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg ND, 2008, SCI WORLD J, V6, P53; Arboleda G, 2009, BRAIN RES REV, V59, P333, DOI 10.1016/j.brainresrev.2008.10.001; Atwal JK, 2000, NEURON, V27, P265, DOI 10.1016/S0896-6273(00)00035-0; Atwal JK, 2003, J NEUROSCI, V23, P7602; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Chiang HC, 2010, P NATL ACAD SCI USA, V107, P7060, DOI 10.1073/pnas.0909314107; de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057; Dere E, 2007, NEUROSCI BIOBEHAV R, V31, P673, DOI 10.1016/j.neubiorev.2007.01.005; Dijkhuizen PA, 2005, J NEUROBIOL, V62, P278, DOI 10.1002/neu.20100; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Gao XW, 2008, J NEUROCHEM, V105, P943, DOI 10.1111/j.1471-4159.2008.05218.x; Gong XQ, 2012, NEUROSCI LETT, V513, P20, DOI 10.1016/j.neulet.2012.01.077; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Huang CR, 2007, NEUROBIOL AGING, V28, P1062, DOI 10.1016/j.neurobiolaging.2006.05.017; Huang L, 2008, CELL MOL NEUROBIOL, V28, P757, DOI 10.1007/s10571-007-9157-x; Jaworski J, 2005, J NEUROSCI, V25, P11300, DOI 10.1523/JNEUROSCI.2270-05.2005; Ji HJ, 2010, EUR J PHARMACOL, V636, P96, DOI 10.1016/j.ejphar.2010.03.038; Koh PO, 2008, J PINEAL RES, V44, P101, DOI 10.1111/j.1600-079X.2007.00495.x; Koh PO, 2006, J VET MED SCI, V68, P1019, DOI 10.1292/jvms.68.1019; Liu H, 2012, CURR NEUROVASC RES, V9, P152, DOI 10.2174/156720212801619027; Liu HX, 2005, MOL BRAIN RES, V139, P169, DOI 10.1016/j.molbrainres.2005.05.014; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Luckhaus C, 2008, NEUROIMAGE, V40, P495, DOI 10.1016/j.neuroimage.2007.11.053; Lunn JS, 2009, DEV NEUROBIOL, V69, P871, DOI 10.1002/dneu.20747; Maeda S, 2009, BRAIN RES, V1305, P1, DOI 10.1016/j.brainres.2009.09.025; Nadam J, 2007, NEUROBIOL DIS, V25, P412, DOI 10.1016/j.nbd.2006.10.009; Ohta H, 1997, NEUROSCIENCE, V79, P1039, DOI 10.1016/S0306-4522(97)00037-7; Osawa A, 2004, DISABIL REHABIL, V26, P739, DOI 10.1080/09638280410001704331; Otori T, 2003, CLIN EXP PHARMACOL P, V30, P266, DOI 10.1046/j.1440-1681.2003.03825.x; Sanchez S, 2001, J NEUROCHEM, V78, P468, DOI 10.1046/j.1471-4159.2001.00453.x; Sarti C, 2002, BEHAV BRAIN RES, V136, P13, DOI 10.1016/S0166-4328(02)00090-6; Shonesy BC, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.12.002; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Sun HM, 2010, CURR NEUROVASC RES, V7, P268, DOI 10.2174/156720210793180819; Takada-Takatori Y, 2006, NEUROPHARMACOLOGY, V51, P474, DOI 10.1016/j.neuropharm.2006.04.007; TSUCHIYA M, 1992, EXP BRAIN RES, V89, P87; Wang HY, 2009, BRAIN RES, V1297, P177, DOI 10.1016/j.brainres.2009.08.054; Won CK, 2005, NEUROSCI LETT, V387, P115, DOI 10.1016/j.neulet.2005.07.021; Xu XS, 2008, BRAIN RES, V1227, P12, DOI 10.1016/j.brainres.2008.06.018; Yao ZH, 2012, CURR NEUROVASC RES, V9, P176, DOI 10.2174/156720212801618974; Zhang L, 2013, PHARMACOL BIOCHEM BE, V103, P693, DOI 10.1016/j.pbb.2012.12.023; Zhang L, 2007, ARTERIOSCL THROM VAS, V27, P2470, DOI 10.1161/ATVBAHA.107.150748; Zhao Q, 2007, J PHARMACOL SCI, V103, P360, DOI 10.1254/jphs.FP0061457; Zheng P, 2008, CURR NEUROVASC RES, V5, P13; Zhou YL, 2010, STROKE, V41, P1521, DOI 10.1161/STROKEAHA.110.583757; Zhu H, 2011, NEUROSCI LETT, V502, P71, DOI 10.1016/j.neulet.2011.04.015	50	53	58	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81901	10.1371/journal.pone.0081901	http://dx.doi.org/10.1371/journal.pone.0081901			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339978	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400051
J	Landau, WM; Liu, P				Landau, William Michael; Liu, Peng			Dispersion Estimation and Its Effect on Test Performance in RNA-seq Data Analysis: A Simulation-Based Comparison of Methods	PLOS ONE			English	Article								A central goal of RNA sequencing (RNA-seq) experiments is to detect differentially expressed genes. In the ubiquitous negative binomial model for RNA-seq data, each gene is given a dispersion parameter, and correctly estimating these dispersion parameters is vital to detecting differential expression. Since the dispersions control the variances of the gene counts, underestimation may lead to false discovery, while overestimation may lower the rate of true detection. After briefly reviewing several popular dispersion estimation methods, this article describes a simulation study that compares them in terms of point estimation and the effect on the performance of tests for differential expression. The methods that maximize the test performance are the ones that use a moderate degree of dispersion shrinkage: the DSS, Tagwise wqCML, and Tagwise APL. In practical RNA-seq data analysis, we recommend using one of these moderate-shrinkage methods with the QLShrink test in QuasiSeq R package.	[Landau, William Michael; Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA 50011 USA	Iowa State University	Landau, WM (corresponding author), Iowa State Univ, Dept Stat, Ames, IA 50011 USA.	landau@iastate.edu		Landau, William/0000-0003-1878-3253	National Science Foundation [IOS-1127017]; Div Of Molecular and Cellular Bioscience [1127017] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported in part by the National Science Foundation Grant IOS-1127017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, GENOME BIOL, V11; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Hammer P, 2010, GENOME RES, V20, P847, DOI 10.1101/gr.101204.109; Joe H, 2006, J MULTIVARIATE ANAL, V97, P2177, DOI 10.1016/j.jmva.2005.05.010; Langmead B, 2012, RECOUNT MULTIEXPERIM; Lund SP, 2012, STAT APPL GENET MOL, V11, DOI 10.1515/1544-6115.1826; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Oshlack A, 2010, GENOME BIOL, V11; Pickrell JK, 2010, NATURE, V464, P768, DOI 10.1038/nature08872; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robinson MD, 2010, GENOME BIOL, V11, P1275; Robinson MD, 2012, PACKAGE EDGER; Si Y, 2012, PACKAGE AMAP SEQ; Si YQ, 2013, BIOMETRICS, V69, P594, DOI 10.1111/biom.12036; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wu H., 2012, BIOSTATISTICS, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0044333; Xiong Y, 2012, EVALUATION NORMALIZA; Yu DN, 2013, BIOINFORMATICS, V29, P1275, DOI 10.1093/bioinformatics/btt143	20	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81415	10.1371/journal.pone.0081415	http://dx.doi.org/10.1371/journal.pone.0081415			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349066	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200026
J	Lu, Q; Tong, B; Luo, YB; Sha, L; Chou, GX; Wang, ZT; Xia, YF; Dai, Y				Lu, Qian; Tong, Bei; Luo, Yubin; Sha, Li; Chou, Guixin; Wang, Zhengtao; Xia, Yufeng; Dai, Yue			Norisoboldine Suppresses VEGF-Induced Endothelial Cell Migration via the cAMP-PKA-NF-kappa B/Notch1 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; SIGNAL-TRANSDUCTION; SRC-FAMILY; ANGIOGENESIS; GROWTH; INHIBITION; ACTIVATION; CURCUMIN; LIFE	The migration of endothelial cells has been regarded as a potential target for the treatment of angiogenesis-related diseases. Previously, we demonstrated that norisoboldine (NOR), an alkaloid compound isolated from Radix Linderae, can significantly suppress synovial angiogenesis by selectively inhibiting endothelial cell migration. In this study, we evaluated the importance of various pathways in VEGF-induced endothelial cell migration using specific inhibitor. VEGF-induced endothelial cell migration and sprouting were significantly inhibited by H-89 (an inhibitor of protein kinase A (PKA)) but not by inhibitors of other pathways. NOR markedly suppressed VEGF-induced intracytoplasmic cAMP production and PKA activation and thereby down-regulated the activation of downstream components of the PKA pathway, including enzymes (src, VASP and eNOS) and the transcription factor NF-kappa B. Moreover, the transcription activation potential of NF-kappa B, which is related to l kappa beta alpha phosphorylation and the disruption of the p65/l kappa beta alpha complex, was reduced by NOR. Meanwhile, NOR selectively inhibited the expression of p-p65 (ser276) but not p-p65 (ser536) or PKAc, indicating that PKAc participates in the regulation of NF-kappa B by NOR. Co-immunoprecipitation and immunofluorescence assays confirmed that NOR inhibited the formation of the PKAc/p65 complex and thereby decreased p65 (ser276) phosphorylation to prevent p65 binding to DNA. Docking models indicated that the affinity of NOR for PKA was higher than that of the original PKA ligand. Moreover, the fact that H-89 improved Notch1 activation, but DAPT (an inhibitor of Notch) failed to affect PKA activation, suggested that PKA may act on upstream of Notch1. In conclusion, the inhibitory effects of NOR on endothelial cell migration can be attributed to its modulation of the PKA pathway, especially on the processes of p65/l kappa beta alpha complex disruption and PKAc/p65 complex formation. These results suggest that NOR inhibit VEGF-induced endothelial cell migration via a cAMP-PKA-NF-kappa B/Notch1 signaling pathway.	[Lu, Qian; Tong, Bei; Luo, Yubin; Xia, Yufeng; Dai, Yue] China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Sha, Li] Nanjing Med Univ, Nanjing Maternal & Child Hlth Hosp, Dept Pediat, Nanjing, Jiangsu, Peoples R China; [Chou, Guixin; Wang, Zhengtao] Shanghai Univ Tradit Chinese Med, Inst Chinese Mat Med, Shanghai, Peoples R China	China Pharmaceutical University; Nanjing Medical University; Shanghai University of Traditional Chinese Medicine	Xia, YF (corresponding author), China Pharmaceut Univ, Dept Pharmacol Chinese Mat Med, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	yfxiacpu@126.com; yuedaicpu@hotmail.com	Wang, Zhengtao/AAH-7360-2019; Tong, Bei/HGE-8171-2022	Wang, Zhengtao/0000-0003-2797-4625; 	National Natural Science Foundation of China [81373426]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University [PCSIRT-IRT1193]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Natural Science Foundation of China (No. 81373426) and the Priority Academic Program Development of Jiangsu Higher Education Institutions, and was partially funded by the Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT-IRT1193). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Basu A, 2007, CELL SIGNAL, V19, P1633, DOI 10.1016/j.cellsig.2007.04.008; Bello G, 2008, ATHEROSCLEROSIS, V200, P286, DOI 10.1016/j.atherosclerosis.2007.12.046; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; Chou Gui-Xin, 2005, Chinese Journal of Natural Medicines, V3, P272; Engen JR, 2008, CELL MOL LIFE SCI, V65, P3058, DOI 10.1007/s00018-008-8122-2; Giorgi C, 2010, ANTIOXID REDOX SIGN, V13, P1051, DOI 10.1089/ars.2009.2825; Hofer E, 2007, THROMB HAEMOSTASIS, V97, P355, DOI 10.1160/TH06-08-0470; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Ichiki T, 2006, ARTERIOSCL THROM VAS, V26, P449, DOI 10.1161/01.ATV.0000196747.79349.d1; Janssen-Heininger YMW, 2000, FREE RADICAL BIO MED, V28, P1317, DOI 10.1016/S0891-5849(00)00218-5; Jutooru I, 2010, J BIOL CHEM, V285, P25332, DOI 10.1074/jbc.M109.095240; Khalil RA, 2013, PHARMACEUTICALS, V6, P407, DOI 10.3390/ph6030407; Kim C, 2006, EUR J CELL BIOL, V85, P651, DOI 10.1016/j.ejcb.2006.02.004; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim SH, 2013, ARCH PHARM IN PRESS; Konoplyannikov M, 2013, STEM CELLS DEV, V22, P204, DOI 10.1089/scd.2011.0575; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lainer-Carr D, 2007, NAT CLIN PRACT RHEUM, V3, P434, DOI 10.1038/ncprheum0559; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Lieu C, 2010, CLIN COLORECTAL CANC, V9, P89, DOI 10.3816/CCC.2010.n.012; Lu DA, 2012, EXP BIOL MED, V237, P919, DOI 10.1258/ebm.2012.011416; Luo YB, 2010, INFLAMMATION, V33, P389, DOI 10.1007/s10753-010-9197-0; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Munoz-Chapuli R, 2004, CELL MOL LIFE SCI, V61, P2224, DOI 10.1007/s00018-004-4070-7; Nakatsu MN, 2003, LAB INVEST, V83, P1873, DOI 10.1097/01.LAB.0000107160.81875.33; Nissen NN, 1998, AM J PATHOL, V152, P1445; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Pandey MK, 2007, BLOOD, V110, P3517, DOI 10.1182/blood-2007-03-079616; Park Hong-Bum, 2011, Korean J Hematol, V46, P265, DOI 10.5045/kjh.2011.46.4.265; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Sastri M, 2005, P NATL ACAD SCI USA, V102, P349, DOI 10.1073/pnas.0408608102; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Szekanecz Z, 2010, CURR OPIN RHEUMATOL, V22, P299, DOI 10.1097/BOR.0b013e328337c95a; Szekanecz Z, 2009, AUTOIMMUNITY, V42, P563, DOI 10.1080/08916930903143083; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Wei ZF, 2013, ACTA PHARMACOL SIN, V34, P403, DOI 10.1038/aps.2012.187; Welf ES, 2011, WIRES SYST BIOL MED, V3, P231, DOI 10.1002/wsbm.110; Xing DQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024021; Zhang DL, 2010, MOL CELL BIOCHEM, V335, P1, DOI 10.1007/s11010-009-0234-y; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; Zhuang LL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060630	44	18	18	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81220	10.1371/journal.pone.0081220	http://dx.doi.org/10.1371/journal.pone.0081220			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349042	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200017
J	Xia, XL; Xing, HL; Liu, XQ				Xia, Xiao-Lei; Xing, Huanlai; Liu, Xueqin			Analyzing Kernel Matrices for the Identification of Differentially Expressed Genes	PLOS ONE			English	Article							SUPPORT VECTOR MACHINES; MICROARRAY DATA; FEATURE-SELECTION; CANCER CLASSIFICATION; STATISTICAL-METHODS; PREDICTION; VALIDATION; ALGORITHMS; DISCOVERY	One of the most important applications of microarray data is the class prediction of biological samples. For this purpose, statistical tests have often been applied to identify the differentially expressed genes (DEGs), followed by the employment of the state-of-the-art learning machines including the Support Vector Machines (SVM) in particular. The SVM is a typical sample-based classifier whose performance comes down to how discriminant samples are. However, DEGs identified by statistical tests are not guaranteed to result in a training dataset composed of discriminant samples. To tackle this problem, a novel gene ranking method namely the Kernel Matrix Gene Selection (KMGS) is proposed. The rationale of the method, which roots in the fundamental ideas of the SVM algorithm, is described. The notion of ''the separability of a sample'' which is estimated by performing t-like statistics on each column of the kernel matrix, is first introduced. The separability of a classification problem is then measured, from which the significance of a specific gene is deduced. Also described is a method of Kernel Matrix Sequential Forward Selection (KMSFS) which shares the KMGS method's essential ideas but proceeds in a greedy manner. On three public microarray datasets, our proposed algorithms achieved noticeably competitive performance in terms of the B.632+ error rate.	[Xia, Xiao-Lei] Jiaxing Univ, Sch Mech & Elect Engn, Jiaxing, Peoples R China; [Xing, Huanlai] Southwest Jiaotong Univ, Sch Informat Sci & Technol, Chengdu, Peoples R China; [Liu, Xueqin] Queens Univ Belfast, Sch Elect Elect Engn & Comp Sci, Belfast, Antrim, North Ireland	Jiaxing University; Southwest Jiaotong University; Queens University Belfast	Xia, XL (corresponding author), Jiaxing Univ, Sch Mech & Elect Engn, Jiaxing, Peoples R China.	xxia01@qub.ac.uk	Xing, Huanlai/AFQ-0689-2022	Xing, Huanlai/0000-0002-6345-7265; Liu, Xueqin/0000-0001-7703-3394	Natural Science Foundation, Zhejiang Province, P.R. China [LQ13F030011]; National Science Foundation of P.R. China [61133010]	Natural Science Foundation, Zhejiang Province, P.R. China; National Science Foundation of P.R. China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Natural Science Foundation, Zhejiang Province, P.R. China (Project No. LQ13F030011) and National Science Foundation of P.R. China (Project No. 61133010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bo TH, 2002, GENOME BIOL, V3; Braga-Neto UM, 2004, BIOINFORMATICS, V20, P374, DOI 10.1093/bioinformatics/btg419; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Burges CJC, 1998, DATA MIN KNOWL DISC, V2, P121, DOI 10.1023/A:1009715923555; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cho JH, 2003, FEBS LETT, V551, P3, DOI 10.1016/S0014-5793(03)00819-6; Cristianini Nello, 2000, INTRO SUPPORT VECTOR; Cui DL, 2001, CONF P INDIUM PHOSPH, P224, DOI 10.1109/ICIPRM.2001.929098; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Devijver P, 1982, PATTERN RECOGNITION; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Ding C, 2003, PROCEEDINGS OF THE 2003 IEEE BIOINFORMATICS CONFERENCE, P523, DOI 10.1109/CSB.2003.1227396; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Dudoit S, 2002, STAT SINICA, V12, P111; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; HOLM S, 1979, SCAND J STAT, V6, P65; Huang DS, 1999, INT J PATTERN RECOGN, V13, P1083, DOI 10.1142/S0218001499000604; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Jirapech-Umpai T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-148; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Li LP, 2001, BIOINFORMATICS, V17, P1131, DOI 10.1093/bioinformatics/17.12.1131; Lonnstedt I, 2002, STAT SINICA, V12, P31; Mamitsuka H, 2006, PATTERN RECOGN, V39, P2393, DOI 10.1016/j.patcog.2006.07.010; Ooi CH, 2003, BIOINFORMATICS, V19, P37, DOI 10.1093/bioinformatics/19.1.37; Pan W, 2002, BIOINFORMATICS, V18, P546, DOI 10.1093/bioinformatics/18.4.546; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Shipp MA, 2002, NAT MED, V8, P68, DOI 10.1038/nm0102-68; Slonim DK, 2002, NAT GENET, V32, P502, DOI 10.1038/ng1033; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Tang EK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-95; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang Y, 2005, COMPUT BIOL CHEM, V29, P37, DOI 10.1016/j.compbiolchem.2004.11.001; Westfall P.H., 1993, RESAMPLING BASED MUL, V279; Xing E.P., 2001, ICML CITESEER, V1, P601; Yang K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-228; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r83; Zhou X, 2005, BIOINFORMATICS, V21, P1559, DOI 10.1093/bioinformatics/bti216; Zhou X, 2006, BIOINFORMATICS, V22, P2507, DOI 10.1093/bioinformatics/btl438	48	2	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81683	10.1371/journal.pone.0081683	http://dx.doi.org/10.1371/journal.pone.0081683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349110	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200044
J	Falcone, M; Yariz, KO; Ross, DB; Foster, J; Menendez, I; Tekin, M				Falcone, Michelle; Yariz, Kemal O.; Ross, David B.; Foster, Joseph, II; Menendez, Ibis; Tekin, Mustafa			An Amino Acid Deletion inSZT2 in a Family with Non-Syndromic Intellectual Disability	PLOS ONE			English	Article							DNA-SEQUENCING DATA; MUTATIONS; FRAMEWORK; SZT2	Autosomal recessive intellectual disability (ID) is characterized by extensive genetic heterogeneity. Recently, three mutations in SZT2 were reported in two unrelated children with unexplained infantile epileptic encephalopathy with severe ID. Here we report a European American family with three children having non-syndromic mild or moderate ID without seizures. Whole-exome sequencing of three affected siblings revealed a three base pair deletion (c. 4202_4204delTTC) located in a 19 mb autozygous region on chromosome 1, leading to an amino acid deletion (p. Phe1401del) in SZT2. All three children were homozygous for the deletion and their parents were heterozygous as expected in autosomal recessive inheritance. SZT2 is highly expressed in neuronal tissues and regulates seizure threshold and neuronal excitation in mice. We conclude that the disruption of SZT2 with some residual function might lead to mild or moderate ID without seizures.	[Falcone, Michelle; Yariz, Kemal O.; Foster, Joseph, II; Menendez, Ibis; Tekin, Mustafa] Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA; [Falcone, Michelle; Yariz, Kemal O.; Foster, Joseph, II; Menendez, Ibis; Tekin, Mustafa] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA; [Ross, David B.] Comprehens Neurobehav Inst, Plantation, FL USA	University of Miami; University of Miami	Tekin, M (corresponding author), Univ Miami, Miller Sch Med, Dr John T Macdonald Dept Human Genet, Miami, FL 33136 USA.	mtekin@med.miami.edu	Tekin, Mustafa/ABG-7627-2020	Tekin, Mustafa/0000-0002-3525-7960	Hayward Foundation	Hayward Foundation	This study was supported by the Hayward Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basel-Vanagaite L, 2013, AM J HUM GENET, V93, P524, DOI 10.1016/j.ajhg.2013.07.005; Carr IM, 2013, HUM MUTAT, V34, P50, DOI 10.1002/humu.22220; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Flore LA, 2012, SEMIN PEDIATR NEUROL, V19, P173, DOI 10.1016/j.spen.2012.09.004; Frankel WN, 2009, GENES BRAIN BEHAV, V8, P568, DOI 10.1111/j.1601-183X.2009.00509.x; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Mefford HC, 2012, NEW ENGL J MED, V366, P733, DOI 10.1056/NEJMra1114194; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Sirmaci A, 2011, AM J HUM GENET, V89, P289, DOI 10.1016/j.ajhg.2011.06.007; Vissers LELM, 2010, NAT GENET, V42, P1109, DOI 10.1038/ng.712	11	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82810	10.1371/journal.pone.0082810	http://dx.doi.org/10.1371/journal.pone.0082810			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324832	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566700111
J	Bateson, M; Callow, L; Holmes, JR; Roche, MLR; Nettle, D				Bateson, Melissa; Callow, Luke; Holmes, Jessica R.; Roche, Maximilian L. Redmond; Nettle, Daniel			Do Images of 'Watching Eyes' Induce Behaviour That Is More Pro-Social or More Normative? A Field Experiment on Littering	PLOS ONE			English	Article							COOPERATION; ALTRUISM; CUES	Displaying images of eyes causes people to behave more pro-socially in a variety of contexts. However, it is unclear whether eyes work by making people universally more pro-social, or by making them more likely to conform to local norms. If the latter, images of eyes could sometimes make people less pro-social if pro-social behaviour is not the local norm. To separate these hypotheses we conducted a field experiment in which we explored whether manipulating a local descriptive norm altered the eyes effect. We recorded litter dropping decisions on a university campus in a 2 x 2 design, comparing situations with and without litter already on the ground (a manipulation of the local descriptive norm) and with and without large signs displaying images of watching eyes. We additionally recorded the number of potential human observers in the vicinity at the time of each littering decision. We observed a norm effect: the presence of litter on the ground increased littering, replicating previous findings. We also found that images of watching eyes reduced littering, although contrary to previous findings this was only when there were larger numbers of people around. With regard to our central aim, we found no evidence that litter on the ground interacted non-additively with images of eyes to induce increased littering behaviour. Our data therefore support the hypothesis that images of eyes induce more pro-social behaviour, independent of local norms. This finding has positive implications for the application of eye images in combating anti-social behaviour.	[Bateson, Melissa; Nettle, Daniel] Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bateson, Melissa; Nettle, Daniel] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Callow, Luke; Holmes, Jessica R.; Roche, Maximilian L. Redmond] Newcastle Univ, Sch Psychol, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Bateson, M (corresponding author), Newcastle Univ, Ctr Behav & Evolut, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	melissa.bateson@ncl.ac.uk	Bateson, Melissa/AAE-7075-2022; Bateson, Melissa/B-1874-2008	Bateson, Melissa/0000-0002-0861-0191; Bateson, Melissa/0000-0002-0861-0191; Nettle, Daniel/0000-0001-9089-2599	School of Psychology, Newcastle University	School of Psychology, Newcastle University	The study was funded by the School of Psychology, Newcastle University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; Burnham TC, 2003, J ECON BEHAV ORGAN, V50, P133, DOI 10.1016/S0167-2681(02)00044-6; Burnham TC, 2007, HUM NATURE-INT BIOS, V18, P88, DOI 10.1007/s12110-007-9012-2; Chudek M, 2011, TRENDS COGN SCI, V15, P218, DOI 10.1016/j.tics.2011.03.003; CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015; Ekstrom M, 2012, EXP ECON, V15, P530, DOI 10.1007/s10683-011-9312-6; Ernest-Jones M, 2011, EVOL HUM BEHAV, V32, P172, DOI 10.1016/j.evolhumbehav.2010.10.006; Erving Goffman, 1963, BEHAV PUBLIC PLACES; FINNIE WC, 1973, ENVIRON BEHAV, V5, P123, DOI 10.1177/001391657300500201; Foulsham T, 2011, VISION RES, V51, P1920, DOI 10.1016/j.visres.2011.07.002; Francey D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037397; GELLER ES, 1977, J APPL PSYCHOL, V62, P344, DOI 10.1037/0021-9010.62.3.344; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Keizer K, 2008, SCIENCE, V322, P1681, DOI 10.1126/science.1161405; Keller J, 2011, EUR J PERSONALITY, V25, P363, DOI 10.1002/per.797; Laidlaw KEW, 2011, P NATL ACAD SCI USA, V108, P5548, DOI 10.1073/pnas.1017022108; Nettle D., 2012, EVOL HUM BEHAV, V34, P35, DOI DOI 10.1016/J.EVOLHUMBEHAV.2012.08.004; Nettle D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051738; Oda R, 2011, EVOL HUM BEHAV, V32, P166, DOI 10.1016/j.evolhumbehav.2010.11.002; Powell KL, 2012, ETHOLOGY, V118, P1096, DOI 10.1111/eth.12011; Rigdon M, 2009, J ECON PSYCHOL, V30, P358, DOI 10.1016/j.joep.2009.02.002; Roberts G, 1998, P ROY SOC B-BIOL SCI, V265, P427, DOI 10.1098/rspb.1998.0312; Schultz P., 2009, EXECUTIVE SUMMARY LI; Schultz PW, 2013, ENVIRON BEHAV, V45, P35, DOI 10.1177/0013916511412179; Sylwester K, 2010, BIOL LETTERS, V6, P659, DOI 10.1098/rsbl.2010.0209	25	70	72	2	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82055	10.1371/journal.pone.0082055	http://dx.doi.org/10.1371/journal.pone.0082055			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24339990	Green Published, gold			2022-12-27	WOS:000328566100082
J	Kazi, MA; Reddy, CRK; Jha, B				Kazi, Mudassar Anisoddin; Reddy, C. R. K.; Jha, Bhavanath			Molecular Phylogeny and Barcoding of Caulerpa (Bryopsidales) Based on the tufA, rbcL, 18S rDNA and ITS rDNA Genes	PLOS ONE			English	Article							RACEMOSA CAULERPALES; NUCLEAR RDNA; DNA BARCODE; CHLOROPHYTA; GREEN; ALGAE; TAXIFOLIA; ORIGIN; PHAEOPHYCEAE; POLYMORPHISM	The biodiversity assessment of different taxa of the genus Caulerpa is of interest from the context of morphological plasticity, invasive potential of some species and biotechnological and pharmacological applications. The present study investigated the identification and molecular phylogeny of different species of Caulerpa occurring along the Indian coast inferred from tufA, rbcL, 18S rDNA and ITS rDNA nucleotide sequences. Molecular data confirmed the identification of 10 distinct Caulerpa species: C. veravalensis, C. verticillata, C. racemosa, C. microphysa, C. taxifolia, C. sertularioides, C. scalpelliformis, C. serrulata, C. peltata and C. mexicana. All datasets significantly supported the sister relationship between C. veravalensis and C. racemosa var. cylindracea. It was also concluded from the results that the specimen identified previously as C. microphysa and C. lentillifera could not be considered as separate species. The molecular data revealed the presence of multiple lineages for C. racemosa which can be resolved into separate species. All four markers were used to ascertain their utility for DNA barcoding. The tufA gene proved a better marker with monophyletic association as the main criteria for identification at the species level. The results also support the use of 18S rDNA insertion sequences to delineate the Caulerpa species through character-based barcoding. The ITS rDNA (5.8S-ITS2) phylogenetic analysis also served as another supporting tool. Further, more sequences from additional Caulerpa specimens will need to be analysed in order to support the role of these two markers (ITS rDNA and 18S insertion sequence) in identification of Caulerpa species. The present study revealed the phylogeny of Caulerpa as complete as possible using the currently available data, which is the first comprehensive report illustrating the molecular phylogeny and barcoding of the genus Caulerpa from Indian waters.	[Kazi, Mudassar Anisoddin; Reddy, C. R. K.; Jha, Bhavanath] CSIR Cent Salt & Marine Chem Res Inst, Discipline Marine Biotechnol & Ecol, Bhavnagar, Gujarat, India; [Kazi, Mudassar Anisoddin; Reddy, C. R. K.; Jha, Bhavanath] CSIR, Acad Sci & Innovat Res AcSIR, New Delhi 110001, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Salt & Marine Chemical Research Institute (CSMCRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Jha, B (corresponding author), CSIR Cent Salt & Marine Chem Res Inst, Discipline Marine Biotechnol & Ecol, Bhavnagar, Gujarat, India.	bjha@csmcri.org	Chennur, Radhakrishna Reddy/G-2014-2012	Chennur, Radhakrishna Reddy/0000-0002-9869-5597	Council of Scientific and Industrial Research, New Delhi [CSC0116: BioEn]	Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	The financial assistance received from Council of Scientific and Industrial Research (www.csir.res.in), New Delhi (CSC0116: BioEn) is duly acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agardh JG, 1873, LUNDS U ARSSKRIFT AF, V9, P1; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bellorin AM, 2002, J PHYCOL, V38, P551, DOI 10.1046/j.1529-8817.2002.t01-1-01152.x; Borgesen F, 1932, J INDIAN BOT SOC, V17, P50; CALVERT H E, 1976, British Phycological Journal, V11, P203; CALVERT HE, 1976, J PHYCOL, V12, P149; Cavas L, 2010, CELL ORIG LIFE EXTRE, V15, P385, DOI 10.1007/978-90-481-8569-6_22; Collins FS, 1909, TUFTS COLL STUD, V2, P79; COPPEJANS E, 1990, NOVA HEDWIGIA, V50, P111, DOI 10.1127/nova.hedwigia/50/1990/111; COPPEJANS E, 1988, BLUMEA, V33, P181; COPPEJANS E, 1989, NOVA HEDWIGIA, V49, P381; Coppejans E, 1992, B SEANC ACAD R SEI O, V37, P667; Coppejans E, 2009, ABC TAXA, V6, p265 ; De Toni JB, 1889, SYLLOGE ALGARUM, V1, P441; Domis LND, 2003, J PHYCOL, V39, P1019; Duraiswamy R, 1990, SEAWEED RES UTILN, V13, P29; Duraiswamy R, 1988, SEAWEED RES UTILN, V11, P83; Duraiswamy R, 1990, SEAWEED RES UTILN, V12, P55; Durand C, 2002, J EVOLUTION BIOL, V15, P122, DOI 10.1046/j.1420-9101.2002.00370.x; Egerod L, 1974, BOT             0317, V17, P130; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Fama P, 2000, EUR J PHYCOL, V35, P349, DOI 10.1080/09670260010001735951; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guiry M., 2013, ALGAEBASE, P74; Handeler K, 2010, MOL ECOL RESOUR, V10, P968, DOI 10.1111/j.1755-0998.2010.02853.x; Hanyuda T, 2000, J PLANT RES, V113, P403, DOI 10.1007/PL00013948; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Islam AKMN, 1976, J CRAMER, V19, P253; Jha B, 2009, DIVERSITY DISTRIBUTI; Jousson O, 2000, NATURE, V408, P157, DOI 10.1038/35041623; Jousson O, 1998, MAR ECOL PROG SER, V172, P275, DOI 10.3354/meps172275; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kooistra WHCF, 2002, PHYCOLOGIA, V41, P453, DOI 10.2216/i0031-8884-41-5-453.1; Kucera H, 2008, BOTANY, V86, P1065, DOI 10.1139/B08-056; Lam DW, 2006, J PHYCOL, V42, P669, DOI 10.1111/j.1529-8817.2006.00230.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; McDevit DC, 2009, PHYCOL RES, V57, P131, DOI 10.1111/j.1440-1835.2009.00530.x; Meusnier I, 2002, MOL ECOL, V11, P2317, DOI 10.1046/j.1365-294X.2002.01627.x; NIZAMUDDIN M, 1967, BOT MAR, V10, P158, DOI 10.1515/botm.1967.10.1-2.158; Nizamuddin M, BOT MAR, V6, P204; OHBA H, 1992, BOT MAG TOKYO, V105, P589, DOI 10.1007/BF02489433; Olsen JL, 1998, J PHYCOL, V34, P850, DOI 10.1046/j.1529-8817.1998.340850.x; Pavey SA, 2010, ANN NY ACAD SCI, V1206, P110, DOI 10.1111/j.1749-6632.2010.05765.x; Pillmann A, 1997, EUR J PHYCOL, V32, P379, DOI 10.1017/S0967026297001352; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Price IR, 2011, AUST SYST BOT, V24, P137, DOI 10.1071/SB10033; Rao UM, 2000, PHYKOS, V39, P85; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sahoo D, 2001, SEAWEEDS INDIAN COAS; Sanders ER, 2003, AM J BOT, V90, P628, DOI 10.3732/ajb.90.4.628; Saunders GW, 2010, CRYPTOGAMIE ALGOL, V31, P487; Saunders GW, 2005, PHILOS T R SOC B, V360, P1879, DOI 10.1098/rstb.2005.1719; Sauvage T, 2013, PHYCOLOGIA, V52, P6, DOI 10.2216/11-116.1; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SHAMEEL M, 1978, BOT MAR, V21, P277, DOI 10.1515/botm.1978.21.5.277; Silberfeld T, 2010, MOL PHYLOGENET EVOL, V56, P659, DOI 10.1016/j.ympev.2010.04.020; Silva PC, 1996, CATALOGUE BNETHIC MA; Srinivasan KS, 1969, BOT SURVEY INDIA, V1, P52; Stam WT, 2006, J PHYCOL, V42, P1113, DOI 10.1111/j.1529-8817.2006.00271.x; Svedelius N, 1906, CEYLON MAR BIOL REP, V2, P81; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor W. R., 1960, MARINE ALGAE E TROPI; Thivy F, BOT MAR, V5, P29; THIVY FRANCESCA, 1963, BOT MAR, V5, P97, DOI 10.1515/botm.1963.5.4.97; Varela-Alvarez E, 2006, J PHYCOL, V42, P741, DOI 10.1111/j.1529-8817.2006.00218.x; Verbruggen H, 2009, MOL PHYLOGENET EVOL, V50, P642, DOI 10.1016/j.ympev.2008.12.018; Verlaque M, 2004, BIOL INVASIONS, V6, P269, DOI 10.1023/B:BINV.0000034589.18347.d3; Verlaque M, 2003, EUR J PHYCOL, V38, P325, DOI 10.1080/09670260310001612592; Weber-van Bosse A, 1898, ANN JARDIN BOT BUITE, V15, P243; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wynne MJ, 2009, PHYCOLOGIA, V48, P291, DOI 10.2216/08-78.1; Yeh WJ, 2004, AQUAT BOT, V80, P193, DOI 10.1016/j.aquabot.2004.07.008; Zimmermann J, 2011, ORG DIVERS EVOL, V11, P173, DOI 10.1007/s13127-011-0050-6	73	23	25	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82438	10.1371/journal.pone.0082438	http://dx.doi.org/10.1371/journal.pone.0082438			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340028	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100107
J	Megson, IL; Haw, SJ; Newby, DE; Pell, JP				Megson, Ian L.; Haw, Sally J.; Newby, David E.; Pell, Jill P.			Association between Exposure to Environmental Tobacco Smoke and Biomarkers of Oxidative Stress Among Patients Hospitalised with Acute Myocardial Infarction	PLOS ONE			English	Article							ACUTE CORONARY SYNDROMES; LOW-DENSITY-LIPOPROTEIN; PASSIVE SMOKING; SECONDHAND SMOKE; CIGARETTE-SMOKE; CARDIOVASCULAR-DISEASE; HEART-DISEASE; DNA-DAMAGE; RATS; NONSMOKERS	Objective: To determine whether exposure to environmental tobacco smoke was associated with oxidative stress among patients hospitalised for acute myocardial infarction. Design: An existing cohort study of 1,261 patients hospitalised for acute myocardial infarction. Setting: Nine acute hospitals in Scotland. Participants: Sixty never smokers who had been exposed to environmental tobacco smoke (admission serum cotinine >= 3.0 ng/mL) were compared with 60 never smokers who had not (admission serum cotinine <= 0.1 ng/mL). Intervention: None. Main outcome measures:Three biomarkers of oxidative stress (protein carbonyl, malondialdehyde (MDA) and oxidised low-density lipoprotein (ox-LDL)) were measured on admission blood samples and adjusted for potential confounders. Results: After adjusting for baseline differences in age, sex and socioeconomic status, exposure to environmental tobacco smoke was associated with serum concentrations of both protein carbonyl (beta coefficient 7.96, 95% Cl 0.76, 15.17, p=0.031) and MDA (beta coefficient 10.57, 95% Cl 4.32, 16.81, p=0.001) but not ox-LDL (beta coefficient 2.14, 95% Cl -8.94, 13.21, p = 0.703). Conclusions: Exposure to environmental tobacco smoke was associated with increased oxidative stress. Further studies are requires to explore the role of oxidative stress in the association between environmental tobacco smoke and myocardial infarction.	[Megson, Ian L.] Univ Highlands & Isl, Dept Diabet & Cardiovasc Sci, Free Rad Res Facil, Inverness, Scotland; [Haw, Sally J.] Univ Stirling, Sch Nursing Midwifery & Hlth, Stirling FK9 4LA, Scotland; [Newby, David E.] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH8 9YL, Midlothian, Scotland; [Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland	UHI Millennium Institute; University of Stirling; University of Edinburgh; University of Glasgow	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jill.pell@glasgow.ac.uk	Stefanadis, Christodoulos/ABH-2232-2020; Newby, David Ernest/AAB-1364-2019; Megson, Ian/K-2195-2012	Stefanadis, Christodoulos/0000-0001-5974-6454; Megson, Ian/0000-0001-8287-2459; Pell, Jill/0000-0002-8898-7035	NHS Health Scotland	NHS Health Scotland	Funded by an NHS Health Scotland project grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Arifi MN, 2012, J TOXICOL SCI, V37, P1083, DOI 10.2131/jts.37.1083; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Aycicek A, 2005, EUR J PEDIATR, V164, P775, DOI 10.1007/s00431-005-1720-1; Aycicek A, 2008, EUR J PEDIATR, V167, P81, DOI 10.1007/s00431-007-0433-z; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Chih-Ching Y, 2008, ENVIRON RES, V106, P219; Clark ML, 2013, NUTRITION, V29, P1304, DOI 10.1016/j.nut.2013.04.003; Ehara S, 2001, CIRCULATION, V103, P1955, DOI 10.1161/01.cir.103.15.1955; Gentner NJ, 2012, AM J PHYSIOL-HEART C, V302, pH818, DOI 10.1152/ajpheart.00852.2011; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; Holvoet P, 1998, CIRCULATION, V98, P1487, DOI 10.1161/01.CIR.98.15.1487; Howard DJ, 1998, CANCER EPIDEM BIOMAR, V7, P141; Jaimes EA, 2004, ARTERIOSCL THROM VAS, V24, P1031, DOI 10.1161/01.ATV.0000127083.88549.58; Kapaki E, 2007, IN VIVO, V21, P523; Kato T, 2006, CAN J PHYSIOL PHARM, V84, P523, DOI 10.1139/Y06-030; Kim Kyoungwoo, 2009, Environmental Health and Preventive Medicine, V14, P60, DOI 10.1007/s12199-008-0060-y; Kosecik M, 2005, INT J CARDIOL, V100, P61, DOI 10.1016/j.ijcard.2004.05.069; Kostikas K, 2013, RESP MED, V107, P172, DOI 10.1016/j.rmed.2012.10.017; Lee R, 2012, CURR MED CHEM, V19, P2504, DOI 10.2174/092986712800493057; Panagiotakos DB, 2007, HEART, V93, P309, DOI 10.1136/hrt.2006.107367; Pell JP, 2009, HEART, V95, P1415, DOI 10.1136/hrt.2009.171702; Pell JP, 2008, NEW ENGL J MED, V359, P482, DOI 10.1056/NEJMsa0706740; Raji L, 2001, J HYPERTENS, V19, P891; Raupach T, 2006, EUR HEART J, V27, P386, DOI 10.1093/eurheartj/ehi601; SANDERSON KJ, 1995, ATHEROSCLEROSIS, V118, P45, DOI 10.1016/0021-9150(95)05591-J; Shermatov K, 2012, INDIAN PEDIATR, V49, P958, DOI 10.1007/s13312-012-0250-y; Tajika K, 2012, CIRC J, V76, P2211, DOI 10.1253/circj.CJ-12-0183; Torok J, 2000, PHYSIOL RES, V49, P135; Valenti VE, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-22; Zalata A, 2007, MUTAT RES-GEN TOX EN, V629, P140, DOI 10.1016/j.mrgentox.2007.02.001; ZHU BQ, 1994, CIRCULATION, V89, P1282, DOI 10.1161/01.CIR.89.3.1282	31	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81209	10.1371/journal.pone.0081209	http://dx.doi.org/10.1371/journal.pone.0081209			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339911	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000328566100043
J	Molina-Navarro, MM; Rosello-Lleti, E; Ortega, A; Tarazon, E; Otero, M; Martinez-Dolz, L; Lago, F; Gonzalez-Juanatey, JR; Espana, F; Garcia-Pavia, P; Montero, JA; Portoles, M; Rivera, M				Micaela Molina-Navarro, Maria; Rosello-Lleti, Esther; Ortega, Ana; Tarazon, Estefania; Otero, Manuel; Martinez-Dolz, Luis; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Espana, Francisco; Garcia-Pavia, Pablo; Anastasio Montero, Jose; Portoles, Manuel; Rivera, Miguel			Differential Gene Expression of Cardiac Ion Channels in Human Dilated Cardiomyopathy	PLOS ONE			English	Article							HUMAN HEART-FAILURE; CALCIUM-CHANNEL; SARCOPLASMIC-RETICULUM; BETA(2A) SUBUNIT; DOWN-REGULATION; CA2+; GUIDELINES; POTASSIUM; DISEASE; CLASSIFICATION	Background: Dilated cardiomyopathy (DCM) is characterized by idiopathic dilation and systolic contractile dysfunction of the cardiac chambers. The present work aimed to study the alterations in gene expression of ion channels involved in cardiomyocyte function. Methods and Results: Microarray profiling using the Affymetrix Human Gene (R) 1.0 ST array was performed using 17 RNA samples, 12 from DCM patients undergoing cardiac transplantation and 5 control donors (CNT). The analysis focused on 7 cardiac ion channel genes, since this category has not been previously studied in human DCM. SCN2B was upregulated, while KCNJ5, KCNJ8, CLIC2, CLCN3, CACNB2, and CACNA1C were downregulated. The RT-qPCR (21 DCM and 8 CNT samples) validated the gene expression of SCN2B (p < 0.0001), KCNJ5 (p < 0.05), KCNJ8 (p < 0.05), CLIC2 (p < 0.05), and CACNB2 (p < 0.05). Furthermore, we performed an IPA analysis and we found a functional relationship between the different ion channels studied in this work. Conclusion: This study shows a differential expression of ion channel genes involved in cardiac contraction in DCM that might partly underlie the changes in left ventricular function observed in these patients. These results could be the basis for new genetic therapeutic approaches.	[Micaela Molina-Navarro, Maria; Rosello-Lleti, Esther; Ortega, Ana; Tarazon, Estefania; Rivera, Miguel] Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain; [Otero, Manuel; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Dept Cardiol, Cellular & Mol Cardiol Res Unit, Santiago De Compostela, Spain; [Otero, Manuel; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain; [Martinez-Dolz, Luis; Anastasio Montero, Jose] Univ Hosp La Fe, Cardiovasc Surg Serv, Valencia, Spain; [Espana, Francisco] Hosp La Fe, Hlth Res Inst, Hemostasis Thrombosis Atherosclerosis & Vasc Biol, E-46009 Valencia, Spain; [Garcia-Pavia, Pablo] Univ Hosp Puerta del Hierro, Serv Cardiol, Madrid, Spain; [Portoles, Manuel] Hosp La Fe, Hlth Res Inst, Cell Biol & Pathol Unit, E-46009 Valencia, Spain	Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe	Rivera, M (corresponding author), Hosp La Fe, Hlth Res Inst, Cardiocirculatory Unit, E-46009 Valencia, Spain.	rivera_jmi@gva.es	España, Francisco/A-7286-2008; Tarazón, Estefanía/D-6950-2017; Dolz, Luis Martinez/X-4627-2018; Roselló Lletí, Esther/ABG-8503-2020; Ortega, Ana/AAG-5941-2020; PORTOLES, MANUEL/B-4789-2009; Roselló-Lletí, Esther/B-2695-2017; Garcia-Pavia, Pablo/T-9100-2019; Ortega, Ana AO/D-3027-2017	Tarazón, Estefanía/0000-0003-3466-2558; Dolz, Luis Martinez/0000-0001-5145-8191; Roselló Lletí, Esther/0000-0003-2627-6104; Ortega, Ana/0000-0002-9763-0505; PORTOLES, MANUEL/0000-0002-4415-7160; Roselló-Lletí, Esther/0000-0003-2627-6104; Ortega, Ana AO/0000-0002-9763-0505; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; Espana, Francisco/0000-0001-7829-2021; , Micaela/0000-0002-2103-0351	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [RD12/0042/0003]; National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [FIS Project] [PI10/00275]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III"; National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [FIS Project]	This work was supported by grants of the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III" [RD12/0042/0003; FIS Project PI10/00275]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054635; Antzelevitch C, 2007, CIRCULATION, V115, P442, DOI 10.1161/CIRCULATIONAHA.106.668392; ARAI M, 1993, CIRC RES, V72, P463, DOI 10.1161/01.RES.72.2.463; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Balse E, 2012, PHYSIOL REV, V92, P1317, DOI 10.1152/physrev.00041.2011; Barth AS, 2011, CIRC-CARDIOVASC GENE, V4, P475, DOI 10.1161/CIRCGENETICS.110.957571; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers Donald M., 2002, Basic Research in Cardiology, V97; Bidaud I, 2006, BBA-MOL CELL RES, V1763, P1169, DOI 10.1016/j.bbamcr.2006.08.049; Board PG, 2004, INT J BIOCHEM CELL B, V36, P1599, DOI 10.1016/j.biocel.2004.01.026; Borjesson SI, 2008, CELL BIOCHEM BIOPHYS, V52, P149, DOI 10.1007/s12013-008-9032-5; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; CATTERALL WA, 1988, SCIENCE, V242, P50, DOI 10.1126/science.2459775; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Cordeiro JM, 2009, J MOL CELL CARDIOL, V46, P695, DOI 10.1016/j.yjmcc.2009.01.014; Cortes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030915; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; Cromer BA, 2007, J MOL BIOL, V374, P719, DOI 10.1016/j.jmb.2007.09.041; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; Dally S, 2006, BIOCHEM J, V395, P249, DOI 10.1042/BJ20051427; Dasgupta T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056590; Deschenes I, 2008, J MOL CELL CARDIOL, V45, P336, DOI 10.1016/j.yjmcc.2008.05.001; Dulhunty AF, 2005, BIOCHEM J, V390, P333, DOI 10.1042/BJ20042113; Dulhunty AF, 2011, DRUG METAB REV, V43, P236, DOI 10.3109/03602532.2010.549134; Ebert AM, 2008, PHYSIOL GENOMICS, V35, P133, DOI 10.1152/physiolgenomics.90264.2008; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Fatkin D, 2011, HEART LUNG CIRC, V20, P691, DOI 10.1016/j.hlc.2011.07.008; Hedin KE, 1996, NEURON, V16, P423, DOI 10.1016/S0896-6273(00)80060-4; Hu D, 2010, PACE, V33, P274, DOI 10.1111/j.1540-8159.2009.02642.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Ivandic BT, 2012, CARDIOVASC RES, V94, P87, DOI 10.1093/cvr/cvs080; Jalilian C, 2008, ANTIOXID REDOX SIGN, V10, P1675, DOI 10.1089/ars.2007.1994; Jefferies JL, 2010, LANCET, V375, P752, DOI 10.1016/S0140-6736(09)62023-7; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Kane GC, 2006, FASEB J, V20, P2271, DOI 10.1096/fj.06-6349com; Kim JI, 2012, KOREAN CIRC J, V42, P479, DOI 10.4070/kcj.2012.42.7.479; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Malhotra JD, 2001, CIRCULATION, V103, P1303; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; Mia S, 2012, CELL PHYSIOL BIOCHEM, V30, P1039, DOI 10.1159/000341480; MORGAN JP, 1990, CIRCULATION, V81, P21; Nobles M, 2010, PFLUG ARCH EUR J PHY, V460, P99, DOI 10.1007/s00424-010-0799-z; Ordog B, 2006, INT J CARDIOL, V111, P386, DOI 10.1016/j.ijcard.2005.07.063; Partemi S, 2013, CARDIOVASC PATHOL, V22, P133, DOI 10.1016/j.carpath.2012.07.003; Prat-Vidal C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054785; Rosello-Lleti E, 2012, BIOCHEM BIOPH RES CO, V418, P222, DOI 10.1016/j.bbrc.2011.12.151; Rougier JS, 2005, AM J PHYSIOL-CELL PH, V288, pC692, DOI 10.1152/ajpcell.00460.2004; Sacher M, 2008, TRAFFIC, V9, P2032, DOI 10.1111/j.1600-0854.2008.00833.x; Swedberg K, 2005, EUR HEART J, V26, P1115, DOI 10.1093/eurheartj/ehi204; Szmit S, 2010, J APPL GENET, V51, P353, DOI 10.1007/BF03208866; Takano K, 2012, HUM MOL GENET, V21, P4497, DOI 10.1093/hmg/dds292; Tarazon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048957; Taylor MRG, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-27; Ufret-Vincenty CA, 2001, J BIOL CHEM, V276, P28197, DOI 10.1074/jbc.M102548200; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Walmsley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056359; Weiss N, 2011, PFLUG ARCH EUR J PHY, V461, P447, DOI 10.1007/s00424-011-0926-5; Winters AL, 2005, ANAL BIOCHEM, V346, P43, DOI 10.1016/j.ab.2005.07.041; Yamaguchi H, 2000, BIOCHEM BIOPH RES CO, V267, P156, DOI 10.1006/bbrc.1999.1926; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zhang HB, 2013, CARDIOVASC RES, V98, P269, DOI 10.1093/cvr/cvt030; Zhou YF, 2012, INVEST OPHTH VIS SCI, V53, P1821, DOI 10.1167/iovs.12-9481; Zicha S, 2004, J MOL CELL CARDIOL, V37, P91, DOI 10.1016/j.yjmcc.2004.04.003	67	39	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e79792	10.1371/journal.pone.0079792	http://dx.doi.org/10.1371/journal.pone.0079792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339868	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100007
J	Pettini, E; Prota, G; Ciabattini, A; Boianelli, A; Fiorino, F; Pozzi, G; Vicino, A; Medaglini, D				Pettini, Elena; Prota, Gennaro; Ciabattini, Annalisa; Boianelli, Alessandro; Fiorino, Fabio; Pozzi, Gianni; Vicino, Antonio; Medaglini, Donata			Vaginal Immunization to Elicit Primary T-Cell Activation and Dissemination	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; GENITAL-TRACT; NAIVE CD4(+); INTRANASAL IMMUNIZATION; LYMPHOCYTE DIVISION; ADAPTIVE IMMUNITY; MUCOSAL; RESPONSES; INDUCTION; INNATE	Primary T-cell activation at mucosal sites is of utmost importance for the development of vaccination strategies. T-cell priming after vaginal immunization, with ovalbumin and CpG oligodeoxynucleotide adjuvant as model vaccine formulation, was studied in vivo in hormone-synchronized mice and compared to the one induced by the nasal route. Twenty-four hours after both vaginal or nasal immunization, antigen-loaded dendritic cells were detected within the respective draining lymph nodes. Vaginal immunization elicited a strong recruitment of antigen-specific CD4(+) T cells into draining lymph nodes that was more rapid than the one observed following nasal immunization. T-cell clonal expansion was first detected in iliac lymph nodes, draining the genital tract, and proliferated T cells disseminated towards distal lymph nodes and spleen similarly to what observed following nasal immunization. T cells were indeed activated by the antigen encounter and acquired homing molecules essential to disseminate towards distal lymphoid organs as confirmed by the modulation of CD45RB, CD69, CD44 and CD62L marker expression. A multi-type Galton Watson branching process, previously used for in vitro analysis of T-cell proliferation, was applied to model in vivo CFSE proliferation data in draining lymph nodes 57 hours following immunization, in order to calculate the probabilistic decision of a cell to enter in division, rest in quiescence or migrate/die. The modelling analysis indicated that the probability of a cell to proliferate was higher following vaginal than nasal immunization. All together these data show that vaginal immunization, despite the absence of an organized mucosal associated inductive site in the genital tract, is very efficient in priming antigen-specific CD4+ T cells and inducing their dissemination from draining lymph nodes towards distal lymphoid organs.	[Pettini, Elena; Prota, Gennaro; Ciabattini, Annalisa; Fiorino, Fabio; Pozzi, Gianni; Medaglini, Donata] Univ Siena, Dipartimento Biotecnol Med, Lab Microbiol Mol & Biotecnol LAMMB, I-53100 Siena, Italy; [Boianelli, Alessandro; Vicino, Antonio] Univ Siena, Ctr Studio Sistemi Complessi CSC, DII, I-53100 Siena, Italy	University of Siena; University of Siena	Medaglini, D (corresponding author), Univ Siena, Dipartimento Biotecnol Med, Lab Microbiol Mol & Biotecnol LAMMB, Via Laterina 8, I-53100 Siena, Italy.	donata.medaglini@unisi.it	Pozzi, Gianni/Q-2713-2018; Medaglini, Donata/R-1149-2018; Pettini, Elena/R-4188-2018; Ciabattini, Annalisa/Q-2721-2018	Pozzi, Gianni/0000-0002-9557-4714; Medaglini, Donata/0000-0003-1729-7325; Pettini, Elena/0000-0002-0308-7127; Ciabattini, Annalisa/0000-0002-4585-7783; VICINO, Antonio/0000-0002-7969-4054; Fiorino, Fabio/0000-0002-1440-8061	Commission of the European Communities [280873]	Commission of the European Communities(European Commission)	This study has been carried out with the financial support from the Commission of the European Communities, Seventh Framework Programme contract 280873 Advanced Immunisation Technologies (ADITEC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athreya KB, 1972, BRANCHING PROCESSES; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bode C, 2011, EXPERT REV VACCINES, V10, P499, DOI [10.1586/erv.10.174, 10.1586/ERV.10.174]; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Brandtzaeg P, 2011, AM J RESP CRIT CARE, V183, P1595, DOI 10.1164/rccm.201011-1783OC; Ciabattini A, 2008, INFECT IMMUN, V76, P5817, DOI 10.1128/IAI.00793-08; Ciabattini A, 2008, VACCINE, V26, P4244, DOI 10.1016/j.vaccine.2008.05.049; Ciabattini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019346; Ciabattini A, 2010, VACCINE, V28, P1226, DOI 10.1016/j.vaccine.2009.11.021; Davis SS, 2001, ADV DRUG DELIVER REV, V51, P21, DOI 10.1016/S0169-409X(01)00162-4; Del Campo J, 2010, VACCINE, V28, P1193, DOI 10.1016/j.vaccine.2009.11.035; Fiorino F, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00128; Fujkuyama Y, 2012, EXPERT REV VACCINES, V11, P367, DOI [10.1586/erv.11.196, 10.1586/ERV.11.196]; Gherardi MM, 2003, J VIROL, V77, P7048, DOI 10.1128/JVI.77.12.7048-7057.2003; Harandi AM, 2010, CURR HIV RES, V8, P330, DOI 10.2174/157016210791208695; Harris Theodore Edward, 1964, THEORY BRANCHING PRO; Hawkins ED, 2007, P NATL ACAD SCI USA, V104, P5032, DOI 10.1073/pnas.0700026104; Hickey DK, 2011, J REPROD IMMUNOL, V88, P185, DOI 10.1016/j.jri.2011.01.005; Hickey DK, 2013, INNATE IMMUN-LONDON, V19, P121, DOI 10.1177/1753425912454026; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Holmgren J, 2012, CURR OPIN IMMUNOL, V24, P343, DOI 10.1016/j.coi.2012.03.014; Hyrien O, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-41; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Kimmel M., 2002, INTERDISCIPLINARY AP; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Kozlowski PA, 2002, J IMMUNOL, V169, P566, DOI 10.4049/jimmunol.169.1.566; LEE WT, 1990, J IMMUNOL, V144, P3288; Lehner T, 2009, ADV DENT RES, V19, P21; Luci C, 2006, J IMMUNOL, V176, P2749, DOI 10.4049/jimmunol.176.5.2749; Lycke N, 2012, NAT REV IMMUNOL, V12, P592, DOI 10.1038/nri3251; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; Mann JFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067412; Marks E, 2011, EUR J IMMUNOL, V41, P2642, DOI 10.1002/eji.201041297; Medaglini D, 2006, INFECT IMMUN, V74, P2760, DOI 10.1128/IAI.74.5.2760-2766.2006; Mestecky J, 2005, AM J REPROD IMMUNOL, V53, P208, DOI 10.1111/j.1600-0897.2005.00267.x; Mitchell DM, 2010, IMMUNITY, V32, P9, DOI 10.1016/j.immuni.2010.01.003; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Naz RK, 2012, J REPROD IMMUNOL, V93, P1, DOI 10.1016/j.jri.2011.09.005; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; Pavot V, 2012, VACCINE, V30, P142, DOI 10.1016/j.vaccine.2011.11.003; Pettini E, 2009, METHODS, V49, P340, DOI 10.1016/j.ymeth.2009.03.026; QUINE MP, 1970, J APPL PROBAB, V7, P411, DOI 10.2307/3211974; Russell MW, 2002, MICROBES INFECT, V4, P667, DOI 10.1016/S1286-4579(02)01585-X; Sancho D, 2005, TRENDS IMMUNOL, V26, P136, DOI 10.1016/j.it.2004.12.006; Seavey MM, 2009, VACCINE, V27, P2342, DOI 10.1016/j.vaccine.2009.02.025; Thompson BS, 2004, J IMMUNOL METHODS, V295, P79, DOI 10.1016/j.jim.2004.09.008; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Wira CR, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P1661, DOI 10.1016/B978-012491543-5/50101-7; Wira CR, 2010, AM J REPROD IMMUNOL, V63, P544, DOI 10.1111/j.1600-0897.2010.00842.x; Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x; Wira CR, 2000, ENDOCRINOLOGY, V141, P2877, DOI 10.1210/en.141.8.2877; Wright PF, 2011, AM J REPROD IMMUNOL, V65, P248, DOI 10.1111/j.1600-0897.2010.00954.x; Yakovlev AY, 2009, ANN APPL PROBAB, V19, P1, DOI 10.1214/08-AAP539; Yates A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-196; Zuercher AW, 2003, VIRAL IMMUNOL, V16, P279, DOI 10.1089/088282403322396091	55	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80545	10.1371/journal.pone.0080545	http://dx.doi.org/10.1371/journal.pone.0080545			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349003	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100013
J	Sanchez-Carron, G; Martinez-Monino, AB; Sola-Carvajal, A; Takami, H; Garcia-Carmona, F; Sanchez-Ferrer, A				Sanchez-Carron, Guiomar; Belen Martinez-Monino, Ana; Sola-Carvajal, Agustin; Takami, Hideto; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro			New Insights into the Phylogeny and Molecular Classification of Nicotinamide Mononucleotide Deamidases	PLOS ONE			English	Article							PYRIDINE-NUCLEOTIDE CYCLE; COMPETENCE-INDUCED OPERON; SALMONELLA-TYPHIMURIUM; ESCHERICHIA-COLI; SEQUENCE; AMIDOHYDROLASE; MUTANTS; GENE; IDENTIFICATION; BIOSYNTHESIS	Nicotinamide mononucleotide (NMN) deamidase is one of the key enzymes of the bacterial pyridine nucleotide cycle (PNC). It catalyzes the conversion of NMN to nicotinic acid mononucleotide, which is later converted to NAD+ by entering the Preiss-Handler pathway. However, very few biochemical data are available regarding this enzyme. This paper represents the first complete molecular characterization of a novel NMN deamidase from the halotolerant and alkaliphilic bacterium Oceanobacillus iheyensis (OiPncC). The enzyme was active over a broad pH range, with an optimum at pH 7.4, whilst maintaining 90 % activity at pH 10.0. Surprisingly, the enzyme was quite stable at such basic pH, maintaining 61 % activity after 21 days. As regard temperature, it had an optimum at 65 degrees C but its stability was better below 50 degrees C. OiPncC was a Michaelian enzyme towards its only substrate NMN, with a K-m value of 0.18 mM and a k(cat)/K-m of 2.1 mM(-1) s(-1). To further our understanding of these enzymes, a complete phylogenetic and structural analysis was carried out taking into account the two Pfam domains usually associated with them (MocF and CinA). This analysis sheds light on the evolution of NMN deamidases, and enables the classification of NMN deamidases into 12 different subgroups, pointing to a novel domain architecture never before described. Using a Logo representation, conserved blocks were determined, providing new insights on the crucial residues involved in the binding and catalysis of both CinA and MocF domains. The analysis of these conserved blocks within new protein sequences could permit the more efficient data curation of incoming NMN deamidases.	[Sanchez-Carron, Guiomar; Belen Martinez-Monino, Ana; Sola-Carvajal, Agustin; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Murcia, Spain; [Belen Martinez-Monino, Ana; Garcia-Carmona, Francisco; Sanchez-Ferrer, Alvaro] Murcia Biomed Res Inst IMIB, Murcia, Spain; [Takami, Hideto] Japan Agcy Marine Earth Sci & Technol, Microbial Genome Res Grp, Inst Biogeosci, Yokosuka, Kanagawa 2370061, Japan	University of Murcia; Japan Agency for Marine-Earth Science & Technology (JAMSTEC)	Sanchez-Ferrer, A (corresponding author), Univ Murcia, Dept Biochem & Mol Biol A, Fac Biol, Reg Campus Int Excellence Campus Mare Nostrum,Cam, Murcia, Spain.	alvaro@um.es	Takami, Hideto/D-4200-2012; Garcia-Carmona, Francisco/K-6520-2017; Sánchez-Ferrer, Alvaro/M-1631-2014	Takami, Hideto/0000-0003-3433-7018; Sánchez-Ferrer, Alvaro/0000-0001-7266-4402; Sola Carvajal, Agustin/0000-0001-6568-0682; Garcia-Carmona, Francisco/0000-0002-1318-7690	MINECO-FEDER [BIO2010-22225-C02-01]; Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, of Fundacion Seneca [04541/GERM/06]; Ministerio de Educacion, Cultura y Deporte, Spain	MINECO-FEDER(Spanish Government); Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, of Fundacion Seneca; Ministerio de Educacion, Cultura y Deporte, Spain(Spanish Government)	This study was partially supported by MINECO-FEDER (BIO2010-22225-C02-01) and Programa de Ayuda a Grupos de Excelencia de la Region de Murcia, of Fundacion Seneca (04541/GERM/06, Plan Regional de Ciencia y Tecnologia 2007-2010). G. S. C. is a holder of a predoctoral research grant (FPU) from Ministerio de Educacion, Cultura y Deporte, Spain. A.-B.M. has a research pre-doctoral contract associated with the above MINECO-FEDER project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; CHENG WL, 1995, J BACTERIOL, V177, P6711, DOI 10.1128/jb.177.23.6711-6717.1995; Cialabrini L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065595; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P327, DOI 10.2174/138945010790711941; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; FOSTER JW, 1980, MICROBIOL REV, V44, P83, DOI 10.1128/MMBR.44.1.83-105.1980; FOSTER JW, 1979, J BACTERIOL, V137, P1165, DOI 10.1128/JB.137.3.1165-1175.1979; FRIEDMANN HC, 1973, BIOCHEM BIOPH RES CO, V50, P54, DOI 10.1016/0006-291X(73)91062-0; Galeazzi L, 2011, J BIOL CHEM, V286, P40365, DOI 10.1074/jbc.M111.275818; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Han MV, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-356; HILLYARD D, 1981, J BIOL CHEM, V256, P8491; IMAI T, 1973, J BIOCHEM-TOKYO, V73, P139; Kaimer C, 2010, ARCH MICROBIOL, V192, P549, DOI 10.1007/s00203-010-0583-7; Karlin S, 2001, TRENDS MICROBIOL, V9, P335, DOI 10.1016/S0966-842X(01)02079-0; KINNEY DM, 1979, J BACTERIOL, V140, P607, DOI 10.1128/JB.140.2.607-611.1979; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu MTW, 2000, J BIOL CHEM, V275, P1814, DOI 10.1074/jbc.275.3.1814; MARTIN B, 1995, MOL MICROBIOL, V15, P367, DOI 10.1111/j.1365-2958.1995.tb02250.x; Nichols JD, 2007, BIOCHEMISTRY-US, V46, P78, DOI 10.1021/bi061551q; OLIVERA BM, 1967, P NATL ACAD SCI USA, V57, P1700, DOI 10.1073/pnas.57.6.1700; PARK UE, 1989, J BACTERIOL, V171, P2173, DOI 10.1128/jb.171.4.2173-2180.1989; PEARCE BJ, 1995, J BACTERIOL, V177, P86, DOI 10.1128/jb.177.1.86-93.1995; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2011, NUCLEIC ACIDS RES, V39, pD465, DOI 10.1093/nar/gkq1091; Quast Christian, 2013, Nucleic Acids Res, V41, pD590, DOI 10.1093/nar/gks1219; Rodionov DA, 2008, NUCLEIC ACIDS RES, V36, P2047, DOI 10.1093/nar/gkn047; Sanchez-Carron G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056727; Sanchez-Carron G, 2011, APPL ENVIRON MICROB, V77, P2471, DOI 10.1128/AEM.02927-10; Schrodinger L, 2010, PYMOL MOLEUCLAR GRAP; Schwarz G, 2001, J MOL BIOL, V312, P405, DOI 10.1006/jmbi.2001.4952; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; Smith BC, 2009, ANAL BIOCHEM, V394, P101, DOI 10.1016/j.ab.2009.07.019; Takami H, 2002, NUCLEIC ACIDS RES, V30, P3927, DOI 10.1093/nar/gkf526; Tamuri AU, 2010, BIOINFORMATICS, V26, P1260, DOI 10.1093/bioinformatics/btq119; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e	42	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82705	10.1371/journal.pone.0082705	http://dx.doi.org/10.1371/journal.pone.0082705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340054	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100125
J	Shen, LM; Higuchi, T; Tubbe, I; Voltz, N; Krummen, M; Pektor, S; Montermann, E; Rausch, K; Schmidt, M; Schild, H; Grabbe, S; Bros, M				Shen, Limei; Higuchi, Tetsuya; Tubbe, Ingrid; Voltz, Nicole; Krummen, Mathias; Pektor, Stefanie; Montermann, Evelyn; Rausch, Kristin; Schmidt, Manfred; Schild, Hansjoerg; Grabbe, Stephan; Bros, Matthias			A Trifunctional Dextran-Based Nanovaccine Targets and Activates Murine Dendritic Cells, and Induces Potent Cellular and Humoral Immune Responses In Vivo	PLOS ONE			English	Article							CROSS-PRESENTATION; ANTIGEN DELIVERY; INNATE IMMUNITY; NANOPARTICLES; MATURATION; ADJUVANTS; SYSTEMS	Dendritic cells (DCs) constitute an attractive target for specific delivery of nanovaccines for immunotherapeutic applications. Here we tested nano-sized dextran (DEX) particles to serve as a DC-addressing nanocarrier platform. Non-functionalized DEX particles had no immunomodulatory effect on bone marrow (BM)-derived murine DCs in vitro. However, when adsorbed with ovalbumine (OVA), DEX particles were efficiently engulfed by BM-DCs in a mannose receptor-dependent manner. A DEX-based nanovaccine containing OVA and lipopolysaccharide (LPS) as a DC stimulus induced strong OVA peptide-specific CD4(+) and CD8(+) T cell proliferation both in vitro and upon systemic application in mice, as well as a robust OVA-specific humoral immune response (IgG1>IgG2a) in vivo. Accordingly, this nanovaccine also raised both a more pronounced delayed-type hypersensitivity response and a stronger induction of cytotoxic CD8(+) T cells than obtained upon administration of OVA and LPS in soluble form. Therefore, DEX-based nanoparticles constitute a potent, versatile and easy to prepare nanovaccine platform for immunotherapeutic approaches.	[Shen, Limei; Tubbe, Ingrid; Voltz, Nicole; Krummen, Mathias; Pektor, Stefanie; Montermann, Evelyn; Grabbe, Stephan; Bros, Matthias] Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany; [Higuchi, Tetsuya] Toho Univ, Sakura Med Ctr, Dept Dermatol, Chiba 2748510, Japan; [Rausch, Kristin; Schmidt, Manfred] Johannes Gutenberg Univ Mainz, Inst Phys Chem, Mainz, Germany; [Schild, Hansjoerg] Univ Med Ctr Mainz, Inst Immunol, Mainz, Germany	Johannes Gutenberg University of Mainz; Toho University; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Grabbe, S (corresponding author), Univ Med Ctr Mainz, Dept Dermatol, Mainz, Germany.	stephan.grabbe@unimedizin-mainz.de	Grabe, Stephan/AAJ-4578-2021	Grabe, Stephan/0000-0002-6863-8719				Agrawal S, 2003, J IMMUNOL, V171, P4984, DOI 10.4049/jimmunol.171.10.4984; Amano K, 2008, P NATL ACAD SCI USA, V105, P3232, DOI 10.1073/pnas.0710412105; Balkow S, 2007, BLOOD, V110, P3949, DOI 10.1182/blood-2007-05-092189; Blank F, 2011, NANOTOXICOLOGY, V5, P606, DOI 10.3109/17435390.2010.541293; Burgdorf S, 2006, J IMMUNOL, V176, P6770, DOI 10.4049/jimmunol.176.11.6770; Carrillo-Conde B, 2011, MOL PHARMACEUT, V8, P1877, DOI 10.1021/mp200213r; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Di Gioacchino M, 2011, INT J IMMUNOPATH PH, V24, P65; Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004; Hamdy S, 2011, PHARM RES-DORDR, V28, P2288, DOI 10.1007/s11095-011-0459-9; Hart SP, 2008, METHODS, V44, P280, DOI 10.1016/j.ymeth.2007.11.009; Heng BC, 2011, ARCH TOXICOL, V85, P1517, DOI 10.1007/s00204-011-0722-1; Hirosue S, 2010, VACCINE, V28, P7897, DOI 10.1016/j.vaccine.2010.09.077; Irache JM, 2008, EXPERT OPIN DRUG DEL, V5, P703, DOI 10.1517/17425247.5.6.703 ; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Klippstein R, 2010, NANOMED-NANOTECHNOL, V6, P523, DOI 10.1016/j.nano.2010.01.001; Krishnamachari Y, 2011, PHARM RES-DORDR, V28, P215, DOI 10.1007/s11095-010-0241-4; Li A, 2010, BIOMATERIALS, V31, P748, DOI 10.1016/j.biomaterials.2009.09.095; Li J, 2010, CLIN EXP IMMUNOL, V162, P251, DOI 10.1111/j.1365-2249.2010.04244.x; Liu CX, 2011, PROG MOL BIOL TRANSL, V104, P509, DOI 10.1016/B978-0-12-416020-0.00013-9; Mao XL, 2003, ELECTROPHORESIS, V24, P3273, DOI 10.1002/elps.200305598; Matsuo K, 2010, BIOL PHARM BULL, V33, P2003, DOI 10.1248/bpb.33.2003; Morel PA, 2011, IMMUNOL RES, V50, P124, DOI 10.1007/s12026-011-8217-y; Mottram PL, 2007, MOL PHARMACEUT, V4, P73, DOI 10.1021/mp060096p; Nabeshi H, 2010, PHARMAZIE, V65, P199, DOI 10.1691/ph.2010.9268; Pearce EJ, 2006, CHEM IMMUNOL ALLERGY, V90, P82, DOI 10.1159/000088882; Peck A, 2010, IMMUNOLOGY, V129, P147, DOI 10.1111/j.1365-2567.2009.03189.x; Rausch K, 2010, BIOMACROMOLECULES, V11, P2836, DOI 10.1021/bm100971q; Rice-Ficht AC, 2010, CURR OPIN MICROBIOL, V13, P106, DOI 10.1016/j.mib.2009.12.001; Robinson MJ, 2006, NAT IMMUNOL, V7, P1258, DOI 10.1038/ni1417; SCHRODER U, 1984, BIOMATERIALS, V5, P100, DOI 10.1016/0142-9612(84)90009-7; SCHRODER U, 1984, J IMMUNOL METHODS, V70, P127, DOI 10.1016/0022-1759(84)90397-1; Tacken PJ, 2011, BLOOD, V118, P6836, DOI 10.1182/blood-2011-07-367615; Tan MCAA, 1998, INT IMMUNOL, V10, P1299, DOI 10.1093/intimm/10.9.1299; Wang J, 2011, SMALL, V7, P1919, DOI 10.1002/smll.201100442	37	19	20	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80904	10.1371/journal.pone.0080904	http://dx.doi.org/10.1371/journal.pone.0080904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339889	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100024
J	McEnroe, NA; Williams, CJ; Xenopoulos, MA; Porcal, P; Frost, PC				McEnroe, Nicola A.; Williams, Clayton J.; Xenopoulos, Marguerite A.; Porcal, Petr; Frost, Paul C.			Distinct Optical Chemistry of Dissolved Organic Matter in Urban Pond Ecosystems	PLOS ONE			English	Article							FLUORESCENCE SPECTROSCOPY; MOLECULAR-WEIGHT; PHOTOCHEMICAL CHANGES; MICROBIAL ACTIVITY; BACTERIAL-GROWTH; SINGLET OXYGEN; NATURAL-WATERS; C-13 ADDITION; LAND-USE; CARBON	Urbanization has the potential to dramatically alter the biogeochemistry of receiving freshwater ecosystems. We examined the optical chemistry of dissolved organic matter (DOM) in forty-five urban ponds across southern Ontario, Canada to examine whether optical characteristics in these relatively new ecosystems are distinct from other freshwater systems. Dissolved organic carbon (DOC) concentrations ranged from 2 to 16 mg C L-1 across the ponds with an average value of 5.3 mg C L-1. Excitation-emission matrix (EEM) spectroscopy and parallel factor analysis (PARAFAC) modelling showed urban pond DOM to be characterized by microbial-like and, less importantly, by terrestrial derived humic-like components. The relatively transparent, non-humic DOM in urban ponds was more similar to that found in open water, lake ecosystems than to rivers or wetlands. After irradiation equivalent to 1.7 days of natural solar radiation, DOC concentrations, on average, decreased by 38% and UV absorbance decreased by 25%. Irradiation decreased the relative abundances of terrestrial humic-like components and increased protein-like aspects of the DOM pool. These findings suggest that high internal production and/or prolonged exposure to sunlight exerts a distinct and significant influence on the chemistry of urban pond DOM, which likely reduces its chemical similarity with upstream sources. These properties of urban pond DOM may alter its biogeochemical role in these relatively novel aquatic ecosystems.	[McEnroe, Nicola A.; Williams, Clayton J.; Xenopoulos, Marguerite A.; Frost, Paul C.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Porcal, Petr] Acad Sci Czech Republ, Inst Hydrobiol, Vvi, Ctr Biol, Ceske Budejovice, Czech Republic	Trent University; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Frost, PC (corresponding author), Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada.	paulfrost@trentu.ca	Porcal, Petr/A-7350-2014; Porcal, Petr/R-4687-2019; Frost, Paul/AAT-6633-2021	Porcal, Petr/0000-0002-7787-4924; 	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding provided by Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/index_eng.asp). Strategic Grant to PCF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anesio AM, 2005, APPL ENVIRON MICROB, V71, P6267, DOI 10.1128/AEM.71.10.6267-6275.2005; Baker A, 2001, ENVIRON SCI TECHNOL, V35, P948, DOI 10.1021/es000177t; Bertilsson S, 2000, LIMNOL OCEANOGR, V45, P753, DOI 10.4319/lo.2000.45.4.0753; Bertilsson S., 2003, AQUATIC ECOSYSTEMS I, P3, DOI DOI 10.1016/B978-012256371-3/50002-0; Brand AB, 2010, CONSERV BIOL, V24, P295, DOI 10.1111/j.1523-1739.2009.01301.x; Caraco N, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P301; Carpenter SR, 2005, ECOLOGY, V86, P2737, DOI 10.1890/04-1282; Chin YP, 1997, ENVIRON SCI TECHNOL, V31, P1630, DOI 10.1021/es960404k; CHIN YP, 1994, ENVIRON SCI TECHNOL, V28, P1853, DOI 10.1021/es00060a015; COBLE PG, 1990, NATURE, V348, P432, DOI 10.1038/348432a0; Cory RM, 2005, ENVIRON SCI TECHNOL, V39, P8142, DOI 10.1021/es0506962; Crowe A. S., 2007, International Journal of Water, V3, P214, DOI 10.1504/IJW.2007.015215; CUTHBERT ID, 1992, LIMNOL OCEANOGR, V37, P1319, DOI 10.4319/lo.1992.37.6.1319; Del Vecchio R, 2002, MAR CHEM, V78, P231, DOI 10.1016/S0304-4203(02)00036-1; Downing JA, 2006, LIMNOL OCEANOGR, V51, P2388, DOI 10.4319/lo.2006.51.5.2388; Downing JA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2006GB002854; Downing JA, 2010, LIMNETICA, V29, P9; Einsele G, 2001, GLOBAL PLANET CHANGE, V30, P167, DOI 10.1016/S0921-8181(01)00105-9; Frost PC, 2006, AQUAT SCI, V68, P40, DOI 10.1007/s00027-005-0802-5; Glaeser J, 2011, ADV MICROB PHYSIOL, V58, P141, DOI 10.1016/B978-0-12-381043-4.00004-0; Hamer AJ, 2011, ECOL APPL, V21, P378, DOI 10.1890/10-0390.1; Hanson PC, 2004, GLOBAL CHANGE BIOL, V10, P1285, DOI 10.1111/j.1529-8817.2003.00805.x; Helms JR, 2008, LIMNOL OCEANOGR, V53, P955, DOI 10.4319/lo.2008.53.3.0955; Hook AM, 2005, BIOGEOCHEMISTRY, V75, P409, DOI 10.1007/s10533-005-1860-4; Huguet A, 2009, ORG GEOCHEM, V40, P706, DOI 10.1016/j.orggeochem.2009.03.002; Kaiser E, 2004, LIMNOL OCEANOGR, V49, P540, DOI 10.4319/lo.2004.49.2.0540; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kritzberg ES, 2006, ECOSYSTEMS, V9, P489, DOI 10.1007/s10021-005-0115-5; Kritzberg ES, 2005, AQUAT MICROB ECOL, V38, P103, DOI 10.3354/ame038103; Lee JG, 2003, J WATER RES PL-ASCE, V129, P419, DOI 10.1061/(ASCE)0733-9496(2003)129:5(419); Maie N, 2008, LIMNOL OCEANOGR, V53, P160, DOI 10.4319/lo.2008.53.1.0160; Maurice PA, 2002, CHEM GEOL, V187, P59, DOI 10.1016/S0009-2541(02)00016-5; Mayer LM, 2009, LIMNOL OCEANOGR, V54, P1688, DOI 10.4319/lo.2009.54.5.1688; McEnroe NA, 2013, URBAN ECOSYST, V16, P327, DOI 10.1007/s11252-012-0258-z; MCKNIGHT DM, 1991, LIMNOL OCEANOGR, V36, P998, DOI 10.4319/lo.1991.36.5.0998; McKnight DM, 2001, LIMNOL OCEANOGR, V46, P38, DOI 10.4319/lo.2001.46.1.0038; Miller MP, 2009, LIMNOL OCEANOGR, V54, P2213, DOI 10.4319/lo.2009.54.6.2213; Mladenov N, 2008, WETLANDS, V28, P747, DOI 10.1672/07-140.1; Mobed JJ, 1996, ENVIRON SCI TECHNOL, V30, P3061, DOI 10.1021/es960132l; Obernosterer I, 1999, LIMNOL OCEANOGR, V44, P1645, DOI 10.4319/lo.1999.44.7.1645; Obernosterer I, 2001, AQUAT MICROB ECOL, V24, P61, DOI 10.3354/ame024061; Osburn CL, 2011, LIMNOL OCEANOGR, V56, P2371, DOI 10.4319/lo.2011.56.6.2371; Parlanti E, 2000, ORG GEOCHEM, V31, P1765, DOI 10.1016/S0146-6380(00)00124-8; Paul MJ, 2001, ANNU REV ECOL SYST, V32, P333, DOI 10.1146/annurev.ecolsys.32.081501.114040; Petrone KC, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001537; Porcal P, 2004, AQUAT SCI, V66, P211, DOI 10.1007/s00027-004-0701-1; Porcal P, 2009, J ENVIRON MONITOR, V11, P1064, DOI 10.1039/b812330f; Prairie YT, 2002, LIMNOL OCEANOGR, V47, P316, DOI 10.4319/lo.2002.47.1.0316; Reche I, 1999, BIOGEOCHEMISTRY, V44, P259; Ruiz-Gonzalez C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00131; Scully NM, 2003, FEMS MICROBIOL ECOL, V46, P353, DOI 10.1016/S0168-6496(03)00198-3; Stanley EH, 2012, FRESHWATER BIOL, V57, P26, DOI 10.1111/j.1365-2427.2011.02613.x; Stedmon CA, 2005, LIMNOL OCEANOGR, V50, P686, DOI 10.4319/lo.2005.50.2.0686; Tranvik LJ, 2001, ECOL LETT, V4, P458, DOI 10.1046/j.1461-0248.2001.00245.x; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walsh CJ, 2005, J N AM BENTHOL SOC, V24, P706, DOI 10.1899/04-020.1; Williams CJ, 2013, ECOL APPL, V23, P1384, DOI 10.1890/12-0825.1; Williams CJ, 2010, LIMNOL OCEANOGR, V55, P1159, DOI 10.4319/lo.2010.55.3.1159; Wilson HF, 2009, NAT GEOSCI, V2, P37, DOI 10.1038/NGEO391; Wissmar RC, 2004, ENVIRON MANAGE, V34, P91, DOI 10.1007/s00267-004-0224-5; Wu FC, 2007, APPL GEOCHEM, V22, P1659, DOI 10.1016/j.apgeochem.2007.03.024; Xenopoulos MA, 1997, PHOTOCHEM PHOTOBIOL, V66, P471, DOI 10.1111/j.1751-1097.1997.tb03175.x; Yamashita Y, 2010, ECOSYSTEMS, V13, P1006, DOI 10.1007/s10021-010-9370-1; ZEPP RG, 1977, NATURE, V267, P421, DOI 10.1038/267421a0; Zsolnay A, 1999, CHEMOSPHERE, V38, P45, DOI 10.1016/S0045-6535(98)00166-0	65	18	20	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80334	10.1371/journal.pone.0080334	http://dx.doi.org/10.1371/journal.pone.0080334			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24348908	Green Submitted, Green Published, gold			2022-12-27	WOS:000327162900078
J	Zagorsky, BM; Reiter, JG; Chatterjee, K; Nowak, MA				Zagorsky, Benjamin M.; Reiter, Johannes G.; Chatterjee, Krishnendu; Nowak, Martin A.			Forgiver Triumphs in Alternating Prisoner's Dilemma	PLOS ONE			English	Article							TIT-FOR-TAT; INFINITELY REPEATED GAMES; EVOLUTIONARY STABILITY; DIRECT RECIPROCITY; HUMAN COOPERATION; STRATEGIES; POPULATIONS; AUTOMATA; PAVLOV; NOISE	Cooperative behavior, where one individual incurs a cost to help another, is a wide spread phenomenon. Here we study direct reciprocity in the context of the alternating Prisoner's Dilemma. We consider all strategies that can be implemented by one and two-state automata. We calculate the payoff matrix of all pairwise encounters in the presence of noise. We explore deterministic selection dynamics with and without mutation. Using different error rates and payoff values, we observe convergence to a small number of distinct equilibria. Two of them are uncooperative strict Nash equilibria representing always-defect (ALLD) and Grim. The third equilibrium is mixed and represents a cooperative alliance of several strategies, dominated by a strategy which we call Forgiver. Forgiver cooperates whenever the opponent has cooperated; it defects once when the opponent has defected, but subsequently Forgiver attempts to re-establish cooperation even if the opponent has defected again. Forgiver is not an evolutionarily stable strategy, but the alliance, which it rules, is asymptotically stable. For a wide range of parameter values the most commonly observed outcome is convergence to the mixed equilibrium, dominated by Forgiver. Our results show that although forgiving might incur a short-term loss it can lead to a long-term gain. Forgiveness facilitates stable cooperation in the presence of exploitation and noise.	[Zagorsky, Benjamin M.; Nowak, Martin A.] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA; [Reiter, Johannes G.; Chatterjee, Krishnendu] IST Austria Inst Sci & Technol Austria, Klosterneuburg, Lower Austria, Austria; [Nowak, Martin A.] Harvard Univ, Dept Math, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Institute of Science & Technology - Austria; Harvard University	Nowak, MA (corresponding author), Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA.	martin_nowak@harvard.edu	Reiter, Johannes G./Y-4083-2019	Reiter, Johannes G./0000-0002-0170-7353	John Templeton Foundation; ERC [279307]; FWF NFN [S11407N23]; FWF [P23499N23]; Microsoft faculty fellows award	John Templeton Foundation; ERC(European Research Council (ERC)European Commission); FWF NFN(Austrian Science Fund (FWF)); FWF(Austrian Science Fund (FWF)); Microsoft faculty fellows award(Microsoft)	This work was supported by grants from the John Templeton Foundation, ERC Start grant (279307: Graph Games), FWF NFN Grant (No S11407N23 RiSE), FWF Grant (No P23499N23), and a Microsoft faculty fellows award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABREU D, 1988, ECONOMETRICA, V56, P383, DOI 10.2307/1911077; [Anonymous], 1995, EVOLUTIONARY GAME TH; Aumann R.J., 1981, ESSAYS GAME THEORY M, P11; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BINMORE KG, 1992, J ECON THEORY, V57, P278, DOI 10.1016/0022-0531(92)90037-I; Boerlijst MC, 1997, AM MATH MON, V104, P303, DOI 10.2307/2974578; Brandt H, 2005, P NATL ACAD SCI USA, V102, P2666, DOI 10.1073/pnas.0407370102; Chen X, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.051120; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; Cressman R, 1996, J ECON THEORY, V68, P234, DOI 10.1006/jeth.1996.0012; Dal Bo P, 2005, AM ECON REV, V95, P1591; Devroye L., 1986, NONUNIFORM RANDOM VA, V4; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; FREAN MR, 1994, P ROY SOC B-BIOL SCI, V257, P75, DOI 10.1098/rspb.1994.0096; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; FUDENBERG D, 1990, AM ECON REV, V80, P274; Fudenberg D, 2012, AM ECON REV, V102, P720, DOI 10.1257/aer.102.2.720; Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035287; Hauert C, 2006, J THEOR BIOL, V239, P195, DOI 10.1016/j.jtbi.2005.08.040; Hilbe C, 2013, P NATL ACAD SCI USA, V110, P6913, DOI 10.1073/pnas.1214834110; Hofbauer J., 1988, THEORY EVOLUTION DYN; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Hopcroft J. E., 2006, INTRO AUTOMATA THEOR; Imhof LA, 2010, P ROY SOC B-BIOL SCI, V277, P463, DOI 10.1098/rspb.2009.1171; Kendall Graham, 2007, ITERATED PRISONERS D; KRAINES D, 1995, J CONFLICT RESOLUT, V39, P439, DOI 10.1177/0022002795039003003; KRAINES D, 1989, THEOR DECIS, V26, P47, DOI 10.1007/BF00134056; Kraines DP, 2000, J THEOR BIOL, V203, P335, DOI 10.1006/jtbi.2000.1089; MAY RM, 1987, NATURE, V327, P15, DOI 10.1038/327015a0; Milinski M, 1998, P NATL ACAD SCI USA, V95, P13755, DOI 10.1073/pnas.95.23.13755; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Miller JH, 1996, J ECON BEHAV ORGAN, V29, P87, DOI 10.1016/0167-2681(95)00052-6; NOWAK M, 1993, NATURE, V364, P56, DOI 10.1038/364056a0; NOWAK M, 1989, J THEOR BIOL, V137, P21, DOI 10.1016/S0022-5193(89)80146-8; NOWAK M, 1990, ACTA APPL MATH, V20, P247, DOI 10.1007/BF00049570; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; NOWAK MA, 1994, J THEOR BIOL, V168, P219, DOI 10.1006/jtbi.1994.1101; NOWAK MA, 1995, J MATH BIOL, V33, P703; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 2012, J THEOR BIOL, V299, P1, DOI 10.1016/j.jtbi.2012.01.014; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Press WH, 2012, P NATL ACAD SCI USA, V109, P10409, DOI 10.1073/pnas.1206569109; Rapoport A, 1965, PRISONERS DILEMMA; RUBINSTEIN A, 1986, J ECON THEORY, V39, P83, DOI 10.1016/0022-0531(86)90021-9; Sigmund K, 2009, CALCULUS SELFISHNESS; Sigmund K., 1993, GAMES LIFE EXPLORATI; Stewart AJ, 2013, P NATL ACAD SCI USA, V110, P15348, DOI 10.1073/pnas.1306246110; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; van Veelen M, 2010, 100371 TI; van Veelen M, 2012, P NATL ACAD SCI USA, V109, P9929, DOI 10.1073/pnas.1206694109; Wang Z, 2013, SCI REPORTS, V3; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; WU JZ, 1995, J CONFLICT RESOLUT, V39, P183, DOI 10.1177/0022002795039001008	55	19	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80814	10.1371/journal.pone.0080814	http://dx.doi.org/10.1371/journal.pone.0080814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349017	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800009
J	Yu, H; Che, XX; Xu, XY; Zheng, MR; Zhao, Y; He, W; Yu, JM; Xiong, JJ; Li, WD				Yu, Huan; Che, Xiangxin; Xu, Xiaoyuan; Zheng, Meirong; Zhao, Yong; He, Wei; Yu, Jingmou; Xiong, Jianjun; Li, Weidong			Insulin Protects Apoptotic Cardiomyocytes from Hypoxia/Reoxygenation Injury through the Sphingosine Kinase/Sphingosine 1-Phosphate Axis	PLOS ONE			English	Article							MYOCARDIAL ISCHEMIA-REPERFUSION; CELL-SURVIVAL; SPHINGOSINE-1-PHOSPHATE; KINASE; AKT; ACTIVATION; REOXYGENATION; MYOCYTES; HYPOXIA; GLUCOSE	Objective: Experimental and clinical studies have shown that administration of insulin during reperfusion is cardioprotective, but the mechanisms underlying this effect are still unknown. In this study, the ability of insulin to protect apoptotic cardiomyocytes from hypoxia/reoxygenation injury using the sphingosine kinase/sphingosine 1-phosphate axis was investigated. Methods and Results: Rat cardiomyocytes were isolated and subjected to hypoxia and reoxygenation. [gamma-32P] ATP was used to assess sphingosine kinase activity. Insulin was found to increase sphingosine kinase activity. Immunocytochemistry and Western blot analysis showed changes in the subcellular location of sphingosine kinase 1 from cytosol to the membrane in cardiomyocytes. Insulin caused cardiomyocytes to accumulate of S1P in a dose-dependent manner. FRET efficiency showed that insulin also transactivates the S1P(1) receptor. TUNEL staining showed that administration of insulin during reoxygenation could to reduce the rate of reoxygenation-induced apoptosis, which is a requirement for SphK 1 activity. It also reduced the rate of activation of the S1P receptor and inhibited hypoxia/reoxygenation-induced cell death in cardiomyocytes. Conclusion: The sphingosine kinase 1/sphingosine 1-phosphate/S1P receptor axis is one pathway through which insulin protects rat cardiomyocytes from apoptosis induced by hypoxia/reoxygenation injury.	[Yu, Huan; Che, Xiangxin; Xu, Xiaoyuan; Zheng, Meirong; Zhao, Yong; He, Wei; Yu, Jingmou; Xiong, Jianjun; Li, Weidong] Jiujiang Univ, Coll Basic Med Sci, Jiujiang, Peoples R China; [Yu, Huan; Che, Xiangxin; Xu, Xiaoyuan; Yu, Jingmou; Xiong, Jianjun; Li, Weidong] Key Lab Jiangxi Syst Biomed, Jiujiang, Peoples R China	Jiujiang University	Li, WD (corresponding author), Key Lab Jiangxi Syst Biomed, Jiujiang, Peoples R China.	33937537@qq.com			National Natural Sciences Foundation of China [81000075]; Science and Technology Project Founded by the Education Department of Jiangxi Province [GJJ11694, GJJ11242, 20113138]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project Founded by the Education Department of Jiangxi Province	This work was supported by National Natural Sciences Foundation of China (81000075); Science and Technology Project Founded by the Education Department of Jiangxi Province (GJJ11694, GJJ11242, 20113138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Engbersen R, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-124; Fu JJ, 2007, EUR J PHARMACOL, V568, P213, DOI 10.1016/j.ejphar.2007.04.031; Gao F, 2004, APOPTOSIS, V9, P553, DOI 10.1023/B:APPT.0000038035.75845.ab; Gao F, 2002, CIRCULATION, V105, P1497, DOI 10.1161/01.CIR.0000012529.00367.0F; Jin ZQ, 2004, CIRCULATION, V110, P1980, DOI 10.1161/01.CIR.0000143632.06471.93; Jin ZQ, 2002, AM J PHYSIOL-HEART C, V282, pH1970, DOI 10.1152/ajpheart.01029.2001; Jonassen AK, 2004, BIOCHEM BIOPH RES CO, V315, P160, DOI 10.1016/j.bbrc.2004.01.029; Jonassen AK, 2000, J MOL CELL CARDIOL, V32, P757, DOI 10.1006/jmcc.2000.1118; Kajimoto T, 2007, MOL CELL BIOL, V27, P3429, DOI 10.1128/MCB.01465-06; Karliner JS, 2009, J CARDIOVASC PHARM, V53, P189, DOI 10.1097/FJC.0b013e3181926706; Karliner JS, 2001, J MOL CELL CARDIOL, V33, P1713, DOI 10.1006/jmcc.2001.1429; Knapp M, 2011, J PHYSIOL PHARMACOL, V62, P601; Krasel C, 2005, J BIOL CHEM, V280, P9528, DOI 10.1074/jbc.M413078200; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Limaye V, 2005, BLOOD, V105, P3169, DOI 10.1182/blood-2004-02-0452; Liu J, 2004, J BIOL CHEM, V279, P55924, DOI 10.1074/jbc.M410024200; Ma H, 2006, CARDIOVASC RES, V69, P57, DOI 10.1016/j.cardiores.2005.08.019; Means CK, 2007, AM J PHYSIOL-HEART C, V292, pH2944, DOI 10.1152/ajpheart.01331.2006; Means CK, 2009, CARDIOVASC RES, V82, P193, DOI 10.1093/cvr/cvp086; Olivera A, 2000, METHOD ENZYMOL, V311, P215; Palanivel R, 2007, CARDIOVASC RES, V75, P148, DOI 10.1016/j.cardiores.2007.04.011; Pchejetski D, 2007, CIRC RES, V100, P41, DOI 10.1161/01.RES.0000253900.66640.34; Piper HM, 2004, CARDIOVASC RES, V61, P365, DOI 10.1016/j.cardiores.2003.12.012; Semple DJ, 2012, AM J PHYSIOL-RENAL, V303, pF1275, DOI 10.1152/ajprenal.00048.2012; Siow DL, 2007, ANAL BIOCHEM, V371, P184, DOI 10.1016/j.ab.2007.08.002; SODIPALLARES D, 1962, AM J CARDIOL, V9, P166, DOI 10.1016/0002-9149(62)90035-8; Song JQ, 2009, APOPTOSIS, V14, P1299, DOI 10.1007/s10495-009-0398-7; Tao R, 2010, AM J PHYSIOL-HEART C, V298, pH1022, DOI 10.1152/ajpheart.00902.2009; Yellon D.M, 2007, NEW ENGL J MED, V357, P1121, DOI [10.1056/NEJMra071667, DOI 10.1056/NEJMRA071667]; Zaha V, 2003, MOL CELL BIOCHEM, V247, P229, DOI 10.1023/A:1024183527668	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80644	10.1371/journal.pone.0080644	http://dx.doi.org/10.1371/journal.pone.0080644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349009	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300012
J	Choi, H; Schneider, H; Klum, S; Chandler-Brown, D; Kaeberlein, M; Shamieh, L				Choi, Haeri; Schneider, Heather; Klum, Shannon; Chandler-Brown, Devon; Kaeberlein, Matt; Shamieh, Lara			UV-Photoconversion of Ethosuximide from a Longevity-Promoting Compound to a Potent Toxin	PLOS ONE			English	Article							LIFE-SPAN EXTENSION; CAENORHABDITIS-ELEGANS; BACTERIAL DEPRIVATION; ANTIEPILEPTIC DRUGS; DIETARY RESTRICTION; DAF-16	The anticonvulsant ethosuximide has been previously shown to increase life span and promote healthspan in the nematode Caenorhabditis elegans at millimolar concentrations. Here we report that following exposure to ultraviolet irradiation at 254 nm, ethosuximide is converted into a compound that displays toxicity toward C. elegans. This effect is specific for ethosuximide, as the structurally related compounds trimethadione and succinimide do not show similar toxicities following UV exposure. Killing by UV-irradiated ethosuximide is not attenuated in chemosensory mutants that are resistant to toxicity associated with high doses of non-irradiated ethosuximide. Non-irradiated ethosuximide extends life span at 15 degrees C or 20 degrees C, but not at 25 degrees C, while irradiated ethosuximide shows similar toxicity at all three temperatures. Dietary restriction by bacterial deprivation does not protect against toxicity from irradiated ethosuximide, while non-irradiated ethosuximide further extends the long life spans of restricted animals. These data support the model that ethosuximide extends life span by a mechanism that is, at least partially, distinct from dietary restriction by bacterial deprivation and demonstrates an unexpected photochemical conversion of ethosuximide into a toxic compound by UV light.	[Choi, Haeri; Schneider, Heather; Klum, Shannon; Chandler-Brown, Devon; Kaeberlein, Matt] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Shamieh, Lara] Regis Univ, Dept Biol, Denver, CO USA	University of Washington; University of Washington Seattle; Regis University	Kaeberlein, M (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	kaeber@uw.edu; lshamieh@regis.edu			NIH [R01AG031108, T32AG000057]; NATIONAL INSTITUTE ON AGING [R01AG031108, T32AG000057] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH Grant R01AG031108 to MK. LS was supported by NIH Training Grant T32AG000057. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Collins JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000230; Evason K, 2005, SCIENCE, V307, P258, DOI 10.1126/science.1105299; Garigan D, 2002, GENETICS, V161, P1101; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Goren MZ, 2007, CNS DRUG REV, V13, P224, DOI 10.1111/j.1527-3458.2007.00009.x; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hughes SE, 2007, PLOS GENET, V3, P254, DOI 10.1371/journal.pgen.0030025; Huguenard John R., 2002, Epilepsy Curr, V2, P49, DOI 10.1046/j.1535-7597.2002.00019.x; Kaeberlein TL, 2006, AGING CELL, V5, P487, DOI 10.1111/j.1474-9726.2006.00238.x; Kornfeld K, 2006, ARCH NEUROL-CHICAGO, V63, P491, DOI 10.1001/archneur.63.4.491; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Lee GD, 2006, AGING CELL, V5, P515, DOI 10.1111/j.1474-9726.2006.00241.x; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Leiser SF, 2011, AGING CELL, V10, P318, DOI 10.1111/j.1474-9726.2011.00672.x; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; MATTSON RH, 1995, EPILEPSIA, V36, pS13, DOI 10.1111/j.1528-1157.1995.tb05995.x; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; RogviHansen BA, 1995, PHARMACOL THERAPEUT, V68, P425, DOI 10.1016/0163-7258(95)02014-4; Smith ED, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-49; Sutphin G.L., 2009, J VIS EXP, V27; Sutphin GL, 2008, EXP GERONTOL, V43, P130, DOI 10.1016/j.exger.2007.10.019; Sutphin George L, 2012, Longev Healthspan, V1, P9, DOI 10.1186/2046-2395-1-9; Xiao R, 2013, CELL, V152, P806, DOI 10.1016/j.cell.2013.01.020	23	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82543	10.1371/journal.pone.0082543	http://dx.doi.org/10.1371/journal.pone.0082543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340038	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400080
J	Hayashi, T; Saito, T; Fujimura, T; Hara, K; Takamochi, K; Mitani, K; Mineki, R; Kazuno, S; Oh, S; Ueno, T; Suzuki, K; Yao, T				Hayashi, Takuo; Saito, Tsuyoshi; Fujimura, Tsutomu; Hara, Kieko; Takamochi, Kazuya; Mitani, Keiko; Mineki, Reiko; Kazuno, Saiko; Oh, Shiaki; Ueno, Takashi; Suzuki, Kenji; Yao, Takashi			Galectin-4, a Novel Predictor for Lymph Node Metastasis in Lung Adenocarcinoma	PLOS ONE			English	Article							GENE-EXPRESSION; INTERNATIONAL ASSOCIATION; GROWTH-FACTOR; CANCER; IDENTIFICATION; INVASION; CLASSIFICATION; HAPTOGLOBIN; MUTATIONS; SERA	Metastasis is still a major issue in cancer, and the discovery of biomarkers predicting metastatic capacity is essential for the development of better therapeutic strategies for treating lung adenocarcinoma. By using a proteomic approach, we aimed to identify novel predictors for lymph node metastasis in lung adenocarcinoma. Two-dimensional sodium dodecyl sulfate polyacrylamide gel electrophoresis showed 6 spots differentially expressed between lymph node metastasis-positive and lymph node metastasis-negative groups in a discovery set. Subsequent mass spectrometry showed that 2 of these spots were derived from galectin-4, and western blot analysis confirmed the overexpression of galectin-4 in metastatic samples. The predictive value of galectin-4 was confirmed by immunohistochemical analysis for a validation set consisting of 707 surgically resected specimens of lung adenocarcinomas (stages I to IV). We observed that 148 lung adenocarcinomas (20.9%) expressed galectin-4, which was significantly associated with variables of disease progression such as tumor size (p<0.0001), pleural invasion (p = 0.0071), venous invasion (p = 0.0178), nodal status (p = 0.0007), and TNM stage (p<0.0001). By the multivariate analysis, Galectin-4 expression was revealed as one of the independent predictor for lymph node metastasis, together with solid predominant and micropapillary histologic pattern. Furthermore, galectin-4 expression was revealed to be an independent predictor for lymph node metastasis and an adverse survival factor in patients with lung adenocarcinoma of acinar predominant type. Galectin-4 plays an important role in metastatic process of lung adenocarcinoma. Immunohistochemical testing for galectin-4 expression may be useful together with the detection of specific histology to predict the metastatic potential of lung adenocarcinoma.	[Hayashi, Takuo; Saito, Tsuyoshi; Hara, Kieko; Mitani, Keiko; Yao, Takashi] Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan; [Fujimura, Tsutomu; Mineki, Reiko; Kazuno, Saiko; Ueno, Takashi] Juntendo Univ, Grad Sch Med, Biomed Res Ctr, Div Prote & Biomol Sci, Tokyo, Japan; [Takamochi, Kazuya; Oh, Shiaki; Suzuki, Kenji] Juntendo Univ, Sch Med, Dept Gen Thorac Surg, Tokyo 113, Japan	Juntendo University; Juntendo University; Juntendo University	Saito, T (corresponding author), Juntendo Univ, Sch Med, Dept Human Pathol, Tokyo 113, Japan.	tysaitou@juntendo.ac.jp	Ueno, Takashi/CAJ-1364-2022	HAYASHI, TAKUO/0000-0002-8544-9370; Fujimura, Tsutomu/0000-0003-1744-7725	High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan [23590434];  [24790363]	High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; 	This study was supported by a Grant-in-Aid for Young Scientists (No. 24790363 to TH) and Scientific Research (No. 23590434 to TS); in part by the High Technology Research Center Grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Barrow H, 2011, CLIN CANCER RES, V17, P7035, DOI 10.1158/1078-0432.CCR-11-1462; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chen GA, 2003, P NATL ACAD SCI USA, V100, P13537, DOI 10.1073/pnas.2233850100; Cooper DNW, 2002, BBA-GEN SUBJECTS, V1572, P209, DOI 10.1016/S0304-4165(02)00310-0; Creighton CJ, 2005, MOL CANCER RES, V3, P119, DOI 10.1158/1541-7786.MCR-04-0189; Fujimura T, 2008, INT J CANCER, V122, P39, DOI 10.1002/ijc.22958; Hippo Y, 2001, CANCER RES, V61, P889; Ho CC, 2002, AM J PATHOL, V161, P1647, DOI 10.1016/S0002-9440(10)64442-2; Horie A, 2009, NAT CHEM BIOL, V5, P673, DOI 10.1038/nchembio.198; Huflejt ME, 2003, GLYCOCONJUGATE J, V20, P247, DOI 10.1023/B:GLYC.0000025819.54723.a0; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Jan YH, 2012, CANCER RES, V72, P5119, DOI 10.1158/0008-5472.CAN-12-1842; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kazuno S, 2011, ANAL BIOCHEM, V419, P241, DOI 10.1016/j.ab.2011.08.029; Kondoh N, 1999, CANCER RES, V59, P4990; Larsen JE, 2007, CLIN CANCER RES, V13, P2946, DOI 10.1158/1078-0432.CCR-06-2525; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Liu YF, 2009, J PATHOL, V217, P54, DOI 10.1002/path.2429; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mitsuta K, 2005, ONCOL REP, V14, P185; Nakahara S, 2007, CANCER METAST REV, V26, P605, DOI 10.1007/s10555-007-9095-6; Nakamura N, 2006, ONCOGENE, V25, P4245, DOI 10.1038/sj.onc.1209442; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Niki T, 2000, CLIN CANCER RES, V6, P2431; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; Saito S, 2008, INT J CANCER, V123, P633, DOI 10.1002/ijc.23490; Satelli A, 2011, INT J CANCER, V129, P799, DOI 10.1002/ijc.25750; Scagliotti GV, 2012, J CLIN ONCOL, V30, P172, DOI 10.1200/JCO.2010.33.7089; Shen HM, 2009, APOPTOSIS, V14, P348, DOI 10.1007/s10495-009-0315-0; Shibata T, 2005, CLIN CANCER RES, V11, P6177, DOI 10.1158/1078-0432.CCR-05-0293; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2005, CLIN CANCER RES, V11, P8070, DOI 10.1158/1078-0432.CCR-05-0687; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Su JL, 2006, CANCER RES, V66, P2553, DOI 10.1158/0008-5472.CAN-05-2645; Travis WD, 2004, PATHOLOGY GENETICS T; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Warth A, 2012, J CLIN ONCOL, V30, P1438, DOI 10.1200/JCO.2011.37.2185; Watanabe M, 2011, ONCOL REP, V25, P1217, DOI 10.3892/or.2011.1198; Zhang PF, 2012, J PROTEOMICS, V77, P202, DOI 10.1016/j.jprot.2012.08.021	43	32	33	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81883	10.1371/journal.pone.0081883	http://dx.doi.org/10.1371/journal.pone.0081883			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339976	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400049
J	Kim, JI; Stott, RT; Soohoo, J; Lee, KM; Zhao, GP; Yeh, H; Deng, SP; Markmann, JF				Kim, James I.; Stott, Ryan T.; Soohoo, Julie; Lee, Kang Mi; Zhao, Gaoping; Yeh, Heidi; Deng, Shaoping; Markmann, James F.			Elevated Levels of Interferon-gamma Production by Memory T Cells Do Not Promote Transplant Tolerance Resistance in Aged Recipients	PLOS ONE			English	Article							IFN-GAMMA; CYTOKINE PRODUCTION; IN-VIVO; HETEROLOGOUS IMMUNITY; ALLOGRAFT-REJECTION; THYMIC INVOLUTION; TYPE-2 CYTOKINES; EFFECTOR-CELLS; TH1 CYTOKINES; LIVING DONOR	Immunosenescence predisposes the elderly to infectious and autoimmune diseases and impairs the response to vaccination. We recently demonstrated that ageing also impedes development of transplantation tolerance. Unlike their young counterparts (8-12 weeks of age) aged male recipients (greater than 12 months of age) transplanted with a full MHC-mismatched heart are resistant to tolerance mediated by anti-CD45RB antibody. Surprisingly, either chemical or surgical castration restored tolerance induction to levels observed using young recipients. Based on the strong impact of endocrine modulation on transplant tolerance, we explored the impact of ageing and castration on the immune system. Here we report a significant increase in the percentage of T cells that produce interferon-gamma (IFN gamma) in aged male versus young male animals and that the overall increase in IFN-gamma production was due to an expansion of IFN-gamma-producing memory T cells in aged animals. In contrast to IFN-gamma production, we did not observe differences in IL-10 expression in young versus old male mice. We hypothesized that endocrine modulation would diminish the elevated levels of IFN-gamma production in aged recipients, however, we observed no significant reduction in the percentage of IFN-gamma+ T cells upon castration. Furthermore, we neutralized interferon-gamma by antibody and did not observe an effect on graft survival. We conclude that while elevated levels of interferon-gamma serves as a marker of tolerance resistance in aged mice, other as yet to be identified factors are responsible for its cause. Defining these factors may be relevant to design of tolerogenic strategies for aged recipients.	[Kim, James I.; Stott, Ryan T.; Soohoo, Julie; Lee, Kang Mi; Zhao, Gaoping; Yeh, Heidi; Deng, Shaoping; Markmann, James F.] Harvard Univ, Sch Med, Dept Surg, Transplantat Unit,Massachusetts Gen Hosp, Boston, MA 02115 USA; [Zhao, Gaoping; Deng, Shaoping] Sichuan Prov Peoples Hosp, Dept Surg, Chengdu, Sichuan Provinc, Peoples R China; [Zhao, Gaoping; Deng, Shaoping] Sichuan Acad Med Sci, Chengdu, Sichuan Provinc, Peoples R China	Harvard University; Harvard Medical School; Massachusetts General Hospital; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Markmann, JF (corresponding author), Harvard Univ, Sch Med, Dept Surg, Transplantat Unit,Massachusetts Gen Hosp, Boston, MA 02115 USA.	jmarkmann@partners.org		Zhao, Gao-ping/0000-0001-5899-9230	National Institutes of Health (NIH) [RO1AI057851-05, NIH K08-DK094965, NIH 5T32AI7529]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007529, R01AI057851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK094965] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided by National Institutes of Health (NIH) RO1AI057851-05 (JFM), NIH K08-DK094965 (HY), and NIH 5T32AI7529 (KML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AB, 2003, IMMUNOL REV, V196, P147, DOI 10.1046/j.1600-065X.2003.00082.x; Adams AB, 2003, J CLIN INVEST, V111, P1887, DOI 10.1172/JCI200317477; Alberti S, 2006, MECH AGEING DEV, V127, P560, DOI 10.1016/j.mad.2006.01.014; Ansaria MJI, 2008, CLIN IMMUNOL, V126, P140, DOI 10.1016/j.clim.2007.07.019; Augustine JJ, 2005, AM J TRANSPLANT, V5, P1971, DOI 10.1111/j.1600-6143.2005.00958.x; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; Bishop DK, 2001, J IMMUNOL, V166, P3248, DOI 10.4049/jimmunol.166.5.3248; Bokos I, 2013, CLIN TRANSPLANT; Bradley BA, 2002, TRANSPL IMMUNOL, V10, P125, DOI 10.1016/S0966-3274(02)00058-8; Brook MO, 2006, TRANSPLANTATION, V82, P1, DOI 10.1097/01.tp.0000226082.17507.da; Coley SM, 2009, J IMMUNOL, V182, P225, DOI 10.4049/jimmunol.182.1.225; Crespo-Leiro MG, 1999, TRANSPLANT P, V31, P2537, DOI 10.1016/S0041-1345(99)00453-4; DALLMAN MJ, 1993, IMMUNOL REV, V133, P5, DOI 10.1111/j.1600-065X.1993.tb01507.x; Deans GD, 2010, J INTERN MED, V267, P220, DOI 10.1111/j.1365-2796.2009.02201.x; DEGREEF GE, 1992, MECH AGEING DEV, V66, P15, DOI 10.1016/0047-6374(92)90070-T; Deng SP, 2006, J IMMUNOL, V176, P2799, DOI 10.4049/jimmunol.176.5.2799; Du W, 2011, J IMMUNOL, V187, P3631, DOI 10.4049/jimmunol.1100441; Glimcher Laurie H., 2001, Journal of Clinical Investigation, V108, pS25; Gourdy P, 2005, BLOOD, V105, P2415, DOI 10.1182/blood-2004-07-2819; Gray DHD, 2006, BLOOD, V108, P3777, DOI 10.1182/blood-2006-02-004531; Grubeck-Loebenstein B, 2009, AGING CLIN EXP RES, V21, P201, DOI 10.1007/BF03324904; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Heeger PS, 1999, J IMMUNOL, V163, P2267; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; Hince M, 2008, CELL IMMUNOL, V252, P122, DOI 10.1016/j.cellimm.2007.10.007; Hirakata A, 2010, TRANSPL IMMUNOL, V24, P76, DOI 10.1016/j.trim.2010.08.001; HOBBS MV, 1991, J CELL BIOCHEM, V46, P312, DOI 10.1002/jcb.240460406; Ide K, 1999, J IMMUNOL, V163, P396; Karanfilov CI, 1999, MECH AGEING DEV, V109, P97, DOI 10.1016/S0047-6374(99)00030-5; Kishimoto K, 2002, J CLIN INVEST, V109, P1471, DOI 10.1172/JCI14947; Konieczny BT, 1998, J IMMUNOL, V160, P2059; Kovacs EJ, 2004, MECH AGEING DEV, V125, P121, DOI 10.1016/j.mad.2003.11.007; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; Lee YJ, 2012, TRANSPL P, V44, P270, DOI 10.1016/j.transproceed.2011.12.013; Luettig B, 2001, SCAND J IMMUNOL, V53, P563, DOI 10.1046/j.1365-3083.2001.00897.x; Maffi P, 2007, DIABETES CARE, V30, P1150, DOI 10.2337/dc06-1794; MAKINODAN T, 1991, EXP GERONTOL, V26, P281, DOI 10.1016/0531-5565(91)90021-D; Markees TG, 1998, J CLIN INVEST, V101, P2446, DOI 10.1172/JCI2703; Martins PN, 2009, EXP CLIN TRANSPLANT, V7, P67; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; McEniery CM, 2008, HYPERTENSION, V51, P1476, DOI 10.1161/HYPERTENSIONAHA.107.105445; Meier-Kriesche HU, 2001, TRANSPLANT P, V33, P1113, DOI 10.1016/S0041-1345(00)02452-0; Meier-Kriesche HU, 2000, TRANSPLANTATION, V70, P306, DOI 10.1097/00007890-200007270-00012; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Molnar MZ, 2012, AM J KIDNEY DIS, V59, P841, DOI 10.1053/j.ajkd.2011.12.014; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; Ortiz-Suarez A, 2002, CLIN IMMUNOL, V104, P282, DOI 10.1006/clim.2002.5221; Paroni R, 2005, AMINO ACIDS, V28, P389, DOI 10.1007/s00726-005-0191-z; Perisic M, 2010, IMMUNOBIOLOGY, V215, P275, DOI 10.1016/j.imbio.2009.06.012; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; ROSENBERG AS, 1994, EUR J IMMUNOL, V24, P1312, DOI 10.1002/eji.1830240611; Rothstein DM, 2001, J IMMUNOL, V166, P322, DOI 10.4049/jimmunol.166.1.322; Sandmand M, 2002, CLIN EXP IMMUNOL, V127, P107, DOI 10.1046/j.1365-2249.2002.01736.x; SAYEGH MH, 1995, J EXP MED, V181, P1869, DOI 10.1084/jem.181.5.1869; Segal R, 1997, MECH AGEING DEV, V96, P47, DOI 10.1016/S0047-6374(97)01891-5; Semposski GD, 2002, MOL IMMUNOL, V38, P841, DOI 10.1016/S0161-5890(01)00122-5; Sesso R, 1998, J AM SOC NEPHROL, V9, P684; Smith P, 2001, EUR J IMMUNOL, V31, P1495, DOI 10.1002/1521-4141(200105)31:5&lt;1495::AID-IMMU1495&gt;3.0.CO;2-8; TAKEUCHI T, 1992, TRANSPLANTATION, V53, P1281, DOI 10.1097/00007890-199206000-00023; Tesar BM, 2009, AM J TRANSPLANT, V9, P54, DOI 10.1111/j.1600-6143.2008.02458.x; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; United Nations PD, 2002, WORLD POP AG 1950 20; Vergani A, 2010, DIABETES, V59, P2253, DOI 10.2337/db09-1264; Zhao GP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002270; Zimmermann C, 1999, EUR J IMMUNOL, V29, P284, DOI 10.1002/(SICI)1521-4141(199901)29:01<284::AID-IMMU284>3.0.CO;2-C	66	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82856	10.1371/journal.pone.0082856	http://dx.doi.org/10.1371/journal.pone.0082856			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340063	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400099
J	Liu, H; Qi, B; Guo, X; Tang, LQ; Chen, QY; Zhang, L; Guo, L; Luo, DH; Huang, PY; Mo, HY; Xiang, YQ; Qiu, F; Sun, R; Zhang, Y; Chen, MY; Hua, YJ; Lv, X; Wang, L; Zhao, C; Cao, KJ; Qian, CN; Hong, MH; Mai, HQ				Liu, Huai; Qi, Bin; Guo, Xiang; Tang, Lin-Quan; Chen, Qiu-Yan; Zhang, Lu; Guo, Ling; Luo, Dong-Hua; Huang, Pei-Yu; Mo, Hao-Yuan; Xiang, Yan-Qun; Qiu, Fang; Sun, Rui; Zhang, Ying; Chen, Ming-Yuan; Hua, Yi-Jun; Lv, Xing; Wang, Lin; Zhao, Chong; Cao, Ka-Jia; Qian, Chao-Nan; Hong, Ming-Huang; Mai, Hai-Qiang			Genetic Variations in Radiation and Chemotherapy Drug Action Pathways and Survival in locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy	PLOS ONE			English	Article							CELL LUNG-CANCER; PLATINUM-BASED CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; BREAST-CANCER; CONCURRENT CHEMORADIOTHERAPY; ERCC1 POLYMORPHISMS; CHINESE POPULATION; CLINICAL-OUTCOMES; RANDOMIZED-TRIAL; GASTRIC-CANCER	Background and Purpose: Treatment outcomes vary greatly in patients with nasopharyngeal carcinoma (NPC). The purpose of this study is to evaluate the influence of radiation and chemotherapy drug action pathway gene polymorphisms on the survival of patients with locoregionally advanced NPC treated with cisplatin-and fluorouracil-based chemoradiotherapy. Material and Methods: Four hundred twenty-one consecutive patients with locoregionally advanced NPC were prospectively recruited. We utilized a pathway approach and examined 18 polymorphisms in 13 major genes. Polymorphisms were detected using the LDR-PCR technique. Multifactor dimensionality reduction (MDR) analysis was performed to detect potential gene-gene interaction. Results: After adjustment for clinicopathological characteristics, overall survival was significantly decreased in patients with the MPO rs2243828 CT/CC genotype (HR=2.453, 95% CI, 1.687-3.566, P<0.001). The ERCC1 rs3212986 CC (HR=1.711, 95% CI, 1.135-2.579, P=0.010), MDM2 rs2279744 GT/GG (HR=1.743, 95% CI, 1.086-2.798, P=0.021), MPO rs2243828 CT/CC (HR=3.184, 95% CI, 2.261-4.483, P<0.001) and ABCB1 rs2032582 AT/AA (HR=1.997, 95% CI, 1.086-3.670, P=0.026) genotypes were associated with poor progression-free survival. Prognostic score models based on independent prognostic factors successfully classified patients into low-, intermediate-, and high-risk groups. Furthermore, MDR analysis showed no significant interaction between polymorphisms. Conclusions: Four single nucleotide polymorphisms were associated with survival in patients with locoregionally advanced NPC treated with cisplatin- and fluorouracil-based chemoradiotherapy. Combining clinical prognostic factors with genetic information was valuable in identifying patients with different risk.	[Liu, Huai; Guo, Xiang; Tang, Lin-Quan; Chen, Qiu-Yan; Zhang, Lu; Guo, Ling; Luo, Dong-Hua; Huang, Pei-Yu; Mo, Hao-Yuan; Xiang, Yan-Qun; Qiu, Fang; Sun, Rui; Zhang, Ying; Chen, Ming-Yuan; Hua, Yi-Jun; Lv, Xing; Wang, Lin; Zhao, Chong; Cao, Ka-Jia; Qian, Chao-Nan; Hong, Ming-Huang; Mai, Hai-Qiang] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Liu, Huai; Guo, Xiang; Tang, Lin-Quan; Chen, Qiu-Yan; Zhang, Lu; Guo, Ling; Luo, Dong-Hua; Huang, Pei-Yu; Mo, Hao-Yuan; Xiang, Yan-Qun; Qiu, Fang; Sun, Rui; Chen, Ming-Yuan; Hua, Yi-Jun; Lv, Xing; Wang, Lin; Zhao, Chong; Cao, Ka-Jia; Qian, Chao-Nan; Mai, Hai-Qiang] Sun Yat Sen Univ, Ctr Canc, Dept Nasopharyngeal Carcinoma, Guangzhou 510275, Guangdong, Peoples R China; [Qi, Bin] Guangzhou Med Univ, Affilated Tumor Hosp, Dept Radiotherapy, Guangzhou, Guangdong, Peoples R China; [Zhang, Ying] Sun Yat Sen Univ, Ctr Canc, Tumor Resources Bank, Guangzhou 510275, Guangdong, Peoples R China; [Hong, Ming-Huang] Sun Yat Sen Univ, Ctr Canc, Clin Trial Study Ctr, Dept Epidemiol, Guangzhou 510275, Guangdong, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; Guangzhou Medical University; Sun Yat Sen University; Sun Yat Sen University	Mai, HQ (corresponding author), State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China.	maihq@mail.sysu.edu.cn	Chen, Ming/GVU-8412-2022		National Natural Science Foundation of China [81072226]; 863 Project [2012AA02A501]; National Key Basic Research Program of China [2013CB910304]; Sci-Tech Project Foundation of Guangdong Province [2011B080701034]; Sci-Tech Project Foundation of Guangzhou City [2011J4300100]; Fundamental Research Funds for the central universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 863 Project(National High Technology Research and Development Program of China); National Key Basic Research Program of China(National Basic Research Program of China); Sci-Tech Project Foundation of Guangdong Province; Sci-Tech Project Foundation of Guangzhou City; Fundamental Research Funds for the central universities(Fundamental Research Funds for the Central Universities)	This research was supported by grants from the National Natural Science Foundation of China (No: 81072226, http://www.nsfc.gov.cn), the 863 Project (No: 2012AA02A501, http://www.863.gov.cn/), the National Key Basic Research Program of China (No: 2013CB910304, http://www.973.gov.cn), the Sci-Tech Project Foundation of Guangdong Province (No: 2011B080701034, http://gdsf.gdstc.gov.cn), the Sci-Tech Project Foundation of Guangzhou City (No: 2011J4300100, http://www.gzsi.gov.cn) and the Fundamental Research Funds for the central universities (http://www.sysu.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2004, CANCER RES, V64, P7634, DOI 10.1158/0008-5472.CAN-04-1843; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Ambrosone CB, 2009, J CLIN ONCOL, V27, P4973, DOI 10.1200/JCO.2009.21.8669; BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X; Cao Su-Mei, 2011, Chin J Cancer, V30, P114; Chen PC, 2000, CANCER EPIDEM BIOMAR, V9, P843; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Fung KL, 2009, BBA-PROTEINS PROTEOM, V1794, P860, DOI 10.1016/j.bbapap.2009.02.014; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Green H, 2006, CLIN CANCER RES, V12, P854, DOI 10.1158/1078-0432.CCR-05-0950; Gryshchenko I, 2008, J CLIN ONCOL, V26, P2252, DOI 10.1200/JCO.2007.11.5212; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Hahn LW, 2003, BIOINFORMATICS, V19, P376, DOI 10.1093/bioinformatics/btf869; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; HOFSTRA AH, 1993, TOXICOLOGY, V82, P221, DOI 10.1016/0300-483X(93)90066-2; Hrstka R, 2009, J CELL MOL MED, V13, P440, DOI 10.1111/j.1582-4934.2008.00634.x; Jin Y, 2012, EUR J CANCER, V48, P882, DOI 10.1016/j.ejca.2011.09.004; Khanna M, 1999, CLIN BIOCHEM, V32, P287, DOI 10.1016/S0009-9120(99)00020-X; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; Krivak TC, 2008, J CLIN ONCOL, V26, P3598, DOI 10.1200/JCO.2008.16.1323; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; Langer R, 2005, CLIN CANCER RES, V11, P7462, DOI 10.1158/1078-0432.CCR-05-0042; Lee AWM, 2010, JNCI-J NATL CANCER I, V102, P1188, DOI 10.1093/jnci/djq258; Liu L, 2013, MOL CARCINOGEN, V52, P923, DOI 10.1002/mc.21942; Liu L, 2011, J THORAC ONCOL, V6, P1793, DOI 10.1097/JTO.0b013e3182272273; Liu L, 2011, LUNG CANCER, V73, P110, DOI 10.1016/j.lungcan.2010.11.004; Lu WF, 2002, INT J CANCER, V102, P275, DOI 10.1002/ijc.10712; Lunn RM, 1999, CANCER RES, V59, P2557; Luo Jun-li, 2000, Hunan Yike Daxue Xuebao, V25, P18; Ma J, 2001, INT J RADIAT ONCOL, V50, P1181, DOI 10.1016/S0360-3016(01)01537-1; Martin DN, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-257; Miao XP, 2006, GASTROENTEROLOGY, V131, P420, DOI 10.1053/j.gastro.2006.05.050; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Moore JH, 2006, J THEOR BIOL, V241, P252, DOI 10.1016/j.jtbi.2005.11.036; Nakazato T, 2007, CLIN CANCER RES, V13, P5436, DOI 10.1158/1078-0432.CCR-07-0481; Oh SY, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-43; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Orina JN, 2009, MOL CANCER THER, V8, P2057, DOI 10.1158/1535-7163.MCT-09-0256; Pander J, 2011, ANN ONCOL, V22, P1147, DOI 10.1093/annonc/mdq572; Park SR, 2011, BRIT J CANCER, V104, P1126, DOI 10.1038/bjc.2011.24; Pyaskovskaya O N, 2007, Exp Oncol, V29, P197; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Reles A, 2001, CLIN CANCER RES, V7, P2984; Shiga H, 1999, CLIN CANCER RES, V5, P4097; Shiraishi K, 2010, J CLIN ONCOL, V28, P4945, DOI 10.1200/JCO.2010.30.5334; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun JM, 2011, INT J RADIAT ONCOL, V80, P655, DOI 10.1016/j.ijrobp.2010.02.061; Thussbas C, 2006, J CLIN ONCOL, V24, P3747, DOI 10.1200/JCO.2005.04.8587; Wee J, 2005, J CLIN ONCOL, V23, P6730, DOI 10.1200/JCO.2005.16.790; Wee Joseph Tien Seng, 2010, Chin J Cancer, V29, P517; Weisberg I, 1998, MOL GENET METAB, V64, P169, DOI 10.1006/mgme.1998.2714; Wen YF, 2011, CLIN CANCER RES, V17, P2451, DOI 10.1158/1078-0432.CCR-10-2264; Winterbourn CC, 2000, CURR OPIN HEMATOL, V7, P53, DOI 10.1097/00062752-200001000-00010; Wu HZ, 2012, J CANCER RES CLIN, V138, P1449, DOI 10.1007/s00432-012-1209-z; Wu XF, 2006, J CLIN ONCOL, V24, P3789, DOI 10.1200/JCO.2005.03.6640; Xiao WW, 2011, CANCER-AM CANCER SOC, V117, P1874, DOI 10.1002/cncr.25754; Zhou GQ, 2007, CLIN CANCER RES, V13, P2627, DOI 10.1158/1078-0432.CCR-06-2281; Zhou W, 2004, CLIN CANCER RES, V10, P4939, DOI 10.1158/1078-0432.CCR-04-0247; ZWEIG MH, 1993, CLIN CHEM, V39, P561	60	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82750	10.1371/journal.pone.0082750	http://dx.doi.org/10.1371/journal.pone.0082750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340057	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400094
J	Miller, JE; Nugent, CN; Gaboda, D; Russell, LB				Miller, Jane E.; Nugent, Colleen N.; Gaboda, Dorothy; Russell, Louise B.			Reasons for Unmet Need for Child and Family Health Services among Children with Special Health Care Needs with and without Medical Homes	PLOS ONE			English	Article							NATIONAL-SURVEY; UNITED-STATES; ACCESS; INSURANCE; QUALITY; UNDERINSURANCE; EXPENDITURES; PROVIDE; COSTS; WILL	Objectives: Medical homes, an important component of U. S. health reform, were first developed to help families of children with special health care needs (CSHCN) find and coordinate services, and reduce their children's unmet need for health services. We hypothesize that CSHCN lacking medical homes are more likely than those with medical homes to report health system delivery or coverage problems as the specific reasons for unmet need. Methods: Data are from the 2005-2006 National Survey of Children with Special Health Care Needs (NS-CSHCN), a national, population-based survey of 40,723 CSHCN. We studied whether lacking a medical home was associated with 9 specific reasons for unmet need for 11 types of medical services, controlling for health insurance, child's health, and sociodemographic characteristics. Results: Weighted to the national population, 17% of CSHCN reported at least one unmet health service need in the previous year. CSHCN without medical homes were 2 to 3 times as likely to report unmet need for child or family health services, and more likely to report no referral (OR=3.3), dissatisfaction with provider (OR=2.5), service not available in area (OR=2.1), can't find provider who accepts insurance (OR=1.8), and health plan problems (OR=1.4) as reasons for unmet need (all p<0.05). Conclusions: CSHCN without medical homes were more likely than those with medical homes to report health system delivery or coverage reasons for unmet child health service needs. Attributable risk estimates suggest that if the 50% of CSHCN who lacked medical homes had one, overall unmet need for child health services could be reduced by as much as 35% and unmet need for family health services by 40%.	[Miller, Jane E.; Nugent, Colleen N.; Russell, Louise B.] Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, New Brunswick, NJ 08903 USA; [Miller, Jane E.] Rutgers State Univ, Bloustein Sch Planning & Publ Policy, New Brunswick, NJ 08903 USA; [Gaboda, Dorothy] Rutgers State Univ, Ctr State Hlth Policy, New Brunswick, NJ 08903 USA; [Russell, Louise B.] Rutgers State Univ, Dept Econ, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University New Brunswick	Russell, LB (corresponding author), Rutgers State Univ, Inst Hlth Hlth Care Policy & Aging Res, 30 Coll Ave, New Brunswick, NJ 08903 USA.	lrussell@ifh.rutgers.edu		Russell, Louise/0000-0003-3599-0991	Institute for Health, Health Care Policy, and Aging Research, Rutgers University	Institute for Health, Health Care Policy, and Aging Research, Rutgers University	This study was supported by the ordinary budget of the Institute for Health, Health Care Policy, and Aging Research, Rutgers University. There was no external funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander J, 2005, PEDIATRICS, V116, P1238, DOI 10.1542/peds.2005-2070; Allison P. D., 1999, MULTIPLE REGRESSION; [Anonymous], 2005 2005 NAT SURV C; Barr MS, 2008, JAMA-J AM MED ASSOC, V300, P834, DOI 10.1001/jama.300.7.834; Benedict RE, 2008, PEDIATRICS, V121, pE127, DOI 10.1542/peds.2007-0066; Blumberg SJ, 2008, VITAL HLTH STAT, V1; Blumberg SJ, 2009, WIRELESS SUBSTITUTIO; Bramlett MD, 2009, MATERN CHILD HLTH J, V13, P151, DOI 10.1007/s10995-008-0339-z; Centers for Disease Control and Prevention, NAT SURV CHILDR SPEC; Child and Adolescent Health Measurement Initiative (CAHMI), 2008, 2005 2006 NAT SURV C; Child and Adolescent Health Measurement Initiative (CAHMI), CHILDR SPEC HLTH CAR; Data Resource Center for Child and Adolescent Health Title V, NEEDS ASS REP DAT CT; Davidoff AJ, 2004, PEDIATRICS, V114, P394, DOI 10.1542/peds.114.2.394; Decker SL, 2011, JAMA-J AM MED ASSOC, V306, P187, DOI 10.1001/jama.2011.956; DeRigne L, 2010, HEALTH SOC WORK, V35, P7, DOI 10.1093/hsw/35.1.7; Farrell K., 2011, AFFORDABLE CARE ACT; Fields D, 2010, HEALTH AFFAIR, V29, P819, DOI 10.1377/hlthaff.2010.0009; Glazier RH, 2010, JAMA-J AM MED ASSOC, V303, P2186, DOI 10.1001/jama.2010.753; Gulley SP, 2011, MED CARE, V49, P149, DOI 10.1097/MLR.0b013e3182028380; Hill KS, 2008, MATERN CHILD HLTH J, V12, P650, DOI 10.1007/s10995-007-0283-3; Homer CJ, 2008, PEDIATRICS, V122, pE922, DOI 10.1542/peds.2007-3762; Kogan MD, 2005, PEDIATRICS, V116, P1162, DOI 10.1542/peds.2004-2432; Kogan MD, 2010, NEW ENGL J MED, V363, P841, DOI 10.1056/NEJMsa0909994; Laraque D, 2010, JAMA-J AM MED ASSOC, V303, P2047; LILIENFELD DE, 1994, FDN EPIDEMIOLOGY; Mayer ML, 2004, PEDIATRICS, V113, P109, DOI 10.1542/peds.113.2.e109; McAllister JW, 2009, J AMBUL CARE MANAG, V32, P188, DOI 10.1097/01.JAC.0000356990.38500.dd; McPherson M, 1998, PEDIATRICS, V102, P137, DOI 10.1542/peds.102.1.137; Miller I. E., 2001, VITAL HLTH STAT METH, V(PHS) 2001-1331; National Center for Health Statistics, 2007, PROGR IMPL COMM BAS, P2005; National Committee for Quality Assurance, 2011, PAT CTR MED HOM; Newacheck PW, 2000, PEDIATRICS, V105, P760, DOI 10.1542/peds.105.4.760; Newacheck PW, 2005, ARCH PEDIAT ADOL MED, V159, P10, DOI 10.1001/archpedi.159.1.10; Okumura Megumi J, 2009, Pediatrics, V124 Suppl 4, pS392, DOI 10.1542/peds.2009-1255J; Porterfield SL, 2011, PEDIATRICS, V128, P892, DOI 10.1542/peds.2010-1307; Rittenhouse DR, 2009, JAMA-J AM MED ASSOC, V301, P2038, DOI 10.1001/jama.2009.691; Romaire MA, 2012, MED CARE, V50, P262, DOI 10.1097/MLR.0b013e318244d345; Schuster MA, 2011, FUTURE CHILD, V21, P91; Sia CJ, 2002, PEDIATRICS, V110, P184; StataCorp L, 2007, STAT DAT AN STAT SOF; Stephen Blumberg, 2013, E COMMUNICATION; Stevens GD, 2011, MED CARE, V49, P828, DOI 10.1097/MLR.0b013e318215d0ef; Strickland B, 2004, PEDIATRICS, V113, P1485; Strickland BB, 2009, PEDIATRICS, V123, pE996, DOI 10.1542/peds.2008-2504; U.S. Department of Health and Human Services Health Resources and Services Administration Maternal and Child Health Bureau, 2008, NAT SURV CHILDR SPEC; Warfield ME, 2006, MATERN CHILD HLTH J, V10, P201, DOI 10.1007/S10995-005-0041-3; Yu H, 2008, MED CARE, V46, P1064, DOI 10.1097/MLR.0b013e318185cdf2	47	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82570	10.1371/journal.pone.0082570	http://dx.doi.org/10.1371/journal.pone.0082570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340042	Green Published, gold			2022-12-27	WOS:000328707400083
J	Tamm, C; Galito, SP; Anneren, C				Tamm, Christoffer; Galito, Sara Pijuan; Anneren, Cecilia			A Comparative Study of Protocols for Mouse Embryonic Stem Cell Culturing	PLOS ONE			English	Article							SELF-RENEWAL; GROUND-STATE; GENE; DIFFERENTIATION; SPECIFICATION; PLURIPOTENCY; INHIBITION; DISTINCT; SERUM; MICE	Most stem cell laboratories still rely on old culture methods to support the expansion and maintenance of mouse embryonic stem (ES) cells. These involve growing cells on mouse embryonic fibroblast feeder cells or on gelatin in media supplemented with fetal bovine serum and leukemia inhibitory factor (LIF). However, these techniques have several drawbacks including the need for feeder-cells and/or use of undefined media containing animal derived components. Culture of stem cells under undefined conditions can induce spontaneous differentiation and reduce reproducibility of experiments. In recent years several new ES cell culture protocols, using more well-defined conditions, have been published and we have compared the standard culture protocols with two of the newly described ones: 1) growing cells in semi-adherence in a medium containing two small molecule inhibitors (CHIR99021, PD0325901) and; 2) growing cells in a spheroid suspension culture in a defined medium containing LIF and bFGF. Two feeder-dependent mouse ES (mES) cell lines and two cell lines adapted to feeder-independent growth were used in the study. The overall aim has not only been to compare self-renewal and differentiation capacity, but also ease-of-use and cost efficiency. We show that mES cells when grown adherently proliferate much faster than when grown in suspension as free-floating spheres, independent of media used. Although all the tested culture protocols could maintain sustained pluripotency after prolonged culturing, our data confirm previous reports showing that the media containing two chemical inhibitors generate more pure stem cell cultures with negligible signs of spontaneous differentiation as compared to standard mES media. Furthermore, we show that this medium effectively rescues and cleans up cultures that have started to deteriorate, as well as allow for effective adaption of feeder-dependent mES cell lines to be maintained in feeder-free conditions.	[Tamm, Christoffer; Galito, Sara Pijuan; Anneren, Cecilia] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden; [Anneren, Cecilia] GE Healthcare Biosci AB, Uppsala, Sweden	Uppsala University; General Electric	Anneren, C (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	cecilia.anneren@imbim.uu.se		Pijuan Galito, Sara/0000-0002-7398-9441; Anneren, Cecilia/0000-0003-3600-6650	Swedish Research Council; Jeanssons' Foundations; Swedish Society for Medical Research; Faculty of Medicine Uppsala University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Jeanssons' Foundations; Swedish Society for Medical Research; Faculty of Medicine Uppsala University	This work was supported by the Swedish Research Council, Jeanssons' Foundations, the Swedish Society for Medical Research and Faculty of Medicine Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andang M, 2008, NAT PROTOC, V3, P1013, DOI 10.1038/nprot.2008.65; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chaudhry MA, 2008, CYTOTECHNOLOGY, V58, P173, DOI 10.1007/s10616-008-9177-5; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Holmborn K, 2004, J BIOL CHEM, V279, P42355, DOI 10.1074/jbc.C400373200; JIANG SW, 1995, J BIOL CHEM, V270, P13906, DOI 10.1074/jbc.270.23.13906; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; MAGIN TM, 1992, NUCLEIC ACIDS RES, V20, P3795, DOI 10.1093/nar/20.14.3795; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Meng GL, 2008, MOL REPROD DEV, V75, P614, DOI 10.1002/mrd.20790; Moliner A, 2008, STEM CELLS DEV, V17, P233, DOI 10.1089/scd.2007.0211; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nichols J, 2009, NAT MED, V15, P814, DOI 10.1038/nm.1996; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; PRICE PJ, 1998, Patent No. 9830679; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tamm C, 2011, J CELL SCI, V124, P1136, DOI 10.1242/jcs.075796; Tong C, 2011, NAT PROTOC, V6, P827, DOI 10.1038/nprot.2011.338; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	32	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81156	10.1371/journal.pone.0081156	http://dx.doi.org/10.1371/journal.pone.0081156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339907	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400012
J	Teichert, T; Vossoughi, M; Vierkotter, A; Sugiri, D; Schikowski, T; Schulte, T; Roden, M; Luckhaus, C; Herder, C; Kramer, U				Teichert, Tom; Vossoughi, Mohammad; Vierkoetter, Andrea; Sugiri, Dorothea; Schikowski, Tamara; Schulte, Thomas; Roden, Michael; Luckhaus, Christian; Herder, Christian; Kraemer, Ursula			Association between Traffic-Related Air Pollution, Subclinical Inflammation and Impaired Glucose Metabolism: Results from the SALIA Study	PLOS ONE			English	Article							LONG-TERM EXPOSURE; FINE PARTICULATE MATTER; USE REGRESSION-MODELS; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; DIABETES PREVALENCE; OXIDATIVE STRESS; PM2.5 ABSORBENCY; RISK-FACTORS; PARTICLES	Background: Environmental and lifestyle factors regulate the expression and release of immune mediators. It has been hypothesised that ambient air pollution may be such an external factor and that the association between air pollution and impaired glucose metabolism may be attributable to inflammatory processes. Therefore, we assessed the associations between air pollution, circulating immune mediators and impaired glucose metabolism. Methods: We analysed concentrations of 14 pro- and anti-inflammatory immune mediators as well as fasting glucose and insulin levels in plasma of 363 women from the Study on the influence of Air pollution on Lung function, Inflammation and Aging (SALIA, Germany). Exposure data for a group of pollutants such as nitrogen oxides (NO2, NOx) and different fractions of particulate matter were available for the participants' residences. We calculated the association between the pollutants and impaired glucose metabolism by multiple regression models. Results: The study participants had a mean age of 74.1 (SD 2.6) years and 48% showed impaired glucose metabolism based on impaired fasting glucose or previously diagnosed type 2 diabetes. Only long-term exposure NO2 and NOx concentrations showed positive associations (NO2: OR 1.465, 95% CI 1.049-2.046, NOx: OR 1.409, 95% CI 1.010-1.967) per increased interquartile range of NO2 (14.65 mu g/m(3)) or NOx (43.16 mu g/m(3)), respectively, but statistical significance was lost after correction for multiple comparisons. Additional adjustment for circulating immune mediators or the use of anti-inflammatory medication had hardly any impact on the observed ORs. Conclusions: Our results suggest that exposure to nitrogen oxides may contribute to impaired glucose metabolism, but the associations did not reach statistical significance so that further studies with larger sample sizes are required to substantiate our findings. Our data do not preclude a role of inflammatory mechanisms in adipose or other tissues which may not be reflected by immune mediators in plasma.	[Teichert, Tom; Roden, Michael; Herder, Christian] Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Vossoughi, Mohammad; Vierkoetter, Andrea; Sugiri, Dorothea; Schikowski, Tamara; Kraemer, Ursula] Univ Dusseldorf, IUF Leibniz Res Inst Environm Med, Dusseldorf, Germany; [Schikowski, Tamara] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Schikowski, Tamara] Univ Basel, Basel, Switzerland; [Schulte, Thomas; Luckhaus, Christian] Univ Dusseldorf, Fac Med, Dept Psychiat & Psychotherapy, Dusseldorf, Germany; [Roden, Michael] Univ Dusseldorf, Univ Hosp Dusseldorf, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Roden, Michael; Herder, Christian] German Ctr Diabet Res DZD eV, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Leibniz Institut fur Umweltmedizinische Forschung (IUF); University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital	Herder, C (corresponding author), Univ Dusseldorf, Inst Clin Diabetol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany.	christian.herder@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019		Deutsche Forschungsgemeinschaft (DFG) [HE-4510/2-1, KR 1938/3-1, LU 691/4-1]; Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance) [VT 266.1]; European Community [211250]; German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf, Germany); Federal Ministry of the Environment (Berlin, Germany); DGUV (German statutory accident assurance); European Community(European Commission); German Federal Ministry of Health (Berlin, Germany); Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia (Dusseldorf, Germany); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG; HE-4510/2-1, KR 1938/3-1, LU 691/4-1). SALIA received funds from the Ministry of the Environment of the state North Rhine-Westphalia (Dusseldorf, Germany) and the Federal Ministry of the Environment (Berlin, Germany). The follow-up investigation was funded by the DGUV (German statutory accident assurance) VT 266.1. Exposure assessment (ESCAPE-data) was funded by the European Community's Seventh Framework Program (FP7/2007-2011) under grant agreement number 211250. The German Diabetes Center is funded by the German Federal Ministry of Health (Berlin, Germany) and the Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia (Dusseldorf, Germany). This study was supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Andersen ZJ, 2012, DIABETES CARE, V35, P92, DOI 10.2337/dc11-1155; Beelen R, 2013, ATMOS ENVIRON, V72, P10, DOI 10.1016/j.atmosenv.2013.02.037; Belvisi MG, 2003, PULM PHARMACOL THER, V16, P1, DOI 10.1016/S1094-5539(02)00180-3; Brook RD, 2008, J OCCUP ENVIRON MED, V50, P32, DOI 10.1097/JOM.0b013e31815dba70; Brook RD, 2013, SCI TOTAL ENVIRON, V448, P66, DOI 10.1016/j.scitotenv.2012.07.034; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Brown DM, 2001, TOXICOL APPL PHARM, V175, P191, DOI 10.1006/taap.2001.9240; Carstensen M, 2010, DIABETES, V59, P1222, DOI 10.2337/db09-1199; Chen H, 2013, ENVIRON HEALTH PERSP, V121, P804, DOI 10.1289/ehp.1205958; Chuang KJ, 2011, OCCUP ENVIRON MED, V68, P64, DOI 10.1136/oem.2009.052704; Coogan PF, 2012, CIRCULATION, V125, P767, DOI 10.1161/CIRCULATIONAHA.111.052753; Cyrys J, 2003, J EXPO ANAL ENV EPID, V13, P134, DOI 10.1038/sj.jea.7500262; Cyrys J, 2012, ATMOS ENVIRON, V62, P374, DOI 10.1016/j.atmosenv.2012.07.080; Dijkema MBA, 2011, ENVIRON HEALTH-GLOB, V10, DOI 10.1186/1476-069X-10-76; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eeftens M, 2012, ATMOS ENVIRON, V62, P303, DOI 10.1016/j.atmosenv.2012.08.038; Eeftens M, 2012, ENVIRON SCI TECHNOL, V46, P11195, DOI 10.1021/es301948k; Fonken LK, 2011, MOL PSYCHIATR, V16, P987, DOI 10.1038/mp.2011.76; Herder C, 2013, DIABETES OBES METAB, V15, P39, DOI 10.1111/dom.12155; Herder C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019852; Herder C, 2009, DIABETES CARE, V32, P1921, DOI 10.2337/dc09-0476; Huang HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037412; Jain M, 2011, AM J RESP CRIT CARE, V183, P1490, DOI 10.1164/rccm.201009-1409OC; Jansen F, 2013, CARDIOVASC RES, V98, P94, DOI 10.1093/cvr/cvt013; Kelishadi R, 2009, ATHEROSCLEROSIS, V203, P311, DOI 10.1016/j.atherosclerosis.2008.06.022; Khafaie MA, 2013, DIABETES CARE, V36, P625, DOI 10.2337/dc12-0388; Kramer U, 2010, ENVIRON HEALTH PERSP, V118, P1273, DOI 10.1289/ehp.0901689; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Nemmar A, 2002, CIRCULATION, V105, P411, DOI 10.1161/hc0402.104118; Nemmar A, 2001, AM J RESP CRIT CARE, V164, P1665, DOI 10.1164/ajrccm.164.9.2101036; Pearson JF, 2010, DIABETES CARE, V33, P2196, DOI 10.2337/dc10-0698; Peters A, 2001, EUR HEART J, V22, P1198, DOI 10.1053/euhj.2000.2483; Puett RC, 2011, ENVIRON HEALTH PERSP, V119, P384, DOI 10.1289/ehp.1002344; Ranft U, 2009, ENVIRON RES, V109, P1004, DOI 10.1016/j.envres.2009.08.003; Roux AVD, 2006, AM J EPIDEMIOL, V164, P437, DOI 10.1093/aje/kwj186; Ruckerl R, 2006, AM J RESP CRIT CARE, V173, P432, DOI 10.1164/rccm.200507-1123OC; Ruckerl R, 2007, ENVIRON HEALTH PERSP, V115, P1072, DOI 10.1289/ehp.10021; Salomaa V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010100; Sattar N, 2008, DIABETOLOGIA, V51, P926, DOI 10.1007/s00125-008-0954-7; Schikowski T, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-152; Schulz H, 2005, J AEROSOL MED, V18, P1, DOI 10.1089/jam.2005.18.1; Seagrave J, 2008, TOXICOL APPL PHARM, V232, P469, DOI 10.1016/j.taap.2008.08.001; Seaton A, 1999, THORAX, V54, P1027, DOI 10.1136/thx.54.11.1027; Sorensen M, 2013, ENVIRON HEALTH PERSP, V121, P217, DOI 10.1289/ehp.1205503; Steinvil A, 2008, ENVIRON RES, V106, P51, DOI 10.1016/j.envres.2007.08.006; Sun QH, 2005, JAMA-J AM MED ASSOC, V294, P3003, DOI 10.1001/jama.294.23.3003; Sun QH, 2009, CIRCULATION, V119, P538, DOI 10.1161/CIRCULATIONAHA.108.799015; Valavanidis A, 2008, J ENVIRON SCI HEAL C, V26, P339, DOI 10.1080/10590500802494538; van Eeden SF, 2001, AM J RESP CRIT CARE, V164, P826, DOI 10.1164/ajrccm.164.5.2010160; Xu XH, 2011, TOXICOL SCI, V124, P88, DOI 10.1093/toxsci/kfr211	51	50	50	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83042	10.1371/journal.pone.0083042	http://dx.doi.org/10.1371/journal.pone.0083042			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340078	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000328707400114
J	Destaing, O; Ferguson, SM; Grichine, A; Oddou, C; De Camilli, P; Albiges-Rizo, C; Baron, R				Destaing, Olivier; Ferguson, Shawn M.; Grichine, Alexei; Oddou, Christiane; De Camilli, Pietro; Albiges-Rizo, Corinne; Baron, Roland			Essential Function of Dynamin in the Invasive Properties and Actin Architecture of v-Src Induced Podosomes/Invadosomes	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; REGULATES PODOSOMES; FLUORESCENT PROTEIN; CRYSTAL-STRUCTURE; GTPASE ACTIVITY; BAR PROTEINS; SEALING ZONE; COATED PITS; N-WASP; CYTOSKELETON	The large GTPase dynamin plays a key role in endocytosis but is also localized at numerous actin rich sites. We investigated dynamin functions at podosomes/invadosomes, actin-based cellular adhesion structures implicated in tissue invasion. Podosomes/invadosomes are constituted of long F-actin bundles perpendicular to the substratum (actin cores), connected to randomly arranged F-actin fibers parallel to the substratum (actin cloud). We show here that dynamin depletion in v-Src-transformed fibroblasts triggers a massive disorganization of podosomes/invadosomes (isolated or in rosettes), with a corresponding inhibition of their invasive properties. The action of dynamin at podosomes/invadosomes requires a functional full-length protein, suggesting that the effects of dynamin at these sites and in membrane remodelling during endocytosis are mediated by similar mechanisms. In order to determine direct effect of dynamin depletion on invadosome, an optogenetic approach based on the photosensitizer KillerRed was developed. Acute dynamin photo-inactivation leads to a very rapid disorganization of invadosome without affecting focal adhesions. Dynamin therefore is a key regulator of the architecture of actin in podosomes/invadosomes.	[Destaing, Olivier; Grichine, Alexei; Oddou, Christiane; Albiges-Rizo, Corinne] Univ Grenoble 1, Inst Albert Bonniot, Grenoble, France; [Destaing, Olivier; Ferguson, Shawn M.; De Camilli, Pietro] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Cell Biol,Program Cellular Neurosci Neurodeg, New Haven, CT 06510 USA; [Baron, Roland] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Med,Endocrine Unit, Boston, MA USA; [De Camilli, Pietro; Albiges-Rizo, Corinne; Baron, Roland] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Howard Hughes Medical Institute; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard School of Dental Medicine	Destaing, O (corresponding author), Univ Grenoble 1, Inst Albert Bonniot, Univ Joseph Fourier Site Sante, Grenoble, France.	olivier.destaing@ujf-grenoble.fr	Grichine, Alexei/M-3923-2013; destaing, olivier/M-3802-2013; Grichine, Alexei/P-8377-2019; Albiges-Rizo, Corinne/M-2568-2013	Grichine, Alexei/0000-0002-7335-9706; Grichine, Alexei/0000-0002-7335-9706; destaing, olivier/0000-0001-7622-3700; Christiane, ODDOU/0000-0002-0992-570X; ALBIGES-RIZO, Corinne/0000-0002-6333-4150	National Institutes of Health [DE-04724, AR-42927, N536251, CA46128, DK45735, DA018343]; G. Harold and Leila Y. Mathers Charitable Foundation; Ligue Nationale Contre le Cancer (Equipe labellisee); fond d'intervention du Pole Chimie Sciences du Vivant; J. Fourier-Grenoble university; LLNC as "Equipe labellisee Ligue"; NATIONAL CANCER INSTITUTE [P01CA046128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE004724, R01DE004724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS036251, R01NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); fond d'intervention du Pole Chimie Sciences du Vivant; J. Fourier-Grenoble university; LLNC as "Equipe labellisee Ligue"; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was supported in part by National Institutes of Health grants DE-04724 and AR-42927 (to R B), by the G. Harold and Leila Y. Mathers Charitable Foundation, National Institutes of Health grants to P.D.C. (N536251, CA46128, DK45735, and DA018343), by the Ligue Nationale Contre le Cancer (Equipe labellisee-2010) and by the "fond d'intervention du Pole Chimie Sciences du Vivant", from J. Fourier-Grenoble university. The French team is supported by LLNC as "Equipe labellisee Ligue 2010".	Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Badowski C, 2008, MOL BIOL CELL, V19, P633, DOI 10.1091/mbc.E06-01-0088; Baldassarre M, 2003, MOL BIOL CELL, V14, P1074, DOI 10.1091/mbc.E02-05-0308; Bharti S, 2007, MOL CELL BIOL, V27, P8271, DOI 10.1128/MCB.01781-06; Bian X, 2011, P NATL ACAD SCI USA, V108, P3976, DOI 10.1073/pnas.1101643108; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Cao H, 1998, MOL BIOL CELL, V9, P2595, DOI 10.1091/mbc.9.9.2595; Chappie JS, 2011, CELL, V147, P209, DOI 10.1016/j.cell.2011.09.003; Chappie JS, 2010, NATURE, V465, P435, DOI 10.1038/nature09032; Chua J, 2009, P NATL ACAD SCI USA, V106, P20770, DOI 10.1073/pnas.0909812106; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Destaing O, 2011, CURR OPIN CELL BIOL; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Eppinga RD, 2011, ONCOGENE; Faelber K, 2011, NATURE, V477, P556, DOI 10.1038/nature10369; Farsad K, 2001, J CELL BIOL, V155, P193, DOI 10.1083/jcb.200107075; Ferguson S, 2009, DEV CELL, V17, P811, DOI 10.1016/j.devcel.2009.11.005; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Ford MGJ, 2011, NATURE, V477, P561, DOI 10.1038/nature10441; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Grabs D, 1997, J BIOL CHEM, V272, P13419, DOI 10.1074/jbc.272.20.13419; Gu C, 2010, EMBO J, V29, P3593, DOI 10.1038/emboj.2010.249; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Huynh KK, 2008, CURR BIOL, V18, pR563, DOI 10.1016/j.cub.2008.05.032; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; Kenniston JA, 2010, EMBO J, V29, P3054, DOI 10.1038/emboj.2010.187; Krueger EW, 2003, MOL BIOL CELL, V14, P1085, DOI 10.1091/mbc.E02-08-0466; Lee E, 2002, P NATL ACAD SCI USA, V99, P161, DOI 10.1073/pnas.012607799; Linder S, 2000, J IMMUNOL, V165, P221, DOI 10.4049/jimmunol.165.1.221; Linder S, 2009, J CELL SCI, V122, P3009, DOI 10.1242/jcs.032631; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MARCHISIO PC, 1984, J CELL BIOL, V99, P1696, DOI 10.1083/jcb.99.5.1696; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; McPherson PS, 2002, TRENDS CELL BIOL, V12, P312, DOI 10.1016/S0962-8924(02)02309-7; Mooren OL, 2009, J BIOL CHEM, V284, P23995, DOI 10.1074/jbc.M109.024398; Ochoa GC, 2000, J CELL BIOL, V150, P377, DOI 10.1083/jcb.150.2.377; Okamoto PM, 1997, J BIOL CHEM, V272, P11629; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Orth JD, 2002, P NATL ACAD SCI USA, V99, P167, DOI 10.1073/pnas.012607899; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pichot CS, 2010, CANCER RES, V70, P8347, DOI 10.1158/0008-5472.CAN-09-4149; Poincloux R, 2009, J CELL SCI, V122, P3015, DOI 10.1242/jcs.034561; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Salazar MA, 2003, J BIOL CHEM, V278, P49031, DOI 10.1074/jbc.M308104200; Saltel F, 2011, EUR J CELL BIOL, V90, P100, DOI 10.1016/j.ejcb.2010.05.011; Schafer DA, 2004, TRAFFIC, V5, P463, DOI 10.1111/j.1600-0854.2004.00199.x; Schmid SL, 2011, ANNU REV CELL DEV BI, V27, P79, DOI 10.1146/annurev-cellbio-100109-104016; Sever S, 2000, J CELL BIOL, V150, P1137, DOI 10.1083/jcb.150.5.1137; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Shen HY, 2011, MOL BIOL CELL, V22, P493, DOI 10.1091/mbc.E10-07-0637; SHPETNER HS, 1989, CELL, V59, P421, DOI 10.1016/0092-8674(89)90027-5; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3; Takei K, 1999, NAT CELL BIOL, V1, P33, DOI 10.1038/9004; TARONE G, 1985, EXP CELL RES, V159, P141, DOI 10.1016/S0014-4827(85)80044-6; Taylor MJ, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000604; Winograd-Katz SE, 2011, EUR J CELL BIOL, V90, P143, DOI 10.1016/j.ejcb.2010.07.006; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417; Yamada H, 2009, BIOCHEM BIOPH RES CO, V390, P1142, DOI 10.1016/j.bbrc.2009.10.105	67	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e77956	10.1371/journal.pone.0077956	http://dx.doi.org/10.1371/journal.pone.0077956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24348990	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200004
J	Jiao, H; Xu, ZD; Wu, LB; Cheng, ZP; Ji, XP; Zhong, H; Meng, C				Jiao, Hui; Xu, Zhuodong; Wu, Lebin; Cheng, Zhaoping; Ji, Xiaopeng; Zhong, Hai; Meng, Chen			Detection of Airway Anomalies in Pediatric Patients with Cardiovascular Anomalies with Low Dose Prospective ECG-Gated Dual-Source CT	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; VIRTUAL BRONCHOSCOPY; MULTIDETECTOR CT; CHILDREN; TRACHEOBRONCHOSCOPY; STENOSES	Objectives: To assess the feasibility of low-dose prospective ECG-gated dual-source CT (DSCT) in detecting airway anomalies in pediatric patients with cardiovascular anomalies compared with flexible tracheobronchoscopy (FTB). Methods: 33 pediatrics with respiratory symptoms who had been revealed cardiovascular anomalies by transthoracic echocardiography underwent FTB and contrast material-enhanced prospective ECG-triggering CT were enrolled. The study was approved by our institution review board and written informed consent was obtained from all patients' guardian. DSCT examinations were performed to detect cardiovascular abnormalities using weight-adjusted low-dose protocol. Two radiologists independently performed CT image analysis. The FTB reports were reviewed by an experienced pulmonologist. The sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy of DSCT in the detection of airway anomalies were assessed. The tracheobronchial stenoses revealed on FTB were graded. Effective radiation dose was calculated. Results: Thirty cases were diagnosed with tracheobronchial narrowing and/or abnormality in 33 patients by FTB, while 3 patients had normal FTB findings. Twenty-eight cases were diagnosed with airway anomalies by CT, of which 27 were correct positive. 3 patients with normal findings at CT had findings of tracheobronchial narrowing due to tracheobronchomalacia at inspiration at FTB. Sensitivity and specificity of CT were 90.0% (95% CI: 72.3%, 97.4%) and 66.7% (95% CI: 12.5 %, 98.2 %), respectively. PPV and NPV were 96.4% (95% CI: 79.8 %, 99.8%) and 40.0% (95% CI: 7.3%, 83.0%), respectively. Overall accuracy of DSCT in detecting airway anomalies in pediatrics with cardiovascular anomalies was 87.9% (95% CI: 74.5%, 97.6%). In grading of tracheobronchial stenosis, images from CT correlated closely (r = 0.89) with those of FTB. Mean effective dose was 0.60 +/- 0.20 mSv. Conclusion: In pediatric patients, ECG-triggered CT to evaluate congenital cardiovascular anomalies can also be used to diagnose and characterize fixed airway involvement in relation to the vascular structures.	[Jiao, Hui; Ji, Xiaopeng] Shandong Univ, Shandong Med Imaging Res Inst, Jinan, Shandong, Peoples R China; [Xu, Zhuodong; Wu, Lebin; Cheng, Zhaoping] Shandong Med Imaging Res Inst, Jinan, Shandong, Peoples R China; [Zhong, Hai] Shandong Univ, Hosp 2, Dept Radiol, Jinan, Shandong, Peoples R China; [Meng, Chen] Shandong Univ, Qilu Children Hosp, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Xu, ZD (corresponding author), Shandong Med Imaging Res Inst, Jinan, Shandong, Peoples R China.	xzd006666@126.com		Cheng, Zhaoping/0000-0001-7217-7284				BACKER CL, 1989, J THORAC CARDIOV SUR, V97, P725; Brown JW, 2006, ANN THORAC SURG, V82, P2221, DOI 10.1016/j.athoracsur.2006.07.022; Cerda J, 2007, PEDIATR PULM, V42, P319, DOI 10.1002/ppul.20577; Cheng ZP, 2010, EUR RADIOL, V20, P2503, DOI 10.1007/s00330-010-1822-7; CORNO A, 1990, J THORAC CARDIOV SUR, V99, P1091; Einstein AJ, 2007, CIRCULATION, V116, P1290, DOI 10.1161/CIRCULATIONAHA.107.688101; Freitag L, 2007, EUR RESPIR J, V30, P7, DOI 10.1183/09031936.00132804; Ghaye B, 2001, RADIOGRAPHICS, V21, P105, DOI 10.1148/radiographics.21.1.g01ja06105; Haliloglu M, 2003, EUR J RADIOL, V48, P188, DOI 10.1016/S0720-048X(02)00295-4; Heyer CM, 2007, RADIOLOGY, V242, P542, DOI 10.1148/radiol.2422060153; Honnef D, 2006, EUR RADIOL, V16, P1684, DOI 10.1007/s00330-006-0230-5; Hoppe H, 2002, AM J ROENTGENOL, V178, P1195, DOI 10.2214/ajr.178.5.1781195; Kauczor HU, 1996, AM J ROENTGENOL, V167, P419, DOI 10.2214/ajr.167.2.8686619; Litmanovich D, 2010, RADIOLOGY, V257, P560, DOI 10.1148/radiol.10100219; LOEFF DS, 1988, J PEDIATR SURG, V23, P744, DOI 10.1016/S0022-3468(88)80416-0; NEWTH CJL, 1998, PEDIAT CARDIAC INTEN, P355; NIKAIDOH H, 1972, ARCH SURG-CHICAGO, V105, P327; SADE RM, 1975, J THORAC CARDIOV SUR, V69, P333; SHRIMPTON PC, 2004, NRPBPE12004; STANGER P, 1969, PEDIATRICS, V43, P760; Summers RM, 1996, RADIOLOGY, V200, P857, DOI 10.1148/radiology.200.3.8756944; Tann OR, 2010, PROG PEDIATR CARDIOL, V28, P21, DOI 10.1016/j.ppedcard.2009.10.007; Zeng Shuang-Lin, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P893	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82826	10.1371/journal.pone.0082826	http://dx.doi.org/10.1371/journal.pone.0082826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324836	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566700115
J	Uribe, PM; Asuncion, JD; Matsui, JI				Uribe, Phillip M.; Asuncion, James D.; Matsui, Jonathan I.			Ethanol Affects the Development of Sensory Hair Cells in Larval Zebrafish (Danio rerio)	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; RETINOIC ACID SYNTHESIS; LATERAL-LINE SYSTEM; VISUAL-SYSTEM; NEUROTROPHIC FACTOR; AUDITORY FUNCTION; OXIDATIVE STRESS; EXPOSURE; DEATH; REGENERATION	Children born to mothers with substantial alcohol consumption during pregnancy can present a number of morphological, cognitive, and sensory abnormalities, including hearing deficits, collectively known as fetal alcohol syndrome (FAS). The goal of this study was to determine if the zebrafish lateral line could be used to study sensory hair cell abnormalities caused by exposure to ethanol during embryogenesis. Some lateral line sensory hair cells are present at 2 days post-fertilization (dpf) and are functional by 5 dpf. Zebrafish embryos were raised in fish water supplemented with varying concentrations of ethanol (0.75%-1.75% by volume) from 2 dpf through 5 dpf. Ethanol treatment during development resulted in many physical abnormalities characteristic of FAS in humans. Also, the number of sensory hair cells decreased as the concentration of ethanol increased in a dose-dependent manner. The dye FM 1-43FX was used to detect the presence of functional mechanotransduction channels. The percentage of FM 1-43-labeled hair cells decreased as the concentration of ethanol increased. Methanol treatment did not affect the development of hair cells. The cell cycle markers proliferating cell nuclear antigen (PCNA) and bromodeoxyuridine (BrdU) demonstrated that ethanol reduced the number of sensory hair cells, as a consequence of decreased cellular proliferation. There was also a significant increase in the rate of apoptosis, as determined by TUNEL-labeling, in neuromasts following ethanol treatment during larval development. Therefore, zebrafish are a useful animal model to study the effects of hair cell developmental disorders associated with FAS.	[Uribe, Phillip M.; Asuncion, James D.; Matsui, Jonathan I.] Pomona Coll, Dept Neurosci, Claremont, CA 91711 USA; [Matsui, Jonathan I.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Matsui, Jonathan I.] Boston Childrens Hosp, Dept Otolaryngol & Commun Enhancement, Boston, MA USA	Claremont Colleges; Pomona College; Harvard University; Harvard University; Boston Children's Hospital	Matsui, JI (corresponding author), Harvard Univ, Sch Med, Off Fac Affairs, Boston, MA 02114 USA.	jonathan_matsui@hms.harvard.edu		Uribe, Phillip/0000-0002-7396-8907	National Institutes for Health [EY 14790]; NIH [DC010998]; National Organization for Hearing Research Foundation; Pomona College; Sarah Fuller Fund of Children's Hospital Boston; NATIONAL EYE INSTITUTE [F32EY014790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R15DC010998] Funding Source: NIH RePORTER	National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Organization for Hearing Research Foundation; Pomona College; Sarah Fuller Fund of Children's Hospital Boston; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a postdoctoral fellowship from the National Institutes for Health EY 14790 (JIM) and NIH Grant DC010998 (JIM). The National Organization for Hearing Research Foundation, Pomona College, and the Sarah Fuller Fund of Children's Hospital Boston also supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandre D, 1999, P NATL ACAD SCI USA, V96, P7558, DOI 10.1073/pnas.96.13.7558; Anthony B, 2008, ALCOHOL ALCOHOLISM, V43, P261, DOI 10.1093/alcalc/agm166; Arenzana FJ, 2006, NEUROTOXICOL TERATOL, V28, P342, DOI 10.1016/j.ntt.2006.02.001; BERMAN RF, 1992, ALCOHOL CLIN EXP RES, V16, P490, DOI 10.1111/j.1530-0277.1992.tb01406.x; BHAVE SA, 1995, J NEUROSCI, V15, P4618; Bilotta J, 2002, NEUROTOXICOL TERATOL, V24, P759, DOI 10.1016/S0892-0362(02)00319-7; Bilotta J, 2004, NEUROTOXICOL TERATOL, V26, P737, DOI 10.1016/j.ntt.2004.06.011; Boyadjieva NI, 2013, ALCOHOL CLIN EXP RES, V37, P1370, DOI 10.1111/acer.12104; Carvan MJ, 2004, NEUROTOXICOL TERATOL, V26, P757, DOI 10.1016/j.ntt.2004.06.016; Chmielewski CE, 1997, ALCOHOL, V14, P313, DOI 10.1016/S0741-8329(97)87948-7; Church M W, 1987, Electroencephalogr Clin Neurophysiol Suppl, V40, P452; CHURCH MW, 1988, PEDIATRICS, V82, P147; CHURCH MW, 1987, ALCOHOL, V4, P231, DOI 10.1016/0741-8329(87)90017-6; Church MW, 1997, ALCOHOL CLIN EXP RES, V21, P495; Church MW, 1996, ALCOHOL CLIN EXP RES, V20, P172, DOI 10.1111/j.1530-0277.1996.tb01061.x; Church MW, 1992, ALCOHOL CLIN EXP RES, V16, P380; Climent E, 2002, J NEUROSCI RES, V68, P213, DOI 10.1002/jnr.10208; Deltour L, 1996, FASEB J, V10, P1050, DOI 10.1096/fasebj.10.9.8801166; Dickman ED, 1997, DEVELOPMENT, V124, P3111; DUESTER G, 1991, ALCOHOL CLIN EXP RES, V15, P568, DOI 10.1111/j.1530-0277.1991.tb00562.x; Gale JE, 2001, J NEUROSCI, V21, P7013, DOI 10.1523/JNEUROSCI.21-18-07013.2001; Giles S, 2008, REPROD TOXICOL, V25, P224, DOI 10.1016/j.reprotox.2007.11.014; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; Kalmijn A.J., 1989, P187; Kashyap B, 2007, VISUAL NEUROSCI, V24, P409, DOI 10.1017/S0952523807070423; Kashyap B, 2011, ALCOHOL CLIN EXP RES, V35, P1644, DOI 10.1111/j.1530-0277.2011.01511.x; KELLEY MW, 1993, DEVELOPMENT, V119, P1041; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; KOTCH LE, 1992, AM J MED GENET, V44, P168, DOI 10.1002/ajmg.1320440210; Kouzoukas DE, 2013, J NEUROCHEM, V124, P323, DOI 10.1111/jnc.12076; Loucks E, 2004, NEUROTOXICOL TERATOL, V26, P745, DOI 10.1016/j.ntt.2004.06.017; Luo J, 1998, BRAIN RES REV, V27, P157, DOI 10.1016/S0165-0173(98)00009-5; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Ma EY, 2009, CURR BIOL, V19, pR381, DOI 10.1016/j.cub.2009.03.057; Maes J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043850; Mann L I, 1975, Am J Obstet Gynecol, V122, P847; Matsui JI, 2006, INVEST OPHTH VIS SCI, V47, P4589, DOI 10.1167/iovs.05-0971; METCALFE WK, 1985, J COMP NEUROL, V233, P377, DOI 10.1002/cne.902330307; Meyers JR, 2003, J NEUROSCI, V23, P4054; Montgomery J, 2000, PHILOS T ROY SOC B, V355, P1325, DOI 10.1098/rstb.2000.0693; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; NORDEMAR H, 1988, ACTA OTO-LARYNGOL, V105, P75, DOI 10.3109/00016488809119448; OBE G, 1979, MUTAT RES, V65, P229, DOI 10.1016/0165-1110(79)90004-6; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Olney JW, 2002, BRAIN PATHOL, V12, P488, DOI 10.1111/j.1750-3639.2002.tb00467.x; Perkins A, 2013, INT J DEV NEUROSCI, V31, P391, DOI 10.1016/j.ijdevneu.2013.03.010; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Raz Y, 1999, DEV BIOL, V213, P180, DOI 10.1006/dbio.1999.9364; Reimers MJ, 2004, NEUROTOXICOL TERATOL, V26, P769, DOI 10.1016/j.ntt.2004.06.012; Sanes D. H., 2011, DEV NERVOUS SYSTEM; Santos F, 2006, HEARING RES, V213, P25, DOI 10.1016/j.heares.2005.12.009; Santos-Ledo A, 2011, NEUROTOXICOL TERATOL, V33, P686, DOI 10.1016/j.ntt.2011.06.001; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Tenkova T, 2003, INVEST OPHTH VIS SCI, V44, P2809, DOI 10.1167/iovs.02-0982; Uribe PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055359; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Zamora LY, 2013, ZEBRAFISH, V10, P52, DOI 10.1089/zeb.2012.0830	61	7	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e83039	10.1371/journal.pone.0083039	http://dx.doi.org/10.1371/journal.pone.0083039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324841	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566700120
J	Achieng, L; Musangi, H; Billingsley, K; Onguit, S; Ombegoh, E; Bryant, L; Mwiindi, J; Smith, N; Keiser, P				Achieng, Loice; Musangi, Helen; Billingsley, Katherine; Onguit, Sharon; Ombegoh, Edwin; Bryant, LeeAnn; Mwiindi, Jonathan; Smith, Nathaniel; Keiser, Philip			The Use of Pill Counts as a Facilitator of Adherence with Antiretroviral Therapy in Resource Limited Settings	PLOS ONE			English	Article							COMMUNICATION	Background: Pill counts are often used to measure adherence to ART, but there is little data on how they affect adherence. We previously showed a bivariate relationship between clinicians counting pills and adherence in patients receiving HIV care in Kenya. We present a secondary analysis of the relationship between numbers of pill counts and clinical outcomes in resource limited settings Methods: Patients initiating ART at Kijabe Hospital were monitored for the number of discretionary pill counts performed by their clinician in the first 6 months of ART. Subjects were followed for at least 1 year after enrollment. The number of clinician pill counts was correlated to ART adherence. The primary endpoints were time to treatment failure, defined as a detectable HIV-1 viral load, death; or loss to follow-up. Results: Clinician pill counts were done at 68% of clinic visits for 304 subjects. There was a positive correlation between the number of clinician pill counts and ART adherence (r = 0.21, p < 0.001). Patients were divided into 3 groups (0 counts, 1 to 3 counts, 4 to 7 counts) and exhibited adherence of 76%, 84%, and 92%, respectively (p = 0.004). Time to treatment failure for these groups was 220 days, 438 days, and 497 days (P < 0.01), respectively. Time to virologic failure in living patients remaining in the cohort was longer in those with more pill count (P = 0.02). Multi-variate analysis adjusting for co-variates affecting time to treatment failure found that that clinician pill counts were associated with a decreased risk of treatment failure (HR = 0.69, p = 0.04). Conclusions: The number of clinician pill count performed was independently associated with better adherence and a decreased risk of treatment failure. The use of clinician pill counts should be further studied as an adherence promoter through a randomized clinical trial.	[Achieng, Loice; Ombegoh, Edwin; Smith, Nathaniel] AIC Kijabe Hosp, Kijabe, Kenya; [Achieng, Loice; Musangi, Helen] Univ Nairobi, Nairobi, Kenya; [Billingsley, Katherine; Onguit, Sharon; Bryant, LeeAnn; Mwiindi, Jonathan; Keiser, Philip] Univ Texas Med Branch, Galveston, TX 77555 USA; [Smith, Nathaniel] Arkansas Dept Hlth, Little Rock, AR 72205 USA	University of Nairobi; University of Texas System; University of Texas Medical Branch Galveston	Keiser, P (corresponding author), Univ Texas Med Branch, Galveston, TX 77555 USA.	pkeise@gmail.com			Fogarty International Center [R25TW008129]; FOGARTY INTERNATIONAL CENTER [R25TW008129] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported in part by a grant from the Fogarty International Center, R25TW008129. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achieng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032727; Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Chang LW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010923; Chung MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000422; de Jong K, 2000, LANCET, V355, P2067, DOI 10.1016/S0140-6736(00)02364-3; EIKHATIB Z, 2011, PLOS ONE; Haberer JE, 2010, AIDS BEHAV, V14, P1340, DOI 10.1007/s10461-010-9799-4; Jerome G, 2010, AIDS, V24, pS67, DOI 10.1097/01.aids.0000366084.75945.c9; Kalichman SC, 2008, HIV CLIN TRIALS, V9, P298, DOI 10.1310/hct0905-298; Kalichman SC, 2010, HIV CLIN TRIALS, V11, P325, DOI 10.1310/hct1106-325; Mugusi F, 2009, TROP MED INT HEALTH, V14, P1226, DOI 10.1111/j.1365-3156.2009.02359.x; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, pS127, DOI 10.1097/01.qai.0000248349.25630.3d; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Zolnierek KBH, 2009, MED CARE, V47, P826, DOI 10.1097/MLR.0b013e31819a5acc	16	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e67259	10.1371/journal.pone.0067259	http://dx.doi.org/10.1371/journal.pone.0067259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339861	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100001
J	Li, FG; Hu, G; Zhang, H; Wang, SZ; Wang, ZP; Li, H				Li, Fangge; Hu, Guo; Zhang, Hui; Wang, Shouzhi; Wang, Zhipeng; Li, Hui			Epistatic Effects on Abdominal Fat Content in Chickens: Results from a Genome-Wide SNP-SNP Interaction Analysis	PLOS ONE			English	Article							GENE-GENE INTERACTIONS; MISSING HERITABILITY; ADIPOSE-TISSUE; BODY-WEIGHT; TNF-ALPHA; EXPRESSION; TRAITS; ARCHITECTURE; PATHWAYS; FATNESS	We performed a pairwise epistatic interaction test using the chicken 60 K single nucleotide polymorphism (SNP) chip for the 11th generation of the Northeast Agricultural University broiler lines divergently selected for abdominal fat content. A linear mixed model was used to test two dimensions of SNP interactions affecting abdominal fat weight. With a threshold of P<1.2x10(-11) by a Bonferroni 5% correction, 52 pairs of SNPs were detected, comprising 45 pairs showing an AdditivexAdditive and seven pairs showing an AdditivexDominance epistatic effect. The contribution rates of significant epistatic interactive SNPs ranged from 0.62% to 1.54%, with 47 pairs contributing more than 1%. The SNP-SNP network affecting abdominal fat weight constructed using the significant SNP pairs was analyzed, estimated and annotated. On the basis of the network's features, SNPs Gga_rs14303341 and Gga_rs14988623 at the center of the subnet should be important nodes, and an interaction between GGAZ and GGA8 was suggested. Twenty-two quantitative trait loci, 97 genes (including nine non-coding genes), and 50 pathways were annotated on the epistatic interactive SNP-SNP network. The results of the present study provide insights into the genetic architecture underlying broiler chicken abdominal fat weight.	[Li, Fangge; Zhang, Hui; Wang, Shouzhi; Wang, Zhipeng; Li, Hui] Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China; [Li, Fangge; Zhang, Hui; Wang, Shouzhi; Wang, Zhipeng; Li, Hui] Educ Dept Heilongjiang Prov, Key Lab Anim Genet Breeding & Reprod, Harbin, Peoples R China; [Li, Fangge; Zhang, Hui; Wang, Shouzhi; Wang, Zhipeng; Li, Hui] Northeast Agr Univ, Coll Anim Sci & Technol, Harbin, Peoples R China; [Hu, Guo] Chinese Acad Fishery Sci, Heilongjiang River Fishery Res Inst, Harbin, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China; Chinese Academy of Fishery Sciences; Heilongjiang River Fisheries Research Institute, CAFS	Wang, ZP (corresponding author), Minist Agr, Key Lab Chicken Genet & Breeding, Harbin, Peoples R China.	zpengwang@gmail.com; lihui@neau.edu.cn	Hu, Guo/K-7879-2012	Hu, Guo/0000-0002-4437-0797	Natural Science Foundation of China [31101709]; National 863 Project of China [2011AA100301, 2013AA102501]; China Agriculture Research System [CARS-42]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 863 Project of China(National High Technology Research and Development Program of China); China Agriculture Research System	This research was supported by Natural Science Foundation of China (No. 31101709), National 863 Project of China (No. 2011AA100301), National 863 Project of China (No. 2013AA102501) and China Agriculture Research System (No. CARS-42). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abasht B, 2007, ANIM GENET, V38, P491, DOI 10.1111/j.1365-2052.2007.01642.x; Abasht B, 2006, POULTRY SCI, V85, P2079, DOI 10.1093/ps/85.12.2079; Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; Alvarez-Castro JM, 2012, GENET RES, V94, P255, DOI 10.1017/S001667231200047X; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; Bottcher Y, 2009, DIABETES, V58, P2119, DOI 10.2337/db08-1458; Campos RLR, 2009, ANIM GENET, V40, P729, DOI 10.1111/j.1365-2052.2009.01910.x; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cui YH, 2007, CURR GENOMICS, V8, P307, DOI 10.2174/138920207782446188; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Ek Weronica, 2012, Frontiers in Genetics, V3, P29, DOI 10.3389/fgene.2012.00029; Fierst JL, 2012, GENOME BIOL EVOL, V4, P1080, DOI 10.1093/gbe/evs083; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Guo L, 2011, POULTRY SCI, V90, P2024, DOI 10.3382/ps.2010-00863; Hu G, 2010, POULTRY SCI, V89, P2341, DOI 10.3382/ps.2010-00857; Huang W, 2012, P NATL ACAD SCI USA, V109, P15553, DOI 10.1073/pnas.1213423109; Khanin R, 2006, J COMPUT BIOL, V13, P810, DOI 10.1089/cmb.2006.13.810; Le Mignon G, 2009, ANIM GENET, V40, P157, DOI 10.1111/j.1365-2052.2008.01817.x; Li M, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-79; Liu X, 2007, POULTRY SCI, V86, P1084, DOI 10.1093/ps/86.6.1084; LIVESEY AK, 1985, ACTA CRYSTALLOGR A, V41, P113, DOI 10.1107/S0108767385000241; Lou XY, 2007, AM J HUM GENET, V80, P1125, DOI 10.1086/518312; Ma Li, 2007, BMC Proc, V1 Suppl 1, pS127; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Rajon E, 2012, ARXIV12108423; Ritchie MD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-28; Saltiel AR, 2002, TRENDS CELL BIOL, V12, P65, DOI 10.1016/S0962-8924(01)02207-3; Schinner S, 2007, INT J OBESITY, V31, P864, DOI 10.1038/sj.ijo.0803508; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Verbeek EC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037384; Wang SZ, 2012, GENET MOL RES, V11, P956, DOI 10.4238/2012.April.19.1; Weaver RE, 2008, INT J OBESITY, V32, P1705, DOI 10.1038/ijo.2008.148; Winkler G, 2003, EUR J ENDOCRINOL, V149, P129, DOI 10.1530/eje.0.1490129; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131; Wunderlich C. M., 2013, JAK STAT, V2, DOI 10.4161/jkst.23878; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang H, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-704; Zhang Y, 2007, NAT GENET, V39, P1167, DOI 10.1038/ng2110; Zuk O, 2012, P NATL ACAD SCI USA, V109, P1193, DOI 10.1073/pnas.1119675109	44	17	17	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81520	10.1371/journal.pone.0081520	http://dx.doi.org/10.1371/journal.pone.0081520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339942	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100066
J	Rivalan, M; Valton, V; Series, P; Marchand, AR; Dellu-Hagedorn, F				Rivalan, Marion; Valton, Vincent; Series, Peggy; Marchand, Alain R.; Dellu-Hagedorn, Francoise			Elucidating Poor Decision-Making in a Rat Gambling Task	PLOS ONE			English	Article							NOVELTY-SEEKING; RISK-TAKING; IMPULSIVITY; BEHAVIOR; REWARD; ADDICTION; ALCOHOL; VULNERABILITY; AMPHETAMINE; PREDICTION	Although poor decision-making is a hallmark of psychiatric conditions such as attention deficit/hyperactivity disorder, pathological gambling or substance abuse, a fraction of healthy individuals exhibit similar poor decision-making performances in everyday life and specific laboratory tasks such as the Iowa Gambling Task. These particular individuals may provide information on risk factors or common endophenotypes of these mental disorders. In a rodent version of the Iowa gambling task - the Rat Gambling Task (RGT), we identified a population of poor decision makers, and assessed how these rats scored for several behavioral traits relevant to executive disorders: risk taking, reward seeking, behavioral inflexibility, and several aspects of impulsivity. First, we found that poor decision-making could not be well predicted by single behavioral and cognitive characteristics when considered separately. By contrast, a combination of independent traits in the same individual, namely risk taking, reward seeking, behavioral inflexibility, as well as motor impulsivity, was highly predictive of poor decision-making. Second, using a reinforcement-learning model of the RGT, we confirmed that only the combination of extreme scores on these traits could induce maladaptive decision-making. Third, the model suggested that a combination of these behavioral traits results in an inaccurate representation of rewards and penalties and inefficient learning of the environment. Poor decision-making appears as a consequence of the over-valuation of high-reward-high-risk options in the task. Such a specific psychological profile could greatly impair clinically healthy individuals in decision-making tasks and may predispose to mental disorders with similar symptoms.	[Rivalan, Marion; Marchand, Alain R.; Dellu-Hagedorn, Francoise] Ctr Natl Rech Sci, Aquitaine Inst Cognit & Integrat Neurosci, UMR 5287, Bordeaux, France; [Rivalan, Marion; Marchand, Alain R.; Dellu-Hagedorn, Francoise] Univ Bordeaux, Aquitaine Inst Cognit & Integrat Neurosci, UMR 5287, Bordeaux, France; [Valton, Vincent; Series, Peggy] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Edinburgh	Dellu-Hagedorn, F (corresponding author), Ctr Natl Rech Sci, Aquitaine Inst Cognit & Integrat Neurosci, UMR 5287, Bordeaux, France.	francoise.dellu@u-bordeaux2.fr	LE MOINE, Catherine/E-2671-2014; INCIA, NeurexTeam/D-6197-2014	Rivalan, Marion/0000-0002-1642-7522; Series, Peggy/0000-0002-8580-7975; Marchand, Alain/0000-0002-0231-5562	CNRS; Univ. of Bordeaux; Conseil Regional d'Aquitaine; French Government; Doctoral Training Center of the Univ. of Edinburgh through the Medical Research Council; Biology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council	CNRS(Centre National de la Recherche Scientifique (CNRS)); Univ. of Bordeaux; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); French Government; Doctoral Training Center of the Univ. of Edinburgh through the Medical Research Council; Biology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported and funded by CNRS, Univ. of Bordeaux, Conseil Regional d'Aquitaine, a fellowship from the French Government to MR, Doctoral Training Center of the Univ. of Edinburgh to VV, through the Medical Research Council, the Biology and Biological Sciences Research Council and the Engineering and Physical Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Bechara A, 2002, NEUROPSYCHOLOGIA, V40, P1675, DOI 10.1016/S0028-3932(02)00015-5; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berger DF, 1998, BEHAV BRAIN RES, V94, P73, DOI 10.1016/S0166-4328(97)00171-X; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Bogacz R, 2011, NEURAL COMPUT, V23, P817, DOI 10.1162/NECO_a_00103; Calu DJ, 2007, LEARN MEMORY, V14, P325, DOI 10.1101/lm.534807; Cohen MX, 2009, BEHAV BRAIN RES, V199, P141, DOI 10.1016/j.bbr.2008.09.029; Dalley JW, 2007, SCIENCE, V315, P1267, DOI 10.1126/science.1137073; Dalley JW, 2011, NEURON, V69, P680, DOI 10.1016/j.neuron.2011.01.020; Davis JF, 2009, NEUROSCIENCE, V162, P23, DOI 10.1016/j.neuroscience.2009.04.039; de Visser L, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00109, 10.3389/fnins.2011.00102]; Dellu-Hagedorn Francoise, 2006, Behav Brain Funct, V2, P10, DOI 10.1186/1744-9081-2-10; Demaree HA, 2009, PERS INDIV DIFFER, V47, P419, DOI 10.1016/j.paid.2009.04.013; Diergaarde L, 2008, BIOL PSYCHIAT, V63, P301, DOI 10.1016/j.biopsych.2007.07.011; Drechsler R, 2008, J NEURAL TRANSM, V115, P201, DOI 10.1007/s00702-007-0814-5; DSM-IV, 1994, DIAGN STAT MAN MENT, V4th; Ernst M, 2003, AM J PSYCHIAT, V160, P33, DOI 10.1176/appi.ajp.160.1.33; Evenden J, 2005, PSYCHOPHARMACOLOGY, V180, P294, DOI 10.1007/s00213-005-2163-0; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Feola TW, 2000, BEHAV NEUROSCI, V114, P838, DOI 10.1037/0735-7044.114.4.838; Fitoussi A, 2011, BEHAV MARKERS NEUROB; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; Gershman SJ, 2010, PSYCHOL REV, V117, P197, DOI 10.1037/a0017808; Gillan CM, 2011, AM J PSYCHIAT, V168, P718, DOI 10.1176/appi.ajp.2011.10071062; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Grant S, 2009, ELECTRONIC PORTFOLIOS: PERSONAL INFORMATION, PERSONAL DEVELOPMENT AND PERSONAL VALUES, P83; Gregoire S, 2012, NEUROBIOL LEARN MEM, V97, P202, DOI 10.1016/j.nlm.2011.12.003; Hayton SJ, 2012, ALCOHOL CLIN EXP RES, V36, P594, DOI 10.1111/j.1530-0277.2011.01668.x; Jentsch JD, 2002, NEUROPSYCHOPHARMACOL, V26, P183, DOI 10.1016/S0893-133X(01)00355-4; Kalueff AV, 2008, BEHAV BRAIN RES, V188, P243, DOI 10.1016/j.bbr.2007.11.011; Holmes M, 2009, BIPOLAR DISORD, V11, P33, DOI 10.1111/j.1399-5618.2008.00657.x; LaPorte JL, 2010, J AFFECT DISORDERS, V121, P1, DOI 10.1016/j.jad.2009.04.010; Li J, 2006, IEEE IJCNN, P534; Ma CL, 2005, BIOL PSYCHIAT, V57, P192, DOI 10.1016/j.biopsych.2004.11.004; Maia TV, 2009, COGN AFFECT BEHAV NE, V9, P343, DOI 10.3758/CABN.9.4.343; Matzel LD, 2010, NEUROSCI BIOBEHAV R, V34, P23, DOI 10.1016/j.neubiorev.2009.07.002; Mazas CA, 2000, ALCOHOL CLIN EXP RES, V24, P1036, DOI 10.1111/j.1530-0277.2000.tb04647.x; Mihatsch O, 2002, MACH LEARN, V49, P267, DOI 10.1023/A:1017940631555; Molander AC, 2011, PSYCHOPHARMACOLOGY, V215, P721, DOI 10.1007/s00213-011-2167-x; Niv Y, 2006, TRENDS COGN SCI, V10, P375, DOI 10.1016/j.tics.2006.06.010; Niv Y, 2012, J NEUROSCI, V32, P551, DOI 10.1523/JNEUROSCI.5498-10.2012; Pickering A.D., 2001, ADV INDIVIDUAL DIFFE, P113; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rivalan M., 2009, ENDOPHENOTYPES PSYCH; Rivalan M, 2007, PSYCHOPHARMACOLOGY, V192, P171, DOI 10.1007/s00213-007-0702-6; Rivalan M, 2011, FRONT BEHAV NEUROSCI, V5, DOI 10.3389/fnbeh.2011.00022; Rivalan M, 2009, BIOL PSYCHIAT, V66, P743, DOI 10.1016/j.biopsych.2009.04.008; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Rubia K, 2010, HUM BRAIN MAPP, V31, P1823, DOI 10.1002/hbm.20975; Scheres A, 2010, BIOL PSYCHIAT, V67, P641, DOI 10.1016/j.biopsych.2009.10.033; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2011, NEURON, V69, P603, DOI 10.1016/j.neuron.2011.02.014; Stedenfeld KA, 2011, PHYSIOL BEHAV, V103, P210, DOI 10.1016/j.physbeh.2011.02.001; Toplak ME, 2010, CLIN PSYCHOL REV, V30, P562, DOI 10.1016/j.cpr.2010.04.002; van der Plas EAA, 2009, J CLIN EXP NEUROPSYC, V31, P706, DOI 10.1080/13803390802484797; van Holst RJ, 2010, NEUROSCI BIOBEHAV R, V34, P87, DOI 10.1016/j.neubiorev.2009.07.007; Walshaw PD, 2010, NEUROPSYCHOL REV, V20, P103, DOI 10.1007/s11065-009-9126-x; Williams J, 2005, J CHILD ADOL PSYCHOP, V15, P160, DOI 10.1089/cap.2005.15.160	62	30	30	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82052	10.1371/journal.pone.0082052	http://dx.doi.org/10.1371/journal.pone.0082052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339988	Green Published, gold			2022-12-27	WOS:000328566100080
J	Shao, S; Zhao, FF; Wang, J; Feng, L; Lu, XQ; Du, J; Yan, YX; Wang, C; Fu, YH; Wu, JJ; Yu, XW; Khoo, K; Wang, YX; Wang, W				Shao, Shuang; Zhao, FeiFei; Wang, Jing; Feng, Lei; Lu, XiaoQin; Du, Juan; Yan, YuXiang; Wang, Chao; Fu, YingHong; Wu, JingJing; Yu, XinWei; Khoo, KayKeng; Wang, YouXin; Wang, Wei			The Ecology of Medical Care in Beijing	PLOS ONE			English	Article							SUBOPTIMAL HEALTH-STATUS; CHINA; SERVICES; EQUITY; ACCESS; SYSTEM; REFORM	Background: We presented the pattern of health care consumption, and the utilization of available resources by describing the ecology of medical care in Beijing on a monthly basis and by describing the socio-demographic characteristics associated with receipt care in different settings. Methods: A cohort of 6,592 adults, 15 years of age and older were sampled to estimate the number of urban-resident adults per 1,000 who visited a medical facility at least once in a month, by the method of three-stage stratified and cluster random sampling. Separate logistic regression analyses assessed the association between those receiving care in different types of setting and their socio-demographic characteristics. Results: On average per 1,000 adults, 295 had at least one symptom, 217 considered seeking medical care, 173 consulted a physician, 129 visited western medical practitioners, 127 visited a hospital-based outpatient clinic, 78 visited traditional Chinese medical practitioners, 43 visited a primary care physician, 35 received care in an emergency department, 15 were hospitalized. Health care seeking behaviors varied with socio-demographic characteristics, such as gender, age, ethnicity, resident census register, marital status, education, income, and health insurance status. In term of primary care, the gate-keeping and referral roles of Community Health Centers have not yet been fully established in Beijing. Conclusions: This study represents a first attempt to map the medical care ecology of Beijing urban population and provides timely baseline information for health care reform in China.	[Shao, Shuang; Feng, Lei; Lu, XiaoQin; Du, Juan] Capital Med Univ, Gen Practice & Continue Educ Sch, Beijing, Peoples R China; [Shao, Shuang; Zhao, FeiFei; Feng, Lei; Yan, YuXiang; Wu, JingJing; Yu, XinWei; Wang, YouXin; Wang, Wei] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Beijing, Peoples R China; [Shao, Shuang; Fu, YingHong] Capital Med Univ, Sch Yan Jing Med Sci, Beijing, Peoples R China; [Wang, Jing] Chinese Acad Sci, Lab Parallel Software & Math Sci, Inst Software, Beijing, Peoples R China; [Wang, Chao] Beijing Nucl Ind Hosp, Beijing, Peoples R China; [Khoo, KayKeng] Lynwood Med Ctr, Lynwood, WA, Australia; [Wang, YouXin; Wang, Wei] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia	Capital Medical University; Capital Medical University; Capital Medical University; Chinese Academy of Sciences; Institute of Software, CAS; Edith Cowan University	Wang, W (corresponding author), Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Sch Publ Hlth, Beijing, Peoples R China.	wei.wang@ecu.edu.au	liu, li/HGC-0900-2022	wang, wei/0000-0002-1430-1360; Wang, Youxin/0000-0002-6574-6706	China National "12th Five-Year" Plan for Science and Technology Support [2012BAI37B03]; China National High Technology Research and Development Program-863 [2006AA02Z434]; Australia-China Science Research Fund [ACSRF06444]; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions, China	China National "12th Five-Year" Plan for Science and Technology Support; China National High Technology Research and Development Program-863(National High Technology Research and Development Program of China); Australia-China Science Research Fund; Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions, China	This work was financially supported by the grants from the China National "12th Five-Year" Plan for Science and Technology Support (Grant No: 2012BAI37B03), the China National High Technology Research and Development Program-863 (Grant No: 2006AA02Z434), and the Australia-China Science Research Fund (Grant No: ACSRF06444). WW is supported by the Importation and Development of High-Caliber Talents Project of Beijing Municipal Institutions, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*6 NAT PUP CENS, 2010, MAN DATA B 6 NATION; Blumenthal D, 2005, NEW ENGL J MED, V353, P1165, DOI 10.1056/NEJMhpr051133; Burke A, 2003, AM J PUBLIC HEALTH, V93, P1082, DOI 10.2105/AJPH.93.7.1082; Central Committee of the Communist Party of China Central Committee (CPC) and State Council, 2017, OPINIONS FORMULATING; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; De Smet PAGM, 2002, NEW ENGL J MED, V347, P2046, DOI 10.1056/NEJMra020398; Du J, 2012, FAM PRACT, V29, P441, DOI 10.1093/fampra/cmr122; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Hesketh T, 2008, PUBLIC HEALTH REP, V123, P189, DOI 10.1177/003335490812300211; Holdaway J, 2011, IHDP UPDATE, V1, P35; *INF OFF STAT COUN, 2005, GEN DER EQ WOM DEV C; Kinsel JE, 2003, ANNU REV PHARMACOL, V43, P463, DOI 10.1146/annurev.pharmtox.43.100901.135757; LAST JM, 1963, LANCET, V2, P28; Ling RE, 2011, PUBLIC HEALTH, V125, P9, DOI 10.1016/j.puhe.2010.10.009; Lu Y, 2008, SOC SCI MED, V67, P1331, DOI 10.1016/j.socscimed.2008.06.017; Meng Q, 2012, LANCET, V379, P805, DOI 10.1016/S0140-6736(12)60278-5; Normile D, 2003, SCIENCE, V299, P188, DOI 10.1126/science.299.5604.188; Razum O, 2000, INT J EPIDEMIOL, V29, P191, DOI 10.1093/ije/29.1.191; Tang SL, 2008, LANCET, V372, P1493, DOI 10.1016/S0140-6736(08)61364-1; Taylor S, 2009, BRIT MED BULL, V91, P29, DOI 10.1093/bmb/ldp024; THOMAS H, 2001, NEW ENGL J MED, V344, P2018, DOI DOI 10.1056/NEJM200106283442610.PUBMED:11430333; Wang G, 2007, CLIN THER, V29, P1456, DOI 10.1016/j.clinthera.2007.07.023; WHITE KL, 1961, NEW ENGL J MED, V265, P885, DOI 10.1056/NEJM196111022651805; White KL, 1997, HEALTH SERV RES, V32, P11; Yan YX, 2012, J URBAN HEALTH, V89, P329, DOI 10.1007/s11524-011-9636-8; Yan YX, 2009, J EPIDEMIOL, V19, P333, DOI 10.2188/jea.JE20080086; Yang J, 2008, ANN FAM MED, V6, P421, DOI 10.1370/afm.888; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yip W, 2009, CHINA ECON REV, V20, P613, DOI 10.1016/j.chieco.2009.08.003; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6	32	35	35	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82446	10.1371/journal.pone.0082446	http://dx.doi.org/10.1371/journal.pone.0082446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24340029	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566100110
J	Zhang, WL; Li, M; Zhang, B; Geng, HY; Liang, YQ; Xu, K; Li, SB				Zhang, Wei-lan; Li, Min; Zhang, Bo; Geng, Hai-yang; Liang, Yin-qiang; Xu, Ke; Li, Song-bai			CT Angiography of the Head-and-Neck Vessels Acquired with Low Tube Voltage, Low Iodine, and Iterative Image Reconstruction: Clinical Evaluation of Radiation Dose and Image Quality	PLOS ONE			English	Article							CONTRAST-INDUCED NEPHROPATHY; COMPUTED-TOMOGRAPHY; ABDOMINAL CT; CHEST CT; CORONARY-ANGIOGRAPHY; CURRENT MODULATION; REDUCTION; ENHANCEMENT; ALGORITHM; EXPOSURE	Objectives: We aimed to assess the effectiveness and feasibility of head-and-neck Computed Tomography Angiography (CTA) with low tube voltage and low concentration contrast media combined with iterative reconstruction algorithm. Methods: 92 patients were randomly divided into group A and B: patients in group A received a conventional scan with 120 kVp and contrast media of 320 mgI/ml. Patients in group B, 80 kVp and contrast media of 270 mgI/ml were used along with iterative reconstruction algorithm techniques. Image quality, radiation dose and the effectively consumed iodine amount between two groups were analyzed and compared. Results: Image quality of CTA of head-and-neck vessels obtained from patients in group B was significantly improved quantitatively and qualitatively. In addition, CT attenuation values in group B were also significantly higher than that in group A (p<0.001). Furthermore, compared with the protocol whereby 120 kVp and 320 mgI/dl were administrated, the mean radiation dose and consumed iodine amount in protocol B were also reduced by 50% and 15.6%, respectively (p<0.001). Conclusions: With the help of iterative reconstruction algorithm techniques, the head-and-neck CTA with diagnostic quality can be adequately acquired with low tube voltage and low concentration contrast media. This method could be potentially extended to include any part of the body to reduce the risks related to ionizing radiation.	[Zhang, Wei-lan; Zhang, Bo; Geng, Hai-yang; Liang, Yin-qiang; Xu, Ke; Li, Song-bai] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China; [Li, Min] China Med Univ, Affiliated Hosp 1, Dept Clin Epidemiol, Shenyang, Peoples R China; [Xu, Ke] China Med Univ, Inst Radiol, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Xu, K (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China.	kexu@vip.sina.com; songbaili001@163.com						Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brink JA, 2003, J COMPUT ASSIST TOMO, V27, pS3, DOI 10.1097/00004728-200305001-00003; Christensen JD, 2011, AM J ROENTGENOL, V197, pW445, DOI 10.2214/AJR.10.6154; Ertl-Wagner BB, 2004, RADIOLOGY, V231, P528, DOI 10.1148/radiol.2312030543; Faggioni L, 2012, AM J ROENTGENOL, V199, P1220, DOI 10.2214/AJR.11.8122; Fenchel S, 2004, BRIT J RADIOL, V77, P821, DOI 10.1259/bjr/19527646; From AM, 2008, MAYO CLIN PROC, V83, P1095, DOI 10.4065/83.10.1095; Funama Y, 2005, RADIOLOGY, V237, P905, DOI 10.1148/radiol.2373041643; Gruberg L, 2000, J AM COLL CARDIOL, V36, P1542, DOI 10.1016/S0735-1097(00)00917-7; Herzog C, 2008, AM J ROENTGENOL, V190, P1232, DOI 10.2214/AJR.07.3124; Honda O, 2011, BRIT J RADIOL, V84, P335, DOI 10.1259/bjr/57998586; Iezzi R, 2012, RADIOLOGY, V263, P287, DOI 10.1148/radiol.11110700; Kalender WA, 2008, PHYS MEDICA, V24, P71, DOI 10.1016/j.ejmp.2008.01.012; Kalra MK, 2004, RADIOLOGY, V232, P347, DOI 10.1148/radiol.2322031304; Kayan M, 2012, EUR J RADIOL, V81, P2144, DOI 10.1016/j.ejrad.2011.05.006; Kubo T, 2008, AM J ROENTGENOL, V190, P335, DOI 10.2214/AJR.07.2556; Leschka S, 2008, EUR RADIOL, V18, P1809, DOI 10.1007/s00330-008-0966-1; Marenzi G, 2006, NEW ENGL J MED, V354, P2773, DOI 10.1056/NEJMoa054209; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Nakaura T, 2012, RADIOLOGY, V264, P445, DOI 10.1148/radiol.12111082; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Namimoto T, 2012, J COMPUT ASSIST TOMO, V36, P495, DOI 10.1097/RCT.0b013e31825b821f; Oda S, 2011, J COMPUT ASSIST TOMO, V35, P631, DOI 10.1097/RCT.0b013e31822a563d; Ohno Y, 2012, AM J ROENTGENOL, V199, pW477, DOI 10.2214/AJR.11.8275; Ozbulbul NI, 2010, CORONARY ARTERY DIS, V21, P414, DOI 10.1097/MCA.0b013e328338cd0b; Ramgren B, 2012, ACTA RADIOL, V53, P929, DOI 10.1258/ar.2012.120218; Rapalino O, 2012, AM J NEURORADIOL, V33, P609, DOI 10.3174/ajnr.A2826; Sanaei-Ardekani M, 2005, CARDIOVASC REVASCULA, V6, P82, DOI 10.1016/j.carrev.2005.07.004; Siegel MJ, 2004, RADIOLOGY, V233, P515, DOI 10.1148/radiol.2332032107; Sigal-Cinqualbre AB, 2004, RADIOLOGY, V231, P169, DOI 10.1148/radiol.2311030191; Singh S, 2010, RADIOLOGY, V257, P373, DOI 10.1148/radiol.10092212; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Sodickson A, 2009, RADIOLOGY, V251, P175, DOI 10.1148/radiol.2511081296; Tatsugami F, 2012, BRIT J RADIOL, V85, pE378, DOI 10.1259/bjr/10084599; Thomsen HS, 2008, ACTA RADIOL, V49, P646, DOI 10.1080/02841850801995413; Thomsen Henrik S, 2007, Eur Radiol, V17 Suppl 6, pF33; Utsunomiya D, 2010, EUR RADIOL, V20, P2758, DOI 10.1007/s00330-010-1841-4; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Yamada Y, 2012, EUR J RADIOL, V81, P4185, DOI 10.1016/j.ejrad.2012.07.013	39	45	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81486	10.1371/journal.pone.0081486	http://dx.doi.org/10.1371/journal.pone.0081486			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339936	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100062
J	Castro, M; Sanchez, L; Perez, D; Sebrango, C; Shkedy, Z; Van der Stuyft, P				Castro, Marta; Sanchez, Lizet; Perez, Dennis; Sebrango, Carlos; Shkedy, Ziv; Van der Stuyft, Patrick			The Relationship between Economic Status, Knowledge on Dengue, Risk Perceptions and Practices	PLOS ONE			English	Article							AEGYPTI CONTROL PROGRAM; COMMUNITY PARTICIPATION; VECTOR CONTROL; PREVENTION; INTERVENTIONS; EMPOWERMENT; ATTITUDES; SANTIAGO; STRATEGY; IMPACT	The reemergence of dengue as an important public health problem reflects the difficulties in sustaining vertically organized, effective, control programs and the need for community-based strategies for Aedes aegypti control that result in behavioral change. We aimed to disentangle the relationships between underlying determinants of dengue related practices. We conducted a cross-sectional study in 780 households in La Lisa, Havana, Cuba. A questionnaire and an observation guide were administrated to collect information on variables related to economic status, knowledge on dengue, risk perception and practices associated with Aedes aegypti breading sites. To test a conceptual model that hypothesized direct relationships among all these constructs, we first used Exploratory Factor Analysis with Principal Component Analysis to establish the relationship between observed variables and the underlying latent variables. Subsequently, we tested whether the observed data supported the conceptual model through Confirmatory Factor Analysis. Exploratory Factor Analysis indicated that the items measured could be reduced into five factors with an eigenvalue >1.0: Knowledge on dengue, Intradomiciliar risk practices, Peridomiciliar risk practices, Risk perception and Economic status. The proportion of the total variance in the data explained by these five factors was 74.3%. The Confirmatory Factor Analysis model differed from our hypothesized conceptual model. Only Knowledge on dengue had a significant, direct, positive, effect on Practices. There was also a direct association of Economic status with Knowledge on dengue, but not with Risk perception and Practices. Clarifying the relationship between direct and indirect determinants of dengue related practices contributes to a better understanding of the potential effect of Information Education and Communication on practices and on the reduction of Aedes aegypti breeding sites and provides inputs for designing a community based strategy for dengue control.	[Castro, Marta; Perez, Dennis] Inst Trop Med Pedro Kouri, Div Epidemiol, Havana, Cuba; [Sanchez, Lizet] Ctr Mol Immunol, Clin Res Direct, Havana, Cuba; [Sebrango, Carlos] Jose Marti Univ, Dept Math, Sancti Spiritus, Cuba; [Shkedy, Ziv] Hasselt Univ, Ctr Stat, Diepenbeek, Belgium; [Van der Stuyft, Patrick] Inst Trop Med, Unit Gen Epidemiol & Dis Control, B-2000 Antwerp, Belgium; [Van der Stuyft, Patrick] Univ Ghent, Dept Publ Hlth, B-9000 Ghent, Belgium	Hasselt University; Institute of Tropical Medicine (ITM); Ghent University	Castro, M (corresponding author), Inst Trop Med Pedro Kouri, Div Epidemiol, Havana, Cuba.	martac@ipk.sld.cu	Shkedy, Ziv/AAQ-3096-2020	Shkedy, Ziv/0000-0002-6306-0823; Perez Chacon, Dennis/0000-0003-2993-933X	Cuban Ministry of Health; Institute of Tropical Medicine 'Pedro Kouri' (Havana City, Cuba); Institute of Tropical Medicine (Antwerp, Belgium); Belgium Directorate-General for Development Cooperation	Cuban Ministry of Health; Institute of Tropical Medicine 'Pedro Kouri' (Havana City, Cuba); Institute of Tropical Medicine (Antwerp, Belgium); Belgium Directorate-General for Development Cooperation	This research was funded by the Cuban Ministry of Health and through a framework agreement between the Institute of Tropical Medicine 'Pedro Kouri' (Havana City, Cuba), the Institute of Tropical Medicine (Antwerp, Belgium) and the Belgium Directorate-General for Development Cooperation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya Anita, 2005, Journal of Vector Borne Diseases, V42, P122; Acosta OS, 1999, REV CUB HIG EPIDEMIO, V37, P6; Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x; Bollen KA, 1989, STRUCTURAL EQUATIONS; Castro M, 2012, T ROY SOC TROP MED H, V106, P315, DOI 10.1016/j.trstmh.2012.01.013; Castro Marta, 2008, Rev Cubana Med Trop, V60, P0; Chiaravalloti Neto F, 1998, Cad Saude Publica, V14 Suppl 2, P101, DOI 10.1590/S0102-311X1998000600009; de la Cruz A M, 1999, Rev Cubana Med Trop, V51, P135; Degallier N, 2000, J AM MOSQUITO CONTR, V16, P114; Donalisio M R, 2001, Rev Soc Bras Med Trop, V34, P197, DOI 10.1590/S0037-86822001000200008; Elder J, 2006, REPORT SCI WORKING G, P140; Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0; Guzman MG, 2009, LANCET, V374, P1660, DOI 10.1016/S0140-6736(09)61975-9; Hatcher L., 1994, STEP BY STEP APPROAC; Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007; Itrat A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002620; Kay BH, 2002, AM J TROP MED HYG, V66, P40, DOI 10.4269/ajtmh.2002.66.40; Koenraadt CJM, 2006, AM J TROP MED HYG, V74, P692, DOI 10.4269/ajtmh.2006.74.692; LEONTSINI E, 1993, T ROY SOC TROP MED H, V87, P267, DOI 10.1016/0035-9203(93)90120-F; LLOYD LS, 1992, AM J TROP MED HYG, V46, P635, DOI 10.4269/ajtmh.1992.46.635; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; Naeem-Ullah U, 2009, PUBLIC HEALTH, V123, P452, DOI 10.1016/j.puhe.2009.04.011; Nam V, 2005, DENGUE B, V28, P57; O' Donell CR, 2005, CULTURE CONTEXT HUMA; Parks W. J., 2004, Dengue Bulletin, V28, P1; Parks WJ, 2004, PLANIFICACION MOVILI; Romani MET, 2007, SOC SCI MED, V64, P976, DOI 10.1016/j.socscimed.2006.10.033; ROSENBAUM J, 1995, AM J TROP MED HYG, V53, P111, DOI 10.4269/ajtmh.1995.53.111; Sanchez L, 2005, TROP MED INT HEALTH, V10, P82, DOI 10.1111/j.1365-3156.2004.01347.x; Sanchez L, 2009, TROP MED INT HEALTH, V14, P1356, DOI 10.1111/j.1365-3156.2009.02379.x; Shuaib F, 2010, W INDIAN MED J, V59, P139; Swaddiwudhipong Witaya, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P200; Toledo ME, 2007, T ROY SOC TROP MED H, V101, P56, DOI 10.1016/j.trstmh.2006.03.006; Toledo-Romani ME, 2006, SALUD PUBLICA MEXICO, V48, P39, DOI 10.1590/s0036-36342006000100007; van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x; Winch PJ, 2002, AM J TROP MED HYG, V67, P363, DOI 10.4269/ajtmh.2002.67.363	36	42	44	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81875	10.1371/journal.pone.0081875	http://dx.doi.org/10.1371/journal.pone.0081875			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349145	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800029
J	Brandenburg, B; Koudstaal, W; Goudsmit, J; Klaren, V; Tang, C; Bujny, MV; Korse, HJWM; Kwaks, T; Otterstrom, JJ; Juraszek, J; van Oijen, AM; Vogels, R; Friesen, RHE				Brandenburg, Boerries; Koudstaal, Wouter; Goudsmit, Jaap; Klaren, Vincent; Tang, Chan; Bujny, Miriam V.; Korse, Hans J. W. M.; Kwaks, Ted; Otterstrom, Jason J.; Juraszek, Jarek; van Oijen, Antoine M.; Vogels, Ronald; Friesen, Robert H. E.			Mechanisms of Hemagglutinin Targeted Influenza Virus Neutralization	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; CELLS; PROSPECTS; EPITOPE; RECOGNIZES; INSIGHTS; IGG	Human monoclonal antibodies have been identified which neutralize broad spectra of influenza A or B viruses. Here, we dissect the mechanisms by which such antibodies interfere with infectivity. We distinguish four mechanisms that link the conserved hemagglutinin (HA) epitopes of broadly neutralizing antibodies to critical processes in the viral life cycle. HA-stem binding antibodies can act intracellularly by blocking fusion between the viral and endosomal membranes and extracellularly by preventing the proteolytic activation of HA. HA-head binding antibodies prevent viral attachment and release. These insights into newly identified ways by which the human immune system can interfere with influenza virus infection may aid the development of novel universal vaccines and antivirals.	[Brandenburg, Boerries; Koudstaal, Wouter; Goudsmit, Jaap; Klaren, Vincent; Tang, Chan; Bujny, Miriam V.; Korse, Hans J. W. M.; Kwaks, Ted; Juraszek, Jarek; Vogels, Ronald; Friesen, Robert H. E.] Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, Leiden, Netherlands; [Otterstrom, Jason J.; van Oijen, Antoine M.] Univ Groningen, Zernike Inst Adv Mat, Ctr Synthet Biol, Groningen, Netherlands; [Otterstrom, Jason J.] Harvard Univ, Sch Med, Harvard Biophys Program, Boston, MA USA	University of Groningen; Harvard University; Harvard Medical School	Friesen, RHE (corresponding author), Janssen Ctr Excellence Immunoprophylaxis, Crucell Vaccine Inst, Leiden, Netherlands.	RFriesen@its.jnj.com	Institute, Zernike/W-7033-2019; Otterstrom, Jason J/H-3356-2015; van Oijen, Antoine/I-3167-2014	Otterstrom, Jason J/0000-0002-0176-9976; van Oijen, Antoine/0000-0002-1794-5161; Brandenburg, Boerries/0000-0002-5025-3802; Juraszek, Jarek/0000-0001-7430-2771; Kwaks, Ted/0000-0003-1608-9372	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN272200900060C]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project has been funded in whole or in part with Federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract No. HHSN272200900060C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Barbey-Martin C, 2002, VIROLOGY, V294, P70, DOI 10.1006/viro.2001.1320; Bertram S, 2010, REV MED VIROL, V20, P298, DOI 10.1002/rmv.657; Bottcher-Friebertshauser E, 2011, J VIROL, V85, P1554, DOI 10.1128/JVI.01294-10; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Brandenburg B, 2007, NAT REV MICROBIOL, V5, P197, DOI 10.1038/nrmicro1615; Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908; Edwards MJ, 2000, VIROLOGY, V278, P423, DOI 10.1006/viro.2000.0631; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2012, CURR OPIN VIROL, V2, P134, DOI 10.1016/j.coviro.2012.02.005; Ekiert DC, 2011, SCIENCE, V333, P843, DOI 10.1126/science.1204839; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Findlay JWA, 2007, AAPS J, V9, pE260, DOI 10.1208/aapsj0902029; Floyd D. L., 2009, JOVE-J VIS EXP, pe1484; Floyd DL, 2008, P NATL ACAD SCI USA, V105, P15382, DOI 10.1073/pnas.0807771105; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Han T, 2011, ANN NY ACAD SCI, V1217, P178, DOI 10.1111/j.1749-6632.2010.05829.x; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Jones D, 2003, BIOTECHNOL PROGR, V19, P163, DOI 10.1021/bp025574h; Julien JP, 2012, IMMUNOL REV, V250, P180, DOI 10.1111/imr.12005; Koudstaal W, 2009, J INFECT DIS, V200, P1870, DOI 10.1086/648378; Krause JC, 2011, J VIROL, V85, P10905, DOI 10.1128/JVI.00700-11; Nabel GJ, 2010, NAT MED, V16, P1389, DOI 10.1038/nm1210-1389; OKUNO Y, 1993, J VIROL, V67, P2552, DOI 10.1128/JVI.67.5.2552-2558.1993; Reading SA, 2007, ARCH VIROL, V152, P1047, DOI 10.1007/s00705-006-0923-8; RIGG RJ, 1989, J GEN VIROL, V70, P2097, DOI 10.1099/0022-1317-70-8-2097; Sanders BP, 2013, VACCINE, V31, P850, DOI 10.1016/j.vaccine.2012.10.070; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Vaughan JC, 2009, BIOPHYS J, V97, P1647, DOI 10.1016/j.bpj.2009.07.011; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231	40	115	121	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80034	10.1371/journal.pone.0080034	http://dx.doi.org/10.1371/journal.pone.0080034			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348996	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300006
J	Hanisch, F; Weidemann, W; Grossmann, M; Joshi, PR; Holzhausen, HJ; Stoltenburg, G; Weis, J; Zierz, S; Horstkorte, R				Hanisch, Frank; Weidemann, Wenke; Grossmann, Mona; Joshi, Pushpa Raj; Holzhausen, Hans-Juergen; Stoltenburg, Gisela; Weis, Joachim; Zierz, Stephan; Horstkorte, Ruediger			Sialylation and Muscle Performance: Sialic Acid Is a Marker of Muscle Ageing	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; N-ACETYLNEURAMINIC ACID; BIFUNCTIONAL ENZYME CATALYZES; 1ST 2 STEPS; SKELETAL-MUSCLE; ASIALOGLYCOPROTEIN RECEPTOR; PROTEIN EXPRESSION; RIMMED VACUOLES; DISTAL MYOPATHY	Sialic acids (Sia) are widely expressed as terminal monosaccharides on eukaryotic glycoconjugates. They are involved in many cellular functions, such as cell-cell interaction and signal recognition. The key enzyme of sialic acid biosynthesis is the bifunctional UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase (GNE), which catalyses the first two steps of Sia biosynthesis in the cytosol. In this study we analysed sialylation of muscles in wild type (C57Bl/6 GNE(+/+)) and heterozygous GNE-deficient (C57Bl/6 GNE(+/-)) mice. We measured a significantly lower performance in the initial weeks of a treadmill exercise in C57Bl/6 GNE(+/-) mice compared to wild type C57Bl/6 GNE(+/+) animals. Membrane bound Sia of C57Bl/6 GNE(+/-) mice were reduced by 33-53% at week 24 and by 12-15% at week 80 in comparison to C57Bl/6 GNE(+/+) mice. Interestingly, membrane bound Sia concentration increased with age of the mice by 16-46% in C57Bl/6 GNE(+/+), but by 87-207% in C57Bl/6 GNE(+/-). Furthermore we could identify specific morphological changes in aged muscles. Here we propose that increased Sia concentrations in muscles are a characteristic feature of ageing and could be used as a marker for age-related changes in muscle.	[Hanisch, Frank; Grossmann, Mona; Joshi, Pushpa Raj; Stoltenburg, Gisela; Zierz, Stephan] Univ Halle Wittenberg, Dept Neurol, Halle, Saale, Germany; [Weidemann, Wenke; Horstkorte, Ruediger] Univ Halle Wittenberg, Inst Physiol Chem, Halle, Saale, Germany; [Stoltenburg, Gisela] Charite, Inst Cell & Neurobiol, D-13353 Berlin, Germany; [Weis, Joachim] Rhein Westfal TH Aachen, Inst Neuropathol, Aachen, Germany; [Weis, Joachim] JARA Brain Translat Med, Aachen, Germany; [Holzhausen, Hans-Juergen] Univ Halle Wittenberg, Inst Pathol, Halle, Saale, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; RWTH Aachen University; Martin Luther University Halle Wittenberg	Hanisch, F (corresponding author), Univ Halle Wittenberg, Dept Neurol, Halle, Saale, Germany.	frank.hanisch@medizin.uni-halle.de; wenke.weidemann@medizin.uni-halle.de	Weis, Joachim/G-1984-2014	Weis, Joachim/0000-0003-3280-6773	Genzyme; Astellas; Biomarin; German Neurological Society	Genzyme(Sanofi-AventisGenzyme Corporation); Astellas(Astellas Pharmaceuticals); Biomarin; German Neurological Society	Frank Hanisch received lecturer honoraria and travel fees from Genzyme, Astellas, Biomarin, and the German Neurological Society. Pushpa Raj Joshi received lecturer honorarium from Genzyme and travel expenses from the World Muscle Society. Stephan Zierz received lecturer honorarium from Genzyme. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Wenke Weidemann, Rudiger Horstkorte, Joachim Weis, Mona Grossmann, Gisela Stoltenburg and Hans-Jurgen Holzhausen received neither travel fees nor lecturer honoraria.	Ahrens J, 2011, PHARMACOLOGY, V87, P311, DOI 10.1159/000327389; ARGOV Z, 1984, J NEUROL SCI, V64, P33, DOI 10.1016/0022-510X(84)90053-4; BEREGI E, 1987, ACTA MORPHOL HUNG, V35, P219; BEREGI E, 1988, Z GERONTOL, V21, P83; Boaro SN, 1998, ANN ANAT, V180, P173, DOI 10.1016/S0940-9602(98)80020-4; Broccolini A, 2002, NEUROLOGY, V59, P1808, DOI 10.1212/01.WNL.0000031808.04545.E0; Broccolini A, 2004, HUM MUTAT, V23, DOI 10.1002/humu.9252; Chen X, 2010, ACS CHEM BIOL, V5, P163, DOI 10.1021/cb900266r; Chevessier F, 2004, NEUROMUSCULAR DISORD, V14, P208, DOI 10.1016/j.nmd.2003.11.007; DUBOIS C, 1994, NEUROMUSCULAR DISORD, V4, P171, DOI 10.1016/0960-8966(94)90018-3; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Eisenberg Iris, 2003, Hum Mutat, V21, P99, DOI 10.1002/humu.9100; Figarella-Branger D, 1999, J NEUROL SCI, V165, P106, DOI 10.1016/S0022-510X(99)00066-0; Figarella-Branger D, 1999, J NEUROL SCI, V170, P149, DOI 10.1016/S0022-510X(99)00284-1; Gagiannis D, 2007, GLYCOCONJUGATE J, V24, P125, DOI 10.1007/s10719-006-9019-7; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hinderlich S, 2001, BIOL CHEM, V382, P291, DOI 10.1515/BC.2001.036; Krause S, 2007, NEUROLOGY, V69, P655, DOI 10.1212/01.wnl.0000267426.97138.fd; Krentsis IM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021389; Malicdan MCV, 2008, PHYSIOL GENOMICS, V35, P106, DOI 10.1152/physiolgenomics.90219.2008; Musaro A, 1999, EXP GERONTOL, V34, P147, DOI 10.1016/S0531-5565(98)00079-5; N'Guessan PD, 2007, J INFECT DIS, V195, P1651, DOI 10.1086/514820; Nakae Y, 2004, J MOL HISTOL, V35, P489; Nakamura K, 2010, PATHOBIOLOGY, V77, P191, DOI 10.1159/000292652; Nishino I, 2002, NEUROLOGY, V59, P1689, DOI 10.1212/01.WNL.0000041631.28557.C6; NONAKA I, 1981, J NEUROL SCI, V51, P141, DOI 10.1016/0022-510X(81)90067-8; O'Connell K, 2008, EUR J CELL BIOL, V87, P793, DOI 10.1016/j.ejcb.2008.04.003; Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Sivakumar K, 1996, NEUROLOGY, V47, P977, DOI 10.1212/WNL.47.4.977; Sprenger N, 2009, GLYCOBIOLOGY, V19, P1492, DOI 10.1093/glycob/cwp124; Stasche R, 1997, J BIOL CHEM, V272, P24319, DOI 10.1074/jbc.272.39.24319; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; Tadokoro T, 2006, GLYCOCONJUGATE J, V23, P443, DOI 10.1007/s10719-006-7152-y; TAUBER R, 1983, P NATL ACAD SCI-BIOL, V80, P4026, DOI 10.1073/pnas.80.13.4026; Venerando B, 2002, BLOOD, V99, P1064, DOI 10.1182/blood.V99.3.1064; WEIGEL PH, 1980, J BIOL CHEM, V255, P6111; WEIS J, 1988, CLIN NEUROPATHOL, V7, P271	39	21	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80520	10.1371/journal.pone.0080520	http://dx.doi.org/10.1371/journal.pone.0080520			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349002	Green Submitted, gold, Green Published			2022-12-27	WOS:000328730300010
J	Oda, K; Miyatake, N; Sakano, N; Saito, T; Miyachi, M; Tabata, I; Numata, T				Oda, Kanae; Miyatake, Nobuyuki; Sakano, Noriko; Saito, Takeshi; Miyachi, Motohiko; Tabata, Izumi; Numata, Takeyuki			Serum Interleukin-18 Levels Are Associated with Physical Activity in Japanese Men	PLOS ONE			English	Article							ADIPOSE-TISSUE AREAS; ENERGY-EXPENDITURE; BODY; PREDICTOR; MORTALITY; HEALTHY; FITNESS; CLONING	Objective: To investigate the link between serum interleukin-18 (IL-18) levels and physical activity in Japanese men. Methods: A total of 81 men (45.7617.6 years old) was enrolled in this cross-sectional investigation study. We assessed anthropometric and body composition parameters. Serum IL-18 levels, physical activity by uniaxial accelerometers, peak oxygen uptake and metabolic risk parameters were also evaluated. Results: Serum IL-18 levels were 179.4 +/- 84.7 pg/mL. Physical activity evaluated by Sigma[metabolic equivalents x h per week (METs.h/w)] was significantly and negatively correlated with serum IL-18 levels (r = -0.252, p = 0.0235). These associations remained even after adjusting for age, peak oxygen uptake and other confounding factors. Conclusion: Serum IL-18 levels were closely associated with physical activity independent of peak oxygen uptake in Japanese men.	[Oda, Kanae; Miyatake, Nobuyuki; Sakano, Noriko; Saito, Takeshi] Kagawa Univ, Dept Hyg, Fac Med, Kita, Kagawa, Japan; [Miyachi, Motohiko] Natl Inst Hlth & Nutr, Hlth Promot & Exercise Program, Shinjuku Ku, Tokyo 162, Japan; [Tabata, Izumi] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Shiga, Japan; [Saito, Takeshi; Numata, Takeyuki] Okayama Hlth Fdn, Okayama Southern Inst Hlth, Kita Ku, Okayama, Japan	Kagawa University; National Institute of Health & Nutrition - Japan; Ritsumeikan University	Oda, K (corresponding author), Kagawa Univ, Dept Hyg, Fac Med, Kita, Kagawa, Japan.	oda@med.kagawa-u.ac.jp	Miyachi, Motohiko/AAW-3403-2020	Miyachi, Motohiko/0000-0002-1146-0905	Ministry of Health, Labor, and Welfare of Japan	Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This research was supported in part by Research Grants from the Ministry of Health, Labor, and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, Nihon Naika Gakkai Zasshi, V94, P794; Aso Y, 2003, DIABETES CARE, V26, P2622, DOI 10.2337/diacare.26.9.2622; Blankenberg S, 2002, CIRCULATION, V106, P24, DOI 10.1161/01.CIR.0000020546.30940.92; Bruun JM, 2007, EUR J ENDOCRINOL, V157, P465, DOI 10.1530/EJE-07-0206; Clemes SA, 2008, MED SCI SPORT EXER, V40, P1589, DOI 10.1249/MSS.0b013e318177eb96; Esposito K, 2004, DIABETES CARE, V27, P272, DOI 10.2337/diacare.27.1.272; GUSTAFSSON L, 1974, MED BIOL ENG, V12, P113, DOI 10.1007/BF02629842; HERD RJM, 1993, BRIT J RADIOL, V66, P303, DOI 10.1259/0007-1285-66-784-303; Kadoglou NPE, 2007, EUR J CARDIOV PREV R, V14, P837, DOI 10.1097/HJR.0b013e3282efaf50; Kawashima M, 2001, ARTHRITIS RHEUM-US, V44, P550, DOI 10.1002/1529-0131(200103)44:3<550::AID-ANR103>3.0.CO;2-5; Kumahara H, 2004, BRIT J NUTR, V91, P235, DOI 10.1079/BJN20031033; Leick L, 2007, OBESITY, V15, P356, DOI 10.1038/oby.2007.528; McClain JJ, 2007, MED SCI SPORT EXER, V39, P630, DOI 10.1249/mss.0b013e3180313056; Ministry of Health Labour and Welfare of Japan, 2007, EX PHYS ACT REF HLTH; Miyachi M, 2001, J APPL PHYSIOL, V90, P2439, DOI 10.1152/jappl.2001.90.6.2439; Miyatake N, 2003, DIABETES RES CLIN PR, V62, P149, DOI 10.1016/S0168-8227(03)00176-1; Miyatake N, 2002, DIABETES RES CLIN PR, V58, P101, DOI 10.1016/S0168-8227(02)00129-8; Nakamura A, 2005, DIABETES CARE, V28, P2890, DOI 10.2337/diacare.28.12.2890; OKAMURA H, 1995, INFECT IMMUN, V63, P3966, DOI 10.1128/IAI.63.10.3966-3972.1995; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; OSHIDA Y, 1989, J APPL PHYSIOL, V66, P2206, DOI 10.1152/jappl.1989.66.5.2206; Parikh Amish, 2004, Diabetes Technol Ther, V6, P65, DOI 10.1089/152091504322783440; SANDVIK L, 1993, NEW ENGL J MED, V328, P533, DOI 10.1056/NEJM199302253280803; Sawada SS, 2003, MED SCI SPORT EXER, V35, P1546, DOI 10.1249/01.MSS.0000084525.06473.8E; Stensvold D, 2012, METAB SYNDR RELAT D, V10, P267, DOI 10.1089/met.2011.0140; Ushio S, 1996, J IMMUNOL, V156, P4274; WANG J, 1989, AM J PHYSIOL, V256, pE829, DOI 10.1152/ajpendo.1989.256.6.E829; Yamada Y, 2009, EUR J APPL PHYSIOL, V105, P141, DOI 10.1007/s00421-008-0883-7; Yamamura M, 2001, ARTHRITIS RHEUM, V44, P275, DOI 10.1002/1529-0131(200102)44:2<275::AID-ANR44>3.3.CO;2-2; YAMANOUCHI K, 1995, DIABETES CARE, V18, P775, DOI 10.2337/diacare.18.6.775; Zaremba J, 2003, NEUROL SCI, V24, P117, DOI 10.1007/s10072-003-0096-0	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81497	10.1371/journal.pone.0081497	http://dx.doi.org/10.1371/journal.pone.0081497			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349077	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300030
J	Zoupanou, Z; Cropley, M; Rydstedt, LW				Zoupanou, Zoe; Cropley, Mark; Rydstedt, Leif W.			Recovery after Work: The Role of Work Beliefs in the Unwinding Process	PLOS ONE			English	Article							PSYCHOLOGICAL DETACHMENT; JOB-PERFORMANCE; WEEK-LEVEL; RUMINATION; SLEEP; VALIDATION; ENGAGEMENT; RESOURCES; STRESSORS; MODERATOR	According to the Effort-Recovery model, mental or physical detachment from work is an important mechanism of work related recovery, as delayed recovery has been associated with range of negative health symptoms. In this paper, we examine whether recovery from work (in the form of mentally disengagement from work) is affected by the concept of 'work ethic', which refers to beliefs workers hold about their work and leisure and the effects of experiencing interruptions at work. Two indices of post-work recovery were utilized: problem solving pondering and psychological detachment. The study was conducted with 310 participants employed from diverse occupational sectors. Main effects of positive and negative appraisal of work interruption and beliefs were analysed using mediated and moderated regression analysis on problem-solving pondering and detachment. Weakened belief in wasted time as a partial mediator, reduced problem-solving pondering post work when interruptions were appraised as positive, and a high evaluation of leisure partially mediated problem-solving pondering when interruptions were appraised as positive. The results also showed that a high evaluation of centrality of work and leisure moderated the effect of negative appraisal of work interruption on elevated problem-solving pondering. Positive appraisal of work interruption was related to problem-solving pondering, and the strength of this association was further moderated by a strong belief in delay of gratification. In addition, employees' positive appraisal of work interruption was related to work detachment, and the strength of this association was further moderated by strong beliefs in hard work and self-reliance. These findings are discussed in terms of their theoretical and practical implications for employees who are strongly influenced by such work beliefs.	[Zoupanou, Zoe; Cropley, Mark] Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England; [Rydstedt, Leif W.] Lillehammer Univ Coll HiL, ASV, Lillehammer, Norway	University of Surrey; Inland Norway University of Applied Sciences	Zoupanou, Z (corresponding author), Univ Surrey, Dept Psychol, Guildford GU2 5XH, Surrey, England.	drzoupanouzoe@hotmail.co.uk	Zoupanou, Zoe (Zoi)/AAH-6493-2020; Cropley, Mark/V-2296-2019					Aiken L. S., 1991, MULTIPLE REGRESSION; Akerstedt T, 2004, J PSYCHOSOM RES, V57, P427, DOI 10.1016/j.jpsychores.2003.12.001; Bakker A.B., 2007, J MANAGE PSYCHOL, V22 (3), P309, DOI [10.1108/02683940710733115, DOI 10.1108/02683940710733115]; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Berset M, 2011, STRESS HEALTH, V27, pE71, DOI 10.1002/smi.1337; Binnewies C, 2010, J OCCUP ORGAN PSYCH, V83, P419, DOI 10.1348/096317909X418049; Binnewies C, 2009, J OCCUP HEALTH PSYCH, V14, P243, DOI 10.1037/a0014933; Binnewies C, 2009, J ORGAN BEHAV, V30, P67, DOI 10.1002/job.541; Boswell WR, 2007, J MANAGE, V33, P592, DOI 10.1177/0149206307302552; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Craig A., 1992, HDB HUMAN PERFORMANC, P289, DOI DOI 10.1016/B978-0-12-650353-1.50017-4; Cropley M., 2003, EUR J WORK ORGAN PSY, V12, P195, DOI [10.1080/13594320344000093, DOI 10.1080/13594320344000093]; Cropley M, 2006, EUR J WORK ORGAN PSY, V15, P181, DOI 10.1080/13594320500513913; Cropley M, 2011, NEW HORIZ MANAG, P487; Cropley M, 2012, STRESS HEALTH, V28, P23, DOI 10.1002/smi.1397; Cropley M, 2009, LEISURE STUD, V28, P333, DOI 10.1080/02614360902951682; Csikszentmihalyi M., 1995, NATURE INSIGHT, P329, DOI [10.1007/978-94-017-9085-7, DOI 10.1007/978-94-017-9085-7, DOI 10.1002/J.2162-6057.1998.TB00816.X]; Demerouti E, 2001, J APPL PSYCHOL, V86, P499, DOI 10.1037//0021-9010.86.3.499; ERBER R, 1996, ADV SOC COG, V9, P73; Etzion D, 1998, J APPL PSYCHOL, V83, P577, DOI 10.1037/0021-9010.83.4.577; Fritz C, 2006, J APPL PSYCHOL, V91, P936, DOI 10.1037/0021-9010.91.4.936; Fritz C, 2005, J OCCUP HEALTH PSYCH, V10, P187, DOI 10.1037/1076-8998.10.3.187; Frohlich D., 1995, C COMP HUM FACT COMP, P262, DOI [10.1145/223355.223665, DOI 10.1145/223355.223665]; FURNHAM A, 1987, HUM RELAT, V40, P561, DOI 10.1177/001872678704000902; Gallie Duncan., 1998, RESTRUCTURING EMPLOY; Hackman J. R., 1980, WORK REDESIGN; Hassall SL, 2005, J ECON PSYCHOL, V26, P327, DOI 10.1016/j.joep.2004.06.005; HINKIN TR, 1989, J APPL PSYCHOL, V74, P561, DOI 10.1037//0021-9010.74.4.561; Hobfoll S.E., 1998, STRESS CULTURE COMMU; HOBFOLL SE, 1989, AM PSYCHOL, V44, P513, DOI 10.1037/0003-066X.44.3.513; Hochschild A.R., 1997, TIME BLIND WORK BECO; Karasek R, 1990, HLTH WORK STRESS PRO; Krediet I, 1994, 94070394 WORC TILB U; MCINTOSH WD, 1995, J APPL SOC PSYCHOL, V25, P1231, DOI 10.1111/j.1559-1816.1995.tb02616.x; Meijman T. F., 1998, HDB WORK ORG PSYCHOL, V2, DOI DOI 10.4324/9781315791265; Miller MJ, 2002, J VOCAT BEHAV, V60, P451, DOI 10.1006/jvbe.2001.1838; MIRELS HL, 1971, J CONSULT CLIN PSYCH, V36, P40, DOI 10.1037/h0030477; Pahl R, 1995, SUCCESS; Pravettoni G, 2007, ERGONOMICS, V50, P1931, DOI 10.1080/00140130701676088; PRENTICE DA, 1992, PSYCHOL BULL, V112, P160, DOI 10.1037/0033-2909.112.1.160; Querstret D, 2012, J OCCUP HEALTH PSYCH, V17, P341, DOI 10.1037/a0028552; ROGER D, 1988, PERS INDIV DIFFER, V9, P721, DOI 10.1016/0191-8869(88)90061-X; Rook JW, 2006, EUR J WORK ORGAN PSY, V15, P218, DOI 10.1080/13594320500513962; Schaufeli WB, 2004, J ORGAN BEHAV, V25, P293, DOI 10.1002/job.248; Smith A, 2000, 2652000 RR HSE BOOKS; Sonnentag S, 2008, WORK STRESS, V22, P257, DOI 10.1080/02678370802379440; Sonnentag S, 2007, J OCCUP HEALTH PSYCH, V12, P204, DOI 10.1037/1076-8998.12.3.204; Sonnentag S, 2006, EUR J WORK ORGAN PSY, V15, P197, DOI 10.1080/13594320500513939; Sonnentag S, 2005, J OCCUP HEALTH PSYCH, V10, P393, DOI 10.1037/1076-8998.10.4.393; Sparks JR, 2001, J ORGAN BEHAV, V22, P849, DOI 10.1002/job.116; Spira J. B., 2005, COST NOT PAYING ATTE; SUADICANI P, 1993, ATHEROSCLEROSIS, V101, P165, DOI 10.1016/0021-9150(93)90113-9; Weber M., 1904, PROTESTANT ETHIC SPI; Weber Max., 1966, CITY; WEGNER DM, 1987, J PERS SOC PSYCHOL, V53, P5, DOI 10.1037/0022-3514.53.1.5; Zeigarnik B, 1927, SOURCE BOOK GESTALT, P300, DOI [10.1037/h0050588, DOI 10.1037/H0050588]; Zijlstra FRH, 1999, J OCCUP ORGAN PSYCH, V72, P163, DOI 10.1348/096317999166581	57	8	8	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81381	10.1371/journal.pone.0081381	http://dx.doi.org/10.1371/journal.pone.0081381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349060	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300027
J	Chu, PHW; Li, HY; Chin, MP; So, KF; Chan, HHL				Chu, Patrick H. W.; Li, Hong-Ying; Chin, Man-Pan; So, Kwok-fai; Chan, Henry H. L.			Effect of Lycium Barbarum (Wolfberry) Polysaccharides on Preserving Retinal Function after Partial Optic Nerve Transection	PLOS ONE			English	Article							LUMINANCE-MODULATED ADAPTATION; GLOBAL FLASH MFERG; GANGLION-CELLS; SECONDARY DEGENERATION; MULTIFOCAL ELECTRORETINOGRAM; EXPERIMENTAL GLAUCOMA; UP-REGULATION; IN-VIVO; RATS; NEUROPROTECTION	Lycium Barbarum Polysaccharides (LBP) are the active components of Wolfberry (a traditional Chinese medicine) which has long been used for improving visual function. This study aims to investigate localized changes of retinal function in a partial optic nerve transection (PONT) model, and effects of LBP on visual function. The multifocal electroretinograms (mfERG) were obtained from 30 eyes of 30 Sprague-Dawley rats. The rats were divided into 6 groups (five treatment groups and one control group). Starting from the first day of the experiment, the rats in the (PONT+LBP) group and the (LBP) group were dosed with LBP; rats in the (PONT+PBS (phosphate buffered saline)) group and the (PBS) group were dosed with PBS via nasogastric tube every day until euthanized. The dorsal part of the optic nerve was transected in the (PONT), (PONT+LBP) and (PONT+PBS) groups at the end of week 1 (day 7 after LBP or PBS feeding began). The mfERG was measured at three time points: week 2, week 3 and week 5. Significant reduction of P1 and PhNR amplitudes of the mfERG were observed in all retinal regions a week after PONT. Feeding with LBP prior to PONT preserved retinal function. All mfERG responses returned to the normal range in the superior retina, which corresponds to the transected dorsal region of the optic nerve, while most of the inferior retinal responses were significantly increased at week 4 after PONT. The ventral part of the retina had secondary degeneration which was not only limited to the ganglion cell layer, but is a widespread effect affecting the outer retina. LBP altered the functional reduction caused by PONT by regulating the signal from the outer retina.	[Chu, Patrick H. W.; Chin, Man-Pan; Chan, Henry H. L.] Hong Kong Polytech Univ, Sch Optometry, Lab Expt Optometry Neurosci, Hong Kong, Hong Kong, Peoples R China; [Li, Hong-Ying; So, Kwok-fai] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Dept Anat, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China; [Chan, Henry H. L.] Hong Kong Polytech Univ, Fac Hlth & Social Sci, Inst Act Ageing, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong; Hong Kong Polytechnic University	So, KF (corresponding author), Univ Hong Kong, State Key Lab Brain & Cognit Sci, Dept Anat, Res Ctr Heart Brain Hormone & Hlth Aging, Hong Kong, Hong Kong, Peoples R China.	hrmaskf@hku.hk; henryhl.chan@polyu.edu.hk	Chu, Patrick HW/H-5532-2011; Li, Hong-Ying/AAH-2462-2019; Li, Hong-Ying/C-5762-2014; Li, Hongying/Q-1909-2016; Li, Hongying/AAU-2379-2021	Chu, Patrick HW/0000-0003-0547-2675; Li, Hong-Ying/0000-0002-1109-0799; Li, Hong-Ying/0000-0002-1109-0799; Li, Hongying/0000-0002-1109-0799; So, Kwok-Fai/0000-0003-4039-4246; CHAN, Henry HL/0000-0002-8516-4711	grant for Postdoctoral Fellowship [YX3C]; Internal Research Grants from The Hong Kong Polytechnic University [GU858]; Research Grants Council of the HKSAR, China [HKU 10208849]; Fundamental Research Funds for The Central Universities [21609101]; Azalea (1972) Foundation	grant for Postdoctoral Fellowship; Internal Research Grants from The Hong Kong Polytechnic University; Research Grants Council of the HKSAR, China(Hong Kong Research Grants Council); Fundamental Research Funds for The Central Universities(Fundamental Research Funds for the Central Universities); Azalea (1972) Foundation	This work was supported by a grant for Postdoctoral Fellowship (G-YX3C), Internal Research Grants (GU858) from The Hong Kong Polytechnic University, a grant from the Research Grants Council of the HKSAR, China (HKU 10208849), the Fundamental Research Funds for The Central Universities Grant 21609101 and the Azalea (1972) Foundation. The funders do not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball SL, 2000, INVEST OPHTH VIS SCI, V41, P610; Blair M, 2005, INVEST OPHTH VIS SCI, V46, P884, DOI 10.1167/iovs.04-0731; Chan HHL, 2011, CLIN EXP OPTOM, V94, P247, DOI 10.1111/j.1444-0938.2010.00571.x; Chan HHL, 2005, J ALTERN COMPLEM MED, V11, P315, DOI 10.1089/acm.2005.11.315; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chan KC, 2011, NEUROIMAGE, V54, P389, DOI 10.1016/j.neuroimage.2010.07.015; Chiu K, 2010, J CELL BIOCHEM, V110, P311, DOI 10.1002/jcb.22539; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P47; Chu PHW, 2008, VISION RES, V48, P1726, DOI 10.1016/j.visres.2008.05.006; Chu PHW, 2007, INVEST OPHTH VIS SCI, V48, P2626, DOI 10.1167/iovs.06-0962; Chu PHW, 2012, GRAEF ARCH CLIN EXP, V250, P261, DOI 10.1007/s00417-011-1790-x; Chu PHW, 2011, BRIT J OPHTHALMOL, V95, P1597, DOI 10.1136/bjophthalmol-2011-300263; Chu PHW, 2006, INVEST OPHTH VIS SCI, V47, P929, DOI 10.1167/iovs.05-0891; Fitzgerald M, 2009, INVEST OPHTH VIS SCI, V50, P5456, DOI 10.1167/iovs.09-3717; Fitzgerald M, 2009, EXP NEUROL, V216, P219, DOI 10.1016/j.expneurol.2008.11.026; Fortune B, 2012, INVEST OPHTH VIS SCI, V53, P3939, DOI 10.1167/iovs.12-9979; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Ho YS, 2010, AGEING RES REV, V9, P354, DOI 10.1016/j.arr.2009.10.001; Hood DC, 2002, INVEST OPHTH VIS SCI, V43, P1673; HUGHES A, 1979, VISION RES, V19, P569, DOI 10.1016/0042-6989(79)90143-3; Kielczewski JL, 2005, INVEST OPHTH VIS SCI, V46, P3188, DOI 10.1167/iovs.05-0321; Lalonde MR, 2006, J PHYSIOL-LONDON, V570, P325, DOI 10.1113/jphysiol.2005.098046; Lam KW, 1999, FOOD CHEM, V67, P173, DOI 10.1016/S0308-8146(99)00119-3; Levkovitch-Verbin H, 2001, INVEST OPHTH VIS SCI, V42, P975; Levkovitch-Verbin H, 2003, INVEST OPHTH VIS SCI, V44, P3388, DOI 10.1167/iovs.02-0646; Levkovitch-Verbin H, 2006, INVEST OPHTH VIS SCI, V47, P2491, DOI 10.1167/iovs.05-0996; Levkovitch-Verbin H, 2010, EXP EYE RES, V91, P127, DOI 10.1016/j.exer.2009.11.014; Li HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068881; Li L, 2007, BRAIN RES, V1159, P8, DOI 10.1016/j.brainres.2007.04.066; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Machida S, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/397178; Mojumder DK, 2008, J PHYSIOL-LONDON, V586, P2551, DOI 10.1113/jphysiol.2008.150755; Ng YF, 2008, DOC OPHTHALMOL, V116, P165, DOI 10.1007/s10633-007-9076-7; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Palmowski-Wolfe AM, 2007, DOC OPHTHALMOL, V114, P9, DOI 10.1007/s10633-006-9033-x; Selt M, 2010, BRAIN RES BULL, V81, P467, DOI 10.1016/j.brainresbull.2009.11.004; SUTTER EE, 1992, VISION RES, V32, P433, DOI 10.1016/0042-6989(92)90235-B; Yu MS, 2007, INT J MOL MED, V20, P261	38	33	35	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81339	10.1371/journal.pone.0081339	http://dx.doi.org/10.1371/journal.pone.0081339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339917	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400013
J	Gu, HG				Gu, Huaguang			Biological Experimental Observations of an Unnoticed Chaos as Simulated by the Hindmarsh-Rose Model	PLOS ONE			English	Article							BIFURCATION SCENARIOS; FIRING PATTERNS; NERVE INJURY; DYNAMICS; PAIN; RAT; SYNCHRONIZATION; DISCHARGES; PACEMAKER; RESONANCE	An unnoticed chaotic firing pattern, lying between period-1 and period-2 firing patterns, has received little attention over the past 20 years since it was first simulated in the Hindmarsh-Rose (HR) model. In the present study, the rat sciatic nerve model of chronic constriction injury (CCI) was used as an experimental neural pacemaker to investigate the transition regularities of spontaneous firing patterns. Chaotic firing lying between period-1 and period-2 firings was observed located in four bifurcation scenarios in different, isolated neural pacemakers. These bifurcation scenarios were induced by decreasing extracellular calcium concentrations. The behaviors after period-2 firing pattern in the four scenarios were period-doubling bifurcation not to chaos, period-doubling bifurcation to chaos, period-adding sequences with chaotic firings, and period-adding sequences with stochastic firings. The deterministic structure of the chaotic firing pattern was identified by the first return map of interspike intervals and a short-term prediction using nonlinear prediction. The experimental observations closely match those simulated in a two-dimensional parameter space using the HR model, providing strong evidences of the existence of chaotic firing lying between period-1 and period-2 firing patterns in the actual nervous system. The results also present relationships in the parameter space between this chaotic firing and other firing patterns, such as the chaotic firings that appear after period-2 firing pattern located within the well-known comb-shaped region, periodic firing patterns and stochastic firing patterns, as predicted by the HR model. We hope that this study can focus attention on and help to further the understanding of the unnoticed chaotic neural firing pattern.	Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China	Tongji University	Gu, HG (corresponding author), Tongji Univ, Sch Aerosp Engn & Appl Mech, Shanghai 200092, Peoples R China.	guhuaguang@tongji.edu.cn	Gu, Huaguang/ABA-5898-2020; Gu, Huaguang/E-3562-2013	Gu, Huaguang/0000-0003-0815-1447; Gu, Huaguang/0000-0003-0815-1447	National Natural Science Foundation of China [11072135, 10772101]; Fundamental Research Funds for Central Universities of Tongji University [1330219127]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Universities of Tongji University	This work was supported by the National Natural Science Foundation of China under Grant Nos. 11072135 and 10772101, and the Fundamental Research Funds for Central Universities of Tongji University under Grant No 1330219127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIHARA K, 1984, J THEOR BIOL, V109, P249, DOI 10.1016/S0022-5193(84)80005-3; Barrio R, 2011, J MATH NEUROSCI, V1, DOI 10.1186/2190-8567-1-6; Belykh I, 2011, CHAOS, V21, DOI 10.1063/1.3563581; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; BRAUN HA, 1994, NATURE, V367, P270, DOI 10.1038/367270a0; Braun HA, 2011, CHAOS, V21, DOI 10.1063/1.3671326; Channell P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.134101; Dhamala M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028101; Djouhri L, 2006, J NEUROSCI, V26, P1281, DOI 10.1523/JNEUROSCI.3388-05.2006; Dong CH, 2002, SCI CHINA SER C, V45, P191, DOI 10.1360/02yc9022; Duan LX, 2006, CHAOS SOLITON FRACT, V30, P1172, DOI 10.1016/j.chaos.2005.08.179; ELBERT T, 1994, PHYSIOL REV, V74, P1, DOI 10.1152/physrev.1994.74.1.1; FAN YS, 1993, CHAOS SOLITON FRACT, V3, P439, DOI 10.1016/0960-0779(93)90029-Z; FARMER JD, 1987, PHYS REV LETT, V59, P845, DOI 10.1103/PhysRevLett.59.845; Feudel U, 2000, CHAOS, V10, P231, DOI 10.1063/1.166488; Gonzalez-Miranda JM, 2007, INT J BIFURCAT CHAOS, V17, P3071, DOI 10.1142/S0218127407018877; Gonzalez-Miranda JM, 2012, CHAOS, V22, DOI 10.1063/1.3687017; Gonzalez-Miranda JM, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051922; Gonzalez-Miranda JM, 2003, CHAOS, V13, P845, DOI 10.1063/1.1594851; Gu H, 2003, PHYS LETT A, V319, P89, DOI 10.1016/j.physleta.2003.09.077; Gu HG, 2002, NEUROREPORT, V13, P1657, DOI 10.1097/00001756-200209160-00018; Gu HG, 2001, PHYS LETT A, V285, P63, DOI 10.1016/S0375-9601(01)00278-X; Gu HG, 2013, PHYS LETT A, V377, P718, DOI 10.1016/j.physleta.2013.01.015; HANSEL D, 1992, PHYS REV LETT, V68, P718, DOI 10.1103/PhysRevLett.68.718; HAYASHI H, 1983, PHYS LETT A, V98, P474, DOI 10.1016/0375-9601(83)90267-0; HINDMARSH JL, 1984, PROC R SOC SER B-BIO, V221, P87, DOI 10.1098/rspb.1984.0024; Holden A. V., 1992, Chaos, Solitons and Fractals, V2, P221, DOI 10.1016/0960-0779(92)90032-I; Holden A. V., 1992, Chaos, Solitons and Fractals, V2, P349, DOI 10.1016/0960-0779(92)90012-C; Innocenti G, 2009, CHAOS, V19, DOI 10.1063/1.3156650; Innocenti G, 2007, CHAOS, V17, DOI 10.1063/1.2818153; Izhikevich EM, 2000, INT J BIFURCAT CHAOS, V10, P1171, DOI 10.1142/S0218127400000840; Jia B, 2012, COGN NEURODYNAMICS, V6, P89, DOI 10.1007/s11571-011-9184-7; Kim MY, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.058101; Li L, 2004, INT J BIFURCAT CHAOS, V14, P1813, DOI 10.1142/S0218127404010114; Linaro D, 2010, PHYS LETT A, V374, P4589, DOI 10.1016/j.physleta.2010.09.030; Lu QS, 2008, ACTA MECH SINICA-PRC, V24, P593, DOI 10.1007/s10409-008-0204-8; Mongan LC, 2005, NEUROSCIENCE, V131, P161, DOI 10.1016/j.neuroscience.2004.09.062; Moore KA, 2002, J NEUROSCI, V22, P6724, DOI 10.1523/jneurosci.22-15-06724.2002; Mosekilde E, 2001, BIOSYSTEMS, V63, P3, DOI 10.1016/S0303-2647(01)00142-3; Quail T, 2012, CHAOS, V22, DOI 10.1063/1.4748854; Rabinovich MI, 1998, NEUROSCIENCE, V87, P5, DOI 10.1016/S0306-4522(98)00091-8; Rech PC, 2011, PHYS LETT A, V375, P1461, DOI 10.1016/j.physleta.2011.02.037; SAUER T, 1994, PHYS REV LETT, V72, P3811, DOI 10.1103/PhysRevLett.72.3811; Shilnikov A, 2008, INT J BIFURCAT CHAOS, V18, P2141, DOI 10.1142/S0218127408021634; Storace M, 2008, CHAOS, V18, DOI 10.1063/1.2975967; Tal M, 1996, PAIN, V64, P511, DOI 10.1016/0304-3959(95)00175-1; TERMAN D, 1991, SIAM J APPL MATH, V51, P1418, DOI 10.1137/0151071; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; WANG XJ, 1993, PHYSICA D, V62, P263, DOI 10.1016/0167-2789(93)90286-A; Wu XB, 2008, CHINESE PHYS LETT, V25, P2799; Xie YK, 2000, CHINESE SCI BULL, V45, P775, DOI 10.1007/BF02887401; Xu JX, 1997, PHYSICA D, V100, P212, DOI 10.1016/S0167-2789(96)00188-1; Yang J, 2006, NEUROSCI LETT, V392, P105, DOI 10.1016/j.neulet.2005.09.007; Yang MH, 2006, NEUROREPORT, V17, P995, DOI 10.1097/01.wnr.0000224770.74528.d6; Yang MH, 2009, INT J BIFURCAT CHAOS, V19, P453, DOI 10.1142/S0218127409023135; Zhang XL, 2003, NEUROSCI LETT, V346, P65, DOI 10.1016/S0304-3940(03)00576-7	56	44	46	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81759	10.1371/journal.pone.0081759	http://dx.doi.org/10.1371/journal.pone.0081759			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339962	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400038
J	He, XY; Zhu, XY; Wang, XX; Wang, W; Dai, Y; Yan, QF				He, Xiangyu; Zhu, Xiaoyu; Wang, Xuexiang; Wang, Wei; Dai, Yu; Yan, Qingfeng			Nuclear Modifier MTO2 Modulates the Aminoglycoside-Sensitivity of Mitochondrial 15S rRNA C1477G Mutation in Saccharomyces cerevisiae	PLOS ONE			English	Article							PAROMOMYCIN-RESISTANCE MUTATION; NON-SYNDROMIC DEAFNESS; A1555G MUTATION; TRANSLATIONAL FIDELITY; GENE; EXPRESSION; PATHOGENESIS; PHENOTYPE; MUTANTS; GROWTH	The phenotypic manifestations of mitochondrial DNA (mtDNA) mutations are modulated by mitochondrial DNA haplotypes, nuclear modifier genes and environmental factors. The yeast mitochondrial 15S rRNA C1477G (P-R or P-454(R)) mutation corresponds to the human 12S rRNA C1494T and A1555G mutations, which are well known as primary factors for aminoglycoside-induced nonsyndromic deafness. Here we report that the deletion of the nuclear modifier gene MTO2 suppressed the aminoglycoside-sensitivity of mitochondrial 15S rRNA C1477G mutation in Saccharomyces cerevisiae. First, the strain with a single mtDNA C1477G mutation exhibited hypersensitivity to neomycin. Functional assays indicated that the steady-state transcription level of mitochondrial DNA, the mitochondrial respiratory rate, and the membrane potential decreased significantly after neomycin treatment. The impaired mitochondria could not produce sufficient energy to maintain cell viability. Second, when the mto2 null and the mitochondrial C1477G mutations co-existed (mto2(P-R)), the oxygen consumption rate in the double mutant decreased markedly compared to that of the control strains (MTO2(P-S), mto2(P-S) and MTO2(P-R)). The expression levels of the key glycolytic genes HXK2, PFK1 and PYK1 in the mto2(P-R) strain were stimulated by neomycin and up-regulated by 89%, 112% and 55%, respectively. The enhanced glycolysis compensated for the respiratory energy deficits, and could be inhibited by the glycolytic enzyme inhibitor. Our findings in yeast will provide a new insight into the pathogenesis of human deafness.	[He, Xiangyu; Zhu, Xiaoyu; Wang, Xuexiang; Wang, Wei; Dai, Yu; Yan, Qingfeng] Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Yan, QF (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China.	qfyan@zju.edu.cn	yan, qing/GZN-2287-2022		National Basic Research Program of China [2012CB966804, 2014CB943001]; National Natural Science Foundation of China [30971599]; Program for New Century Excellent Talents in University [NCET-06-0526]; 151 Excellent Talents in Zhejiang Province [06-2-008]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); 151 Excellent Talents in Zhejiang Province	This work was supported by National Basic Research Program of China (Grant Nos. 2012CB966804, 2014CB943001), National Natural Science Foundation of China (No. 30971599), and the Program for New Century Excellent Talents in University (NCET-06-0526) and 151 Excellent Talents in Zhejiang Province (No. 06-2-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bae JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042463; Bruckmann A, 2009, J PROTEOMICS, V71, P662, DOI 10.1016/j.jprot.2008.11.012; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; DECOSTER E, 1993, J MOL BIOL, V232, P79, DOI 10.1006/jmbi.1993.1371; Estivill X, 1998, AM J HUM GENET, V62, P27, DOI 10.1086/301676; Fan-Minogue H, 2008, RNA, V14, P148, DOI 10.1261/rna.805208; Feldman MB, 2010, NAT CHEM BIOL, V6, P54, DOI [10.1038/NCHEMBIO.274, 10.1038/nchembio.274]; Fourmy D, 1998, J MOL BIOL, V277, P347, DOI 10.1006/jmbi.1997.1552; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Goncalves P, 1998, TRENDS MICROBIOL, V6, P314, DOI 10.1016/S0966-842X(98)01305-5; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 2001, HUM MOL GENET, V10, P573, DOI 10.1093/hmg/10.6.573; Guan MX, 1996, HUM MOL GENET, V5, P963, DOI 10.1093/hmg/5.7.963; KUTZLEB R, 1973, MOL GEN GENET, V125, P91, DOI 10.1007/BF00292984; LI M, 1982, J BIOL CHEM, V257, P5921; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Lu JX, 2010, MITOCHONDRION, V10, P380, DOI 10.1016/j.mito.2010.01.007; MOORE PA, 1991, MOL CELL BIOL, V11, P5330, DOI 10.1128/MCB.11.10.5330; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5180, DOI 10.1073/pnas.0501598102; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Qian YP, 2009, ANTIMICROB AGENTS CH, V53, P4612, DOI 10.1128/AAC.00965-08; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Ralser M, 2008, P NATL ACAD SCI USA, V105, P17807, DOI 10.1073/pnas.0803090105; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; Sasarman F, 2011, HUM MOL GENET, V20, P4634, DOI 10.1093/hmg/ddr397; Schara U, 2011, J INHERIT METAB DIS, V34, P197, DOI 10.1007/s10545-010-9250-z; de Moraes VCS, 2009, BIOCHEM BIOPH RES CO, V381, P210, DOI 10.1016/j.bbrc.2009.02.014; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Wang XJ, 2007, FEBS LETT, V581, P4228, DOI 10.1016/j.febslet.2007.07.067; Wang YM, 2007, J BIOL CHEM, V282, P8228, DOI 10.1074/jbc.M609635200; Weiss A, 2004, ANAL BIOCHEM, V327, P23, DOI 10.1016/j.ab.2003.12.020; WEISSBRUMMER B, 1989, MOL GEN GENET, V217, P362, DOI 10.1007/BF02464905; Yan QF, 2005, J BIOL CHEM, V280, P29151, DOI 10.1074/jbc.M504247200; Young WY, 2005, BIOCHEM BIOPH RES CO, V328, P1244, DOI 10.1016/j.bbrc.2005.01.085; Yuan H, 1999, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V16, P141; Zeharia A, 2009, AM J HUM GENET, V85, P401, DOI 10.1016/j.ajhg.2009.08.004; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133	39	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81490	10.1371/journal.pone.0081490	http://dx.doi.org/10.1371/journal.pone.0081490			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339937	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400021
J	Li, LF; Rasnitsyn, AP; Shih, CK; Ren, D				Li, Longfeng; Rasnitsyn, Alexandr P.; Shih, Chungkun; Ren, Dong			Anomopterellidae Restored, with Two New Genera and Its Phylogeny in Evanioidea (Hymenoptera)	PLOS ONE			English	Article							INNER-MONGOLIA; INSECTA HYMENOPTERA; WASPS HYMENOPTERA; YIXIAN FORMATION; MIDDLE; EVOLUTION; PROCTOTRUPOIDEA; PRAEAULACIDAE; PELECINIDAE; REANALYSIS	Background: Anomopterellidae was originally classified as a family within the Evanioidea, and later lowered to a subfamily, Anomopterellinae, of Praeaulacidae. Up to date, only Rasnitsyn 1975, with four species, was assigned to Anomopterellinae. Due to their special wing venation and their metasomal attachment similar to those known in Evanioidea, the systematic position of Anomopterellinae in Evanioidea has been in contention. Principal Findings: Here we report a new fossil genus Synaphopterella gen. nov. and six species from the Middle Jurassic of China and transfer Anomopterella stenocera Rasnitsyn, 1975, from Upper Jurassic of Kazakhstan, to Choristopterella gen. nov. We place these three genera in the restored family Anomopterellidae and provide a key to known genera and species. Conclusions/Significance: Based on new fossil specimens and phylogenetic analyses, Praeaulacidae has the most basal position in Evanioidea and it is justifiable to restore Anomopterellidae Rasnitsyn, 1975 as a full family. Comparing the size of all described anomopterellids from China, Mongolia and Kazakhstan, we conclude that the species from China have larger bodies and forewings. Diversity of the Praeaulacidae and Anomopterellidae in the late Middle Jurassic of Daohugou suggests that Evanioidea appeared at least before the late Middle Jurassic.	[Li, Longfeng; Shih, Chungkun; Ren, Dong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Rasnitsyn, Alexandr P.] Russian Acad Sci, Inst Paleontol, Moscow V71, Russia; [Rasnitsyn, Alexandr P.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England	Capital Normal University; Russian Academy of Sciences; Natural History Museum London	Ren, D (corresponding author), Capital Normal Univ, Coll Life Sci, 105 Xisanhuanbeilu, Beijing, Peoples R China.	rendong@mail.cnu.edu.cn	Rasnitsyn, Alexandr/P-2393-2015	Rasnitsyn, Alexandr/0000-0002-6350-0040	National Natural Science Foundation of China [31071964, 40872022]; Beijing Natural Science Foundation Program [5082002]; Key Project of Beijing Municipal Commission of Education; Presidium RAS Program "Origin of biosphere and evolution of the geo-biological systems"	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation Program(Beijing Natural Science Foundation); Key Project of Beijing Municipal Commission of Education(Beijing Municipal Commission of Education); Presidium RAS Program "Origin of biosphere and evolution of the geo-biological systems"	This program of research has been financially supported by the National Natural Science Foundation of China (No. 31071964, 40872022), Beijing Natural Science Foundation Program (No. 5082002), and Key Project of Beijing Municipal Commission of Education. For Alexandr P. Rasnitsyn, this work was partially supported by the Presidium RAS Program "Origin of biosphere and evolution of the geo-biological systems." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[陈文 Chen Wen], 2004, [地质通报, Geological Bulletin of China], V23, P1165; Gao TP, 2011, ACTA GEOL SIN-ENGL, V85, P528, DOI 10.1111/j.1755-6724.2011.00447.x; Gao TP, 2009, ZOOTAXA, P52, DOI 10.11646/zootaxa.2094.1.6; Gao TP, 2009, ANN ENTOMOL SOC AM, V102, P588, DOI 10.1603/008.102.0402; Goloboff PA., 1997, NONAME NONA VERSION; Gu JJ, 2012, P NATL ACAD SCI USA, V109, P3868, DOI 10.1073/pnas.1118372109; Li Long-Feng, 2012, Acta Zootaxonomica Sinica, V37, P848; Nel A, 2004, GEOL ACTA, P67; Nixon K.C., 2002, WINCLADA VERSION 1 0; Oberprieler SK, 2012, ZOOTAXA, P47; Penalver E, 2010, ACTA GEOL SIN-ENGL, V84, P809, DOI 10.1111/j.1755-6724.2010.00257.x; Rasnitsyn A. P., 2008, Russian Entomological Journal, V17, P299; Rasnitsyn A.P., 1969, T PALEONTOLOGICAL I, V123, P1; Rasnitsyn A.P., 1975, T PALEONTOLOGICHESKO, V147, P1; Rasnitsyn A. P., 1980, T PAL I, P174; Rasnitsyn AP, 2010, ACTA GEOL SIN-ENGL, V84, P834, DOI 10.1111/j.1755-6724.2010.00254.x; RASNITSYN AP, 1988, ORIENT INSECTS, V22, P115, DOI 10.1080/00305316.1988.11835485; Rasnitsyn AP., 1972, PALEONTOL J, V6, P62; Rasnitsyn AP., 1973, PALEONTOL J+, V1, P1; Rasnitsyn AP, 1983, PALEONTOL ZH, V42, P269; Ren D, 2002, ANN ZOOL, V52, P207; Ren D., 2010, SILENT STORIES INSEC; [任东 Ren Dong], 2002, [地质通报, Geological Bulletin of China], V21, P584; Roderic D. M., 2001, NEXUS DATA VERSION 0; Ronquist F, 1999, ZOOL SCR, V28, P13, DOI 10.1046/j.1463-6409.1999.00023.x; Shih CK, 2011, ANN ENTOMOL SOC AM, V104, P1334, DOI 10.1603/AN10194; Shih CK, 2010, ANN ENTOMOL SOC AM, V103, P875, DOI 10.1603/AN09043; Shih CK, 2009, ANN ENTOMOL SOC AM, V102, P20, DOI 10.1603/008.102.0103; Wang M, 2012, ZOOTAXA, P82; Wang YJ, 2012, P NATL ACAD SCI USA, V109, P20514, DOI 10.1073/pnas.1205517109; Yang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044762; Yao YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037289; Zhang HC, 2007, INSECT SYST EVOL, V38, P149, DOI 10.1163/187631207788783987; Zhang HC, 2007, CRETACEOUS RES, V28, P310, DOI 10.1016/j.cretres.2006.05.003; Zhang HC, 2008, J SYST PALAEONTOL, V6, P463, DOI 10.1017/S1477201907002428; Zhang JF, 2004, CRETACEOUS RES, V25, P797, DOI 10.1016/j.cretres.2004.08.001	36	16	16	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82587	10.1371/journal.pone.0082587	http://dx.doi.org/10.1371/journal.pone.0082587			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340047	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400087
J	Otani, J; Kimura, H; Sharif, J; Endo, TA; Mishima, Y; Kawakami, T; Koseki, H; Shirakawa, M; Suetake, I; Tajima, S				Otani, Junji; Kimura, Hironobu; Sharif, Jafar; Endo, Takaho A.; Mishima, Yuichi; Kawakami, Toru; Koseki, Haruhiko; Shirakawa, Masahiro; Suetake, Isao; Tajima, Shoji			Cell Cycle-Dependent Turnover of 5-Hydroxymethyl Cytosine in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; DNA METHYLTRANSFERASES DNMT3A; HEMI-METHYLATED DNA; ENZYMATIC-PROPERTIES; SELF-RENEWAL; SRA DOMAIN; 5-METHYLCYTOSINE; TET; RECOGNITION; MAINTENANCE	Hydroxymethylcytosine in the genome is reported to be an intermediate of demethylation. In the present study, we demonstrated that maintenance methyltransferase Dnmt1 scarcely catalyzed hemi-hydroxymethylated DNA and that the hemi-hydroxymethylated DNA was not selectively recognized by the SRA domain of Uhrf1, indicating that hydroxymethylcytosine is diluted in a replication-dependent manner. A high level of 5-hydroxymethylcytosine in mouse embryonic stem cells was produced from the methylcytosine supplied mainly by de novo-type DNA methyltransferases Dnmt3a and Dnmt3b. The promoter regions of the HoxA gene cluster showed a high hydroxymethylation level whilst the methylcytosine level was quite low, suggesting that methylated CpG is actively hydroxylated during proliferation. All the results indicate that removal and production of hydroxymethylcytosine are regulated in replication-dependent manners in mouse embryonic stem cells.	[Otani, Junji; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Nishikyo Ku, Kyoto, Japan; [Kimura, Hironobu; Mishima, Yuichi; Kawakami, Toru; Suetake, Isao; Tajima, Shoji] Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan; [Sharif, Jafar; Endo, Takaho A.; Koseki, Haruhiko] RIKEN Ctr Integrat Med Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Shirakawa, Masahiro; Suetake, Isao] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	Kyoto University; Osaka University; RIKEN; Japan Science & Technology Agency (JST)	Tajima, S (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka 565, Japan.	tajima@protein.osaka-u.ac.jp	Endo, Takaho/B-5763-2017; Kimura, Hironobu/B-3731-2010; Suetake, Isao/G-3144-2013; Suetake, Isao/D-4326-2009; Koseki, Haruhiko/I-3825-2014	Endo, Takaho/0000-0002-2801-2463; Suetake, Isao/0000-0002-1246-8474; Koseki, Haruhiko/0000-0001-8424-5854	Ministry of Education, Science, Sport and Culture; Japan Society for the Promotion of Science; CREST, Japan Science and Technology Agency; Grants-in-Aid for Scientific Research [24570153] Funding Source: KAKEN	Ministry of Education, Science, Sport and Culture; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CREST, Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grant-in-Aids from the Ministry of Education, Science, Sport and Culture to ST, and the Japan Society for the Promotion of Science to ST and IS. IS and MS were supported by a grant from CREST, Japan Science and Technology Agency. JO was supported by the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki A, 2001, NUCLEIC ACIDS RES, V29, P3506, DOI 10.1093/nar/29.17.3506; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Ficz G, 2011, NATURE, V473, P398, DOI 10.1038/nature10008; Frauer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021306; Gu TP, 2011, NATURE, V477, P606, DOI 10.1038/nature10443; Hackett JA, 2013, SCIENCE, V339, P448, DOI 10.1126/science.1229277; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hashimoto H, 2012, NUCLEIC ACIDS RES, V40, P4841, DOI 10.1093/nar/gks155; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Hirayama T, 2013, PROG MOL BIOL TRANSL, V116, P145, DOI 10.1016/B978-0-12-394311-8.00007-8; Huebert DJ, 2006, METHODS, V40, P365, DOI 10.1016/j.ymeth.2006.07.032; Inoue A, 2011, SCIENCE, V334, P194, DOI 10.1126/science.1212483; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jin P, 1998, J CELL BIOL, V141, P875, DOI 10.1083/jcb.141.4.875; Kimura H, 2004, MOL CELL BIOL, V24, P5710, DOI 10.1128/MCB.24.13.5710-5720.2004; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Montavon T, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0367; Morita S, 2012, INT J MOL SCI, V13, P8259, DOI 10.3390/ijms13078259; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Sakai Y, 2004, GENE EXPR PATTERNS, V5, P231, DOI 10.1016/j.modgep.2004.07.011; Sambrook J., 2001, MOL CLONING LAB MANU; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Spruijt CG, 2013, CELL, V152, P1146, DOI 10.1016/j.cell.2013.02.004; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Suetake I, 2003, J BIOCHEM, V133, P737, DOI 10.1093/jb/mvg095; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takeshima H, 2006, J BIOCHEM, V139, P503, DOI 10.1093/jb/mvj044; Takeshima H, 2008, J MOL BIOL, V383, P810, DOI 10.1016/j.jmb.2008.03.001; Takeshita K, 2011, P NATL ACAD SCI USA, V108, P9055, DOI 10.1073/pnas.1019629108; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Valinluck V, 2007, CANCER RES, V67, P946, DOI 10.1158/0008-5472.CAN-06-3123; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Wossidlo M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1240; Wu H, 2011, GENE DEV, V25, P2436, DOI 10.1101/gad.179184.111; Wu H, 2011, NATURE, V473, P389, DOI 10.1038/nature09934; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Zhang EM, 2005, BIOCHEM BIOPH RES CO, V333, P1171, DOI 10.1016/j.bbrc.2005.05.200	52	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82961	10.1371/journal.pone.0082961	http://dx.doi.org/10.1371/journal.pone.0082961			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340069	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400105
J	Roman, N; Christie, M; Swarbrick, CMD; Kobe, B; Forwood, JK				Roman, Noelia; Christie, Mary; Swarbrick, Crystall M. D.; Kobe, Bostjan; Forwood, Jade K.			Structural Characterisation of the Nuclear Import Receptor Importin Alpha in Complex with the Bipartite NLS of Prp20	PLOS ONE			English	Article							LOCALIZATION SIGNAL; CRYSTAL-STRUCTURE; RECOGNITION; TRANSPORT; SYSTEM; DOMAIN; BETA	The translocation of macromolecules into the nucleus is a fundamental eukaryotic process, regulating gene expression, cell division and differentiation, but which is impaired in a range of significant diseases including cancer and viral infection. The import of proteins into the nucleus is generally initiated by a specific, high affinity interaction between nuclear localisation signals (NLSs) and nuclear import receptors in the cytoplasm, and terminated through the disassembly of these complexes in the nucleus. For classical NLSs (cNLSs), this import is mediated by the importin-alpha (IMP alpha) adaptor protein, which in turn binds to IMP beta to mediate translocation of nuclear cargo across the nuclear envelope. The interaction and disassembly of import receptor: cargo complexes is reliant on the differential localisation of nucleotide bound Ran across the envelope, maintained in its low affinity, GDP-bound form in the cytoplasm, and its high affinity, GTP-bound form in the nucleus. This in turn is maintained by the differential localisation of Ran regulating proteins, with RanGAP in the cytoplasm maintaining Ran in its GDP-bound form, and RanGEF (Prp20 in yeast) in the nucleus maintaining Ran in its GTP-bound form. Here, we describe the 2.1 angstrom resolution x-ray crystal structure of IMP alpha in complex with the NLS of Prp20. We observe 1,091 A 2 of buried surface area mediated by an extensive array of contacts involving residues on armadillo repeats 2-7, utilising both the major and minor NLS binding sites of IMP alpha to contact bipartite NLS clusters (17)RAKKMSK(23) and (KR4)-K-3, respectively. One notable feature of the major site is the insertion of Prp20NLS Ala(18) between the P0 and P1 NLS sites, noted in only a few classical bipartite NLSs. This study provides a detailed account of the binding mechanism enabling Prp20 interaction with the nuclear import receptor, and additional new information for the interaction between IMP alpha and cargo.	[Roman, Noelia; Swarbrick, Crystall M. D.; Forwood, Jade K.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia; [Christie, Mary; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Inst Mol Biosci, Brisbane, Qld, Australia; [Christie, Mary; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld, Australia	Charles Sturt University; University of Queensland; University of Queensland	Forwood, JK (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW, Australia.	jforwood@csu.edu.au	Kobe, Bostjan/D-1292-2009; Forwood, Jade K/K-4123-2014	Kobe, Bostjan/0000-0001-9413-9166; Forwood, Jade K/0000-0003-3267-9997; Swarbrick, Crystall/0000-0002-9337-3361; Roman, Noelia/0000-0003-0856-2131; Christie, Mary/0000-0002-0955-665X	ARC	ARC(Australian Research Council)	Funding came from an ARC Federation Fellowship and an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Chang CW, 2013, TRAFFIC, V14, P1144, DOI 10.1111/tra.12098; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chook Y. M., 2010, BIOCHIM BIOPHYS ACTA, V1813, P1593; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; FLEISCHMANN M, 1991, MOL GEN GENET, V227, P417, DOI 10.1007/BF00273932; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Forwood JK, 2008, J MOL BIOL, V383, P772, DOI 10.1016/j.jmb.2008.07.090; Hahn S, 2008, J MOL BIOL, V379, P678, DOI 10.1016/j.jmb.2008.04.038; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Lee SJ, 2005, NATURE, V435, P693, DOI 10.1038/nature03578; Lonhienne TG, 2009, J BIOL CHEM, V284, P22549, DOI 10.1074/jbc.M109.019935; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Romanelli MG, 2002, EUR J BIOCHEM, V269, P2727, DOI 10.1046/j.1432-1033.2002.02942.x; Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116; Strambio-De-Castillia C, 2010, NAT REV MOL CELL BIO, V11, P490, DOI 10.1038/nrm2928; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Teh T, 1999, ACTA CRYSTALLOGR D, V55, P561, DOI 10.1107/S0907444998012943; Wagstaff KM, 2009, TRAFFIC, V10, P1188, DOI 10.1111/j.1600-0854.2009.00937.x; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wozniak R, 2010, CELL MOL LIFE SCI, V67, P2215, DOI 10.1007/s00018-010-0325-7	30	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82038	10.1371/journal.pone.0082038	http://dx.doi.org/10.1371/journal.pone.0082038			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339986	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400056
J	Zechmann, M; Reese, S; Gobel, TW				Zechmann, Maria; Reese, Sven; Goebel, Thomas W.			Chicken CRTAM Binds Nectin-Like 2 Ligand and Is Upregulated on CD8(+) alpha beta and gamma delta T Lymphocytes with Different Kinetics	PLOS ONE			English	Article							LEUKOCYTE RECEPTOR COMPLEX; CELL-ASSOCIATED MOLECULE; MONOCLONAL-ANTIBODY; MULTIGENE FAMILY; NK-CELL; IDENTIFICATION; EXPRESSION; PROTEINS; ADHESION; ASSOCIATION	During a search for immunomodulatory receptors in the chicken genome, we identified a previously cloned chicken sequence as CRTAM homologue by its overall identity and several conserved sequence features. For further characterization, we generated a CRTAM specific mab. No staining was detectable in freshly isolated cell preparations from thymus, bursa, caecal tonsils, spleen, blood and intestine. Activation of splenocytes with recombinant IL-2 increased rapid CRTAM expression within a 2 h period on about 30% of the cells. These CRTAM(+) cells were identified as CD8(+) gamma delta T lymphocytes. In contrast, CRTAM expression could not be stimulated on PBL with IL-2, even within a 48 h stimulation period. As a second means of activation, T cell receptor (TCR) crosslinking using an anti-alpha beta-TCR induced CRTAM on both PBL and splenocytes. While CRTAM expression was again rapidly upregulated on splenocytes within 2 h, it took 48 h to reach maximum levels of CRTAM expression in PBL. Strikingly, albeit the stimulation of splenocytes was performed with anti-alpha beta-TCR, CRTAM expression after 2 h was mainly restricted to CD8(+) gamma delta T lymphocytes, however, the longer anti-TCR stimulation of peripheral blood lymphocytes (PBL) resulted in CRTAM expression on alpha beta T lymphocytes. In order to characterize the potential ligand we cloned and expressed chicken Necl-2, a member of the nectin and nectin-like family which is highly homologous to its mammalian counterpart. Three independent assays including a reporter assay, staining with a CRTAM-Ig fusion protein and a cell conjugate assay confirmed the interaction of CRTAM with Necl-2 which could also be blocked by a soluble CRTAM-Ig fusion protein or a CRTAM specific mab. These results suggest that chicken CRTAM represents an early activation antigen on CD8(+) T cells which binds to Necl-2 and is upregulated with distinct kinetics on alpha beta versus gamma delta T lymphocytes.	[Zechmann, Maria; Goebel, Thomas W.] Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany; [Reese, Sven] Univ Munich, Dept Vet Sci, Inst Anat Histol & Embryol, Munich, Germany	University of Munich; University of Munich	Gobel, TW (corresponding author), Univ Munich, Dept Vet Sci, Inst Anim Physiol, Munich, Germany.	goebel@lmu.de	Reese, Sven/F-1826-2016	Reese, Sven/0000-0002-4605-9791	Deutsche Forschungsgemeinschaft (DFG) [GO489/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft (DFG) grant number GO489/5-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez Y, 2008, MOL IMMUNOL, V45, P253, DOI 10.1016/j.molimm.2007.05.006; Arase N, 2005, INT IMMUNOL, V17, P1227, DOI 10.1093/intimm/dxh299; Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356; Boles KS, 2005, BLOOD, V106, P779, DOI 10.1182/blood-2005-02-0817; Chan CJ, 2012, CURR OPIN IMMUNOL, V24, P246, DOI 10.1016/j.coi.2012.01.009; CHAN MM, 1988, J IMMUNOL, V140, P2133; CHAR D, 1990, J IMMUNOL, V145, P3547; Chen CH, 1996, CURR TOP MICROBIOL, V212, P37; CHEN CH, 1988, EUR J IMMUNOL, V18, P539, DOI 10.1002/eji.1830180408; CHEN CH, 1989, P NATL ACAD SCI USA, V86, P2351, DOI 10.1073/pnas.86.7.2351; CHEN CLH, 1986, J EXP MED, V164, P375, DOI 10.1084/jem.164.1.375; CIHAK J, 1988, EUR J IMMUNOL, V18, P533, DOI 10.1002/eji.1830180407; Dessarth B, 2013, J IMMUNOL, V190, P4868, DOI 10.4049/jimmunol.1202596; Diaz-Coranguez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060655; Du Pasquier L, 2004, CR BIOL, V327, P591, DOI 10.1016/j.crvi.2004.04.004; Fuchs A, 2006, SEMIN CANCER BIOL, V16, P359, DOI 10.1016/j.semcancer.2006.07.002; Fukuhara H, 2003, ONCOGENE, V22, P6160, DOI 10.1038/sj.onc.1206744; Galibert L, 2005, J BIOL CHEM, V280, P21955, DOI 10.1074/jbc.M502095200; Garay E, 2010, J CELL BIOCHEM, V111, P111, DOI 10.1002/jcb.22673; Gobel TW, 2003, J IMMUNOL, V171, P1809, DOI 10.4049/jimmunol.171.4.1809; Gobel TWF, 1996, EUR J IMMUNOL, V26, P1743, DOI 10.1002/eji.1830260812; Gobel TWF, 2000, METH MOL B, V121, P337; Gobel TWF, 2001, INT IMMUNOL, V13, P757, DOI 10.1093/intimm/13.6.757; Hung AY, 2002, J BIOL CHEM, V277, P5699, DOI 10.1074/jbc.R100065200; KARTTUNEN J, 1991, P NATL ACAD SCI USA, V88, P3972, DOI 10.1073/pnas.88.9.3972; KASAHARA Y, 1993, EUR J IMMUNOL, V23, P2230, DOI 10.1002/eji.1830230927; Kennedy J, 2000, J LEUKOCYTE BIOL, V67, P725, DOI 10.1002/jlb.67.5.725; Koskinen R, 1998, J IMMUNOL, V160, P4943; Patino-Lopez G, 2006, J NEUROIMMUNOL, V171, P145, DOI 10.1016/j.jneuroim.2005.09.017; Purzel J, 2009, J IMMUNOL, V183, P4554, DOI 10.4049/jimmunol.0901699; Rogers SL, 2008, SEMIN IMMUNOL, V20, P353, DOI 10.1016/j.smim.2008.09.005; Rothwell CJ, 1996, VET IMMUNOL IMMUNOP, V55, P225, DOI 10.1016/S0165-2427(96)05635-8; Rubinstein R, 2013, STRUCTURE, V21, P766, DOI 10.1016/j.str.2013.02.022; Ruble DM, 2000, IMMUNOGENETICS, V51, P347, DOI 10.1007/s002510050629; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; SOWDER JT, 1988, J EXP MED, V167, P315, DOI 10.1084/jem.167.2.315; Straub C, 2013, DEV COMP IM IN PRESS; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TREGASKES CA, 1995, J IMMUNOL, V154, P4485; Viertlboeck BC, 2007, VET IMMUNOL IMMUNOP, V119, P137, DOI 10.1016/j.vetimm.2007.06.017; Viertlboeck BC, 2005, J IMMUNOL, V175, P385, DOI 10.4049/jimmunol.175.1.385; Viertlboeck BC, 2004, J IMMUNOL, V173, P7385, DOI 10.4049/jimmunol.173.12.7385; Viertlboeck BC, 2006, IMMUNOGENETICS, V58, P180, DOI 10.1007/s00251-006-0091-8; Viertlboeck BC, 2008, MOL IMMUNOL, V45, P2097, DOI 10.1016/j.molimm.2007.10.012; Viertlboeck BC, 2008, MOL IMMUNOL, V45, P1398, DOI 10.1016/j.molimm.2007.08.024; Viertlboeck BC, 2007, P NATL ACAD SCI USA, V104, P11718, DOI 10.1073/pnas.0702011104; Viertlboeck BC, 2011, VET IMMUNOL IMMUNOP, V144, P1, DOI 10.1016/j.vetimm.2011.07.001; Yageta M, 2002, CANCER RES, V62, P5129; Zucchetti I, 2009, IMMUNOGENETICS, V61, P463, DOI 10.1007/s00251-009-0373-z	49	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81942	10.1371/journal.pone.0081942	http://dx.doi.org/10.1371/journal.pone.0081942			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339981	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400053
J	Rao, XQ; Zhong, JX; Xu, XH; Jordan, B; Maurya, S; Braunstein, Z; Wang, TY; Huang, W; Aggarwal, S; Periasamy, M; Rajagopalan, S; Mehta, K; Sun, QH				Rao, Xiaoquan; Zhong, Jixin; Xu, Xiaohua; Jordan, Brianna; Maurya, Santosh; Braunstein, Zachary; Wang, Tse-Yao; Huang, Wei; Aggarwal, Sudha; Periasamy, Muthu; Rajagopalan, Sanjay; Mehta, Kamal; Sun, Qinghua			Exercise, Protects against Diet-Induced Insulin Resistance through Downregulation of Protein Kinase C beta in Mice	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; ADIPOSE-TISSUE; MITOCHONDRIAL DYSFUNCTION; MACROPHAGE INFILTRATION; CHRONIC INFLAMMATION; GLUCOSE-TRANSPORT; FAT; OBESITY; INTERLEUKIN-6; ACID	Physical exercise is an important and effective therapy for diabetes. However, its underlying mechanism is not fully understood. Protein kinase C beta (PKC beta) has been suggested to be involved in the pathogenesis of obesity and insulin resistance, but the role of PKC beta in exercise-induced improvements in insulin resistance is completely unknown. In this study, we evaluated the involvement of PKC beta in exercise-attenuated insulin resistance in high-fat diet (HFD)-fed mice. PKC beta(-/-) and wild-type mice were fed a HFD with or without exercise training. PKC protein expression, body and tissue weight change, glucose and insulin tolerance, metabolic rate, mitochondria size and number, adipose inflammation, and AKT activation were determined to evaluate insulin sensitivity and metabolic changes after intervention. PKC beta expression decreased in both skeletal muscle and liver tissue after exercise. Exercise and PKC beta deficiency can alleviate HFD-induced insulin resistance, as evidenced by improved insulin tolerance. In addition, fat accumulation and mitochondrial dysfunction induced by HFD were also ameliorated by both exercise and PKC beta deficiency. On the other hand, exercise had little effect on PKC beta(-/-) mice. Further, our data indicated improved activation of AKT, the downstream signal molecule of insulin, in skeletal muscle and liver of exercised mice, whereas PKC beta deficiency blunted the difference between sedentary and exercised mice. These results suggest that downregulation of PKC beta contributes to exercise-induced improvement of insulin resistance in HFD-fed mice.	[Rao, Xiaoquan; Xu, Xiaohua; Jordan, Brianna; Wang, Tse-Yao; Sun, Qinghua] Ohio State Univ, Coll Publ Hlth, Columbus, OH 43210 USA; [Zhong, Jixin; Braunstein, Zachary; Huang, Wei; Aggarwal, Sudha; Rajagopalan, Sanjay; Mehta, Kamal; Sun, Qinghua] Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Maurya, Santosh; Periasamy, Muthu] Ohio State Univ, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Huang, Wei; Aggarwal, Sudha; Mehta, Kamal] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Mehta, K (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	mehta.80@osu.edu; sun.224@osu.edu	Zhong, Jixin/ABE-3768-2020; Maurya, Santosh/O-9066-2017	Maurya, Santosh/0000-0002-7610-2463; Periasamy, Muthu/0000-0001-8834-5975; Rao, Xiaoquan/0000-0001-7316-4530; Zhong, Jixin/0000-0002-3534-7480	 [ES018900]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES018900, R56ES018900] Funding Source: NIH RePORTER	; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by ES018900 to Dr. Qinghua Sun. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2005, DIABETES, V54, P2188; Bal NC, 2012, NAT MED, V18, P1575, DOI 10.1038/nm.2897; Bhattacharya A, 2005, J NUTR, V135, P1124, DOI 10.1093/jn/135.5.1124; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bruun JM, 2006, AM J PHYSIOL-ENDOC M, V290, pE961, DOI 10.1152/ajpendo.00506.2005; Carhuatanta KAK, 2011, ENDOCRINOLOGY, V152, P2655, DOI 10.1210/en.2010-1340; COOPER DR, 1993, ENDOCRINOLOGY, V133, P2241, DOI 10.1210/en.133.5.2241; DEVLIN JT, 1987, DIABETES, V36, P434, DOI 10.2337/diabetes.36.4.434; Geraldes P, 2010, CIRC RES, V106, P1319, DOI 10.1161/CIRCRESAHA.110.217117; GOLDSTEIN MS, 1953, AM J PHYSIOL, V173, P212, DOI 10.1152/ajplegacy.1953.173.2.212; Goodyear LJ, 1998, ANNU REV MED, V49, P235, DOI 10.1146/annurev.med.49.1.235; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hennige AM, 2010, J CELL MOL MED, V14, P903, DOI 10.1111/j.1582-4934.2008.00629.x; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huang W, 2012, J LIPID RES, V53, P368, DOI 10.1194/jlr.M019687; Huang W, 2009, HEPATOLOGY, V49, P1525, DOI 10.1002/hep.22815; Ishizaka N, 2005, ARTERIOSCL THROM VAS, V25, P1038, DOI 10.1161/01.ATV.0000161274.87407.26; Itani SI, 2001, METABOLISM, V50, P553, DOI 10.1053/meta.2001.22512; Itani SI, 2000, DIABETES, V49, P1353, DOI 10.2337/diabetes.49.8.1353; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Leitges M, 1996, SCIENCE, V273, P788, DOI 10.1126/science.273.5276.788; Liu ML, 2010, BIOCHEM J, V425, P41, DOI 10.1042/BJ20091045; Moon MK, 2012, APPL PHYSIOL NUTR ME, V37, P631, DOI [10.1139/h2012-039, 10.1139/H2012-039]; Nicklas BJ, 2008, J AM GERIATR SOC, V56, P2045, DOI 10.1111/j.1532-5415.2008.01994.x; Niebauer J, 2005, EUR J HEART FAIL, V7, P189, DOI 10.1016/j.ejheart.2004.07.012; Oberbach A, 2008, EUR J ENDOCRINOL, V159, P129, DOI 10.1530/EJE-08-0220; Perseghin G, 1996, NEW ENGL J MED, V335, P1357, DOI 10.1056/NEJM199610313351804; Rall LC, 1996, MED SCI SPORT EXER, V28, P1356, DOI 10.1097/00005768-199611000-00003; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Tuttle KR, 2005, DIABETES CARE, V28, P2686, DOI 10.2337/diacare.28.11.2686; Webb BLJ, 2000, BRIT J PHARMACOL, V130, P1433, DOI 10.1038/sj.bjp.0703452; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu XH, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-40; Xu XH, 2011, AM J PHYSIOL-REG I, V300, pR1115, DOI 10.1152/ajpregu.00806.2010; Zhong J, 2012, DIABETES	41	17	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81364	10.1371/journal.pone.0081364	http://dx.doi.org/10.1371/journal.pone.0081364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349059	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200025
J	Finger, RP; Fenwick, E; Hirneiss, CW; Hsueh, A; Guymer, RH; Lamoureux, EL; Keeffe, JE				Finger, Robert P.; Fenwick, Eva; Hirneiss, Christoph W.; Hsueh, Arthur; Guymer, Robyn H.; Lamoureux, Ecosse L.; Keeffe, Jill E.			Visual Impairment as a Function of Visual Acuity in Both Eyes and Its Impact on Patient Reported Preferences	PLOS ONE			English	Article							QUALITY-OF-LIFE; MACULAR DEGENERATION; CONTRAST SENSITIVITY; COST-EFFECTIVENESS; VISION; UTILITY; VALUATIONS; SURGERY; EUROQOL	Purpose: To assess the impact of VA loss on patient reported utilities taking both eyes into account compared to taking only the better or the worse eye into account. Methods: In this cross-sectional study 1085 patients and 254 controls rated preferences with the generic health-related (EQ-5D; n = 868) and vision-specific (Vision and Quality of Life Index (VisQoL); n = 837) multi-attribute utility instruments (MAUIs). Utilities were calculated for three levels of VA in the better and worse eyes, as well as for 6 different vision states based on combinations of the better and worse eye VA. Results: Using the VisQoL, utility scores decreased significantly with deteriorating vision in both the better and worse eyes when analysed separately. When stratified by the 6 vision states, VisQoL utilities decreased as VA declined in the worse eye despite stable VA in the better eye. Differences in VisQoL scores were statistically significant for cases where the better eye had no vision impairment and the worse seeing fellow eye had mild, moderate or severe vision impairment. In contrast, the EQ-5D failed to capture changes in better or worse eye VA, or any of the six vision states. Conclusions: Calculating utilities based only on better eye VA or using a generic MAUI is likely to underestimate the impact of vision impairment, particularly when the better eye has no or little VA loss and the worse eye is moderately to severely visually impaired. These findings have considerable implications for the assessment of overall visual impairment as well as economic evaluations within eye health.	[Finger, Robert P.; Fenwick, Eva; Guymer, Robyn H.; Lamoureux, Ecosse L.; Keeffe, Jill E.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Finger, Robert P.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Lamoureux, Ecosse L.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore; [Hirneiss, Christoph W.] Univ Munich, Dept Ophthalmol, Munich, Germany; [Hsueh, Arthur] Univ Melbourne, Sch Populat Hlth, Ctr Hlth Policy Programs & Econ, Melbourne, Vic, Australia	Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Bonn; National University of Singapore; Singapore National Eye Center; University of Munich; University of Melbourne	Finger, RP (corresponding author), Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia.	robertfinger@gmx.net	Lamoureux, Ecosse/Z-5482-2019	Guymer, Robyn/0000-0002-9441-4356; Finger, Robert P/0000-0003-4253-7597	German Research Council [DFG FI 1540/5-1]; National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence [529923]; NHMRC [590205]; Victorian Government; Novartis Pharma Germany	German Research Council(German Research Foundation (DFG)); National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government; Novartis Pharma Germany	This work was in part supported by the German Research Council (DFG FI 1540/5-1, grant to RPF), by the National Health and Medical Research Council (NHMRC) Centre for Clinical Research Excellence #529923, and NHMRC project grant 590205, NHMRC practitioner fellowship (RG). CERA receives Operational Infrastructure Support from the Victorian Government. Additional support by grants of Novartis Pharma Germany to CWH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansback N, 2007, EYE, V21, P1455, DOI 10.1038/sj.eye.6702636; Bansback N, 2007, QUAL LIFE RES, V16, P533, DOI 10.1007/s11136-006-9126-8; Bourne R, 2012, ARCH OPHTHALMOL-CHIC, V130, P645, DOI 10.1001/archophthalmol.2012.1032; Bressler NM, 2010, OPHTHALMOLOGY, V117, P747, DOI 10.1016/j.ophtha.2009.09.002; Brown G C, 1999, Trans Am Ophthalmol Soc, V97, P473; Brown G C, 2001, Trans Am Ophthalmol Soc, V99, P199; Brown M M, 1999, Curr Opin Ophthalmol, V10, P221, DOI 10.1097/00055735-199906000-00012; Brown MM, 2001, OPHTHALMOLOGY, V108, P643, DOI 10.1016/S0161-6420(00)00635-7; Devlin NJ, 2003, HEALTH ECON, V12, P529, DOI 10.1002/hec.741; Dolan P, 1997, MED CARE, V35, P1095, DOI 10.1097/00005650-199711000-00002; Espallargues M, 2005, INVEST OPHTH VIS SCI, V46, P4016, DOI 10.1167/iovs.05-0072; Eye Care Comparative Effectiveness, 2011, JPN J OPHTHALMOL, V55, P333, DOI 10.1007/s10384-011-0041-3; Fenwick EK, 2012, INVEST OPHTH VIS SCI, V53, P677, DOI 10.1167/iovs.11-8992; Finger R, 2012, BRIT J OPHTHALMOLOGY; Finger R, 2012, BRIT J OPHTHALMOL, V96, P997, DOI 10.1136/bjophthalmol-2011-301201; Hirneiss C, 2006, OPHTHALMOLOGE, V103, P109, DOI 10.1007/s00347-005-1252-0; Hirneiss C, 2007, BRIT J OPHTHALMOL, V91, P481, DOI 10.1136/bjo.2006.102376; Holton H, 2009, ACTA OPHTHALMOL; Hurley Susan F, 2008, Cost Eff Resour Alloc, V6, P12, DOI 10.1186/1478-7547-6-12; Misajon RA, 2005, INVEST OPHTH VIS SCI, V46, P4007, DOI 10.1167/iovs.04-1389; Mitchell P, 2011, PHARMACOECONOMICS, V29, P107, DOI 10.2165/11585520-000000000-00000; National Institute for Health and Clinical Excellence (NICE), 2007, NICE ISS IN PRESS; Peacock S, 2008, OPHTHAL EPIDEMIOL, V15, P218, DOI 10.1080/09286580801979417; Sharma S, 2000, CAN J OPHTHALMOL, V35, P267, DOI 10.1016/S0008-4182(00)80077-0; Vu HTV, 2005, BRIT J OPHTHALMOL, V89, P360, DOI 10.1136/bjo.2004.047498; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	26	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81042	10.1371/journal.pone.0081042	http://dx.doi.org/10.1371/journal.pone.0081042			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339893	Green Published, gold			2022-12-27	WOS:000328566100027
J	Freeman, LA; Kleypas, JA; Miller, AJ				Freeman, Lauren A.; Kleypas, Joan A.; Miller, Arthur J.			Coral Reef Habitat Response to Climate Change Scenarios	PLOS ONE			English	Article							BIODIVERSITY; SUITABILITY; SHIFTS	Coral reef ecosystems are threatened by both climate change and direct anthropogenic stress. Climate change will alter the physico-chemical environment that reefs currently occupy, leaving only limited regions that are conducive to reef habitation. Identifying these regions early may aid conservation efforts and inform decisions to transplant particular coral species or groups. Here a species distribution model (Maxent) is used to describe habitat suitable for coral reef growth. Two climate change scenarios (RCP4.5, RCP8.5) from the National Center for Atmospheric Research's Community Earth System Model were used with Maxent to determine environmental suitability for corals (order Scleractinia). Environmental input variables best at representing the limits of suitable reef growth regions were isolated using a principal component analysis. Climate-driven changes in suitable habitat depend strongly on the unique region of reefs used to train Maxent. Increased global habitat loss was predicted in both climate projections through the 21st century. A maximum habitat loss of 43% by 2100 was predicted in RCP4.5 and 82% in RCP8.5. When the model is trained solely with environmental data from the Caribbean/Atlantic, 83% of global habitat was lost by 2100 for RCP4.5 and 88% was lost for RCP8.5. Similarly, global runs trained only with Pacific Ocean reefs estimated that 60% of suitable habitat would be lost by 2100 in RCP4.5 and 90% in RCP8.5. When Maxent was trained solely with Indian Ocean reefs, suitable habitat worldwide increased by 38% in RCP4.5 by 2100 and 28% in RCP8.5 by 2050. Global habitat loss by 2100 was just 10% for RCP8.5. This projection suggests that shallow tropical sites in the Indian Ocean basin experience conditions today that are most similar to future projections of worldwide conditions. Indian Ocean reefs may thus be ideal candidate regions from which to select the best strands of coral for potential re-seeding efforts.	[Freeman, Lauren A.; Miller, Arthur J.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Kleypas, Joan A.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; National Center Atmospheric Research (NCAR) - USA	Freeman, LA (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	lfranck@ucsd.edu		Miller, Arthur/0000-0003-3459-2676	NSF IGERT fellowship under the "Global Change, Marine Ecosystems and Society" program at SIO [0903551]; MCR-SBC-CCE LTER collaboration; NSF [OCE06-47815, OCE-0960770, CCE-LTER: OCE-0417616, OCE1026607]; Division Of Ocean Sciences [1026607] Funding Source: National Science Foundation	NSF IGERT fellowship under the "Global Change, Marine Ecosystems and Society" program at SIO; MCR-SBC-CCE LTER collaboration; NSF(National Science Foundation (NSF)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	LAF was supported by an NSF IGERT fellowship under the "Global Change, Marine Ecosystems and Society" program at SIO (0903551) and received partial support from a joint MCR-SBC-CCE LTER collaboration. AJM gratefully acknowledges funding from NSF (OCE06-47815, OCE-0960770, and CCE-LTER: OCE-0417616 and OCE1026607). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Bridge T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048203; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Cheung WWL, 2009, FISH FISH, V10, P235, DOI 10.1111/j.1467-2979.2008.00315.x; Coles S.L., 1992, P147; Couce E, 2012, J BIOGEOGR, P1; Davies AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018483; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dobrowski SZ, 2011, ECOL MONOGR, V81, P241, DOI 10.1890/10-1325.1; Freeman LA, 2012, ENV ENTOMOL J GEOPHY, V117; Frieler K., 2012, NAT CLIM CHANGE, DOI DOI 10.1038/NCLIMATE1674; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; GLYNN PW, 1993, CORAL REEFS, V12, P1, DOI 10.1007/BF00303779; Guinotte JM, 2003, CORAL REEFS, V22, P551, DOI 10.1007/s00338-003-0331-4; Hellmann JJ, 2013, ENCY BIODIVERSITY, P236; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Kleypas JA, 1999, AM ZOOL, V39, P146; Kleypas JA, 2009, OCEANOGRAPHY, V22, P108, DOI 10.5670/oceanog.2009.101; Kreyling J, 2011, RESTOR ECOL, V19, P433, DOI 10.1111/j.1526-100X.2011.00777.x; Kumar S., 2009, J ECOLOGY NATURAL EN, V1, P94, DOI 10.5897/ JENE.9000071; Langdon C, 2000, GLOBAL BIOGEOCHEM CY, V14, P639, DOI 10.1029/1999GB001195; Long MC, 2013, J CLIMATE, V26, P6775, DOI 10.1175/JCLI-D-12-00184.1; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marsh ND, 2000, PHYS REV LETT, V85, P5004, DOI 10.1103/PhysRevLett.85.5004; McClanahan TR, 2005, MAR ECOL PROG SER, V298, P131, DOI 10.3354/meps298131; McManus JW, 2004, PROG OCEANOGR, V60, P263, DOI 10.1016/j.pocean.2004.02.014; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Mumby PJ, 2004, MAR POLLUT BULL, V48, P219, DOI 10.1016/j.marpolbul.2003.10.031; Pereira HM, 2010, SCIENCE, V330, P1496, DOI 10.1126/science.1196624; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Precht WF, 2004, FRONT ECOL ENVIRON, V2, P307; Redfield A. C., 1934, PROPORTIONS ORGANIC, P176; ReefBase, 2013, GLOB INF SYST COR RE; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Riegl B, 2003, INT J EARTH SCI, V92, P520, DOI 10.1007/s00531-003-0328-9; Riegl BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024802; Schwartz MW, 2012, BIOSCIENCE, V62, P732, DOI 10.1525/bio.2012.62.8.6; Silverman J, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003770; Silverman J, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036282; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Teneva L, 2012, CORAL REEFS, V31, P1, DOI 10.1007/s00338-011-0812-9; Tittensor DP, 2009, J BIOGEOGR, V36, P1111, DOI 10.1111/j.1365-2699.2008.02062.x; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Weil E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P465, DOI 10.1007/978-94-007-0114-4_27; Yamano H, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046474; Yesson C, 2012, J BIOGEOGR, V39, P1278, DOI 10.1111/j.1365-2699.2011.02681.x	49	43	46	4	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82404	10.1371/journal.pone.0082404	http://dx.doi.org/10.1371/journal.pone.0082404			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340025	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100104
J	Nippert, JB; Ocheltree, TW; Orozco, GL; Ratajczak, Z; Ling, BH; Skibbe, AM				Nippert, Jesse B.; Ocheltree, Troy W.; Orozco, Graciela L.; Ratajczak, Zak; Ling, Bohua; Skibbe, Adam M.			Evidence of Physiological Decoupling from Grassland Ecosystem Drivers by an Encroaching Woody Shrub	PLOS ONE			English	Article							MESIC GRASSLAND; C-4 GRASSLAND; PLANT ENCROACHMENT; N AVAILABILITY; LAND-USE; SAVANNA; FIRE; EXPANSION; CARBON; DYNAMICS	Shrub encroachment of grasslands is a transformative ecological process by which native woody species increase in cover and frequency and replace the herbaceous community. Mechanisms of encroachment are typically assessed using temporal data or experimental manipulations, with few large spatial assessments of shrub physiology. In a mesic grassland in North America, we measured inter-and intra-annual variability in leaf delta C-13 in Cornus drummondii across a grassland landscape with varying fire frequency, presence of large grazers and topographic variability. This assessment of changes in individual shrub physiology is the largest spatial and temporal assessment recorded to date. Despite a doubling of annual rainfall (in 2008 versus 2011), leaf delta C-13 was statistically similar among and within years from 2008-11 (range of 228 to 227%). A topography*grazing interaction was present, with higher leaf delta C-13 in locations that typically have more bare soil and higher sensible heat in the growing season (upland topographic positions and grazed grasslands). Leaf delta C-13 from slopes varied among grazing contrasts, with upland and slope leaf delta C-13 more similar in ungrazed locations, while slopes and lowlands were more similar in grazed locations. In 2011, canopy greenness (normalized difference vegetation index - NDVI) was assessed at the centroid of individual shrubs using high-resolution hyperspectral imagery. Canopy greenness was highest mid-summer, likely reflecting temporal periods when C assimilation rates were highest. Similar to patterns seen in leaf delta C-13, NDVI was highest in locations that typically experience lowest sensible heat (lowlands and ungrazed). The ability of Cornus drummondii to decouple leaf physiological responses from climate variability and fire frequency is a likely contributor to the increase in cover and frequency of this shrub species in mesic grassland and may be generalizable to other grasslands undergoing woody encroachment.	[Nippert, Jesse B.; Ocheltree, Troy W.; Orozco, Graciela L.; Ratajczak, Zak; Skibbe, Adam M.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Ocheltree, Troy W.] Colorado State Univ, Dept Forest & Rangeland Stewardship, Ft Collins, CO 80523 USA; [Ling, Bohua] Kansas State Univ, Dept Geog, Manhattan, KS 66506 USA	Kansas State University; Colorado State University; Kansas State University	Nippert, JB (corresponding author), Kansas State Univ, Div Biol, Ackert Hall, Manhattan, KS 66506 USA.	nippert@ksu.edu		Nippert, Jesse/0000-0002-7939-342X; Ratajczak, Zak/0000-0002-4675-5738	NSF-LTER award [DEB-0823341]; Kansas State University Open Access Publishing Fund; KSU McNair scholars program	NSF-LTER award; Kansas State University Open Access Publishing Fund; KSU McNair scholars program	This work was supported by the NSF-LTER award to the Konza Prairie (DEB-0823341). Publication of this article was funded in part by the Kansas State University Open Access Publishing Fund. GLO was supported by the KSU McNair scholars program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranjuelo I, 2011, OECOLOGIA, V167, P339, DOI 10.1007/s00442-011-1996-y; ARCHER S, 1995, CLIMATIC CHANGE, V29, P91, DOI 10.1007/BF01091640; Bai E, 2008, OECOLOGIA, V156, P479, DOI 10.1007/s00442-008-1003-4; Bai E, 2013, ECOSPHERE, V4, DOI 10.1890/ES12-00187.1; Blair JM, 1997, ECOLOGY, V78, P2359, DOI 10.1890/0012-9658(1997)078[2359:FNAAPR]2.0.CO;2; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Brandt JS, 2013, BIOL CONSERV, V158, P116, DOI 10.1016/j.biocon.2012.07.026; Briggs JM, 2005, BIOSCIENCE, V55, P243, DOI 10.1641/0006-3568(2005)055[0243:AEITCA]2.0.CO;2; Briggs JM, 2002, ECOSYSTEMS, V5, P578, DOI 10.1007/s10021-002-0187-4; Buitenwerf R, 2012, GLOBAL CHANGE BIOL, V18, P675, DOI 10.1111/j.1365-2486.2011.02561.x; Collins SL, 2012, J VEG SCI, V23, P563, DOI 10.1111/j.1654-1103.2011.01369.x; Collins SL, 2002, OIKOS, V99, P571, DOI 10.1034/j.1600-0706.2002.12112.x; Craine JM, 2014, ECOSYSTEMS, V17, P54, DOI 10.1007/s10021-013-9706-8; Craine JM, 2012, PLANT SOIL, V356, P395, DOI 10.1007/s11104-012-1141-7; D'Odorico P, 2013, GLOBAL ECOL BIOGEOGR, V22, P364, DOI 10.1111/geb.12000; D'Odorico P, 2012, ECOHYDROLOGY, V5, P520, DOI 10.1002/eco.259; D'Odorico P, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00073.1; Dawson TE, 2002, ANNU REV ECOL SYST, V33, P507, DOI 10.1146/annurev.ecolsys.33.020602.095451; Dodd MB, 1998, OECOLOGIA, V117, P504, DOI 10.1007/s004420050686; Eggemeyer KD, 2009, TREE PHYSIOL, V29, P157, DOI 10.1093/treephys/tpn019; Eggemeyer KD, 2009, ECOHYDROLOGY, V2, P81, DOI 10.1002/eco.42; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gibbens RP, 2005, J ARID ENVIRON, V61, P651, DOI 10.1016/j.jaridenv.2004.10.001; Heisler JL, 2004, ECOLOGY, V85, P2245, DOI 10.1890/03-0574; Heisler JL, 2003, AM J BOT, V90, P423, DOI 10.3732/ajb.90.3.423; Higgins SI, 2012, NATURE, V488, P209, DOI 10.1038/nature11238; Huxman TE, 2005, ECOLOGY, V86, P308, DOI 10.1890/03-0583; Killian PD., 2012, THESIS KANSAS STATE; Knapp A.K., 1998, GRASSLAND DYNAMICS L, V1st; Knapp AK, 1999, BIOSCIENCE, V49, P39, DOI 10.2307/1313492; KNAPP AK, 1985, ECOLOGY, V66, P1309, DOI 10.2307/1939184; KNAPP AK, 1984, OECOLOGIA, V65, P35, DOI 10.1007/BF00384460; Knapp AK, 2008, GLOBAL CHANGE BIOL, V14, P615, DOI 10.1111/j.1365-2486.2007.01512.x; Lett MS, 2005, AM MIDL NAT, V153, P217, DOI 10.1674/0003-0031(2005)153[0217:WPEARI]2.0.CO;2; Lett MS, 2003, J VEG SCI, V14, P487, DOI 10.1111/j.1654-1103.2003.tb02175.x; Letts MG, 2010, BOTANY, V88, P850, DOI 10.1139/B10-054; Litvak M.E., 2011, ECOSYSTEM FUNCTION S, P117; McCarron JK, 2003, AM J BOT, V90, P1496, DOI 10.3732/ajb.90.10.1496; McCarron JK, 2001, AM J BOT, V88, P1818, DOI 10.2307/3558358; McKinley DC, 2008, ECOSYSTEMS, V11, P454, DOI 10.1007/s10021-008-9133-4; Nippert JB, 2007, OECOLOGIA, V153, P261, DOI 10.1007/s00442-007-0745-8; Nippert JB, 2007, ENVIRON EXP BOT, V60, P412, DOI 10.1016/j.envexpbot.2006.12.012; Nippert JB, 2011, OECOLOGIA, V166, P1131, DOI 10.1007/s00442-011-1948-6; Norris MD, 2007, AM MIDL NAT, V158, P432, DOI 10.1674/0003-0031(2007)158[432:AENDAA]2.0.CO;2; Pinheiro J., 2011, NLME LINEAR NONLINEA; Pinheiro J, 2001, MIXED EFFECTS MODELS; R Development Core Team, 2011, R LANG ENV STAT COMP; Ratajczak Z, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00212.1; Roques KG, 2001, J APPL ECOL, V38, P268, DOI 10.1046/j.1365-2664.2001.00567.x; SCHLESINGER WH, 1990, SCIENCE, V247, P1043, DOI 10.1126/science.247.4946.1043; Shaver GR, 2001, ECOLOGY, V82, P3163, DOI 10.1890/0012-9658(2001)082[3163:SCIWFT]2.0.CO;2; Sheffer M, 2009, CRITICAL TRANSITIONS; Staver AC, 2011, SCIENCE, V334, P230, DOI 10.1126/science.1210465; Throop HL, 2012, OECOLOGIA, V169, P373, DOI 10.1007/s00442-011-2217-4; Van Auken OW, 2000, ANNU REV ECOL SYST, V31, P197, DOI 10.1146/annurev.ecolsys.31.1.197; WALKER BH, 1981, J ECOL, V69, P473, DOI 10.2307/2259679; Weaver JohnJ., 1965, NATIVE VEGETATION NE; Weltzin JF, 1997, OECOLOGIA, V112, P156, DOI 10.1007/s004420050295; Wigley BJ, 2009, AFR J ECOL, V47, P62, DOI 10.1111/j.1365-2028.2008.01051.x	59	24	24	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81630	10.1371/journal.pone.0081630	http://dx.doi.org/10.1371/journal.pone.0081630			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339950	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100070
J	Shao, HW; Peng, T; Ji, ZW; Su, J; Zhou, XB				Shao, Hongwei; Peng, Tao; Ji, Zhiwei; Su, Jing; Zhou, Xiaobo			Systematically Studying Kinase Inhibitor Induced Signaling Network Signatures by Integrating Both Therapeutic and Side Effects	PLOS ONE			English	Article							CELL LUNG-CANCER; MATHEMATICAL-MODELS; CHECKPOINTS; KEGG; STEM; MAP	Substantial effort in recent years has been devoted to analyzing data based large-scale biological networks, which provide valuable insight into the topologies of complex biological networks but are rarely context specific and cannot be used to predict the responses of cell signaling proteins to specific ligands or compounds. In this work, we proposed a novel strategy to investigate kinase inhibitor induced pathway signatures by integrating multiplex data in Library of Integrated Network-based Cellular Signatures (LINCS), e.g. KINOMEscan data and cell proliferation/mitosis imaging data. Using this strategy, we first established a PC9 cell line specific pathway model to investigate the pathway signatures in PC9 cell line when perturbed by a small molecule kinase inhibitor GW843682. This specific pathway revealed the role of PI3K/AKT in modulating the cell proliferation process and the absence of two anti-proliferation links, which indicated a potential mechanism of abnormal expansion in PC9 cell number. Incorporating the pathway model for side effects on primary human hepatocytes, it was used to screen 27 kinase inhibitors in LINCS database and PF02341066, known as Crizotinib, was finally suggested with an optimal concentration 4.6 uM to suppress PC9 cancer cell expansion while avoiding severe damage to primary human hepatocytes. Drug combination analysis revealed that the synergistic effect region can be predicted straightforwardly based on a threshold which is an inherent property of each kinase inhibitor. Furthermore, this integration strategy can be easily extended to other specific cell lines to be a powerful tool for drug screen before clinical trials.	[Shao, Hongwei; Ji, Zhiwei; Su, Jing; Zhou, Xiaobo] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Shao, Hongwei] Univ Sci & Technol China, Dept Modern Mech, Hefei 230026, Anhui, Peoples R China; [Peng, Tao] Methodist Hosp, Res Inst, Dept Translat Imaging, Houston, TX 77030 USA	Wake Forest University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; The Methodist Hospital System; The Methodist Hospital - Houston	Zhou, XB (corresponding author), Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA.	xizhou@wakehealth.edu		Su, Jing/0000-0003-4917-6173	National Institutes of Health [U01HL111560-01]; NATIONAL CANCER INSTITUTE [U01CA166886] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health U01HL111560-01 (Zhou)(http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2008, MOL BIOL CELL, Vxxxiii, P1601; Alvarez M, 2007, EXPERT REV ANTICANC, V7, P1423, DOI 10.1586/14737140.7.10.1423; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Ellinger-Ziegelbauer H, 2000, GENES CELLS, V5, P491, DOI 10.1046/j.1365-2443.2000.00337.x; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Grendell JH, 2003, CURRENT DIAGNOSIS TR, Vxv; Gutenkunst RN, 2007, PLOS COMPUT BIOL, V3, P1871, DOI 10.1371/journal.pcbi.0030189; Heinrich R, 2002, MOL CELL, V9, P957, DOI 10.1016/S1097-2765(02)00528-2; Hendriks BS, 2010, BIOINFORMATICS, V26, P432, DOI 10.1093/bioinformatics/btp667; Jacobberger JW, 2008, CYTOM PART A, V73A, P5, DOI 10.1002/cyto.a.20501; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katayama K, 2005, MOL CELL BIOL, V25, P5725, DOI 10.1128/MCB.25.13.5725-5737.2005; Kirouac DC, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.49; LATT SA, 1975, J HISTOCHEM CYTOCHEM, V23, P493, DOI 10.1177/23.7.1095650; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Morohashi M, 2002, J THEOR BIOL, V216, P19, DOI 10.1006/jtbi.2002.2537; Morris MK, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001099; Mumoli N, 2006, NEW ENGL J MED, V354, P2192; Ou SHI, 2012, ONCOLOGIST, V17, P1351, DOI 10.1634/theoncologist.2012-0311; Patricelli MP, 2007, BIOCHEMISTRY-US, V46, P350, DOI 10.1021/bi062142x; Saez-Rodriguez J, 2008, BIOINFORMATICS, V24, P840, DOI 10.1093/bioinformatics/btn018; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; SRINIVAS M, 1994, IEEE T SYST MAN CYB, V24, P656, DOI 10.1109/21.286385; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tsui M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007339; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Vazquez A, 2003, NAT BIOTECHNOL, V21, P697, DOI 10.1038/nbt825; Walter SA, 2003, J BIOL CHEM, V278, P18221, DOI 10.1074/jbc.M212556200; Woolf PJ, 2005, BIOINFORMATICS, V21, P741, DOI 10.1093/bioinformatics/bti056; Xing JL, 2007, CANCER EPIDEM BIOMAR, V16, P1517, DOI 10.1158/1055-9965.EPI-07-0111; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	33	15	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80832	10.1371/journal.pone.0080832	http://dx.doi.org/10.1371/journal.pone.0080832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339888	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100023
J	Spena, G; D'Agata, F; Panciani, PP; di Monale, MB; Fontanella, MM				Spena, Giannantonio; D'Agata, Federico; Panciani, Pier Paolo; di Monale, Michela Buglione; Fontanella, Marco Maria			Supratentorial Gliomas in Eloquent Areas: Which Parameters Can Predict Functional Outcome and Extent of Resection?	PLOS ONE			English	Article							LOW-GRADE GLIOMA; PROGNOSTIC-FACTORS; GLIOBLASTOMA-MULTIFORME; MULTIVARIATE-ANALYSIS; II GLIOMA; SURVIVAL; SURGERY; TUMOR; COMPLICATIONS; ASSOCIATION	Background: To date, few parameters have been found that can aid in patient selection and surgical strategy for eloquent area gliomas. Aims: The aim of the study was to analyze preoperative and intraoperative factors that can predict functional outcome and extent of resection in eloquent area tumors. Patients and Methods: A retrospective analysis was conducted on 60 patients harboring supratentorial gliomas in eloquent areas undergoing awake surgery. The analysis considered clinical, neuroradiologic (morphologic), intraoperative, and postoperative factors. End-points were extent of resection (EOR) as well as functional short-and long-term outcome. Postoperatively, MRI objectively established the EOR. chi(2) analyses were used to evaluate parameters that could be predictive. Multivariate logistic regression analyses were used to evaluate the best combination to predict binary positive outcomes. Results: In 90% of the cases, subcortical stimulation was positive in the margins of the surgical cavity. Postoperatively, 51% of the patients deteriorated but 90% of the patients regained their preoperative neurological score. Factors negatively affecting EOR were volume, degree of subcortical infiltration, and presence of paresis (P<0.01). Sharp margins and cystic components were more amenable to gross total resection (P<0.01). Contrast enhancement (P<0.02), higher grade (P<0.01), paresis (P<0.01), and residual tumor in the cortex (P<0.02) negatively affected long-term functional outcomes, whereas postoperative deterioration could not be predicted for any factor other than paresis. Subcortical stimulation did not correlate with deterioration, both postoperatively (P<0.08) and at follow-up (P<0.042). Conclusions: Biological and morphological factors such as type of margins, volume, preoperative neurological status, cystic components, histology and the type of infiltration into the white matter must be considered when planning intraoperative mapping.	[Spena, Giannantonio; Panciani, Pier Paolo; Fontanella, Marco Maria] Spedali Civil Brescia, Dept Neurosurg, I-25125 Brescia, Italy; [Spena, Giannantonio; Panciani, Pier Paolo; Fontanella, Marco Maria] Univ Brescia, Brescia, Italy; [D'Agata, Federico] Univ Turin, Dept Psychol, Turin, Italy; [D'Agata, Federico] Univ Turin, Dept Neurosci, Turin, Italy; [di Monale, Michela Buglione] Spedali Civil Brescia, Dept Radiotherapy, I-25125 Brescia, Italy	Hospital Spedali Civili Brescia; University of Brescia; University of Turin; University of Turin; Hospital Spedali Civili Brescia	Spena, G (corresponding author), Spedali Civil Brescia, Dept Neurosurg, I-25125 Brescia, Italy.	giannantonios@hotmail.com	D'Agata, Federico/ABG-8839-2021; Buglione di Monale e Bastia, Michela/AAC-7240-2022; FONTANELLA, Marco Maria/AAD-1160-2022	D'Agata, Federico/0000-0001-9432-0248; FONTANELLA, Marco Maria/0000-0002-4023-1909; Fontanella, Marco/0000-0002-2084-0504; BUGLIONE DI MONALE E BASTIA, Michela/0000-0002-5485-1260				BERGER MS, 1994, CANCER, V74, P1784, DOI 10.1002/1097-0142(19940915)74:6<1784::AID-CNCR2820740622>3.0.CO;2-D; Bloch O, 2012, J NEUROSURG, V117, P1032, DOI 10.3171/2012.9.JNS12504; Brell M, 2000, ACTA NEUROCHIR, V142, P739, DOI 10.1007/s007010070088; Castellano A, 2012, NEURO-ONCOLOGY, V14, P192, DOI 10.1093/neuonc/nor188; Chang EF, 2008, J NEUROSURG, V109, P817, DOI 10.3171/JNS/2008/109/11/0817; Duffau H, 2005, LANCET NEUROL, V4, P476, DOI 10.1016/S1474-4422(05)70140-X; Duffau H, 2008, J NEUROSURG, V109, P461, DOI 10.3171/JNS/2008/109/9/0461; Duffau H, 2012, ACTA NEUROCHIR, V154, P569, DOI 10.1007/s00701-012-1275-7; Duffau Hugues, 2005, Expert Rev Neurother, V5, P473, DOI 10.1586/14737175.5.4.473; Gorlia T, 2008, LANCET ONCOL, V9, P29, DOI 10.1016/S1470-2045(07)70384-4; Gulati S, 2011, WORLD NEUROSURG, V76, P572, DOI 10.1016/j.wneu.2011.06.014; Hamer PCD, 2012, J CLIN ONCOL, V30, P2559, DOI 10.1200/JCO.2011.38.4818; Jakola AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051450; Jung TY, 2011, CLIN NEUROL NEUROSUR, V113, P752, DOI 10.1016/j.clineuro.2011.08.002; Keles GE, 2004, J NEUROSURG, V100, P369, DOI 10.3171/jns.2004.100.3.0369; Kilic T, 2002, J CLIN NEUROSCI, V9, P549, DOI 10.1054/jocn.2002.1136; Kim SS, 2009, NEUROSURGERY, V64, P836, DOI 10.1227/01.NEU.0000342405.80881.81; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Laws ER, 2003, J NEUROSURG, V99, P467, DOI 10.3171/jns.2003.99.3.0467; Majchrzak K, 2012, CLIN NEUROL NEUROSUR, V114, P1135, DOI 10.1016/j.clineuro.2012.02.054; Mandonnet E, 2007, NEURO-ONCOLOGY, V9, P63, DOI 10.1215/15228517-2006-015; McGirt MJ, 2008, NEUROSURGERY, V63, P700, DOI 10.1227/01.NEU.0000325729.41085.73; McGirt MJ, 2009, NEUROSURGERY, V65, P463, DOI 10.1227/01.NEU.0000349763.42238.E9; McGirt MJ, 2009, J NEUROSURG, V110, P156, DOI 10.3171/2008.4.17536; Mineo JF, 2007, ACTA NEUROCHIR, V149, P245, DOI 10.1007/s00701-006-1092-y; Pichlmeier U, 2008, NEURO-ONCOLOGY, V10, P1025, DOI 10.1215/15228517-2008-052; Pignatti F, 2002, J CLIN ONCOL, V20, P2076, DOI 10.1200/JCO.2002.08.121; Rezvan A, 2009, ACTA NEUROCHIR, V151, P1359, DOI 10.1007/s00701-009-0435-x; Robles SG, 2008, J NEUROSURG, V109, P615, DOI 10.3171/JNS/2008/109/10/0615; Sanai N, 2012, ADV EXP MED BIOL, V746, P12, DOI 10.1007/978-1-4614-3146-6_2; Sawaya R, 1998, NEUROSURGERY, V42, P1044, DOI 10.1097/00006123-199805000-00054; Shaw EG, 2008, J NEUROSURG, V109, P835, DOI 10.3171/JNS/2008/109/11/0835; Smith JS, 2008, J CLIN ONCOL, V26, P1338, DOI 10.1200/JCO.2007.13.9337; Spena G, 2010, ACTA NEUROCHIR, V152, P1835, DOI 10.1007/s00701-010-0764-9; Talos IF, 2006, RADIOLOGY, V239, P506, DOI 10.1148/radiol.2392050661; Yeh SA, 2005, BRIT J RADIOL, V78, P230, DOI 10.1259/bjr/28534346	36	28	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80916	10.1371/journal.pone.0080916	http://dx.doi.org/10.1371/journal.pone.0080916			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339890	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100025
J	Yu, PH; Chou, SF; Chen, CL; Hung, H; Lai, CY; Yang, PM; Jeng, YM; Liaw, SF; Kuo, HH; Hsu, HC; Chen, JY; Wang, WB				Yu, Ping-Hung; Chou, Shu-Fan; Chen, Chi-Long; Hung, Hung; Lai, Ching-Yu; Yang, Pei-Ming; Jeng, Yung-Ming; Liaw, Shwu-Fang; Kuo, Huan-Hsien; Hsu, Hey-Chi; Chen, Jen-Yang; Wang, Won-Bo			Upregulation of Endocan by Epstein-Barr Virus Latent Membrane Protein 1 and Its Clinical Significance in Nasopharyngeal Carcinoma	PLOS ONE			English	Article							CELL SPECIFIC MOLECULE-1; LYMPH-NODE METASTASIS; HUMAN CANCER-CELLS; NF-KAPPA-B; VASCULAR ENDOCAN; DNA-REPAIR; VEGF-A; EXPRESSION; MEMBRANE-PROTEIN-1; INDUCTION	Endocan (or called Esm-1) has been shown to have tumorigenic activities and its expression is associated with poor prognosis in various cancers. Latent membrane protein 1 (LMP1) is an Epstein-Barr virus (EBV)-encoded oncoprotein and has been shown to play an important role in the pathogenesis of EBV-associated nasopharyngeal carcinoma (NPC). To further understand the role of LMP1 in the pathogenesis of NPC, microarray analysis of LMP1-regulated genes in epithelial cells was performed. We found that endocan was one of the major cellular genes upregulated by LMP1. This induction of endocan by LMP1 was confirmed in several epithelial cell lines including an NPC cell line. Upregulation of endocan by LMP1 was found to be mediated through the CTAR1 and CTAR2 domains of LMP1 and through the LMP1-activated NF-kappa B, MEK-ERK and JNK signaling pathways. To study whether endocan was expressed in NPC and whether endocan expression was associated with LMP1 expression in NPC, the expression of endocan and LMP1 in tumor tissues from 42 NPC patients was evaluated by immunohistochemistry. Expression of endocan was found in 52% of NPC specimens. Significant correlation between LMP1 and endocan expression was observed (p<0.0001). Moreover, NPC patients with endocan expression were found to have a shorter survival than NPC patients without endocan expression (p=0.0104, log-rank test). Univariate and Multivariate analyses revealed that endocan was a potential prognostic factor for NPC. Finally, we demonstrated that endocan could stimulate the migration and invasion ability of endothelial cells and this activity of endocan was dependent on the glycan moiety and the phenylalanine-rich region of endocan. Together, these studies not only identify a new molecular marker that may predict the survival of NPC patients but also provide a new insight to the pathogenesis of NPC.	[Yu, Ping-Hung; Chou, Shu-Fan; Lai, Ching-Yu; Liaw, Shwu-Fang; Kuo, Huan-Hsien; Wang, Won-Bo] Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan; [Chen, Chi-Long] Taipei Medial Univ, Dept Pathol, Taipei, Taiwan; [Hung, Hung] Natl Taiwan Univ, Coll Publ Hlth, Grad Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Yang, Pei-Ming] Taipei Med Univ, Ph D Program Canc Biol & Drug Discovery, Coll Med Sci & Technol, Taipei, Taiwan; [Jeng, Yung-Ming; Hsu, Hey-Chi] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Chen, Jen-Yang] Natl Hlth Res Inst, Natl Inst Canc Res, Zhunan, Taiwan	National Taiwan University; National Taiwan University; Taipei Medical University; National Taiwan University; National Health Research Institutes - Taiwan	Wang, WB (corresponding author), Natl Taiwan Univ, Coll Med, Grad Inst Microbiol, Taipei 10764, Taiwan.	wbwang@ntu.edu.tw	Chen, Jen-Yang/D-2085-2010; Yang, Pei-Ming/G-3763-2014	Yang, Pei-Ming/0000-0002-4004-2518; JENG, YUNG-MING/0000-0002-3878-4491; HUNG, HUNG/0000-0003-4022-2081	National Science Council, Taiwan [NSC96-2320-B-002-035-MY3, NSC-2320-B-002-009-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by grants (NSC96-2320-B-002-035-MY3 and NSC-2320-B-002-009-MY3) from National Science Council, Taiwan (http://web1.nsc.gov.tw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2006, MICROVASC RES, V72, P136, DOI 10.1016/j.mvr.2006.05.010; Almog N, 2009, CANCER RES, V69, P836, DOI 10.1158/0008-5472.CAN-08-2590; Bechard D, 2001, J BIOL CHEM, V276, P48341, DOI 10.1074/jbc.M108395200; Bechard D, 2001, J IMMUNOL, V167, P3099, DOI 10.4049/jimmunol.167.6.3099; BROOKS L, 1992, J VIROL, V66, P2689, DOI 10.1128/JVI.66.5.2689-2697.1992; Brutsch R, 2010, CIRC RES, V107, P592, DOI 10.1161/CIRCRESAHA.110.217257; Chen J, 2010, RADIAT PROT DOSIM, V142, P1, DOI 10.1093/rpd/ncq205; Chia JS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-175; Cornelius A, 2012, BRAIN PATHOL, V22, P757, DOI 10.1111/j.1750-3639.2012.00578.x; D'Souza BN, 2004, J VIROL, V78, P1800, DOI 10.1128/JVI.78.4.1800-1816.2004; Dawson CW, 2008, J VIROL, V82, P3654, DOI 10.1128/JVI.01888-07; Dawson CW, 2003, J BIOL CHEM, V278, P3694, DOI 10.1074/jbc.M209840200; del Toro R, 2010, BLOOD, V116, P4025, DOI 10.1182/blood-2010-02-270819; Delehedde Maryse, 2013, Int J Cell Biol, V2013, P705027, DOI 10.1155/2013/705027; Dudziak D, 2003, J VIROL, V77, P8290, DOI 10.1128/JVI.77.15.8290-8298.2003; Eliopoulos AG, 1999, J BIOL CHEM, V274, P16085, DOI 10.1074/jbc.274.23.16085; Fries KL, 1996, J VIROL, V70, P8653, DOI 10.1128/JVI.70.12.8653-8659.1996; Gires O, 1999, EMBO J, V18, P3064, DOI 10.1093/emboj/18.11.3064; Grigoriu BD, 2006, CLIN CANCER RES, V12, P4575, DOI 10.1158/1078-0432.CCR-06-0185; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HILDRETH JEK, 1983, EUR J IMMUNOL, V13, P202, DOI 10.1002/eji.1830130305; Horikawa T, 2001, AM J PATHOL, V159, P27, DOI 10.1016/S0002-9440(10)61669-0; Hsueh SP, 2012, CANCER LETT, V324, P48, DOI 10.1016/j.canlet.2012.04.019; Huang GW, 2009, DIGEST DIS SCI, V54, P389, DOI 10.1007/s10620-008-0346-3; Izumi KM, 1997, P NATL ACAD SCI USA, V94, P12592, DOI 10.1073/pnas.94.23.12592; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Jiang W, 1999, CRIT REV ONCOL HEMAT, V29, P209, DOI 10.1016/S1040-8428(98)00019-5; Kang YH, 2012, CELL SIGNAL, V24, P1940, DOI 10.1016/j.cellsig.2012.06.004; Kang YH, 2011, AMINO ACIDS, V40, P1003, DOI 10.1007/s00726-010-0729-6; Kieser A, 1997, EMBO J, V16, P6478, DOI 10.1093/emboj/16.21.6478; Kitagawa N, 2013, CANCER LETT, V331, P52, DOI 10.1016/j.canlet.2012.12.002; Lassalle P, 1996, J BIOL CHEM, V271, P20458, DOI 10.1074/jbc.271.34.20458; Leroy X, 2010, HISTOPATHOLOGY, V56, P180, DOI 10.1111/j.1365-2559.2009.03458.x; Lin YC, 2000, ONCOGENE, V19, P2704, DOI 10.1038/sj.onc.1203582; Liu MT, 2005, ONCOGENE, V24, P2635, DOI 10.1038/sj.onc.1208319; Liu MT, 2004, ONCOGENE, V23, P2531, DOI 10.1038/sj.onc.1207375; Liu N, 2010, ANN SURG ONCOL, V17, P2628, DOI 10.1245/s10434-010-1037-9; Lo KW, 2002, SEMIN CANCER BIOL, V12, P451, DOI 10.1016/S1044579X02000883; Lu J, 2003, CANCER RES, V63, P256; Lu JJY, 1996, J GEN VIROL, V77, P1883, DOI 10.1099/0022-1317-77-8-1883; Mainou BA, 2005, ONCOGENE, V24, P6917, DOI 10.1038/sj.onc.1208846; Maurage CA, 2009, J NEUROPATH EXP NEUR, V68, P633, DOI 10.1097/NEN.0b013e3181a52a7f; Morris MA, 2009, FUTURE ONCOL, V5, P811, DOI [10.2217/fon.09.53, 10.2217/FON.09.53]; Murono S, 2001, P NATL ACAD SCI USA, V98, P6905, DOI 10.1073/pnas.121016998; Pan SH, 2009, CARCINOGENESIS, V30, P366, DOI 10.1093/carcin/bgn291; Qian CN, 2002, CANCER RES, V62, P589; Rennel E, 2007, EXP CELL RES, V313, P1285, DOI 10.1016/j.yexcr.2007.01.021; RHIM JS, 1985, SCIENCE, V227, P1250, DOI 10.1126/science.2579430; Roudnicky F, 2013, CANCER RES, V73, P1097, DOI 10.1158/0008-5472.CAN-12-1855; Scherpereel A, 2003, CANCER RES, V63, P6084; Tsao SW, 2002, SEMIN CANCER BIOL, V12, P473, DOI 10.1016/S1044579X02000901; Tsuji A, 2008, CLIN CANCER RES, V14, P5368, DOI 10.1158/1078-0432.CCR-08-0198; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wakisaka N, 2004, MOL CELL BIOL, V24, P5223, DOI 10.1128/MCB.24.12.5223-5234.2004; WALTER J, 1995, INT J CANCER, V61, P363, DOI 10.1002/ijc.2910610315; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1990, J VIROL, V64, P2309, DOI 10.1128/JVI.64.5.2309-2318.1990; Wen CC, 2006, CANCER RES, V66, P5847, DOI 10.1158/0008-5472.CAN-05-2109; Yoshizaki T, 1998, P NATL ACAD SCI USA, V95, P3621, DOI 10.1073/pnas.95.7.3621; Yuan RH, 2007, CLIN CANCER RES, V13, P5368, DOI 10.1158/1078-0432.CCR-07-1113; Zho L, 2006, ACTA U MED ANHUI, V41, P26; Zhou HY, 2008, FEBS LETT, V582, P3415, DOI 10.1016/j.febslet.2008.09.004	62	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82254	10.1371/journal.pone.0082254	http://dx.doi.org/10.1371/journal.pone.0082254			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340011	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100094
J	Calderon-Patron, JM; Moreno, CE; Pineda-Lopez, R; Sanchez-Rojas, G; Zuria, I				Calderon-Patron, Jaime M.; Moreno, Claudia E.; Pineda-Lopez, Ruben; Sanchez-Rojas, Gerardo; Zuria, Iriana			Vertebrate Dissimilarity Due to Turnover and Richness Differences in a Highly Beta-Diverse Region: The Role of Spatial Grain Size, Dispersal Ability and Distance	PLOS ONE			English	Article							COMPARATIVE PHYLOGEOGRAPHY; SPECIES RICHNESS; GLOBAL PATTERNS; TEHUANTEPEC; ISTHMUS; CLIMATE; DRIVERS; EUROPE; BIRDS	We explore the influence of spatial grain size, dispersal ability, and geographic distance on the patterns of species dissimilarity of terrestrial vertebrates, separating the dissimilarity explained by species replacement (turnover) from that resulting from richness differences. With data for 905 species of terrestrial vertebrates distributed in the Isthmus of Tehuantepec, classified into five groups according to their taxonomy and dispersal ability, we calculated total dissimilarity and its additive partitioning as two components: dissimilarity derived from turnover and dissimilarity derived from richness differences. These indices were compared using fine (10 x 10 km), intermediate (20 x 20 km) and coarse (40 x 40 km) grain grids, and were tested for any correlations with geographic distance. The results showed that total dissimilarity is high for the terrestrial vertebrates in this region. Total dissimilarity, and dissimilarity due to turnover are correlated with geographic distance, and the patterns are clearer when the grain is fine, which is consistent with the distance-decay pattern of similarity. For all terrestrial vertebrates tested on the Isthmus of Tehuantepec both the dissimilarity derived from turnover and the dissimilarity resulting from richness differences make important contributions to total dissimilarity, and dispersal ability does not seem to influence the dissimilarity patterns. These findings support the idea that conservation efforts in this region require a system of interconnected protected areas that embrace the environmental, climatic and biogeographic heterogeneity of the area.	[Calderon-Patron, Jaime M.; Moreno, Claudia E.; Sanchez-Rojas, Gerardo; Zuria, Iriana] Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Pachuca, Hidalgo, Mexico; [Pineda-Lopez, Ruben] Univ Autonoma Queretaro, Fac Ciencias Nat, Juriquilla, Queretaro, Mexico	Universidad Autonoma del Estado de Hidalgo; Universidad Autonoma de Queretaro	Moreno, CE (corresponding author), Univ Autonoma Estado Hidalgo, Inst Ciencias Basicas & Ingn, Ctr Invest Biol, Pachuca, Hidalgo, Mexico.	cmoreno@uaeh.edu.mx	Sanchez-Rojas, Gerardo/AAI-8312-2021; Sanchez-Rojas, Gerardo/AAG-6616-2021; Sanchez-Rojas, Gerardo/C-3068-2008; Zuria, Iriana/A-8490-2018; Moreno, Claudia E./B-2733-2013; Moreno, Claudia/GRJ-1036-2022	Sanchez-Rojas, Gerardo/0000-0003-1994-8611; Sanchez-Rojas, Gerardo/0000-0003-1994-8611; Zuria, Iriana/0000-0002-0004-3540; Moreno, Claudia E./0000-0002-9584-2619; Calderon-Patron, Jaime Manuel/0000-0002-5426-1228	CONACyT [374658/250634]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	J.M. Calderon-Patron received a scholarship (374658/250634) from CONACyT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Neto M, 2012, GLOBAL ECOL BIOGEOGR, V21, P772, DOI 10.1111/j.1466-8238.2011.00709.x; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Arita HT, 1997, BIODIVERS CONSERV, V6, P787, DOI 10.1023/B:BIOC.0000010402.08813.ab; Arita HT, 2002, ECOGRAPHY, V25, P541, DOI 10.1034/j.1600-0587.2002.250504.x; Barber BR, 2010, P ROY SOC B-BIOL SCI, V277, P2675, DOI 10.1098/rspb.2010.0343; Barreto-Oble D, 2001, REFLEXIONES MEGAPROY, P245; Barrier E, 1998, TECTONOPHYSICS, V287, P77, DOI 10.1016/S0040-1951(98)80062-0; Barton PS, 2013, GLOBAL ECOL BIOGEOGR, V22, P639, DOI 10.1111/geb.12031; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1106, DOI 10.1111/j.1466-8238.2011.00753.x; Baselga A, 2012, GLOBAL ECOL BIOGEOGR, V21, P1223, DOI 10.1111/j.1466-8238.2011.00756.x; Baselga A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032341; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Boieiro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064591; Briones-Salas Miguel, 2004, P423; Cardoso P, 2009, DIVERS DISTRIB, V15, P1081, DOI 10.1111/j.1472-4642.2009.00607.x; Carvalho JC, 2013, OIKOS, V122, P825, DOI 10.1111/j.1600-0706.2012.20980.x; Carvalho JC, 2012, GLOBAL ECOL BIOGEOGR, V21, P760, DOI 10.1111/j.1466-8238.2011.00694.x; Casas-Andreu G, 2004, BIODIVERSIDAD OAXACA, P374; Castoe TA, 2009, J BIOGEOGR, V36, P88, DOI 10.1111/j.1365-2699.2008.01991.x; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Dobrovolski R, 2012, GLOBAL ECOL BIOGEOGR, V21, P191, DOI 10.1111/j.1466-8238.2011.00671.x; Flores Villela Oscar, 2005, m3m Monografias Tercer Milenio, V4, P143; Gaston Kevin J., 2007, P181; Hammer O., 2009, PALAEONTOLOGICAL STA; Howell S. N. G., 1995, GUIDE BIRDS MEXICO N; Keil P, 2012, J BIOGEOGR, V39, P1473, DOI 10.1111/j.1365-2699.2012.02701.x; Koleff P., 2008, CAPITAL NATURAL ME X; Leon-Paniagua L, 2007, MOL PHYLOGENET EVOL, V42, P653, DOI 10.1016/j.ympev.2006.08.019; Leprieur F, 2011, ECOL LETT, V14, P325, DOI 10.1111/j.1461-0248.2011.01589.x; Liner EA, 2007, SCIENCE, V80, P1; Mac Nally R, 2004, J BIOGEOGR, V31, P917, DOI 10.1111/j.1365-2699.2004.01089.x; Manea VC, 2006, GEOL SOC AM SPEC PAP, V412, P27, DOI 10.1130/2006.2412(02); Melo AS, 2009, ECOGRAPHY, V32, P226, DOI 10.1111/j.1600-0587.2008.05502.x; Navarro S. Adolfo G., 2004, P391; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Ortiz-Perez MA, 2004, BIODIVERSIDAD OAXACA, P43; Pineda E, 2009, J ANIM ECOL, V78, P182, DOI 10.1111/j.1365-2656.2008.01471.x; Qian H, 2012, ACTA OECOL, V39, P67, DOI 10.1016/j.actao.2011.12.003; Qian H, 2009, J SYST EVOL, V47, P509, DOI 10.1111/j.1759-6831.2009.00043.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ramírez-Pulido José, 2005, Acta Zool. Mex, V21, P21; Rodriguez P, 2004, ECOGRAPHY, V27, P547, DOI 10.1111/j.0906-7590.2004.03788.x; Rodríguez Pilar, 2003, Acta Zool. Mex, P241; Romero-Centeno R, 2003, J CLIMATE, V16, P2628, DOI 10.1175/1520-0442(2003)016<2628:IOTWCA>2.0.CO;2; Sibley David Allen, 2000, SIBLEY GUIDE BIRDS; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Sullivan J, 2000, AM NAT, V155, P755, DOI 10.1086/303362; Svenning JC, 2011, J ANIM ECOL, V80, P393, DOI 10.1111/j.1365-2656.2010.01771.x; Vellend M, 2001, J VEG SCI, V12, P545, DOI 10.2307/3237006	49	21	23	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e82905	10.1371/journal.pone.0082905	http://dx.doi.org/10.1371/journal.pone.0082905			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24324840	gold, Green Submitted, Green Published			2022-12-27	WOS:000327949300166
J	Sakurai, T; Nakagawa, S; Kim, MS; Bai, H; Bai, RL; Li, JY; Min, KS; Ideta, A; Aoyagi, Y; Imakawa, K				Sakurai, Toshihiro; Nakagawa, So; Kim, Min-Su; Bai, Hanako; Bai, Rulan; Li, Junyou; Min, Kwan-Sik; Ideta, Atsushi; Aoyagi, Yoshito; Imakawa, Kazuhiko			Transcriptional Regulation of Two Conceptus Interferon Tau Genes Expressed. in Japanese Black Cattle during Peri-Implantation Period	PLOS ONE			English	Article							OVINE TROPHOBLAST PROTEIN-1; EARLY-PREGNANCY; IFN-TAU; BOVINE CONCEPTUSES; SHEEP; TROPHECTODERM; SEQUENCE; CELLS; CDX2; IDENTIFICATION	Interferon tau (IFNT), produced by the mononuclear trophectoderm, signals the process of maternal recognition of pregnancy in ruminants. However, its expression in vivo and its transcriptional regulation are not yet well characterized. Objectives of this study were to determine conceptus IFNT gene isoforms expressed in the bovine uterus and to identify differences in promoter sequences of IFNT genes that differ in their expression. RNA-seq data analysis of bovine conceptuses on days 17, 20, and 22 (day 0 = day of estrus) detected the expression of two IFNT transcripts, IFNT1 and IFNTc1, which were indeed classified into the IFNT gene clade. RNA-seq and quantitative RT-PCR analyses also revealed that the expression levels of both IFNT mRNAs were highest on day 17, and then decreased on days 20 and 22. Bovine ear-derived fibroblast (EF) cells, a model system commonly used for bovine IFNT gene transcription study in this laboratory, were cotransfected with luciferase reporter constructs carrying upstream (positions -637 to +51) regions of IFNT1 or IFNTc1 gene and various transcription factor expression plasmids including CDX2, AP-1 (Jun) and ETS2. CDX2, either alone or with the other transcription factors, markedly increased luciferase activity. The upstream regions of IFNT1 and IFNTc1 loci were then serially deleted or point-mutated at potential CDX-, AP-1-, and ETS-binding sites. Compared to the wild-type constructs, deletion or mutation at CDX2 or ETS2 binding sites similarly reduced the luciferase activities of IFNT7- or IFNTc1-promoter constructs. However, with the AP-1 site mutated construct, IFNT1- and IFNTc1-reporters behaved differently. These results suggest that two forms of bovine conceptus IFNT genes are expressed in utero and their transcriptional regulations differ.	[Sakurai, Toshihiro; Kim, Min-Su; Bai, Hanako; Bai, Rulan; Imakawa, Kazuhiko] Univ Tokyo, Grad Sch Agr & Life Sci, Lab Anim Breeding, Tokyo, Japan; [Nakagawa, So] Tokai Univ, Sch Med, Dept Mol Life Sci, Hiratsuka, Kanagawa 25912, Japan; [Li, Junyou] Univ Tokyo, Anim Resource Ctr, Grad Sch Agr & Life Sci, Tokyo, Japan; [Min, Kwan-Sik] Hankyong Natl Univ, Kyonggi Do, South Korea; [Ideta, Atsushi; Aoyagi, Yoshito] Zen Noh ET Ctr, Sapporo, Hokkaido, Japan	University of Tokyo; Tokai University; University of Tokyo; Hankyong National University	Imakawa, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Anim Breeding, Tokyo, Japan.	akaz@mail.ecc.u-tokyo.ac.jp	Bai, Hanako/K-4769-2019; Imakawa, Kazuhiko/AAD-3211-2022; Nakagawa, So/Q-2712-2015	Bai, Hanako/0000-0001-9940-1880; Nakagawa, So/0000-0003-1760-3839	program for Promotion of Basic Research Activities for Innovative Bioscience (BRAIN)	program for Promotion of Basic Research Activities for Innovative Bioscience (BRAIN)	This work was supported by the program for Promotion of Basic Research Activities for Innovative Bioscience (BRAIN) (http://vvww.naro.affrc.go.jp/brain/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexenko AP, 2000, J INTERF CYTOK RES, V20, P817, DOI 10.1089/10799900050151085; Bai H, 2009, MOL REPROD DEV, V76, P1143, DOI 10.1002/mrd.21082; BARTOL FF, 1985, BIOL REPROD, V32, P681, DOI 10.1095/biolreprod32.3.681; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Ealy AD, 1998, BIOL REPROD, V58, P566, DOI 10.1095/biolreprod58.2.566; Ealy AD, 2001, ENDOCRINOLOGY, V142, P2906, DOI 10.1210/en.142.7.2906; Ezashi T, 1998, P NATL ACAD SCI USA, V95, P7882, DOI 10.1073/pnas.95.14.7882; Ezashi T, 2004, ENDOCRINOLOGY, V145, P4452, DOI 10.1210/en.2004-0606; Ezashi T, 2001, MOL CELL BIOL, V21, P7883, DOI 10.1128/MCB.21.23.7883-7891.2001; GODKIN JD, 1982, J REPROD FERTIL, V65, P141, DOI 10.1530/jrf.0.0650141; GUILLOMOT M, 1990, BIOL CELL, V68, P205, DOI 10.1016/0248-4900(90)90309-Q; HELMER SD, 1987, J REPROD FERTIL, V79, P83, DOI 10.1530/jrf.0.0790083; Ideta A, 2007, CLONING STEM CELLS, V9, P571, DOI 10.1089/clo.2007.0017; Imakawa K, 2006, MOL REPROD DEV, V73, P559, DOI 10.1002/mrd.20457; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; IMAKAWA K, 1989, MOL ENDOCRINOL, V3, P127, DOI 10.1210/mend-3-1-127; Imakawa K, 2004, J REPROD DEVELOP, V50, P155, DOI 10.1262/jrd.50.155; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kaminuma E, 2010, NUCLEIC ACIDS RES, V38, pD33, DOI 10.1093/nar/gkp847; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; LEAMAN DW, 1992, J INTERFERON RES, V12, P1, DOI 10.1089/jir.1992.12.1; Martal J, 1995, REPROD FERT DEVELOP, V9, P355; MEYER MD, 1995, J DAIRY SCI, V78, P1921, DOI 10.3168/jds.S0022-0302(95)76817-5; Nakagawa S, 2013, GENOME BIOL EVOL, V5, P296, DOI 10.1093/gbe/evt007; NEPHEW KP, 1993, BIOL REPROD, V48, P768, DOI 10.1095/biolreprod48.4.768; ROBERTS RM, 1992, ENDOCR REV, V13, P432, DOI 10.1210/er.13.3.432; Ryan AM, 1993, ANIM GENET, V24, P9216; Sakurai T, 2013, MOL REPROD DEV, V80, P371, DOI 10.1002/mrd.22171; Sakurai T, 2010, ENDOCRINOLOGY, V151, P5873, DOI 10.1210/en.2010-0458; Sakurai T, 2009, BIOL REPROD, V80, P1223, DOI 10.1095/biolreprod.108.073916; Spencer TE, 1996, ENDOCRINOLOGY, V137, P1144, DOI 10.1210/en.137.3.1144; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Talbot NC, 2000, BIOL REPROD, V62, P235, DOI 10.1095/biolreprod62.2.235; VALLET JL, 1988, J REPROD FERTIL, V84, P493, DOI 10.1530/jrf.0.0840493; Walker AM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-187; Walker AM, 2009, THERIOGENOLOGY, V72, P44, DOI 10.1016/j.theriogenology.2009.01.017; Xie S, 1997, P NATL ACAD SCI USA, V94, P12809, DOI 10.1073/pnas.94.24.12809; Xu NC, 2003, MOL REPROD DEV, V65, P23, DOI 10.1002/mrd.10293; Yamaguchi H, 1999, BIOCHEM J, V340, P767, DOI 10.1042/0264-6021:3400767	40	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e80427	10.1371/journal.pone.0080427	http://dx.doi.org/10.1371/journal.pone.0080427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24348910	Green Published, gold, Green Submitted			2022-12-27	WOS:000327652100040
J	Finkel, RS; Flanigan, KM; Wong, B; Bonnemann, C; Sampson, J; Sweeney, HL; Reha, A; Northcutt, VJ; Elfring, G; Barth, J; Peltz, SW				Finkel, Richard S.; Flanigan, Kevin M.; Wong, Brenda; Boennemann, Carsten; Sampson, Jacinda; Sweeney, H. Lee; Reha, Allen; Northcutt, Valerie J.; Elfring, Gary; Barth, Jay; Peltz, Stuart W.			Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy	PLOS ONE			English	Article							6-MINUTE WALK TEST; READ-THROUGH; MOUSE MODEL; PTC124; COMPOUND; CELLS	Background: Approximately 13% of boys with Duchenne muscular dystrophy (DMD) have a nonsense mutation in the dystrophin gene, resulting in a premature stop codon in the corresponding mRNA and failure to generate a functional protein. Ataluren (PTC124) enables ribosomal readthrough of premature stop codons, leading to production of full-length, functional proteins. Methods: This Phase 2a open-label, sequential dose-ranging trial recruited 38 boys with nonsense mutation DMD. The first cohort (n = 6) received ataluren three times per day at morning, midday, and evening doses of 4, 4, and 8 mg/kg; the second cohort (n = 20) was dosed at 10, 10, 20 mg/kg; and the third cohort (n = 12) was dosed at 20, 20, 40 mg/kg. Treatment duration was 28 days. Change in full-length dystrophin expression, as assessed by immunostaining in pre- and post-treatment muscle biopsy specimens, was the primary endpoint. Findings: Twenty three of 38 (61%) subjects demonstrated increases in post-treatment dystrophin expression in a quantitative analysis assessing the ratio of dystrophin/spectrin. A qualitative analysis also showed positive changes in dystrophin expression. Expression was not associated with nonsense mutation type or exon location. Ataluren trough plasma concentrations active in the mdx mouse model were consistently achieved at the mid- and high-dose levels in participants. Ataluren was generally well tolerated. Interpretation: Ataluren showed activity and safety in this short-term study, supporting evaluation of ataluren 10, 10, 20 mg/kg and 20, 20, 40 mg/kg in a Phase 2b, double-blind, long-term study in nonsense mutation DMD.	[Finkel, Richard S.; Boennemann, Carsten] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Finkel, Richard S.] Nemours Childrens Hosp, Orlando, FL USA; [Flanigan, Kevin M.; Sampson, Jacinda] Univ Utah Sch Med, Salt Lake City, UT USA; [Wong, Brenda] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA; [Sweeney, H. Lee] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Reha, Allen; Northcutt, Valerie J.; Elfring, Gary; Barth, Jay; Peltz, Stuart W.] PTC Therapeut Inc, South Plainfield, NJ USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utah System of Higher Education; University of Utah; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; Pennsylvania Medicine	Finkel, RS (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	info@ptcbio.com		Flanigan, Kevin/0000-0001-6440-3376	PTC Therapeutics; MDA; FDA: FDA Orphan Products Development (OPD) [FD-R-003110-01]; Muscular Dystrophy Association (MDA) Translational Research Corporate Grant (TR CG); FOOD AND DRUG ADMINISTRATION [R01FD003110] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003129] Funding Source: NIH RePORTER	PTC Therapeutics; MDA(Muscular Dystrophy Association); FDA: FDA Orphan Products Development (OPD); Muscular Dystrophy Association (MDA) Translational Research Corporate Grant (TR CG); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by PTC Therapeutics and grants from MDA and FDA: FDA Orphan Products Development (OPD) Grant#FD-R-003110-01; Muscular Dystrophy Association (MDA) Translational Research Corporate Grant (TR CG). The MDA and FDA had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PTC Therapeutics designed the study, collected the data, interpreted the analyses, and wrote and prepared this manuscript. The authors also wish to clarify that the external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; Dent KM, 2005, AM J MED GENET A, V134A, P295, DOI 10.1002/ajmg.a.30617; Du M, 2008, P NATL ACAD SCI USA, V105, P2064, DOI 10.1073/pnas.0711795105; FLORENCE JM, 1985, NEUROLOGY, V35, P758, DOI 10.1212/WNL.35.5.758; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Goldmann T, 2011, HUM GENE THER, V22, P537, DOI 10.1089/hum.2010.067; GRUBBS FE, 1969, TECHNOMETRICS, V11, P1, DOI 10.2307/1266761; Hirawat S, 2007, J CLIN PHARMACOL, V47, P430, DOI 10.1177/0091270006297140; Kayali R, 2012, HUM MOL GENET, V21, P4007, DOI 10.1093/hmg/dds223; Linde L, 2007, EUR J HUM GENET, V15, P1156, DOI 10.1038/sj.ejhg.5201889; McDonald CM, 2010, MUSCLE NERVE, V42, P966, DOI 10.1002/mus.21808; McDonald CM, 2010, MUSCLE NERVE, V41, P500, DOI 10.1002/mus.21544; Mizuno H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018388; Nadarajah VD, 2011, NEUROMUSCULAR DISORD, V21, P569, DOI 10.1016/j.nmd.2011.05.011; Nelson SF, 2009, CURR OPIN NEUROL, V22, P532, DOI 10.1097/WCO.0b013e32832fd487; Sarkar C, 2011, MOL GENET METAB, V104, P338, DOI 10.1016/j.ymgme.2011.05.021; Stedman Hansell, 2000, Human Gene Therapy, V11, P777; Tan L, 2011, J INHERIT METAB DIS, V34, P443, DOI 10.1007/s10545-010-9265-5; Tay S. K. H., 2000, Annals Academy of Medicine Singapore, V29, P719; Taylor LE, 2012, NEUROPATH APPL NEURO, V38, P591, DOI 10.1111/j.1365-2990.2012.01250.x; Wang D, 2010, MOL GENET METAB, V99, P62, DOI 10.1016/j.ymgme.2009.08.002; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756	22	155	163	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81302	10.1371/journal.pone.0081302	http://dx.doi.org/10.1371/journal.pone.0081302			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349052	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300023
J	Xue, H; Wang, JL; Hou, JH; Zhu, H; Gao, JS; Chen, SH; Wang, YT; Chen, YD; Wu, SL				Xue, Hao; Wang, Jianli; Hou, Jinhong; Zhu, Hang; Gao, Jingsheng; Chen, Shuohua; Wang, Yutang; Chen, Yundai; Wu, Shouling			Association of Ideal Cardiovascular Metrics and Serum High-Sensitivity C-Reactive Protein in Hypertensive Population	PLOS ONE			English	Article							METABOLIC SYNDROME; BLOOD-PRESSURE; HEALTH; PREVALENCE; PREVENTION; MORTALITY; MARKERS; IMPACT; WOMEN; MEN	Increased levels of the inflammatory biomarker high-sensitivity C-reactive protein (hs-CRP) are associated with increased risk of cardiovascular disease. However, ideal cardiovascular health indicates lower risk of cardiovascular disease. This study aimed to investigate the effect of ideal cardiovascular health behaviors and health factors on hs-CRP levels among a hypertensive population. From 2006 to 2007, a cross-sectional study was conducted to survey 41,476 hypertensive subjects among the employees of Kailuan Corporation. Data from unified questionnaires and blood biochemical examinations were collected. The effects of ideal cardiovascular health behaviors and health factors on hs-CRP levels were evaluated through multivariate logistic regression analysis. A negative correlation was observed between hs-CRP levels and the number of ideal cardiovascular health metrics. The mean hs-CRP levels of subjects with zero to one, two, three, and four to six ideal cardiovascular health metrics were 1.11, 0.96, 0.90, and 0.80 mg/L, respectively (P<0.01). Multivariate logistic regression analysis revealed that after adjustment for sex, age, triglyceride, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, and other risk factors, the risks for subjects with two, three, and four to six ideal health metrics with serum hs-CRP >3 mg/L were lower than those with zero to one ideal health metrics, with corresponding odd ratios of 0.86 (95% CI: 0.79-0.93, P<0.01), 0.76 (95% CI: 0.69-0.83, P<0.01), and 0.68 (95% CI: 0.64-0.75, P<0.01), respectively. This finding suggests that ideal cardiovascular health behaviors and health factors were related to decreased hs-CRP levels in a hypertensive population.	[Xue, Hao; Zhu, Hang; Wang, Yutang; Chen, Yundai] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China; [Wang, Jianli; Hou, Jinhong; Gao, Jingsheng; Chen, Shuohua; Wu, Shouling] Hebei United Univ, Dept Cardiol, Kailuan Hosp, Tangshan, Peoples R China	Chinese People's Liberation Army General Hospital; North China University of Science & Technology	Wang, YT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing, Peoples R China.	wyt301@yeah.net; cyundai@medmail.com.cn; drwusl@163.com	chen, yundai/I-4353-2019; wang, jian/GVS-0711-2022; Xue, Hao/GXV-4717-2022	chen, yundai/0000-0003-2252-8992; 				Azadbakht L, 2011, J NUTR, V141, P1083, DOI 10.3945/jn.110.136739; Belfki H, 2012, EUR J INTERN MED, V23, pE5, DOI 10.1016/j.ejim.2011.10.011; Chuang SY, 2013, AM J HYPERTENS, V26, P657, DOI 10.1093/ajh/hps095; Cozma Angela, 2009, Rom J Intern Med, V47, P133; Dar MS, 2010, INDIAN J CLIN BIOCHE, V25, P208, DOI 10.1007/s12291-010-0037-7; Higashiyama A, 2012, J ATHEROSCLER THROMB, V19, P1027, DOI 10.5551/jat.13599; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hung J, 2008, AM J CARDIOL, V101, P193, DOI 10.1016/j.amjcard.2007.07.061; Kantor ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067833; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Labonte ME, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.19066; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Marques-Vidal P, 2012, OBESITY FACTS, V5, P734, DOI 10.1159/000345045; Michigan A, 2011, MOL DIAGN THER, V15, P265, DOI 10.2165/11593400-000000000-00000; Ministry of health of the people's Republic of China, 2010, CHIN HLTH STAT YB, V276, P315; Mitchell JA, 2010, AM HEART J, V160, P102, DOI 10.1016/j.ahj.2010.05.001; Nechuta SJ, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000339; Odegaard AO, 2011, CIRCULATION, V124, P2847, DOI 10.1161/CIRCULATIONAHA.111.048843; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rabkin SW, 2013, HYPERTENS RES, V7; Rojo-Martinez G, 2013, EUR J CLIN INVEST, V43, P1, DOI 10.1111/eci.12002; Villegas R, 2012, NUTR METAB CARDIOVAS, V22, P223, DOI 10.1016/j.numecd.2010.07.007; Wen JP, 2009, CLIN BIOCHEM, V42, P976, DOI 10.1016/j.clinbiochem.2009.03.026; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Wu SL, 2012, INT J CARDIOL, V157, P75, DOI 10.1016/j.ijcard.2010.12.019; Zhu YN, 2011, J AM DIET ASSOC, V111, P1536, DOI 10.1016/j.jada.2011.07.010	27	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81597	10.1371/journal.pone.0081597	http://dx.doi.org/10.1371/journal.pone.0081597			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349092	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300037
J	Jiang, YY; Lu, GR; Trescott, LR; Hou, YN; Guan, XQ; Wang, S; Stamenkovich, A; Brunzelle, J; Sirinupong, N; Li, CY; Yang, Z				Jiang, Yuanyuan; Lu, Guorong; Trescott, Laura R.; Hou, Yuning; Guan, Xiaoqing; Wang, Shuo; Stamenkovich, Angelique; Brunzelle, Joseph; Sirinupong, Nualpun; Li, Chunying; Yang, Zhe			New Conformational State of NHERF1-CXCR2 Signaling Complex Captured by Crystal Lattice Trapping	PLOS ONE			English	Article							CXCR2 MACROMOLECULAR COMPLEX; PDZ DOMAINS; BINDING SELECTIVITY; PROTEIN; DYNAMICS; PROMISCUITY; FLEXIBILITY; SPECIFICITY; TRANSPORT; PARTNERS	NHERF1 is a PDZ adaptor protein that scaffolds the assembly of diverse signaling complexes and has been implicated in many cancers. However, little is known about the mechanism responsible for its scaffolding promiscuity or its ability to bind to multiple targets. Computational studies have indicated that PDZ promiscuity may be attributed to its conformational dynamics, but experimental evidence for this relationship remains very limited. Here we examine the conformational flexibility of the NHERF1 PDZ1 domain using crystal lattice trapping via solving PDZ1 structure of a new crystal form. The structure, together with prior PDZ1 structures of a different space group, reveals that 4 of 11 ligand-interacting residues undergo significant crystal packing-induced structural changes. Most of these residues correspond to the residues involved in allosteric transition when a peptide ligand binds. In addition, a subtle difference in ligand conformations causes the same peptide to bind in slightly different modes in different crystal forms. These findings indicate that substantial structural flexibility is present in the PDZ1 peptide-binding pocket, and the structural substate trapped in the present crystal form can be utilized to represent the conformational space accessible to the protein. Such knowledge will be critical for drug design against the NHERF1 PDZ1 domain, highlighting the continued need for experimentally determined PDZ1-ligand complexes.	[Jiang, Yuanyuan; Lu, Guorong; Trescott, Laura R.; Hou, Yuning; Guan, Xiaoqing; Wang, Shuo; Stamenkovich, Angelique; Li, Chunying; Yang, Zhe] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Brunzelle, Joseph] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Sirinupong, Nualpun] Prince Songkla Univ, Nutraceut & Funct Food Res & Dev Ctr, Hat Yai, Songkhla, Thailand	Wayne State University; United States Department of Energy (DOE); Argonne National Laboratory; Prince of Songkla University	Li, CY (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	cl@med.wayne.edu; zyang@med.wayne.edu	jiang, anyi/GPT-0379-2022; Sirinupong, Nualpun/AAX-4886-2020	Sirinupong, Nualpun/0000-0002-9986-3011; Hou, Yuning/0000-0001-9894-3821	Leukemia Research Foundation; Aplastic Anemia & MDS International Foundation; Elsa U. Pardee Foundation; American Heart Association; American Cancer Society [11-053-01-IRG]	Leukemia Research Foundation; Aplastic Anemia & MDS International Foundation; Elsa U. Pardee Foundation; American Heart Association(American Heart Association); American Cancer Society(American Cancer Society)	This study was supported by the Leukemia Research Foundation (to ZY) and the Aplastic Anemia & MDS International Foundation (to ZY), as well as the Elsa U. Pardee Foundation (to CL), American Heart Association (to CL), and American Cancer Society Institutional Research Grant (# 11-053-01-IRG) (to CL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ardura JA, 2011, PHARMACOL REV, V63, P882, DOI 10.1124/pr.110.004176; Basdevant N, 2006, J AM CHEM SOC, V128, P12766, DOI 10.1021/ja060830y; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Cardone RA, 2012, MOL BIOL CELL, V23, P2028, DOI 10.1091/mbc.E11-11-0911; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cushing PR, 2008, BIOCHEMISTRY-US, V47, P10084, DOI 10.1021/bi8003928; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gerek ZN, 2010, PROTEIN SCI, V19, P914, DOI 10.1002/pro.366; Gerek ZN, 2009, PROTEINS, V77, P796, DOI 10.1002/prot.22492; Harris BZ, 2001, J CELL SCI, V114, P3219; Karthikeyan S, 2002, J BIOL CHEM, V277, P18973, DOI 10.1074/jbc.M201507200; Karthikeyan S, 2001, J BIOL CHEM, V276, P19683, DOI 10.1074/jbc.C100154200; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; Lu GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076219; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Munz M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002749; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pohlmann T, 2004, J BIOL CHEM, V279, P28197, DOI 10.1074/jbc.C400128200; Roujeinikova A, 1999, J BIOL CHEM, V274, P30811, DOI 10.1074/jbc.274.43.30811; Roujeinikova A, 2002, STRUCTURE, V10, P825, DOI 10.1016/S0969-2126(02)00775-X; Runyon ST, 2007, PROTEIN SCI, V16, P2454, DOI 10.1110/ps.073049407; Sheng M, 2001, ANNU REV NEUROSCI, V24, P1, DOI 10.1146/annurev.neuro.24.1.1; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Stiffler MA, 2007, SCIENCE, V317, P364, DOI 10.1126/science.1144592; Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232; Tonikian R, 2008, PLOS BIOL, V6, P2043, DOI 10.1371/journal.pbio.0060239; Totrov M, 2008, CURR OPIN STRUC BIOL, V18, P178, DOI 10.1016/j.sbi.2008.01.004; Van Aalten DMF, 2000, PROTEIN SCI, V9, P64; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Wang S, 2013, TRANSL ONCOL, V6, P216, DOI 10.1593/tlo.13133; Wang SS, 1998, FEBS LETT, V427, P103, DOI 10.1016/S0014-5793(98)00402-5; Weinman EJ, 2000, AM J PHYSIOL-RENAL, V279, pF393, DOI 10.1152/ajprenal.2000.279.3.F393; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu YN, 2012, J BIOL CHEM, V287, P5744, DOI 10.1074/jbc.M111.315762; ZHANG XJ, 1995, J MOL BIOL, V250, P527, DOI 10.1006/jmbi.1995.0396	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81904	10.1371/journal.pone.0081904	http://dx.doi.org/10.1371/journal.pone.0081904			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339979	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400052
J	Mondal, S; Roy, P; Das, S; Halder, A; Mukherjee, A; Bera, T				Mondal, Subhasish; Roy, Partha; Das, Suvadra; Halder, Asim; Mukherjee, Arup; Bera, Tanmoy			In Vitro Susceptibilities of Wild and Drug Resistant Leishmania donovani Amastigote Stages to Andrographolide Nanoparticle: Role of Vitamin E Derivative TPGS for Nanoparticle Efficacy	PLOS ONE			English	Article							CELLULAR UPTAKE; PARTICLE-SIZE; CHEMOTHERAPY; DELIVERY; EFFLUX; PROMASTIGOTES; TRANSPORTERS; INHIBITION; EXPRESSION; REDUCTION	Visceral leishmaniasis (VL) is a chronic protozoan infection in humans associated with significant global morbidity and mortality. There is an urgent need to develop drugs and strategy that will improve therapeutic response for effective clinical treatment of drug resistant VL. To address this need, andrographolide (AG) nanoparticles were designed with P-gp efflux inhibitor vitamin E TPGS (D-a-tocopheryl polyethyleneglycol 1000 succinate) for sensitivity against drug resistant Leishmania strains. AG loaded PLGA (50: 50) nanoparticles (AGnps) stabilized by vitamin E TPGS were prepared for delivery into macrophage cells infested with sensitive and drug resistant amastigotes of Leishmania parasites. Physico-chemical characterization of AGnps by photon correlation spectroscopy exhibited an average particle size of 179.6 nm, polydispersity index of 0.245 and zeta potential of -37.6 mV. Atomic force microscopy and transmission electron microscopy visualization revealed spherical nanoparticles with smooth surfaces. AGnps displayed sustained AG release up to 288 hours as well as minimal particle aggregation and drug loss even after three months study period. Antileishmanial activity as revealed from selectivity index in wild-type strain was found to be significant for AGnp with TPGS in about one-tenth of the dosage of the free AG and one-third of the dosage of the AGnp without TPGS. Similar observations were also found in case of in vitro generated drug resistant and field isolated resistant strains of Leishmania. Cytotoxicity of AGnp with and without TPGS was significantly less than standard antileishmanial chemotherapeutics like amphotericin B, paromomycin or sodium stibogluconate. Macrophage uptake of AGnps was almost complete within one hour as evident from fluorescent microscopy studies. Thus, based on these observations, it can be concluded that the low-selectivity of AG in in vitro generated drug resistant and field isolated resistant strains was improved in case of AG nanomedicines designed with vitamin E TPGS.	[Mondal, Subhasish; Bera, Tanmoy] Jadavpur Univ, Dept Pharmaceut Technol, Div Med Biochem, Kolkata, W Bengal, India; [Roy, Partha; Das, Suvadra; Halder, Asim; Mukherjee, Arup] Univ Calcutta, Dept Chem Technol, Kolkata, W Bengal, India	Jadavpur University; University of Calcutta	Bera, T (corresponding author), Jadavpur Univ, Dept Pharmaceut Technol, Div Med Biochem, Kolkata, W Bengal, India.	proftanmoybera@gmail.com	Halder, Asim/AAV-4359-2021; Roy, Partha/GNP-6565-2022	Roy, Partha/0000-0002-9641-6136; Halder, Asim/0000-0002-1850-7542	Indian Council of Medical Research (ICMR), New Delhi, India [AMR/48/2011-ECD-I]; ICMR; Council of Scientific and Industrial Research	Indian Council of Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR)); ICMR(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from Indian Council of Medical Research (ICMR), New Delhi, India (Grant No.: AMR/48/2011-ECD-I). Dr. Subhasish Mondal was also awarded Research Associateship from ICMR to carry out this research work. Research Associateship to Dr. Partha Roy and Senior Research Fellowships to Suvadra Das from Council of Scientific and Industrial Research are also gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek Niranjan, 2010, Indian Journal of Natural Products and Resources, V1, P125; Basu JM, 2008, ANTIMICROB AGENTS CH, V52, P1080, DOI 10.1128/AAC.01196-07; Biyani N, 2011, MOL BIOCHEM PARASIT, V179, P91, DOI 10.1016/j.molbiopara.2011.06.004; Budhian A, 2007, INT J PHARM, V336, P367, DOI 10.1016/j.ijpharm.2006.11.061; Collnot EM, 2006, J CONTROL RELEASE, V111, P35, DOI 10.1016/j.jconrel.2005.11.005; Collnot EM, 2007, MOL PHARM, V4, P465, DOI 10.1021/mp060121r; Cortes-Selva F, 2005, BIOCHEM BIOPH RES CO, V329, P502, DOI 10.1016/j.bbrc.2005.02.009; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Das S, 2013, COLLOID SURFACE B, V107, P27, DOI 10.1016/j.colsurfb.2013.01.061; Debrabant A, 2004, INT J PARASITOL, V34, P205, DOI 10.1016/j.ijpara.2003.10.011; Denton H, 2004, BIOCHEM J, V381, P405, DOI 10.1042/BJ20040283; Ferreira CD, 2003, BIOMETALS, V16, P441, DOI 10.1023/A:1022823605068; Garcia-Hernandez R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001974; Gelderblom H, 2001, EUR J CANCER, V37, P1590, DOI 10.1016/S0959-8049(01)00171-X; Grattard N, 2002, J CONTROL RELEASE, V84, P125, DOI 10.1016/S0168-3659(02)00260-2; HUBER W, 1993, ACTA TROP, V55, P257, DOI 10.1016/0001-706X(93)90083-N; IOVANNISCI DM, 1983, J PARASITOL, V69, P633, DOI 10.2307/3281131; Jalali N, 2011, COLLOID SURFACE A, V392, P335, DOI 10.1016/j.colsurfa.2011.10.012; KAR K, 1990, J PROTOZOOL, V37, P277, DOI 10.1111/j.1550-7408.1990.tb01147.x; KORSMEYER RW, 1983, INT J PHARM, V15, P25, DOI 10.1016/0378-5173(83)90064-9; Lala S, 2003, INDIAN J BIOCHEM BIO, V40, P169; Lu Z, 1999, J CONTROL RELEASE, V61, P107, DOI 10.1016/S0168-3659(99)00112-1; Maharjan M, 2008, AM J TROP MED HYG, V79, P69, DOI 10.4269/ajtmh.2008.79.69; Mandal S, 2010, J ANTIMICROB CHEMOTH, V65, P496, DOI 10.1093/jac/dkp468; Misra Purnima, 1992, International Journal of Pharmacognosy, V30, P263; Mukherjee A, 2007, J ANTIMICROB CHEMOTH, V59, P204, DOI 10.1093/jac/dkl494; Mukhopadhyay R, 2011, INT J PARASITOL, V41, P1311, DOI 10.1016/j.ijpara.2011.07.013; Mundargi RC, 2008, J CONTROL RELEASE, V125, P193, DOI 10.1016/j.jconrel.2007.09.013; Nwaka S, 2006, NAT REV DRUG DISCOV, V5, P941, DOI 10.1038/nrd2144; Roy P, 2013, PHARM RES-DORDR, V30, P1252, DOI 10.1007/s11095-012-0964-5; Roy P, 2010, INT J NANOMED, V5, P1113, DOI 10.2147/IJN.S14787; Sereno D, 1997, ANTIMICROB AGENTS CH, V41, P972, DOI 10.1128/AAC.41.5.972; Sinha J, 2000, DRUG DELIV, V7, P209; Staud F, 2010, METHODS MOL BIOL, V596, P199, DOI 10.1007/978-1-60761-416-6_10; Vasir JK, 2005, CURR NANOSCI, V1, P47, DOI 10.2174/1573413052953110; Werle M, 2008, PHARM RES-DORDR, V25, P500, DOI 10.1007/s11095-007-9347-8; Win KY, 2005, BIOMATERIALS, V26, P2713, DOI 10.1016/j.biomaterials.2004.07.050; Xu AR, 2012, INT J NANOMED, V7, P3547, DOI 10.2147/IJN.S32188; Zhang ZP, 2008, PHARM RES-DORDR, V25, P1925, DOI 10.1007/s11095-008-9611-6; Zhang ZP, 2012, BIOMATERIALS, V33, P4889, DOI 10.1016/j.biomaterials.2012.03.046; Zhang ZP, 2006, BIOMATERIALS, V27, P262, DOI 10.1016/j.biomaterials.2005.05.104; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200; ZHU S-P, 1981, Acta Pharmacologica Sinica, V2, P266	43	36	36	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81492	10.1371/journal.pone.0081492	http://dx.doi.org/10.1371/journal.pone.0081492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339938	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400022
J	Wilson, B; Muirhead, A; Bazanella, M; Huete-Stauffer, C; Vezzulli, L; Bourne, DG				Wilson, Bryan; Muirhead, Andrew; Bazanella, Monika; Huete-Stauffer, Carla; Vezzulli, Luigi; Bourne, David G.			An Improved Detection and Quantification Method for the Coral Pathogen Vibrio coralliilyticus	PLOS ONE			English	Article							REAL-TIME PCR; VULNIFICUS SEROVAR-E; EXTRACELLULAR METALLOPROTEASE; POCILLOPORA-DAMICORNIS; VIRULENCE FACTOR; RAPID DETECTION; SP-NOV.; GENE; TUBIASHII; DISEASE	DNA- and RNA-based PCR and reverse-transcription real-time PCR assays were developed for diagnostic detection of the vcpA zinc-metalloprotease implicated in the virulence of the coral pathogen Vibrio coralliilyticus. Both PCR methods were highly specific for V. coralliilyticus and failed to amplify strains of closely-related Vibrio species. The assays correctly detected all globally occurring V. coralliilyticus isolates including a newly-described isolate [TAV24] infecting gorgonians in the Mediterranean Sea and highlighted those isolates that had been potentially misidentified, in particular V. tubiashii strains ATCC 19105 and RE22, historically described as important oyster pathogens. The real-time assay is sensitive, detecting 10 gene copies and the relationships between gene copy number and cycle threshold (C-T) were highly linear (R-2 >= 99.7). The real-time assay was also not affected by interference from non-target DNA. These assays are useful for rapid detection of V. coralliilyticus and monitoring of virulence levels in environmental samples, allowing for implementation of timely management steps to limit and possibly prevent losses due to V. coralliilyticus infection, as well as furthering investigations of factors affecting pathogenesis of this important marine pathogen.	[Wilson, Bryan; Muirhead, Andrew; Bazanella, Monika; Huete-Stauffer, Carla; Bourne, David G.] Australian Inst Marine Sci, Ctr Marine Microbiol & Genet, Townsville, Qld 4810, Australia; [Bazanella, Monika] Fachhsch Krems, Krems, Austria; [Huete-Stauffer, Carla; Vezzulli, Luigi] Univ Genoa, Genoa, Italy	Australian Institute of Marine Science; University of Genoa	Bourne, DG (corresponding author), Australian Inst Marine Sci, Ctr Marine Microbiol & Genet, PMB 3, Townsville, Qld 4810, Australia.	d.bourne@aims.gov.au	Bourne, David G/B-5073-2008; Vezzulli, Luigi/J-2312-2015	Bourne, David G/0000-0002-1492-8710; Vezzulli, Luigi/0000-0002-4368-1454; Wilson, Bryan/0000-0001-9000-2920	Queensland Government Smart State Fellowship	Queensland Government Smart State Fellowship	B. Wilson was nancially supported by the Queensland Government Smart State Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arotsker L, 2009, FEMS MICROBIOL ECOL, V70, P515, DOI 10.1111/j.1574-6941.2009.00770.x; Austin B, 2005, ENVIRON MICROBIOL, V7, P1488, DOI 10.1111/j.1462-2920.2005.00847.x; Banin E, 2003, CURR MICROBIOL, V46, P418, DOI 10.1007/s00284-002-3912-5; Banin E, 2001, APPL ENVIRON MICROB, V67, P1536, DOI 10.1128/AEM.67.4.1536-1541.2001; Banin E, 2000, APPL ENVIRON MICROB, V66, P3031, DOI 10.1128/AEM.66.7.3031-3036.2000; Beaubrun JJG, 2008, APPL ENVIRON MICROB, V74, P907, DOI 10.1128/AEM.02052-07; Beaubrun JJG, 2011, FOOD MICROBIOL, V28, P1409, DOI 10.1016/j.fm.2011.04.003; Ben-Haim Y, 2003, APPL ENVIRON MICROB, V69, P4236, DOI 10.1128/AEM.69.7.4236-4242.2003; Ben-Haim Y, 2002, MAR BIOL, V141, P47, DOI 10.1007/s00227-002-0797-6; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Binesse J, 2008, APPL ENVIRON MICROB, V74, P7108, DOI 10.1128/AEM.01261-08; Blackstone GM, 2007, J MICROBIOL METH, V68, P254, DOI 10.1016/j.mimet.2006.08.006; Boroujerdi AFB, 2009, ENVIRON SCI TECHNOL, V43, P7658, DOI 10.1021/es901675w; Bourne DG, 2009, TRENDS MICROBIOL, V17, P554, DOI 10.1016/j.tim.2009.09.004; Cano-Gomez A, 2010, FEMS MICROBIOL LETT, V302, P175, DOI 10.1111/j.1574-6968.2009.01850.x; Efrony R, 2007, CORAL REEFS, V26, P7, DOI 10.1007/s00338-006-0170-1; Estes RM, 2004, DIS AQUAT ORGAN, V58, P223, DOI 10.3354/dao058223; Geffen Y, 2009, FEMS MICROBIOL LETT, V295, P103, DOI 10.1111/j.1574-6968.2009.01590.x; Gharaibeh DN, 2009, J MICROBIOL METH, V76, P262, DOI 10.1016/j.mimet.2008.12.001; Goarant C, 2006, J MICROBIOL METH, V67, P27, DOI 10.1016/j.mimet.2006.02.013; Gordon KV, 2008, APPL ENVIRON MICROB, V74, P1704, DOI 10.1128/AEM.01100-07; HADA HS, 1984, INT J SYST BACTERIOL, V34, P1, DOI 10.1099/00207713-34-1-1; Hasegawa H, 2008, APPL ENVIRON MICROB, V74, P4101, DOI 10.1128/AEM.00061-08; Hasegawa H, 2009, APPL ENVIRON MICROB, V75, P7602, DOI 10.1128/AEM.01016-09; Hasegawa H, 2009, MICROBIOL-SGM, V155, P2296, DOI 10.1099/mic.0.028605-0; Jeong KC, 2000, INFECT IMMUN, V68, P5096, DOI 10.1128/IAI.68.9.5096-5106.2000; Jones MK, 2009, INFECT IMMUN, V77, P1723, DOI 10.1128/IAI.01046-08; Kawase T, 2004, FEMS MICROBIOL LETT, V240, P55, DOI 10.1016/j.femsle.2004.09.023; Kesarcodi-Watson A, 2009, J FISH DIS, V32, P499, DOI 10.1111/j.1365-2761.2009.01006.x; Kreader CA, 1996, APPL ENVIRON MICROB, V62, P1102, DOI 10.1128/AEM.62.3.1102-1106.1996; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Le Roux F, 2007, APPL ENVIRON MICROB, V73, P777, DOI 10.1128/AEM.02147-06; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Liu GF, 2010, LETT APPL MICROBIOL, V51, P301, DOI 10.1111/j.1472-765X.2010.02894.x; Luna GM, 2007, ENVIRON MICROBIOL, V9, P1851, DOI 10.1111/j.1462-2920.2007.01287.x; Luna GM, 2010, ENV MICROBIOL REP, V2, P120, DOI 10.1111/j.1758-2229.2009.00114.x; Meron D, 2009, APPL ENVIRON MICROB, V75, P5704, DOI 10.1128/AEM.00198-09; MILTON DL, 1992, J BACTERIOL, V174, P7235, DOI 10.1128/jb.174.22.7235-7244.1992; Miyoshi S, 2000, MICROBES INFECT, V2, P91, DOI 10.1016/S1286-4579(00)00280-X; Miyoshi S, 2006, J DERMATOL, V33, P589, DOI 10.1111/j.1346-8138.2006.00139.x; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Munn CB, 2008, FEMS MICROBIOL LETT, V281, P58, DOI 10.1111/j.1574-6968.2008.01073.x; Nhung PH, 2007, SYST APPL MICROBIOL, V30, P309, DOI 10.1016/j.syapm.2006.11.004; Nielsen Kaare M., 2007, Environmental Biosafety Research, V6, P37, DOI 10.1051/ebr:2007031; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Pollock FJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002183; Pollock FJ, 2010, APPL ENVIRON MICROB, V76, P5282, DOI 10.1128/AEM.00330-10; Pollock FJ, 2010, ENV MICROBIOL REP, V2, P172, DOI 10.1111/j.1758-2229.2009.00131.x; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Ruwandeepika HAD, 2011, ENV MICROBIOL REP, V3, P597, DOI 10.1111/j.1758-2229.2011.00268.x; Santos ED, 2011, ISME J, V5, P1471, DOI 10.1038/ismej.2011.19; Saulnier D, 2009, J MICROBIOL METH, V77, P191, DOI 10.1016/j.mimet.2009.01.021; Shao CP, 2001, J BACTERIOL, V183, P1369, DOI 10.1128/JB.183.4.1369-1375.2001; Sudheesh PS, 2001, AQUACULTURE, V196, P37, DOI 10.1016/S0044-8486(00)00575-5; Sussman M, 2003, ENVIRON MICROBIOL, V5, P250, DOI 10.1046/j.1462-2920.2003.00424.x; Sussman M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002393; Sussman M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004511; Temperton B, 2011, STAND GENOMIC SCI, V4, P183, DOI 10.4056/sigs.1654066; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; TUBIASH HS, 1965, J BACTERIOL, V90, P1036, DOI 10.1128/JB.90.4.1036-1044.1965; Valiente E, 2008, MICROB PATHOGENESIS, V45, P386, DOI 10.1016/j.micpath.2008.09.001; Valiente E, 2008, ENVIRON MICROBIOL, V10, P328, DOI 10.1111/j.1462-2920.2007.01454.x; Vandenberghe J, 2003, AQUACULTURE, V219, P9, DOI 10.1016/S0044-8486(02)00312-5; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Vidal-Dupiol J, 2011, J EXP BIOL, V214, P1533, DOI 10.1242/jeb.053165; Vizcaino MI, 2010, MICROB ECOL, V59, P646, DOI 10.1007/s00248-010-9644-3; Wang HX, 2011, J BACTERIOL, V193, P6529, DOI 10.1128/JB.05166-11; Wilson B, 2012, FEMS MICROBIOL ECOL, V80, P509, DOI 10.1111/j.1574-6941.2012.01319.x; Work TM, 2008, J EXP MAR BIOL ECOL, V362, P63, DOI 10.1016/j.jembe.2008.05.011	71	34	36	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81800	10.1371/journal.pone.0081800	http://dx.doi.org/10.1371/journal.pone.0081800			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339968	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400044
J	Barendse, J; Best, PB; Carvalho, I; Pomilla, C				Barendse, Jaco; Best, Peter B.; Carvalho, Ines; Pomilla, Cristina			Mother Knows Best: Occurrence and Associations of Resighted Humpback Whales Suggest Maternally Derived Fidelity to a Southern Hemisphere Coastal Feeding Ground	PLOS ONE			English	Article							MEGAPTERA-NOVAEANGLIAE CALVES; MAXIMUM-LIKELIHOOD-ESTIMATION; NORTH-ATLANTIC OCEAN; GULF-OF-MAINE; WEST-COAST; POPULATION-STRUCTURE; REPRODUCTIVE SUCCESS; HISTORICAL RECORDS; BREEDING AREAS; MIGRATION	Site fidelity is common among migratory cetaceans, including humpback whales (Megaptera novaeangliae). In the Northern Hemisphere it has been found that fidelity to humpback whale feeding grounds is transferred maternally but this has never been shown for the species in the Southern Hemisphere. We examined this in a unique feeding area off west South Africa using resighting data of 68 individually identified humpback whales by means of photographic (tail flukes and dorsal fins) and/or molecular methods (microsatellite genotyping) over an 18 year span. We found short-term association patterns and recurrent visits typical of other feeding grounds. Males and females had different seasonality of attendance. Significant female-dominated presence corresponded to timing of an expected influx of females on their southward migration from the breeding ground: firstly non-nursing (possibly pregnant) females in mid-spring, and mothers and calves in mid-to late summer. The potential benefit of this mid-latitude feeding area for females is illustrated by a record of a cow with known age of at least 23 years that produced calves in three consecutive years, each of which survived to at least six months of age: the first record of successful post-partum ovulation for this species in the Southern Hemisphere. We recorded association of a weaned calf with its mother, and a recurring association between a non-lactating female and male over more than two years. Moreover, three animals first identified as calves returned to the same area in subsequent years, sometimes on the same day as their mothers. This, together with numerous Parent-Offspring relations detected genetically among and between resighted and non-resighted whales is strongly suggestive of maternally derived site fidelity at a small spatial scale by a small sub-population of humpback whales.	[Barendse, Jaco; Best, Peter B.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Barendse, Jaco] Nelson Mandela Metropolitan Univ, Sustainabil Res Unit, George, South Africa; [Carvalho, Ines; Pomilla, Cristina] Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA; [Carvalho, Ines; Pomilla, Cristina] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Carvalho, Ines] Univ Algarve, Fac Ciencias Mar & Ambiente, Faro, Portugal; [Pomilla, Cristina] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	University of Pretoria; Nelson Mandela University; Wildlife Conservation Society; American Museum of Natural History (AMNH); Universidade do Algarve; University of Cambridge	Barendse, J (corresponding author), Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa.	jaco.barendse@gmail.com	Pomilla, Cristina/AAC-4035-2020; Pomilla, Cristina/GYD-9678-2022; Carvalho, Inês/E-9270-2012; Barendse, Jaco/F-7064-2012	Pomilla, Cristina/0000-0002-2581-8365; Carvalho, Inês/0000-0002-4641-8037; Barendse, Jaco/0000-0003-2859-4501	National Research Foundation (NRF), South Africa [2047517]; PADI Project AWARE (UK) [095]; Earthwatch Institute (project title "Whales of South Africa")	National Research Foundation (NRF), South Africa(National Research Foundation - South Africa); PADI Project AWARE (UK); Earthwatch Institute (project title "Whales of South Africa")	The work was supported by the National Research Foundation (NRF), South Africa (grant number 2047517); PADI Project AWARE (UK) (small grant number 095); Earthwatch Institute (project title "Whales of South Africa"). NRF, the Society for Marine Mammalogy, University of Pretoria, and the Wildlife Society of South Africa (Charles Astley Maberley Memorial Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo J, 2007, MAR MAMMAL SCI, V23, P453, DOI 10.1111/j.1748-7692.2007.00116.x; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Anderson C, 2001, BEHAV ECOL, V12, P534, DOI 10.1093/beheco/12.5.534; Baker CS, 1998, MAR MAMMAL SCI, V14, P721, DOI 10.1111/j.1748-7692.1998.tb00758.x; BAKER CS, 1986, MAR ECOL PROG SER, V31, P105, DOI 10.3354/meps031105; BAKER CS, 1987, MAR ECOL PROG SER, V41, P103, DOI 10.3354/meps041103; BAKER CS, 1990, NATURE, V344, P238, DOI 10.1038/344238a0; BAKER CS, 1994, J HERED, V85, P52; BARAFF L, 1993, MAR MAMMAL SCI, V9, P431, DOI 10.1111/j.1748-7692.1993.tb00476.x; Barendse J, 2011, AFR J MAR SCI, V33, P353, DOI 10.2989/1814232X.2011.637343; Barendse J, 2010, AFR J MAR SCI, V32, P1, DOI 10.2989/18142321003714203; Barlow J, 1997, ECOLOGY, V78, P535; Beck S, 2012, BEHAV ECOL, V23, P246, DOI 10.1093/beheco/arr151; Best PB, 2006, AFR J MAR SCI, V28, P159, DOI 10.2989/18142320609504140; BEST PB, 1995, MAR ECOL PROG SER, V118, P1, DOI 10.3354/meps118001; Best PB., 1994, REPORTS INT WHALING, V44, P467; Best Peter B., 2011, Journal of Cetacean Research and Management, P71; Blouin MS, 2003, TRENDS ECOL EVOL, V18, P503, DOI 10.1016/S0169-5347(03)00225-8; Borgatti S. P., 2002, NETDRAW SOFTWARE NET; BROWN M, 1995, BEHAVIOUR, V132, P163, DOI 10.1163/156853995X00676; BROWN MR, 1995, P ROY SOC B-BIOL SCI, V259, P229, DOI 10.1098/rspb.1995.0034; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Carroll EL, 2014, MAR MAMMAL SCI, V30, P206, DOI 10.1111/mms.12031; Cartwright R, 2009, MAR MAMMAL SCI, V25, P659, DOI 10.1111/j.1748-7692.2009.00286.x; Carvalho I, 2013, MAR BIOL IN PRESS; Cerchio S, 2005, ANIM BEHAV, V70, P267, DOI 10.1016/j.anbehav.2004.10.028; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clapham Phillip J., 1993, Symposia of the Zoological Society of London, V66, P131; CLAPHAM PJ, 1987, CAN J ZOOL, V65, P2853, DOI 10.1139/z87-434; Clapham PJ, 1997, P ROY SOC B-BIOL SCI, V264, P95, DOI 10.1098/rspb.1997.0014; Clapham PJ, 2000, CETACEAN SOCIETIES, P173; CLAPHAM PJ, 1990, MAR MAMMAL SCI, V6, P155, DOI 10.1111/j.1748-7692.1990.tb00238.x; CLAPHAM PJ, 1993, CAN J ZOOL, V71, P440, DOI 10.1139/z93-063; Clapham PJ, 1996, MAMMAL REV, V26, P27, DOI 10.1111/j.1365-2907.1996.tb00145.x; CLAPHAM PJ, 1990, REP INT WHALING COMM, V12, P171; Colbeck GJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2552; CORKERON PJ, 1994, WILDLIFE RES, V21, P293, DOI 10.1071/WR9940293; Craig AS, 2003, BEHAVIOUR, V140, P981, DOI 10.1163/156853903322589605; Dalla Rosa L, 2008, POLAR BIOL, V31, P771, DOI 10.1007/s00300-008-0415-2; Dawbin WH, 1997, QUEENSLAND MUS MEM, V42, P105; Donovan G.P., 1991, Reports of the International Whaling Commission Special Issue, P39; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; Fetterer F, 2002, SEA ICE INDEX; FINDLAY KP, 1995, S AFR J MARINE SCI, V15, P279; Glockner-Ferrari D.A., 1990, REP INTERWHAL COM, V12, P161; Goldbogen JA, 2008, J EXP BIOL, V211, P3712, DOI 10.1242/jeb.023366; Herman LM, 2011, MAR MAMMAL SCI, V27, P736, DOI 10.1111/j.1748-7692.2010.00441.x; Hucke-Gaete R, 2013, AQUAT CONSERV, V23, P858, DOI 10.1002/aqc.2343; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Karczmarski L, 2005, BEHAV ECOL, V16, P675, DOI 10.1093/beheco/ari028; Kenney Robert D., 2001, Journal of Cetacean Research and Management Special Issue, V2, P251; Krutzen M, 2002, MAR MAMMAL SCI, V18, P863, DOI 10.1111/j.1748-7692.2002.tb01078.x; LOCKYER CH, 1981, ANIMAL MIGRATION, P105; Lusseau D, 2003, BEHAV ECOL SOCIOBIOL, V54, P396, DOI 10.1007/s00265-003-0651-y; Madon B, 2013, MAR MAMMAL SCI, V29, P669, DOI 10.1111/j.1748-7692.2012.00610.x; MATTHEWS L. HARRISON, 1938, DISCOVERY REPTS [GOVT DEPENDENCIES FALKLAND ISLANDS], V17, P7; Milligan BG, 2003, GENETICS, V163, P1153; Moore MJ, 1999, MAR MAMMAL SCI, V15, P1287, DOI 10.1111/j.1748-7692.1999.tb00891.x; Nowacek DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019173; Olsen O, 1914, BERGENS MUSEUM ARBOK, V5, P1; Pomilla C, 2005, THESIS NEW YORK U, P202; Pomilla C, 2006, MOL ECOL, V15, P2541, DOI 10.1111/j.1365-294X.2006.02943.x; Ramp C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1563, DOI 10.1007/s00265-010-0970-8; Rasmussen K, 2007, BIOLOGY LETT, V3, P302, DOI 10.1098/rsbl.2007.0067; Reeves RR, 2004, MAR MAMMAL SCI, V20, P774, DOI 10.1111/j.1748-7692.2004.tb01192.x; Rendell L, 2001, BEHAV BRAIN SCI, V24, P309, DOI 10.1017/S0140525X0100396X; Rew MB, 2011, ECOL APPL, V21, P877, DOI 10.1890/10-0348.1; Rock J., 2006, Journal of Cetacean Research and Management, V8, P301; Rosenbaum HC, 2002, J HERED, V93, P389, DOI 10.1093/jhered/93.6.389; Rosenbaum HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007318; Sharpe FA, 2001, THESIS SIMON FRASER, P141; Smith TD, 1999, MAR MAMMAL SCI, V15, P1, DOI 10.1111/j.1748-7692.1999.tb00779.x; Smith TD, 2006, MAR MAMMAL SCI, V22, P723, DOI 10.1111/j.1748-7692.2006.00067.x; Stamation Kasey A., 2007, Aquatic Mammals, V33, P165, DOI 10.1578/AM.33.2.2007.165; Steiger GH, 2000, MAR MAMMAL SCI, V16, P220, DOI 10.1111/j.1748-7692.2000.tb00914.x; Stevick Peter T., 2004, Journal of Cetacean Research and Management, V6, P109; Stevick PT, 2011, BIOL LETTERS, V7, P299, DOI 10.1098/rsbl.2010.0717; Stevick PT, 2003, J ZOOL, V259, P231, DOI 10.1017/S0952836902003151; Stimpert AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051214; STRALEY JM, 1994, MAR MAMMAL SCI, V10, P87, DOI 10.1111/j.1748-7692.1994.tb00392.x; Szabo A, 2008, ANIM BEHAV, V75, P1085, DOI 10.1016/j.anbehav.2007.08.019; Valenzuela LO, 2009, MOL ECOL, V18, P782, DOI 10.1111/j.1365-294X.2008.04069.x; Valsecchi E, 2002, MOL ECOL, V11, P507, DOI 10.1046/j.0962-1083.2001.01459.x; Valsecchi E, 2010, MAR ECOL PROG SER, V398, P275, DOI 10.3354/meps08280; Vigness-Raposa KJ, 2010, MAR MAMMAL SCI, V26, P161, DOI 10.1111/j.1748-7692.2009.00336.x; Vu ET, 2012, AQUAT BIOL, V14, P175, DOI 10.3354/ab00390; Weinrich M, 1998, J MAMMAL, V79, P163, DOI 10.2307/1382851; Weinrich MT, 2006, J HERED, V97, P226, DOI 10.1093/jhered/esj018; WEINRICH MT, 1993, MAR MAMMAL SCI, V9, P325, DOI 10.1111/j.1748-7692.1993.tb00461.x; WEINRICH MT, 1991, CAN J ZOOL, V69, P3005, DOI 10.1139/z91-424; WEINRICH MT, 1991, CAN J ZOOL, V69, P3012, DOI 10.1139/z91-425; WHITEHEAD H, 1983, CAN J ZOOL, V61, P1391, DOI 10.1139/z83-186; WHITEHEAD H, 2008, ANAL ANIMAL SOC QUAN, P320; Whitehead H, 2008, ANIM BEHAV, V75, P1093, DOI 10.1016/j.anbehav.2007.08.022; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Witteveen BH, 2011, AQUAT MAMM, V37, P101, DOI 10.1578/AM.37.2.2011.101; Yurk H, 2002, ANIM BEHAV, V63, P1103, DOI 10.1006/anbe.2002.3012; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295	99	27	29	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81238	10.1371/journal.pone.0081238	http://dx.doi.org/10.1371/journal.pone.0081238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349047	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200020
J	Cheng, M; Li, JH; Negri, A; Coller, BS				Cheng, Ming; Li, Jihong; Negri, Ana; Coller, Barry S.			Swing-Out of the beta 3 Hybrid Domain Is Required for alpha IIb beta 3 Priming and Normal Cytoskeletal Reorganization, but Not Adhesion to Immobilized Fibrinogen	PLOS ONE			English	Article							MURINE MONOCLONAL-ANTIBODY; GLYCOPROTEIN-IIB-IIIA; GPIIB-IIIA; EXTRACELLULAR SEGMENT; PLATELET-AGGREGATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ACTIVATION; BINDING; CONFORMATION	Structural and functional analyses of integrin alpha IIb beta 3 has implicated swing-out motion of the beta 3 hybrid domain in alpha IIb beta 3 activation and ligand binding. Using data from targeted molecular dynamics (TMD) simulations, we engineered two disulfide-bonded mutant receptors designed to limit swing-out (XS-O). XS-O mutants cannot bind the high Mr ligand fibrinogen in the presence of an activating mAb or after introducing mutations into the alpha IIb subunit designed to simulate inside-out signaling. They also have reduced capacity to be "primed'' to bind fibrinogen by pretreatment with eptifibatide. They can, however, bind the small RGD venom protein kistrin. Despite their inability to bind soluble fibrinogen, the XS-O mutants can support adhesion to immobilized fibrinogen, although such adhesion does not initiate outside-in signaling leading to normal cytoskeletal reorganization. Collectively, our data further define the biologic role of beta 3 hybrid domain swing-out in both soluble and immobilized high Mr ligand binding, as well as in priming and outside-in signaling. We also infer that swing-out is likely to be a downstream effect of receptor extension.	[Cheng, Ming; Li, Jihong; Coller, Barry S.] Rockefeller Univ, Allen & Frances Adler Lab Blood & Vasc Biol, New York, NY 10021 USA; [Negri, Ana] Icahn Sch Med Mt Sinai, Dept Struct & Chem Biol, New York, NY USA	Rockefeller University; Icahn School of Medicine at Mount Sinai	Coller, BS (corresponding author), Rockefeller Univ, Allen & Frances Adler Lab Blood & Vasc Biol, 1230 York Ave, New York, NY 10021 USA.	collerb@rockefeller.edu			National Center for Research Resource [HL 19278, UL1-RR024143]; Stony Brook University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019278] Funding Source: NIH RePORTER	National Center for Research Resource(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Stony Brook University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grants HL 19278 and UL1-RR024143 (Clinical and Translational Science Award) from the National Center for Research Resource, and funds from Stony Brook University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Blue R, 2008, BLOOD, V111, P1248, DOI 10.1182/blood-2007-08-105544; Blue R, 2010, J BIOL CHEM, V285, P17604, DOI 10.1074/jbc.M110.107763; Blue R, 2009, BLOOD, V114, P195, DOI 10.1182/blood-2008-08-169243; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; CHERESH DA, 1987, P NATL ACAD SCI USA, V84, P6471, DOI 10.1073/pnas.84.18.6471; Chew D P, 2001, Am J Cardiovasc Drugs, V1, P421, DOI 10.2165/00129784-200101060-00002; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; COLLER BS, 1980, BLOOD, V55, P169; Coller BS, 2001, THROMB HAEMOSTASIS, V86, P427; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; COLLER BS, 1983, J CLIN INVEST, V72, P325, DOI 10.1172/JCI110973; COLLER BS, 1993, J CLIN INVEST, V92, P2796, DOI 10.1172/JCI116899; Cox D, 2004, CURR PHARM DESIGN, V10, P1587, DOI 10.2174/1381612043384673; DENNIS MS, 1990, P NATL ACAD SCI USA, V87, P2471, DOI 10.1073/pnas.87.7.2471; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Eng ET, 2011, J BIOL CHEM; Hantgan RR, 2009, BIOCHEMISTRY-US, V48, P8355, DOI 10.1021/bi900475k; HONDA S, 1995, J BIOL CHEM, V270, P11947, DOI 10.1074/jbc.270.20.11947; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Jones ML, 2010, J THROMB HAEMOST, V8, P567, DOI 10.1111/j.1538-7836.2009.03719.x; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Kamata T, 2010, J BIOL CHEM, V285, P38428, DOI 10.1074/jbc.M110.139667; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; KUTOK JL, 1994, THROMB HAEMOSTASIS, V72, P964; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Luo BH, 2004, J BIOL CHEM, V279, P10215, DOI 10.1074/jbc.M312732200; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Moskowitz KA, 1998, THROMB HAEMOSTASIS, V79, P824, DOI 10.1055/s-0037-1615072; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PHILLIPS DR, 1991, CELL, V65, P359, DOI 10.1016/0092-8674(91)90451-4; Provasi D, 2009, PROTEINS, V77, P477, DOI 10.1002/prot.22463; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SHATTIL SJ, 1987, BLOOD, V70, P307; Smagghe BJ, 2010, J BIOL CHEM, V285, P32954, DOI 10.1074/jbc.M110.145177; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Tokuhira M, 1996, THROMB HAEMOSTASIS, V76, P1038; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Ye F, 2010, J CELL BIOL, V188, P157, DOI 10.1083/jcb.200908045; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; Zhu JQ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003576	46	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81609	10.1371/journal.pone.0081609	http://dx.doi.org/10.1371/journal.pone.0081609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349096	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200037
J	Sermadiras, I; Revell, J; Linley, JE; Sandercock, A; Ravn, P				Sermadiras, Isabelle; Revell, Jefferson; Linley, John E.; Sandercock, Alan; Ravn, Peter			Recombinant Expression and In Vitro Characterisation of Active Huwentoxin-IV	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; SODIUM-CHANNEL ANTAGONIST; SALMON-CALCITONIN; BONDED PROTEINS; PURIFICATION; PEPTIDES; VENOM; NEUROTOXIN; AMIDATION; BINDING	Huwentoxin-IV (HwTx-IV) is a 35-residue neurotoxin peptide with potential application as a novel analgesic. It is a member of the inhibitory cystine knot (ICK) peptide family, characterised by a compact globular structure maintained by three intramolecular disulfide bonds. Here we describe a novel strategy for producing non-tagged, fully folded ICK-toxin in a bacterial system. HwTx-IV was expressed as a cleavable fusion to small ubiquitin-related modifier (SUMO) in the cytoplasm of the SHuffle T7 Express lysY Escherichia coli strain, which allows cytosolic disulfide bond formation. Purification by IMAC with selective elution of monomeric SUMO fusion followed by proteolytic cleavage and polishing chromatographic steps yielded pure homogeneous toxin. Recombinant HwTx-IV is produced with a C-terminal acid, whereas the native peptide is C-terminally amidated. HwTx-IV(acid) inhibited Na(v)1.7 in a dose dependent manner (IC50 = 463-727 nM). In comparison to HwTx-IV(amide) (IC50 = 11 +/- 3 nM), the carboxylate was similar to 50 fold less potent on Na(v)1.7, which highlights the impact of the C-terminus. As the amide bond of an additional amino acid may mimic the carboxamide, we expressed the glycine-extended analogue HwTx-IVG36(acid) in the SUMO/SHuffle system. The peptide was approximately three fold more potent on Na(v)1.7 in comparison to HwTx-IV( acid) (IC50 = 190 nM). In conclusion, we have established a novel system for expression and purification of fully folded and active HwTx-IV(acid) in bacteria, which could be applicable to other structurally complex and cysteine rich peptides. Furthermore, we discovered that glycine extension of HwTx-IV(acid) restores some of the potency of the native carboxamide. This finding may also apply to other C-terminally amidated peptides produced recombinantly.	[Sermadiras, Isabelle; Revell, Jefferson; Sandercock, Alan; Ravn, Peter] MedImmune, Antibody Discovery & Prot Engn, Res, Cambridge, England; [Linley, John E.] MedImmune, Neurosci In Vitro Biol, Cambridge, England	AstraZeneca; Medimmune; AstraZeneca; Medimmune	Sermadiras, I (corresponding author), MedImmune, Antibody Discovery & Prot Engn, Res, Cambridge, England.	sermadirasi@medimmune.com		Linley, John/0000-0001-6450-8805; Sermadiras, Isabelle/0000-0002-9443-9131	MedImmune	MedImmune(AstraZenecaMedimmune)	This work was funded by MedImmune. MedImmune employees had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Berkmen M, 2005, J BIOL CHEM, V280, P11387, DOI 10.1074/jbc.M411774200; Berkmen M, 2012, PROTEIN EXPRES PURIF, V82, P240, DOI 10.1016/j.pep.2011.10.009; Bessette PH, 1999, P NATL ACAD SCI USA, V96, P13703, DOI 10.1073/pnas.96.24.13703; Bosse-Doenecke E, 2008, PROTEIN EXPRES PURIF, V58, P114, DOI 10.1016/j.pep.2007.10.012; Cao ZJ, 2003, PEPTIDES, V24, P187, DOI 10.1016/S0196-9781(03)00025-1; Chakraborty C, 2004, PROTEIN PEPTIDE LETT, V11, P165, DOI 10.2174/0929866043478266; Che NY, 2009, PROTEIN EXPRES PURIF, V65, P154, DOI 10.1016/j.pep.2009.02.002; Cottingham IR, 2001, NAT BIOTECHNOL, V19, P974, DOI 10.1038/nbt1001-974; Cox JJ, 2006, NATURE, V444, P894, DOI 10.1038/nature05413; Craik DJ, 2001, TOXICON, V39, P43, DOI 10.1016/S0041-0101(00)00160-4; Cummins TR, 2004, J NEUROSCI, V24, P8232, DOI 10.1523/JNEUROSCI.2695-04.2004; Diao JB, 2003, TOXICON, V42, P715, DOI 10.1016/j.toxicon.2003.08.007; Escoubas P, 2003, PROTEIN SCI, V12, P1332, DOI 10.1110/ps.0307003; Ji WJ, 2005, PROTEIN EXPRES PURIF, V41, P454, DOI 10.1016/j.pep.2005.02.012; Klint JK, 2012, TOXICON, V60, P478, DOI 10.1016/j.toxicon.2012.04.337; Kurokawa Y, 2001, J BIOL CHEM, V276, P14393, DOI 10.1074/jbc.M100132200; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Li M, 2000, TOXICON, V38, P153, DOI 10.1016/S0041-0101(99)00123-3; Lobstein J, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-56; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Mao YC, 2008, TOXICON, V51, P230, DOI 10.1016/j.toxicon.2007.09.008; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Mehta NM, 2009, POSTTRANSLATIONAL MO, P253; Meng E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021608; Nozach H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-37; Peng K, 2002, J BIOL CHEM, V277, P47564, DOI 10.1074/jbc.M204063200; Pluzhnikov K, 2007, TOXICON, V50, P993, DOI 10.1016/j.toxicon.2007.07.004; Prigge ST, 1997, SCIENCE, V278, P1300, DOI 10.1126/science.278.5341.1300; Qi XQ, 2008, J MICROBIOL BIOTECHN, V18, P1076; Qiu J, 1998, APPL ENVIRON MICROB, V64, P4891; Ray MVL, 2002, PROTEIN EXPRES PURIF, V26, P249, DOI 10.1016/S1046-5928(02)00523-5; Revell JD, 2013, PEPTIDES, V44, P40, DOI 10.1016/j.peptides.2013.03.011; Satakarni M, 2011, PROTEIN EXPRES PURIF, V78, P113, DOI 10.1016/j.pep.2011.04.015; Schmoldt HU, 2005, PROTEIN EXPRES PURIF, V39, P82, DOI 10.1016/j.pep.2004.09.016; Seong B. L., 2001, BIOTECHNOL BIOPROC E, V6, P244; Singer HM, 2012, MBIO, V3, P1, DOI [10.3391/mbi.2012.3.1.01, DOI 10.3391/MBI.2012.3.1.01.PUBMED:22647788]; Smith JJ, 2007, J BIOL CHEM, V282, P12687, DOI 10.1074/jbc.M610462200; Tait AR, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-51; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Zhang ZZ, 2004, PROTEIN EXPRES PURIF, V36, P292, DOI 10.1016/j.pep.2004.03.014	40	21	23	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e83202	10.1371/journal.pone.0083202	http://dx.doi.org/10.1371/journal.pone.0083202			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324842	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566700122
J	Caddy, S; Emmott, E; El-Attar, L; Mitchell, J; de Rougemont, A; Brownlie, J; Goodfellow, I				Caddy, Sarah; Emmott, Edward; El-Attar, Laila; Mitchell, Judy; de Rougemont, Alexis; Brownlie, Joe; Goodfellow, Ian			Serological Evidence for Multiple Strains of Canine Norovirus in the UK Dog Population	PLOS ONE			English	Article							NORWALK-LIKE VIRUS; SPORADIC GASTROENTERITIS; INFECTION; PCR; CALICIVIRUSES; CORONAVIRUS; OUTBREAK; DISEASE	Noroviruses are associated with intestinal disease in humans, cows, pigs, mice, and, more recently, dogs. In 2007, the first canine norovirus (CNV) was identified and characterized in Italy. Subsequent studies have identified CNV in stools of dogs from Portugal, Greece, and the United States. To investigate the prevalence of CNV in the UK dog population, 228 canine stool samples were screened for CNV by qPCR, and 396 serum samples were screened for anti-CNV antibodies. qPCR of RNA extracted from canine stool samples did not reveal any CNV-positive samples, based on samples collected from diarrhoeic and control dogs in 2012-2013. CNV virus-like particles to three different CNV strains were produced using recombinant baculoviruses and a seroprevalence screen undertaken. Anti-CNV antibodies were identified at significant levels in canine serum; 38.1% of samples collected between 1999-2001 and 60.1% of samples collected in 2012-2013 were seropositive. The increase in seroprevalence over time (p<0.001) suggests that the CNV strains screened for are becoming more widespread. Variation in seroprevalence to different CNV strains was also identified. Two-thirds of the dogs were seropositive to a single strain, whereas the remaining third were seropositive to two or three of the strains analysed. This study has provided the first evidence that CNV is present in the UK, with seroprevalence identified to multiple circulating strains. This warrants further study and increased awareness of this recently discovered canine virus.	[Caddy, Sarah; Emmott, Edward; Goodfellow, Ian] Univ Cambridge, Dept Pathol, Div Virol, Addenbrookes Hosp, Cambridge CB2 1TN, England; [Caddy, Sarah] Univ London Imperial Coll Sci Technol & Med, Fac Med, Virol Sect, London, England; [El-Attar, Laila; Mitchell, Judy; Brownlie, Joe] Univ London Royal Vet Coll, Dept Pathol & Pathogen Biol, Hatfield, Herts, England; [de Rougemont, Alexis] Univ Bourgogne, Virol Lab, Univ Hosp Dijon, Natl Reference Ctr Enter Viruses, Dijon, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; University of London; University of London Royal Veterinary College; CHU Dijon Bourgogne; Universite de Bourgogne	Caddy, S (corresponding author), Univ Cambridge, Dept Pathol, Div Virol, Addenbrookes Hosp, Hills Rd, Cambridge CB2 1TN, England.	slc50@cam.ac.uk; ig299@cam.ac.uk	de ROUGEMONT, Alexis/M-1090-2016; Caddy, Sarah/AAG-9891-2019	de ROUGEMONT, Alexis/0000-0002-3084-9414; Caddy, Sarah/0000-0002-9790-7420; Emmott, Edward/0000-0002-3239-8178; Goodfellow, Ian/0000-0002-9483-510X	MRC DTA grant [G1100171]; Wellcome Trust grant [WT097997MA]; Medical Research Council [1110704] Funding Source: researchfish	MRC DTA grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust grant(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: SC: MRC DTA grant - G1100171 www.mrc.ac.uk; IG: Wellcome Trust grant - WT097997MA www.wellcome.ac.uk. IG is a Wellcome Senior Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azevedo M., 2012, AM SOC VIR C, P23; Belliot G, 2001, J CLIN MICROBIOL, V39, P4288, DOI 10.1128/JCM.39.12.4288-4295.2001; Decaro N, 2005, VET MICROBIOL, V105, P19, DOI 10.1016/j.vetmic.2004.09.018; Di Martino B, 2010, CLIN VACCINE IMMUNOL, V17, P180, DOI 10.1128/CVI.00312-09; Erles K, 2003, VIROLOGY, V310, P216, DOI 10.1016/S0042-6822(03)00160-0; Jiang X, 1999, J VIROL METHODS, V83, P145, DOI 10.1016/S0166-0934(99)00114-7; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kobayashi S, 2009, MICROBIOL IMMUNOL, V53, P356, DOI 10.1111/j.1348-0421.2009.00132.x; Martella V, 2008, EMERG INFECT DIS, V14, P1306, DOI 10.3201/eid1408.080062; Martella V, 2007, EMERG INFECT DIS, V13, P1071, DOI 10.3201/eid1307.070268; Martella V, 2009, J VIROL, V83, P11391, DOI 10.1128/JVI.01385-09; Mesquita JR, 2012, TRANSBOUND EMERG DIS, V59, P456, DOI 10.1111/j.1865-1682.2011.01284.x; Mesquita JR, 2010, EMERG INFECT DIS, V16, P980, DOI 10.3201/eid1606.091861; Ntafis V, 2010, J CLIN MICROBIOL, V48, P2605, DOI 10.1128/JCM.02528-09; Nurminen K, 2011, J MED VIROL, V83, P525, DOI 10.1002/jmv.21990; Patel MM, 2008, EMERG INFECT DIS, V14, P1224, DOI 10.3201/eid1408.071114; Pereira C, 2012, J MICROBIOL METH, V91, P358, DOI 10.1016/j.mimet.2012.09.007; Phan TG, 2007, J MED VIROL, V79, P1388, DOI 10.1002/jmv.20924; Pinto P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032739; Rockx B, 2002, CLIN INFECT DIS, V35, P246, DOI 10.1086/341408; Scheltinga SA, 2005, J CLIN VIROL, V33, P306, DOI 10.1016/j.jcv.2004.08.021; Stavisky J, 2012, INFECT GENET EVOL, V12, P1419, DOI 10.1016/j.meegid.2012.04.010; Sugieda M, 1998, ARCH VIROL, V143, P1215, DOI 10.1007/s007050050369; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; TENNANT BJ, 1993, VET REC, V132, P7, DOI 10.1136/vr.132.1.7; TENNANT BJ, 1991, J SMALL ANIM PRACT, V32, P175, DOI 10.1111/j.1748-5827.1991.tb00539.x; Tran TNH, 2013, J CLIN VIROL, V56, P185, DOI 10.1016/j.jcv.2012.11.011; Tse H, 2012, J VIROL, V86, P9531, DOI 10.1128/JVI.01312-12; Wang YH, 2012, ARCH VIROL, V157, P2417, DOI 10.1007/s00705-012-1437-1; WOODE GN, 1978, J MED MICROBIOL, V11, P441, DOI 10.1099/00222615-11-4-441; WYATT RG, 1974, J INFECT DIS, V129, P709, DOI 10.1093/infdis/129.6.709; XI JA, 1992, J VIROL, V66, P6527, DOI 10.1128/JVI.66.11.6527-6532.1992; Zheng DP, 2006, VIROLOGY, V346, P312, DOI 10.1016/j.virol.2005.11.015	33	21	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81596	10.1371/journal.pone.0081596	http://dx.doi.org/10.1371/journal.pone.0081596			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339947	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100068
J	Gijsbers, EF; Feenstra, KA; van Nuenen, AC; Navis, M; Heringa, J; Schuitemaker, H; Kootstra, NA				Gijsbers, Esther F.; Feenstra, K. Anton; van Nuenen, Ad C.; Navis, Marjon; Heringa, Jaap; Schuitemaker, Hanneke; Kootstra, Neeltje A.			HIV-1 Replication Fitness of HLA-B*57/58:01 CTL Escape Variants Is Restored by the Accumulation of Compensatory Mutations in Gag	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DETECTING FUNCTIONAL SPECIFICITY; T-LYMPHOCYTE ESCAPE; IMMUNE-RESPONSES; SEQUENCE HARMONY; CELL RESPONSES; INFECTION; VIREMIA; RESTRICTION; ASSOCIATION	Expression of HLA-B*57 and the closely related HLA-B*58:01 are associated with prolonged survival after HIV-1 infection. However, large differences in disease course are observed among HLA-B*57/58:01 patients. Escape mutations in CTL epitopes restricted by these HLA alleles come at a fitness cost and particularly the T242N mutation in the TW10 CTL epitope in Gag has been demonstrated to decrease the viral replication capacity. Additional mutations within or flanking this CTL epitope can partially restore replication fitness of CTL escape variants. Five HLA-B*57/58:01 progressors and 5 HLA-B*57/58:01 long-term nonprogressors (LTNPs) were followed longitudinally and we studied which compensatory mutations were involved in the restoration of the viral fitness of variants that escaped from HLA-B*57/58:01-restricted CTL pressure. The Sequence Harmony algorithm was used to detect homology in amino acid composition by comparing longitudinal Gag sequences obtained from HIV-1 patients positive and negative for HLA-B*57/58:01 and from HLA-B*57/58:01 progressors and LTNPs. Although virus isolates from HLA-B*57/58:01 individuals contained multiple CTL escape mutations, these escape mutations were not associated with disease progression. In sequences from HLA-B*57/58:01 progressors, 5 additional mutations in Gag were observed: 5126N, L215T, H219Q, M228I and N252H. The combination of these mutations restored the replication fitness of CTL escape HIV-1 variants. Furthermore, we observed a positive correlation between the number of escape and compensatory mutations in Gag and the replication fitness of biological HIV-1 variants isolated from HLA-B*57/58:01 patients, suggesting that the replication fitness of HLA-B*57/58:01 escape variants is restored by accumulation of compensatory mutations.	[Gijsbers, Esther F.; van Nuenen, Ad C.; Navis, Marjon; Schuitemaker, Hanneke; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, NL-1105 AZ Amsterdam, Netherlands; [Gijsbers, Esther F.; van Nuenen, Ad C.; Navis, Marjon; Schuitemaker, Hanneke; Kootstra, Neeltje A.] Univ Amsterdam, Acad Med Ctr, Ctr Infect Dis & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Feenstra, K. Anton; Heringa, Jaap] Vrije Univ Amsterdam, Ctr Integrat Bioinformat IBIVU, Amsterdam, Netherlands; [Feenstra, K. Anton; Heringa, Jaap] Vrije Univ Amsterdam, AIMMS, Amsterdam, Netherlands; [Feenstra, K. Anton; Heringa, Jaap] Netherlands Bioinformat Ctr NBIC, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Kootstra, NA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Expt Immunol, Landsteiner Lab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	N.A.Kootstra@amc.uva.nl	Feenstra, Anton/H-9195-2019	Feenstra, Anton/0000-0001-6755-9667; Kootstra, Neeltje A./0000-0001-9429-7754	Aids Fonds Netherlands [2008023]	Aids Fonds Netherlands	This work was supported by the Aids Fonds Netherlands [grant 2008023]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Altfeld M, 2006, PLOS MED, V3, P1851, DOI 10.1371/journal.pmed.0030403; Battivelli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052434; Battivelli E, 2011, J VIROL, V85, P11846, DOI 10.1128/JVI.05201-11; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brandt BW, 2010, NUCLEIC ACIDS RES, V38, pW35, DOI 10.1093/nar/gkq415; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Brockman MA, 2010, J VIROL, V84, P11937, DOI 10.1128/JVI.01086-10; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chopera DR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000033; Crawford H, 2007, J VIROL, V81, P8346, DOI 10.1128/JVI.00465-07; Crawford H, 2011, J VIROL, V85, P1384, DOI 10.1128/JVI.01879-10; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Feenstra KA, 2007, NUCLEIC ACIDS RES, V35, pW495, DOI 10.1093/nar/gkm406; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Goulder P, 1997, IMMUNOL REV, V159, P17, DOI 10.1111/j.1600-065X.1997.tb01004.x; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Kent SJ, 1997, J INFECT DIS, V176, P1188, DOI 10.1086/514112; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Kootstra NA, 2007, AIDS, V21, P2015, DOI 10.1097/QAD.0b013e3282effa87; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie AJ, 2004, NAT MED, V10, P282, DOI 10.1038/nm992; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; TERSMETTE M, 1989, VIROLOGY, V171, P149, DOI 10.1016/0042-6822(89)90521-7; van't Wout AB, 2008, NAT PROTOC, V3, P363, DOI 10.1038/nprot.2008.3; Wang YYE, 2009, J VIROL, V83, P1845, DOI 10.1128/JVI.01061-08	40	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81235	10.1371/journal.pone.0081235	http://dx.doi.org/10.1371/journal.pone.0081235			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339913	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100045
J	Qiu, ZX; Zhang, K; Qiu, XS; Zhou, M; Li, WM				Qiu, Zhi-Xin; Zhang, Kui; Qiu, Xue-Song; Zhou, Min; Li, Wei-Min			The Prognostic Value of Phosphorylated AKT Expression in Non-Small Cell Lung Cancer: A Meta-Analysis	PLOS ONE			English	Article							PROTEIN-KINASE-B; ACTIVATION; SURVIVAL; OVEREXPRESSION; PATHWAY; AMPLIFICATION; STATISTICS; CARCINOMA; ONCOGENE; 3-KINASE	Objectives: Phosphorylated AKT (p-AKT), constitutive activation of AKT, is a potentially interesting prognostic marker and therapeutic target in non-small cell lung cancer (NSCLC). However, the available results of p-AKT expression in NSCLC are heterogeneous. Therefore, a meta-analysis of published researches investigating the prognostic relevance of p-AKT expression in patients with NSCLC was performed. Materials and Methods: A literature search via PubMed, EMBASE and CNKI (China National Knowledge Infrastructure) databases was conducted. Data from eligible studies were extracted and included into meta-analysis using a random effects model. Results: A total of 1049 patients from nine studies were included in the meta-analysis. Nine studies investigated the relationship between p-AKT expression and overall survival using univariate analysis, and five of these undertook multivariate analysis. The pooled hazard ratio (HR) for overall survival was 1.49 (95% confidence interval (CI): 1.01-2.20) by univariate analysis and 1.02 (95% CI: 0.54-1.95) by multivariate analysis. Conclusion: Our study shows that positive expression of p-AKT is associated with poor prognosis in patients with NSCLC. However, adequately designed prospective studies need to perform.	[Qiu, Zhi-Xin; Li, Wei-Min] Sichuan Univ, Dept Resp Med, West China Hosp, Chengdu 610064, Peoples R China; [Zhang, Kui] Sichuan Univ, West China Sch Preclin & Forens Med, Chengdu 610064, Sichuan, Peoples R China; [Qiu, Xue-Song] Yubei Dist Peoples Hosp, Dept Pathol, Chongqing, Peoples R China; [Zhou, Min] Ctr Dis Control & Prevent, Chongqing, Peoples R China	Sichuan University; Sichuan University; Chinese Center for Disease Control & Prevention	Li, WM (corresponding author), Sichuan Univ, Dept Resp Med, West China Hosp, Chengdu 610064, Peoples R China.	weimi003@yahoo.com	qiu, zhixin/HHC-0554-2022	qiu, zhixin/0000-0003-0256-4419	Nature Science Foundation of China [30771227, 81241068]; Technology Support Program of Science and Technology Department of Sichuan Province [2011SZ0194]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Support Program of Science and Technology Department of Sichuan Province	This work was supported by grants from the Nature Science Foundation of China (30771227, 81241068), and Technology Support Program of Science and Technology Department of Sichuan Province (2011SZ0194). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SJ, 2012, EXP THER MED, V4, P226, DOI 10.3892/etm.2012.577; Brognard J, 2001, CANCER RES, V61, P3986; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cappuzzo F, 2004, JNCI-J NATL CANCER I, V96, P1133, DOI 10.1093/jnci/djh217; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Coffer PJ, 1998, BIOCHEM J, V335, P1; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; Davies MA, 1999, CANCER RES, V59, P2551; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Ermoian RP, 2002, CLIN CANCER RES, V8, P1100; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Horiguchi A, 2003, J UROLOGY, V169, P710, DOI 10.1016/S0022-5347(05)63998-5; Huang Y.Y, 2011, THESIS NATL CHUNG CH; Hutchinson J, 2001, MOL CELL BIOL, V21, P2203, DOI 10.1128/MCB.21.6.2203-2212.2001; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Liu D, 2011, CANCER-AM CANCER SOC, V117, P3763, DOI 10.1002/cncr.25959; Malik SN, 2002, CLIN CANCER RES, V8, P1168; Moore SM, 1998, CANCER RES, V58, P5239; Nakanishi K, 2002, CANCER RES, V62, P2971; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Pu Rong, 2010, Sichuan Da Xue Xue Bao Yi Xue Ban, V41, P586; Ruggeri BA, 1998, MOL CARCINOGEN, V21, P81, DOI 10.1002/(SICI)1098-2744(199802)21:2<81::AID-MC1>3.0.CO;2-R; Shah A, 2005, CLIN CANCER RES, V11, P2930, DOI 10.1158/1078-0432.CCR-04-1385; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Tsao AS, 2003, CANCER EPIDEM BIOMAR, V12, P660; Tsurutani J, 2007, LUNG CANCER, V55, P115, DOI 10.1016/j.lungcan.2006.09.026; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang J, 2011, CARCINOGENESIS, V32, P411, DOI 10.1093/carcin/bgq266; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; ZHANG K, 2013, FAM CANC	33	19	20	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81451	10.1371/journal.pone.0081451	http://dx.doi.org/10.1371/journal.pone.0081451			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24349071	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100059
J	Talasila, KM; Brekka, N; Mangseth, K; Stieber, D; Evensen, L; Rosland, GV; Torsvik, A; Wagner, M; Niclou, SP; Mahesparan, R; Vintermyr, OK; Bjerkvig, R; Nigro, JM; Miletic, H				Talasila, Krishna M.; Brekka, Narve; Mangseth, Kjersti; Stieber, Daniel; Evensen, Lasse; Rosland, Gro V.; Torsvik, Anja; Wagner, Marek; Niclou, Simone P.; Mahesparan, Rupavathana; Vintermyr, Olav K.; Bjerkvig, Rolf; Nigro, Janice M.; Miletic, Hrvoje			Tumor versus Stromal Cells in Culture-Survival of the Fittest?	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; GROWTH-FACTOR RECEPTORS; HUMAN GLIOBLASTOMA; GLIOMA-CELLS; FATE CHOICE; IN-VIVO; LINES; EXPRESSION; TUMORIGENICITY; XENOGRAFTS	Two of the signature genetic events that occur in human gliomas, EGFR amplification and IDH mutation, are poorly represented in experimental models in vitro. EGFR amplification, for example, occurs in 40 to 50% of GBM, and yet, EGFR amplification is rarely preserved in cell cultures derived from human tumors. To analyze the fate of EGFR amplified and IDH mutated cells in culture, we followed the development over time of cultures derived from human xenografts in nude rats enriched for tumor cells with EGFR amplification and of cultures derived from patient samples with IDH mutations, in serum monolayer and spheroid suspension culture, under serum and serum free conditions. We observed under serum monolayer conditions, that nestin positive or nestin and SMA double positive rat stromal cells outgrew EGFR amplified tumor cells, while serum spheroid cultures preserved tumor cells with EGFR amplification. Serum free suspension culture exhibited a more variable cell composition in that the resultant cell populations were either predominantly nestin/SOX2 co-expressing rat stromal cells or human tumor cells, or a mixture of both. The selection for nestin/SMA positive stromal cells under serum monolayer conditions was also consistently observed in human oligodendrogliomas and oligoastrocytomas with IDH mutations. Our results highlight for the first time that serum monolayer conditions can select for stromal cells instead of tumor cells in certain brain tumor subtypes. This result has an important impact on the establishment of new tumor cell cultures from brain tumors and raises the question of the proper conditions for the growth of the tumor cell populations of interest.	[Talasila, Krishna M.; Brekka, Narve; Evensen, Lasse; Rosland, Gro V.; Torsvik, Anja; Wagner, Marek; Bjerkvig, Rolf; Nigro, Janice M.; Miletic, Hrvoje] Univ Bergen, Dept Biomed, Bergen, Norway; [Mangseth, Kjersti; Vintermyr, Olav K.; Miletic, Hrvoje] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Stieber, Daniel; Niclou, Simone P.; Bjerkvig, Rolf] CRP Sante, Dept Oncol, NorLux Neurooncol Lab, Luxembourg, Luxembourg; [Mahesparan, Rupavathana] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Luxembourg Institute of Health; University of Bergen; Haukeland University Hospital	Miletic, H (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	Hrvoje.miletic@biomed.uib.no	Wagner, Marek/AAV-9589-2020; Røsland, Gro/E-9291-2019; Niclou, Simone/P-2304-2018; Røsland, Gro/AAQ-8328-2020	Røsland, Gro/0000-0003-3889-1016; Niclou, Simone/0000-0002-3417-9534; Røsland, Gro/0000-0003-3889-1016; Torsvik, Anja/0000-0001-8638-8357; Wagner, Marek/0000-0003-3967-9527	University of Bergen; Norwegian Cancer Society [PK01-2009-0349]; Research Council of Norway [186492]; Norwegian Cancer Society; Helse Vest; Haukeland University Hospital; Bergen Medical Research Foundation	University of Bergen; Norwegian Cancer Society(Norwegian Cancer Society); Research Council of Norway(Research Council of Norway); Norwegian Cancer Society(Norwegian Cancer Society); Helse Vest; Haukeland University Hospital; Bergen Medical Research Foundation	KMT was supported by a Ph.D. fellowship from the University of Bergen. JMN is grateful for the support from the Norwegian Cancer Society (PK01-2009-0349). This work was supported by the Research Council of Norway (grant 186492 to HM), the Norwegian Cancer Society, Helse Vest, Haukeland University Hospital, and the Bergen Medical Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Alliot F, 1999, J NEUROSCI RES, V58, P367; BIGNER SH, 1990, CANCER RES, V50, P8017; BIGNER SH, 1981, J NEUROPATH EXP NEUR, V40, P390, DOI 10.1097/00005072-198107000-00004; BJERKVIG R, 1990, J NEUROSURG, V72, P463, DOI 10.3171/jns.1990.72.3.0463; Branle F, 2002, CANCER-AM CANCER SOC, V95, P641, DOI 10.1002/cncr.10710; Calatozzolo C, 2006, CANCER BIOL THER, V5, P827, DOI 10.4161/cbt.5.7.2838; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Claes A, 2008, BRAIN PATHOL, V18, P423, DOI 10.1111/j.1750-3639.2008.00141.x; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; DAHLSTRAND J, 1992, CANCER RES, V52, P5334; DERIDDER LI, 1987, ACTA NEUROPATHOL, V72, P207, DOI 10.1007/BF00691091; Dudley AC, 2008, CANCER CELL, V14, P201, DOI 10.1016/j.ccr.2008.06.017; Ernst A, 2009, CLIN CANCER RES, V15, P6541, DOI 10.1158/1078-0432.CCR-09-0695; Eshleman JS, 2002, CANCER RES, V62, P7291; Evensen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005798; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Golebiewska A, 2013, BRAIN, V136, P1462, DOI 10.1093/brain/awt025; Huszthy PC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006314; Kelly JJP, 2010, NEURO-ONCOLOGY, V12, P745, DOI 10.1093/neuonc/noq031; Kelly JJP, 2009, STEM CELLS, V27, P1722, DOI 10.1002/stem.98; Kim SM, 2011, CHILD NERV SYST, V27, P911, DOI 10.1007/s00381-011-1396-y; Klink B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059773; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; MARTIN F, 1952, AM J PATHOL, V28, P1107; MAUNOURY R, 1977, ACTA NEUROPATHOL, V39, P33, DOI 10.1007/BF00690383; Mazzoleni S, 2010, CANCER RES, V70, P7500, DOI 10.1158/0008-5472.CAN-10-2353; McLean K, 2011, J CLIN INVEST, V121, P3206, DOI 10.1172/JCI45273; Morozov A, 2010, CLIN CANCER RES, V16, P5630, DOI 10.1158/1078-0432.CCR-09-2886; Najbauer J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035150; Pandita A, 2004, GENE CHROMOSOME CANC, V39, P29, DOI 10.1002/gcc.10300; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Rajan P, 2003, J CELL BIOL, V161, P911, DOI 10.1083/jcb.200211021; Sakariassen PO, 2006, P NATL ACAD SCI USA, V103, P16466, DOI 10.1073/pnas.0607668103; Schulte A, 2012, CLIN CANCER RES, V18, P1901, DOI 10.1158/1078-0432.CCR-11-3084; Talasila KM, 2013, ACTA NEUROPATHOL; The WHO, 2020, CLASSIFICATION TUMOU; Thomas C, 2001, ACTA NEUROPATHOL, V101, P605; Thomas CY, 2003, INT J CANCER, V104, P19, DOI 10.1002/ijc.10880; Tsai RYL, 2000, J NEUROSCI, V20, P3725, DOI 10.1523/JNEUROSCI.20-10-03725.2000; Wang J, 2011, NEUROPATH APPL NEURO, V37, P189, DOI 10.1111/j.1365-2990.2010.01119.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	43	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81183	10.1371/journal.pone.0081183	http://dx.doi.org/10.1371/journal.pone.0081183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24349039	Green Submitted, Green Published, gold			2022-12-27	WOS:000327944500057
J	Deng, JY; Zhang, RP; Zhang, L; Liu, Y; Hao, XS; Liang, H				Deng, Jingyu; Zhang, Rupeng; Zhang, Li; Liu, Yong; Hao, Xishan; Liang, Han			Negative Node Count Improvement Prognostic Prediction of the Seventh Edition of the TNM Classification for Gastric Cancer	PLOS ONE			English	Article							METASTATIC LYMPH-NODES; STAGING SYSTEM; RATIO; SURVIVAL; LYMPHADENECTOMY; CARCINOMA; MICROMETASTASES; ADENOCARCINOMA; NUMBER; APPROPRIATE	Objective: To demonstrate that the seventh edition of the tumor-node-metastasis (TNM) classification for gastric cancer (GC) should be updated with the number of negative lymph nodes for the improvement of its prognostic prediction accuracy. Methods: Clinicopathological data of 769 GC patients who underwent curative gastrectomy with lymphadenectomy between 1997 and 2006 were retrospectively analyzed to demonstrate the superiority of prognostic efficiency of the seventh edition of the TNM classification, which can be improved by combining the number of negative lymph nodes. Results: With the Cox regression multivariate analysis, the seventh edition of the TNM classification, the number of negative nodes, the type of gastrectomy, and the depth of tumor invasion (T stage) were identified as independent factors for predicting the overall survival of GC patients. Furthermore, we confirmed that the T stage-N stage-number of negative lymph nodes-metastasis (TNnM) classification is the most appropriate prognostic predictor of GC patients by using case-control matched fashion and multinominal logistic regression. Finally, we were able to clarify that TNnM classification may provide more precise survival differences among the different TNM sub-stages of GC by using the measure of agreement (Kappa coefficient), the McNemar value, the Akaike information criterion, and the Bayesian Information Criterion compared with the seventh edition of the TNM classification. Conclusion: The number of negative nodes, as an important prognostic predictor of GC, can improve the prognostic prediction efficiency of the seventh edition of the TNM classification for GC, which should be recommended for conventional clinical applications.	[Deng, Jingyu; Zhang, Rupeng; Zhang, Li; Liu, Yong; Hao, Xishan; Liang, Han] Tianjin Med Univ, Canc Inst & Hosp, Gastr Canc Surg Div, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China	Tianjin Medical University	Liang, H (corresponding author), Tianjin Med Univ, Canc Inst & Hosp, Gastr Canc Surg Div, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China.	tjlianghan@sohu.com			National Basic Research Program of China (973 Program) [2010CB529301]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was partly supported by grants from the National Basic Research Program of China (973 Program) 2010CB529301. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ADACHI Y, 1994, BRIT J SURG, V81, P414, DOI 10.1002/bjs.1800810331; Ahn HS, 2010, CANCER-AM CANCER SOC, V116, P5592, DOI 10.1002/cncr.25550; Ampil FL, 2009, J ORAL MAXIL SURG, V67, P2473, DOI 10.1016/j.joms.2009.04.126; Arigami T, 2013, ANN SURG ONCOL, V20, P515, DOI 10.1245/s10434-012-2355-x; Bilici A, 2010, ONKOLOGIE, V33, P101, DOI 10.1159/000277927; Cao LA, 2011, J SURG ONCOL, V103, P53, DOI 10.1002/jso.21755; Chae S, 2011, GASTRIC CANCER, V14, P166, DOI 10.1007/s10120-011-0024-6; Cho YK, 2008, CANCER-AM CANCER SOC, V112, P352, DOI 10.1002/cncr.23185; Deng JY, 2008, J SURG ONCOL, V98, P343, DOI 10.1002/jso.21119; Deng JY, 2011, LANGENBECK ARCH SURG, V396, P615, DOI 10.1007/s00423-011-0753-3; Deng JY, 2010, ANN SURG ONCOL, V17, P1259, DOI 10.1245/s10434-010-0939-x; Deng JY, 2010, ANN SURG ONCOL, V17, P1043, DOI 10.1245/s10434-009-0863-0; Fang WL, 2011, WORLD J SURG, V35, P2723, DOI 10.1007/s00268-011-1275-4; Fukagawa T, 2009, ANN SURG ONCOL, V16, P609, DOI 10.1245/s10434-008-0290-7; Gobbi PG, 2011, J GASTROINTEST SURG, V15, P935, DOI 10.1007/s11605-011-1522-x; Harrison L E, 1998, J Gastrointest Surg, V2, P126, DOI 10.1016/S1091-255X(98)80002-4; HERMANEK P, 1994, SEMIN SURG ONCOL, V10, P12, DOI 10.1002/ssu.2980100105; Huang CM, 2011, EJSO-EUR J SURG ONC, V37, P481, DOI 10.1016/j.ejso.2011.01.012; Ishida K, 1997, CANCER, V79, P1069, DOI 10.1002/(SICI)1097-0142(19970315)79:6<1069::AID-CNCR3>3.0.CO;2-B; JAEHNE J, 1992, ARCH SURG-CHICAGO, V127, P290; Johnson PM, 2006, J CLIN ONCOL, V24, P3570, DOI 10.1200/JCO.2006.06.8866; Katai H, 2000, CANCER-AM CANCER SOC, V88, P1796, DOI 10.1002/(SICI)1097-0142(20000415)88:8<1796::AID-CNCR6>3.3.CO;2-U; Kikuchi S, 2011, ANTICANCER RES, V31, P2361; Kim JJ, 2009, EJSO-EUR J SURG ONC, V35, P409, DOI 10.1016/j.ejso.2008.05.004; Kim JH, 2008, J SURG ONCOL, V97, P125, DOI 10.1002/jso.20937; Kulig J, 2009, BRIT J SURG, V96, P910, DOI 10.1002/bjs.6653; Lee SY, 2010, INT J ONCOL, V36, P1461, DOI 10.3892/ijo_00000632; Maduekwe UN, 2010, ANN SURG ONCOL, V17, P1267, DOI 10.1245/s10434-010-0914-6; Marchet A, 2007, ANN SURG, V245, P543, DOI 10.1097/01.sla.0000250423.43436.e1; Marrelli D, 2012, ANN SURG, V255, P486, DOI 10.1097/SLA.0b013e3182389b1a; Nakajima Toshifusa, 2002, Gastric Cancer, V5, P1, DOI 10.1007/s101200200000; Nitsche Ulrich, 2011, Ann Surg, V254, P793, DOI 10.1097/SLA.0b013e3182369101; Ogino S, 2010, AM J GASTROENTEROL, V105, P420, DOI 10.1038/ajg.2009.578; Persiani R, 2009, WORLD J SURG, V33, P2106, DOI 10.1007/s00268-009-0157-5; Qiu MZ, 2011, ANN SURG ONCOL, V18, P1869, DOI 10.1245/s10434-010-1542-x; Saito H, 2007, HEPATO-GASTROENTEROL, V54, P620; Schwarz RE, 2007, ANN SURG ONCOL, V14, P317, DOI 10.1245/s10434-006-9218-2; Smith DD, 2005, J CLIN ONCOL, V23, P7114, DOI 10.1200/JCO.2005.14.621; Sun Z, 2012, ANN SURG ONCOL, V19, P1918, DOI 10.1245/s10434-011-2206-1; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Wang W, 2011, ANN ONCOL, V22, P2049, DOI 10.1093/annonc/mdq716; Wang W, 2011, ANN SURG ONCOL, V18, P1060, DOI 10.1245/s10434-010-1424-2; Warneke VS, 2011, J CLIN ONCOL, V29, P2364, DOI 10.1200/JCO.2010.34.4358; Wu CW, 2001, HEPATO-GASTROENTEROL, V48, P279; Yanagita S, 2008, J SURG RES, V145, P238, DOI 10.1016/j.jss.2007.04.037; Yano K, 2012, GASTRIC CANCER, V15, P287, DOI 10.1007/s10120-011-0105-6; Yonemura Y, 2007, BRIT J SURG, V94, P731, DOI 10.1002/bjs.5604; Yoon HM, 2012, J AM COLL SURGEONS, V214, P88, DOI 10.1016/j.jamcollsurg.2011.09.018	48	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2013	8	11							e80082	10.1371/journal.pone.0080082	http://dx.doi.org/10.1371/journal.pone.0080082			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254KD	24348906	Green Published, Green Submitted, gold			2022-12-27	WOS:000327162900061
J	Mosley, JD; Van Driest, SL; Larkin, EK; Weeke, PE; Witte, JS; Wells, QS; Karnes, JH; Guo, Y; Bastarache, L; Olson, LM; McCarty, CA; Pacheco, JA; Jarvik, GP; Carrell, DS; Larson, EB; Crosslin, DR; Kullo, IJ; Tromp, G; Kuivaniemi, H; Carey, DJ; Ritchie, MD; Denny, JC; Roden, DM				Mosley, Jonathan D.; Van Driest, Sara L.; Larkin, Emma K.; Weeke, Peter E.; Witte, John S.; Wells, Quinn S.; Karnes, Jason H.; Guo, Yan; Bastarache, Lisa; Olson, Lana M.; McCarty, Catherine A.; Pacheco, Jennifer A.; Jarvik, Gail P.; Carrell, David S.; Larson, Eric B.; Crosslin, David R.; Kullo, Iftikhar J.; Tromp, Gerard; Kuivaniemi, Helena; Carey, David J.; Ritchie, Marylyn D.; Denny, Josh C.; Roden, Dan M.			Mechanistic Phenotypes: An Aggregative Phenotyping Strategy to Identify Disease Mechanisms Using GWAS Data	PLOS ONE			English	Article							ELECTRONIC MEDICAL-RECORDS; GENOMIC INSTABILITY; EMERGE NETWORK; CANCER; SUSCEPTIBILITY; ASSOCIATION; RISK; IDENTIFICATION; HERITABILITY; HALLMARKS	A single mutation can alter cellular and global homeostatic mechanisms and give rise to multiple clinical diseases. We hypothesized that these disease mechanisms could be identified using low minor allele frequency (MAF < 0.1) non-synonymous SNPs (nsSNPs) associated with "mechanistic phenotypes'', comprised of collections of related diagnoses. We studied two mechanistic phenotypes: (1) thrombosis, evaluated in a population of 1,655 African Americans; and (2) four groupings of cancer diagnoses, evaluated in 3,009 white European Americans. We tested associations between nsSNPs represented on GWAS platforms and mechanistic phenotypes ascertained from electronic medical records (EMRs), and sought enrichment in functional ontologies across the top-ranked associations. We used a two-step analytic approach whereby nsSNPs were first sorted by the strength of their association with a phenotype. We tested associations using two reverse genetic models and standard additive and recessive models. In the second step, we employed a hypothesis-free ontological enrichment analysis using the sorted nsSNPs to identify functional mechanisms underlying the diagnoses comprising the mechanistic phenotypes. The thrombosis phenotype was solely associated with ontologies related to blood coagulation (Fisher's p = 0.0001, FDR p = 0.03), driven by the F5, P2RY12 and F2RL2 genes. For the cancer phenotypes, the reverse genetics models were enriched in DNA repair functions (p = 261025, FDR p = 0.03) (POLG/FANCI, SLX4/FANCP, XRCC1, BRCA1, FANCA, CHD1L) while the additive model showed enrichment related to chromatid segregation (p = 461026, FDR p = 0.005) (KIF25, PINX1). We were able to replicate nsSNP associations for POLG/FANCI, BRCA1, FANCA and CHD1L in independent data sets. Mechanism-oriented phenotyping using collections of EMR-derived diagnoses can elucidate fundamental disease mechanisms.	[Mosley, Jonathan D.; Larkin, Emma K.; Weeke, Peter E.; Wells, Quinn S.; Karnes, Jason H.; Denny, Josh C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN 37203 USA; [Van Driest, Sara L.] Vanderbilt Univ, Dept Pediat, Nashville, TN USA; [Witte, John S.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bastarache, Lisa; Denny, Josh C.] Vanderbilt Univ, Nashville, TN 37235 USA; [Guo, Yan] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37235 USA; [Olson, Lana M.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Pacheco, Jennifer A.] Northwestern Univ, Ctr Genet Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Jarvik, Gail P.; Crosslin, David R.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Jarvik, Gail P.; Crosslin, David R.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Carrell, David S.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Tromp, Gerard; Kuivaniemi, Helena; Carey, David J.] Geisinger Hlth Syst, Sigfried & Janet Weis Ctr Res, Danville, PA USA; [Ritchie, Marylyn D.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Vanderbilt University; Vanderbilt University; University of California System; University of California San Francisco; Vanderbilt University; Vanderbilt University; Vanderbilt University; Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Mayo Clinic; Geisinger Health System; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Roden, DM (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37203 USA.	dan.roden@vanderbilt.edu	Jarvik, Gail P/N-6476-2014; Denny, Josh/AAL-3359-2021; Roden, Dan/ABD-5412-2021; Kuivaniemi, Helena/Q-8178-2019; Tromp, Gerard/B-2677-2017; Wells, Quinn/D-2686-2014	Jarvik, Gail P/0000-0002-6710-8708; Denny, Josh/0000-0002-3049-7332; Kuivaniemi, Helena/0000-0001-5753-8766; Tromp, Gerard/0000-0002-7761-0806; Wells, Quinn/0000-0003-3899-0313; McCarty, Catherine/0000-0003-1089-0142; Mosley, Jonathan/0000-0001-6421-2887; Pacheco, Jennifer/0000-0001-8021-5818	VUMC Clinical Pharmacology Training grant [T32 GM07569]; electronic MEdical Records and GEnomics (eMERGE) Network [U01-HG-04603, 1U02HG004608-01, 5U01HG006389-02, UO1HG006375, U01-HG04599, U01-HG004609, U01HG006382]; ARRA grant [RC2 GM092618, R01 LM 010685]; Vanderbilt CTSA grant from NCATS/NIH [UL1 TR000445]; NIH [P30DK072488, R01DK088231, R01DK091601]; Pennsylvania Commonwealth Universal Research Enhancement Program; Ben Franklin Technology Development Fund of PA; Geisinger Clinical Research Fund; American Heart Association; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006378, U01HG004599, U01HG006382, U01HG004603, U01HG006389, U01HG006375, U01HG004609, U01HG004608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091601, R01DK088231, P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RC2GM092618, T32GM007569] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM010685] Funding Source: NIH RePORTER	VUMC Clinical Pharmacology Training grant; electronic MEdical Records and GEnomics (eMERGE) Network; ARRA grant; Vanderbilt CTSA grant from NCATS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Commonwealth Universal Research Enhancement Program; Ben Franklin Technology Development Fund of PA; Geisinger Clinical Research Fund; American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the VUMC Clinical Pharmacology Training grant (T32 GM07569), the electronic MEdical Records and GEnomics (eMERGE) Network U01-HG-04603 (Vanderbilt), 1U02HG004608-01 and 5U01HG006389-02 (Marshfield/EIRH), UO1HG006375 (Group Health/University of Washington), U01-HG04599 (Mayo Clinic), U01-HG004609 (Northwestern University), U01HG006382 (Geisinger), an ARRA grant RC2 GM092618, R01 LM 010685, and the Vanderbilt CTSA grant UL1 TR000445 from NCATS/NIH. At Geisinger the work was supported by NIH (P30DK072488, R01DK088231 and R01DK091601), Pennsylvania Commonwealth Universal Research Enhancement Program, the Ben Franklin Technology Development Fund of PA, the Geisinger Clinical Research Fund, and a Grant-In-Aid from the American Heart Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2003, J CLIN INVEST, V112, P398, DOI 10.1172/JCI200317864; Cerhan JR, 2012, CANCER EPIDEM BIOMAR, V21, P1799, DOI 10.1158/1055-9965.EPI-12-0696; Chan THM, 2012, HEPATOLOGY, V55, P491, DOI 10.1002/hep.24709; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cookson WOCM, 1999, BRIT MED BULL, V55, P358, DOI 10.1258/0007142991902420; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Cramer TJ, 2012, THROMB HAEMOSTASIS, V107, P15, DOI 10.1160/TH11-06-0431; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Eyfjord JE, 2005, MUTAT RES-FUND MOL M, V592, P18, DOI 10.1016/j.mrfmmm.2005.05.010; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; FITZMAURICE GM, 1993, BIOMETRIKA, V80, P141, DOI 10.1093/biomet/80.1.141; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; Gottesman O, 2013, GENET MED, V15, P761, DOI 10.1038/gim.2013.72; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Jenkins RB, 2012, NAT GENET, V44, P1122, DOI 10.1038/ng.2388; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Klei L, 2008, GENET EPIDEMIOL, V32, P9, DOI 10.1002/gepi.20257; Kottemann MC, 2013, NATURE, V493, P356, DOI 10.1038/nature11863; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Liu JF, 2009, GENET EPIDEMIOL, V33, P217, DOI 10.1002/gepi.20372; Manis JP, 2007, NEW ENGL J MED, V357, P2426, DOI 10.1056/NEJMp0707712; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; Okamoto S, 1998, CYTOGENET CELL GENET, V83, P25, DOI 10.1159/000015159; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Yang Q, 2012, J PROBAB STAT, V2012, DOI 10.1155/2012/652569; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Seligsohn U, 2001, NEW ENGL J MED, V344, P1222, DOI 10.1056/NEJM200104193441607; Shah NH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002827; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; Wagner GP, 2011, NAT REV GENET, V12, P204, DOI 10.1038/nrg2949; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Yonekawa T, 2012, MOL CELL BIOL, V32, P1387, DOI 10.1128/MCB.05641-11	39	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81503	10.1371/journal.pone.0081503	http://dx.doi.org/10.1371/journal.pone.0081503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349080	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800020
J	Arakaki, Y; Kawai-Toyooka, H; Hamamura, Y; Higashiyama, T; Noga, A; Hirono, M; Olson, BJSC; Nozaki, H				Arakaki, Yoko; Kawai-Toyooka, Hiroko; Hamamura, Yuki; Higashiyama, Tetsuya; Noga, Akira; Hirono, Masafumi; Olson, Bradley J. S. C.; Nozaki, Hisayoshi			The Simplest Integrated Multicellular Organism Unveiled	PLOS ONE			English	Article							FLAGELLAR APPARATUS; COLONY FORMATION; VOLVOCALES; ULTRASTRUCTURE; EVOLUTION; CHLAMYDOMONAS; ORIGIN; CELL; MORPHOGENESIS; CHLOROPLAST	Volvocine green algae represent the "evolutionary time machine" model lineage for studying multicellularity, because they encompass the whole range of evolutionary transition of multicellularity from unicellular Chlamydomonas to >500-celled Volvox. Multicellular volvocalean species including Gonium pectorale and Volvox carteri generally have several common morphological features to survive as integrated multicellular organisms such as "rotational asymmetry of cells" so that the cells become components of the individual and "cytoplasmic bridges between protoplasts in developing embryos" to maintain the species-specific form of the multicellular individual before secretion of new extracellular matrix (ECM). However, these morphological features have not been studied in the four-celled colonial volvocine species Tetrabaena socialis that is positioned in the most basal lineage within the colonial or multicellular volvocine greens. Here we established synchronous cultures of T. socialis and carried out immunofluorescence microscopic and ultrastructural observations to elucidate these two morphological attributes. Based on immunofluorescence microscopy, four cells of the mature T. socialis colony were identical in morphology but had rotational asymmetry in arrangement of microtubular rootlets and separation of basal bodies like G. pectorale and V. carteri. Ultrastructural observations clearly confirmed the presence of cytoplasmic bridges between protoplasts in developing embryos of T. socialis even after the formation of new flagella in each daughter protoplast within the parental ECM. Therefore, these two morphological attributes might have evolved in the common four-celled ancestor of the colonial volvocine algae and contributed to the further increase in cell number and complexity of the multicellular individuals of this model lineage. T. socialis is one of the simplest integrated multicellular organisms in which four identical cells constitute the individual.	[Arakaki, Yoko; Kawai-Toyooka, Hiroko; Noga, Akira; Hirono, Masafumi; Nozaki, Hisayoshi] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan; [Hamamura, Yuki] Nagoya Univ, Div Biol Sci, Grad Sch Sci, Nagoya, Aichi 4648601, Japan; [Higashiyama, Tetsuya] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648601, Japan; [Higashiyama, Tetsuya] Nagoya Univ, JST ERATO Higashiyama Live Holon Project, Nagoya, Aichi 4648601, Japan; [Olson, Bradley J. S. C.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA	University of Tokyo; Nagoya University; Nagoya University; Nagoya University; Kansas State University	Nozaki, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 113, Japan.	nozaki@biol.s.u-tokyo.ac.jp	HIRONO, MASAFUMI/G-4948-2014; Higashiyama, Tetsuya/C-2882-2012; Hirono, Masafumi/G-5140-2013	HIRONO, MASAFUMI/0000-0002-2497-4227; Higashiyama, Tetsuya/0000-0002-7346-360X; Hirono, Masafumi/0000-0002-2497-4227; Nozaki, Hisayoshi/0000-0002-9308-4498	MEXT/JSPS KAKENHI [25-9234, 24657045, 24247042]; Grants-in-Aid for Scientific Research [24657045, 13J09234] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research on JSPS Fellows (number 25-9234 to YA), Challenging Exploratory Research (number 24657045 to HN) and Scientific Research (A) (number 24247042 to HN) from MEXT/JSPS KAKENHI (http://www.jsps.go.jp/english/e-grants/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin M, 2010, TRENDS CELL BIOL, V20, P734, DOI 10.1016/j.tcb.2010.08.002; Fairclough SR, 2010, CURR BIOL, V20, pR875, DOI 10.1016/j.cub.2010.09.014; FULTON AB, 1978, DEV BIOL, V64, P236, DOI 10.1016/0012-1606(78)90075-1; Gerisch G, 1959, ARCH PROTISTENKD, V104, P292; GREEN KJ, 1981, J CELL BIOL, V91, P756, DOI 10.1083/jcb.91.3.756; GREUEL BT, 1985, J PHYCOL, V21, P358; Grosberg RK, 2007, ANNU REV ECOL EVOL S, V38, P621, DOI 10.1146/annurev.ecolsys.36.102403.114735; Hamaji T, 2008, GENETICS, V178, P283, DOI 10.1534/genetics.107.078618; Hamaji T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057177; Harris E.H, 2009, INTRO CHLAMYDOMONAS; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; Hobbs M.J., 1972, British phycol J, V7, P347; HOOPS HJ, 1982, BRIT PHYCOL J, V17, P297, DOI 10.1080/00071618200650301; HOOPS HJ, 1983, J CELL SCI, V63, P21; Hoops HJ, 1997, PROTOPLASMA, V199, P99, DOI 10.1007/BF01294499; HOOPS HJ, 1984, J PHYCOL, V20, P20, DOI 10.1111/j.0022-3646.1984.00020.x; HOOPS HJ, 1993, J CELL SCI, V104, P105; Iida H, 2013, J PLANT RES, V126, P699, DOI 10.1007/s10265-013-0553-7; Iidai H, 2011, PHYCOLOGIA, V50, P530, DOI 10.2216/10-80.1; KIRK DL, 1983, DEV BIOL, V96, P493, DOI 10.1016/0012-1606(83)90186-0; Kirk DL, 2005, BIOESSAYS, V27, P299, DOI 10.1002/bies.20197; Kirk DL., 1998, VOLVOX; LANG NJ, 1963, AM J BOT, V50, P280, DOI 10.2307/2440022; MARCHANT HJ, 1977, PROTOPLASMA, V93, P325, DOI 10.1007/BF01275663; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michod RE, 2005, BIOL PHILOS, V20, P967, DOI 10.1007/s10539-005-9018-2; Mogi Y, 2012, J PHYCOL, V48, P670, DOI 10.1111/j.1529-8817.2012.01149.x; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Niklas KJ, 2013, EVOL DEV, V15, P41, DOI 10.1111/ede.12013; Nishii I, 2003, CELL, V113, P743, DOI 10.1016/S0092-8674(03)00431-8; NOZAKI H, 1994, J PHYCOL, V30, P353, DOI 10.1111/j.0022-3646.1994.00353.x; Nozaki H, 1996, EUR J PHYCOL, V31, P67, DOI 10.1080/09670269600651211a; Nozaki H, 2000, MOL PHYLOGENET EVOL, V17, P256, DOI 10.1006/mpev.2000.0831; Nozaki H, 2003, BIOLOGIA, V58, P425; NOZAKI H, 1990, PHYCOLOGIA, V29, P1, DOI 10.2216/i0031-8884-29-1-1.1; Pickett-Heaps J. D., 1975, GREEN ALGAE STRUCTUR; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Preble AM, 2001, GENETICS, V157, P163; Prochnik SE, 2010, SCIENCE, V329, P223, DOI 10.1126/science.1188800; RINGO DL, 1967, J CELL BIOL, V33, P543, DOI 10.1083/jcb.33.3.543; Sachs JL, 2008, TRENDS ECOL EVOL, V23, P245, DOI 10.1016/j.tree.2008.02.003; SAGER R, 1957, J BIOPHYS BIOCHEM CY, V3, P463, DOI 10.1083/jcb.3.3.463; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; STEIN JR, 1959, AM J BOT, V46, P366, DOI 10.2307/2439197; TAYLOR MG, 1985, J PHYCOL, V21, P533; Ueki N, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-103	46	29	29	4	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81641	10.1371/journal.pone.0081641	http://dx.doi.org/10.1371/journal.pone.0081641			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349103	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300042
J	Davenport, RJ				Davenport, Romola J.			Year of Birth Effects in the Historical Decline of Tuberculosis Mortality: A Reconsideration	PLOS ONE			English	Article							LUNG-CANCER MORTALITY; SEX-DIFFERENCES; UNITED-STATES; LIFE CONDITIONS; COHORT; SMOKING; AGE; PERIOD; TRENDS; JAPAN	Birth cohort patterns in mortality are often used to infer long-lasting impacts of early life conditions. One of the most widely accepted examples of a birth cohort effect is that of tuberculosis mortality before the late 1940s. However the evidential basis for claims of cohort-specific declines in tuberculosis mortality is very slight. Reanalysis of original or enhanced versions of datasets used previously to support claims of cohort effects in tuberculosis mortality indicated that: 1. where the initial decline in tuberculosis mortality occurred within the period of observation, onset of decline occurred simultaneously in many age groups, in a pattern indicative of 'period' not cohort-dependent effects. 2. there was little evidence of 'proportional hazard'-type cohort patterns in tuberculosis mortality for any female population studied. Therefore any mechanisms proposed to underlie this type of cohort pattern in male mortality must be sex-specific. 3. sex ratios of tuberculosis mortality at older ages peaked in cohorts born around 1900, and resembled cohort sex ratios of lung cancer mortality. This analysis indicates that age-specific patterns in the decline in tuberculosis mortality before 1950 are unlikely to reflect improvements in early life conditions. The patterns observed are generally more consistent with the influence of factors that reduced mortality simultaneously in most age groups. Additional influences, possibly smoking habits, impeded the decline of tuberculosis in older adult males, and produced the sex-specific shifts in age distributions of mortality that were previously interpreted as evidence of cohort-dependent mortality decline.	Univ Cambridge, Dept Geog, Cambridge CB2 3EN, England	University of Cambridge	Davenport, RJ (corresponding author), Univ Cambridge, Dept Geog, Downing Pl, Cambridge CB2 3EN, England.	rjd23@cam.ac.uk			Wellcome Trust [088708]; British Academy [SG-42924]; James Martin School of the 2st Century; Oxford Institute of Ageing	Wellcome Trust(Wellcome TrustEuropean Commission); British Academy; James Martin School of the 2st Century; Oxford Institute of Ageing	Wellcome Trust strategic award "Generation to Reproduction", grant no. 088708 (http://www.wellcome.ac.uk/); British Academy small grant SG-42924 (http://www.britac.ac.uk/); James Martin School of the 2st Century and the Oxford Institute of Ageing (http://www.ageing.ox.ac.uk/: provided fellowship funding for RJD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELSTEIN A., 1977, Population Trends, P20; Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Andvord KF, 2002, INT J TUBERC LUNG D, V6, P562; Andvord KF, 2008, INT J EPIDEMIOL, V37, P917, DOI 10.1093/ije/dyn102; Australian Institute of Health and Welfare, 2010, GRIM GEN REC INC MOR; Backer JE, 1961, TREND MORTALITY CAUS; Barbi Elisabetta, 2005, Science, V308, P1743, DOI 10.1126/science.1108707; Beevor H, 1899, LANCET, V3946, P1005; Borgdorff MW, 2005, EMERG INFECT DIS, V11, P597, DOI 10.3201/eid1104.041103; Bothamley GH, 2005, THORAX, V60, P527, DOI 10.1136/thx.2004.036012; Brownlee J, 1916, PUBLIC HLTH, V29, P130, DOI DOI 10.1016/S0033-3506(15)80528-9; Carter SB, 2006, HIST STAT US A, V1; Centers for Disease Control and Prevention, HIST290 DEATH RAT SE; COLLINS JJ, 1982, DEMOGRAPHY, V19, P409, DOI 10.2307/2060979; Comstock GW, 2001, SOZ PRAVENTIV MED, V46, P7, DOI 10.1007/BF01318793; D'Arcy Hart P, 1939, TUBERCULOSIS SOCIAL; Dahlberg G, 1949, BR J SOC MED, V3, P220; Davenport R, 2011, ANN DEATHS CAUSE AGE, P5705; Daw R., 1950, J I ACTU, V76, P143; DOEGE TC, 1965, JAMA-J AM MED ASSOC, V192, P103; Donald PR, 2010, LANCET, V375, P1852, DOI 10.1016/S0140-6736(10)60580-6; ELO IT, 1992, POPUL INDEX, V58, P186, DOI 10.2307/3644718; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Frost WH, 1939, AGE SELECTION MORTAL, V151, P4; Funatogawa I, 2013, B WORLD HEALTH ORGAN, V91, P332, DOI 10.2471/BLT.12.108092; Gomez JE, 2004, TUBERCULOSIS, V84, P29, DOI 10.1016/j.tube.2003.08.003; Greenwood M, 1936, J R STAT SOC, V99, P674, DOI 10.2307/2980090; Greenwood M., 1935, EPIDEMICS CROWD DIS; GRZYBOWS S, 1963, CAN MED ASSOC J, V89, P737; Haro AS, 1994, TUBERCLE LUNG DIS, V75, P771; HILL A. B., 1936, Journal of the Royal Statistical Society, V99, P247, DOI 10.2307/2980581; Hinde P, 2010, SEX DIFFERENTIALS MO; HOBCRAFT J, 1982, POPUL INDEX, V48, P4, DOI 10.2307/2736356; Holmes CB, 1998, INT J TUBERC LUNG D, V2, P96; Institut National d'Etudes Demographiques, DAT CAUS DEATH FRANC; Kaufmann SHE, 2010, LANCET, V375, P2110, DOI 10.1016/S0140-6736(10)60393-5; Kendall M. G., 1975, RANK CORRELATION MET; Keyes KM, 2010, SOC SCI MED, V70, P1100, DOI 10.1016/j.socscimed.2009.12.018; Lancaster HO, 1950, MED J AUSTRALIA, V1, P665; Liaw YP, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-22; Lipsitch M, 2002, GENETICS, V161, P1599; Marugame T, 2005, JPN J CLIN ONCOL, V35, P168, DOI 10.1093/jjco/hyi048; Mason W. M., 1985, COHORT ANAL SOCIAL R, P151; Maurya V, 2002, INT J TUBERC LUNG D, V6, P942; MCDONALD JC, 1954, BRIT MED BULL, V10, P77, DOI 10.1093/oxfordjournals.bmb.a069409; McDougall JB, 1949, TUBERCULOSIS GLOBAL; MCKEOWN T, 1962, POP STUD-J DEMOG, V16, P94, DOI 10.2307/2173119; Moine M, 1947, B I NAT HYG, V2, P240; Murphy M, 2010, POPUL DEV REV, V36, P365, DOI 10.1111/j.1728-4457.2010.00334.x; Myrskyla M, 2010, POPUL DEV REV, V36, P803, DOI 10.1111/j.1728-4457.2010.00358.x; Nass O, 2008, INT J EPIDEMIOL, V37, P923, DOI 10.1093/ije/dyn107; Newsholme A, 1910, PREVENTION TUBERCULO; Noymer A, 2000, POPUL DEV REV, V26, P565, DOI 10.1111/j.1728-4457.2000.00565.x; Noymer A, 2011, VACCINE, V29, pB38, DOI 10.1016/j.vaccine.2011.02.053; Pampel FC, 2003, DEMOGRAPHY, V40, P45, DOI 10.1353/dem.2003.0007; PICKEN R. M. F., 1940, Public Health, V53, P145, DOI 10.1016/S0033-3506(39)80102-0; Preston S., 2000, DEMOGRAPHY MEASURING; Preston SH, 2006, DEMOGRAPHY, V43, P631, DOI 10.1353/dem.2006.0037; Rieder HL, 1998, SOZ PRAVENTIV MED, V43, P162, DOI 10.1007/BF01359724; Sacher G., 1977, HDB BIOL AGING, P582; Secretary of the Commonwealth of Massachusetts, 1880, ANN REP VIT STAT MAS; Smith GD, 2004, INT J EPIDEMIOL, V33, P691, DOI 10.1093/ije/dyh261; SPICER CC, 1954, J HYG-CAMBRIDGE, V52, P361, DOI 10.1017/S0022172400027558; SPRINGETT VH, 1952, LANCET, V262, P521; SPRINGETT VH, 1950, J HYG-CAMBRIDGE, V48, P361, DOI 10.1017/S0022172400015138; SPRINGETT VH, 1952, LANCET, V262, P575; Swerdlow AJ, 2001, CANC INCIDENCE MORTA; Takahashi I, 2008, PUBLIC HEALTH, V122, P891, DOI 10.1016/j.puhe.2007.10.004; Tocque K, 1998, AM J RESP CRIT CARE, V158, P484, DOI 10.1164/ajrccm.158.2.9709125; Uys PW, 2009, J R SOC INTERFACE, V6, P11, DOI 10.1098/rsif.2008.0184; Vaupel JW, 1997, POPULATION DATA GLAN; Verver S, 2005, AM J RESP CRIT CARE, V171, P1430, DOI 10.1164/rccm.200409-1200OC; Vynnycky E, 1999, INT J EPIDEMIOL, V28, P327, DOI 10.1093/ije/28.2.327; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; WALDRON I, 1993, SOC SCI MED, V36, P451, DOI 10.1016/0277-9536(93)90407-U; Watkins RE, 2006, EPIDEMIOL INFECT, V134, P333, DOI 10.1017/S0950268805005042; Welton T., 1872, J I ACTUARIES, V16, P153; WILSON LG, 1990, J HIST MED ALL SCI, V45, P366, DOI 10.1093/jhmas/45.3.366; Winston CA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-206; Woods R., 2000, DEMOGRAPHY VICTORIAN; World Health Organisation, WHO MORT DAT COMP FI	81	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81797	10.1371/journal.pone.0081797	http://dx.doi.org/10.1371/journal.pone.0081797			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349130	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300051
J	Guo, XQ; Su, SK; Skogerboe, G; Dai, SAJ; Li, WF; Li, ZG; Liu, F; Ni, RF; Guo, Y; Chen, SL; Zhang, SW; Chen, RS				Guo, Xiangqian; Su, Songkun; Skogerboe, Geir; Dai, Shuanjin; Li, Wenfeng; Li, Zhiguo; Liu, Fang; Ni, Ruifeng; Guo, Yu; Chen, Shenglu; Zhang, Shaowu; Chen, Runsheng			Recipe for a Busy Bee: MicroRNAs in Honey Bee Caste Determination	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; INSULIN-LIKE PEPTIDES; DNA METHYLATION; SOCIAL INSECT; IDENTIFICATION; PATTERNS; PROTEIN; REPRODUCTION; BIOGENESIS; WIDESPREAD	Social caste determination in the honey bee is assumed to be determined by the dietary status of the young larvae and translated into physiological and epigenetic changes through nutrient-sensing pathways. We have employed Illumina/Solexa sequencing to examine the small RNA content in the bee larval food, and show that worker jelly is enriched in miRNA complexity and abundance relative to royal jelly. The miRNA levels in worker jelly were 7-215 fold higher than in royal jelly, and both jellies showed dynamic changes in miRNA content during the 4th to 6th day of larval development. Adding specific miRNAs to royal jelly elicited significant changes in queen larval mRNA expression and morphological characters of the emerging adult queen bee. We propose that miRNAs in the nurse bee secretions constitute an additional element in the regulatory control of caste determination in the honey bee.	[Guo, Xiangqian; Skogerboe, Geir; Ni, Ruifeng; Guo, Yu; Zhang, Shaowu; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Bioinformat Lab, Beijing 100080, Peoples R China; [Guo, Xiangqian; Skogerboe, Geir; Ni, Ruifeng; Guo, Yu; Zhang, Shaowu; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Su, Songkun; Dai, Shuanjin; Li, Wenfeng; Li, Zhiguo; Liu, Fang; Chen, Shenglu; Zhang, Shaowu] Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Guo, Xiangqian; Ni, Ruifeng; Guo, Yu] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Zhang, Shaowu] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Su, Songkun] Fujian Agr & Forestry Univ, Coll Bee Sci, Fuzhou, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Zhejiang University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Australian National University; Fujian Agriculture & Forestry University	Chen, SL (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou 310003, Zhejiang, Peoples R China.	slchen@zju.edu.cn; shaowu.zhang@anu.edu.au; crs@sun5.ibp.ac.cn	Guo, Xiangqian/AAN-4599-2020	Guo, Xiangqian/0000-0001-6645-5786; LI, WENFENG/0000-0001-8819-6009	National Sciences Foundation of China [30630040]; National Key Basic Research & Development Program 973 [2009CB825401, 2007CB946901]; earmarked fund for Modern Agro-industry Technology Research System [CARS-45-KXJ3]; National Natural Science Foundation of China [NSFC 30571409]; Nature and Science Foundation Commission of Zhejiang Province [R3080306]; Australian Research Council through the ARC Centre of Excellence in Vision Science [CE0561903]	National Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research & Development Program 973(National Basic Research Program of China); earmarked fund for Modern Agro-industry Technology Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature and Science Foundation Commission of Zhejiang Province; Australian Research Council through the ARC Centre of Excellence in Vision Science(Australian Research Council)	The research was supported by National Sciences Foundation of China Grant No. 30630040; National Key Basic Research & Development Program 973 under Grant Nos. 2009CB825401 and 2007CB946901 to RSC, the earmarked fund for Modern Agro-industry Technology Research System (No. CARS-45-KXJ3), and a grant of the National Natural Science Foundation of China (NSFC 30571409) to SKS, and the Nature and Science Foundation Commission of Zhejiang Province (R3080306) to SKS. Zhang was supported by the Australian Research Council through the ARC Centre of Excellence in Vision Science (CE0561903). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Amdam GV, 2006, BEHAV BRAIN RES, V169, P201, DOI 10.1016/j.bbr.2006.01.006; Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; Amdam GV, 2004, P NATL ACAD SCI USA, V101, P11350, DOI 10.1073/pnas.0403073101; Amdam GV, 2003, P NATL ACAD SCI USA, V100, P1799, DOI 10.1073/pnas.0333979100; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Behura SK, 2010, INSECT MOL BIOL, V19, P431, DOI 10.1111/j.1365-2583.2010.01010.x; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bloch Guy, 2002, P195; Bohnsack MT, 2004, RNA, V10, P185, DOI 10.1261/rna.5167604; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bryant B, 2010, P NATL ACAD SCI; Chen S., 2001, APICULTURE SCI CHINA; Chen X, 2010, INSECT MOL BIOL, V19, P799, DOI 10.1111/j.1365-2583.2010.01039.x; Chittka A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000532; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; de Azevedo SV, 2008, J INSECT PHYSIOL, V54, P1064, DOI 10.1016/j.jinsphys.2008.04.009; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Evans JD, 2001, GENOME BIOL, V2; HANES J, 1992, J APICULT RES, V31, P22, DOI 10.1080/00218839.1992.11101256; Hartfelder K, 1998, CURR TOP DEV BIOL, V40, P45, DOI 10.1016/S0070-2153(08)60364-6; Hartfelder K, 2006, APIDOLOGIE, V37, P144, DOI 10.1051/apido:2006013; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; Hayden MA, 2007, DEV BIOL, V305, P358, DOI 10.1016/j.ydbio.2007.02.018; Herranz H, 2010, GENE DEV, V24, P1339, DOI 10.1101/gad.1937010; Hori S, 2010, APIDOLOGIE; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; KRAMER KJ, 1982, INSECT BIOCHEM, V12, P91, DOI 10.1016/0020-1790(82)90075-0; Kronforst MR, 2008, CURR BIOL, V18, pR287, DOI 10.1016/j.cub.2008.02.015; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Kwon C, 2005, PNAS; Lee J, 2007, PLOS COMPUT BIOL, V3, P721, DOI 10.1371/journal.pcbi.0030067; LERCKER G, 1986, FOOD CHEM, V19, P255, DOI 10.1016/0308-8146(86)90049-X; LERCKER G, 1982, J APICULT RES, V21, P178, DOI 10.1080/00218839.1982.11100538; LERCKER G, 1981, LIPIDS, V16, P912, DOI 10.1007/BF02534997; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-455; Loya CM, 2009, NAT METHODS, V6, P897, DOI 10.1038/nmeth.1402; Lyko F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000506; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; MARKO P, 1964, NATURE, V202, P188, DOI 10.1038/202188b0; Martins JR, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-23; Nomura T, 2008, HUM MOL GENET, V17, P1192, DOI 10.1093/hmg/ddn011; Page RE, 2007, BIOESSAYS, V29, P334, DOI 10.1002/bies.20549; PAINTER TS, 1969, P NATL ACAD SCI USA, V64, P64, DOI 10.1073/pnas.64.1.64; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Peng L., 2010, 2010 IEEE INT 3D SYS, P1; Pinto LZ, 2002, J INSECT PHYSIOL, V48, P783, DOI 10.1016/S0022-1910(02)00103-8; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sesta G, 2006, APIDOLOGIE, V37, P84, DOI 10.1051/apido:2005061; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Siomi H, 2010, MOL CELL, V38, P323, DOI 10.1016/j.molcel.2010.03.013; Skalsky RL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-119; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Thompson GJ, 2006, INSECT MOL BIOL, V15, P637, DOI 10.1111/j.1365-2583.2006.00678.x; Wang XW, 2005, BIOINFORMATICS, V21, P3610, DOI 10.1093/bioinformatics/bti562; Wang Y, 2006, SCIENCE, V314, P645, DOI 10.1126/science.1135213; Weaver DB, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r97; Wheeler DE, 2006, INSECT MOL BIOL, V15, P597, DOI 10.1111/j.1365-2583.2006.00681.x; Wheeler SR, 2008, DEVELOPMENT, V135, P3071, DOI 10.1242/dev.022343; WOLSCHIN F, 2010, BIOL LETT; Yamazaki Y, 2006, FEBS LETT, V580, P2667, DOI 10.1016/j.febslet.2006.04.016	71	48	56	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81661	10.1371/journal.pone.0081661	http://dx.doi.org/10.1371/journal.pone.0081661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349106	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300044
J	Abu-Tair, L; Axelrod, JH; Doron, S; Ovadya, Y; Krizhanovsky, V; Galun, E; Amer, J; Safadi, R				Abu-Tair, Lina; Axelrod, Jonathan H.; Doron, Sarit; Ovadya, Yossi; Krizhanovsky, Valery; Galun, Eithan; Amer, Johnny; Safadi, Rifaat			Natural Killer Cell-Dependent Anti-Fibrotic Pathway in Liver Injury via Toll-Like Receptor-9	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; NK CELLS; ACTIVATION; TLR9; TOLL-LIKE-RECEPTOR-9; ACCUMULATION; MODULATION; SENESCENCE; RESPONSES; DISEASE	The toll-like receptor-9 (TLR9) agonist cytosine phosphate guanine (CpG), activates hepatic stellate cells (HSCs) and mediates fibrosis. We investigated the TLR9 effects on lymphocyte/HSCs interactions. Liver fibrosis was induced in wild-type (WT) mice by intra-peritoneal carbon-tetrachloride (CCl4) induction for 6 weeks. Fibrotic groups were intravenously treated by a vehicle versus CpG along last 2 weeks. Compared to vehicle-treated fibrotic WT, the in-vivo CpG-treatment significantly attenuated hepatic fibrosis and inflammation, associated with decreased CD8 and increased NK liver cells. In-vitro, co-cultures with vehicle-treated fibrotic NK cells increased HSCs proliferation (P<0.001) while their CpG-treated counterparts achieved a significant decrease. To investigate the role of lymphocytes, TLR9(-/-) mice induced-hepatic fibrosis were used. Although TLR9(-/-) mice manifested lower fibrotic profile as compared to their wild-type (WT) counterparts, senescence (SA-beta-Gal activity) in the liver and ALT serum levels were significantly greater. In an adoptive transfer model; irradiated WT and TLR9(-/-) recipients were reconstituted with naive WT or TLR9(-/-) lymphocytes. The adoptive transfer of TLR9(-/-) versus WT lymphocytes led to increased fibrosis of WT recipients. TLR9(-/-) fibrotic recipients reconstituted with TLR9(-/-) or WT lymphocytes showed no changes in hepatic fibrosis severity or ALT serum levels. TLR9 activation had inconsistent effects on lymphocytes and HSCs. The net balance of TLR9 activation in WT, displayed significant anti-fibrotic activity, accompanied by CD8 suppression and increased NK-cells, activity and adherence to HSCs. The pro-fibrotic and pro-inflammatory properties of TLR9(-/-) lymphocytes fail to activate HSCs with an early senescence in TLR9(-/-) mice.	[Abu-Tair, Lina; Doron, Sarit; Amer, Johnny; Safadi, Rifaat] Hadassah Med Ctr, Div Med, Liver Unit, IL-91120 Jerusalem, Israel; [Abu-Tair, Lina; Doron, Sarit; Amer, Johnny; Safadi, Rifaat] Hadassah Med Ctr, Div Med, Gastroenterol Unit, IL-91120 Jerusalem, Israel; [Axelrod, Jonathan H.; Galun, Eithan] Hadassah Med Ctr, Goldyne Savad Inst Gene Therapy, IL-91120 Jerusalem, Israel; [Ovadya, Yossi; Krizhanovsky, Valery] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; Hadassah University Medical Center; Weizmann Institute of Science	Amer, J (corresponding author), Hadassah Med Ctr, Div Med, Liver Unit, Kiryat Haddasah, IL-91120 Jerusalem, Israel.	johnnyamer@hotmail.com	Galun, Eithan/AAD-9117-2022	Galun, Eithan/0000-0002-6243-6702	Israel Science Foundation [1169/09]; Chief Scientist Office - Ministry of Health, Israel [3-5937]	Israel Science Foundation(Israel Science Foundation); Chief Scientist Office - Ministry of Health, Israel	This research was supported by the Israel Science Foundation no. 1169/09. This study was also supported (in part) by grant no. 3-5937 from the Chief Scientist Office - Ministry of Health, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/192543; Arad U, 2005, HUM GENE THER, V16, P361, DOI 10.1089/hum.2005.16.361; Avraham Y, 2012, AM J PHYSIOL-GASTR L, V302, pG1364, DOI 10.1152/ajpgi.00191.2011; Ballas ZK, 2007, IMMUNOL RES, V39, P15, DOI 10.1007/s12026-007-0066-3; Bamboat ZM, 2010, HEPATOLOGY, V51, P621, DOI 10.1002/hep.23365; Gabele E, 2008, BIOCHEM BIOPH RES CO, V376, P271, DOI 10.1016/j.bbrc.2008.08.096; Gao B, 2010, GASTROENTEROLOGY, V139, P27, DOI 10.1053/j.gastro.2010.05.018; Girart MV, 2007, J IMMUNOL, V179, P3472, DOI 10.4049/jimmunol.179.6.3472; Graubardt N, 2012, HEPATOLOGY, V2, P1; Guicciardi ME, 2010, SEMIN LIVER DIS, V30, P402, DOI 10.1055/s-0030-1267540; Guillerey C, 2012, BLOOD, V120, P90, DOI 10.1182/blood-2012-02-410936; Gur C, 2012, GUT, V61, P885, DOI 10.1136/gutjnl-2011-301400; Horani A, 2007, AM J PHYSIOL-GASTR L, V292, pG628, DOI 10.1152/ajpgi.00137.2006; Jiang W, 2009, J IMMUNOL, V182, P3768, DOI 10.4049/jimmunol.0800973; Kamar N, 2005, J MED VIROL, V76, P482, DOI 10.1002/jmv.20387; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lichtenegger FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044266; Marcenaro E, 2011, ADV EXP MED BIOL, V780, P45, DOI 10.1007/978-1-4419-5632-3_5; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Merlo A, 2007, J LEUKOCYTE BIOL, V82, P509, DOI 10.1189/jlb.0207100; Miranda SRP, 1997, BLOOD, V90, P444; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Muhanna N, 2008, HEPATOLOGY, V48, P963, DOI 10.1002/hep.22413; Muhanna N, 2011, GUT, V60, P90, DOI 10.1136/gut.2010.211136; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Rosenstiel P, 2013, CURR OPIN GASTROEN, V29, P125, DOI 10.1097/MOG.0b013e32835da2c7; Sagiv A, 2013, ONCOGENE, V32, P1971, DOI 10.1038/onc.2012.206; Seki E, 2008, HEPATOLOGY, V48, P322, DOI 10.1002/hep.22306; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sugauchi F, 2006, J INFECT DIS, V193, P563, DOI 10.1086/499823; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Watanabe A, 2007, HEPATOLOGY, V46, P1509, DOI 10.1002/hep.21867; Yan Z, 2012, NANOTECHNOLOGY, V23, P1	37	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82571	10.1371/journal.pone.0082571	http://dx.doi.org/10.1371/journal.pone.0082571			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340043	gold, Green Submitted, Green Published			2022-12-27	WOS:000328707400084
J	He, HB; Ma, FY; Yang, R; Chen, L; Jia, B; Cui, J; Fan, H; Wang, X; Li, L				He, Haibing; Ma, Fuyu; Yang, Ru; Chen, Lin; Jia, Biao; Cui, Jing; Fan, Hua; Wang, Xin; Li, Li			Rice Performance and Water Use Efficiency under Plastic Mulching with Drip Irrigation	PLOS ONE			English	Article							ORYZA-SATIVA L.; FLOODED RICE; ROOT DISTRIBUTION; PRODUCTION SYSTEM; LOWLAND RICE; AEROBIC RICE; GRAIN-YIELD; SOIL; GROWTH; STERILITY	Plastic mulching with drip irrigation is a new water-saving rice cultivation technology, but little is known on its productivity and water-saving capacity. This study aimed to assess the production potential, performance, and water use efficiency (WUE) of rice under plastic mulching with drip irrigation. Field experiments were conducted over 2 years with two rice cultivars under different cultivation systems: conventional flooding (CF), non-flooded irrigation incorporating plastic mulching with furrow irrigation (FIM), non-mulching with furrow irrigation (FIN), and plastic mulching with drip irrigation (DI). Compared with the CF treatment, grain yields were reduced by 31.76-52.19% under the DI treatment, by 57.16-61.02% under the FIM treatment, by 74.40-75.73% under the FIN treatment, which were mainly from source limitation, especially a low dry matter accumulation during post-anthesis, in non-flooded irrigation. WUE was the highest in the DI treatment, being 1.52-2.12 times higher than with the CF treatment, 1.35-1.89 times higher than with the FIM treatment, and 2.37-3.78 times higher than with the FIN treatment. The yield contribution from tillers (YCFTs) was 50.65-62.47% for the CF treatment and 12.07-20.62% for the non-flooded irrigation treatments. These low YCFTs values were attributed to the poor performance in tiller panicles rather than the total tiller number. Under non-flooded irrigation, root length was significantly reduced with more roots distributed in deep soil layers compared with the CF treatment; the DI treatment had more roots in the topsoil layer than the FIM and FIN treatments. The experiment demonstrates that the DI treatment has greater water saving capacity and lower yield and economic benefit gaps than the FIM and FIN treatments compared with the CF treatment, and would therefore be a better water-saving technology in areas of water scarcity.	[He, Haibing; Ma, Fuyu; Yang, Ru; Jia, Biao; Cui, Jing; Fan, Hua; Wang, Xin] Shihezi Univ, Coll Agr, Key Lab Oasis Ecol Agr Xinjiang Bingtuan, Shihezi, Xinjiang, Peoples R China; [Chen, Lin; Li, Li] Agr Drought Res Inst Tianye Grp Co, Xinjiang, Peoples R China	Shihezi University	Ma, FY (corresponding author), Shihezi Univ, Coll Agr, Key Lab Oasis Ecol Agr Xinjiang Bingtuan, Shihezi, Xinjiang, Peoples R China.	mfy_agr@163.com	jia, biao/GQA-7846-2022		National High Technology Research and Development Program of China [2011AA100508]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The authors are grateful for grants from the National High Technology Research and Development Program of China (2011AA100508). The authors state that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeysiriwardena DSDZ, 2002, SRI J NATL SCI FDN, V3, P33; [Anonymous], 2003, WATER WISE RICE PROD; Barker R, 1999, P 19 SESSION INT RIC, P96; Belder P, 2004, AGR WATER MANAGE, V65, P193, DOI 10.1016/j.agwat.2003.09.002; Bouman BAM, 2007, ADV AGRON, V92, P187, DOI 10.1016/S0065-2113(04)92004-4; Bouman B. A. M., 2002, 12 ISCO C BEIJ CHIN; Bouman BAM, 2005, AGR WATER MANAGE, V74, P87, DOI 10.1016/j.agwat.2004.11.007; Bouman BAM, 2001, AGR WATER MANAGE, V49, P11, DOI 10.1016/S0378-3774(00)00128-1; Bouman BAM, 2010, FIELD CROPS RES, V116, P252, DOI [10.1016/j.fcr.2010.01.002, DOI 10.1016/J.FCR.2010.01.002]; Coelho EF, 1999, PLANT SOIL, V206, P123, DOI 10.1023/A:1004325219804; EKANAYAKE IJ, 1989, ANN BOT-LONDON, V63, P257, DOI 10.1093/oxfordjournals.aob.a087740; Fan XL, 2002, J PLANT NUTR, V25, P1855, DOI 10.1081/PLN-120013279; HODGSON AS, 1990, IRRIGATION SCI, V11, P143, DOI 10.1007/BF00189451; IRRI, 2008, RICE TODAY; Jiang PengYan, 1999, Chinese Journal of Rice Science, V13, P211; Kato Y, 2006, PLANT PROD SCI, V9, P422, DOI 10.1626/pps.9.422; Kato Y, 2011, ANN BOT-LONDON, V108, P575, DOI 10.1093/aob/mcr184; Kato Y, 2010, FIELD CROP RES, V118, P194, DOI 10.1016/j.fcr.2010.04.013; Li Jie, 2011, Acta Agronomica Sinica, V37, P309, DOI 10.3724/SP.J.1006.2011.00309; Liang YC, 2003, PLANT SOIL, V257, P407, DOI 10.1023/A:1027313902195; Liang YongChao, 1999, Scientia Agricultura Sinica, V32, P26; LILLEY JM, 1994, FIELD CROP RES, V37, P205, DOI 10.1016/0378-4290(94)90099-X; Ling Q.H., 2000, CROP POPULATION QUAL, P96; Ling QH, 1986, CHIN JIANGSU AGR, V31, P1; Lv GH, 2010, IRRIGATION SCI, V28, P387, DOI 10.1007/s00271-009-0200-1; Malash NM, 2008, IRRIGATION SCI, V26, P313, DOI 10.1007/s00271-007-0095-7; Matsui T, 2001, PLANT PROD SCI, V4, P90, DOI 10.1626/pps.4.90; O'Toole JC, 1984, OVERVIEW UPLAND RICE, P394; PAPAKOSTA DK, 1991, AGRON J, V83, P864, DOI 10.2134/agronj1991.00021962008300050018x; PEACOCK WL, 1977, AM J ENOL VITICULT, V28, P193; Peng SB, 2006, FIELD CROP RES, V96, P252, DOI 10.1016/j.fcr.2005.07.007; Qin J, 2010, J AGRON CROP SCI, V196, P397, DOI 10.1111/j.1439-037X.2010.00430.x; Qin JT, 2006, AGR WATER MANAGE, V83, P252, DOI 10.1016/j.agwat.2006.01.001; Qin JiangTao, 2006, Rice Science, V13, P59; SHARP RE, 1985, J EXP BOT, V36, P1441, DOI 10.1093/jxb/36.9.1441; TAKEDA TOMOSHIRO, 1961, JAPANESE JOUR BOT, V17, P403; Tao HB, 2006, FIELD CROP RES, V95, P1, DOI 10.1016/j.fcr.2005.01.019; Tuong TP, 2003, COMP ASSESS WAT MAN, V1, P53, DOI 10.1079/9780851996691.0053; Wang F, 2006, PLANT GROWTH REGUL, V49, P1, DOI 10.1007/s10725-006-0017-3; Wang FY, 1997, ACTA AGRON SIN, V30, P26; Wang Xiao-juan, 2012, Yingyong Shengtai Xuebao, V23, P2751; Wang YuBao, 2010, Zhongguo Shengtai Nongye Xuebao / Chinese Journal of Eco-Agriculture, V18, P399, DOI 10.3724/SP.J.1011.2010.00399; Weerakoon WMW, 2008, J AGRON CROP SCI, V194, P135, DOI 10.1111/j.1439-037X.2008.00293.x; Xie GH, 2008, CHIN AGR SCI, V7, P641, DOI [10.1016/S1671-2927(08)60097-8, DOI 10.1016/S1671-2927(08)60097-8]; YOSHIDA S, 1972, ANN REV PLANT PHYSIO, V23, P437, DOI 10.1146/annurev.pp.23.060172.002253; Yoshida S, 1981, FUNDAMENTALS RICE CR, P29; Zhang LM, 2009, FIELD CROP RES, V114, P45, DOI 10.1016/j.fcr.2009.07.001; Zhang ZC, 2008, FIELD CROP RES, V108, P71, DOI 10.1016/j.fcr.2008.03.004; Zhao BuHong, 2006, Rice Science, V13, P34; Zhao QuanZhi, 2001, Scientia Agricultura Sinica, V34, P304; Zhu Q., 1997, ACTA AGRON SIN, V30, P52	51	53	64	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83103	10.1371/journal.pone.0083103	http://dx.doi.org/10.1371/journal.pone.0083103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340087	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400122
J	Mocking, RJT; Lok, A; Assies, J; Koeter, MWJ; Visser, I; Ruhe, HG; Bockting, CLH; Schene, AH				Mocking, Roel J. T.; Lok, Anja; Assies, Johanna; Koeter, Maarten W. J.; Visser, Ieke; Ruhe, Henricus G.; Bockting, Claudi L. H.; Schene, Aart H.			Ala54Thr Fatty Acid-Binding Protein 2 (FABP2) Polymorphism in Recurrent Depression: Associations with Fatty Acid Concentrations and Waist Circumference	PLOS ONE			English	Article							PITUITARY-ADRENAL-AXIS; BODY-MASS INDEX; BIMODAL DISTRIBUTION; INSULIN-RESISTANCE; ABDOMINAL OBESITY; ADIPOSE-TISSUE; RISK-FACTORS; GENE; DISORDER; RATIO	Background: Fatty acid (FA)-alterations may mediate the mutual association between Major Depressive Disorder (MDD) and cardiovascular disease (CVD). However, etiology of observed FA-alterations in MDD and CVD remains largely unclear. An interesting candidate may be a mutation in the fatty acid-binding protein 2 (FABP2)-gene, because it regulates dietary FA-uptake. Therefore, we aimed to test the hypotheses that in MDD-patients the FABP2 Ala54Thr-polymorphism would be (I) more prevalent than in sex-and age-matched controls, (II) associated with observed alterations in FA-metabolism, and (III) associated with CVD-risk factor waist circumference. Methods: We measured concentrations of 29 different erythrocyte FAs, FABP2-genotype, and waist circumference in recurrent MDD-patients and matched never-depressed controls. Results: FABP2-genotype distribution did not significantly differ between the 137 MDD-patients and 73 matched controls. However, patients with the Ala54Thr-polymorphism had (I) higher concentrations of especially eicosadienoic acid (C20:2 omega 6; P=.009) and other 20-carbon FAs, and associated (II) lower waist circumference (P=.019). In addition, FABP2-genotype effects on waist circumference in patients seemed (I) mediated by its effect on C20:2 omega 6, and (II) different from controls. Conclusions: Although Ala54Thr-polymorphism distribution was not associated with recurrent MDD, our results indicate that FABP2 may play a role in the explanation of observed FA-alterations in MDD. For Ala54Thr-polymorphism patients, potentially adaptive conversion of increased bioavailable dietary precursors into eicosadienoic acid instead of arachidonic acid might be related to a low waist circumference. Because this is the first investigation of these associations, replication is warranted, preferably by nutrigenetic studies applying lipidomics and detailed dietary assessment.	[Mocking, Roel J. T.; Lok, Anja; Assies, Johanna; Koeter, Maarten W. J.; Visser, Ieke; Ruhe, Henricus G.; Schene, Aart H.] Univ Amsterdam, Acad Med Ctr, Dept Psychiat, NL-1105 AZ Amsterdam, Netherlands; [Ruhe, Henricus G.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Psychiat, Program Mood & Anxiety Disorders, Groningen, Netherlands; [Bockting, Claudi L. H.] Univ Groningen, Dept Clin Psychol, Groningen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; University of Groningen	Mocking, RJT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Psychiat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	R.J.Mocking@amc.uva.nl	Bockting, Claudi L/K-3768-2019; Ruhe, Henricus G/K-8764-2012; Schene, A.H./H-8085-2014; Mocking, Roel JT/H-8131-2012	Bockting, Claudi L/0000-0002-9220-9244; Ruhe, Henricus G/0000-0001-6072-0358; Schene, A.H./0000-0002-1756-3235; Mocking, Roel JT/0000-0003-3543-3810	Netherlands Foundation for Mental Health, Utrecht; Health Research Development Council, Department Prevention Program (ZonMw); NWO/ZonMw VENI-Grant [016.126.059]	Netherlands Foundation for Mental Health, Utrecht; Health Research Development Council, Department Prevention Program (ZonMw); NWO/ZonMw VENI-Grant	This study has been made possible due to financial aid of the Netherlands Foundation for Mental Health, Utrecht and the Health Research Development Council, Department Prevention Program (ZonMw). HGR is supported by a NWO/ZonMw VENI-Grant #016.126.059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren JJ, 2001, AM J CLIN NUTR, V73, P31; Albala C, 2004, OBES RES, V12, P340, DOI 10.1038/oby.2004.42; Assies J, 2004, PROSTAG LEUKOTR ESS, V70, P349, DOI 10.1016/j.plefa.2003.12.009; Assies J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010635; BAIER LJ, 1995, J CLIN INVEST, V95, P1281, DOI 10.1172/JCI117778; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bentsen H, 2011, BIOL PSYCHIAT, V70, P97, DOI 10.1016/j.biopsych.2011.02.011; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; de Luis D, 2012, J INVEST MED, V60, P1194, DOI 10.2310/JIM.0b013e318271fb25; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Erkkila AT, 2002, NUTR METAB CARDIOVAS, V12, P53; Greden JF, 2001, J CLIN PSYCHIAT, V62, P5; Gueorguieva R, 2004, ARCH GEN PSYCHIAT, V61, P310, DOI 10.1001/archpsyc.61.3.310; Hegele RA, 1998, CLIN BIOCHEM, V31, P609, DOI 10.1016/S0009-9120(98)00078-2; HIBBELN JR, 1995, AM J CLIN NUTR, V62, P1; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; Inoue K, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-25; Lin PY, 2010, BIOL PSYCHIAT, V68, P140, DOI 10.1016/j.biopsych.2010.03.018; Lok A, 2010, PSYCHOTHER PSYCHOSOM, V79, P386, DOI 10.1159/000320898; Lok A, 2012, PSYCHONEUROENDOCRINO, V37, P892, DOI 10.1016/j.psyneuen.2011.10.005; Marshall A, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-57; Martinez-Lopez E, 2013, NUTRITION, V29, P46, DOI 10.1016/j.nut.2012.03.002; McNamara RK, 2007, BIOL PSYCHIAT, V62, P17, DOI 10.1016/j.biopsych.2006.08.026; McNamara RK, 2006, PROSTAG LEUKOTR ESS, V75, P329, DOI 10.1016/j.plefa.2006.07.010; Mocking RJ, 2012, STAT METHODOLOGICAL; Mocking RJT, 2013, PSYCHONEUROENDOCRINO, V38, P1607, DOI 10.1016/j.psyneuen.2013.01.013; Mocking RJT, 2012, BIOL PSYCHIAT, V71, pE3, DOI 10.1016/j.biopsych.2011.09.004; Mozaffarian D, 2011, J AM COLL CARDIOL, V58, P2047, DOI 10.1016/j.jacc.2011.06.063; Mutch DM, 2005, FASEB J, V19, P1602, DOI 10.1096/fj.05-3911rev; Osby U, 2001, ARCH GEN PSYCHIAT, V58, P844, DOI 10.1001/archpsyc.58.9.844; Piomelli D, 2007, NAT REV NEUROSCI, V8, P743, DOI 10.1038/nrn2233; Pishva H, 2012, J DIABETES METAB DIS, V11, DOI 10.1186/2251-6581-11-25; Pouwer F, 2012, BIOL EFFECTS ADD ON; Pratley RE, 2000, J LIPID RES, V41, P2002; Pusch W, 2002, PHARMACOGENOMICS, V3, P537, DOI 10.1517/14622416.3.4.537; Savva SC, 2004, BRIT J NUTR, V91, P643, DOI 10.1079/BJN20031084; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Vidgren HM, 1997, EUR J CLIN INVEST, V27, P405, DOI 10.1046/j.1365-2362.1997.1320679.x; Wanby P, 2005, VASC MED, V10, P103, DOI 10.1191/1358863x05vm609oa; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130	42	14	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82980	10.1371/journal.pone.0082980	http://dx.doi.org/10.1371/journal.pone.0082980			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340071	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400107
J	Navia-Gine, WG; Loaiza, JR; Miller, MJ				Navia-Gine, Wayra G.; Loaiza, Jose R.; Miller, Matthew J.			Mosquito-Host Interactions during and after an Outbreak of Equine Viral Encephalitis in Eastern Panama	PLOS ONE			English	Article							AMAZON BASIN REGION; FEEDING PATTERNS; ENCEPHALOMYELITIS VIRUS; EXPERIMENTAL-INFECTION; CULEX MELANOCONION; BLOOD MEALS; IDENTIFICATION; DIPTERA; BEHAVIOR; TRANSMISSION	Mosquito blood meals provide information about the feeding habits and host preference of potential arthropod-borne disease vectors. Although mosquito-borne diseases are ubiquitous in the Neotropics, few studies in this region have assessed patterns of mosquito-host interactions, especially during actual disease outbreaks. Based on collections made during and after an outbreak of equine viral encephalitis, we identified the source of 338 blood meals from 10 species of mosquitoes from Aruza Abajo, a location in Darien province in eastern Panama. A PCR based method targeting three distinct mitochondrial targets and subsequent DNA sequencing was used in an effort to delineate vector-host relationships. At Aruza Abajo, large domesticated mammals dominated the assemblage of mosquito blood meals while wild bird and mammal species represented only a small portion of the blood meal pool. Most mosquito species fed on a variety of hosts; foraging index analysis indicates that eight of nine mosquito species utilize hosts at similar proportions while a stochastic model suggests dietary overlap among species was greater than would be expected by chance. The results from our null-model analysis of mosquito diet overlap are consistent with the hypothesis that in landscapes where large domestic animals dominate the local biomass, many mosquito species show little host specificity, and feed upon hosts in proportion to their biomass, which may have implications for the role of livestocking patterns in vector-borne disease ecology.	[Navia-Gine, Wayra G.; Loaiza, Jose R.; Miller, Matthew J.] Smithsonian Trop Res Inst, Panama City, Panama; [Loaiza, Jose R.] Inst Invest Cient & Serv Alta Tecnol, Ctr Biodiversidad & Descubrimiento Drogas, Clayton, Panama; [Loaiza, Jose R.] Univ Panama, Programa Ctr Amer Maestria Entomol Vicerrectoria, Panama City, Panama	Smithsonian Institution; Smithsonian Tropical Research Institute; Instituto de Investigacion Cientificas y Servicios de Alta Tecnologia (INDICASAT-AIP); Universidad de Panama	Miller, MJ (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	millerma@si.edu	Miller, Matthew/B-4560-2008	Miller, Matthew/0000-0002-2939-0239	National Institutes of Health/National Science Foundation (NIH/NSF); Fogarty International Center [3R01-TW005869-05S1]; Office of the Secretary of the Department of Health and Human Services; Smithsonian Institution's DNA Barcoding Network; Smithsonian Institution Molecular Evolution Post-doctoral Fellowship; JRL by the Secretariat for Science, Technology and Innovation of Panama (SENACYT) through the National Research Investigator Board (SNI); FOGARTY INTERNATIONAL CENTER [R01TW005869] Funding Source: NIH RePORTER	National Institutes of Health/National Science Foundation (NIH/NSF)(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Office of the Secretary of the Department of Health and Human Services; Smithsonian Institution's DNA Barcoding Network; Smithsonian Institution Molecular Evolution Post-doctoral Fellowship; JRL by the Secretariat for Science, Technology and Innovation of Panama (SENACYT) through the National Research Investigator Board (SNI); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Funding was provided by an inter-agency award from the United States Centers for Disease Control ("Effect of Anthropogenic Climate Change on the Ecology of Zoonotic and Vector-borne Diseases''). Additionally, the STRI Bird Collection is supported by a National Institutes of Health/National Science Foundation (NIH/NSF) "Ecology and Evolution of Infectious Diseases'' award from the Fogarty International Center 3R01-TW005869-05S1 which is supported by International Influenza Funds from the Office of the Secretary of the Department of Health and Human Services. DNA sequencing was supported from a grant from the Smithsonian Institution's DNA Barcoding Network. MJM was supported by a Smithsonian Institution Molecular Evolution Post-doctoral Fellowship, and JRL by the Secretariat for Science, Technology and Innovation of Panama (SENACYT) through the National Research Investigator Board (SNI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken TH., 1972, P WORKSHOP S VENEZUE, P254; Arrigo NC, 2008, AM J TROP MED HYG, V78, P93, DOI 10.4269/ajtmh.2008.78.93; Carrera JP, 2013, NEW ENGL J MED, V369, P732, DOI 10.1056/NEJMoa1212628; Chamberlain R. W., 1972, Venezuelan encephalitis-proceedings of the workshop-symposium on Venezuelan encephalitis virus., P144; Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3; Christensen HA, 1996, AM J TROP MED HYG, V55, P202, DOI 10.4269/ajtmh.1996.55.202; Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Dove CJ, 2008, J WILDLIFE MANAGE, V72, P1231, DOI 10.2193/2007-272; DOWNS WG, 1959, SCIENCE, V130, P1471, DOI 10.1126/science.130.3387.1471; EDMAN JD, 1971, ANN ENTOMOL SOC AM, V64, P513, DOI 10.1093/aesa/64.2.513; Empresa de Transmision Electrica S.A. (ETESA), 2010, GER HIDR EST TOT MEN; Ferro C, 2003, EMERG INFECT DIS, V9, P49; Garros C, 2011, INFECT GENET EVOL, V11, P1103, DOI 10.1016/j.meegid.2011.04.002; Gotelli NJ, 2000, ECOSIM NULL MODELS S; GRAYSON MA, 1968, AM J EPIDEMIOL, V88, P80, DOI 10.1093/oxfordjournals.aje.a120870; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; HESS AD, 1968, MOSQ NEWS, V28, P386; Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008; KAY BH, 1979, MOSQ NEWS, V39, P68; Kent RJ, 2005, AM J TROP MED HYG, V73, P336, DOI 10.4269/ajtmh.2005.73.336; Kilpatrick AM, 2007, AM J TROP MED HYG, V77, P667, DOI 10.4269/ajtmh.2007.77.667; Kondig JP, 2007, AM J TROP MED HYG, V76, P408, DOI 10.4269/ajtmh.2007.76.408; Lefevre T, 2009, AM J TROP MED HYG, V81, P1023, DOI 10.4269/ajtmh.2009.09-0124; Lorosa ES, 2010, J AM MOSQUITO CONTR, V26, P18, DOI 10.2987/09-5914.1; Mesa FA, 2005, ENCEPHALITIS EQUINAS; Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004; Muturi CN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017284; Ngo KA, 2003, J MED ENTOMOL, V40, P215, DOI 10.1603/0022-2585-40.2.215; O'Guinn ML, 2004, AM J TROP MED HYG, V70, P164, DOI 10.4269/ajtmh.2004.70.164; Palumbi Stephen R., 1996, P205; Pecor James E., 1992, Contributions of the American Entomological Institute, V27, P1; Pongsiri MJ, 2009, BIOSCIENCE, V59, P945, DOI 10.1525/bio.2009.59.11.6; Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472; R Development Core Team, 2008, R LANG ENV STAT COMP; Sallum MAM, 1996, J AM MOSQUITO CONTR, V12, P517; Sehgal RNM, 2010, J EXP BIOL, V213, P955, DOI 10.1242/jeb.037663; SOTA T, 1991, J MED ENTOMOL, V28, P428, DOI 10.1093/jmedent/28.3.428; SUDIA WD, 1971, AM J EPIDEMIOL, V93, P206, DOI 10.1093/oxfordjournals.aje.a121247; TEMPELIS CH, 1975, J MED ENTOMOL, V12, P205, DOI 10.1093/jmedent/12.2.205; Thiemann TC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001452; Turell MJ, 2008, J MED ENTOMOL, V45, P720, DOI 10.1603/0022-2585(2008)45[720:SOPMTE]2.0.CO;2; TURELL MJ, 1994, J MED ENTOMOL, V31, P287, DOI 10.1093/jmedent/31.2.287; Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3; Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006; WILKERSON RC, 1990, J AM MOSQUITO CONTR, V6, P7	46	13	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81788	10.1371/journal.pone.0081788	http://dx.doi.org/10.1371/journal.pone.0081788			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339965	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400041
J	Niu, MM; Dong, FG; Tang, S; Fida, G; Qin, JY; Qiu, JD; Liu, KB; Gao, WD; Gu, YQ				Niu, Miaomiao; Dong, Fenggong; Tang, Shi; Fida, Guissi; Qin, Jingyi; Qiu, Jiadan; Liu, Kangbo; Gao, Weidong; Gu, Yueqing			Pharmacophore Modeling and Virtual Screening for the Discovery of New type 4 cAMP Phosphodiesterase (PDE4) Inhibitors	PLOS ONE			English	Article							BIOLOGICAL EVALUATION; PREDICTION	Type 4 cAMP phosphodiesterase (PDE4) inhibitors show a broad spectrum of anti-inflammatory effects in almost all kinds of inflamed cells, by an increase in cAMP levels which is a pivotal second messenger responsible for various biological processes. These inhibitors are now considered as the potential drugs for treatment of chronic inflammatory diseases. However, some recently marketed inhibitors e. g., roflumilast, have shown adverse effects such as nausea and emesis, thus restricting its use. In order to identify novel PDE4 inhibitors with improved therapeutic indexes, a highly correlating (r = 0.963930) pharmacophore model (Hypo1) was established on the basis of known PDE4 inhibitors. Validated Hypo1 was used in database screening to identify chemical with required pharmacophoric features. These compounds are further screened by using the rule of five, ADMET and molecular docking. Finally, twelve hits which showed good results with respect to following properties such as estimated activity, calculated drug-like properties and scores were proposed as potential leads to inhibit the PDE4 activity. Therefore, this study will not only assist in the development of new potent hits for PDE4 inhibitors, but also give a better understanding of their interaction with PDE4. On a wider scope, this will be helpful for the rational design of novel potent enzyme inhibitors.	[Niu, Miaomiao; Dong, Fenggong; Tang, Shi; Fida, Guissi; Qin, Jingyi; Qiu, Jiadan; Liu, Kangbo; Gao, Weidong; Gu, Yueqing] China Pharmaceut Univ, Sch Life Sci & Technol, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Gu, YQ (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Dept Biomed Engn, Nanjing, Jiangsu, Peoples R China.	guyueqing@cpu.edu.cn	Gao, Wei/GXH-0380-2022		National Natural Science Foundation of China [30970776, 31050110123, 81071194, 81000666, 81171395, 81220108012]; Ministry of Science and Technology for new drug development [2009ZX09310-004]; Graduate Innovation Project of Jiangsu Province [CXLX11_0795]; Fundamental Research Funds for the Central Universities [JKY2011006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology for new drug development; Graduate Innovation Project of Jiangsu Province; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was financially supported by the National Natural Science Foundation of China (No. 30970776, No. 31050110123, No. 81071194, No. 81000666, No. 81171395 and No. 81220108012), the major project from the Ministry of Science and Technology for new drug development (2009ZX09310-004), the Graduate Innovation Project of Jiangsu Province (CXLX11_0795), the Fundamental Research Funds for the Central Universities (JKY2011006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arooj M, 2011, INT J MOL SCI, V12, P9236, DOI 10.3390/ijms12129236; Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b; Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e; Jin S-L Catherine, 2012, Chang Gung Med J, V35, P197; John S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S4; Lipworth BJ, 2005, LANCET, V365, P167, DOI 10.1016/S0140-6736(05)17708-3; Ochiai H, 2004, EUR J MED CHEM, V39, P555, DOI 10.1016/j.ejmech.2004.02.010; Ochiai H, 2004, BIOORGAN MED CHEM, V12, P5063, DOI 10.1016/j.bmc.2004.07.040; Ochiai H, 2004, BIOORGAN MED CHEM, V12, P4645, DOI 10.1016/j.bmc.2004.06.032; Ochiai H, 2004, BIOORG MED CHEM LETT, V14, P1323, DOI 10.1016/j.bmcl.2003.12.018; Ochiai H, 2004, BIOORG MED CHEM LETT, V14, P207, DOI 10.1016/j.bmcl.2003.09.087; Provins L, 2006, BIOORG MED CHEM LETT, V16, P1834, DOI 10.1016/j.bmcl.2006.01.006; Stoll F, 2002, MOL PHARMACOL, V62, P1103, DOI 10.1124/mol.62.5.1103; Susnow RG, 2003, J CHEM INF COMP SCI, V43, P1308, DOI 10.1021/ci030283p; Thangapandian S, 2011, J CHEM INF MODEL, V51, P33, DOI 10.1021/ci1002813; Walters WP, 2002, ADV DRUG DELIVER REV, V54, P255, DOI 10.1016/S0169-409X(02)00003-0; Zampieri D, 2009, J MED CHEM, V52, P5380, DOI 10.1021/jm900366z	17	22	22	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82360	10.1371/journal.pone.0082360	http://dx.doi.org/10.1371/journal.pone.0082360			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340020	gold, Green Submitted, Green Published			2022-12-27	WOS:000328707400072
J	Thanunchai, M; Kanrai, P; Wiboon-Ut, S; Puthavathana, P; Hongeng, S; Thitithanyanont, A				Thanunchai, Maytawan; Kanrai, Pumaree; Wiboon-ut, Suwimon; Puthavathana, Pilaipan; Hongeng, Suradej; Thitithanyanont, Arunee			Tropism of Avian Influenza A (H5N1) Virus to Mesenchymal Stem Cells and CD34(+) Hematopoietic Stem Cells	PLOS ONE			English	Article							BONE-MARROW; PROINFLAMMATORY CYTOKINES; CYTOMEGALOVIRUS-INFECTION; RESPIRATORY-TRACT; VIRAL REPLICATION; HUMAN MACROPHAGES; IMMUNE EVASION; STROMAL CELLS; GENERATION; SUSCEPTIBILITY	The presence of abnormal hematologic findings such as lymphopenia, thrombocytopenia, and pancytopenia were diagnosed in severe cases of avian influenza A H5N1. Whether direct viral dissemination to bone marrow (BM) cells causes this phenomenon remains elusive. We explore the susceptibility of the two stem cell types; hematopoietic stem cells (HSCs) and mesenchymal stromal cells (MSCs) isolated from human BM cells or cord blood, to infection with avian H5N1 viruses. For the first time, we demonstrated that the H5N1 virus could productively infect and induce cell death in both human stem cell types. In contrast, these activities were not observed upon human influenza virus infection. We also determined whether infection affects the immunomodulatory function of MSCs. We noted a consequent dysregulation of MSCmediated immune modulation as observed by high cytokine and chemokine production in H5N1 infected MSCs and monocytes cocultures. These findings provide a better understanding of H5N1 pathogenesis in terms of broad tissue tropism and systemic spread.	[Thanunchai, Maytawan; Kanrai, Pumaree; Wiboon-ut, Suwimon; Thitithanyanont, Arunee] Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand; [Puthavathana, Pilaipan] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Microbiol, Bangkok 10700, Thailand; [Hongeng, Suradej] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pediat, Bangkok 10400, Thailand	Mahidol University; Mahidol University; Mahidol University	Thitithanyanont, A (corresponding author), Mahidol Univ, Fac Sci, Dept Microbiol, Bangkok 10400, Thailand.	arunee.thi@mahidol.ac.th	Thitithanyanont, Arunee/AAN-4383-2021	Thitithanyanont, Arunee/0000-0002-9756-4763; Manopwisedjaroen, Suwimon/0000-0002-7571-8733; Hongeng, Suradej/0000-0002-7376-9393	National Institutes of Health and National Institute of Allergy and Infectious Disease [YI-AI-5026-01]; National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand [P-00-10072]; Faculty of Science, Mahidol University; Faculty of Medicine Siriraj Hospital, Mahidol University; The Royal Golden Jubilee Ph.D. Program (RGJPHD) scholarship	National Institutes of Health and National Institute of Allergy and Infectious Disease; National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand; Faculty of Science, Mahidol University; Faculty of Medicine Siriraj Hospital, Mahidol University; The Royal Golden Jubilee Ph.D. Program (RGJPHD) scholarship	This work was supported by National Institutes of Health and National Institute of Allergy and Infectious Disease (YI-AI-5026-01), National Center for Genetic Engineering and Biotechnology (BIOTEC), Thailand (P-00-10072) and Faculty of Science, Mahidol University. The confocal microscope was partially supported by Faculty of Medicine Siriraj Hospital, Mahidol University M. Thanunchai received financial support during graduate study from The Royal Golden Jubilee Ph.D. Program (RGJPHD) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Bego MG, 2006, EXP HEMATOL, V34, P555, DOI 10.1016/j.exphem.2005.11.012; Beigel H, 2005, NEW ENGL J MED, V353, P1374, DOI 10.1056/NEJMra052211; Brandau S, 2010, J LEUKOCYTE BIOL, V88, P1005, DOI 10.1189/jlb.0410207; Cardenes N, 2013, RESPIRATION, V85, P267, DOI 10.1159/000347072; Chamberlain G, 2007, STEM CELLS, V25, P2739, DOI 10.1634/stemcells.2007-0197; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Cinatl J, 2007, MED MICROBIOL IMMUN, V196, P191, DOI 10.1007/s00430-007-0045-2; Corcione A, 2006, BLOOD, V107, P367, DOI 10.1182/blood-2005-07-2657; Daidoji T, 2008, J VIROL, V82, P11294, DOI 10.1128/JVI.01192-08; Darwish I, 2011, EXPERT REV ANTI-INFE, V9, P807, DOI [10.1586/eri.11.56, 10.1586/ERI.11.56]; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Fisman DN, 2000, EMERG INFECT DIS, V6, P601, DOI 10.3201/eid0606.000608; Friesenhagen J, 2012, J LEUKOCYTE BIOL, V92, P11, DOI 10.1189/jlb.0911479; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Gurkan UA, 2008, ANN BIOMED ENG, V36, P1978, DOI 10.1007/s10439-008-9577-x; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; Khatri M, 2012, CELL TRANSPLANT; Khatri M, 2010, DEV COMP IMMUNOL, V34, P474, DOI 10.1016/j.dci.2009.12.008; Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791; Kumlin U, 2008, INFLUENZA OTHER RESP, V2, P147, DOI 10.1111/j.1750-2659.2008.00051.x; Magnon C., 2008, HEMATOPOIETIC STEM C; Manchester M, 2002, J VIROL, V76, P6636, DOI 10.1128/JVI.76.13.6636-6642.2002; Musina RA, 2007, B EXP BIOL MED+, V143, P127, DOI 10.1007/s10517-007-0032-z; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nicholls JM, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-73; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; NIH, 2013, STEM CELL INF AD STE; Rajam L, 2008, INDIAN J PEDIATR, V75, P1261, DOI 10.1007/s12098-008-0170-y; Sabatini F, 2005, LAB INVEST, V85, P962, DOI 10.1038/labinvest.3700300; Shahid MA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-38; Sinclair K, 2013, RESPIROLOGY, V18, P397, DOI 10.1111/resp.12050; Singer NG, ANN REV PATHOL, V6, P457; Smirnov SV, 2007, VIROLOGY, V360, P6, DOI 10.1016/j.virol.2006.09.017; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Thitithanyanont A, 2007, J IMMUNOL, V179, P5220, DOI 10.4049/jimmunol.179.8.5220; To KF, 2001, J MED VIROL, V63, P242, DOI 10.1002/1096-9071(200103)63:3&lt;242::AID-JMV1007&gt;3.0.CO;2-N; Tran TT, 2008, INT J BIOCHEM CELL B, V40, P2671, DOI 10.1016/j.biocel.2008.05.019; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Uiprasertkul M, 2005, EMERG INFECT DIS, V11, P1036, DOI 10.3201/eid1107.041313; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; WHO, 2013, CUM NUMB CONF HUM CA; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Yu WCL, 2011, J VIROL, V85, P6844, DOI 10.1128/JVI.02200-10; Zhang ZF, 2009, HUM PATHOL, V40, P735, DOI 10.1016/j.humpath.2008.08.015; Zhao YY, 2008, CLIN INFECT DIS, V47, P1575, DOI 10.1086/593196	54	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81805	10.1371/journal.pone.0081805	http://dx.doi.org/10.1371/journal.pone.0081805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339969	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400045
J	Wang, CL; Kane, RL; Xu, DJ; Li, LG; Guan, WH; Li, H; Meng, QY				Wang, Cuili; Kane, Robert L.; Xu, Dongjuan; Li, Lingui; Guan, Weihua; Li, Hui; Meng, Qingyue			Maternal Education and Micro-Geographic Disparities in Nutritional Status among School-Aged Children in Rural Northwestern China	PLOS ONE			English	Article							RISK-FACTORS; HEALTH; UNDERNUTRITION; DETERMINANTS; MALNUTRITION; HOUSEHOLD; BANGLADESH; INDONESIA; MORTALITY	Objectives: Prior evidence suggests geographic disparities in the effect of maternal education on child nutritional status between countries, between regions and between urban and rural areas. We postulated its effect would also vary by micro-geographic locations (indicated by mountain areas, plain areas and the edge areas) in a Chinese minority area. Methods: A cross-sectional study was conducted with a multistage random sample of 1474 school children aged 5-12 years in Guyuan, China. Child nutritional status was measured by height-for-age z scores (HAZ). Linear mixed models were used to examine its association with place of residence and maternal education. Results: Micro-geographic disparities in child nutritional status and the level of socioeconomic composition were found. Children living in mountain areas had poorer nutritional status, even after adjusting for demographic (plain versus kmountain, beta = 0.16, P = 0.033; edge versus mountain, beta = 0.29, P = 0.002) and socioeconomic factors (plain versus mountain, beta = 0.12, P = 0.137; edge versus mountain, beta = 0.25, P = 0.009). The disparities significantly widened with increasing years of mothers' schooling (maternal education*plain versus mountain: beta = 0.06, P = 0.007; maternal education* edge versus mountain: beta = 0.07, P = 0.005). Moreover, the association between maternal education and child nutrition was negative (beta = 0.03, P = 0.056) in mountain areas but positive in plain areas (beta = 0.02, P = 0.094) or in the edge areas (beta = 0.04, P = 0.055). Conclusions: Micro-geographic disparities in child nutritional status increase with increasing level of maternal education and the effect of maternal education varies by micro-geographic locations, which exacerbates child health inequity. Educating rural girls alone is not sufficient; improving unfavorable conditions in mountain areas might make such investments more effective in promoting child health. Nutrition programs targeting to the least educated groups in plain and in edge areas would be critical to their cost-effectiveness.	[Wang, Cuili; Xu, Dongjuan] Shandong Univ, Sch Nursing, Jinan 250100, Shandong, Peoples R China; [Wang, Cuili; Li, Hui; Meng, Qingyue] Shandong Univ, Ctr Hlth Management & Policy, Jinan 250100, Shandong, Peoples R China; [Kane, Robert L.; Xu, Dongjuan; Guan, Weihua] Univ Minnesota, Sch Publ Hlth, Minneapolis, MN USA; [Li, Lingui] Ningxia Med Univ, Coll Management, Ningxia, Peoples R China; [Meng, Qingyue] Peking Univ, China Ctr Hlth Dev Studies, Beijing 100871, Peoples R China	Shandong University; Shandong University; University of Minnesota System; University of Minnesota Twin Cities; Ningxia Medical University; Peking University	Meng, QY (corresponding author), Peking Univ, China Ctr Hlth Dev Studies, Beijing 100871, Peoples R China.	qmeng@bjmu.edu.cn		Wang, Cuili/0000-0002-8496-5621	CMB (China Medical Board) [09-947]	CMB (China Medical Board)	The research team is grateful to the CMB (China Medical Board, 09-947) for their financial support. URL:http://www.chinamedicalboard.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2007, CARLETON COLL DEP EC; Attanasio O, 2004, ECON HUM BIOL, V2, P411, DOI 10.1016/j.ehb.2004.10.005; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boyle MH, 2006, SOC SCI MED, V63, P2242, DOI 10.1016/j.socscimed.2006.04.034; CALDWELL JC, 1979, POP STUD-J DEMOG, V33, P395, DOI 10.2307/2173888; Chen YY, 2009, J HEALTH ECON, V28, P413, DOI 10.1016/j.jhealeco.2008.10.005; Chopra M, 2003, PUBLIC HEALTH NUTR, V6, P645, DOI 10.1079/PHN2003477; Currie A, 2007, J HEALTH ECON, V26, P213, DOI 10.1016/j.jhealeco.2006.08.003; Du Q, 2011, CHINESE PRIMARY HLTH, V25, P38; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Frost MB, 2005, SOC SCI MED, V60, P395, DOI 10.1016/j.socscimed.2004.05.010; Grace K, 2012, APPL GEOGR, V35, P405, DOI 10.1016/j.apgeog.2012.06.017; GROSSMAN M, 1972, J POLIT ECON, V80, P223, DOI 10.1086/259880; Han Q, 2009, HLTH EC RES, V9, P5; Hansen BE, 2000, ECONOMETRICA, V68, P575, DOI 10.1111/1468-0262.00124; Janevic T, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-509; Ji C, 2008, PREVALENCE MALNUTRIT, P273; Lavy V, 1996, J HEALTH ECON, V15, P333, DOI 10.1016/0167-6296(95)00021-6; LeVine RA, 2009, J DEV BEHAV PEDIATR, V30, P340, DOI 10.1097/DBP.0b013e3181b0eeff; Liu B., 2005, CHINESE HLTH RESOURC, V8, P214; Liu J., 2008, EC RES J, V43, P136; MARTIN LG, 1983, POP STUD-J DEMOG, V37, P417, DOI 10.2307/2174507; Miller J. E., 2009, ASIAN DEV J, V26, P131; Mohsena M, 2010, PUBLIC HEALTH NUTR, V13, P1498, DOI 10.1017/S1368980010001758; Mosley WH, 1984, POPUL DEV REV, V10, P25, DOI 10.2307/2807954; Mushtaq MU, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-724; Pebley AR, 1996, DEMOGRAPHY, V33, P231, DOI 10.2307/2061874; Pfeiffer J, 2001, SOC SCI MED, V53, P83, DOI 10.1016/S0277-9536(00)00311-7; Pongou R, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-98; Rahman A, 2007, J BIOSOC SCI, V39, P161, DOI 10.1017/S0021932006001295; Schultz TP, 1984, POPUL DEV REV, V10, P215, DOI 10.2307/2807962; Schultz TP, 2002, WORLD DEV, V30, P207; Semba RD, 2008, LANCET, V371, P322, DOI 10.1016/S0140-6736(08)60169-5; Senbanjo IO, 2011, J HEALTH POPUL NUTR, V29, P364, DOI 10.3329/jhpn.v29i4.8452; Song Y, 2004, COLLECTION WOMENS ST, V58, P21; Song Y, 2006, CHINESE POPULATION S, P43; THOMAS D, 1991, J HUM RESOUR, V26, P183, DOI 10.2307/145920; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Webb P, 2004, ECON DEV CULT CHANGE, V52, P801, DOI 10.1086/420901; WHO, 2006, WHO CHILD GROWTH STA; Zhang L, 2000, 5 AN C WORLD C WOM 1; Zhao F, 2004, THESIS J HOPKINS U B; 宋月萍, 2007, [中国农村经济, Chinese Rural Economy], P69	43	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82500	10.1371/journal.pone.0082500	http://dx.doi.org/10.1371/journal.pone.0082500			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VW	24340034	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400077
J	Wang, Y; Feng, YG; Jia, YB; Xie, YP; Wang, WS; Guan, YF; Zhong, SM; Zhu, D; Huang, L				Wang, Ying; Feng, Yigang; Jia, Yanbin; Xie, Yanping; Wang, Wensheng; Guan, Yufang; Zhong, Shuming; Zhu, Dan; Huang, Li			Absence of Auditory M100 Source Asymmetry in Schizophrenia and Bipolar Disorder: A MEG Study	PLOS ONE			English	Article							PLANUM TEMPORALE ASYMMETRY; CEREBRAL ASYMMETRY; HEMISPHERIC-ASYMMETRY; MAGNETIC-FIELDS; SYLVIAN FISSURE; SOURCE LOCATION; HESCHLS GYRUS; MAGNETOENCEPHALOGRAPHY; LATERALIZATION; PSYCHOSIS	Background: Whether schizophrenia and bipolar disorder are the clinical outcomes of discrete or shared causative processes is much debated in psychiatry. Several studies have demonstrated anomalous structural and functional superior temporal gyrus (STG) symmetries in schizophrenia. We examined bipolar patients to determine if they also have altered STG asymmetry. Methods: Whole-head magnetoencephalography (MEG) recordings of auditory evoked fields were obtained for 20 subjects with schizophrenia, 20 with bipolar disorder, and 20 control subjects. Neural generators of the M100 auditory response were modeled using a single equivalent current dipole for each hemisphere. The source location of the M100 response was used as a measure of functional STG asymmetry. Results: Control subjects showed the typical M100 asymmetrical pattern with more anterior sources in the right STG. In contrast, both schizophrenia and bipolar disorder patients displayed a symmetrical M100 source pattern. There was no significant difference in the M100 latency and strength in bilateral hemispheres within three groups. Conclusions: Our results indicate that disturbed asymmetry of temporal lobe function may reflect a common deviance present in schizophrenia and bipolar disorder, suggesting the two disorders might share etiological and pathophysiological factors.	[Wang, Ying; Huang, Li] Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Ying] Jinan Univ, Affiliated Hosp 1, Clin Expt Ctr, Guangzhou, Guangdong, Peoples R China; [Feng, Yigang; Xie, Yanping; Wang, Wensheng; Guan, Yufang; Zhu, Dan] Guangdong 999 Brain Hosp, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China; [Jia, Yanbin; Zhong, Shuming] Jinan Univ, Affiliated Hosp 1, Dept Psychiat, Guangzhou, Guangdong, Peoples R China	Jinan University; Jinan University; Jinan University	Wang, Y (corresponding author), Jinan Univ, Affiliated Hosp 1, Med Imaging Ctr, Guangzhou, Guangdong, Peoples R China.	johneil@vip.sina.com; cjr.huangli@vip.163.com			Doctoral Fund of Ministry of Education of China [20134401120004]; Natural Science Foundation of Guangdong Province, China [S2013040016820]; Medical Scientific Research Foundation of Guangdong Province, China [B2013218]; Fundamental Research Funds for the Central Universities of China [21613309]; Cultivation Fund of First Affiliated Hospital of Jinan University [2013201]	Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province, China; Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); Cultivation Fund of First Affiliated Hospital of Jinan University	This work was supported by Doctoral Fund of Ministry of Education of China (20134401120004), Natural Science Foundation of Guangdong Province, China (S2013040016820), Medical Scientific Research Foundation of Guangdong Province, China (B2013218), the Fundamental Research Funds for the Central Universities of China (21613309) and the Cultivation Fund of First Affiliated Hospital of Jinan University (2013201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahveninen J, 2006, BIOL PSYCHIAT, V60, P612, DOI 10.1016/j.biopsych.2006.04.015; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; Barta PE, 1997, AM J PSYCHIAT, V154, P661; BARTLEY AJ, 1993, BIOL PSYCHIAT, V34, P853, DOI 10.1016/0006-3223(93)90053-G; BAUMANN SB, 1991, ELECTROEN CLIN NEURO, V80, P53, DOI 10.1016/0168-5597(91)90043-W; Bilder RM, 1999, INT J PSYCHOPHYSIOL, V34, P197, DOI 10.1016/S0167-8760(99)00077-X; Caligiuri MP, 2004, BIPOLAR DISORD, V6, P183, DOI 10.1111/j.1399-5618.2004.00116.x; Chance SA, 2006, NEUROSCIENCE, V143, P1041, DOI 10.1016/j.neuroscience.2006.08.057; Chance SA, 2008, BRAIN, V131, P3178, DOI 10.1093/brain/awn211; Craddock N, 2006, SCHIZOPHRENIA BULL, V32, P9, DOI 10.1093/schbul/sbj033; CROW TJ, 1990, BRIT J PSYCHIAT, V156, P788, DOI 10.1192/bjp.156.6.788; Crow TJ, 2000, BRAIN RES REV, V31, P118, DOI 10.1016/S0165-0173(99)00029-6; Crow TJ, 1997, TRENDS NEUROSCI, V20, P339; CROW TJ, 1989, ARCH GEN PSYCHIAT, V46, P1145; Cui LQ, 2011, PSYCHIAT RES-NEUROIM, V194, P347, DOI 10.1016/j.pscychresns.2011.03.010; DELISI LE, 1994, SCHIZOPHR RES, V12, P19, DOI 10.1016/0920-9964(94)90080-9; Edgar JC, 2012, SCHIZOPHR RES, V140, P250, DOI 10.1016/j.schres.2012.06.009; Edgar JC, 2006, NEUROPSYCHOLOGIA, V44, P289, DOI 10.1016/j.neuropsychologia.2005.04.016; FALKAI P, 1995, SCHIZOPHR RES, V14, P161, DOI 10.1016/0920-9964(94)00035-7; Fridberg DJ, 2009, BIPOLAR DISORD, V11, P857, DOI 10.1111/j.1399-5618.2009.00758.x; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; GESCHWIND N, 1968, SCIENCE, V161, P186, DOI 10.1126/science.161.3837.186; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Hahn C, 2011, BRAIN COGNITION, V76, P300, DOI 10.1016/j.bandc.2011.03.015; Hajek M, 1997, SCHIZOPHR RES, V24, P329, DOI 10.1016/S0920-9964(96)00107-7; HAMALAINEN M, 1993, REV MOD PHYS, V65, P413, DOI 10.1103/RevModPhys.65.413; Hari R, 2012, NEUROIMAGE, V61, P386, DOI 10.1016/j.neuroimage.2011.11.074; Heim S, 2004, NEUROPSYCHOLOGIA, V42, P692, DOI 10.1016/j.neuropsychologia.2003.09.007; Mazzarini L, 2010, PSYCHIAT ANN, V40, P143, DOI 10.3928/00485713-20100303-05; Moller HJ, 2010, PSYCHIAT ANN, V40, P163, DOI 10.3928/00485713-20100303-07; NASH AJ, 1982, BIOL PSYCHOL, V15, P15, DOI 10.1016/0301-0511(82)90028-X; Poch-Broto J, 2008, ACTA OTO-LARYNGOL, V128, P547, DOI 10.1080/00016480701596088; Potash JB, 2009, NAT REV NEUROL, V5, P299, DOI 10.1038/nrneurol.2009.71; REITE M, 1988, ELECTROEN CLIN NEURO, V70, P490, DOI 10.1016/0013-4694(88)90147-2; REITE M, 1989, ARCH GEN PSYCHIAT, V46, P565; Reite M, 1997, ARCH GEN PSYCHIAT, V54, P433; Reite M, 2009, BIPOLAR DISORD, V11, P371, DOI 10.1111/j.1399-5618.2009.00701.x; Rockstroh B, 2001, BIOL PSYCHIAT, V49, P694, DOI 10.1016/S0006-3223(00)01023-4; Rojas DC, 2002, BIOL PSYCHIAT, V52, P32, DOI 10.1016/S0006-3223(01)01365-8; Rojas DC, 2007, SCHIZOPHR RES, V97, P206, DOI 10.1016/j.schres.2007.08.011; Rosburg T, 2008, PSYCHIAT RES, V161, P259, DOI 10.1016/j.psychres.2008.03.017; Sakuma M, 1996, PSYCHIAT RES, V65, P1, DOI 10.1016/0165-1781(96)02818-1; Schmidt GL, 2009, NEUROREPORT, V20, P1037, DOI 10.1097/WNR.0b013e32832e0ca7; SHAGASS C, 1978, BIOL PSYCHIAT, V13, P163; Shapleske J, 2001, BIOL PSYCHIAT, V49, P685, DOI 10.1016/S0006-3223(00)01006-4; Shirakawa O, 2001, PROG NEURO-PSYCHOPH, V25, P867, DOI 10.1016/S0278-5846(01)00149-X; Sowell ER, 2002, DEV MED CHILD NEUROL, V44, P4, DOI 10.1017/S0012162201001591; STEINMETZ H, 1989, J COMPUT ASSIST TOMO, V13, P996, DOI 10.1097/00004728-198911000-00011; Takahashi T, 2010, J AFFECT DISORDERS, V123, P276, DOI 10.1016/j.jad.2009.08.022; Teale P, 1998, NEUROREPORT, V9, P2647, DOI 10.1097/00001756-199808030-00041; Tiihonen J, 1998, SCHIZOPHR RES, V30, P209, DOI 10.1016/S0920-9964(97)00154-0; Torrey EF, 2005, BIOL PSYCHIAT, V57, P252, DOI 10.1016/j.biopsych.2004.10.019; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Umbricht D, 2003, BIOL PSYCHIAT, V53, P1120, DOI 10.1016/S0006-3223(02)01642-6; WADA JA, 1975, ARCH NEUROL-CHICAGO, V32, P239, DOI 10.1001/archneur.1975.00490460055007; Walker J, 2002, INT CLIN PSYCHOPHARM, V17, pS11; Warrier C, 2009, J NEUROSCI, V29, P61, DOI 10.1523/JNEUROSCI.3489-08.2009; Williams MA, 2010, CURR OPIN PSYCHIATR, V23, P273, DOI 10.1097/YCO.0b013e328338621d; Wilson TW, 2007, PSYCHIAT RES-NEUROIM, V156, P59, DOI 10.1016/j.pscychresns.2007.01.004; Xiang J, 2001, NEUROREPORT, V12, P3923, DOI 10.1097/00001756-200112210-00014; Yeo RA, 1999, SCHIZOPHR RES, V39, P197, DOI 10.1016/S0920-9964(99)00074-2	61	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82682	10.1371/journal.pone.0082682	http://dx.doi.org/10.1371/journal.pone.0082682			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340052	gold, Green Submitted, Green Published			2022-12-27	WOS:000328707400090
J	Shamaei, K; Sawicki, GS; Dollar, AM				Shamaei, Kamran; Sawicki, Gregory S.; Dollar, Aaron M.			Estimation of Quasi-Stiffness of the Human Hip in the Stance Phase of Walking	PLOS ONE			English	Article							ANKLE JOINT DYNAMICS; TRANSTIBIAL PROSTHESIS; POSITION DEPENDENCE; LEG EXOSKELETON; LIMB JOINTS; GAIT; LOCOMOTION; DESIGN; MODEL; SPEED	This work presents a framework for selection of subject-specific quasi-stiffness of hip orthoses and exoskeletons, and other devices that are intended to emulate the biological performance of this joint during walking. The hip joint exhibits linear moment-angular excursion behavior in both the extension and flexion stages of the resilient loading-unloading phase that consists of terminal stance and initial swing phases. Here, we establish statistical models that can closely estimate the slope of linear fits to the moment-angle graph of the hip in this phase, termed as the quasi-stiffness of the hip. Employing an inverse dynamics analysis, we identify a series of parameters that can capture the nearly linear hip quasi-stiffnesses in the resilient loading phase. We then employ regression analysis on experimental moment-angle data of 216 gait trials across 26 human adults walking over a wide range of gait speeds (0.75-2.63 m/s) to obtain a set of general-form statistical models that estimate the hip quasi-stiffnesses using body weight and height, gait speed, and hip excursion. We show that the general-form models can closely estimate the hip quasi-stiffness in the extension (R-2 = 92%) and flexion portions (R-2 = 89%) of the resilient loading phase of the gait. We further simplify the general-form models and present a set of stature-based models that can estimate the hip quasi-stiffness for the preferred gait speed using only body weight and height with an average error of 27% for the extension stage and 37% for the flexion stage.	[Shamaei, Kamran; Dollar, Aaron M.] Yale Univ, Sch Engn & Appl Sci, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA; [Sawicki, Gregory S.] Joint Dept Biomed Engn North Carolina State Univ, Raleigh, NC USA	Yale University; University of North Carolina; North Carolina State University	Shamaei, K (corresponding author), Yale Univ, Sch Engn & Appl Sci, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA.	kamran.shamaei@yale.edu		Dollar, Aaron/0000-0002-2409-4668	US Defense Medical Research Development Program [W81XWH-11-2-0054]	US Defense Medical Research Development Program	This work was supported by the US Defense Medical Research Development Program, grant #W81XWH-11-2-0054. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER RM, 1992, PHILOS T ROY SOC B, V338, P189, DOI 10.1098/rstb.1992.0138; ANDRIACCHI TP, 1977, J BIOMECH, V10, P261, DOI 10.1016/0021-9290(77)90049-5; Banala SK, 2009, IEEE T NEUR SYS REH, V17, P2, DOI 10.1109/TNSRE.2008.2008280; CAVAGNA GA, 1983, J PHYSIOL-LONDON, V343, P323, DOI 10.1113/jphysiol.1983.sp014895; Cherry MS, 2006, P IDETC CIE ASME INT; Collins S, 2005, SCIENCE, V307, P1082, DOI 10.1126/science.1107799; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Crenna P, 2011, HUM MOVEMENT SCI, V30, P1185, DOI 10.1016/j.humov.2011.02.009; CROWINSHIELD RD, 1978, CLIN ORTHOP RELAT R, P140; Davis RB, 1996, GAIT POSTURE, V4, P224, DOI 10.1016/0966-6362(95)01045-9; Dean JC, 2009, J R SOC INTERFACE, V6, P561, DOI 10.1098/rsif.2008.0415; DEVITA P, 1994, J BIOMECH, V27, P501, DOI 10.1016/0021-9290(94)90025-6; Dollar AM, 2008, IEEE T ROBOT, V24, P144, DOI 10.1109/TRO.2008.915453; Duan XH, 1997, MED ENG PHYS, V19, P518, DOI 10.1016/S1350-4533(97)00022-2; Dubbeldam R, 2010, CLIN BIOMECH, V25, P796, DOI 10.1016/j.clinbiomech.2010.06.007; Dumas R, 2008, GAIT POSTURE, V28, P243, DOI 10.1016/j.gaitpost.2007.12.003; Edwards WT, 2007, GAIT POSTURE, V25, P432, DOI 10.1016/j.gaitpost.2006.05.009; Eilenberg MF, 2010, IEEE T NEUR SYS REH, V18, P164, DOI 10.1109/TNSRE.2009.2039620; Endo K, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P4935, DOI 10.1109/IROS.2006.282454; Endo K, 2009, IEEE INT CONF ROBOT, P2790; Farley CT, 1996, J BIOMECH, V29, P181, DOI 10.1016/0021-9290(95)00029-1; Farley CT, 1998, J APPL PHYSIOL, V85, P1044, DOI 10.1152/jappl.1998.85.3.1044; Farris DJ, 2012, J APPL PHYSIOL, V113, P1862, DOI 10.1152/japplphysiol.00802.2012; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Ferrari A, 2008, GAIT POSTURE, V28, P207, DOI 10.1016/j.gaitpost.2007.11.009; FERRIGNO G, 1985, IEEE T BIO-MED ENG, V32, P943, DOI 10.1109/TBME.1985.325627; Ferris DP, 2009, IEEE ENG MED BIO, P2119, DOI 10.1109/IEMBS.2009.5333984; Frigo C, 1998, MED BIOL ENG COMPUT, V36, P179, DOI 10.1007/BF02510740; Frigo C, 1996, J ELECTROMYOGR KINES, V6, P177, DOI 10.1016/1050-6411(96)00030-2; Frigo C, 1998, GAIT POSTURE, V8, P91, DOI 10.1016/S0966-6362(98)00031-9; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Geyer H, 2010, IEEE T NEUR SYS REH, V18, P263, DOI 10.1109/TNSRE.2010.2047592; Geyer H, 2006, P R SOC B, V273, P2861, DOI 10.1098/rspb.2006.3637; H?skuldsson A., 1988, J CHEMOMETR, V2, P211, DOI DOI 10.1002/CEM.1180020306; Hansen AH, 2004, J BIOMECH, V37, P1467, DOI 10.1016/j.jbiomech.2004.01.017; Hitt J, 2009, IND ROBOT, V36, P441, DOI 10.1108/01439910910980169; Hortobagyi T, 2011, J APPL PHYSIOL, V111, P1391, DOI 10.1152/japplphysiol.00291.2011; Jezernik S, 2004, IEEE T ROBOTIC AUTOM, V20, P574, DOI 10.1109/TRA.2004.825515; Kuitunen S, 2002, MED SCI SPORT EXER, V34, P166, DOI 10.1097/00005768-200201000-00025; Kuo AD, 2002, J BIOMECH ENG-T ASME, V124, P113, DOI 10.1115/1.1427703; Lark SD, 2003, CLIN BIOMECH, V18, P848, DOI 10.1016/S0268-0033(03)00150-5; Lenzi T, 2013, IEEE T NEUR SYS REH, V99, P1; Leurs F, 2011, J EXP BIOL, V214, P2276, DOI 10.1242/jeb.054452; Markowitz J, 2011, PHILOS T R SOC B, V366, P1621, DOI 10.1098/rstb.2010.0347; Martinez-Vilialpando EC, 2009, J REHABIL RES DEV, V46, P361, DOI 10.1682/JRRD.2008.09.0131; McGeer T., 1990, Proceedings 1990 IEEE International Conference on Robotics and Automation (Cat. No.90CH2876-1), P1640, DOI 10.1109/ROBOT.1990.126245; MINETTI AE, 1994, EUR J APPL PHYSIOL O, V68, P285, DOI 10.1007/BF00571444; Minetti AE, 2000, EUR J ENDOCRINOL, V142, P35, DOI 10.1530/eje.0.1420035; MOCHON S, 1980, MATH BIOSCI, V52, P241, DOI 10.1016/0025-5564(80)90070-X; Pedotti A., 1992, FUNCT NEUROL, V7, P47; Perry J., 1992, GAIT ANAL NORMAL PAT; PICARD RR, 1984, J AM STAT ASSOC, V79, P575, DOI 10.2307/2288403; Rose J., 2006, HUMAN WALKING, V3rd ed.; Rouse EJ, 2013, IEEE T BIO-MED ENG, V60, P562, DOI 10.1109/TBME.2012.2230261; Salsich GB, 2000, GAIT POSTURE, V11, P207, DOI 10.1016/S0966-6362(00)00047-3; Shamaei K, 2013, IEEE INT C IN PRESS; Shamaei K, 2011, INT C REHAB ROBOT; Shamaei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059993; Shamaei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059935; Shamaei K, 2011, IEEE ENG MED BIO, P8135, DOI 10.1109/IEMBS.2011.6092007; Silder A, 2008, J BIOMECH, V41, P1520, DOI 10.1016/j.jbiomech.2008.02.016; SKINNER SR, 1985, ORTHOPEDICS, V8, P355; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; Srinivasan M, 2006, NATURE, V439, P72, DOI 10.1038/nature04113; Sup F, 2008, INT J ROBOT RES, V27, P263, DOI 10.1177/0278364907084588; TAGA G, 1995, BIOL CYBERN, V73, P97, DOI 10.1007/BF00204048; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Walsh CJ, 2006, 2006 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-12, P1410, DOI 10.1109/IROS.2006.281932; Walsh CJ, 2006, IEEE INT CONF ROBOT, P3485, DOI 10.1109/ROBOT.2006.1642234; Walsh CJ, 2007, INT J HUM ROBOT, V4, P487, DOI 10.1142/S0219843607001126; WEISS PL, 1986, J BIOMECH, V19, P737, DOI 10.1016/0021-9290(86)90197-1; WEISS PL, 1986, J BIOMECH, V19, P727, DOI 10.1016/0021-9290(86)90196-X; Winter D, 2005, BIOMECHANICS MOTOR C; Winter DA., 1987, BIOMECHANICS MOTOR C; Zoss A, 2005, 2005 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-4, P3132, DOI 10.1109/IROS.2005.1545453; Zoss AB, 2006, IEEE-ASME T MECH, V11, P128, DOI 10.1109/TMECH.2006.871087	76	34	35	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81841	10.1371/journal.pone.0081841	http://dx.doi.org/10.1371/journal.pone.0081841			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349136	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200052
J	Carrillo, JA; Cordier, S; Deco, G; Mancini, S				Carrillo, Jose Antonio; Cordier, Stephane; Deco, Gustavo; Mancini, Simona			Complexity Reduction of Rate-Equations Models for Two-Choice Decision-Making	PLOS ONE			English	Article							REACTION-TIME; SOBOLEV INEQUALITIES; PERCEPTUAL DECISION; DISCRIMINATION; INTEGRATION; MECHANISM; AREA	We are concerned with the complexity reduction of a stochastic system of differential equations governing the dynamics of a neuronal circuit describing a decision-making task. This reduction is based on the slow-fast behavior of the problem and holds on the whole phase space and not only locally around the spontaneous state. Macroscopic quantities, such as performance and reaction times, computed applying this reduction are in agreement with previous works in which the complexity reduction is locally performed at the spontaneous point by means of a Taylor expansion.	[Carrillo, Jose Antonio] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Cordier, Stephane; Mancini, Simona] Univ Orleans, CNRS, MAPMO, UMR 7349, Orleans, France; [Cordier, Stephane; Mancini, Simona] FR 2964, Orleans, France; [Deco, Gustavo] ICREA, Barcelona, Spain; [Deco, Gustavo] Univ Pompeu Fabra, Computat Neurosci Unit, Barcelona, Spain	Imperial College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); Universite de Orleans; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); ICREA; Pompeu Fabra University	Mancini, S (corresponding author), Univ Orleans, CNRS, MAPMO, UMR 7349, Orleans, France.	simona.mancini@univ-orleans.fr	DECO, GUSTAVO/A-6341-2008; Carrillo, Jose Antonio/C-7048-2008	DECO, GUSTAVO/0000-0002-8995-7583; Carrillo, Jose Antonio/0000-0001-8819-4660	Royal Society by a Wolfson Research Merit Award; Engineering and Physical Sciences Research Council [EP/K008404/1]; DGI ( Spain) [MTM2011-27739-C04-02]; AGAUR-Generalitat de Catalunya [2009-SGR-345]; ANR project MANDy, Mathematical Analysis of Neuronal Dynamics [ANR-09-BLAN-0008-01]; ICREA Funding Source: Custom; EPSRC [EP/K008404/1] Funding Source: UKRI	Royal Society by a Wolfson Research Merit Award; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DGI ( Spain); AGAUR-Generalitat de Catalunya(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)Generalitat de Catalunya); ANR project MANDy, Mathematical Analysis of Neuronal Dynamics(French National Research Agency (ANR)); ICREA(ICREA); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	J.A. Carrillo acknowledges support from the Royal Society by a Wolfson Research Merit Award and by the Engineering and Physical Sciences Research Council grant with references EP/K008404/1. J.A. Carrillo was partially supported by the project MTM2011-27739-C04-02 DGI ( Spain) and 2009-SGR-345 from AGAUR-Generalitat de Catalunya. S. Cordier and S. Mancini acknowledge support by the ANR project MANDy, Mathematical Analysis of Neuronal Dynamics, ANR-09-BLAN-0008-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrillo JA, 2011, J MATH BIOL, V63, P801, DOI 10.1007/s00285-010-0391-3; Arnold A, 2001, COMMUN PART DIFF EQ, V26, P43, DOI 10.1081/PDE-100002246; Berglund N, 2005, SPRINGER PROBABILITY; Carrillo JA, 2013, COMMUN MATH SCI, V11, P523, DOI 10.4310/CMS.2013.v11.n2.a10; CRAWFORD JD, 1991, REV MOD PHYS, V63, P991, DOI 10.1103/RevModPhys.63.991; Deco G, 2007, BIOL CYBERN, V96, P487, DOI 10.1007/s00422-007-0144-6; Gardiner C. W., 1985, HDB STOCHASTIC METHO, V3; Hartman P., 1960, P AM MATH SOC, V11, P610, DOI [10.1090/S0002-9939-1960- 0121542-7, DOI 10.1090/S0002-9939-1960-0121542-7]; HOLLEY R, 1987, J STAT PHYS, V46, P1159, DOI 10.1007/BF01011161; Huk AC, 2005, J NEUROSCI, V25, P10420, DOI 10.1523/JNEUROSCI.4684-04.2005; Lo CC, 2006, NAT NEUROSCI, V9, P956, DOI 10.1038/nn1722; Ratcliff R, 2004, PSYCHOL REV, V111, P333, DOI 10.1037/0033-295X.111.2.333; Roitman JD, 2002, J NEUROSCI, V22, P9475; Romo R, 2003, NAT REV NEUROSCI, V4, P203, DOI 10.1038/nrn1058; Romo R, 2001, ANNU REV NEUROSCI, V24, P107, DOI 10.1146/annurev.neuro.24.1.107; Roxin A, 2008, PLOS COMPUT BIOL, V4, P43; Shadlen MN, 2001, J NEUROPHYSIOL, V86, P1916, DOI 10.1152/jn.2001.86.4.1916; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	19	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80820	10.1371/journal.pone.0080820	http://dx.doi.org/10.1371/journal.pone.0080820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339885	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566100021
J	Yang, XH; Chen, XH; Chen, S; Xu, XY; Yang, YF				Yang, Xiaohong; Chen, Xuhai; Chen, Shuang; Xu, Xiaoying; Yang, Yufang			Topic Structure Affects Semantic Integration: Evidence from Event-Related Potentials	PLOS ONE			English	Article							EYE-MOVEMENTS; PRAGMATIC ANOMALIES; BRAIN POTENTIALS; DISCOURSE; N400; P600; COMPREHENSION; SENTENCE; ERP; ACCESSIBILITY	This study investigated whether semantic integration in discourse context could be influenced by topic structure using event-related brain potentials. Participants read discourses in which the last sentence contained a critical word that was either congruent or incongruent with the topic established in the first sentence. The intervening sentences between the first and the last sentence of the discourse either maintained or shifted the original topic. Results showed that incongruent words in topic-maintained discourses elicited an N400 effect that was broadly distributed over the scalp while those in topic-shifted discourses elicited an N400 effect that was lateralized to the right hemisphere and localized over central and posterior areas. Moreover, a late positivity effect was only elicited by incongruent words in topic-shifted discourses, but not in topic-maintained discourses. This suggests an important role for discourse structure in semantic integration, such that compared with topic-maintained discourses, the complexity of discourse structure in topic-shifted condition reduces the initial stage of semantic integration and enhances the later stage in which a mental representation is updated.	[Yang, Xiaohong; Chen, Shuang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Xuhai] Shannxi Normal Univ, Sch Psychol, Xian, Peoples R China; [Xu, Xiaoying] Beijing Normal Univ, Sch Chinese Language & Literature, Beijing 100875, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Shaanxi Normal University; Beijing Normal University		yangyf@psych.ac.cn			Scientific Research Foundation for Young Scientists, Institute of Psychology, Chinese Academic of Sciences [Y1CX322005]; National Natural Science Foundation of China [31070989]; K. C. Wong Education Foundation, Hong Kong	Scientific Research Foundation for Young Scientists, Institute of Psychology, Chinese Academic of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Education Foundation, Hong Kong	This research was supported by the Scientific Research Foundation for Young Scientists, Institute of Psychology, Chinese Academic of Sciences (Y1CX322005), the National Natural Science Foundation of China (31070989), and K. C. Wong Education Foundation, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON A, 1983, Q J EXP PSYCHOL-A, V35, P427, DOI 10.1080/14640748308402480; Beijing Institute of Language, 1986, MOD CHIN FREQ DICT; BINDER KS, 1995, J EXP PSYCHOL LEARN, V21, P1186, DOI 10.1037/0278-7393.21.5.1186; Brouwer H, 2012, BRAIN RES, V1446, P127, DOI 10.1016/j.brainres.2012.01.055; Burkhardt P, 2007, NEUROREPORT, V18, P1851, DOI 10.1097/WNR.0b013e3282f1a999; Burkhardt P, 2006, BRAIN LANG, V98, P159, DOI 10.1016/j.bandl.2006.04.005; Camblin CC, 2007, J MEM LANG, V56, P103, DOI 10.1016/j.jml.2006.07.005; Eckstein K, 2006, J COGNITIVE NEUROSCI, V18, P1696, DOI 10.1162/jocn.2006.18.10.1696; Filik R, 2008, PSYCHOPHYSIOLOGY, V45, P554, DOI 10.1111/j.1469-8986.2008.00656.x; Filik R, 2008, COGNITION, V106, P1038, DOI 10.1016/j.cognition.2007.04.006; Friederici AD, 2002, J PSYCHOLINGUIST RES, V31, P45, DOI 10.1023/A:1014376204525; Friederici AD, 2000, J MEM LANG, V43, P476, DOI 10.1006/jmla.2000.2709; Gernsbacher MA, 1997, DISCOURSE PROCESS, V23, P265, DOI 10.1080/01638539709544994; Gouvea AC, 2010, LANG COGNITIVE PROC, V25, P149, DOI 10.1080/01690960902965951; Hald LA, 2007, BRAIN RES, V1146, P210, DOI 10.1016/j.brainres.2007.02.054; Hirotani M, 2011, J NEUROLINGUIST, V24, P276, DOI 10.1016/j.jneuroling.2010.09.007; Hung YC, 2012, NEUROSCIENCE LETT, V511, P59; HYONA J, 1995, J EXP PSYCHOL LEARN, V21, P1365, DOI 10.1037/0278-7393.21.5.A; Hyona J, 1994, READING RES Q, V29, P76; Jiang XM, 2009, NEUROPSYCHOLOGIA, V47, P1282, DOI 10.1016/j.neuropsychologia.2009.01.013; Kaan E, 2000, LANG COGNITIVE PROC, V15, P159, DOI 10.1080/016909600386084; Kaan E, 2003, J COGNITIVE NEUROSCI, V15, P98, DOI 10.1162/089892903321107855; Kim A, 2005, J MEM LANG, V52, P205, DOI 10.1016/j.jml.2004.10.002; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; LORCH RF, 1986, DISCOURSE PROCESS, V9, P489, DOI 10.1080/01638538609544654; LORCH RF, 1985, J MEM LANG, V24, P350, DOI 10.1016/0749-596X(85)90033-6; MCCARTHY G, 1985, ELECTROEN CLIN NEURO, V62, P203, DOI 10.1016/0168-5597(85)90015-2; MCKOON G, 1993, J MEM LANG, V32, P56, DOI 10.1006/jmla.1993.1004; Nieuwand MS, 2005, COGNITIVE BRAIN RES, V24, P691, DOI 10.1016/j.cogbrainres.2005.04.003; Nieuwland MS, 2006, J COGNITIVE NEUROSCI, V18, P1098, DOI 10.1162/jocn.2006.18.7.1098; OBRIEN EJ, 1986, J EXP PSYCHOL LEARN, V12, P346, DOI 10.1037/0278-7393.12.3.346; Salmon N, 2002, BRAIN LANG, V83, P367, DOI 10.1016/S0093-934X(02)00507-2; Stekelenburg JJ, 2012, NEUROPSYCHOLOGIA, V50, P1425, DOI 10.1016/j.neuropsychologia.2012.02.027; van Berkum JJA, 1999, J COGNITIVE NEUROSCI, V11, P657, DOI 10.1162/089892999563724; Van Berkum JJA, 2005, J EXP PSYCHOL LEARN, V31, P443, DOI 10.1037/0278-7393.31.3.443; van Berkum JJA, 2003, COGNITIVE BRAIN RES, V17, P701, DOI 10.1016/S0926-6410(03)00196-4; van de Meerendonk N, 2010, J COGNITIVE NEUROSCI, V22, P67, DOI 10.1162/jocn.2008.21170; van Herten M, 2005, COGNITIVE BRAIN RES, V22, P241, DOI 10.1016/j.cogbrainres.2004.09.002; Wang L, 2011, NEUROPSYCHOLOGIA, V49, P813, DOI 10.1016/j.neuropsychologia.2010.12.035; Wang L, 2009, BRAIN RES, V1282, P50, DOI 10.1016/j.brainres.2009.05.069; Warren T, 2008, J EXP PSYCHOL LEARN, V34, P1001, DOI 10.1037/0278-7393.34.4.1001	42	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e79734	10.1371/journal.pone.0079734	http://dx.doi.org/10.1371/journal.pone.0079734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	265IN	24348994	Green Published, Green Submitted, gold			2022-12-27	WOS:000327944500007
J	Tonteri, E; Kipar, A; Voutilainen, L; Vene, S; Vaheri, A; Vapalahti, O; Lundkvist, A				Tonteri, Elina; Kipar, Anja; Voutilainen, Liina; Vene, Sirkka; Vaheri, Antti; Vapalahti, Olli; Lundkvist, Ake			The Three Subtypes of Tick-Borne Encephalitis Virus Induce Encephalitis in a Natural Host, the Bank Vole (Myodes glareolus)	PLOS ONE			English	Article							WILD RODENTS; INFECTION; TRANSMISSION; ADAPTATION; STRAINS; FLAVIVIRUSES; EPIDEMIOLOGY; DETERMINANTS; PATHOGENESIS; PERSISTENCE	Tick-borne encephalitis virus (TBEV) infects bank voles (Myodes glareolus) in nature, but the relevance of rodents for TBEV transmission and maintenance is unclear. We infected colonized bank voles subcutaneously to study and compare the infection kinetics, acute infection, and potential viral persistence of the three known TBEV subtypes: European (TBEV-Eur), Siberian (TBEV-Sib) and Far Eastern (TBEV-FE). All strains representing the three subtypes were infective and highly neurotropic. They induced (meningo) encephalitis in some of the animals, however most of the cases did not present with apparent clinical symptoms. TBEV-RNA was cleared significantly slower from the brain as compared to other organs studied. Supporting our earlier findings in natural rodent populations, TBEV-RNA could be detected in the brain for up to 168 days post infection, but we could not demonstrate infectivity by cell culture isolation. Throughout all time points post infection, RNA of the TBEV-FE was detected significantly more often than RNA of the other two strains in all organs studied. TBEV-FE also induced prolonged viremia, indicating distinctive kinetics in rodents in comparison to the other two subtypes. This study shows that bank voles can develop a neuroinvasive TBEV infection with persistence of viral RNA in brain, and mount an anti-TBEV IgG response. The findings also provide further evidence that bank voles can serve as sentinels for TBEV endemicity.	[Tonteri, Elina; Voutilainen, Liina; Vaheri, Antti; Vapalahti, Olli] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Tonteri, Elina; Lundkvist, Ake] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Tonteri, Elina; Vene, Sirkka; Lundkvist, Ake] Swedish Inst Infect Dis Control, Solna, Sweden; [Kipar, Anja] Univ Helsinki, Fac Vet Med, Finnish Ctr Lab Anim Pathol, Helsinki, Finland; [Kipar, Anja] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja] Univ Liverpool, Dept Infect Biol, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Kipar, Anja; Vapalahti, Olli] Fac Vet Med, Dept Vet Biosci, Helsinki, Finland; [Voutilainen, Liina] Finnish Forest Res Inst, Vantaa, Finland; [Vaheri, Antti; Vapalahti, Olli] Helsinki Univ Hosp Lab HUSLAB, Dept Virol & Immunol, Helsinki, Finland; [Lundkvist, Ake] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	University of Helsinki; Karolinska Institutet; Swedish Institute for Infectious Disease Control; University of Helsinki; University of Liverpool; University of Liverpool; Natural Resources Institute Finland (Luke); University of Helsinki; Helsinki University Central Hospital; Uppsala University	Tonteri, E (corresponding author), Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland.	elina.rintala@helsinki.fi	Vaheri, Antti/AAV-1523-2020; Kipar, Anja/L-7214-2014	Kipar, Anja/0000-0001-7289-3459; Vapalahti, Olli/0000-0003-2270-6824	Niemi Foundation; Helsinki Biomedical Graduate School; Biocenter Finland; Academy of Finland [122827, 251836]; Swedish Institute of Communicable Diseases	Niemi Foundation; Helsinki Biomedical Graduate School; Biocenter Finland; Academy of Finland(Academy of Finland); Swedish Institute of Communicable Diseases	The work was supported by the Niemi Foundation (no URL available); the Helsinki Biomedical Graduate School (http://www.hbgs.helsinki.fi/HBGS_2/Home.html); Biocenter Finland (www.biocenter.fi); the Academy of Finland (www.aka.fi) (122827 and 251836) and the Swedish Institute of Communicable Diseases (www.smittskyddsinstitutet.se). All funders have contributed to fund the labour costs and Swedish Institute of Communicable Diseases and Academy of Finland did also fund the experiments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achazi K, 2011, VECTOR-BORNE ZOONOT, V11, P641, DOI 10.1089/vbz.2010.0236; ALEKSEEV A N, 1991, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P50; Antoine DJ, 2009, TOXICOL SCI, V112, P521, DOI 10.1093/toxsci/kfp235; Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416; Bakhvalova VN, 2009, VIRUS RES, V140, P172, DOI 10.1016/j.virusres.2008.12.001; Bakhvalova VN, 2006, VECTOR-BORNE ZOONOT, V6, P32, DOI 10.1089/vbz.2006.6.32; BAKHVALOVA VN, 2003, PARAZITOLOGIIA, V37, P71222; Bates D, 2011, LME4 LINEAR MIXED EF; Bolzoni L, 2012, INT J PARASITOL, V42, P373, DOI 10.1016/j.ijpara.2012.02.006; BURNHAM KP, 2000, MODEL SELECTION INTE, P71222; CHUNIKHIN SP, 1979, ACTA VIROL, V23, P257; DIZIJ A, 1995, PARASITE IMMUNOLOGY, V17, P71222; Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; FOKINA GI, 1982, ACTA VIROL, V26, P369; Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506; Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746; Gerlinskaia L A, 1997, Biull Eksp Biol Med, V123, P327; Golovljova I, 2004, J MED VIROL, V74, P580, DOI 10.1002/jmv.20224; Golovljova I, 2008, INT J MED MICROBIOL, V298, P108, DOI 10.1016/j.ijmm.2007.12.004; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003; Hayasaka D, 2009, VIROLOGY, V390, P139, DOI 10.1016/j.virol.2009.04.026; Hughes DJ, 2012, ARCH VIROL, V157, P2207, DOI 10.1007/s00705-012-1397-5; Jaaskelainen AE, 2006, EMERG INFECT DIS, V12, P1568, DOI 10.3201/eid1210.060320; Jaaskelainen AE, 2011, EMERG INFECT DIS, V17, P323, DOI 10.3201/eid1702.101487; Jaaskelainen AE, 2010, J GEN VIROL, V91, P2706, DOI 10.1099/vir.0.023663-0; JONES LD, 1987, SCIENCE, V237, P775, DOI 10.1126/science.3616608; Kaneko Y, 1998, RES POPUL ECOL, V40, P21, DOI 10.1007/BF02765219; Khasnatinov MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007295; Kim SY, 2008, VECTOR-BORNE ZOONOT, V8, P7, DOI 10.1089/vbz.2006.0634; Knap N, 2012, VECTOR-BORNE ZOONOT, V12, P236, DOI 10.1089/vbz.2011.0728; Kovalev SY, 2010, J GEN VIROL, V91, P2941, DOI 10.1099/vir.0.023879-0; KOZUCH O, 1990, ACTA VIROL, V34, P537; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; Labuda M, 1999, ZBL BAKT-INT J MED M, V289, P513; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001; Mitzel DN, 2008, VIROLOGY, V381, P268, DOI 10.1016/j.virol.2008.08.030; Moshkin MP, 2009, BIOESSAYS, V31, P620, DOI 10.1002/bies.200800196; Plekhova NG, 2012, B EXP BIOL MED+, V153, P105, DOI 10.1007/s10517-012-1655-2; POGODINA VV, 1981, ACTA VIROL, V25, P337; R Development Core Team, 2011, R LANG ENV STAT COMP; Randolph SE, 2011, TICKS TICK-BORNE DIS, V2, P179, DOI 10.1016/j.ttbdis.2011.07.004; Randolph SE, 2000, P ROY SOC B-BIOL SCI, V267, P1741, DOI 10.1098/rspb.2000.1204; Rigby MC, 2002, TRENDS PARASITOL, V18, P116, DOI 10.1016/S1471-4922(01)02203-6; Ruzek D, 2010, TRAVEL MED INFECT DI, V8, P223, DOI 10.1016/j.tmaid.2010.06.004; Sandland GJ, 2003, TRENDS PARASITOL, V19, P571, DOI 10.1016/j.pt.2003.10.006; Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Takeda T, 1999, AM J TROP MED HYG, V60, P287, DOI 10.4269/ajtmh.1999.60.287; Tonteri E, 2011, EMERG INFECT DIS, V17, P72, DOI 10.3201/eid1701.100051; Uzcategui NY, 2012, J GEN VIROL, V93, P786, DOI 10.1099/vir.0.035766-0; Vene S, 1998, J VIROL METHODS, V73, P71, DOI 10.1016/S0166-0934(98)00041-X; Waldenstrom J, 2007, EMERG INFECT DIS, V13, P1215, DOI 10.3201/eid1308.061416; Weissenbock H, 1998, ACTA NEUROPATHOL, V95, P361, DOI 10.1007/s004010050811	57	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81214	10.1371/journal.pone.0081214	http://dx.doi.org/10.1371/journal.pone.0081214			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349041	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328734200006
J	Andersen, GS				Andersen, Guri Sogn			Patterns of Saccharina latissima Recruitment	PLOS ONE			English	Article							LAMINARIALES; TEMPERATURE; PHAEOPHYTA; SEAWEEDS	The lack of recovery in Norwegian populations of the kelp Saccharina latissima (Linnaeus) C. E. Lane, C. Mayes, Druehl & G. W. Saunders after a large-scale disturbance that occurred sometime between the late 1990s and early 2000s has raised considerable concerns. Kelp forests are areas of high production that serve as habitats for numerous species, and their continued absence may represent the loss of an entire ecosystem. Some S. latissima populations remain as scattered patches within the affected areas, but today, most of the areas are completely devoid of kelp. The question is if natural recolonization by kelp and the reestablishment of the associated ecosystem is possible. Previous studies indicate that a high degree of reproductive synchrony in macrophytes has a positive effect on their potential for dispersal and on the connectivity between populations, but little is known about the patterns of recruitment in Norwegian S. latissima. More is, however, known about the development of fertile tissue (sori) on adult individuals, which is easily observed. The present study investigated the degree of coupling between the appearance of sori and the recruitment on clean artificial substrate beneath adult specimens. The pattern of recruitment was linked to the retreat of visible sori (i. e. spore release) and a seasonal component unrelated to the fertility of the adults. The formation and the retreat of visible sori are processes that seem synchronized along the south coast of Norway, and the link between sori development and recruitment may therefore suggest that the potential for S. latissima dispersal is relatively large. These results support the notion that the production and dispersal of viable spores is unlikely to be the bottleneck preventing recolonization in the south of Norway, but studies over larger temporal and spatial scales are still needed to confirm this hypothesis.	Univ Oslo, Dept Biosci, Oslo, Norway	University of Oslo	Andersen, GS (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	guri.s.andersen@gmail.com	Andersen, Guri Sogn/T-9566-2019	Sogn Andersen, Guri/0000-0003-2382-2114	Norwegian Research Council [178681]; legacy of Sunniva and Egil Baardseth	Norwegian Research Council(Research Council of NorwayEuropean Commission); legacy of Sunniva and Egil Baardseth	The research was funded by the Norwegian Research Council (grant no. 178681) and a grant from the legacy of Sunniva and Egil Baardseth. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Cie DK, 2011, PHYCOLOGIA, V50, P340, DOI 10.2216/10-48.1; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Deiman M, 2012, ALGAE-SEOUL, V27, P115, DOI 10.4490/algae.2012.27.2.115; Fonck E, 1998, J APPL PHYCOL, V10, P399, DOI 10.1023/A:1008037026834; Gaylord B, 2006, ECOL MONOGR, V76, P481, DOI 10.1890/0012-9615(2006)076[0481:MSDICE]2.0.CO;2; Gorman D, 2009, J APPL ECOL, V46, P1258, DOI 10.1111/j.1365-2664.2009.01711.x; Graham MH, 2003, ECOLOGY, V84, P1250, DOI 10.1890/0012-9658(2003)084[1250:CPOTSA]2.0.CO;2; Harley CDG, 2012, J PHYCOL, V48, P1064, DOI 10.1111/j.1529-8817.2012.01224.x; LEE JA, 1988, J PHYCOL, V24, P181, DOI 10.1111/j.1529-8817.1988.tb04232.x; Leinaas HP, 1996, OECOLOGIA, V105, P524, DOI 10.1007/BF00330016; Mohring MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065310; Moy FE, 2012, MAR BIOL RES, V8, P309, DOI 10.1080/17451000.2011.637561; Muller R, 2009, BOT MAR, V52, P617, DOI 10.1515/BOT.2009.080; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Oppliger LV, 2011, J PHYCOL, V47, P5, DOI 10.1111/j.1529-8817.2010.00930.x; R Core Team, 2021, R LANGUAGE ENV STAT; Reed DC, 1997, ECOLOGY, V78, P2443; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schiel DR, 2006, J EXP MAR BIOL ECOL, V331, P158, DOI 10.1016/j.jembe.2005.10.015; Sjotun K, 2002, PHYCOLOGIA, V41, P147, DOI 10.2216/i0031-8884-41-2-147.1; Sogn Andersen G, 2013, J PHYCOLOGY; Sogn Andersen G., 2011, J MAR BIOL, V2011, P1, DOI DOI 10.1155/2011/690375; Steinhoff FS, 2011, POLAR BIOL, V34, P1011, DOI 10.1007/s00300-011-0960-y; Venables WN., 2002, MODERN APPL STAT S 4; Waycott M, 2009, P NATL ACAD SCI USA, V106, P12377, DOI 10.1073/pnas.0905620106; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08; Zuur Alain F., 2009, P1	29	7	7	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81092	10.1371/journal.pone.0081092	http://dx.doi.org/10.1371/journal.pone.0081092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349034	gold, Green Published			2022-12-27	WOS:000328731800011
J	Bonnet, S; Dekaezemacker, J; Turk-Kubo, KA; Moutin, T; Hamersley, RM; Grosso, O; Zehr, JP; Capone, DG				Bonnet, Sophie; Dekaezemacker, Julien; Turk-Kubo, Kendra A.; Moutin, Thierry; Hamersley, Robert M.; Grosso, Olivier; Zehr, Jonathan P.; Capone, Douglas G.			Aphotic N-2 Fixation in the Eastern Tropical South Pacific Ocean	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; NITROGEN-FIXATION; UNICELLULAR DIAZOTROPHS; DENITRIFICATION RATES; ORGANIC-MATTER; TRICHODESMIUM; CYANOBACTERIA; DIVERSITY; GROWTH; CARBON	We examined rates of N-2 fixation from the surface to 2000 m depth in the Eastern Tropical South Pacific (ETSP) during El Nino (2010) and La Nina (2011). Replicated vertical profiles performed under oxygen-free conditions show that N-2 fixation takes place both in euphotic and aphotic waters, with rates reaching 155 to 509 mu mol N m(-2) d(-1) in 2010 and 24 +/- 14 to 118 +/- 87 mu mol N m(-2) d(-1) in 2011. In the aphotic layers, volumetric N-2 fixation rates were relatively low (< 1.00 nmol N L-1 d(-1)), but when integrated over the whole aphotic layer, they accounted for 87-90% of total rates (euphotic+ aphotic) for the two cruises. Phylogenetic studies performed in microcosms experiments confirm the presence of diazotrophs in the deep waters of the Oxygen Minimum Zone (OMZ), which were comprised of non-cyanobacterial diazotrophs affiliated with nifH clusters 1K (predominantly comprised of alpha-proteobacteria), 1G (predominantly comprised of gamma-proteobacteria), and 3 (sulfate reducing genera of the delta-proteobacteria and Clostridium spp., Vibrio spp.). Organic and inorganic nutrient addition bioassays revealed that amino acids significantly stimulated N-2 fixation in the core of the OMZ at all stations tested and as did simple carbohydrates at stations located nearest the coast of Peru/Chile. The episodic supply of these substrates from upper layers are hypothesized to explain the observed variability of N-2 fixation in the ETSP.	[Bonnet, Sophie; Dekaezemacker, Julien; Moutin, Thierry; Grosso, Olivier] Aix Marseille Univ, Ctr Natl Rech Sci Marseille, Inst Rech Dev, Mediterranean Inst Oceanog, Noumea, New Caledonia; [Turk-Kubo, Kendra A.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Hamersley, Robert M.] Soka Univ Amer, Aliso Viejo, CA USA; [Capone, Douglas G.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California Santa Cruz; University of Southern California	Bonnet, S (corresponding author), Aix Marseille Univ, Ctr Natl Rech Sci Marseille, Inst Rech Dev, Mediterranean Inst Oceanog, Noumea, New Caledonia.	sophie.bonnet@univ-amu.fr	Hamersley, M. Robert/B-8993-2008; Hamersley, M. Robert/AAE-6543-2019; Bonnet, Sophie/I-6274-2015; Zehr, Jonathan P/B-3513-2014	Hamersley, M. Robert/0000-0001-7806-2488; Hamersley, M. Robert/0000-0001-7806-2488; Bonnet, Sophie/0000-0002-9886-8216; Zehr, Jonathan P/0000-0002-5691-5408	Institut National des Sciences de l'Univers France; National Science Foundation (division of OCEan sciences) USA [0850801]	Institut National des Sciences de l'Univers France; National Science Foundation (division of OCEan sciences) USA	Funding agencies: Institut National des Sciences de l'Univers (Humboldt-Fix project, PI: S. Bonnet), France, and the National Science Foundation (division of OCEan sciences 0850801, PI: D. G Capone), USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2007, APPL ENVIRON MICROB, V73, P3528, DOI 10.1128/AEM.02627-06; Aminot A., 2007, DOSAGE AUTOMATIQUE N; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Bonnet S, 2008, BIOGEOSCIENCES, V5, P215, DOI 10.5194/bg-5-215-2008; Bonnet S, 2011, BIOGEOSCIENCES, V8, P2257, DOI 10.5194/bg-8-2257-2011; Bonnet S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003439; Burgess BK, 1996, CHEM REV, V96, P2983, DOI 10.1021/cr950055x; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Capone DG, 2005, GLOBAL BIOGEOCHEM CY, V19, P786; CARPENTER EJ, 1992, NATO ADV SCI I C-MAT, V362, P211; Carpenter EJ, 1999, MAR ECOL PROG SER, V185, P273, DOI 10.3354/meps185273; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; CODISPOTI LA, 1980, J MAR RES, V38, P453; Dekaezemacker J, 2013, GLOBAL BIOGEOCHEM CY, V27, P768, DOI 10.1002/gbc.20063; del Giorgio PA, 1998, ANNU REV ECOL SYST, V29, P503, DOI 10.1146/annurev.ecolsys.29.1.503; Deutsch C, 2001, GLOBAL BIOGEOCHEM CY, V15, P483, DOI 10.1029/2000GB001291; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; DUPOUY C, 1988, INT J REMOTE SENS, V9, P389, DOI 10.1080/01431168808954862; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FARNELID H, 2008, NITROGEN FIXATION RE, P409; Farnelid H, 2013, ISME J, V7, P1413, DOI 10.1038/ismej.2013.26; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Fernandez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020539; GOERING JJ, 1968, DEEP-SEA RES, V15, P157, DOI 10.1016/0011-7471(68)90037-5; Grosskopf T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00236; Grosskopf T, 2012, NATURE, V488, P361, DOI 10.1038/nature11338; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Halm H, 2012, ISME J, V6, P1238, DOI 10.1038/ismej.2011.182; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Hamersley MR, 2011, AQUAT MICROB ECOL, V63, P193, DOI 10.3354/ame01494; HARTMANN A, 1988, APPL ENVIRON MICROB, V54, P87, DOI 10.1128/AEM.54.1.87-93.1988; Helm I, 2009, ANAL CHIM ACTA, V648, P167, DOI 10.1016/j.aca.2009.06.067; Hewson I, 2007, AQUAT MICROB ECOL, V46, P15, DOI 10.3354/ame046015; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Kustka AB, 2003, LIMNOL OCEANOGR, V48, P1869, DOI 10.4319/lo.2003.48.5.1869; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Lam P, 2009, P NATL ACAD SCI USA, V106, P4752, DOI 10.1073/pnas.0812444106; Landolfi A, 2013, BIOGEOSCIENCES, V10, P1351, DOI 10.5194/bg-10-1351-2013; LIPSCHULTZ F, 1990, DEEP-SEA RES, V37, P1513, DOI 10.1016/0198-0149(90)90060-9; LIU KK, 1984, EARTH PLANET SC LETT, V68, P88, DOI 10.1016/0012-821X(84)90142-0; Lodwig EM, 2003, NATURE, V422, P722, DOI 10.1038/nature01527; Mahaffey C, 2005, AM J SCI, V305, P546, DOI 10.2475/ajs.305.6-8.546; Mills MM, 2004, NATURE, V429, P292, DOI 10.1038/nature02550; Moffett JW, 2007, DEEP-SEA RES PT I, V54, P1341, DOI 10.1016/j.dsr.2007.04.004; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Moisander PH, 2012, ISME J, V6, P733, DOI 10.1038/ismej.2011.152; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Moutin T, 2008, BIOGEOSCIENCES, V5, P95, DOI 10.5194/bg-5-95-2008; Mulholland MR, 2001, LIMNOL OCEANOGR, V46, P436, DOI 10.4319/lo.2001.46.2.0436; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Postgate J., 1998, NITROGEN FIXATION; Rahav E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00227; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Turk KA, 2013, ENV MICROBI IN PRESS; Turk-Kubo KA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00386; Wambeke F, 2008, BIOGEOSCIENCES, V5, P833; Ward BB, 2008, DEEP-SEA RES PT I, V55, P1672, DOI 10.1016/j.dsr.2008.07.005; Wilson ST, 2012, APPL ENVIRON MICROB, V78, P6516, DOI 10.1128/AEM.01146-12; Zani S, 2000, APPL ENVIRON MICROB, V66, P3119, DOI 10.1128/AEM.66.7.3119-3124.2000; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 1998, APPL ENVIRON MICROB, V64, P3444; Zehr JP, 2003, BIOTECHNIQUES, V35, P996, DOI 10.2144/03355st08; Zehr JP, 1996, MICROB ECOL, V32, P263; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	71	66	67	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81265	10.1371/journal.pone.0081265	http://dx.doi.org/10.1371/journal.pone.0081265			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349048	Green Published, gold			2022-12-27	WOS:000328731800014
J	Njai, HF; Ewings, FM; Lyimo, E; Foulongne, V; Ngerageza, D; Mongi, A; Ssemwanga, D; Andreasen, A; Nyombi, B; Ao, T; Michael, D; Urassa, M; Todd, J; Zaba, B; Changalucha, J; Hayes, R; Kapiga, SH				Njai, Harr F.; Ewings, Fiona M.; Lyimo, Eric; Foulongne, Vincent; Ngerageza, Dhamira; Mongi, Aika; Ssemwanga, Deogratius; Andreasen, Aura; Nyombi, Balthazar; Ao, Tony; Michael, Denna; Urassa, Mark; Todd, Jim; Zaba, Basia; Changalucha, John; Hayes, Richard; Kapiga, Saidi H.			Deciphering the Complex Distribution of Human Immunodeficiency Virus Type 1 Subtypes among Different Cohorts in Northern Tanzania	PLOS ONE			English	Article							DISEASE PROGRESSION; SEQUENCE ALIGNMENT; HIV DIVERSITY; SUSCEPTIBILITY; SURVEILLANCE; ZIDOVUDINE; RESISTANCE; CHALLENGE; INFECTION; WORKERS	Background: Increased understanding of the genetic diversity of HIV-1 is challenging but important in the development of an effective vaccine. We aimed to describe the distribution of HIV-1 subtypes in northern Tanzania among women enrolled in studies preparing for HIV-1 prevention trials (hospitality facility-worker cohorts), and among men and women in an open cohort demographic surveillance system (Kisesa cohort). Methods: The polymerase encompassing partial reverse transcriptase was sequenced and phylogenetic analysis performed and subtype determined. Questionnaires documented demographic data. We examined factors associated with subtype using multinomial logistic regression, adjusted for study, age, and sex. Results: Among 140 individuals (125 women and 15 men), subtype A1 predominated (54, 39%), followed by C (46, 33%), D (25, 18%) and unique recombinant forms (URFs) (15, 11%). There was weak evidence to suggest different subtype frequencies by study (for example, 18% URFs in the Kisesa cohort versus 5-9% in the hospitality facility-worker cohorts; adjusted relative-risk ratio (aRR) = 2.35 [95% CI 0.59,9.32]; global p = 0.09). Compared to men, women were less likely to have subtype D versus A (aRR = 0.12 [95% CI 0.02,0.76]; global p = 0.05). There was a trend to suggest lower relative risk of subtype D compared to A with older age (aRR = 0.44 [95% CI 0.23,0.85] per 10 years; global p = 0.05). Conclusions: We observed multiple subtypes, confirming the complex genetic diversity of HIV-1 strains circulating in northern Tanzania, and found some differences between cohorts and by age and sex. This has important implications for vaccine design and development, providing opportunity to determine vaccine efficacy in diverse HIV-1 strains.	[Njai, Harr F.; Ewings, Fiona M.; Mongi, Aika; Andreasen, Aura; Ao, Tony; Kapiga, Saidi H.] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania; [Njai, Harr F.; Andreasen, Aura; Ao, Tony; Todd, Jim; Zaba, Basia; Kapiga, Saidi H.] London Sch Hyg & Trop Med, London WC1, England; [Ewings, Fiona M.; Hayes, Richard] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London WC1, England; [Lyimo, Eric; Ngerageza, Dhamira; Michael, Denna; Urassa, Mark; Todd, Jim; Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania; [Foulongne, Vincent] Univ Montpellier, Virol Lab, F-34059 Montpellier, France; [Ssemwanga, Deogratius] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Nyombi, Balthazar; Todd, Jim] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; Universite de Montpellier; Kilimanjaro Christian Medical Centre	Kapiga, SH (corresponding author), Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania.	Saidi.Kapiga@lshtm.ac.uk	Mkwashapi, Denna/ABE-8894-2021	Hayes, Richard/0000-0002-1729-9892; Todd, Jim/0000-0001-5918-4914; Mkwashapi, Denna/0000-0001-6883-1431; Andreasen, Aura/0000-0003-0664-7342; Lyimo, Eric/0000-0002-1904-7410; Kapiga, Saidi/0000-0003-1753-4060	European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_32070_002]; Bill and Melinda Gates Foundation [CG_ct_06_33111]; Global Fund for AIDS TB and Malaria [GFR4-TNZ-405-G04-H, GFR9-TNZ-911-G14-S]; Medical Research Council [MR/K012126/1] Funding Source: researchfish; MRC [G0901756] Funding Source: UKRI	European and Developing Countries Clinical Trials Partnership (EDCTP); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Global Fund for AIDS TB and Malaria(United States Agency for International Development (USAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The microbicide-preparedness study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP; project code: CT_ct_05_32070_002) and the vaccines-preparedness study was funded by EDCTP and the Bill and Melinda Gates Foundation (project code: CG_ct_06_33111). The Kisesa cohort study (TAZAMA project) is funded by the Global Fund for AIDS TB and Malaria through grant numbers GFR4-TNZ-405-G04-H and GFR9-TNZ-911-G14-S to the Tanzanian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghokeng AF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007702; Boerma JT, 2002, SEX TRANSM INFECT, V78, pI97, DOI 10.1136/sti.78.suppl_1.i97; Carr JK, 2006, CURR OPIN HIV AIDS, V1, P294, DOI 10.1097/01.COH.0000232344.23533.be; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Easterbrook PJ, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-4; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Herbinger KH, 2006, AIDS RES HUM RETROV, V22, P599, DOI 10.1089/aid.2006.22.599; Huang DD, 2005, J CLIN MICROBIOL, V43, P3963, DOI 10.1128/JCM.43.8.3963-3970.2005; JUNG M, 1992, J ACQ IMMUN DEF SYND, V5, P359; Kageha S, 2012, AIDS RES HUM RETROV, V28, P228, DOI 10.1089/aid.2011.0089; Kaleebu P, 2001, AIDS, V15, P293, DOI 10.1097/00002030-200102160-00001; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; Kiwelu IE, 2003, AIDS RES HUM RETROV, V19, P57, DOI 10.1089/08892220360473970; Kiwelu IE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047605; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; LARDER BA, 1991, AIDS, V5, P137, DOI 10.1097/00002030-199102000-00002; Lihana RW, 2012, AIDS REV, V14, P83; McCutchan FE, 2006, J MED VIROL, V78, pS7, DOI 10.1002/jmv.20599; Nyombi BM, 2008, APMIS, V116, P507, DOI 10.1111/j.1600-0463.2008.00996.x; Nyombi BM, 2008, AIDS RES HUM RETROV, V24, P761, DOI 10.1089/aid.2007.0311; Pasquier C, 2001, J VIROL METHODS, V94, P45, DOI 10.1016/S0166-0934(01)00272-5; Rambura M, 2007, JAIDS-J ACQ IMM DEF, V46, P616, DOI 10.1097/QAI.0b013e31815a571a; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rusine J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042557; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Somi GR, 2008, ANTIVIR THER, V13, P77; Ssemwanga D, 2012, AIDS RES HUM RETROV, V28, P357, DOI [10.1089/aid.2011.0024, 10.1089/AID.2011.0024]; Tanzania Commission for AIDS (TACAIDS) ZACZ National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and Macro International Inc, 2008, TANZ HIV AIDS MAL IN; Taylor BS, 2008, NEW ENGL J MED, V359, P1965, DOI 10.1056/NEJMc086373; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Waters L, 2012, CURR OPIN INFECT DIS, V25, P42, DOI 10.1097/QCO.0b013e32834ef5af	34	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81848	10.1371/journal.pone.0081848	http://dx.doi.org/10.1371/journal.pone.0081848			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349139	Green Accepted, Green Published, gold			2022-12-27	WOS:000328730300056
J	Sakiyama, T; Gunji, YP				Sakiyama, Tomoko; Gunji, Yukio-Pegio			The Muller-Lyer Illusion in Ant Foraging	PLOS ONE			English	Article							OBJECT RECOGNITION; STATISTICS; PERCEPTION; BEHAVIOR	The Muller-Lyer illusion is a classical geometric illusion in which the apparent (perceived) length of a line depends on whether the line terminates in an arrow tail or arrowhead. This effect may be caused by economic compensation for the gap between the physical stimulus and visual fields. Here, we show that the Muller-Lyer illusion can also be produced by the foraging patterns of garden ants (Lasius niger) and that the pattern obtained can be explained by a simple, asynchronously updated foraging ant model. Our results suggest that the geometric illusion may be a byproduct of the foraging process, in which local interactions underlying efficient exploitation can also give rise to global exploration, and that visual information processing in human could implement similar modulation between local efficient processing and widespread computation.	[Sakiyama, Tomoko; Gunji, Yukio-Pegio] Kobe Univ, Dept Earth & Planetary Sci, Fac Sci, Nada Ku, Kobe, Hyogo 657, Japan	Kobe University	Gunji, YP (corresponding author), Kobe Univ, Dept Earth & Planetary Sci, Fac Sci, Nada Ku, Kobe, Hyogo 657, Japan.	yukio@kobe-u.ac.jp	Sakiyama, Tomoko/ABC-5297-2020; Sakiyama, Tomoko/AAB-4082-2019	Sakiyama, Tomoko/0000-0002-2687-7228; Sakiyama, Tomoko/0000-0002-2687-7228	Kobe University;  [JSPS24320008]; Grants-in-Aid for Scientific Research [25280091] Funding Source: KAKEN	Kobe University; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Kobe University funding and JSPS24320008 (organized by Hiroyuki Miyoshi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badcock DR, 1996, VISION RES, V36, P1467, DOI 10.1016/0042-6989(95)00205-7; BECKERS R, 1993, J INSECT BEHAV, V6, P751, DOI 10.1007/BF01201674; Bulatov A, 1997, BIOL CYBERN, V77, P395, DOI 10.1007/s004220050399; Bulatov A, 2010, BIOL CYBERN, V102, P475, DOI 10.1007/s00422-010-0379-5; CARLSON CR, 1984, VISION RES, V24, P1407, DOI 10.1016/0042-6989(84)90196-2; Choudhury S., 2006, DOES CONSCIOUSNESS C, P39; COOPER MR, 1970, PERCEPT MOTOR SKILL, V31, P535, DOI 10.2466/pms.1970.31.2.535; DENEUBOURG JL, 1990, J INSECT BEHAV, V3, P159, DOI 10.1007/BF01417909; DENEUBOURG JL, 1983, J THEOR BIOL, V105, P259, DOI 10.1016/S0022-5193(83)80007-1; Detrain C, 2006, PHYS LIFE REV, V3, P162, DOI 10.1016/j.plrev.2006.07.001; DEWAR RE, 1968, PERCEPT PSYCHOPHYS, V3, P246, DOI 10.3758/BF03212737; ERLEBACH.A, 1969, J EXP PSYCHOL, V80, P462; ERMENTROUT GB, 1979, BIOL CYBERN, V34, P137, DOI 10.1007/BF00336965; Fermuller C, 2004, VISION RES, V44, P727, DOI 10.1016/j.visres.2003.09.038; Ginsburg A. P., 1971, Proceedings of the national aerospace electronics conference 1971, P283; GREGORY RL, 1963, NATURE, V199, P678, DOI 10.1038/199678a0; Gregory RL, 1966, EYE BRAIN PSYCHOL SE; Hamaguchi K., 1995, JAPANESE J PSYCHONOM, V13, P89, DOI [10.14947/psychono.KJ00004413271, DOI 10.14947/PSYCHONO.KJ00004413271]; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1234, DOI 10.1073/pnas.0409314102; Howe CQ, 2005, P NATL ACAD SCI USA, V102, P1228, DOI 10.1073/pnas.0409311102; Howe CQ, 2002, P NATL ACAD SCI USA, V99, P13184, DOI 10.1073/pnas.162474299; Jeanson R, 2003, PHYSIOL ENTOMOL, V28, P192, DOI 10.1046/j.1365-3032.2003.00332.x; LIBET B, 1985, BEHAV BRAIN SCI, V8, P529, DOI 10.1017/S0140525X00044903; Libet B, 2004, MIND TIME TEMPORAL F; LIMB JO, 1977, VISION RES, V17, P571, DOI 10.1016/0042-6989(77)90056-6; Mailleux AC, 2000, ANIM BEHAV, V59, P1061, DOI 10.1006/anbe.2000.1396; MARR D, 1980, PROC R SOC SER B-BIO, V207, P187, DOI 10.1098/rspb.1980.0020; Muller-Lyer FC, 1896, Z PSYCHOL, V10, pS421; Pockett S., 2006, DOES CONSCIOUSNESS C, P9, DOI [10.7551/mitpress/9780262162371.001.0001, DOI 10.7551/MITPRESS/9780262162371.001.0001]; RESTLE F, 1977, PERCEPT PSYCHOPHYS, V21, P489, DOI 10.3758/BF03198729; Riesenhuber M, 2002, CURR OPIN NEUROBIOL, V12, P162, DOI 10.1016/S0959-4388(02)00304-5; Rock I., 1995, PERCEPTION; Sakiyama T, 2013, INSECT SOC, V60, P155, DOI 10.1007/s00040-012-0279-x; Seizova-Cajic T, 2006, VISION RES, V46, P2525, DOI 10.1016/j.visres.2006.02.010; Serre T, 2002, LECT NOTES COMPUT SC, V2525, P387; Serre T., 2005, P 2005 IEEE COMP SOC; Serre T, 2007, IEEE T PATTERN ANAL, V29, P411, DOI 10.1109/TPAMI.2007.56; Sumpter DJT, 2003, ANIM BEHAV, V66, P273, DOI 10.1006/anbe.2003.2224; TSAI LS, 1967, PERCEPT MOTOR SKILL, V25, P641, DOI 10.2466/pms.1967.25.2.641; WARD LM, 1976, B PSYCHONOMIC SOC, V7, P483, DOI 10.3758/BF03337255; WARD R, 1985, CAN J PSYCHOL, V39, P387, DOI 10.1037/h0080067; Wegner DM, 2002, BRADFORD BOOKS, P1; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Zeman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056126	44	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81714	10.1371/journal.pone.0081714	http://dx.doi.org/10.1371/journal.pone.0081714			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349117	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300047
J	Chauvel, V; Schoenen, J; Multon, S				Chauvel, Virginie; Schoenen, Jean; Multon, Sylvie			Influence of Ovarian Hormones on Cortical Spreading Depression and Its Suppression by L-kynurenine in Rat	PLOS ONE			English	Article							RECEPTOR-DEPENDENT MECHANISM; MIGRAINE AURA; ESTROGEN; HEADACHE; BRAIN; NMDA; PROGESTERONE; ESTRADIOL; PREGNANCY; DENSITY	Migraine is sexually dimorphic and associated in 20-30% of patients with an aura most likely caused by cortical spreading depression (CSD). We have previously shown that systemic L-kynurenine (L-KYN), the precursor of kynurenic acid, suppresses CSD and that this effect depends on the stage of the estrous cycle in female rats. The objectives here are to determine the influence of ovarian hormones on KCl-induced CSD and its suppression after L-KYN by directly modulating estradiol or progesterone levels in ovariectomized rats. Adult female rats were ovariectomized and subcutaneously implanted with silastic capsules filled with progesterone or 17 beta-estradiol mixed with cholesterol, with cholesterol only or left empty. Two weeks after the ovariectomy/capsule implantation, the animals received an i.p. injection of L-KYN (300 mg/kg) or NaCl as control. Thirty minutes later CSDs were elicited by applying KCl over the occipital cortex and recorded by DC electrocorticogram for 1 hour. The results show that both estradiol and progesterone increase CSD frequency after ovariectomy. The suppressive effect of L-KYN on CSD frequency, previously reported in normal cycling females, is not found anymore after ovariectomy, but reappears after progesterone replacement therapy. Taken together, these results emphasize the complex role of sex hormones on cortical excitability. The CSD increase by estradiol and, more surprisingly, progesterone may explain why clinically migraine with aura appears or worsens during pregnancy or with combined hormonal treatments.	[Chauvel, Virginie; Schoenen, Jean; Multon, Sylvie] Univ Liege, Cephal Pain Unit GIGA Neurosci, Liege, Belgium; [Schoenen, Jean] Univ Liege, Dept Neurol, Headache Res Unit, CHR Citadelle Liege, Liege, Belgium	University of Liege; University of Liege	Multon, S (corresponding author), Univ Liege, Cephal Pain Unit GIGA Neurosci, Liege, Belgium.	s.multon@ulg.ac.be			Belgian National Fund for Scientific Research (FNRS) [3.4.650.09]; Special Research Funds of the University of Liege	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Special Research Funds of the University of Liege	This work was supported by the Belgian National Fund for Scientific Research (FNRS) [convention 3.4.650.09] and by Special Research Funds of the University of Liege. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Guedes RCA, 2009, EPILEPSY RES, V83, P207, DOI 10.1016/j.eplepsyres.2008.11.003; Baudry M, 2012, NEUROSCIENCE; Bogdanov VB, 2011, NEUROBIOL DIS, V41, P430, DOI 10.1016/j.nbd.2010.10.014; Brennan KC, 2007, ANN NEUROL, V61, P603, DOI 10.1002/ana.21138; Brinton RD, 1997, EXP NEUROL, V147, P211, DOI 10.1006/exnr.1997.6619; BROWN RR, 1961, J CLIN INVEST, V40, P617, DOI 10.1172/JCI104292; Chauvel V, 2012, EXP NEUROL, V236, P207, DOI 10.1016/j.expneurol.2012.05.002; Cyr M, 2000, J NEUROENDOCRINOL, V12, P445; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; Finocchi C, 2011, NEUROL SCI, V32, pS31, DOI 10.1007/s10072-011-0532-5; Freeman ME, 2000, KNOBIL NEILLS PHYSL, P2327; FUKUI S, 1991, J NEUROCHEM, V56, P2007, DOI 10.1111/j.1471-4159.1991.tb03460.x; Gogos A, 2004, J PHARMACOL EXP THER, V309, P267, DOI 10.1124/jpet.103.061432; Granella F, 2000, CEPHALALGIA, V20, P701, DOI 10.1046/j.1468-2982.2000.00112.x; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; KESSLER M, 1989, J NEUROCHEM, V52, P1319, DOI 10.1111/j.1471-4159.1989.tb01881.x; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Leao A, 1944, J NEUROPHYSIOL, V7, P159; Maggioni F, 1997, CEPHALALGIA, V17, P765, DOI 10.1046/j.1468-2982.1997.1707765.x; MARCUS DA, 1995, PAIN, V62, P129, DOI 10.1016/0304-3959(95)00052-T; Marino M, 2006, CURR GENOMICS, V7, P497, DOI 10.2174/138920206779315737; Merki-Feld GS, 2013, CEPHALALGIA, V33, P340, DOI 10.1177/0333102412473373; Nappi RE, 2011, CONTRACEPTION, V83, P223, DOI 10.1016/j.contraception.2010.07.024; NELLGARD B, 1992, ACTA PHYSIOL SCAND, V146, P497, DOI 10.1111/j.1748-1716.1992.tb09451.x; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; RASMUSSEN BK, 1991, J CLIN EPIDEMIOL, V44, P1147, DOI 10.1016/0895-4356(91)90147-2; SAAD AA, 1974, BIOCHEM PHARMACOL, V23, P999, DOI 10.1016/0006-2952(74)90030-6; Sachs M, 2007, NEUROBIOL DIS, V25, P27, DOI 10.1016/j.nbd.2006.08.013; Santamaria A, 1996, NEUROPHARMACOLOGY, V35, P23, DOI 10.1016/0028-3908(95)00145-X; Sato K, 2003, J NEUROCHEM, V86, P1498, DOI 10.1046/j.1471-4159.2003.01953.x; Silberstein SD, 2001, MED CLIN N AM, V85, P1017, DOI 10.1016/S0025-7125(05)70357-6; Smith MJ, 2003, BIOL PSYCHIAT, V54, P757, DOI 10.1016/S0006-3223(02)01924-8; SOMERVILLE BW, 1972, NEUROLOGY, V22, P824, DOI 10.1212/WNL.22.8.824; Tang B, 2008, PAIN, V137, P540, DOI 10.1016/j.pain.2007.10.017; VECSEI L, 1992, BRAIN RES BULL, V28, P233, DOI 10.1016/0361-9230(92)90184-Y; WOOLLEY CS, 1992, J NEUROSCI, V12, P2549; WOOLLEY CS, 1994, J NEUROSCI, V14, P7680	37	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82279	10.1371/journal.pone.0082279	http://dx.doi.org/10.1371/journal.pone.0082279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340013	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400069
J	Houser, J; Komarek, J; Kostlanova, N; Cioci, G; Varrot, A; Kerr, SC; Lahmann, M; Balloy, V; Fahy, JV; Chignard, M; Imberty, A; Wimmerova, M				Houser, Josef; Komarek, Jan; Kostlanova, Nikola; Cioci, Gianluca; Varrot, Annabelle; Kerr, Sheena C.; Lahmann, Martina; Balloy, Viviane; Fahy, John V.; Chignard, Michel; Imberty, Anne; Wimmerova, Michaela			A Soluble Fucose-Specific Lectin from Aspergillus fumigatus Conidia - Structure, Specificity and Possible Role in Fungal Pathogenicity	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; EPITHELIAL-CELLS; RECOGNITION; PROTEIN; PREDICTION; LAMININ	Aspergillus fumigatus is an important allergen and opportunistic pathogen. Similarly to many other pathogens, it is able to produce lectins that may be involved in the host-pathogen interaction. We focused on the lectin AFL, which was prepared in recombinant form and characterized. Its binding properties were studied using hemagglutination and glycan array analysis. We determined the specificity of the lectin towards l-fucose and fucosylated oligosaccharides, including alpha 1-6 linked core-fucose, which is an important marker for cancerogenesis. Other biologically relevant saccharides such as sialic acid, d-mannose or d-galactose were not bound. Blood group epitopes of the ABH and Lewis systems were recognized, Le(Y) being the preferred ligand among others. To provide a correlation between the observed functional characteristics and structural basis, AFL was crystallized in a complex with methyl-alpha,L-selenofucoside and its structure was solved using the SAD method. Six binding sites, each with different compositions, were identified per monomer and significant differences from the homologous AAL lectin were found. Structure-derived peptides were utilized to prepare anti-AFL polyclonal antibodies, which suggested the presence of AFL on the Aspergillus' conidia, confirming its expression in vivo. Stimulation of human bronchial cells by AFL led to IL-8 production in a dose-dependent manner. AFL thus probably contributes to the inflammatory response observed upon the exposure of a patient to A. fumigatus. The combination of affinity to human epithelial epitopes, production by conidia and pro-inflammatory activity is remarkable and shows that AFL might be an important virulence factor involved in an early stage of A. fumigatus infection.	[Houser, Josef; Kostlanova, Nikola; Wimmerova, Michaela] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic; [Houser, Josef; Komarek, Jan; Kostlanova, Nikola; Wimmerova, Michaela] Masaryk Univ, Fac Sci, Natl Ctr Biomol Res, CS-61137 Brno, Czech Republic; [Cioci, Gianluca] European Synchrotron Radiat Facil, F-38043 Grenoble, France; [Varrot, Annabelle; Imberty, Anne] Univ Grenoble, CERMAV CNRS, Grenoble, France; [Kerr, Sheena C.; Balloy, Viviane] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kerr, Sheena C.; Fahy, John V.] Univ Calif San Francisco, CVRI, San Francisco, CA 94143 USA; [Lahmann, Martina] Univ Bangor, Sch Chem, Bangor, Gwynedd, Wales; [Balloy, Viviane; Chignard, Michel] Inst Pasteur, Unite Def Innee & Inflammat, Paris, France; [Balloy, Viviane; Chignard, Michel] INSERM U874, Paris, France; [Wimmerova, Michaela] Masaryk Univ, Fac Sci, Dept Biochem, CS-61137 Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; European Synchrotron Radiation Facility (ESRF); Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; Bangor University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Masaryk University Brno	Wimmerova, M (corresponding author), Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic.	michaw@chemi.muni.cz	Lahmann, Martina/A-3090-2010; Houser, Josef/D-7319-2012; Komarek, Jan/N-5564-2019; Balloy, Viviane/B-8551-2014; Wimmerova, Michaela/A-4114-2010; Imberty, Anne/P-6451-2018	Lahmann, Martina/0000-0002-8513-1952; Houser, Josef/0000-0003-4504-3891; Komarek, Jan/0000-0003-4496-1658; Balloy, Viviane/0000-0001-9093-9676; Wimmerova, Michaela/0000-0002-7108-4198; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527	European Union [CZ.1.05/1.1.00/02.0068]; SYLICA [286154]; Czech Ministry of Education [LH13055]; Czech Science Foundation [GA13-25401S]; French National Centre for Scientific Research, France; FINOVI; French Association Vaincre la Mucoviscidose; Consortium for Functional Glycomics [GM62116]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080414] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	European Union(European Commission); SYLICA; Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); French National Centre for Scientific Research, France; FINOVI; French Association Vaincre la Mucoviscidose; Consortium for Functional Glycomics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The research leading to these results obtained financial contribution from the European Union under the Seventh Framework Programme by CEITEC (CZ.1.05/1.1.00/02.0068) project from European Regional Development Fund, SYLICA (Contract No. 286154 under "Capacities" specific programme), Czech Ministry of Education (LH13055) and the Czech Science Foundation (GA13-25401S). This work was further supported by French National Centre for Scientific Research, France, FINOVI and French Association Vaincre la Mucoviscidose. The glycan array resources were provided by the Consortium for Functional Glycomics grant number GM62116. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balloy V, 2008, J BIOL CHEM, V283, P30513, DOI 10.1074/jbc.M803149200; Becker DJ, 2003, GLYCOBIOLOGY, V13, p41R, DOI 10.1093/glycob/cwg054; Bouchara JP, 1997, INFECT IMMUN, V65, P2717, DOI 10.1128/IAI.65.7.2717-2724.1997; Breitenbach M, 2008, INT ARCH ALLERGY IMM, V145, P58, DOI 10.1159/000107578; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fujihashi M, 2003, BIOCHEMISTRY-US, V42, P11093, DOI 10.1021/bi034983z; Gabius H.J., 2009, SUGAR CODE FUNDAMENT; Imberty A, 2008, CURR OPIN STRUC BIOL, V18, P567, DOI 10.1016/j.sbi.2008.08.001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klepser M, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.08.005; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Kohno S, 2010, J INFECTION, V61, P410, DOI 10.1016/j.jinf.2010.08.005; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; Kostlanova N, 2005, J BIOL CHEM, V280, P27839, DOI 10.1074/jbc.M505184200; Lamarre C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-417; Lameignere E, 2008, BIOCHEM J, V411, P307, DOI [10.1042/BJ20071276, 10.1042/bj20071276]; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Matsumura K, 2007, J BIOL CHEM, V282, P15700, DOI 10.1074/jbc.M701195200; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perlin DS, 2013, J INFECT CHEMOTHER; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Richardson A, 2012, BIOMARKERS J GERON A; Ruvoen-Clouet N, 2011, J BIOL CHEM; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sharon N, 2006, BBA-GEN SUBJECTS, V1760, P527, DOI 10.1016/j.bbagen.2005.12.008; Singh B, 2010, J PROTEOME RES, V9, P5517, DOI 10.1021/pr100604x; Singh N, 2005, CLIN MICROBIOL REV, V18, P44, DOI 10.1128/CMR.18.1.44-69.2005; Singh RS, 2008, J BASIC MICROB, V48, P112, DOI 10.1002/jobm.200700314; Sulak O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002238; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Tielker D, 2005, MICROBIOL-SGM, V151, P1313, DOI 10.1099/mic.0.27701-0; Tronchin G, 1997, INFECT IMMUN, V65, P9, DOI 10.1128/IAI.65.1.9-15.1997; Tronchin G, 2002, INFECT IMMUN, V70, P6891, DOI 10.1128/IAI.70.12.6891-6895.2002; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Wimmerova M, 2003, J BIOL CHEM, V278, P27059, DOI 10.1074/jbc.M302642200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang ZH, 2005, J INFECTION, V51, P375, DOI 10.1016/j.jinf.2004.12.012	44	76	78	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83077	10.1371/journal.pone.0083077	http://dx.doi.org/10.1371/journal.pone.0083077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340081	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400117
J	Royan, A; Hannah, DM; Reynolds, SJ; Noble, DG; Sadler, JP				Royan, Alexander; Hannah, David M.; Reynolds, S. James; Noble, David G.; Sadler, Jonathan P.			Avian Community Responses to Variability in River Hydrology	PLOS ONE			English	Article							CLIMATE-CHANGE; FLOW REGIMES; BIODIVERSITY; SELECTION; IMPACTS; POPULATIONS; DISTURBANCE; DISPERSAL; DYNAMICS; CINCLUS	River flow is a major driver of morphological structure and community dynamics in riverine-floodplain ecosystems. Flow influences in-stream communities through changes in water velocity, depth, temperature, turbidity and nutrient fluxes, and perturbations in the organisation of lower trophic levels are cascaded through the food web, resulting in shifts in food availability for consumer species. River birds are sensitive to spatial and phenological mismatches with aquatic prey following flow disturbances; however, the role of flow as a determinant of riparian ecological structure remains poorly known. This knowledge is crucial to help to predict if, and how, riparian communities will be influenced by climate-induced changes in river flow characterised by more extreme high (i.e. flood) and/or low (i.e. drought) flow events. Here, we combine national-scale datasets of river bird surveys and river flow archives to understand how hydrological disturbance has affected the distribution of riparian species at higher trophic levels. Data were analysed for 71 river locations using a Generalized Additive Model framework and a model averaging procedure. Species had complex but biologically interpretable associations with hydrological indices, with species' responses consistent with their ecology, indicating that hydrological-disturbance has implications for higher trophic levels in riparian food webs. Our quantitative analysis of river flow-bird relationships demonstrates the potential vulnerability of riparian species to the impacts of changing flow variability and represents an important contribution in helping to understand how bird communities might respond to a climate change-induced increase in the intensity of floods and droughts. Moreover, the success in relating parameters of river flow variability to species' distributions highlights the need to include river flow data in climate change impact models of species' distributions.	[Royan, Alexander; Hannah, David M.; Sadler, Jonathan P.] Univ Birmingham, Coll Life & Environm Sci, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England; [Reynolds, S. James; Sadler, Jonathan P.] Univ Birmingham, Coll Life & Environm Sci, Ctr Ornithol, Sch Biosci, Birmingham, W Midlands, England; [Noble, David G.] British Trust Ornithol, Thetford, Norfolk, England	University of Birmingham; University of Birmingham; British Trust for Ornithology	Royan, A (corresponding author), Univ Birmingham, Coll Life & Environm Sci, Sch Geog Earth & Environm Sci, Birmingham, W Midlands, England.	axr196@bham.ac.uk; j.p.sadler@bham.ac.uk	Reynolds, Silas James/AAM-1372-2020; Hannah, David M./B-9221-2015	Hannah, David M./0000-0003-1714-1240; Sadler, Jonathan/0000-0003-0443-4458	National Environment Research Council (NERC) [NE/J500240/1]; British Trust for Ornithology; Natural Environment Research Council [1118595] Funding Source: researchfish	National Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); British Trust for Ornithology; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was made possible by financial support to AR from a National Environment Research Council (NERC) studentship (NE/J500240/1) with support from the British Trust for Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthur AD, 2012, WETLANDS, V32, P257, DOI 10.1007/s13157-011-0235-y; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Bates AJ, 2006, OECOLOGIA, V150, P50, DOI 10.1007/s00442-006-0508-y; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bower D, 2004, HYDROL PROCESS, V18, P2515, DOI 10.1002/hyp.1479; Brook BW, 2009, BIOL LETTERS, V5, P723, DOI 10.1098/rsbl.2009.0480; Bunn SE, 2002, ENVIRON MANAGE, V30, P492, DOI 10.1007/s00267-002-2737-0; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Chiu MC, 2008, FRESHWATER BIOL, V53, P1335, DOI 10.1111/j.1365-2427.2008.01968.x; Chiu MC, 2013, IBIS, V155, P377, DOI 10.1111/ibi.12035; Cumming GS, 2012, FRESHWATER BIOL, V57, P1202, DOI 10.1111/j.1365-2427.2012.02789.x; Daufresne M, 2009, P NATL ACAD SCI USA, V106, P12788, DOI 10.1073/pnas.0902080106; Davey CM, 2012, GLOBAL ECOL BIOGEOGR, V21, P568, DOI 10.1111/j.1466-8238.2011.00693.x; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Henshall SE, 2011, ECOHYDROLOGY, V4, P512, DOI 10.1002/eco.188; Huntley B., 2007, CLIMATIC ATLAS EUROP; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Jonsson M, 2013, RIVER RES APPL, V29, P537, DOI 10.1002/rra.2559; Jonsson M, 2012, ECOL RES, V27, P945, DOI 10.1007/s11284-012-0974-0; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Lambeets K, 2009, BIOL CONSERV, V142, P625, DOI 10.1016/j.biocon.2008.11.015; Lambeets K, 2008, J ANIM ECOL, V77, P1162, DOI 10.1111/j.1365-2656.2008.01443.x; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Ledger ME, 2013, NAT CLIM CHANGE, V3, P223, DOI [10.1038/nclimate1684, 10.1038/NCLIMATE1684]; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Monk WA, 2008, RIVER RES APPL, V24, P988, DOI 10.1002/rra.1120; Monk WA, 2007, RIVER RES APPL, V23, P113, DOI 10.1002/rra.964; Murakami M, 2001, ECOL RES, V16, P913, DOI 10.1046/j.1440-1703.2001.00448.x; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; O'Callaghan MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061866; Olden JD, 2003, RIVER RES APPL, V19, P101, DOI 10.1002/rra.700; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Palmer MA, 1996, OECOLOGIA, V105, P247, DOI 10.1007/BF00328554; Palmer MA, 2009, ENVIRON MANAGE, V44, P1053, DOI 10.1007/s00267-009-9329-1; Poff NL, 1997, BIOSCIENCE, V47, P769, DOI 10.2307/1313099; Prudhomme C, 2012, HYDROL PROCESS, V26, P1115, DOI 10.1002/hyp.8434; Roche EA, 2012, AUK, V129, P296, DOI 10.1525/auk.2012.11196; SMITH KG, 1982, ECOLOGY, V63, P952, DOI 10.2307/1937235; Stephens PA, 2005, J APPL ECOL, V42, P4, DOI 10.1111/j.1365-2664.2005.01002.x; Strasevicius D, 2013, IBIS, V155, P348, DOI 10.1111/ibi.12024; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Taylor AJ, 2001, BIRD STUDY, V48, P173, DOI 10.1080/00063650109461215; Vaughan IP, 2007, FRESHWATER BIOL, V52, P2270, DOI 10.1111/j.1365-2427.2007.01837.x; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; Whittingham MJ, 2005, J APPL ECOL, V42, P270, DOI 10.1111/j.1365-2664.2005.01007.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wilson J, 2006, ANIM CONSERV, V9, P463, DOI 10.1111/j.1469-1795.2006.00063.x; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodward G, 2012, PHILOS T R SOC B, V367, P2990, DOI 10.1098/rstb.2012.0245; Woodward G, 2010, ADV ECOL RES, V42, P71, DOI 10.1016/S0065-2504(10)42002-4; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	53	24	25	2	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83221	10.1371/journal.pone.0083221	http://dx.doi.org/10.1371/journal.pone.0083221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340094	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400128
J	Shen, YC; Wang, JF; Han, XH; Yang, HY; Wang, S; Lin, DM; Shi, YK				Shen, Yinchen; Wang, Jianfei; Han, Xiaohong; Yang, Hongying; Wang, Shuai; Lin, Dongmei; Shi, Yuankai			Effectors of Epidermal Growth Factor Receptor Pathway: The Genetic Profiling of KRAS, BRAF, PIK3CA, NRAS Mutations in Colorectal Cancer Characteristics and Personalized Medicine	PLOS ONE			English	Article							WILD-TYPE; MONOCLONAL-ANTIBODIES; TARGETED THERAPIES; 1ST-LINE TREATMENT; METASTATIC SITES; PHASE-III; K-RAS; PANITUMUMAB; CETUXIMAB; FLUOROURACIL	Mutations in KRAS oncogene are recognized biomarkers that predict lack of response to anti- epidermal growth factor receptor (EGFR) antibody therapies. However, some patients with KRAS wild-type tumors still do not respond, so other downstream mutations in BRAF, PIK3CA and NRAS should be investigated. Herein we used direct sequencing to analyze mutation status for 676 patients in KRAS (codons 12, 13 and 61), BRAF (exon 11 and exon 15), PIK3CA (exon 9 and exon 20) and NRAS (codons12, 13 and 61). Clinicopathological characteristics associations were analyzed together with overall survival (OS) of metastatic colorectal cancer patients (mCRC). We found 35.9% (242/674) tumors harbored a KRAS mutation, 6.96% (47/675) harbored a BRAF mutation, 9.9% (62/625) harbored a PIK3CA mutation and 4.19% (26/621) harbored a NRAS mutation. KRAS mutation coexisted with BRAF, PIK3CA and NRAS mutation, PIK3CA exon9 mutation appeared more frequently in KRAS mutant tumors (P = 0.027) while NRAS mutation almost existed in KRAS wild-types (P<0.001). Female patients and older group harbored a higher KRAS mutation (P = 0.018 and P = 0.031, respectively); BRAF (V600E) mutation showed a higher frequency in colon cancer and poor differentiation tumors (P = 0.020 and P = 0.030, respectively); proximal tumors appeared a higher PIK3CA mutation (P<0.001) and distant metastatic tumors shared a higher NRAS mutation (P = 0.010). However, in this study no significant result was found between OS and gene mutation in mCRC group. To our knowledge, the first large-scale retrospective study on comprehensive genetic profile which associated with anti- EGFR MoAbs treatment selection in East Asian CRC population, appeared a specific genotype distribution picture, and the results provided a better understanding between clinicopathological characteristics and gene mutations in CRC patients.	[Shen, Yinchen; Wang, Jianfei; Han, Xiaohong; Wang, Shuai; Shi, Yuankai] Peking Union Med Coll, Canc Inst Hosp, Dept Med Oncol, Beijing 100021, Peoples R China; [Shen, Yinchen; Wang, Jianfei; Han, Xiaohong; Yang, Hongying; Wang, Shuai; Lin, Dongmei; Shi, Yuankai] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Shen, Yinchen; Wang, Jianfei; Han, Xiaohong; Wang, Shuai; Shi, Yuankai] Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China; [Yang, Hongying; Lin, Dongmei] Peking Union Med Coll, Canc Inst Hosp, Dept Pathol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College	Shi, YK (corresponding author), Peking Union Med Coll, Canc Inst Hosp, Dept Med Oncol, Beijing 100021, Peoples R China.	syuankaipumc@126.com	han, xiao/HDN-9782-2022	, Yinchen Shen/0000-0003-0179-2911	Research Special Fund for Public Welfare Industry of Health [200902002-1]; National Science and Technology Major Project [2008ZX09312, 2012ZX09303012]; National High Technology Research and Development Program of China [2011AA02A110]; Beijing Municipal Science and Technology Commission [Z121107005112005, Z121102009212055]; Special Funds for Central Health Authority [B2009B124]; Major Research Program of Cancer Institute and Hospital of Chinese Academy of Medical Sciences [LC2012A18]	Research Special Fund for Public Welfare Industry of Health; National Science and Technology Major Project; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Special Funds for Central Health Authority; Major Research Program of Cancer Institute and Hospital of Chinese Academy of Medical Sciences	This study was supported in part by grants from the Research Special Fund for Public Welfare Industry of Health (200902002-1), National Science and Technology Major Project (2008ZX09312, 2012ZX09303012), National High Technology Research and Development Program of China (2011AA02A110) (http://www.863.gov.cn/); Beijing Municipal Science and Technology Commission (Z121107005112005, Z121102009212055), Special Funds for Central Health Authority (B2009B124) and Major Research Program of Cancer Institute and Hospital of Chinese Academy of Medical Sciences (LC2012A18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Artale S, 2008, J CLIN ONCOL, V26, P4217, DOI 10.1200/JCO.2008.18.7286; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cappuzzo F, 2008, BRIT J CANCER, V99, P83, DOI 10.1038/sj.bjc.6604439; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Day FL, 2013, CLIN CANCER RES, V19, P3285, DOI 10.1158/1078-0432.CCR-12-3614; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; De Roock W, 2009, NEW ENGL J MED, V360, P834; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Hsieh LL, 2012, CLIN CHIM ACTA, V413, P1605, DOI 10.1016/j.cca.2012.04.029; Irahara N, 2010, DIAGN MOL PATHOL, V19, P157, DOI 10.1097/PDM.0b013e3181c93fd1; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim A, 2013, INT J CANCER, V133, P984, DOI 10.1002/ijc.28073; Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029; Laurent-Puig P, 2009, J CLIN ONCOL, V27, P5924, DOI 10.1200/JCO.2008.21.6796; Li HT, 2011, ONCOL REP, V25, P1691, DOI 10.3892/or.2011.1217; Liao WJ, 2010, ANAT REC, V293, P1506, DOI 10.1002/ar.21202; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mao C, 2012, ANN ONCOL, V23, P1518, DOI 10.1093/annonc/mdr464; Mao C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036653; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Neumann J, 2009, PATHOL RES PRACT, V205, P858, DOI 10.1016/j.prp.2009.07.010; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Peeters M, 2013, CLIN CANCER RES, V19, P1902, DOI 10.1158/1078-0432.CCR-12-1913; Rako I, 2012, NEOPLASMA, V59, P376, DOI 10.4149/neo_2012_049; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Santini D, 2008, ONCOLOGIST, V13, P1270, DOI 10.1634/theoncologist.2008-0181; Saridaki Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015980; Sartore-Bianchi A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007287; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Seymour MT, 2013, LANCET ONCOL, V14, P749, DOI 10.1016/S1470-2045(13)70163-3; Shen H, 2011, WORLD J GASTROENTERO, V17, P809, DOI 10.3748/wjg.v17.i6.809; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Souglakos J, 2009, BRIT J CANCER, V101, P465, DOI 10.1038/sj.bjc.6605164; Tejpar S, 2012, J CLIN ONCOL, V30, P3570, DOI 10.1200/JCO.2012.42.2592; Velho S, 2005, EUR J CANCER, V41, P1649, DOI 10.1016/j.ejca.2005.04.022; Wang JF, 2013, CANCER BIOMARK, V13, P89, DOI 10.3233/CBM-130334; Zhao L, 2008, P NATL ACAD SCI USA, V105, P2652, DOI 10.1073/pnas.0712169105	50	73	76	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81628	10.1371/journal.pone.0081628	http://dx.doi.org/10.1371/journal.pone.0081628			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339949	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400026
J	Altamirano, F; Valladares, D; Henriquez-Olguin, C; Casas, M; Lopez, JR; Allen, PD; Jaimovich, E				Altamirano, Francisco; Valladares, Denisse; Henriquez-Olguin, Carlos; Casas, Mariana; Lopez, Jose R.; Allen, Paul D.; Jaimovich, Enrique			Nifedipine Treatment Reduces Resting Calcium Concentration, Oxidative and Apoptotic Gene Expression, and Improves Muscle Function in Dystrophic mdx Mice	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; CONTROLLED-TRIAL; CREATINE-KINASE; RECEPTORS; ANTIOXIDANT; DYSFUNCTION; MECHANISMS; AMLODIPINE; MEMBRANE; PROTEINS	Duchenne Muscular Dystrophy (DMD) is a recessive X-linked genetic disease, caused by mutations in the gene encoding dystrophin. DMD is characterized in humans and in mdx mice by a severe and progressive destruction of muscle fibers, inflammation, oxidative/nitrosative stress, and cell death. In mdx muscle fibers, we have shown that basal ATP release is increased and that extracellular ATP stimulation is pro-apoptotic. In normal fibers, depolarization-induced ATP release is blocked by nifedipine, leading us to study the potential therapeutic effect of nifedipine in mdx muscles and its relation with extracellular ATP signaling. Acute exposure to nifedipine (10 mu M) decreased [Ca2+](r), NF-kappa B activity and iNOS expression in mdx myotubes. In addition, 6-week-old mdx mice were treated with daily intraperitoneal injections of nifedipine, 1 mg/Kg for 1 week. This treatment lowered the [Ca2+](r) measured in vivo in the mdx vastus lateralis. We demonstrated that extracellular ATP levels were higher in adult mdx flexor digitorum brevis (FDB) fibers and can be significantly reduced after 1 week of treatment with nifedipine. Interestingly, acute treatment of mdx FDB fibers with apyrase, an enzyme that completely degrades extracellular ATP to AMP, reduced [Ca2+](r), to a similar extent as was seen in FDB fibers after 1-week of nifedipine treatment. Moreover, we demonstrated that nifedipine treatment reduced mRNA levels of pro-oxidative/nitrosative (iNOS and gp91(phox)/P47(phox) NOX2 subunits) and pro-apoptotic (Bax) genes in mdx diaphragm muscles and lowered serum creatine kinase (CK) levels. In addition, nifedipine treatment increased muscle strength assessed by the inverted grip-hanging test and exercise tolerance measured with forced swimming test in mdx mice. We hypothesize that nifedipine reduces basal ATP release, thereby decreasing purinergic receptor activation, which in turn reduces [Ca2+](r) in mdx skeletal muscle cells. The results in this work open new perspectives towards possible targets for pharmacological approaches to treat DMD.	[Altamirano, Francisco; Valladares, Denisse; Henriquez-Olguin, Carlos; Casas, Mariana; Jaimovich, Enrique] Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 7, Chile; [Altamirano, Francisco; Lopez, Jose R.; Allen, Paul D.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Lopez, Jose R.; Allen, Paul D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Casas, Mariana] Univ Chile, Fac Med, Inst Ciencias Biomed, Programa Fisiol & Biofis, Santiago 7, Chile	Universidad de Chile; University of California System; University of California Davis; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Universidad de Chile	Jaimovich, E (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed, Ctr Estudios Mol Celula, Santiago 7, Chile.	ejaimovi@med.uchile.cl	Jaimovich, Enrique/AAY-7632-2020; Henríquez-Olguín, Carlos/ABB-6846-2021; Jaimovich, Enrique/A-2782-2008; Valladares-Ide, Denisse/AAE-6675-2019; Altamirano, Francisco/I-1928-2013	Henríquez-Olguín, Carlos/0000-0002-9315-9365; Jaimovich, Enrique/0000-0002-4938-7176; Altamirano, Francisco/0000-0002-1612-2729; Valladares-Ide, Denisse/0000-0001-7625-7978	Fondo de Investigacion Avanzado en Areas Prioritarias [15010006]; Fondo Nacional de Desarrollo Cientffico y Tecnolegico [1110467, ACT1111, AFM14562]; National Institutes of Health [AR43140, AR052534]; Program U-INICIA VID [U-INICIA 02/12M]; University of Chile; Comision Nacional de Ciencia y Tecnologia (CONICYT) [AT-24100066, AT-24110211]; Vicerrectoria Asuntos Academicos; MECESUP [UCH0714]; REDES [120003]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043140, P01AR052354] Funding Source: NIH RePORTER	Fondo de Investigacion Avanzado en Areas Prioritarias; Fondo Nacional de Desarrollo Cientffico y Tecnolegico; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program U-INICIA VID; University of Chile; Comision Nacional de Ciencia y Tecnologia (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Vicerrectoria Asuntos Academicos; MECESUP; REDES; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Fondo de Investigacion Avanzado en Areas Prioritarias 15010006, Fondo Nacional de Desarrollo Cientffico y Tecnolegico 1110467, ACT1111 and AFM14562 (EJ, MC), National Institutes of Health AR43140, AR052534 (PDA and JRL), Program U-INICIA VID 2011, grant U-INICIA 02/12M; University of Chile (MC) supported this work. FA and DV were recipients of a doctoral fellowship and a doctoral thesis support grants AT-24100066 (FA), AT-24110211 (DV) from Comision Nacional de Ciencia y Tecnologia (CONICYT). FA thanks Vicerrectoria Asuntos Academicos and MECESUP UCH0714 (Universidad de Chile) and REDES 120003 (CONICYT) for travel support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2006, PHARMACOL REV, V58, P281, DOI 10.1124/pr.58.3.3; Allen DG, 2010, CAN J PHYSIOL PHARM, V88, P83, DOI 10.1139/Y09-058; Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Bellinger AM, 2009, NAT MED, V15, P325, DOI 10.1038/nm.1916; Blake DJ, 2002, PHYSIOL REV, V82, P291, DOI 10.1152/physrev.00028.2001; BROOKE MH, 1983, MUSCLE NERVE, V6, P204, DOI 10.1002/mus.880060307; Burnstock G, 2006, PHARMACOL THERAPEUT, V110, P433, DOI 10.1016/j.pharmthera.2005.08.013; Buvinic S, 2009, J BIOL CHEM, V284, P34490, DOI 10.1074/jbc.M109.057315; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; Cases M, 2012, METHODS MOL BIOL, V798, P383, DOI 10.1007/978-1-61779-343-1_22; Collet C, 2003, BIOPHYS J, V84, P251, DOI 10.1016/S0006-3495(03)74846-2; Desguerre I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004347; Eltit JM, 2012, FASEB J; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Escolar DM, 2005, ANN NEUROL, V58, P151, DOI 10.1002/ana.20523; Friedrich O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001762; Ho CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057666; HOLLINGWORTH S, 1990, MUSCLE NERVE, V13, P16, DOI 10.1002/mus.880130105; Honda A, 2007, J MUSCLE RES CELL M, V28, P243, DOI 10.1007/s10974-007-9122-9; Imbert N, 2001, J PHYSIOL-LONDON, V534, P343, DOI 10.1111/j.1469-7793.2001.00343.x; Jorquera G, 2013, J CELL SCI; Kaja S, 2007, EUR J NEUROSCI, V25, P2009, DOI 10.1111/j.1460-9568.2007.05438.x; KNUDSON CM, 1988, J BIOL CHEM, V263, P8480; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KONAGAYA M, 1986, JPN J MED, V25, P2; Liberona JL, 1998, MUSCLE NERVE, V21, P902, DOI 10.1002/(SICI)1097-4598(199807)21:7<902::AID-MUS8>3.0.CO;2-A; LOPEZ JR, 1987, ACTA CIENT VENEZ, V38, P503; MAK IT, 1990, CIRC RES, V66, P1449, DOI 10.1161/01.RES.66.5.1449; Miller JB, 2006, TRENDS MOL MED, V12, P279, DOI 10.1016/j.molmed.2006.04.003; MOXLEY RT, 1987, MUSCLE NERVE, V10, P22, DOI 10.1002/mus.880100106; NEUHAUS R, 1990, J PHYSIOL-LONDON, V427, P187, DOI 10.1113/jphysiol.1990.sp018167; NICHOLSON LVB, 1993, J MED GENET, V30, P745, DOI 10.1136/jmg.30.9.745; Niebroj-Dobosz I, 1996, EUROPEAN J TRANSLATI, V6, P377; Ozawa E, 1999, MOL CELL BIOCHEM, V190, P143, DOI 10.1023/A:1006974613418; Phillips MF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004571.pub2; Razani B, 2002, MOL CELL BIOL, V22, P2329, DOI 10.1128/MCB.22.7.2329-2344.2002; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; TANABE T, 1988, NATURE, V336, P134, DOI 10.1038/336134a0; Tews DS, 1997, NEUROPATH APPL NEURO, V23, P331, DOI 10.1046/j.1365-2990.1997.5998059.x; Toma L, 2011, BIOCHEM BIOPH RES CO, V411, P202, DOI 10.1016/j.bbrc.2011.06.137; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; Valladares D, 2013, PLOS ONE IN PRESS; Whitehead NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015354; Woods CE, 2004, J PHYSIOL-LONDON, V557, P59, DOI 10.1113/jphysiol.2004.061291; Yeung D, 2004, NEUROBIOL DIS, V15, P212, DOI 10.1016/j.nbd.2003.10.014; Yeung D, 2006, FASEB J, V20, P610, DOI 10.1096/fj.05-4022com; Yoshida H, 2006, EUR J PHARMACOL, V540, P1, DOI 10.1016/j.ejphar.2006.04.008; Yoshii T, 2006, HYPERTENS RES, V29, P457, DOI 10.1291/hypres.29.457	48	35	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81222	10.1371/journal.pone.0081222	http://dx.doi.org/10.1371/journal.pone.0081222			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349043	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200018
J	Boyles, TH; Whitelaw, A; Bamford, C; Moodley, M; Bonorchis, K; Morris, V; Rawoot, N; Naicker, V; Lusakiewicz, I; Black, J; Stead, D; Lesosky, M; Raubenheimer, P; Dlamini, S; Mendelson, M				Boyles, Tom H.; Whitelaw, Andrew; Bamford, Colleen; Moodley, Mischka; Bonorchis, Kim; Morris, Vida; Rawoot, Naazneen; Naicker, Vanishree; Lusakiewicz, Irena; Black, John; Stead, David; Lesosky, Maia; Raubenheimer, Peter; Dlamini, Sipho; Mendelson, Marc			Antibiotic Stewardship Ward Rounds and a Dedicated Prescription Chart Reduce Antibiotic Consumption and Pharmacy Costs without Affecting Inpatient Mortality or Re-Admission Rates	PLOS ONE			English	Article							INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; MANAGEMENT PROGRAM; RESISTANCE; ENTEROBACTERIACEAE; GUIDELINES; AMERICA; IMPACT	Background: Antibiotic consumption is a major driver of bacterial resistance. To address the increasing burden of multi-drug resistant bacterial infections, antibiotic stewardship programmes are promoted worldwide to rationalize antibiotic prescribing and conserve remaining antibiotics. Few studies have been reported from developing countries and none from Africa that report on an intervention based approach with outcomes that include morbidity and mortality. Methods: An antibiotic prescription chart and weekly antibiotic stewardship ward round was introduced into two medical wards of an academic teaching hospital in South Africa between January-December 2012. Electronic pharmacy records were used to collect the volume and cost of antibiotics used, the patient database was analysed to determine inpatient mortality and 30-day re-admission rates, and laboratory records to determine use of infection-related tests. Outcomes were compared to a control period, January-December 2011. Results: During the intervention period, 475.8 defined daily doses were prescribed per 1000 inpatient days compared to 592.0 defined daily doses/1000 inpatient days during the control period. This represents a 19.6% decrease in volume with a cost reduction of 35% of the pharmacy's antibiotic budget. There was a concomitant increase in laboratory tests driven by requests for procalcitonin. There was no difference in inpatient mortality or 30-day readmission rate during the control and intervention periods. Conclusions: Introduction of antibiotic stewardship ward rounds and a dedicated prescription chart in a developing country setting can achieve reduction in antibiotic consumption without harm to patients. Increased laboratory costs should be anticipated when introducing an antibiotic stewardship program.	[Boyles, Tom H.; Black, John; Stead, David; Dlamini, Sipho; Mendelson, Marc] Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew; Bamford, Colleen; Moodley, Mischka; Bonorchis, Kim] Groote Schuur Hosp, Natl Hlth Lab Serv, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew; Bamford, Colleen; Moodley, Mischka; Bonorchis, Kim] Univ Cape Town, Div Med Microbiol, ZA-7925 Cape Town, South Africa; [Whitelaw, Andrew] Univ Stellenbosch, Div Med Microbiol, Cape Town, South Africa; [Morris, Vida; Rawoot, Naazneen; Naicker, Vanishree; Lusakiewicz, Irena] Groote Schuur Hosp, ZA-7925 Cape Town, South Africa; [Lesosky, Maia] Univ Cape Town, Dept Gen Med, ZA-7925 Cape Town, South Africa; [Raubenheimer, Peter] Univ Cape Town, Groote Schuur Hosp, Div Gen Internal Med, ZA-7925 Cape Town, South Africa	University of Cape Town; University of Cape Town; University of Cape Town; Stellenbosch University; University of Cape Town; University of Cape Town; University of Cape Town	Mendelson, M (corresponding author), Univ Cape Town, Dept Med, Groote Schuur Hosp, Div Infect Dis & HIV Med, ZA-7925 Cape Town, South Africa.	Marc.mendelson@uct.ac.za	Lesosky, Maia/AAM-4174-2020; Raubenheimer, Peter/L-6306-2019	Lesosky, Maia/0000-0002-2026-958X; Raubenheimer, Peter/0000-0002-5416-1286; Whitelaw, Andrew/0000-0001-9070-5247; Boyles, Tom/0000-0002-5676-8081; Black, John/0000-0002-7845-4972; Mendelson, Marc/0000-0001-6668-3893				BAMFORD C, 2010, S AFR J EPIDEMIOL 2, V26, P243; Brink A, 2012, SAMJ S AFR MED J, V102, P599, DOI 10.7196/SAMJ.5789; Brink AJ, 2012, J CLIN MICROBIOL, V50, P525, DOI 10.1128/JCM.05956-11; Carling P, 2003, INFECT CONT HOSP EP, V24, P699, DOI 10.1086/502278; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; DURBIN WA, 1981, JAMA-J AM MED ASSOC, V246, P1796, DOI 10.1001/jama.246.16.1796; ECHOLS RM, 1984, J INFECT DIS, V150, P803, DOI 10.1093/infdis/150.6.803; Fraser GL, 1997, ARCH INTERN MED, V157, P1689, DOI 10.1001/archinte.157.15.1689; Gross R, 2001, CLIN INFECT DIS, V33, P289, DOI 10.1086/321880; Hoffman D., 2003, SA FAM PRACT, V45, P20; LaRocco A, 2003, CLIN INFECT DIS, V37, P742, DOI 10.1086/377286; Lepper PM, 2002, ANTIMICROB AGENTS CH, V46, P2920, DOI 10.1128/AAC.46.9.2920-2925.2002; Nobre V, 2008, AM J RESP CRIT CARE, V177, P498, DOI 10.1164/rccm.200708-1238OC; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Paruk F, 2012, SAMJ S AFR MED J, V102, P613, DOI 10.7196/SAMJ.5833; Ramsay C, 2003, J ANTIMICROB CHEMOTH, V52, P764, DOI 10.1093/jac/dkg460; Schroeder S, 2009, LANGENBECK ARCH SURG, V394, P221, DOI 10.1007/s00423-008-0432-1; Shlaes DM, 1997, CLIN INFECT DIS, V25, P584, DOI 10.1086/513766; Visser A, 2011, SAMJ S AFR MED J, V101, P587; Woodford N, 2009, J INFECTION, V59, pS4, DOI 10.1016/S0163-4453(09)60003-7; World Health Organization, URG ACT NEED SAF DRU	22	63	64	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e79747	10.1371/journal.pone.0079747	http://dx.doi.org/10.1371/journal.pone.0079747			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24348995	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200006
J	Gromnicova, R; Davies, HA; Sreekanthreddy, P; Romero, IA; Lund, T; Roitt, IM; Phillips, JB; Male, DK				Gromnicova, Radka; Davies, Heather A.; Sreekanthreddy, Peddagangannagari; Romero, Ignacio A.; Lund, Torben; Roitt, Ivan M.; Phillips, James B.; Male, David K.			Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro	PLOS ONE			English	Article							SIZE-DEPENDENT ENDOCYTOSIS; CELLULAR UPTAKE; GENE-THERAPY; BARRIER; TRANSPORT; CELLS; CYTOTOXICITY; PENETRATION; BINDING	The blood-brain barrier prevents the entry of many therapeutic agents into the brain. Various nanocarriers have been developed to help agents to cross this barrier, but they all have limitations, with regard to tissue-selectivity and their ability to cross the endothelium. This study investigated the potential for 4 nm coated gold nanoparticles to act as selective carriers across human brain endothelium and subsequently to enter astrocytes. The transfer rate of glucose-coated gold nanoparticles across primary human brain endothelium was at least three times faster than across non-brain endothelia. Movement of these nanoparticles occurred across the apical and basal plasma membranes via the cytosol with relatively little vesicular or paracellular migration; antibiotics that interfere with vesicular transport did not block migration. The transfer rate was also dependent on the surface coating of the nanoparticle and incubation temperature. Using a novel 3-dimensional co-culture system, which includes primary human astrocytes and a brain endothelial cell line hCMEC/D3, we demonstrated that the glucose-coated nanoparticles traverse the endothelium, move through the extracellular matrix and localize in astrocytes. The movement of the nanoparticles through the matrix was >10 mu m/hour and they appeared in the nuclei of the astrocytes in considerable numbers. These nanoparticles have the correct properties for efficient and selective carriers of therapeutic agents across the blood-brain barrier.	[Gromnicova, Radka; Davies, Heather A.; Sreekanthreddy, Peddagangannagari; Romero, Ignacio A.; Phillips, James B.; Male, David K.] Open Univ, Biomed Res Network, Milton Keynes MK7 6AA, Bucks, England; [Lund, Torben; Roitt, Ivan M.] Middlesex Univ, Dept Nat Sci, London N17 8HR, England	Open University - UK; Middlesex University	Male, DK (corresponding author), Open Univ, Biomed Res Network, Milton Keynes MK7 6AA, Bucks, England.	D.K.Male@Open.ac.uk	Phillips, James/G-7926-2014	Male, David/0000-0002-1242-3137; Phillips, James/0000-0001-8117-3074; Romero, Ignacio/0000-0002-0322-9180	Open University; Migraine Trust; BBSRC	Open University; Migraine Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the Open University, the Migraine Trust (http://www.migrainetrust.org) and the BBSRC (http://bbsrc.ac.uk). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Baker D, 2003, GENE THER, V10, P844, DOI 10.1038/sj.gt.3302025; BARNETT JEG, 1973, BIOCHEM J, V131, P211, DOI 10.1042/bj1310211; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Chen L, 2008, J NEUROIMMUNE PHARM, V3, P286, DOI 10.1007/s11481-008-9131-5; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Chithrani BD, 2006, NANO LETT, V6, P662, DOI 10.1021/nl052396o; Cho EC, 2011, NAT NANOTECHNOL, V6, P385, DOI [10.1038/NNANO.2011.58, 10.1038/nnano.2011.58]; Chu Y, 2006, ARTERIOSCL THROM VAS, V26, P1985, DOI 10.1161/01.ATV.0000234921.88489.5c; de la Fuente JM, 2005, BIOCONJUGATE CHEM, V16, P1176, DOI 10.1021/bc050033+; Deverman BE, 2012, J NEUROSCI, V32, P2100, DOI 10.1523/JNEUROSCI.3803-11.2012; East E, 2012, TISSUE ENG PART C-ME, V18, P526, DOI [10.1089/ten.tec.2011.0587, 10.1089/ten.TEC.2011.0587]; East E, 2009, J TISSUE ENG REGEN M, V3, P634, DOI 10.1002/term.209; Etame AB, 2011, NANOMED-NANOTECHNOL, V7, P992, DOI 10.1016/j.nano.2011.04.004; Gannon Christopher J., 2008, Journal of Nanobiotechnology, V6, P2, DOI 10.1186/1477-3155-6-2; Gao HJ, 2005, P NATL ACAD SCI USA, V102, P9469, DOI 10.1073/pnas.0503879102; Georgieva JV, 2011, MOL THER, V19, P318, DOI 10.1038/mt.2010.236; Hainfeld JF, 2012, NANOMEDICIN IN PRESS; Huang SH, 2011, J BIOL CHEM, V286, P34761, DOI 10.1074/jbc.M111.219378; Jackson AM, 2004, NAT MATER, V3, P330, DOI 10.1038/nmat1116; Kanwar JR, 2012, NANOMED-NANOTECHNOL, V8, P399, DOI 10.1016/j.nano.2011.08.006; Li QA, 2010, MED MICROBIOL IMMUN, V199, P333, DOI 10.1007/s00430-010-0168-8; Lin JQ, 2010, ACS NANO, V4, P5421, DOI 10.1021/nn1010792; Lund T, 2011, BIOMATERIALS, V32, P9776, DOI 10.1016/j.biomaterials.2011.09.018; Male DK, 1996, NEURAL CELL CULTURE; Male KB, 2008, ANAL CHEM, V80, P5487, DOI 10.1021/ac8004555; Manfredsson FP, 2010, DISCOV MED, V9, P204; MARCHESI V. T., 1965, INVEST OPHTHALMOL, V4, P1111; McAllister MS, 2001, BRAIN RES, V904, P20, DOI 10.1016/S0006-8993(01)02418-0; MORGELLO S, 1995, GLIA, V14, P43, DOI 10.1002/glia.440140107; Muneer PMA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-23; Patel T, 2012, ADV DRUG DELIVER REV, V64, P701, DOI 10.1016/j.addr.2011.12.006; Phillips JB, 2011, METHODS MOL BIOL, V695, P183, DOI 10.1007/978-1-60761-984-0_12; Santos WLC, 1996, J NEUROIMMUNOL, V66, P125; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Schweitzer KM, 1997, LAB INVEST, V76, P25; Shan YP, 2011, CHEM COMMUN, V47, P8091, DOI 10.1039/c1cc11453k; Sloane E, 2009, BRAIN BEHAV IMMUN, V23, P92, DOI 10.1016/j.bbi.2008.09.004; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Verma A, 2004, J AM CHEM SOC, V126, P13987, DOI 10.1021/ja046572r; Verma A, 2008, NAT MATER, V7, P588, DOI 10.1038/nmat2202; Wang YY, 2009, IMMUNOTHERAPY-UK, V1, P983, DOI 10.2217/IMT.09.75; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wolburg H, 2002, VASC PHARMACOL, V38, P323, DOI 10.1016/S1537-1891(02)00200-8; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393	46	101	105	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81043	10.1371/journal.pone.0081043	http://dx.doi.org/10.1371/journal.pone.0081043			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339894	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328566100028
J	Santulli-Marotto, S; Boakye, K; Lacy, E; Wu, SJ; Luongo, J; Kavalkovich, K; Coelho, A; Hogaboam, CM; Ryan, M				Santulli-Marotto, Sandra; Boakye, Ken; Lacy, Eilyn; Wu, Sheng-Jiun; Luongo, Jennifer; Kavalkovich, Karl; Coelho, Ana; Hogaboam, Cory M.; Ryan, Mary			Engagement of Two Distinct Binding Domains on CCL17 Is Required for Signaling through CCR4 and Establishment of Localized Inflammatory Conditions in the Lung	PLOS ONE			English	Article							MACROPHAGE-DERIVED CHEMOKINE; ACTIVATION-REGULATED CHEMOKINE; DENDRITIC CELLS; RECEPTOR 4; AIRWAY HYPERREACTIVITY; PULMONARY-FIBROSIS; SKIN DISEASES; TH2 CELLS; THYMUS; CCL22	CCL17 (TARC) function can be completely abolished by mAbs that block either one of two distinct sites required for CCR4 signaling. This chemokine is elevated in sera of asthma patients and is responsible for establishing inflammatory sites through CCR4-mediated recruitment of immune cells. CCL17 shares the GPCR CCR4, with CCL22 (MDC) but these two chemokines differentially affect the immune response. To better understand chemokine mediated effects through CCR4, we have generated chimeric anti-mouse CCL17 surrogate antibodies that inhibit function of this ligand in vitro and in vivo. The affinities of the surrogate antibodies for CCL17 range from 685 pM for B225 to 4.9 nM for B202. One antibody, B202, also exhibits weak binding to CCL22 (K-D similar to 2 mu M) and no binding to CCL22 is detectable with the second antibody, B225. In vitro, both antibodies inhibit CCL17-mediated calcium mobilization, beta-arrestin recruitment and chemotaxis; B202 can also partially inhibit CCL22-mediated beta-arrestin recruitment. Both B202 and B225 antibodies neutralize CCL17 in vivo as demonstrated by reduction of methacholine-induced airway hyperreactivity in the A. fumigatus model of asthma. That both antibodies block CCL17 function but only B202 shows any inhibition of CCL22 function suggests that they bind CCL17 at different sites. Competition binding studies confirm that these two antibodies recognize unique epitopes that are non-overlapping despite the small size of CCL17. Taking into consideration the data from both the functional and binding studies, we propose that effective engagement of CCR4 by CCL17 involves two distinct binding domains and interaction with both is required for signaling.	[Santulli-Marotto, Sandra; Boakye, Ken; Lacy, Eilyn; Wu, Sheng-Jiun; Luongo, Jennifer; Kavalkovich, Karl; Ryan, Mary] Janssen Res & Dev, Spring House, PA USA; [Santulli-Marotto, Sandra; Coelho, Ana; Hogaboam, Cory M.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Johnson & Johnson; Janssen Pharmaceuticals; University of Michigan System; University of Michigan	Santulli-Marotto, S (corresponding author), Janssen Res & Dev, Spring House, PA USA.	ssantull@its.jnj.com	hogaboam, cory/M-3578-2014; Hogaboam, Cory M./AAI-1433-2021	Hogaboam, Cory M./0000-0003-3366-4850	Janssen, Research Development	Janssen, Research Development	AC and CMH receive funding from Janssen, Research & Development. This work is the result of a research collaboration between Univ of Mich and Janssen R&D. The authors would like to emphasize that the studies reported in this manuscript are a result of joint research efforts employing our complimentary but non-overlapping expertise. This work is the result of collaborative research between Univ of Mich and Janssen R&D such that scientists from both institutions worked together on study design and data collection/analysis. The decision to publish and preparation of the manuscript are a culmination of joint efforts.	Abi-Younes S, 2001, THROMB RES, V101, P279, DOI 10.1016/S0049-3848(00)00402-3; Alferink J, 2003, J EXP MED, V197, P585, DOI 10.1084/jem.20021859; Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Baatar D, 2007, J IMMUNOL, V179, P1996, DOI 10.4049/jimmunol.179.3.1996; Belperio JA, 2004, J IMMUNOL, V173, P4692, DOI 10.4049/jimmunol.173.7.4692; Berin MC, 2001, AM J RESP CELL MOL, V24, P382, DOI 10.1165/ajrcmb.24.4.4360; Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO;2-A; Bonecchi R, 2004, J IMMUNOL, V172, P4972, DOI 10.4049/jimmunol.172.8.4972; BRUGGEMANN M, 1986, P NATL ACAD SCI USA, V83, P6075, DOI 10.1073/pnas.83.16.6075; Carpenter KJ, 2005, INFECT IMMUN, V73, P7198, DOI 10.1128/IAI.73.11.7198-7207.2005; Christophi GP, 2012, INFLAMM BOWEL DIS, V18, P2342, DOI 10.1002/ibd.22957; Conroy DM, 2003, J LEUKOCYTE BIOL, V74, P558, DOI 10.1189/jlb.0103030; Cronshaw D, 2004, J IMMUNOLOGY, V172; Dijstelbloem HM, 2001, TRENDS IMMUNOL, V22, P510, DOI 10.1016/S1471-4906(01)02014-2; Fox JM, 2006, J BIOL CHEM, V281, P36652, DOI 10.1074/jbc.M605584200; Godiska R, 1997, J EXP MED, V185, P1595, DOI 10.1084/jem.185.9.1595; Hazenbos WLW, 1998, J IMMUNOL, V161, P3026; Heiseke AF, GASTROENTEROLOGY, V142, P335; Hogaboam CM, 2000, AM J PATHOL, V156, P723, DOI 10.1016/S0002-9440(10)64775-X; Hogaboam CM, 2005, MED MYCOL, V43, pS197, DOI 10.1080/13693780400025211; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Imai T, 1996, J BIOL CHEM, V271, P21514, DOI 10.1074/jbc.271.35.21514; Imai T, 1998, J BIOL CHEM, V273, P1764, DOI 10.1074/jbc.273.3.1764; Inoue T, 2004, EUR RESPIR J, V24, P49, DOI 10.1183/09031936.04.00110203; Ismailoglu UB, 2010, THERAPEUTIC TARGETIN; Jakubzick C, 2004, AM J PATHOL, V165, P1211, DOI 10.1016/S0002-9440(10)63381-0; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Kawasaki S, 2001, J IMMUNOL, V166, P2055, DOI 10.4049/jimmunol.166.3.2055; Lehtimaki S, 2010, J INVEST DERMATOL, V130, P2743, DOI 10.1038/jid.2010.208; Mariani M, 2004, EUR J IMMUNOL, V34, P231, DOI 10.1002/eji.200324429; Matsukawa A, 2000, Rev Immunogenet, V2, P339; Meyer EH, 2007, J IMMUNOL, V179, P4661, DOI 10.4049/jimmunol.179.7.4661; Montane J, 2011, J CLIN INVEST, V121, P3024, DOI 10.1172/JCI43048; Moroi Y, 2004, J DERMATOL SCI, V36, P186, DOI 10.1016/j.jdermsci.2004.08.013; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nakagami Y, 2009, EUR J PHARMACOL, V624, P38, DOI 10.1016/j.ejphar.2009.09.058; Ness TL, 2006, J IMMUNOL, V177, P7531, DOI 10.4049/jimmunol.177.11.7531; Perros F, 2009, ALLERGY, V64, P995, DOI 10.1111/j.1398-9995.2009.02095.x; Proost P, 1999, J BIOL CHEM, V274, P3988, DOI 10.1074/jbc.274.7.3988; Radstake TRDJ, 2005, ANN RHEUM DIS, V64, P359, DOI 10.1136/ard.2003.017566; RASHID A, 1992, J IMMUNOL, V148, P1382; Saeki H, 2006, J DERMATOL SCI, V43, P75, DOI 10.1016/j.jdermsci.2006.06.002; Santulli-Marotto Sandra, 2013, Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, V32, P162, DOI 10.1089/mab.2012.0112; Schuh JM, 2002, FASEB J, V16, P1313, DOI 10.1096/fj.02-0193fje; Sebastiani S, 2005, EUR J IMMUNOL, V35, P746, DOI 10.1002/eji.200525800; STUTTE S, P NATL ACAD SCI US, V107, P8736; Tamaki K, 2006, J DERMATOL, V33, P300, DOI 10.1111/j.1346-8138.2006.00072.x; Weber C, J CLIN INVEST, V121, P2898; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619	49	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81465	10.1371/journal.pone.0081465	http://dx.doi.org/10.1371/journal.pone.0081465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339934	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100061
J	Sutcliffe, P; Connock, M; Gurung, T; Freeman, K; Johnson, S; Ngianga-Bakwin, K; Grove, A; Gurung, B; Morrow, S; Stranges, S; Clarke, A				Sutcliffe, Paul; Connock, Martin; Gurung, Tara; Freeman, Karoline; Johnson, Samantha; Ngianga-Bakwin, Kandala; Grove, Amy; Gurung, Binu; Morrow, Sarah; Stranges, Saverio; Clarke, Aileen			Aspirin in Primary Prevention of Cardiovascular Disease and Cancer: A Systematic Review of the Balance of Evidence from Reviews of Randomized Trials	PLOS ONE			English	Review							LOW-DOSE ASPIRIN; DIABETES-MELLITUS; COLORECTAL-CANCER; FOLLOW-UP; EVENTS; MORTALITY; RISK; METAANALYSIS; METASTASIS; PEOPLE	Background: Aspirin has been recommended for primary prevention of cardiovascular disease (CVD) and cancer, but overall benefits are unclear. We aimed to use novel methods to re-evaluate the balance of benefits and harms of aspirin using evidence from randomised controlled trials, systematic reviews and meta-analyses. Methods and Findings: Data sources included ten electronic bibliographic databases, contact with experts, and scrutiny of reference lists of included studies. Searches were undertaken in September 2012 and restricted to publications since 2008. Of 2,572 potentially relevant papers 27 met the inclusion criteria. Meta-analysis of control arms to estimate event rates, modelling of all-cause mortality and L'Abbe plots to estimate heterogeneity were undertaken. Absolute benefits and harms were low: 60-84 major CVD events and 34-36 colorectal cancer deaths per 100,000 person-years were averted, whereas 46-49 major bleeds and 68-117 gastrointestinal bleeds were incurred. Reductions in all-cause mortality were minor and uncertain (Hazard Ratio 0.96; 95% CI: 0.90-1.02 at 20 years, Relative Risk [RR] 0.94, 95% CI: 0.88-1.00 at 8 years); there was a non-significant change in total CVD (RR 0.85, 95% CI: 0.69-1.06) and change in total cancer mortality ranged from 0.76 (95% CI: 0.66-0.88) to 0.93 (95% CI: 0.84-1.03) depending on follow-up time and studies included. Risks were increased by 37% for gastrointestinal bleeds (RR 1.37, 95% CI: 1.15-1.62), 54%-66% for major bleeds (Rate Ratio from IPD analysis 1.54, 95% CI: 1.30-1.82, and RR 1.62, 95% CI: 1.31-2.00), and 32%-38% for haemorrhagic stroke (Rate Ratio from IPD analysis 1.32; 95% CI: 1.00-1.74; RR 1.38; 95% CI: 1.01-1.82). Conclusions: Findings indicate small absolute effects of aspirin relative to the burden of these diseases. When aspirin is used for primary prevention of CVD the absolute harms exceed the benefits. Estimates of cancer benefit rely on selective retrospective re-analysis of RCTs and more information is needed.	[Sutcliffe, Paul; Connock, Martin; Gurung, Tara; Freeman, Karoline; Johnson, Samantha; Ngianga-Bakwin, Kandala; Grove, Amy; Gurung, Binu; Stranges, Saverio; Clarke, Aileen] Univ Warwick, Warwick Med Sch, Coventry, Warwick, England; [Morrow, Sarah] Univ Oxford, Oxford Med Sch, Oxford, England	University of Warwick; University of Oxford	Clarke, A (corresponding author), Univ Warwick, Warwick Med Sch, Coventry, Warwick, England.	aileen.clarke@warwick.ac.uk	Sutcliffe, Paul/AAB-7325-2020; Clarke, Aileen/I-5679-2012; Johnson, Samantha/D-4736-2014	Clarke, Aileen/0000-0001-8299-3146; Johnson, Samantha/0000-0002-4716-1229; Stranges, Saverio/0000-0001-5226-8373; Freeman, Karoline/0000-0002-9963-2918; Grove, Prof Amy/0000-0002-8027-7274	NIHR HTA Programme [HTA11/130/02]	NIHR HTA Programme	This project was commissioned by the NIHR HTA Programme as project number HTA11/130/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adly G, 2013, ANN PHARMACOTHER, V47, DOI 10.1345/aph.1R570; Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Bartolucci AA, 2011, AM J CARDIOL, V107, P1796, DOI 10.1016/j.amjcard.2011.02.325; Belch J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1840; Berger JS, 2011, AM HEART J, V162, P115, DOI 10.1016/j.ahj.2011.04.006; BETHESDA MD, 2000, ASPIRIN REDUCING EVE; BETHESDA MD, 2000, STUDY ASSESS EFFICAC; BETHESDA MD, 2000, ASCEND STUDY CARDIOV; BETHESDA MD, 2000, CHRONOTHERAPY LOW DO; Bloom DE, 2012, PGDA WORKING PAPERS; Butalia S, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-25; Calonge N, 2009, ANN INTERN MED, V150, P396; Calvin AD, 2009, DIABETES CARE, V32, P2300, DOI 10.2337/dc09-1297; *CARD SOC BRIT HYP, 2005, HEART, V91, pV1; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cook NR, 2005, JAMA-J AM MED ASSOC, V294, P47, DOI 10.1001/jama.294.1.47; *DATA STATA, 2012, AN STAT SOFTW; De Berardis Giorgia, 2009, BMJ, V339, pb4531, DOI 10.1136/bmj.b4531; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000; Fowkes FGR, 2010, JAMA-J AM MED ASSOC, V303, P841, DOI 10.1001/jama.2010.221; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Meade TW, 1998, LANCET, V351, P233; *NHS CTR RES DISS, 1999, 4 CRD NHS CTR REV DI; NICOLUCCI A, 2000, ASPIRIN SIMVASTATIN; Ogawa H, 2008, JAMA-J AM MED ASSOC, V300, P2134, DOI 10.1001/jama.2008.623; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; PETO R, 1988, BRIT MED J, V296, P313, DOI 10.1136/bmj.296.6618.313; Pignone M, 2010, CIRCULATION, V121, P2694, DOI 10.1161/CIR.0b013e3181e3b133; Raju N, 2011, AM J MED, V124, P621, DOI 10.1016/j.amjmed.2011.01.018; Ridker PM, 2005, NEW ENGL J MED, V352, P1293, DOI 10.1056/NEJMoa050613; Rothwell PM, 2012, LANCET, V379, P1591, DOI 10.1016/S0140-6736(12)60209-8; Rothwell PM, 2012, LANCET, V379, P1602, DOI 10.1016/S0140-6736(11)61720-0; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Rothwell PM, 2010, LANCET, V376, P1741, DOI 10.1016/S0140-6736(10)61543-7; Seshasai SRK, 2012, ARCH INTERN MED, V172, P209, DOI 10.1001/archinternmed.2011.628; Simpson SH, 2011, J GEN INTERN MED, V26, P1336, DOI 10.1007/s11606-011-1757-y; Stavrakis S, 2011, AM J MED SCI, V341, P1, DOI 10.1097/MAJ.0b013e3181f1fba8; Sturmer T, 1998, ANN INTERN MED, V128, P713, DOI 10.7326/0003-4819-128-9-199805010-00003; Tognoni G, 2001, LANCET, V357, P89, DOI 10.1016/S0140-6736(00)03539-X; Wolff T, 2009, ANN INTERN MED, V150, P405, DOI 10.7326/0003-4819-150-6-200903170-00009; Younis N, 2010, EXPERT OPIN PHARMACO, V11, P1459, DOI 10.1517/14656561003792538; Zhang CY, 2010, DIABETES RES CLIN PR, V87, P211, DOI 10.1016/j.diabres.2009.09.029	47	50	53	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81970	10.1371/journal.pone.0081970	http://dx.doi.org/10.1371/journal.pone.0081970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339983	gold, Green Published			2022-12-27	WOS:000328566100076
J	Vanhooren, V; Vandenbroucke, RE; Dewaele, S; Van Hamme, E; Haigh, JJ; Hochepied, T; Libert, C				Vanhooren, Valerie; Vandenbroucke, Roosmarijn E.; Dewaele, Sylviane; Van Hamme, Evelien; Haigh, Jody J.; Hochepied, Tino; Libert, Claude			Mice Overexpressing beta-1,4-Galactosyltransferase I Are Resistant to TNF-Induced Inflammation and DSS-Induced Colitis	PLOS ONE			English	Article							PANETH CELLS; ALPHA-DEFENSINS; N-GLYCANS; GLYCOSYLATION; MUCIN; BARRIER; MUCUS; PROLIFERATION; BIOSYNTHESIS; ACTIVATION	Glycosylation is an essential post-translational modification, which determines the function of proteins and important processes such as inflammation. beta-1,4-galactosyltransferase I (beta GalT1) is a key enzyme involved in the addition of galactose moieties to glycoproteins. Intestinal mucins are glycoproteins that protect the gut barrier against invading pathogens and determine the composition of the intestinal microbiota. Proper glycosylation of mucus is important in this regard. By using ubiquitously expressing beta GalT1 transgenic mice, we found that this enzyme led to strong galactosylation of mucus proteins, isolated from the gut of mice. This galactosylation was associated with a drastic change in composition of gut microbiota, as TG mice had a significantly higher Firmicutes to Bacteroidetes ratio. TG mice were strongly protected against TNF-induced systemic inflammation and lethality. Moreover, beta GalT1 transgenic mice were protected in a model of DSS-induced colitis, at the level of clinical score, loss of body weight, colon length and gut permeability. These studies put beta GalT1 forward as an essential protective player in exacerbated intestinal inflammation. Optimal galactosylation of N-glycans of mucus proteins, determining the bacterial composition of the gut, is a likely mechanism of this function.	[Vanhooren, Valerie; Vandenbroucke, Roosmarijn E.; Dewaele, Sylviane; Van Hamme, Evelien; Haigh, Jody J.; Hochepied, Tino; Libert, Claude] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Vanhooren, Valerie; Vandenbroucke, Roosmarijn E.; Dewaele, Sylviane; Van Hamme, Evelien; Haigh, Jody J.; Hochepied, Tino; Libert, Claude] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Libert, C (corresponding author), VIB, Dept Mol Biomed Res, Ghent, Belgium.	Claude.libert@dmbr.vib-UGent.be	Vandenbroucke, Roosmarijn/AAC-2757-2019; Vandenbroucke, Roosmarijn E/B-9419-2009	Vandenbroucke, Roosmarijn E/0000-0002-8327-620X	Fund for Scientific Research, Flanders (FWO); Belgian Interuniversity Attraction Poles program [IAP VI/18]; agency for Innovation by Science and Technology (IWT); EC project MarkAge; Belgian Association Against Cancer	Fund for Scientific Research, Flanders (FWO)(FWO); Belgian Interuniversity Attraction Poles program(Belgian Federal Science Policy Office); agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); EC project MarkAge; Belgian Association Against Cancer	The work was supported by the Fund for Scientific Research, Flanders (FWO), the Belgian Interuniversity Attraction Poles program (IAP VI/18), the agency for Innovation by Science and Technology (IWT), the EC project MarkAge and the Belgian Association Against Cancer. The authors have no conflicting financial interests. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	An GY, 2007, J EXP MED, V204, P1417, DOI 10.1084/jem.20061929; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Asano M, 2003, BLOOD, V102, P1678, DOI 10.1182/blood-2003-03-0836; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Callewaert N, 2001, GLYCOBIOLOGY, V11, P275, DOI 10.1093/glycob/11.4.275; Dharmani P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025058; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Groux-Degroote S, 2008, BIOCHEM J, V410, P213, DOI 10.1042/BJ20070958; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hennet T, 2002, CELL MOL LIFE SCI, V59, P1081, DOI 10.1007/s00018-002-8489-4; Iwaya H, 2012, EXP BIOL MED MAYWOOD; Keshav S, 2006, J LEUKOCYTE BIOL, V80, P500, DOI 10.1189/jlb.1005556; Kotani N, 2001, BIOCHEM J, V357, P827, DOI 10.1042/0264-6021:3570827; Kukuruzinska MA, 1998, CRIT REV ORAL BIOL M, V9, P415, DOI 10.1177/10454411980090040301; Laroy W, 2006, NAT PROTOC, V1, P397, DOI 10.1038/nprot.2006.60; LIBERT C, 1990, EUR J IMMUNOL, V20, P691, DOI 10.1002/eji.1830200333; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Magalhaes A, 2009, GLYCOBIOLOGY, V19, P1525, DOI 10.1093/glycob/cwp131; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Moran AP, 2011, GUT, V60, P1412, DOI 10.1136/gut.2010.212704; Mori R, 2004, AM J PATHOL, V164, P1303, DOI 10.1016/S0002-9440(10)63217-8; Niu SQ, 2008, J CHEM NEUROANAT, V35, P245, DOI 10.1016/j.jchemneu.2008.01.002; Nyabi O, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp112; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; PODOLSKY DK, 1984, GASTROENTEROLOGY, V87, P991; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Rhodes JM, 1997, GUT, V40, P807, DOI 10.1136/gut.40.6.807; Rini J., 2009, GLYCOSYLTRANSFERASES; ROZEE KR, 1982, APPL ENVIRON MICROB, V43, P1451, DOI 10.1128/AEM.43.6.1451-1463.1982; Sando L, 2009, J DAIRY SCI, V92, P5276, DOI 10.3168/jds.2009-2216; Schroers V, 2008, DIS AQUAT ORGAN, V81, P135, DOI 10.3354/dao01947; Shen AG, 2009, GLYCOCONJUGATE J, V26, P19, DOI 10.1007/s10719-008-9158-0; Shinzaki S, 2012, GASTROENTEROLOGY; Shinzaki S, 2008, AM J GASTROENTEROL, V103, P1173, DOI 10.1111/j.1572-0241.2007.01699.x; Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Strugala V, 2003, P NUTR SOC, V62, P237, DOI 10.1079/PNS2002205; Takahashi N, 2008, J EXP MED, V205, P1755, DOI 10.1084/jem.20080588; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; TRACEY KJ, 1986, SCIENCE, V234, P470, DOI 10.1126/science.3764421; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Van Hauwermeiren FAM, 2013, J CLIN INVEST   0515, DOI [10.1172/JCI65624., DOI 10.1172/JCI65624.[]; Van Hauwermeiren F, 2011, CYTOKINE GROWTH F R, V22, P311, DOI 10.1016/j.cytogfr.2011.09.004; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Vandenbroucke RE VI, 2013, MUCOSAL IMM IN PRESS; Vandenbroucke RE, 2013, EMBO MOL MED, V5, P1000, DOI 10.1002/emmm.201202100; Vanhooren V, 2008, BIOGERONTOLOGY, V9, P351, DOI 10.1007/s10522-008-9140-z; Vanhooren V, 2011, AGING CELL, V10, P1056, DOI 10.1111/j.1474-9726.2011.00749.x; Vanhooren V, 2010, EXP GERONTOL, V45, P738, DOI 10.1016/j.exger.2010.08.009; Vanhooren V, 2009, MECH AGEING DEV, V130, P92, DOI 10.1016/j.mad.2008.11.008; VANSNICK J, 1986, P NATL ACAD SCI USA, V83, P9679; Varki A., 2009, BIOL ROLES GLYCANS; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Wu YM, 2009, J PROTEOME RES, V8, P1876, DOI 10.1021/pr8008379; Xu DW, 2011, INFLAMMATION, V34, P531, DOI 10.1007/s10753-010-9260-x; Yan MJ, 2007, J MOL NEUROSCI, V33, P155, DOI 10.1007/s12031-007-0033-4; Yuan Q, 2012, MOL CELL BIOCHEM, V365, P149, DOI 10.1007/s11010-012-1254-6	71	13	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e79883	10.1371/journal.pone.0079883	http://dx.doi.org/10.1371/journal.pone.0079883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339869	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100008
J	Da Sacco, S; Lemley, KV; Sedrakyan, S; Zanusso, I; Petrosyan, A; Peti-Peterdi, J; Burford, J; De Filippo, RE; Perin, L				Da Sacco, Stefano; Lemley, Kevin V.; Sedrakyan, Sargis; Zanusso, Ilenia; Petrosyan, Astgik; Peti-Peterdi, Janos; Burford, James; De Filippo, Roger E.; Perin, Laura			A Novel Source of Cultured Podocytes	PLOS ONE			English	Article							DEPENDENT KINASE INHIBITORS; GLOMERULAR SLIT DIAPHRAGM; STEM-CELLS; EXPRESSION; KIDNEY; DISEASE; PROGRESSION; DIFFERENTIATION; PHENOTYPE; RECOVERY	Amniotic fluid is in continuity with multiple developing organ systems, including the kidney. Committed, but still stem-like cells from these organs may thus appear in amniotic fluid. We report having established for the first time a stem-like cell population derived from human amniotic fluid and possessing characteristics of podocyte precursors. Using a method of triple positive selection we obtained a population of cells (hAKPC-P) that can be propagated in vitro for many passages without immortalization or genetic manipulation. Under specific culture conditions, these cells can be differentiated to mature podocytes. In this work we compared these cells with conditionally immortalized podocytes, the current gold standard for in vitro studies. After in vitro differentiation, both cell lines have similar expression of the major podocyte proteins, such as nephrin and type IV collagen, that are characteristic of mature functional podocytes. In addition, differentiated hAKPC-P respond to angiotensin II and the podocyte toxin, puromycin aminonucleoside, in a way typical of podocytes. In contrast to immortalized cells, hAKPC-P have a more nearly normal cell cycle regulation and a pronounced developmental pattern of specific protein expression, suggesting their suitability for studies of podocyte development for the first time in vitro. These novel progenitor cells appear to have several distinct advantages for studies of podocyte cell biology and potentially for translational therapies.	[Da Sacco, Stefano; Sedrakyan, Sargis; Petrosyan, Astgik; De Filippo, Roger E.; Perin, Laura] Univ So Calif, Childrens Hosp Los Angeles, GOFARR Lab Organ Regenerat Res & Cell Therapeut, Saban Res Inst,Dept Urol, Los Angeles, CA 90089 USA; [Lemley, Kevin V.] Univ So Calif, Dept Pediat, Childrens Hosp Los Angeles, Div Nephrol, Los Angeles, CA 90089 USA; [Zanusso, Ilenia] Univ Padua, Dept Pharmaceut Sci, Interdept Res & Serv Ctr Biol & Regenerat Med, Padua, Italy; [Peti-Peterdi, Janos; Burford, James] Univ So Calif, Dept Physiol & Biophys, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; University of Padua; University of Southern California	Perin, L (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, GOFARR Lab Organ Regenerat Res & Cell Therapeut, Saban Res Inst,Dept Urol, Los Angeles, CA 90089 USA.	lperin@chla.usc.edu	Petrosyan, Astgik/I-7206-2019; Da Sacco, Stefano/G-6346-2011	Da Sacco, Stefano/0000-0001-9654-6822; Burford, James/0000-0001-9714-8578; Petrosyan, Astgik/0000-0001-9147-7303	Alport Syndrome Foundation; California Institute for Regenerative Medicine [TG2 01168]; GOFARR Foundation at Children's Hospital Los Angeles	Alport Syndrome Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); GOFARR Foundation at Children's Hospital Los Angeles	Research funded by: Alport Syndrome Foundation, California Institute for Regenerative Medicine Training Grant TG2 01168 and the GOFARR Foundation at Children's Hospital Los Angeles. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bruno S, 2009, STEM CELLS DEV, V18, P867, DOI 10.1089/scd.2008.0320; Brunskill EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024640; Challen GA, 2004, J AM SOC NEPHROL, V15, P2344, DOI 10.1097/01.ASN.0000136779.17837.8F; Chittiprol S, 2011, AM J PHYSIOL-RENAL, V301, pF660, DOI 10.1152/ajprenal.00234.2011; Da Sacco S, 2010, J UROLOGY, V183, P1193, DOI 10.1016/j.juro.2009.11.006; Dai CS, 2006, J AM SOC NEPHROL, V17, P2164, DOI 10.1681/ASN.2006010033; Duncan AW, 2010, NATURE, V467, P707, DOI 10.1038/nature09414; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Fukuda A, 2012, KIDNEY INT, V81, P40, DOI 10.1038/ki.2011.306; Greka A, 2011, J AM SOC NEPHROL, V22, P1969, DOI 10.1681/ASN.2011040370; Hendry C, 2011, PEDIATR NEPHROL, V26, P1395, DOI 10.1007/s00467-010-1750-4; Holthofer H, 2007, NEPHROL DIAL TRANSPL, V22, P2124, DOI 10.1093/ndt/gfm344; Kramer J, 2006, DIFFERENTIATION, V74, P91, DOI 10.1111/j.1432-0436.2006.00062.x; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Lemley KV, 2002, KIDNEY INT, V61, P1475, DOI 10.1046/j.1523-1755.2002.00269.x; Little MH, 2012, COLD SPRING HARBOR P, V4; Marshall CB, 2006, NEPHRON EXP NEPHROL, V102, P39, DOI 10.1159/000088400; MEEZAN E, 1975, LIFE SCI, V17, P1721, DOI 10.1016/0024-3205(75)90119-8; Mora CF, 2012, STEM CELLS DEV, V21, P296, DOI 10.1089/scd.2010.0470; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Mundel P, 1996, EXP NEPHROL, V4, P263; Nagata M, 1999, NEPHROL DIAL TRANSPL, V14, P48, DOI 10.1093/ndt/14.suppl_1.48; NORGAARD JOR, 1987, LAB INVEST, V57, P277; Pagtalunan ME, 1997, J CLIN INVEST, V99, P342, DOI 10.1172/JCI119163; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Perin L, 2011, ADV DRUG DELIVER REV, V63, P379, DOI 10.1016/j.addr.2010.12.001; Perry J, 2006, J AM SOC NEPHROL, V17, P66, DOI 10.1681/ASN.2005060586; Pozzi A, 2012, J CLIN INVEST, V122, P13, DOI 10.1172/JCI61858; Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081; Ransom RF, 2005, KIDNEY INT, V68, P2473, DOI 10.1111/j.1523-1755.2005.00723.x; Reiser J, 2000, J AM SOC NEPHROL, V11, P1, DOI 10.1681/ASN.V1111; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Schordan S, 2011, AM J PHYSIOL-RENAL, V300, pF119, DOI 10.1152/ajprenal.00143.2010; Sedrakyan S, 2012, J AM SOC NEPHROL, V23, P661, DOI 10.1681/ASN.2011030243; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2000, KIDNEY INT, V58, P674, DOI 10.1046/j.1523-1755.2000.00213.x; Song B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046453; Takano Y, 2007, AM J PHYSIOL-RENAL, V292, pF1573, DOI 10.1152/ajprenal.00423.2006; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Warsow G, 2013, KIDNEY INT, V84, P104, DOI 10.1038/ki.2013.64	42	33	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81812	10.1371/journal.pone.0081812	http://dx.doi.org/10.1371/journal.pone.0081812			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349133	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800027
J	Zhang, RL; Hu, ZH; Debi, R; Zhang, LC; Li, H; Liu, Q				Zhang, Ruiling; Hu, Zhonghua; Debi, Roberson; Zhang, Lingcong; Li, Hong; Liu, Qiang			Neural Processes Underlying the "Same"-"Different'' Judgment of Two Simultaneously Presented Objects- An EEG Study	PLOS ONE			English	Article							HUMAN BRAIN; CATEGORICAL PERCEPTION; IRRELEVANT INFORMATION; POTENTIAL N270; CONFLICT; DISCRIMINATION; TIME; PARALLEL	The present study investigated the neural processes underlying "same'' and -"different'' judgments for two simultaneously presented objects, that varied on one or both, of two dimensions: color and shape. Participants judged whether or not the two objects were "same'' or "different'' on either the color dimension (color task) or the shape dimension (shape task). The unattended irrelevant dimension of the objects was either congruent (same-same; different-different) or incongruent (same-different). ERP data showed a main effect of color congruency in the time window 190-260 ms post-stimulus presentation and a main effect of shape congruency in the time window 220-280 ms post-stimulus presentation in both color and shape tasks. The interaction between color and shape congruency in the ERP data occurred in a later time window than the two main effects, indicating that mismatches in task-relevant and task-irrelevant dimensions were processed automatically and independently before a response was selected. The fact that the interference of the task-irrelevant dimension occurred after mismatch detection, supports a confluence model of processing.	[Zhang, Ruiling; Hu, Zhonghua; Li, Hong; Liu, Qiang] Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China; [Debi, Roberson] Univ Essex, Dept Psychol, Colchester CO4 3SQ, Essex, England; [Zhang, Lingcong] Minnan Normal Univ Zhangzhou, Dept Educ Sci & Technol, Zhangzhou, Peoples R China	Liaoning Normal University; University of Essex	Liu, Q (corresponding author), Liaoning Normal Univ, Sch Psychol, Dalian, Peoples R China.	lq780614@163.com	Liu, Qiang/AAA-2260-2020		National Natural Science Foundation of China [NSFC 31170982]; Royal Society [IE121122]; International Cooperation and Exchanges NSFC [31311130123]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Royal Society(Royal Society of London); International Cooperation and Exchanges NSFC	This study was supported by the National Natural Science Foundation of China (NSFC 31170982) and Royal Society (IE121122) International Cooperation and Exchanges NSFC (31311130123. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cui LL, 2000, NEUROREPORT, V11, P2415, DOI 10.1097/00001756-200008030-00015; EGETH HE, 1966, PERCEPT PSYCHOPHYS, V1, P245, DOI 10.3758/BF03207389; ERIKSEN CW, 1982, PERCEPT PSYCHOPHYS, V32, P261, DOI 10.3758/BF03206230; EVIATAR Z, 1994, PERCEPT PSYCHOPHYS, V56, P62, DOI 10.3758/BF03211691; FARELL B, 1985, PSYCHOL BULL, V98, P419, DOI 10.1037/0033-2909.98.3.419; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; GRICE GR, 1982, J EXP PSYCHOL GEN, V111, P135, DOI 10.1037/0096-3445.111.1.135; HAWKINS HL, 1969, PERCEPT PSYCHOPHYS, V5, P56, DOI 10.3758/BF03210482; HAWKINS HL, 1972, J EXP PSYCHOL, V96, P389, DOI 10.1037/h0033642; HAWKINS HL, 1973, J EXP PSYCHOL, V98, P435, DOI 10.1037/h0034356; Kong J, 2000, NEUROREPORT, V11, P1195, DOI 10.1097/00001756-200004270-00010; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Mao W, 2008, INT J PSYCHOPHYSIOL, V67, P47, DOI 10.1016/j.ijpsycho.2007.10.003; OVERMYER SP, 1985, ACTA PSYCHOL, V58, P237, DOI 10.1016/0001-6918(85)90023-X; Pilling M, 2003, MEM COGNITION, V31, P538, DOI 10.3758/BF03196095; PROCTOR RW, 1981, PSYCHOL REV, V88, P291, DOI 10.1037/0033-295X.88.4.291; Roberson D, 2000, MEM COGNITION, V28, P977, DOI 10.3758/BF03209345; Roberson D, 2002, J COGNITION CULTURE, V2, P29, DOI DOI 10.1163/156853702753693299; ROSCH EH, 1973, COGNITIVE PSYCHOL, V4, P328, DOI 10.1016/0010-0285(73)90017-0; SIMON JR, 1967, J APPL PSYCHOL, V51, P300, DOI 10.1037/h0020586; Sternberg S, 1969, ACTA PSYCHOL, V30, P276, DOI 10.1016/0001-6918(69)90055-9; TAYLOR DA, 1976, PSYCHOL BULL, V83, P161, DOI 10.1037/0033-2909.83.2.161; Tian SJ, 2001, CLIN ELECTROENCEPHAL, V32, P82, DOI 10.1177/155005940103200207; Wang HJ, 2001, NEUROSCI LETT, V298, P155, DOI 10.1016/S0304-3940(00)01757-2; Wang YP, 2000, NEUROSCI LETT, V293, P17, DOI 10.1016/S0304-3940(00)01480-4; Wang YP, 1998, NEUROSCI LETT, V257, P143, DOI 10.1016/S0304-3940(98)00828-3; Wang YP, 2004, PSYCHOPHYSIOLOGY, V41, P21, DOI 10.1111/j.1469-8986.2003.00134.x; Wang YP, 2003, EXP BRAIN RES, V148, P451, DOI 10.1007/s00221-002-1319-y; WILLIAMS C, 1974, Q J EXP PSYCHOL, V26, P26, DOI 10.1080/14640747408400384; Yang J, 2002, NEUROSCI LETT, V326, P73, DOI 10.1016/S0304-3940(02)00204-5; Zhang HW, 2001, J CHROMATOGR B, V757, P151, DOI 10.1016/S0378-4347(01)00132-3; Zhang XL, 2004, J PHARMACOL EXP THER, V311, P373, DOI 10.1124/jpet.104.069872; Zhang YY, 2001, NEUROSCI LETT, V303, P157, DOI 10.1016/S0304-3940(01)01700-1	33	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81737	10.1371/journal.pone.0081737	http://dx.doi.org/10.1371/journal.pone.0081737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349122	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000328731800026
J	Flowe, HD; Hope, L; Hillstrom, AP				Flowe, Heather D.; Hope, Lorraine; Hillstrom, Anne P.			Oculomotor Examination of the Weapon Focus Effect: Does a Gun Automatically Engage Visual Attention?	PLOS ONE			English	Article							FEAR-RELEVANT STIMULI; EMOTION; CAPTURE; CROWD; FACE	Background: A person is less likely to be accurately remembered if they appear in a visual scene with a gun, a result that has been termed the weapon focus effect (WFE). Explanations of the WFE argue that weapons engage attention because they are unusual and/or threatening, which causes encoding deficits for the other items in the visual scene. Previous WFE research has always embedded the weapon and nonweapon objects within a larger context that provides information about an actor's intention to use the object. As such, it is currently unknown whether a gun automatically engages attention to a greater extent than other objects independent of the context in which it is presented. Method: Reflexive responding to a gun compared to other objects was examined in two experiments. Experiment 1 employed a prosaccade gap-overlap paradigm, whereby participants looked toward a peripheral target, and Experiment 2 employed an antisaccade gap-overlap paradigm, whereby participants looked away from a peripheral target. In both experiments, the peripheral target was a gun or a nonthreatening object (i.e., a tomato or pocket watch). We also controlled how unexpected the targets were and compared saccadic reaction times across types of objects. Results: A gun was not found to differentially engage attention compared to the unexpected object (i.e., a pocket watch). Some evidence was found (Experiment 2) that both the gun and the unexpected object engaged attention to a greater extent compared the expected object (i.e., a tomato). Conclusion: An image of a gun did not engage attention to a larger extent than images of other types of objects (i.e., a pocket watch or tomato). The results suggest that context may be an important determinant of WFE. The extent to which an object is threatening may depend on the larger context in which it is presented.	[Flowe, Heather D.] Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England; [Hope, Lorraine; Hillstrom, Anne P.] Univ Portsmouth, Dept Psychol, Portsmouth, Hants, England	University of Leicester; University of Portsmouth	Flowe, HD (corresponding author), Univ Leicester, Coll Med Biol Sci & Psychol, Leicester, Leics, England.	hf49@le.ac.uk		Flowe, Heather/0000-0001-5343-5313; Hope, Lorraine/0000-0002-0012-8165; Hillstrom, Anne/0000-0002-4959-1695	British Academy [RM43G0120]; University of Leicester Capital Investment Fund	British Academy; University of Leicester Capital Investment Fund	This research was supported by a grant from the British Academy, Grant number RM43G0120, and from the University of Leicester Capital Investment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanchette I, 2006, Q J EXP PSYCHOL, V59, P1484, DOI 10.1080/02724980543000204; Brosch T, 2005, EMOTION, V5, P360, DOI 10.1037/1528-3542.5.3.360; COMBS SB, 2010, THESIS U ALABAMA TUS; EASTERBROOK JA, 1959, PSYCHOL REV, V66, P183, DOI 10.1037/h0047707; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Fawcett JM, 2013, PSYCHOL CRIME LAW, V19, P35, DOI 10.1080/1068316X.2011.599325; FELSON FB, 1996, CRIMINOLOGY, V34, P201, DOI DOI 10.1111/J.1745-9125.1996.TB01218.X; Fox E, 2007, EMOTION, V7, P691, DOI 10.1037/1528-3542.7.4.691; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Heath L., 2001, J OFFENDER REHABILIT, V33, P1, DOI [https://doi.org/10.1300/J076v33n02_01, DOI 10.1300/J076V33N02_01]; Henderson JM, 1999, J EXP PSYCHOL HUMAN, V25, P210, DOI 10.1037/0096-1523.25.1.210; Hope L, 2007, APPL COGNITIVE PSYCH, V21, P951, DOI 10.1002/acp.1307; Howard CJ, 2010, ATTEN PERCEPT PSYCHO, V72, P2087, DOI 10.3758/APP.72.8.2087; HUSTON A, 1992, BIG WORLD SMALL SCRE; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; JOHNSON RN, 1996, PEACE CONFLICT J PEA, V2, P201; JOHNSTON WA, 1990, J EXP PSYCHOL GEN, V119, P397, DOI 10.1037/0096-3445.119.4.397; Kershaw C., 2008, HOME OFFICE STAT B, V07/08; LOFTUS EF, 1987, LAW HUMAN BEHAV, V11, P55, DOI 10.1007/BF01044839; LOFTUS EF, 1980, MEMORY; MACLEOD C, 1991, BEHAV RES THER, V29, P599, DOI 10.1016/0005-7967(91)90009-R; Mitchell K. J., 1998, LEGAL CRIMINOL PSYCH, V3, P287, DOI DOI 10.1111/J.2044-8333.1998.TB00367.X; Ohman A, 2001, J PERS SOC PSYCHOL, V80, P381, DOI 10.1037//0022-3514.80.3.381; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Ohman A, 2003, CURR DIR PSYCHOL SCI, V12, P5, DOI 10.1111/1467-8721.01211; Peters D.P., 1988, PRACTICAL ASPECTS ME, V1, P89; Pickel KL, 2006, APPL COGNITIVE PSYCH, V20, P871, DOI 10.1002/acp.1235; Pickel KL, 1999, LAW HUMAN BEHAV, V23, P299, DOI 10.1023/A:1022356431375; RAND M, 2007, NCJ219413 US BUR JUS, P19413; Sander D, 2003, REV NEUROSCIENCE, V14, P303, DOI 10.1515/REVNEURO.2003.14.4.303; Sander D, 2005, NEURAL NETWORKS, V18, P317, DOI 10.1016/j.neunet.2005.03.001; SHAW JI, 1994, J SOC PSYCHOL, V134, P413, DOI 10.1080/00224545.1994.9712191; SOKOLOV YN, 1963, PERCEPTION CONDITION, V1958; Trottier L, 2005, VISION RES, V45, P1349, DOI 10.1016/j.visres.2004.12.007; WEBENSMITH MG, 1991, EXPT BRAIN RES, V87, P218, DOI DOI 10.1007/BF00228523; Wells W, 2002, CRIMINOLOGY, V40, P265, DOI 10.1111/j.1745-9125.2002.tb00957.x	37	3	3	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81011	10.1371/journal.pone.0081011	http://dx.doi.org/10.1371/journal.pone.0081011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349028	Green Published, gold, Green Accepted			2022-12-27	WOS:000328730300018
J	Matilainen, K; Mantysaari, EA; Lidauer, MH; Stranden, I; Thompson, R				Matilainen, Kaarina; Mantysaari, Esa A.; Lidauer, Martin H.; Stranden, Ismo; Thompson, Robin			Employing a Monte Carlo Algorithm in Newton-Type Methods for Restricted Maximum Likelihood Estimation of Genetic Parameters	PLOS ONE			English	Article							LINEAR MIXED-MODEL; EM ALGORITHM; COMPONENT ESTIMATION; VARIANCE-COMPONENTS; AVERAGE INFORMATION; REML; ACCELERATION; MATRIX	Estimation of variance components by Monte Carlo (MC) expectation maximization (EM) restricted maximum likelihood (REML) is computationally efficient for large data sets and complex linear mixed effects models. However, efficiency may be lost due to the need for a large number of iterations of the EM algorithm. To decrease the computing time we explored the use of faster converging Newton-type algorithms within MC REML implementations. The implemented algorithms were: MC Newton-Raphson (NR), where the information matrix was generated via sampling; MC average information(AI), where the information was computed as an average of observed and expected information; and MC Broyden's method, where the zero of the gradient was searched using a quasi-Newton-type algorithm. Performance of these algorithms was evaluated using simulated data. The final estimates were in good agreement with corresponding analytical ones. MC NR REML and MC AI REML enhanced convergence compared to MC EM REML and gave standard errors for the estimates as a by-product. MC NR REML required a larger number of MC samples, while each MC AI REML iteration demanded extra solving of mixed model equations by the number of parameters to be estimated. MC Broyden's method required the largest number of MC samples with our small data and did not give standard errors for the parameters directly. We studied the performance of three different convergence criteria for the MC AI REML algorithm. Our results indicate the importance of defining a suitable convergence criterion and critical value in order to obtain an efficient Newton-type method utilizing a MC algorithm. Overall, use of a MC algorithm with Newton-type methods proved feasible and the results encourage testing of these methods with different kinds of large-scale problem settings.	[Matilainen, Kaarina; Mantysaari, Esa A.; Lidauer, Martin H.; Stranden, Ismo] MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen, Finland; [Thompson, Robin] Rothamsted Res, Biomath & Bioinformat Dept, Harpenden, Herts, England	Natural Resources Institute Finland (Luke); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research	Matilainen, K (corresponding author), MTT Agrifood Res Finland, Biotechnol & Food Res, Jokioinen, Finland.	kaarina.matilainen@mtt.fi	Strandén, Ismo/AAD-6351-2020	Strandén, Ismo/0000-0003-0161-2618; Lidauer, Martin/0000-0003-0508-9991; Thompson, Robin/0000-0003-3319-6938	Rothamsted Research; MTT Agrifood Research Finland	Rothamsted Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MTT Agrifood Research Finland	The study was funded by Rothamsted Research (URL: www.rothamsted.ac.uk) and MTT Agrifood Research Finland (URL: www.mtt.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Booth JG, 1999, J ROY STAT SOC B, V61, P265, DOI 10.1111/1467-9868.00176; Broyden C.G., 1965, MATH COMPUT, V19, P577, DOI [DOI 10.1090/S0025-5718-1965-0198670-6, 10.1090/s0025-5718-1965-0198670-6]; Garcia-Cortes LA, 2001, GENET SEL EVOL, V33, P443, DOI 10.1051/gse:2001106; GARCIACORTES LA, 1995, J ANIM BREED GENET, V112, P176, DOI 10.1111/j.1439-0388.1995.tb00556.x; GARCIACORTES LA, 1992, J ANIM BREED GENET, V109, P358, DOI 10.1111/j.1439-0388.1992.tb00415.x; Gauderman WJ, 2001, COMPUT STAT DATA AN, V35, P395, DOI 10.1016/S0167-9473(00)00021-9; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; GROENEVELD E, 1994, GENET SEL EVOL, V26, P537, DOI 10.1051/gse:19940605; Harville D, 2004, J STAT COMPUT SIM, V74, P135, DOI 10.1080/0094965031000110588; Jamshidian M, 1997, J ROY STAT SOC B MET, V59, P569, DOI 10.1111/1467-9868.00083; JAMSHIDIAN M, 1993, J AM STAT ASSOC, V88, P221, DOI 10.2307/2290716; Jensen J., 1997, J IND SOC AGR STAT, V49, P215; JOHNSON DL, 1995, J DAIRY SCI, V78, P449, DOI 10.3168/jds.S0022-0302(95)76654-1; Kuk AYC, 1997, J STAT COMPUT SIM, V59, P233, DOI 10.1080/00949657708811858; LOUIS TA, 1982, J ROY STAT SOC B MET, V44, P226; MANTYSAARI E, 1989, J ANIM BREED GENET, V106, P409, DOI 10.1111/j.1439-0388.1989.tb00259.x; Matilainen K, 2012, J ANIM BREED GENET, V129, P457, DOI 10.1111/j.1439-0388.2012.01000.x; Nocedal J, 2006, SPRINGER SER OPER RE, P1, DOI 10.1007/978-0-387-40065-5; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; R Core Team, 2012, R LANG ENV STAT COMP; WEI GCG, 1990, J AM STAT ASSOC, V85, P699, DOI 10.2307/2290005	22	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e80821	10.1371/journal.pone.0080821	http://dx.doi.org/10.1371/journal.pone.0080821			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339886	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400008
J	Sadsad, R; Sintchenko, V; McDonnell, GD; Gilbert, GL				Sadsad, Rosemarie; Sintchenko, Vitali; McDonnell, Geoff D.; Gilbert, Gwendolyn L.			Effectiveness of Hospital-Wide Methicillin-Resistant Staphylococcus aureus (MRSA) Infection Control Policies Differs by Ward Specialty	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; TRANSMISSION DYNAMICS; NOSOCOMIAL INFECTIONS; RISK-FACTORS; COMMUNITY; MODEL; COLONIZATION; BACTEREMIA; SIMULATION; IMPACT	Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of preventable nosocomial infections and is endemic in hospitals worldwide. The effectiveness of infection control policies varies significantly across hospital settings. The impact of the hospital context towards the rate of nosocomial MRSA infections and the success of infection control is understudied. We conducted a modelling study to evaluate several infection control policies in surgical, intensive care, and medical ward specialties, each with distinct ward conditions and policies, of a tertiary public hospital in Sydney, Australia. We reconfirm hand hygiene as the most successful policy and find it to be necessary for the success of other policies. Active screening for MRSA, patient isolation in single-bed rooms, and additional staffing were found to be less effective. Across these ward specialties, MRSA transmission risk varied by 13% and reductions in the prevalence and nosocomial incidence rate of MRSA due to infection control policies varied by up to 45%. Different levels of infection control were required to reduce and control nosocomial MRSA infections for each ward specialty. Infection control policies and policy targets should be specific for the ward and context of the hospital. The model we developed is generic and can be calibrated to represent different ward settings and pathogens transmitted between patients indirectly through health care workers. This can aid the timely and cost effective design of synergistic and context specific infection control policies.	[Sadsad, Rosemarie; Sintchenko, Vitali; Gilbert, Gwendolyn L.] Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW, Australia; [Sadsad, Rosemarie; Sintchenko, Vitali; McDonnell, Geoff D.] Univ New S Wales, Australian Inst Hlth Innovat, Ctr Hlth Informat, Sydney, NSW, Australia; [Sadsad, Rosemarie; Sintchenko, Vitali; Gilbert, Gwendolyn L.] Univ Sydney, Sydney Med Sch Westmead, Sydney, NSW 2006, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney	Sadsad, R (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Publ Hlth, Sydney, NSW, Australia.	r.sadsad@unswalumni.com	Gilbert, Gwendolyn/B-7733-2013	Gilbert, Gwendolyn/0000-0001-7490-6727; Sadsad, Rosemarie/0000-0003-2488-953X; Sintchenko, Vitali/0000-0002-9261-3650	HCF Health and Medical Research Foundation	HCF Health and Medical Research Foundation	Rosemarie Sadsad was supported by a PhD research scholarship from the HCF Health and Medical Research Foundation (http://www.hcf.com.au/about-us/hcf-foundation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1999, J INFECT DIS, V179, P883, DOI 10.1086/314682; Austin DJ, 2002, INFECT CONTROL ICU E, P245; Axelrod R., 2011, ON LINE GUIDE NEWCOM; BARLAS Y, 1989, EUR J OPER RES, V42, P59, DOI 10.1016/0377-2217(89)90059-3; Barnes S, 2010, INFORMS J COMPUT, V22, P635, DOI 10.1287/ijoc.1100.0386; Beggs CB, 2006, AM J INFECT CONTROL, V34, P621, DOI 10.1016/j.ajic.2006.06.011; Beggs CB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-64; Bonten MJM, 2010, STAT BIOL HEALTH, P395, DOI 10.1007/978-0-387-93835-6_22; Bonten MJM, 2001, CLIN INFECT DIS, V33, P1739, DOI 10.1086/323761; Bootsma MCJ, 2006, P NATL ACAD SCI USA, V103, P5620, DOI 10.1073/pnas.0510077103; BOYCE JM, 1994, INFECT CONT HOSP EP, V15, P105; Brailsford SC, DISCRETE EVENT SIMUL; Carley KM, 1996, VALIDATING COMPUTATI, V0793, P1; Centers for Disease Control and Prevention, 2010, DEF MRSA; Cohen P, 2012, INFECT CONTROL UPDAT; Collignon P, 2005, EMERG INFECT DIS, V11, P554, DOI 10.3201/eid1104.040772; Cooper BS, 1999, J HOSP INFECT, V43, P131, DOI 10.1053/jhin.1998.0647; Cooper BS, 2004, P NATL ACAD SCI USA, V101, P10223, DOI 10.1073/pnas.0401324101; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; Cosgrove SE, 2005, INFECT CONT HOSP EP, V26, P166, DOI 10.1086/502522; D'Agata EMC, 2009, CLIN INFECT DIS, V48, P274, DOI 10.1086/595844; Diekema DJ, 2007, CLIN INFECT DIS, V44, P1101, DOI 10.1086/512820; Ducel G, 2002, PREVENTION HOSP ACQU, V2nd; Duguid M, 2011, ANTIMICROBIAL STEWAR; Epstein J.M., 1996, GROWING ARTIFICIAL S; Forrester J.W., 1961, IND DYNAMICS; Forrester M, 2005, INFECT CONT HOSP EP, V26, P598, DOI 10.1086/502588; Fu MC, 2005, PROCEEDINGS OF THE 2005 WINTER SIMULATION CONFERENCE, VOLS 1-4, P83, DOI 10.1109/WSC.2005.1574242; Girou E, 2002, BRIT MED J, V325, P362, DOI 10.1136/bmj.325.7360.362; Glover F, 2000, CONTROL CYBERN, V29, P653; Grundmann H, 2006, LANCET INFECT DIS, V6, P39, DOI 10.1016/S1473-3099(05)70325-X; Grundmann H, 2002, J INFECT DIS, V185, P481, DOI 10.1086/338568; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412; Hubben G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014783; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Macdonald G., 1957, EPIDEMIOLOGY CONTROL; McBryde ES, 2007, J THEOR BIOL, V245, P470, DOI 10.1016/j.jtbi.2006.11.008; McBryde ES, 2004, J HOSP INFECT, V58, P104, DOI 10.1016/j.jhin.2004.06.010; Morgan MG., 1992, UNCERTAINTY GUIDE DE; Pressley J, 2010, J THEOR BIOL, V264, P645, DOI 10.1016/j.jtbi.2010.03.036; Productivity Commission, 2009, HOSP ACQ INF, P123; Raboud J, 2005, INFECT CONT HOSP EP, V26, P607, DOI 10.1086/502589; Robotham JV, 2007, EPIDEMIOL INFECT, V135, P328, DOI 10.1017/S095026880600687X; Ross R, 1910, INT J NURS PRACT; Sadsad R, 2013, HOSP ACQUIRED INFECT; Sadsad R, DISCRETE EV IN PRESS; Scanvic A, 2001, CLIN INFECT DIS, V32, P1393, DOI 10.1086/320151; Sebille V, 1997, COMPUT BIOMED RES, V30, P307, DOI 10.1006/cbmr.1997.1451; Temime L, 2009, P NATL ACAD SCI USA, V106, P18420, DOI 10.1073/pnas.0900974106; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Ueno T, 2008, J THEOR BIOL, V254, P655, DOI 10.1016/j.jtbi.2008.07.001; VOSS A, 1995, INT J ANTIMICROB AG, V5, P101, DOI 10.1016/0924-8579(94)00036-T; World Health Organization, 2009, WHO GUID HAND HYG HL	54	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83099	10.1371/journal.pone.0083099	http://dx.doi.org/10.1371/journal.pone.0083099			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340085	gold, Green Submitted, Green Published			2022-12-27	WOS:000328707400120
J	Tan, CQ; Peng, LB; Zeng, XH; Li, JH; Wan, XM; Chen, GN; Yi, LD; Luo, X; Zhao, ZY				Tan, Chongqing; Peng, Liubao; Zeng, Xiaohui; Li, Jianhe; Wan, Xiaomin; Chen, Gannong; Yi, Lidan; Luo, Xia; Zhao, Ziying			Economic Evaluation of First-Line Adjuvant Chemotherapies for Resectable Gastric Cancer Patients in China	PLOS ONE			English	Article							MULTICENTER PHASE-II; S-1 PLUS CISPLATIN; ORAL FLUOROPYRIMIDINE; CAPECITABINE; OXALIPLATIN; TRIAL; ADENOCARCINOMA; GASTRECTOMY; THERAPY	Background: First-line postoperative adjuvant chemotherapies with S-1 and capecitabine and oxaliplatin (XELOX) were first recommended for resectable gastric cancer patients in the 2010 and 2011 Chinese NCCN Clinical Practice Guidelines in Oncology: Gastric Cancer; however, their economic impact in China is unknown. Objective: The aim of this study was to compare the cost-effectiveness of adjuvant chemotherapy with XELOX, with S-1 and no treatment after a gastrectomy with extended (D2) lymph-node dissection among patients with stage II-IIIB gastric cancer. Methods: A Markov model, based on data from two clinical phase III trials, was developed to analyse the cost-effectiveness of patients in the XELOX group, S-1 group and surgery only (SO) group. The costs were estimated from the perspective of Chinese healthcare system. The utilities were assumed on the basis of previously published reports. Costs, quality-adjusted life-years (QALYs) and incremental cost-effectiveness ratios (ICER) were calculated with a lifetime horizon. One-way and probabilistic sensitivity analyses were performed. Results: For the base case, XELOX had the lowest total cost ($44,568) and cost-effectiveness ratio ($7,360/QALY). The relative scenario analyses showed that SO was dominated by XELOX and the ICERs of S-1 was $58,843/QALY compared with XELOX. The one-way sensitivity analysis showed that the most influential parameter was the utility of disease-free survival. The probabilistic sensitivity analysis predicted a 75.8% likelihood that the ICER for XELOX would be less than $13,527 compared with S-1. When ICER was more than $38,000, the likelihood of cost-effectiveness achieved by S-1 group was greater than 50%. Conclusions: Our results suggest that for patients in China with resectable disease, first-line adjuvant chemotherapy with XELOX after a D2 gastrectomy is a best option comparing with S-1 and SO in view of our current study. In addition, S-1 might be a better choice, especially with a higher value of willingness-to-pay threshold.	[Tan, Chongqing; Peng, Liubao; Li, Jianhe; Wan, Xiaomin; Yi, Lidan] Cent S Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China; [Tan, Chongqing; Peng, Liubao; Li, Jianhe; Wan, Xiaomin; Yi, Lidan; Luo, Xia; Zhao, Ziying] Cent S Univ, Sch Pharmaceut Sci, Changsha, Hunan, Peoples R China; [Zeng, Xiaohui] Cent S Univ, Xiangya Hosp 2, PET CT Ctr, Changsha, Hunan, Peoples R China; [Chen, Gannong] Cent S Univ, Xiangya Hosp 2, Dept Surg, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University	Peng, LB (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Pharm, Changsha, Hunan, Peoples R China.	pengliubao@126.com	Wan, Xiaomin/GPX-4388-2022	/0000-0001-5315-8141	National Natural Science Foundation of China [81173028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The manuscript was supported by a grant from the National Natural Science Foundation of China (No. 81173028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2006, J CLIN ONCOL, V24, P663, DOI 10.1200/JCO.2005.04.2994; [Anonymous], 2007, RITUXMIAB TREATMENT; [Anonymous], 2010, GROSS DOMESTIC PRODU; Bang YJ, 2012, LANCET, V379, P315, DOI 10.1016/S0140-6736(11)61873-4; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; China Center for Health Economic Research, CHIN GUID PHARM EV V; [寸晓乐 Cun Xiaole], 2010, [中国公共卫生, China Public Health], V26, P703; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Dong NN, 2009, AM J CLIN ONCOL-CANC, V32, P559, DOI 10.1097/COC.0b013e3181967db3; Gockel I, 2005, CHIRURG, V76, P250, DOI 10.1007/s00104-004-0950-5; Guangzhou, 2010, REPORT ANTITUMOR ANT; Hoyle M, 2010, VALUE HEALTH, V13, P61, DOI 10.1111/j.1524-4733.2009.00617.x; Hu Bing, 2012, CHINESE MED, V30, P280; International Agency for Research on Cancer, 2008, STOM CANC IND MORT P; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI 10.1016/S1470-2045(08)70035-4; Kubota T, 2008, BRIT J CANCER, V98, P1301, DOI 10.1038/sj.bjc.6604332; Liu CY, 2008, ANTI-CANCER DRUG, V19, P825, DOI 10.1097/CAD.0b013e32830c457e; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; National Comprehensive Cancer Network (NCCN), 2010, NCCN CLIN PRACT GUID, V2; NCCN, 2019, NCCN CLIN PRACTICE G; Paoletti X, 2010, JAMA-J AM MED ASSOC, V303, P1729, DOI 10.1001/jama.2010.534; Park YH, 2008, CANCER CHEMOTH PHARM, V61, P623, DOI 10.1007/s00280-007-0515-7; Peng LB, 2009, PHARMACOECONOMICS, V27, P873, DOI 10.2165/11314750-000000000-00000; Sakamaki H., 2009, OPEN HLTH SERV POLIC, V2, P26, DOI [10.2174/1874924000902010026, DOI 10.2174/1874924000902010026]; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sasako M, 2011, J CLIN ONCOL, V29, P4387, DOI 10.1200/JCO.2011.36.5908; Shen Jinfang, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032530, DOI 10.1371/JOURNAL.PONE.0032530]; ShuPeng, 2011, GANSU J TCM, V24, P76; Tong Zong-pei, 2011, J ANHUI TCM COLL, V30, P30; Wilson D, 2005, CLIN ONCOL-UK, V17, P81, DOI 10.1016/j.clon.2004.10.006; Wu B, 2012, CLIN THER, V34, P468, DOI 10.1016/j.clinthera.2012.01.012	31	8	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83396	10.1371/journal.pone.0083396	http://dx.doi.org/10.1371/journal.pone.0083396			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340099	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400132
J	Cardelli, M; Zirngibl, RA; Boetto, JF; McKenzie, KP; Troy, TC; Turksen, K; Aubin, JE				Cardelli, Marco; Zirngibl, Ralph A.; Boetto, Jonathan F.; McKenzie, Kristen P.; Troy, Tammy-Claire; Turksen, Kursad; Aubin, Jane E.			Cartilage-Specific Overexpression of ERR gamma Results in Chondrodysplasia and Reduced Chondrocyte Proliferation	PLOS ONE			English	Article							ESTROGEN-RELATED RECEPTOR; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; ENDOCHONDRAL BONE-FORMATION; ORPHAN NUCLEAR RECEPTORS; LIGAND-BINDING DOMAIN; EMBRYONIC STEM-CELLS; INDIAN-HEDGEHOG; TRANSGENIC MICE; GROWTH-PLATE; ALPHA	While the role of estrogen receptor-related receptor alpha (ERR alpha) in chondrogenesis has been investigated, the involvement of ERR gamma (ERR gamma) has not been determined. To assess the effect of increased ERR gamma activity on cartilage development in vivo, we generated two transgenic (Tg) lines overexpressing ERR gamma 2 via a chondrocyte-specific promoter; the two lines exhibited similar to 3 and similar to 5 fold increased ERR gamma 2 protein expression respectively in E14.5 Tg versus wild type (WT) limbs. On postnatal day seven (P7), we observed a 4-10% reduction in the size of the craniofacial, axial and appendicular skeletons in Tg versus WT mice. The reduction in bone length was already present at birth and did not appear to involve bones that are derived via intramembranous bone formation as the bones of the calvaria, clavicle, and the mandible developed normally. Histological analysis of P7 growth plates revealed a reduction in the length of the Tg versus WT growth plate, the majority of which was attributable to a reduced proliferative zone. The reduced proliferative zone paralleled a decrease in the number of Ki67-positive proliferating cells, with no significant change in apoptosis, and was accompanied by large cell-free swaths of cartilage matrix, which extended through multiple zones of the growth plate. Using a bioinformatics approach, we identified known chondrogenesis-associated genes with at least one predicted ERR binding site in their proximal promoters, as well as cell cycle regulators known to be regulated by ERR gamma. Of the genes identified, Col2al, Agg, Pth1r, and Cdkn1b (p27) were significantly upregulated, suggesting that ERR gamma 2 negatively regulates chondrocyte proliferation and positively regulates matrix synthesis to coordinate growth plate height and organization.	[Cardelli, Marco; Aubin, Jane E.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Zirngibl, Ralph A.; Boetto, Jonathan F.; McKenzie, Kristen P.; Aubin, Jane E.] Univ Toronto, Dept Med Genet, Toronto, ON, Canada; [Troy, Tammy-Claire; Turksen, Kursad] Ottawa Hosp Res Inst, Regenerat Med Program, Sprott Ctr Stem Cell Res, Ottawa, ON, Canada	University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Aubin, JE (corresponding author), Univ Toronto, Dept Med Biophys, Toronto, ON, Canada.	jane.aubin@utoronto.ca	Zirngibl, Ralph/AHB-0565-2022	Aubin, Jane E./0000-0002-7268-5235	Canadian Institutes of Health Research (CIHR) [FRN 88104]; Doctoral Research Award; Canadian Arthritis Network operating grant; CIHR/Osteoporosis Society fellowship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Doctoral Research Award; Canadian Arthritis Network operating grant; CIHR/Osteoporosis Society fellowship	This work was supported by a Canadian Institutes of Health Research (CIHR) operating grant (FRN 88104, JEA) and a Doctoral Research Award (MC); a Canadian Arthritis Network operating grant (JEA) and postdoctoral fellowship (RAZ), and a CIHR/Osteoporosis Society fellowship (RAZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Amano K, 2008, J BIOL CHEM, V283, P29513, DOI 10.1074/jbc.M803681200; Aszodi A, 2003, GENE DEV, V17, P2465, DOI 10.1101/gad.277003; Blumbach K, 2008, MATRIX BIOL, V27, P306, DOI 10.1016/j.matbio.2007.11.007; Bonnelye E, 2008, RHEUMATOLOGY, V47, P1785, DOI 10.1093/rheumatology/ken368; Bonnelye E, 2007, ENDOCRINOLOGY, V148, P1195, DOI 10.1210/en.2006-0962; Bonnelye E, 2013, J BONE MINER RES, V28, P225, DOI 10.1002/jbmr.1836; Bonnelye E, 2011, ARTHRITIS RHEUM-US, V63, P2374, DOI 10.1002/art.30398; Bonnelye E, 2010, J MOL ENDOCRINOL, V45, P365, DOI 10.1677/JME-10-0024; Borjesson AE, 2010, J BONE MINER RES, V25, P2414, DOI 10.1002/jbmr.156; Day TF, 2008, J BONE JOINT SURG AM, V90A, P19, DOI 10.2106/JBJS.G.01174; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Elfassihi L, 2010, J BONE MINER RES, V25, P901, DOI 10.1359/jbmr.091014; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618; Huppunen J, 2004, BIOCHEM BIOPH RES CO, V314, P964, DOI 10.1016/j.bbrc.2003.12.194; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ikeda K, 2012, BIOCHEM BIOPH RES CO, V425, P912, DOI 10.1016/j.bbrc.2012.07.170; Jeong BC, 2009, J BIOL CHEM, V284, P14211, DOI 10.1074/jbc.M808345200; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102; Kawato Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034703; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Maeda Y, 2007, P NATL ACAD SCI USA, V104, P6382, DOI 10.1073/pnas.0608449104; Mirski SEL, 1997, EXP CELL RES, V237, P452, DOI 10.1006/excr.1997.3805; Naski M C, 1998, Front Biosci, V3, pd781; Naski MC, 1998, DEVELOPMENT, V125, P4977; PARR BA, 1995, NATURE, V374, P350, DOI 10.1038/374350a0; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; ROSSERT J, 1995, J CELL BIOL, V129, P1421, DOI 10.1083/jcb.129.5.1421; Schipani E, 1997, P NATL ACAD SCI USA, V94, P13689, DOI 10.1073/pnas.94.25.13689; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Tsuda M, 2003, J BIOL CHEM, V278, P27224, DOI 10.1074/jbc.M303471200; Turksen K, 2002, DEVELOPMENT, V129, P1775; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; ZHOU G, 1995, J CELL SCI, V108, P3677	46	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81511	10.1371/journal.pone.0081511	http://dx.doi.org/10.1371/journal.pone.0081511			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349082	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200032
J	Sasikala-Appukuttan, AK; Kim, HO; Kinzel, NJ; Hong, JJ; Smith, AJ; Wagstaff, R; Reilly, C; Piatak, M; Lifson, JD; Reeves, RK; Johnson, RP; Haase, AT; Skinner, PJ				Sasikala-Appukuttan, Arun K.; Kim, Hyeon O.; Kinzel, Nikilyn J.; Hong, Jung Joo; Smith, Anthony J.; Wagstaff, Reece; Reilly, Cavan; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Reeves, R. Keith; Johnson, R. Paul; Haase, Ashley T.; Skinner, Pamela J.			Location and Dynamics of the Immunodominant CD8 T Cell Response to SIV Delta nef Immunization and SIVmac251 Vaginal Challenge	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; HIGHLY PATHOGENIC SIV; CONTROL REPLICATION; VACCINE PROTECTION; LIVE; ACQUISITION; INFECTION; EPITOPES; CERVIX	Live-attenuated SIV vaccines (LAVs) have been the most effective to date in preventing or partially controlling infection by wild-type SIV in non-human primate models of HIV-1 transmission to women acting by mechanisms of protection that are not well understood. To gain insights into mechanisms of protection by LAVs that could aid development of effective vaccines to prevent HIV-1 transmission to women, we used in situ tetramer staining to determine whether increased densities or changes in the local distribution of SIV-specific CD8 T cells correlated with the maturation of SIV Delta nef vaccine-induced protection prior to and after intra-vaginal challenge with wild-type SIVmac251. We evaluated the immunodominant Mamu-A1*001:01/Gag (CM9) and Mamu-A1*001:01/Tat (SL8) epitope response in genital and lymphoid tissues, and found that tetramer+ cells were present at all time points examined. In the cervical vaginal tissues, most tetramer+ cells were distributed diffusely throughout the lamina propria or co-localized with other CD8 T cells within lymphoid aggregates. The distribution and densities of the tetramer+ cells at the portal of entry did not correlate with the maturation of protection or change after challenge. Given these findings, we discuss the possibility that changes in other aspects of the immune system, including the quality of the resident population of virus-specific effector CD8 T cells could contribute to maturation of protection, as well as the potential for vaccine strategies that further increase the size and quality of this effector population to prevent HIV-1 transmission.	[Sasikala-Appukuttan, Arun K.; Kim, Hyeon O.; Kinzel, Nikilyn J.; Hong, Jung Joo; Wagstaff, Reece; Skinner, Pamela J.] Univ Minnesota, Vet & Biomed Sci Dept, St Paul, MN 55108 USA; [Smith, Anthony J.; Haase, Ashley T.] Univ Minnesota, Dept Microbiol, St Paul, MN USA; [Reilly, Cavan] Univ Minnesota, Sch Publ Hlth, Div Biostat, St Paul, MN 55108 USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomedical Res Inc, Frederick Natl Lab, AIDS & Canc Virus Program, Frederick, MD USA; [Reeves, R. Keith; Johnson, R. Paul] Harvard Univ, Sch Med, Div Immunol, New England Primate Res Ctr, Southborough, MA 01772 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University	Skinner, PJ (corresponding author), Univ Minnesota, Vet & Biomed Sci Dept, St Paul, MN 55108 USA.	skinn002@umn.edu		Skinner, Pamela/0000-0003-3388-1687	International AIDS Vaccine Initiative, NIH [AI080418]; National Cancer Institute, National Institutes of Health (NIH) [HHSN261200800001E]; National Center for Research Resources [P51 RR00168]; Office of Research Infrastructure Programs [P51 OD011103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI080418] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011103] Funding Source: NIH RePORTER	International AIDS Vaccine Initiative, NIH; National Cancer Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the International AIDS Vaccine Initiative, NIH grant AI080418, in part with federal funds from the National Cancer Institute, National Institutes of Health (NIH), under contract HHSN261200800001E (J.D.L.), by the National Center for Research Resources P51 RR00168, and is currently supported by the Office of Research Infrastructure Programs P51 OD011103. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services or NIH, nor does mention of trade names, commercial products, or organizations imply endorsement by the U. S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, GLOB REP UNAIDS REP; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bilello JP, 2011, J VIROL, V85, P12708, DOI 10.1128/JVI.00865-11; Connor RI, 1998, J VIROL, V72, P7501, DOI 10.1128/JVI.72.9.7501-7509.1998; Corey L, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001863; DANIEL MD, 1992, SCIENCE, V258, P1938, DOI 10.1126/science.1470917; de Groot NG, 2012, IMMUNOGENETICS, V64, P615, DOI 10.1007/s00251-012-0617-1; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; Genesca M, 2008, MUCOSAL IMMUNOL, V1, P219, DOI 10.1038/mi.2008.6; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hong JJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004131; Johansson EL, 1999, IMMUNOLOGY, V96, P272; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Johnson RP, 1999, NAT MED, V5, P154, DOI 10.1038/5515; Johnson RP, 1998, CURR OPIN IMMUNOL, V10, P436, DOI 10.1016/S0952-7915(98)80118-0; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Manrique M, 2011, J IMMUNOL, V186, P3581, DOI 10.4049/jimmunol.1002594; MILLER CJ, 1992, LAB INVEST, V67, P628; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Mothe BR, 2002, J VIROL, V76, P875, DOI 10.1128/JVI.76.2.875-884.2002; Mudd PA, 2012, NATURE, V491, P129, DOI 10.1038/nature11443; Patel V, 2013, P NATL ACAD SCI USA, V110, P2975, DOI 10.1073/pnas.1215393110; Quinn TC, 2005, SCIENCE, V308, P1582, DOI 10.1126/science.1112489; Reynolds MR, 2008, J EXP MED, V205, P2537, DOI 10.1084/jem.20081524; Reynolds MR, 2010, J VIROL, V84, P9190, DOI 10.1128/JVI.00041-10; Reynolds MR, 2005, J VIROL, V79, P9228, DOI 10.1128/JVI.79.14.9228-9235.2005; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Skinner PJ, 2000, J IMMUNOL, V165, P613, DOI 10.4049/jimmunol.165.2.613; SKINNER PJ, 2005, CURR PROTOC IMMUNOL, pCH17; Tenner-Racz K, 2004, P NATL ACAD SCI USA, V101, P3017, DOI 10.1073/pnas.0308677101; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999	34	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81623	10.1371/journal.pone.0081623	http://dx.doi.org/10.1371/journal.pone.0081623			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349100	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200039
J	Lambrechts, A; Walsh, V; van Wassenhove, V				Lambrechts, Anna; Walsh, Vincent; van Wassenhove, Virginie			Evidence Accumulation in the Magnitude System	PLOS ONE			English	Article							TIME; SPACE; NUMBER; REPRESENTATION; JUDGMENTS; ATTENTION; DURATION; INTERFERENCE; INTEGRATION; COGNITION	Perceptual interferences in the estimation of quantities (time, space and numbers) have been interpreted as evidence for a common magnitude system. However, if duration estimation has appears sensitive to spatial and numerical interferences, space and number estimation tend to be resilient to temporal manipulations. These observations question the relative contribution of each quantity in the elaboration of a representation in a common mental metric. Here, we elaborated a task in which perceptual evidence accumulated over time for all tested quantities (space, time and number) in order to match the natural requirement for building a duration percept. For this, we used a bisection task. Experimental trials consisted of dynamic dots of different sizes appearing progressively on the screen. Participants were asked to judge the duration, the cumulative surface or the number of dots in the display while the two non-target dimensions varied independently. In a prospective experiment, participants were informed before the trial which dimension was the target; in a retrospective experiment, participants had to attend to all dimensions and were informed only after a given trial which dimension was the target. Surprisingly, we found that duration was resilient to spatial and numerical interferences whereas space and number estimation were affected by time. Specifically, and counter-intuitively, results revealed that longer durations lead to smaller number and space estimates whether participants knew before (prospectively) or after (retrospectively) a given trial which quantity they had to estimate. Altogether, our results support a magnitude system in which perceptual evidence for time, space and numbers integrate following Bayesian cue-combination rules.	[Lambrechts, Anna] City Univ London, Dept Psychol, London EC1V 0HB, England; [Lambrechts, Anna; Walsh, Vincent] UCL, Inst Cognit Neurosci, London, England; [Lambrechts, Anna; van Wassenhove, Virginie] INSERM, Cognit Neuroimaging Unit, U992, Gif Sur Yvette, France; [Lambrechts, Anna; van Wassenhove, Virginie] CEA, DSV I2BM, NeuroSpin Ctr, Gif Sur Yvette, France; [Lambrechts, Anna; van Wassenhove, Virginie] Univ Paris 11, Gif Sur Yvette, France	City University London; University of London; University College London; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	van Wassenhove, V (corresponding author), INSERM, Cognit Neuroimaging Unit, U992, Gif Sur Yvette, France.	Virginie.van.Wassenhove@gmail.com	van Wassenhove, Virginie/F-4129-2010	van Wassenhove, Virginie/0000-0002-2569-5502; Lambrechts, Anna/0000-0002-0497-1475	Agence Nationale pour la Recherche [1904]; European Research Council [263854]	Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	This work was funded by an Agence Nationale pour la Recherche 2010 Jeunes Chercheurs Jeunes Chercheuses-1904 and a European Research Council Starting Grant 263854 granted to V.v.W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; ALLAN LG, 1991, LEARN MOTIV, V22, P39, DOI 10.1016/0023-9690(91)90016-2; Block RA, 1997, PSYCHON B REV, V4, P184, DOI 10.3758/BF03209393; Block RA, 2010, ACTA PSYCHOL, V134, P330, DOI 10.1016/j.actpsy.2010.03.006; Bottini R, 2010, COGNITION IN FLUX, P1348; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bresciani JP, 2007, NEUROREPORT, V18, P1157, DOI 10.1097/WNR.0b013e3281ace0ca; BROWN SW, 1985, PERCEPT PSYCHOPHYS, V38, P115, DOI 10.3758/BF03198848; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2010, COGNITIVE SCI, V34, P387, DOI 10.1111/j.1551-6709.2010.01094.x; Casini L, 1997, MEM COGNITION, V25, P812, DOI 10.3758/BF03211325; Chang AYC, 2011, PSYCHOL SCI, V22, P1567, DOI 10.1177/0956797611418837; Cheng K, 2007, PSYCHOL BULL, V133, P625, DOI 10.1037/0033-2909.133.4.625; Cicchini GM, 2012, J NEUROSCI, V32, P1056, DOI 10.1523/JNEUROSCI.3411-11.2012; Coull JT, 2004, SCIENCE, V303, P1506, DOI 10.1126/science.1091573; Dehaene S, 2004, CURR OPIN NEUROBIOL, V14, P218, DOI 10.1016/j.conb.2004.03.008; Dehaene S, 1998, SPRING, V21, P670; Dehaene S, 2010, TRENDS COGN SCI, V14, P517, DOI 10.1016/j.tics.2010.09.009; Dormal V, 2006, ACTA PSYCHOL, V121, P109, DOI 10.1016/j.actpsy.2005.06.003; Dormal V, 2007, EXP PSYCHOL, V54, P289, DOI 10.1027/1618-3169.54.4.289; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fruend I, 2011, J VISION, V11, DOI 10.1167/11.6.16; Gallistel CR, 2011, ATTENTION PERFORM, P3, DOI 10.1016/B978-0-12-385948-8.00001-3; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; GALLISTEL CR, 1989, ANNU REV PSYCHOL, V40, P155, DOI 10.1146/annurev.ps.40.020189.001103; Gepshtein S, 2003, CURR BIOL, V13, P483, DOI 10.1016/S0960-9822(03)00133-7; Javadi AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054098; Javadi AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041496; Kersten D, 2003, CURR OPIN NEUROBIOL, V13, P150, DOI 10.1016/S0959-4388(03)00042-4; Kleiner M., 2007, WHATS NEW PSYCHTOOLB; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Lakoff G., 1993, METAPHOR THOUGHT, V2nd; Lakoff G., 1999, PHILOS FLESH; Lourenco SF, 2012, P NATL ACAD SCI USA, V109, P18737, DOI 10.1073/pnas.1207212109; Macar F, 2002, ACTA PSYCHOL, V111, P243, DOI 10.1016/S0001-6918(02)00052-5; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Merritt DJ, 2010, COGNITION, V117, P191, DOI 10.1016/j.cognition.2010.08.011; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Oliveri M, 2008, NEUROSCI LETT, V438, P308, DOI 10.1016/j.neulet.2008.04.051; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Roitman JD, 2007, ACTA PSYCHOL, V124, P296, DOI 10.1016/j.actpsy.2006.03.008; van Wassenhove V, 2009, PHILOS T R SOC B, V364, P1815, DOI 10.1098/rstb.2009.0023; Volet SD, 2008, Q J EXP PSYCHOL, V61, P1827, DOI 10.1080/17470210701743643; Wackermann J, 2006, J THEOR BIOL, V239, P482, DOI 10.1016/j.jtbi.2005.08.024; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Xuan B, 2007, J VISION, V7, DOI 10.1167/7.10.2; Xuan B, 2009, BRAIN RES, V1269, P135, DOI 10.1016/j.brainres.2009.03.016	49	40	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82122	10.1371/journal.pone.0082122	http://dx.doi.org/10.1371/journal.pone.0082122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24339998	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000328566100087
J	Tervo, CJ; Reed, JL				Tervo, Christopher J.; Reed, Jennifer L.			BioMog: A Computational Framework for the De Novo Generation or Modification of Essential Biomass Components	PLOS ONE			English	Article							RECONSTRUCTION; GENES	The success of genome-scale metabolic modeling is contingent on a model's ability to accurately predict growth and metabolic behaviors. To date little focus has been directed towards developing systematic methods of proposing modifying and interrogating an organism's biomass requirements that are used in constraint-based models. To address this gap, the biomass modification and generation (BioMog) framework was created and used to generate lists of biomass components de novo, as well as to modify predefined biomass component lists for models of Escherichia coli (iJO1366) and of Shewanella oneidenst (iSO783) from high-throughput growth phenotype an d datasets. BioMog's de novo biomass component lists included, either implicitly or explicitly, up to seventy percent of the components included in the predefined biomass equations, and the resLilting de 1701M biomass equations outperformed he predefined biomass equations at qualitatively predicting mutant growth phenotypes by up to five percent. Additionally, the BioNlog procedure can quantify how many experiments support or refute a particular metabolite's essentiality to a f cell, and it facilitates the determination of inconsistent experiments and inaccurate reaction and/or gene to reaction associations. To further interrogate metabolite essentiality, the BioMog framework includes an experiment generation alaorithm that allows or the design of xperiment to test whether a metabolite is essential. Using BloMog we correct experimental results relating o h essentiality of thyA gene in E. coli well as perform knockout experiments supporting the essentiality of protoheme. With these capabilities, Mog can be a valuable resource for analyzing growth phenotyping data and component of a model developer's toolbox.	[Tervo, Christopher J.; Reed, Jennifer L.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison	Reed, JL (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53715 USA.	reed@engr.wisc.edu	Reed, Jennifer L/E-5137-2011	Reed, Jennifer L/0000-0001-7854-6220	NHGRI [T32HG002760]; NSF [NSF 1053712]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1053712] Funding Source: National Science Foundation	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	CT is supported by an NHGRI training grant to the Genomic Sciences Training Program (T32HG002760). Additional support for this research was provided by a grant from the NSF (NSF 1053712). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2012, P NATL ACAD SCI USA, V109, P17406, DOI 10.1073/pnas.1207028109; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barua D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000970; Copeland WB, 2012, METAB ENG, V14, P270, DOI 10.1016/j.ymben.2012.03.001; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deutschbauer A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002385; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Joyce AR, 2006, J BACTERIOL, V188, P8259, DOI 10.1128/JB.00740-06; Kim HU, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.115; Kim TY, 2010, METAB ENG, V12, P105, DOI 10.1016/j.ymben.2009.05.004; Kumar VS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-212; KUMAR VS, 2009, PLOS COMPUT BIOL, V5, DOI DOI 10.1371/JOURNAL.PCBI.1000308; Lee DS, 2009, J BACTERIOL, V191, P4015, DOI 10.1128/JB.01743-08; Oh J, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq419; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Pinchuk GE, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000822; Reed JL, 2006, P NATL ACAD SCI USA, V103, P17480, DOI 10.1073/pnas.0603364103; Sigurdsson G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034337; Tervo CJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r116; Thomason Lynn, 2007, Curr Protoc Mol Biol, VChapter 1, DOI 10.1002/0471142727.mb0117s79; Vitkin E, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r111; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Warner JR, 2010, NAT BIOTECHNOL, V28, P856, DOI 10.1038/nbt.1653; Weiss B, 2007, J BACTERIOL, V189, P2186, DOI 10.1128/JB.01645-06; Wiechert W, 2001, METAB ENG, V3, P195, DOI 10.1006/mben.2001.0187; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81322	10.1371/journal.pone.0081322	http://dx.doi.org/10.1371/journal.pone.0081322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339916	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100048
J	Xu, X; Ball, L; Chen, WY; Tian, XL; Lambrecht, A; Hanna, M; Xiao, W				Xu, Xin; Ball, Lindsay; Chen, Wangyang; Tian, Xuelei; Lambrecht, Amanda; Hanna, Michelle; Xiao, Wei			The Yeast Shu Complex Utilizes Homologous Recombination Machinery for Error-free Lesion Bypass via Physical Interaction with a Rad51 Paralogue	PLOS ONE			English	Article							FREE POSTREPLICATION REPAIR; DNA-DAMAGE TOLERANCE; REPLICATION PROTEIN-A; SACCHAROMYCES-CEREVISIAE; INDUCED MUTAGENESIS; ULTRAVIOLET-LIGHT; STRAND EXCHANGE; SRS2; PATHWAY; PCNA	DNA-damage tolerance (DDT) is defined as a mechanism by which eukaryotic cells resume DNA synthesis to fill the single stranded DNA gaps left by replication-blocking lesions. Eukaryotic cells employ two different means of DDT, namely translesion DNA synthesis (TLS) and template switching, both of which are coordinately regulated through sequential ubiquitination of PCNA at he K164 residue. In the budding yeast Saccharomyces cerevisiae, the same KNA-K164 residue can also be sumoylated, which recrLlits the Srs2 lielicase to prevent undesired homologous recombination (HR). While the mediation of TLS by PCNA monoubiquitination has been extensively characterized, the method by which K63-linked PCNA polyiabiquitination leads to template switching remains unclear. We recently identified a yeast heteratetrarneric Shu complex that couples error-free DDT to HR as a critical step of template switching. Here we report that the Csm2 subunit of Shu physically interacts with Rad55, an accessory protein involved in HR. RacI55 and Rad57 are Rad51 paralogues and form a heterodirner to promote Rad51-ssDNA filament formation by antagonizing Srs2 activity. Although Rad55-Rad57 and Shu function in the same pathway and both act to inhibit Srs2 activity, Shu appears to be dedicated to error-free DDT while the Rac155-RacI57 complex is also involved in double-strand break repair. This study reveals the detailed steps of error-free lesion bypass and also brings to light an intrinsic interplay between error-free DDT and Srs2-mediated inhibition of HR.	[Xu, Xin; Chen, Wangyang; Tian, Xuelei; Xiao, Wei] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Ball, Lindsay; Lambrecht, Amanda; Hanna, Michelle; Xiao, Wei] Univ Saskatchewan, Dept Microbiol & Immunol, Saskatoon, SK, Canada	Capital Normal University; University of Saskatchewan	Xiao, W (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	wei.xiao@usask.ca		Xiao, Wei/0000-0001-7568-0782	Capital Normal University [11530470709, 12530530209]; Canadian Institutes of Health Research [MOP-93612]	Capital Normal University; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Start-up funds 11530470709 and 12530530209 from Capital Normal University; Canadian Institutes of Health Research operating grant MOP-93612. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; Ball LG, 2009, MOL MICROBIOL, V73, P89, DOI 10.1111/j.1365-2958.2009.06748.x; Barbour L, 2006, GENETICS, V174, P1789, DOI 10.1534/genetics.106.056283; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bernstein KA, 2011, MOL BIOL CELL, V22, P1599, DOI 10.1091/mbc.E10-08-0691; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Broomfield S, 2002, NUCLEIC ACIDS RES, V30, P732, DOI 10.1093/nar/30.3.732; Broomfield S, 2001, MUTAT RES-DNA REPAIR, V486, P167, DOI 10.1016/S0921-8777(01)00091-X; Brusky J, 2000, CURR GENET, V37, P168, DOI 10.1007/s002940050515; Deng CH, 2009, MOL CELL PROTEOMICS, V8, P1413, DOI 10.1074/mcp.M800397-MCP200; FIRMENICH AA, 1995, MOL CELL BIOL, V15, P1620; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; Godin S, 2013, NUCLEIC ACIDS RES, V41, P4525, DOI 10.1093/nar/gkt138; HAAF T, 1995, P NATL ACAD SCI USA, V92, P2298, DOI 10.1073/pnas.92.6.2298; HAYS SL, 1995, P NATL ACAD SCI USA, V92, P6925, DOI 10.1073/pnas.92.15.6925; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; James P, 1996, GENETICS, V144, P1425; Jiang H, 1996, J BIOL CHEM, V271, P33181, DOI 10.1074/jbc.271.52.33181; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; LAWRENCE CW, 1979, J BACTERIOL, V139, P866, DOI 10.1128/JB.139.3.866-876.1979; LAWRENCE CW, 1976, GENETICS, V82, P207; LEMONTT JF, 1971, GENETICS, V68, P21; Li ZQ, 2002, P NATL ACAD SCI USA, V99, P4459, DOI 10.1073/pnas.062047799; Liu J, 2011, NATURE; Martin V, 2006, EMBO J, V25, P2564, DOI 10.1038/sj.emboj.7601141; McVey M, 2001, GENETICS, V157, P1531; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; PRAKASH L, 1981, MOL GEN GENET, V184, P471, DOI 10.1007/BF00352525; PRAKASH S, 1993, ANNU REV GENET, V27, P33, DOI 10.1146/annurev.ge.27.120193.000341; RONG L, 1991, GENETICS, V127, P75; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Sasanuma H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2678; SCHIESTL RH, 1990, GENETICS, V124, P817; She Z, 2012, FEBS LETT, V586, P2306, DOI 10.1016/j.febslet.2012.06.024; Sherman F., 1983, METHODS YEAST GENETI; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shor E, 2005, GENETICS, V169, P1275, DOI 10.1534/genetics.104.036764; Shor E, 2002, GENETICS, V162, P647; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Tao YY, 2012, J BIOL CHEM, V287, P20231, DOI 10.1074/jbc.M111.334698; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Xiao W, 1999, MUTAT RES-DNA REPAIR, V435, P1, DOI 10.1016/S0921-8777(99)00034-8; Xiao W, 1996, CURR GENET, V30, P461, DOI 10.1007/s002940050157; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102; Zhang WW, 2011, FEBS LETT, V585, P2786, DOI 10.1016/j.febslet.2011.04.044	57	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81371	10.1371/journal.pone.0081371	http://dx.doi.org/10.1371/journal.pone.0081371			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339919	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100049
J	Cohen, Y; Vaknin, M; Ben-Naim, Y; Rubin, AE				Cohen, Yigal; Vaknin, Moshe; Ben-Naim, Yariv; Rubin, Avia E.			Light Suppresses Sporulation and Epidemics of Peronospora belbahrii	PLOS ONE			English	Article							BASIL OCIMUM-BASILICUM; DOWNY MILDEW; 1ST REPORT; SWEET BASIL; PHYTOPHTHORA-INFESTANS; DIFFERENTIATION; RESISTANCE; AGENT	Peronospora belbahrii is a biotrophic oomycete attacking sweet basil. It propagates asexually by producing spores on dichotomously branched sporophores emerging from leaf stomata. Sporulation occurs when infected plants are incubated for at least 7.5h in the dark in moisture-saturated atmosphere at 10-27 degrees C. Exposure to light suppresses spore formation but allows sporophores to emerge from stomata. Incandescent or CW fluorescent light of 3.5 or 6 mu moles.m(2).s(-1) respectively, caused 100% inhibition of spore formation on lower leaf surface even when only the upper leaf surface was exposed to light. The inhibitory effect of light failed to translocate from an illuminated part of a leaf to a shaded part of the same leaf. Inhibition of sporulation by light was temperature-dependent. Light was fully inhibitory at 15-27 degrees C but not at 10 degrees C, suggesting that enzyme(s) activity and/or photoreceptor protein re-arrangement induced by light occur at >= 15 degrees C. DCMU or paraquat could not abolish light inhibition, indicating that photosystem I and photosystem II are not involved. Narrow band led illumination showed that red light (lambda max 625 nm) was most inhibitory and blue light (lambda max 440 nm) was least inhibitory, suggesting that inhibition in P. belbahrii, unlike other oomycetes, operates via a red light photoreceptor. Nocturnal illumination of basil in the field (4-10 mu moles.m(2).s(-1) from 7pm to 7am) suppressed sporulation of P. belbahrii and reduced epidemics of downy mildew, thus reducing the need for fungicide applications. This is the first report on red light inhibition of sporulation in oomycetes and on the practical application of light for disease control in the field.	[Cohen, Yigal; Vaknin, Moshe; Ben-Naim, Yariv; Rubin, Avia E.] Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel	Bar Ilan University	Cohen, Y (corresponding author), Bar Ilan Univ, Mina & Everard Fac Life Sci, Ramat Gan, Israel.	yigal.cohen@biu.ac.il			Plant Production and Marketing Board, Israel	Plant Production and Marketing Board, Israel	This study was financed by The Plant Production and Marketing Board, Israel; www.plants.org.il. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avalos J, 2010, FUNGAL GENET BIOL, V47, P930, DOI 10.1016/j.fgb.2010.05.001; Belbahri L, 2005, MYCOL RES, V109, P1276, DOI 10.1017/S0953756205003928; Cohen Y, 2013, PLANT DIS, V97, P692, DOI 10.1094/PDIS-12-12-1126-PDN; COHEN Y, 1977, PHYSIOL PLANT PATHOL, V10, P93, DOI 10.1016/0048-4059(77)90013-3; COHEN Y, 1976, AUST J BIOL SCI, V29, P281, DOI 10.1071/BI9760281; COHEN Y, 1975, CAN J BOT, V53, P2680, DOI 10.1139/b75-296; COHEN Y, 1977, PHYTOPATHOLOGY, V67, P515, DOI 10.1094/Phyto-67-515; Cohen Y, 2010, EUR J PLANT PATHOL, V126, P553, DOI 10.1007/s10658-009-9564-6; Garibaldi A, 2005, PLANT DIS, V89, P683, DOI 10.1094/PD-89-0683C; Garibaldi A, 2004, PLANT DIS, V88, P312, DOI 10.1094/PDIS.2004.88.3.312A; Gilardi G, 2013, PHYTOPARASITICA, V41, P59, DOI 10.1007/s12600-012-0264-y; Idnurm A, 2010, FUNGAL GENET BIOL, V47, P881, DOI 10.1016/j.fgb.2010.04.009; Judelson HS, 2009, MOL GENET GENOMICS, V281, P193, DOI 10.1007/s00438-008-0407-5; de la Parte EM, 2010, PLANT PATHOL, V59, P800, DOI 10.1111/j.1365-3059.2009.02249.x; Mcgrath MT, 2010, PHYTOPATHOLOGY, V100, pS196; McLeod A, 2006, PLANT DIS, V90, P1115, DOI 10.1094/PD-90-1115A; Mersha Z, 2013, J PHYTOPATHOL, V161, P154, DOI [10.1111/jph.12045, 10.1111/jph.120]; Nagy G, 2011, PLANT DIS, V95, P1034, DOI 10.1094/PDIS-04-11-0329; Roberts PD, 2009, PLANT DIS, V93, P199, DOI 10.1094/PDIS-93-2-0199B; Rodriguez-Romero J, 2010, ANNU REV MICROBIOL, V64, P585, DOI 10.1146/annurev.micro.112408.134000; RONCO L, 2008, DROSOPHILA INF SERVI, V18, P14; ROTEM J, 1978, ANNU REV PHYTOPATHOL, V16, P83, DOI 10.1146/annurev.py.16.090178.000503; Rumbolz J, 2002, PLANT BIOLOGY, V4, P413, DOI 10.1055/s-2002-32342; Summers L.A., 1980, BIPYRIDINIUM HERBICI; Thines M, 2009, MYCOL RES, V113, P532, DOI 10.1016/j.mycres.2008.12.005; Tisch D, 2010, APPL MICROBIOL BIOT, V85, P1259, DOI 10.1007/s00253-009-2320-1; VOGLMAYR H, 2008, DROSOPHILA INF SERVI, V18, P37	27	30	32	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 27	2013	8	11							e81282	10.1371/journal.pone.0081282	http://dx.doi.org/10.1371/journal.pone.0081282			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261GG	24348919	Green Submitted, gold, Green Published			2022-12-27	WOS:000327652100070
J	Mravljak, M; Vizjak, A; Ferluga, D; Pajek, J; Kovac, D; Skoberne, A; Rigler, AA; Kveder, R; Kosir, A; Lindic, J				Mravljak, Marija; Vizjak, Alenka; Ferluga, Dusan; Pajek, Jernej; Kovac, Damjan; Skoberne, Andrej; Rigler, Andreja Ales; Kveder, Radoslav; Kosir, Andrej; Lindic, Jelka			Urinary Immunoglobulin G to Albumin Ratio and N-Acetyl-Beta-D-Glucosaminidase as Early Predictors of Therapeutic Response in ANCA-Associated Glomerulonephritis	PLOS ONE			English	Article							ANTIBODY-ASSOCIATED VASCULITIS; PROTEINURIA SELECTIVITY INDEX; RENAL SURVIVAL; KIDNEY-DISEASE; IGM EXCRETION; PATHOPHYSIOLOGY; CLASSIFICATION; DETERMINANTS; VALIDATION; MORTALITY	Background: The aim of our study was to evaluate the prognostic value of glomerular and tubular proteinuria and tubular enzymuria as early indicators of therapeutic response to induction therapy with i.v. pulse cyclophosphamide (CyC) and methylprednisolone (MP) in patients with antineutrophil cytoplasmic antibody (ANCA) associated glomerulonephritis. Methods and Findings: An observational single-center study was conducted in 30 patients with ANCA-associated glomerulonephritis. Patients were divided into subgroups with good or poor response to CyC therapy according to clinical and laboratory parameters. The diagnosis of ANCA-associated glomerulonephritis was based on the Chapel-Hill disease definitions. Good response to induction therapy was significantly associated with higher absolute values of urine N-acetyl-beta-D-glucosaminidase (NAG) to creatinine ratio (above 14.83 microcat/mol) and urine immunoglobulin G (IgG) to albumin ratio (above 0.09) at the time of diagnosis, while albuminuria or proteinuria did not have any early predictive value. The remission of renal disease was anticipated as early as 3 months after introduction of induction therapy in patients with reduction of urine NAG to creatinine ratio below the baseline value and in patients with at least 24% rise in eGFR. Conclusions: Urine IgG to albumin and urine NAG to creatinine ratio are better early predictors of treatment response in patients with ANCA-associated glomerulonephritis than proteinuria or albuminuria.	[Mravljak, Marija; Pajek, Jernej; Kovac, Damjan; Skoberne, Andrej; Rigler, Andreja Ales; Kveder, Radoslav; Lindic, Jelka] Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia; [Vizjak, Alenka; Ferluga, Dusan] Univ Ljubljana, Fac Med, Inst Pathol, Ljubljana, Slovenia; [Kosir, Andrej] Univ Ljubljana, Fac Elect Engn, Ljubljana, Slovenia	University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana	Lindic, J (corresponding author), Univ Med Ctr Ljubljana, Dept Nephrol, Ljubljana, Slovenia.	jelka.lindic@kclj.si	Pajek, Jernej/AAD-6776-2020	Pajek, Jernej/0000-0003-3265-8053				Bacon PA, 2005, NEW ENGL J MED, V352, P330, DOI 10.1056/NEJMp048338; Bakoush O, 2006, NEPHROL DIAL TRANSPL, V21, P1263, DOI 10.1093/ndt/gfk074; Bakoush O, 2003, CLIN NEPHROL, V59, P345; Bakoush O, 2001, NEPHROL DIAL TRANSPL, V16, P1357, DOI 10.1093/ndt/16.7.1357; Bazzi C, 2002, NEPHROL DIAL TRANSPL, V17, P1890, DOI 10.1093/ndt/17.11.1890; Bazzi C, 2001, AM J KIDNEY DIS, V38, P240, DOI 10.1053/ajkd.2001.26080; Berden AE, 2010, J AM SOC NEPHROL, V21, P1628, DOI 10.1681/ASN.2010050477; Bosomworth MP, 1999, NEPHROL DIAL TRANSPL, V14, P620, DOI 10.1093/ndt/14.3.620; Burton CJ, 1999, NEPHROL DIAL TRANSPL, V14, P2628, DOI 10.1093/ndt/14.11.2628; D'Amico G, 2003, KIDNEY INT, V63, P809, DOI 10.1046/j.1523-1755.2003.00840.x; DAMSGAARD EM, 1990, BRIT MED J, V300, P297, DOI 10.1136/bmj.300.6720.297; de Groot K, 2001, CLIN NEPHROL, V55, P31; de Groot K, 2009, ANN INTERN MED, V150, P670, DOI 10.7326/0003-4819-150-10-200905190-00004; EDDY AA, 1994, J AM SOC NEPHROL, V5, P1273; Erdener D, 2005, J CLIN LAB ANAL, V19, P172, DOI 10.1002/jcla.20073; Exley AR, 1997, ARTHRITIS RHEUM, V40, P371, DOI 10.1002/art.1780400222; Falk RJ, 2010, J AM SOC NEPHROL, V21, P745, DOI 10.1681/ASN.2009121238; Fogo A, 2000, NEPHRON, V85, P8, DOI 10.1159/000045623; Franssen CFM, 1998, J AM SOC NEPHROL, V9, P1915; Gluhovschi C, 2012, IMMUNOPHARM IMMUNOT, V34, P170, DOI 10.3109/08923973.2011.585343; Hauer HA, 2002, KIDNEY INT, V62, P1732, DOI 10.1046/j.1523-1755.2002.00605.x; Hilhorst M, 2013, J AM SOC NEPHROL, V24, P1371, DOI 10.1681/ASN.2012090912; Jennette JC, 2001, NEPHROL DIAL TRANSPL, V16, P80, DOI 10.1093/ndt/16.suppl_6.80; Kamesh L, 2002, J AM SOC NEPHROL, V13, P1953, DOI 10.1097/01.ASN.0000016442.33680.3E; Kapitsinou PP, 2003, AM J KIDNEY DIS, V41, P29, DOI 10.1053/ajkd.2003.50013; LAURENT J, 1993, NEPHRON, V65, P185, DOI 10.1159/000187472; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; MANSFIELD N, 2011, NEPHROL DIAL TRANSPL, V10, P1; Mukhtyar C, 2008, ANN RHEUM DIS, V67, P1004, DOI 10.1136/ard.2007.071936; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P1827, DOI 10.1136/ard.2008.101279; Mukhtyar C, 2009, ANN RHEUM DIS, V68, P310, DOI 10.1136/ard.2008.088096; Nachman PH, 1996, J AM SOC NEPHROL, V7, P33; Neumann I, 2005, NEPHROL DIAL TRANSPL, V20, P96, DOI 10.1093/ndt/gfh563; Perico N, 2005, KIDNEY INT, V67, pS79, DOI 10.1111/j.1523-1755.2005.09420.x; Reichert LJM, 1997, CLIN NEPHROL, V48, P79; SAVAGE COS, 1985, Q J MED, V56, P467; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; Stone JH, 2005, NEW ENGL J MED, V352, P351; Tarella C, 2011, J CLIN ONCOL, V29, P814, DOI 10.1200/JCO.2010.28.9777; Tencer J, 1998, KIDNEY INT, V53, P709, DOI 10.1046/j.1523-1755.1998.00797.x; Tesch GH, 2010, NEPHROLOGY, V15, P609, DOI 10.1111/j.1440-1797.2010.01361.x; Thakkar H, 1998, KIDNEY INT, V54, P1197, DOI 10.1046/j.1523-1755.1998.00098.x; Weidner S, 2004, NEPHROL DIAL TRANSPL, V19, P1403, DOI 10.1093/ndt/gfh161; Woo KT, 2000, KIDNEY INT, V58, P2485, DOI 10.1046/j.1523-1755.2000.00432.x; YU H, 1983, J CLIN PATHOL, V36, P253, DOI 10.1136/jcp.36.3.253	45	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81703	10.1371/journal.pone.0081703	http://dx.doi.org/10.1371/journal.pone.0081703			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349116	Green Published, Green Submitted, gold			2022-12-27	WOS:000328734200014
J	Rowe, SJ; Rowlatt, A; Davies, G; Harris, SE; Porteous, DJ; Liewald, DC; McNeill, G; Starr, JM; Deary, IJ; Tenesa, A				Rowe, Suzanne J.; Rowlatt, Amy; Davies, Gail; Harris, Sarah E.; Porteous, David J.; Liewald, David C.; McNeill, Geraldine; Starr, John M.; Deary, Ian J.; Tenesa, Albert			Complex Variation in Measures of General Intelligence and Cognitive Change	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; MAXIMUM-LIKELIHOOD; GENETIC-VARIATION; COMMON SNPS; SCHIZOPHRENIA; MORTALITY; TRAIT; PREDICTION; DISEASE	Combining information from multiple SNPs may capture a greater amount of genetic variation than from the sum of individual SNP effects and help identifying missing heritability. Regions may capture variation from multiple common variants of small effect, multiple rare variants or a combination of both. We describe regional heritability mapping of human cognition. Measures of crystallised (g(c)) and fluid intelligence (g(f)) in late adulthood (64-79 years) were available for 1806 individuals genotyped for 549,692 autosomal single nucleotide polymorphisms (SNPs). The same individuals were tested at age 11, enabling us the rare opportunity to measure cognitive change across most of their lifespan. 547,750 SNPs ranked by position are divided into 10, 908 overlapping regions of 101 SNPs to estimate the genetic variance each region explains, an approach that resembles classical linkage methods. We also estimate the genetic variation explained by individual autosomes and by SNPs within genes. Empirical significance thresholds are estimated separately for each trait from whole genome scans of 500 permutated data sets. The 5% significance threshold for the likelihood ratio test of a single region ranged from 17-17.5 for the three traits. This is the equivalent to nominal significance under the expectation of a chi-squared distribution (between 1df and 0) of P < 1.44x10(-5). These thresholds indicate that the distribution of the likelihood ratio test from this type of variance component analysis should be estimated empirically. Furthermore, we show that estimates of variation explained by these regions can be grossly overestimated. After applying permutation thresholds, a region for gf on chromosome 5 spanning the PRRC1 gene is significant at a genome-wide 10% empirical threshold. Analysis of gene methylation on the temporal cortex provides support for the association of PRRC1 and fluid intelligence (P = 0.004), and provides a prime candidate gene for high throughput sequencing of these uniquely informative cohorts.	[Rowe, Suzanne J.; Rowlatt, Amy; Tenesa, Albert] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Davies, Gail; Harris, Sarah E.; Porteous, David J.; Liewald, David C.; Starr, John M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Harris, Sarah E.; Porteous, David J.] Univ Edinburgh, Med Genet Sect, Edinburgh, Midlothian, Scotland; [McNeill, Geraldine] Univ Aberdeen, Inst Appl Hlth Sci, Aberdeen, Scotland; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Med Res Council Human Genet Unit, Med Res Council Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Aberdeen; University of Edinburgh; University of Edinburgh; University of Edinburgh	Tenesa, A (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	Albert.Tenesa@ed.ac.uk	Deary, Ian J/C-6297-2009; Rowe, Suzanne/HGF-1418-2022; Porteous, David/AAA-3446-2021	Deary, Ian J/0000-0002-1733-263X; Rowe, Suzanne/0000-0001-8727-5960; Porteous, David/0000-0003-1249-6106; Tenesa, Albert/0000-0003-4884-4475; McNeill, Geraldine/0000-0003-0373-650X	UK's Biotechnology and Biological Sciences Research Council (BBSRC); Royal Society; Chief Scientist Office of the Scottish Government; Research Into Ageing; Wellcome Trust; Alzheimer's Research Trust; BBSRC through the Roslin Institute's [BB/K000195/1]; Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology (NIA) through the NIH GWAS Data Repository (dbGaP) [phs000249.v1.p1]; NIA; Biotechnology and Biological Sciences Research Council [BB/K000195/1, BB/F019394/1] Funding Source: researchfish; Medical Research Council [G0700704, MR/K026992/1, G0100266] Funding Source: researchfish; BBSRC [BB/F019394/1, BB/K000195/1] Funding Source: UKRI; MRC [G0100266, G0700704] Funding Source: UKRI	UK's Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Chief Scientist Office of the Scottish Government; Research Into Ageing; Wellcome Trust(Wellcome Trust); Alzheimer's Research Trust; BBSRC through the Roslin Institute's(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology (NIA) through the NIH GWAS Data Repository (dbGaP); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Genotyping of the ABC1936, LBC1921, and LBC1936 cohorts and the analyses conducted here were supported by the UK's Biotechnology and Biological Sciences Research Council (BBSRC). Phenotype collection in the Lothian Birth Cohort 1921 was supported by the BBSRC, The Royal Society, and The Chief Scientist Office of the Scottish Government. Phenotype collection in the Lothian Birth Cohort 1936 was supported by Research Into Ageing (continues as part of Age UK's The Disconnected Mind project). Phenotype collection in the Aberdeen Birth Cohort 1936 was supported by the BBSRC, the Wellcome Trust, and the Alzheimer's Research Trust. SJR, AR and AT are funded by the BBSRC through the Roslin Institute's strategic programme grant and project grant BB/K000195/1. The Brain data was provided by the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology (NIA) through the NIH GWAS Data Repository (dbGaP Accession Number: phs000249.v1.p1) and funded as part of the Intramural Research Program, NIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Almasy L, 2008, AM J PSYCHIAT, V165, P1185, DOI 10.1176/appi.ajp.2008.07121869; Batterham PJ, 2012, PSYCHOL AGING, V27, P229, DOI 10.1037/a0024517; Batterham PJ, 2011, PSYCHOL AGING, V26, P844, DOI 10.1037/a0023300; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2010, EUR J CARDIOV PREV R, V17, P24, DOI 10.1097/HJR.0b013e328321311b; Batty GD, 2010, BRIT MED J, V340; Cattell RB, 1941, PSYCHOL BULL, V38, P592; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Deary IJ, 2007, INTELLIGENCE, V35, P451, DOI 10.1016/j.intell.2006.09.003; Deary IJ, 2012, NATURE, V482, P212, DOI 10.1038/nature10781; Deary IJ, 2009, BRIT MED BULL, V92, P135, DOI 10.1093/bmb/ldp033; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Falconer D. S., 1996, INTRO QUANTITATIVE G; FERNANDO RL, 1989, GENET SEL EVOL, V21, P467, DOI 10.1051/gse:19890407; FINKEL D, 1995, BEHAV GENET, V25, P421, DOI 10.1007/BF02253371; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Gilmour AR, 1995, BIOMETRICS, V51, P1440, DOI 10.2307/2533274; GOLDGAR DE, 1990, AM J HUM GENET, V47, P957; Gray A, 2012, BIOINFORMATICS, V28, P3134, DOI 10.1093/bioinformatics/bts571; Gunnell D, 2002, BRIT J PSYCHIAT, V181, P298, DOI 10.1192/bjp.181.4.298; HORN JL, 1966, J EDUC PSYCHOL, V57, P253, DOI 10.1037/h0023816; Lander ES, 2011, NATURE, V470, P187, DOI 10.1038/nature09792; Lee SH, 2012, BIOINFORMATICS, V28, P2540, DOI 10.1093/bioinformatics/bts474; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meuwissen THE, 2001, GENETICS, V157, P1819; Nagamine Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046501; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Panichareon B, 2012, BEHAV BRAIN FUNCT, V8, DOI 10.1186/1744-9081-8-27; Perry RJ, 1999, BRAIN, V122, P383, DOI 10.1093/brain/122.3.383; Potkin SG, 2009, SCHIZOPHRENIA BULL, V35, P96, DOI 10.1093/schbul/sbn155; Powell JE, 2010, NAT REV GENET, V11, P800, DOI 10.1038/nrg2865; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rowe SJ, 2008, GENET RES, V90, P363, DOI 10.1017/S0016672308009336; Schulz J, 2012, SCHIZOPHR B; Scottish Council for Research in Education, 1933, INT SCOTT CHILDR NAT; Scottish Council for Research in Education, 1949, TREND SCOTT INT TREND SCOTT INT; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shipley BA, 2007, PSYCHOSOM MED, V69, P640, DOI 10.1097/PSY.0b013e31814c3e7c; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yang J, 2011, NAT GENET, V43, P519, DOI 10.1038/ng.823; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608	47	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81189	10.1371/journal.pone.0081189	http://dx.doi.org/10.1371/journal.pone.0081189			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349040	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800013
J	Jafari, S; Huang, XF; Andrews, JL; Fernandez-Enright, F				Jafari, Somayeh; Huang, Xu-Feng; Andrews, Jessica L.; Fernandez-Enright, Francesca			In Vivo Pharmacological Evaluations of Novel Olanzapine Analogues in Rats: A Potential New Avenue for the Treatment of Schizophrenia	PLOS ONE			English	Article							INDUCED WEIGHT-GAIN; ATYPICAL ANTIPSYCHOTIC-DRUGS; HISTAMINE H-1 RECEPTOR; BODY-WEIGHT; SEROTONIN RECEPTORS; FEEDING RHYTHM; PCP TREATMENT; PHENCYCLIDINE; DOPAMINE; CLOZAPINE	Olanzapine (Olz) is one of the most effective antipsychotic drugs commonly used for treating schizophrenia. Unfortunately, Olz administration is associated with severe weight gain and metabolic disturbances. Both patients and clinicians are highly interested in the development of new antipsychotics which are as effective as atypical antipsychotics but which have a lower propensity to induce metabolic side effects. In the present study, we examined two new derivatives of Olz; OlzEt(2-ethyl-4-(4'-methylpiperazin-1'-yl)10H-benzo[b]thieno[2,3-e][1,4]diazepine), and OlzHomo (2-ethyl-4-(4'-methyl-1',4'-diazepan-1'-yl)-10H-benzo[b]thieno[2,3-e] [1,4] diazepine), for their tendency to induce weight gain in rats. Weight gain and metabolic changes were measured in female Sprague Dawley rats. Animals were treated orally with Olz, OlzEt, OlzHomo (3 or 6 mg/kg/day), or vehicle (n = 8), three times daily at eight-hour intervals for 5 weeks. Furthermore, a phencyclidine (PCP)-treated rat model was used to examine the prevention of PCP-induced hyperlocomotor activity relevant for schizophrenia therapy. Male Sprague Dawley rats were pre-treated with a single dose (3 mg/kg/day) of Olz, OlzEt, OlzHomo, or vehicle (n = 12), for 2 weeks. Locomotor activity was recorded following a subcutaneous injection with either saline or PCP (10 mg/kg). Olz was found to induce weight gain, hyperphagia, visceral fat accumulation, and metabolic changes associated with reduced histamatergic H-1 receptor density in the hypothalamus of treated rats. In contrast, OlzEt and OlzHomo presented promising antipsychotic effects, which did not induce weight gain or fat deposition in the treated animals. Behavioural analysis showed OlzEt to attenuate PCP-induced hyperactivity to a level similar to that of Olz; however, OlzHomo showed a lower propensity to inhibit these stereotyped behaviours. Our data suggest that the therapeutic effectiveness of OlzHomo may be delivered at a higher dose than that of Olz and OlzEt. Overall, OlzEt and OlzHomo may offer a better pharmacological profile than Olz for treating patients with schizophrenia. Clinical trials are needed to test this hypothesis.	[Jafari, Somayeh; Huang, Xu-Feng; Andrews, Jessica L.; Fernandez-Enright, Francesca] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia; [Jafari, Somayeh; Huang, Xu-Feng; Andrews, Jessica L.; Fernandez-Enright, Francesca] Univ Wollongong, Sch Med, Wollongong, NSW, Australia; [Jafari, Somayeh] Univ Wollongong, Sch Chem, Wollongong, NSW, Australia; [Huang, Xu-Feng; Andrews, Jessica L.; Fernandez-Enright, Francesca] Schizophrenia Res Inst, Darlinghurst, NSW, Australia	University of Wollongong; University of Wollongong; University of Wollongong	Fernandez-Enright, F (corresponding author), Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW, Australia.	fernande@uow.edu.au	Huang, Xu-Feng/D-6053-2013; Huang, Xu-Feng/H-7408-2015; Fernandez, Francesca/T-6689-2017	Huang, Xu-Feng/0000-0002-5895-2253; Huang, Xu-Feng/0000-0002-5895-2253; Fernandez, Francesca/0000-0002-0926-5473; Andrews, Jessica/0000-0003-2449-8002; Jafari, Pari/0000-0002-9696-428X	Schizophrenia Research Institute, Sydney, Australia; Research Committee of the University of Wollongong, Wollongong, Australia	Schizophrenia Research Institute, Sydney, Australia; Research Committee of the University of Wollongong, Wollongong, Australia	This work was supported by the Schizophrenia Research Institute, Sydney, Australia and Research Committee of the University of Wollongong, Wollongong, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Andersen JD, 2004, NEUROPSYCHOPHARMACOL, V29, P1080, DOI 10.1038/sj.npp.1300394; Asayama K, 2003, OBES RES, V11, P1072, DOI 10.1038/oby.2003.147; Bai YM, 2009, SCHIZOPHR RES, V111, P1, DOI 10.1016/j.schres.2009.03.014; Ballmaier M, 2001, PSYCHOPHARMACOLOGY, V159, P105, DOI 10.1007/s002130100905; Breden EL., 2009, J PHARM PRACT, V22, P478, DOI DOI 10.1177/0897190008330200; Campiani G, 2005, J MED CHEM, V48, P1705, DOI 10.1021/jm049629t; Campiani G, 2004, J MED CHEM, V47, P143, DOI 10.1021/jm0309811; CASTELLANI S, 1981, EUR J PHARMACOL, V73, P143, DOI 10.1016/0014-2999(81)90086-8; Chiu CC, 2006, J CLIN PSYCHOPHARM, V26, P504, DOI 10.1097/01.jcp.0000237947.80764.d9; Choi YK, 2009, J MOL NEUROSCI, V38, P227, DOI 10.1007/s12031-009-9204-9; Coccurello R, 2008, J PHARMACOL EXP THER, V326, P905, DOI 10.1124/jpet.108.137240; Cooper GD, 2007, J PSYCHOPHARMACOL, V21, P405, DOI 10.1177/0269881106069637; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Davey KJ, 2012, PSYCHOPHARMACOLOGY, V221, P155, DOI 10.1007/s00213-011-2555-2; du Bois TM, 2008, BEHAV BRAIN RES, V188, P416, DOI 10.1016/j.bbr.2007.11.017; Durand M, 2000, NEUROPHARMACOLOGY, V39, P2464, DOI 10.1016/S0028-3908(00)00088-5; Eder U, 2001, AM J PSYCHIAT, V158, P1719, DOI 10.1176/appi.ajp.158.10.1719; Esen-Danac A, 2008, PROG NEURO-PSYCHOPH, V32, P1434, DOI 10.1016/j.pnpbp.2008.03.015; Fell MJ, 2007, PSYCHOPHARMACOLOGY, V194, P221, DOI 10.1007/s00213-007-0833-9; Fitzgerald PB, 2003, HUM PSYCHOPHARM CLIN, V18, P551, DOI 10.1002/hup.519; Gandolfi O, 2003, N-S ARCH PHARMACOL, V367, P615, DOI 10.1007/s00210-003-0761-0; Gardner DM, 2005, CAN MED ASSOC J, V172, P1703, DOI 10.1503/cmaj.1041064; Gleason SD, 1997, PSYCHOPHARMACOLOGY, V129, P79, DOI 10.1007/s002130050165; Gothelf D, 2002, AM J PSYCHIAT, V159, P1055, DOI 10.1176/appi.ajp.159.6.1055; HOLT RI, 2006, BJDVD, V6, P199; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang XF, 2006, BEHAV BRAIN RES, V171, P355, DOI 10.1016/j.bbr.2006.03.040; Jafari Somayeh, 2012, BMC Pharmacology, V12, P8, DOI 10.1186/1471-2210-12-8; Jafari S, 2012, J NEUROCHEM, V120, P371, DOI 10.1111/j.1471-4159.2011.07590.x; Jones B, 2001, J CLIN PSYCHIAT, V62, P41; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Kraus T, 1999, AM J PSYCHIAT, V156, P312; Kroeze WK, 2003, NEUROPSYCHOPHARMACOL, V28, P519, DOI 10.1038/sj.npp.1300027; Large CH, 2007, J PSYCHOPHARMACOL, V21, P283, DOI 10.1177/0269881107077712; Martin P, 1998, NEUROREPORT, V9, P2985, DOI 10.1097/00001756-199809140-00012; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Masaki T, 2006, TRENDS PHARMACOL SCI, V27, P279, DOI 10.1016/j.tips.2006.03.008; Mathews M, 2007, CLEV CLIN J MED, V74, P597, DOI 10.3949/ccjm.74.8.597; McIntyre RS, 2003, J CLIN PSYCHOPHARM, V23, P323, DOI 10.1097/01.jcp.0000085403.08426.f4; Melkersson K, 2004, EUR NEUROPSYCHOPHARM, V14, P115, DOI 10.1016/S0924-977X(03)00072-5; Meltzer HY, 1999, NEUROPSYCHOPHARMACOL, V21, pS106, DOI 10.1038/sj.npp.1395370; MELTZER HY, 1989, J PHARMACOL EXP THER, V251, P238; MELTZER HY, 1989, PSYCHOPHARMACOL BULL, V25, P390; MELTZER HY, 1991, PHARMACOL REV, V43, P587; Mercer LP, 1997, NUTRITION, V13, P581, DOI 10.1016/S0899-9007(97)00028-2; Mercer LP, 1996, J AM COLL NUTR, V15, P223; Moy SS, 2004, PHARMACOL BIOCHEM BE, V78, P47, DOI 10.1016/j.pbb.2004.02.013; Nemeroff CB, 1997, J CLIN PSYCHIAT, V58, P45; Oriot P, 2008, DIABETES METAB, V34, P490, DOI 10.1016/j.diabet.2008.03.003; Perez-Iglesias R, 2008, J CLIN PSYCHOPHARM, V28, P289, DOI 10.1097/JCP.0b013e318172b8e6; Pijl H, 1996, DRUG SAFETY, V14, P329, DOI 10.2165/00002018-199614050-00005; Rasmussen BA, 2007, PSYCHOPHARMACOLOGY, V190, P43, DOI 10.1007/s00213-006-0584-z; Recasens C, 2001, ENCEPHALE, V27, P269; Reynolds GP, 2010, PHARMACOL THERAPEUT, V125, P169, DOI 10.1016/j.pharmthera.2009.10.010; Reynolds GP, 2002, LANCET, V359, P2086, DOI 10.1016/S0140-6736(02)08913-4; Roerig JL, 2009, BIOL PSYCHIAT, V65, P607, DOI 10.1016/j.biopsych.2008.10.037; SEEMAN P, 1992, NEUROPSYCHOPHARMACOL, V7, P261; Shastri JA, 2006, Patent No. [US Patent, 2006 WO 2006006180 A1 20060119, 2006006180]; Silvestre JS, 2005, METHOD FIND EXP CLIN, V27, P289, DOI 10.1358/mf.2005.27.5.908643; Sircar R, 2003, PHARMACOL BIOCHEM BE, V74, P943, DOI 10.1016/S0091-3057(03)00025-X; Stefanidis A, 2009, OBESITY, V17, P16, DOI 10.1038/oby.2008.468; Steinpreis RE, 1999, PHARMACOL BIOCHEM BE, V63, P387, DOI 10.1016/S0091-3057(99)00010-6; Togo T, 2004, INT CLIN PSYCHOPHARM, V19, P37, DOI 10.1097/00004850-200401000-00007; Tomic M, 1997, EUR NEUROPSYCHOPHARM, V7, P295, DOI 10.1016/S0924-977X(97)00398-2; Wampers M, 2012, EUR NEUROPSYCHOPHARM, V22, P17, DOI 10.1016/j.euroneuro.2011.03.010; Weston-Green K, 2011, BEHAV BRAIN RES, V217, P337, DOI 10.1016/j.bbr.2010.10.039; Wu RR, 2008, AM J PSYCHIAT, V165, P352, DOI 10.1176/appi.ajp.2007.07010079; Yang LH, 2007, PHARMACOL RES, V56, P202, DOI 10.1016/j.phrs.2007.05.007	70	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80979	10.1371/journal.pone.0080979	http://dx.doi.org/10.1371/journal.pone.0080979			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349027	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300017
J	Stokholm, J; Schjorring, S; Pedersen, L; Bischoff, AL; Folsgaard, N; Carson, CG; Chawes, BLK; Bonnelykke, K; Molgaard, A; Krogfelt, KA; Bisgaard, H				Stokholm, Jakob; Schjorring, Susanne; Pedersen, Louise; Bischoff, Anne Louise; Folsgaard, Nilofar; Carson, Charlotte G.; Chawes, Bo L. K.; Bonnelykke, Klaus; Molgaard, Anne; Krogfelt, Karen A.; Bisgaard, Hans			Prevalence and Predictors of Antibiotic Administration during Pregnancy and Birth	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; B-STREPTOCOCCAL DISEASE; PRESCRIPTION DRUG-USE; RISK-FACTORS; SMOKING; ASTHMA; PREVENTION; BLOOD	Background: Antibiotic treatment during pregnancy and birth is very common. In this study, we describe the estimated prevalence of antibiotic administration during pregnancy and birth in the COPSAC(2010) pregnancy cohort, and analyze dependence on social and lifestyle-related factors. Methods: 706 pregnant women from the novel unselected Copenhagen Prospective Study on Asthma in Childhood (COPSAC(2010)) pregnancy cohort participated in this analysis. Detailed information on oral antibiotic prescriptions during pregnancy filled at the pharmacy was obtained and verified longitudinally. Information on intrapartum antibiotics, social, and lifestyle-factors was obtained by personal interviews. Results: The prevalence of antibiotic use was 37% during pregnancy and 33% intrapartum. Lower maternal age at birth; adjusted odds ratio (aOR) 0.94, 95% CI, [0.90-0.98], p = 0.003 and maternal smoking; aOR 1.97, 95% CI, [1.07-3.63], p = 0.030 were associated with use of antibiotics for urinary tract infection during pregnancy. Maternal educational level (low vs. high), aOR 2.32, 95% CI, [1.24-4.35], p = 0.011, maternal asthma; aOR 1.99, 95% CI, [1.33-2.98], p < 0.001 and previous childbirth; aOR 1.80, 95% CI, [1.21-2.66], p = 0.004 were associated with use of antibiotics for respiratory tract infection during pregnancy. Lower gestational age; aOR 0.72, 95% CI, [0.61-0.85], p < 0.001, maternal smoking; aOR 2.84, 95% CI, [1.33-6.06], p = 0.007, and nulliparity; aOR 1.79, 95% CI, [1.06-3.02], p = 0.030 were associated with administration of intrapartum antibiotics in women giving birth vaginally. Conclusion: Antibiotic administration during pregnancy and birth may be influenced by social and lifestyle-factors. Understanding such risk factors may guide preventive strategies in order to avoid unnecessary use of antibiotics.	[Stokholm, Jakob; Pedersen, Louise] Univ Copenhagen, Naestved Hosp, Copenhagen Prospect Studies Asthma Childhood, Naestved, Denmark; [Stokholm, Jakob; Pedersen, Louise; Bischoff, Anne Louise; Folsgaard, Nilofar; Carson, Charlotte G.; Chawes, Bo L. K.; Bonnelykke, Klaus; Molgaard, Anne; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark; [Schjorring, Susanne; Krogfelt, Karen A.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark	Naestved Hospital; University of Copenhagen; University of Copenhagen; Statens Serum Institut	Bisgaard, H (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Copenhagen, Denmark.	bisgaard@copsac.com	Krogfelt, Karen Angeliki A/O-8145-2016; Krogfelt, Karen Angeliki/P-2430-2018; Bisgaard, Hans/N-4761-2016	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Bisgaard, Hans/0000-0003-4131-7592; Chawes, Bo/0000-0001-6846-6243; Bonnelykke, Klaus/0000-0003-2003-1018; Stokholm, Jakob/0000-0003-4989-9769; Schjorring, Susanne/0000-0001-5575-7252	Lundbeck Foundation; Strategic Research Foundation; Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council	Lundbeck Foundation(Lundbeckfonden); Strategic Research Foundation; Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	COPSAC is funded by private and public research funds all listed on www.copsac.com. The Lundbeck Foundation; The Strategic Research Foundation; the Pharmacy Foundation of 1991; Augustinus Foundation; the Danish Medical Research Council and The Danish Pediatric Asthma Centre provided core support for COPSAC. No pharmaceutical companies were involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann U, 2006, PHARMACOEPIDEM DR S, V15, P327, DOI 10.1002/pds.1225; Ananth CV, 1996, AM J EPIDEMIOL, V144, P881, DOI 10.1093/oxfordjournals.aje.a009022; Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025; [Anonymous], 2004, INT J GYNECOL OBSTET, V85, P315; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; Beyens MN, 2003, THERAPIE, V58, P505, DOI 10.2515/therapie:2003082; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2013, CLIN EXP ALLERGY, V43, P1384, DOI 10.1111/cea.12213; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; BONATI M, 1992, INT J GYNECOL OBSTET, V39, P185; CEDERQVIST LL, 1984, AM J OBSTET GYNECOL, V148, P1123, DOI 10.1016/0002-9378(84)90639-2; CUNNINGHAM FG, 1994, BAILLIERE CLIN OB GY, V8, P353, DOI 10.1016/S0950-3552(05)80325-6; Daw JR, 2012, CLIN THER, V34, P239, DOI 10.1016/j.clinthera.2011.11.025; Forbes RL, 2011, THORAX; Haider G, 2010, J PAK MED ASSOC, V60, P213; Hanif Shamayela, 2006, J Coll Physicians Surg Pak, V16, P514; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Little P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13190; Marchant S, 2006, PAEDIATR PERINAT EP, V20, P392, DOI 10.1111/j.1365-3016.2006.00743.x; Mignini L, 2009, OBSTET GYNECOL, V113, P346, DOI 10.1097/AOG.0b013e318194f109; Mitchell AA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.029; Moore MR, 2003, LANCET INFECT DIS, V3, P201, DOI 10.1016/S1473-3099(03)00577-2; NICHOLSON KG, 1993, BRIT MED J, V307, P982, DOI 10.1136/bmj.307.6910.982; Norgaard M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030850; Olesen C, 1999, EUR J CLIN PHARMACOL, V55, P139, DOI 10.1007/s002280050608; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Salihu HM, 2007, EARLY HUM DEV, V83, P713, DOI 10.1016/j.earlhumdev.2007.08.002; Santos F, 2010, PHARMACOEPIDEM DR S, V19, P418, DOI 10.1002/pds.1915; Smaill FM, 2011, COCHRANE LIB; STAMM WE, 1991, REV INFECT DIS, V13, P77; Turan A, 2011, ANESTHESIOLOGY, V114, P837, DOI 10.1097/ALN.0b013e318210f560; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]	33	73	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82932	10.1371/journal.pone.0082932	http://dx.doi.org/10.1371/journal.pone.0082932			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340068	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400104
J	Tsai, AC; Scott, JA; Hung, KJ; Zhu, JQ; Matthews, LT; Psaros, C; Tomlinson, M				Tsai, Alexander C.; Scott, Jennifer A.; Hung, Kristin J.; Zhu, Jennifer Q.; Matthews, Lynn T.; Psaros, Christina; Tomlinson, Mark			Reliability and Validity of Instruments for Assessing Perinatal Depression in African Settings: Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMMON MENTAL-DISORDERS; COMMUNITY-HEALTH WORKERS; POSTNATAL-DEPRESSION; PRIMARY-CARE; POSTPARTUM DEPRESSION; GLOBAL BURDEN; LOW-INCOME; NONPOSTPARTUM DEPRESSION; MATERNAL DEPRESSION; ANXIETY DISORDERS	Background: A major barrier to improving perinatal mental health in Africa is the lack of locally validated tools for identifying probable cases of perinatal depression or for measuring changes in depression symptom severity. We systematically reviewed the evidence on the reliability and validity of instruments to assess perinatal depression in African settings. Methods and Findings: Of 1,027 records identified through searching 7 electronic databases, we reviewed 126 full-text reports. We included 25 unique studies, which were disseminated in 26 journal articles and 1 doctoral dissertation. These enrolled 12,544 women living in nine different North and sub-Saharan African countries. Only three studies (12%) used instruments developed specifically for use in a given cultural setting. Most studies provided evidence of criterion-related validity (20 [80%]) or reliability (15 [60%]), while fewer studies provided evidence of construct validity, content validity, or internal structure. The Edinburgh postnatal depression scale (EPDS), assessed in 16 studies (64%), was the most frequently used instrument in our sample. Ten studies estimated the internal consistency of the EPDS (median estimated coefficient alpha, 0.84; interquartile range, 0.71-0.87). For the 14 studies that estimated sensitivity and specificity for the EPDS, we constructed 2 x 2 tables for each cut-off score. Using a bivariate random-effects model, we estimated a pooled sensitivity of 0.94 (95% confidence interval [CI], 0.68-0.99) and a pooled specificity of 0.77 (95% CI, 0.59-0.88) at a cut-off score of >= 9, with higher cut-off scores yielding greater specificity at the cost of lower sensitivity. Conclusions: The EPDS can reliably and validly measure perinatal depression symptom severity or screen for probable postnatal depression in African countries, but more validation studies on other instruments are needed. In addition, more qualitative research is needed to adequately characterize local understandings of perinatal depression-like syndromes in different African contexts.	[Tsai, Alexander C.; Matthews, Lynn T.] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Tsai, Alexander C.; Psaros, Christina] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Tsai, Alexander C.; Scott, Jennifer A.; Matthews, Lynn T.; Psaros, Christina] Harvard Univ, Sch Med, Boston, MA USA; [Scott, Jennifer A.; Hung, Kristin J.] Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Boston, MA 02215 USA; [Scott, Jennifer A.] Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02115 USA; [Scott, Jennifer A.] Harvard Humanitarian Initiat, Cambridge, MA USA; [Zhu, Jennifer Q.] Harvard Univ, Cambridge, MA USA; [Matthews, Lynn T.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Matthews, Lynn T.] Beth Israel Deaconess Med Ctr, Div Infect Dis, Boston, MA 02215 USA; [Tomlinson, Mark] Univ Stellenbosch, Dept Psychol, Ctr Publ Mental Hlth, ZA-7600 Stellenbosch, South Africa	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Stellenbosch University	Tsai, AC (corresponding author), Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA.	actsai@partners.org	Tsai, Alexander C./F-4247-2015	Tsai, Alexander C./0000-0001-6397-7917	U.S. National Institutes of Health (NIH) [K23 MH-096620, NIH K23 MH-095655, NIH K23 MH-096651]; National Research Foundation (South Africa); Department for International Development; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH095655, K23MH096620, K23MH096651] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Research Foundation (South Africa)(National Research Foundation - South Africa); Department for International Development; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors received no specific funding to conduct this study but acknowledge the following sources of salary support: U.S. National Institutes of Health (NIH) K23 MH-096620 (ACT), NIH K23 MH-095655 (LTM), NIH K23 MH-096651 (CP), and the National Research Foundation (South Africa) and the Department for International Development (MT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiodun OA, 2006, GEN HOSP PSYCHIAT, V28, P133, DOI 10.1016/j.genhosppsych.2005.11.002; ABIODUN OA, 1994, BRIT J PSYCHIAT, V165, P669, DOI 10.1192/bjp.165.5.669; ABIODUN OA, 1993, GEN HOSP PSYCHIAT, V15, P125, DOI 10.1016/0163-8343(93)90109-2; ADERIBIGBE YA, 1992, SOC PSYCH PSYCH EPID, V27, P280; Adewuya AO, 2006, J PSYCHOSOM OBST GYN, V27, P267, DOI 10.1080/01674820600915478; Adewuya AO, 2006, AM J PSYCHIAT, V163, P1435, DOI 10.1176/appi.ajp.163.8.1435; Adewuya AO, 2005, INT J PSYCHIAT CLIN, V9, P60, DOI 10.1080/13651500510018211; Agoub M, 2005, ARCH WOMEN MENT HLTH, V8, P37, DOI 10.1007/s00737-005-0069-9; Aidoo M, 2001, HEALTH POLICY PLANN, V16, P206, DOI 10.1093/heapol/16.2.206; Alami KM, 2006, ARCH WOMEN MENT HLTH, V9, P343, DOI 10.1007/s00737-006-0154-8; Alamo S, 2012, AIDS PATIENT CARE ST, V26, P101, DOI 10.1089/apc.2011.0279; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; [Anonymous], PRIM PSYCHIAT; Arends LR, 2008, MED DECIS MAKING, V28, P621, DOI 10.1177/0272989X08319957; Baggaley RF, 2007, TROP MED INT HEALTH, V12, P1225, DOI 10.1111/j.1365-3156.2007.01906.x; Bass JK, 2008, TROP MED INT HEALTH, V13, P1534, DOI 10.1111/j.1365-3156.2008.02160.x; Bebbington Paul, 1993, International Review of Psychiatry, V5, P145, DOI 10.3109/09540269309028305; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Beck CT, 2000, NURS RES, V49, P272, DOI 10.1097/00006199-200009000-00006; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Chibanda D, 2010, ARCH WOMEN MENT HLTH, V13, P201, DOI 10.1007/s00737-009-0073-6; Clarke K, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001541; Cooper PJ, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b974; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Coyne JC, 2000, APPL PREV PSYCHOL, V9, P101, DOI 10.1016/S0962-1849(00)80009-8; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Derogatis L R, 1974, Mod Probl Pharmacopsychiatry, V7, P79; Dewing S, 2013, J AFFECT DISORDERS, V150, P460, DOI 10.1016/j.jad.2013.04.040; Eberhard-Gran M, 2001, ACTA PSYCHIAT SCAND, V104, P243, DOI 10.1034/j.1600-0447.2001.00187.x; Elliott SA, 2000, J REPROD INFANT PSYC, V18, P297, DOI 10.1080/713683046; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; FLAHERTY JA, 1988, J NERV MENT DIS, V176, P257; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Gelfand M, 1967, Cent Afr J Med, V13, P39; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Goldberg DP, 1972, OXFORD U PRESS MONOG, V21; Guedeney N, 2000, J AFFECT DISORDERS, V61, P107, DOI 10.1016/S0165-0327(99)00186-X; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993; Hendrick V, 2000, DEPRESS ANXIETY, V11, P66, DOI 10.1002/(SICI)1520-6394(2000)11:2<66::AID-DA3>3.0.CO;2-D; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Honikman S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001222; Jaskiewicz W, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-38; Kaaya SF, 2002, ACTA PSYCHIAT SCAND, V106, P9, DOI 10.1034/j.1600-0447.2002.01205.x; Kaaya SF, 2008, INT J SOC PSYCHIATR, V54, P21, DOI 10.1177/0020764006075024; Kagee A, 2013, INT HEALTH, V5, P11, DOI 10.1093/inthealth/ihs004; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kleinman A., 1988, RETHINKING PSYCHIAT; KLEINMAN AM, 1977, SOC SCI MED, V11, P3, DOI 10.1016/0037-7856(77)90138-X; Lawrie TA, 1998, S AFR MED J, V88, P1340; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Matthey S, 2011, NEUROPSYCHIATRY-LOND, V1, P413, DOI 10.2217/NPY.11.56; Miranda JJ, 2005, PLOS MED, V2, P962, DOI 10.1371/journal.pmed.0020291; Mitchell AJ, 2007, BRIT J GEN PRACT, V57, P144; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Munoz RF, 2000, APPL PREV PSYCHOL, V9, P123, DOI 10.1016/S0962-1849(00)80010-4; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Ngo VK, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001443; Nhiwatiwa S, 1998, J EPIDEMIOL COMMUN H, V52, P262, DOI 10.1136/jech.52.4.262; Okello Elialilia S, 2006, Transcult Psychiatry, V43, P287, DOI 10.1177/1363461506064871; Patel V, 1997, ACTA PSYCHIAT SCAND, V95, P469, DOI 10.1111/j.1600-0447.1997.tb10134.x; Patel V., 1995, Central African Journal of Medicine, V41, P209; PATEL V, 1995, SOC SCI MED, V40, P1291, DOI 10.1016/0277-9536(94)00231-H; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel V, 2010, LANCET, V376, P2086, DOI 10.1016/S0140-6736(10)61508-5; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rahman A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001442; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Ribeiro PS, 2008, INT J GYNECOL OBSTET, V102, P82, DOI 10.1016/j.ijgo.2008.01.025; Rochat TJ, 2011, THESIS STELLENBOSCH; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; Spies G, 2009, ARCH WOMEN MENT HLTH, V12, P69, DOI 10.1007/s00737-009-0050-0; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; STEIN G, 1992, J PSYCHOSOM RES, V36, P67, DOI 10.1016/0022-3999(92)90115-I; STEIN GS, 1980, J PSYCHOSOM RES, V24, P165, DOI 10.1016/0022-3999(80)90038-0; Taiwo O. J., 2007, Journal of Medicine in the Tropics, V9, P29; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; Tomlinson M, 2007, J AFFECT DISORDERS, V102, P191, DOI 10.1016/j.jad.2006.09.029; Tomlinson M, 2013, S AFR J INFORM MANAG, V15, DOI 10.4102/sajim.v15i1.528; Tomlinson M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001382; Tomlinson M, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001178; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51; Tomlinson M, 2009, B WORLD HEALTH ORGAN, V87, P438, DOI 10.2471/BLT.08.054353; Tsai AC, 2005, AM J MANAG CARE, V11, P478; Tsai Alexander C, 2012, J Glob Health, V2, P010302, DOI 10.7189/jogh.02.010302; Uwakwe R, 2003, ACTA PSYCHIAT SCAND, V107, P251, DOI 10.1034/j.1600-0447.2003.02477.x; Ventevogel Peter, 2013, Confl Health, V7, P3, DOI 10.1186/1752-1505-7-3; Walter SD, 2002, STAT MED, V21, P1237, DOI 10.1002/sim.1099; Weissman MM, 2006, JAMA-J AM MED ASSOC, V295, P1389, DOI 10.1001/jama.295.12.1389; Weobong B, 2009, J AFFECT DISORDERS, V113, P109, DOI 10.1016/j.jad.2008.05.009; WHIFFEN VE, 1993, J CONSULT CLIN PSYCH, V61, P485; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	98	85	86	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82521	10.1371/journal.pone.0082521	http://dx.doi.org/10.1371/journal.pone.0082521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VW	24340036	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400078
J	Xu, YC; Hu, XY; Wang, LH; Jiang, Z; Liu, XB; Yu, H; Zhang, ZC; Chen, HQ; Chen, H; Steinhoff, G; Li, J; Wang, JA				Xu, Yinchuan; Hu, Xinyang; Wang, Lihan; Jiang, Zhi; Liu, Xianbao; Yu, Hong; Zhang, Zhaocai; Chen, Huiqiang; Chen, Han; Steinhoff, Gustav; Li, Jun; Wang, Jian'an			Preconditioning via Angiotensin Type 2 Receptor Activation Improves Therapeutic Efficacy of Bone Marrow Mononuclear Cells for Cardiac Repair	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; MYOCARDIAL-INFARCTION; HEART; BRAIN; MECHANISMS; EXPRESSION; SURVIVAL; DELETION; RESTORE; DISEASE	Background: The therapeutic efficiency of bone marrow mononuclear cells (BMMNCs) autologous transplantation for myocardial infarction (MI) remains low. Here we developed a novel strategy to improve cardiac repair by preconditioning BMMNCs via angiotensin II type 2 receptor (AT2R) stimulation. Methods and Results: Acute MI in rats led to a significant increase of AT2R expression in BMMNCs. Preconditioning of BMMNCs via AT2R stimulation directly with an AT2R agonist CGP42112A or indirectly with angiotensin II plus AT1R antagonist valsartan led to ERK activation and increased eNOS expression as well as subsequent nitric oxide generation, ultimately improved cardiomyocyte protection in vitro as measured by co-culture approach. Intramyocardial transplantation of BMMNCs preconditioned via AT2R stimulation improved survival of transplanted cells in ischemic region of heart tissue and reduced cardiomyocyte apoptosis and inflammation at 3 days after MI. At 4 weeks after transplantation, compared to DMEM and non-preconditioned BMMNCs group, AT2R stimulated BMMNCs group showed enhanced vessel density in peri-infarct region and attenuated infarct size, leading to global heart function improvement. Conclusions: Preconditioning of BMMNCs via AT2R stimulation exerts protective effect against MI. Stimulation of AT2R in BMMNCs may provide a new strategy to improving therapeutic efficiency of stem cells for post MI cardiac repair.	[Xu, Yinchuan; Hu, Xinyang; Wang, Lihan; Jiang, Zhi; Liu, Xianbao; Yu, Hong; Zhang, Zhaocai; Chen, Huiqiang; Chen, Han; Wang, Jian'an] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Dept Cardiol, Hangzhou 310003, Zhejiang, Peoples R China; [Xu, Yinchuan; Hu, Xinyang; Wang, Lihan; Jiang, Zhi; Liu, Xianbao; Yu, Hong; Zhang, Zhaocai; Chen, Huiqiang; Chen, Han; Wang, Jian'an] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Cardiovasc Key Lab Zhejiang Prov, Hangzhou 310003, Zhejiang, Peoples R China; [Steinhoff, Gustav] Univ Rostock, Reference & Translat Ctr Cardiac Stem Cell Therap, D-18055 Rostock, Germany; [Li, Jun] Shanghai Jiao Tong Univ, Sch Med, Clin Stem Cell Res Ctr, Shanghai 200030, Peoples R China; [Li, Jun] Shanghai Jiao Tong Univ, Sch Med, Dept Cardiovasc Surg, Renji Hosp, Shanghai 200030, Peoples R China	Zhejiang University; Zhejiang University; University of Rostock; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Li, J (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Clin Stem Cell Res Ctr, Shanghai 200030, Peoples R China.	jun.li@sjtu.edu.cn; jian_an_wang@yahoo.com	Steinhoff, Gustav/AAB-1848-2020; Chen, Han/AAA-8050-2021; Zhang, Zhaocai/AAS-3160-2020	Chen, Han/0000-0002-6412-0808; 	National Natural Science Foundation of China [31000650, 81170308]; International Joint Research Project of National Natural Science Foundation of China [81128003]; International Cooperation Major Foundation of Zhejiang Province [2009C14009]; Project of Health Bureau of Zhejiang Province [2011ZDA010]; Shanghai Pujiang Program [13PJ1405800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Joint Research Project of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Major Foundation of Zhejiang Province; Project of Health Bureau of Zhejiang Province; Shanghai Pujiang Program(Shanghai Pujiang Program)	This work was supported by grants from the National Natural Science Foundation of China (No. 31000650 and 81170308), International Joint Research Project of National Natural Science Foundation of China (No. 81128003), International Cooperation Major Foundation of Zhejiang Province (No. 2009C14009), Project of Health Bureau of Zhejiang Province (No 2011ZDA010) and Shanghai Pujiang Program (13PJ1405800). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Benndorf R, 2003, CIRC RES, V93, P438, DOI 10.1161/01.RES.0000088358.99466.04; Calvert JW, 2009, CARDIOVASC RES, V83, P195, DOI 10.1093/cvr/cvp079; Clifford DM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub3; Coyne TM, 2006, STEM CELLS, V24, P2483, DOI 10.1634/stemcells.2006-0174; Della Bona R, 2011, CURR PHARM DESIGN, V17, P4172, DOI 10.2174/138161211798764771; Gajarsa JJ, 2011, HEART FAIL REV, V16, P13, DOI 10.1007/s10741-010-9181-7; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Haider KH, 2012, PROG MOL BIOL TRANSL, V111, P323, DOI 10.1016/B978-0-12-398459-3.00015-0; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Hoke NN, 2012, STEM CELLS, V30, P326, DOI 10.1002/stem.789; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Iwanami J, 2008, STROKE, V39, P2554, DOI 10.1161/STROKEAHA.107.513275; Iwanami J, 2011, HYPERTENSION, V58, P404, DOI 10.1161/HYPERTENSIONAHA.111.177873; Kaschina E, 2008, CIRCULATION, V118, P2523, DOI 10.1161/CIRCULATIONAHA.108.784868; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; LEENEN FHH, 1995, CIRC RES, V77, P993, DOI 10.1161/01.RES.77.5.993; Li JU, 2007, AM J PHYSIOL-CELL PH, V292, pC2185, DOI 10.1152/ajpcell.00204.2006; Lovell MJ, 2010, ATHEROSCLEROSIS, V213, P67, DOI 10.1016/j.atherosclerosis.2010.07.045; Ludwig M, 2012, CAN J PHYSIOL PHARM, V90, P287, DOI [10.1139/Y11-108, 10.1139/y11-108]; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Matsubara H, 1998, CIRC RES, V83, P1182, DOI 10.1161/01.RES.83.12.1182; Menasche P, 2011, J MOL CELL CARDIOL, V50, P258, DOI 10.1016/j.yjmcc.2010.06.010; Min JY, 1999, J PHARMACOL EXP THER, V291, P1038; Nabel EG, 2012, NEW ENGL J MED, V366, P54, DOI 10.1056/NEJMra1112570; Numasawa Y, 2011, STEM CELLS, V29, P1405, DOI 10.1002/stem.691; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Sasaki K, 2006, P NATL ACAD SCI USA, V103, P14537, DOI 10.1073/pnas.0604144103; Strawn WB, 2004, BRIT J HAEMATOL, V126, P120, DOI 10.1111/j.1365-2141.2004.04998.x; Tongers J, 2011, EUR HEART J, V32, P1197, DOI 10.1093/eurheartj/ehr018; van der Laan AM, 2009, NAT REV CARDIOL, V6, P515, DOI 10.1038/nrcardio.2009.103; Wen ZZ, 2011, J CELL MOL MED, V15, P1032, DOI 10.1111/j.1582-4934.2010.01255.x; Yasuda T, 2005, J THORAC CARDIOV SUR, V129, P904, DOI 10.1016/j.jtcvs.2004.06.027; Yayama K, 2006, HYPERTENSION, V48, P958, DOI 10.1161/01.HYP.0000244108.30909.27; Yoon CH, 2010, CIRCULATION, V121, P2001, DOI 10.1161/CIRCULATIONAHA.109.909291	35	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82997	10.1371/journal.pone.0082997	http://dx.doi.org/10.1371/journal.pone.0082997			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340072	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400108
J	Zuo, XY; Rao, SQ; Fan, A; Lin, MH; Li, HL; Zhao, XL; Qin, JH				Zuo, Xiaoyu; Rao, Shaoqi; Fan, An; Lin, Meihua; Li, Haoli; Zhao, Xiaolei; Qin, Jiheng			To Control False Positives in Gene-Gene Interaction Analysis: Two Novel Conditional Entropy-Based Approaches	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MUTUAL INFORMATION; ENVIRONMENT INTERACTIONS; LINKAGE DISEQUILIBRIUM; COMPUTATIONAL ANALYSIS; P53 ARG72PRO; POLYMORPHISMS; MDM2; EPISTASIS; TESTS	Genome-wide analysis of gene-gene interactions has been recognized as a powerful avenue to identify the missing genetic components that can not be detected by using current single-point association analysis. Recently, several model-free methods (e.g. the commonly used information based metrics and several logistic regression-based metrics) were developed for detecting non-linear dependence between genetic loci, but they are potentially at the risk of inflated false positive error, in particular when the main effects at one or both loci are salient. In this study, we proposed two conditional entropy-based metrics to challenge this limitation. Extensive simulations demonstrated that the two proposed metrics, provided the disease is rare, could maintain consistently correct false positive rate. In the scenarios for a common disease, our proposed metrics achieved better or comparable control of false positive error, compared to four previously proposed model-free metrics. In terms of power, our methods outperformed several competing metrics in a range of common disease models. Furthermore, in real data analyses, both metrics succeeded in detecting interactions and were competitive with the originally reported results or the logistic regression approaches. In conclusion, the proposed conditional entropy-based metrics are promising as alternatives to current model-based approaches for detecting genuine epistatic effects.	[Zuo, Xiaoyu; Rao, Shaoqi; Fan, An] Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Rao, Shaoqi; Lin, Meihua; Li, Haoli; Zhao, Xiaolei; Qin, Jiheng] Guangdong Med Coll, Inst Med Syst Biol, Dongguan, Peoples R China; [Rao, Shaoqi; Lin, Meihua; Li, Haoli; Zhao, Xiaolei; Qin, Jiheng] Guangdong Med Coll, Dept Med Stat & Epidemiol, Dongguan, Peoples R China	Sun Yat Sen University; Guangdong Medical University; Guangdong Medical University	Rao, SQ (corresponding author), Sun Yat Sen Univ, Dept Med Stat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	raoshaoq@gdmc.edu.cn		Rao, Shaoqi/0000-0001-7809-3700	National Natural Science Foundation of China [30830104, 31071166]; Natural Science Foundation of Guangdong Province, China [8251008901000007]; Science and Technology Planning Project of Guangdong Province [2009A030301004]; Dongguan City Science and Technology Project [2011108101015]; Guangdong Medical College [XG1001, XZ1105, STIF201122, JB1214]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangdong Province; Dongguan City Science and Technology Project; Guangdong Medical College	This work was supported in part by the National Natural Science Foundation of China (grant nos. 30830104 and 31071166), Natural Science Foundation of Guangdong Province, China (grant no. 8251008901000007), Science and Technology Planning Project of Guangdong Province (grant no. 2009A030301004), Dongguan City Science and Technology Project (grant no. 2011108101015) and the grants from Guangdong Medical College (grant nos. XG1001, XZ1105, STIF201122, JB1214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktulga HM, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/14741; Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brillinger DR., 2004, BRAZ J PROBAB STAT, V18, P163; Chanda P, 2009, EUR J HUM GENET, V17, P1274, DOI 10.1038/ejhg.2009.38; Cheng PE, 2007, J DATA SCI, V5, P297; Cheng PE, 2010, J AM STAT ASSOC, V105, P740, DOI 10.1198/jasa.2010.tm09061; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cordell HJ, 2002, HUM MOL GENET, V11, P2463, DOI 10.1093/hmg/11.20.2463; Cox DG, 2007, CANCER CAUSE CONTROL, V18, P621, DOI 10.1007/s10552-007-9004-x; Dong CZ, 2008, EUR J HUM GENET, V16, P229, DOI 10.1038/sj.ejhg.5201921; Edwards TL, 2008, LECT NOTES COMPUT SC, V4973, P24, DOI 10.1007/978-3-540-78757-0_3; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; GREENLAND S, 1993, ENVIRON HEALTH PERSP, V101, P59, DOI 10.2307/3431660; Hallgrimsdottir IB, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-17; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hoyer D, 2002, MED ENG PHYS, V24, P33, DOI 10.1016/S1350-4533(01)00120-5; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Khan S, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026209; Kim S, 2010, GENET EPIDEMIOL, V34, P67, DOI 10.1002/gepi.20436; Kingsmore SF, 2007, BIOMARK INSIGHTS, V2, P283; Li CX, 2008, GENE, V408, P104, DOI 10.1016/j.gene.2007.10.028; Li WT, 2000, HUM HERED, V50, P334, DOI 10.1159/000022939; Li X, 2004, NUCLEIC ACIDS RES, V32, P2685, DOI 10.1093/nar/gkh563; Lunetta KL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-32; Moore JH, 2004, EXPERT REV MOL DIAGN, V4, P795, DOI 10.1586/14737159.4.6.795; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Rao SQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026435; Schork NJ, 2009, CURR OPIN GENET DEV, V19, P212, DOI 10.1016/j.gde.2009.04.010; Thomas D, 2010, ANNU REV PUBL HEALTH, V31, P21, DOI 10.1146/annurev.publhealth.012809.103619; Thomas D, 2010, NAT REV GENET, V11, P259, DOI 10.1038/nrg2764; Thomas M, 1999, MOL CELL BIOL, V19, P1092; Thomas MC, 2006, ELEMENTS INFORM THEO; Ueki M, 2012, PLOS GENET, V8, P141, DOI 10.1371/journal.pgen.1002625; VanderWeele TJ, 2010, NAT REV GENET, V11, P166, DOI 10.1038/nrg2579-c1; Wang XF, 2010, HUM HERED, V70, P269, DOI 10.1159/000321967; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Witte JS, 2010, ANNU REV PUBL HEALTH, V31, P9, DOI 10.1146/annurev.publhealth.012809.103723; Wu XS, 2008, EUR J HUM GENET, V16, P644, DOI 10.1038/sj.ejhg.5202004; Wu XS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001131; Wu XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004578; Yang M, 2007, CARCINOGENESIS, V28, P1996, DOI 10.1093/carcin/bgm168; Yoon YJ, 2008, CARCINOGENESIS, V29, P1192, DOI 10.1093/carcin/bgn090; Zhang XM, 2006, HUM MUTAT, V27, P110, DOI 10.1002/humu.20277; Zhao JY, 2006, AM J HUM GENET, V79, P831, DOI 10.1086/508571	47	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81984	10.1371/journal.pone.0081984	http://dx.doi.org/10.1371/journal.pone.0081984			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339984	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400055
J	Kutmon, M; Kelder, T; Mandaviya, P; Evelo, CTA; Coort, SL				Kutmon, Martina; Kelder, Thomas; Mandaviya, Pooja; Evelo, Chris T. A.; Coort, Susan L.			CyTargetLinker: A Cytoscape App to Integrate Regulatory Interactions in Network Analysis	PLOS ONE			English	Article							GENE; INSIGHTS	Introduction: The high complexity and dynamic nature of the regulation of gene expression, protein synthesis, and protein activity pose a challenge to fully understand the cellular machinery. By deciphering the role of important players, including transcription factors, microRNAs, or small molecules, a better understanding of key regulatory processes can be obtained. Various databases contain information on the interactions of regulators with their targets for different organisms, data recently being extended with the results of the ENCODE (Encyclopedia of DNA Elements) project. A systems biology approach integrating our understanding on different regulators is essential in interpreting the regulation of molecular biological processes. Implementation: We developed CyTargetLinker (http://projects.bigcat.unimaas.nl/cytargetlinker), a Cytoscape app, for integrating regulatory interactions in network analysis. Recently we released CyTargetLinker as one of the first apps for Cytoscape 3. It provides a user-friendly and flexible interface to extend biological networks with regulatory interactions, such as microRNA-target, transcription factor-target and/or drug-target. Importantly, CyTargetLinker employs identifier mapping to combine various interaction data resources that use different types of identifiers. Results: Three case studies demonstrate the strength and broad applicability of CyTargetLinker, (i) extending a mouse molecular interaction network, containing genes linked to diabetes mellitus, with validated and predicted microRNAs, (ii) enriching a molecular interaction network, containing DNA repair genes, with ENCODE transcription factor and (iii) building a regulatory meta-network in which a biological process is extended with information on transcription factor, microRNA and drug regulation. Conclusions: CyTargetLinker provides a simple and extensible framework for biologists and bioinformaticians to integrate different regulatory interactions into their network analysis approaches. Visualization options enable biological interpretation of complex regulatory networks in a graphical way. Importantly the incorporation of our tool into the Cytoscape framework allows the application of CyTargetLinker in combination with a wide variety of other apps for state-of-the-art network analysis.	[Kutmon, Martina; Mandaviya, Pooja; Evelo, Chris T. A.; Coort, Susan L.] Univ Maastricht, Dept Bioinformat BiGCaT, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands; [Kutmon, Martina; Evelo, Chris T. A.] Netherlands Consortium Syst Biol NCSB, Amsterdam, Netherlands; [Kelder, Thomas] TNO, Res Grp Microbiol & Syst Biol, NL-3700 AJ Zeist, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC); Netherlands Organization Applied Science Research	Kutmon, M (corresponding author), Univ Maastricht, Dept Bioinformat BiGCaT, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands.	mkutmon@gmail.com	Coort, Susan/ABF-1021-2021; Kutmon, Martina/AAT-2718-2021; Evelo, Chris TA/D-2914-2009	Kutmon, Martina/0000-0002-7699-8191; Evelo, Chris TA/0000-0002-5301-3142; Coort, Susan/0000-0003-1224-9690	Netherlands Consortium for Systems Biology (NCSB) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research	Netherlands Consortium for Systems Biology (NCSB) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was (co)financed by the Netherlands Consortium for Systems Biology (NCSB) which is part of the Netherlands Genomics Initiative/Netherlands Organisation for Scientific Research (http://www.ncsb.org). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ade AS, 2007, GENE2MESH; Apweiler R, 2012, NUCLEIC ACIDS RES, V40, pD71, DOI 10.1093/nar/gkr981; Avila-Campillo I, 2007, BIOINFORMATICS, V23, P392, DOI 10.1093/bioinformatics/btl604; Bentley DR, 2000, MED RES REV, V20, P189, DOI 10.1002/(SICI)1098-1128(200005)20:3<189::AID-MED2>3.0.CO;2-#; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Flicek P, 2012, NUCL ACIDS RES; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Heneghan HM, 2009, J ONCOL, V2009, DOI DOI 10.1155/2010/950201; Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074; Kida K, 2011, PHARM RES-DORDR, V28, P2467, DOI 10.1007/s11095-011-0473-y; Knox C, 2011, NUCLEIC ACIDS RES, V39, pD1035, DOI 10.1093/nar/gkq1126; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagana A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562; Nelson SJ, 2004, ST HEAL T, V107, P67; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pico AR, 2008, PLOS BIOL, V6, P1403, DOI 10.1371/journal.pbio.0060184; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schafer SA, 2011, DIABETES RES CLIN PR, V93, pS9, DOI 10.1016/S0168-8227(11)70008-0; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; van Iersel MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-5; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031	28	89	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82160	10.1371/journal.pone.0082160	http://dx.doi.org/10.1371/journal.pone.0082160			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340000	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100088
J	Chopra, M; Kraus, S; Schwinn, S; Ritz, M; Mattenheimer, K; Mottok, A; Rosenwald, A; Einsele, H; Beilhack, A				Chopra, Martin; Kraus, Sabrina; Schwinn, Stefanie; Ritz, Miriam; Mattenheimer, Katharina; Mottok, Anja; Rosenwald, Andreas; Einsele, Hermann; Beilhack, Andreas			Non-Invasive Bioluminescence Imaging to Monitor the Immunological Control of a Plasmablastic Lymphoma-Like B Cell Neoplasia after Hematopoietic Cell Transplantation	PLOS ONE			English	Article							DISTINGUISHING BURKITT-LYMPHOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; C-MYC; DISEASE; TRANSLOCATION; MORPHOLOGY; FEATURES; TUMOR; GENE	To promote cancer research and to develop innovative therapies, refined pre-clinical mouse tumor models that mimic the actual disease in humans are of dire need. A number of neoplasms along the B cell lineage are commonly initiated by a translocation recombining c-myc with the immunoglobulin heavy-chain gene locus. The translocation is modeled in the C.129S1-Igha(tm1(Myc)Janz)/J mouse which has been previously engineered to express c-myc under the control of the endogenous IgH promoter. This transgenic mouse exhibits B cell hyperplasia and develops diverse B cell tumors. We have isolated tumor cells from the spleen of a C.129S1-Igha(tm1(Myc)Janz)/J mouse that spontaneously developed a plasmablastic lymphoma-like disease. These cells were cultured, transduced to express eGFP and firefly luciferase, and gave rise to a highly aggressive, transplantable B cell lymphoma cell line, termed IM380. This model bears several advantages over other models as it is genetically induced and mimics the translocation that is detectable in a number of human B cell lymphomas. The growth of the tumor cells, their dissemination, and response to treatment within immunocompetent hosts can be imaged non-invasively in vivo due to their expression of firefly luciferase. IM380 cells are radioresistant in vivo and mice with established tumors can be allogeneically transplanted to analyze graft-versus-tumor effects of transplanted T cells. Allogeneic hematopoietic stem cell transplantation of tumor-bearing mice results in prolonged survival. These traits make the IM380 model very valuable for the study of B cell lymphoma pathophysiology and for the development of innovative cancer therapies.	[Chopra, Martin; Kraus, Sabrina; Schwinn, Stefanie; Ritz, Miriam; Mattenheimer, Katharina; Einsele, Hermann; Beilhack, Andreas] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany; [Chopra, Martin; Kraus, Sabrina; Schwinn, Stefanie; Ritz, Miriam; Mattenheimer, Katharina; Beilhack, Andreas] Univ Wurzburg, Ctr Interdisciplinary Clin Res, D-97070 Wurzburg, Germany; [Mottok, Anja; Rosenwald, Andreas] Univ Wurzburg, Inst Pathol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Beilhack, A (corresponding author), Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany.	beilhack_a@ukw.de	Mottok, Anja/AAO-1801-2021	Kraus, Sabrina/0000-0001-8954-4220; Mottok, Anja/0000-0003-3125-0494	Deutsche Forschungsgemeinschaft [SFB TR 52 Z2, KFO 216 Z1]; Else-Kroner-Fresenius-Stiftung [2010_ Kolleg.52]; Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg [B-233]; German Research Foundation (DFG); University of Wuerzburg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else-Kroner-Fresenius-Stiftung; Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the Deutsche Forschungsgemeinschaft (grants SFB TR 52 Z2, KFO 216 Z1), the Else-Kroner-Fresenius-Stiftung (2010_ Kolleg.52), and the Interdisziplinare Zentrum fur Klinische Forschung der Universitat Wurzburg (grant B-233). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attarbaschi A, 2007, LEUKEMIA, V21, P1110, DOI 10.1038/sj.leu.2404608; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Blum KA, 2004, BLOOD, V104, P3009, DOI 10.1182/blood-2004-02-0405; Cheon DJ, 2011, ANNU REV PATHOL-MECH, V6, P95, DOI 10.1146/annurev.pathol.3.121806.154244; Chopra M, 2013, CARCINOGENESIS, V34, P1296, DOI 10.1093/carcin/bgt038; Choy G, 2003, BIOTECHNIQUES, V35, P1022, DOI 10.2144/03355rr02; Chuang SS, 2007, AM J CLIN PATHOL, V128, P558, DOI 10.1309/EQJR3D3V0CCQGP04; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; Cortelazzo S, 2011, CRIT REV ONCOL HEMAT, V79, P330, DOI 10.1016/j.critrevonc.2010.12.003; Cultrera JL, 2012, CANCER CONTROL, V19, P204, DOI 10.1177/107327481201900305; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; Dib Amel, 2008, J Natl Cancer Inst Monogr, P25, DOI 10.1093/jncimonographs/lgn011; Donnou S, 2012, ADV HEMATOL; Ferry JA, 2006, ONCOLOGIST, V11, P375, DOI 10.1634/theoncologist.11-4-375; Frost M, 2004, AM J CLIN PATHOL, V121, P384, DOI 10.1309/8WYNVUTGV9RPHUQH; Gaur S, 2013, LYMPHOMA; God JM, 2011, J CLIN CELL IMMUNOL, pe103; GOULD J, 1988, BLOOD, V71, P453; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Kelemen K, 2010, AM J CLIN PATHOL, V134, P127, DOI 10.1309/AJCP93LJPTRQPDKR; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Lin P, 2000, AM J SURG PATHOL, V24, P1480, DOI 10.1097/00000478-200011000-00003; McClure RE, 2005, AM J SURG PATHOL, V29, P1652, DOI 10.1097/01.pas.0000180442.87022.08; Mori S, 2008, CANCER RES, V68, P8525, DOI 10.1158/0008-5472.CAN-08-1329; Mussolin L, 2007, J CLIN ONCOL, V25, P5254, DOI 10.1200/JCO.2007.11.3159; Navid F, 1999, LEUKEMIA, V13, P135, DOI 10.1038/sj.leu.2401244; Niitsu N, 2010, INT J HEMATOL, V92, P231, DOI 10.1007/s12185-010-0666-x; O'Connell FP, 2004, AM J CLIN PATHOL, V121, P254, DOI 10.1309/617DWB5GNFWXHW4L; Park SS, 2005, CANCER RES, V65, P1306, DOI 10.1158/0008-5472.CAN-04-0268; Prochazka V, 2012, ISRN IMMUNOLOGY; ROSS DD, 1989, CANCER RES, V49, P3776; Schniederjan SD, 2010, AM J CLIN PATHOL, V133, P718, DOI 10.1309/AJCP0XQDGKFR0HTW; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; Teruya-Feldstein J, 2004, ANN ONCOL, V15, P1673, DOI 10.1093/annonc/mdh399; Zuo Z, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-123	36	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81320	10.1371/journal.pone.0081320	http://dx.doi.org/10.1371/journal.pone.0081320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349055	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800016
J	Liu, ZQ; Xu, JD; Li, HY; Zheng, YH; He, J; Liu, H; Zhong, YP; Lu, Y; Hong, BX; Zhang, MJ; Lin, P; Du, J; Hou, J; Qian, JF; Kwak, LW; Yi, Q; Yang, J				Liu, Zhiqiang; Xu, Jingda; Li, Haiyan; Zheng, Yuhuan; He, Jin; Liu, Huan; Zhong, Yuping; Lu, Yong; Hong, Bangxing; Zhang, Mingjun; Lin, Pei; Du, Juan; Hou, Jian; Qian, Jianfei; Kwak, Larry W.; Yi, Qing; Yang, Jing			Bone Marrow Stromal Cells Derived MCP-1 Reverses the Inhibitory Effects of Multiple Myeloma Cells on Osteoclastogenesis by Upregulating the RANK Expression	PLOS ONE			English	Article							KAPPA-B LIGAND; FORMATION IN-VITRO; RECEPTOR ACTIVATOR; DISEASE; MICROENVIRONMENT; OSTEOPROTEGERIN; PATHOGENESIS; MECHANISMS; RANKL/RANK; EXPANSION	Multiple myeloma (MM) cells are responsible for aberrant osteoclast (OC) activation. However, when cocultured monocytes, but not OC precursors, with MM cells, we made a novel observation that MM cells inhibited receptor activator of nuclear factor kappa B ligand (RANKL)-induced increase of OC differentiation, OC gene expression, signaling pathways and bone resorption activity. Our results showed that MM cells produced multiple inhibitory cytokines of osteoclastogenesis, such as IL-10, which activated STAT3 signaling and induce OC inhibition. However, cocultures of bone marrow stromal cells (BMSCs) reversed MM-induced OC inhibition. We found that MM cells increased production of MCP-1 from BMSCs and BMSC-derived MCP-1 enhanced OC formation. Mechanistic studies showed that IL-10 downregulated RANK expression in monocytes and thus, inhibited RANKL-induced OC formation. In contrast, MCP-1 upregulated RANK expression and thus, enhanced OC formation. Overall, our studies for the first time demonstrated that MM cell have inhibitory effects on osteoclastogenesis by producing inhibitory cytokines. Our results further indicate that activation of osteoclastogenesis in bone marrow requests the crosstalk of MM cells, BMSCs and their produced cytokines. Thus, our studies provide evidences that targeting bone marrow microenvironmental cells and/or cytokines may be a new approach to treating MM bone destruction.	[Liu, Zhiqiang; Xu, Jingda; He, Jin; Liu, Huan; Zhong, Yuping; Kwak, Larry W.; Yang, Jing] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Div Canc Med, Ctr Canc Immunol Res, Houston, TX 77030 USA; [Li, Haiyan; Zheng, Yuhuan; Lu, Yong; Hong, Bangxing; Zhang, Mingjun; Qian, Jianfei; Yi, Qing] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Lin, Pei] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Du, Juan; Hou, Jian] Second Mil Med Univ, Changzheng Hosp, Myeloma & Lymphoma Ctr, Dept Hematol, Shanghai, Peoples R China	University of Texas System; UTMD Anderson Cancer Center; Cleveland Clinic Foundation; University of Texas System; UTMD Anderson Cancer Center; Naval Medical University	Yang, J (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Div Canc Med, Ctr Canc Immunol Res, Houston, TX 77030 USA.	jiyang@mdanderson.org	Liu, Zhiqiang/E-6950-2014; Lu, Young/E-8451-2014; zhang, mingjun/H-8303-2014	Liu, Zhiqiang/0000-0002-0677-8097; Kwak, Larry/0000-0002-1884-5349	National Cancer Institute K99/R00 grant [CA137158]; American Society of Hematology; National Cancer Institute R01 grants [CA138402, CA138398, P50 CA142509]; NATIONAL CANCER INSTITUTE [R00CA137158, P50CA142509, R01CA138402, R01CA138398, K99CA137158] Funding Source: NIH RePORTER	National Cancer Institute K99/R00 grant; American Society of Hematology; National Cancer Institute R01 grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute K99/R00 grant CA137158 (J. Yang); American Society of Hematology (J. Yang); and National Cancer Institute R01 grants CA138402, CA138398, and P50 CA142509 (Q. Yi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Masahiro, 2011, Clin Calcium, V21, P1167, DOI CliCa110811671174; Abe Masahiro, 2010, Clin Calcium, V20, P1474, DOI CliCa101014741480; Aggarwal R, 2006, EXP HEMATOL, V34, P1289, DOI 10.1016/j.exphem.2006.06.017; Anderson KC, 2011, ANNU REV PATHOL-MECH, V6, P249, DOI 10.1146/annurev-pathol-011110-130249; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Athanasou NA, 2011, SKELETAL RADIOL, V40, P1137, DOI 10.1007/s00256-011-1180-9; Binder NB, 2009, NAT MED, V15, P417, DOI 10.1038/nm.1945; Boyce BF, 2012, EUR J CLIN INVEST, V42, P1332, DOI 10.1111/j.1365-2362.2012.02717.x; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; CAFFORIO P, 2013, J BONE MINER RES, P87729; Cao HL, 2010, J CLIN INVEST, V120, P2755, DOI 10.1172/JCI42106; Collin-Osdoby P, 2003, METH MOLEC MED, V80, P153; De Raeve HR, 2005, HISTOL HISTOPATHOL, V20, P1227, DOI 10.14670/HH-20.1227; Dougall WC, 2012, CLIN CANCER RES, V18, P326, DOI 10.1158/1078-0432.CCR-10-2507; Farrugia AN, 2003, CANCER RES, V63, P5438; Giuliani N, 2004, EXP HEMATOL, V32, P685, DOI 10.1016/j.exphem.2004.03.015; Giuliani N, 2002, BLOOD, V100, P4615, DOI 10.1182/blood-2002-04-1121; Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; He J, 2012, CANCER RES, V72, P6393, DOI 10.1158/0008-5472.CAN-12-2664; Hecht M, 2008, EXP CELL RES, V314, P1082, DOI 10.1016/j.yexcr.2007.10.021; Heider U, 2003, CLIN CANCER RES, V9, P1436; Helfrich MH, 2005, ARCH ORAL BIOL, V50, P115, DOI 10.1016/j.archoralbio.2004.11.016; Ivashkiv LB, 2011, ANN NY ACAD SCI, V1237, P88, DOI 10.1111/j.1749-6632.2011.06217.x; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kim MS, 2006, J BIOL CHEM, V281, P1274, DOI 10.1074/jbc.M510156200; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; KOVACIC N, 2013, CALCIFIED TISSUE INT, P46000; Lee SK, 2008, MOL CELLS, V26, P67; Lee SK, 2006, BONE, V38, P678, DOI 10.1016/j.bone.2005.10.011; Lee SK, 2006, CURR OPIN RHEUMATOL, V18, P411, DOI 10.1097/01.bor.0000231911.42666.78; Leibbrandt A, 2009, ADV EXP MED BIOL, V649, P100; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Nakashima T, 2011, ANN NY ACAD SCI, V1240, pE13, DOI 10.1111/j.1749-6632.2011.06373.x; Park-Min KH, 2009, J IMMUNOL, V183, P2444, DOI 10.4049/jimmunol.0804165; Roodman GD, 2009, LEUKEMIA, V23, P435, DOI 10.1038/leu.2008.336; ROODMAN GD, 1995, BONE, V17, pS57, DOI 10.1016/8756-3282(95)00179-H; Seidel C, 2001, BLOOD, V98, P2269, DOI 10.1182/blood.V98.7.2269; Sezer O, 2003, BLOOD, V101, P2094, DOI 10.1182/blood-2002-09-2684; Tai YT, 2012, BLOOD; Tanaka S, 2007, AM J NEPHROL, V27, P466, DOI 10.1159/000106484; Tolar J, 2004, NEW ENGL J MED, V351, P2839, DOI 10.1056/NEJMra040952; Vaananen HK, 2008, ARCH BIOCHEM BIOPHYS, V473, P132, DOI 10.1016/j.abb.2008.03.037; Xing LP, 2005, IMMUNOL REV, V208, P19, DOI 10.1111/j.0105-2896.2005.00336.x; Yaccoby S, 2006, HAEMATOL-HEMATOL J, V91, P192; Yaccoby S, 2004, CANCER RES, V64, P2016, DOI 10.1158/0008-5472.CAN-03-1131; Yao ZQ, 2008, J BIOL CHEM, V283, P9917, DOI 10.1074/jbc.M706415200	47	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82453	10.1371/journal.pone.0082453	http://dx.doi.org/10.1371/journal.pone.0082453			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340030	gold, Green Submitted, Green Published			2022-12-27	WOS:000328707400076
J	Schmitz, N; Gariepy, G; Smith, KJ; Malla, A; Boyer, R; Strychar, I; Lesage, A; Wang, JL				Schmitz, Norbert; Gariepy, Genevieve; Smith, Kimberley J.; Malla, Ashok; Boyer, Richard; Strychar, Irene; Lesage, Alain; Wang, JianLi			Trajectories of Self-Rated Health in People with Diabetes: Associations with Functioning in a Prospective Community Sample	PLOS ONE			English	Article							OLDER-ADULTS; SOCIOECONOMIC-STATUS; UNITED-STATES; SAS PROCEDURE; DEPRESSION; MORTALITY; PATTERNS; DISABILITY	Background: Self-rated health (SRH) is a single-item measure that is one of the most widely used measures of general health in population health research. Relatively little is known about changes and the trajectories of SRH in people with chronic medical conditions. The aims of the present study were to identify and describe longitudinal trajectories of self-rated health (SRH) status in people with diabetes. Methods: A prospective community study was carried out between 2008 and 2011. SRH was assessed at baseline and yearly at follow-ups (n=1288). Analysis was carried out through trajectory modeling. The trajectory groups were subsequently compared at 4 years follow-up with respect to functioning. Results: Four distinct trajectories of SRH were identified: 1) 72.2% of the participants were assigned to a persistently good SRH trajectory; 2) 10.1% were assigned to a persistently poor SRH trajectory; 3) mean SRH scores changed from good to poor for one group (7.3%); while 4) mean SRH scores changed from poor to medium/good for another group (10.4%). Those with a persistently poor perception of health status were at higher risk for poor functioning at 4 years follow-up than those whose SRH scores decreased from good to poor. Conclusions: SRH is an important predictor for poor functioning in diabetes, but the trajectory of SRH seems to be even more important. Health professionals should pay attention to not only SRH per se, but also changes in SRH over time.	[Schmitz, Norbert; Smith, Kimberley J.; Malla, Ashok] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Schmitz, Norbert; Gariepy, Genevieve; Smith, Kimberley J.; Malla, Ashok] Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Schmitz, Norbert; Gariepy, Genevieve; Malla, Ashok] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada; [Schmitz, Norbert; Strychar, Irene] Montreal Diabet Res Ctr, Montreal, PQ, Canada; [Boyer, Richard; Lesage, Alain] Univ Montreal, Ctr Rech Fernand Seguin, Hop Louis H Lafontaine, Montreal, PQ, Canada; [Wang, JianLi] Univ Calgary, Fac Med, Dept Psychiat, Calgary, AB, Canada; [Wang, JianLi] Univ Calgary, Fac Med, Dept Community Hlth Sci, Calgary, AB, Canada; [Strychar, Irene] Univ Montreal, Fac Med, Dept Nutr, Montreal, PQ H3C 3J7, Canada; [Strychar, Irene] CRCHUM, Montreal, PQ, Canada	McGill University; McGill University; Universite de Montreal; Universite de Montreal; University of Calgary; University of Calgary; Universite de Montreal; Universite de Montreal	Schmitz, N (corresponding author), McGill Univ, Dept Psychiat, Montreal, PQ, Canada.	norbert.schmitz@mcgill.ca	Schmitz, Norbert/AAH-3624-2020; Schmitz, Norbert/A-5177-2010	Schmitz, Norbert/0000-0001-7777-6323; Smith, Kimberley/0000-0002-1323-627X	Canadian Institutes of Health Research (CIHR) [MOP-84574]; CIHR	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by Operating Grant MOP-84574 from the Canadian Institutes of Health Research (CIHR). GG was supported by a doctoral fellowship from the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews G., 2009, PLOS ONE, P4; Andruff H, 2009, TUTOR QUANT METHODS, V5, P11, DOI 10.20982/tqmp.05.1.p011; Ayyagari P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053278; Banks J, 2006, JAMA-J AM MED ASSOC, V295, P2037, DOI 10.1001/jama.295.17.2037; Benyamini Y, 2011, PSYCHOL HEALTH, V26, P1407, DOI 10.1080/08870446.2011.621703; Chwastiak LA, 2003, J CLIN EPIDEMIOL, V56, P507, DOI 10.1016/S0895-4356(03)00051-9; Diehr P, 2001, J AM GERIATR SOC, V49, P36, DOI 10.1046/j.1532-5415.2001.49007.x; Dowd JB, 2007, INT J EPIDEMIOL, V36, P1214, DOI 10.1093/ije/dym214; Fayers PM, 2002, LANCET, V359, P187, DOI 10.1016/S0140-6736(02)07466-4; Fincke BG, 2005, J AMBUL CARE MANAG, V28, P262, DOI 10.1097/00004479-200507000-00010; Foraker RE, 2011, AGE AGEING, V40, P706, DOI 10.1093/ageing/afr069; Garin O, 2010, HEALTH QUAL LIFE OUT, V19, P8, DOI DOI 10.1186/1477-7525-8-51.PUBMED:20482853; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Han B, 2005, GERONTOLOGIST, V45, P216, DOI 10.1093/geront/45.2.216; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Idler EL, 2000, AM J EPIDEMIOL, V152, P874, DOI 10.1093/aje/152.9.874; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Jones BL, 2001, SOCIOL METHOD RES, V29, P374, DOI 10.1177/0049124101029003005; Jones BL, 2007, SOCIOL METHOD RES, V35, P542, DOI 10.1177/0049124106292364; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Katon W, 2004, DIABETES CARE, V27, P914, DOI 10.2337/diacare.27.4.914; Kramers PGN, 2003, EUR J PUBLIC HEALTH, V13, P101, DOI 10.1093/eurpub/13.suppl_1.101; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018; Lee HL, 2012, ARCH GERONTOL GERIAT, V54, pE334, DOI 10.1016/j.archger.2011.10.009; Liang J, 2005, J GERONTOL B-PSYCHOL, V60, pS224, DOI 10.1093/geronb/60.4.S224; Ludman EJ, 2004, GEN HOSP PSYCHIAT, V26, P430, DOI 10.1016/j.genhosppsych.2004.08.010; Mansson NO, 2001, SCAND J PUBLIC HEALT, V29, P151, DOI 10.1177/14034948010290020201; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Pietilainen O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025004; Sacker A, 2007, AM J PUBLIC HEALTH, V97, P812, DOI 10.2105/AJPH.2006.092320; Sacker A, 2011, J EPIDEMIOL COMMUN H, V65, P130, DOI 10.1136/jech.2009.091199; Salomon JA, 2009, AM J EPIDEMIOL, V170, P343, DOI 10.1093/aje/kwp144; Sargent-Cox KA, 2010, HEALTH PSYCHOL, V29, P143, DOI 10.1037/a0017652; Schmitz N, 2009, DIABETES CARE, V32, P1998, DOI 10.2337/dc09-0838; World Health Organization, 1996, WHO REGIONAL PUBLICA, V58; Zajacova A, 2011, AM J EPIDEMIOL, V174, P977, DOI 10.1093/aje/kwr204	37	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83088	10.1371/journal.pone.0083088	http://dx.doi.org/10.1371/journal.pone.0083088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VW	24340083	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400119
J	Yomosa, M; Mizuguchi, T; Hayakawa, Y				Yomosa, Makoto; Mizuguchi, Tsuyoshi; Hayakawa, Yoshinori			Spatio-Temporal Structure of Hooded Gull Flocks	PLOS ONE			English	Article							COLLECTIVE ANIMAL BEHAVIOR; DYNAMICS; MOTION; SYSTEM; FLIGHT; BIRDS	We analyzed the spatio-temporal structure of hooded gull flocks with a portable stereo camera system. The 3-dimensional positions of individuals were reconstructed from pairs of videos. The motions of each individual were analyzed, and both gliding and flapping motions were quantified based on the velocity time series. We analyzed the distributions of the nearest neighbor's position in terms of coordinates based on each individual's motion. The obtained results were consistent with the aerodynamic interaction between individuals. We characterized the leader-follower relationship between individuals by a delay time to mimic the direction of a motion. A relation between the delay time and a relative position was analyzed quantitatively, which suggested the basic properties of the formation flight that maintains order in the flock.	[Yomosa, Makoto; Mizuguchi, Tsuyoshi] Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 591, Japan; [Mizuguchi, Tsuyoshi] Japan Sci & Technol Agcy JST, PRESTO, Chiyoda Ku, Tokyo, Japan; [Hayakawa, Yoshinori] Tohoku Univ, Ctr Informat Technol Educ, Sendai, Miyagi 980, Japan	Osaka Metropolitan University; Japan Science & Technology Agency (JST); Tohoku University	Yomosa, M (corresponding author), Osaka Prefecture Univ, Dept Math Sci, Sakai, Osaka 591, Japan.	yomosa@ms.osakafu-u.ac.jp			PRESTO, JST	PRESTO, JST(Japan Science & Technology Agency (JST))	This work was supported by PRESTO, JST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Ballerini M, 2008, ANIM BEHAV, V76, P201, DOI 10.1016/j.anbehav.2008.02.004; Fish F.E., 1999, Comments on Theoretical Biology, V5, P283; Hayakawa Y, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/48004; Liao JC, 2007, PHILOS T R SOC B, V362, P1973, DOI 10.1098/rstb.2007.2082; LISSAMAN PB, 1970, SCIENCE, V168, P1003, DOI 10.1126/science.168.3934.1003; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pennycuick CJ, 2008, THEOR ECOL SER, P1; POMEROY H, 1992, AUK, V109, P256; Shimoyama N, 1996, PHYS REV LETT, V76, P3870, DOI 10.1103/PhysRevLett.76.3870; Sumpter DJT, 2006, PHILOS T R SOC B, V361, P5, DOI 10.1098/rstb.2005.1733; Takita K, 2003, IEICE T FUND ELECTR, VE86A, P1925; Usherwood JR, 2011, NATURE, V474, P494, DOI 10.1038/nature10164; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670	16	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81754	10.1371/journal.pone.0081754	http://dx.doi.org/10.1371/journal.pone.0081754			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339960	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400036
J	Benz, AH; Renne, C; Maronde, E; Koch, M; Grabiec, U; Kallendrusch, S; Rengstl, B; Newrzela, S; Hartmann, S; Hansmann, ML; Dehghani, F				Benz, Alexander H.; Renne, Christoph; Maronde, Erik; Koch, Marco; Grabiec, Urszula; Kallendrusch, Sonja; Rengstl, Benjamin; Newrzela, Sebastian; Hartmann, Sylvia; Hansmann, Martin-Leo; Dehghani, Faramarz			Expression and Functional Relevance of Cannabinoid Receptor 1 in Hodgkin Lymphoma	PLOS ONE			English	Article							CANCER CELL-GROWTH; FACTOR-KAPPA-B; CB1 RECEPTOR; ALPHA-GENE; ANTAGONIST RIMONABANT; HIGH-LEVEL; INHIBITION; DISEASE; MUTATIONS; OVEREXPRESSION	Background: Cannabinoid receptor 1 (CB1) is expressed in certain types of malignancies. An analysis of CB1 expression and function in Hodgkin lymphoma (HL), one of the most frequent lymphomas, was not performed to date. Design and Methods: We examined the distribution of CB1 protein in primary cases of HL. Using lymphoma derived cell lines, the role of CB1 signaling on cell survival was investigated. Results: A predominant expression of CB1 was found in Hodgkin-Reed-Sternberg cells in a vast majority of classical HL cases. The HL cell lines L428, L540 and KM-H2 showed strong CB1-abundance and displayed a dose-dependent decline of viability under CB1 inhibition with AM251. Further, application of AM251 led to decrease of constitutively active NF kappa B/p65, a crucial survival factor of HRS-cells, and was followed by elevation of apoptotic markers in HL cells. Conclusions: The present study identifies CB1 as a feature of HL, which might serve as a potential selective target in the treatment of Hodgkin lymphoma.	[Benz, Alexander H.] Univ Giessen, Inst Pathol, D-35390 Giessen, Germany; [Benz, Alexander H.; Renne, Christoph; Rengstl, Benjamin; Newrzela, Sebastian; Hartmann, Sylvia; Hansmann, Martin-Leo] Goethe Univ Frankfurt, Inst Pathol, D-60054 Frankfurt, Germany; [Maronde, Erik; Dehghani, Faramarz] Goethe Univ Frankfurt, Inst Anat, D-60054 Frankfurt, Germany; [Koch, Marco; Kallendrusch, Sonja] Univ Leipzig, Inst Anat, D-04109 Leipzig, Germany; [Grabiec, Urszula; Dehghani, Faramarz] Univ Halle Wittenberg, Dept Anat & Cell Biol, D-06108 Halle, Germany	Justus Liebig University Giessen; Goethe University Frankfurt; Goethe University Frankfurt; Leipzig University; Martin Luther University Halle Wittenberg	Dehghani, F (corresponding author), Goethe Univ Frankfurt, Inst Anat, D-60054 Frankfurt, Germany.	faramarz.dehghani@medizin.uni-halle.de	Kallendrusch, Sonja/AAV-7179-2020; Hohmann, Urszula/ABB-7323-2020; Maronde, Erik/J-1915-2019; Hartmann, Sylvia/AAJ-4376-2021; Kallendrusch, Sonja/ABG-1789-2021	Maronde, Erik/0000-0002-5574-6323; Kallendrusch, Sonja/0000-0003-2474-8307; Grabiec, Urszula/0000-0001-8376-4767				Alexander A, 2009, CANCER LETT, V285, P6, DOI 10.1016/j.canlet.2009.04.005; Bargou RC, 1997, J CLIN INVEST, V100, P2961, DOI 10.1172/JCI119849; Bargou RC, 1996, BLOOD, V87, P4340, DOI 10.1182/blood.V87.10.4340.bloodjournal87104340; Benz AH, 2010, BRIT J PHARMACOL, V160, P1621, DOI 10.1111/j.1476-5381.2010.00812.x; Cabannes E, 1999, ONCOGENE, V18, P3063, DOI 10.1038/sj.onc.1202893; Caffarel MM, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-196; Campo E, 2011, BLOOD, V117, P5019, DOI 10.1182/blood-2011-01-293050; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Cudaback E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008702; Daaka Y, 1997, DNA CELL BIOL, V16, P301, DOI 10.1089/dna.1997.16.301; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Diehl Volker, 2003, Hematology Am Soc Hematol Educ Program, P225, DOI 10.1182/asheducation-2003.1.225; Emmerich F, 1999, BLOOD, V94, P3129, DOI 10.1182/blood.V94.9.3129.421k03_3129_3134; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Gallotta D, 2010, BIOCHEM PHARMACOL, V80, P370, DOI 10.1016/j.bcp.2010.04.023; Gazzerro P, 2010, ONCOL REP, V23, P171, DOI 10.3892/or_00000619; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2004, NEUROPHARMACOLOGY, V47, P345, DOI 10.1016/j.neuropharm.2004.07.030; Islam TC, 2003, LEUKEMIA, V17, P1880, DOI 10.1038/sj.leu.2403057; Jungnickel B, 2000, J EXP MED, V191, P395, DOI 10.1084/jem.191.2.395; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Katona I, 2008, NAT MED, V14, P923, DOI 10.1038/nm.f.1869; Koch M, 2011, HIPPOCAMPUS, V21, P554, DOI 10.1002/hipo.20772; Krappmann D, 1999, ONCOGENE, V18, P943, DOI 10.1038/sj.onc.1202351; Kraus J, 2012, ANN NY ACAD SCI, V1261, P1, DOI 10.1111/j.1749-6632.2012.06524.x; Kreutz S, 2007, EXP NEUROL, V203, P246, DOI 10.1016/j.expneurol.2006.08.010; KUPPERS R, 1994, P NATL ACAD SCI USA, V91, P10962, DOI 10.1073/pnas.91.23.10962; Kuppers Ralf, 2009, Hematology Am Soc Hematol Educ Program, P491, DOI 10.1182/asheducation-2009.1.491; Laezza C, 2010, ENDOCR-RELAT CANCER, V17, P495, DOI 10.1677/ERC-10-0009; Ligresti A, 2003, GASTROENTEROLOGY, V125, P677, DOI 10.1016/S0016-5085(03)00881-3; Marshall AD, 2011, CANCER RES, V71, P7471, DOI 10.1158/0008-5472.CAN-11-0924; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; McKallip RJ, 2005, J IMMUNOL, V174, P3281, DOI 10.4049/jimmunol.174.6.3281; Mukhopadhyay B, 2011, P NATL ACAD SCI USA, V108, P6323, DOI 10.1073/pnas.1017689108; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pertwee RG, 2010, PHARMACOL REV, V62, P588, DOI 10.1124/pr.110.003004; Pisanti S, 2013, TRENDS PHARMACOL SCI, V34, P273, DOI 10.1016/j.tips.2013.03.003; Qamri Z, 2009, MOL CANCER THER, V8, P3117, DOI 10.1158/1535-7163.MCT-09-0448; Renne C, 2005, BLOOD, V105, P4051, DOI 10.1182/blood-2004-10-4008; Renne C, 2008, LEUKEMIA RES, V32, P163, DOI 10.1016/j.leukres.2007.05.019; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Ruiz-Llorente L, 2003, PROSTATE, V54, P95, DOI 10.1002/pros.10165; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Santoro A, 2009, INT J CANCER, V125, P996, DOI 10.1002/ijc.24483; Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Wicht H, 1999, J HISTOCHEM CYTOCHEM, V47, P411, DOI 10.1177/002215549904700315; Xu XD, 2006, CANCER GENET CYTOGEN, V171, P31, DOI 10.1016/j.cancergencyto.2006.06.014	51	25	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81675	10.1371/journal.pone.0081675	http://dx.doi.org/10.1371/journal.pone.0081675			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349109	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200043
J	Rossetti, CA; Drake, KL; Siddavatam, P; Lawhon, SD; Nunes, JES; Gull, T; Khare, S; Everts, RE; Lewin, HA; Adams, LG				Rossetti, Carlos A.; Drake, Kenneth L.; Siddavatam, Prasad; Lawhon, Sara D.; Nunes, Jairo E. S.; Gull, Tamara; Khare, Sangeeta; Everts, Robin E.; Lewin, Harris A.; Adams, Leslie Garry			Systems Biology Analysis of Brucella Infected Peyer's Patch Reveals Rapid Invasion with Modest Transient Perturbations of the Host Transcriptome	PLOS ONE			English	Article							MONOCYTE-DERIVED MACROPHAGES; DENDRITIC CELL MATURATION; INNATE IMMUNE-RESPONSE; GENE-EXPRESSION; ABORTUS LIPOPOLYSACCHARIDE; MELITENSIS INFECTION; NATURALLY RESISTANT; EPITHELIAL-CELLS; ACTIVATION; PROTEIN	Brucella melitensis causes the most severe and acute symptoms of all Brucella species in human beings and infects hosts primarily through the oral route. The epithelium covering domed villi of jejunal-ileal Peyer's patches is an important site of entry for several pathogens, including Brucella. Here, we use the calf ligated ileal loop model to study temporal in vivo Brucella-infected host molecular and morphological responses. Our results document Brucella bacteremia occurring within 30 min after intraluminal inoculation of the ileum without histopathologic traces of lesions. Based on a system biology Dynamic Bayesian Network modeling approach (DBN) of microarray data, a very early transient perturbation of the host enteric transcriptome was associated with the initial host response to Brucella contact that is rapidly averted allowing invasion and dissemination. A detailed analysis revealed active expression of Syndecan 2, Integrin alpha L and Integrin beta 2 genes, which may favor initial Brucella adhesion. Also, two intestinal barrier-related pathways (Tight Junction and Trefoil Factors Initiated Mucosal Healing) were significantly repressed in the early stage of infection, suggesting subversion of mucosal epithelial barrier function to facilitate Brucella transepithelial migration. Simultaneously, the strong activation of the innate immune response pathways would suggest that the host mounts an appropriate protective immune response; however, the expression of the two key genes that encode innate immunity anti-Brucella cytokines such as TNF-alpha and IL12p40 were not significantly changed throughout the study. Furthermore, the defective expression of Toll-Like Receptor Signaling pathways may partially explain the lack of proinflammatory cytokine production and consequently the absence of morphologically detectable inflammation at the site of infection. Cumulatively, our results indicate that the in vivo pathogenesis of the early infectious process of Brucella is primarily accomplished by compromising the mucosal immune barrier and subverting critical immune response mechanisms.	[Rossetti, Carlos A.; Lawhon, Sara D.; Nunes, Jairo E. S.; Gull, Tamara; Khare, Sangeeta; Adams, Leslie Garry] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA; [Drake, Kenneth L.; Siddavatam, Prasad] Ltd Liabil Corp, Seralogix, Austin, TX USA; [Everts, Robin E.; Lewin, Harris A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	Texas A&M University System; Texas A&M University College Station; University of Illinois System; University of Illinois Urbana-Champaign	Adams, LG (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX 77843 USA.	gadams@cvm.tamu.edu	Lawhon, Sara D./G-5147-2011; LEWIN, HARRIS/HGC-6543-2022; Khare, SangeetA/Q-5470-2019	Lawhon, Sara D./0000-0001-9154-8909; LEWIN, HARRIS/0000-0002-1043-7287; Khare, SangeetA/0000-0002-9496-6636	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases Western Regional Center of Excellence [1U54 AI057156-01]; U.S. Department of Homeland Security National Center of Excellence for Foreign Animal and Zoonotic Disease Defense [ONR-N00014-04-1-0]; I.N.T.A.-Fulbright Argentina Fellowship; NIH cardiology fellowship, Cardiology Department, University of Texas Southwestern Medical Center	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases Western Regional Center of Excellence; U.S. Department of Homeland Security National Center of Excellence for Foreign Animal and Zoonotic Disease Defense; I.N.T.A.-Fulbright Argentina Fellowship; NIH cardiology fellowship, Cardiology Department, University of Texas Southwestern Medical Center	LGA and HRG were supported by grants from the National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases Western Regional Center of Excellence 1U54 AI057156-01. LGA is also supported by the U.S. Department of Homeland Security National Center of Excellence for Foreign Animal and Zoonotic Disease Defense ONR-N00014-04-1-0 grant. CAR was supported by an I.N.T.A.-Fulbright Argentina Fellowship. CLG received support from an NIH cardiology fellowship, Cardiology Department, University of Texas Southwestern Medical Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMANN MR, 1988, VET PATHOL, V25, P28, DOI 10.1177/030098588802500104; Adams LG, 2011, VACCINE, V29, P7197, DOI 10.1016/j.vaccine.2011.05.080; Adams L Garry, 2011, BMC Proc, V5 Suppl 4, pS6, DOI 10.1186/1753-6561-5-S4-S6; Adams LG, 2002, VET MICROBIOL, V90, P553, DOI 10.1016/S0378-1135(02)00235-3; Alton G. G., 1990, Animal brucellosis., P383; [Anonymous], 2000, J AM VET MED ASSOC, V216, P648; Baldi P, 2002, DNA MICROARRAYS GENE, P107; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Barquero-Calvo E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000631; Billard E, 2007, INFECT IMMUN, V75, P4980, DOI 10.1128/IAI.00637-07; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bolton AJ, 1999, MICROBIOL-SGM, V145, P2431, DOI 10.1099/00221287-145-9-2431; CAMPBELL GA, 1994, VET IMMUNOL IMMUNOP, V41, P295, DOI 10.1016/0165-2427(94)90103-1; Carpenter C.M., 1924, CORNELL VET, V14, P16; Castaneda-Roldan EI, 2004, CELL MICROBIOL, V6, P435, DOI 10.1111/j.1462-5822.2004.00372.x; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; DAVIS DS, 1988, J WILDLIFE DIS, V24, P533, DOI 10.7589/0090-3558-24.3.533; DEPANFILIS G, 1991, J INVEST DERMATOL, V96, P512, DOI 10.1111/1523-1747.ep12470220; Dimitrakopoulos O, 2013, MICROBES INFECT, V15, P450, DOI 10.1016/j.micinf.2013.04.007; Dornand J, 2002, VET MICROBIOL, V90, P383, DOI 10.1016/S0378-1135(02)00223-7; Enright F. M., 1990, Animal brucellosis., P301; Fernandez-Prada CM, 2001, INFECT IMMUN, V69, P4407, DOI 10.1128/IAI.69.7.4407-4416.2001; Finlay BB, 1997, MICROBIOL MOL BIOL R, V61, P136, DOI 10.1128/.61.2.136-169.1997; Forestier C, 2000, J IMMUNOL, V165, P5202, DOI 10.4049/jimmunol.165.9.5202; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Freissler E, 2000, CELL MICROBIOL, V2, P69, DOI 10.1046/j.1462-5822.2000.00036.x; Galdiero E, 2000, MICROBIOLOGICA, V23, P271; Galindo RC, 2009, VET IMMUNOL IMMUNOP, V127, P295, DOI 10.1016/j.vetimm.2008.10.326; Gorvel JP, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2012-c1; Gross A, 2000, INFECT IMMUN, V68, P342, DOI 10.1128/IAI.68.1.342-351.2000; Guzman-Verri C, 2001, J BIOL CHEM, V276, P44435, DOI 10.1074/jbc.M105606200; Hauck CR, 2012, CURR OPIN CELL BIOL, V24, P637, DOI 10.1016/j.ceb.2012.07.004; Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005; He YQ, 2006, INFECT IMMUN, V74, P5035, DOI 10.1128/IAI.01998-05; Henry-Stanley MJ, 2005, SHOCK, V24, P571, DOI 10.1097/01.shk.0000184286.95493.78; Khare S, 2009, VET PATHOL, V46, P717, DOI 10.1354/vp.08-VP-0187-G-FL; Khare S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042127; Lapaque N, 2006, CELL MICROBIOL, V8, P197, DOI 10.1111/j.1462-5822.2005.00609.x; Lawhon SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026869; Liautard Jean-Pierre, 1996, Microbiologia (Madrid), V12, P197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loor JJ, 2007, PHYSIOL GENOMICS, V32, P105, DOI 10.1152/physiolgenomics.00188.2007; Martirosyan A, 2011, IMMUNOL REV, V240, P211, DOI 10.1111/j.1600-065X.2010.00982.x; Nakato G, 2012, J IMMUNOL, V189, P1540, DOI 10.4049/jimmunol.1103332; Neta AVC, 2008, INFECT IMMUN, V76, P1897, DOI 10.1128/IAI.01554-07; Nikitas Georgios, 2012, Subcell Biochem, V60, P415, DOI 10.1007/978-94-007-4186-7_17; Nunes JS, 2010, VET PATHOL, V47, P322, DOI 10.1177/0300985809358037; Olsen SC, 2004, BRUCELLA, P309; Plommet M., 1977, Bovine brucellosis - an international symposium,, P116; Rossetti CA, 2011, RES VET SCI, V91, P40, DOI 10.1016/j.rvsc.2010.09.002; Rossetti CA, 2012, MICROBES INFECT, V14, P756, DOI 10.1016/j.micinf.2012.03.003; Rossetti CA, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-81; Roxas JL, 2010, LAB INVEST, V90, P1152, DOI 10.1038/labinvest.2010.91; Salcedo S, 2013, FRONTIERS CELLULAR I, V3, P1; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Santos RL, 2001, INFECT IMMUN, V69, P2293, DOI 10.1128/IAI.69.4.2293-2301.2001; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Scholz HC, 2010, INT J SYST EVOL MICR, V60, P801, DOI 10.1099/ijs.0.011148-0; Starr T, 2012, CELL HOST MICROBE, V11, P33, DOI 10.1016/j.chom.2011.12.002; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Verger J. M., 1985, Brucella melitensis. CEC seminar, Brussels, November 1984, P197; Verger JM, 1988, TECHNIQUES BRUCELLOS; Wang FK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028485; Watarai M, 2002, CELL MICROBIOL, V4, P341, DOI 10.1046/j.1462-5822.2002.00195.x; YOUNG EJ, 1995, CLIN INFECT DIS, V21, P283, DOI 10.1093/clinids/21.2.283; Zheng K, 2012, INT J BIOL SCI, V8, P1013, DOI 10.7150/ijbs.3836	67	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81719	10.1371/journal.pone.0081719	http://dx.doi.org/10.1371/journal.pone.0081719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349118	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200046
J	Sisignano, M; Angioni, C; Ferreiros, N; Schuh, CD; Suo, J; Schreiber, Y; Dawes, JM; Antunes-Martins, A; Bennett, DLH; McMahon, SB; Geisslinger, G; Scholich, K				Sisignano, Marco; Angioni, Carlo; Ferreiros, Nerea; Schuh, Claus-Dieter; Suo, Jing; Schreiber, Yannick; Dawes, John M.; Antunes-Martins, Ana; Bennett, David L. H.; McMahon, Stephen B.; Geisslinger, Gerd; Scholich, Klaus			Synthesis of Lipid Mediators during UVB-Induced Inflammatory Hyperalgesia in Rats and Mice	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; EPOXYEICOSATRIENOIC ACIDS; NOCICEPTOR SENSITIZATION; PERIPHERAL MECHANISMS; LEUKOTRIENE B-4; NITRIC-OXIDE; PAIN; EXPRESSION; HYPERSENSITIVITY; MANAGEMENT		[Sisignano, Marco; Angioni, Carlo; Ferreiros, Nerea; Schuh, Claus-Dieter; Suo, Jing; Schreiber, Yannick; Geisslinger, Gerd; Scholich, Klaus] Univ Hosp Goethe Univ, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany; [Dawes, John M.; Bennett, David L. H.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Antunes-Martins, Ana; McMahon, Stephen B.] Kings Coll London, Wolfson CARD, London WC2R 2LS, England	Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Oxford; University of London; King's College London	Scholich, K (corresponding author), Univ Hosp Goethe Univ, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.	Marco.Sisignano@med.uni-frankfurt.de	bennett, david/ABG-1184-2020; Schuh, Claus D/G-9032-2013	Bennett, David/0000-0002-7996-2696; Sisignano, Marco/0000-0002-7581-0951; McMahon, Stephen/0000-0003-4656-5536	DFG (German Research Association) [SCHO817, SFB1039 TPA08, 09]; Europain Collaboration from the Innovative Medicines Initiative Joint Undertaking [115007]; European Union; EFPIA	DFG (German Research Association)(German Research Foundation (DFG)); Europain Collaboration from the Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); EFPIA	This work was supported by the DFG (German Research Association) grants SCHO817 and SFB1039 TPA08 and 09 and is part of the Europain Collaboration, which has received support from the Innovative Medicines Initiative Joint Undertaking, under grant agreement no 115007, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution, www.imi.europa.eu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aley KO, 1998, J NEUROSCI, V18, P7008; Aley KO, 2000, J NEUROSCI, V20, P4680, DOI 10.1523/JNEUROSCI.20-12-04680.2000; Bhalala OG, 2012, J NEUROSCI, V32, P17935, DOI 10.1523/JNEUROSCI.3860-12.2012; Bishop T, 2007, PAIN, V131, P70, DOI 10.1016/j.pain.2006.12.014; Bishop T, 2010, PAIN, V150, P141, DOI 10.1016/j.pain.2010.04.018; Bishop T, 2009, EUR J PAIN, V13, P524, DOI 10.1016/j.ejpain.2008.06.006; Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Brohawn SG, 2012, SCIENCE, V335, P436, DOI 10.1126/science.1213808; Canetti C, 2001, BRIT J PHARMACOL, V134, P1619, DOI 10.1038/sj.bjp.0704403; Dawes JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002193; Driscoll MS, 2000, CUTIS, V66, P53; Gemes G, 2012, J PHYSL; GOETZL EJ, 1980, IMMUNOLOGY, V40, P709; Green D, 2013, PAIN; Gregus AM, 2012, P NATL ACAD SCI US; Han A, 2004, AM J CLIN DERMATOL, V5, P39, DOI 10.2165/00128071-200405010-00006; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; Konkel A, 2011, BBA-PROTEINS PROTEOM, V1814, P210, DOI 10.1016/j.bbapap.2010.09.009; Levine JD, 2007, BBA-MOL BASIS DIS, V1772, P989, DOI 10.1016/j.bbadis.2007.01.008; Liu M, 2006, EUR J NEUROSCI, V24, P1, DOI 10.1111/j.1460-9568.2006.04889.x; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Masek V, 2009, ANTI-CANCER DRUG, V20, P305, DOI 10.1097/CAD.0b013e328323a7a8; MIGLIORISI G, 1987, AM J PATHOL, V127, P157; Moore C, 2013, P NATL ACAD SCI US; Nieto-Posadas A, 2011, NATURE CHEM BIOL; Okubo M, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-57; PALMBLAD J, 1981, BLOOD, V58, P658; Patapoutian A, 2009, NAT REV DRUG DISCOV, V8, P55, DOI 10.1038/nrd2757; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Ruparel S, 2012, PAIN, V153, P2031, DOI 10.1016/j.pain.2012.04.027; Schaible HG, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3305; Sisignano M, 2012, J NEUROSCI, V32, P6364, DOI 10.1523/JNEUROSCI.5793-11.2012; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Stein C, 2009, BRAIN RES REV, V60, P90, DOI 10.1016/j.brainresrev.2008.12.017; Storey A, 2007, CARCINOGENESIS, V28, P1329, DOI 10.1093/carcin/bgm065; Subramanian N, 2005, DRUG DEV IND PHARM, V31, P405, DOI 10.1080/03639040500214605; Thompson DA, 2007, J BIOSCIENCES, V32, P279, DOI 10.1007/s12038-007-0028-x; Wang S, 2008, BRAIN, V131, P1241, DOI 10.1093/brain/awn060; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wen H, 2012, J BIOL CHEM; WIJKANDER J, 1995, J BIOL CHEM, V270, P26543, DOI 10.1074/jbc.270.44.26543; Xiao WH, 2012, PAIN; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Zhang QW, 2009, J INVEST DERMATOL, V129, P167, DOI 10.1038/jid.2008.181; Zheng J, 2001, AM J RESP CELL MOL, V25, P434, DOI 10.1165/ajrcmb.25.4.4104	47	30	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81228	10.1371/journal.pone.0081228	http://dx.doi.org/10.1371/journal.pone.0081228			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349046	Green Submitted, gold, Green Published			2022-12-27	WOS:000328705200019
J	McHugh, KJ; Mandalapu, S; Kolls, JK; Ross, TM; Alcorn, JF				McHugh, Kevin J.; Mandalapu, Sivanarayana; Kolls, Jay K.; Ross, Ted M.; Alcorn, John F.			A Novel Outbred Mouse Model of 2009 Pandemic Influenza and Bacterial Co-Infection Severity	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; COLLABORATIVE CROSS; LETHAL SYNERGISM; GENE-EXPRESSION; UNITED-STATES; LUNG INJURY; VIRUS; INFECTION; PNEUMONIA; EPIDEMIOLOGY	Influenza viruses pose a significant health risk and annually impose a great cost to patients and the health care system. The molecular determinants of influenza severity, often exacerbated by secondary bacterial infection, are largely unclear. We generated a novel outbred mouse model of influenza virus, Staphylococcus aureus, and co-infection utilizing influenza A/CA/07/2009 virus and S. aureus (USA300). Outbred mice displayed a wide range of pathologic phenotypes following influenza virus or co-infection ranging broadly in severity. Influenza viral burden positively correlated with weight loss although lung histopathology did not. Inflammatory cytokines including IL-6, TNF-alpha, G-CSF, and CXCL10 positively correlated with both weight loss and viral burden. In S. aureus infection, IL-1 beta, G-CSF, TNF-alpha, and IL-6 positively correlated with weight loss and bacterial burden. In co-infection, IL-1 beta production correlated with decreased weight loss suggesting a protective role. The data demonstrate an approach to identify biomarkers of severe disease and to understand pathogenic mechanisms in pneumonia.	[McHugh, Kevin J.; Mandalapu, Sivanarayana; Alcorn, John F.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [Kolls, Jay K.] UPMC, Childrens Hosp Pittsburgh, Richard K Mellon Fdn Inst, Pittsburgh, PA USA; [Ross, Ted M.] Univ Pittsburgh, Ctr Vaccine Res, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Alcorn, JF (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA.	john.alcorn@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304; Ross, Ted/0000-0003-1947-7469	NIH [R01 HL107380]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107380] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work presented was supported by NIH R01 HL107380 (JFA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Beadling C, 2004, CURR OPIN INFECT DIS, V17, P185, DOI 10.1097/00001432-200406000-00003; Bottomly D, 2012, G3-GENES GENOM GENET, V2, P213, DOI 10.1534/g3.111.001800; Cameron CM, 2008, J VIROL, V82, P11308, DOI 10.1128/JVI.00691-08; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1071; Chesler EJ, 2008, MAMM GENOME, V19, P382, DOI 10.1007/s00335-008-9135-8; Chia R, 2005, NAT GENET, V37, P1181, DOI 10.1038/ng1665; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Crowe CR, 2009, J IMMUNOL, V183, P5301, DOI 10.4049/jimmunol.0900995; Davey RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057121; Didierlaurent A, 2008, J EXP MED, V205, P323, DOI 10.1084/jem.20070891; Dienz O, 2012, MUCOSAL IMMUNOL, V5, P258, DOI 10.1038/mi.2012.2; Fadell SA, 2008, EUR J IMMUNOL, V38, P3376, DOI 10.1002/eji.200838628; Ferris MT, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003196; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Goulding John, 2007, Proc Am Thorac Soc, V4, P618, DOI 10.1513/pats.200706-066TH; Hagau N, 2010, CRIT CARE, V14, DOI 10.1186/cc9324; Ichikawa A, 2013, AM J RESP CRIT CARE, V187, P65, DOI 10.1164/rccm.201203-0508OC; JAKAB GJ, 1979, J INFECT DIS, V140, P105, DOI 10.1093/infdis/140.1.105; Jia DL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013927; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Kudva A, 2011, J IMMUNOL, V186, P1666, DOI 10.4049/jimmunol.1002194; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Li CG, 2012, CELL RES, V22, P528, DOI 10.1038/cr.2011.165; Li WJ, 2012, J VIROL, V86, P12304, DOI 10.1128/JVI.01269-12; Longhi MP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000006; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McCullers JA, 2003, J INFECT DIS, V187, P1000, DOI 10.1086/368163; Miettinen M, 2001, GENES IMMUN, V2, P349, DOI 10.1038/sj.gene.6363791; Miller LS, 2007, J IMMUNOL, V179, P6933, DOI 10.4049/jimmunol.179.10.6933; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nguyen-Van-Tam JS, 2003, VACCINE, V21, P1762, DOI 10.1016/S0264-410X(03)00069-0; Paget C, 2012, J BIOL CHEM, V287, P8816, DOI 10.1074/jbc.M111.304758; Pociask DA, 2013, AM J PATHOL, V182, P1286, DOI 10.1016/j.ajpath.2012.12.007; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Robinson KM, 2013, J IMMUNOL; Shahangian A, 2009, J CLIN INVEST, V119, P1910, DOI 10.1172/JCI35412; Small CL, 2010, J IMMUNOL, V184, P2048, DOI 10.4049/jimmunol.0902772; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; TASHIRO M, 1987, VIROLOGY, V157, P421, DOI 10.1016/0042-6822(87)90284-4; TASHIRO M, 1987, NATURE, V325, P536, DOI 10.1038/325536a0; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Vardakas KZ, 2009, INT J TUBERC LUNG D, V13, P1476; Williams DJ, 2011, ARCH PEDIAT ADOL MED, V165, P506, DOI 10.1001/archpediatrics.2010.295; Wu CL, 2003, CRIT CARE MED, V31, P812, DOI 10.1097/01.CCM.0000054865.47068.58; Yu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020575, 10.1371/journal.pone.0028680]; Zhang WJ, 1996, J IMMUNOL, V157, P5049	47	18	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82865	10.1371/journal.pone.0082865	http://dx.doi.org/10.1371/journal.pone.0082865			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324838	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000328566700117
J	Ammann, TW; Belibasakis, GN; Thurnheee, T				Ammann, Thomas W.; Belibasakis, Georgios N.; Thurnheee, Thomas			Impact of Early Colonizers on In Vitro Subgingival Biofilm Formation	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; FUSOBACTERIUM-NUCLEATUM; ACTINOMYCES-NAESLUNDII; MODEL; PLAQUE; PERIODONTITIS; GINGIVITIS	The aim of this study was to investigate the impact of early colonizing species on the structure and the composition of the bacterial community developing in a subgingival 10-species biofilm model system. The model included Streptococcus oralis, Streptococcus anginosus, Actinomycesoris, Fusobacterium nucleatum subsp. nucleatum, Veillonella dispar, Campylobacter rectus, Prevotella intermedia, Porphyromonas gingivalis, Tannerella forsythia, and Treponema denticola. Based on literature, we considered Streptococcus oralis, Streptococcus anginosus, and Actinomyces oris as early colonizers and examined their role in the biofilms by either a delayed addition to the consortium, or by not inoculating at all the biofilms with these species. We quantitatively evaluated the resulting biofilms by real-time quantitative PCR and further compared the structures using confocal laser scanning microscopy following fluorescence in situ hybridisation. The absence of the early colonizers did not hinder biofilm formation. The biofilms reached the same total counts and developed to normal thickness. However, quantitative shifts in the abundances of individual species were observed. In the absence of streptococci, the overall biofilm structure appeared looser and more dispersed. Moreover, besides a significant increase of P. intermedia and a decrease of P. gingivalis, P. intermedia appeared to form filamented long chains that resembled streptococci. A. oris, although growing to significantly higher abundance in absence of streptococci, did not have a visible impact on the biofilms. Hence, in the absence of the early colonizers, there is a pronounced effect on P. intermedia and P. gingivalis that may cause distinct shifts in the structure of the biofilm. Streptococci possibly facilitate the establishment of P. gingivalis into subgingival biofilms, while in their absence P. intermedia became more dominant and forms elongated chains.	[Ammann, Thomas W.; Belibasakis, Georgios N.; Thurnheee, Thomas] Univ Zurich, Ctr Dent Med, Inst Oral Biol, Zurich, Switzerland	University of Zurich	Thurnheee, T (corresponding author), Univ Zurich, Ctr Dent Med, Inst Oral Biol, Zurich, Switzerland.	thomas.thurnheer@zzm.uzh.ch	Belibasakis, Georgios/AAL-3159-2020	Belibasakis, Georgios/0000-0002-8164-0653; Thurnheer, Thomas/0000-0002-8615-8209				Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Al-Ahmad A, 2007, J MED MICROBIOL, V56, P681, DOI 10.1099/jmm.0.47094-0; Ammann TW, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-227; Ammann TW, 2012, J PERIODONTAL RES; Belibasakis GN, 2013, INNATE IMMUN-LONDON, V19, P3, DOI 10.1177/1753425912444767; Belibasakis GN, 2011, MICROB PATHOGENESIS, V50, P6, DOI 10.1016/j.micpath.2010.11.002; Belibasakis GN, 2013, J PERIODONTOL, DOI [10.1902/jop. 2013.130167., DOI 10.1902/J0P.2013.130167.PUBMED:23659420]; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Brown LJ, 2002, PERIODONTOL 2000, V29, P223, DOI 10.1034/j.1600-0757.2002.290111.x; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Guggenheim B, 2001, J DENT RES, V80, P363, DOI 10.1177/00220345010800011201; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Guggenheim M, 2001, APPL ENVIRON MICROB, V67, P1343, DOI 10.1128/AEM.67.3.1343-1350.2001; Hajishengallis G, 2012, MOL ORAL MICROBIOL, V27, P409, DOI 10.1111/j.2041-1014.2012.00663.x; Jenkinson HF, 2011, ENVIRON MICROBIOL, V13, P3077, DOI 10.1111/j.1462-2920.2011.02573.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; LOE H, 1965, J PERIODONTOL, V36, P177, DOI 10.1902/jop.1965.36.3.177; Marsh PD, 2006, INT DENT J, V56, P233; Milner P, 1996, FEMS MICROBIOL LETT, V140, P125, DOI 10.1016/0378-1097(96)00159-0; Palmer RJ, 2001, INFECT IMMUN, V69, P5794, DOI 10.1128/IAI.69.9.5794-5804.2001; Paster BJ, 2006, PERIODONTOL 2000, V42, P80, DOI 10.1111/j.1600-0757.2006.00174.x; Sahrmann P, 2012, CLIN IMPLANT DENT RE; Shapiro S, 2002, CARIES RES, V36, P93, DOI 10.1159/000057866; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tanner A, 1998, J CLIN PERIODONTOL, V25, P85, DOI 10.1111/j.1600-051X.1998.tb02414.x; Tompkins GR, 1997, J BACTERIOL, V179, P620, DOI 10.1128/jb.179.3.620-626.1997; WYSS C, 1989, INFECT IMMUN, V57, P1757, DOI 10.1128/IAI.57.6.1757-1759.1989; Zijnge V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009321	30	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e83090	10.1371/journal.pone.0083090	http://dx.doi.org/10.1371/journal.pone.0083090			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340084	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100133
J	Lagache, T; Lang, G; Sauvonnet, N; Olivo-Marin, JC				Lagache, Thibault; Lang, Gabriel; Sauvonnet, Nathalie; Olivo-Marin, Jean-Christophe			Analysis of the Spatial Organization of Molecules with Robust Statistics	PLOS ONE			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; PATTERN; COMPLEX; CARGO	One major question in molecular biology is whether the spatial distribution of observed molecules is random or organized in clusters. Indeed, this analysis gives information about molecules' interactions and physical interplay with their environment. The standard tool for analyzing molecules' distribution statistically is the Ripley's K function, which tests spatial randomness through the computation of its critical quantiles. However, quantiles' computation is very cumbersome, hindering its use. Here, we present an analytical expression of these quantiles, leading to a fast and robust statistical test, and we derive the characteristic clusters' size from the maxima of the Ripley's K function. Subsequently, we analyze the spatial organization of endocytic spots at the cell membrane and we report that clathrin spots are randomly distributed while clathrin-independent spots are organized in clusters with a radius of 2 mm, which suggests distinct physical mechanisms and cellular functions for each pathway.	[Lagache, Thibault; Olivo-Marin, Jean-Christophe] Inst Pasteur, Unite Analyse Images Quantitat, Paris, France; [Lagache, Thibault; Sauvonnet, Nathalie; Olivo-Marin, Jean-Christophe] CNRS, Unite Rech Associee 2582, Paris, France; [Lang, Gabriel] AgroParisTech, Unite Mixte Rech Math & Informat Appl 518, Paris, France; [Lang, Gabriel] INRA, Paris, France; [Sauvonnet, Nathalie] Inst Pasteur, Unite Biol Interact Cellulaires, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); AgroParisTech; INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lagache, T (corresponding author), Inst Pasteur, Unite Analyse Images Quantitat, Paris, France.	thibault.lagache@pasteur.fr; jcolivo@pasteur.fr	Olivo-Marin, Jean-Christophe/K-4428-2015; Lagache, Thibaut/AAC-1067-2020	Olivo-Marin, Jean-Christophe/0000-0001-6796-0696; Lagache, Thibaut/0000-0002-7033-4677; sauvonnet, nathalie/0000-0003-0306-3376	Agence Nationale de la Recherche [ANR-10-INBS-04-06 FranceBioImaging]; Institut Pasteur [PTR 387]; Institut Pasteur	Agence Nationale de la Recherche(French National Research Agency (ANR)); Institut Pasteur(European Commission); Institut Pasteur(European Commission)	This work was funded in part by grants from the Agence Nationale de la Recherche (ANR-10-INBS-04-06 FranceBioImaging) and the Institut Pasteur (PTR 387). TL is funded by a Bourse Roux from Institut Pasteur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, STAT INFERENCE SPATI, DOI DOI 10.1017/CBO9780511624131; BESAG J, 1977, J ROYAL STAT SOC B, V39, P193, DOI DOI 10.1016/J.FORECO.2009.04.009; Cornish E., 1938, REV LINSTITUT INT ST, V5, P307, DOI DOI 10.2307/1400905; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Diaz E, 2008, IEEE T PATTERN ANAL, V30, P1659, DOI 10.1109/TPAMI.2007.70821; Diggle P., 2003, STAT ANAL SPATIAL PO; Draper G, 1991, STUDIES MED POPULATI, V53, P1966; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Gatrell AC, 1996, T I BRIT GEOGR, V21, P256, DOI 10.2307/622936; Gesbert F, 2004, CURR TOP MICROBIOL, V286, P119; Illian J, 2008, STAT ANAL MODELLING; Jafari-Mamaghani M, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fninf.2010.00009; Kiskowski MA, 2009, BIOPHYS J, V97, P1095, DOI 10.1016/j.bpj.2009.05.039; Lamaze C, 2001, MOL CELL, V7, P661, DOI 10.1016/S1097-2765(01)00212-X; Lang G, 2013, ESAIM PROBA IN PRESS; Lasserre R, 2010, EMBO J, V29, P2301, DOI 10.1038/emboj.2010.127; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Liao W, 2011, CURR OPIN IMMUNOL, V23, P598, DOI 10.1016/j.coi.2011.08.003; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mettlen M, 2010, J CELL BIOL, V188, P919, DOI 10.1083/jcb.200908078; Mounier J, 2012, CELL HOST MICROBE, V12, P381, DOI 10.1016/j.chom.2012.07.010; NEYMAN J, 1952, ASTROPHYS J, V116, P144, DOI 10.1086/145599; Nunez D, 2011, TRAFFIC, V12, P1868, DOI 10.1111/j.1600-0854.2011.01273.x; Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3; PETERSON CJ, 1995, J ECOL, V83, P847, DOI 10.2307/2261421; Prior IA, 2003, J CELL BIOL, V160, P165, DOI 10.1083/jcb.200209091; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Sigismund S, 2012, PHYSIOL REV, V92, P273, DOI 10.1152/physrev.00005.2011; STRAUSS DJ, 1975, BIOMETRIKA, V62, P467, DOI 10.1093/biomet/62.2.467; White AC, 2012, PHYS REV A, V86, DOI 10.1103/PhysRevA.86.013635	30	44	44	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80914	10.1371/journal.pone.0080914	http://dx.doi.org/10.1371/journal.pone.0080914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349021	Green Published, gold, Green Submitted			2022-12-27	WOS:000327949300056
J	Saarela, JM; Sokoloff, PC; Gillespie, LJ; Consaul, LL; Bull, RD				Saarela, Jeffery M.; Sokoloff, Paul C.; Gillespie, Lynn J.; Consaul, Laurie L.; Bull, Roger D.			DNA Barcoding the Canadian Arctic Flora: Core Plastid Barcodes (rbcL plus matK) for 490 Vascular Plant Species	PLOS ONE			English	Article							AMERICAN PETASITES ASTERACEAE; INTERNAL TRANSCRIBED SPACER; WESTERN NORTH-AMERICA; PHYLOGENETIC-RELATIONSHIPS; PUCCINELLIA POACEAE; RIBOSOMAL DNA; SEQUENCE DATA; LAND PLANTS; COMPLEX CARYOPHYLLACEAE; SAXIFRAGA SAXIFRAGACEAE	Accurate identification of Arctic plant species is critical for understanding potential climate-induced changes in their diversity and distributions. To facilitate rapid identification we generated DNA barcodes for the core plastid barcode loci (rbcL and matK) for 490 vascular plant species, representing nearly half of the Canadian Arctic flora and 93% of the flora of the Canadian Arctic Archipelago. Sequence recovery was higher for rbcL than matK (93% and 81%), and rbcL was easier to recover than matK from herbarium specimens (92% and 77%). Distance-based and sequence-similarity analyses of combined rbcL + matK data discriminate 97% of genera, 56% of species, and 7% of infraspecific taxa. There is a significant negative correlation between the number of species sampled per genus and the percent species resolution per genus. We characterize barcode variation in detail in the ten largest genera sampled (Carex, Draba, Festuca, Pedicularis, Poa, Potentilla, Puccinellia, Ranunculus, Salix, and Saxifraga) in the context of their phylogenetic relationships and taxonomy. Discrimination with the core barcode loci in these genera ranges from 0% in Salix to 85% in Carex. Haplotype variation in multiple genera does not correspond to species boundaries, including Taraxacum, in which the distribution of plastid haplotypes among Arctic species is consistent with plastid variation documented in non-Arctic species. Introgression of Poa glauca plastid DNA into multiple individuals of P. hartzii is problematic for identification of these species with DNA barcodes. Of three supplementary barcode loci (psbA-trnH, psbK-psbI, atpF-atpH) collected for a subset of Poa and Puccinellia species, only atpF-atpH improved discrimination in Puccinellia, compared with rbcL and matK. Variation in matK in Vaccinium uliginosum and rbcL in Saxifraga oppositifolia corresponds to variation in other loci used to characterize the phylogeographic histories of these Arctic-alpine species.	[Saarela, Jeffery M.] Canadian Museum Nat, Bot Sect, Res Serv, Ottawa, ON K1P 6P4, Canada; Canadian Museum Nat, Bot Sect, Collect Serv, Ottawa, ON K1P 6P4, Canada		Saarela, JM (corresponding author), Canadian Museum Nat, Bot Sect, Res Serv, POB 3443 Stn D, Ottawa, ON K1P 6P4, Canada.	jsaarela@mus-nature.ca		Sokoloff, Paul/0000-0002-7053-8557; Saarela, Jeffery/0000-0003-1790-4332	Natural Sciences and Engineering Research Council of Canada (NSERC); Government of Canada through Genome Canada; Government of Canada through Ontario Genomics Institute [2008-0GI-ICI-03]; Canadian Museum of Nature	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Government of Canada through Genome Canada(Genome Canada); Government of Canada through Ontario Genomics Institute; Canadian Museum of Nature	Laboratory work was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC), the Government of Canada through Genome Canada and the Ontario Genomics Institute (2008-0GI-ICI-03) in support of the International Barcode of Life Project, and the Canadian Museum of Nature. Fieldwork in the Arctic was supported by the Polar Continental Shelf Program (Natural Resources Canada), the Canadian Museum of Nature, and Parks Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aares E, 2000, PLANT SYST EVOL, V220, P241, DOI 10.1007/BF00985048; Abbott RJ, 2000, SCIENCE, V289, P1343, DOI 10.1126/science.289.5483.1343; Abbott RJ, 2004, NEW PHYTOL, V161, P211, DOI 10.1046/j.1469-8137.2003.00953.x; Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Aiken S. G., 2007, FLORA CANADIAN ARCTI; AIKEN SG, 1990, CAN J BOT, V68, P2422, DOI 10.1139/b90-308; AIKEN SG, 1988, CAN J BOT, V66, P1, DOI 10.1139/b88-001; AIKEN SG, 1993, AM J BOT, V80, P76, DOI 10.2307/2445122; AIKEN SG, 1995, SYST BOT, V20, P374, DOI 10.2307/2419501; AIKEN SG, 1994, NORD J BOT, V14, P137, DOI 10.1111/j.1756-1051.1994.tb00580.x; Aiken SG, 1990, FESCUE GRASSES CANAD, DOI [10.5962/bhl.title.59072, DOI 10.5962/BHL.TITLE.59072]; Alice LA, 1999, AM J BOT, V86, P81, DOI 10.2307/2656957; Allen GA, 2012, ECOL EVOL, V2, P649, DOI 10.1002/ece3.213; Alsos IG, 2005, MOL ECOL, V14, P2739, DOI 10.1111/j.1365-294X.2005.02621.x; Anderberg AA, 2002, AM J BOT, V89, P677, DOI 10.3732/ajb.89.4.677; Arca M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034089; Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Armenise L, 2012, EUR J FOREST RES, V131, P1337, DOI 10.1007/s10342-012-0602-0; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Azuma H, 2011, J PLANT RES, V124, P349, DOI 10.1007/s10265-010-0387-5; Azuma T, 2000, AM J BOT, V87, P67, DOI 10.2307/2656686; Ball P. W., 2002, FLORA N AM N MEXICO, V23, P416; Ball PW, 2002, FLORA N AM N MEXICO, V23, P424; Ball PW., 2002, FLORA N AM N MEXICO, V23, P556; BARKLEY TM, 2006, FLORA N AM N MEXICO, V20, P541; Bayer RJ, 1996, AM J BOT, V83, P516, DOI 10.2307/2446220; Bell D, 2012, MOL ECOL RESOUR, V12, P36, DOI 10.1111/j.1755-0998.2011.03053.x; Bennett BA, 2010, CAN FIELD NAT, V124, P1; Bhatt US, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI315.1; Bonos SA, 2002, CROP SCI, V42, P192, DOI 10.2135/cropsci2002.0192; Brochmann C, 1998, AM J BOT, V85, P135, DOI 10.2307/2446562; Brock MT, 2004, AM J BOT, V91, P656, DOI 10.3732/ajb.91.5.656; Brouillet L., 2006, FLORA N AM N MEXICO, V19, P239; BROUILLET L, 2010, DATABASE VASCULAR PL, DOI DOI 10.5886/1BFT7W5F; Brouillet L., 2009, FLORA N AM N MEXICO, V8, P132; Brown R., 1823, CHLORIS MELVILLIANA, DOI [10.5962/bhl.title.8114, DOI 10.5962/BHL.TITLE.8114]; Brysting AK, 2004, TAXON, V53, P365, DOI 10.2307/4135615; Brysting AK, 2003, CAN J BOT, V81, P769, DOI [10.1139/B03-067, 10.1139/b03-067]; Brysting AK, 2000, TAXON, V49, P189, DOI 10.2307/1223835; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cai ZM, 2012, J SYST EVOL, V50, P527, DOI 10.1111/j.1759-6831.2012.00216.x; Callaghan TV, 2011, AMBIO, V40, P624, DOI 10.1007/s13280-011-0169-x; Carlsen T, 2009, ANN MO BOT GARD, V96, P215, DOI 10.3417/2007047; Catalan P, 2004, MOL PHYLOGENET EVOL, V31, P517, DOI 10.1016/j.ympev.2003.08.025; CATLING PM, 1987, CAN J BOT, V65, P750, DOI 10.1139/b87-100; Cayouette Jacques, 2004, SIDA Contributions to Botany, V21, P791; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cherniawsky DM, 1998, CAN J BOT, V76, P1476, DOI 10.1139/cjb-76-8-1476; Cherniawsky DM, 1998, CAN J BOT, V76, P23, DOI 10.1139/b97-152; Cherniawsky DM, 1998, CAN J BOT, V76, P2061, DOI 10.1139/cjb-76-12-2061; Chiapella JO, 2011, AM J BOT, V98, P1366, DOI 10.3732/ajb.1000495; CHINNAPPA CC, 1991, RHODORA, V93, P129; Chinnappa CC, 2005, CAN J BOT, V83, P1367, DOI 10.1139/b05-117; Chiurugwi T, 2011, HEREDITY, V106, P854, DOI 10.1038/hdy.2010.128; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Christenhusz MJM, 2011, PHYTOTAXA, V19, P7, DOI 10.11646/phytotaxa.19.1.2; Christenhusz MJM, 2011, PHYTOTAXA, V19, P55, DOI 10.11646/phytotaxa.19.1.3; Cieslak T, 2005, AM J BOT, V92, P1723, DOI 10.3732/ajb.92.10.1723; Clement WL, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-73; Cochrane TS., 2002, FLORA N AM N MEXICO, V23, P278; Cochrane TS., 2002, FLORA N AM N MEXICO, V23, P299; Cody W. J., 2000, FLORA YUKON TERRITOR; Cody WJ, 2005, CAN FIELD NAT, V119, P276, DOI 10.22621/cfn.v119i2.115; Collins RA, 2012, METHODS ECOL EVOL, V3, P457, DOI 10.1111/j.2041-210X.2011.00176.x; Consaul LL, 2005, CAN FIELD NAT, V119, P497, DOI 10.22621/cfn.v119i4.179; Consaul LL, 2008, BOTANY, V86, P916, DOI 10.1139/B08-073; Consaul LL, 2008, SYST BOT, V33, P251, DOI 10.1600/036364408784571662; Consaul LL, 2008, NOVON, V18, P16, DOI 10.3417/2007029; Consaul Laurie L., 2010, P645; Consaul LL, 2010, AM J BOT, V97, P324, DOI 10.3732/ajb.0900180; Consaul LL, 2001, CAN J BOT, V79, P927, DOI 10.1139/cjb-79-8-927; Consaul LL, 2007, FLORA N AM N MEXIC 1, V24, P478; Conti E, 1999, MOL PHYLOGENET EVOL, V13, P536, DOI 10.1006/mpev.1999.0673; Cowan RS, 2006, TAXON, V55, P611, DOI 10.2307/25065638; Crins WJ, 2002, FLORA N AM N MEXICO, V23, P546; Cuenoud P, 2002, AM J BOT, V89, P132, DOI 10.3732/ajb.89.1.132; Danby RK, 2011, AMBIO, V40, P660, DOI 10.1007/s13280-011-0172-2; Daniels FJA, 2011, AMBIO, V40, P650, DOI 10.1007/s13280-011-0171-3; Daniels FJA, 2011, APPL VEG SCI, V14, P230, DOI 10.1111/j.1654-109X.2010.01107.x; DARBYSHIRE SJ, 2007, FLORA N AM N MEXICO, V24, P389; DAVIS JI, 1983, SYST BOT, V8, P341, DOI 10.2307/2418354; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; de Vere N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037945; Des Marais DL, 2003, INT J PLANT SCI, V164, P737, DOI 10.1086/376817; Desmet P, 2013, PHYTOKEYS, V25, P55, DOI 10.3897/phytokeys.25.3100; DOBE S, 2012, MOL ECOL RESOUR, V12, P726, DOI DOI 10.1111/J.1755-0998.2012.03134.X.PUBMED:22463760; Dobes C, 2010, MOL PHYLOGENET EVOL, V56, P156, DOI 10.1016/j.ympev.2010.03.005; Drabkova L, 2006, CLADISTICS, V22, P132, DOI 10.1111/j.1096-0031.2006.00095.x; Drabkova L, 2003, PLANT SYST EVOL, V240, P133, DOI 10.1007/s00606-003-0001-6; Dragon JA, 2009, AM J BOT, V96, P1896, DOI 10.3732/ajb.0800404; Dragon Julie A., 2008, V108, P215; Drumwright AM, 2011, CASTANEA, V76, P300, DOI 10.2179/11-005.1; Du ZY, 2011, J SYST EVOL, V49, P246, DOI 10.1111/j.1759-6831.2011.00131.x; Duffy AM, 2009, GENE, V438, P17, DOI 10.1016/j.gene.2009.02.006; Dunlop DA, 2002, FLORA N AM N MEXICO, V23, P549; Dunning LT, 2010, BOT J LINN SOC, V164, P1, DOI 10.1111/j.1095-8339.2010.01071.x; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eidesen PB, 2007, MOL ECOL, V16, P3902, DOI 10.1111/j.1365-294X.2007.03425.x; Ekenas C, 2007, SYST BOT, V32, P917, DOI 10.1600/036364407783390728; Elven R., 2011, ANNOTATED CHECKLIST; Elven R, 2008, NOVON, V18, P325, DOI 10.3417/2007178; Emadzade K, 2011, MOL PHYLOGENET EVOL, V58, P4, DOI 10.1016/j.ympev.2010.11.002; Eriksen B, 2006, AM J BOT, V93, P460, DOI 10.3732/ajb.93.3.460; Escudero M, 2010, FLORA, V205, P118, DOI 10.1016/j.flora.2009.01.005; Fazekas Aron J, 2012, Methods Mol Biol, V858, P223, DOI 10.1007/978-1-61779-591-6_11; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FERNALD ML, 1916, RHODORA, V18, P1, DOI DOI 10.5962/BHL.TITLE.47083; FERREN WR, 2004, FLORA N AM N MEXIC 1, V4; Fjellheim S, 2001, AM J BOT, V88, P869, DOI 10.2307/2657039; Flora of North America Editorial Committee, 1993, FLORA N AM N MEXICO, V22; Fofana B, 1997, BELG J BOT, V129, P118; Forbes BC, 2010, GLOBAL CHANGE BIOL, V16, P1542, DOI 10.1111/j.1365-2486.2009.02047.x; Ford BA, 2006, SYST BOT, V31, P70, DOI 10.1600/036364406775971813; Ford BA, 2012, SYST BOT, V37, P913, DOI 10.1600/036364412X656464; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Frederiksen S., 1981, Nordic Journal of Botany, V1, P277, DOI 10.1111/j.1756-1051.1981.tb00697.x; Freeman CC, 2007, FLORA N AM N MEXICO, V8, P70; Gao T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-324; Garcia S, 2011, AM J BOT, V98, P638, DOI 10.3732/ajb.1000386; Ghahramanzadeh R, 2013, MOL ECOL RESOUR, V13, P21, DOI 10.1111/1755-0998.12020; Gillespie LJ, 2005, SYST BOT, V30, P84, DOI 10.1600/0363644053661940; Gillespie LJ, 1997, CAN J BOT, V75, P1978, DOI 10.1139/b97-910; Gillespie LJ, 2001, CAN J BOT, V79, P679, DOI 10.1139/cjb-79-6-679; Gillespie LJ, 2008, BOTANY, V86, P938, DOI 10.1139/B08-076; Gillespie Lynn J., 2007, Aliso, V23, P420; Goetsch L, 2005, SYST BOT, V30, P616, DOI 10.1600/0363644054782170; Golden JL, 2001, CAN J BOT, V79, P1195, DOI 10.1139/b01-100; Gonzalez MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007483; Greenberg AK, 2011, TAXON, V60, P1637, DOI 10.1002/tax.606009; Guggisberg A, 2006, NEW PHYTOL, V171, P617, DOI 10.1111/j.1469-8137.2006.01722.x; Guillon JM, 2007, J PLANT RES, V120, P569, DOI 10.1007/s10265-007-0088-x; Guillon JM, 2004, SYST BOT, V29, P251, DOI 10.1600/036364404774195467; Guldahl AS, 2001, BOT J LINN SOC, V137, P107, DOI 10.1111/j.1095-8339.2001.tb01112.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hansen KT, 2000, AM J BOT, V87, P1466, DOI 10.2307/2656873; Harbaugh DT, 2010, INT J PLANT SCI, V171, P185, DOI 10.1086/648993; Hardig T. M., 2010, Journal of Botany, V2010, P197696, DOI 10.1155/2010/197696; Harris JG, 2006, NOVON, V16, P344, DOI 10.3417/1055-3177(2006)16[344:FNSOBB]2.0.CO;2; Harrison Kristen, 2011, Madrono, V58, P32, DOI 10.3120/0024-9637-58.1.32; Harsch MA, 2009, ECOL LETT, V12, P1040, DOI 10.1111/j.1461-0248.2009.01355.x; HAUKE RICHARD L., 1962, AMER FERN JOUR, V52, P57, DOI 10.2307/1546651; Hendrichs M, 2004, PLANT SYST EVOL, V246, P89, DOI 10.1007/s00606-004-0128-0; Horandl E, 2012, PERSPECT PLANT ECOL, V14, P310, DOI 10.1016/j.ppees.2012.04.001; Horandl E, 2011, TAXON, V60, P415, DOI 10.1002/tax.602011; Hoffmann MH, 2010, INT J PLANT SCI, V171, P90, DOI 10.1086/647918; Hoffmann MH, 2009, NEW PHYTOL, V182, P774, DOI 10.1111/j.1469-8137.2009.02782.x; Holderegger R, 2003, AM J BOT, V90, P931, DOI 10.3732/ajb.90.6.931; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hoot SB, 2012, SYST BOT, V37, P139, DOI 10.1600/036364412X616729; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Hudson JMG, 2009, ECOLOGY, V90, P2657, DOI 10.1890/09-0102.1; Hulten E, 1968, FLORA ALASKA NEIGHBO; IVANOVA N, 2011, GLASS FIBER PLATE DN; IVANOVA N, 2005, SEQUENCING; Ivanova N., 2006, PREMADE FROZEN PCR S; Ivanova NV, 2008, PLANT MOL BIOL REP, V26, P186, DOI 10.1007/s11105-008-0029-4; Jeanson ML, 2011, ANN BOT-LONDON, V108, P1445, DOI 10.1093/aob/mcr158; Jia GSJ, 2009, J ENVIRON MONITOR, V11, P2231, DOI 10.1039/b911677j; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; JOHNSON LA, 1994, SYST BOT, V19, P143, DOI 10.2307/2419718; Jordon-Thaden I, 2010, MOL PHYLOGENET EVOL, V55, P524, DOI 10.1016/j.ympev.2010.02.012; Jorgensen MH, 2006, SYST BOT, V31, P702, DOI 10.1600/036364406779695988; Jorgensen T, 2012, MOL ECOL, V21, P1980, DOI 10.1111/j.1365-294X.2011.05278.x; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; Kaplan Z, 2008, FOLIA GEOBOT, V43, P159, DOI 10.1007/s12224-008-9010-0; Kapralov MV, 2006, SYST BOT, V31, P571, DOI 10.1600/036364406778388674; Kelly LJ, 2010, TAXON, V59, P251, DOI 10.1002/tax.591023; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Kesanakurti PR, 2011, MOL ECOL, V20, P1289, DOI 10.1111/j.1365-294X.2010.04989.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; KING LM, 1993, EVOLUTION, V47, P136, DOI 10.1111/j.1558-5646.1993.tb01205.x; King MG, 2008, SYST BOT, V33, P514, DOI 10.1600/036364408785679860; Kirschner J, 2003, PLANT SYST EVOL, V239, P231, DOI 10.1007/s00606-003-0002-5; KIRSCHNER J, 1994, FOLIA GEOBOT PHYTOTX, V29, P265, DOI 10.1007/BF02803800; Kirschner J, 1997, TAXON, V46, P87, DOI 10.2307/1224294; Kirschner J, 1996, FOLIA GEOBOT PHYTOTX, V31, P415, DOI 10.1007/BF02815386; Kirschner J., 2002, JUNCACEAE 1 ROSTKO 6; Kool A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039459; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; KUZMINA M, 2011, PRIMERS SETS PLANTS; Kuzmina M, 2011, PCR AMPLIFICATION PL; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lantz TC, 2010, J BIOGEOGR, V37, P1597, DOI 10.1111/j.1365-2699.2010.02317.x; Le Clerc-Blain J, 2010, MOL ECOL RESOUR, V10, P69, DOI 10.1111/j.1755-0998.2009.02725.x; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026597; Li HQ, 2012, MOL ECOL RESOUR, V12, P783, DOI 10.1111/j.1755-0998.2012.03147.x; Li M, 2011, J SYST EVOL, V49, P271, DOI 10.1111/j.1759-6831.2011.00132.x; Li Y, 2011, J SYST EVOL, V49, P169, DOI 10.1111/j.1759-6831.2011.00128.x; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Little DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020552; Liu J, 2011, MOL ECOL RESOUR, V11, P89, DOI 10.1111/j.1755-0998.2010.02907.x; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Liu YM, 2012, PHARMACOGN MAG, V8, P29, DOI 10.4103/0973-1296.93311; Lucas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029987; Luo K, 2010, SCI CHINA LIFE SCI, V53, P701, DOI 10.1007/s11427-010-4009-1; Madesis P, 2012, GENET MOL RES, V11, P2548, DOI 10.4238/2012.July.10.10; Maia VH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029877; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; Marr KL, 2008, J BIOGEOGR, V35, P1323, DOI 10.1111/j.1365-2699.2007.01879.x; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Milstein D, 2012, PHYCOLOGIA, V51, P247, DOI 10.2216/11-40.1; Molau U., 1996, SYMBOLAE BOT ANICAE, V31, P33; Morton J.K., 2005, FLORA N AM N MEXICO, V5, P96; Mower JP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-135; Muellner AN, 2011, MOL ECOL RESOUR, V11, P450, DOI 10.1111/j.1755-0998.2011.02984.x; Murray D. F., 2002, FLORA N AM N MEXICO, P414; Murray D. F., 2002, FLORA N AM N MEXICO, V23, P401; Myers-Smith IH, 2011, AMBIO, V40, P610, DOI 10.1007/s13280-011-0168-y; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nicole S, 2011, GENOME, V54, P529, DOI [10.1139/G11-018, 10.1139/g11-018]; Nylehn J, 2003, BOT J LINN SOC, V142, P373, DOI 10.1046/j.1095-8339.2003.00190.x; PACKER J. C., 1963, CANADIAN JOUR BOT, V41, P85; Pang X, 2012, PLANT BIOLOGY, V14, P839, DOI 10.1111/j.1438-8677.2011.00554.x; Pang XH, 2011, CLADISTICS, V27, P165, DOI 10.1111/j.1096-0031.2010.00328.x; Paun O, 2005, TAXON, V54, P911, DOI 10.2307/25065478; PAVLICK LE, 1984, CAN J BOT, V62, P2448, DOI 10.1139/b84-334; Pettengill JB, 2010, AM J BOT, V97, P1391, DOI 10.3732/ajb.0900176; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; PORSILD AE, 1964, BIOL SER, V50, P1; Porsild AE, 1980, VASCULAR PLANTS CONT; PORSILD AE, 1957, BIOL SERIES, V50, P1; Pouliot D, 2009, INT J REMOTE SENS, V30, P149, DOI 10.1080/01431160802302090; Powell EA, 2002, SYST BOT, V27, P768; Presting GG, 2006, CAN J BOT, V84, P1434, DOI 10.1139/B06-117; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Quintanar A, 2007, AM J BOT, V94, P1554, DOI 10.3732/ajb.94.9.1554; Ran JH, 2010, J INTEGR PLANT BIOL, V52, P1109, DOI 10.1111/j.1744-7909.2010.00995.x; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Ree RH, 2005, INT J PLANT SCI, V166, P595, DOI 10.1086/430191; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Reznicek AA., 2002, FLORA N AM N MEXICO, V23, P426; Reznicek AA, 2002, FLORA N AM N MEXICO, V23, P298; Reznicek AA, 2002, FLORA N AM N MEXICO, V23, P501; RICHARDS AJ, 1973, BOT J LINN SOC, V66, P189, DOI 10.1111/j.1095-8339.1973.tb02169.x; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Saarela Jeffeg M., 2010, P557; Saarela JM, 2013, PHYTOTAXA, V102, P1; Saarela JM, 2012, ARCTIC, V65, P1; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Schaefer H, 2011, ECOL LETT, V14, P389, DOI 10.1111/j.1461-0248.2011.01600.x; Scheen AC, 2004, AM J BOT, V91, P943, DOI 10.3732/ajb.91.6.943; Schonswetter P, 2008, AM J BOT, V95, P1006, DOI 10.3732/ajb.2007196; SCHWARZENBACH FH, 2010, BOT OBSERVATION PENN; SCOGGAN HJ, 1978, FLORA CANADA 2, P545; SCOTT PJ, 1974, CAN J BOT, V52, P1713, DOI 10.1139/b74-223; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Shekhovtsov SV, 2012, NORD J BOT, V30, P343, DOI 10.1111/j.1756-1051.2011.01405.x; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sojak Jiri, 2010, Thaiszia, V20, P91; Sokoloff PC, 2012, BOTANY, V90, P11, DOI [10.1139/B11-077, 10.1139/b11-077]; SOLSTAD H, 2008, THESIS U OSLO OSLO; Soltis DE, 1996, AM J BOT, V83, P371, DOI 10.2307/2446171; SOLTIS PS, 1992, P NATL ACAD SCI USA, V89, P449, DOI 10.1073/pnas.89.1.449; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Soreng R.J., 2007, FLORA N AM N MEXICO, V24, P486; SORENG RJ, 1991, SYST BOT, V16, P507, DOI 10.2307/2419340; SORENSEN THORVALD, 1953, MEDDEL GRONLAND, V136, P1; Srivathsan A, 2012, CLADISTICS, V28, P190, DOI 10.1111/j.1096-0031.2011.00370.x; Standley L.A., 2002, FLORA N AM N MEXICO, V23, P379; Starr JR, 2004, SYST BOT, V29, P528, DOI 10.1600/0363644041744455; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Starr Julian R., 2008, V108, P243; Starr JR, 2009, BOT REV, V75, P110, DOI 10.1007/s12229-008-9020-x; Steen NW, 2004, PLANT SYST EVOL, V245, P215, DOI 10.1007/s00606-003-0109-8; Stow DA, 2004, REMOTE SENS ENVIRON, V89, P281, DOI 10.1016/j.rse.2003.10.018; Sun GL, 2006, GENOME, V49, P1160, DOI 10.1139/G06-062; Swallen Jason R., 1944, JOUR WASHINGTON ACAD SCI, V34, P16; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tape K, 2006, GLOBAL CHANGE BIOL, V12, P686, DOI 10.1111/j.1365-2486.2006.01128.x; Tate JA, 2003, SYST BOT, V28, P723; Tkach NV, 2008, EVOLUTION, V62, P184, DOI 10.1111/j.1558-5646.2007.00270.x; Toivonen H, 2002, FLORA N AM N MEXICO, V23, P311, DOI DOI 10.1088/1748-9326/7/3/035501; Topel Mats, 2011, PLoS Curr, V3, pRRN1237, DOI 10.1371/currents.RRN1237; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Van De Wiel CCM, 2009, MOL ECOL RESOUR, V9, P1086, DOI 10.1111/j.1755-0998.2009.02547.x; von Crautlein M, 2011, BIODIVERS CONSERV, V20, P373, DOI 10.1007/s10531-010-9964-0; Walker DA, 2005, J VEG SCI, V16, P267, DOI 10.1111/j.1654-1103.2005.tb02365.x; Walker MD, 2006, P NATL ACAD SCI USA, V103, P1342, DOI 10.1073/pnas.0503198103; Wallace LJ, 2012, FOOD RES INT, V49, P446, DOI 10.1016/j.foodres.2012.07.048; Waterway Marcia J., 2007, Aliso, V23, P165; Wendling BM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023559; Westergaard KB, 2011, MOL ECOL, V20, P376, DOI 10.1111/j.1365-294X.2010.04928.x; Whittemore A.T., 1997, FLORA N AM N MEXICO, V3, P88; Winkler M, 2012, MOL ECOL, V21, P4618, DOI 10.1111/j.1365-294X.2012.05705.x; Wittzell H, 1999, MOL ECOL, V8, P2023, DOI 10.1046/j.1365-294x.1999.00807.x; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; WOLF SJ, 1979, CAN J BOT, V57, P1673, DOI 10.1139/b79-205; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Yan HF, 2011, J SYST EVOL, V49, P225, DOI 10.1111/j.1759-6831.2011.00115.x; Yang HQ, 2012, ANN BOT FENN, V49, P319, DOI 10.5735/085.049.0603; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Yesson C, 2011, MOL ECOL RESOUR, V11, P775, DOI 10.1111/j.1755-0998.2011.03009.x; Yu WB, 2011, J SYST EVOL, V49, P425, DOI 10.1111/j.1759-6831.2011.00154.x; Zaveska Drabkova L, 2010, MOL PHYLOGENET EVOL, V57, P536, DOI 10.1016/j.ympev.2010.07.022; Zaveska Drabkova L, 2009, PLANT SYST EVOL, V278, P169, DOI 10.1007/s00606-008-0135-7; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x	316	61	65	4	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2013	8	10							e77982	10.1371/journal.pone.0077982	http://dx.doi.org/10.1371/journal.pone.0077982			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	239OF	24348895	gold, Green Published, Green Submitted			2022-12-27	WOS:000326034500051
J	Biancotto, A; Wank, A; Perl, S; Cook, W; Olnes, MJ; Dagur, PK; Fuchs, JC; Langweiler, M; Wang, E; McCoy, JP				Biancotto, Angelique; Wank, Abigail; Perl, Shira; Cook, Wendell; Olnes, Matthew J.; Dagur, Pradeep K.; Fuchs, J. Christopher; Langweiler, Marc; Wang, Ena; McCoy, J. Philip			Baseline Levels and Temporal Stability of 27 Multiplexed Serum Cytokine Concentrations in Healthy Subjects	PLOS ONE			English	Article							BEAD ARRAY ASSAYS; SENSITIVITY; ASSOCIATION; EOTAXIN; RANTES; PLASMA; ALPHA	Background: Cytokines are humoral molecules that elicit regulatory function in immunologic pathways. The level and type of cytokine production has become critical in distinguishing physiologic from pathologic immune conditions. Cytokine profiling has become an important biomarker discovery tool in monitoring of the immune system. However, the variations in cytokine levels in individual subjects over time in healthy individuals have not been extensively studied. In this study, we use multiplex bead arrays to evaluate 27 analytes in paired serum samples taken seven days apart from 144 healthy individuals in order to assess variations over a short time period. Methods: Fluorescent bead-based immunoassay (Luminex) was used to measure 27 analytes in serum samples. Measurements were performed on matched samples from 144 healthy donors. To assess inter-plate variability, one arbitrarily selected serum sample was analyzed on each of the first ten plates as bridge sample. Results: Using the bridge sample, we showed minimal inter-plate variations in the measurement of most analytes. In measurement of cytokines from the 144 patients at two time points, we found that three cytokines (IL-2, IL-15 and GM-CSF) were undetectable and five analytes (RANTES, MCP-1, VEGF, MIP-1 beta and PDGF-BB) showed significant difference in concentrations at Day 0 compared to Day 7. Conclusions: The current study demonstrated higher variations in cytokine levels among individuals than were observed for samples obtained one week apart from identical donors. These data suggest that a serum sample from each subject for use as a baseline measurement is a better control for clinical trials rather than sera from a paired cohort.	[Biancotto, Angelique; Wank, Abigail; Perl, Shira; Cook, Wendell; Olnes, Matthew J.; Dagur, Pradeep K.; Fuchs, J. Christopher; Langweiler, Marc; Wang, Ena; McCoy, J. Philip] NIH, Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	McCoy, JP (corresponding author), NIH, Ctr Human Immunol Autoimmun & Inflammat, Bldg 10, Bethesda, MD 20892 USA.	Mccoyj@nhlbi.nih.gov	biancotto, angelique/C-4632-2011; mccoy, john philip/ABD-9348-2021	biancotto, angelique/0000-0003-2271-009X; Langweiler, Marc/0000-0001-6802-3610	NIH CHI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005905] Funding Source: NIH RePORTER	NIH CHI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NIH CHI intramural research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam R, 1996, AM J RESP CRIT CARE, V153, P1398, DOI 10.1164/ajrccm.153.4.8616572; Bastarache JA, 2011, J IMMUNOL METHODS, V367, P33, DOI 10.1016/j.jim.2011.01.005; Biancotto A, 2012, CYTOKINE, V60, P438, DOI 10.1016/j.cyto.2012.05.019; Chaturvedi AK, 2011, CANCER EPIDEM BIOMAR, V20, P1902, DOI 10.1158/1055-9965.EPI-11-0221; Comini-Frota ER, 2011, CNS DRUGS, V25, P971, DOI 10.2165/11595060-000000000-00000; de Jager W, 2006, METHODS, V38, P294, DOI 10.1016/j.ymeth.2005.11.008; Deo R, 2004, J AM COLL CARDIOL, V44, P1812, DOI 10.1016/j.jacc.2004.07.047; Dorner BG, 2002, P NATL ACAD SCI USA, V99, P6181, DOI 10.1073/pnas.092141999; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Gu Y, 2009, CYTOKINE, V45, P44, DOI 10.1016/j.cyto.2008.10.014; Hao XJ, 2007, CARDIOVASC RES, V75, P178, DOI 10.1016/j.cardiores.2007.03.028; Hatta K, 2009, AM J REPROD IMMUNOL, V62, P158, DOI 10.1111/j.1600-0897.2009.00725.x; Jahnz-Rozyk K, 2007, J INVEST ALLERG CLIN, V17, P345; KENNEDY RL, 1991, J ENDOCRINOL, V129, P167, DOI 10.1677/joe.0.1290167; Khan SS, 2004, CYTOM PART B-CLIN CY, V61B, P35, DOI 10.1002/cyto.b.20021; Kovats S, 2012, HORM BEHAV, V62, P254, DOI 10.1016/j.yhbeh.2012.04.011; Leung J, 2008, GENDER MED, V5, P44, DOI 10.1016/S1550-8579(08)80007-1; Melenhorst JJ, 2012, HAEMATOL-HEMATOL J, V97, P867, DOI 10.3324/haematol.2011.053363; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055756; Moncunill G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052587; Olson NC, 2012, J CLIN ENDOCR METAB, V97, P1032, DOI 10.1210/jc.2011-2155; Targowski T, 2005, J INVEST ALLERG CLIN, V15, P277; Wong HL, 2008, CANCER EPIDEM BIOMAR, V17, P3450, DOI 10.1158/1055-9965.EPI-08-0311	23	73	75	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e76091	10.1371/journal.pone.0076091	http://dx.doi.org/10.1371/journal.pone.0076091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24348989	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800001
J	Herdtweck, C; Wallraven, C				Herdtweck, Christian; Wallraven, Christian			Estimation of the Horizon in Photographed Outdoor Scenes by Human and Machine	PLOS ONE			English	Article							RELATIVE SIZE; PERCEPTION; DISTANCE; ORIENTATION; PITCH; WORLD; MISLOCALIZATIONS; REPRESENTATION; INFORMATION; JUDGMENTS	We present three experiments on horizon estimation. In Experiment 1 we verify the human ability to estimate the horizon in static images from only visual input. Estimates are given without time constraints with emphasis on precision. The resulting estimates are used as baseline to evaluate horizon estimates from early visual processes. Stimuli are presented for only 153 ms and then masked to purge visual short-term memory and enforcing estimates to rely on early processes, only. The high agreement between estimates and the lack of a training effect shows that enough information about viewpoint is extracted in the first few hundred milliseconds to make accurate horizon estimation possible. In Experiment 3 we investigate several strategies to estimate the horizon in the computer and compare human with machine "behavior'' for different image manipulations and image scene types.	[Herdtweck, Christian] Max Planck Inst Biol Cybernet, Dept Human Percept Cognit & Act, D-72076 Tubingen, Germany; [Wallraven, Christian] Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea	Max Planck Society; Korea University	Wallraven, C (corresponding author), Korea Univ, Dept Brain & Cognit Engn, Seoul, South Korea.	wallraven@korea.ac.kr		Wallraven, Christian/0000-0002-2604-9115	World Class University program through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R31-2008-000-10008-0]; Max Planck Society	World Class University program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This research was supported by the World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R31-2008-000-10008-0) and a PhD stipend from the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASCH SE, 1948, J EXP PSYCHOL, V38, P325, DOI 10.1037/h0057855; Aubert H., 1861, ARCH PATHOL ANAT PH, V20, P381, DOI [10.1007/BF02355256, DOI 10.1007/BF02355256]; Bringoux L, 2004, EXP BRAIN RES, V155, P385, DOI 10.1007/s00221-003-1742-8; Bringoux L, 2000, J VESTIBUL RES-EQUIL, V10, P251; Cohen MM, 2001, PERCEPT PSYCHOPHYS, V63, P29, DOI 10.3758/BF03200500; COHEN MM, 1974, PERCEPT PSYCHOPHYS, V16, P508, DOI 10.3758/BF03198579; Cooper EA, 2011, J VISION, V11, DOI 10.1167/11.3.20; Coughlan JM, 2003, NEURAL COMPUT, V15, P1063, DOI 10.1162/089976603765202668; Deutscher J, 2002, P EUR C COMP VIS ECC; DiZio P, 1997, J VESTIBUL RES-EQUIL, V7, P381, DOI 10.1016/S0957-4271(96)00163-2; Durgin F. H., 2005, ACM T APPL PERCEPT, V2, P234, DOI [10.1145/1077399.1077403, DOI 10.1145/1077399.1077403]; Foulsham T, 2008, VISION RES, V48, P1777, DOI 10.1016/j.visres.2008.05.018; GIBSON JJ, 1978, LEONARDO, V11, P227, DOI 10.2307/1574154; Gibson JJ, 1938, PSYCHOL REV, V45, P300, DOI 10.1037/h0060402; Greene MR, 2009, PSYCHOL SCI, V20, P464, DOI 10.1111/j.1467-9280.2009.02316.x; Hardle W, 2004, NONPARAMETRIC DENSIT; Herdtweck C, 2010, APGV 10, P49; Hoiem D, 2006, P IEEE COMP VIS PATT; Hoiem D, 2008, P IEEE COMP VIS PATT; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kleiner M, 2007, PERCEPTION, V36, P14; Kosecka J, 2002, LECT NOTES COMPUT SC, V2353, P476; Lalonde JF, 2007, ACM T GRAPH SIGGRAPH, P26; LAND MF, 1992, ANNU REV NEUROSCI, V15, P1, DOI 10.1146/annurev.ne.15.030192.000245; MATIN L, 1982, SCIENCE, V216, P198, DOI 10.1126/science.7063881; MATIN L, 1992, ANN NY ACAD SCI, V656, P242, DOI 10.1111/j.1749-6632.1992.tb25213.x; Oliva A, 2001, INT J COMPUT VISION, V42, P145, DOI 10.1023/A:1011139631724; Ooi TL, 2006, PERCEPTION, V35, P605, DOI 10.1068/p5492; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Ozkan K, 2010, VIS COGN, V18, P229, DOI 10.1080/13506280802674101; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Philbeck JW, 1997, J EXP PSYCHOL HUMAN, V23, P72, DOI 10.1037/0096-1523.23.1.72; Rand KM, 2011, PERCEPTION, V40, P143, DOI 10.1068/p6843; Rogers S, 1996, PERCEPT PSYCHOPHYS, V58, P142, DOI 10.3758/BF03205483; Rousselet GA, 2005, VIS COGN, V12, P852, DOI 10.1080/13506280444000553; Russell BC, 2008, INT J COMPUT VISION, V77, P157, DOI 10.1007/s11263-007-0090-8; Scott D. W., 1992, MULTIVARIATE DENSITY, DOI 10.1002/9780470316849; Sedgwick H., 1986, HDB PERCEPTION HUMAN, V1, P1; Sedgwick H. A., 1980, PERCEPTION PICTURES, V1, P33; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sivic J, 2008, 1 IEEE WORKSH INT VI; STOPER AE, 1986, PERCEPT PSYCHOPHYS, V40, P311, DOI 10.3758/BF03203022; Thompson WB, 2007, PERCEPTION, V36, P1559, DOI 10.1068/p5667; Torralba A, 2001, P ICCV; Tremblay L, 2004, PERCEPTION, V33, P329, DOI 10.1068/p5209; Wertheimer M, 1912, Z PSYCHOL, P61; Wu B, 2004, NATURE, V428, P73, DOI 10.1038/nature02350; Wu B, 2007, PERCEPT PSYCHOPHYS, V69, P654, DOI 10.3758/BF03193769; Wyszecki G., 2000, COLOR SCI CONCEPTS M	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81462	10.1371/journal.pone.0081462	http://dx.doi.org/10.1371/journal.pone.0081462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349073	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800018
J	Kakkad, SM; Penet, MF; Akhbardeh, A; Pathak, AP; Solaiyappan, M; Raman, V; Leibfritz, D; Glunde, K; Bhujwalla, ZM				Kakkad, Samata M.; Penet, Marie-France; Akhbardeh, Alireza; Pathak, Arvind P.; Solaiyappan, Meiyappan; Raman, Venu; Leibfritz, Dieter; Glunde, Kristine; Bhujwalla, Zaver M.			Hypoxic Tumor Environments Exhibit Disrupted Collagen I Fibers and Low Macromolecular Transport	PLOS ONE			English	Article							MAGNETIC-RESONANCE; PANCREATIC-CANCER; BREAST-CARCINOMA; MR-IMAGES; REGISTRATION; INTERSTITIUM; INFORMATION; DELIVERY; DENSITY; CELLS	Hypoxic tumor microenvironments result in an aggressive phenotype and resistance to therapy that lead to tumor progression, recurrence, and metastasis. While poor vascularization and the resultant inadequate drug delivery are known to contribute to drug resistance, the effect of hypoxia on molecular transport through the interstitium, and the role of the extracellular matrix (ECM) in mediating this transport are unexplored. The dense mesh of fibers present in the ECM can especially influence the movement of macromolecules. Collagen 1 (Col1) fibers form a key component of the ECM in breast cancers. Here we characterized the influence of hypoxia on macromolecular transport in tumors, and the role of Col1 fibers in mediating this transport using an MDA-MB-231 breast cancer xenograft model engineered to express red fluorescent protein under hypoxia. Magnetic resonance imaging of macromolecular transport was combined with second harmonic generation microscopy of Col1 fibers. Hypoxic tumor regions displayed significantly decreased Col1 fiber density and volume, as well as significantly lower macromolecular draining and pooling rates, than normoxic regions. Regions adjacent to severely hypoxic areas revealed higher deposition of Col1 fibers and increased macromolecular transport. These data suggest that Col1 fibers may facilitate macromolecular transport in tumors, and their reduction in hypoxic regions may reduce this transport. Decreased macromolecular transport in hypoxic regions may also contribute to poor drug delivery and tumor recurrence in hypoxic regions. High Col1 fiber density observed around hypoxic regions may facilitate the escape of aggressive cancer cells from hypoxic regions.	[Kakkad, Samata M.; Penet, Marie-France; Akhbardeh, Alireza; Pathak, Arvind P.; Solaiyappan, Meiyappan; Raman, Venu; Glunde, Kristine; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA; [Pathak, Arvind P.; Raman, Venu; Glunde, Kristine; Bhujwalla, Zaver M.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD USA; [Kakkad, Samata M.; Leibfritz, Dieter] Univ Bremen, Fachbereich 2, D-28359 Bremen, Germany	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; University of Bremen	Bhujwalla, ZM (corresponding author), Johns Hopkins Univ, Sch Med, Russell H Morgan Dept Radiol & Radiol Sci, JHU ICMIC Program,Div Canc Imaging Res, Baltimore, MD 21218 USA.	zaver@mri.jhu.edu	Penet, Marie-France/AGZ-6991-2022; Kakkad, Samata/B-9266-2017	Kakkad, Samata/0000-0002-2959-8320	NIH [R01CA136576, R01CA138515, R01CA73850, R01CA82337, P50CA103175, P30CA006973]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R01CA136576, R01CA138515, R01CA73850, R01CA82337, P50CA103175, and P30CA006973. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbarzadeh A, 2013, J APPL CLIN MED PHYS, V14, P238, DOI 10.1120/jacmp.v14i4.4163; Brown E, 2003, NAT MED, V9, P796, DOI 10.1038/nm879; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Chappelow J, 2011, MED PHYS, V38, P2005, DOI 10.1118/1.3560879; COLLIGNON A, 1995, COMP IMAG VIS, V3, P263; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dunn J. C., 1973, Journal of Cybernetics, V3, P32, DOI 10.1080/01969727308546046; Falanga V, 2002, J CELL PHYSIOL, V191, P42, DOI 10.1002/jcp.10065; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; JAIN RK, 1987, CANCER RES, V47, P3039; Kakkad SM, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116017; Kakkad SM, 2010, NEOPLASIA, V12, P608, DOI 10.1593/neo.10344; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Li J, 2010, AAPS J, V12, P223, DOI 10.1208/s12248-010-9181-5; LOCHTER A, 1995, SEMIN CANCER BIOL, V6, P165, DOI 10.1006/scbi.1995.0017; MAEMURA M, 1995, CLIN EXP METASTAS, V13, P223, DOI 10.1007/BF00133478; Mazaheri Y, 2010, J MAGN RESON IMAGING, V32, P1149, DOI 10.1002/jmri.22347; Miyamoto S, 2008, STUD FUZZ SOFT COMP, V229, P1; Netti PA, 2000, CANCER RES, V60, P2497; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Pajares G, 2004, PATTERN RECOGN, V37, P1855, DOI 10.1016/j.patcog.2004.03.010; Pathak AP, 2005, CANCER RES, V65, P1425, DOI 10.1158/0008-5472.CAN-04-3682; Provenzano PP, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-11; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Raman V, 2006, CANCER RES, V66, P9929, DOI 10.1158/0008-5472.CAN-06-0886; Ramanujan S, 2002, BIOPHYS J, V83, P1650, DOI 10.1016/S0006-3495(02)73933-7; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Serebriiskii I, 2008, MATRIX BIOL, V27, P573, DOI 10.1016/j.matbio.2008.02.008; Swartz MA, 2001, ADV DRUG DELIVER REV, V50, P3, DOI 10.1016/S0169-409X(01)00150-8	35	14	16	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81869	10.1371/journal.pone.0081869	http://dx.doi.org/10.1371/journal.pone.0081869			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349142	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800028
J	Liu, YH; Li, XN; Xu, LL; Shen, WB				Liu, Yahui; Li, Xinna; Xu, Langlai; Shen, Wenbiao			De-Etiolation of Wheat Seedling Leaves: Cross Talk between Heme Oxygenase/Carbon Monoxide and Nitric Oxide	PLOS ONE			English	Article							INDUCED OXIDATIVE DAMAGE; CARBON-MONOXIDE; PHYTOCHROME CHROMOPHORE; SIGNAL-TRANSDUCTION; ANTIOXIDANT; GERMINATION; EXPRESSION; STRESS; BIOSYNTHESIS; INVOLVEMENT	Greening of etiolated plants is predominantly stimulated by light but the complete molecular mechanism is still unknown. Multiple studies currently focus on the important physiological effects of heme oxygenase (HO)/carbon monoxide (CO) in plants. In this report, firstly, the role of HO/CO in light-induced de-etiolation process was investigated. We discovered that light could significantly increase HO activities, HO-1 gene expression, CO release, and chlorophyll accumulation, all of which were sensitive to zinc protoporphyrin (ZnPPIX), the potent inhibitor of HO-1, respectively. Both HO-1 inducer hematin (H) and CO aqueous solution were able to relieve etiolation in wheat seedling leaves under completely darkness by up-regulating endogenous HO/CO system, so as nitric oxide (NO) donor sodium nitroprusside (SNP) did. Similarly, endogenous NO production was also boost in response to light, SNP, hematin and CO aqueous solution in wheat seedling leaves. Additionally, the restoration of chlorophyll contents was blocked, when the inhibitor of mammalian nitric oxide synthase N-G-nitro-L-arginine methylester hydrochloride (L-NAME) or the specific scavenger of NO 2-(4-carboxyphenyl)-4, 4, 5, 5-tetramethylimidazoline- 1-oxyl-3-oxide potassium salt (cPTIO) was added, respectively. Furthermore, the inducible effects of light were different from those of SNP, hematin, and CO on Pfr accumulation and PHYA transcripts. However, all of sodium nitroprusside (SNP), hematin, and CO could accelerate NO emission, which suggested that HO/CO in wheat seedlings de-etiolation under dark-light transition may have a cross talk with NO.	[Liu, Yahui] Ningbo First Hosp, Ningbo, Zhejiang, Peoples R China; [Liu, Yahui; Xu, Langlai; Shen, Wenbiao] Nanjing Agr Univ, Coll Life Sci, Cooperat Demonstrat Lab Centrifuge Tech, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Li, Xinna] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China	Nanjing Agricultural University; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS	Liu, YH (corresponding author), Ningbo First Hosp, Ningbo, Zhejiang, Peoples R China.	702820686@qq.com			program for new century excellent talents in university [NCET-07-0441]; 111 project of China [B07030]	program for new century excellent talents in university(Program for New Century Excellent Talents in University (NCET)); 111 project of China(Ministry of Education, China - 111 Project)	This work was supported by the program for new century excellent talents in university (grant no. NCET-07-0441), and the 111 project of China (grant no. B07030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beligni MV, 2000, PLANTA, V210, P215, DOI 10.1007/PL00008128; Beligni MV, 2001, PLANT CELL ENVIRON, V24, P267, DOI 10.1046/j.1365-3040.2001.00672.x; Boardman N.K., 1978, CURR TOP BIOENERG, V8, P35; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cao ZY, 2007, J INTEGR PLANT BIOL, V49, P1070, DOI 10.1111/j.1672-9072.2007.00482.x; Cao ZY, 2007, CHINESE SCI BULL, V52, P2365, DOI 10.1007/s11434-007-0358-y; CHERRY JR, 1992, P NATL ACAD SCI USA, V89, P5039, DOI 10.1073/pnas.89.11.5039; Correa-Aragunde N, 2004, PLANTA, V218, P900, DOI 10.1007/s00425-003-1172-7; Crawford NM, 2006, TRENDS PLANT SCI, V11, P526, DOI 10.1016/j.tplants.2006.09.007; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; Dekker J, 2002, AM J BOT, V89, P410, DOI 10.3732/ajb.89.3.410; Delledonne M, 2005, CURR OPIN PLANT BIOL, V8, P390, DOI 10.1016/j.pbi.2005.05.002; Emborg TJ, 2006, PLANT PHYSIOL, V140, P856, DOI 10.1104/pp.105.074211; GULICK P, 1987, P NATL ACAD SCI USA, V84, P99, DOI 10.1073/pnas.84.1.99; Han Y, 2008, NEW PHYTOL, V177, P155, DOI 10.1111/j.1469-8137.2007.02251.x; Huang BK, 2006, J INTEGR PLANT BIOL, V48, P249, DOI 10.1111/j.1744-7909.2006.00220.x; Lamar CA, 1996, ENDOCRINOLOGY, V137, P790, DOI 10.1210/en.137.2.790; LANE HC, 1963, PLANT PHYSIOL, V38, P414, DOI 10.1104/pp.38.4.414; Liu KL, 2007, PLANT SCI, V172, P544, DOI 10.1016/j.plantsci.2006.11.007; LUTTGE U, 1980, PLANTA, V149, P59, DOI 10.1007/BF00386228; MASONER M, 1975, PLANTA, V126, P111, DOI 10.1007/BF00380614; MORITA T, 1995, P NATL ACAD SCI USA, V92, P1475, DOI 10.1073/pnas.92.5.1475; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Noriega GO, 2004, BIOCHEM BIOPH RES CO, V323, P1003, DOI 10.1016/j.bbrc.2004.08.199; Noriega GO, 2007, PLANTA, V226, P1155, DOI 10.1007/s00425-007-0561-8; QUAIL PH, 1991, ANNU REV GENET, V25, P389, DOI 10.1146/annurev.ge.25.120191.002133; QUAIL PH, 1995, SCIENCE, V268, P675, DOI 10.1126/science.7732376; Sa ZS, 2007, J INTEGR PLANT BIOL, V49, P638, DOI 10.1111/j.1744-7909.2007.00461.x; Schade GW, 1999, TELLUS B, V51, P889, DOI 10.1034/j.1600-0889.1999.t01-4-00003.x; Schafer E, 2002, EMBO REP, V3, P1042, DOI 10.1093/embo-reports/kvf222; SHARROCK RA, 1989, GENE DEV, V3, P1745, DOI 10.1101/gad.3.11.1745; SIEGEL SM, 1962, SCIENCE, V137, P683, DOI 10.1126/science.137.3531.683; TARR MA, 1995, J GEOPHYS RES-ATMOS, V100, P11403, DOI 10.1029/94JD03324; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; VERMA A, 1993, SCIENCE, V259, P381, DOI 10.1126/science.7678352; VON WETTSTEIN D, 1995, PLANT CELL, V7, P1039, DOI 10.1105/tpc.7.7.1039; Watts RN, 2003, BIOCHEM J, V369, P429, DOI 10.1042/BJ20021302; WILKS SS, 1959, SCIENCE, V129, P964, DOI 10.1126/science.129.3354.964; Xie YJ, 2008, PLANT CELL ENVIRON, V31, P1864, DOI 10.1111/j.1365-3040.2008.01888.x; Xuan W, 2008, PLANT PHYSIOL, V148, P881, DOI 10.1104/pp.108.125567; Zemojtel T, 2006, TRENDS PLANT SCI, V11, P524, DOI 10.1016/j.tplants.2006.09.008; Zhang LG, 2006, J PLANT PHYSIOL, V163, P818, DOI 10.1016/j.jplph.2005.07.011; Zhou BY, 2005, J EXP BOT, V56, P3223, DOI 10.1093/jxb/eri319; ZHUO M, 1993, SCIENCE, V260, P1946, DOI 10.1126/science.8100368	45	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81470	10.1371/journal.pone.0081470	http://dx.doi.org/10.1371/journal.pone.0081470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349074	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800019
J	Chen, C; Ruan, DK; Wu, CF; Wu, WD; Sun, PD; Zhang, YZ; Wu, JG; Lu, S; Ouyang, J				Chen, Chun; Ruan, Dike; Wu, Changfu; Wu, Weidong; Sun, Peidong; Zhang, Yuanzhi; Wu, Jigong; Lu, Sheng; Ouyang, Jun			CT Morphometric Analysis to Determine the Anatomical Basis for the Use of Transpedicular Screws during Reconstruction and Fixations of Anterior Cervical Vertebrae	PLOS ONE			English	Article							QUANTITATIVE 3-DIMENSIONAL ANATOMY; PEDICLE SCREWS; SPINE; FEASIBILITY; INSERTION; ACCURACY; COMPLICATIONS; PLACEMENT; TOMOGRAPHY; DIAMETER	Background: Accurate placement of pedicle screw during Anterior Transpedicular Screw fixation (ATPS) in cervical spine depends on accurate anatomical knowledge of the vertebrae. However, little is known of the morphometric characteristics of cervical vertebrae in Chinese population. Methods: Three-dimensional reconstructions of CT images were performed for 80 cases. The anatomic data and screw fixation parameters for ATPS fixation were measured using the Mimics software. Findings: The overall mean OPW, OPH and PAL ranged from 5.81 to 7.49 mm, 7.77 to 8.69 mm, and 33.40 to 31.13 mm separately, and SPA was 93.54 to 109.36 degrees from C3 to C6, 104.99 degrees at C7, whereas, 49.00 to 32.26 degrees from C4 to C7, 46.79 degrees at C3 (TPA). Dl/rSIP had an increasing trend away from upper endplate with mean value from 1.87 to 5.83 mm. Dl/rTIP was located at the lateral portion of the anterior cortex of vertebrae for C3 to C5 and ipsilateral for C6 to C7 with mean value from -2.70 to -3.00 mm, and 0.17 to 3.18 mm. The entrance points for pedicular screw insertion for C3 to C5 and C6 to C7 were recommended -2 similar to-3 mm and 0-4 mm from the median sagittal plane, respectively, 1-4 mm and 5-6 mm from the upper endplate, with TPA being 46.79-49.00 degrees and 40.89-32.26 degrees, respectively, and SPA being 93.54-106.69 degrees and 109.36-104.99 degrees, respectively. The pedicle screw insertion diameter was recommended 3.5 mm (C3 and C4), 4.0 mm (C5 to C7), and the pedicle axial length was 21-24 mm for C3 to C7 for both genders. However, the ATPS insertion in C3 should be individualized given its relatively small anatomical dimensions. Conclusions: The data provided a morphometric basis for the ATPS fixation technique in lower cervical fixation. It will help in preoperative planning and execution of this surgery.	[Chen, Chun; Wu, Changfu; Wu, Weidong; Sun, Peidong; Ouyang, Jun] Southern Med Univ, Dept Anat, Guangzhou, Guangdong, Peoples R China; [Chen, Chun; Wu, Changfu; Wu, Weidong; Sun, Peidong; Ouyang, Jun] Guangdong Prov Med Biomech Key Lab, Guangzhou, Guangdong, Peoples R China; [Chen, Chun; Wu, Changfu; Wu, Weidong; Sun, Peidong; Ouyang, Jun] Acad Orthoped Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Chen, Chun; Ruan, Dike] Southern Med Univ, Navy Gen Hosp, Dept Orthoped Surg, Beijing, Peoples R China; [Chen, Chun] Southern Med Univ, Sch Clin Med 3, Guangzhou, Guangdong, Peoples R China; [Wu, Jigong] Peoples Liberat Army, Hosp 306, Dept Orthoped Surg, Beijing, Peoples R China; [Lu, Sheng] Kunming Gen Hosp, Dept Orthoped Surg, Kunming, Yunnan, Peoples R China; [Ouyang, Jun] Shenzhen Digital Orthoped Engn Lab, Shenzhen, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Sixth Medical Center of Chinese PLA General Hospital; Southern Medical University - China; Southern Medical University - China; Kunming General Hospital	Ouyang, J (corresponding author), Southern Med Univ, Dept Anat, Guangzhou, Guangdong, Peoples R China.	jouyang@126.com			National Natural Science Foundation of China [31170903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China grant No. 31170903. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abumi K, 2000, SPINE, V25, P962, DOI 10.1097/00007632-200004150-00011; ABUMI K, 1994, J SPINAL DISORD, V7, P19, DOI 10.1097/00002517-199407010-00003; Bing D, 2010, ACTA ACAD MED XUZHOU, V30, P520; Bozbuga M, 2004, SPINE, V29, P1876, DOI 10.1097/01.brs.0000137065.62516.01; Chazono M, 2006, J NEUROSURG-SPINE, V4, P472, DOI 10.3171/spi.2006.4.6.472; Daentzer D, 2004, UNFALLCHIRURG, V107, P175, DOI 10.1007/s00113-003-0722-6; Epstein NE, 2001, SURG NEUROL, V56, P73, DOI 10.1016/S0090-3019(01)00523-7; Fallah A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043407; Fu M, 2013, PLOS ONE; Gupta R, 2013, SURG RADIOL ANAT, V35, P181, DOI 10.1007/s00276-012-1013-0; Ishikawa Y, 2011, J NEUROSURG-SPINE, V15, P472, DOI 10.3171/2011.6.SPINE10809; Ito H, 2007, RHEUMATOL INT, V27, P567, DOI 10.1007/s00296-006-0256-7; Jin BL, 2001, CHIN J CLIN ANAT, V19, P23; Jones EL, 1997, SPINE, V22, P977, DOI 10.1097/00007632-199705010-00009; Kantelhardt SR, 2005, NEUROSURG REV, V28, P308, DOI 10.1007/s10143-005-0386-5; Karaikovic EE, 1997, SPINE, V22, P493, DOI 10.1097/00007632-199703010-00005; Kast E, 2006, EUR SPINE J, V15, P327, DOI 10.1007/s00586-004-0861-7; Kayalioglu G, 2007, NEUROL MED-CHIR, V47, P102, DOI 10.2176/nmc.47.102; Koller H, 2008, EUR SPINE J, V17, P523, DOI 10.1007/s00586-007-0572-y; Koller H, 2008, EUR SPINE J, V17, P539, DOI 10.1007/s00586-007-0573-x; Koller H, 2007, EUR SPINE J, V16, P2055, DOI 10.1007/s00586-007-0398-7; Koller H, 2009, EUR SPINE J, V18, P1300, DOI 10.1007/s00586-009-1054-1; Kotani Y, 2003, J NEUROSURG, V99, P257, DOI 10.3171/spi.2003.99.3.0257; Kotil K, 2012, J CLIN NEUROSCI, V19, P546, DOI 10.1016/j.jocn.2011.05.041; Kotil Kadir, 2011, J Orthop Surg (Hong Kong), V19, P326; Kotil K, 2011, TURK NEUROSURG, V21, P606, DOI [10.5137/1019-5149.JTN .4739-11.2, 10.5137/1019-5149.JTN.4739-11.2]; Lee MJ, 2013, SPINE, V38, P223, DOI 10.1097/BRS.0b013e318268ffc9; Liu JY, 2010, SPINE, V35, pE1373, DOI 10.1097/BRS.0b013e3181e92272; Liu K, 2013, CLIN ORTHOP RELAT R, V471, P2219, DOI 10.1007/s11999-013-2889-7; Ludwig SC, 2000, SPINE, V25, P1655, DOI 10.1097/00007632-200007010-00009; Massin P, 2000, J ARTHROPLASTY, V15, P93, DOI 10.1016/S0883-5403(00)91337-8; Nishinome M, 2013, EUR SPINE J; NOBLE PC, 1988, CLIN ORTHOP RELAT R, P148; Oh SH, 1996, NEUROSURGERY, V38, P1139, DOI 10.1097/00006123-199606000-00016; Pateder Dhruv B, 2006, Spine J, V6, P40, DOI 10.1016/j.spinee.2005.04.010; Qing YL, 2005, ACDA J SEC MIL MED U, V26, P1029; Reinhold M, 2007, EUR SPINE J, V16, P47, DOI 10.1007/s00586-006-0104-1; Rihn JA, 2012, ORTHOP CLIN N AM, V43, P123, DOI 10.1016/j.ocl.2011.09.001; Rong MX, 2011, CHIN J ORTHO, V31, P1337; Sakamoto T, 2004, SPINE, V29, P2510, DOI 10.1097/01.brs.0000144404.68486.85; Senol U, 2001, CLIN ANAT, V14, P15, DOI 10.1002/1098-2353(200101)14:1<15::AID-CA1002>3.0.CO;2-X; Tan SH, 2004, EUR SPINE J, V13, P137, DOI 10.1007/s00586-003-0586-z; Tian W, 2013, EUR SPINE J, V22, P148, DOI 10.1007/s00586-012-2494-6; Tomasino A, 2010, J NEUROSURG-SPINE, V13, P52, DOI 10.3171/2010.3.SPINE09231; [王远政 Wang Yuanzheng], 2012, [重庆医科大学学报, Acta Universitatis Scientiae Medicinae Chongqing], V37, P1063; Yang B, 2012, PLOS ONE; Yang YL, 2013, J SPINAL DISORD TECH, V26, P127, DOI 10.1097/BSD.0b013e31823d36b6; Yusof MI, 2006, SPINE, V31, pE221, DOI 10.1097/01.brs.0000210263.87578.65; Zhu RF, 2008, SURG RADIOL ANAT, V30, P389, DOI 10.1007/s00276-008-0339-0	49	15	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81159	10.1371/journal.pone.0081159	http://dx.doi.org/10.1371/journal.pone.0081159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349038	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300020
J	Johnson, AD; Thomson, DR; Atwood, S; Alley, I; Beckerman, JL; Kone, I; Diakite, D; Diallo, H; Traore, B; Traore, K; Farmer, PE; Murray, M; Mukherjee, J				Johnson, Ari D.; Thomson, Dana R.; Atwood, Sidney; Alley, Ian; Beckerman, Jessica L.; Kone, Ichiaka; Diakite, Djoume; Diallo, Hamed; Traore, Boubacar; Traore, Klenon; Farmer, Paul E.; Murray, Megan; Mukherjee, Joia			Assessing Early Access to Care and Child Survival during a Health System Strengthening Intervention in Mali: A Repeated Cross Sectional Survey	PLOS ONE			English	Article							NEONATAL DEATHS; USER FEES; MORTALITY; COUNTRIES; IMPACT; UGANDA; RESUSCITATION; DISTRICT; PROGRESS; SEEKING	Background: In 2012, 6.6 million children under age five died worldwide, most from diseases with known means of prevention and treatment. A delivery gap persists between well-validated methods for child survival and equitable, timely access to those methods. We measured early child health care access, morbidity, and mortality over the course of a health system strengthening model intervention in Yirimadjo, Mali. The intervention included Community Health Worker active case finding, user fee removal, infrastructure development, community mobilization, and prevention programming. Methods and Findings: We conducted four household surveys using a cluster-based, population-weighted sampling methodology at baseline and at 12, 24, and 36 months. We defined our outcomes as the percentage of children initiating an effective antimalarial within 24 hours of symptom onset, the percentage of children reported to be febrile within the previous two weeks, and the under-five child mortality rate. We compared prevalence of febrile illness and treatment using chi-square statistics, and estimated and compared under-five mortality rates using Cox proportional hazard regression. There was a statistically significant difference in under-five mortality between the 2008 and 2011 surveys; in 2011, the hazard of under-five mortality in the intervention area was one tenth that of baseline (HR 0.10, p<0.0001). After three years of the intervention, the prevalence of febrile illness among children under five was significantly lower, from 38.2% at baseline to 23.3% in 2011 (PR = 0.61, p = 0.0009). The percentage of children starting an effective antimalarial within 24 hours of symptom onset was nearly twice that reported at baseline (PR = 1.89, p = 0.0195). Conclusions: Community-based health systems strengthening may facilitate early access to prevention and care and may provide a means for improving child survival.	[Diallo, Hamed; Traore, Boubacar; Traore, Klenon] Malian Minist Hlth, Bamako, Mali; [Thomson, Dana R.; Farmer, Paul E.; Murray, Megan; Mukherjee, Joia] Harvard Univ, Sch Med, Dept Global Hlth & Social Med, Boston, MA USA; [Murray, Megan] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Johnson, Ari D.; Beckerman, Jessica L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [Atwood, Sidney; Farmer, Paul E.; Murray, Megan; Mukherjee, Joia] Brigham & Womens Hosp, Div Global Hlth Equ, Boston, MA 02115 USA; [Johnson, Ari D.; Alley, Ian; Beckerman, Jessica L.; Kone, Ichiaka; Diakite, Djoume] Yirimadjo, Div Res, Muso, Bamako, Mali	Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California San Francisco; Harvard University; Brigham & Women's Hospital	Johnson, AD (corresponding author), Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA.	ari.johnson@ucsf.edu		Thomson, Dana Renee/0000-0002-9507-9123	University of California Center of Excellence in Women's Health and Empowerment; Conservation, Food, and Health Foundation	University of California Center of Excellence in Women's Health and Empowerment; Conservation, Food, and Health Foundation	This study was funded by the University of California Center of Excellence in Women's Health and Empowerment and the Conservation, Food, and Health Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akin J.S., 1987, FINANCING HLTH SERVI; [Anonymous], 2004, SCAL HOM BAS MAN MAL; Ardeshir Sepehri, 2001, Journal of International Development, V13, P183, DOI 10.1002/jid.726; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Chinbuah MA, 2012, AM J TROP MED HYG, V87, P11, DOI 10.4269/ajtmh.2012.12-0078; de Souza ACT, 2000, SOC SCI MED, V51, P1675, DOI 10.1016/S0277-9536(00)00100-3; Ersdal HL, 2012, RESUSCITATION, V83, P869, DOI 10.1016/j.resuscitation.2011.12.011; Frenk J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000089; Fryatt R, 2010, B WORLD HEALTH ORGAN, V88, P476, DOI 10.2471/BLT.09.075507; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; INFO-STAT Cellule de Planification et de Statistiques (CPS) Institut National de la Statistique (INSTAT) ICF International, 2013, ENQ DEM SANT MAL EDS; Jacobs B, 2004, HEALTH POLICY PLANN, V19, P310, DOI 10.1093/heapol/czh036; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Lagarde M, 2011, COCHRANE DB SYST REV, V4, DOI [10.1002/14651858.CD14009094, DOI 10.1002/14651858.CD14009094]; Lake A, 2012, LANCET, V380, P1286, DOI 10.1016/S0140-6736(12)61539-6; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lee ACC, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S12; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Measure DHS, 2008, DHS MOD QUEST PHAS 6; Millman M., 1993, ACCESS HLTH CARE AM; Nabyonga J, 2005, HEALTH POLICY PLANN, V20, P100, DOI 10.1093/heapol/czi012; Perez F, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-28; Ponsar F, 2011, HLTH POLICY PLAN, DOI [10.1093/heapol/czr068, DOI 10.1093/HEAP0L/CZR068]; Pronyk P, 2012, LANCET, V379, P1946, DOI 10.1016/S0140-6736(12)60824-1; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rakha MA, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001852; Reyes H, 1997, HEALTH POLICY PLANN, V12, P214, DOI 10.1093/heapol/12.3.214; Taylor TE, 2011, TREATMENT SEVERE FAL; United Nations Children's Fund (UNICEF), 2010, UNICEF, V9, P22; United Nations Development Programme, 2011, HUM DEV IND 2011; Waiswa P, 2010, TROP MED INT HEALTH, V15, P964, DOI 10.1111/j.1365-3156.2010.02557.x; Weaver M, 1995, HEALTH POLICY PLANN, V10, P350, DOI 10.1093/heapol/10.4.350; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Winch PJ, 2003, T ROY SOC TROP MED H, V97, P481, DOI 10.1016/S0035-9203(03)80001-9; World Health Organization, 2001, BACKGR PAP TECHN CON; You D, 2013, LEVELS TRENDS CHILD; You D, 2013, LEVELS TRENDS CHILD	38	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81304	10.1371/journal.pone.0081304	http://dx.doi.org/10.1371/journal.pone.0081304			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349053	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000328730300024
J	Nepusz, T; Vicsek, T				Nepusz, Tamas; Vicsek, Tamas			Hierarchical Self-Organization of Non-Cooperating Individuals	PLOS ONE			English	Article								Hierarchy is one of the most conspicuous features of numerous natural, technological and social systems. The underlying structures are typically complex and their most relevant organizational principle is the ordering of the ties among the units they are made of according to a network displaying hierarchical features. In spite of the abundant presence of hierarchy no quantitative theoretical interpretation of the origins of a multi-level, knowledge-based social network exists. Here we introduce an approach which is capable of reproducing the emergence of a multi-levelled network structure based on the plausible assumption that the individuals (representing the nodes of the network) can make the right estimate about the state of their changing environment to a varying degree. Our model accounts for a fundamental feature of knowledge-based organizations: the less capable individuals tend to follow those who are better at solving the problems they all face. We find that relatively simple rules lead to hierarchical self-organization and the specific structures we obtain possess the two, perhaps most important features of complex systems: a simultaneous presence of adaptability and stability. In addition, the performance (success score) of the emerging networks is significantly higher than the average expected score of the individuals without letting them copy the decisions of the others. The results of our calculations are in agreement with a related experiment and can be useful from the point of designing the optimal conditions for constructing a given complex social structure as well as understanding the hierarchical organization of such biological structures of major importance as the regulatory pathways or the dynamics of neural networks.	[Nepusz, Tamas; Vicsek, Tamas] Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary; [Vicsek, Tamas] Hungarian Acad Sci, Stat & Biol Phys Res Grp, Budapest, Hungary	Eotvos Lorand University; Hungarian Academy of Sciences	Vicsek, T (corresponding author), Eotvos Lorand Univ, Dept Biol Phys, Budapest, Hungary.	vicsek@hal.elte.hu	Nepusz, Tamás/E-2832-2016	Nepusz, Tamás/0000-0002-1451-338X	EU FP = COLLMOT project [227878]	EU FP = COLLMOT project	This work has benn supported in part by the EU FP = COLLMOT project No: 227878. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Aliprantis CD, 2010, GAMES DECISION MAKIN; Bonabeau E, 1999, B MATH BIOL, V61, P727, DOI 10.1006/bulm.1999.0108; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Costanzo MC, 2001, NUCLEIC ACIDS RES, V29, P75, DOI 10.1093/nar/29.1.75; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Cvitanic J, 2004, INTRO EC FINANCIAL M; Dastani M, 2010, SPECIFICATION AND VERIFICATION OF MULTI-AGENT SYSTEMS, P1, DOI 10.1007/978-1-4419-6984-2; Dubreuil Benoit, 2010, HUMAN EVOLUTION ORIG; EADES P, 1993, INFORM PROCESS LETT, V47, P319, DOI 10.1016/0020-0190(93)90079-O; Galam S, 2012, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-1-4614-2032-3; Hemelrijk CK, 2003, BEHAVIOUR, V140, P1189, DOI 10.1163/156853903771980549; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kaiser M., 2010, FRONT NEUROINFORM, V4, P112, DOI DOI 10.3389/FNINF.2010.00112; Lane D, 2006, METHODS SER, V3, P81; Lazer D, 2011, INT PUBLIC MANAG J, V14, P311, DOI 10.1080/10967494.2011.618308; Lee S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028702; Liska TF, 2007, SOC EC, V29, P363; Luo JX, 2011, COMPLEXITY, V16, P53, DOI 10.1002/cplx.20368; MACRAE D, 1960, SOCIOMETRY, V23, P360, DOI 10.2307/2785690; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Nagy M, 2010, NATURE, V464, P890, DOI 10.1038/nature08891; Pumain D, 2006, METHODS SER, V3, P1, DOI 10.1007/1-4020-4127-6; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rowe R, 2007, P 9 WEBKDD 1 SNA KDD, P109; Salthe S., 1985, EVOLVING HIERARCHICA; Sethi S.P., 1994, HIERARCHICAL DECISIO; Simon HA., 1973, HIERARCHY THEORY CHA, P1; Stein D L, 2012, SPIN GLASSES COMPLEX; Surowiecki J., 2005, WISDOM CROWDS; Wimberley E. T., 2009, NESTED ECOLOGY PLACE; Yu HY, 2006, P NATL ACAD SCI USA, V103, P14724, DOI 10.1073/pnas.0508637103	33	11	12	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81449	10.1371/journal.pone.0081449	http://dx.doi.org/10.1371/journal.pone.0081449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349070	gold, Green Submitted, Green Published			2022-12-27	WOS:000328730300028
J	Bocquier, A; Pambrun, E; Dumesnil, H; Villani, P; Verdoux, H; Verger, P				Bocquier, Aurelie; Pambrun, Elodie; Dumesnil, Helene; Villani, Patrick; Verdoux, Helene; Verger, Pierre			Physicians' Characteristics Associated with Exploring Suicide Risk among Patients with Depression: A French Panel Survey of General Practitioners	PLOS ONE			English	Article							PRIMARY-CARE PHYSICIANS; MENTAL-HEALTH PROBLEMS; PREVENTION; IDEATION; IDENTIFICATION; PREDICTORS; MANAGEMENT; ATTITUDES; SERVICES; FRANCE	Background: General practitioners (GPs) have a key role to play in suicide prevention, but the rates at which they question patients with depression about suicidal thoughts and plans are rather low. Little is known about GPs' characteristics associated with such inquiries. Our objectives were to describe GPs' attitudes, perceived barriers, and self-reported practices in this questioning of these patients and to analyze factors associated with these practices. Methodology: This cross-sectional survey was conducted among participants in a panel of randomly selected French GPs (1249/1431 participated: 87.3%). GPs were interviewed with a standardized questionnaire covering their professional and personal characteristics, attitudes, and practices in exploring the suicide risk of their patients with depression. We built a suicide inquiry score by summing the responses to 5 items and used a multiple linear regression analysis to explore the characteristics associated with this score. Principal Findings: Most GPs reported inquiring about the presence of suicidal ideation often or very often; less than 30% reported that they frequently explored signs of a specific suicide plan. The mean suicide inquiry score was 12.4 (SD, 2.9; range, 5-20). False ideas, such as thinking that patients who report suicidal ideas do not often commit suicide, were frequent (42.3%). Previous continuing medical education on suicide, participation in a formal mental health network, and patients who committed suicide in the past 5 years were associated with a higher score. Reluctance to question patients about suicide and perception of insufficient skill were associated with a lower score. Conclusions/Significance: This study showed great variability in French GPs' practices in exploring suicide risk in patients with depression. Interventions aiming at improving GPs' initial training and continuing medical education in suicide and/or depression, and their collaboration with mental health specialists should be developed, and their impacts assessed.	[Bocquier, Aurelie; Dumesnil, Helene; Verger, Pierre] INSERM, Econ & Social Sci Appl Hlth & Anal Med Informat S, F-13258 Marseille, France; [Bocquier, Aurelie; Dumesnil, Helene; Villani, Patrick; Verger, Pierre] Aix Marseille Univ, IRD, UMR S912, Marseille, France; [Bocquier, Aurelie; Dumesnil, Helene; Verger, Pierre] Southeastern Hlth Reg Observ, ORS PACA, Marseille, France; [Pambrun, Elodie; Verdoux, Helene] Bordeaux Univ, U657, Bordeaux, France; [Pambrun, Elodie; Verdoux, Helene] INSERM, U657, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Bocquier, A (corresponding author), INSERM, Econ & Social Sci Appl Hlth & Anal Med Informat S, F-13258 Marseille, France.	aurelie.bocquier@inserm.fr	VILLANI, Patrick/AHB-0513-2022; Verdoux, Helene/T-1996-2019; Pambrun, Elodie/T-2756-2019	VILLANI, Patrick/0000-0002-4559-9446; Verdoux, Helene/0000-0003-2948-3782; Dumesnil, Helene/0000-0002-4214-8949	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES) - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Institut de la Recherche en Sante Publique (IReSP)	Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES) - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; Institut de la Recherche en Sante Publique (IReSP)	The French Regional Panel of General Practices received funding from: 1) the Direction de la Recherche, des Etudes, de l'Evaluation et des Statistiques (DREES) - Ministere du travail, des relations sociales, de la famille, de la solidarite et de la ville/Ministere de la Sante et des Sports; 2) the Institut de la Recherche en Sante Publique (IReSP) in the frame of the Research Program 2011 "Sante mentale, prevention, prospective, thematiques generales de l'IReSP.'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj Priya, 2008, Ment Health Fam Med, V5, P229; Beautrais AL, 2004, AUST NZ J PSYCHIAT, V38, P260, DOI 10.1111/j.1440-1614.2004.01334.x; Bryan CJ, 2008, PRIMARY CARE COMMUN, V13, P143, DOI 10.1080/17468840802168268; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; Chee CC, 2011, SANTE PUBLIQUE, V23, pS13; Coryell W, 2005, J CLIN PSYCHIAT, V66, P412, DOI 10.4088/JCP.v66n0401; Crawford MJ, 2011, BRIT J PSYCHIAT, V198, P379, DOI 10.1192/bjp.bp.110.083592; Davidsen AS, 2011, PATIENT EDUC COUNS, V85, P113, DOI 10.1016/j.pec.2010.08.020; Dumesnil H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052429; Fanello S, 2002, Sante Publique, V14, P263; Feldman MD, 2007, ANN FAM MED, V5, P412, DOI 10.1370/afm.719; Gensichen J, 2010, J AFFECT DISORDERS, V125, P124, DOI 10.1016/j.jad.2009.12.008; Hardy-Bayle MC, 2004, REV FRANCAISE AFFAIR, P127; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hjelmeland Heidi, 2004, Arch Suicide Res, V8, P345, DOI 10.1080/13811110490476725; Hooper LM, 2012, J BEHAV HEALTH SER R, V39, P103, DOI 10.1007/s11414-011-9268-5; Joyce CM, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-50; Kaplan MS, 2001, INT J GERIATR PSYCH, V16, P728, DOI 10.1002/gps.420; Kaplan MS, 1998, AM J PREV MED, V15, P60, DOI 10.1016/S0749-3797(98)00019-1; Kisely Stephen, 2006, Can Fam Physician, V52, P876; Kocmur M, 2003, INT J SOC PSYCHIATR, V49, P8, DOI 10.1177/0020764003049001537; Kovess-Masfety V, 2007, PSYCHIAT SERV, V58, P213, DOI 10.1176/appi.ps.58.2.213; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McDowell AK, 2011, MAYO CLIN PROC, V86, P792, DOI 10.4065/mcp.2011.0076; MCNAMEE JE, 1994, PREVENTION SUICIDE, P456; [National Agency for Health Accreditation and Evaluation] Agence Nationale d'Accreditation et d'Evaluation en Sante, 2002, OUTP MAN IS DEPR EP; National Institute for Health and Clinical Excellence, 2009, DEPR TREATM MAN DEPR; Nock MK, 2008, EPIDEMIOL REV, V30, P133, DOI 10.1093/epirev/mxn002; Nutting PA, 2005, ANN FAM MED, V3, P529, DOI 10.1370/afm.371; O'Connor E, 2013, ANN INTERN MED, V158, P741, DOI 10.7326/0003-4819-158-10-201305210-00642; Peabody JW, 2000, JAMA-J AM MED ASSOC, V283, P1715, DOI 10.1001/jama.283.13.1715; Pfaff JJ, 2001, MED J AUSTRALIA, V174, P222, DOI 10.5694/j.1326-5377.2001.tb143241.x; POTTHOFF RF, 1994, AM J EPIDEMIOL, V139, P967, DOI 10.1093/oxfordjournals.aje.a116946; Rihmer Zoltan, 2012, Neuropsychopharmacol Hung, V14, P245; Saliba B, 2007, HEALTH POLICY, V81, P166, DOI 10.1016/j.healthpol.2006.05.017; Schulberg HC, 2004, GEN HOSP PSYCHIAT, V26, P337, DOI 10.1016/j.genhosppsych.2004.06.007; Sicart D, 2008, SERIE STAT MINISTERE; Stoppe G, 1999, J AFFECT DISORDERS, V54, P193, DOI 10.1016/S0165-0327(98)00149-9; Timonen M, 2008, BMJ-BRIT MED J, V336, P435, DOI 10.1136/bmj.39478.609097.BE; US Department of Health and Human Services. Office of the Surgeon General and National Action Alliance for Suicide Prevention, 2012, 2012 NAT STRAT SUIC; Vannoy SD, 2011, J GEN INTERN MED, V26, P1005, DOI 10.1007/s11606-011-1726-5; Ventelou B, 2005, REV FRANCAISE AFFAIR, P127; Verger P, 2013, SOC PSYCHIA IN PRESS; Verger P, 2007, J AFFECT DISORDERS, V99, P253, DOI 10.1016/j.jad.2006.09.012; Verger P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041837; Videau Y, 2010, J HEALTH SERV RES PO, V15, P76, DOI 10.1258/jhsrp.2009.009034; Wasserman D, 2012, EUR PSYCHIAT, V27, P129, DOI 10.1016/j.eurpsy.2011.06.003; Williams JW, 1999, ARCH FAM MED, V8, P58, DOI 10.1001/archfami.8.1.58	49	22	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e80797	10.1371/journal.pone.0080797	http://dx.doi.org/10.1371/journal.pone.0080797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VW	24339883	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400006
J	Chen, XP; Tan, XJ; Li, J; Jin, Y; Gong, LM; Hong, M; Shi, YL; Zhu, SL; Zhang, BM; Zhang, S; Zhang, Y; Mao, NY; Xu, WB				Chen, Xiangpeng; Tan, Xiaojuan; Li, Jing; Jin, Yu; Gong, Liming; Hong, Mei; Shi, Yonglin; Zhu, Shuangli; Zhang, Baomin; Zhang, Shuang; Zhang, Yong; Mao, Naiying; Xu, Wenbo			Molecular Epidemiology of Coxsackievirus A16: Intratype and Prevalent Intertype Recombination Identified	PLOS ONE			English	Article							HUMAN ENTEROVIRUS 71; MOUTH-DISEASE; HAND; FOOT; EVOLUTION; CHILDREN; SEQUENCE	Coxsackievirus A16 (CVA16) is responsible for nearly 50% of all the confirmed hand, foot, and mouth disease (HFMD) cases in mainland China, sometimes it could also cause severe complications, and even death. To clarify the genetic characteristics and the epidemic patterns of CVA16 in mainland China, comprehensive bioinfomatics analyses were performed by using 35 CVA16 whole genome sequences from 1998 to 2011, 593 complete CVA16 VP1 sequences from 1981 to 2011, and prototype strains of human enterovirus species A (EV-A). Analysis on complete VP1 sequences revealed that subgenotypes B1a and B1b were prevalent strains and have been co-circulating in many Asian countries since 2000, especially in mainland China for at least 13 years. While the prevalence of subgenotype B1c (totally 20 strains) was much limited, only found in Malaysia from 2005 to 2007 and in France in 2010. Genotype B2 only caused epidemic in Japan and Malaysia from 1981 to 2000. Both subgenotypes B1a and B1b were potential recombinant viruses containing sequences from other EV-A donors in the 5'-untranslated region and P2, P3 non-structural protein encoding regions.	[Chen, Xiangpeng; Tan, Xiaojuan; Li, Jing; Zhu, Shuangli; Zhang, Baomin; Zhang, Shuang; Zhang, Yong; Mao, Naiying; Xu, Wenbo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China; [Li, Jing] Yangzhou Peoples Hosp, Yangzhou, Peoples R China; [Jin, Yu] Nanjing Med Univ, Nanjing Childrens Hosp, Nanjing, Jiangsu, Peoples R China; [Gong, Liming] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Hong, Mei] Xizang Prov Ctr Dis Control & Prevent, Lasa, Peoples R China; [Shi, Yonglin] Anhui Prov Ctr Dis Control & Prevent, Hefei, Peoples R China; [Zhang, Shuang] Shunyi Ctr Dis Control & Prevent, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Nanjing Medical University; Zhejiang Provincial Center for Disease Control & Prevention	Xu, WB (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Minist Hlth, Key Lab Med Virol, Beijing, Peoples R China.	wenbo_xu1@aliyun.com		Zhang, Yong/0000-0002-2692-5437	National Basic Research Program of China (973 Program) [2011CB504902]; Key Technologies Research & Development Program of National Ministry of Science [2013ZX10004-202, 2012ZX10004201-003, 2013ZX09304101]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Key Technologies Research & Development Program of National Ministry of Science	This work was supported by the National Basic Research Program of China (973 Program): (Grant No. 2011CB504902) and Key Technologies Research & Development Program of National Ministry of Science (Grant No. 2013ZX10004-202; 2012ZX10004201-003, 2013ZX09304101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang LW, 2009, ANN ACAD MED SINGAP, V38, P106; ARNOLD E, 1987, P NATL ACAD SCI USA, V84, P21, DOI 10.1073/pnas.84.1.21; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chen L, 2012, MOL MED REP, V5, P1001, DOI 10.3892/mmr.2012.742; Chen XM, 2010, VIROLOGY, V398, P251, DOI 10.1016/j.virol.2009.12.007; Hosoya M, 2007, J CLIN MICROBIOL, V45, P112, DOI 10.1128/JCM.00718-06; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Jia Lei, 2011, Zhongguo Dang Dai Er Ke Za Zhi, V13, P635; Komatsu H, 1999, PEDIATR NEUROL, V20, P17, DOI 10.1016/S0887-8994(98)00087-3; Legay F, 2007, EMERG INFECT DIS, V13, P1084, DOI 10.3201/eid1307.070295; Leitch ECM, 2012, J VIROL, V86, P2676, DOI 10.1128/JVI.06065-11; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Liu QW, 2011, J VIROL METHODS, V173, P115, DOI 10.1016/j.jviromet.2011.01.016; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Ma E, 2011, PEDIATR INFECT DIS J, V30, P675, DOI 10.1097/INF.0b013e3182116e95; McMinn PC, 2012, CURR OPIN VIROL, V2, P199, DOI 10.1016/j.coviro.2012.02.009; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; PALMENBERG AC, 1990, ANNU REV MICROBIOL, V44, P603, DOI 10.1146/annurev.mi.44.100190.003131; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Svitkin YV, 2001, RNA, V7, P1743; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Wang CY, 2004, PEDIATR INFECT DIS J, V23, P275, DOI 10.1097/01.inf.0000115950.63906.78; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Wu D, 2011, ARCH VIROL, V156, P945, DOI 10.1007/s00705-011-0929-8; Wu TC, 2007, J VIROL, V81, P10310, DOI 10.1128/JVI.00372-07; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhao K, 2011, EMERG INFECT DIS, V17, P1537, DOI 10.3201/eid1708.101719; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	35	33	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82861	10.1371/journal.pone.0082861	http://dx.doi.org/10.1371/journal.pone.0082861			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340064	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400100
J	Essaidi-Laziosi, M; Shevtsova, A; Gerlier, D; Roux, L				Essaidi-Laziosi, Manel; Shevtsova, Anastasia; Gerlier, Denis; Roux, Laurent			Mutation of the TYTLE Motif in the Cytoplasmic Tail of the Sendai Virus Fusion Protein Deeply Affects Viral Assembly and Particle Production	PLOS ONE			English	Article							PARAMYXOVIRUS SIMIAN-VIRUS-5; ENDOPLASMIC-RETICULUM; ENVELOPE PROTEINS; INTERFERING RNA; MATRIX PROTEIN; HN; DOMAIN; CELLS; GLYCOPROTEINS; EXPRESSION	Enveloped viruses contain glycoproteins protruding from the viral membrane. These proteins play a crucial role in the extracellular steps of the virus life cycle, namely attachment to and entry into cells. Their role during the intracellular late phase of virus multiplication has been less appreciated, overlooked by the documented central organizer role of the matrix M protein. Sendai virus, a member of the Paramyxoviridae family, expresses two trans-membrane proteins on its surface, HN and F. In previous work, we have shown that suppression of F in the context of an infection, results in about 70% reduction of virus particle production, a reduction similar to that observed upon suppression of the matrix M protein. Moreover, a TYTLE motif present in F cytoplasmic tail has been proposed essential for virus particle production. In the present work, using original alternate conditional siRNA suppression systems, we generated a double F gene recombinant Sendai virus expressing wt-F and a nonviable mutated TYTLE/5A F protein (F-5A). Suppression of the wild type F gene expression in cells infected with this virus allowed the analysis of F-5A properties in the context of the infection. Coupling confocal imaging analysis to biochemical characterization, we found that F-5A i) was not expressed at the cell surface but restricted to the endoplasmic reticulum, ii) was still capable of interaction with M and iii) had profound effect on M and HN cellular distribution. On the basis of these data, we propose a model for SeV particle formation based on an M/F complex that would serve as nucleation site for virus particle assembly at the cell surface.	[Essaidi-Laziosi, Manel; Shevtsova, Anastasia; Roux, Laurent] Univ Geneva, Fac Med, Dept Microbiol & Mol Med, Geneva, Switzerland; [Gerlier, Denis] Univ Lyon 1, Ctr Int Rech Infectiol, ENS Lyon, F-69365 Lyon, France	University of Geneva; Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Roux, L (corresponding author), Univ Geneva, Fac Med, Dept Microbiol & Mol Med, Geneva, Switzerland.	laurent.roux@unige.ch	Gerlier, Denis/L-6094-2014	Gerlier, Denis/0000-0001-5539-456X	Swiss National Foundation for Scientific Research; Agence Nationale de la Recherche, France, specific program "Physico-Chimie du Vivant'' [ANR-08-PCVI-0020-01]	Swiss National Foundation for Scientific Research(Swiss National Science Foundation (SNSF)); Agence Nationale de la Recherche, France, specific program "Physico-Chimie du Vivant''(French National Research Agency (ANR))	This work was carried out with the financial support of the Swiss National Foundation for Scientific Research (to LR) and of the Agence Nationale de la Recherche, France, specific program "Physico-Chimie du Vivant'', ANR-08-PCVI-0020-01 (to DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accola MA, 2000, J VIROL, V74, P5395, DOI 10.1128/JVI.74.12.5395-5402.2000; Ali A, 2000, VIROLOGY, V276, P289, DOI 10.1006/viro.2000.0556; BLUMBERG B, 1985, CELL, V41, P269, DOI 10.1016/0092-8674(85)90080-7; CALAIN P, 1993, J VIROL, V67, P4822, DOI 10.1128/JVI.67.8.4822-4830.1993; Chen BJ, 2007, J VIROL, V81, P7111, DOI 10.1128/JVI.00361-07; Favoreel HW, 2006, VIRUS RES, V117, P202, DOI 10.1016/j.virusres.2005.11.007; Fouillot-Coriou N, 2000, VIROLOGY, V270, P464, DOI 10.1006/viro.2000.0291; Gosselin-Grenet AS, 2007, VIROLOGY, V365, P101, DOI 10.1016/j.virol.2007.03.039; Gosselin-Grenet AS, 2010, VIROLOGY, V405, P439, DOI 10.1016/j.virol.2010.06.030; Irie T, 2007, J VIROL, V81, P2263, DOI 10.1128/JVI.02218-06; KARACOSTAS V, 1989, P NATL ACAD SCI USA, V86, P8964, DOI 10.1073/pnas.86.22.8964; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; Manie SN, 2000, J VIROL, V74, P305, DOI 10.1128/JVI.74.1.305-311.2000; Mebatsion T, 1996, CELL, V84, P941, DOI 10.1016/S0092-8674(00)81072-7; MOTTET G, 1986, J VIROL, V59, P132, DOI 10.1128/JVI.59.1.132-141.1986; MOTTET G, 1989, VIRUS RES, V14, P175, DOI 10.1016/0168-1702(89)90037-3; Mottet G, 1996, VIROLOGY, V221, P159, DOI 10.1006/viro.1996.0362; Mottet-Osman G, 2007, J VIROL, V81, P2861, DOI 10.1128/JVI.02291-06; Plemper RK, 2001, J BIOL CHEM, V276, P44239, DOI 10.1074/jbc.M105967200; ROUX L, 1981, VIROLOGY, V112, P400, DOI 10.1016/0042-6822(81)90287-7; ROYER M, 1992, J VIROL, V66, P3230, DOI 10.1128/JVI.66.5.3230-3235.1992; Runkler N, 2008, J GEN VIROL, V89, P687, DOI 10.1099/vir.0.83407-0; Runkler N, 2007, CELL MICROBIOL, V9, P1203, DOI 10.1111/j.1462-5822.2006.00860.x; SANDERSON CM, 1993, J VIROL, V67, P651, DOI 10.1128/JVI.67.2.651-663.1993; SANDERSON CM, 1994, J VIROL, V68, P69, DOI 10.1128/JVI.68.1.69-76.1994; Schmitt AP, 1999, J VIROL, V73, P8703, DOI 10.1128/JVI.73.10.8703-8712.1999; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; Sevier CS, 2000, MOL BIOL CELL, V11, P13, DOI 10.1091/mbc.11.1.13; SHIODA T, 1990, VIROLOGY, V175, P139, DOI 10.1016/0042-6822(90)90194-V; Stone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061281; SUGITA K, 1974, JPN J MICROBIOL, V18, P262, DOI 10.1111/j.1348-0421.1974.tb00955.x; Takimoto T, 1998, J VIROL, V72, P9747, DOI 10.1128/JVI.72.12.9747-9754.1998; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; TUFFEREAU C, 1988, VIROLOGY, V162, P417, DOI 10.1016/0042-6822(88)90482-5; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; Welsch S, 2007, FEBS LETT, V581, P2089, DOI 10.1016/j.febslet.2007.03.060	37	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e78074	10.1371/journal.pone.0078074	http://dx.doi.org/10.1371/journal.pone.0078074			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339863	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400002
J	Majkut, P; Claussnitzer, I; Merk, H; Freund, C; Hackenberger, CPR; Gerrits, M				Majkut, Paul; Claussnitzer, Iris; Merk, Helmut; Freund, Christian; Hackenberger, Christian P. R.; Gerrits, Michael			Completion of Proteomic Data Sets by K-d Measurement Using Cell-Free Synthesis of Site-Specifically Labeled Proteins	PLOS ONE			English	Article							AFFINITY PHOSPHOTYROSYL PEPTIDE; SH2 DOMAIN; MOLECULAR INTERACTION; SEQUENCE SPECIFICITY; INTERACTIONS DEFINE; FUSION PROTEINS; BINDING; THROUGHPUT; FYN; TRANSCRIPTION	The characterization of phosphotyrosine mediated protein-protein interactions is vital for the interpretation of downstream pathways of transmembrane signaling processes. Currently however, there is a gap between the initial identification and characterization of cellular binding events by proteomic methods and the in vitro generation of quantitative binding information in the form of equilibrium rate constants (K-d values). In this work we present a systematic, accelerated and simplified approach to fill this gap: using cell-free protein synthesis with site-specific labeling for pull-down and microscale thermophoresis (MST) we were able to validate interactions and to establish a binding hierarchy based on K-d values as a completion of existing proteomic data sets. As a model system we analyzed SH2-mediated interactions of the human T-cell phosphoprotein ADAP. Putative SH2 domain-containing binding partners were synthesized from a cDNA library using Expression-PCR with site-specific biotinylation in order to analyze their interaction with fluorescently labeled and in vitro phosphorylated ADAP by pull-down. On the basis of the pull-down results, selected SH2's were subjected to MST to determine K-d values. In particular, we could identify an unexpectedly strong binding of ADAP to the previously found binding partner Rasa1 of about 100 nM, while no evidence of interaction was found for the also predicted SH2D1A. Moreover, K-d values between ADAP and its known binding partners SLP-76 and Fyn were determined. Next to expanding data on ADAP suggesting promising candidates for further analysis in vivo, this work marks the first K-d values for phosphotyrosine/SH2 interactions on a phosphoprotein level.	[Majkut, Paul; Hackenberger, Christian P. R.] Leibniz Inst Mol Pharmakol FMP, Dept Chem Biol 2, Berlin, Germany; [Claussnitzer, Iris; Merk, Helmut; Gerrits, Michael] RiNA GmbH, Berlin, Germany; [Freund, Christian] Free Univ Berlin, Inst Chem & Biochem, Berlin, Germany; [Hackenberger, Christian P. R.] Humboldt Univ, Inst Chem, D-10099 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Humboldt University of Berlin	Hackenberger, CPR (corresponding author), Leibniz Inst Mol Pharmakol FMP, Dept Chem Biol 2, Berlin, Germany.	hackenbe@fmp-berlin.de; gerrits@rina-gmbh.eu		Hackenberger, Christian/0000-0001-7457-4742	Boehringer Ingelheim Stiftung "Plus 3 program"; Deutsche Forschungsgesellschaft [Sonderforschungsbereich 765]; Fonds der Chemischen Industrie; Federal Ministry of Education and Research [0315027A]	Boehringer Ingelheim Stiftung "Plus 3 program"(Boehringer Ingelheim); Deutsche Forschungsgesellschaft(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was funded in part by the Boehringer Ingelheim Stiftung "Plus 3 program", the Deutsche Forschungsgesellschaft (Sonderforschungsbereich 765), the Fonds der Chemischen Industrie and the Federal Ministry of Education and Research, 0315027A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Arasada R, 2011, CURR BIOL, V21, P1450, DOI 10.1016/j.cub.2011.07.046; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Baker RG, 2009, MOL CELL BIOL, V29, P5578, DOI 10.1128/MCB.00283-09; Bussow K, 2000, GENOMICS, V65, P1, DOI 10.1006/geno.2000.6141; Chandramouli Kondethimmanahalli, 2009, Hum Genomics Proteomics, V2009, DOI 10.4061/2009/239204; DaSilva AJ, 1997, P NATL ACAD SCI USA, V94, P7493, DOI 10.1073/pnas.94.14.7493; DASILVA AJ, 1993, J EXP MED, V178, P2107, DOI 10.1084/jem.178.6.2107; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Dunant NM, 1997, J VIROL, V71, P199, DOI 10.1128/JVI.71.1.199-206.1997; ECK MJ, 1993, NATURE, V362, P87, DOI 10.1038/362087a0; Ettmayer P, 1999, J MED CHEM, V42, P971, DOI 10.1021/jm9811007; Freyer MW, 2008, METHOD CELL BIOL, V84, P79, DOI 10.1016/S0091-679X(07)84004-0; Geng LP, 1999, J IMMUNOL, V163, P5753; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; GERRITS M, 2007, CELL FREE EXPRESSION, P166; Gerrits M, 2001, THESIS FREIE U BERLI; Gift SK, 2011, BIOCHEMISTRY-US, V50, P2756, DOI 10.1021/bi101160r; Griffiths EK, 2001, SCIENCE, V293, P2260, DOI 10.1126/science.1063397; Hassan NJ, 2006, MOL CELL BIOL, V26, P6727, DOI 10.1128/MCB.00688-06; Imhof D, 2006, J BIOL CHEM, V281, P20271, DOI 10.1074/jbc.M601047200; Jadwin JA, 2012, FEBS LETT, V586, P2586, DOI 10.1016/j.febslet.2012.04.019; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kaneko T, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-32; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; Keppler A, 2004, P NATL ACAD SCI USA, V101, P9955, DOI 10.1073/pnas.0401923101; Keppler A, 2003, NAT BIOTECHNOL, V21, P86, DOI 10.1038/nbt765; Ksionda O, 2012, J CELL SCI, V125, P5302, DOI 10.1242/jcs.105148; LADBURY JE, 1995, P NATL ACAD SCI USA, V92, P3199, DOI 10.1073/pnas.92.8.3199; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Liu BA, 2012, FEBS LETT, V586, P2597, DOI 10.1016/j.febslet.2012.04.054; McCubrey JA, 2012, ONCOTARGET, V3, P954, DOI 10.18632/oncotarget.652; Merk H, 2003, CELL-FREE PROTEIN EXPRESSION, P15; Musci MA, 1997, J BIOL CHEM, V272, P11674, DOI 10.1074/jbc.272.18.11674; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pauker MH, 2011, MOL CELL BIOL, V31, P2653, DOI 10.1128/MCB.01358-10; Pawson T, 2000, GENE DEV, V14, P1027; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Payne G, 1994, Chem Biol, V1, P99, DOI 10.1016/1074-5521(94)90047-7; Pollard TD, 2010, MOL BIOL CELL, V21, P4061, DOI 10.1091/mbc.E10-08-0683; Raab M, 1999, J BIOL CHEM, V274, P21170, DOI 10.1074/jbc.274.30.21170; Resh MD, 1998, INT J BIOCHEM CELL B, V30, P1159, DOI 10.1016/S1357-2725(98)00089-2; Rich RL, 2007, ANAL BIOCHEM, V361, P1, DOI 10.1016/j.ab.2006.10.040; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sweeney MC, 2005, BIOCHEMISTRY-US, V44, P14932, DOI 10.1021/bi051408h; Sylvester M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011708; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tinti M, 2013, CELL REP, V3, P1293, DOI 10.1016/j.celrep.2013.03.001; WAKSMAN G, 1993, CELL, V72, P779, DOI 10.1016/0092-8674(93)90405-F; Widmann C, 1998, J BIOL CHEM, V273, P7141, DOI 10.1074/jbc.273.12.7141; Yaoi T, 2006, MOL CELL PROTEOMICS, V5, P959, DOI 10.1074/mcp.T600002-MCP200	52	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82352	10.1371/journal.pone.0082352	http://dx.doi.org/10.1371/journal.pone.0082352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340019	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400071
J	Nagata, N; Niikura, R; Shimbo, T; Kishida, Y; Sekine, K; Tanaka, S; Aoki, T; Watanabe, K; Akiyama, J; Yanase, M; Itoh, T; Mizokami, M; Uemura, N				Nagata, Naoyoshi; Niikura, Ryota; Shimbo, Takuro; Kishida, Yoshihiro; Sekine, Katsunori; Tanaka, Shohei; Aoki, Tomonori; Watanabe, Kazuhiro; Akiyama, Junichi; Yanase, Mikio; Itoh, Toshiyuki; Mizokami, Masashi; Uemura, Naomi			Alcohol and Smoking Affect Risk of Uncomplicated Colonic Diverticulosis in Japan	PLOS ONE			English	Article							NITRIC-OXIDE; DISEASE; EPIDEMIOLOGY; PATHOGENESIS; FIBER; DIET	Colonic diverticula are located predominantly on the right side in Asia and on the left side in Europe and the United States. Factors associated with uncomplicated colonic diverticulosis and its distribution pattern have been unknown. Our aims are to investigate the prevalence and risk factors for uncomplicated colonic diverticulosis. We conducted a prospective cross-sectional study in adults who underwent colonoscopy. Alcohol, alcohol related flushing, smoking, medications, and comorbidities were assessed by interview on the colonoscopy day. Alcohol consumption was categorized as nondrinker, light (1-180 g/week), moderate (181-360 g/week), and heavy (>= 361 g/week). Smoking index was defined as the number of cigarettes per day multiplied by the number of smoking years and categorized as nonsmoker, <400, 400-799, and >= 800. A total of 2,164 consecutive patients were enrolled. Overall, 542 patients (25.1%) had uncomplicated colonic diverticulosis located on the right side (50%), bilaterally (29%), and on the left side (21%). Univariate analysis revealed age, male, smoking index, alcohol consumption, aspirin use, anticoagulants use, corticosteroid use, hypertension, and atherosclerotic disease as factors significantly associated with diverticulosis. Alcohol related flushing was not associated with the disease. Multivariate analysis showed increasing age (P<0.01), increasing alcohol consumption (P<0.01) and smoking (P<0.01), and atherosclerotic disease (P<0.01) as significantly associated factors. Alcohol and smoking were associated with right-sided and bilateral diverticula. In conclusion, one in four Japanese adults have colonic diverticulosis (50% right-sided). Age, alcohol consumption, and smoking were found to be significant risk factors for uncomplicated colonic diverticulosis, particularly right-sided and bilateral.	[Nagata, Naoyoshi; Niikura, Ryota; Kishida, Yoshihiro; Sekine, Katsunori; Tanaka, Shohei; Aoki, Tomonori; Watanabe, Kazuhiro; Akiyama, Junichi; Yanase, Mikio] Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Shimbo, Takuro] Natl Ctr Global Hlth & Med, Int Clin Res Ctr Res Inst, Tokyo, Japan; [Itoh, Toshiyuki] Natl Ctr Global Hlth & Med, Clin Res Ctr Clin Sci, Tokyo, Japan; [Mizokami, Masashi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba, Japan; [Uemura, Naomi] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Nagata, N (corresponding author), Natl Ctr Global Hlth & Med, Dept Gastroenterol & Hepatol, Tokyo, Japan.	nnagata_ncgm@yahoo.co.jp	Kishida, Yoshihiro/AAN-3654-2020	Kishida, Yoshihiro/0000-0002-5068-6990	Ministry of Health Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science, and Technology of Japan [271000]; National Center for Global Health and Medicine [22-302]	Ministry of Health Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Global Health and Medicine(National Center for Global Health & Medicine - Japan)	This study was supported in part by a Grant-in-Aid from the Ministry of Health Labor and Welfare of Japan and a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (271000) and The Grant of National Center for Global Health and Medicine (22-302). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENSON MM, 1981, DIGESTION, V22, P210, DOI 10.1159/000198647; Commane DM, 2009, WORLD J GASTROENTERO, V15, P2479, DOI 10.3748/wjg.15.2479; Heise CP, 2008, J GASTROINTEST SURG, V12, P1309, DOI 10.1007/s11605-008-0492-0; KUBO A, 1983, JPN J MED, V22, P185; Martel J, 2008, J CLIN GASTROENTEROL, V42, P1125, DOI 10.1097/MCG.0b013e3181865f18; Matrana Marc R, 2009, Clin Colon Rectal Surg, V22, P141, DOI 10.1055/s-0029-1236157; MILNER P, 1990, GASTROENTEROLOGY, V99, P666, DOI 10.1016/0016-5085(90)90953-X; Miotto D, 2004, EUR RESPIR J, V24, P958, DOI 10.1183/09031936.04.10031504; Miura S, 1996, INT J COLORECTAL DIS, V11, P71; Miura S, 2000, DIS COLON RECTUM, V43, P1383, DOI 10.1007/BF02236634; MUNAKATA A, 1993, TOHOKU J EXP MED, V171, P145, DOI 10.1620/tjem.171.145; NAKADA I, 1995, DIS COLON RECTUM, V38, P755, DOI 10.1007/BF02048036; Nakaji S, 2002, INT J COLORECTAL DIS, V17, P365, DOI 10.1007/s00384-002-0403-x; Niikura R, 2013, WORLD J GASTROENTERO, V19, P2362, DOI 10.3748/wjg.v19.i15.2362; PAINTER NS, 1971, BMJ-BRIT MED J, V2, P450, DOI 10.1136/bmj.2.5759.450; Peery AF, 2012, GASTROENTEROLOGY, V142, P266, DOI 10.1053/j.gastro.2011.10.035; Sharara AI, 2012, J CLIN GASTROENTEROL; Song Jung Hoon, 2010, Korean Journal of Internal Medicine, V25, P140, DOI 10.3904/kjim.2010.25.2.140; Strate LL, 2012, DIGEST DIS, V30, P35, DOI 10.1159/000335707; Tomita R, 2000, HEPATO-GASTROENTEROL, V47, P692; VANDIJK JPM, 1995, EUR J PHARMACOL, V278, pR11, DOI 10.1016/0014-2999(95)00211-3; Wang C, 2010, ALCOHOL CLIN EXP RES, V34, P57, DOI 10.1111/j.1530-0277.2009.01066.x; WESS L, 1995, GUT, V37, P91, DOI 10.1136/gut.37.1.91; Yokoyama T, 2003, CANCER EPIDEM BIOMAR, V12, P1227; Zhou HB, 2011, ANN OTO RHINOL LARYN, V120, P455, DOI 10.1177/000348941112000706	25	52	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81137	10.1371/journal.pone.0081137	http://dx.doi.org/10.1371/journal.pone.0081137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339905	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400011
J	Rafiq, K; Sherajee, SJ; Hitomi, H; Nakano, D; Kobori, H; Ohmori, K; Mori, H; Kobara, H; Masaki, T; Kohno, M; Nishiyama, A				Rafiq, Kazi; Sherajee, Shamshad J.; Hitomi, Hirofumi; Nakano, Daisuke; Kobori, Hiroyuki; Ohmori, Koji; Mori, Hirohito; Kobara, Hideki; Masaki, Tsutomu; Kohno, Masakazu; Nishiyama, Akira			Calcium Channel Blocker Enhances Beneficial Effects of an Angiotensin II AT(1) Receptor Blocker against Cerebrovascular-Renal Injury in type 2 Diabetic Mice	PLOS ONE			English	Article							2013 ESH/ESC GUIDELINES; CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; PODOCYTE INJURY; HIGH-RISK; CARDIOVASCULAR EVENTS; STRAIN VESSELS; AZELNIDIPINE; HYPERTENSION; OLMESARTAN	Recent clinical trials have demonstrated that combination therapy with renin-angiotensin system inhibitors plus calcium channel blockers (CCBs) elicits beneficial effects on cardiovascular and renal events in hypertensive patients with high cardiovascular risks. In the present study, we hypothesized that CCB enhances the protective effects of an angiotensin II type 1 receptor blocker (ARB) against diabetic cerebrovascular-renal injury. Saline-drinking type 2 diabetic KK-Ay mice developed hypertension and exhibited impaired cognitive function, blood-brain barrier (BBB) disruption, albuminuria, glomerular sclerosis and podocyte injury. These brain and renal injuries were associated with increased gene expression of NADPH oxidase components, NADPH oxidase activity and oxidative stress in brain and kidney tissues as well as systemic oxidative stress. Treatment with the ARB, olmesartan (10 mg/kg/day) reduced blood pressure in saline-drinking KK-Ay mice and attenuated cognitive decline, BBB disruption, glomerular injury and albuminuria, which were associated with a reduction of NADPH oxidase activity and oxidative stress in brain and kidney tissues as well as systemic oxidative stress. Furthermore, a suppressive dose of azelnidipine (3 mg/kg/day) exaggerated these beneficial effects of olmesartan. These data support the hypothesis that a CCB enhances ARB-associated cerebrovascular-renal protective effects through suppression of NADPH oxidase-dependent oxidative stress in type 2 diabetes.	[Rafiq, Kazi; Sherajee, Shamshad J.; Hitomi, Hirofumi; Nakano, Daisuke; Kobori, Hiroyuki; Nishiyama, Akira] Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan; [Ohmori, Koji; Mori, Hirohito; Kobara, Hideki; Masaki, Tsutomu; Kohno, Masakazu] Kagawa Univ, Fac Med, Takamatsu, Kagawa 760, Japan	Kagawa University; Kagawa University	Rafiq, K (corresponding author), Kagawa Univ, Fac Med, Dept Pharmacol, Takamatsu, Kagawa 760, Japan.	krafiq73@yahoo.com	Rafiq, Kazi/AEU-4834-2022; Hitomi, Hirofumi/ABA-2086-2021; Kobori, Hiroyuki/F-1994-2014	Nishiyama, Akira/0000-0001-5971-820X; Kobori, Hiroyuki/0000-0001-5128-5059	Japan Society for the Promotion of Science (JSPS) KAKENHI [23590303]; JSPS [24.02420]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072408] Funding Source: NIH RePORTER	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI to AN (No. 23590303) and JSPS Postdoctoral Fellowship for Foreign Researchers to KR (No. 24.02420). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2011, HYPERTENS RES, V34, P935, DOI 10.1038/hr.2011.67; Autan SM, 2011, BRAIN RES, V1412, P63, DOI 10.1016/j.brainres.2011.07.020; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; Dobrian AD, 2003, AM J PHYSIOL-RENAL, V285, pF619, DOI 10.1152/ajprenal.00388.2002; Goodarzi MT, 2010, J CLIN LAB ANAL, V24, P72, DOI 10.1002/jcla.20328; Hashimoto J, 2008, AM J HYPERTENS, V21, P1304, DOI 10.1038/ajh.2008.291; Hoffmann A, 2011, STROKE, V42, P2054, DOI 10.1161/STROKEAHA.110.597997; Iwai M, 2006, J PHARMACOL EXP THER, V319, P1081, DOI 10.1124/jpet.106.108894; Iwai M, 2006, J HYPERTENS, V24, P2023, DOI 10.1097/01.hjh.0000244952.54738.f6; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jinno T, 2004, HYPERTENSION, V43, P263, DOI 10.1161/01.HYP.0000113627.08110.6f; Keller JN, 2005, NEUROLOGY, V64, P1152, DOI 10.1212/01.WNL.0000156156.13641.BA; Kim-Mitsuyama S, 2013, KIDNEY INT, V83, P167, DOI 10.1038/ki.2012.326; Kobayashi M, 2010, AM J KIDNEY DIS, V56, P468, DOI 10.1053/j.ajkd.2010.03.018; Kondo N, 2006, J PHARMACOL EXP THER, V316, P1047, DOI 10.1124/jpet.105.095331; Kumai Y, 2012, Neurology, V78, P1909, DOI 10.1212/WNL.0b013e318259e110; Li JM, 2005, MOL PHARMACOL, V67, P1666, DOI 10.1124/mol.104.008144; Liu RL, 2003, P NATL ACAD SCI USA, V100, P8526, DOI 10.1073/pnas.1332809100; Manaenko A, 2011, NEUROCHEM INT, V58, P542, DOI 10.1016/j.neuint.2011.01.018; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Mogi M, 2007, NEUROPHARMACOLOGY, V53, P899, DOI 10.1016/j.neuropharm.2007.08.020; Nagasawa T, 2012, HYPERTENS RES, V35, P1024, DOI 10.1038/hr.2012.112; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; Nishiyama A, 2010, J PHARMACOL EXP THER, V332, P1072, DOI 10.1124/jpet.109.158113; Ogawa H, 2012, AM J MED, V125, P981, DOI 10.1016/j.amjmed.2011.12.010; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Pelisch N, 2011, AM J HYPERTENS, V24, P362, DOI 10.1038/ajh.2010.241; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Popescu BO, 2009, J NEUROL SCI, V283, P99, DOI 10.1016/j.jns.2009.02.321; Rafiq K, 2012, CIRCULATION, V125, P1402, DOI 10.1161/CIRCULATIONAHA.111.064097; Rafiq K, 2011, J HYPERTENS, V29, P290, DOI 10.1097/HJH.0b013e32834103a9; Rahman M, 2006, J PHARMACOL EXP THER, V318, P1323, DOI 10.1124/jpet.106.105106; Ravandi Amir, 2009, Expert Rev Cardiovasc Ther, V7, P667, DOI 10.1586/erc.09.47; Selvakumar K, 2013, HUM EXP TOXICOL, V32, P706, DOI 10.1177/0960327112464798; Serlin Yonatan, 2011, Cardiovasc Psychiatry Neurol, V2011, P609202, DOI 10.1155/2011/609202; Sherajee SJ, 2012, ARTERIOSCL THROM VAS, V32, P257, DOI 10.1161/ATVBAHA.111.240697; Sofue T, 2012, AM J HYPERTENS, V25, P604, DOI 10.1038/ajh.2012.1; Suzuki J, 2005, J HYPERTENS, V23, P1383, DOI 10.1097/01.hjh.0000173521.91104.5f; Tamura K, 2012, HYPERTENS RES, V35, P972, DOI 10.1038/hr.2012.108; Thomas MC, 2005, ADV CHRONIC KIDNEY D, V12, P177, DOI 10.1053/j.ackd.2005.01.008; Tsukuda K, 2007, HYPERTENSION, V50, P1099, DOI 10.1161/HYPERTENSIONAHA.107.099374; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Venkataraman P, 2008, INT J DEV NEUROSCI, V26, P585, DOI 10.1016/j.ijdevneu.2008.05.002; Wada M, 2007, J NEUROL SCI, V255, P27, DOI 10.1016/j.jns.2007.01.066; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Yaffe K, 2004, JAMA-J AM MED ASSOC, V292, P2237, DOI 10.1001/jama.292.18.2237	50	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82082	10.1371/journal.pone.0082082	http://dx.doi.org/10.1371/journal.pone.0082082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339994	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400060
J	Tang, QL; Chen, QR; Lai, XL; Liu, SZ; Chen, YZ; Zheng, ZX; Xie, QD; Maldonado, M; Cai, ZW; Qin, S; Ho, GY; Ma, L				Tang, Qiuling; Chen, Qiurong; Lai, Xiulan; Liu, Sizheng; Chen, Yezeng; Zheng, Zexin; Xie, Qingdong; Maldonado, Martin; Cai, Zhiwei; Qin, Shan; Ho, Guyu; Ma, Lian			Malignant Transformation Potentials of Human Umbilical Cord Mesenchymal Stem Cells Both Spontaneously and via 3-Methycholanthrene Induction	PLOS ONE			English	Article							RODENT MODEL; IN-VITRO; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; NEURONS; CULTURE; CANCER; P53	Human umbilical cord mesenchymal stem cells (HUMSCs) are highly proliferative and can be induced to differentiate into advanced derivatives of all three germ layers. Thus, HUMSCs are considered to be a promising source for cell-targeted therapies and tissue engineering. However there are reports on spontaneous transformation of mesenchymal stem cells (MSCs) derived from human bone marrows. The capacity for HUMSCs to undergo malignant transform spontaneously or via induction by chemical carcinogens is presently unknown. Therefore, we isolated HUMSCs from 10 donors and assessed their transformation potential either spontaneously or by treating them with 3-methycholanthrene (3-MCA), a DNA-damaging carcinogen. The malignant transformation of HUMSCs in vitro was evaluated by morphological changes, proliferation rates, ability to enter cell senescence, the telomerase activity, chromosomal abnormality, and the ability to form tumors in vivo. Our studies showed that HUMSCs from all 10 donors ultimately entered senescence and did not undergo spontaneous malignant transformation. However, HUMSCs from two of the 10 donors treated with 3-MCA displayed an increased proliferation rate, failed to enter senescence, and exhibited an altered cell morphology. When these cells (tHUMSCs) were injected into immunodeficient mice, they gave rise to sarcoma-like or poorly differentiated tumors. Moreover, in contrast to HUMSCs, tHUMSCs showed a positive expression of human telomerase reverse transcriptase (hTERT) and did not exhibit a shortening of the relative telomere length during the long-term culture in vitro. Our studies demonstrate that HUMSCs are not susceptible to spontaneous malignant transformation. However, the malignant transformation could be induced by chemical carcinogen 3-MCA.	[Tang, Qiuling; Chen, Qiurong; Lai, Xiulan; Liu, Sizheng; Chen, Yezeng; Zheng, Zexin; Maldonado, Martin; Cai, Zhiwei; Qin, Shan; Ho, Guyu; Ma, Lian] Shantou Univ, Coll Med, Affiliated Hosp 2, Transforming Med Ctr, Shantou, Guangdong, Peoples R China; [Tang, Qiuling; Chen, Qiurong; Lai, Xiulan; Liu, Sizheng; Chen, Yezeng; Zheng, Zexin; Maldonado, Martin; Ho, Guyu; Ma, Lian] Shantou Univ, Coll Med, Affiliated Hosp 2, Dept Pediat, Shantou, Guangdong, Peoples R China; [Chen, Qiurong; Xie, Qingdong; Maldonado, Martin] Shantou Univ, Coll Med, Res Ctr Reprod Med, Shantou, Guangdong, Peoples R China; [Ho, Guyu] Shantou Univ, Coll Med, Mol Pathol Lab, Shantou, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University; Shantou University	Ho, GY (corresponding author), Shantou Univ, Coll Med, Affiliated Hosp 2, Transforming Med Ctr, Shantou, Guangdong, Peoples R China.	guyuh@yahoo.com; malian8965@sina.com	Lai, Xiula/GMX-1854-2022		Guangdong Natural Science Foundation [C03031902]	Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by grant from Guangdong Natural Science Foundation (C03031902). http://gdsf.gdstc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bernardo ME, 2007, CANCER RES, V67, P9142, DOI 10.1158/0008-5472.CAN-06-4690; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Dai WT, 2010, J HUAZHONG U SCI-MED, V30, P709, DOI 10.1007/s11596-010-0645-8; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fu YS, 2006, STEM CELLS, V24, P115, DOI 10.1634/stemcells.2005-0053; Guengerich F, 1989, CRITICAL REV BIOCH M, V25, P97; HARVEY RG, 1982, AM SCI, V70, P386; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; HIYAMA E, 1992, JPN J CANCER RES, V83, P159, DOI 10.1111/j.1349-7006.1992.tb00081.x; Huang P, 2010, J CELL BIOCHEM, V109, P747, DOI 10.1002/jcb.22453; Karahuseyinoglu S, 2008, STEM CELLS, V26, P682, DOI 10.1634/stemcells.2007-0738; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Liu CF, 2006, NEOPLASIA, V8, P716, DOI 10.1593/neo.06253; Lu LL, 2006, HAEMATOLOGICA, V91, P1017; Lund RD, 2007, STEM CELLS, V25, P602, DOI 10.1634/stemcells.2006-0308; Ma L, 2005, CHINESE MED J-PEKING, V118, P1987; Meza-Zepeda LA, 2008, J CELL MOL MED, V12, P553, DOI 10.1111/j.1582-4934.2007.00146.x; Mitchell KE, 2003, STEM CELLS, V21, P50, DOI 10.1634/stemcells.21-1-50; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; NURNBERG P, 1993, HUM GENET, V91, P190; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; Poloni A, 2011, CELL TRANSPLANT, V20, P643, DOI 10.3727/096368910X536518; Popov B V, 2009, Tsitologiia, V51, P91; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosland GV, 2009, CANCER RES, V69, P5331, DOI 10.1158/0008-5472.CAN-08-4630; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; SHELLABARGER CJ, 1967, JNCI-J NATL CANCER I, V38, P73; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stute N, 2004, EXP HEMATOL, V32, P1212, DOI 10.1016/j.exphem.2004.09.003; UWAGAWA S, 1992, JPN J CANCER RES, V83, P812, DOI 10.1111/j.1349-7006.1992.tb01985.x; VAZIRI H, 1993, AM J HUM GENET, V52, P661; Wang HS, 2004, STEM CELLS, V22, P1330, DOI 10.1634/stemcells.2004-0013; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Weiss ML, 2006, STEM CELLS, V24, P781, DOI 10.1634/stemcells.2005-0330; Weiss ML, 2008, STEM CELLS, V26, P2865, DOI 10.1634/stemcells.2007-1028; Wick M, 1999, GENE, V232, P97, DOI 10.1016/S0378-1119(99)00108-0; Wu KH, 2007, J CELL BIOCHEM, V100, P608, DOI 10.1002/jcb.21078; Xu T, 2011, PROSTATE, V71, P1390, DOI 10.1002/pros.21355; Yang CC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003336	43	29	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81844	10.1371/journal.pone.0081844	http://dx.doi.org/10.1371/journal.pone.0081844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339974	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400048
J	Safadi, Z; Lichtenstein-Vidne, L; Dobrusin, M; Henik, A				Safadi, Ziad; Lichtenstein-Vidne, Limor; Dobrusin, Michael; Henik, Avishai			Investigating Thought Disorder in Schizophrenia: Evidence for Pathological Activation	PLOS ONE			English	Article							SPREADING ACTIVATION; WORD PRONUNCIATION; LEXICAL DECISION; WORKING-MEMORY; FACILITATION; RECOGNITION; INHIBITION; CONTEXT; PEOPLE; CORTEX	Background: Previous research has yielded evidence for enhanced semantic priming in formal thought-disordered schizophrenia patients, a result that fits well with the hypothesis of disinhibited processes of spreading activation in this population. Objective: The current study examined whether hyper priming among schizophrenia patients is an outcome of further spreading of activation of a node or a result of farther activation of nodes in the semantic network. We also try to shed light on the fate of this activation. Methods: The present study tested this hypothesis by using semantic and identical priming in two different experiments. SOA (stimulus onset asynchrony) was manipulated (240 ms vs. 740 ms) within block. It is assumed that among healthy individuals, performance relies on a balance between activation and inhibition processes, contrary to in schizophrenic individuals. In order to examine this hypothesis, we compared formal thought-disordered schizophrenia patients, non thought-disordered schizophrenia patients, and healthy controls. Results: For thought-disordered schizophrenia patients, we found a large positive semantic effect and identical priming effect (129 ms and 154 ms, respectively) only with short SOA. SOA and type of priming did not modulate priming effects in the control groups. Conclusions: This result supports the claim that there is a lack of inhibitory processes among thought-disordered patients. Hyper priming in the thought-disorder group may be an outcome of hyper activation followed by rapid decay below baseline threshold.	[Safadi, Ziad] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA; [Safadi, Ziad; Lichtenstein-Vidne, Limor; Henik, Avishai] Ben Gurion Univ Negev, Dept Psychol, IL-84105 Beer Sheva, Israel; [Safadi, Ziad; Lichtenstein-Vidne, Limor; Henik, Avishai] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel; [Dobrusin, Michael] Ben Gurion Univ Negev, Mental Hlth Ctr, Fac Hlth Sci, IL-84105 Beer Sheva, Israel	University of Rochester; Ben Gurion University; Ben Gurion University; Ben Gurion University	Safadi, Z (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	ziad_safadi@urmc.rochester.edu	HENIK, AVISHAI/F-1176-2012	Henik, Avishai/0000-0002-5665-6004	Ministry of Science, Israel	Ministry of Science, Israel(Israel Science Foundation)	Funded by Ministry of Science, Israel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia MS, 1998, AM J PSYCHIAT, V155, P1677, DOI 10.1176/ajp.155.12.1677; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Barch DM, 2007, AM J PSYCHIAT, V164, P1090, DOI 10.1176/appi.ajp.164.7.1090; Barch DM, 1996, J ABNORM PSYCHOL, V105, P592, DOI 10.1037/0021-843X.105.4.592; Barch DM, 1999, SCHIZOPHR RES, V39, P51, DOI 10.1016/S0920-9964(99)00025-0; BESNER D, 1990, J EXP PSYCHOL LEARN, V16, P862, DOI 10.1037/0278-7393.16.5.862; BLUM NA, 1995, SCHIZOPHR RES, V16, P217, DOI 10.1016/0920-9964(94)00078-M; BULLEN JG, 1987, BRIT J CLIN PSYCHOL, V26, P25, DOI 10.1111/j.2044-8260.1987.tb00720.x; CARR TH, 1990, J EXP PSYCHOL LEARN, V16, P341, DOI 10.1037/0278-7393.16.2.341; CARTER CS, 1992, PSYCHIAT RES, V41, P137, DOI 10.1016/0165-1781(92)90105-C; CHAPIN K, 1992, SCHIZOPHR RES, V6, P251, DOI 10.1016/0920-9964(92)90008-S; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Condray R, 1999, BIOL PSYCHIAT, V45, P1336, DOI 10.1016/S0006-3223(98)00317-5; FRIEDRICH FJ, 1991, J EXP PSYCHOL HUMAN, V17, P792; FRITH CD, 1981, ASPECTS CONSCIOUSNES, V2, P437; Gouzoulis-Mayfrank E, 2003, SCHIZOPHR RES, V65, P65, DOI 10.1016/S0920-9964(03)00066-5; Han SD, 2007, NEUROIMAGE, V35, P273, DOI 10.1016/j.neuroimage.2006.11.029; HENIK A, 1993, J COGNITIVE NEUROSCI, V5, P45, DOI 10.1162/jocn.1993.5.1.45; HENIK A, 1995, J ABNORM PSYCHOL, V104, P576, DOI 10.1037/0021-843X.104.4.576; HENIK A, 1993, ISRAEL J MED SCI, V29, P597; Henik A., 1992, NEUROPSY NEUROPSY BE, V5, P161; Kerns JG, 2002, J ABNORM PSYCHOL, V111, P211, DOI 10.1037//0021-843X.111.2.211; Kiang M, 2012, PSYCHIAT RES, V196, P171, DOI 10.1016/j.psychres.2012.02.026; Kiefer M, 2009, SCHIZOPHR RES, V114, P79, DOI 10.1016/j.schres.2009.07.024; Kreher DA, 2008, SCHIZOPHRENIA BULL, V34, P473, DOI 10.1093/schbul/sbm108; KWAPIL TR, 1990, J ABNORM PSYCHOL, V99, P215, DOI 10.1037/0021-843X.99.3.215; Lecardeur L, 2007, SCHIZOPHR RES, V89, P243, DOI 10.1016/j.schres.2006.08.025; Lerner I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040663; MAHER BA, 1983, PROGR EXPT PERSONALI, P1; MAHER BA, 1987, POSITIVE NEGATIVE SY, P195; MANSCHRECK TC, 1988, SCHIZOPHR RES, V1, P61, DOI 10.1016/0920-9964(88)90041-2; Mathalon DH, 2010, INT J PSYCHOPHYSIOL, V75, P157, DOI 10.1016/j.ijpsycho.2009.12.003; McNamara T. P., 2005, SEMANTIC PRIMING PER, DOI DOI 10.4324/9780203338001; Minzenberg MJ, 2002, J INT NEUROPSYCH SOC, V8, P699, DOI 10.1017/S1355617702801357; Moritz S, 2001, SCHIZOPHR RES, V48, P291, DOI 10.1016/S0920-9964(00)00056-6; Moritz S, 2002, SCHIZOPHR RES, V59, P181, DOI DOI 10.1016/S0920-9964(01)00337-1; Neely J. H., 1991, BASIC PROCESSES READ, P264; NEELY JH, 1977, J EXP PSYCHOL GEN, V106, P226, DOI 10.1037/0096-3445.106.3.226; Ober BA, 1997, NEUROPSYCHOLOGY, V11, P506, DOI 10.1037/0894-4105.11.4.506; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Pomarol-Clotet E, 2008, BRIT J PSYCHIAT, V192, P92, DOI 10.1192/bjp.bp.106.032102; Posner M., 1975, INFORM PROCESSING CO; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1975, PMA RABBITS DORNIC A, P669; Quelen F, 2005, SCHIZOPHR RES, V80, P173, DOI 10.1016/j.schres.2005.07.020; Salisbury DF, 2008, CLIN EEG NEUROSCI, V39, P103, DOI 10.1177/155005940803900217; Salisbury DF, 2002, CLIN NEUROPHYSIOL, V113, P383, DOI 10.1016/S1388-2457(02)00003-2; SPITZER M, 1994, J ABNORM PSYCHOL, V103, P485, DOI 10.1037/0021-843X.103.3.485; SPITZER M, 1993, BIOL PSYCHIAT, V34, P864, DOI 10.1016/0006-3223(93)90054-H; Spitzer M, 1997, SCHIZOPHRENIA BULL, V23, P29, DOI 10.1093/schbul/23.1.29; VINOGRADOV S, 1992, SCHIZOPHR RES, V8, P171, DOI 10.1016/0920-9964(92)90033-2; Wang K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025435; Wang Y, 2000, NAT NEUROSCI, V3, P807, DOI 10.1038/77712; Weisbrod M, 1998, BRIT J PSYCHIAT, V172, P142, DOI 10.1192/bjp.172.2.142	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82882	10.1371/journal.pone.0082882	http://dx.doi.org/10.1371/journal.pone.0082882			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WJ	24324839	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566700118
J	Perry, JC; Tse, CT				Perry, Jennifer C.; Tse, Crystal T.			Extreme Costs of Mating for Male Two-Spot Ladybird Beetles	PLOS ONE			English	Article							ADALIA-BIPUNCTATA COLEOPTERA; EJACULATE SIZE; TRADE-OFF; REPRODUCTION; LONGEVITY; LEPIDOPTERA; RESISTANCE; EVOLUTION; HISTORY	Male costs of mating are now thought to be widespread. The two-spot ladybird beetle (Adalia bipunctata) has been the focus of many studies of mating and sexual selection, yet the costs of mating for males are unknown. The mating system of A. bipunctata involves a spermatophore nuptial gift ingested by females after copulation. In this study, we investigate the cost to males of mating and of transferring spermatophores in terms of lifespan, ejaculate production and depletion of nutritional reserves. We found that males faced a strong trade-off between mating and survival, with males that were randomly assigned to mate a single time experiencing a 53% reduction in post-mating lifespan compared to non-mating males. This is among the most severe survival costs of a single mating yet reported. However, spermatophore transfer did not impact male survival. Instead, the costs associated with spermatophores appeared as a reduced ability to transfer spermatophores in successive matings. Furthermore, males ingested more food following spermatophore transfer than after matings without spermatophores, suggesting that spermatophore transfer depletes male nutritional reserves. This is to our knowledge the first report of an effect of variation in copulatory behaviour on male foraging behaviour. Overall, our study highlights the advantages of assessing mating costs using multiple currencies, and suggests that male A. bipunctata should exhibit mate choice.	[Perry, Jennifer C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England; [Perry, Jennifer C.] Univ Oxford, Jesus Coll, Oxford, England; [Tse, Crystal T.] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	University of Oxford; University of Oxford; University of Waterloo	Perry, JC (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	jennifer.perry@zoo.ox.ac.uk		Perry, Jennifer/0000-0002-8449-2764	Natural Sciences and Engineering Research Council (NSERC); Entomological Society of Canada; Government of Ontario/Dr. F. M. Hill Scholarship in Science and Technology; NSERC; Canada Research Chairs program	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Entomological Society of Canada; Government of Ontario/Dr. F. M. Hill Scholarship in Science and Technology; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	The authors were supported by scholarships from the Natural Sciences and Engineering Research Council (NSERC, to JCP and CTT), the Entomological Society of Canada (JCP), and the Government of Ontario/Dr. F. M. Hill Scholarship in Science and Technology (JCP). The study was funded by grants to Locke Rowe from NSERC and the Canada Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albo MJ, 2011, J ETHOL, V29, P473, DOI 10.1007/s10164-011-0281-1; Arnqvist Goran, 2005, pUnpaginated; Bissoondath CJ, 1996, BEHAV ECOL SOCIOBIOL, V39, P285, DOI 10.1007/s002650050291; Boggs Carol L., 1995, P215; De Clercq P, 2005, PEST MANAG SCI, V61, P1129, DOI 10.1002/ps.1111; de Jong PW, 1998, BEHAV ECOL, V9, P559, DOI 10.1093/beheco/9.6.559; Edward DA, 2011, TRENDS ECOL EVOL, V26, P647, DOI 10.1016/j.tree.2011.07.012; Ferkau C, 2006, ETHOLOGY, V112, P1117, DOI 10.1111/j.1439-0310.2006.01266.x; Haddrill PR, 2008, MOL ECOL, V17, P3189, DOI 10.1111/j.1365-294X.2008.03812.x; Hettyey A, 2009, BIOL J LINN SOC, V96, P361, DOI 10.1111/j.1095-8312.2008.01126.x; Himuro C, 2010, PHYSIOL ENTOMOL, V35, P128, DOI 10.1111/j.1365-3032.2009.00719.x; Kerr AM, 2010, BEHAV ECOL, V21, P647, DOI 10.1093/beheco/arq035; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; Martin OY, 2004, J EVOLUTION BIOL, V17, P357, DOI 10.1046/j.1420-9101.2003.00668.x; Mishra G, 2006, EUR J ENTOMOL, V103, P33, DOI 10.14411/eje.2006.005; OBATA S, 1991, BEHAVIOUR AND IMPACT OF APHIDOPHAGA, P207; Omkar, 2005, J APPL ENTOMOL, V129, P432, DOI 10.1111/j.1439-0418.2005.00996.432-436; Omkar, 2002, EUR J ENTOMOL, V99, P465; Perry JC, 2008, ANIM BEHAV, V76, P993, DOI 10.1016/j.anbehav.2008.05.017; Perry JC, 2011, J EVOLUTION BIOL, V24, P1727, DOI 10.1111/j.1420-9101.2011.02299.x; Perry JC, 2008, ETHOLOGY, V114, P504, DOI 10.1111/j.1439-0310.2008.01499.x; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; Perry JC, 2010, P ROY SOC B-BIOL SCI, V277, P3639, DOI 10.1098/rspb.2010.0810; Perry JC, 2009, ANIM BEHAV, V77, P743, DOI 10.1016/j.anbehav.2008.12.013; Ransford MO, 1997, SPERM COMPETITION 2; RITCHIE MG, 1992, TRENDS ECOL EVOL, V7, P328, DOI 10.1016/0169-5347(92)90123-S; SAKALUK SK, 1987, BEHAV ECOL SOCIOBIOL, V21, P173, DOI 10.1007/BF00303207; Salehialavi Y, 2011, BEHAV ECOL, V22, P1104, DOI 10.1093/beheco/arr097; Scharf I, 2013, EVOL BIOL, V40, P169, DOI 10.1007/s11692-012-9213-4; Simmons L. W., 2001, MG BEH ECOL; SIMMONS LW, 1992, BEHAV ECOL SOCIOBIOL, V31, P57, DOI 10.1007/BF00167816; SIMMONS LW, 1990, BEHAV ECOL SOCIOBIOL, V27, P43; South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991; Takeuchi T, 2012, PHYSIOL ENTOMOL, V37, P171, DOI 10.1111/j.1365-3032.2012.00832.x; Thornhill R., 1983, pi; Vahed K, 2007, BEHAV ECOL, V18, P499, DOI 10.1093/beheco/arm021; Watanabe M, 1998, J INSECT BEHAV, V11, P559, DOI 10.1023/A:1022319514424; Webberley KM, 2006, J ANIM ECOL, V75, P33, DOI 10.1111/j.1365-2656.2005.01020.x; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8	39	22	23	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81934	10.1371/journal.pone.0081934	http://dx.doi.org/10.1371/journal.pone.0081934			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339980	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566100075
J	Yooseph, S; Andrews-Pfannkoch, C; Tenney, A; McQuaid, J; Williamson, S; Thiagarajan, M; Brami, D; Zeigler-Allen, L; Hoffman, J; Goll, JB; Fadrosh, D; Glass, J; Adams, MD; Friedman, R; Venter, JC				Yooseph, Shibu; Andrews-Pfannkoch, Cynthia; Tenney, Aaron; McQuaid, Jeff; Williamson, Shannon; Thiagarajan, Mathangi; Brami, Daniel; Zeigler-Allen, Lisa; Hoffman, Jeff; Goll, Johannes B.; Fadrosh, Douglas; Glass, John; Adams, Mark D.; Friedman, Robert; Venter, J. Craig			A Metagenomic Framework for the Study of Airborne Microbial Communities	PLOS ONE			English	Article							BACTERIAL VIRULENCE; RADICAL GENERATION; DIVERSITY; DATABASE; MICROORGANISMS; ECOSYSTEMS; GENOMES; AIR; DNA; ASSEMBLAGES	Understanding the microbial content of the air has important scientific, health, and economic implications. While studies have primarily characterized the taxonomic content of air samples by sequencing the 16S or 18S ribosomal RNA gene, direct analysis of the genomic content of airborne microorganisms has not been possible due to the extremely low density of biological material in airborne environments. We developed sampling and amplification methods to enable adequate DNA recovery to allow metagenomic profiling of air samples collected from indoor and outdoor environments. Air samples were collected from a large urban building, a medical center, a house, and a pier. Analyses of metagenomic data generated from these samples reveal airborne communities with a high degree of diversity and different genera abundance profiles. The identities of many of the taxonomic groups and protein families also allows for the identification of the likely sources of the sampled airborne bacteria.	[Yooseph, Shibu; Tenney, Aaron; McQuaid, Jeff; Williamson, Shannon; Brami, Daniel; Zeigler-Allen, Lisa; Hoffman, Jeff; Fadrosh, Douglas; Adams, Mark D.; Friedman, Robert; Venter, J. Craig] J Craig Venter Inst, San Diego, CA USA; [Andrews-Pfannkoch, Cynthia; Thiagarajan, Mathangi; Goll, Johannes B.; Glass, John] J Craig Venter Inst, Rockville, MD USA	J. Craig Venter Institute; J. Craig Venter Institute	Yooseph, S (corresponding author), J Craig Venter Inst, San Diego, CA USA.	syooseph@jcvi.org	Glass, John/A-6572-2015	Glass, John/0000-0002-3784-5301; Yooseph, Shibu/0000-0001-5581-5002; McQuaid, Jeff/0000-0002-2646-9283	Alfred P. Sloan Foundation	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	Funding for this work was provided by the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen L, 2012, ISME J; Allen LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017722; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amato P, 2007, FEMS MICROBIOL ECOL, V59, P242, DOI 10.1111/j.1574-6941.2006.00199.x; Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Binga EK, 2008, ISME J, V2, P233, DOI 10.1038/ismej.2008.10; Bowers RM, 2011, APPL ENVIRON MICROB, V77, P6350, DOI 10.1128/AEM.05498-11; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Burrows SM, 2009, ATMOS CHEM PHYS, V9, P9263, DOI 10.5194/acp-9-9263-2009; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Codina R, 2008, J INVEST ALLERG CLIN, V18, P156; Creamean JM, 2013, SCIENCE; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dimmick R., 1975, J AEROSOL SCI, V6, P387, DOI [DOI 10.1016/0021-8502(75)90054-3, 10.1016/0021-8502(75)90054-3]; Fahlgren C, 2010, APPL ENVIRON MICROB, V76, P3015, DOI 10.1128/AEM.02092-09; Fierer N, 2008, APPL ENVIRON MICROB, V74, P200, DOI 10.1128/AEM.01467-07; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; HANCOCK JM, 1994, COMPUT APPL BIOSCI, V10, P67; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hospodsky D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034867; Hutchison CA, 2005, P NATL ACAD SCI USA, V102, P17332, DOI 10.1073/pnas.0508809102; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kembel SW, 2012, ISME J; Klepeis NE, 2001, J EXPO ANAL ENV EPID, V11, P231, DOI 10.1038/sj.jea.7500165; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lasken Roger S, 2007, BMC Biotechnol, V7, P19, DOI 10.1186/1472-6750-7-19; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Liu B, 2009, NUCLEIC ACIDS RES, V37, pD443, DOI 10.1093/nar/gkn656; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MAKI LR, 1974, APPL MICROBIOL, V28, P456, DOI 10.1128/AEM.28.3.456-459.1974; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marine R, 2011, APPL ENVIRON MICROB, V77, P8071, DOI 10.1128/AEM.05610-11; Mohler O, 2007, BIOGEOSCIENCES, V4, P1059; Neas LM, 1996, AM J EPIDEMIOL, V143, P797, DOI 10.1093/oxfordjournals.aje.a008818; Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7; Radosevich JL, 2002, LETT APPL MICROBIOL, V34, P162, DOI 10.1046/j.1472-765x.2002.01048.x; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sattler B, 2001, GEOPHYS RES LETT, V28, P239, DOI 10.1029/2000GL011684; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sharon I, 2009, LECT NOTES COMPUT SC, V5541, P496, DOI 10.1007/978-3-642-02008-7_35; Shi T, 2003, OCCUP ENVIRON MED, V60, P315, DOI 10.1136/oem.60.5.315; Smit A, 1996, REPEATMASKER OPEN 30; Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098; Tanenbaum DM, 2010, STAND GENOMIC SCI, V2, P229, DOI 10.4056/sigs.651139; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Taubel M, 2009, J ALLERGY CLIN IMMUN, V124, P834, DOI 10.1016/j.jaci.2009.07.045; Teal TK, 2010, COLD SPRING HARBOR P; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Urbano R, 2011, BIOGEOSCIENCES, V8, P301, DOI 10.5194/bg-8-301-2011; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Welch KD, 2002, ARCH BIOCHEM BIOPHYS, V397, P360, DOI 10.1006/abbi.2001.2694; Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031; Williamson SJ, 2012, METHODS MOL BIOL, V804, P35, DOI 10.1007/978-1-61779-361-5_3; Willner D, 2013, BIOESSAYS, V35, P436, DOI 10.1002/bies.201200174; Womack AM, 2010, PHILOS T R SOC B, V365, P3645, DOI 10.1098/rstb.2010.0283; Wu ZH, 2003, APPL ENVIRON MICROB, V69, P5389, DOI 10.1128/AEM.69.9.5389-5397.2003; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	61	80	83	2	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81862	10.1371/journal.pone.0081862	http://dx.doi.org/10.1371/journal.pone.0081862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349140	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300057
J	Jang, BG; Lee, BL; Kim, WH				Jang, Bo Gun; Lee, Byung Lan; Kim, Woo Ho			Distribution of LGR5(+) Cells and Associated Implications during the Early Stage of Gastric Tumorigenesis	PLOS ONE			English	Article							CANCER STEM-CELLS; MUCIN PHENOTYPE; SMALL-INTESTINE; SECRETORY-CELL; SELF-RENEWAL; MARKER; EXPRESSION; METAPLASIA; IDENTIFICATION; PROGENITORS	Lgr5 was identified as a promising gastrointestinal tract stem cell marker in mice. Lineage tracing indicates that Lgr5(+) cells may not only be the cells responsible for the origin of tumors; they may also be the so-called cancer stem cells. In the present study, we investigated the presence of Lgr5(+) cells and their biological significance in normal human gastric mucosa and gastric tumors. RNAscope, a newly developed RNA in situ hybridization technique, specifically labeled Lgr5(+) cells at the basal glands of the gastric antrum. Notably, the number of Lgr5(+) cells was remarkably increased in intestinal metaplasia. In total, 76% of gastric adenomas and 43% of early gastric carcinomas were positive for LGR5. Lgr5(+) cells were found more frequently in low-grade tumors with active Wnt signaling and an intestinal gland type, suggesting that LGR5 is likely involved in the very early stages of Wnt-driven tumorigenesis in the stomach. Interestingly, similar to stem cells in normal tissues, Lgr5(+) cells were often restricted to the base of the tumor glands, and such Lgr5(+) restriction was associated with high levels of intestinal stem cell markers such as EPHB2, OLFM4, and ASCL2. Thus, our findings show that Lgr5(+) cells are present at the base of the antral glands in the human stomach and that this cell population significantly expands in intestinal metaplasias. Furthermore, Lgr5(+) cells are seen in a large number of gastric tumors; their frequent basal arrangements and coexpression of ISC markers support the idea that Lgr5(+) cells act as stem cells during the early stage of intestinal-type gastric tumorigenesis.	[Jang, Bo Gun; Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Lee, Byung Lan] Seoul Natl Univ, Coll Med, Dept Anat, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kim, WH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.	woohokim@snu.ac.kr			SNUH Research Fund [2013-0393]	SNUH Research Fund	The study was supported by the SNUH Research Fund, grant no 2013-0393. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SC, 2002, AM J SURG PATHOL, V26, P1276, DOI 10.1097/00000478-200210000-00004; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Bonin S, 2010, VIRCHOWS ARCH, V457, P309, DOI 10.1007/s00428-010-0917-5; Capoccia BJ, 2013, J CLIN INVEST, V123, P1475, DOI 10.1172/JCI65703; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Fan XS, 2010, INT J COLORECTAL DIS, V25, P583, DOI 10.1007/s00384-010-0903-z; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kim TH, 2012, P NATL ACAD SCI USA, V109, P3932, DOI 10.1073/pnas.1113890109; Lee JH, 2002, AM J PATHOL, V161, P611, DOI 10.1016/S0002-9440(10)64216-2; Leedham SJ, 2013, GUT, V62, P83, DOI 10.1136/gutjnl-2011-301601; Lennerz JKM, 2010, AM J PATHOL, V177, P1514, DOI 10.2353/ajpath.2010.100328; Leushacke M, 2012, ONCOGENE, V31, P3009, DOI 10.1038/onc.2011.479; Lewis A, 2010, GUT, V59, P1680, DOI 10.1136/gut.2009.193680; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Mutoh H, 2004, CANCER RES, V64, P7740, DOI 10.1158/0008-5472.CAN-04-1617; Nakata S, 2013, BRAIN PATHOL, V23, P60, DOI 10.1111/j.1750-3639.2012.00618.x; Nam KT, 2012, GUT, V61, P1678, DOI 10.1136/gutjnl-2011-301193; Nam KT, 2010, GASTROENTEROLOGY, V139, P2028, DOI 10.1053/j.gastro.2010.09.005; Namikawa T, 2010, WORLD J GASTROENTERO, V16, P4634, DOI 10.3748/wjg.v16.i37.4634; Qiao XTT, 2011, J GASTROENTEROL, V46, P855, DOI 10.1007/s00535-011-0413-y; Rothenberg ME, 2012, GASTROENTEROLOGY, V142, P1195, DOI 10.1053/j.gastro.2012.02.006; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Schepers AG, 2012, SCIENCE, V337, P730, DOI 10.1126/science.1224676; Simon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035486; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Takahashi H, 2011, ANN SURG ONCOL, V18, P1166, DOI 10.1245/s10434-010-1373-9; Tanese K, 2008, AM J PATHOL, V173, P835, DOI 10.2353/ajpath.2008.071091; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; Uchida H, 2010, CANCER SCI, V101, P1731, DOI 10.1111/j.1349-7006.2010.01571.x; Uehara T, 2013, DIGEST DIS SCI, V58, P140, DOI 10.1007/s10620-012-2360-8; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; von Rahden BHA, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-23; Wakatsuki K, 2008, J SURG ONCOL, V98, P124, DOI 10.1002/jso.21093; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang TT, 2012, GUT, V61, P1777, DOI 10.1136/gutjnl-2012-302372; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wu C, 2013, GENE, V525, P18, DOI 10.1016/j.gene.2013.04.067; Yan KS, 2012, P NATL ACAD SCI USA, V109, P466, DOI 10.1073/pnas.1118857109; Yuasa Y, 2003, NAT REV CANCER, V3, P592, DOI 10.1038/nrc1141	45	51	54	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82390	10.1371/journal.pone.0082390	http://dx.doi.org/10.1371/journal.pone.0082390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340024	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400075
J	Velvarska, H; Niessing, D				Velvarska, Hana; Niessing, Dierk			Structural Insights into the Globular Tails of the Human Type V Myosins Myo5a, Myo5b, and Myo5c	PLOS ONE			English	Article							MONOMERIC MYOSIN; BINDING; CALCIUM; DOMAIN; MELANOPHILIN; CALMODULIN; ACTIVATION; MUTATIONS; COMPLEX; MYO4P	Vertebrate type V myosins (MyoV) Myo5a, Myo5b, and Myo5c mediate transport of several different cargoes. All MyoV paralogs bind to cargo complexes mainly by their C-terminal globular domains. In absence of cargo, the globular domain of Myo5a inhibits its motor domain. Here, we report low-resolution SAXS models for the globular domains from human Myo5a, Myo5b, and Myo5c, which suggest very similar overall shapes of all three paralogs. We determined the crystal structures of globular domains from Myo5a and Myo5b, and provide a homology model for human Myo5c. When we docked the Myo5a crystal structure into a previously published electron microscopy density of the autoinhibited full-length Myo5a, only one domain orientation resulted in a good fit. This structural arrangement suggests the participation of additional region of the globular domain in autoinhibition. Quantification of the interaction of the Myo5a globular domain with its motor complex revealed a tight binding with dissociation half-life in the order of minutes, suggesting a rather slow transition between the active and inactive states.	[Velvarska, Hana; Niessing, Dierk] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Struct Biol, Neuherberg, Germany; [Velvarska, Hana; Niessing, Dierk] Univ Munich, Gene Ctr, Munich, Germany; [Velvarska, Hana; Niessing, Dierk] Univ Munich, Dept Biochem, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich	Niessing, D (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Struct Biol, Neuherberg, Germany.	niessing@helmholtz-muenchen.de	Niessing, Dierk/AAE-4936-2022; Niessing, Dierk/M-4619-2014	Niessing, Dierk/0000-0002-5589-369X; Niessing, Dierk/0000-0002-5589-369X	Helmholtz Association [VG-NH 142]; Deutsche Forschungsgemeinschaft [FOR855, SFB646]	Helmholtz Association(Helmholtz Association); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Helmholtz Association (VG-NH 142) and the Deutsche Forschungsgemeinschaft (FOR855 and SFB646). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Desnos C, 2007, BIOL CELL, V99, P411, DOI 10.1042/BC20070021; Dunn AR, 2007, NAT STRUCT MOL BIOL, V14, P246, DOI 10.1038/nsmb1206; Dunn BD, 2007, J CELL BIOL, V178, P1193, DOI 10.1083/jcb.200707080; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukuda M, 2004, J CELL SCI, V117, P583, DOI 10.1242/jcs.00891; Fukuda M, 2002, J BIOL CHEM, V277, P12432, DOI 10.1074/jbc.C200005200; Graebsch A, 2009, P NATL ACAD SCI USA, V106, P18521, DOI 10.1073/pnas.0907990106; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hammer JA, 2012, NAT REV MOL CELL BIO, V13, P13, DOI 10.1038/nrm3248; Heuck A, 2007, P NATL ACAD SCI USA, V104, P19778, DOI 10.1073/pnas.0706780104; Heuck A, 2010, J CELL BIOL, V189, P497, DOI 10.1083/jcb.201002076; Hodges AR, 2008, J BIOL CHEM, V283, P6906, DOI 10.1074/jbc.M708865200; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang JD, 1998, GENETICS, V148, P1963; Jacobs DT, 2009, MOL BIOL CELL, V20, P4471, DOI 10.1091/mbc.E08-08-0865; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krementsov DN, 2004, J CELL BIOL, V164, P877, DOI 10.1083/jcb.200310065; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2004, BIOCHEM BIOPH RES CO, V315, P538, DOI 10.1016/j.bbrc.2004.01.084; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Liu J, 2006, NATURE, V442, P208, DOI 10.1038/nature04719; Lu ZK, 2012, J BIOL CHEM, V287, P16530, DOI 10.1074/jbc.M112.343079; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Muller M, 2009, RNA, V15, P2002, DOI 10.1261/rna.1753309; Muller T, 2008, NAT GENET, V40, P1163, DOI 10.1038/ng.225; Pashkova N, 2006, EMBO J, V25, P693, DOI 10.1038/sj.emboj.7600965; Pastural E, 2000, GENOMICS, V63, P299, DOI 10.1006/geno.1999.6081; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rodriguez OC, 2002, J CELL SCI, V115, P991; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger L, PYMOL; Seabra MC, 2002, TRENDS MOL MED, V8, P23, DOI 10.1016/S1471-4914(01)02227-4; Sellers JR, 2008, BIOCHEM BIOPH RES CO, V369, P176, DOI 10.1016/j.bbrc.2007.11.109; Sellers JR, 2006, CURR OPIN CELL BIOL, V18, P68, DOI 10.1016/j.ceb.2005.12.014; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Shiroguchi K, 2007, SCIENCE, V316, P1208, DOI 10.1126/science.1140468; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Szperl AM, 2011, J PEDIATR GASTR NUTR, V52, P307, DOI 10.1097/MPG.0b013e3181eea177; Thirumurugan K, 2006, NATURE, V442, P212, DOI 10.1038/nature04865; Thompson Julie D, 2002, Curr Protoc Bioinformatics, VChapter 2, DOI 10.1002/0471250953.bi0203s00; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Wei Z, 2013, P NATL ACAD SCI US; Wu XF, 2006, FEBS LETT, V580, P5863, DOI 10.1016/j.febslet.2006.09.047	52	11	12	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82065	10.1371/journal.pone.0082065	http://dx.doi.org/10.1371/journal.pone.0082065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339992	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400058
J	Ren, HY; Lin, DS; Mou, ZY; Dong, P				Ren, Haiyong; Lin, Dingsheng; Mou, Zhenyu; Dong, Pu			The Adverse Effect of Selective Cyclooxygenase-2 Inhibitor on Random Skin Flap Survival in Rats	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; COX-2 INHIBITORS; LATE-PHASE; VASCULAR-PERMEABILITY; POSTOPERATIVE PAIN; VESSEL DEVELOPMENT; VEGF; EXPRESSION; ISCHEMIA; PATHWAY	Background: Cyclooxygenase-2(COX-2) inhibitors provide desired analgesic effects after injury or surgery, but evidences suggested they also attenuate wound healing. The study is to investigate the effect of COX-2 inhibitor on random skin flap survival. Methods: The McFarlane flap model was established in 40 rats and evaluated within two groups, each group gave the same volume of Parecoxib and saline injection for 7 days. The necrotic area of the flap was measured, the specimens of the flap were stained with haematoxylin-eosin(HE) for histologic analysis. Immunohistochemical staining was performed to analyse the level of VEGF and COX-2. Results: 7 days after operation, the flap necrotic area ratio in study group (66.65 +/- 2.81)% was significantly enlarged than that of the control group(48.81 +/- 2.33)%(P <0.01). Histological analysis demonstrated angiogenesis with mean vessel density per mm(2) being lower in study group (15.4 +/- 4.4) than in control group (27.2 +/- 4.1) (P <0.05). To evaluate the expression of COX-2 and VEGF protein in the intermediate area II in the two groups by immunohistochemistry test. The expression of COX-2 in study group was (1022.45 +/- 153.1), and in control group was (2638.05 +/- 132.2) (P <0.01). The expression of VEGF in the study and control groups were (2779.45 +/- 472.0) vs (4938.05 +/- 123.6)(P <0.01). In the COX-2 inhibitor group, the expressions of COX-2 and VEGF protein were remarkably down-regulated as compared with the control group. Conclusion: Selective COX-2 inhibitor had adverse effect on random skin flap survival. Suppression of neovascularization induced by low level of VEGF was supposed to be the biological mechanism.	[Ren, Haiyong; Lin, Dingsheng; Mou, Zhenyu; Dong, Pu] Wenzhou Med Coll, Dept Hand & Plast Surg, Affiliated Hosp 2, Clin Med Coll 2, Wenzhou, Peoples R China	Wenzhou Medical University	Lin, DS (corresponding author), Wenzhou Med Coll, Dept Hand & Plast Surg, Affiliated Hosp 2, Clin Med Coll 2, Wenzhou, Peoples R China.	lindingsheng@gmail.com			Zhejiang province natural science foundation of China [Y2100897]; Zhejiang Province [2012R413032]	Zhejiang province natural science foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Province	This study was supported by Zhejiang province natural science foundation of China under Grant Y2100897 and 2012 college students of science and technology innovation program of Zhejiang Province under Grant 2012R413032. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sukhun J, 2006, NEW ENGL J MED, V355, P528, DOI 10.1056/NEJMc060373; Bolli R, 2002, CARDIOVASC RES, V55, P506, DOI 10.1016/S0008-6363(02)00414-5; Bondesen BA, 2004, AM J PHYSIOL-CELL PH, V287, pC475, DOI 10.1152/ajpcell.00088.2004; Carmeliet P, 1997, ANN NY ACAD SCI, V811, P191, DOI 10.1111/j.1749-6632.1997.tb52002.x; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carnieto A, 2009, CLINICS, V64, P245, DOI 10.1590/S1807-59322009000300016; Cattabriga I, 2007, EUR J CARDIO-THORAC, V32, P527, DOI 10.1016/j.ejcts.2007.05.017; Chen ZG, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-10; Cheng ASL, 2004, INT J ONCOL, V24, P853; Davies NM, 2013, EPIDEMIOLOGY, V24, P352, DOI 10.1097/EDE.0b013e318289e024; FLAMME I, 1995, DEV BIOL, V171, P399, DOI 10.1006/dbio.1995.1291; Gottlieb S, 2001, BRIT MED J, V323, P471, DOI 10.1136/bmj.323.7311.471a; Herschman Harvey R, 2003, Mol Imaging Biol, V5, P286; Hippenstiel S, 1998, AM J PHYSIOL-LUNG C, V274, pL678, DOI 10.1152/ajplung.1998.274.5.L678; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; KENNY D, 1994, AM HEART J, V127, P1456, DOI 10.1016/0002-8703(94)90370-0; Kryger Z, 2000, BRIT J PLAST SURG, V53, P234, DOI 10.1054/bjps.1999.3315; Liu XH, 1999, CLIN EXP METASTAS, V17, P687, DOI 10.1023/A:1006728119549; Mandriota SJ, 2000, AM J PATHOL, V156, P2077, DOI 10.1016/S0002-9440(10)65079-1; MCFARLANE R M, 1965, Plast Reconstr Surg, V35, P177, DOI 10.1097/00006534-196502000-00007; Olliges A, 2011, BRIT J PHARMACOL, V163, P927, DOI 10.1111/j.1476-5381.2011.01313.x; Ott E, 2003, J THORAC CARDIOV SUR, V125, P1481, DOI 10.1016/S0022-5223(03)00125-9; Ozkan O, 2006, PLAST RECONSTR SURG, V117, P1671, DOI 10.1097/01.prs.0000208874.61037.2b; Rinsch C, 2001, GENE THER, V8, P523, DOI 10.1038/sj.gt.3301436; Rodriguez LAG, 2001, CLIN EXP RHEUMATOL, V19, pS41; Romsing J, 2004, ACTA ANAESTH SCAND, V48, P525, DOI 10.1111/j.0001-5172.2004.00379.x; Shinmura K, 2000, P NATL ACAD SCI USA, V97, P10197, DOI 10.1073/pnas.97.18.10197; Wang W, 1996, AM J PHYSIOL-CELL PH, V271, pC1973, DOI 10.1152/ajpcell.1996.271.6.C1973; Wang Y, 2004, CIRC RES, V95, P84, DOI 10.1161/01.RES.0000133679.38825.a6; Wiedrich TA, 2001, J AM SOC SURG HAND, V1, P25, DOI 10.1053/jssh.2001.21783; Wu GF, 2006, CARDIOVASC RES, V69, P512, DOI 10.1016/j.cardiores.2005.09.019; Yu Z, 2012, P NATL ACAD SCI USA, V109, P6727, DOI 10.1073/pnas.1115313109; Zachary I, 1998, INT J BIOCHEM CELL B, V30, P1169, DOI 10.1016/S1357-2725(98)00082-X; Zhang F, 2003, BRIT J PLAST SURG, V56, P653, DOI 10.1016/s0007-1226(03)00214-5	34	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82802	10.1371/journal.pone.0082802	http://dx.doi.org/10.1371/journal.pone.0082802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324831	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566700110
J	Brito, I; Hupe, P; Neuvial, P; Barillot, E				Brito, Isabel; Hupe, Philippe; Neuvial, Pierre; Barillot, Emmanuel			Stability-Based Comparison of Class Discovery Methods for DNA Copy Number Profiles	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; ARRAY-CGH; MICROARRAY; ABERRATIONS	Motivation: Array-CGH can be used to determine DNA copy number, imbalances in which are a fundamental factor in the genesis and progression of tumors. The discovery of classes with similar patterns of array-CGH profiles therefore adds to our understanding of cancer and the treatment of patients. Various input data representations for array-CGH, dissimilarity measures between tumor samples and clustering algorithms may be used for this purpose. The choice between procedures is often difficult. An evaluation procedure is therefore required to select the best class discovery method (combination of one input data representation, one dissimilarity measure and one clustering algorithm) for array-CGH. Robustness of the resulting classes is a common requirement, but no stability-based comparison of class discovery methods for array-CGH profiles has ever been reported. Results: We applied several class discovery methods and evaluated the stability of their solutions, with a modified version of Bertoni's chi(2)-based test [1]. Our version relaxes the assumption of independency required by original Bertoni's chi(2)-based test. We conclude that Minimal Regions of alteration (a concept introduced by [2]) for input data representation, sim [3] or agree [4] for dissimilarity measure and the use of average group distance in the clustering algorithm produce the most robust classes of array-CGH profiles. Availability: The software is available from http://bioinfo.curie.fr/projects/cgh-clustering. It has also been partly integrated into "Visualization and analysis of array-CGH"(VAMP)[5]. The data sets used are publicly available from ACTuDB [6].	[Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] Inst Curie, Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] INSERM, U900, Paris, France; [Brito, Isabel; Hupe, Philippe; Barillot, Emmanuel] Mines ParisTech, Fontainebleau, France; [Hupe, Philippe] CNRS, UMR144, Paris, France; [Neuvial, Pierre] Univ Evry Val Essonne, Lab Stat & Genome, USC INRA, UMR CNRS 8071, Evry, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Brito, I (corresponding author), Inst Curie, Paris, France.	isabel.brito@curie.fr	Neuvial, Pierre/ABG-7649-2020; Hupe, Philippe/T-8793-2017	Neuvial, Pierre/0000-0003-3584-9998; Hupe, Philippe/0000-0001-8468-3424; BARILLOT, Emmanuel/0000-0003-2724-2002	Institute Curie	Institute Curie	Institute Curie have supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Ben-Hur Asa, 2002, Pac Symp Biocomput, P6; Bertoni A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S2-S7; Blaveri E, 2005, CLIN CANCER RES, V11, P7012, DOI 10.1158/1078-0432.CCR-05-0177; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Gysin S, 2005, GENE CHROMOSOME CANC, V44, P37, DOI 10.1002/gcc.20216; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; HOLM S, 1979, SCAND J STAT, V6, P65; Hupe P, 2007, ONCOGENE, V26, P6641, DOI 10.1038/sj.onc.1210488; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Lai C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-422; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Legendre P., 2012, NUMERICAL ECOLOGY; Levine E, 2001, NEURAL COMPUT, V13, P2573, DOI 10.1162/089976601753196030; Liu J, 2007, BIOINFORMATICS, V23, P450, DOI 10.1093/bioinformatics/btl624; Liu J, 2006, BIOINFORMATICS, V22, P1971, DOI 10.1093/bioinformatics/btl185; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Mattfeldt T, 2001, ANAL CELL PATHOL, V23, P29, DOI 10.1155/2001/852674; Mitelman F, 2005, ATLAS GENET CYTOGENE, V9, P342; Patil MA, 2005, CARCINOGENESIS, V26, P2050, DOI 10.1093/carcin/bgi178; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Quackenbush J, 2006, METHOD INFORM MED, V45, P91; Rouveirol C, 2006, BIOINFORMATICS, V22, P849, DOI 10.1093/bioinformatics/btl004; Snijders AM, 2001, NAT GENET, V29, P263, DOI 10.1038/ng754; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Thalamuthu A, 2006, BIOINFORMATICS, V22, P2405, DOI 10.1093/bioinformatics/btl406; Trolet J, 2009, INVESTIGATIVE OPHTHA; van de Wiel MA, 2007, CANCER INFORM, V3, P55; Van Wieringen WN, 2008, BIOSTATISTICS, V9, P484, DOI 10.1093/biostatistics/kxm048; van Wieringen WN, 2007, CANCER INFORM, V3, P321; Veltman JA, 2003, CANCER RES, V63, P2872; Vogel CL, 2002, J CLIN ONCOL, V20, P719, DOI 10.1200/JCO.20.3.719; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	39	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81458	10.1371/journal.pone.0081458	http://dx.doi.org/10.1371/journal.pone.0081458			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339933	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100060
J	Grande, R; Corsi, D; Mancini, R; Gemma, D; Ciancola, F; Sperduti, I; Rossi, L; Fabbri, A; Diodoro, MG; Ruggeri, E; Zampa, G; Bianchetti, S; Gamucci, T				Grande, Roberta; Corsi, Domenico; Mancini, Raffaello; Gemma, Donatello; Ciancola, Fabrizio; Sperduti, Isabella; Rossi, Lorena; Fabbri, Agnese; Diodoro, Maria G.; Ruggeri, Enzo; Zampa, Germano; Bianchetti, Sara; Gamucci, Teresa			Evaluation of Relapse-Free Survival in T3N0 Colon Cancer: The Role of Chemotherapy, a Multicentric Retrospective Analysis	PLOS ONE			English	Article							STAGE-II; ADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; MICROSATELLITE-INSTABILITY; PROGNOSTIC-FACTORS; MISMATCH REPAIR; FLUOROURACIL; THERAPY; OXALIPLATIN; LEUCOVORIN	Background: Adjuvant chemotherapy (AC) in Stage II Colon Cancer (CC) is still under debate. Choice should be based on patients and disease characteristics. According to guidelines AC should be considered in high-risk T3N0 patients. No data are available for better option in low-risk patients. The aim of the study is to retrospectively evaluate relapse-free survival (RFS) and disease-free survival (DFS) according to treatment received in T3N0 CC. Methods: RFS and DFS are evaluated with Kaplan-Meier method. Multivariate Cox proportional hazard model was developed using stepwise regression, enter limit and remove limit were p = 0.10 and p = 0.15, respectively. Results: 834 patients with T3N0 CC were recruited. Median age was 69 (29-93), M/F 463/371, 335 low-risk patients (40.2%), 387 high-risk (46.4%), 112 unknown (13.4%); 127 (15.2%) patients showed symptoms at diagnosis. Median sampled lymph nodes were 15 (1-76); 353 (42.3%) patients were treated with AC. Median follow up was 5 years (range 3-24). The 5-years RFS was 78.4% and the 5-years DFS was 76.7%. At multivariate analysis symptoms, lymph nodes, and adjuvant chemotherapy were prognostic factors for RFS. AC is prognostic factor for all endpoints. In low-risk group 5-years RFS was 87.3% in treated patients and 74.7% in non-treated patients (p 0.03); in high-risk group was respectively 82.7% and 71.4% (p 0.005). Conclusions: Data confirmed the role of known prognostic factors and suggest the relevance of adjuvant chemotherapy also in low-risk stage II T3N0 CC patients. However, the highest risk in low-risk subgroup should be identified to be submitted to AC.	[Corsi, Domenico; Rossi, Lorena] S Giovanni Calibita Hosp Fatebenefratelli Isola T, Rome, Italy; [Mancini, Raffaello] Regina Elena Inst Canc Res, Dept Surg, Rome, Italy; [Sperduti, Isabella] Regina Elena Inst Canc Res, Biostat Unit, Rome, Italy; [Fabbri, Agnese; Ruggeri, Enzo] Belcolle Hosp, Med Oncol Unit, Viterbo, Italy; [Zampa, Germano] UOSA Oncol ASL RM A, Rome, Italy; [Bianchetti, Sara] Regina Apostolorum, Med Oncol Unit, Rome, Italy; [Diodoro, Maria G.] Regina Elena Inst Canc Res, Dept Pathol, Rome, Italy	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena		robertagrande@virgilio.it	Sperduti, Isabella/K-8902-2016	Sperduti, Isabella/0000-0001-5115-3099; Mancini, Raffaello/0000-0002-7700-3467; Fabbri, Maria Agnese/0000-0002-3357-6343				Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Chang GJ, 2007, J NATL CANCER I, V99, P433, DOI 10.1093/jnci/djk092; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Figueredo A, 2004, J CLIN ONCOL, V22, P3395, DOI 10.1200/JCO.2004.03.087; Figueredo A, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005390.pub2; Gertler R, 2009, EUR J CANCER, V45, P2992, DOI 10.1016/j.ejca.2009.07.008; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; Gray RG, 2011, J CLIN ONCOL, V29, P4611, DOI 10.1200/JCO.2010.32.8732; HALL WH, 1990, JAMA-J AM MED ASSOC, V264, P1444; Hutchins G, 2011, J CLIN ONCOL, V29, P1261, DOI 10.1200/JCO.2010.30.1366; Jonker DJ, 2011, CLIN ONCOL-UK, V23, P314, DOI 10.1016/j.clon.2011.02.010; Kim GP, 2007, J CLIN ONCOL, V25, P767, DOI 10.1200/JCO.2006.05.8172; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Laubert T, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-24; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Niedzwiecki D, 2011, J CLIN ONCOL, V29, P3146, DOI 10.1200/JCO.2010.32.5357; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Otchy D, 2004, DIS COLON RECTUM, V47, P1269, DOI 10.1007/s10350-004-0598-8; Poynter JN, 2008, CANCER EPIDEM BIOMAR, V17, P3208, DOI 10.1158/1055-9965.EPI-08-0512; Quah HM, 2008, DIS COLON RECTUM, V51, P503, DOI 10.1007/s10350-008-9246-z; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Roth AD, 2012, JNCI-J NATL CANCER I, V104, P1635, DOI 10.1093/jnci/djs427; Salazar R, 2011, J CLIN ONCOL, V29, P17, DOI 10.1200/JCO.2010.30.1077; Santos C, 2012, COLORECTAL DIS, DOI [10.1111/codi.12028., DOI 10.1111/C0DI.12028]; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Sargent DJ, 2010, J CLIN ONCOL, V28, P3219, DOI 10.1200/JCO.2009.27.1825; Sarli L, 2005, EUR J CANCER, V41, P272, DOI 10.1016/j.ejca.2004.10.010; Sato H, 2011, J SURG ONCOL, DOI [10.1002/jso.21914, DOI 10.1002/JS0.21914]; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Schrag D, 2002, J CLIN ONCOL, V20, P3999, DOI 10.1200/JCO.2002.11.084; Sinicrope FA, 2012, CLIN CANCER RES, V18, P1506, DOI 10.1158/1078-0432.CCR-11-1469; Sinicrope FA, 2009, CURR OPIN ONCOL, V21, P369, DOI 10.1097/CCO.0b013e32832c94bd; Stocchi L, 2011, ANN SURG ONCOL, V18, P405, DOI 10.1245/s10434-010-1308-5; The International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2), 1999, J CLIN ONCOL, V17, P1356; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80188	10.1371/journal.pone.0080188	http://dx.doi.org/10.1371/journal.pone.0080188			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339871	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100010
J	Jones, MH; Corso, AL; Tepper, RS; Edelweiss, MIA; Friedrich, L; Pitrez, PMC; Stein, RT				Jones, Marcus H.; Corso, Andrea L.; Tepper, Robert S.; Edelweiss, Maria I. A.; Friedrich, Luciana; Pitrez, Paulo M. C.; Stein, Renato T.			Chorioamnionitis and Subsequent Lung Function in Preterm Infants	PLOS ONE			English	Article							BIRTH-WEIGHT INFANTS; BRONCHOPULMONARY DYSPLASIA; RESPIRATORY-INFECTIONS; INFLAMMATION; OUTCOMES; GENDER; RISK; INTERLEUKIN-6; MARKERS; GROWTH	Objective: To explore the relationship between prematurity, gender and chorioamnionitis as determinants of early life lung function in premature infants. Methods: Placenta and membranes were collected from preterm deliveries (<37 weeks gestational age) and evaluated for histological chorioamnionitis (HCA). Patients were followed and lung function was performed in the first year of life by Raised Volume-Rapid Thoracic Compression Technique. Results: Ninety-five infants (43 males) born prematurely (median gestational age 34.2 weeks) were recruited. HCA was detected in 66(69%) of the placentas, and of these 55(58%) were scored HCA Grade 1, and 11(12%) HCA Grade 2. Infants exposed to HCA Grade 1 and Grade 2, when compared to those not exposed, presented significantly lower gestational ages, higher prevalence of RDS, clinical early-onset sepsis, and the use of supplemental oxygen more than 28 days. Infants exposed to HCA also had significantly lower maximal flows. There was a significant negative trend for z-scores of lung function in relation to levels of HCA; infants had lower maximal expiratory flows with increasing level of HCA. (p =0.012 for FEF50, p = 0.014 for FEF25-75 and p = 0.32 for FEV0.5). Two-way ANOVA adjusted for length and gestational age indicated a significant interaction between sex and HCA in determining expiratory flows (p<0.01 for FEF50, FEF25-75 and p<0.05 for FEV0.5). Post-hoc comparisons revealed that female preterm infants exposed to HCA Grade 1 and Grade 2 had significant lower lung function than those not exposed, and this effect was not observed among males. Conclusions:Our findings show a sex-specific negative effect of prenatal inflammation on lung function of female preterm infants. This study confirms and expands knowledge upon the known association between chorioamnionitis and early life chronic lung disease.	[Jones, Marcus H.; Corso, Andrea L.; Pitrez, Paulo M. C.; Stein, Renato T.] Pontificia Univ Catolica Rio Grande do Sul, Inst Biomed Res, Porto Alegre, RS, Brazil; [Jones, Marcus H.; Corso, Andrea L.; Pitrez, Paulo M. C.; Stein, Renato T.] Pontificia Univ Catolica Rio Grande do Sul, Sch Med, Porto Alegre, RS, Brazil; [Tepper, Robert S.] Indiana Univ, James Whitcomb Riley Hosp Children, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN USA; [Edelweiss, Maria I. A.] Univ Fed Rio Grande do Sul, Sch Med, Dept Pathol, BR-90046900 Porto Alegre, RS, Brazil; [Edelweiss, Maria I. A.] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, BR-90046900 Porto Alegre, RS, Brazil; [Friedrich, Luciana] Hosp Clin Porto Alegre, Neonatol Sect, Porto Alegre, RS, Brazil	Pontificia Universidade Catolica Do Rio Grande Do Sul; Pontificia Universidade Catolica Do Rio Grande Do Sul; Indiana University System; Indiana University-Purdue University Indianapolis; James Whitcomb Riley Hospital Children; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Jones, MH (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Inst Biomed Res, Porto Alegre, RS, Brazil.	mhjones@pucrs.br	Stein, Renato Tetelbom/K-2568-2014; Jones, Marcus Herbert/A-3580-2011; Pitrez, Paulo/W-2098-2019; Pitrez, Paulo/A-3040-2011	Jones, Marcus Herbert/0000-0002-8263-1265; Corso, Andrea Lucia/0000-0003-1118-1145; STEIN, RENATO/0000-0003-0269-0757; Pitrez, Paulo/0000-0001-7319-1133	CNPq/Brazil; CAPES/Brazil	CNPq/Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by CNPq/Brazil and CAPES/Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X; Anadkat JS, 2012, J PERINATOL, V32, P780, DOI 10.1038/jp.2011.191; Andrews WW, 2006, AM J OBSTET GYNECOL, V195, P803, DOI 10.1016/j.ajog.2006.06.083; BALLARD JL, 1991, J PEDIATR-US, V119, P417, DOI 10.1016/S0022-3476(05)82056-6; Bancalari E, 2006, SEMIN PERINATOL, V30, P164, DOI 10.1053/j.semperi.2006.05.002; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Feher A, 1996, J APPL PHYSIOL, V80, P2019, DOI 10.1152/jappl.1996.80.6.2019; Friedrich L, 2006, AM J RESP CRIT CARE, V173, P442, DOI 10.1164/rccm.200503-444OC; GERDES JS, 1991, CLIN PERINATOL, V18, P361, DOI 10.1016/S0095-5108(18)30528-1; Getahun D, 2010, ARCH PEDIAT ADOL MED, V164, P187, DOI 10.1001/archpediatrics.2009.238; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Greenough A, 2005, ARCH DIS CHILD-FETAL, V90, pF320, DOI 10.1136/adc.2004.062018; Hanrahan JP, 1996, AM J RESP CRIT CARE, V154, P670, DOI 10.1164/ajrccm.154.3.8810604; Holzman C, 2007, AM J EPIDEMIOL, V166, P786, DOI 10.1093/aje/kwm168; Jobe A H, 2001, Semin Neonatol, V6, P331, DOI 10.1053/siny.2001.0068; Jobe AH, 2010, OBSTET GYNECOL, V116, P1184, DOI 10.1097/AOG.0b013e3181f60b1d; *JOINT AM THOR SOC, 2000, AM J RESP CRIT CARE, V161, P1760; Jones M, 2000, AM J RESP CRIT CARE, V161, P353, DOI 10.1164/ajrccm.161.2.9903026; Kallopur SG, 2006, ARCH DIS CHILD-FETAL, V91, pF132, DOI 10.1136/adc.2004.068544; Kent A, 2004, J PAEDIATR CHILD H, V40, P356, DOI 10.1111/j.1440-1754.2004.00366.x; Klein MI, 2008, PEDIATRICS, V121, pE1510, DOI 10.1542/peds.2007-1757; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kumar R, 2008, CURR OPIN PEDIATR, V20, P682, DOI 10.1097/MOP.0b013e3283154f26; Libster R, 2009, PEDIATR INFECT DIS J, V28, P131, DOI 10.1097/INF.0b013e31818a8a82; Maxwell NC, 2006, CURR OPIN INFECT DIS, V19, P253, DOI 10.1097/01.qco.0000224819.42729.2e; Milner AD, 1999, ARCH DIS CHILD-FETAL, V80, pF8, DOI 10.1136/fn.80.1.F8; Mu SC, 2008, J FORMOS MED ASSOC, V107, P304, DOI 10.1016/S0929-6646(08)60091-1; Munshi UK, 1997, PEDIATR PULM, V24, P331; Peacock JL, 2012, PEDIATR RES, V71, P305, DOI 10.1038/pr.2011.50; Prendergast M, 2010, ARCH DIS CHILD FETAL; Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y; Sinha A, 2003, PEDIATRICS, V112, pE303, DOI 10.1542/peds.112.4.e303; Speer CP, 2006, SEMIN FETAL NEONAT M, V11, P354, DOI 10.1016/j.siny.2006.03.004; Stevenson DK, 2000, ARCH DIS CHILD-FETAL, V83, pF182, DOI 10.1136/fn.83.3.F182; Viscardi RM, 2004, PEDIATR RES, V55, P1009, DOI 10.1203/01.pdr.0000127015.60185.8a; Watterberg KL, 1996, PEDIATRICS, V97, P210; Yoon BH, 1999, AM J OBSTET GYNECOL, V181, P773, DOI 10.1016/S0002-9378(99)70299-1; Yoon BH, 1997, AM J OBSTET GYNECOL, V177, P19, DOI 10.1016/S0002-9378(97)70432-0	38	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81193	10.1371/journal.pone.0081193	http://dx.doi.org/10.1371/journal.pone.0081193			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339909	Green Published, gold			2022-12-27	WOS:000328566100041
J	Kawahara, T; Hotta, N; Ozawa, Y; Kato, S; Kano, K; Yokoyama, Y; Nagino, M; Takahashi, T; Yanagisawa, K				Kawahara, Takeo; Hotta, Naoe; Ozawa, Yukiko; Kato, Seiichi; Kano, Keiko; Yokoyama, Yukihiro; Nagino, Masato; Takahashi, Takashi; Yanagisawa, Kiyoshi			Quantitative Proteomic Profiling Identifies DPYSL3 as Pancreatic Ductal Adenocarcinoma-Associated Molecule That Regulates Cell Adhesion and Migration by Stabilization of Focal Adhesion Complex	PLOS ONE			English	Article							RESPONSE MEDIATOR PROTEIN-1; GROWTH CONE COLLAPSE; LUNG-CANCER; LINE NCI-H460-LNM35; METASTASIS; GENE; PHOSPHORYLATION; EXPRESSION; SIGNATURE; PATHWAYS	Elucidation of how pancreatic cancer cells give rise to distant metastasis is urgently needed in order to provide not only a better understanding of the underlying molecular mechanisms, but also to identify novel targets for greatly improved molecular diagnosis and therapeutic intervention. We employed combined proteomic technologies including mass spectrometry and isobaric tags for relative and absolute quantification peptide tagging to analyze protein profiles of surgically resected human pancreatic ductal adenocarcinoma tissues. We identified a protein, dihydropyrimidinase-like 3, as highly expressed in human pancreatic ductal adenocarcinoma tissues as well as pancreatic cancer cell lines. Characterization of the roles of dihydropyrimidinase-like 3 in relation to cancer cell adhesion and migration in vitro, and metastasis in vivo was performed using a series of functional analyses, including those employing multiple reaction monitoring proteomic analysis. Furthermore, dihydropyrimidinase-like 3 was found to interact with Ezrin, which has important roles in cell adhesion, motility, and invasion, while that interaction promoted stabilization of an adhesion complex consisting of Ezrin, c-Src, focal adhesion kinase, and Talin1. We also found that exogenous expression of dihydropyrimidinase-like 3 induced activating phosphorylation of Ezrin and c-Src, leading to up-regulation of the signaling pathway. Taken together, the present results indicate successful application of combined proteomic approaches to identify a novel key player, dihydropyrimidinase-like 3, in pancreatic ductal adenocarcinoma tumorigenesis, which may serve as an important biomarker and/or drug target to improve therapeutic strategies.	[Kawahara, Takeo; Hotta, Naoe; Ozawa, Yukiko; Kato, Seiichi; Kano, Keiko; Takahashi, Takashi; Yanagisawa, Kiyoshi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Nagoya, Aichi 4648601, Japan; [Yanagisawa, Kiyoshi] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648601, Japan; [Kawahara, Takeo; Yokoyama, Yukihiro; Nagino, Masato] Nagoya Univ Hosp, Div Surg Oncol, Nagoya, Aichi, Japan; [Kato, Seiichi] Nagoya Univ Hosp, Dept Pathol & Mol Diagnost, Nagoya, Aichi, Japan	Nagoya University; Nagoya University; Nagoya University; Nagoya University	Yanagisawa, K (corresponding author), Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Nagoya, Aichi 4648601, Japan.	kyana@med.nagoya-u.ac.jp	Yanagisawa, Kiyoshi/I-7263-2014; Nagino, Masato/I-7342-2014; KATO, Seiichi/I-7298-2014; Yokoyama, Yukihiro/I-7379-2014; Takahashi, Takashi/I-7262-2014	Yokoyama, Yukihiro/0000-0003-2385-5610; Takahashi, Takashi/0000-0003-0615-7001; Kato, Seiichi/0000-0001-9713-3691	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Ministry of Health, Labor and Welfare	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	This work was supported in part by Exploratory Research and Program for Improvement of Research Environment for Young Researchers from Special Coordination Funds for Promoting Science and Technology commissioned from the Ministry of Education, Culture, Sports, Science and Technology of Japan; and Grants-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science; and Grant-in-Aid for the Third Term Comprehensive Control Research for Cancer commissioned from Ministry of Health, Labor and Welfare. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Dong J, NAT GENET; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Frame MC, 2010, NAT REV MOL CELL BIO, V11, P802, DOI 10.1038/nrm2996; Fukada M, 2000, J BIOL CHEM, V275, P37957, DOI 10.1074/jbc.M003277200; Gaetano C, 1997, J BIOL CHEM, V272, P12195, DOI 10.1074/jbc.272.18.12195; Giaccone G, 2002, ONCOGENE, V21, P6970, DOI 10.1038/sj.onc.1205565; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Hanash S, 2003, NATURE, V422, P226, DOI 10.1038/nature01514; Ketterer B, 2001, CHEM-BIOL INTERACT, V138, P27, DOI 10.1016/S0009-2797(01)00277-0; Koshikawa K, 2002, ONCOGENE, V21, P2822, DOI 10.1038/sj.onc.1205405; Kozaki K, 2000, CANCER RES, V60, P2535; Kozaki K, 2001, ONCOGENE, V20, P4228, DOI 10.1038/sj.onc.1204561; Medina R, 2012, MOL CELL BIOL, V32, P3860, DOI 10.1128/MCB.00736-12; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Shih JY, 2001, JNCI-J NATL CANCER I, V93, P1392, DOI 10.1093/jnci/93.18.1392; Shih JY, 2003, CLIN EXP METASTAS, V20, P69, DOI 10.1023/A:1022598604565; Srivastava J, 2005, MOL BIOL CELL, V16, P1481, DOI 10.1091/mbc.e04-08-0721; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; Sun C, 2011, WORLD J GASTROENTERO, V17, P4845, DOI 10.3748/wjg.v17.i44.4845; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tomida S, 2007, ONCOGENE, V26, P4600, DOI 10.1038/sj.onc.1210242; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Turtoi A, 2011, J PROTEOME RES, V10, P4302, DOI 10.1021/pr200527z; Wang LH, 1997, J NEUROCHEM, V69, P2261; Yanagisawa K, 2003, LANCET, V362, P433, DOI 10.1016/S0140-6736(03)14068-8; Yanagisawa K, 2007, JNCI-J NATL CANCER I, V99, P858, DOI 10.1093/jnci/djk197; Yanagisawa K, 2010, CANCER RES, V70, P9949, DOI 10.1158/0008-5472.CAN-10-1055	28	24	24	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e79654	10.1371/journal.pone.0079654	http://dx.doi.org/10.1371/journal.pone.0079654			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339867	gold, Green Published			2022-12-27	WOS:000328566100006
J	Cuadrado, A; Carmona, A; Jouve, N				Cuadrado, Angeles; Carmona, Alejandro; Jouve, Nicolas			Chromosomal Characterization of the Three Subgenomes in the Polyploids of Hordeum murinum L.: New Insight into the Evolution of This Complex	PLOS ONE			English	Article							REPETITIVE DNA-SEQUENCES; GENUS HORDEUM; GENOME; ALLOPOLYPLOIDY; HYBRIDIZATION; ORGANIZATION; ELIMINATION; RDNA; 5S	Hordeum murinum L. is a species complex composed of related taxa, including the subspecies glaucum, murinum and leporinum. However, the phylogenetic relationships between the different taxa and their cytotypes, and the origin of the polyploid forms, remain points of controversy. The present work reports a comparative karyotype analysis of seven accessions of the H. murinum complex representing all subspecies and cytotypes. The karyotypes were determined by examining the distribution of the repetitive Triticeae DNA sequences pTa71, pTa794, pSc119.2, pAs1 and pHch950, the simple sequence repeats (SSRs) (AG)(10), (AAC)(5), (AAG)(5), (ACT)(5), (ATC)(5), and (CCCTAAA)(3) via in situ hybridization. The chromosomes of the three subgenomes involved in the polyploids were identified. All tetraploids of all subspecies shared the same two subgenomes (thus suggesting them to in fact belong to the same taxon), the result of hybridization between two diploid ancestors. One of the subgenomes present in all tetraploids of all subspecies was found to be very similar (though not identical) to the chromosome complement of the diploid glaucum. The hexaploid form of leporinum came about through a cross between a tetraploid and a third diploid form. Exclusively bivalent associations among homologous chromosomes were observed when analyzing pollen mother cells of tetraploid taxa. In conclusion, the present results identify all the individual chromosomes within the H. murinum complex, reveal its genome structure and phylogeny, and explain the appearance of the different cytotypes. Three cryptic species are proposed according to ploidy level that may deserve full taxonomic recognition.	[Cuadrado, Angeles; Carmona, Alejandro; Jouve, Nicolas] Univ Alcala, Dept Biomed & Biotecnol, Madrid, Spain	Universidad de Alcala	Cuadrado, A (corresponding author), Univ Alcala, Dept Biomed & Biotecnol, Madrid, Spain.	angeles.cuadrado@uah.es	Jouve, Nicolás/F-1274-2016; Cuadrado, Angeles/H-3470-2015	Jouve, Nicolás/0000-0003-0348-0268; Cuadrado, Angeles/0000-0003-0089-5249	Spanish Ministry of Science and Innovation [AGL 2009-10373, AGL2012-34052]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was funded by grants from the Spanish Ministry of Science and Innovation (AGL 2009-10373 and AGL2012-34052. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUM BR, 1990, CAN J BOT, V68, P2433, DOI 10.1139/b90-309; Bianchi DS, 2002, WEED RES, V42, P325, DOI 10.1046/j.1365-3180.2002.00292.x; Blattner FR, 2009, BREEDING SCI, V59, P471, DOI 10.1270/jsbbs.59.471; Bothmer R.V., 1995, ECOGEOGRAPHICAL STUD, P129; Bothmer R. von, 1988, Hereditas, Sweden, V108, P141, DOI 10.1111/j.1601-5223.1988.tb00294.x; Bothmer R. von, 1986, Canadian Journal of Genetics and Cytology, V28, P525; Bothmer RV, 1987, EVOLUTIONARY TRENDS, V1, P41; Brassac J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033808; CABRERA A, 1995, GENOME, V38, P435, DOI 10.1139/g95-057; Cuadrado A, 1994, CHROMOSOME RES, V2, P331, DOI 10.1007/BF01552727; Cuadrado A, 2007, CHROMOSOME RES, V15, P711, DOI 10.1007/s10577-007-1156-8; Cuadrado A, 2010, CHROMOSOMA, V119, P495, DOI 10.1007/s00412-010-0273-x; Cuadrado A, 2009, CHROMOSOME RES, V17, P755, DOI 10.1007/s10577-009-9060-z; deBustos A, 1996, CHROMOSOME RES, V4, P491, DOI 10.1007/BF02261776; El-Rabey HA, 2002, PLANT BIOLOGY, V4, P567, DOI 10.1055/s-2002-35435; GILES BE, 1986, PLANT SYST EVOL, V153, P181, DOI 10.1007/BF00983686; GUPTA PK, 1989, GENOME, V32, P383, DOI 10.1139/g89-459; GUPTA PK, 1985, J HERED, V76, P365; Han FP, 2005, GENETICS, V170, P1239, DOI 10.1534/genetics.104.039263; Jacobsen N, 1995, NORD J BOT, V15, P449, DOI 10.1111/j.1756-1051.1995.tb00177.x; JAHAN B, 1992, Cytologia (Tokyo), V57, P51, DOI 10.1508/cytologia.57.51; Jakob SS, 2010, MOL PHYLOGENET EVOL, V55, P650, DOI 10.1016/j.ympev.2009.10.021; Kakeda K, 2009, BREEDING SCI, V59, P595, DOI 10.1270/jsbbs.59.595; LindeLaursen I, 1997, HEREDITAS, V126, P1, DOI 10.1111/j.1601-5223.1997.00001.x; LINDELAURSEN IB, 1992, HEREDITAS, V116, P111, DOI 10.1111/j.1601-5223.1992.tb00213.x; Ourari M, 2011, GENOME, V54, P639, DOI [10.1139/G11-032, 10.1139/g11-032]; Ozkan H, 2009, GENOME, V52, P926, DOI [10.1139/G09-067, 10.1139/g09-067]; Pickering R, 2006, GENOME, V49, P73, DOI 10.1139/G05-071; RAJHATHY T, 1962, CAN J GENET CYTOL, V4, P240, DOI 10.1139/g62-029; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Smith D. F., 1972, Herbage Abstracts, V42, P213; Taketa S, 1999, THEOR APPL GENET, V98, P1, DOI 10.1007/s001220051033; Taketa S, 2000, THEOR APPL GENET, V100, P169, DOI 10.1007/s001220050023; Tanno K, 2010, HEREDITAS, V147, P34, DOI 10.1111/j.1601-5223.2009.02142.x; Van de Peer Y, 2009, NAT REV GENET, V10, P725, DOI 10.1038/nrg2600; Wang RRC, 1996, P 2 INT TRIT S LOG U, P29	37	33	33	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81385	10.1371/journal.pone.0081385	http://dx.doi.org/10.1371/journal.pone.0081385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349062	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200009
J	Conde, DA; Colchero, F; Gusset, M; Pearce-Kelly, P; Byers, O; Flesness, N; Browne, RK; Jones, OR				Conde, Dalia A.; Colchero, Fernando; Gusset, Markus; Pearce-Kelly, Paul; Byers, Onnie; Flesness, Nate; Browne, Robert K.; Jones, Owen R.			Zoos through the Lens of the IUCN Red List: A Global Metapopulation Approach to Support Conservation Breeding Programs	PLOS ONE			English	Article							ARK; BIODIVERSITY; COMMUNITY; IMPACTS; FUTURE	Given current extinction trends, the number of species requiring conservation breeding programs (CBPs) is likely to increase dramatically. To inform CBP policies for threatened terrestrial vertebrates, we evaluated the number and representation of threatened vertebrate species on the IUCN Red List held in the ISIS zoo network and estimated the complexity of their management as metapopulations. Our results show that 695 of the 3,955 (23%) terrestrial vertebrate species in ISIS zoos are threatened. Only two of the 59 taxonomic orders show a higher proportion of threatened species in ISIS zoos than would be expected if species were selected at random. In addition, for most taxa, the management of a zoo metapopulation of more than 250 individuals will require the coordination of a cluster of 11 to 24 ISIS zoos within a radius of 2,000 km. Thus, in the zoo network, the representation of species that may require CBPs is currently low and the spatial distribution of these zoo populations makes management difficult. Although the zoo community may have the will and the logistical potential to contribute to conservation actions, including CBPs, to do so will require greater collaboration between zoos and other institutions, alongside the development of international agreements that facilitate cross-border movement of zoo animals. To maximize the effectiveness of integrated conservation actions that include CBPs, it is fundamental that the non-zoo conservation community acknowledges and integrates the expertise and facilities of zoos where it can be helpful.	[Conde, Dalia A.; Colchero, Fernando; Jones, Owen R.] Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging, Odense M, Denmark; [Conde, Dalia A.; Jones, Owen R.] Univ Southern Denmark, Dept Biol, Odense M, Denmark; [Conde, Dalia A.; Browne, Robert K.] Royal Zool Soc Antwerp, Ctr Res & Conservat, Antwerp, Belgium; [Colchero, Fernando] Univ Southern Denmark, Dept Math & Comp Sci, Odense M, Denmark; [Gusset, Markus] World Assoc Zoos & Aquariums, Gland, Switzerland; [Pearce-Kelly, Paul] Zool Soc London, London, England; [Byers, Onnie] IUCN SSC Conservat Breeding Specialist Grp, Apple Valley, MN USA; [Flesness, Nate] Int Species Informat Syst, Eagan, MN USA	University of Southern Denmark; University of Southern Denmark; University of Southern Denmark; Zoological Society of London	Conde, DA (corresponding author), Univ Southern Denmark, Max Planck Odense Ctr Biodemog Aging, Odense M, Denmark.	dalia@biology.sdu.dk	Jones, Owen/B-8439-2008; Gusset, Markus/AAA-3497-2019; Andersen, Mette Adalheidur/D-5608-2017; Colchero, Fernando/A-9368-2015	Jones, Owen/0000-0001-5720-4686; Gusset, Markus/0000-0003-1186-3218; Colchero, Fernando/0000-0001-8613-4568; Conde, Dalia A./0000-0002-7923-8163; Pearce-Kelly, Paul/0000-0003-2356-7061				[Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; BALMFORD A, 1995, BIODIVERS CONSERV, V4, P595, DOI 10.1007/BF00222516; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bowkett AE, 2009, CONSERV BIOL, V23, P773, DOI 10.1111/j.1523-1739.2008.01157.x; Brook BW, 2008, TRENDS ECOL EVOL, V23, P453, DOI 10.1016/j.tree.2008.03.011; Browne Robert K., 2011, Amphibian & Reptile Conservation, V5, P1; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Byers O., 2013, WAZA MAGAZINE, V14, P2; Collen B, 2009, CONSERV BIOL, V23, P317, DOI 10.1111/j.1523-1739.2008.01117.x; Conde DA, 2011, SCIENCE, V332, P1150, DOI 10.1126/science.332.6034.1150; Conde DA, 2011, SCIENCE, V331, P1390, DOI 10.1126/science.1200674; Conway WG, 2011, ZOO BIOL, V30, P1, DOI 10.1002/zoo.20352; Fa JE, 2011, ZOO CONSERVATION BIO; Gusset M., 2010, International Zoo Yearbook, V44, P183, DOI 10.1111/j.1748-1090.2009.00101.x; Harley Dan, 2012, Victorian Naturalist (Blackburn), V129, P175; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Hoffmann M, 2010, SCIENCE, V330, P1503, DOI 10.1126/science.1194442; IUCN Red List of Threatened Species, 2013, IUCN RED LIST THREAT; Lacy RC, 2013, ZOO BIOL; Lees C. M., 2009, International Zoo Yearbook, V43, P6, DOI 10.1111/j.1748-1090.2008.00066.x; Martin TG, 2012, CONSERV LETT, V5, P274, DOI 10.1111/j.1755-263X.2012.00239.x; Parr MJ, 2009, TRENDS ECOL EVOL, V24, P181, DOI 10.1016/j.tree.2009.01.001; Pritchard DJ, 2012, ORYX, V46, P18, DOI 10.1017/S0030605310001766; RAHBEK C, 1993, BIODIVERS CONSERV, V2, P426, DOI 10.1007/BF00114044; Redford KH, 2012, SCIENCE, V338, P1157, DOI 10.1126/science.1228899; RYDER OA, 1995, BIODIVERS CONSERV, V4, P671, DOI 10.1007/BF00222522; Seto KC, 2012, P NATL ACAD SCI USA, V109, P16083, DOI 10.1073/pnas.1211658109; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Shrestha AB, 2010, CLIMATE CHANGE E HIM; Snyder NFR, 1996, CONSERV BIOL, V10, P338, DOI 10.1046/j.1523-1739.1996.10020338.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Traylor-Holzer K, 2012, WAZA MAGAZINE, V12, P30; Zippel K, 2011, HERPETOL CONSERV BIO, V6, P340	34	57	63	1	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80311	10.1371/journal.pone.0080311	http://dx.doi.org/10.1371/journal.pone.0080311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348999	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300008
J	Motani, R; Ji, C; Tomita, T; Kelley, N; Maxwell, E; Jiang, DY; Sander, M				Motani, Ryosuke; Ji, Cheng; Tomita, Taketeru; Kelley, Neil; Maxwell, Erin; Jiang, Da-yong; Sander, Martin			Absence of Suction Feeding Ichthyosaurs and Its Implications for Triassic Mesopelagic Paleoecology	PLOS ONE			English	Article							AQUATIC PREY CAPTURE; HYOID APPARATUS; DEEP-SEA; FUNCTIONAL-MORPHOLOGY; GIANT-SQUID; GRAY WHALE; KINEMATICS; EVOLUTION; ANATOMY; ADAPTATIONS	Mesozoic marine reptiles and modern marine mammals are often considered ecological analogs, but the extent of their similarity is largely unknown. Particularly important is the presence/absence of deep-diving suction feeders among Mesozoic marine reptiles because this would indicate the establishment of mesopelagic cephalopod and fish communities in the Mesozoic. A recent study suggested that diverse suction feeders, resembling the extant beaked whales, evolved among ichthyosaurs in the Triassic. However, this hypothesis has not been tested quantitatively. We examined four osteological features of jawed vertebrates that are closely linked to the mechanism of suction feeding, namely hyoid corpus ossification/calcification, hyobranchial apparatus robustness, mandibular bluntness, and mandibular pressure concentration index. Measurements were taken from 18 species of Triassic and Early Jurassic ichthyosaurs, including the presumed suction feeders. Statistical comparisons with extant sharks and marine mammals of known diets suggest that ichthyosaurian hyobranchial bones are significantly more slender than in suction-feeding sharks or cetaceans but similar to those of ram-feeding sharks. Most importantly, an ossified hyoid corpus to which hyoid retractor muscles attach is unknown in all but one ichthyosaur, whereas a strong integration of the ossified corpus and cornua of the hyobranchial apparatus has been identified in the literature as an important feature of suction feeders. Also, ichthyosaurian mandibles do not narrow rapidly to allow high suction pressure concentration within the oral cavity, unlike in beaked whales or sperm whales. In conclusion, it is most likely that Triassic and Early Jurassic ichthyosaurs were 'ram-feeders', without any beaked-whale-like suction feeder among them. When combined with the inferred inability for dim-light vision in relevant Triassic ichthyosaurs, the fossil record of ichthyosaurs does not suggest the establishment of modern-style mesopelagic animal communities in the Triassic. This new interpretation matches the fossil record of coleoids, which indicates the absence of soft-bodied deepwater species in the Triassic.	[Motani, Ryosuke; Tomita, Taketeru; Kelley, Neil] Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA; [Ji, Cheng; Jiang, Da-yong] Peking Univ, Dept Geol & Geol Museum, Beijing 100871, Peoples R China; [Tomita, Taketeru] Hokkaido Univ Museum, Hakodate, Hokkaido, Japan; [Maxwell, Erin] Univ Zurich, Palaontol Inst & Museum, Zurich, Switzerland; [Sander, Martin] Univ Bonn, Div Palaeontol, Steinmann Inst, Bonn, Germany	University of California System; University of California Davis; Peking University; Hokkaido University; University of Zurich; University of Bonn	Motani, R (corresponding author), Univ Calif Davis, Dept Earth & Planetary Sci, Davis, CA 95616 USA.	rmotani@ucdavis.edu	Motani, Ryosuke/K-2607-2015	Motani, Ryosuke/0000-0001-5022-1053; Maxwell, Erin/0000-0002-6032-6251	National Geographic Society Committee for Research and Exploration [8669-09]; National Natural Science Foundation of China [40920124002]; Grants-in-Aid for Scientific Research [11J05588] Funding Source: KAKEN	National Geographic Society Committee for Research and Exploration(National Geographic Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The specimen of Chaohusaurus was collected with funds from the National Geographic Society Committee for Research and Exploration (#8669-09) to RM and Project 40920124002 from the National Natural Science Foundation of China to DJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M.N., 1967, FUNCTIONAL DESIGN FI; Aoki K, 2012, MAR ECOL PROG SER, V444, P289, DOI 10.3354/meps09371; Arranz P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028353; BANDEL K, 1985, Palaeontologische Zeitschrift, V59, P223; Bloodworth B, 2005, J EXP BIOL, V208, P3721, DOI 10.1242/jeb.01807; Bloodworth BE, 2007, J ANAT, V211, P78, DOI 10.1111/j.1469-7580.2007.00755.x; BRAMBLE DM, 1973, AM ZOOL, V13, P1342; CHILDRESS JJ, 1995, TRENDS ECOL EVOL, V10, P30, DOI 10.1016/S0169-5347(00)88957-0; Dean MN, 2005, BIOL LETTERS, V1, P357, DOI 10.1098/rsbl.2005.0319; Donovan DT, 2006, PALAEONTOLOGY, V49, P673, DOI 10.1111/j.1475-4983.2006.00552.x; Doyle P, 1997, ALCHERINGA, V21, P219, DOI 10.1080/03115519708619175; Doyle P., 1994, PALEONTOLOGICAL CONT, V5, P1; Dutton A, 2007, PALAIOS, V22, P642, DOI 10.2110/palo.2005.p05-064r; Ferry-Graham LA, 2001, J MORPHOL, V248, P99, DOI 10.1002/jmor.1023; Feyrer LJ, 2011, HYDROBIOLOGIA, V678, P37, DOI 10.1007/s10750-011-0816-z; Fuchs D, 2011, J PALEONTOL, V85, P815, DOI 10.1666/10-159.1; Hassan MA, 2002, PALEOBIOLOGY, V28, P113, DOI 10.1666/0094-8373(2002)028<0113:FEAOSA>2.0.CO;2; HEWITT RA, 1988, ALCHERINGA, V12, P123, DOI 10.1080/03115518808619000; Heyning John E., 1996, Contributions in Science (Los Angeles), V464, P1; Higham TE, 2005, J EXP BIOL, V208, P2653, DOI 10.1242/jeb.01682; Hooker SK, 1999, P ROY SOC B-BIOL SCI, V266, P671, DOI 10.1098/rspb.1999.0688; Iba Y, 2012, GEOLOGY, V40, P911, DOI 10.1130/G33402.1; Jeletzky J.A, 1966, U KANSAS PALEONTOLOG, V42, P1; Ji C, 2013, J VERTEBR PALEONTOL, V33, P340, DOI 10.1080/02724634.2013.723082; Johnston C, 2011, MAR MAMMAL SCI, V27, P493, DOI 10.1111/j.1748-7692.2010.00420.x; Kane EA, 2009, J EXP BIOL, V212, P3939, DOI 10.1242/jeb.034686; Kelley N. P., 2012, PALAEOGEOGR PALAEOCL, DOI [10.1016/j.palaeo.2012.07.026, DOI 10.1016/J.PALAE0.2012.07.026]; Kelley N, 2009, J VERTEBR PALEONTOL, V29, p125A; Kelley NP, 2012, THESIS U CALIFORNIA; Kroger B, 2011, BIOESSAYS, V33, P602, DOI 10.1002/bies.201100001; Kubodera T, 2005, P ROY SOC B-BIOL SCI, V272, P2583, DOI 10.1098/rspb.2005.3158; Kubodera T, 2007, P R SOC B, V274, P1029, DOI 10.1098/rspb.2006.0236; Kundrat M, 2009, ZOOL J LINN SOC-LOND, V156, P384, DOI 10.1111/j.1096-3642.2009.00537.x; Langebartel D. A., 1968, Illinois Biological Monographs, VNo. 38, P1; LAUDER GV, 1981, ENVIRON BIOL FISH, V6, P257, DOI 10.1007/BF00005755; LAUDER GV, 1992, J EXP BIOL, V164, P55; Lemell P, 2002, J EXP BIOL, V205, P1495; Lemell P, 2002, AMPHIB REPTL, V31, P97; Li C, 2004, SCIENCE, V305, P1931, DOI 10.1126/science.1100498; Liem K.F., 1980, NATO ASI (Advanced Science Institutes) Series Series A Life Sciences, V35, P299; Lindberg DR, 2007, LETHAIA, V40, P335, DOI 10.1111/j.1502-3931.2007.00032.x; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Massare J.A., 1987, Journal of Vertebrate Paleontology, V7, P121; MCGOWAN C, 2003, HDB PALAOHERPETOLO 8; Meyers JJ, 2002, ANAT RECORD, V267, P177, DOI 10.1002/ar.10096; Motani R, 2005, ANNU REV EARTH PL SC, V33, P395, DOI 10.1146/annurev.earth.33.092203.122707; Motani R, 1999, NATURE, V402, P747, DOI 10.1038/45435; Motani Ryosuke, 2008, Paleontological Society Papers, V14, P147; Motani Ryosuke., 2009, Evolution Education and Outreach, V2, P224; Motani R, 2010, SCIENCE, V328, P1361, DOI 10.1126/science.1191409; Motta PJ, 2008, J MORPHOL, V269, P1041, DOI 10.1002/jmor.10626; MOTTA PJ, 1995, J MORPHOL, V226, P309, DOI 10.1002/jmor.1052260307; Natchev N, 2011, CONTRIB ZOOL, V80, P143, DOI 10.1163/18759866-08002004; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Nilsson DE, 2012, CURR BIOL, V22, P683, DOI 10.1016/j.cub.2012.02.031; NORTON SF, 1993, J EXP BIOL, V176, P11; Price GD, 2008, P GEOLOGIST ASSOC, V119, P153, DOI 10.1016/S0016-7878(08)80315-X; RAY GC, 1974, MAR FISH REV, V36, P31; REESE AM, 1945, ANAT REC, V92, P273, DOI 10.1002/ar.1090920308; REIDENBERG JS, 1994, ANAT RECORD, V240, P598, DOI 10.1002/ar.1092400417; RIEPPEL O, 1981, J HERPETOL, V15, P433, DOI 10.2307/1563533; Rieppel O, 2002, ZOOL J LINN SOC-LOND, V135, P33, DOI 10.1046/j.1096-3642.2002.00019.x; Ritterbush KA, 2012, PALEOBIOLOGY, V38, P424, DOI 10.1666/10027.1; Romer AS, 1957, OSTEOLOGY REPTILES, P772; Rothschild BM, 2012, NATURWISSENSCHAFTEN, V99, P443, DOI 10.1007/s00114-012-0918-0; Sander PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019480; Santos MB, 2007, J MAR BIOL ASSOC UK, V87, P243, DOI 10.1017/S0025315407054380; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P687, DOI 10.1017/S0025315401004386; Santos MB, 2001, J MAR BIOL ASSOC UK, V81, P143, DOI 10.1017/S0025315401003484; Schmitz L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-45; Seibel BA, 2000, BIOL BULL-US, V198, P284, DOI 10.2307/1542531; Smith AS, 2008, NATURWISSENSCHAFTEN, V95, P975, DOI 10.1007/s00114-008-0402-z; SMITH KK, 1986, J MORPHOL, V187, P261, DOI 10.1002/jmor.1051870302; SMITH KK, 1984, J ZOOL, V202, P115; Sokal RR, 1995, BIOMETRY; Sollas WJ, 1918, PHILOS T R SOC LON B, V208, P63, DOI 10.1098/rstb.1918.0003; Summers AP, 1998, J EXP ZOOL, V281, P280, DOI 10.1002/(SICI)1097-010X(19980701)281:4<280::AID-JEZ4>3.0.CO;2-K; Tomita T, 2011, J MORPHOL, V272, P513, DOI 10.1002/jmor.10905; Tyack PL, 2006, J EXP BIOL, V209, P4238, DOI 10.1242/jeb.02505; VanDamme J, 1997, J MORPHOL, V233, P113, DOI 10.1002/(SICI)1097-4687(199708)233:2<113::AID-JMOR3>3.0.CO;2-7; Wainwright PC, 2001, J EXP BIOL, V204, P3039; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Werth AJ, 2006, J MAMMAL, V87, P579, DOI 10.1644/05-MAMM-A-279R1.1; Werth AJ, 2007, ANAT REC, V290, P546, DOI 10.1002/ar.20538; Werth AJ, 2006, J MORPHOL, V267, P1415, DOI 10.1002/jmor.10486; WESTERMA.GE, 1973, LETHAIA, V6, P383, DOI 10.1111/j.1502-3931.1973.tb01205.x; WESTERMANN GEG, 1980, PALEOBIOLOGY, V6, P48, DOI 10.1017/S0094837300012495; Wilga CD, 2007, INTEGR COMP BIOL, V47, P55, DOI 10.1093/icb/icm029; Zakharov YD, 2007, RUSS J PAC GEOL, V1, P29, DOI 10.1134/S1819714007010058; Zhu K.-y., 1984, Acta Palaeontologica Sinica, V23, P300	90	33	35	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e66075	10.1371/journal.pone.0066075	http://dx.doi.org/10.1371/journal.pone.0066075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348983	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000328730300001
J	Alderks, PW; Sisneros, JA				Alderks, Peter W.; Sisneros, Joseph A.			Development of the Acoustically Evoked Behavioral Response in Larval Plainfin Midshipman Fish, Porichthys notatus	PLOS ONE			English	Article							GOLDFISH CARASSIUS-AURATUS; FAST STARTLE RESPONSES; ZEBRAFISH DANIO-RERIO; LATERAL-LINE ORGANS; INNER-EAR; TELEOST FISH; ESCAPE RESPONSE; MAUTHNER CELL; REEF FISHES; HAIR CELL	The ontogeny of hearing in fishes has become a major interest among bioacoustics researchers studying fish behavior and sensory ecology. Most fish begin to detect acoustic stimuli during the larval stage which can be important for navigation, predator avoidance and settlement, however relatively little is known about the hearing capabilities of larval fishes. We characterized the acoustically evoked behavioral response (AEBR) in the plainfin midshipman fish, Porichthys notatus, and used this innate startle-like response to characterize this species' auditory capability during larval development. Age and size of larval midshipman were highly correlated (r(2) = 0.92). The AEBR was first observed in larvae at 1.4 cm TL. At a size >= 1.8 cm TL, all larvae responded to a broadband stimulus of 154 dB re1 mu Pa or -15.2 dB re 1 g (z-axis). Lowest AEBR thresholds were 140-150 dB re 1 mu Pa or -33 to -23 dB re 1 g for frequencies below 225 Hz. Larval fish with size ranges of 1.9-2.4 cm TL had significantly lower best evoked frequencies than the other tested size groups. We also investigated the development of the lateral line organ and its function in mediating the AEBR. The lateral line organ is likely involved in mediating the AEBR but not necessary to evoke the startle-like response. The midshipman auditory and lateral line systems are functional during early development when the larvae are in the nest and the auditory system appears to have similar tuning characteristics throughout all life history stages.	[Alderks, Peter W.; Sisneros, Joseph A.] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Sisneros, Joseph A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Sisneros, Joseph A.] Univ Washington, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Alderks, PW (corresponding author), Univ Washington, Dept Psychol, Seattle, WA 98195 USA.	pwa2@u.washington.edu	Sisneros, Joseph/AAU-9965-2020	Sisneros, Joseph/0000-0002-3114-773X	Royalty Research Grant; National Institutes of Health Auditory Neuroscience Training Fellowship [NIH NIDCD 2T32DC005361-06]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC005361] Funding Source: NIH RePORTER	Royalty Research Grant; National Institutes of Health Auditory Neuroscience Training Fellowship; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by a Royalty Research Grant to JAS and a National Institutes of Health Auditory Neuroscience Training Fellowship (NIH NIDCD 2T32DC005361-06) to PWA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderks PW, 2011, J COMP PHYSIOL A, V197, P387, DOI 10.1007/s00359-010-0623-4; Bartsch P, 1997, ACTA ZOOL-STOCKHOLM, V78, P309, DOI 10.1111/j.1463-6395.1997.tb01014.x; Bass AH, 1999, DESIGN OF ANIMAL COMMUNICATION, P493; Bass AH, 2003, PROG NEUROBIOL, V69, P1, DOI 10.1016/S0301-0082(03)00004-2; Bhandiwad AA, 2013, J EXP BIO IN PRESS; BLAXTER JHS, 1990, J MAR BIOL ASSOC UK, V70, P413, DOI 10.1017/S0025315400035505; BLAXTER JHS, 1987, BIOL REV, V62, P471, DOI 10.1111/j.1469-185X.1987.tb01638.x; BLAXTER JHS, 1981, J MAR BIOL ASSOC UK, V61, P871, DOI 10.1017/S0025315400023018; Bleckmann H, 1985, PROGR SENSORY PHYSL; BRANTLEY RK, 1993, BRAIN BEHAV EVOLUT, V42, P336, DOI 10.1159/000114170; BRANTLEY RK, 1994, ETHOLOGY, V96, P213, DOI 10.1111/j.1439-0310.1994.tb01011.x; Braun CB, 2000, PHILOS T ROY SOC B, V355, P1115, DOI 10.1098/rstb.2000.0650; Brown AD, 2011, HEARING RES, V272, P1, DOI 10.1016/j.heares.2010.10.014; CANFIELD JG, 1993, J COMP PHYSIOL A, V173, P463; Catania KC, 2009, P NATL ACAD SCI USA, V106, P11183, DOI 10.1073/pnas.0905183106; Coombs Sheryl, 2003, P122, DOI 10.1007/978-0-387-22628-6_7; CRANE JM, 1981, COPEIA, P895, DOI 10.2307/1444196; DENTON EJ, 1976, J MAR BIOL ASSOC UK, V56, P787, DOI 10.1017/S0025315400020804; DIJKGRAAF S, 1963, BIOL REV, V38, P51, DOI 10.1111/j.1469-185X.1963.tb00654.x; DIJKGRAAF S, 1960, PROC R SOC SER B-BIO, V152, P51, DOI 10.1098/rspb.1960.0022; EATON RC, 1977, J EXP BIOL, V66, P65; EATON RC, 1991, BRAIN BEHAV EVOLUT, V37, P272, DOI 10.1159/000114365; EATON RC, 1986, T AM FISH SOC, V115, P128, DOI 10.1577/1548-8659(1986)115<128:ROTTER>2.0.CO;2; EATON RC, 1982, J COMP PHYSIOL, V145, P485, DOI 10.1007/BF00612814; EATON RC, 1984, J COMP PHYSIOL, V155, P813, DOI 10.1007/BF00611598; Elliott M, 2007, FISH FISH, V8, P241, DOI 10.1111/j.1467-2679.2007.00253.x; Fay R. R., 1988, HEARING VERTEBRATES; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; FAY RR, 1984, SCIENCE, V225, P951, DOI 10.1126/science.6474161; FAY RR, 1975, J EXP BIOL, V62, P379; FAY RR, 1974, J EXP BIOL, V61, P243; FOREMAN MB, 1993, J NEUROSCI, V13, P4101; Fuiman L. A., 1999, Journal of Fish Biology, V55, P215, DOI 10.1111/j.1095-8649.1999.tb01057.x; Gagliano M, 2008, P R SOC B, V275, P527, DOI 10.1098/rspb.2007.1388; Gill T. N., 1907, Smithsonian Institution Miscellaneous Collections Q, V48; Greene CW, 1924, AM J PHYSIOL, V70, P496, DOI 10.1152/ajplegacy.1924.70.3.496; GREENE CW, 1899, J MORPHOL, V15, P667; Greenfield David W., 2008, Proceedings of the California Academy of Sciences, V59, P665; Greenwood AK, 2010, J EXP BIOL, V213, P613, DOI 10.1242/jeb.037085; Hale ME, 2002, EVOLUTION, V56, P993; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Higgs DM, 2013, J EXP BIOL, V216, P1484, DOI 10.1242/jeb.078816; Higgs DM, 1998, COPEIA, P133, DOI 10.2307/1447709; Higgs DM, 2004, J EXP BIOL, V207, P155, DOI 10.1242/jeb.00735; Higgs DM, 2003, J ACOUST SOC AM, V113, P1145, DOI 10.1121/1.1536185; HOSS DE, 1982, J FISH BIOL, V20, P131, DOI 10.1111/j.1095-8649.1982.tb03914.x; Hubbs CL, 1920, AM NAT, V54, P380, DOI 10.1086/279770; Ibara R.M., 1983, PREDATORS PREY FISHE, P205, DOI 10.1007/978-94-009-7296-4_22; JAKUBOWSKI M, 1966, ACTA BIOL CRACOV ZOO, V9, P225; Jeffs A, 2003, MAR FRESHWATER RES, V54, P841, DOI 10.1071/MF03007; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; Kohashi T, 2008, J NEUROSCI, V28, P10641, DOI 10.1523/JNEUROSCI.1435-08.2008; Landford PJ, 1996, HEARING RES, V100, P1; LEE RKK, 1991, J COMP NEUROL, V304, P34; Leis JM, 2011, INTEGR COMP BIOL, V51, P826, DOI 10.1093/icb/icr004; Leis JM, 2005, B MAR SCI, V76, P715; Leis JM, 2003, J FISH BIOL, V63, P724, DOI 10.1046/j.1095-8649.2003.00182.x; Leis JM, 2002, MAR ECOL PROG SER, V232, P259, DOI 10.3354/meps232259; Liu KS, 1999, NEURON, V23, P325, DOI 10.1016/S0896-6273(00)80783-7; LOMBARTE A, 1994, J COMP NEUROL, V345, P419, DOI 10.1002/cne.903450308; MacGINITIE G. E., 1935, AMER MIDLAND NAT, V16, P629, DOI 10.2307/2420105; Martin KL, 2009, J FISH BIOL, V75, P17, DOI 10.1111/j.1095-8649.2009.02260.x; Martinez GM, 2003, J MORPHOL, V255, P162, DOI 10.1002/jmor.10053; Meyers JR, 1998, BRAIN BEHAV EVOLUT, V52, P7, DOI 10.1159/000006548; Mirjany M, 2011, J EXP BIOL, V214, P3358, DOI 10.1242/jeb.052894; Montgomery JC, 2006, ADV MAR BIOL, V51, P143, DOI 10.1016/S0065-2881(06)51003-X; Ouagazzal AM, 2006, BEHAV BRAIN RES, V172, P307, DOI 10.1016/j.bbr.2006.05.018; PLATT C, 1981, HEARING SOUND COMMUN, P3, DOI DOI 10.1007/978-1-4615-7186-5_; Popper A.N., 1983, P125; POPPER AN, 1984, HEARING RES, V15, P133, DOI 10.1016/0378-5955(84)90044-3; POPPER AN, 1993, BRAIN BEHAV EVOLUT, V41, P14, DOI 10.1159/000113821; POPPER AN, 1990, HEARING RES, V45, P33, DOI 10.1016/0378-5955(90)90180-W; Popper AN, 2000, FISH RES, V46, P15, DOI 10.1016/S0165-7836(00)00129-6; POPPER AN, 1981, J COMP PHYSIOL, V144, P27, DOI 10.1007/BF00612794; POPPER AN, 1999, COMP HEARING FISH AM, P43; SHARDO JD, 1995, J MORPHOL, V225, P125, DOI 10.1002/jmor.1052250202; Simpson SD, 2008, ANIM BEHAV, V75, P1861, DOI 10.1016/j.anbehav.2007.11.004; Simpson SD, 2005, SCIENCE, V308, P221, DOI 10.1126/science.1107406; Simpson SD, 2005, MAR ECOL PROG SER, V287, P201, DOI 10.3354/meps287201; Simpson SD, 2010, BEHAV ECOL, V21, P1098, DOI 10.1093/beheco/arq117; Sisneros JA, 2005, J EXP BIOL, V208, P3121, DOI 10.1242/jeb.01742; Sisneros JA, 2007, J COMP PHYSIOL A, V193, P413, DOI 10.1007/s00359-006-0195-5; Sisneros JA, 2009, INTEGR ZOOL, V4, P33, DOI 10.1111/j.1749-4877.2008.00133.x; Sisneros JA, 2009, HEARING RES, V252, P9, DOI 10.1016/j.heares.2008.12.007; Tanimoto M, 2009, J NEUROSCI, V29, P2762, DOI 10.1523/JNEUROSCI.5530-08.2009; TAYLOR EB, 1985, T AM FISH SOC, V114, P552, DOI 10.1577/1548-8659(1985)114<552:OOTSRI>2.0.CO;2; Tolimieri N, 2004, CORAL REEFS, V23, P184, DOI 10.1007/s00338-004-0383-0; Weiss SA, 2006, J EXP BIOL, V209, P4788, DOI 10.1242/jeb.02582; Wright KJ, 2008, J FISH BIOL, V72, P2543, DOI 10.1111/j.1095-8649.2008.01864.x; Wright KJ, 2011, MAR ECOL PROG SER, V424, P1, DOI 10.3354/meps09004; Wright KJ, 2010, CORAL REEFS, V29, P235, DOI 10.1007/s00338-009-0572-y; Wright KJ, 2005, MAR BIOL, V147, P1425, DOI 10.1007/s00227-005-0028-z; Yasargil GM, 1968, NATURE, V200, P241; YOUNG JS, 1983, J ACOUST SOC AM, V73, P1686, DOI 10.1121/1.389391; Zeddies DG, 2005, J EXP BIOL, V208, P1363, DOI 10.1242/jeb.01534; Zottoli SJ, 1999, J COMP PHYSIOL A, V184, P207, DOI 10.1007/s003590050319; ZOTTOLI SJ, 1995, BRAIN BEHAV EVOLUT, V46, P151, DOI 10.1159/000113268	97	10	10	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82182	10.1371/journal.pone.0082182	http://dx.doi.org/10.1371/journal.pone.0082182			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340003	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400062
J	Bosak, J; Micenkova, L; Vrba, M; Sevcikova, A; Dedicova, D; Garzetti, D; Smajs, D				Bosak, Juraj; Micenkova, Lenka; Vrba, Martin; Sevcikova, Alena; Dedicova, Daniela; Garzetti, Debora; Smajs, David			Unique Activity Spectrum of Colicin F-Y: All 110 Characterized Yersinia enterocolitica Isolates Were Colicin F-Y Susceptible	PLOS ONE			English	Article							BACTERIOCIN-LIKE ANTAGONISM; FIELD GEL-ELECTROPHORESIS; TAIL-LIKE BACTERIOCIN; ESCHERICHIA-COLI; IN-VITRO; PESTICIN; INFECTION; STRAINS; VIRULENCE; INFANTS	Colicin F-Y is a plasmid encoded toxin that recognizes a yersinia-specific outer membrane protein (YiuR) as a receptor molecule. We have previously shown that the activity spectrum of colicin F-Y comprises strains of the genus Yersinia. In this study, we analyzed the activity of colicin F-Y against 110 Yersinia enterocolitica isolates differing in geographical origin and source. All isolates were characterized through analysis of 16S rRNA genes, serotyping, biotyping, restriction profiling of genomic DNA, detection of virulence markers and susceptibility to antibiotics. This confirmed the broad variability of the collection, in which all 110 Y. enterocolitica isolates, representing 77 various strains, were inhibited by colicin F-Y. Although isolates showed variable levels of susceptibility to colicin F-Y, it was not associated with any strain characteristic. The universal susceptibility of Y. enterocolitica strains to colicin F-Y together with the absence of activity towards strains outside the Yersinia genus suggests potential therapeutic applications for colicin F-Y. S.	[Bosak, Juraj; Micenkova, Lenka; Smajs, David] Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic; [Vrba, Martin; Sevcikova, Alena] Univ Hosp Brno, Dept Clin Microbiol, Brno, Czech Republic; [Dedicova, Daniela] Natl Inst Publ Hlth, Natl Reference Lab Salmonella, Prague, Czech Republic; [Garzetti, Debora] Univ Munich, Max von Pettenkofer Inst, Munich, Germany	Masaryk University Brno; University Hospital Brno; National Institute of Public Health (SZU) - Czech Republic; University of Munich	Smajs, D (corresponding author), Masaryk Univ, Fac Med, Dept Biol, Brno, Czech Republic.	dsmajs@med.muni.cz	Bosak, Juraj/AAV-2191-2020; Smajs, David/I-3479-2016	Micenkova, Lenka/0000-0003-0930-4396	Ministry of Health of the Czech Republic [NT13413-4/2012]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by the Ministry of Health of the Czech Republic (NT13413-4/2012) to D.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Haq NM, 2000, PEDIATR INFECT DIS J, V19, P954, DOI 10.1097/00006454-200010000-00002; ALEKSIC S, 1984, J CLIN MICROBIOL, V20, P99; Asplund K, 1998, EPIDEMIOL INFECT, V121, P579, DOI 10.1017/S0950268898001629; Batzilla J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-348; BENGURION R, 1958, J GEN MICROBIOL, V19, P289, DOI 10.1099/00221287-19-2-289; Bhaduri S, 2009, FOODBORNE PATHOG DIS, V6, P351, DOI 10.1089/fpd.2008.0197; BISSETT ML, 1990, J CLIN MICROBIOL, V28, P910, DOI 10.1128/JCM.28.5.910-912.1990; Bosak J, 2012, J BACTERIOL, V194, P1950, DOI 10.1128/JB.05885-11; BOTTONE EJ, 1979, J CLIN MICROBIOL, V10, P433, DOI 10.1128/JCM.10.4.433-436.1979; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Bottone EJ, 1999, MICROBES INFECT, V1, P323, DOI 10.1016/S1286-4579(99)80028-8; CAFFERKEY MT, 1989, J CLIN MICROBIOL, V27, P677, DOI 10.1128/JCM.27.4.677-680.1989; CALVO C, 1986, FOLIA MICROBIOL, V31, P177, DOI 10.1007/BF02927998; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chen PE, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r1; Clinical and Laboratory Standards Institute, 2012, PERF STAND ANT DISK, P58; CSISZAR K, 1992, ACTA MICROBIOL HUNG, V39, P193; Cursino L, 2006, J APPL MICROBIOL, V100, P821, DOI 10.1111/j.1365-2672.2006.02834.x; Damasko C, 2005, J VET MED B, V52, P171, DOI 10.1111/j.1439-0450.2005.00841.x; European Food Safety Authority, 2012, EFSA J, V10, DOI 10.2903/j.efsa.2012.2597; Fabrega A, 2012, ENFERM INFEC MICR CL, V30, P24, DOI 10.1016/j.eimc.2011.07.017; Feldgarden M, 1998, EVOLUTION, V52, P1270, DOI 10.1111/j.1558-5646.1998.tb02008.x; FERBER DM, 1979, J BACTERIOL, V139, P495, DOI 10.1128/JB.139.2.495-501.1979; Fredriksson-Ahomaa M, 2003, CLIN MICROBIOL REV, V16, P220, DOI 10.1128/CMR.16.2.220-229.2003; Fredriksson-Ahomaa M, 2001, EPIDEMIOL INFECT, V127, P37, DOI 10.1017/S0950268801005611; Gordon DM, 1998, MICROBIOL-SGM, V144, P2233, DOI 10.1099/00221287-144-8-2233; Gray JT, 2001, J APPL MICROBIOL, V90, P358, DOI 10.1046/j.1365-2672.2001.01252.x; GREENWOOD M, 1987, J MED MICROBIOL, V23, P345, DOI 10.1099/00222615-23-4-345; Harnett N, 1996, EPIDEMIOL INFECT, V117, P59, DOI 10.1017/S0950268800001138; HOOGKAMPKORSTANJE JAA, 1995, PEDIATR INFECT DIS J, V14, P771, DOI 10.1097/00006454-199509000-00008; Iteman I, 1996, J MED MICROBIOL, V45, P48, DOI 10.1099/00222615-45-1-48; Kerr B, 2002, NATURE, V418, P171, DOI 10.1038/nature00823; Kirillina O, 2006, INFECT IMMUN, V74, P6171, DOI 10.1128/IAI.00874-06; Kotetishvili M, 2005, J CLIN MICROBIOL, V43, P2674, DOI 10.1128/JCM.43.6.2674-2684.2005; LEE LA, 1991, J INFECT DIS, V163, P660, DOI 10.1093/infdis/163.3.660; LEE LA, 1990, NEW ENGL J MED, V322, P984, DOI 10.1056/NEJM199004053221407; LodinovaZadnikova R, 1997, BIOL NEONATE, V71, P224, DOI 10.1159/000244421; MARRIOTT DJE, 1985, MED J AUSTRALIA, V143, P489, DOI 10.5694/j.1326-5377.1985.tb119908.x; Nahum JR, 2011, P NATL ACAD SCI USA, V108, P10831, DOI 10.1073/pnas.1100296108; NAJDENSKI H, 1994, J CLIN MICROBIOL, V32, P2913, DOI 10.1128/JCM.32.12.2913-2920.1994; Neubauer H, 2000, INT J MED MICROBIOL, V290, P61; PAI CH, 1984, J PEDIATR-US, V104, P308, DOI 10.1016/S0022-3476(84)81020-3; Patzer SI, 2003, MICROBIOL-SGM, V149, P2557, DOI 10.1099/mic.0.26396-0; Patzer SI, 2012, J BIOL CHEM, V287, P23381, DOI 10.1074/jbc.M112.362913; Pilsl H, 1996, J BACTERIOL, V178, P2431, DOI 10.1128/jb.178.8.2431-2435.1996; Rahman A, 2011, J PATHOG, V2011, DOI 10.4061/2011/239391; Rakin A, 1996, MICROBIOL-UK, V142, P3415, DOI 10.1099/13500872-142-12-3415; RAKIN A, 1994, MOL MICROBIOL, V13, P253, DOI 10.1111/j.1365-2958.1994.tb00420.x; Ray SM, 2004, CLIN INFECT DIS, V38, pS181, DOI 10.1086/381585; Reuter S, 2012, ADV EXP MED BIOL, V954, P15, DOI 10.1007/978-1-4614-3561-7_2; Riley MA, 1999, TRENDS MICROBIOL, V7, P129, DOI 10.1016/S0966-842X(99)01459-6; SAKEN E, 1994, J MED MICROBIOL, V41, P329, DOI 10.1099/00222615-41-5-329; SHAYEGANI M, 1981, J CLIN MICROBIOL, V14, P304, DOI 10.1128/JCM.14.3.304-312.1981; Sihvonen LM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-208; Smarda J, 2006, FOLIA MICROBIOL, V51, P387, DOI 10.1007/BF02931581; Soltan-Dallal M M, 2004, East Mediterr Health J, V10, P152; Stock I, 1999, J ANTIMICROB CHEMOTH, V43, P37, DOI 10.1093/jac/43.1.37; Strauch E, 2001, APPL ENVIRON MICROB, V67, P5634, DOI 10.1128/AEM.67.12.5634-5642.2001; TOORA S, 1994, LETT APPL MICROBIOL, V19, P40, DOI 10.1111/j.1472-765X.1994.tb00899.x; TOORA S, 1995, LETT APPL MICROBIOL, V20, P171, DOI 10.1111/j.1472-765X.1995.tb00419.x; TOORA S, 1995, J APPL BACTERIOL, V78, P224, DOI 10.1111/j.1365-2672.1995.tb05020.x; Vollmer W, 1997, J BACTERIOL, V179, P1580, DOI 10.1128/jb.179.5.1580-1583.1997; Wang X, 2009, EUR J CLIN MICROBIOL, V28, P1237, DOI 10.1007/s10096-009-0773-x; Wauters G, 1987, Contrib Microbiol Immunol, V9, P14; WAUTERS G, 1991, CONTRIB TO MICROBIOL, V12, P239; Wooley RE, 1999, AVIAN DIS, V43, P245, DOI 10.2307/1592614; Zheng HX, 2008, FEMS IMMUNOL MED MIC, V53, P368, DOI 10.1111/j.1574-695X.2008.00436.x	67	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81829	10.1371/journal.pone.0081829	http://dx.doi.org/10.1371/journal.pone.0081829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339971	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400047
J	Braeken, MAKA; Kemp, AH; Outhred, T; Otte, RA; Monsieur, GJYJ; Jones, A; Van den Bergh, BRH				Braeken, Marijke A. K. A.; Kemp, Andrew H.; Outhred, Tim; Otte, Renee A.; Monsieur, Geert J. Y. J.; Jones, Alexander; Van den Bergh, Bea R. H.			Pregnant Mothers with Resolved Anxiety Disorders and Their Offspring Have Reduced Heart Rate Variability: Implications for the Health of Children	PLOS ONE			English	Article							STRESS; BRAIN; PERIOD; TEMPERAMENT; INHIBITION; DEPRESSION; BEHAVIOR; LINKS; RISK; TIME	Objective: Active anxiety disorders have lasting detrimental effects on pregnant mothers and their offspring but it is unknown if historical, non-active, maternal anxiety disorders have similar effects. Anxiety-related conditions, such as reduced autonomic cardiac control, indicated by reduced heart rate variability (HRV) could persist despite disorder resolution, with long-term health implications for mothers and children. The objective in this study is to test the hypotheses that pregnant mothers with a history of, but not current anxiety and their children have low HRV, predicting anxiety-like offspring temperaments. Methods: The participants in this case-control study consist of 56 women during their first trimester and their offspring (15 male, 29 female). Women had a history of an anxiety disorder (n=22) or no psychopathology (n=34) determined using the Mini-International Neuropsychiatric Interview. The main outcome measures were indices of autonomic cardiac control including root mean square of successive differences (RMSSD) and high frequency (HF) variability. Children's fearfulness was also assessed using the Laboratory Temperament Assessment Battery (Lab-TAB)-Locomotor Version. Results: HRV was lower in women and children in the past anxiety group compared to controls. HRV measures for mothers and children were positively correlated in the anxiety group only. In all children, low HRV measures at 2-4 months were associated with a higher chance of fearful behavior at 9-10 months. Conclusions: Pregnant women with previous but not current anxiety and their children have low HRV. Children with low HRV tend to show more fearfulness. These findings have implications for identifying children at risk of anxiety disorders and point to possible underlying mechanisms of child psychopathology.	[Braeken, Marijke A. K. A.; Otte, Renee A.; Van den Bergh, Bea R. H.] Tilburg Univ, Dept Dev Psychol, NL-5000 LE Tilburg, Netherlands; [Braeken, Marijke A. K. A.] Hasselt Univ, Fac Med & Life Sci, Biomed Res Inst, REVAL Rehabil Res Ctr, Hasselt, Belgium; [Kemp, Andrew H.; Outhred, Tim] Univ Sydney, Sch Psychol, SCAN Res & Teaching Unit, Sydney, NSW 2006, Australia; [Kemp, Andrew H.; Outhred, Tim] Univ Sydney, Sydney Med Sch, Discipline Psychiat, CADE Clin, Sydney, NSW 2006, Australia; [Kemp, Andrew H.] Univ Sao Paulo, Univ Hosp, Sao Paulo, Brazil; [Monsieur, Geert J. Y. J.] Tilburg Univ, ERISS, Dept Informat Management, NL-5000 LE Tilburg, Netherlands; [Monsieur, Geert J. Y. J.] Katholieke Univ Leuven, Dept Informat Management, LIRIS, Louvain, Belgium; [Jones, Alexander] UCL, Inst Cardiovasc Sci, London, England; [Van den Bergh, Bea R. H.] Katholieke Univ Leuven, Dept Psychol, Louvain, Belgium	Tilburg University; Hasselt University; University of Sydney; University of Sydney; Universidade de Sao Paulo; Tilburg University; KU Leuven; University of London; University College London; KU Leuven	Van den Bergh, BRH (corresponding author), Tilburg Univ, Dept Dev Psychol, NL-5000 LE Tilburg, Netherlands.	bea.vdnbergh@tilburguniversity.edu	Otte, Renée/B-7559-2016; Kemp, Andrew Haddon/C-7984-2012; Van den Bergh, Bea R.H R.H./H-8126-2013	Kemp, Andrew Haddon/0000-0003-1146-3791; Van den Bergh, Bea R.H R.H./0000-0002-1560-6545; Outhred, Tim/0000-0003-2534-3635	EuroSTRESS programme of The European Science Foundation (ESF); Brain and Cognition Programme of the Netherlands Organisation for Scientific Research (NWO)	EuroSTRESS programme of The European Science Foundation (ESF); Brain and Cognition Programme of the Netherlands Organisation for Scientific Research (NWO)	The PELS study is funded by the EuroSTRESS programme of The European Science Foundation (ESF) and the Brain and Cognition Programme of the Netherlands Organisation for Scientific Research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksan N, 2004, CHILD DEV, V75, P1477, DOI 10.1111/j.1467-8624.2004.00752.x; Alder J, 2007, J MATERN-FETAL NEO M, V20, P189, DOI 10.1080/14767050701209560; [Anonymous], 1980, HANDLEIDING BIJ ZELF; Benitez D, 2001, COMPUT BIOL MED, V31, P399, DOI 10.1016/S0010-4825(01)00009-9; Bergman K, 2007, J AM ACAD CHILD PSY, V46, P1454, DOI 10.1097/chi.0b013e31814a62f6; BERNTSON GG, 1990, PSYCHOPHYSIOLOGY, V27, P586, DOI 10.1111/j.1469-8986.1990.tb01982.x; Blom EH, 2010, ACTA PAEDIATR, V99, P604, DOI 10.1111/j.1651-2227.2009.01657.x; Calkins SD., 2012, HDB TEMPERAMENT, P229; Camm AJ, 1996, CIRCULATION, V93, P1043; Corp IBM, 2010, IBM SPSS STAT WIND V; Degnan KA, 2010, J CHILD PSYCHOL PSYC, V51, P497, DOI 10.1111/j.1469-7610.2010.02228.x; Dierckx B, 2009, PSYCHOSOM MED, V71, P313, DOI 10.1097/PSY.0b013e318198a82c; DiPietro JA, 2000, DEV PSYCHOBIOL, V37, P221, DOI 10.1002/1098-2302(2000)37:4<221::AID-DEV2>3.0.CO;2-A; Friedman BH, 1998, BIOL PSYCHOL, V47, P243, DOI 10.1016/S0301-0511(97)00027-6; Gatt JM, 2009, MOL PSYCHIATR, V14, P681, DOI 10.1038/mp.2008.143; Goedhart AD, 2007, PSYCHOPHYSIOLOGY, V44, P203, DOI 10.1111/j.1469-8986.2006.00490.x; Goldsmith H. H., 1999, LAB TEMPERAMENT ASSE; Hanson CS, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00259; KAGAN J, 1987, CHILD DEV, V58, P1459, DOI 10.1111/j.1467-8624.1987.tb03858.x; Kagan J., 1982, MEASURING EMOTIONS I, P38; Kemp AH, INT J PSYCH IN PRESS; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kessler RC, 2006, INT J METH PSYCH RES, V21, P169; Lee SSH, 2011, ASIAN AMER HIST CULT, P203; Licht CMM, 2008, ARCH GEN PSYCHIAT, V65, P1358, DOI 10.1001/archpsyc.65.12.1358; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Matthews SG, 2010, ENDOCRINOLOGY, V151, P7, DOI 10.1210/en.2009-0916; Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006; Monk C, 2004, J AM ACAD CHILD PSY, V43, P283, DOI 10.1097/00004583-200403000-00009; Otte RA, 2013, BIOL PSYCHOL, V92, P315, DOI 10.1016/j.biopsycho.2012.09.009; Pittig A, 2013, INT J PSYCHOPHYSIOL, V87, P19, DOI 10.1016/j.ijpsycho.2012.10.012; Raikkonen K, 2011, STRESS, V14, P590, DOI 10.3109/10253890.2011.602147; Rapee RM, 2002, BIOL PSYCHIAT, V52, P947, DOI 10.1016/S0006-3223(02)01572-X; Rettew DC, 2005, HARVARD REV PSYCHIAT, V13, P14, DOI 10.1080/10673220590923146; Ross LE, 2006, J CLIN PSYCHIAT, V67, P1285, DOI 10.4088/JCP.v67n0818; Rutter M, 2002, CHILD DEV, V73, DOI 10.1111/1467-8624.00388; Sheehan D. V., 2010, MINI INT NEUROPSYCHI; Stern DN., 2009, 1 RELATIONSHIP INFAN; Taelman J, 2009, IFMBE PROC, V22, P1366; Thayer JF, 2000, PSYCHOPHYSIOLOGY, V37, P361, DOI 10.1111/1469-8986.3730361; Thayer JF, 2006, ANN NY ACAD SCI, V1088, P361, DOI 10.1196/annals.1366.014; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thoemmes F, 2012, PROPENSITY SCORE MAT; Van den Bergh BRH, 2011, DEV MED CHILD NEUROL, V53, P19, DOI 10.1111/j.1469-8749.2011.04057.x; Van den Bergh BRH, 2005, NEUROSCI BIOBEHAV R, V29, P237, DOI 10.1016/j.neubiorev.2004.10.007; Vlemincx E, 2011, PSYCHOPHYSIOLOGY, V48, P117, DOI 10.1111/j.1469-8986.2010.01043.x; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Young JB, 2002, TRENDS ENDOCRIN MET, V13, P381, DOI 10.1016/S1043-2760(02)00661-6	50	16	16	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83186	10.1371/journal.pone.0083186	http://dx.doi.org/10.1371/journal.pone.0083186			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VW	24340091	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400125
J	Linz, B; Windsor, HM; Gajewski, JP; Hake, CM; Drautz, DI; Schuster, SC; Marshall, BJ				Linz, Bodo; Windsor, Helen M.; Gajewski, John P.; Hake, Caylie M.; Drautz, Daniela I.; Schuster, Stephan C.; Marshall, Barry J.			Helicobacter pylori Genomic Microevolution during Naturally Occurring Transmission between Adults	PLOS ONE			English	Article							GASTRIC COLONIZATION; INFECTION; STRAINS; ACQUISITION; POPULATION; PREVALENCE; DIVERSITY; EVOLUTION; PATIENT; HUMANS	The human gastric pathogen Helicobacter pylori is usually acquired during childhood and, in the absence of treatment, chronic infection persists through most of the host's life. However, the frequency and importance of H. pylori transmission between adults is underestimated. Here we sequenced the complete genomes of H. pylori strains that were transmitted between spouses and analysed the genomic changes. Similar to H. pylori from chronic infection, a significantly high proportion of the determined 31 SNPs and 10 recombinant DNA fragments affected genes of the hop family of outer membrane proteins, some of which are known to be adhesins. In addition, changes in a fucosyltransferase gene modified the LPS component of the bacterial cell surface, suggesting strong diversifying selection. In contrast, virulence factor genes were not affected by the genomic changes. We propose a model of the genomic changes that are associated with the transmission and adaptation of H. pylori to a new human host.	[Linz, Bodo; Gajewski, John P.; Schuster, Stephan C.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Linz, Bodo; Gajewski, John P.; Hake, Caylie M.; Drautz, Daniela I.; Schuster, Stephan C.; Marshall, Barry J.] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Windsor, Helen M.; Marshall, Barry J.] Univ Western Australia, Sch Pathol, Crawley, WA, Australia; [Drautz, Daniela I.; Schuster, Stephan C.] Nanyang Technol Univ, Singapore Ctr Environm Life Sci Engn, Singapore 639798, Singapore	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Western Australia; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Linz, B (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.	BXL29@PSU.EDU		Marshall, Barry/0000-0003-4853-5015	Australian National Health and Medical Research Council; University of Western Australia; Ondek Company, Australia; Pennsylvania State University	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); University of Western Australia; Ondek Company, Australia; Pennsylvania State University	This work was supported by the Australian National Health and Medical Research Council (to BJM, HMW), by the University of Western Australia Vice Chancellor's fund (to BJM), by the Ondek Company, Australia (to BJM), and by the Francis R. and Helen M. Pentz Professor of Science Award of the Pennsylvania State University (to BJM, BL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKOPYANZ N, 1992, NUCLEIC ACIDS RES, V20, P5137, DOI 10.1093/nar/20.19.5137; Alvi A, 2007, J CLIN MICROBIOL, V45, P4039, DOI 10.1128/JCM.01631-07; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Carroll IM, 2004, J MED MICROBIOL, V53, P669, DOI 10.1099/jmm.0.05440-0; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Feldman RA, 1998, BRIT MED BULL, V54, P39; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Ghai R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-198; Ghose C, 2005, J CLIN MICROBIOL, V43, P2635, DOI 10.1128/JCM.43.6.2635-2641.2005; Gibson JR, 1998, J CLIN MICROBIOL, V36, P2580, DOI 10.1128/JCM.36.9.2580-2585.1998; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Kang J, 2006, NAT REV MICROBIOL, V4, P826, DOI 10.1038/nrmicro1528; Kennemann L, 2011, P NATL ACAD SCI USA, V108, P5033, DOI 10.1073/pnas.1018444108; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kivi M, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-54; Kraft C, 2006, J BACTERIOL, V188, P249, DOI 10.1128/JB.188.1.249-254.2006; Kuo CH, 1999, J INFECT DIS, V180, P2064, DOI 10.1086/315130; Lee JYH, 2001, GUT, V49, pA31; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Logan SM, 2000, MOL MICROBIOL, V35, P1156, DOI 10.1046/j.1365-2958.2000.01784.x; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MARSHALL BJ, 1985, MED J AUSTRALIA, V142, P436, DOI 10.5694/j.1326-5377.1985.tb113443.x; Moodley Y, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002693; Moodley Y, 2009, SCIENCE, V323, P527, DOI 10.1126/science.1166083; Morales-Espinosa R, 1999, J CLIN MICROBIOL, V37, P3001, DOI 10.1128/JCM.37.9.3001-3004.1999; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Mourad-Baars P, 2010, HELICOBACTER, V15, P53, DOI 10.1111/j.1523-5378.2010.00776.x; Muhsen K, 2012, J TROP PEDIATRICS, V58, P208, DOI 10.1093/tropej/fmr068; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Oleastro M, 2011, HELICOBACTER, V16, P363, DOI 10.1111/j.1523-5378.2011.00858.x; Patra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043370; Prouzet-Mauleon V, 2005, J CLIN MICROBIOL, V43, P4237, DOI 10.1128/JCM.43.8.4237-4241.2005; Raymond J, 2004, EMERG INFECT DIS, V10, P1816, DOI 10.3201/eid1010.040042; Raymond J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002259; Schuster Stephan C., 2008, P193; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Soltani J, 2013, IRAN J PEDIATR, V23, P13	39	25	27	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82187	10.1371/journal.pone.0082187	http://dx.doi.org/10.1371/journal.pone.0082187			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340004	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400063
J	Preissner, SC; Hoffmann, MF; Preissner, R; Dunkel, M; Gewiess, A; Preissner, S				Preissner, Sarah C.; Hoffmann, Michael F.; Preissner, Robert; Dunkel, Mathias; Gewiess, Andreas; Preissner, Saskia			Polymorphic Cytochrome P450 Enzymes (CYPs) and Their Role in Personalized Therapy	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; CLOPIDOGREL-TREATED PATIENTS; DRUG-INTERACTIONS; CYP2C19 GENOTYPE; ALLELIC VARIANT; GENE-THERAPY; CANCER RISK; CYP2D6; ACTIVATION; EXPRESSION	The cytochrome P450 (CYP) enzymes are major players in drug metabolism. More than 2,000 mutations have been described, and certain single nucleotide polymorphisms (SNPs) have been shown to have a large impact on CYP activity. Therefore, CYPs play an important role in inter-individual drug response and their genetic variability should be factored into personalized medicine. To identify the most relevant polymorphisms in human CYPs, a text mining approach was used. We investigated their frequencies in different ethnic groups, the number of drugs that are metabolized by each CYP, the impact of CYP SNPs, as well as CYP expression patterns in different tissues. The most important polymorphic CYPs were found to be 1A2, 2D6, 2C9 and 2C19. Thirty-four common allele variants in Caucasians led to altered enzyme activity. To compare the relevant Caucasian SNPs with those of other ethnicities a search in 1,000 individual genomes was undertaken. We found 199 non-synonymous SNPs with frequencies over one percent in the 1,000 genomes, many of them not described so far. With knowledge of frequent mutations and their impact on CYP activities, it may be possible to predict patient response to certain drugs, as well as adverse side effects. With improved availability of genotyping, our data may provide a resource for an understanding of the effects of specific SNPs in CYPs, enabling the selection of a more personalized treatment regimen.	[Preissner, Sarah C.; Hoffmann, Michael F.; Preissner, Robert; Dunkel, Mathias; Preissner, Saskia] Charite, ECRC Struct Bioinformat Grp, DKTK, D-13353 Berlin, Germany; [Gewiess, Andreas] Inst Lab Med, Berlin, Germany; [Preissner, Saskia] Charite, CC3, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Preissner, S (corresponding author), Charite, ECRC Struct Bioinformat Grp, DKTK, D-13353 Berlin, Germany.	saskia.preissner@charite.de		preissner, robert/0000-0002-2407-1087; Dunkel, Mathias/0000-0002-6642-483X	BMBF ImmunoTox; European Union Seventh Framework Programme SYNSYS (Synaptic Systems: dissecting brain function in health and disease); DKTK	BMBF ImmunoTox; European Union Seventh Framework Programme SYNSYS (Synaptic Systems: dissecting brain function in health and disease); DKTK	This work was supported by: BMBF ImmunoTox, European Union Seventh Framework Programme SYNSYS (Synaptic Systems: dissecting brain function in health and disease), DKTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT A, 1958, NATURE, V182, P421, DOI 10.1038/182421a0; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Angiolillo DJ, 2007, J AM COLL CARDIOL, V49, P1505, DOI 10.1016/j.jacc.2006.11.044; Berka K, 2011, J PHYS CHEM A, V115, P11248, DOI 10.1021/jp204488j; Bradford LD, 2002, PHARMACOGENOMICS, V3, P229, DOI 10.1517/14622416.3.2.229; Culhane AC, 2010, NUCLEIC ACIDS RES, V38, pD716, DOI 10.1093/nar/gkp1015; Dai Ze-long, 2012, Zhong Xi Yi Jie He Xue Bao, V10, P647; De Leon J, 2006, PSYCHOSOMATICS, V47, P75, DOI 10.1176/appi.psy.47.1.75; de Leon J, 2009, CNS SPECTRUMS, V14, P19, DOI 10.1017/S1092852900020022; de Leon J, 2009, PHARMACOL RES, V59, P81, DOI 10.1016/j.phrs.2008.10.002; Deenen MJ, 2011, ONCOLOGIST, V16, P820, DOI 10.1634/theoncologist.2010-0259; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Dupont AG, 2009, THROMB RES, V124, P6, DOI 10.1016/j.thromres.2009.01.014; Fernandez-Santander A, 2012, CLIN TRANSL ONCOL, V14, P157, DOI 10.1007/s12094-012-0776-4; Flockhart DA, 2000, CHILD ADOL PSYCH CL, V9, P43; Grover S, 2012, CNS NEUROSCI THER, V18, P705, DOI 10.1111/j.1755-5949.2012.00343.x; Guengerich FP, 2008, CHEM RES TOXICOL, V21, P70, DOI 10.1021/tx700079z; Guengerich FP, 1998, MUTAT RES-FUND MOL M, V400, P201; Hasler J A, 1999, Mol Aspects Med, V20, P12; Hulot JS, 2010, J AM COLL CARDIOL, V56, P134, DOI 10.1016/j.jacc.2009.12.071; Huo R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034809; Huttunen KM, 2008, CURR MED CHEM, V15, P2346, DOI 10.2174/092986708785909120; Ingelman-Sundberg M, 2007, PHARMACOL THERAPEUT, V116, P496, DOI 10.1016/j.pharmthera.2007.09.004; Ingelman-Sundberg Magnus, 2005, Toxicol Appl Pharmacol, V207, P52; Johnson M, 2006, CNS SPECTRUMS, V11, P757, DOI 10.1017/S1092852900014887; Jounaidi Y, 2006, MOL CANCER THER, V5, P541, DOI 10.1158/1535-7163.MCT-05-0321; Kassimis G, 2012, THROMB RES, V129, P441, DOI 10.1016/j.thromres.2011.07.022; Kim S, 2011, BLOOD PRESSURE, V9, P7; Kirchheiner J, 2001, ACTA PSYCHIAT SCAND, V104, P173, DOI 10.1034/j.1600-0447.2001.00299.x; Kirchheiner J, 2004, MOL PSYCHIATR, V9, P442, DOI 10.1038/sj.mp.4001494; Laine K, 2004, THER DRUG MONIT, V26, P685, DOI 10.1097/00007691-200412000-00016; Matetzky S, 2004, CIRCULATION, V109, P3171, DOI 10.1161/01.CIR.0000130846.46168.03; McGraw J, 2012, EXPERT OPIN DRUG MET, V8, P371, DOI 10.1517/17425255.2012.657626; McLean KJ, 2005, BIOCHEM SOC T, V33, P796, DOI 10.1042/BST0330796; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mrozikiewicz P, 2011, GINEKOL POL, V82, P925; Nishimura M, 2003, YAKUGAKU ZASSHI, V123, P369; Papp-Jambor C, 2002, ANAESTHESIST, V51, P2, DOI 10.1007/s101-002-8365-5; Patterson LH, 1999, ANTI-CANCER DRUG DES, V14, P473; Penas-Lledo EM, 2012, PHARMACOGENOMICS, V13, P179, DOI [10.2217/PGS.11.146, 10.2217/pgs.11.146]; Pettersen AAR, 2011, THROMB J, V9, DOI 10.1186/1477-9560-9-4; Preissner S, 2010, NUCLEIC ACIDS RES, V38, pD237, DOI 10.1093/nar/gkp970; RAETHER W, 1978, ANN TROP MED PARASIT, V72, P543, DOI 10.1080/00034983.1978.11719358; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Relling MV, 2011, CLIN PHARMACOL THER, V89, P464, DOI 10.1038/clpt.2010.279; Roots I, 2007, E SCHERING RES FDN W, V59, P81; Roth RB, 2006, NEUROGENETICS, V7, P67, DOI 10.1007/s10048-006-0032-6; Ruwali M, 2010, INDIAN J EXP BIOL, V48, P651; Sata F, 2000, CLIN PHARMACOL THER, V67, P48, DOI 10.1067/mcp.2000.104391; Savi P, 2005, SEMIN THROMB HEMOST, V31, P174, DOI 10.1055/s-2005-869523; Seeringer A, 2008, CLIN LAB MED, V28, P619, DOI 10.1016/j.cll.2008.05.006; Sergentanis TN, 2012, MOL BIOL REP, V39, P9921, DOI 10.1007/s11033-012-1860-0; Shalapour S, 2011, HAEMATOL-HEMATOL J, V96, P1627, DOI 10.3324/haematol.2011.047993; Sibbing D, 2010, CIRCULATION, V121, P512, DOI 10.1161/CIRCULATIONAHA.109.885194; Sim Sarah C., 2010, Human Genomics, V4, P278; Sofi F, 2011, PHARMACOGENOMICS J, V11, P199, DOI 10.1038/tpj.2010.21; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Sulem P, 2011, HUM MOL GENET, V20, P2071, DOI 10.1093/hmg/ddr086; Tanabe K, 2012, BIOORG MED CHEM LETT, V22, P1682, DOI 10.1016/j.bmcl.2011.12.106; Tazaki J, 2012, J ATHEROSCLER THROMB, V19, P186, DOI 10.5551/jat.10009; Topf N, 1998, GENE THER, V5, P507, DOI 10.1038/sj.gt.3300611; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Zhou SF, 2009, DRUG METAB REV, V41, P89, DOI 10.1080/03602530902843483	66	110	115	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82562	10.1371/journal.pone.0082562	http://dx.doi.org/10.1371/journal.pone.0082562			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340040	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000328707400081
J	Boone, D; Mallett, S; Zhu, SH; Yao, GL; Bell, N; Ghanouni, A; von Wagner, C; Taylor, SA; Altman, DG; Lilford, R; Halligan, S				Boone, Darren; Mallett, Susan; Zhu, Shihua; Yao, Guiqing Lily; Bell, Nichola; Ghanouni, Alex; von Wagner, Christian; Taylor, Stuart A.; Altman, Douglas G.; Lilford, Richard; Halligan, Steve			Patients' & Healthcare Professionals' Values Regarding True- & False-Positive Diagnosis when Colorectal Cancer Screening by CT Colonography: Discrete Choice Experiment	PLOS ONE			English	Article							CONJOINT-ANALYSIS APPLICATIONS; COMPUTER-AIDED DETECTION; HANDS-ON GUIDE; PREFERENCES; COLONOSCOPY; MAMMOGRAPHY; QUESTIONNAIRE; PERFORMANCE; TRIAL	Purpose:To establish the relative weighting given by patients and healthcare professionals to gains in diagnostic sensitivity versus loss of specificity when using CT colonography (CTC) for colorectal cancer screening. Materials and Methods: Following ethical approval and informed consent, 75 patients and 50 healthcare professionals undertook a discrete choice experiment in which they chose between "standard" CTC and "enhanced" CTC that raised diagnostic sensitivity 10% for either cancer or polyps in exchange for varying levels of specificity. We established the relative increase in false-positive diagnoses participants traded for an increase in true-positive diagnoses. Results: Data from 122 participants were analysed. There were 30 (25%) non-traders for the cancer scenario and 20 (16%) for the polyp scenario. For cancer, the 10% gain in sensitivity was traded up to a median 45% (IQR 25 to >85) drop in specificity, equating to 2250 (IQR 1250 to >4250) additional false-positives per additional true-positive cancer, at 0.2% prevalence. For polyps, the figure was 15% (IQR 7.5 to 55), equating to 6 (IQR 3 to 22) additional false-positives per additional true-positive polyp, at 25% prevalence. Tipping points were significantly higher for patients than professionals for both cancer (85 vs 25, p<0.001) and polyps (55 vs 15, p<0.001). Patients were willing to pay significantly more for increased sensitivity for cancer (p = 0.021). Conclusion: When screening for colorectal cancer, patients and professionals believe gains in true-positive diagnoses are worth much more than the negative consequences of a corresponding rise in false-positives. Evaluation of screening tests should account for this.	[Boone, Darren; Bell, Nichola; Taylor, Stuart A.; Halligan, Steve] UCL, Ctr Med Imaging, London, England; [Mallett, Susan] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England; [Zhu, Shihua; Lilford, Richard] Univ Birmingham, Dept Publ Hlth & Epidemiol, Birmingham, W Midlands, England; [Yao, Guiqing Lily] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England; [Ghanouni, Alex; von Wagner, Christian] UCL, Dept Epidemiol & Publ Hlth, London, England; [Altman, Douglas G.] Univ Oxford, Ctr Stat Med, Oxford, England	University of London; University College London; University of Oxford; University of Birmingham; University of Southampton; University of London; University College London; University of Oxford	Halligan, S (corresponding author), UCL, Ctr Med Imaging, London, England.	s.halligan@ucl.ac.uk	Halligan, Steve/C-5875-2009; Mallett, Sue/GPS-9933-2022	Halligan, Steve/0000-0003-0632-5108; Lilford, Richard/0000-0002-0634-984X; Von Wagner, Christian/0000-0002-7971-0691; Mallett, Sue/0000-0002-0596-8200; Taylor, Stuart/0000-0002-6765-8806	UK National Institute for Health Research (NIHR) [RP-PG-0407-10338]; NIHR Biomedical Research Centre; Cancer Research UK [14134] Funding Source: researchfish; National Institute for Health Research [RP-PG-0407-10338, NF-SI-0611-10008] Funding Source: researchfish	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by the UK National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0407-10338). The views expressed are those of the authors and not necessarily those of the UK NHS, the NIHR, or the Department of Health. A proportion of this work was undertaken at UCL and UCLH, who receive a proportion of funding from the NIHR Biomedical Research Centre funding scheme.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; Arnold D, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2688; Boynton PM, 2004, BMJ-BRIT MED J, V328, P1433, DOI 10.1136/bmj.328.7453.1433; Boynton PM, 2004, BRIT MED J, V328, P1312, DOI 10.1136/bmj.328.7451.1312; Bridges JFP, 2011, VALUE HEALTH, V14, P403, DOI 10.1016/j.jval.2010.11.013; Dachman AH, 2010, RADIOLOGY, V256, P827, DOI 10.1148/radiol.10091890; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Dhruva SS, 2009, NEW ENGL J MED, V360, P2699, DOI 10.1056/NEJMp0904408; Eng J, 2003, RADIOLOGY, V227, P309, DOI 10.1148/radiol.2272012051; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Gatta G, 2000, GUT, V47, P533, DOI 10.1136/gut.47.4.533; Ghanouni A, 2012, PATIENT EDUC COUNS, V89, P116, DOI 10.1016/j.pec.2012.05.007; Halligan S, 2010, RADIOLOGY; Halligan S, 2006, GASTROENTEROLOGY, V131, P1690, DOI 10.1053/j.gastro.2006.09.051; Halligan S, 2011, RADIOLOGY, V258, P469, DOI 10.1148/radiol.10100354; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Lucas NP, 2010, J CLIN EPIDEMIOL, V63, P854, DOI 10.1016/j.jclinepi.2009.10.002; Mallett S, 2006, BMJ-BRIT MED J, V333, P413, DOI 10.1136/bmj.38895.467130.55; Mallett S, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3999; Marshall D, 2010, PATIENT, V3, P249, DOI 10.2165/11539650-000000000-00000; Marshall DA, 2007, VALUE HEALTH, V10, P415, DOI 10.1111/j.1524-4733.2007.00196.x; METZ CE, 1989, INVEST RADIOL, V24, P234, DOI 10.1097/00004424-198903000-00012; Metz Charles E, 2006, J Am Coll Radiol, V3, P413, DOI 10.1016/j.jacr.2006.02.021; Moons KGM, 1997, MED DECIS MAKING, V17, P447, DOI 10.1177/0272989X9701700410; Nayaradou M, 2010, MED DECIS MAKING, V30, P224, DOI 10.1177/0272989X09342747; Ozdemir S, 2010, HEALTH ECON, V19, P111, DOI 10.1002/hec.1452; Pisani P, 2002, INT J CANCER, V97, P72, DOI 10.1002/ijc.1571; Robinson MHE, 1999, GUT, V45, P588, DOI 10.1136/gut.45.4.588; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Ryan M, 2001, Health Technol Assess, V5, P1; Ryan M, 2001, QUAL HEALTH CARE, V10, pI55; Salz T, 2010, PSYCHO-ONCOLOGY, V19, P1026, DOI 10.1002/pon.1676; Schoenfeld P, 2005, NEW ENGL J MED, V352, P2061, DOI 10.1056/NEJMoa042990; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Shiraishi J, 2009, RADIOLOGY, V253, P822, DOI 10.1148/radiol.2533081632; Skaane P, 2007, RADIOLOGY, V244, P708, DOI 10.1148/radiol.2443061478; Spiegelhalter D, 2011, SCIENCE, V333, P1393, DOI 10.1126/science.1191181; Steele RJC, 2004, BMJ-BRIT MED J, V329, P133, DOI 10.1136/bmj.38153.491887.7C; Summers RM, 2005, GASTROENTEROLOGY, V129, P1832, DOI 10.1053/j.gastro.2005.08.054; Von Wagner C, 2009, BRIT J RADIOL, V82, P13, DOI 10.1259/bjr/61732956; von Wagner C, 2009, HEALTH EXPECT, V12, P18, DOI 10.1111/j.1369-7625.2008.00520.x; Watson V, 2011, J PUBLIC HLTH OXF; Winawer SJ, 2007, BEST PRACT RES CL GA, V21, P1031, DOI 10.1016/j.bpg.2007.09.004; Yankaskas BC, 2005, RADIOLOGY, V234, P363, DOI 10.1148/radiol.2342040048; Yi D, 2011, EUR J PAIN, V15, DOI 10.1016/j.ejpain.2010.10.008	45	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80767	10.1371/journal.pone.0080767	http://dx.doi.org/10.1371/journal.pone.0080767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349014	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328705200011
J	Bari, BA; Ollerenshaw, DR; Millard, DC; Wang, Q; Stanley, GB				Bari, Bilal A.; Ollerenshaw, Douglas R.; Millard, Daniel C.; Wang, Qi; Stanley, Garrett B.			Behavioral and Electrophysiological Effects of Cortical Microstimulation Parameters	PLOS ONE			English	Article							RAT BARREL CORTEX; INTRACORTICAL MICROSTIMULATION; THALAMIC MICROSTIMULATION; ELECTRICAL-STIMULATION; VISUAL-CORTEX; SUSPECTED INTERNEURONS; SOMATOSENSORY CORTEX; AXONAL PROPERTIES; RECEPTIVE-FIELDS; EFFERENT NEURONS	Electrical microstimulation has been widely used to artificially activate neural circuits on fast time scales. Despite the ubiquity of its use, little is known about precisely how it activates neural pathways. Current is typically delivered to neural tissue in a manner that provides a locally balanced injection of positive and negative charge, resulting in negligible net charge delivery to avoid the neurotoxic effects of charge accumulation. Modeling studies have suggested that the most common approach, using a temporally symmetric current pulse waveform as the base unit of stimulation, results in preferential activation of axons, causing diffuse activation of neurons relative to the stimulation site. Altering waveform shape and using an asymmetric current pulse waveform theoretically reverses this bias and preferentially activates cell bodies, providing increased specificity. In separate studies, measurements of downstream cortical activation from sub-cortical microstimulation are consistent with this hypothesis, as are recent measurements of behavioral detection threshold currents from cortical microstimulation. Here, we compared the behavioral and electrophysiological effects of symmetric vs. asymmetric current waveform shape in cortical microstimulation. Using a go/no-go behavioral task, we found that microstimulation waveform shape significantly shifts psychometric performance, where a larger current pulse was necessary when applying an asymmetric waveform to elicit the same behavioral response, across a large range of behaviorally relevant current amplitudes. Using voltage-sensitive dye imaging of cortex in anesthetized animals with simultaneous cortical microstimulation, we found that altering microstimulation waveform shape shifted the cortical activation in a manner that mirrored the behavioral results. Taken together, these results are consistent with the hypothesis that asymmetric stimulation preferentially activates cell bodies, albeit at a higher threshold, as compared to symmetric stimulation. These findings demonstrate the sensitivity of the pathway to varying electrical stimulation parameters and underscore the importance of designing electrical stimuli for optimal activation of neural circuits.	[Stanley, Garrett B.] Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; Emory Univ, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Stanley, GB (corresponding author), Georgia Inst Technol, Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	garrett.stanley@bme.gatech.edu		Stanley, Garrett/0000-0003-2039-7706; Bari, Bilal/0000-0002-8381-3802	National Institute of Neurological Disorders and Stroke Grant [2R01-NS-048285]; National Institutes of Health Ruth L. Kirschstein National Research Service Award [F31-NS-074797]; National Science Foundation Graduate Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085447, R01NS048285, F31NS074797] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Neurological Disorders and Stroke Grant 2R01-NS-048285 to G.B. Stanley. D.R. Ollerenshaw is supported by National Institutes of Health Ruth L. Kirschstein National Research Service Award F31-NS-074797. D.C. Millard is supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi M, 2011, J NEUROPHYSIOL, V105, P356, DOI 10.1152/jn.00794.2010; Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006; BRINDLEY GS, 1968, J PHYSIOL-LONDON, V196, P479, DOI 10.1113/jphysiol.1968.sp008519; Butovas S, 2003, J NEUROPHYSIOL, V90, P3024, DOI 10.1152/jn.00245.2003; Butovas S, 2007, EUR J NEUROSCI, V25, P2161, DOI 10.1111/j.1460-9568.2007.05449.x; Butovas S, 2006, J NEUROPHYSIOL, V96, P1227, DOI 10.1152/jn.01170.2005; Deliano M, 2009, J NEUROSCI, V29, P15898, DOI 10.1523/JNEUROSCI.1949-09.2009; DeYoe EA, 2005, J NEUROPHYSIOL, V94, P3443, DOI 10.1152/jn.00407.2005; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Fridman GY, 2010, EXP BRAIN RES, V203, P499, DOI 10.1007/s00221-010-2254-y; GANTZ BJ, 1988, OTOLARYNG HEAD NECK, V98, P72, DOI 10.1177/019459988809800113; Gao PH, 2003, SOMATOSENS MOT RES, V20, P191, DOI 10.1080/08990220310001622924; Graziano MSA, 2002, NEURON, V34, P841, DOI 10.1016/S0896-6273(02)00698-0; Grill WM, 2005, CLIN NEUROPHYSIOL, V116, P1227, DOI 10.1016/j.clinph.2004.12.020; Hentschke H, 2006, CEREB CORTEX, V16, P1142, DOI 10.1093/cercor/bhj056; Histed MH, 2009, NEURON, V63, P508, DOI 10.1016/j.neuron.2009.07.016; Horsager A, 2010, INVEST OPHTH VIS SCI, V51, P1223, DOI 10.1167/iovs.09-3746; Houweling AR, 2008, NATURE, V451, P65, DOI 10.1038/nature06447; Koivuniemi AS, 2012, IEEE ENG MED BIO, P2489, DOI 10.1109/EMBC.2012.6346469; Koivuniemi AS, 2011, IEEE T NEUR SYS REH, V19, P468, DOI 10.1109/TNSRE.2011.2166563; McCreery D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036005; McIntyre CC, 2000, ANN BIOMED ENG, V28, P219, DOI 10.1114/1.262; Moore T, 2003, NATURE, V421, P370, DOI 10.1038/nature01341; Nadig MN, 1999, CLIN NEUROPHYSIOL, V110, P1545, DOI 10.1016/S1388-2457(99)00027-9; O'Connor DH, 2010, J NEUROSCI, V30, P1947, DOI 10.1523/JNEUROSCI.3762-09.2010; Oberlaender M, 2012, CEREB CORTEX, V22, P2375, DOI 10.1093/cercor/bhr317; Ohara S, 2004, J NEUROPHYSIOL, V91, P736, DOI 10.1152/jn.00648.2003; Ollerenshaw DR, 2012, J NEUROPHYSIOL, V108, P479, DOI 10.1152/jn.00004.2012; Patel S, 2006, J NEUROPHYSIOL, V95, P646, DOI 10.1152/jn.00756.2005; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; Pezaris JS, 2007, P NATL ACAD SCI USA, V104, P7670, DOI 10.1073/pnas.0608563104; Pezaris JS, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0986; Richard A N, 2009, J NEURAL ENG, V6, DOI DOI 10.1088/1741-2560/6/3/035001.PUBMED:19458403; Romo R, 1998, NATURE, V392, P387, DOI 10.1038/32891; Romo R, 2000, NEURON, V26, P273, DOI 10.1016/S0896-6273(00)81156-3; SALZMAN CD, 1990, NATURE, V346, P174, DOI 10.1038/346174a0; Schwarz C, 2010, SOMATOSENS MOT RES, V27, P131, DOI 10.3109/08990220.2010.513111; Stanley GB, 2013, NAT NEUROSCI, V16, P259, DOI 10.1038/nn.3330; STONEY SD, 1968, J NEUROPHYSIOL, V31, P659, DOI 10.1152/jn.1968.31.5.659; Stuttgen MC, 2006, J NEUROSCI, V26, P7933, DOI 10.1523/JNEUROSCI.1864-06.2006; SWADLOW HA, 1994, J NEUROPHYSIOL, V71, P437, DOI 10.1152/jn.1994.71.2.437; SWADLOW HA, 1990, J NEUROPHYSIOL, V63, P1477, DOI 10.1152/jn.1990.63.6.1477; SWADLOW HA, 1981, J COMP NEUROL, V203, P799, DOI 10.1002/cne.902030415; Tehovnik EJ, 2009, PROG BRAIN RES, V175, P347, DOI 10.1016/S0079-6123(09)17524-6; Tehovnik EJ, 1996, J NEUROSCI METH, V65, P1, DOI 10.1016/0165-0270(95)00131-X; Tolias AS, 2005, NEURON, V48, P901, DOI 10.1016/j.neuron.2005.11.034; Wang Q, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026008; Yang Y, 2008, NAT NEUROSCI, V11, P1262, DOI 10.1038/nn.2211	49	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82170	10.1371/journal.pone.0082170	http://dx.doi.org/10.1371/journal.pone.0082170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340002	Green Published, gold			2022-12-27	WOS:000328566100090
J	Cosby, MT; Pimentel, G; Nevin, RL; Ahmed, SF; Klena, JD; Amir, E; Younan, M; Browning, R; Sebeny, PJ				Cosby, Michael T.; Pimentel, Guillermo; Nevin, Remington L.; Ahmed, Salwa Fouad; Klena, John D.; Amir, Ehab; Younan, Mary; Browning, Robert; Sebeny, Peter J.			Outbreak of H3N2 Influenza at a US Military Base in Djibouti during the H1N1 Pandemic of 2009	PLOS ONE			English	Article							A(H3N2) VIRUSES; RESISTANCE; SURVEILLANCE; ILLNESS; SITE; PCR	Background: Influenza pandemics have significant operational impact on deployed military personnel working in areas throughout the world. The US Department of Defense global influenza-like illness (ILI) surveillance network serves an important role in establishing baseline trends and can be leveraged to respond to outbreaks of respiratory illness. Objective: We identified and characterized an operationally unique outbreak of H3N2 influenza at Camp Lemonnier, Djibouti occurring simultaneously with the H1N1 pandemic of 2009 [A(H1N1)pdm09]. Methods: Enhanced surveillance for ILI was conducted at Camp Lemonnier in response to local reports of a possible outbreak during the A(H1N1) pdm09 pandemic. Samples were collected from consenting patients presenting with ILI (utilizing a modified case definition) and who completed a case report form. Samples were cultured and analyzed using standard real-time reverse transcriptase PCR (rt-RT-PCR) methodology and sequenced genetic material was phylogenetically compared to other published strains. Results: rt-RT-PCR and DNA sequencing revealed that 25 (78%) of the 32 clinical samples collected were seasonal H3N2 and only 2 (6%) were A(H1N1) pdm09 influenza. The highest incidence of H3N2 occurred during the month of May and 80% of these were active duty military personnel. Phylogenetic analysis revealed that sequenced H3N2 strains were genetically similar to 2009 strains from the United States of America, Australia, and South east Asia. Conclusions: This outbreak highlights challenges in the investigation of influenza among deployed military populations and corroborates the public health importance of maintaining surveillance systems for ILI that can be enhanced locally when needed.	[Cosby, Michael T.; Ahmed, Salwa Fouad; Amir, Ehab; Younan, Mary] US Naval Med Res Unit 3 NAMRU 3, Cairo, Egypt; [Pimentel, Guillermo] Naval Med Res Ctr NMRC Frederick, Ft Detrick, MD USA; [Nevin, Remington L.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Klena, John D.] US Ctr Dis Control & Prevent, Emerging Infect Dis Program, China Off, Beijing, Peoples R China; [Browning, Robert] Walter Reed Natl Mil Med Ctr, Bethesda, MD USA; [Sebeny, Peter J.] Naval Med Res Ctr NMRC, Silver Spring, MD USA	Egyptian Knowledge Bank (EKB); Cairo University; Naval Medical Research Center (NMRC); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Walter Reed National Military Medical Center; Naval Medical Research Center (NMRC)	Nevin, RL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.	rnevin@jhsph.edu	Browning, Robert/GNW-3995-2022	Nevin, Remington/0000-0002-0534-1889	US government [847705.82000.25.GB.E001]; Johns Hopkins University Libraries	US government; Johns Hopkins University Libraries(Johns Hopkins University)	Funding for this work was provided in part by the US government (work unit #847705.82000.25.GB.E001). Publication of this article was funded in part by the Open Access Promotion Fund of the Johns Hopkins University Libraries. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed Y, 2006, ANTIVIR THER, V11, P971; Laguna-Torres VA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006118; Deyde V, 2009, INFLUENZA OTHER RESP, V3, P297, DOI 10.1111/j.1750-2659.2009.00103.x; Earhart KC, 2001, EMERG INFECT DIS, V7, P463, DOI 10.3201/eid0703.017320; Erkoreka Anton, 2009, J Mol Genet Med, V3, P190; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Ghedin E, 2010, J VIROL, V84, P5715, DOI 10.1128/JVI.00018-10; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Jackson D, 2005, J ANTIMICROB CHEMOTH, V55, P162, DOI 10.1093/jac/dkh528; Jeger V, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13307; Johns MC, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0010722, 10.1371/journal.pone.0015801]; Lin YP, 2010, J VIROL, V84, P6769, DOI 10.1128/JVI.00458-10; Liu W, 2010, CLIN INFECT DIS, V50, P1359, DOI 10.1086/652143; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Mayet A, 2011, PUBLIC HEALTH, V125, P494, DOI 10.1016/j.puhe.2011.04.005; Richard M, 2011, ANTIMICROB AGENTS CH, V55, P2942, DOI 10.1128/AAC.01699-10; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seah SGK, 2010, J CLIN VIROL, V47, P289, DOI 10.1016/j.jcv.2009.12.011; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; Steel J, 2011, J VIROL, V85, P1400, DOI 10.1128/JVI.02186-10; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Swerdlow DL, 2011, CLIN INFECT DIS, V52, pS1, DOI 10.1093/cid/ciq005; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Witkop CT, 2010, AM J PREV MED, V38, P121, DOI 10.1016/j.amepre.2009.10.005; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321	28	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82089	10.1371/journal.pone.0082089	http://dx.doi.org/10.1371/journal.pone.0082089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339995	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100084
J	Hicks, JA; Yoo, D; Liu, HC				Hicks, Julie A.; Yoo, Dongwan; Liu, Hsiao-Ching			Characterization of the microRNAome in Porcine Reproductive and Respiratory Syndrome Virus Infected Macrophages	PLOS ONE			English	Article							EXPRESSION; REPLICATION; PATHWAY; DISEASE; H1N1	Porcine Reproductive and Respiratory Syndrome Virus (PRRSV), a member of the arterivirus family, is the causative agent of Porcine Reproductive and Respiratory Syndrome (PRRS). PRRS is characterized by late term abortions and respiratory disease, particularly in young pigs. Small regulatory RNAs termed microRNA (miRNA) are associated with gene regulation at the post-transcriptional level. MiRNAs are known to play many diverse and complex roles in viral infections. To discover the impact of PRRSV infections on the cellular miRNAome, Illumina deep sequencing was used to construct small RNA expression profiles from in vitro cultured PRRSV-infected porcine alveolar macrophages (PAMs). A total of forty cellular miRNAs were significantly differentially expressed within the first 48 hours post infection (hpi). The expression of six miRNAs, miR-30a-3p, miR-132, miR-27b*, miR-29b, miR-146a and miR-9-2, were altered at more than one time point. Target gene identification suggests that these miRNAs are involved in regulating immune signaling pathways, cytokine, and transcription factor production. The most highly repressed miRNA at 24 hpi was miR-147. A miR-147 mimic was utilized to maintain miR-147 levels in PRRSV-infected PAMs. PRRSV replication was negatively impacted by high levels of miR-147. Whether down-regulation of miR-147 is directly induced by PRRSV or if it is part of the cellular response and PRRSV indirectly benefits remains to be determined. No evidence could be found of PRRSV-encoded miRNAs. Overall, the present study has revealed that a large and diverse group of miRNAs are expressed in swine alveolar macrophages and that the expression of a subset of these miRNAs is altered in PRRSV infected macrophages.	[Hicks, Julie A.; Liu, Hsiao-Ching] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA; [Yoo, Dongwan] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA	University of North Carolina; North Carolina State University; University of Illinois System; University of Illinois Urbana-Champaign	Liu, HC (corresponding author), N Carolina State Univ, Dept Anim Sci, Box 7621, Raleigh, NC 27695 USA.	hc_liu@ncsu.edu	Yoo, Dongwan/AAG-8884-2021	Yoo, Dongwan/0000-0002-6730-9729	North Carolina Agricultural Research Service; USDA AFRI PRRS-CAP2 project	North Carolina Agricultural Research Service; USDA AFRI PRRS-CAP2 project	This work was supported by the North Carolina Agricultural Research Service and by the USDA AFRI PRRS-CAP2 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anselmo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017374; Badaoui B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-220; Ban JY, 2011, KOREAN J PHYSIOL PHA, V15, P23, DOI 10.4196/kjpp.2011.15.1.23; Chand RJ, 2012, CURR OPIN VIROL, V2, P256, DOI 10.1016/j.coviro.2012.02.002; Chen M, 2008, VIROLOGY, V377, P265, DOI 10.1016/j.virol.2008.03.019; Contreras J, 2012, LEUKEMIA, V26, P404, DOI 10.1038/leu.2011.356; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Cullen BR, 2011, CURR OPIN VIROL, V1, P211, DOI 10.1016/j.coviro.2011.04.003; Dhiman R, 2011, J IMMUNOL, V186, P1638, DOI 10.4049/jimmunol.1003146; Guo XK, 2013, J VIROL, V87, P1159, DOI 10.1128/JVI.02386-12; He T, 2009, BIOINFORMATION, V4, P112, DOI 10.6026/97320630004112; KAUSHANSKY K, 1986, P NATL ACAD SCI USA, V83, P3101, DOI 10.1073/pnas.83.10.3101; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kopp A, 2010, ENDOCRINOLOGY, V151, P5267, DOI 10.1210/en.2010-0571; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Lee SM, 2005, VIROLOGY, V342, P47, DOI 10.1016/j.virol.2005.07.034; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; McDermott JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014673; Meyer E, 2010, AM J HUM GENET, V86, P471, DOI 10.1016/j.ajhg.2010.02.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sang YM, 2008, VIRAL IMMUNOL, V21, P303, DOI 10.1089/vim.2008.0042; Sever-Chroneos Z, 2011, ANTIVIR RES, V92, P319, DOI 10.1016/j.antiviral.2011.08.022; Tamura R, 2012, BIOORG MED CHEM LETT, V22, P207, DOI 10.1016/j.bmcl.2011.11.029; Tanimoto A, 2008, J BIOL CHEM, V283, P4643, DOI 10.1074/jbc.M708853200; Van Gucht S, 2004, VET IMMUNOL IMMUNOP, V102, P165, DOI 10.1016/j.vetimm.2004.09.006; Wang D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055838; Wysocki M, 2012, ANIM GENET, V43, P328, DOI 10.1111/j.1365-2052.2011.02251.x; Zhou P, 2011, INT J BIOL SCI, V7, P947, DOI 10.7150/ijbs.7.947	30	30	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82054	10.1371/journal.pone.0082054	http://dx.doi.org/10.1371/journal.pone.0082054			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339989	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100081
J	Saliou, P; Le Gac, G; Mercier, AY; Chanu, B; Gueguen, P; Merour, MC; Gourlaouen, I; Autret, S; Le Marechal, C; Rouault, K; Nousbaum, JB; Ferec, C; Scotet, V				Saliou, Philippe; Le Gac, Gerald; Mercier, Anne-Yvonne; Chanu, Brigitte; Gueguen, Paul; Merour, Marie-Christine; Gourlaouen, Isabelle; Autret, Sandrine; Le Marechal, Cedric; Rouault, Karen; Nousbaum, Jean-Baptiste; Ferec, Claude; Scotet, Virginie			Evidence for the High Importance of Co-Morbid Factors in HFE C282Y/H63D Patients Cared by Phlebotomies: Results from an Observational Prospective Study	PLOS ONE			English	Article							HEREDITARY HEMOCHROMATOSIS; IRON-OVERLOAD; PENETRANCE; H63D; BETA(2)-MICROGLOBULIN; HETEROZYGOTES; EXPRESSION; MUTATION; DISEASE	Despite type I haemochromatosis (HC) is mainly associated with the HFE C282Y/C282Y genotype, a second genotype - C282Y/H63D- has mostly been described in other patients. Its association with HC, apart from any associated co-morbid factors, remains unclear and complex to interpret for physicians. This study assesses the weight of this genotype and the role of co-morbid factors in the occurrence of iron overload. This prospective study included the C282Y/C282Y (n = 172) and C282Y/H63D (n = 58) patients enrolled in a phlebotomy program between 2004 and 2007 in a blood centre of western Brittany (Brest, France), where HC is frequent. We compared prevalence of these two genotypes, as well as patients' profile regarding degree of iron overload and prevalence of co-morbid factors. First, we confirmed the obvious deficit of C282Y/H63D compound heterozygotes among patients cared by phlebotomies. This genotype was 3.0 times less frequent than the C282Y/C282Y genotype among those patients (18.9% vs. 56.0%) whereas it was 4.9 times more frequent in the general population (4.3% vs. 0.9%; p<0.0001). Despite a similar level of hyperferritinaemia, the C282Y/H63D patients who came to medical attention had a milder plasma iron overload, reflected by a lower transferrin saturation median (52.0% vs. 84.0%; p<0.0001). They also exhibited more frequently co-morbid factors, as heavy drinking (26.0% vs. 13.9%; p = 0.0454), overweight (66.7% vs. 39.4%; p = 0.0005) or both (21.3% vs. 2.6%; p<0.0001). Ultimately, they required a lower amount of iron removed to reach depletion (2.1 vs. 3.4 g; p<0.0001), clearly reflecting their lower tissue iron. This study confirms that H63D is a discrete genetic susceptibility factor whose expression is most visible in association with other co-factors. It highlights the importance of searching for co-morbidities in these diagnostic situations and of providing lifestyle and dietary advice.	[Saliou, Philippe; Le Gac, Gerald; Gueguen, Paul; Le Marechal, Cedric; Rouault, Karen; Nousbaum, Jean-Baptiste; Ferec, Claude; Scotet, Virginie] INSERM, UMR 1078, Brest, France; [Saliou, Philippe; Le Gac, Gerald; Gueguen, Paul; Le Marechal, Cedric; Rouault, Karen; Nousbaum, Jean-Baptiste; Ferec, Claude; Scotet, Virginie] Univ Bretagne Occidentale, Brest, France; [Saliou, Philippe; Le Gac, Gerald; Mercier, Anne-Yvonne; Chanu, Brigitte; Gueguen, Paul; Merour, Marie-Christine; Gourlaouen, Isabelle; Le Marechal, Cedric; Rouault, Karen; Nousbaum, Jean-Baptiste; Ferec, Claude; Scotet, Virginie] Etab Francais Sang Bretagne, Brest, France; [Saliou, Philippe] CHRU Brest, Hop Morvan, Lab Hyg & Sante Publ, Brest, France; [Le Gac, Gerald; Gueguen, Paul; Autret, Sandrine; Le Marechal, Cedric; Rouault, Karen; Ferec, Claude] CHRU Brest, Hop Morvan, Lab Genet Mol & Histocompatibil, Brest, France; [Nousbaum, Jean-Baptiste] CHRU Brest, Hop La Cavale Blanche, Serv Hepatogastroenterol, Brest, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale	Scotet, V (corresponding author), INSERM, UMR 1078, Brest, France.	virginie.scotet@inserm.fr	Saliou, Philippe/ABA-6773-2020; Le Gac, Gérald/AFQ-1679-2022; Ferec, Claude/ABG-9699-2020	Saliou, Philippe/0000-0002-9089-2000; Ferec, Claude/0000-0002-2325-0710; LE GAC, Gerald/0000-0003-3236-7280; Scotet, Virginie/0000-0002-5447-4207; GUEGUEN, Paul/0000-0003-2533-3226; ROUAULT, Karen/0000-0001-7586-3212	Etablissement Francais du Sang	Etablissement Francais du Sang	This study was supported by a grant from the Etablissement Francais du Sang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-Martinez P, 2011, HAEMATOL-HEMATOL J, V96, P507, DOI 10.3324/haematol.2010.029751; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Allen KJ, 2008, NEW ENGL J MED, V358, P221, DOI 10.1056/NEJMoa073286; Aranda N, 2010, ANN HEMATOL, V89, P767, DOI 10.1007/s00277-010-0901-9; Bacon BR, 2008, NEW ENGL J MED, V358, P291, DOI 10.1056/NEJMe078215; Beutler E, 1997, LANCET, V349, P296, DOI 10.1016/S0140-6736(97)22005-2; Charles MA, 2008, OBESITY, V16, P2180, DOI [10.1038/oby.2008.285, 10.1038/oby.2008.286]; Deugnier Y, 2009, GASTROEN CLIN BIOL, V33, P323, DOI 10.1016/j.gcb.2009.02.009; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Feder JN, 1997, J BIOL CHEM, V272, P14025, DOI 10.1074/jbc.272.22.14025; Gurrin LC, 2009, HEPATOLOGY, V50, P94, DOI 10.1002/hep.22972; Jouanolle AM, 1998, ANN GENET-PARIS, V41, P195; Le Gac G, 2005, EUR J HUM GENET, V13, P1172, DOI 10.1038/sj.ejhg.5201490; Mariani R, 2010, BLOOD CELL MOL DIS, V44, P159, DOI 10.1016/j.bcmd.2010.01.002; Pedersen P, 2009, ANN HEMATOL, V88, P775, DOI 10.1007/s00277-008-0679-1; Pietrangelo A, 2000, J HEPATOL, V33, P485, DOI 10.1016/S0168-8278(00)80288-3; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Pietrangelo A, 2010, J HEPATOL, V53, P3, DOI 10.1016/j.jhep.2010.03.001; Risch N, 1997, NAT GENET, V17, P375, DOI 10.1038/ng1297-375; Rochette J, 2010, HUM GENET, V128, P233, DOI 10.1007/s00439-010-0852-1; Scotet V, 2003, AM J EPIDEMIOL, V158, P129, DOI 10.1093/aje/kwg123; Scotet V, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-24; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Walsh A, 2006, CLIN GASTROENTEROL H, V4, P1403, DOI 10.1016/j.cgh.2006.07.009	24	4	4	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81128	10.1371/journal.pone.0081128	http://dx.doi.org/10.1371/journal.pone.0081128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339903	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100038
J	Yamane, T; Suzui, S; Kitaura, H; Takahashi-Niki, K; Iguchi-Ariga, SMM; Ariga, H				Yamane, Takuya; Suzui, Sayaka; Kitaura, Hirotake; Takahashi-Niki, Kazuko; Iguchi-Ariga, Sanae M. M.; Ariga, Hiroyoshi			Transcriptional Activation of the Cholecystokinin Gene by DJ-1 through Interaction of DJ-1 with RREB1 and the Effect of DJ-1 on the Cholecystokinin Level in Mice	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; ANDROGEN RECEPTOR; TYROSINE-HYDROXYLASE; DOPAMINE NEURONS; PROSTATE-CANCER; BINDING; EXPRESSION; CELLS; RAS; P53	DJ-1 is an oncogene and also causative gene for familial Parkinson's disease. DJ-1 has multiple functions, including transcriptional regulation. DJ-1 acts as a coactivator that binds to various transcription factors, resulting in stimulation or repression of the expression of their target genes. In this study, we found that the cholecystokinin (CCK) gene is a transcriptional target gene for DJ-1. CCK is a peptide hormone and plays roles in contraction of the gallbladder and in promotion of secretion of pancreatic fluid. CCK is co-localized with dopamine in the substantia nigra to regulate release of dopamine. Reduced expression of CCK mRNA was observed in DJ-1-knockdown cells. The Ras-responsive element (RRE) and Sp1 site were essential for promoter activity, and DJ-1 stimulated promoter activity by binding to RRE-binding protein 1 (RREBP1). The complex of DJ-1 with RREB1 but not with Sp1 bound to the RRE. Furthermore, the reduced CCK level in the serum from DJ-1-knockout mice compared to that from wild-type mice was observed. This is the first report showing that DJ-1 participates in peptide hormone synthesis.	[Yamane, Takuya; Suzui, Sayaka; Kitaura, Hirotake; Takahashi-Niki, Kazuko; Ariga, Hiroyoshi] Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Iguchi-Ariga, Sanae M. M.] Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Ariga, H (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Sapporo, Hokkaido, Japan.	hiro@pharm.hokudai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); National Institute of Biomedical Innovation (NIBIO) in Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation (NIBIO) in Japan(National Institute of Biomedical Innovation)	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation (NIBIO) in Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariga H, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/683920; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Chen RL, 2010, J BIOL CHEM, V285, P10189, DOI 10.1074/jbc.M109.049130; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Ebihara M, 2003, AM J MED GENET B, V118B, P32, DOI 10.1002/ajmg.b.10058; Fan J, 2008, J BIOL CHEM, V283, P4022, DOI 10.1074/jbc.M707176200; FREEMAN AS, 1991, BRAIN RES, V555, P281, DOI 10.1016/0006-8993(91)90353-W; HOMMER DW, 1983, EUR J PHARMACOL, V91, P151, DOI 10.1016/0014-2999(83)90380-1; Ishikawa S, 2012, BIOCHEM BIOPH RES CO, V421, P813, DOI 10.1016/j.bbrc.2012.04.095; Ishikawa S, 2010, J BIOL CHEM, V285, P39718, DOI 10.1074/jbc.M110.137034; Ishikawa S, 2009, J BIOL CHEM, V284, P28832, DOI 10.1074/jbc.M109.019950; Kahle PJ, 2009, FREE RADICAL BIO MED, V47, P1354, DOI 10.1016/j.freeradbiomed.2009.08.003; Kato I, 2013, MOL CELL BIOL, V33, P340, DOI 10.1128/MCB.01350-12; Lev N, 2009, J NEURAL TRANSM, V116, P151, DOI 10.1007/s00702-008-0134-4; Miyazaki S, 2008, J NEUROCHEM, V105, P2418, DOI 10.1111/j.1471-4159.2008.05327.x; Mukhopadhyay NK, 2007, MOL ENDOCRINOL, V21, P2056, DOI 10.1210/me.2006-0503; Mukhopadhyay NK, 2006, EXP CELL RES, V312, P3782, DOI 10.1016/j.yexcr.2006.07.017; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Niki T, 2003, MOL CANCER RES, V1, P247; Nishinaga H, 2005, NEUROSCI LETT, V390, P54, DOI 10.1016/j.neulet.2005.07.053; PIETROWSKY R, 1994, INT J PSYCHOPHYSIOL, V17, P79, DOI 10.1016/0167-8760(94)90058-2; SCHREIBER H, 1995, BIOL PSYCHIAT, V37, P702, DOI 10.1016/0006-3223(94)00207-J; SEROOGY KB, 1989, J COMP NEUROL, V279, P397, DOI 10.1002/cne.902790306; Shinbo YM, 2005, INT J ONCOL, V26, P641; SKIRBOLL LR, 1981, NEUROSCIENCE, V6, P2111, DOI 10.1016/0306-4522(81)90002-6; Takahashi K, 2001, J BIOL CHEM, V276, P37556, DOI 10.1074/jbc.M101730200; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Thiagalingam A, 1996, MOL CELL BIOL, V16, P5335; Tillman JE, 2007, CANCER RES, V67, P4630, DOI 10.1158/0008-5472.CAN-06-4556; Wilson MA, 2011, ANTIOXID REDOX SIGN, V15, P111, DOI 10.1089/ars.2010.3481; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yamaguchi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038144; Yoshida T, 2008, EXP CELL RES, V314, P1217, DOI 10.1016/j.yexcr.2008.01.002; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257; Zhong N, 2006, J BIOL CHEM, V281, P20940, DOI 10.1074/jbc.M601935200	35	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e78374	10.1371/journal.pone.0078374	http://dx.doi.org/10.1371/journal.pone.0078374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	247EE	24348900	Green Published, gold			2022-12-27	WOS:000326597400022
J	Clifford, EL; Collins, MM; Buckley, CM; Fitzgerald, AP; Perry, IJ				Clifford, Emma Louise; Collins, Margaret M.; Buckley, Claire M.; Fitzgerald, Anthony P.; Perry, Ivan J.			Unhealthy Days and Quality of Life in Irish Patients with Diabetes	PLOS ONE			English	Article							HEALTH-STATUS; ADULTS; INSTRUMENTS; MELLITUS; HABITS	Objectives: To study the determinants of health-related quality of life (HRQoL) in Irish patients with diabetes using the Centres for Disease Controls' (CDC's) 'Unhealthy Days' summary measure and to assesses the agreement between this generic HRQoL measure and the disease-specific Audit of Diabetes Dependant Quality of Life (ADDQoL) measure. Research Design and Methods: Data were analysed from the Diabetes Quality of Life Study, a cross-sectional study of 1,456 people with diabetes in Ireland (71% response rate). Unhealthy days were assessed using the CDC's 'Unhealthy days' summary measure. Quality of life (QoL) was also assessed using the ADDQoL measure. Analyses were conducted primarily using logistic regression. The agreement between the two QoL instruments was measured using the kappa co-efficient. Results: Participants reported a median of 2 unhealthy days per month. In multivariate analyses, female gender (P = 0.001), insulin use (P = 0.030), diabetes complications (P =<0.001) were significantly associated with more unhealthy days. Older patients had fewer unhealthy days per month (P = 0.003). Agreement between the two measures of QoL (unhealthy days measure and ADDQoL) was poor, Kappa = 0.234 Conclusions: The findings highlight the determinants of HRQoL in patients with diabetes using a generic HRQoL summary measure. The 'Unhealthy Days' and the ADDQoL have poor agreement, therefore the 'Unhealthy Days' summary measure may be assessing a different construct. Nonetheless, this study demonstrates that the generic 'Unhealthy Days' summary measure can be used to detect determinants of HRQoL in patients with diabetes.	[Clifford, Emma Louise] South Infirm Victoria Univ Hosp, Dept Nutr & Dietet, Cork, Ireland; [Collins, Margaret M.] Univ Calif Cooperat Extens, Sonora, CA USA; [Clifford, Emma Louise; Buckley, Claire M.; Fitzgerald, Anthony P.; Perry, Ivan J.] Natl Univ Ireland Univ Coll Cork, Dept Epidemiol & Publ Hlth, Cork, Ireland; [Fitzgerald, Anthony P.] Natl Univ Ireland Univ Coll Cork, Dept Stat, Cork, Ireland	University of California System; University College Cork; University College Cork	Clifford, EL (corresponding author), South Infirm Victoria Univ Hosp, Dept Nutr & Dietet, Cork, Ireland.	emmaclifford@hotmail.com	Fitzgerald, Tony/AAB-5331-2020	Fitzgerald, Tony/0000-0001-6437-5686; Perry, Ivan/0000-0002-4965-9792	Irish Health Research Board (HRB) project [RP/16-/2002]	Irish Health Research Board (HRB) project	This project was funded by the Irish Health Research Board (HRB) project grant (grant RP/16-/2002). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1990, Diabet Med, V7, P360; Bradley C, 1999, QUAL LIFE RES, V8, P79, DOI 10.1023/A:1026485130100; Brown DW, 2004, DIABETES RES CLIN PR, V65, P105, DOI 10.1016/j.diabres.2003.11.014; Campbell HM, 2011, RES SOC ADMIN PHARM, V7, P151, DOI 10.1016/j.sapharm.2010.03.002; Collins MM, 2009, DIABETIC MED, V26, P153, DOI 10.1111/j.1464-5491.2008.02648.x; Collins MM, 2009, BMC ENDOCR DISORD, V9, DOI 10.1186/1472-6823-9-6; Collins MM, 2009, DIABETES CARE, V32, P603, DOI 10.2337/dc08-1169; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Department of Health, 2019, MAT HLTH 1 2000 DAYS; El Achhab Y, 2008, DIABETES RES CLIN PR, V80, P171, DOI 10.1016/j.diabres.2007.12.020; Hart HE, 2007, INDIAN J MED RES, V125, P203; HENNESSY CH, 1994, PUBLIC HEALTH REP, V109, P665; Huang IC, 2008, VALUE HEALTH, V11, P450, DOI 10.1111/j.1524-4733.2007.00261.x; Leong KP, 2005, CLIN EXP ALLERGY, V35, P288, DOI 10.1111/j.1365-2222.2005.02201.x; Li CY, 2008, VALUE HEALTH, V11, P689, DOI 10.1111/j.1524-4733.2007.00307.x; Li CY, 2007, DIABETES CARE, V30, P1770, DOI 10.2337/dc06-2571; Moriarty D, 2003, HEALTH QUAL LIFE OUT, V37, P1, DOI DOI 10.1186/1477-7525-1-37; Newschaffer C. J., 1998, VALIDATION BEHAV RIS; Organisation for Economic Co-operation and Development, 2011, BETT LIF IND IR; Ostini R, 2012, QUAL LIFE RES, V21, P1471, DOI 10.1007/s11136-011-0043-0; Pallant J., 2010, SPSS SURVIVAL MANUAL, DOI DOI 10.1108/jacpr.2011.55003baa.002; Papadopoulos AA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-186; PARKERSON GR, 1993, MED CARE, V31, P629, DOI 10.1097/00005650-199307000-00005; Redekop WK, 2002, DIABETES CARE, V25, P458, DOI 10.2337/diacare.25.3.458; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Schunk M, 2012, DIABETIC MED, V29, P646, DOI 10.1111/j.1464-5491.2011.03465.x; Shim YT, 2012, DIABETIC MED, V29, pE241, DOI 10.1111/j.1464-5491.2012.03689.x; Speight J, 2009, DIABETIC MED, V26, P315, DOI 10.1111/j.1464-5491.2009.02682.x; Sundaram M, 2007, QUAL LIFE RES, V16, P165, DOI 10.1007/s11136-006-9105-0; Sundaram M, 2009, PATIENT, V2, P121, DOI 10.2165/01312067-200902020-00008; Trief PM, 2003, AGE AGEING, V32, P613, DOI 10.1093/ageing/afg105; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; Wiebe S, 2003, J CLIN EPIDEMIOL, V56, P52, DOI 10.1016/S0895-4356(02)00537-1	33	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81102	10.1371/journal.pone.0081102	http://dx.doi.org/10.1371/journal.pone.0081102			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276FP	24349036	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200005
J	Green, HK; Andrews, N; Fleming, D; Zambon, M; Pebody, R				Green, Helen K.; Andrews, Nick; Fleming, Douglas; Zambon, Maria; Pebody, Richard			Mortality Attributable to Influenza in England and Wales Prior to, during and after the 2009 Pandemic	PLOS ONE			English	Article							VIRUS; DEATHS; RISK	Very different influenza seasons have been observed from 2008/09-2011/12 in England and Wales, with the reported burden varying overall and by age group. The objective of this study was to estimate the impact of influenza on all-cause and cause-specific mortality during this period. Age-specific generalised linear regression models fitted with an identity link were developed, modelling weekly influenza activity through multiplying clinical influenza-like illness consultation rates with proportion of samples positive for influenza A or B. To adjust for confounding factors, a similar activity indicator was calculated for Respiratory Syncytial Virus. Extreme temperature and seasonal trend were controlled for. Following a severe influenza season in 2008/09 in 65+yr olds (estimated excess of 13,058 influenza A all-cause deaths), attributed all-cause mortality was not significant during the 2009 pandemic in this age group and comparatively low levels of influenza A mortality were seen in post-pandemic seasons. The age shift of the burden of seasonal influenza from the elderly to young adults during the pandemic continued into 2010/11; a comparatively larger impact was seen with the same circulating A(H1N1) pdm09 strain, with the burden of influenza A all-cause excess mortality in 15-64 yr olds the largest reported during 2008/09-2011/12 (436 deaths in 15-44 yr olds and 1,274 in 45-64 yr olds). On average, 76% of seasonal influenza A all-age attributable deaths had a cardiovascular or respiratory cause recorded (average of 5,849 influenza A deaths per season), with nearly a quarter reported for other causes (average of 1,770 influenza A deaths per season), highlighting the importance of all-cause as well as cause-specific estimates. No significant influenza B attributable mortality was detected by season, cause or age group. This analysis forms part of the preparatory work to establish a routine mortality monitoring system ahead of introduction of the UK universal childhood seasonal influenza vaccination programme in 2013/14.	[Green, Helen K.; Pebody, Richard] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Resp Dis, London, England; [Andrews, Nick] Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Stat, London, England; [Fleming, Douglas] Royal Coll Gen Practitioners, Birmingham Res Unit, Birmingham, W Midlands, England; [Zambon, Maria] Publ Hlth England, Microbiol Serv, Virus Reference Dept, Resp Virus Unit, London, England	Public Health England; Public Health England; Public Health England	Pebody, R (corresponding author), Publ Hlth England, Ctr Infect Dis Surveillance & Control, Dept Resp Dis, London, England.	richard.pebody@phe.gov.uk		Pebody, Richard/0000-0002-9069-2885	Public Health England; Department of Health	Public Health England; Department of Health	This work was supported by Public Health England where the lead author and corresponding author are employees. his work was supported through core surveillance funding from the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, EUROPEAN MONITORING; Athanasiou M, 2011, EUROSURVEILLANCE, V16, P14; Bolotin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030279; Brandeis GH, 1998, ALZ DIS ASSOC DIS, V12, P140, DOI 10.1097/00002093-199809000-00004; Centers for Disease Control and Prevention, 2013, FLUVIEW WEEKL INFL S; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Charu V, 2013, INFLUENZA OTHER RESP, DOI [10.1111/irv.12096, DOI 10.1111/IRV.12096.[]; Chuang JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036120; Cociuba S, 2009, US HOURS PRODUCTIVIT; Dawood FS, 2012, LANCET INFECT DIS, V12, P687, DOI 10.1016/S1473-3099(12)70121-4; Department of Health, 2013, NAT IMM PROGR PLANN; Devis T, 1997, Popul Trends, P48; European Centre for Disease Prevention and Control, 2013, WEEKL INFL SURV OV; European Centre for Disease Prevention and Control, 2012, SEAS INFL 2011 2012; European Centre for Disease Prevention and Control, 2011, INFL SURV EUR 2010 2; Freitas FT, 2012, EPIDEMIOL INFECT, V8, P1; Gay NJ, 2003, JAMA-J AM MED ASSOC, V289, P2499, DOI 10.1001/jama.289.19.2499-a; Goldstein E, 2012, EPIDEMIOLOGY, V23, P829, DOI 10.1097/EDE.0b013e31826c2dda; Goldstein E, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001051; Green HK, 2013, EURO SURVEILL, V18; Hardelid P, 2013, INFLUENZA OTHER RESP, V7, P35, DOI 10.1111/j.1750-2659.2012.00345.x; Health Protection Agency, 2013, HPA NAT INFL REP; Health Protection Agency, 2012, SURV INFL OTH RESP V; Health Protection Agency, 2010, EP REP PAND H1N1 200; Health Protection Agency, 2011, SURV INFL OTH RESP V; Health Protection Agency, 2009, SURV INFL OTH RESP V; Hervas D, 2012, EUR J CLIN MICROBIOL, V31, P1975, DOI 10.1007/s10096-011-1529-y; Lemaitre M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045051; Lopez-Cuadrado T, 2012, GAC SANIT, V26, P325, DOI 10.1016/j.gaceta.2011.09.033; Met Office, 2010, HADCET CENTR ENGL TE; Nicoll A, 2012, EURO SURVEILL, V3, P17; Office for National Statistics, 2013, POP EST UK ENGL WAL; Pebody RG, 2010, EUROSURVEILLANCE, V15; Pitman RJ, 2007, J INFECTION, V54, P530, DOI 10.1016/j.jinf.2006.09.017; Redlberger-Fritz M, 2012, EUR J EPIDEMIOL, V27, P567, DOI 10.1007/s10654-012-9701-y; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2012, ISIRV INC IMP SEV C; van den Wijngaard CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031197; Viboud C, 2010, PLOS CURR, V2; Wong JY, 2013, AM J EPIDEMIOL, V177, P834, DOI 10.1093/aje/kws314; World Health Organization, 2011, SUMM REV 2010 2011 N; World Health Organization, 2010, INT CLASS DIS ICD; World Health Organization (WHO), 2009, LIF TABL WHO MEMB ST; Wu P, 2012, J INFECT DIS, V206, P1862, DOI 10.1093/infdis/jis628; Wu W, 2013, SCI TOTAL ENVIRON, V449, P355, DOI 10.1016/j.scitotenv.2013.01.090; Yu H, 2013, INFLUENZA OTHER RESP, DOI [10.1111/irv.12121, DOI 10.1111/IRV.12121.[]	46	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e79360	10.1371/journal.pone.0079360	http://dx.doi.org/10.1371/journal.pone.0079360			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348993	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300005
J	Yates, WR; Johnson, C; McKee, P; Cannon-Albright, LA				Yates, William R.; Johnson, Craig; McKee, Patrick; Cannon-Albright, Lisa A.			Genetic Analysis of Low BMI Phenotype in the Utah Population Database	PLOS ONE			English	Article							BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; HERITABLE PREDISPOSITION; UNDERWEIGHT; MELANOMA; RISK; PEDIGREES; CANDIDATE; OBESITY; CANCER	The low body mass index (BMI) phenotype of less than 18.5 has been linked to medical and psychological morbidity as well as increased mortality risk. Although genetic factors have been shown to influence BMI across the entire BMI, the contribution of genetic factors to the low BMI phenotype is unclear. We hypothesized genetic factors would contribute to risk of a low BMI phenotype. To test this hypothesis, we conducted a genealogy data analysis using height and weight measurements from driver's license data from the Utah Population Data Base. The Genealogical Index of Familiality (GIF) test and relative risk in relatives were used to examine evidence for excess relatedness among individuals with the low BMI phenotype. The overall GIF test for excess relatedness in the low BMI phenotype showed a significant excess over expected (GIF 4.47 for all cases versus 4.10 for controls, overall empirical p-value<0.001). The significant excess relatedness was still observed when close relationships were ignored, supporting a specific genetic contribution rather than only a family environmental effect. This study supports a specific genetic contribution in the risk for the low BMI phenotype. Better understanding of the genetic contribution to low BMI holds promise for weight regulation and potentially for novel strategies in the treatment of leanness and obesity.	[Yates, William R.; McKee, Patrick] Laureate Inst Brain Res, Tulsa, OK USA; [Yates, William R.] Univ Oklahoma Coll Med, Tulsa, OK USA; [Johnson, Craig] Eating Recovery Ctr, Denver, CO USA; [McKee, Patrick] Univ Oklahoma Coll Med, Oklahoma City, OK USA; [Cannon-Albright, Lisa A.] Univ Utah Sch Med, Dept Med Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa A.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA	Laureate Institute for Brain Research, Inc.; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs	Yates, WR (corresponding author), Laureate Inst Brain Res, Tulsa, OK USA.	WRY888@gmail.com		albright, lisa/0000-0003-2602-3668	National Library of Medicine [LM009331]; Huntsman Cancer Institute's Cancer Center Support grant from National Cancer Institute [P30 CA42014]; NATIONAL CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM009331] Funding Source: NIH RePORTER	National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Huntsman Cancer Institute's Cancer Center Support grant from National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Primary Funding Source: National Library of Medicine grant LM009331 (to LACA). LACA acknowledges support from the Huntsman Cancer Foundation. Partial support for all data sets within the Utah Population Database (UPDB) was provided by Huntsman Cancer Institute, University of Utah and the Huntsman Cancer Institute's Cancer Center Support grant, P30 CA42014 from National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Albright LAC, 2008, HUM HERED, V65, P209, DOI 10.1159/000112368; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Bah J, 2010, METABOLISM, V59, P1156, DOI 10.1016/j.metabol.2009.11.007; Borecki IB, 1998, OBES RES, V6, P107, DOI 10.1002/j.1550-8528.1998.tb00323.x; CANNON LA, 1986, GENET EPIDEMIOL, P43; CANNONALBRIGHT LA, 1994, GENOMICS, V23, P265, DOI 10.1006/geno.1994.1491; CANNONALBRIGHT LA, 1992, SCIENCE, V258, P1148, DOI 10.1126/science.1439824; Center for Disease Control and Prevention (CDC) National Center for Health Statistics (NCHS), 2003, PREV LOW BMI AD US 2; Centers for Disease Control and Prevention, 2008, BEH RISK FACT SURV S; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; COSTANZO PR, 1989, NEUROSCI BIOBEHAV R, V13, P55, DOI 10.1016/S0149-7634(89)80052-1; Day FR, 2011, J NUTRIGENET NUTRIGE, V4, P222, DOI 10.1159/000332158; Deutsch AB, 2010, AM J PERINAT, V27, P235, DOI 10.1055/s-0029-1239490; Dubois L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030153; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Hai R, 2012, J HUM GENET, V57, P33, DOI 10.1038/jhg.2011.125; Hill JR, 1980, CANC INCIDENCE DEFIN, P299; Horne BD, 2006, AM HEART J, V152, P305, DOI 10.1016/j.ahj.2005.12.028; Hunt SC, 2008, OBESITY, V16, P902, DOI 10.1038/oby.2007.126; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kalk P, 2009, EUR J MED RES, V14, P216; Kamb A, 1994, Nat Genet, V8, P23; Khashan AS, 2009, EUR J EPIDEMIOL, V24, P697, DOI 10.1007/s10654-009-9375-2; LASKARZEWSKI PM, 1983, INT J OBESITY, V7, P505; Lederer DJ, 2009, AM J RESP CRIT CARE, V180, P887, DOI 10.1164/rccm.200903-0425OC; Liu XG, 2009, AM J HUM GENET, V84, P418, DOI 10.1016/j.ajhg.2009.02.004; Magnusson PKE, 2002, INT J OBESITY, V26, P1225, DOI 10.1038/sj.ijo.0802041; Malecot G., 1948, MATH HEREDITE; Maul JS, 2007, CLIN GASTROENTEROL H, V5, P1080, DOI 10.1016/j.cgh.2007.04.025; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; National Center for Health Statistics, 2018, NAT HLTH NUTR EX SUR; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Salihu HM, 2009, J MATERN-FETAL NEO M, V22, P428, DOI 10.1080/14767050802385764; Shirts BH, 2010, CLIN GASTROENTEROL H, V8, P812, DOI 10.1016/j.cgh.2010.05.012; Skolnick M, 1980, BANBURY REPORT, P285; STUNKARD AJ, 1990, NEW ENGL J MED, V322, P1483, DOI 10.1056/NEJM199005243222102; Tamakoshi A, 2010, OBESITY, V18, P362, DOI 10.1038/oby.2009.190; Tashjian RZ, 2009, J BONE JOINT SURG AM, V91A, P1136, DOI 10.2106/JBJS.H.00831; Tavtigian SV, 1996, NAT GENET, V12, P333, DOI 10.1038/ng0396-333; Teerlink C, 2012, HUM GENET, V131, P77, DOI 10.1007/s00439-011-1048-z; Teerlink CC, 2007, AM J RESP CRIT CARE, V176, P865, DOI 10.1164/rccm.200703-448OC; Vesprini D, 2001, AM J HUM GENET, V68, P912, DOI 10.1086/319502; Vitonis AF, 2010, HUM REPROD, V25, P1325, DOI 10.1093/humrep/deq039; Weires MB, 2007, EXP CLIN ENDOCR DIAB, V115, P634, DOI 10.1055/s-2007-984443	46	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80287	10.1371/journal.pone.0080287	http://dx.doi.org/10.1371/journal.pone.0080287			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348998	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300007
J	Bostrom, EA; Lundberg, P				Bostrom, Elisabeth A.; Lundberg, Pernilla			The Newly Discovered Cytokine IL-34 Is Expressed in Gingival Fibroblasts, Shows Enhanced Expression by Pro-Inflammatory Cytokines, and Stimulates Osteoclast Differentiation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; INTERLEUKIN-6 PRODUCTION; CREVICULAR FLUID; FACTOR-ALPHA; KEY ROLE; M-CSF; ARTHRITIS; HEALTHY; CELLS	Background: Interleukin-34 (IL-34) is a recently discovered cytokine functionally overlapping macrophage colony stimulating factor (M-CSF), a mediator of inflammation and osteoclastogenesis in bone-degenerative diseases such as rheumatoid arthritis. The objective of this study was to assess the expression of IL-34 in human gingival fibroblasts and investigate if the pro-inflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and Interleukin-1B (IL-1 beta) modulate its expression, and moreover if IL-34 could contribute to recruitment of bone-resorbing osteoclasts. Methods: IL-34 expression was evaluated in gingival fibroblasts by real time PCR following stimulation by TNF-alpha, IL-1 beta, and treatment with inhibitors of intracellular pathways. The formation of osteoclasts was evaluated by tartrate-resistant acid phosphatase (TRAP) staining of bone marrow macrophages treated with IL-34 or M-CSF in addition to receptor activator of nuclear factor kappa-B ligand (RANKL). Results: IL-34 was expressed in gingival fibroblasts. The expression was enhanced by TNF-alpha and IL-1 beta, regulated by the transcription factor nuclear factor kappa B (NF-kappa B) and activation of c-Jun N-terminal kinase (JNK). Further, IL-34 supports RANKL-induced osteoclastogensis of bone marrow macrophages, independently of M-CSF. Summary: In conclusion, this study shows for the first time IL-34 expression in human gingival fibroblasts, stimulated by TNF-alpha and IL-1 beta, key mediators of periodontal inflammation. Furthermore, IL-34 can be substituted for M-CSF in RANKL-induced osteoclastogenesis. IL-34 may contribute to inflammation and osteoclastogenesis in bone-degenerative diseases such as periodontitis.	[Bostrom, Elisabeth A.] Karolinska Inst, Div Periodontol, Dept Dent Med, Stockholm, Sweden; [Lundberg, Pernilla] Umea Univ, Dept Mol Periodontol, Umea, Sweden	Karolinska Institutet; Umea University	Bostrom, EA (corresponding author), Karolinska Inst, Div Periodontol, Dept Dent Med, Stockholm, Sweden.	elisabeth.bostrom@ki.se			Swedish Patent Revenue Fund; Ollie och Elof Ericssons stiftelse; Tore Nilsson Stiftelse; Alex och Eva Wallstroms Stiftelse/Karolinska Institutet; Faculty of Medicine, Umea University; County Council of Vasterbotten; Swedish Dental Society	Swedish Patent Revenue Fund; Ollie och Elof Ericssons stiftelse; Tore Nilsson Stiftelse; Alex och Eva Wallstroms Stiftelse/Karolinska Institutet; Faculty of Medicine, Umea University; County Council of Vasterbotten; Swedish Dental Society	This study was supported by funds from the Swedish Patent Revenue Fund (EAB), Ollie och Elof Ericssons stiftelse (EAB), Tore Nilsson Stiftelse (EAB), Alex och Eva Wallstroms Stiftelse/Karolinska Institutet (EAB), Faculty of Medicine, Umea University (PL), County Council of Vasterbotten (PL), Swedish Dental Society (PL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bage T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-241; Baud'Huin M, 2010, J PATHOL, V221, P77, DOI 10.1002/path.2684; Brage M, 2004, BONE, V34, P412, DOI 10.1016/j.bone.2003.11.018; Campbell IK, 2000, J LEUKOCYTE BIOL, V68, P144; Chemel M, 2012, ANN RHEUM DIS, V71, P150, DOI 10.1136/annrheumdis-2011-200096; Ciccia F, 2013, RHEUMATOLOGY, V52, P1009, DOI 10.1093/rheumatology/kes435; Costa-Rodrigues J, 2011, CELL PROLIFERAT, V44, P264, DOI 10.1111/j.1365-2184.2011.00751.x; Eda H, 2011, RHEUMATOL INT, V31, P1525, DOI 10.1007/s00296-010-1688-7; Graves DT, 2003, J PERIODONTOL, V74, P391, DOI 10.1902/jop.2003.74.3.391; Hamilton JA, 2008, NAT REV IMMUNOL, V8, P533, DOI 10.1038/nri2356; Hwang SJ, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3693; Kent LW, 1999, J PERIODONTOL, V70, P274, DOI 10.1902/jop.1999.70.3.274; Kent LW, 1998, INFECT IMMUN, V66, P608, DOI 10.1128/IAI.66.2.608-614.1998; Kimura K, 2013, ORAL DIS; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; Lekic PC, 1997, CRIT REV ORAL BIOL M, V8, P253, DOI 10.1177/10454411970080030201; LERNER U, 1987, J PERIODONTAL RES, V22, P284, DOI 10.1111/j.1600-0765.1987.tb01586.x; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Lin SJ, 2005, CYTOKINE, V30, P160, DOI 10.1016/j.cyto.2004.12.018; Liu YCG, 2010, PERIODONTOL 2000, V52, P163, DOI 10.1111/j.1600-0757.2009.00321.x; Modeer T, 1998, CYTOKINE, V10, P26, DOI 10.1006/cyto.1997.0255; Mogi M, 1999, ARCH ORAL BIOL, V44, P535, DOI 10.1016/S0003-9969(99)00020-5; Palmqvist P, 2008, J DENT RES, V87, P558, DOI 10.1177/154405910808700614; Rabello D, 2006, BIOCHEM BIOPH RES CO, V347, P791, DOI 10.1016/j.bbrc.2006.06.166; Ritchlin C, 2000, ARTHRITIS RES, V2, P356, DOI 10.1186/ar112; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Takashiba S, 2003, J PERIODONTOL, V74, P103, DOI 10.1902/jop.2003.74.1.103; Tian Y, 2013, J INTERFERON CYTOKIN; Wang PL, 2003, BIOCHEM BIOPH RES CO, V305, P970, DOI 10.1016/S0006-291X(03)00821-0; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822	30	56	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81665	10.1371/journal.pone.0081665	http://dx.doi.org/10.1371/journal.pone.0081665			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339952	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400028
J	Pagotto, A; Caballero, OL; Volkmar, N; Devalle, S; Simpson, AJG; Lu, X; Christianson, JC				Pagotto, Anna; Caballero, Otavia L.; Volkmar, Norbert; Devalle, Sylvie; Simpson, Andrew J. G.; Lu, Xin; Christianson, John C.			Centrosomal Localisation of the Cancer/Testis (CT) Antigens NY-ESO-1 and MAGE-C1 Is Regulated by Proteasome Activity in Tumour Cells	PLOS ONE			English	Article							CANCER-TESTIS ANTIGEN; HUMORAL IMMUNE-RESPONSES; CYTOLYTIC T-LYMPHOCYTES; SUBCELLULAR-LOCALIZATION; AGGRESOME FORMATION; INCLUSION-BODIES; GENE FAMILY; EXPRESSION; PROTEIN; IDENTIFICATION	The Cancer/Testis (CT) antigen family of genes are transcriptionally repressed in most human tissues but are atypically re-expressed in many malignant tumour types. Their restricted expression profile makes CT antigens ideal targets for cancer immunotherapy. As little is known about whether CT antigens may be regulated by post-translational processing, we investigated the mechanisms governing degradation of NY-ESO-1 and MAGE-C1 in selected cancer cell lines. Inhibitors of proteasome-mediated degradation induced the partitioning of NY-ESO-1 and MAGE-C1 into a detergent insoluble fraction. Moreover, this treatment also resulted in increased localisation of NY-ESO-1 and MAGE-C1 at the centrosome. Despite their interaction, relocation of either NY-ESO-1 or MAGE-C1 to the centrosome could occur independently of each other. Using a series of truncated fragments, the regions corresponding to NY-ESO-1(91-150) and MAGE-C1(900-1116) were established as important for controlling both stability and localisation of these CT antigens. Our findings demonstrate that the steady state levels of NY-ESO-1 and MAGE-C1 are regulated by proteasomal degradation and that both behave as aggregation-prone proteins upon accumulation. With proteasome inhibitors being increasingly used as front-line treatment in cancer, these data raise issues about CT antigen processing for antigenic presentation and therefore immunogenicity in cancer patients.	[Pagotto, Anna; Volkmar, Norbert; Lu, Xin; Christianson, John C.] Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England; [Caballero, Otavia L.; Simpson, Andrew J. G.] Johns Hopkins Univ, Sch Med, Dept Neurosurg, Ludwig Collaborat Grp, Baltimore, MD 21205 USA; [Devalle, Sylvie] Mem Sloan Kettering Canc Ctr, Ludwig Inst Canc Res, New York Branch, New York, NY 10021 USA	Ludwig Institute for Cancer Research; University of Oxford; Johns Hopkins University; Ludwig Institute for Cancer Research; Memorial Sloan Kettering Cancer Center	Lu, X (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Ludwig Inst Canc Res, Oxford, England.	xin.lu@ludwig.ox.ac.uk	Christianson, John C/Y-4567-2019	Volkmar, Norbert/0000-0003-0766-5606; Christianson, John/0000-0002-0474-1207; Devalle, Sylvie/0000-0002-9533-2571	Ludwig Cancer Research	Ludwig Cancer Research	This work was supported by funding from Ludwig Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida LG, 2009, NUCLEIC ACIDS RES, V37, pD816, DOI 10.1093/nar/gkn673; Alves PMS, 2007, CANCER IMMUNOL IMMUN, V56, P839, DOI 10.1007/s00262-006-0228-5; Anderson LD, 2011, CANCER IMMUNOL IMMUN, V60, P985, DOI 10.1007/s00262-011-1009-3; Anton LC, 1999, J CELL BIOL, V146, P113, DOI 10.1083/jcb.146.1.113; Arcaro A, 2002, EMBO J, V21, P5097, DOI 10.1093/emboj/cdf512; Atanackovic D, 2010, HAEMATOL-HEMATOL J, V95, P785, DOI 10.3324/haematol.2009.014464; Barker PA, 2002, J NEUROSCI RES, V67, P705, DOI 10.1002/jnr.10160; BOEL P, 1995, IMMUNITY, V2, P167, DOI 10.1016/S1074-7613(95)80053-0; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Chen QY, 2004, P NATL ACAD SCI USA, V101, P9363, DOI 10.1073/pnas.0403271101; Chen YT, 1997, CYTOGENET CELL GENET, V79, P237, DOI 10.1159/000134734; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Ching WJ, 2009, ENVIRON MOL MUTAGEN, V50, P697, DOI 10.1002/em.20528; Cho Hearn J, 2006, Cancer Immun, V6, P12; Chomez P, 2001, CANCER RES, V61, P5544; Corboy Michael J., 2005, V301, P305; Cruz CR, 2011, CLIN CANCER RES, V17, P7058, DOI 10.1158/1078-0432.CCR-11-1873; Curioni-Fontecedro A, 2008, LEUKEMIA, V22, P1646, DOI 10.1038/leu.2008.43; Davis ID, 2004, P NATL ACAD SCI USA, V101, P10697, DOI 10.1073/pnas.0403572101; de Carvalho F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027707; Didier C, 2008, MOL BIOL CELL, V19, P1220, DOI 10.1091/mbc.E06-12-1140; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Fabunmi RP, 2000, J BIOL CHEM, V275, P409, DOI 10.1074/jbc.275.1.409; Garcia-Mata R, 1999, J CELL BIOL, V146, P1239, DOI 10.1083/jcb.146.6.1239; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gnjatic S, 2000, P NATL ACAD SCI USA, V97, P10917, DOI 10.1073/pnas.97.20.10917; Gnjatic S, 2006, ADV CANCER RES, V95, P1, DOI 10.1016/S0065-230X(06)95001-5; GOELZ SE, 1985, SCIENCE, V228, P187, DOI 10.1126/science.2579435; Goodyear O, 2010, BLOOD, V116, P1908, DOI 10.1182/blood-2009-11-249474; Graff-Dubois S, 2002, J IMMUNOL, V169, P575, DOI 10.4049/jimmunol.169.1.575; Grizzi F, 2003, J HISTOCHEM CYTOCHEM, V51, P1245, DOI 10.1177/002215540305100916; Hideshima T, 2001, CANCER RES, V61, P3071; Hofmann O, 2008, P NATL ACAD SCI USA, V105, P20422, DOI 10.1073/pnas.0810777105; Jackson HM, 2004, J IMMUNOL METHODS, V291, P51, DOI 10.1016/j.jim.2004.04.017; Jager E, 1998, J EXP MED, V187, P265, DOI 10.1084/jem.187.2.265; Jager E, 2000, P NATL ACAD SCI USA, V97, P4760, DOI 10.1073/pnas.97.9.4760; Jager E, 1999, INT J CANCER, V84, P506, DOI 10.1002/(SICI)1097-0215(19991022)84:5<506::AID-IJC10>3.0.CO;2-6; Johnston JA, 2002, CELL MOTIL CYTOSKEL, V53, P26, DOI 10.1002/cm.10057; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jungbluth AA, 2000, BRIT J CANCER, V83, P493, DOI 10.1054/bjoc.2000.1291; Jungbluth AA, 2002, INT J CANCER, V99, P839, DOI 10.1002/ijc.10416; Jungbluth AA, 2000, INT J CANCER, V85, P460, DOI 10.1002/(SICI)1097-0215(20000215)85:4<460::AID-IJC3>3.0.CO;2-N; Jungbluth AA, 2001, INT J CANCER, V92, P856, DOI 10.1002/ijc.1282; Jungbluth Achim A, 2007, Cancer Immun, V7, P15; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kisseleva-Romanova E, 2006, EMBO J, V25, P3576, DOI 10.1038/sj.emboj.7601235; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Lendvai Nikoletta, 2010, Cancer Immun, V10, P4; Lucas S, 2000, INT J CANCER, V87, P55, DOI 10.1002/1097-0215(20000701)87:1<55::AID-IJC8>3.3.CO;2-A; Lucas S, 1998, CANCER RES, V58, P743; Nelson Peter T, 2007, Cancer Immun, V7, P1; Nicholaou T, 2006, IMMUNOL CELL BIOL, V84, P303, DOI 10.1111/j.1440-1711.2006.01446.x; Rimoldi D, 1999, INT J CANCER, V82, P901, DOI 10.1002/(SICI)1097-0215(19990909)82:6<901::AID-IJC21>3.0.CO;2-X; Sang MX, 2011, CANCER LETT, V302, P85, DOI 10.1016/j.canlet.2010.10.021; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Scanlan MJ, 2002, IMMUNOL REV, V188, P22, DOI 10.1034/j.1600-065X.2002.18803.x; Scanlan MJ, 2002, INT J CANCER, V98, P485, DOI 10.1002/ijc.10276; Serrano A, 2001, INT J CANCER, V94, P243, DOI 10.1002/ijc.1452; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Tapparel C, 2003, GENE, V323, P189, DOI 10.1016/j.gene.2003.09.038; Tinguely M, 2008, CANCER SCI, V99, P720, DOI 10.1111/j.1349-7006.2008.00738.x; Tyagi P, 2009, CLIN LUNG CANCER, V10, P371, DOI 10.3816/CLC.2009.n.052; VANDENEYNDE B, 1995, J EXP MED, V182, P689, DOI 10.1084/jem.182.3.689; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wigley WC, 1999, J CELL BIOL, V145, P481; Xiao J, 2004, WORLD J GASTROENTERO, V10, P1849; Xu HP, 2004, UROLOGY, V64, P826, DOI 10.1016/j.urology.2004.05.012	70	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83212	10.1371/journal.pone.0083212	http://dx.doi.org/10.1371/journal.pone.0083212			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340093	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400127
J	Falke, K; Kruger, P; Hosten, N; Zimpfer, A; Guthoff, R; Langner, S; Stachs, O				Falke, Karen; Krueger, Paul; Hosten, Norbert; Zimpfer, Annette; Guthoff, Rudolf; Langner, Soenke; Stachs, Oliver			Experimental Differentiation of Intraocular Masses Using Ultrahigh-Field Magnetic Resonance Imaging - A Case Series	PLOS ONE			English	Article							CHOROIDAL MELANOMA; ANTERIOR SEGMENT; HUMAN EYE; HUMAN LENS; IN-VIVO; MRI; ACCOMMODATION; SCHEIMPFLUG; TOMOGRAPHY; AREA	Purpose: The case reports presented here were compiled to demonstrate the potential for improved diagnosis and monitoring of disease progress of intraocular lesions using ultrahigh-field magnetic resonance microscopy (MRM) at 7.1 Tesla. Methods: High-resolution ex vivo ocular magnetic resonance (MR) images were acquired on an ultrahigh-field MR system (7.1 Tesla, ClinScan, Bruker BioScan, Germany) using a 2-channel coil with 4 coil elements and T2-weighted turbo spin echo (TSE) sequences of human eyes enucleated because of different intraocular lesions. Imaging parameters were: 40x40 mm field of view, 512x512 matrix, and 700 pm slice thickness. The results were correlated with in vivo ultrasound and histology of the enucleated eyes. Results: Imaging was performed in enucleated eyes with choroidal melanoma, malignant melanoma of iris and ciliary body with scleral perforation, ciliary body melanoma, intraocular metastasis of esophageal cancer, subretinal bleeding in the presence of perforated corneal ulcer, hemorrhagic choroidal detachment, and premature retinopathy with phthisis and ossification of bulbar structures. MR imaging allowed differentiation between solid and cystic tumor components. In case of hemorrhage, fluid-fluid levels were identified. Melanin and calcifications caused significant hypointensity. Microstructural features of eye lesions identified by MRM were confirmed by histology. Conclusion: This study demonstrates the potential of MRM for the visualization and differential diagnosis of intraocular lesions. At present, the narrow bore of the magnet still limits the use of this technology in humans in vivo. Further advances in ultrahigh-field MR imaging will permit visualization of tumor extent and evaluation of nonclassified intraocular structures in the near future.	[Falke, Karen; Guthoff, Rudolf; Stachs, Oliver] Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany; [Krueger, Paul; Hosten, Norbert; Langner, Soenke] Greifswald Univ Hosp, Inst Diagnost Radiol & Neuroradiol, Greifswald, Germany; [Zimpfer, Annette] Univ Rostock, Inst Pathol, D-18055 Rostock, Germany	University of Rostock; University of Rostock	Falke, K (corresponding author), Univ Rostock, Dept Ophthalmol, D-18055 Rostock, Germany.	karen.falke2@uni-rostock.de	Zimpfer, Annette/AAQ-4994-2020; Langner, Soenke/ABB-6744-2021; Krueger, Paul-Christian/AAV-9226-2021	Langner, Soenke/0000-0001-7241-1173; Krueger, Paul-Christian/0000-0002-9545-8115				Aironi V D, 2009, Indian J Radiol Imaging, V19, P109, DOI 10.4103/0971-3026.50827; Berkowitz BA, 2001, MAGN RESON MED, V46, P412, DOI 10.1002/mrm.1206; Bert RJ, 2006, ACAD RADIOL, V13, P368, DOI 10.1016/j.acra.2005.10.023; BRADY LW, 1993, FRONT RADIAT THER ON, V27, P1; Braun RD, 2007, INVEST OPHTH VIS SCI, V48, P963, DOI 10.1167/iovs.06-1156; Damato B, 2006, EXPERT REV ANTICANC, V6, P493, DOI 10.1586/14737140.6.4.493; Georgouli T, 2008, EYE, V22, P994, DOI 10.1038/sj.eye.6702755; Graessl A, 2013, SOC MAG RESON MED, V21, P2747; Gunduz K, 2007, OPHTHALMOLOGICA, V221, P305, DOI 10.1159/000104760; GUTHOFF R, 1992, ACTA OPHTHALMOL, V70, P59; HELLER M, 1982, NEURORADIOLOGY, V23, P23, DOI 10.1007/BF00399701; Hermans EA, 2009, INVEST OPHTH VIS SCI, V50, P281, DOI 10.1167/iovs.08-2124; Hosten N, 1997, AM J NEURORADIOL, V18, P1788; Kim M, 2013, INVEST OPHTH VIS SCI, V54, P6033, DOI 10.1167/iovs.13-12231; Koretz JF, 2004, J OPT SOC AM A, V21, P346, DOI 10.1364/JOSAA.21.000346; Langner S, 2010, INVEST OPHTH VIS SCI, V51, P6575, DOI 10.1167/iovs.09-4865; Mantel I, 2009, AM J OPHTHALMOL, V148, P932, DOI 10.1016/j.ajo.2009.06.032; McCannel TA, 2010, ARCH OPHTHALMOL-CHIC, V128, P1170, DOI 10.1001/archophthalmol.2010.180; Patz S, 2007, J MAGN RESON IMAGING, V26, P510, DOI 10.1002/jmri.21017; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Richdale K, 2009, J MAGN RESON IMAGING, V30, P924, DOI 10.1002/jmri.21959; Say EAT, 2012, J OPHTHALMOL, V2012; SEILER T, 1987, KLIN MONATSBL AUGENH, V191, P203, DOI 10.1055/s-2008-1050494; Shields Carol L, 2005, Curr Opin Ophthalmol, V16, P141, DOI 10.1097/01.icu.0000158258.01681.40; Singh AD, 2004, EYE, V18, P91, DOI 10.1038/sj.eye.6700512; Strenk SA, 2004, INVEST OPHTH VIS SCI, V45, P539, DOI 10.1167/iovs.03-0092; Strenk SA, 2006, J CATARACT REFR SURG, V32, P1792, DOI 10.1016/j.jcrs.2006.05.031; Trick GL, 2008, NMR BIOMED, V21, P1003, DOI 10.1002/nbm.1314	28	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81284	10.1371/journal.pone.0081284	http://dx.doi.org/10.1371/journal.pone.0081284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349051	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200021
J	Ycart, B				Ycart, Bernard			Fluctuation Analysis: Can Estimates Be Trusted?	PLOS ONE			English	Article							DELBRUCK; MUTATION; GROWTH; MUTANTS; DISTRIBUTIONS; DIVISION; NUMBER; CELLS; TIMES	The estimation of mutation rates and relative fitnesses in fluctuation analysis is based on the unrealistic hypothesis that the single-cell times to division are exponentially distributed. Using the classical Luria-Delbruck distribution outside its modelling hypotheses induces an important bias on the estimation of the relative fitness. The model is extended here to any division time distribution. Mutant counts follow a generalization of the Luria-Delbruck distribution, which depends on the mean number of mutations, the relative fitness of normal cells compared to mutants, and the division time distribution of mutant cells. Empirical probability generating function techniques yield precise estimates both of the mean number of mutations and the relative fitness of normal cells compared to mutants. In the case where no information is available on the division time distribution, it is shown that the estimation procedure using constant division times yields more reliable results. Numerical results both on observed and simulated data are reported.	[Ycart, Bernard] Univ Grenoble Alpes, Bernard Ycart Lab Jean Kuntzmann, Grenoble, France; [Ycart, Bernard] CNRS, UMR 5224, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI)	Ycart, B (corresponding author), Univ Grenoble Alpes, Bernard Ycart Lab Jean Kuntzmann, Grenoble, France.	Bernard.Ycart@imag.fr			Laboratoire d'Excellence Toulouse Cancer "TOUCAN", France	Laboratoire d'Excellence Toulouse Cancer "TOUCAN", France	This work was supported by Laboratoire d'Excellence Toulouse Cancer "TOUCAN", France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angerer WP, 2001, MUTAT RES-FUND MOL M, V479, P207, DOI 10.1016/S0027-5107(01)00203-2; ARMITAGE P, 1952, J ROY STAT SOC B, V14, P1; Arnold TB, 2011, R J, V3, P34; Athreya KB, 1972, BRANCHING PROCESSES; Bartlett M.S., 1978, INTRO STOCHASTIC PRO, V3rd ed.; Bean JM, 2006, MOL CELL, V21, P3, DOI 10.1016/j.molcel.2005.10.035; BOE L, 1994, J BACTERIOL, V176, P2781, DOI 10.1128/JB.176.10.2781-2787.1994; CRUMP KS, 1969, J APPL PROBAB, V6, P205, DOI 10.2307/3212288; Deenick EK, 2003, J IMMUNOL, V170, P4963, DOI 10.4049/jimmunol.170.10.4963; Fontaine F, 2008, MOL MICROBIOL, V67, P2, DOI 10.1111/j.1365-2958.2007.05988.x; Foster PL, 2006, METHOD ENZYMOL, V409, P195, DOI 10.1016/S0076-6879(05)09012-9; Hall BM, 2009, BIOINFORMATICS, V25, P1564, DOI 10.1093/bioinformatics/btp253; Hamon A, 2012, ELECTRON J STAT, V6, P1251, DOI 10.1214/12-EJS711; Harris T. E., 1963, THEORY BRANCHING PRO; HARVEY JD, 1972, J GEN MICROBIOL, V70, P99, DOI 10.1099/00221287-70-1-99; JAEGER G, 1995, GENETICA, V96, P217, DOI 10.1007/BF01439575; Jean LW, 2010, COMPUT MATH METHOD M, V11, P239, DOI 10.1080/17486700903535922; John P, 1981, CELL CYCLE; JONES ME, 1993, COMPUT BIOL MED, V23, P525, DOI 10.1016/0010-4825(93)90099-M; JONES ME, 1994, J THEOR BIOL, V166, P355, DOI 10.1006/jtbi.1994.1032; Kelly CD, 1932, J BACTERIOL, V23, P147, DOI 10.1128/JB.23.2.147-153.1932; Kendall D, 1952, ANN I H POINCARE, V13, P43; KENDALL DG, 1948, BIOMETRIKA, V35, P316, DOI 10.1093/biomet/35.3-4.316; KENDALL DG, 1966, J LONDON MATH SOC, V41, P385, DOI 10.1112/jlms/s1-41.1.385; KENDALL DG, 1952, J ROY STAT SOC B, V14, P41; Kimmel M., 2002, BRANCHING PROCESSES; KOCH AL, 1982, MUTAT RES, V95, P129, DOI 10.1016/0027-5107(82)90252-4; KUBITSCHEK HE, 1971, CELL TISSUE KINET, V4, P113, DOI 10.1111/j.1365-2184.1971.tb01522.x; LEA DE, 1949, J GENET, V49, P264, DOI 10.1007/BF02986080; Luria SE, 1943, GENETICS, V28, P491; MA WT, 1992, J APPL PROBAB, V29, P255, DOI 10.2307/3214564; MANDELBROT B, 1974, J APPL PROBAB, V11, P437, DOI 10.2307/3212688; MURPHY JS, 1984, P NATL ACAD SCI-BIOL, V81, P2379, DOI 10.1073/pnas.81.8.2379; Niven GW, 2008, APPL ENVIRON MICROB, V74, P3757, DOI 10.1128/AEM.02551-07; PAKES AG, 1993, J APPL PROBAB, V30, P991, DOI 10.2307/3214530; POWELL EO, 1956, J GEN MICROBIOL, V15, P492, DOI 10.1099/00221287-15-3-492; R Development Core Team, 2008, R LANG ENV STAT COMP; Rahn O, 1932, J GEN PHYSIOL, V15, P257, DOI 10.1085/jgp.15.3.257; Rosche WA, 2000, METHODS, V20, P4, DOI 10.1006/meth.1999.0901; SARKAR S, 1991, GENETICS, V127, P257; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; STEWART FM, 1990, GENETICS, V124, P175; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; Wu XW, 2009, MUTAT RES-FUND MOL M, V661, P101, DOI 10.1016/j.mrfmmm.2008.11.015; Ycart B, 2014, J APPL PROB IN PRESS, V9; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zheng Q, 2005, MATH BIOSCI, V196, P198, DOI 10.1016/j.mbs.2005.03.011; Zheng Q, 2002, MATH BIOSCI, V176, P237, DOI 10.1016/S0025-5564(02)00087-1; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0; Zheng Q, 2010, CHANCE, V23, P15; Zheng Q, 2007, MATH BIOSCI, V209, P500, DOI 10.1016/j.mbs.2007.03.003; Zilman A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012775	52	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80958	10.1371/journal.pone.0080958	http://dx.doi.org/10.1371/journal.pone.0080958			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349026	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200014
J	Choi, YJ; Park, GM; Rho, JK; Kim, SY; So, GS; Kim, HR; Choi, CM; Lee, JC				Choi, Yun Jung; Park, Gun Min; Rho, Jin Kyung; Kim, Sun Ye; So, Gwang Sup; Kim, Hyeong Ryul; Choi, Chang-Min; Lee, Jae Cheol			Role of IGF-Binding Protein 3 in the Resistance of EGFR Mutant Lung Cancer Cells to EGFR-Tyrosine Kinase Inhibitors	PLOS ONE			English	Article							FACTOR-RECEPTOR GENE; ACQUIRED-RESISTANCE; GEFITINIB SENSITIVITY; CLINICAL-SIGNIFICANCE; GROWTH; MUTATIONS; EXPRESSION; THERAPY; PATHWAY; TUMORS	Most patients treated with EGFR-tyrosine kinase inhibitors (EGFR-TKIs) eventually develop acquired resistance. Loss of expression of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) has been suggested as a possible mechanism of resistance to EGFR-TKIs in the A431 and HN11 cell lines. Here, we investigated IGFBP-3 expression in two EGFR mutant lung cancer cell lines with resistance to EGFR-TKIs and examined the value of serum IGFBP-3 level as a marker of resistance. The effect of the induction or suppression of IGFBP-3 expression on resistance was also evaluated. HCC827 sublines with resistance to gefitinib (HCC827/GR) and erlotinib (HCC827/ER) were established. Loss of IGFBP-3 expression was detected by Western blotting in both cell lines without changes in transcriptional activity, and ELISA showed significantly lower amounts of secreted IGFBP-3 in the culture media of the mutant cell lines than in that of the parental line. Despite the loss of IGFBP-3 expression, IGFR signalling activity remained unchanged. Forced expression of IGFBP-3 by adenovirus-mediated transfection or recombinant IGFBP-3 slightly increased the growth-inhibitory and apoptotic effects of EGFR-TKIs, whereas suppression of IGFBP-3 did not affect sensitivity to EGFR-TKI. Serum IGFBP-3 levels measured by ELISA before and after the development of EGFR-TKI resistance in 20 patients showed no significant changes (1815.3 +/- 94.6 ng/mL before treatment vs. 1778.9 +/- 87.8 ng/mL after EGFR-TKI resistance). In summary, although IGFBP-3 downregulation is associated with the acquisition of resistance to EGFR-TKIs regardless of the mechanism, its effect on resistance was not significant, indicating that IGFBP-3 may not play an important role in resistance to EGFR-TKIs and serum IGFBP-3 level is not a reliable indicator of resistance.	[Choi, Yun Jung; Rho, Jin Kyung; Kim, Sun Ye; So, Gwang Sup; Choi, Chang-Min] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Rho, Jin Kyung] Univ Ulsan, Coll Med, Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea; [Kim, Hyeong Ryul] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Choi, Chang-Min; Lee, Jae Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; [Park, Gun Min] Daehan Hosp, Dept Internal Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Lee, JC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea.	jclee@amc.seoul.kr	Lee, Jae Cheol/AAA-2678-2021		Asan Institute for Life Science, Seoul, Korea [2011-467]	Asan Institute for Life Science, Seoul, Korea	This study was supported by a grant (2011-467) from Asan Institute for Life Science, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chang YS, 2002, CLIN CANCER RES, V8, P3669; Chang YS, 2002, CLIN CANCER RES, V8, P3796; Choi YJ, 2010, CANCER CHEMOTH PHARM, V66, P381, DOI 10.1007/s00280-009-1174-7; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dziadziuszko R, 2008, J THORAC ONCOL, V3, P815, DOI 10.1097/JTO.0b013e31818180f5; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Grimberg A, 2000, J CELL PHYSIOL, V183, P1, DOI 10.1002/(SICI)1097-4652(200004)183:1<1::AID-JCP1>3.0.CO;2-J; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Han SW, 2005, J CLIN ONCOL, V23, P2493, DOI 10.1200/JCO.2005.01.388; JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3; Kim YH, 2012, CLIN LUNG CANCER, V13, P385, DOI 10.1016/j.cllc.2011.11.009; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kosaka T, 2006, CLIN CANCER RES, V12, P5764, DOI 10.1158/1078-0432.CCR-06-0714; Lee HY, 2002, CANCER RES, V62, P3530; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Masago K, 2011, ONCOL REP, V26, P795, DOI 10.3892/or.2011.1354; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Rho JK, 2009, MOL CANCER RES, V7, P1736, DOI 10.1158/1541-7786.MCR-08-0504; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; SALOMON DS, 1995, CRIT REV ONCOL HEMAT, V19, P183, DOI 10.1016/1040-8428(94)00144-I; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Takano T, 2005, J CLIN ONCOL, V23, P6829, DOI 10.1200/JCO.2005.01.0793; Takaoka M, 2004, CANCER RES, V64, P7711, DOI 10.1158/0008-5472.CAN-04-0715; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zimmermann EM, 2000, AM J PHYSIOL-GASTR L, V278, pG447, DOI 10.1152/ajpgi.2000.278.3.G447	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81393	10.1371/journal.pone.0081393	http://dx.doi.org/10.1371/journal.pone.0081393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339922	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100052
J	Elango, B; Rajendran, P; Bornmann, L				Elango, Bakthavachalam; Rajendran, Periyaswamy; Bornmann, Lutz			Global Nanotribology Research Output (1996-2010): A Scientometric Analysis	PLOS ONE			English	Article							BIBLIOMETRIC ANALYSIS; NANOMECHANICS; TRENDS; INDEX; MODEL	This study aims to assess the nanotribology research output at global level using scientometric tools. The SCOPUS database was used to retrieve records related to the nanotribology research for the period 1996-2010. Publications were counted on a fractional basis. The level of collaboration and its citation impact were examined. The performance of the most productive countries, institutes and most preferred journals is assessed. Various visualization tools such as the Sci(2) tool and Ucinet were employed. The USA ranked top in terms of number of publications, citations per paper and h-index, while Switzerland published a higher percentage of international collaborative papers. The most productive institution was Tsinghua University followed by Ohio State University and Lanzhou Institute of Chemical Physics, CAS. The most preferred journals were Tribology Letters, Wear and Journal of Japanese Society of Tribologists. The result of author keywords analysis reveals that Molecular Dynamics, MEMS, Hard Disk and Diamond like Carbon are major research topics.	[Elango, Bakthavachalam] IFET Coll Engn, Villupuram, Tamil Nadu, India; [Rajendran, Periyaswamy] SRM Univ, Univ Lib, Kattangulathur, Tamil Nadu, India; [Bornmann, Lutz] Adm Headquarters Max Planck Soc, Div Sci & Innovat Studies, Munich, Germany	SRM Institute of Science & Technology Chennai; Max Planck Society	Bornmann, L (corresponding author), Adm Headquarters Max Planck Soc, Div Sci & Innovat Studies, Munich, Germany.	bornmann@gv.mpg.de	Bornmann, Lutz/A-3926-2008; Periyaswamy, Rajendran/GLQ-7780-2022; Elango, B/H-5722-2013	Bornmann, Lutz/0000-0003-0810-7091; Periyaswamy, Rajendran/0000-0002-6562-344X; Elango, B/0000-0002-8938-0155				ADAR E, 2006, GUESS LANGUAGE INTER; Asha G., 2011, INT J ADV ENG TECH, V2, P300; Ball R., 2006, Information Services & Use, V26, P293; Bhushan B, 2008, PHILOS T R SOC A, V366, P1351, DOI 10.1098/rsta.2007.2163; Bhushan B, 2008, PHILOS T R SOC A, V366, P1499, DOI 10.1098/rsta.2007.2170; Borgatti S.P., 2002, UCINET 6 WINDOWS SOF; Borgatti S.P., 2002, NETDRAW NETWORK VISU; Bornmann L, 2013, EMBO REP, V14, P226, DOI 10.1038/embor.2013.9; Borsi B, 2011, SCIENTOMETRICS, V86, P133, DOI 10.1007/s11192-010-0235-3; Cao Y, 2013, SCIENTOMETRICS, V96, P717, DOI 10.1007/s11192-012-0942-z; Carpick R W, 2008, P STLE ASME INT JOIN; Chiu WT, 2007, SCIENTOMETRICS, V73, P3, DOI 10.1007/s11192-005-1523-1; Chuang KY, 2007, SCIENTOMETRICS, V72, P201, DOI [10.1007/s11192-007-1721-0, 10.1007/s11192-007-1693-0]; Dong BS, 2012, SCIENTOMETRICS, V93, P1101, DOI 10.1007/s11192-012-0730-9; Egghe L, 2006, SCIENTOMETRICS, V69, P121, DOI 10.1007/s11192-006-0143-8; Erman Nusa, 2011, Electronic Journal of e-Government, V9, P141; Fu HZ, 2013, SCI TOTAL ENVIRON, V443, P757, DOI 10.1016/j.scitotenv.2012.11.061; Fu JY, 2012, SCIENTOMETRICS, V93, P1061, DOI 10.1007/s11192-012-0737-2; Gebeshuber I C, 2012, 6 INT COLL MICR OS W; Glanzel W, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P257; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; Jost HP., 1966, LUBRICATION TRIBOLOG; Kademani BS, 2013, SCIENTOMETRICS, V94, P1275, DOI 10.1007/s11192-012-0835-1; Konur O, 2011, APPL ENERG, V88, P3532, DOI 10.1016/j.apenergy.2010.12.059; KRIM J, 1991, PHYS REV LETT, V66, P181, DOI 10.1103/PhysRevLett.66.181; Kumar A, 2011, DESIDOC J LIB INF TE, V31, P452; Lee JD, 2005, HUM FACTORS, V47, P753, DOI 10.1518/001872005775570970; Li JF, 2011, GLOBAL PLANET CHANGE, V77, P13, DOI 10.1016/j.gloplacha.2011.02.005; Malarvizhi R., 2010, World Applied Sciences Journal, V8, P930; Meho LI, 2007, PHYS WORLD, V20, P32; Modak JM, 2008, CURR SCI INDIA, V94, P1265; Ortiz AP, 2009, REV PANAM SALUD PUBL, V25, P353, DOI 10.1590/S1020-49892009000400010; Patra SK, 2006, SCIENTOMETRICS, V67, P477, DOI 10.1556/Scient.67.2006.3.9; Rymuza Z, 2010, SCI PROBLEMS MACHINE, V1, P33; Schubert A, 2007, J INFORMETR, V1, P179, DOI 10.1016/j.joi.2006.12.002; Schubert A, 2007, SCIENTOMETRICS, V70, P201, DOI 10.1007/s11192-007-0112-x; Sci2Team, 2009, SCI SCI SCI TOOL; Simonton DK, 1997, PSYCHOL REV, V104, P66, DOI 10.1037/0033-295X.104.1.66; Sun JS, 2012, MAR POLLUT BULL, V64, P13, DOI 10.1016/j.marpolbul.2011.10.034; Tsay MY, 2008, SCIENTOMETRICS, V75, P421, DOI 10.1007/s11192-007-1785-x; Van Raan AFJ, 2006, SCIENTOMETRICS, V67, P491, DOI 10.1556/Scient.67.2006.3.10; Van Rensselar J, 2009, TRIBOL LUBR TECHNOL, V65, P34; Wang HJ, 2013, SCIENTOMETRICS, V95, P35, DOI 10.1007/s11192-012-0853-z; Ye FY, 2009, SCIENTOMETRICS, V81, P493, DOI 10.1007/s11192-008-2169-6; Yu JJ, 2012, PHOTOSYNTHETICA, V50, P5, DOI 10.1007/s11099-012-0010-1; Zhang GF, 2010, SCIENTOMETRICS, V83, P477, DOI 10.1007/s11192-009-0065-3	46	28	28	6	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81094	10.1371/journal.pone.0081094	http://dx.doi.org/10.1371/journal.pone.0081094			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24339900	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100035
J	Klampfl, MK; Lobinger, BH; Raab, M				Klaempfl, Martin Karl; Lobinger, Babett Helen; Raab, Markus			Reinvestment - the Cause of the Yips?	PLOS ONE			English	Article							FOCAL DYSTONIA; ATTENTION; SKILL; PERFORMANCE; CHOKING; FOCUS; GOLF; BREAKDOWN	The yips is a multi-etiological phenomenon consisting of involuntary movements during the execution of a skill (e. g., a golf putt). Reinvestment, the conscious control of a movement that detrimentally affects automated movements, is thought to be a potential mechanism leading to the yips. Preventing yips-affected golfers from consciously controlling their movement, therefore, should be beneficial. The aim of the study was to be the first to empirically test in a laboratory whether reinvestment causes the yips and to explore if the tendency to reinvest can explain yips behavior. Nineteen yips-affected golfers participated in a lab experiment. They putted with the dominant arm in a skill-focus and an extraneous condition, in which they had to perform different dual tasks designed either to direct their focus on their own skill or to distract them from it. The tendency to reinvest was estimated via the Movement-Specific Reinvestment Scale. Yips behavior was assessed by putting performance and movement variability. Although the dual-task performance showed that the attentional manipulation worked, the tendency to reinvest did not predict the behavior of the yips-affected golfers in either putting condition. The yips-affected golfers also showed no difference in yips behavior between the skill-focus and the extraneous condition. In other words, the attentional manipulation did not change yips behavior. The data do not support the assumption that there is a link between the yips and reinvestment, likely because of the multi-etiological nature of the yips. Other psychological or neurological mechanisms such as conditioned reactions may better explain the yips and should be investigated.	[Klaempfl, Martin Karl; Lobinger, Babett Helen; Raab, Markus] German Sport Univ Cologne, Dept Performance Psychol, Inst Psychol, Cologne, North Rhine Wes, Germany; [Raab, Markus] London S Bank Univ, Dept Appl Sci, London, England	German Sport University Cologne; London South Bank University	Klampfl, MK (corresponding author), German Sport Univ Cologne, Dept Performance Psychol, Inst Psychol, Cologne, North Rhine Wes, Germany.	martin.klaempfl@gmail.com	Raab, Markus/B-4919-2009		German Research Foundation; project "Focal Dystonia in Musicians and Athletes"	German Research Foundation(German Research Foundation (DFG)); project "Focal Dystonia in Musicians and Athletes"	This work was funded by the German Research Foundation (http://www.dfg.de) and is part of a larger project called "Focal Dystonia in Musicians and Athletes". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bawden M, 2001, J SPORT SCI, V19, P937, DOI 10.1080/026404101317108444; Beilock SL, 2012, HUM MOVEMENT SCI, V31, P1473, DOI 10.1016/j.humov.2012.02.014; Beilock SL, 2002, J EXP PSYCHOL-APPL, V8, P6, DOI 10.1037/1076-898X.8.1.6; Button C., 2006, MOVEMENT SYSTEM VARI, VX, P133; Castaneda B, 2007, J SPORT EXERCISE PSY, V29, P60, DOI 10.1123/jsep.29.1.60; Ehrlenspiel F, 2004, PERCEPT MOTOR SKILL, V99, P127, DOI 10.2466/PMS.99.5.127-130; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gray R, 2004, J EXP PSYCHOL-APPL, V10, P42, DOI 10.1037/1076-898X.10.1.42; Hill DM, 2009, EUR J SPORT SCI, V9, P203, DOI 10.1080/17461390902818278; Jancke L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004785; Klampfl MK, 2013, HUM MOVEMENT SCI, DOI [10.1016/j.humov.2013.04.004, DOI 10.1016/J.HUM0V.2013.04.004.PUBMED:24016710]; Kristof W., 1963, ARCH GES PSYCHOL, V115, P230; Lee C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026016; MacMahon, 2008, DEV ELITE SPORTS PER, P104; Marquardt C., 2009, INT J SPORTS SCI COA, V4, P67, DOI [DOI 10.1260/174795409789577506, 10.1260/174795409789577506]; Masters R, 2004, SKILL ACQUISITION SP, P207; Masters R., 2008, INT REV SPORT EXER P, V1, P160, DOI [10.1080/17509840802287218, DOI 10.1080/17509840802287218]; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; MASTERS RSW, 1993, PERS INDIV DIFFER, V14, P655, DOI 10.1016/0191-8869(93)90113-H; MCDANIEL KD, 1989, NEUROLOGY, V39, P192, DOI 10.1212/WNL.39.2.192; Mesagno C, 2010, J APPL SPORT PSYCHOL, V22, P343, DOI 10.1080/10413200.2010.491780; Mesagno C, 2009, J APPL SPORT PSYCHOL, V21, P131, DOI 10.1080/10413200902795091; Philippen PB, 2012, SPORT PSYCHOL, V26, P325, DOI 10.1123/tsp.26.3.325; Pont-Sunyer C, 2010, EUR J NEUROL, V17, P22, DOI 10.1111/j.1468-1331.2010.03046.x; Rotheram M, 2007, J SPORTS SCI, V25, pS5, DOI [10.1080/02640410701619937, DOI 10.1080/02640410701619937]; Rotheram M., 2007, J SPORTS SCI, V25, P323, DOI [10.1080/02640410600958410., DOI 10.1080/02640410600958410]; Rotheram M, 2012, SPORT PSYCHOL, V26, P551, DOI 10.1123/tsp.26.4.551; SACHDEV P, 1992, MOVEMENT DISORD, V7, P326, DOI 10.1002/mds.870070405; Smith AM, 2003, SPORTS MED, V33, P13, DOI 10.2165/00007256-200333010-00002; Smith AM, 2000, SPORTS MED, V30, P423, DOI 10.2165/00007256-200030060-00004; van Beers RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064332; Wulf G, 2007, RES Q EXERCISE SPORT, V78, P384, DOI 10.5641/193250307X13082505158336	32	15	15	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82470	10.1371/journal.pone.0082470	http://dx.doi.org/10.1371/journal.pone.0082470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24340032	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000328566100114
J	Somasekharan, S; Monette, MY; Forbush, B				Somasekharan, Suma; Monette, Michelle Y.; Forbush, Biff			Functional Expression of Human NKCC1 from a Synthetic Cassette-Based cDNA: Introduction of Extracellular Epitope Tags and Removal of Cysteines	PLOS ONE			English	Article							K-CL COTRANSPORTER; FLUORESCENT PROTEIN; REGULATORY PHOSPHORYLATION; EPITHELIAL-CELLS; SENSITIVITY; TERMINUS; VOLUME	The Na-K-Cl cotransporter (NKCC) couples the movement of Na+, K+, and Cl 2 ions across the plasma membrane of most animal cells and thus plays a central role in cellular homeostasis and human physiology. In order to study the structure, function, and regulation of NKCC1 we have engineered a synthetic cDNA encoding the transporter with 30 unique silent restriction sites throughout the open reading frame, and with N-terminal 3xFlag and YFP tags. We show that the novel cDNA is appropriately expressed in HEK-293 cells and that the YFP-tag does not alter the transport function of the protein. Utilizing the Cl- -sensing capability of YFP, we demonstrate a sensitive assay of Na-K-Cl cotransport activity that measures normal cotransport activity in a fully activated transporter. In addition we present three newly developed epitope tags for NKCC1 all of which can be detected from outside of the cell, one of which is very efficiently delivered to the plasma membrane. Finally, we have characterized cysteine mutants of NKCC1 and found that whereas many useful combinations of cysteine mutations are tolerated by the biosynthetic machinery, the fully "cys-less" NKCC1 is retained in the endoplasmic reticulum. Together these advances are expected to greatly assist future studies of NKCC1.	[Somasekharan, Suma; Monette, Michelle Y.; Forbush, Biff] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA	Yale University	Forbush, B (corresponding author), Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA.	biff.forbush@yale.edu			NIH [R01-GM083340, P01-DK17433]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK017433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083340] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants R01-GM083340 and P01-DK17433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Carmosino M, 2008, MOL BIOL CELL, V19, P4341, DOI 10.1091/mbc.E08-05-0478; Carmosino M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-16; Darman RB, 2002, J BIOL CHEM, V277, P37542, DOI 10.1074/jbc.M206293200; Galietta LJV, 2001, FEBS LETT, V499, P220, DOI 10.1016/S0014-5793(01)02561-3; Gimenez I, 2005, AM J PHYSIOL-RENAL, V289, pF1341, DOI 10.1152/ajprenal.00214.2005; Gimenez I, 2006, CURR OPIN NEPHROL HY, V15, P517, DOI 10.1097/01.mnh.0000242178.44576.b0; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Haas M, 2000, ANNU REV PHYSIOL, V62, P515, DOI 10.1146/annurev.physiol.62.1.515; Lytle C, 1998, AM J PHYSIOL-CELL PH, V274, pC1002, DOI 10.1152/ajpcell.1998.274.4.C1002; Lytle C, 1996, AM J PHYSIOL-CELL PH, V270, pC437, DOI 10.1152/ajpcell.1996.270.2.C437; Maglova LM, 1998, AM J PHYSIOL-CELL PH, V275, pC1330, DOI 10.1152/ajpcell.1998.275.5.C1330; Monette Michelle Y, 2012, J Biol Chem, V287, P2210, DOI 10.1074/jbc.M111.309211; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Orlov SN, 2012, ANN MED, V44, pS111, DOI 10.3109/07853890.2011.653395; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Somasekharan S, 2012, J BIOL CHEM, V287, P17308, DOI 10.1074/jbc.M112.356014; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	21	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82060	10.1371/journal.pone.0082060	http://dx.doi.org/10.1371/journal.pone.0082060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339991	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100083
J	Dahmke, IN; Backes, C; Rudzitis-Auth, J; Laschke, MW; Leidinger, P; Menger, MD; Meese, E; Mahlknecht, U				Dahmke, Indra N.; Backes, Christina; Rudzitis-Auth, Jeannette; Laschke, Matthias W.; Leidinger, Petra; Menger, Michael D.; Meese, Eckart; Mahlknecht, Ulrich			Curcumin Intake Affects miRNA Signature in Murine Melanoma with mmu-miR-205-5p Most Significantly Altered	PLOS ONE			English	Article							PANCREATIC-CANCER CELLS; EXPRESSION PROFILES; MICRORNA EXPRESSION; MIR-21 EXPRESSION; GENE-EXPRESSION; ANALOG CDF; LUNG; METASTASIS; TRIAL; CARCINOGENESIS	Melanoma is the most aggressive form of skin cancer with estimated 48,000 deaths per year worldwide. The polyphenol curcumin derived from the plant Curcuma longa is well known for its anti-inflammatory and anti-cancerogenic properties. Accordingly, dietary intake of this compound may be suitable for melanoma prevention. However, how this compound affects basic cellular mechanisms in developing melanoma still remains elusive. Therefore, the aim of this study was to investigate for the first time the impact of oral curcumin administration on the miRNA signature of engrafting melanoma. For this purpose, the effects of a 4% curcumin diet were tested on melanoma, which were established by injection of murine B78H1 cells in the flank of C57BL/6 mice. Curcumin diet or standard chow (control) was administered two weeks prior to injection of tumor cells until termination of the experiment. High throughput chip-based array analysis was deployed to detect alterations in the miRNA signature of the tumors. Curcumin treatment significantly reduced the growth of the flank tumors. Furthermore the miRNA expression signature in tumors was substantially altered by curcumin intake with mmu-miR-205-5p over 100 times higher expressed when compared to controls. The expression levels of identified key miRNAs in the tumor samples were confirmed by quantitative real-time polymerase chain reaction (qRT-PCR). A comparable expression pattern of these miRNAs was also detected in other curcumin-treated melanoma cell lines under in vitro conditions. Putative targets of curcumin-induced up-regulated miRNAs were enriched in `o-glycan biosynthesis', `endoplasmatic reticulum protein processing' and different cancer-related pathways. Western Blot analyses revealed that of these targets anti-apoptotic B-cell CLL/lymphoma 2 (Bcl-2) and proliferating cell nuclear antigen (PCNA) were significantly down-regulated in curcumin-treated tumors. These findings demonstrate a profound alteration of the miRNA expression signature in engrafting curcumin-treated melanoma with mmu-miR-205-5p being up-regulated most significantly.	[Dahmke, Indra N.; Rudzitis-Auth, Jeannette; Laschke, Matthias W.; Menger, Michael D.] Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany; [Backes, Christina; Leidinger, Petra; Meese, Eckart] Univ Saarland, Inst Human Genet, Homburg, Germany; [Mahlknecht, Ulrich] St Lukas Klin, Dept Internal Med Hematol Oncol, Solingen, Germany; [Dahmke, Indra N.; Mahlknecht, Ulrich] Univ Saarland, Dept Internal Med, Div Immunotherapy & Gene Therapy, Med Ctr, Homburg, Germany	Saarland University; Saarland University; Saarland University	Dahmke, IN (corresponding author), Univ Saarland, Inst Clin & Expt Surg, Homburg, Germany.	navina.dahmke@uks.eu	Meese, Eckart Ulrich/ABD-1983-2021		German Jose Carreras Leukemia Foundation [DJCLS R 09/20]	German Jose Carreras Leukemia Foundation	This work was supported by funds from the German Jose Carreras Leukemia Foundation (DJCLS R 09/20) to UM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali S, 2010, CANCER RES, V70, P3606, DOI 10.1158/0008-5472.CAN-09-4598; Alla V, 2012, CELL CYCLE, V11, P3067, DOI 10.4161/cc.21476; Backes C, 2007, NUCLEIC ACIDS RES, V35, pW186, DOI 10.1093/nar/gkm323; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Bao B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017850; Bayet-Robert M, 2010, CANCER BIOL THER, V9, P8, DOI 10.4161/cbt.9.1.10392; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carroll RE, 2011, CANCER PREV RES, V4, P354, DOI 10.1158/1940-6207.CAPR-10-0098; Chitwood DH, 2010, NATURE, V467, P415, DOI 10.1038/nature09351; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Dar AA, 2011, J BIOL CHEM, V286, P16606, DOI 10.1074/jbc.M111.227611; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Friedman JM, 2009, SWISS MED WKLY, V139, P466, DOI smw-12794; Greene SB, 2010, J CELL SCI, V123, P606, DOI 10.1242/jcs.056812; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hlatky L, 2002, JNCI-J NATL CANCER I, V94, P883; Izzotti A, 2012, MUTAT RES-REV MUTAT, V751, P287, DOI 10.1016/j.mrrev.2012.05.004; Izzotti A, 2010, CARCINOGENESIS, V31, P894, DOI 10.1093/carcin/bgq037; Jensen JD, 2010, CLIN DERMATOL, V28, P644, DOI 10.1016/j.clindermatol.2010.03.026; Kanai M, 2011, CANCER CHEMOTH PHARM, V68, P157, DOI 10.1007/s00280-010-1470-2; Keller A, 2011, RNA BIOL, V8, P506, DOI 10.4161/rna.8.3.14994; Kunnumakkara AB, 2008, CANCER LETT, V269, P199, DOI 10.1016/j.canlet.2008.03.009; Leyon PV, 2003, J EXP CLIN CANC RES, V22, P77; Li BL, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0484-0; Limtrakul P, 1997, CANCER LETT, V116, P197, DOI 10.1016/S0304-3835(97)00187-0; Litz J, 2006, MOL CANCER THER, V5, P1415, DOI 10.1158/1535-7163.MCT-05-0503; LOLLINI PL, 1987, CLIN EXP METASTAS, V5, P277, DOI 10.1007/BF00120723; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; NEWCOMB EW, 1978, J CELL PHYSIOL, V95, P169, DOI 10.1002/jcp.1040950206; Nico B, 2008, HISTOL HISTOPATHOL, V23, P601, DOI 10.14670/HH-23.601; Ohuchida K, 2011, ANN SURG ONCOL, V18, P2381, DOI 10.1245/s10434-011-1602-x; Okunieff P, 2006, SEMIN RADIAT ONCOL, V16, P65, DOI 10.1016/j.semradonc.2005.12.001; Phillips JM, 2011, OTOLARYNG HEAD NECK, V145, P58, DOI 10.1177/0194599811400711; Poliseno L, 2012, J INVEST DERMATOL, V132, P1860, DOI 10.1038/jid.2011.451; Sand M, 2013, CELL TISSUE RES, V351, P85, DOI 10.1007/s00441-012-1514-5; Singh M, 2009, MOL CELL BIOCHEM, V325, P107, DOI 10.1007/s11010-009-0025-5; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Subramaniam D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030590; Sun M, 2008, MOL CANCER THER, V7, P464, DOI 10.1158/1535-7163.MCT-07-2272; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Tanabe M., 2012, CURR PROTOC BIOINFOR, V38, DOI [10.1002/0471250953.bi0112s38, DOI 10.1002/0471250953.BI0112S11]; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Yang J, 2010, MED ONCOL, V27, P1114, DOI 10.1007/s12032-009-9344-3; Zhang J, 2010, ONCOL REP, V24, P1217, DOI 10.3892/or_00000975; Zhang X, 2011, ANN ONCOL, V22, P2257, DOI 10.1093/annonc/mdq758	50	44	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81122	10.1371/journal.pone.0081122	http://dx.doi.org/10.1371/journal.pone.0081122			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349037	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800012
J	Houghton, J; Cortes, T; Schubert, O; Rose, G; Rodgers, A; De Ste Croix, M; Aebersold, R; Young, DB; Arnvig, KB				Houghton, Joanna; Cortes, Teresa; Schubert, Olga; Rose, Graham; Rodgers, Angela; De Ste Croix, Megan; Aebersold, Rudolf; Young, Douglas B.; Arnvig, Kristine B.			A Small RNA Encoded in the Rv2660c Locus of Mycobacterium tuberculosis Is Induced during Starvation and Infection	PLOS ONE			English	Article							BACTERIOPHAGE-LAMBDA; LYTIC DEVELOPMENT; VACCINE; PROTEIN; EXPRESSION; GENES	Enhanced transcription of the Rv2660c locus in response to starvation of Mycobacterium tuberculosis H37Rv encouraged addition of the predicted Rv2660c protein to an improved vaccine formulation. Using strand-specific RNA sequencing, we show that the up-regulated transcript is in fact a small RNA encoded on the opposite strand to the annotated Rv2660c. The transcript originates within a prophage and is expressed only in strains that carry PhiRv2. The small RNA contains both host and phage sequences and provides a useful biomarker to monitor bacterial starvation during infection and/or non-replicating persistence. Using different approaches we do not find any evidence of Rv2660c at the level of mRNA or protein. Further efforts to understand the mechanism by which Rv2660c improves efficacy of the H56 vaccine are likely to provide insights into the pathology and immunology of tuberculosis.	[Houghton, Joanna; Cortes, Teresa; Rose, Graham; Rodgers, Angela; De Ste Croix, Megan; Young, Douglas B.; Arnvig, Kristine B.] MRC Natl Inst Med Res, Div Mycobacterial Res, London, England; [Schubert, Olga; Aebersold, Rudolf] ETH, Inst Mol Syst Biol, Zurich, Switzerland	MRC National Institute for Medical Research; Swiss Federal Institutes of Technology Domain; ETH Zurich	Arnvig, KB (corresponding author), UCL, London, England.	karnvig@nimr.mrc.ac.uk	Cortes, Teresa/AAR-5922-2021; Schubert, Olga T./N-1802-2019; Cortes, Teresa/D-1690-2014	Schubert, Olga T./0000-0002-2613-0714; Cortes, Teresa/0000-0002-5746-3300; Rose, Graham/0000-0002-5097-5426; De Ste Croix, Megan/0000-0001-6992-1471; Houghton, Joanna/0000-0001-9820-8122; Arnvig, Kristine/0000-0002-6850-2547	British Medical Research Council [U117581288]; European Union FP7 program [SysteMTb HEALTH-F4-2010-241587]; US National Institutes of Health [RO1 HL106804]; MRC [MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106804] Funding Source: NIH RePORTER	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union FP7 program(European Commission); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the British Medical Research Council ( programme number U117581288) and the European Union FP7 program (SysteMTb HEALTH-F4-2010-241587) and the US National Institutes of Health (RO1 HL106804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Albrethsen J, 2013, MOL CELL PROTEOMICS, V12, P1180, DOI 10.1074/mcp.M112.018846; Argaman L, 2001, CURR BIOL, V11, P941, DOI 10.1016/S0960-9822(01)00270-6; Arnvig KB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002342; Arnvig KB, 2009, MOL MICROBIOL, V73, P397, DOI 10.1111/j.1365-2958.2009.06777.x; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Carver T, 2012, BIOINFORMATICS, V28, P464, DOI 10.1093/bioinformatics/btr703; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Cortes T, 2013, CELL REPORT IN PRESS; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Gengenbacher M, 2010, MICROBIOL-SGM, V156, P81, DOI 10.1099/mic.0.033084-0; Govender L, 2010, VACCINE, V29, P51, DOI 10.1016/j.vaccine.2010.10.022; Hendrix RW, 1999, P NATL ACAD SCI USA, V96, P2192, DOI 10.1073/pnas.96.5.2192; Kelkar DS, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011627, 10.1074/mcp.M111.011445]; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Lamichhane G, 2013, TUBERCULOSIS, V93, P26, DOI 10.1016/j.tube.2012.11.010; Lin PL, 2012, J CLIN INVEST, V122, P303, DOI 10.1172/JCI46252; Los M, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-13; Pellin D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032723; Picotti P, 2012, NAT METHODS, V9, P555, DOI [10.1038/NMETH.2015, 10.1038/nmeth.2015]; Picotti P, 2009, CELL, V138, P795, DOI 10.1016/j.cell.2009.05.051; Rose G, 2013, GENOME BIOL EVOL, V5, P1849, DOI 10.1093/gbe/evt138; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Slominska M, 1999, VIROLOGY, V262, P431, DOI 10.1006/viro.1999.9907; Supply P, 2013, NAT GENET, V45, P172, DOI 10.1038/ng.2517; Tameris M, 2013, TUBERCULOSIS, V93, P143, DOI 10.1016/j.tube.2013.01.003; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Uplekar S, 2013, NUCLEIC ACIDS RES, V41, P961, DOI 10.1093/nar/gks1260; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; WILLIAMS MD, 1991, GENE, V109, P21, DOI 10.1016/0378-1119(91)90584-X; Zheng JH, 2012, J PROTEOMICS, V77, P357, DOI 10.1016/j.jprot.2012.09.010	35	21	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80047	10.1371/journal.pone.0080047	http://dx.doi.org/10.1371/journal.pone.0080047			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24348997	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000328731800002
J	Inceoglu, B; Zolkowska, D; Yoo, HJ; Wagner, KM; Yang, J; Hackett, E; Hwang, SH; Lee, KSS; Rogawski, MA; Morisseau, C; Hammock, BD				Inceoglu, Bora; Zolkowska, Dorota; Yoo, Hyun Ju; Wagner, Karen M.; Yang, Jun; Hackett, Edward; Hwang, Sung Hee; Lee, Kin Sing Stephen; Rogawski, Michael A.; Morisseau, Christophe; Hammock, Bruce D.			Epoxy Fatty Acids and Inhibition of the Soluble Epoxide Hydrolase Selectively Modulate GABA Mediated Neurotransmission to Delay Onset of Seizures	PLOS ONE			English	Article							EPOXYEICOSATRIENOIC ACIDS; INFLAMMATORY PAIN; ARACHIDONIC-ACID; RAT MODEL; BRAIN; RECEPTORS; ACTIVATE; EPILEPSY; DRUGS; CELLS	In the brain, seizures lead to release of large amounts of polyunsaturated fatty acids including arachidonic acid (ARA). ARA is a substrate for three major enzymatic routes of metabolism by cyclooxygenase, lipoxygenase and cytochrome P450 enzymes. These enzymes convert ARA to potent lipid mediators including prostanoids, leukotrienes and epoxyeicosatrienoic acids (EETs). The prostanoids and leukotrienes are largely pro-inflammatory molecules that sensitize neurons whereas EETs are anti-inflammatory and reduce the excitability of neurons. Recent evidence suggests a GABA-related mode of action potentially mediated by neurosteroids. Here we tested this hypothesis using models of chemically induced seizures. The level of EETs in the brain was modulated by inhibiting the soluble epoxide hydrolase (sEH), the major enzyme that metabolizes EETs to inactive molecules, by genetic deletion of sEH and by direct administration of EETs into the brain. All three approaches delayed onset of seizures instigated by GABA antagonists but not seizures through other mechanisms. Inhibition of neurosteroid synthesis by finasteride partially blocked the anticonvulsant effects of sEH inhibitors while the efficacy of an inactive dose of neurosteroid allopregnanolone was enhanced by sEH inhibition. Consistent with earlier findings, levels of prostanoids in the brain were elevated. In contrast, levels of bioactive EpFAs were decreased following seizures. Overall these results demonstrate that EETs are natural molecules which suppress the tonic component of seizure related excitability through modulating the GABA activity and that exploration of the EET mediated signaling in the brain could yield alternative approaches to treat convulsive disorders.	[Inceoglu, Bora; Wagner, Karen M.; Yang, Jun; Hackett, Edward; Hwang, Sung Hee; Lee, Kin Sing Stephen; Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Sacramento, CA 95817 USA; [Inceoglu, Bora; Wagner, Karen M.; Yang, Jun; Hackett, Edward; Hwang, Sung Hee; Lee, Kin Sing Stephen; Morisseau, Christophe; Hammock, Bruce D.] Univ Calif Davis, UC Davis Comprehens Canc Ctr, Sacramento, CA 95817 USA; [Zolkowska, Dorota; Rogawski, Michael A.] Univ Calif Davis, Sch Med, Dept Neurol, Sacramento, CA 95817 USA; [Yoo, Hyun Ju] Asan Inst Life Sci, Biomed Res Ctr, Metabol Core Lab, Seoul, South Korea	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Hammock, BD (corresponding author), Univ Calif Davis, Dept Entomol, Sacramento, CA 95817 USA.	bdhammock@ucdavis.edu	Yang, Jun/B-2262-2010; Rogawski, Michael A/B-6353-2009; Lee, Kin Sing Stephen/I-9476-2012; Zolkowska, Dorota/S-9727-2018; Inceoglu, Bora/G-2892-2015	Yang, Jun/0000-0001-8126-1728; Rogawski, Michael A/0000-0002-3296-8193; Lee, Kin Sing Stephen/0000-0003-4541-3063; Zolkowska, Dorota/0000-0003-1988-0119; Inceoglu, Bora/0000-0002-8473-6036; Hackett, Edward/0000-0002-7344-6076	US National Institute of Environmental Health Sciences (NIEHS) [R01 ES002710]; NIEHS Superfund Basic Research Program [P42 ES004699]; NIEHS [T32ES007059]; National Institute of Neurological Disorders and Stroke (NINDS) [U54 NS079202-01]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R21 AR062866]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR062866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R01ES002710, T32ES007059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS079202] Funding Source: NIH RePORTER	US National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Superfund Basic Research Program; NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by US National Institute of Environmental Health Sciences (NIEHS) Grant R01 ES002710 (to B. D. H.), NIEHS Superfund Basic Research Program P42 ES004699, NIEHS Grant T32ES007059 (to K. W.), National Institute of Neurological Disorders and Stroke (NINDS) U54 NS079202-01 (to M. R. and B. D. H.), National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Grant R21 AR062866 (to B. I. and B. D. H.). B. D. H. is a George and Judy Marcus Senior Fellow of the American Asthma Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu E, 2011, J NEUROCHEM, V117, P632, DOI 10.1111/j.1471-4159.2010.07139.x; Baron A, 1997, J PHYSIOL-LONDON, V504, P537, DOI 10.1111/j.1469-7793.1997.537bd.x; BAZAN NG, 1971, J NEUROCHEM, V18, P1379, DOI 10.1111/j.1471-4159.1971.tb00002.x; BAZAN NG, 1970, LIFE SCI, V9, P501, DOI 10.1016/0024-3205(70)90205-5; Bialer M, 2010, NAT REV DRUG DISCOV, V9, P68, DOI 10.1038/nrd2997; CAMPBELL WB, 1991, ENDOCRINOLOGY, V128, P2183, DOI 10.1210/endo-128-4-2183; CHACOS N, 1983, ARCH BIOCHEM BIOPHYS, V223, P639, DOI 10.1016/0003-9861(83)90628-8; Conroy JL, 2010, NAT NEUROSCI, V13, P284, DOI 10.1038/nn.2497; Fromel T, 2012, P NATL ACAD SCI USA, V109, P9995, DOI 10.1073/pnas.1206493109; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Guedes AGP, 2013, VET ANAESTH ANALG, V40, P440, DOI 10.1111/vaa.12030; Huang RQ, 2001, J PHARMACOL EXP THER, V298, P986; Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004; Inceoglu B, 2006, LIFE SCI, V79, P2311, DOI 10.1016/j.lfs.2006.07.031; Inceoglu B, 2012, P NATL ACAD SCI USA, V109, P11390, DOI 10.1073/pnas.1208708109; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; Inceoglu B, 2008, P NATL ACAD SCI USA, V105, P18901, DOI 10.1073/pnas.0809765105; Jiang HL, 2012, PROSTAG OTH LIPID M, V98, P91, DOI 10.1016/j.prostaglandins.2011.11.008; Kaminski RM, 2004, EPILEPSIA, V45, P864, DOI 10.1111/j.0013-9580.2004.04504.x; KOKATE TG, 1994, J PHARMACOL EXP THER, V270, P1223; Liu JY, 2010, BIOCHEM PHARMACOL, V79, P880, DOI 10.1016/j.bcp.2009.10.025; Loscher W, 1997, PROG NEUROBIOL, V53, P239, DOI 10.1016/S0301-0082(97)00035-X; Morisseau C, 2002, BIOCHEM PHARMACOL, V63, P1599, DOI 10.1016/S0006-2952(02)00952-8; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Rose TE, 2010, J MED CHEM, V53, P7067, DOI 10.1021/jm100691c; Sarkar P, 2011, NEUROSCIENCE, V194, P241, DOI 10.1016/j.neuroscience.2011.07.058; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Sinal CJ, 2000, J BIOL CHEM, V275, P40504, DOI 10.1074/jbc.M008106200; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Trinka E, 2013, EPILEPSIA, V54, P495, DOI 10.1111/epi.12014; Tsai HJ, 2010, EUR J PHARM SCI, V40, P222, DOI 10.1016/j.ejps.2010.03.018; Williams JM, 2010, J CARDIOVASC PHARM, V56, P336, DOI 10.1097/FJC.0b013e3181f04b1c; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n	35	45	49	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80922	10.1371/journal.pone.0080922	http://dx.doi.org/10.1371/journal.pone.0080922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349022	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300014
J	Kuwayama, H; Miyanaga, Y; Urushihara, H; Ueda, M				Kuwayama, Hidekazu; Miyanaga, Yukihiro; Urushihara, Hideko; Ueda, Masahiro			A RabGAP Regulates Life-Cycle Duration via Trimeric G-protein Cascades in Dictyostelium discoideum	PLOS ONE			English	Article							ADENYLYL-CYCLASE; PHAGOSOME MATURATION; ROLES; ACTIVATION; SUBUNIT; TUBBY; DIFFERENTIATION; TRANSFORMATION; MYXAMOEBAE; RECEPTOR	Background: The life-cycle of cellular slime molds comprises chronobiologically regulated processes. During the growth phase, the amoeboid cells proliferate at a definite rate. Upon starvation, they synthesize cAMP as both first and second messengers in signalling pathways and form aggregates, migrating slugs, and fruiting bodies, consisting of spores and stalk cells, within 24 h. In Dictyostelium discoideum, because most growth-specific events cease during development, proliferative and heterochronic mutations are not considered to be interrelated and no genetic factor governing the entire life-cycle duration has ever been identified. Methodology/Principal Findings: Using yeast 2-hybrid library screening, we isolated a Dictyostelium discoideum RabGAP, Dd Rbg-3, as a candidate molecule by which the Dictyostelium G alpha 2 subunit directs its effects. Rab GTPase-activating protein, RabGAP, acts as a negative regulator of Rab small GTPases, which orchestrate the intracellular membrane trafficking involved in cell proliferation. Deletion mutants of Dd rbg-3 exhibited an increased growth rate and a shortened developmental period, while an overexpression mutant demonstrated the opposite effects. We also show that Dd Rbg-3 interacts with 2 G alpha subunits in an activity-dependent manner in vitro. Furthermore, both human and Caenorhabditis elegans rbg-3 homologs complemented the Dd rbg-3-deletion phenotype in D. discoideum, indicating that similar pathways may be generally conserved in multicellular organisms. Conclusions/Significance: Our findings suggest that Dd Rbg-3 acts as a key element regulating the duration of D. discoideum life-span potentially via trimeric G-protein cascades.	[Kuwayama, Hidekazu; Urushihara, Hideko] Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Miyanaga, Yukihiro; Ueda, Masahiro] Osaka Univ, Dept Biol Sci, Grad Sch Sci, Toyonaka, Osaka 560, Japan; [Miyanaga, Yukihiro; Ueda, Masahiro] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Toyonaka, Osaka, Japan; [Ueda, Masahiro] RIKEN, Quantitat Biol Ctr, Osaka, Japan	University of Tsukuba; Osaka University; Japan Science & Technology Agency (JST); RIKEN	Kuwayama, H (corresponding author), Univ Tsukuba, Fac Life & Environm Sci, Tsukuba, Ibaraki, Japan.	hidekuwayama@biol.tsukuba.ac.jp		Ueda, Masahiro/0000-0002-9354-3404; Miyanaga, Yukihiro/0000-0001-7999-6610	Japan Society for the Promotion of Science [22510202]; Institute of Biological Sciences at the University of Tsukuba, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Biological Sciences at the University of Tsukuba, Japan	This work was supported by a Grant-in-Aid for Scientific Research (C) (no. 22510202) from the Japan Society for the Promotion of Science (HK) and by a special fund for tenure-track faculty members of the Institute of Biological Sciences at the University of Tsukuba, Japan (HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Curto E, 2007, BIOCHEM J, V401, P309, DOI 10.1042/BJ20060880; Anjard C, 2001, DEVELOPMENT, V128, P3649; Bakthavatsalam D, 2008, J CELL SCI, V121, P2473, DOI 10.1242/jcs.026682; Bakthavatsalam D, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-44; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; BRENNER M, 1984, DEV BIOL, V101, P136, DOI 10.1016/0012-1606(84)90124-6; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Duhon D, 2002, J MUSCLE RES CELL M, V23, P803, DOI 10.1023/A:1024435913949; Frasa MAM, 2012, NAT REV MOL CELL BIO, V13, P67, DOI 10.1038/nrm3267; GINSBURG GT, 1995, J EUKARYOT MICROBIOL, V42, P200, DOI 10.1111/j.1550-7408.1995.tb01565.x; Heikoop JC, 1998, EUR J BIOCHEM, V256, P359, DOI 10.1046/j.1432-1327.1998.2560359.x; INSALL R, 1994, J CELL BIOL, V126, P1537, DOI 10.1083/jcb.126.6.1537; KESBEKE F, 1988, J CELL BIOL, V107, P521, DOI 10.1083/jcb.107.2.521; KONIJN TM, 1969, J BACTERIOL, V99, P510, DOI 10.1128/JB.99.2.510-512.1969; Kriebel PW, 2008, J CELL BIOL, V183, P949, DOI 10.1083/jcb.200808105; Kriebel PW, 2003, CELL, V112, P549, DOI 10.1016/S0092-8674(03)00081-3; KUMAGAI A, 1989, CELL, V57, P265, DOI 10.1016/0092-8674(89)90964-1; KUWAYAMA H, 1993, J CELL BIOL, V123, P1453, DOI 10.1083/jcb.123.6.1453; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Kuwayama H, 2008, J MOL MICROB BIOTECH, V14, P157, DOI 10.1159/000107371; Kuwayama H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00577; Kuwayama H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006658; MANN SKO, 1992, P NATL ACAD SCI USA, V89, P10701, DOI 10.1073/pnas.89.22.10701; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Mukhopadhyay A, 2007, EMBO REP, V8, P931, DOI 10.1038/sj.embor.7401055; OKAICHI K, 1992, MOL BIOL CELL, V3, P735, DOI 10.1091/mbc.3.7.735; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Parent CA, 1998, CELL, V11, P3218; PITT GS, 1992, CELL, V69, P305, DOI 10.1016/0092-8674(92)90411-5; Raisley B, 2004, DEV BIOL, V265, P433, DOI 10.1016/j.ydbio.2003.09.035; Rupper A, 2001, J CELL SCI, V114, P2449; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; SIMON MN, 1989, EMBO J, V8, P2039, DOI 10.1002/j.1460-2075.1989.tb03612.x; SUTOH K, 1993, PLASMID, V30, P150, DOI 10.1006/plas.1993.1042; Swaney KF, 2010, ANNU REV BIOPHYS, V39, P265, DOI 10.1146/annurev.biophys.093008.131228; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; WATTS DJ, 1970, BIOCHEM J, V119, P171, DOI 10.1042/bj1190171; Williams JG, 2010, GENETICS, V185, P717, DOI 10.1534/genetics.110.119297	38	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81811	10.1371/journal.pone.0081811	http://dx.doi.org/10.1371/journal.pone.0081811			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349132	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300053
J	Chihara, N; Aranami, T; Oki, S; Matsuoka, T; Nakamura, M; Kishida, H; Yokoyama, K; Kuroiwa, Y; Hattori, N; Okamoto, T; Murata, M; Toda, T; Miyake, S; Yamamura, T				Chihara, Norio; Aranami, Toshimasa; Oki, Shinji; Matsuoka, Takako; Nakamura, Masakazu; Kishida, Hitaru; Yokoyama, Kazumasa; Kuroiwa, Yoshiyuki; Hattori, Nobutaka; Okamoto, Tomoko; Murata, Miho; Toda, Tatsushi; Miyake, Sachiko; Yamamura, Takashi			Plasmablasts as Migratory IgG-Producing Cells in the Pathogenesis of Neuromyelitis Optica	PLOS ONE			English	Article							MEMORY B-CELLS; MULTIPLE-SCLEROSIS; MONOCLONAL-ANTIBODIES; INTERLEUKIN-6; AQUAPORIN-4; DEMYELINATION; DISTINCTION; EXPRESSION; GENERATION; CLONING	Neuromyelitis optica (NMO) is an inflammatory disease characterized by recurrent attacks of optic neuritis and myelitis. It is generally accepted that autoantibodies against aquaporin 4 water channel protein play a pathogenic role in neuromyelitis optica. We have recently reported that plasmablasts are increased in the peripheral blood of this autoimmune disease, and are capable of producing autoantibodies against aquaporin 4. Here, we demonstrate that CD138(+)HLA-DR+ plasmablasts, a subset of IgG-producing cells, are increased in the peripheral blood and are enriched among the cerebrospinal fluid (CSF) lymphocytes during the relapse of neuromyelitis optica. Notably, these CD138(+)HLA-DR+ plasmablasts overexpress CXCR3, whose ligands are present in the cerebrospinal fluid during the relapse of neuromyelitis optica. These results led us to speculate that plasmablasts producing anti-aquaporin 4 autoantibodies might traffic toward the central nervous system (CNS). Furthermore, we performed single-cell sorting of plasmablasts from peripheral blood and CSF samples from NMO and sequenced the complementarity-determining regions (CDRs) of the IgG heavy chain expressed by the sorted plasmablast clones. There were high frequencies of mutations in the CDRs compared with framework regions, indicating that these plasmablast clones would represent a post-germinal center B-cell lineage. Consistent with the preceding results, the plasmablast clones from the peripheral blood shared the same CDR sequences with the clones from the CSF. These results indicate that IgG-producing plasmablasts, which are guided by helper T-cells, may migrate from the peripheral blood preferentially to the CSF. Since migratory plasmablasts could be involved in the inflammatory pathology of NMO, the B-cell subset and their migration might be an attractive therapeutic target.	[Chihara, Norio; Aranami, Toshimasa; Oki, Shinji; Matsuoka, Takako; Nakamura, Masakazu; Miyake, Sachiko; Yamamura, Takashi] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Tokyo, Japan; [Chihara, Norio; Toda, Tatsushi] Kobe Univ, Grad Sch Med, Dept Neurol, Kobe, Hyogo 657, Japan; [Kishida, Hitaru; Kuroiwa, Yoshiyuki] Yokohama City Univ, Grad Sch Med, Dept Neurol, Yokohama, Kanagawa 232, Japan; [Yokoyama, Kazumasa; Hattori, Nobutaka] Juntendo Univ, Grad Sch Med, Dept Neurol, Tokyo, Japan; [Okamoto, Tomoko; Murata, Miho] NCNP, Natl Ctr Hosp, Dept Neurol, Tokyo, Japan; [Aranami, Toshimasa; Okamoto, Tomoko; Miyake, Sachiko; Yamamura, Takashi] NCNP, Natl Ctr Hosp, Multiple Sclerosis Ctr, Tokyo, Japan	National Center for Neurology & Psychiatry - Japan; Kobe University; Yokohama City University; Juntendo University; National Center for Neurology & Psychiatry - Japan; National Center for Neurology & Psychiatry - Japan	Yamamura, T (corresponding author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Immunol, Tokyo, Japan.	yamamura@ncnp.go.jp	chihara, norio/GMX-0691-2022; Chihara, Norio/AFW-3477-2022; Hattori, Nobutaka/ACR-0069-2022; yokoyama, kazumasa/AAR-6441-2021; Chihara, Norio/AAU-6956-2020	chihara, norio/0000-0003-4499-0790; 	Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan [247]; Japan Multiple Sclerosis Society; Research Grant on "Super Special Consortia" for Supporting the Development of Cutting-Edge Medical Care from the Cabinet Office [1512]; Government of Japan; Japan Society for the Promotion of Science [18109009]	Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan; Japan Multiple Sclerosis Society; Research Grant on "Super Special Consortia" for Supporting the Development of Cutting-Edge Medical Care from the Cabinet Office; Government of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Health and Labor Sciences Research Grant on Intractable Diseases (Neuroimmunological Diseases) from the Ministry of Health, Labor and Welfare of Japan (http://www.mhlw.go.jp/bunya/kenkyuujigyou/hojokin- koubo16/14.html; No. 247), a Research Grant for Young Researcher from the Japan Multiple Sclerosis Society (http://www.jmss-s.jp; the award in 2011), a Research Grant on "Super Special Consortia" for Supporting the Development of Cutting-Edge Medical Care from the Cabinet Office (http://www.nanbyou.or.jp/entry/1512; No. 1512), Government of Japan, and a Grant-in-Aid for Scientific Research (S) from the Japan Society for the Promotion of Science (https://kaken.nii.ac.jp/d/p/18109009.ja.html; No. 18109009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki M, 2013, MOD RHEUMATOL, V23, P827, DOI 10.1007/s10165-012-0715-9; Ayzenberg I, 2013, JAMA NEUROL, V70, P394, DOI 10.1001/jamaneurol.2013.1246; Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Chihara N, 2011, P NATL ACAD SCI USA, V108, P3701, DOI 10.1073/pnas.1017385108; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Jacobi AM, 2010, ANN RHEUM DIS, V69, P305, DOI 10.1136/ard.2008.096495; Jarius S, 2011, J NEUROL SCI, V306, P82, DOI 10.1016/j.jns.2011.03.038; Jenh CH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-2; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kleiter I, 2012, ARCH NEUROL-CHICAGO, V69, P239, DOI 10.1001/archneurol.2011.216; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; LIEBERSBACH BF, 1994, J BIOL CHEM, V269, P20013; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; Marques CP, 2011, J VIROL, V85, P6136, DOI 10.1128/JVI.00202-11; Mei HE, 2009, BLOOD, V113, P2461, DOI 10.1182/blood-2008-04-153544; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Narikawa K, 2004, J NEUROIMMUNOL, V149, P182, DOI 10.1016/j.jneuroim.2003.12.010; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Okada K, 2010, NEUROLOGY, V74, P177, DOI 10.1212/WNL.0b013e3181c919ee; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Ratelade J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027412; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Takano R, 2010, NEUROLOGY, V75, P208, DOI 10.1212/WNL.0b013e3181e2414b; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Uzawa A, 2010, MULT SCLER J, V16, P1443, DOI 10.1177/1352458510379247; Warabi Y, 2007, J NEUROL SCI, V252, P57, DOI 10.1016/j.jns.2006.10.008; Wingerchuk DM, 2006, NEUROLOGY, V66, P1485, DOI 10.1212/01.wnl.0000216139.44259.74; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8; Wingerchuk DM, 1999, NEUROLOGY, V53, P1107, DOI 10.1212/WNL.53.5.1107; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	34	45	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83036	10.1371/journal.pone.0083036	http://dx.doi.org/10.1371/journal.pone.0083036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340077	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400113
J	Drake, TK; Shah, T; Peters, JJ; Wax, A; Katz, DF				Drake, Tyler K.; Shah, Tejen; Peters, Jennifer J.; Wax, Adam; Katz, David F.			Measuring Dilution of Microbicide Gels with Optical Imaging	PLOS ONE			English	Article							COHERENCE INTERFEROMETRY INSTRUMENT; VAGINAL FLUID	We present a novel approach for measuring topical microbicide gel dilution using optical imaging. The approach compares gel thickness measurements from fluorimetry and multiplexed low coherence interferometry in order to calculate dilution of a gel. As a microbicide gel becomes diluted at fixed thickness, its mLCI thickness measurement remains constant, while the fluorimetry signal decreases in intensity. The difference between the two measurements is related to the extent of gel dilution. These two optical modalities are implemented in a single endoscopic instrument that enables simultaneous data collection. A preliminary validation study was performed with in vitro placebo gel measurements taken in a controlled test socket. It was found that change in slope of the regression line between fluorimetry and mLCI based measurements indicates dilution. A dilution calibration curve was then generated by repeating the test socket measurements with serial dilutions of placebo gel with vaginal fluid simulant. This methodology can provide valuable dilution information on candidate microbicide products, which could substantially enhance our understanding of their in vivo functioning.	[Drake, Tyler K.; Shah, Tejen; Peters, Jennifer J.; Wax, Adam; Katz, David F.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Katz, David F.] Duke Univ, Dept Obstet & Gynecol, Durham, NC USA	Duke University; Duke University	Drake, TK (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	tkd3@duke.edu		Wax, Adam/0000-0002-1827-5112	National Institutes of Health [U19-AI 077289]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI077289] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health Grant No. U19-AI 077289. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDOOL KQ, 2010, SCIENCE, V329, P1168, DOI DOI 10.1126/SCIENCE.1193748; CONRAD, 2012, SAF EFF TEN GEL PREV; Deming WE, 1943, DATA REDUCTION ERROR; Drake TK, 2013, THESIS; Drake TK, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116014; Drake TK, 2011, BIOMED OPT EXPRESS, V2, P2850, DOI 10.1364/BOE.2.002850; Drake TK, 2009, APPL OPTICS, V48, pD14, DOI 10.1364/AO.48.000D14; Henderson MH, 2007, CONTRACEPTION, V75, P142, DOI 10.1016/j.contraception.2006.08.014; Henderson MH, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1863832; Katz DF, 2011, DRUG DELIV TRANSL RE, V1, P256, DOI 10.1007/s13346-011-0029-z; Krystek M, 2007, MEAS SCI TECHNOL, V18, P3438, DOI 10.1088/0957-0233/18/11/025; Lai BE, 2008, J PHARM SCI-US, V97, P1030, DOI 10.1002/jps.21132; Network MT, 2011, MTN STATEMENT DECISI; Owen DH, 1999, CONTRACEPTION, V59, P91, DOI 10.1016/S0010-7824(99)00010-4; Tasoglu S, 2012, J NON-NEWTON FLUID, V187, P36, DOI 10.1016/j.jnnfm.2012.08.008; Tasoglu S, 2011, PHYS FLUIDS, V23, DOI 10.1063/1.3633337; Vermund SH, 2011, SCIENCE, V331, P284, DOI 10.1126/science.331.6015.284-a; YORK D, 1966, CAN J PHYS, V44, P1079, DOI 10.1139/p66-090	18	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82213	10.1371/journal.pone.0082213	http://dx.doi.org/10.1371/journal.pone.0082213			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340006	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400064
J	Ganna, A; Ortega-Alonso, A; Havulinna, A; Salomaa, V; Kaprio, J; Pedersen, NL; Sullivan, PF; Ingelsson, E; Hultman, CM; Magnusson, PKE				Ganna, Andrea; Ortega-Alonso, Alfredo; Havulinna, Aki; Salomaa, Veikko; Kaprio, Jaakko; Pedersen, Nancy L.; Sullivan, Patrick F.; Ingelsson, Erik; Hultman, Christina M.; Magnusson, Patrik K. E.			Utilizing Twins as Controls for Non-Twin Case-Materials in Genome Wide Association Studies	PLOS ONE			English	Article							LOCI; POPULATION; RISK; REPLICATION; VARIANTS	Twin registries around the globe have collected DNA samples from large numbers of monozygotic and dizygotic twins. The twin sample collections are frequently used as controls in disease-specific studies together with non-twins. This approach is unbiased under the hypothesis that twins and singletons are comparable in terms of allele frequencies; i.e. there are no genetic variants associated with being a twin per se. To test this hypothesis we performed a genome-wide association study comparing the allele frequency of 572,352 single nucleotide polymorphisms (SNPs) in 1,413 monozygotic (MZ) and 5,451 dizygotic (DZ) twins with 3,720 healthy singletons. Twins and singletons have been genotyped using the same platform. SNPs showing association with being a twin at P-value < 1 x 10(-5) were selected for replication analysis in 1,492 twins (463 MZ and 1,029 DZ) and 1,880 singletons from Finland. No SNPs reached genome-wide significance (P-value < 5 x 10(-8)) in the main analysis combining MZ and DZ twins. In a secondary analysis including only DZ twins two SNPs (rs2033541 close to ADAMTSL1 and rs4149283 close to ABCA1) were genome-wide significant after meta-analysis with the Finnish population. The estimated proportion of variance on the liability scale explained by all SNPs was 0.08 (P-value=0.003) when MZ and DZ were considered together and smaller for MZ (0.06, P-value=0.10) compared to DZ (0.09, P-value=0.003) when analyzed separately. In conclusion, twins and singletons can be used in genetic studies together with general population samples without introducing large bias. Further research is needed to explore genetic variances associated with DZ twinning.	[Ganna, Andrea; Pedersen, Nancy L.; Hultman, Christina M.; Magnusson, Patrik K. E.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Ortega-Alonso, Alfredo; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med FIMM, Helsinki, Finland; [Havulinna, Aki; Salomaa, Veikko] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Helsinki, Finland; [Sullivan, Patrick F.] Univ N Carolina, FRANZCP, Dept Genet, Chapel Hill, NC USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA; [Ingelsson, Erik] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Karolinska Institutet; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Uppsala University	Magnusson, PKE (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	Patrik.Magnusson@ki.se	Havulinna, Aki/AAM-4769-2021; Kaprio, Jaakko/A-1820-2008; Magnusson, Patrik KE/C-4458-2017	Kaprio, Jaakko/0000-0002-3716-2455; Magnusson, Patrik KE/0000-0002-7315-7899; Ganna, Andrea/0000-0002-8147-240X	Ministry for Higher Education; Swedish Research Council [M-2005-1112, 2009-2298]; GenomEUtwin [EU/QLRT-2001-01254, QLG2-CT-2002-01254]; National Institutes of Health [DK U01-066134]; Swedish Foundation for Strategic Research (SSF) [ICA08-0047]; Stanley Center for Psychiatric Research; Sylvan Herman Foundation; National Institute of Mental Health [R01 MH077139]; Swedish Research Council; Academy of Finland Center of Excellence in Complex Disease Genetics [213506, 129680]; Academy of Finland [100499, 205585, 118555, 141054]; Pfizer Inc. (GRAND); European Network for Genetic and Genomic Epidemiology [201413, DA12854, AA-12502, AA-00145, AA-09203, AA15416, K02AA018755]; Wellcome Trust Sanger Institute for genotyping; Finland Distinguished Professor Programme of the Academy of Finland [139904]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK066134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH077139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA012502, R01AA009203, R01AA015416, R01AA012502, K02AA018755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012854, R56DA012854] Funding Source: NIH RePORTER	Ministry for Higher Education; Swedish Research Council(Swedish Research CouncilEuropean Commission); GenomEUtwin; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); Stanley Center for Psychiatric Research; Sylvan Herman Foundation; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); Academy of Finland(Academy of Finland); Pfizer Inc. (GRAND)(Pfizer); European Network for Genetic and Genomic Epidemiology; Wellcome Trust Sanger Institute for genotyping; Finland Distinguished Professor Programme of the Academy of Finland; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	TwinGene was supported by grants from the Ministry for Higher Education, the Swedish Research Council (M-2005-1112 and 2009-2298), GenomEUtwin (EU/QLRT-2001-01254; QLG2-CT-2002-01254), National Institutes of Health (grant DK U01-066134) and the Swedish Foundation for Strategic Research (SSF; ICA08-0047). The Swedish schizophrenia study was supported by: Stanley Center for Psychiatric Research, the Sylvan Herman Foundation, National Institute of Mental Health R01 MH077139 and the Swedish Research Council. The Finnish Twin Cohort data collections and genotyping have been supported by Academy of Finland Center of Excellence in Complex Disease Genetics (grant numbers: 213506, 129680), the Academy of Finland (grants 100499, 205585, 118555, and 141054 to JK), Global Research Awards for Nicotine Dependence from Pfizer Inc. (GRAND), European Network for Genetic and Genomic Epidemiology, FP7-HEALTH-F4-2007, grant agreement number 201413, DA12854 to P A F Madden, and AA-12502, AA-00145, and AA-09203 to RJRose, AA15416 and K02AA018755 to DM Dick. The authors acknowledge the support of the Wellcome Trust Sanger Institute for genotyping. AO-A has been supported by the Finland Distinguished Professor Programme of the Academy of Finland (grant number: 139904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Barker D. J. P., 1998, MOTHERS BABIES HLTH, Vix; Christensen K, 2001, Twin Res, V4, P344, DOI 10.1375/twin.4.5.344; Cornes BK, 2009, INT J OBESITY, V33, P75, DOI 10.1038/ijo.2008.223; de Geus E J, 2001, Twin Res, V4, P385, DOI 10.1375/twin.4.5.385; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Hur YM, 2013, TWIN RES HUM GENET, V16, P1, DOI 10.1017/thg.2012.147; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Keith LG, 1995, MULTIPLE PREGNANCY E, Vxxiii; Kim YJ, 2011, NAT GENET, V43, P990, DOI 10.1038/ng.939; Kulathinal Sangita, 2007, Epidemiol Perspect Innov, V4, P15; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lewis CM, 1996, AM J MED GENET, V61, P237, DOI 10.1002/(SICI)1096-8628(19960122)61:3<237::AID-AJMG7>3.0.CO;2-R; Liu JZ, 2010, TWIN RES HUM GENET, V13, P179, DOI 10.1375/twin.13.2.179; Luong HTT, 2011, TWIN RES HUM GENET, V14, P408, DOI 10.1375/twin.14.5.408; MacGillivray I, 1988, TWINNING TWINS, pviii; Magnusson PKE, 2013, TWIN RES HUM GENET, V16, P317, DOI 10.1017/thg.2012.104; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Moayyeri A, 2013, TWIN RES HUM GENET, V16, P144, DOI 10.1017/thg.2012.89; Montgomery GW, 2004, TWIN RES, V7, P548, DOI 10.1375/1369052042663823; Naukkarinen J, 2012, INT J OBESITY, V36, P1017, DOI 10.1038/ijo.2011.192; Oberg S, 2012, INT J EPIDEMIOL, V41, P1002, DOI 10.1093/ije/dys067; Painter JN, 2010, HUM REPROD, V25, P1569, DOI 10.1093/humrep/deq084; PARISI P, 1983, NATURE, V304, P626, DOI 10.1038/304626a0; POWERS WF, 1994, AM J OBSTET GYNECOL, V170, P456, DOI 10.1016/S0002-9378(94)70211-X; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; van Dongen J, 2012, NAT REV GENET, V13, P640, DOI 10.1038/nrg3243; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Visscher PM, 2008, EUR J HUM GENET, V16, P387, DOI 10.1038/sj.ejhg.5201990; Visscher PM, 2006, PLOS GENET, V2, P316, DOI 10.1371/journal.pgen.0020041; Yang Jian, 2013, Methods Mol Biol, V1019, P215, DOI 10.1007/978-1-62703-447-0_9	34	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83101	10.1371/journal.pone.0083101	http://dx.doi.org/10.1371/journal.pone.0083101			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340086	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400121
J	McKinney, BA; White, BC; Grill, DE; Li, PW; Kennedy, RB; Poland, GA; Oberg, AL				McKinney, Brett A.; White, Bill C.; Grill, Diane E.; Li, Peter W.; Kennedy, Richard B.; Poland, Gregory A.; Oberg, Ann L.			ReliefSeq: A Gene-Wise Adaptive-K Nearest-Neighbor Feature Selection Tool for Finding Gene-Gene Interactions and Main Effects in mRNA-Seq Gene Expression Data	PLOS ONE			English	Article							CANALIZATION; NETWORK	Relief-F is a nonparametric, nearest-neighbor machine learning method that has been successfully used to identify relevant variables that may interact in complex multivariate models to explain phenotypic variation. While several tools have been developed for assessing differential expression in sequence-based transcriptomics, the detection of statistical interactions between transcripts has received less attention in the area of RNA-seq analysis. We describe a new extension and assessment of Relief-F for feature selection in RNA-seq data. The ReliefSeq implementation adapts the number of nearest neighbors (k) for each gene to optimize the Relief-F test statistics (importance scores) for finding both main effects and interactions. We compare this gene-wise adaptive-k (gwak) Relief-F method with standard RNA-seq feature selection tools, such as DESeq and edgeR, and with the popular machine learning method Random Forests. We demonstrate performance on a panel of simulated data that have a range of distributional properties reflected in real mRNA-seq data including multiple transcripts with varying sizes of main effects and interaction effects. For simulated main effects, gwak-Relief-F feature selection performs comparably to standard tools DESeq and edgeR for ranking relevant transcripts. For gene-gene interactions, gwak-Relief-F outperforms all comparison methods at ranking relevant genes in all but the highest fold change/highest signal situations where it performs similarly. The gwak-Relief-F algorithm outperforms Random Forests for detecting relevant genes in all simulation experiments. In addition, Relief-F is comparable to the other methods based on computational time. We also apply ReliefSeq to an RNA-Seq study of smallpox vaccine to identify gene expression changes between vaccinia virus-stimulated and unstimulated samples. ReliefSeq is an attractive tool for inclusion in the suite of tools used for analysis of mRNA-Seq data; it has power to detect both main effects and interaction effects. Software Availability: http://insilico.utulsa.edu/ReliefSeq.php.	[McKinney, Brett A.; White, Bill C.] Univ Tulsa, Dept Math, Tandy Sch Comp Sci, Tulsa, OK 74104 USA; [McKinney, Brett A.] Laureate Inst Brain Res, Tulsa, OK USA; [Grill, Diane E.; Li, Peter W.; Oberg, Ann L.] Mayo Clin, Dept Hlth Sci Res, Div Biomed Stat & Informat, Rochester, MN USA; [Grill, Diane E.; Li, Peter W.; Kennedy, Richard B.; Poland, Gregory A.; Oberg, Ann L.] Mayo Clin, Vaccine Res Grp, Rochester, MN USA; [Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Dept Med, Rochester, MN USA; [Kennedy, Richard B.; Poland, Gregory A.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA	University of Tulsa; Laureate Institute for Brain Research, Inc.; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	McKinney, BA (corresponding author), Univ Tulsa, Dept Math, Tandy Sch Comp Sci, Tulsa, OK 74104 USA.	brett.mckinney@gmail.com		White, Bill/0000-0002-0684-5210; Kennedy, Rick/0000-0001-6164-4967	National Institute of Allergy And Infectious Diseases of the National Institutes of Health, Department of Health and Human Services [U01AI089859, U01IOFAI89859, R01AI33144, HHSN266200400065C (N01AI40065)]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033144, U01AI089859] Funding Source: NIH RePORTER	National Institute of Allergy And Infectious Diseases of the National Institutes of Health, Department of Health and Human Services; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy And Infectious Diseases of the National Institutes of Health, Department of Health and Human Services under award numbers U01AI089859, U01IOFAI89859, R01AI33144 and under contract number HHSN266200400065C (N01AI40065). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Chen X, 2007, P NATL ACAD SCI USA, V104, P19199, DOI 10.1073/pnas.0709868104; Davis NA, 2010, GENES IMMUN, V11, P630, DOI 10.1038/gene.2010.37; de la Fuente A, 2010, TRENDS GENET, V26, P326, DOI 10.1016/j.tig.2010.05.001; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Greene CS, 2009, BIODATA MIN, V2, DOI 10.1186/1756-0381-2-5; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Haralambieva IH, 2013, PLOS ONE IN PRESS; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Kennedy RB, 2013, GENES IMMUN, V14, P277, DOI 10.1038/gene.2013.14; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Kononenko I., 1994, EUR C MACH LEARN, V784, P171, DOI DOI 10.1007/3-540-57868-4_57; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Li J, 2012, BIOSTATISTICS, V13, P523, DOI 10.1093/biostatistics/kxr031; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McKinney BA, 2007, BIOINFORMATICS, V23, P2113, DOI 10.1093/bioinformatics/btm317; McKinney BA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000432; Milton CC, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000075; Moore JH, 2007, LECT NOTES COMPUT SC, V4447, P166; Oberg AL, 2012, BMC GENOMICS, V13, P2, DOI 10.1186/1471-2164-13-304; Pandey A, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.80; Park S, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.2; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robnik-Sikonja M, 2003, MACH LEARN, V53, P23, DOI 10.1023/A:1025667309714; Siegal ML, 2002, P NATL ACAD SCI USA, V99, P10528, DOI 10.1073/pnas.102303999; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; White BC, 2013, GENET EPIDEMIOL; Winham SJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-164	34	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81527	10.1371/journal.pone.0081527	http://dx.doi.org/10.1371/journal.pone.0081527			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339943	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400023
J	Llana, MN; Sarnacki, SH; Castaneda, MDA; Bernal, MI; Giacomodonato, MN; Cerquetti, MC				Noto Llana, Mariangeles; Hernan Sarnacki, Sebastian; Aya Castaneda, Maria del Rosario; Isabel Bernal, Maria; Nancy Giacomodonato, Monica; Cristina Cerquetti, Maria			Consumption of Lactobacillus casei Fermented Milk Prevents Salmonella Reactive Arthritis by Modulating IL-23/IL-17 Expression	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; DELTA-T-CELLS; CROHNS-DISEASE; INNATE IMMUNITY; CUTTING EDGE; NK CELLS; INFLAMMATION; MECHANISMS; SECRETION; COLITIS	Reactive arthritis is the development of sterile joint inflammation as a sequel to a remote infection, often in the gut. We have previously shown that a low dose of S. enteritidis inoculated to streptomycin-pretreated mice generates a self-limiting enterocolitis suitable for studying reactive arthritis. Here we show that consumption of Lactobacillus casei prior to infection abolishes intestinal and joint inflammation triggered by Salmonella. BALB/c mice were sacrificed after infection; intestinal and joint samples were analyzed for histological changes and expression of cytokines. TNF-alpha was measured by ELISA and the expression of IL-1 beta, IL-6, IL-10, IL-17, IL-23 and TGF-beta was assessed by qPCR. L. casei consumption prevented Salmonella-induced synovitis, the increment of TNF-alpha in knees and the increase of IL-17 expression in popliteal and inguinal lymph nodes. At intestinal level consumption of L. casei drastically diminished S. enteritidis invasiveness and shortened splenic persistence of the pathogen. Bacterial loads recovered at days 2 and 5 from Peyer's patches were 10-fold lower in mice fed with L. casei. In accordance, we found that the augment in gut permeability induced during enterocolitis was decreased in those animals. Consumption of L. casei prior to infection failed to increase anti-inflammatory molecules such as IL-10 and TGF-beta in the intestine. On the other hand, consumption of L. casei abrogated the expression of TNF-alpha, IL-17, IL-23, IL-1 beta and IL-6 in cecum and mesenteric lymph nodes. These cytokines are needed for differentiation of immune cells involved in the development of reactive arthritis such as Th17 and gamma delta T cells. Trafficking of these inflammatory cells from the gut to the joints has been proposed as a mechanism of generation of reactive arthritis. Our results suggest that L. casei consumption prevents Salmonella-induced synovitis by altering the intestinal milieu necessary for differentiation of cells involved in the generation of joint inflammation.	[Noto Llana, Mariangeles] Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med IMPaM CONICET, Buenos Aires, DF, Argentina; Univ Buenos Aires, Fac Med, Dept Microbiol Parasitol & Inmunol, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Llana, MN (corresponding author), Univ Buenos Aires, Fac Med, Inst Microbiol & Parasitol Med IMPaM CONICET, Buenos Aires, DF, Argentina.	mnotollana@yahoo.com; ccerquetti@fmed.uba.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina [PIP 2012-2014 GI]; Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina [UBACyT M009, 20020100100541]	Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina(Secretaria de Ciencia y Tecnologia (SECYT))	This work was supported in part by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas, Argentina (PIP 2012-2014 GI), and Secretaria de Ciencia y Tecnica de la Universidad de Buenos Aires, Argentina (UBACyT M009 and 20020100100541). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mossawi MH, 2013, CURR OPIN RHEUMATOL, V25, P434, DOI 10.1097/BOR.0b013e3283620163; Atorrasagasti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054962; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Bi Y, 2012, SCAND J IMMUNOL, V75, P543, DOI 10.1111/j.1365-3083.2012.02686.x; Bjarnason I, 2003, GASTROENTEROLOGY, V125, P1598, DOI 10.1053/j.gastro.2003.08.035; Borruel N, 2002, GUT, V51, P659, DOI 10.1136/gut.51.5.659; Borruel N, 2003, AM J GASTROENTEROL, V98, P865, DOI 10.1111/j.1572-0241.2003.07384.x; Boyle EC, 2006, CELL MICROBIOL, V8, P1946, DOI 10.1111/j.1462-5822.2006.00762.x; Caccamo N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041940; Castillo NA, 2013, J APPL MICROBIOL, V114, P861, DOI 10.1111/jam.12074; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chessa D, 2009, MOL MICROBIOL, V71, P864, DOI 10.1111/j.1365-2958.2008.06566.x; Chung YW, 2008, CLIN EXP IMMUNOL, V151, P182, DOI 10.1111/j.1365-2249.2007.03549.x; Ciccia F, 2012, ARTHRITIS RHEUM-US, V64, P1869, DOI 10.1002/art.34355; Colmegna I, 2004, CLIN MICROBIOL REV, V17, P348, DOI 10.1128/CMR.17.2.348-369.2004; de Moreno de Leblanc Alejandra, 2011, ISRN Gastroenterol, V2011, P892971, DOI 10.5402/2011/892971; Dhanoa A, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-15; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; dos Santos Luciana Ruschel, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P247, DOI 10.1590/S0036-46652001000500002; Egan PJ, 2008, ARTHRITIS RHEUM-US, V58, P3720, DOI 10.1002/art.24075; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fabrega A, 2013, CLIN MICROBIOL REV, V26, P308, DOI 10.1128/CMR.00066-12; Giacomodonato MN, 2009, FEMS MICROBIOL LETT, V292, P71, DOI 10.1111/j.1574-6968.2008.01473.x; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Guerin-Danan C, 1998, AM J CLIN NUTR, V67, P111, DOI 10.1093/ajcn/67.1.111; Guo YY, 2013, CHINESE MED J-PEKING, V126, P850, DOI 10.3760/cma.j.issn.0366-6999.20113093; Gupta P, 2000, J PEDIATR GASTR NUTR, V31, P453, DOI 10.1097/00005176-200010000-00024; Hacini-Rachinel F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004903; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hovsepian E, 2010, SHOCK, V34, P60, DOI 10.1097/SHK.0b013e3181cdc398; Inoue R, 2007, FEMS IMMUNOL MED MIC, V50, P67, DOI 10.1111/j.1574-695X.2007.00233.x; Jacques P, 2008, MUCOSAL IMMUNOL, V1, P364, DOI 10.1038/mi.2008.24; Jacques P, 2007, CURR OPIN RHEUMATOL, V19, P353, DOI 10.1097/BOR.0b013e328133f59f; Jacques P, 2010, CURR OPIN RHEUMATOL, V22, P368, DOI 10.1097/BOR.0b013e3283393807; Jeon Seong Gyu, 2012, PLoS Pathog, V8, pe1002714, DOI 10.1371/journal.ppat.1002714; Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Lee YK, 2002, BRIT J NUTR, V88, pS101, DOI 10.1079/BJN2002635; Lee YK., 1999, HDB PROBIOTICS; Liu ZH, 2011, MOL BIOL REP, V38, P1353, DOI 10.1007/s11033-010-0237-5; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Llana MN, 2012, INFECT IMMUN, V80, P2231, DOI 10.1128/IAI.00324-12; Llana MN, 2009, MICROBES INFECT, V11, P74, DOI 10.1016/j.micinf.2008.10.010; Oozeer R, 2002, APPL ENVIRON MICROB, V68, P3570, DOI 10.1128/AEM.68.7.3570-3574.2002; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Pedone CA, 1999, INT J CLIN PRACT, V53, P179; Pedone CA, 2000, INT J CLIN PRACT, V54, P568; Perdigon G, 1999, J DAIRY SCI, V82, P1108, DOI 10.3168/jds.S0022-0302(99)75333-6; Peritt D, 1998, J IMMUNOL, V161, P5821; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Raymond B, 2013, TRENDS MICROBIOL, V21, P430, DOI 10.1016/j.tim.2013.06.008; Reiff C, 2009, INFLAMM BOWEL DIS, V15, P1721, DOI 10.1002/ibd.20999; Rodriguez-Diaz J, 2012, APPL ENVIRON MICROB, V78, P4613, DOI 10.1128/AEM.00474-12; Salminen S, 1998, INT J FOOD MICROBIOL, V44, P93, DOI 10.1016/S0168-1605(98)00128-7; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schulz SM, 2008, INT IMMUNOL, V20, P1129, DOI 10.1093/intimm/dxn069; Servin AL, 2004, FEMS MICROBIOL REV, V28, P405, DOI 10.1016/j.femsre.2004.01.003; Sherlock JP, 2012, NAT MED, V18, P1069, DOI 10.1038/nm.2817; Sinha R, 2003, J RHEUMATOL, V30, P105; Srikanth CV, 2007, IMMUNOL RES, V37, P61, DOI 10.1007/BF02686090; Wang Q, 2001, AM J PHYSIOL-REG I, V281, pR1013, DOI 10.1152/ajpregu.2001.281.3.R1013; Wang XW, 2009, RHEUMATOL INT, V29, P1343, DOI 10.1007/s00296-009-0883-x; Wendling D, 2010, RHEUMATOL INT, V30, P1547, DOI 10.1007/s00296-009-1226-7; Zakostelska Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027961; ZIERLER MK, 1995, INFECT IMMUN, V63, P4024, DOI 10.1128/IAI.63.10.4024-4028.1995	66	21	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82588	10.1371/journal.pone.0082588	http://dx.doi.org/10.1371/journal.pone.0082588			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340048	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400088
J	Othman, N; In, LLA; Harikrishna, JA; Hasima, N				Othman, Norahayu; In, Lionel L. A.; Harikrishna, Jennifer A.; Hasima, Noor			Bcl-xL Silencing Induces Alterations in hsa-miR-608 Expression and Subsequent Cell Death in A549 and SK-LU1 Human Lung Adenocarcinoma Cells	PLOS ONE			English	Article							INDUCED APOPTOSIS; GENE-EXPRESSION; TGF-BETA; MICRORNAS; PROTEIN; RESISTANCE; BCL-X(L); MCL-1	Bcl-xL is an anti-apoptotic protein that is frequently found to be overexpressed in non-small cell lung cancer leading to an inhibition of apoptosis and poor prognosis. Recently, the role of miRNAs in regulating apoptosis and cell survival during tumorigenesis has become evident, with cancer cells showing perturbed expression of various miRNAs. In this study, we utilized miRNA microarrays to determine if miRNA dysregulation in bcl-xL silenced lung adenocarcinoma cells could be involved in regulating cell death. Short interfering RNA-based transfection of A549 and SK-LU1 lung adenocarcinoma cells was successful in inducing a reduction in bcl-xL expression levels, resulting in a decrease in cell viability. A total of 10 miRNAs were found to be significantly differentially expressed when compared between siRNA-transfected and non-transfected cells including hsa-miR-181a, hsa-miR-769-5p, hsa-miR-361-5p, hsa-miR-1304 and hsa-miR-608. When overexpression studies on hsa-miR-608 was performed via transfection of miRNA mimics, cell death was found to be induced in A549 and SK-LU1 cells in comparison to untreated cells. This effect was reversed when knockdown studies involving anti-sense inhibitors were introduced. Combination of siRNA based silencing of bcl-xL (siBcl-xL) followed by antisense inhibitor transfection led to a decrease in the apoptotic population of A549 and SK-LU1 cells in comparison to cells only treated with siBcl-xL, illustrating the connection between bcl-xL, hsa-miR-608 and cell death. Gene target prediction analysis implicated the PI3K/AKT, WNT, TGF-beta, and ERK signaling pathways as targets of bcl-xL induced miRNA alterations. We have demonstrated that bcl-xL silencing in A549 and SK-LU1 cells leads to the occurrence of cell death through the dysregulation of specific miRNAs. This study also provides a platform for anti-sense gene therapy whereby miRNA expression can be exploited to increase the apoptotic properties in lung adenocarcinoma cells.	[Othman, Norahayu; In, Lionel L. A.; Harikrishna, Jennifer A.; Hasima, Noor] Univ Malaya, Fac Sci, Div Genet & Mol Biol, Inst Biol Sci, Kuala Lumpur, Wilayah Perseku, Malaysia; [Harikrishna, Jennifer A.; Hasima, Noor] Univ Malaya, Ctr Res Biotechnol Agr CEBAR, Kuala Lumpur, Wilayah Perseku, Malaysia	Universiti Malaya; Universiti Malaya	In, LLA (corresponding author), Univ Malaya, Fac Sci, Div Genet & Mol Biol, Inst Biol Sci, Kuala Lumpur, Wilayah Perseku, Malaysia.	lionelin@um.edu.my; hasima@um.edu.my	PITCHAI, NOOR HASIMA A K NAGOOR/B-9270-2010; In, Lionel/D-1338-2013; Othman, Norahayu/B-1690-2017; Harikrishna, Jennifer Ann/B-2778-2010; Othman, Norahayu/R-3982-2018; IN, LIONEL/AAI-9847-2020	In, Lionel/0000-0001-7182-112X; Othman, Norahayu/0000-0003-4163-1987; Harikrishna, Jennifer Ann/0000-0002-4687-709X; IN, LIONEL/0000-0001-7182-112X	University of Malaya [PS295/2010A, PV058/2011B, RG037-10BIO]; High Impact Research Grant (HIR) [H-50001-A000041]	University of Malaya(Universiti Malaya); High Impact Research Grant (HIR)	This study was supported by University of Malaya Postgraduate Research Grants (PPP) (PS295/2010A and PV058/2011B), the University of Malaya Research Grant (UMRG) (RG037-10BIO) and the High Impact Research Grant (HIR) (H-50001-A000041). All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviel-Ronen S, 2006, CLIN LUNG CANCER, V8, P30, DOI 10.3816/CLC.2006.n.030; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Daniel Jonathan C, 2004, Semin Thorac Cardiovasc Surg, V16, P19, DOI 10.1053/j.semtcvs.2004.01.002; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FISHER TC, 1993, CANCER RES, V53, P3321; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Gao W, 2010, BIOMED PHARMACOTHER, V64, P399, DOI 10.1016/j.biopha.2010.01.018; Gesbert F, 2000, BLOOD, V96, P2269, DOI 10.1182/blood.V96.6.2269.h8002269_2269_2276; Gottlieb E, 2000, MOL CELL BIOL, V20, P5680, DOI 10.1128/MCB.20.15.5680-5689.2000; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; In LLA, 2010, ANTI-CANCER DRUG, V22, P424; Ivanovska I, 2008, CELL CYCLE, V7, P3137, DOI 10.4161/cc.7.20.6923; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Leech SH, 2000, INT J CANCER, V86, P570, DOI 10.1002/(SICI)1097-0215(20000515)86:4<570::AID-IJC20>3.0.CO;2-T; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liam CK, 2006, LUNG CANCER, V53, P23, DOI 10.1016/j.lungcan.2006.03.009; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; LIVAK KJ, 1997, USER B, V2; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MIYASHITA T, 1993, BLOOD, V81, P151; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reeve JG, 1996, BRIT J CANCER, V73, P1193, DOI 10.1038/bjc.1996.230; Sanchez-Ceja SG, 2006, LUNG CANCER, V54, P163, DOI 10.1016/j.lungcan.2006.07.012; Shi L, 2008, BRAIN RES, V1236, P185, DOI 10.1016/j.brainres.2008.07.085; Shivdasani RA, 2006, BLOOD, V108, P3646, DOI 10.1182/blood-2006-01-030015; SLEBOS RJC, 1990, NEW ENGL J MED, V323, P561, DOI 10.1056/NEJM199008303230902; Soini Y, 1999, CLIN CANCER RES, V5, P3508; TANG C, 1994, LEUKEMIA, V8, P1960; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; Wiemer EAC, 2007, EUR J CANCER, V43, P1529, DOI 10.1016/j.ejca.2007.04.002; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xu CQ, 2007, J CELL SCI, V120, P3045, DOI 10.1242/jcs.010728	40	39	42	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81735	10.1371/journal.pone.0081735	http://dx.doi.org/10.1371/journal.pone.0081735			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339958	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400034
J	Kanojia, D; Garg, M; Saini, S; Agarwal, S; Parashar, D; Jagadish, N; Seth, A; Bhatnagar, A; Gupta, A; Kumar, R; Lohiya, NK; Suri, A				Kanojia, Deepika; Garg, Manoj; Saini, Shikha; Agarwal, Sumit; Parashar, Deepak; Jagadish, Nirmala; Seth, Amlesh; Bhatnagar, Amar; Gupta, Anju; Kumar, Rajive; Lohiya, Nirmal Kumar; Suri, Anil			Sperm Associated Antigen 9 Plays an Important Role in Bladder Transitional Cell Carcinoma	PLOS ONE			English	Article							CANCER-TESTIS ANTIGEN; BREAST-CANCER; COLORECTAL-CANCER; TUMOR-GROWTH; EXPRESSION; BIOMARKER; IMMUNOTHERAPY; SURVIVAL; ACCURACY	Background: Majority of bladder cancer deaths are caused due to transitional cell carcinoma (TCC) which is the most prevalent and chemoresistant malignancy of urinary bladder. Therefore, we analyzed the role of Sperm associated antigen 9 (SPAG9) in bladder TCC. Methodology and Findings: We examined SPAG9 expression and humoral response in 125 bladder TCC patients. Four bladder cancer cell lines were assessed for SPAG9 expression. In addition, we investigated the effect of SPAG9 ablation on cellular proliferation, cell cycle, migration and invasion in UM-UC-3 bladder cancer cells by employing gene silencing approach. Our SPAG9 gene and protein expression analysis revealed SPAG9 expression in 81% of bladder TCC tissue specimens. High SPAG9 expression (>60% SPAG9 positive cells) was found to be significantly associated with superficial non-muscle invasive stage (P = 0.042) and low grade tumors (P = 0.002) suggesting SPAG9 putative role in early spread and tumorigenesis. Humoral response against SPAG9 was observed in 95% of patients found positive for SPAG9 expression. All four bladder cancer cell lines revealed SPAG9 expression. In addition, SPAG9 gene silencing in UM-UC-3 cells resulted in induction of G(0)-G(1) arrest characterized by up-regulation of p16 and p21 and consequent down-regulation of cyclin E, cyclin D and cyclin B, CDK4 and CDK1. Further, SPAG9 gene silencing also resulted in reduction in cellular growth, and migration and invasion ability of cancer cells in vitro. Conclusions: Collectively, our data in clinical specimens indicated that SPAG9 is potential biomarker and therapeutic target for bladder TCC.	[Kanojia, Deepika; Garg, Manoj; Saini, Shikha; Agarwal, Sumit; Parashar, Deepak; Jagadish, Nirmala; Suri, Anil] Natl Inst Immunol, Canc Microarray Genes & Prot Lab, New Delhi 110067, India; [Seth, Amlesh] All India Inst Med Sci, Dept Urol, New Delhi, India; [Bhatnagar, Amar] Safdarjang Hosp, Dept Canc Surg, New Delhi, India; [Bhatnagar, Amar] Vardhman Mahavir Med Coll, New Delhi, India; [Gupta, Anju] Vidyasagar Inst Mental Hlth & Neurosci, NMC Imaging & Diagnost Ctr, New Delhi, India; [Kumar, Rajive] All India Inst Med Sci, Inst Rotary Canc Hosp, New Delhi, India; [Lohiya, Nirmal Kumar] Univ Rajasthan, Dept Zool, Reprod Physiol Sect, Jaipur 302004, Rajasthan, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); All India Institute of Medical Sciences (AIIMS) New Delhi; Vardhman Mahavir Medical College & Safdarjung Hospital; Vardhman Mahavir Medical College & Safdarjung Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; DR. B.R.A. Institute Rotary Cancer Hospital; University of Rajasthan	Suri, A (corresponding author), Natl Inst Immunol, Canc Microarray Genes & Prot Lab, Aruna Asaf Ali Marg, New Delhi 110067, India.	anil@nii.res.in	AGARWAL, SUMIT/I-9349-2019; Parashar, Deepak/T-8609-2017; Saini, Shikha/ABC-7231-2020; Garg, Manoj/C-4076-2019; Suri, Anil/P-5128-2016; Jagadish, Nirmala/AAR-3046-2020	AGARWAL, SUMIT/0000-0003-4051-7146; Parashar, Deepak/0000-0002-5062-8950; Saini, Shikha/0000-0003-0557-1649; Garg, Manoj/0000-0002-3492-2957; Suri, Anil/0000-0001-5231-5555; Jagadish, Nirmala/0000-0002-5812-9283	Indo-UK Cancer Research Program [BT/IN/UK/NII/2006]; Centre for Molecular Medicine [BT/PR/14549/MED/14/1291]; Department of Biotechnology, Government of India	Indo-UK Cancer Research Program; Centre for Molecular Medicine; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work is supported by grants from Indo-UK Cancer Research Program (Grant No. BT/IN/UK/NII/2006), Centre for Molecular Medicine (Grant No. BT/PR/14549/MED/14/1291), Nil-core funding, Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Carlucci A, 2010, J BIOL CHEM, V285, P39260, DOI 10.1074/jbc.M110.174706; DeLellis R. A., 2004, PATHOLOGY GENETICS T; Fradet Y, 2006, PROG UROL, V16, P421; Garg M, 2008, CANCER RES, V68, P8240, DOI 10.1158/0008-5472.CAN-08-1708; Garg M, 2007, CLIN CANCER RES, V13, P1421, DOI 10.1158/1078-0432.CCR-06-2340; Garg M, 2010, EUR J CANCER, V46, P207, DOI 10.1016/j.ejca.2009.10.020; Garg M, 2009, J CLIN ENDOCR METAB, V94, P4613, DOI 10.1210/jc.2009-0703; Garg M, 2009, CANCER-AM CANCER SOC, V115, P2671, DOI 10.1002/cncr.24293; Greene FL, 2002, AM JOINT COMMITTEE C; Jagadish N, 2005, BIOCHEM J, V389, P73, DOI 10.1042/BJ20041577; Kanojia D, 2011, AM J PATHOL, V178, P1009, DOI 10.1016/j.ajpath.2010.11.047; Kanojia D, 2009, CANCER EPIDEM BIOMAR, V18, P630, DOI 10.1158/1055-9965.EPI-08-0629; Karakiewicz PI, 2006, BJU INT, V97, P997, DOI 10.1111/j.1464-410X.2006.06036.x; Kausch I, 2001, EUR UROL, V39, P498, DOI 10.1159/000052495; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Kim M, 2005, CARCINOGENESIS, V26, P1553, DOI 10.1093/carcin/bgi104; Messing EM, 2002, CAMPBELLS UROLOGY, P2733; Mitropoulos D, 2005, J ENDOUROL, V19, P861, DOI 10.1089/end.2005.19.861; Pandya AY, 2004, CLIN CANCER RES, V10, P2709, DOI 10.1158/1078-0432.CCR-03-0484; Quentin T, 2004, ANTICANCER RES, V24, P1011; Sharma P, 2006, CLIN CANCER RES, V12, P5442, DOI 10.1158/1078-0432.CCR-06-0527; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Suri A, 2006, EXPERT OPIN BIOL TH, V6, P379, DOI 10.1517/14712598.6.4.379; Tan PX, 2012, BIOCHEM BIOPH RES CO, V419, P801, DOI 10.1016/j.bbrc.2012.02.110; Yang XW, 2003, CLIN CANCER RES, V9, P201; Yin B, 2011, UROL ONCOL, V30, P886	28	27	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81348	10.1371/journal.pone.0081348	http://dx.doi.org/10.1371/journal.pone.0081348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349057	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200023
J	Voskamp, AL; Prickett, SR; Mackay, F; Rolland, JM; O'Hehir, RE				Voskamp, Astrid L.; Prickett, Sara R.; Mackay, Fabienne; Rolland, Jennifer M.; O'Hehir, Robyn E.			MHC Class II Expression in Human Basophils: Induction and Lack of Functional Significance	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; HUMAN BLOOD BASOPHILS; HUMAN IGE SYNTHESIS; HUMAN EOSINOPHILS; TH2 IMMUNITY; HLA-DR; HELMINTH INFECTION; MAST-CELLS; T-CELLS; B-CELLS	The antigen-presenting abilities of basophils and their role in initiating a Th2 phenotype is a topic of current controversy. We aimed to determine whether human basophils can be induced to express MHC Class II and act as antigen presenting cells for T cell stimulation. Isolated human basophils were exposed to a panel of cytokines and TLR-ligands and assessed for MHC Class II expression. MHC Class II was expressed in up to 17% of isolated basophils following incubation with a combination of IL-3, IFN-gamma and GM-CSF for 72 hours. Costimulatory molecules (CD80 and CD86) were expressed at very low levels after stimulation. Gene expression analysis of MHC Class II-positive basophils confirmed up-regulation of HLA-DR, HLA-DM, CD74 and Cathepsin S. However, MHC Class II expressing basophils were incapable of inducing antigen-specific T cell activation or proliferation. This is the first report of significant cytokine-induced MHC Class II up-regulation, at both RNA and protein level, in isolated human basophils. By testing stimulation with relevant T cell epitope peptide as well as whole antigen, the failure of MHC Class II expressing basophils to induce T cell response was shown not to be solely due to inefficient antigen uptake and/or processing.	[Voskamp, Astrid L.; Prickett, Sara R.; Mackay, Fabienne; Rolland, Jennifer M.; O'Hehir, Robyn E.] Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia; [Voskamp, Astrid L.; Prickett, Sara R.; Rolland, Jennifer M.; O'Hehir, Robyn E.] Alfred Hosp, Dept Allergy Immunol & Resp Med, Melbourne, Vic, Australia; [Voskamp, Astrid L.; Prickett, Sara R.; Rolland, Jennifer M.; O'Hehir, Robyn E.] Monash Univ, Melbourne, Vic 3004, Australia	Monash University; Florey Institute of Neuroscience & Mental Health; Monash University	O'Hehir, RE (corresponding author), Monash Univ, Dept Immunol, Melbourne, Vic 3004, Australia.	R.OHehir@alfred.org.au	O'Hehir, Robyn E/H-3627-2011; Mackay, Fabienne/B-7440-2008	O'Hehir, Robyn E/0000-0002-3489-7595; Mackay, Fabienne/0000-0002-6074-2693	Ilhan Food Allergy Foundation; National Health and Medical Research Council of Australia; The Alfred Research Trust	Ilhan Food Allergy Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); The Alfred Research Trust	This work was supported by Ilhan Food Allergy Foundation, the National Health and Medical Research Council of Australia and The Alfred Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arock M, 2002, J LEUKOCYTE BIOL, V71, P557; Celestin J, 2001, J IMMUNOL, V167, P6097, DOI 10.4049/jimmunol.167.11.6097; Charles N, 2010, NAT MED, V16, P701, DOI 10.1038/nm.2159; DAMLE NK, 1992, J IMMUNOL, V148, P1985; Eckl-Dorna J, 2012, ALLERGY, V67, P601, DOI 10.1111/j.1398-9995.2012.02792.x; Eusebius NP, 2002, INT ARCH ALLERGY IMM, V127, P234, DOI 10.1159/000053868; FUREDER W, 1994, ALLERGY, V49, P861, DOI 10.1111/j.1398-9995.1994.tb00788.x; GAUCHAT JF, 1993, NATURE, V365, P340, DOI 10.1038/365340a0; Grundstrom J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048308; GUO CB, 1994, AM J RESP CELL MOL, V10, P384, DOI 10.1165/ajrcmb.10.4.7510984; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; HANSEL TT, 1992, J IMMUNOL, V149, P2130; Ito Y, 2011, ALLERGY, V66, P1107, DOI 10.1111/j.1398-9995.2011.02570.x; Jung YJ, 2008, INT ARCH ALLERGY IMM, V146, P227, DOI 10.1159/000115891; Kim S, 2010, J IMMUNOL, V184, P1143, DOI 10.4049/jimmunol.0902447; Kitzmuller C, 2012, ALLERGY, V67, P593, DOI 10.1111/j.1398-9995.2011.02764.x; Komiya A, 2006, INT ARCH ALLERGY IMM, V140, P23, DOI 10.1159/000092707; Li HM, 1996, J IMMUNOL, V156, P4833; LUCEY DR, 1989, P NATL ACAD SCI USA, V86, P1348, DOI 10.1073/pnas.86.4.1348; MACGLASHAN D, 1994, J IMMUNOL, V152, P3006; MAWHORTER SD, 1994, IMMUNOLOGY, V81, P584; Munitz A, 2005, J IMMUNOL, V174, P110, DOI 10.4049/jimmunol.174.1.110; Ochensberger B, 1996, BLOOD, V88, P3028, DOI 10.1182/blood.V88.8.3028.bloodjournal8883028; Ohnmacht C, 2010, IMMUNITY, V33, P364, DOI 10.1016/j.immuni.2010.08.011; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Otsuka A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2740; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Phillips C, 2003, J LEUKOCYTE BIOL, V73, P165, DOI 10.1189/jlb.0702356; Poulsen BC, 2012, J IMMUNOL METHODS, V381, P66, DOI 10.1016/j.jim.2012.04.009; Prickett SR, 2013, CLIN EXP ALLERGY, V43, P684, DOI 10.1111/cea.12113; Prickett SR, 2011, J ALLERGY CLIN IMMUN, V127, P608, DOI 10.1016/j.jaci.2010.09.027; SCHROEDER JT, 1994, J IMMUNOL, V153, P1808; Sharma M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01188; Siegmund R, 2000, J ALLERGY CLIN IMMUN, V106, P1190, DOI 10.1067/mai.2000.110928; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; VALENT P, 1992, ADV IMMUNOL, V52, P333, DOI 10.1016/S0065-2776(08)60879-2; VALENT P, 1990, CRIT REV ONCOL HEMAT, V10, P327, DOI 10.1016/1040-8428(90)90009-H; Wakahara K, 2012, BLOOD, V120, P4761, DOI 10.1182/blood-2012-04-424226; WELLER PF, 1993, J IMMUNOL, V150, P2554; Yanagihara Y, 1998, CLIN EXP IMMUNOL, V111, P136; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	41	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81777	10.1371/journal.pone.0081777	http://dx.doi.org/10.1371/journal.pone.0081777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349126	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200049
J	Gornik, SG; Cranenburgh, A; Waller, RF				Gornik, Sebastian G.; Cranenburgh, Andrea; Waller, Ross F.			New Host Range for Hematodinium in Southern Australia and Novel Tools for Sensitive Detection of Parasitic Dinoflagellates	PLOS ONE			English	Article							LOBSTER NEPHROPS-NORVEGICUS; NORWAY LOBSTER; MOLECULAR-DETECTION; BLUE-CRAB; INFECTION; PEREZI; POPULATION; DECLINE; SPP.; BAY	Hematodinium is a parasitic dinoflagellate and emerging pathogen of crustaceans. It preferably manifests in haemolymph of marine decapod crustaceans, killing a large variety of genera with significant impacts on fisheries worldwide. There is, however, evidence that some crustacean stocks harbor high prevalence, low intensity infections that may not result in widespread host mortality and are therefore hard to detect. The most widely used methods for detection of Hematodinium are conventional blood smears and polymerase chain reaction (PCR) against ribosomal RNAs. Blood smears demand a trained investigator, are labor intensive and not readily scalable for high-throughput sampling. PCRs only detect parasite DNA and can also suffer from false negatives and positives. In order to develop alternative detection tools for Hematodinium cells in decapod crustaceans we employed an immunological approach against a newly identified, abundant dinoflagellate-specific nuclear protein-Dinoflagellate/Viral NucleoProtein (DVNP). Both immunofluorescence assay (IFA) and Western blot methods against DVNP showed high sensitivity of detection. The Western blot detects Hematodinium parasites to levels of 25 parasites per milliliter of crustacean haemolymph, with the potential for sample pooling and screening of large samples. Using both PCR and these new tools, we have identified Hematodinium cells present in three new host crab taxa, at high prevalence but with no sign of pathogenesis. This extends the known range of Hematodinium to southern Australia.	[Gornik, Sebastian G.; Cranenburgh, Andrea; Waller, Ross F.] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Waller, Ross F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Melbourne; University of Cambridge	Gornik, SG (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	sebastian.gornik@gmail.com; r.waller@unimelb.edu.au	Waller, Ross F/D-5761-2016	Waller, Ross F/0000-0001-6961-9344; Gornik, Sebastian/0000-0002-8026-1336	Australian Research Council [DP1093395]	Australian Research Council(Australian Research Council)	This work was supported by an Australian Research Council grant (DP1093395). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beevers ND, 2012, DIS AQUAT ORGAN, V100, P95, DOI 10.3354/dao02473; Bushek D, 2002, J EUKARYOT MICROBIOL, V49, P11, DOI 10.1111/j.1550-7408.2002.tb00333.x; Chualain CN, 2011, ICES J MAR SCI, V68, P454, DOI 10.1093/icesjms/fsq197; Eigemann F, 2010, DIS AQUAT ORGAN, V92, P59, DOI 10.3354/dao02257; Field RH, 1996, DIS AQUAT ORGAN, V24, P199, DOI 10.3354/dao024199; FIELD RH, 1992, DIS AQUAT ORGAN, V13, P1, DOI 10.3354/dao013001; Gornik SG, 2012, CURR BIOL, V22, P2303, DOI 10.1016/j.cub.2012.10.036; Gornik SG, 2010, MAR BIOL RES, V6, P223, DOI 10.1080/17451000903147468; Hanif Ammar W, 2013, Aquat Biosyst, V9, P11, DOI 10.1186/2046-9063-9-11; HUDSON DA, 1994, DIS AQUAT ORGAN, V19, P109, DOI 10.3354/dao019109; HUDSON DA, 1994, DIS AQUAT ORGAN, V20, P203; Lee RFD, 2004, AM SCI, V92, P548, DOI 10.1511/2004.50.946; MESSICK GA, 1994, DIS AQUAT ORGAN, V19, P77, DOI 10.3354/dao019077; Morado JF, 2012, J INVERTEBR PATHOL, V110, P201, DOI 10.1016/j.jip.2012.03.008; Mullowney DR, 2011, ICES J MAR SCI, V68, P463, DOI 10.1093/icesjms/fsq189; Musgrove R, 2007, SARDI RES REPORT SER, V325; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Shields JD, 2007, DIS AQUAT ORGAN, V77, P61, DOI 10.3354/dao01825; Shields Jeffrey D., 1994, Annual Review of Fish Diseases, V4, P241, DOI 10.1016/0959-8030(94)90031-0; Small HJ, 2006, DIS AQUAT ORGAN, V69, P185, DOI 10.3354/dao069185; Small HJ, 2007, J SHELLFISH RES, V26, P131, DOI 10.2983/0730-8000(2007)26[131:MDOHSI]2.0.CO;2; Small HJ, 2012, J INVERTEBR PATHOL, V110, P234, DOI 10.1016/j.jip.2012.03.012; Small HJ, 2012, J EUKARYOT MICROBIOL, V59, P54, DOI 10.1111/j.1550-7408.2011.00592.x; Small HJ, 2002, DIS AQUAT ORGAN, V52, P175, DOI 10.3354/dao052175; Stentiford GD, 2005, DIS AQUAT ORGAN, V66, P47, DOI 10.3354/dao066047; Stentiford GD, 2001, ICES J MAR SCI, V58, P814, DOI 10.1006/jmsc.2001.1072; Stentiford GD, 2001, DIS AQUAT ORGAN, V46, P223, DOI 10.3354/dao046223; Wilhelm G, 1996, DIS AQUAT ORGAN, V26, P213, DOI 10.3354/dao026213; Xu WJ, 2010, AQUACULTURE, V300, P25, DOI 10.1016/j.aquaculture.2009.12.024	29	6	6	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82774	10.1371/journal.pone.0082774	http://dx.doi.org/10.1371/journal.pone.0082774			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324829	Green Published, gold			2022-12-27	WOS:000328566700108
J	Hubas, C; Jesus, B; Ruivo, M; Meziane, T; Thiney, N; Davoult, D; Spilmont, N; Paterson, DM; Jeanthon, C				Hubas, Cedric; Jesus, Bruno; Ruivo, Mickael; Meziane, Tarik; Thiney, Najet; Davoult, Dominique; Spilmont, Nicolas; Paterson, David M.; Jeanthon, Christian			Proliferation of Purple Sulphur Bacteria at the Sediment Surface Affects Intertidal Mat Diversity and Functionality	PLOS ONE			English	Article							ROSCOFF-ABER BAY; ANNUAL BENTHIC METABOLISM; ORKNEY-ISLANDS; FATTY-ACIDS; THIOCAPSA-ROSEOPERSICINA; SHELTERED BEACHES; ORGANIC-MATTER; MICROBIAL MATS; MASS BLOOMS; SCAPA FLOW	There is a relative absence of studies dealing with mats of purple sulphur bacteria in the intertidal zone. These bacteria display an array of metabolic pathways that allow them to disperse and develop under a wide variety of conditions, making these mats important in terms of ecosystem processes and functions. Mass blooms of purple sulphur bacteria develop during summer on sediments in the intertidal zone especially on macroalgal deposits. The microbial composition of different types of mats differentially affected by the development of purple sulphur bacteria was examined, at low tide, using a set of biochemical markers (fatty acids, pigments) and composition was assessed against their influence on ecosystem functions (sediment cohesiveness, CO2 fixation). We demonstrated that proliferation of purple sulphur bacteria has a major impact on intertidal mats diversity and functions. Indeed, assemblages dominated by purple sulphur bacteria (Chromatiaceae) were efficient exopolymer producers and their biostabilisation potential was significant. In addition, the massive growth of purple sulphur bacteria resulted in a net CO2 degassing whereas diatom dominated biofilms represented a net CO2 sink.	[Hubas, Cedric; Meziane, Tarik; Thiney, Najet] Museum Natl Hist Nat, UMR BOREA MNHN CNRS IRD UPMC 7208, F-75231 Paris, France; [Jesus, Bruno] Univ Nantes, LUNAM Univ, Mer Mol Sante EA 2160, Fac Sci & Tech, Nantes, France; [Jesus, Bruno; Ruivo, Mickael] Univ Lisbon, Ctr Biodiversidade Genom Integrat & Func BioFIG, Fac Ciencias, P-1699 Lisbon, Portugal; [Davoult, Dominique; Jeanthon, Christian] Univ Paris 06, UPMC, UMR Adaptat & Diversite Milieu Marin 7144, Stn Biol Roscoff, Roscoff, France; [Davoult, Dominique; Jeanthon, Christian] CNRS, UMR Adaptat & Diversite Milieu Marin 7144, Stn Biol Roscoff, Roscoff, France; [Spilmont, Nicolas] CNRS, UMR 8187, LOG, Stn Marine Wimereux, Wimereux, France; [Paterson, David M.] Univ St Andrews, Sediment Ecol Res Grp, Scottish Ocean Inst, St Andrews, Fife, Scotland	Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Nantes Universite; Universidade de Lisboa; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); University of St Andrews	Hubas, C (corresponding author), Museum Natl Hist Nat, UMR BOREA MNHN CNRS IRD UPMC 7208, F-75231 Paris, France.	hubas@mnhn.fr	Jesus, Bruno/B-5441-2011; Meziane, Tarik/AAF-7906-2020; Davoult, dominique/D-5932-2012; BOREA, UMR BOREA/C-6165-2008; Hubas, Cédric/P-4200-2019; Paterson, David/D-5202-2013	Jesus, Bruno/0000-0002-2047-3783; Meziane, Tarik/0000-0003-2142-6441; Davoult, dominique/0000-0001-8678-3998; BOREA, UMR BOREA/0000-0002-9110-9292; Hubas, Cédric/0000-0002-9110-9292; Spilmont, Nicolas/0000-0002-2380-1113; Paterson, David/0000-0003-1174-6476; Jeanthon, Christian/0000-0002-7339-574X	French National Centre for Scientific Research/INSU; European Community [227799]; Region Pays de la Loire (France); Marine Alliance for Science and Technology for Scotland; Scottish Funding Council	French National Centre for Scientific Research/INSU; European Community(European Commission); Region Pays de la Loire (France)(Region Pays de la Loire); Marine Alliance for Science and Technology for Scotland; Scottish Funding Council	Funding provided by French National Centre for Scientific Research/INSU program EC2CO-MicroBien (Microbiologie Environnementale - BIOPOURPRE Project), European Community (ASSEMBLE grant agreement no 227799), Region Pays de la Loire (France), Marine Alliance for Science and Technology for Scotland and the Scottish Funding Council and participating institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Najjar MAA, 2012, ENVIRON MICROBIOL, V14, P982, DOI 10.1111/j.1462-2920.2011.02676.x; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOON JJ, 1977, J BACTERIOL, V129, P1183, DOI 10.1128/JB.129.3.1183-1191.1977; Brotas V, 2003, ACTA OECOL, V24, pS109, DOI 10.1016/S1146-609X(03)00013-4; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; de Carvalho CCCR, 2012, MAR DRUGS, V10, P2698, DOI 10.3390/md10122698; Decho A. W., 1990, MICROBIAL EXOPOLYMER; DEWIT R, 1987, FEMS MICROBIOL ECOL, V45, P117, DOI 10.1016/0378-1097(87)90033-4; Ford RB, 2002, MAR ECOL PROG SER, V229, P33, DOI 10.3354/meps229033; Frolund B, 1996, WATER RES, V30, P1749, DOI 10.1016/0043-1354(95)00323-1; GRANT J, 1987, NATURE, V330, P244, DOI 10.1038/330244a0; Guezennec J, 1996, FEMS MICROBIOL ECOL, V19, P83, DOI 10.1016/0168-6496(95)00078-X; HERBERT RA, 1985, P ROY SOC EDINB B, V87, P15, DOI 10.1017/S0269727000004139; Hoehler TM, 2004, GEOBIOLOGY, V2, P205, DOI 10.1111/j.1472-4677.2004.00033.x; Hubas C, 2007, MAR ECOL PROG SER, V344, P39, DOI 10.3354/meps06947; Hubas C, 2006, ESTUAR COAST SHELF S, V70, P287, DOI 10.1016/j.ecss.2006.06.019; Hubas C, 2006, MAR ECOL PROG SER, V316, P53, DOI 10.3354/meps316053; Hubas C, 2011, RES MICROBIOL, V162, P858, DOI 10.1016/j.resmic.2011.03.010; Imhoff JF, 2001, ARCH MICROBIOL, V176, P243, DOI 10.1007/s002030100326; Imhoff JF, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P846, DOI 10.1007/0-387-30746-x_31; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; KHARLAMENKO VI, 1995, MAR ECOL PROG SER, V120, P231, DOI 10.3354/meps120231; KONDRATIEVA EN, 1976, ARCH MICROBIOL, V108, P287, DOI 10.1007/BF00454854; KRAAY GW, 1992, J PHYCOL, V28, P708, DOI 10.1111/j.0022-3646.1992.00708.x; Larson F, 2009, LIMNOL OCEANOGR-METH, V7, P490, DOI 10.4319/lom.2009.7.490; Lubarsky HV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013794; Meziane T, 2006, MAR ECOL PROG SER, V312, P15, DOI 10.3354/meps312015; Meziane T, 2002, J SEA RES, V47, P1, DOI 10.1016/S1385-1101(01)00092-2; Migne A, 2002, MAR BIOL, V140, P865, DOI 10.1007/s00227-001-0741-1; Riera P, 2003, MAR ECOL PROG SER, V260, P151, DOI 10.3354/meps260151; Spector AA, 1999, LIPIDS, V34, pS1, DOI 10.1007/BF02562220; Stal LJ, 2010, ECOL ENG, V36, P236, DOI 10.1016/j.ecoleng.2008.12.032; Taylor IS, 1998, ESTUAR COAST SHELF S, V46, P359, DOI 10.1006/ecss.1997.0288; VANGEMERDEN H, 1989, FEMS MICROBIOL ECOL, V62, P87, DOI 10.1016/0378-1097(89)90018-9; VANGEMERDEN H, 1989, FEMS MICROBIOL ECOL, V62, P111, DOI 10.1016/0378-1097(89)90020-7; Wieland A, 2003, MICROB ECOL, V46, P371, DOI 10.1007/s00248-002-0108-2; Zhang CL, 2005, APPL ENVIRON MICROB, V71, P2106, DOI 10.1128/AEM.71.4.2106-2112.2005	37	7	8	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82329	10.1371/journal.pone.0082329	http://dx.doi.org/10.1371/journal.pone.0082329			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340018	Green Published, gold			2022-12-27	WOS:000328566100100
J	Song, PP; Li, L; Liu, JG				Song, Pingping; Li, Ling; Liu, Jianguo			Proteomic Analysis in Nitrogen-Deprived Isochrysis galbana during Lipid Accumulation	PLOS ONE			English	Article							SEED OIL CONTENT; GLYCEROL-3-PHOSPHATE ACYLTRANSFERASE; CHEMICAL-COMPOSITION; CYCLOTELLA-CRYPTICA; OVER-EXPRESSION; GROWTH; GENE; PROTEIN; DIATOM; MICROALGAE	The differentially co-expressed proteins in N-deprived and N-enriched I. galbana were comparatively analyzed by using two dimensional electrophoresis (2-DE) and matrix-assisted laser desorption/ionization-time-of-flight/time-of-flight-mass spectrometry (MALDI-TOF/TOF-MS) with the aim of better understanding lipid metabolism in this oleaginous microalga. Forty-five of the 900 protein spots showed dramatic changes in N-deprived I. galbana compared with the N-enriched cells. Of these, 36 protein spots were analyzed and 27 proteins were successfully identified. The identified proteins were classified into seven groups by their molecular functions, including the proteins related to energy production and transformation, substance metabolism, signal transduction, molecular chaperone, transcription and translation, immune defense and cytoskeleton. These altered proteins slowed cell growth and photosynthesis of I. galbana directly or indirectly, but at the same time increased lipid accumulation. Eight key enzymes involved in lipid metabolism via different pathways were identified as glyceraldehyde-3-phosphate dehydrogenase (GAPDH), phosphoglycerate kinase (PGK), enolase, aspartate aminotransferase (AST), fumarate hydratase (FH), citrate synthase (CS), O-acetyl-serine lyase (OAS-L) and ATP sulfurylase (ATPS). The results suggested that the glycolytic pathway and citrate transport system might be the main routes for lipid anabolism in N-deprived I. galbana, and that the tricarboxylic acid (TCA) cycle, glyoxylate cycle and sulfur assimilation system might be the major pathways involved in lipid catabolism.	[Song, Pingping; Li, Ling; Liu, Jianguo] Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China; [Song, Pingping] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Song, PP (corresponding author), Chinese Acad Sci, Inst Oceanol, Qingdao, Peoples R China.	songqian70@163.com			National Basic Research Program of China (973 Program) [2011CB200904]; Marine Renewable Energy Project of State Oceanic Administration [GHME2011SW01]; Key Project of Jiangsu Natural Science Foundation [BK2011009]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Marine Renewable Energy Project of State Oceanic Administration; Key Project of Jiangsu Natural Science Foundation	This work was financially supported by National Basic Research Program of China (973 Program, No. 2011CB200904), Marine Renewable Energy Project of State Oceanic Administration (GHME2011SW01) and The Key Project of Jiangsu Natural Science Foundation (BK2011009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabolaza A, 2008, APPL ENVIRON MICROB, V74, P2573, DOI 10.1128/AEM.02638-07; BASSI R, 2008, PHOTOCHEM PHOTOBIOL, V52, P1187; Berges JA, 1998, LIMNOL OCEANOGR, V43, P129, DOI 10.4319/lo.1998.43.1.0129; BERGES JA, 1993, MAR BIOL, V115, P187, DOI 10.1007/BF00346334; BJORKMAN O, 1988, AUST J PLANT PHYSIOL, V15, P43, DOI 10.1071/PP9880043; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chan LL, 2004, PROTEOMICS, V4, P180, DOI 10.1002/pmic.200300548; Cho S. H., 1986, BIOCHIM BIOPHYS ACTA, V878, P353, DOI DOI 10.1016/0005-2760(86)90243-2; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; DEMPSTER TA, 2002, J PHYCOL, V34, P712; DORTCH Q, 1982, J EXP MAR BIOL ECOL, V61, P243, DOI 10.1016/0022-0981(82)90072-7; DOWNTON W, 2006, NEW PHYTOL, V110, P503, DOI DOI 10.1111/J.1469-8137.1988.TB00289.X; Dunahay TG, 1995, J PHYCOL, V31, P1004, DOI 10.1111/j.0022-3646.1995.01004.x; Dunahay TG, 1996, APPL BIOCHEM BIOTECH, V57-8, P223, DOI 10.1007/BF02941703; Forster B, 2006, PROTEOMICS, V6, P4309, DOI 10.1002/pmic.200500907; Fuentes SI, 2001, J EXP BOT, V52, P1071, DOI 10.1093/jexbot/52.358.1071; GARCIAFERRIS C, 1994, PLANTA, V193, P208; Greenwell HC, 2010, J R SOC INTERFACE, V7, P703, DOI 10.1098/rsif.2009.0322; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; Guy C. L., 1982, Plant cold hardiness and freezing stress. Mechanisms and crop implications. Volume 2, P169; He ML, 2012, INT J HYDROGEN ENERG, V37, P16903, DOI 10.1016/j.ijhydene.2012.08.121; Howard J, 1997, NATURE, V389, P561, DOI 10.1038/39247; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Jain RK, 2000, BIOCHEM SOC T, V28, P958, DOI 10.1042/BST0280958; Jiang H, 2009, PROTEOMICS, V9, P3353, DOI 10.1002/pmic.200800518; Khozin-Goldberg I, 2006, PHYTOCHEMISTRY, V67, P696, DOI 10.1016/j.phytochem.2006.01.010; Khozin-Goldberg I, 2011, BIOCHIMIE, V93, P91, DOI 10.1016/j.biochi.2010.07.020; Kopriva S, 2004, J EXP BOT, V55, P1831, DOI 10.1093/jxb/erh203; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Lappartient AG, 1999, PLANT J, V18, P89, DOI 10.1046/j.1365-313X.1999.00416.x; Lappartient AG, 1996, PLANT PHYSIOL, V111, P147, DOI 10.1104/pp.111.1.147; Lardizabal K, 2008, PLANT PHYSIOL, V148, P89, DOI 10.1104/pp.108.123042; Lee FWF, 2008, J MICROBIOL METH, V73, P26, DOI 10.1016/j.mimet.2008.01.006; LEVY I, 2004, J PHYCOL, V26, P62; LEWITUS AJ, 1990, MAR ECOL PROG SER, V61, P171, DOI 10.3354/meps061171; [Liu Jianguo 刘建国], 2002, Chinese Journal of Oceanology and Limnology, V20, P149; Maisonneuve S, 2010, PLANT PHYSIOL, V152, P670, DOI 10.1104/pp.109.148247; McGinnis KM, 1997, J APPL PHYCOL, V9, P19, DOI 10.1023/A:1007972214462; Msanne J, 2012, PHYTOCHEMISTRY, V75, P50, DOI 10.1016/j.phytochem.2011.12.007; Pracharoenwattana I, 2005, PLANT CELL, V17, P2037, DOI 10.1105/tpc.105.031856; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; RATHA SK, 2013, AQUACULTURE; Rodolfi L, 2009, BIOTECHNOL BIOENG, V102, P100, DOI 10.1002/bit.22033; ROESSLER PG, 1988, ARCH BIOCHEM BIOPHYS, V267, P521, DOI 10.1016/0003-9861(88)90059-8; ROESSLER PG, 1993, J BIOL CHEM, V268, P19254; Schnarrenberger C, 2002, EUR J BIOCHEM, V269, P868, DOI 10.1046/j.0014-2956.2001.02722.x; Scragg AH, 2002, BIOMASS BIOENERG, V23, P67, DOI 10.1016/S0961-9534(02)00028-4; Sheehan J., 1998, LOOK BACK US DEP ENE; Shen SH, 2003, BIOL PHARM BULL, V26, P129, DOI 10.1248/bpb.26.129; Shin R, 2005, PLANT CELL PHYSIOL, V46, P1350, DOI 10.1093/pcp/pci145; Strasser BJ, 1995, PHOTOSYNTHESIS: FROM LIGHT TO BIOSPHERE, VOL 5, P977; VERWOERT IIGS, 1995, PLANT MOL BIOL, V27, P875, DOI 10.1007/BF00037016; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Wagner M, 2010, PLANT PHYSIOL BIOCH, V48, P407, DOI 10.1016/j.plaphy.2010.03.008; Wang SB, 2004, PROTEOMICS, V4, P692, DOI 10.1002/pmic.200300634; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; WIKFORS GH, 1986, AQUACULTURE, V59, P1, DOI 10.1016/0044-8486(86)90073-6; Wind M, 2000, BIOESSAYS, V22, P327, DOI 10.1002/(SICI)1521-1878(200004)22:4<327::AID-BIES3>3.0.CO;2-4; Wolanin PM, 2002, GENOME BIOL, V3; WOODS SA, 1986, BIOCHEM J, V237, P547, DOI 10.1042/bj2370547; Xu JY, 2009, BOTANY, V87, P544, DOI 10.1139/B08-145; Zhang LT, 2011, PHYSIOL PLANTARUM, V143, P396, DOI 10.1111/j.1399-3054.2011.01514.x; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	64	28	30	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82188	10.1371/journal.pone.0082188	http://dx.doi.org/10.1371/journal.pone.0082188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340005	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100091
J	Drakesmith, M; El-Deredy, W; Welbourne, S				Drakesmith, Mark; El-Deredy, Wael; Welbourne, Stephen			Reconstructing Coherent Networks from Electroencephalography and Magnetoencephalography with Reduced Contamination from Volume Conduction or Magnetic Field Spread	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; EEG DATA; MEG; LOCALIZATION; SYNCHRONIZATION; INTEGRATION; PERCEPTION; DYNAMICS; FMRI; BIAS	Volume conduction (VC) and magnetic field spread (MFS) induce spurious correlations between EEG/MEG sensors, such that the estimation of functional networks from scalp recordings is inaccurate. Imaginary coherency [1] reduces VC/MFS artefacts between sensors by assuming that instantaneous interactions are caused predominantly by VC/MFS and do not contribute to the imaginary part of the cross-spectral densities (CSDs). We propose an adaptation of the dynamic imaging of coherent sources (DICS) [2] - a method for reconstructing the CSDs between sources, and subsequently inferring functional connectivity based on coherences between those sources. Firstly, we reformulate the principle of imaginary coherency by performing an eigenvector decomposition of the imaginary part of the CSD to estimate the power that only contributes to the non-zero phase-lagged (NZPL) interactions. Secondly, we construct an NZPL-optimised spatial filter with two a priori assumptions: (1) that only NZPL interactions exist at the source level and (2) the NZPL CSD at the sensor level is a good approximation of the projected source NZPL CSDs. We compare the performance of the NZPL method to the standard method by reconstructing a coherent network from simulated EEG/MEG recordings. We demonstrate that, as long as there are phase differences between the sources, the NZPL method reliably detects the underlying networks from EEG and MEG. We show that the method is also robust to very small phase lags, noise from phase jitter, and is less sensitive to regularisation parameters. The method is applied to a human dataset to infer parts of a coherent network underpinning face recognition.	[Drakesmith, Mark; El-Deredy, Wael; Welbourne, Stephen] Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England; [Drakesmith, Mark] Cardiff Univ, Cardiff Univ Brain Imaging Res Ctr CUBRIC, Cardiff CF10 3AX, S Glam, Wales	University of Manchester; Cardiff University	Drakesmith, M (corresponding author), Univ Manchester, Sch Psychol Sci, Manchester, Lancs, England.	drakesmithm@cardiff.ac.uk	El-deredy, Wael/H-6521-2015	El-deredy, Wael/0000-0002-9822-1092; Drakesmith, Mark/0000-0001-8574-9560	University of Manchester School of Psychological Sciences; University of Manchester Alumni Fund	University of Manchester School of Psychological Sciences; University of Manchester Alumni Fund	Funding was provided by the University of Manchester School of Psychological Sciences and the University of Manchester Alumni Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Astolfi L, 2005, CLIN NEUROPHYSIOL, V116, P920, DOI 10.1016/j.clinph.2004.10.012; Babiloni F, 2003, NEUROIMAGE, V19, P1, DOI 10.1016/S1053-8119(03)00052-1; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Brookes MJ, 2010, NEUROIMAGE, V49, P525, DOI 10.1016/j.neuroimage.2009.07.043; Clark RD, 2008, J COMPUT AID MOL DES, V22, P141, DOI 10.1007/s10822-008-9181-z; Dale AM, 2000, NEURON, V26, P55, DOI 10.1016/S0896-6273(00)81138-1; David O, 2008, PLOS BIOL, V6, P2683, DOI 10.1371/journal.pbio.0060315; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; Fuchs M, 2002, CLIN NEUROPHYSIOL, V113, P702, DOI 10.1016/S1388-2457(02)00030-5; GESELOWI.DB, 1967, BIOPHYS J, V7, P1, DOI 10.1016/S0006-3495(67)86571-8; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Guellmar D, 2006, IEEE T BIO-MED ENG, V53, P1841, DOI 10.1109/TBME.2006.876641; Guggisberg AG, 2008, ANN NEUROL, V63, P193, DOI 10.1002/ana.21224; Haxby JV, 2000, TRENDS COGN SCI, V4, P223, DOI 10.1016/S1364-6613(00)01482-0; Helmholtz H.V., 1853, ANN PHYS-NEW YORK, V165, P353, DOI DOI 10.1002/ANDP.18531650603; Henson RN, 2009, NEUROIMAGE, V47, P581, DOI 10.1016/j.neuroimage.2009.04.063; Henson RN, 2003, CEREB CORTEX, V13, P793, DOI 10.1093/cercor/13.7.793; Hillebrand A, 2005, INT REV NEUROBIOL, V68, P149, DOI 10.1016/S0074-7742(05)68006-3; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Hinkley LBN, 2011, BIOL PSYCHIAT, V70, P1134, DOI 10.1016/j.biopsych.2011.06.029; Hipp JF, 2011, NEURON, V69, P387, DOI 10.1016/j.neuron.2010.12.027; Kamphuisen A, 2008, J VISION, V8, DOI 10.1167/8.5.4; KAVANAGH RN, 1978, IEEE T BIO-MED ENG, V25, P421, DOI 10.1109/TBME.1978.326339; Kujala J, 2008, NEUROIMAGE, V39, P1706, DOI 10.1016/j.neuroimage.2007.10.042; Kujala J, 2007, CEREB CORTEX, V17, P1476, DOI 10.1093/cercor/bhl059; Lachaux JP, 2002, NEUROPHYSIOL CLIN, V32, P157, DOI 10.1016/S0987-7053(02)00301-5; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Marzetti L, 2008, NEUROIMAGE, V42, P87, DOI 10.1016/j.neuroimage.2008.04.250; Michel CM, 2004, CLIN NEUROPHYSIOL, V115, P2195, DOI 10.1016/j.clinph.2004.06.001; MONDT JP, 1989, PHYS MED BIOL, V34, P1073, DOI 10.1088/0031-9155/34/8/009; Mosher JC, 2003, PROCEEDINGS OF THE 2003 IEEE WORKSHOP ON STATISTICAL SIGNAL PROCESSING, P294; Muthuraman M, 2010, IEEE ENG MED BIO, P154, DOI 10.1109/IEMBS.2010.5627211; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Nolte G, 2003, PHYS MED BIOL, V48, P3637, DOI 10.1088/0031-9155/48/22/002; Nunez PL, 1997, ELECTROEN CLIN NEURO, V103, P499, DOI 10.1016/S0013-4694(97)00066-7; OBRADOR S, 1950, ELECTROEN CLIN NEURO, V2, P143, DOI 10.1016/0013-4694(50)90026-5; Ollikainen JO, 1999, MED ENG PHYS, V21, P143, DOI 10.1016/S1350-4533(99)00038-7; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRETT DI, 1985, PROC R SOC SER B-BIO, V223, P293, DOI 10.1098/rspb.1985.0003; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024; Schoffelen JM, 2011, HUM BRAIN MAPP, V32, P426, DOI 10.1002/hbm.21031; Sekihara K, 2011, IEEE T BIO-MED ENG, V58, P3121, DOI 10.1109/TBME.2011.2162514; Siapas AG, 2005, NEURON, V46, P141, DOI 10.1016/j.neuron.2005.02.028; SINGER W, 1995, ANNU REV NEUROSCI, V18, P555, DOI 10.1146/annurev.neuro.18.1.555; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Srinivasan R, 1998, IEEE T BIO-MED ENG, V45, P814, DOI 10.1109/10.686789; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stinstra JG, 1998, MED BIOL ENG COMPUT, V36, P711, DOI 10.1007/BF02518873; Uhlhaas PJ, 2009, P NATL ACAD SCI USA, V106, P9866, DOI 10.1073/pnas.0900390106; van den Broek SP, 1998, ELECTROEN CLIN NEURO, V106, P522, DOI 10.1016/S0013-4694(97)00147-8; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Winter WR, 2007, STAT MED, V26, P3946, DOI 10.1002/sim.2978; Wipf D, 2009, NEUROIMAGE, V44, P947, DOI 10.1016/j.neuroimage.2008.02.059; Wolters CH, 2004, INVERSE PROBL, V20, P1099, DOI 10.1088/0266-5611/20/4/007	63	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2013	8	12							e81553	10.1371/journal.pone.0081553	http://dx.doi.org/10.1371/journal.pone.0081553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265IN	24349088	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000327944500074
J	Kim, ES; Cole, JB; Huson, H; Wiggans, GR; Van Tassell, CP; Crooker, BA; Liu, G; Da, Y; Sonstegard, TS				Kim, Eui-Soo; Cole, John B.; Huson, Heather; Wiggans, George R.; Van Tassell, Curtis P.; Crooker, Brian A.; Liu, George; Da, Yang; Sonstegard, Tad S.			Effect of Artificial Selection on Runs of Homozygosity in US Holstein Cattle	PLOS ONE			English	Article							POSITIVE SELECTION; GENOMIC DIVERSITY; SIGNATURES; POPULATION; POLYMORPHISM; ADMIXTURE; SCAN	The intensive selection programs for milk made possible by mass artificial insemination increased the similarity among the genomes of North American (NA) Holsteins tremendously since the 1960s. This migration of elite alleles has caused certain regions of the genome to have runs of homozygosity (ROH) occasionally spanning millions of continuous base pairs at a specific locus. In this study, genome signatures of artificial selection in NA Holsteins born between 1953 and 2008 were identified by comparing changes in ROH between three distinct groups under different selective pressure for milk production. The ROH regions were also used to estimate the inbreeding coefficients. The comparisons of genomic autozygosity between groups selected or unselected since 1964 for milk production revealed significant differences with respect to overall ROH frequency and distribution. These results indicate selection has increased overall autozygosity across the genome, whereas the autozygosity in an unselected line has not changed significantly across most of the chromosomes. In addition, ROH distribution was more variable across the genomes of selected animals in comparison to a more even ROH distribution for unselected animals. Further analysis of genome-wide autozygosity changes and the association between traits and haplotypes identified more than 40 genomic regions under selection on several chromosomes (Chr) including Chr 2, 7, 16 and 20. Many of these selection signatures corresponded to quantitative trait loci for milk, fat, and protein yield previously found in contemporary Holsteins.	[Kim, Eui-Soo; Huson, Heather; Van Tassell, Curtis P.; Liu, George; Sonstegard, Tad S.] USDA ARS, Bovine Funct Genom Lab, Beltsville, MD USA; [Cole, John B.; Wiggans, George R.; Van Tassell, Curtis P.] USDA ARS, Anim Improvement Programs Lab, Beltsville, MD USA; [Crooker, Brian A.; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities	Sonstegard, TS (corresponding author), USDA ARS, Bovine Funct Genom Lab, Beltsville, MD USA.	Tad.sonstegard@ars.usda.gov	Cole, John B./J-8571-2014; Liu, George/K-3371-2019; Van Tassell, Curtis P./O-4247-2019	Cole, John B./0000-0003-1242-4401; Liu, George/0000-0003-0192-6705; Van Tassell, Curtis P./0000-0002-8416-2087; Huson, Heather/0000-0001-8299-0447	USDA Agricultural Research Service [1265-31000-104-00D]; Rural Development Administration, Republic of Korea [PJ008196]; ARS [ARS-0423740] Funding Source: Federal RePORTER	USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Rural Development Administration, Republic of Korea(Rural Development Administration (RDA), Republic of Korea); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This project was supported by projects 1265-31000-104-00D (BFGL) from the USDA Agricultural Research Service. E.-S. Kim was partially supported by a grant from the Next-Generation BioGreen 21 Program (No. PJ008196), Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson L, 2004, NAT REV GENET, V5, P202, DOI 10.1038/nrg1294; Auton A, 2009, GENOME RES, V19, P795, DOI 10.1101/gr.088898.108; Barendse W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-178; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Bray SM, 2010, P NATL ACAD SCI USA, V107, P16222, DOI 10.1073/pnas.1004381107; Brinks JS, 1982, MARYLAND AGR EXP STA, V976, P23; CHURCHILL GA, 1994, GENETICS, V138, P963; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Fay JC, 2000, GENETICS, V155, P1405; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Flori L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006595; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Gillespie JH, 1998, POPULATION GENETICS; GIMPL G, 2001, REVIEW, V81, P629; Glick G, 2012, ANIM GENET, V43, P45, DOI 10.1111/j.1365-2052.2012.02348.x; Hayes BJ, 2008, ANIM GENET, V39, P105, DOI 10.1111/j.1365-2052.2007.01683.x; Hedrick P.W., 2011, GENETICS POPULATIONS; Keller MC, 2012, PLOS GENET, V8, P425, DOI 10.1371/journal.pgen.1002656; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kim E, 2010, PLANT ANIMAL GENOME; Kim ES, 2009, ANIM GENET, V40, P279, DOI 10.1111/j.1365-2052.2008.01831.x; Kuningas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022580; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; MacEachern S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-181; Malecot G., 1969, MATH HEREDITY; Matukumalli LK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005350; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; MIGLIOR F, 1992, J DAIRY SCI, V75, P1112, DOI 10.3168/jds.S0022-0302(92)77856-4; Nalls MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000415; Nothnagel M, 2010, HUM MOL GENET, V19, P2927, DOI 10.1093/hmg/ddq198; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; Ron M, 2004, J DAIRY SCI, V87, P476, DOI 10.3168/jds.S0022-0302(04)73187-2; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sonstegard TS, 2010, 9 WORLD C GEN APPL L; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden PM, 2004, J DAIRY SCI, V87, P3125, DOI 10.3168/jds.S0022-0302(04)73447-5; VanRaden PM, 2004, J DAIRY SCI, V87, P2285, DOI 10.3168/jds.S0022-0302(04)70049-1; VanRaden PM, 2005, INTERBULL B, V33, P81; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weber WJ, 2007, J DAIRY SCI, V90, P3314, DOI 10.3168/jds.2006-899; Weigel KA, 2006, ANIM REPROD SCI, V96, P323, DOI 10.1016/j.anireprosci.2006.08.010; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Young CW, 1996, J DAIRY SCI, V79, P502, DOI 10.3168/jds.S0022-0302(96)76392-0	45	115	123	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2013	8	11							e80813	10.1371/journal.pone.0080813	http://dx.doi.org/10.1371/journal.pone.0080813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	254DJ	24348915	Green Submitted, Green Published, gold			2022-12-27	WOS:000327143800165
J	Hsu, YY; Chen, HY; Kao, HY				Hsu, Yi-Yu; Chen, Hung-Yu; Kao, Hung-Yu			Using a Search Engine-Based Mutually Reinforcing Approach to Assess the Semantic Relatedness of Biomedical Terms	PLOS ONE			English	Article							GENE ONTOLOGY; SIMILARITY	Background: Determining the semantic relatedness of two biomedical terms is an important task for many text-mining applications in the biomedical field. Previous studies, such as those using ontology-based and corpus-based approaches, measured semantic relatedness by using information from the structure of biomedical literature, but these methods are limited by the small size of training resources. To increase the size of training datasets, the outputs of search engines have been used extensively to analyze the lexical patterns of biomedical terms. Methodology/Principal Findings: In this work, we propose the Mutually Reinforcing Lexical Pattern Ranking (ReLPR) algorithm for learning and exploring the lexical patterns of synonym pairs in biomedical text. ReLPR employs lexical patterns and their pattern containers to assess the semantic relatedness of biomedical terms. By combining sentence structures and the linking activities between containers and lexical patterns, our algorithm can explore the correlation between two biomedical terms. Conclusions/Significance: The average correlation coefficient of the ReLPR algorithm was 0.82 for various datasets. The results of the ReLPR algorithm were significantly superior to those of previous methods.	[Hsu, Yi-Yu; Kao, Hung-Yu] Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan; [Chen, Hung-Yu; Kao, Hung-Yu] Natl Cheng Kung Univ, Inst Med Informat, Tainan 70101, Taiwan	National Cheng Kung University; National Cheng Kung University	Kao, HY (corresponding author), Natl Cheng Kung Univ, Dept Comp Sci & Informat Engn, Tainan 70101, Taiwan.	hykao@mail.ncku.edu.tw						Al-Mubaid H, 2009, IEEE T SYST MAN CY C, V39, P389, DOI 10.1109/TSMCC.2009.2020689; [Anonymous], THESIS; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BOLLEGALA D, 2010, KNOWLEDGE DATA ENG I, P1; BOLLEGALA D, 2007, P 16 INT C WORLD WID; Caviedes JE, 2004, J BIOMED INFORM, V37, P77, DOI 10.1016/j.jbi.2004.02.001; Chen CH, 2010, IEEE ENG MED BIO, P4436, DOI 10.1109/IEMBS.2010.5626008; CHEN HH, 2006, P 21 INT C COMP LING; Cilibrasi RL, 2007, IEEE T KNOWL DATA EN, V19, P370, DOI 10.1109/TKDE.2007.48; Hanks P., 1990, COMPUT LINGUIST, V16, P22, DOI DOI 10.3115/981623.981633; Jiang J.J., 1997, P INT C RES COMP LIN, P19; Kleinberg JM, 1999, J ACM, V46, P604, DOI 10.1145/324133.324140; Leacock C, 1998, LANG SPEECH & COMMUN, P265; LI M, 2003, P 14 ANN ACM SIAM S; LIN D, 1998, REV WORDNET ELECT LE; Lin D, 1998, P 17 INT C COMP LING, V2; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; McCrae J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-159; Patwardhan S., 2006, P EACL 2006 WORKSH M, P1; Pedersen T, 2007, J BIOMED INFORM, V40, P288, DOI 10.1016/j.jbi.2006.06.004; RADA R, 1989, IEEE T SYST MAN CYB, V19, P17, DOI 10.1109/21.24528; Resnik P, 1999, J ARTIF INTELL RES, V11, P95, DOI 10.1613/jair.514; Sahami M., 2006, P 15 INT C WORLD WID; Schutze H, 1998, COMPUT LINGUIST, V24, P97; Wilbur WJ, 1996, COMPUT BIOL MED, V26, P209, DOI 10.1016/0010-4825(95)00055-0; Wu Z, 1994, P 32 ANN M ASS COMP	27	0	0	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e77868	10.1371/journal.pone.0077868	http://dx.doi.org/10.1371/journal.pone.0077868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255QK	24348899	Green Published, Green Submitted, gold			2022-12-27	WOS:000327254700003
J	Butt, TM; Greenfield, BPJ; Greig, C; Maffeis, TGG; Taylor, JWD; Piasecka, J; Dudley, E; Abdulla, A; Dubovskiy, IM; Garrido-Jurado, I; Quesada-Moraga, E; Penny, MW; Eastwood, DC				Butt, Tariq M.; Greenfield, Bethany P. J.; Greig, Carolyn; Maffeis, Thierry G. G.; Taylor, James W. D.; Piasecka, Justyna; Dudley, Ed; Abdulla, Ahmed; Dubovskiy, Ivan M.; Garrido-Jurado, Inmaculada; Quesada-Moraga, Enrique; Penny, Mark W.; Eastwood, Daniel C.			Metarhizium anisopliae Pathogenesis of Mosquito Larvae: A Verdict of Accidental Death	PLOS ONE			English	Article							VIRULENCE; RELEASE; GERMINATION; EXPRESSION; MORTALITY; ADHESIN; INSECT; MAD1	Metarhizium anisopliae, a fungal pathogen of terrestrial arthropods, kills the aquatic larvae of Aedes aegypti, the vector of dengue and yellow fever. The fungus kills without adhering to the host cuticle. Ingested conidia also fail to germinate and are expelled in fecal pellets. This study investigates the mechanism by which this fungus adapted to terrestrial hosts kills aquatic mosquito larvae. Genes associated with the M. anisopliae early pathogenic response (proteinases Pr1 and Pr2, and adhesins, Mad1 and Mad2) are upregulated in the presence of larvae, but the established infection process observed in terrestrial hosts does not progress and insecticidal destruxins were not detected. Protease inhibitors reduce larval mortality indicating the importance of proteases in the host interaction. The Ae. aegypti immune response to M. anisopliae appears limited, whilst the oxidative stress response gene encoding for thiol peroxidase is upregulated. Cecropin and Hsp70 genes are downregulated as larval death occurs, and insect mortality appears to be linked to autolysis through caspase activity regulated by Hsp70 and inhibited, in infected larvae, by protease inhibitors. Evidence is presented that a traditional host-pathogen response does not occur as the species have not evolved to interact. M. anisopliae retains pre-formed pathogenic determinants which mediate host mortality, but unlike true aquatic fungal pathogens, does not recognise and colonise the larval host.	[Butt, Tariq M.; Greenfield, Bethany P. J.; Greig, Carolyn; Taylor, James W. D.; Piasecka, Justyna; Abdulla, Ahmed; Eastwood, Daniel C.] Swansea Univ, Coll Sci, Swansea, W Glam, Wales; [Maffeis, Thierry G. G.; Penny, Mark W.] Swansea Univ, Coll Engn, Swansea, W Glam, Wales; [Dudley, Ed] Swansea Univ, Coll Med, Swansea, W Glam, Wales; [Dubovskiy, Ivan M.] Russian Acad Sci, Inst Systemat & Ecol Anim, Siberian Branch, Novosibirsk, Russia; [Garrido-Jurado, Inmaculada; Quesada-Moraga, Enrique] Univ Cordoba, Dept Agr & Forestry Sci, Cordoba, Spain	Swansea University; Swansea University; Swansea University; Russian Academy of Sciences; Universidad de Cordoba	Butt, TM (corresponding author), Swansea Univ, Coll Sci, Swansea, W Glam, Wales.	t.butt@swansea.ac.uk	Garrido-Jurado, Inmaculada/K-6466-2014; Dubovskiy, Ivan/B-8252-2008; QUESADA-MORAGA, ENRIQUE/K-3419-2014	Garrido-Jurado, Inmaculada/0000-0002-2178-0013; Dubovskiy, Ivan/0000-0001-9691-3960; QUESADA-MORAGA, ENRIQUE/0000-0003-4021-3900; Greenfield, Bethany/0000-0002-8435-9795; Butt, Tariq/0000-0002-8789-9543; Taylor, James/0000-0003-2374-7222; Eastwood, Daniel/0000-0002-7015-0739	EU	EU(European Commission)	INBIOSOIL is an EU funded project. INTERREG IVA (http://wefo.wales.gov.uk/programmes/territorial/irelandwales/?lang=en). KESS (http://www.higherskillswales.co.uk/kess/). RFBR (http://www.rfbr.ru/rffi/eng/about). Spanish Ministry of Science (http://www.mineco.gob.es/portal/site/mineco/idi). EU FP7 (http://inbiosoil.uni-goettingen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAIDROOS K, 1978, CAN J GENET CYTOL, V20, P211, DOI 10.1139/g78-024; Ansari MA, 2011, J APPL MICROBIOL, V110, P1460, DOI 10.1111/j.1365-2672.2011.04994.x; Ansari MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016108; Barelli L, 2011, FUNGAL BIOL-UK, V115, P1174, DOI 10.1016/j.funbio.2011.08.003; Bukhari T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-22; Butt TM, 2009, RAPID COMMUN MASS SP, V23, P1426, DOI 10.1002/rcm.4018; BUTT TM, 1995, MYCOL RES, V99, P945, DOI 10.1016/S0953-7562(09)80754-5; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; CRISAN EV, 1971, J INVERTEBR PATHOL, V17, P260, DOI 10.1016/0022-2011(71)90101-7; de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001; Dubovskiy IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060248; Eastwood DC, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-66; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Hambarde S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058261; IMB corp, 2012, IBM SPSS STAT WIND; LACEY CM, 1988, J INVERTEBR PATHOL, V52, P108, DOI 10.1016/0022-2011(88)90109-7; Li CY, 2000, J BIOL CHEM, V275, P25665, DOI 10.1074/jbc.M906383199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord J, 2004, MYCOPATHOLOGIA, V10; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814; Miranpuri G, 1991, ENTOMOLOGIA EXPT APP, V18, P955; RIBA G, 1986, J AM MOSQUITO CONTR, V2, P469; Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19; Schrank A, 2010, TOXICON, V56, P1267, DOI 10.1016/j.toxicon.2010.03.008; SWEENEY AW, 1983, J INVERTEBR PATHOL, V42, P162, DOI 10.1016/0022-2011(83)90058-7; Tantral L, 2004, CELL BIOCHEM FUNCT, V22, P35, DOI 10.1002/cbf.1050; Vestergaard S, 1999, J INVERTEBR PATHOL, V73, P25, DOI 10.1006/jipa.1998.4802; Wang CS, 2007, EUKARYOT CELL, V6, P808, DOI 10.1128/EC.00409-06	30	69	74	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81686	10.1371/journal.pone.0081686	http://dx.doi.org/10.1371/journal.pone.0081686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349111	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200013
J	Kaiser, O; Aliuos, P; Wissel, K; Lenarz, T; Werner, D; Reuter, G; Kral, A; Warnecke, A				Kaiser, Odett; Aliuos, Pooyan; Wissel, Kirsten; Lenarz, Thomas; Werner, Darja; Reuter, GueNter; Kral, Andrej; Warnecke, Athanasia			Dissociated Neurons and Glial Cells Derived from Rat Inferior Colliculi after Digestion with Papain	PLOS ONE			English	Article							BRAIN-STEM IMPLANT; AUDITORY MIDBRAIN IMPLANT; AGE-DEPENDENT FAILURE; IN-VITRO; COCHLEAR NUCLEUS; PRIMARY CULTURE; NMDA RECEPTORS; SINGLE-CELL; SURVIVAL; PERFORMANCE	The formation of gliosis around implant electrodes for deep brain stimulation impairs electrode-tissue interaction. Unspecific growth of glial tissue around the electrodes can be hindered by altering physicochemical material properties. However, in vitro screening of neural tissue-material interaction requires an adequate cell culture system. No adequate model for cells dissociated from the inferior colliculus ( IC) has been described and was thus the aim of this study. Therefore, IC were isolated from neonatal rats ( P3_5) and a dissociated cell culture was established. In screening experiments using four dissociation methods (Neural Tissue Dissociation Kit [NTDK] T, NTDK P; NTDK PN, and a validated protocol for the dissociation of spiral ganglion neurons [SGN]), the optimal media, and seeding densities were identified. Thereafter, a dissociation protocol containing only the proteolytic enzymes of interest (trypsin or papain) was tested. For analysis, cells were fixed and immunolabeled using glial-and neuron-specific antibodies. Adhesion and survival of dissociated neurons and glial cells isolated from the IC were demonstrated in all experimental settings. Hence, preservation of type-specific cytoarchitecture with sufficient neuronal networks only occurred in cultures dissociated with NTDK P, NTDK PN, and fresh prepared papain solution. However, cultures obtained after dissociation with papain, seeded at a density of 2x10(4) cells/well and cultivated with Neuro Medium for 6 days reliably revealed the highest neuronal yield with excellent cytoarchitecture of neurons and glial cells. The herein described dissociated culture can be utilized as in vitro model to screen interactions between cells of the IC and surface modifications of the electrode.	[Kaiser, Odett; Aliuos, Pooyan; Wissel, Kirsten; Lenarz, Thomas; Werner, Darja; Reuter, GueNter; Kral, Andrej; Warnecke, Athanasia] Hannover Med Sch, Dept Otolaryngol, Hannover, Germany	Hannover Medical School	Warnecke, A (corresponding author), Hannover Med Sch, Dept Otolaryngol, Hannover, Germany.	Warnecke.Athanasia@mh-hannover.de	Warnecke, Athanasia/HHC-6174-2022	Kral, Andrej/0000-0002-7762-4642	German Research Foundation (DFG) [SFB 599]; cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft")	German Research Foundation (DFG)(German Research Foundation (DFG)); cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft")	This project was supported by the German Research Foundation (DFG; SFB 599, subproject D2; www.dfg.de; http://www.sfb599.de/). Andrej Kral, Pooyan Aliuos, and Athanasia Warnecke are supported by the cluster of excellence of the DFG ("Deutsche Forschungsgemeinschaft") "Hearing4all". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliuos P, 2013, J BIOMED MATER RES A, V101, P981, DOI 10.1002/jbm.a.34401; Assender H, 2002, SCIENCE, V297, P973, DOI 10.1126/science.1074955; Bailey JL, 2011, J NEUROCHEM, V117, P1020, DOI 10.1111/j.1471-4159.2011.07276.x; Basta D, 2004, NEUROSCI RES, V50, P237, DOI 10.1016/j.neures.2004.07.003; Belanger M, 2011, CELL METAB, V14, P724, DOI 10.1016/j.cmet.2011.08.016; Berkingali N, 2008, HEARING RES, V243, P121, DOI 10.1016/j.heares.2008.07.003; Brigande JV, 2009, NAT NEUROSCI, V12, P679, DOI 10.1038/nn.2311; BRORSON JR, 1991, J NEUROSCI, V11, P4024; Callizot N, 2011, EXP CELL RES, V317, P2374, DOI 10.1016/j.yexcr.2011.07.002; Chen WS, 2011, NEUROSCI RES, V70, P118, DOI 10.1016/j.neures.2011.01.002; Cheng SG, 2009, J HUAZHONG U SCI-MED, V29, P413, DOI 10.1007/s11596-009-0404-x; Colletti Vittorio, 2006, Adv Otorhinolaryngol, V64, P167, DOI 10.1159/000094651; Colletti V, 2009, OTOL NEUROTOL, V30, P614, DOI 10.1097/MAO.0b013e3181a864f2; Daneman R, 2012, ANN NEUROL, V72, P648, DOI 10.1002/ana.23648; de Vellis J, 2010, SPRINGER PROTOC HAND, P193, DOI 10.1007/978-1-60761-292-6_11; DELOSMONTEROS AE, 1993, INT J DEV NEUROSCI, V11, P625, DOI 10.1016/0736-5748(93)90051-E; Desclaux M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006227; Deuschl G, 2013, LANCET NEUROL, V12, P1025, DOI 10.1016/S1474-4422(13)70151-0; Fitzakerley JL, 1997, HEARING RES, V114, P148, DOI 10.1016/S0378-5955(97)00158-5; FITZGERALD SC, 1992, J NEUROSCI RES, V33, P579, DOI 10.1002/jnr.490330410; Fredrich M, 2009, EXP BRAIN RES, V195, P241, DOI 10.1007/s00221-009-1776-7; Gruters KG, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00096; Gutfreund Y, 2002, SCIENCE, V297, P1556, DOI 10.1126/science.1073712; Hafidi A, 2004, J COMP NEUROL, V470, P80, DOI 10.1002/cne.20003; HAFIDI A, 1995, J NEUROSCI, V15, P1298; Hafidi A, 1996, BRAIN RES, V736, P35; Hafidi A, 2003, DEV BRAIN RES, V143, P167, DOI 10.1016/S0165-3806(03)00110-X; Hafidi A, 1999, J NEUROBIOL, V41, P267; HATTEN ME, 1991, GLIA, V4, P233, DOI 10.1002/glia.440040215; Hendricks JL, 2008, HEARING RES, V242, P117, DOI 10.1016/j.heares.2008.06.003; HUETTNER JE, 1986, J NEUROSCI, V6, P3044; Jones SM, 2011, J NEUROSCI METH, V199, P241, DOI 10.1016/j.jneumeth.2011.05.015; Kakade S, 2013, DRUG DES DEV THER, V7, P529, DOI 10.2147/DDDT.S45162; Lenarz M, 2002, OTOL NEUROTOL, V23, P694, DOI 10.1097/00129492-200209000-00015; Lenarz M, 2007, OTOL NEUROTOL, V28, P1045, DOI 10.1097/MAO.0b013e318159e74f; Lenarz T, 2001, OTOL NEUROTOL, V22, P823, DOI 10.1097/00129492-200111000-00019; Lenarz Thomas, 2006, Audiol Neurootol, V11 Suppl 1, P34, DOI 10.1159/000095612; Lenarz T, 2006, OTOL NEUROTOL, V27, P838, DOI 10.1097/01.mao.0000232010.01116.e9; Lim Hubert H, 2009, Trends Amplif, V13, P149, DOI 10.1177/1084713809348372; Loizou Philipos C., 2003, Ear and Hearing, V24, P12, DOI 10.1097/01.AUD.0000052900.42380.50; Macedo CE, 2005, SYNAPSE, V55, P58, DOI 10.1002/syn.20094; McCreery D, 2007, IEEE T BIO-MED ENG, V54, P1042, DOI 10.1109/TBME.2007.891167; McCreery D, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/3/036005; Melo LL, 2010, BRAIN RES, V1349, P41, DOI 10.1016/j.brainres.2010.06.020; Miko IJ, 2009, HEARING RES, V251, P39, DOI 10.1016/j.heares.2009.02.003; Nevison B, 2002, EAR HEARING, V23, P170, DOI 10.1097/00003446-200206000-00002; Oluigbo Chima O, 2012, IEEE Rev Biomed Eng, V5, P88, DOI 10.1109/RBME.2012.2197745; Othman A, 2011, GLIA, V59, P914, DOI 10.1002/glia.21163; Otto SR, 2002, J NEUROSURG, V96, P1063, DOI 10.3171/jns.2002.96.6.1063; Ouda L, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00068; Rak K, 2011, J BIOMED MATER RES A, V97A, P158, DOI 10.1002/jbm.a.33042; Reich U, 2012, J BIOMED MATER RES B, V100B, P940, DOI 10.1002/jbm.b.32656; Reilly JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026478; Ridet JL, 1996, CELL TISSUE RES, V283, P39; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; SCHAAD NC, 1993, BRAIN RES, V614, P251, DOI 10.1016/0006-8993(93)91042-Q; Shannon RV, 2012, CURR OPIN NEUROL, V25, P61, DOI 10.1097/WCO.0b013e32834ef878; SHANNON RV, 1993, OTOLARYNG HEAD NECK, V108, P634, DOI 10.1177/019459989310800603; Souza DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060282; Stark DT, 2011, J NEUROSCI, V31, P13710, DOI 10.1523/JNEUROSCI.3544-11.2011; Tabata T, 2000, J NEUROSCI METH, V104, P45, DOI 10.1016/S0165-0270(00)00323-X; van Zessen R, 2012, NEURON, V73, P1184, DOI 10.1016/j.neuron.2012.02.016; Vandenhaute E, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-11; WAMSLEY JK, 1989, J CHEM NEUROANAT, V2, P119; Ward BC, 2006, BIOMATERIALS, V27, P3064, DOI 10.1016/j.biomaterials.2005.12.027; Warnecke A, 2012, HEARING RES, V289, P86, DOI 10.1016/j.heares.2012.04.007; WEBER A, 1984, BRAIN RES, V311, P119, DOI 10.1016/0006-8993(84)91404-5; Wefstaedt P, 2005, NEUROREPORT, V16, P2011, DOI 10.1097/00001756-200512190-00008; Wei L, 2010, NEUROSCIENCE, V168, P288, DOI 10.1016/j.neuroscience.2010.03.015; Winer J.A., 2005, INFERIOR COLLICULUS, DOI [10.1007/b138578, DOI 10.1007/B138578]	70	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80490	10.1371/journal.pone.0080490	http://dx.doi.org/10.1371/journal.pone.0080490			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349001	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800003
J	Xu, ZX; Zheng, P; Sun, JB; Ma, YH				Xu, Zixiang; Zheng, Ping; Sun, Jibin; Ma, Yanhe			ReacKnock: Identifying Reaction Deletion Strategies for Microbial Strain Optimization Based on Genome-Scale Metabolic Network	PLOS ONE			English	Article							ESCHERICHIA-COLI; KNOCKOUT STRATEGIES; LINEAR BILEVEL; RECONSTRUCTION; FRAMEWORK; MODELS; GSM/GPR	Gene knockout has been used as a common strategy to improve microbial strains for producing chemicals. Several algorithms are available to predict the target reactions to be deleted. Most of them apply mixed integer bi-level linear programming (MIBLP) based on metabolic networks, and use duality theory to transform bi-level optimization problem of large-scale MIBLP to single-level programming. However, the validity of the transformation was not proved. Solution of MIBLP depends on the structure of inner problem. If the inner problem is continuous, Karush-Kuhn-Tucker (KKT) method can be used to reformulate the MIBLP to a single-level one. We adopt KKT technique in our algorithm ReacKnock to attack the intractable problem of the solution of MIBLP, demonstrated with the genome-scale metabolic network model of E. coli for producing various chemicals such as succinate, ethanol, threonine and etc. Compared to the previous methods, our algorithm is fast, stable and reliable to find the optimal solutions for all the chemical products tested, and able to provide all the alternative deletion strategies which lead to the same industrial objective.	[Xu, Zixiang; Zheng, Ping; Sun, Jibin] Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China; [Xu, Zixiang; Zheng, Ping; Sun, Jibin; Ma, Yanhe] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Sun, JB (corresponding author), Chinese Acad Sci, Key Lab Syst Microbial Biotechnol, Tianjin, Peoples R China.	sun_jb@tib.cas.cn	MA, YAN/HHN-2912-2022	Sun, Jibin/0000-0002-0208-504X	National Basic Research Program of China [2011CBA00804, 2009CB724703]; National High Technology Program [2012AA023402, 2012AA023401]; Key Technologies Research and Development Program of Tianjin [11ZCZDSY08300, 11ZCZDSY08400, 11ZCZDSY08500]; National Natural Science Foundation of China [31370829]	National Basic Research Program of China(National Basic Research Program of China); National High Technology Program(National High Technology Research and Development Program of China); Key Technologies Research and Development Program of Tianjin; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Support for this work was provided by "National Basic Research Program of China (2011CBA00804, 2009CB724703)'', "National High Technology Program (2012AA023402, 2012AA023401)'', "Key Technologies Research and Development Program of Tianjin (11ZCZDSY08300, 11ZCZDSY08400, 11ZCZDSY08500), "National Natural Science Foundation of China (31370829).'' The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet C, 1997, J OPTIMIZ THEORY APP, V93, P273, DOI 10.1023/A:1022645805569; Bailey JE, 2001, NAT BIOTECHNOL, V19, P503, DOI 10.1038/89204; BALAS E, 1972, SIAM J APPL MATH, V23, P61, DOI 10.1137/0123007; Bard J.F., 1999, PRACTICAL BILEVEL OP; Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8; Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99; Betenbaugh M, 2008, CURR OPIN BIOTECH, V19, P411, DOI 10.1016/j.copbio.2008.08.009; Blazeck J, 2010, BIOTECHNOL J, V5, P647, DOI 10.1002/biot.200900247; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Burgard AP, 2003, BIOTECHNOL BIOENG, V82, P670, DOI 10.1002/bit.10617; DeNegre, 2011, INTERDICTION DISCRET; Duarte NC, 2004, GENOME RES, V14, P1298, DOI 10.1101/gr.2250904; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Feist AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100046; Gumus ZH, 2005, COMPUT MANAG SCI, V2, P181, DOI 10.1007/s10287-005-0025-1; Lee S, 2000, COMPUT CHEM ENG, V24, P711, DOI 10.1016/S0098-1354(00)00323-9; Lun DS, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.57; MOORE JT, 1990, OPER RES, V38, P911, DOI 10.1287/opre.38.5.911; Oh YK, 2007, J BIOL CHEM, V282, P28791, DOI 10.1074/jbc.M703759200; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Pharkya P, 2004, GENOME RES, V14, P2367, DOI 10.1101/gr.2872004; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Reed JL, 2004, GENOME RES, V14, P1797, DOI 10.1101/gr.2546004; Schellenberger J, 2009, J BIOL CHEM, V284, P5457, DOI 10.1074/jbc.R800048200; STEPHANOPOULOS G, 1991, SCIENCE, V252, P1675, DOI 10.1126/science.1904627; Tepper N, 2010, BIOINFORMATICS, V26, P536, DOI 10.1093/bioinformatics/btp704; Thiele I, 2005, J BACTERIOL, V187, P5818, DOI 10.1128/JB.187.16.5818-5830.2005; Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006	29	3	6	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e72150	10.1371/journal.pone.0072150	http://dx.doi.org/10.1371/journal.pone.0072150			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348984	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300002
J	Chen, J; Chen, H; Shi, Y; Hu, F; Lao, XZ; Gao, XD; Zheng, H; Yao, WB				Chen, Jiao; Chen, Hui; Shi, Yun; Hu, Feng; Lao, Xingzhen; Gao, Xiangdong; Zheng, Heng; Yao, Wenbing			Probing the Effect of the Non-Active-Site Mutation Y229W in New Delhi Metallo-beta-lactamase-1 by Site-Directed Mutagenesis, Kinetic Studies, and Molecular Dynamics Simulations	PLOS ONE			English	Article							METALLO-BETA-LACTAMASE; MECHANISM; IMP-1; NDM-1; COORDINATION; RECOGNITION; INHIBITORS; LOOP; CCRA	New Delhi metallo-beta-lactmase-1 (NDM-1) has attracted extensive attention for its high catalytic activities of hydrolyzing almost all beta-lactam antibiotics. NDM-1 shows relatively higher similarity to subclass B1 metallo-beta-lactmases (M beta Ls), but its residue at position 229 is identical to that of B2/B3 M beta Ls, which is a Tyr instead of a B1-M beta L-conserved Trp. To elucidate the possible role of Y229 in the bioactivity of NDM-1, we performed mutagenesis study and molecular dynamics (MD) simulations. Although residue Y229 is spatially distant from the active site and not contacting directly with the substrate or zinc ions, the Y229W mutant was found to have higher k(cat) and K-m values than those of wild-type NDM-1, resulting in 1,7 fold increases in k(cat)/K-m values against tested antibiotics. In addition, our MD simulations illustrated the enhanced flexibility of Loop 2 upon Y229W mutation, which could increase the kinetics of both substrate entrance (kon) and product egress (koff). The enhanced flexibility of Loop 2 might allow the enzyme to adjust the geometry of its active site to accommodate substrates with different structures, broadening its substrate spectrum. This study indicated the possible role of the residue at position 229 in the evolution of NDM-1.	[Chen, Jiao; Chen, Hui; Shi, Yun; Hu, Feng; Lao, Xingzhen; Gao, Xiangdong; Zheng, Heng; Yao, Wenbing] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Zheng, H (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhengh18@hotmail.com; wbyao@cpu.edu.cn	Shi, Yun/AAG-3890-2020; Gao, Xiang/HDO-3543-2022; CHEN, JIAO/GZA-5784-2022; chen, JJ/HGB-6029-2022	Shi, Yun/0000-0003-3365-4679; 	National Natural Science Foundation of China [31300643]; National High Technology Research and Development Program of China (863 Program) [2012AA020304]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China)	This work has been supported by the National Natural Science Foundation of China (Grant No. 31300643) and the National High Technology Research and Development Program of China (863 Program) (No. 2012AA020304). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Brown NG, 2011, ANTIMICROB AGENTS CH, V55, P5696, DOI 10.1128/AAC.00340-11; Case DA, 2012, AMBER 12; Chen H, 2012, J PHYS CHEM B, V116, P10219, DOI 10.1021/jp304736e; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Galleni M, 2001, ANTIMICROB AGENTS CH, V45, P660, DOI 10.1128/AAC.45.3.660-663.2001; Giamarellou H, 2009, DRUGS, V69, P1879, DOI 10.2165/11315690-000000000-00000; Gonzalez JM, 2010, BIOCHEMISTRY-US, V49, P7930, DOI 10.1021/bi100894r; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Hornsey M, 2011, ANTIMICROB AGENTS CH, V55, P5952, DOI 10.1128/AAC.05108-11; Hsu LY, 2011, SINGAP MED J, V52, P230; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Perez-Llarena FJ, 2009, CURR MED CHEM, V16, P3740, DOI 10.2174/092986709789104957; Kim Y, 2013, FASEB J, V27, P1917, DOI 10.1096/fj.12-224014; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902, DOI 10.1128/AAC.43.4.902; Liang ZJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023606; Nordmann P, 2012, ANTIMICROB AGENTS CH, V56, P2184, DOI 10.1128/AAC.05961-11; Oelschlaeger P, 2003, BIOCHEMISTRY-US, V42, P8945, DOI 10.1021/bi0300332; Oelschlaeger P, 2003, PROTEIN ENG, V16, P341, DOI 10.1093/protein/gzg049; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Pang YP, 1999, J MOL MODEL, V5, P196, DOI 10.1007/s008940050119; Park H, 2005, J AM CHEM SOC, V127, P4232, DOI 10.1021/ja042607b; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salsbury FR, 2009, J MOL MODEL, V15, P133, DOI 10.1007/s00894-008-0410-0; Shen BZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062955; Thomas PA, 2011, CURR CLIN PATHOL, P1, DOI 10.1007/978-1-60327-154-7_1; Valdez CE, 2013, J CHEM THEORY COMPUT, V9, P730, DOI 10.1021/ct300712j; Vanhove M, 2003, CELL MOL LIFE SCI, V60, P2501, DOI 10.1007/s00018-003-3092-x; Yang H, 2012, BIOCHEMISTRY-US, V51, P3839, DOI 10.1021/bi300056y; Yong D, 2009, ANTIMICROB AGENTS CH, V53, P5046, DOI 10.1128/AAC.00774-09; Zhang H, 2012, INSECT BIOCHEM MOLEC, V42, P583, DOI 10.1016/j.ibmb.2012.04.005; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036; Zhu KK, 2013, J COMPUT AID MOL DES, V27, P247, DOI 10.1007/s10822-012-9630-6	37	18	19	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82080	10.1371/journal.pone.0082080	http://dx.doi.org/10.1371/journal.pone.0082080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339993	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400059
J	Kasper, LH; Fukuyama, T; Lerach, S; Chang, YC; Xu, W; Wu, S; Boyd, KL; Brindle, PK				Kasper, Lawryn H.; Fukuyama, Tomofusa; Lerach, Stephanie; Chang, Yunchao; Xu, Wu; Wu, Song; Boyd, Kelli L.; Brindle, Paul K.			Genetic Interaction between Mutations in c-Myb and the KIX Domains of CBP and p300 Affects Multiple Blood Cell Lineages and Influences Both Gene Activation and Repression	PLOS ONE			English	Article							CREB-BINDING PROTEIN; RUBINSTEIN-TAYBI-SYNDROME; HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION-FACTOR; TARGET GENES; TRANSACTIVATION DOMAIN; HISTONE MODIFICATION; EXPRESSION PROFILES; COACTIVATOR CBP; MPL(-/-) MICE	Adult blood cell production or definitive hematopoiesis requires the transcription factor c-Myb. The closely related KAT3 histone acetyltransferases CBP (CREBBP) and p300 (EP300) bind c-Myb through their KIX domains and mice homozygous for a p300 KIX domain mutation exhibit multiple blood defects. Perplexingly, mice homozygous for the same KIX domain mutation in CBP have normal blood. Here we test the hypothesis that the CBP KIX domain contributes subordinately to hematopoiesis via a genetic interaction with c-Myb. We assessed hematopoiesis in mice bearing compound mutations of c-Myb and/or the KIX domains of CBP and p300, and measured the effect of KIX domain mutations on c-Myb-dependent gene expression. We found that in the context of a p300 KIX mutation, the CBP KIX domain mutation affects platelets, B cells, T cells, and red cells. Gene interaction (epistasis) analysis provides mechanistic evidence that blood defects in KIX mutant mice are consistent with reduced c-Myb and KIX interaction. Lastly, we demonstrated that the CBP and p300 KIX domains contribute to both c-Myb-dependent gene activation and repression. Together these results suggest that the KIX domains of CBP, and especially p300, are principal mediators of c-Myb-dependent gene activation and repression that is required for definitive hematopoiesis.	[Kasper, Lawryn H.; Fukuyama, Tomofusa; Lerach, Stephanie; Chang, Yunchao; Xu, Wu; Brindle, Paul K.] St Jude Childrens Res Hosp, Dept Biochem, Memphis, TN 38105 USA; [Wu, Song] St Jude Childrens Res Hosp, Dept Biostat, Memphis, TN 38105 USA; [Boyd, Kelli L.] St Jude Childrens Res Hosp, Vet Pathol Core, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Brindle, PK (corresponding author), St Jude Childrens Res Hosp, Dept Biochem, 332 N Lauderdale St, Memphis, TN 38105 USA.	paul.brindle@stjude.org	Kasper, Lawryn/GWV-5700-2022	Fukuyama, Tomofusa/0000-0002-0709-3188; Brindle, Paul/0000-0001-7172-8478; Xu, Wu/0000-0002-2982-3276	National Institutes of Health [R01DK058199, R01CA161202, P30CA021765]; American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital; NATIONAL CANCER INSTITUTE [R01CA161202, P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health [grant numbers R01DK058199, R01CA161202 and P30CA021765] and by the American Lebanese Syrian Associated Charities of St. Jude Children's Research Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alm-Kristiansen AH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-21; Bedford DC, 2012, AGING-US, V4, P247, DOI 10.18632/aging.100453; Bedford DC, 2011, CELL METAB, V14, P219, DOI 10.1016/j.cmet.2011.06.010; Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Bies J, 2002, J BIOL CHEM, V277, P8999, DOI 10.1074/jbc.M110453200; Carpinelli MR, 2004, P NATL ACAD SCI USA, V101, P6553, DOI 10.1073/pnas.0401496101; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Chen J, 2001, BLOOD CELL MOL DIS, V27, P429, DOI 10.1006/bcmd.2001.0401; Clarke D, 2000, ONCOGENE, V19, P3343, DOI 10.1038/sj.onc.1203661; Dahle O, 2004, EXP CELL RES, V297, P118, DOI 10.1016/j.yexcr.2004.03.014; Dash AB, 1996, GENE DEV, V10, P1858, DOI 10.1101/gad.10.15.1858; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Egoh A, 2010, GENES CELLS, V15, P829, DOI 10.1111/j.1365-2443.2010.01421.x; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Fang F, 2009, ENDOCRINOLOGY, V150, P1597, DOI 10.1210/en.2008-1079; Fukuyama T, 2009, MOL CELL BIOL, V29, P3894, DOI 10.1128/MCB.01598-08; Greig KT, 2010, BLOOD, V115, P2796, DOI 10.1182/blood-2009-08-239210; Haarer B, 2007, GENE DEV, V21, P148, DOI 10.1101/gad.1477507; Haas M, 2004, BIOCHEMISTRY-US, V43, P8152, DOI 10.1021/bi035857y; Hegde SP, 1998, MOL CELL BIOL, V18, P2729, DOI 10.1128/MCB.18.5.2729; Henikoff S, 2011, TRENDS GENET, V27, P389, DOI 10.1016/j.tig.2011.06.006; Jasnos L, 2007, NAT GENET, V39, P550, DOI 10.1038/ng1986; Jin SH, 2010, J CLIN INVEST, V120, P593, DOI 10.1172/JCI38030; Jin W, 2011, BREAST CANCER RES TR, V125, P699, DOI 10.1007/s10549-010-0876-1; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kanei-Ishii C, 2008, J BIOL CHEM, V283, P30540, DOI 10.1074/jbc.M804340200; Kanei-Ishii C, 2012, BIOCHEM BIOPH RES CO, V426, P59, DOI 10.1016/j.bbrc.2012.08.032; Kasper LH, 2005, EMBO J, V24, P3846, DOI 10.1038/sj.emboj.7600846; Kasper LH, 2006, MOL CELL BIOL, V26, P789, DOI 10.1128/MCB.26.3.789-809.2006; Kasper LH, 2002, NATURE, V419, P738, DOI 10.1038/nature01062; Kauppi M, 2008, BLOOD, V112, P3148, DOI 10.1182/blood-2007-10-119677; Kimbrel EA, 2009, BLOOD, V114, P4804, DOI 10.1182/blood-2009-04-217794; Kishi H, 2002, BLOOD, V99, P576, DOI 10.1182/blood.V99.2.576; Kitagawa K, 2009, ONCOGENE, V28, P2393, DOI 10.1038/onc.2009.111; Kowenz-Leutz E, 1999, MOL CELL, V4, P735, DOI 10.1016/S1097-2765(00)80384-6; Kozuka T, 2011, J IMMUNOL, V187, P5974, DOI 10.4049/jimmunol.1100550; Kung AL, 2000, GENE DEV, V14, P272; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Ladendorff NE, 2001, ONCOGENE, V20, P125, DOI 10.1038/sj.onc.1204048; Lang G, 2005, ONCOGENE, V24, P1375, DOI 10.1038/sj.onc.1208301; Leonard D, 2003, BIOCHEM BIOPH RES CO, V308, P793, DOI 10.1016/S0006-291X(03)01486-4; Lieu YK, 2004, P NATL ACAD SCI USA, V101, P14853, DOI 10.1073/pnas.0405338101; Lorenzo Petra Isabel, 2011, Genes Cancer, V2, P805, DOI 10.1177/1947601911428224; Mertz JA, 2007, J VIROL, V81, P3503, DOI 10.1128/JVI.02253-06; Miyamoto-Sato E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009289; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Ness SA, 1999, ONCOGENE, V18, P3039, DOI 10.1038/sj.onc.1202726; Nicot C, 2001, MOL CELL BIOL, V21, P7391, DOI 10.1128/MCB.21.21.7391-7402.2001; Nomura T, 2004, J BIOL CHEM, V279, P16715, DOI 10.1074/jbc.M313069200; Pani E, 2008, BBA-MOL CELL RES, V1783, P1121, DOI 10.1016/j.bbamcr.2008.02.020; Papathanasiou P, 2010, BLOOD, V116, P5849, DOI 10.1182/blood-2010-04-269951; Parker D, 1999, MOL CELL BIOL, V19, P5601; Pattabiraman DR, 2009, MOL CANCER RES, V7, P1477, DOI 10.1158/1541-7786.MCR-09-0070; PETRIJ F, 1995, NATURE, V376, P348, DOI 10.1038/376348a0; Pham LV, 2008, J BIOL CHEM, V283, P5081, DOI 10.1074/jbc.M706307200; Phillips PC, 2008, NAT REV GENET, V9, P855, DOI 10.1038/nrg2452; Quintana AM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-30; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Roelfsema JH, 2005, AM J HUM GENET, V76, P572, DOI 10.1086/429130; Saether T, 2011, ONCOGENE, V30, P212, DOI 10.1038/onc.2010.397; Saether T, 2007, J BIOL CHEM, V282, P13994, DOI 10.1074/jbc.M700755200; Sandberg ML, 2005, DEV CELL, V8, P153, DOI 10.1016/j.devcel.2004.12.015; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Shi LH, 2008, J BIOL CHEM, V283, P36474, DOI 10.1074/jbc.M805980200; Sramko M, 2006, J BIOL CHEM, V281, P40065, DOI 10.1074/jbc.M609404200; Steensma DP, 2006, BLOOD, V107, P1733, DOI 10.1182/blood-2005-09-3646; Streubel G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003343; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; Tahirov TH, 2002, CELL, V108, P57, DOI 10.1016/S0092-8674(01)00636-5; Tallmadge RL, 2012, CLIN VACCINE IMMUNOL, V19, P1054, DOI 10.1128/CVI.00237-12; Tanaka Y, 2000, MECH DEVELOP, V95, P133, DOI 10.1016/S0925-4773(00)00360-9; Tanikawa J, 2000, J BIOL CHEM, V275, P15578, DOI 10.1074/jbc.M000372200; Tober J, 2008, BLOOD, V111, P2636, DOI 10.1182/blood-2007-11-124685; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Verbeek W, 1999, BLOOD, V93, P3327, DOI 10.1182/blood.V93.10.3327; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Xiao SY, 2003, CELL RES, V13, P265, DOI 10.1038/sj.cr.7290171; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Xu W, 2006, BLOOD, V107, P4407, DOI 10.1182/blood-2005-08-3263; Yao TP, 1998, CELL, V93, P361, DOI 10.1016/S0092-8674(00)81165-4; Ying GG, 2000, J BIOL CHEM, V275, P4152, DOI 10.1074/jbc.275.6.4152; Yuan J, 2010, J IMMUNOL, V184, P2793, DOI 10.4049/jimmunol.0902846; Zhao HW, 2012, J BIOL CHEM, V287, P925, DOI 10.1074/jbc.M111.279950; Zhao L, 2011, NUCLEIC ACIDS RES, V39, P4664, DOI 10.1093/nar/gkr024; Zhou FF, 2011, MOL BIOL CELL, V22, P3533, DOI 10.1091/mbc.E11-06-0483; Zor T, 2004, J MOL BIOL, V337, P521, DOI 10.1016/j.jmb.2004.01.038; Zor T, 2002, J BIOL CHEM, V277, P42241, DOI 10.1074/jbc.M207361200	92	22	22	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82684	10.1371/journal.pone.0082684	http://dx.doi.org/10.1371/journal.pone.0082684			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340053	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400091
J	Oh, H; Kim, H; Chung, KH; Hong, NH; Shin, B; Park, WJ; Jun, Y; Rhee, S; Song, WK				Oh, Hyejin; Kim, Hwan; Chung, Kyung-Hwun; Hong, Nan Hyung; Shin, Baehyun; Park, Woo Jin; Jun, Youngsoo; Rhee, Sangmyung; Song, Woo Keun			SPIN90 Knockdown Attenuates the Formation and Movement of Endosomal Vesicles in the Early Stages of Epidermal Growth Factor Receptor Endocytosis	PLOS ONE			English	Article							2 DISTINCT PHASES; SIGNAL-TRANSDUCTION; CELL-PROLIFERATION; DOWN-REGULATION; ERBB RECEPTORS; EGF RECEPTOR; CYCLIN D1; IN-VIVO; MIGRATION; PATHWAY	The finding that SPIN90 colocalizes with epidermal growth factor (EGF) in EEA1-positive endosomes prompted us to investigate the role of SPIN90 in endocytosis of the EGF receptor (EGFR). In the present study, we demonstrated that SPIN90 participates in the early stages of endocytosis, including vesicle formation and trafficking. Stable HeLa cells with knockdown of SPIN90 displayed significantly higher levels of surface EGFR than control cells. Analysis of the abundance and cellular distribution of EGFR via electron microscopy revealed that SPIN90 knockdown cells contain residual EGFR at cell membranes and fewer EGFR-containing endosomes, both features that reflect reduced endosome formation. The delayed early endosomal targeting capacity of SPIN90 knockdown cells led to increased EGFR stability, consistent with the observed accumulation of EGFR at the membrane. Small endosome sizes and reduced endosome formation in SPIN90 knockdown cells, observed using fluorescent confocal microscopy, strongly supported the involvement of SPIN90 in endocytosis of EGFR. Overexpression of SPIN90 variants, particularly the SH3, PRD, and CC (positions 643 - 722) domains, resulted in aberrant morphology of Rab5-positive endosomes (detected as small spots located near the cell membrane) and defects in endosomal movement. These findings clearly suggest that SPIN90 participates in the formation and movement of endosomes. Consistent with this, SPIN90 knockdown enhanced cell proliferation. The delay in EGFR endocytosis effectively increased the levels of endosomal EGFR, which triggered activation of ERK1/2 and cell proliferation via upregulation of cyclin D1. Collectively, our findings suggest that SPIN90 contributes to the formation and movement of endosomal vesicles, and modulates the stability of EGFR protein, which affects cell cycle progression via regulation of the activities of downstream proteins, such as ERK1/2, after EGF stimulation.	[Oh, Hyejin; Kim, Hwan; Chung, Kyung-Hwun; Song, Woo Keun] GIST, Sch Life Sci, Bio Imaging & Cell Dynam Res Ctr, Gwangju Metrocity, South Korea; [Park, Woo Jin] GIST, Sch Life Sci, Bio Remodeling & Gene Therapy Lab, Gwangju Metrocity, South Korea; [Jun, Youngsoo] GIST, Sch Life Sci, Cell Biol & Membrane Biochem Lab, Gwangju Metrocity, South Korea; [Hong, Nan Hyung] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN 37235 USA; [Rhee, Sangmyung] Chung Ang Univ, Dept Life Sci, Seoul 156756, South Korea; [Shin, Baehyun] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Vanderbilt University; Chung Ang University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Song, WK (corresponding author), GIST, Sch Life Sci, Bio Imaging & Cell Dynam Res Ctr, Cheomdan Gwagi Ro 261, Gwangju Metrocity, South Korea.	wksong@gist.ac.kr	Jun, Youngsoo/Q-3624-2018	Jun, Youngsoo/0000-0002-2387-032X	Bio Imaging and Cell Dynamics Research Center through the National Research Foundation of Korea (NRF) [2007-0056492]; Converging Research Center Program through the National Research Foundation of Korea (NRF) [2013K000381]; Basic Science Research Program through the National Research Foundation of Korea (NRF) [2010-0024096]; Ministry of Education, Science and Technology	Bio Imaging and Cell Dynamics Research Center through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Converging Research Center Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Bio Imaging and Cell Dynamics Research Center (2007-0056492), the Converging Research Center Program (2013K000381), and Basic Science Research Program through the National Research Foundation of Korea (NRF, Sangmyung Rhee: 2010-0024096) funded by the Ministry of Education, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON ED, 1982, DEV BIOL, V90, P430, DOI 10.1016/0012-1606(82)90392-X; Andl CD, 2003, J BIOL CHEM, V278, P1824, DOI 10.1074/jbc.M209148200; BRYANT RE, 1966, J EXP MED, V124, P483, DOI 10.1084/jem.124.3.483; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; COHEN STANLEY, 1965, DEVELOP BIOL, V12, P394, DOI 10.1016/0012-1606(65)90005-9; Dannhauser PN, 2012, NAT CELL BIOL, V14, P634, DOI 10.1038/ncb2478; de Graauw M, 2013, ONCOGENE; DIGUGLIELMO GM, 1994, EMBO J, V13, P4269, DOI 10.1002/j.1460-2075.1994.tb06747.x; Fung TK, 2005, SEMIN CELL DEV BIOL, V16, P335, DOI 10.1016/j.semcdb.2005.02.014; Galderisi U, 2003, ONCOGENE, V22, P5208, DOI 10.1038/sj.onc.1206558; Galperin E, 2003, J CELL SCI, V116, P4799, DOI 10.1242/jcs.00801; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; Holbro T, 2004, ANNU REV PHARMACOL, V44, P195, DOI 10.1146/annurev.pharmtox.44.101802.121440; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Jones SM, 2001, CHEM REV, V101, P2413, DOI 10.1021/cr000101f; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kawada K, 2009, MOL CELL BIOL, V29, P4508, DOI 10.1128/MCB.00015-09; Kerkhoff E, 1998, ONCOGENE, V17, P1457, DOI 10.1038/sj.onc.1202185; Kim HJ, 2012, J CELL SCI, V125, P4740, DOI 10.1242/jcs.100339; Kim SM, 2011, EXP CELL RES, V317, P2276, DOI 10.1016/j.yexcr.2011.06.018; Kim SH, 2006, GENES CELLS, V11, P1197, DOI 10.1111/j.1365-2443.2006.01008.x; Kim Y, 2005, J NEUROSCI, V25, P9515, DOI 10.1523/JNEUROSCI.1643-05.2005; Kobayashi S, 2006, CANCER RES, V66, P11389, DOI 10.1158/0008-5472.CAN-06-2318; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Pennock S, 2003, MOL CELL BIOL, V23, P5803, DOI 10.1128/MCB.23.16.5803-5815.2003; Planque Nathalie, 2006, Cell Commun Signal, V4, P7, DOI 10.1186/1478-811X-4-7; Poch B, 2001, PANCREAS, V23, P280, DOI 10.1097/00006676-200110000-00009; Robles AI, 1998, GENE DEV, V12, P2469, DOI 10.1101/gad.12.16.2469; Rodman JS, 2000, J CELL SCI, V113, P183; Saikawa Y, 2001, JPN J CANCER RES, V92, P1102, DOI 10.1111/j.1349-7006.2001.tb01065.x; Schweitzer JK, 2011, SEMIN CELL DEV BIOL, V22, P39, DOI 10.1016/j.semcdb.2010.09.002; Sebastian S, 2006, BBA-REV CANCER, V1766, P120, DOI 10.1016/j.bbcan.2006.06.001; SHEN WC, 1984, P NATL ACAD SCI-BIOL, V81, P1445, DOI 10.1073/pnas.81.5.1445; Simpson F, 1999, NAT CELL BIOL, V1, P119, DOI 10.1038/10091; Singh AK, 2011, J BIOL CHEM, V286, P21961, DOI 10.1074/jbc.M111.238238; Skepper JN, 2008, CSH PROTOC; Skorobogata O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036489; Sorkin A, 2010, CURR PROTOC CELL BIO; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Y, 2002, MOL CELL BIOL, V22, P7279, DOI 10.1128/MCB.22.20.7279-7290.2002; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	49	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82610	10.1371/journal.pone.0082610	http://dx.doi.org/10.1371/journal.pone.0082610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340049	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400089
J	Qin, KF; Ding, TB; Xiao, Y; Ma, WY; Wang, Z; Gao, JM; Zhao, LL				Qin, Kefeng; Ding, Tianbing; Xiao, Yi; Ma, Wenyu; Wang, Zhen; Gao, Jimin; Zhao, Lili			Differential Responses of Neuronal and Spermatogenic Cells to the Doppel Cytotoxicity	PLOS ONE			English	Article							PRP-LIKE PROTEIN; PRION PROTEIN; TRANSCRIPTION FACTORS; CDNA SEQUENCE; FUGU-RUBRIPES; GENE PRND; MICE; EXPRESSION; SP1; BINDING	Although structurally and biochemically similar to the cellular prion (PrPC), doppel (Dpl) is unique in its biological functions. There are no reports about any neurodegenerative diseases induced by Dpl. However the artificial expression of Dpl in the PrP-deficient mouse brain causes ataxia with Purkinje cell death. Abundant Dpl proteins have been found in testis and depletion of the Dpl gene (Prnd) causes male infertility. Therefore, we hypothesize different regulations of Prnd in the nerve and male productive systems. In this study, by electrophoretic mobility shift assays we have determined that two different sets of transcription factors are involved in regulation of the Prnd promoter in mouse neuronal N2a and GC-1 spermatogenic (spg) cells, i.e., upstream stimulatory factors (USF) in both cells, Brn-3 and Sp1 in GC-1 spg cells, and Sp3 in N2a cells, leading to the expression of Dpl in GC-1 spg but not in N2a cells. We have further defined that, in N2a cells, Dpl induces oxidative stress and apoptosis, which stimulate ataxia-telangiectasia mutated (ATM)-modulating bindings of transcription factors, p53 and p21, to Prnp promoter, resulting the PrPC elevation for counteraction of the Dpl cytotoxicity; in contrast, in GC-1 spg cells, phosphorylation of p21 and N-terminal truncated PrP may play roles in the control of Dpl-induced apoptosis, which may benefit the physiological function of Dpl in the male reproduction system.	[Qin, Kefeng; Wang, Zhen; Gao, Jimin; Zhao, Lili] Wenzhou Med Univ, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China; [Qin, Kefeng; Ding, Tianbing; Xiao, Yi; Ma, Wenyu] Fourth Mil Med Univ, Dept Microbiol, Xian 710032, Peoples R China; [Qin, Kefeng; Zhao, Lili] Univ Chicago, Dept Neurol, Chicago, IL 60637 USA	Wenzhou Medical University; Air Force Military Medical University; University of Chicago	Qin, KF (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Technol & Applicat Model Or, Wenzhou, Peoples R China.	kqin1@neurology.bsd.uchicago.edu			National Natural Scientific Foundation of China [30080006, 8177022]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	The authors gratefully acknowledge the financial support in part from National Natural Scientific Foundation of China, No: 30080006 and No: 8177022 (to KQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronoff-Spencer E, 2000, BIOCHEMISTRY-US, V39, P13760, DOI 10.1021/bi001472t; Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Behrens A, 2002, EMBO J, V21, P3652, DOI 10.1093/emboj/cdf386; Birnbaum MJ, 1995, BIOCHEMISTRY-US, V34, P16503, DOI 10.1021/bi00050a034; Calissano M, 2004, NEUROREPORT, V15, P483, DOI 10.1097/00001756-200403010-00020; Caputo A, 2010, BIOCHEM J, V425, P341, DOI 10.1042/BJ20091050; Cereghetti GM, 2004, J BIOL CHEM, V279, P36497, DOI 10.1074/jbc.M404341200; Drisaldi B, 2004, J BIOL CHEM, V279, P55443, DOI 10.1074/jbc.M404794200; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espenes A, 2006, INT J ANDROL, V29, P400, DOI 10.1111/j.1365-2605.2005.00618.x; HAGEN G, 1995, J BIOL CHEM, V270, P24989, DOI 10.1074/jbc.270.42.24989; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Helt CE, 2001, TOXICOL SCI, V63, P214, DOI 10.1093/toxsci/63.2.214; HOFFMAN PW, 1995, NUCLEIC ACIDS RES, V23, P2229, DOI 10.1093/nar/23.12.2229; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kocer A, 2007, DEV DYNAM, V236, P836, DOI 10.1002/dvdy.21066; La Mendola D, 2010, CHEM-EUR J, V16, P6212, DOI 10.1002/chem.200902405; La Mendola D, 2009, J INORG BIOCHEM, V103, P758, DOI 10.1016/j.jinorgbio.2009.01.017; Laggner H, 2006, ANAL BIOANAL CHEM, V385, P959, DOI 10.1007/s00216-006-0498-y; Li AM, 2000, AM J PATHOL, V157, P1447, DOI 10.1016/S0002-9440(10)64782-7; Li P, 2009, ACTA BIOCH BIOPH SIN, V41, P42, DOI 10.1093/abbs/gmn005; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MASTRANGELO IA, 1991, P NATL ACAD SCI USA, V88, P5670, DOI 10.1073/pnas.88.13.5670; Moore RC, 1999, J MOL BIOL, V292, P797, DOI 10.1006/jmbi.1999.3108; Moore RC, 2001, P NATL ACAD SCI USA, V98, P15288, DOI 10.1073/pnas.251550798; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nagyova J, 2004, BBA-GENE STRUCT EXPR, V1679, P288, DOI 10.1016/j.bbaexp.2004.08.002; Nishida N, 1999, LAB INVEST, V79, P689; Oidtmann B, 2003, FEBS LETT, V538, P96, DOI 10.1016/S0014-5793(03)00149-2; Ostrakhovitch EA, 2005, APOPTOSIS, V10, P111, DOI 10.1007/s10495-005-6066-7; Paisley D, 2004, AM J PATHOL, V164, P2279, DOI 10.1016/S0002-9440(10)63784-4; Pan Q, 2002, CANCER RES, V62, P4854; Peoc'h K, 2002, J BIOL CHEM, V277, P43071, DOI 10.1074/jbc.M206357200; Peoc'h K, 2000, NEUROSCI LETT, V286, P144, DOI 10.1016/S0304-3940(00)01100-9; Pimenta J, 2012, REPROD DOMEST ANIM, V47, P196, DOI 10.1111/j.1439-0531.2011.01827.x; Qin K, 2006, NEUROSCIENCE, V141, P1375, DOI 10.1016/j.neuroscience.2006.04.068; Qin K, 2006, NEUROSCIENCE, V141, P1, DOI 10.1016/j.neuroscience.2006.04.057; Qin KF, 2009, J BIOL CHEM, V284, P4582, DOI 10.1074/jbc.M808410200; Qin KF, 2003, J BIOL CHEM, V278, P8888, DOI 10.1074/jbc.M210875200; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Rossi D, 2001, EMBO J, V20, P694, DOI 10.1093/emboj/20.4.694; Sakaguchi S, 1996, NATURE, V380, P528, DOI 10.1038/380528a0; Sepelakova J, 2005, BBA-GENE STRUCT EXPR, V1731, P209, DOI 10.1016/j.bbaexp.2005.10.002; Silverman GL, 2000, J BIOL CHEM, V275, P26834; SU W, 1991, GENE DEV, V5, P820, DOI 10.1101/gad.5.5.820; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Tranulis MA, 2001, MAMM GENOME, V12, P376, DOI 10.1007/s003350010285; Uboldi C, 2005, MAMM GENOME, V16, P963, DOI 10.1007/s00335-005-0084-1; Watts JC, 2007, BBA-MOL BASIS DIS, V1772, P654, DOI 10.1016/j.bbadis.2007.05.001; WESTAWAY D, 1994, P NATL ACAD SCI USA, V91, P6418, DOI 10.1073/pnas.91.14.6418; Westaway D, 2011, TOP CURR CHEM, V305, P225, DOI 10.1007/128_2011_190; Wong BS, 2001, MOL CELL NEUROSCI, V17, P768, DOI 10.1006/mcne.2001.0963; Yu B, 2003, NUCLEIC ACIDS RES, V31, P5368, DOI 10.1093/nar/gkg706; Zhao CT, 2005, DEV GROWTH DIFFER, V47, P201; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032	57	5	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82130	10.1371/journal.pone.0082130	http://dx.doi.org/10.1371/journal.pone.0082130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339999	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400061
J	Sun, S; Chen, G; Xu, MH; Qiao, YL; Zheng, S				Sun, Song; Chen, Gong; Xu, Menghua; Qiao, Yingli; Zheng, Shan			Differentiation and Migration of Bone Marrow Mesenchymal Stem Cells Transplanted through the Spleen in Rats with Portal Hypertension	PLOS ONE			English	Article							IN-VITRO DIFFERENTIATION; HEPATOCYTE TRANSPLANTATION; HEPATIC DIFFERENTIATION; LIVER-REGENERATION; EXPRESSION; RESISTANT; FIBROSIS; THERAPY; PATHWAY; VIVO	Aims: The goals of this paper were to evaluate the differentiation of bone marrow mesenchymal stem cells (BMSCs) into hepatocyte-like cells in vitro, and to determine whether stem cells can migrate and plant into the liver with portal hypertension accompanied by the end-stage of liver disease. Methods: BMSCs were isolated from rats and amplified with hepatocyte growth factor (HGF) and fibroblast growth factor-4 (FGF-4). The expression of alpha-fetoprotein (AFP), cytokeratin 18 (CK-18), and albumin (ALB) was detected by immunofluorescence in induced cells. Rats were randomly divided into experimental (with common bile duct ligation) and control groups. After injection of fluorescence labeled cells, cell distribution was observed under a fluorescence microscope. The integrated optical density (IOD) and cell distribution scores were evaluated using Image-Pro Plus 6.0 software. The portal pressure was measured before the rats were killed. Results: After being induced with HGF and FGF-4, the Golgi apparatus, endoplasmic reticulum, ribosomes, and mitochondria all significantly increased in the fifth generation cells. Immunofluorescent analysis showed that the induced cells expressed AFP, CK-18, and ALB. BMSCs were stained by CM-Dil, and the labeling rate was as high as 95.5%. The portal pressure in experimental group was much higher than that of the control group (18.04 +/- 2.35 vs. 9.75 +/- 1.40cm H2O p<0.01). The IOD of transplanted cells in the experimental group was also significantly higher than that of the control group (11.30 +/- 2.09x10(5) vs. 2.93 +/- 0.88x10(5), p<0.01). In addition, the cell distribution score in the experimental group was lower than that of the control group (1.99 +/- 0.36 vs. 2.36 +/- 0.27, P<0.05). Conclusions: The combination of HGF and FGF-4 induces the differentiation of BMSCs into hepatocyte-like cells, which express AFP, CK-18, and ALB. In addition, the recruitment of BMSCs (after transplantation in the spleen) was improved in rats with portal hypertension.	[Sun, Song; Chen, Gong; Xu, Menghua; Qiao, Yingli; Zheng, Shan] Fudan Univ, Childrens Hosp, Dept Surg, Shanghai 200433, Peoples R China	Fudan University	Zheng, S (corresponding author), Fudan Univ, Childrens Hosp, Dept Surg, Shanghai 200433, Peoples R China.	szheng@shmu.edu.cn		Zheng, Shan/0000-0002-9712-4573	Shanghai Health Bureau	Shanghai Health Bureau	The funding was sponsored by Shanghai Health Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aziz MTA, 2007, CLIN BIOCHEM, V40, P893, DOI 10.1016/j.clinbiochem.2007.04.017; Banas A, 2009, J GASTROEN HEPATOL, V24, P70, DOI 10.1111/j.1440-1746.2008.05496.x; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BRILL S, 1993, P SOC EXP BIOL MED, V204, P261; Bunnell BA, 2005, CAN J PHYSIOL PHARM, V83, P529, DOI 10.1139/Y05-043; Chang YJ, 2009, LIFE SCI, V85, P517, DOI 10.1016/j.lfs.2009.08.003; Chivu M, 2009, TRANSL RES, V154, P122, DOI 10.1016/j.trsl.2009.05.007; Cho KA, 2009, CELL BIOL INT, V33, P772, DOI 10.1016/j.cellbi.2009.04.023; CHU YK, 2003, GAN DAN WAI KE ZA ZH, V11, P149; Dinarvand P, 2010, BIOL PHARM BULL, V33, P1212, DOI 10.1248/bpb.33.1212; Dong XJ, 2010, WORLD J GASTROENTERO, V16, P3267, DOI 10.3748/wjg.v16.i26.3267; El-Badri NS, 2004, STEM CELLS DEV, V13, P463, DOI 10.1089/scd.2004.13.463; Fang BJ, 2004, TRANSPLANTATION, V78, P83, DOI 10.1097/01.TP.0000128326.95294.14; Hashemi SM, 2009, CELLS TISSUES ORGANS, V190, P135, DOI 10.1159/000187716; Hong SH, 2005, BIOCHEM BIOPH RES CO, V330, P1153, DOI 10.1016/j.bbrc.2005.03.086; Kaibori M, 2012, TRANSPL P, V44, P1107, DOI 10.1016/j.transproceed.2012.01.088; Keeffe EB, 2001, GASTROENTEROLOGY, V120, P749, DOI 10.1053/gast.2001.22583; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kuo TK, 2008, GASTROENTEROLOGY, V134, P2111, DOI 10.1053/j.gastro.2008.03.015; Lam SP, 2010, LIVER TRANSPLANT, V16, P1195, DOI 10.1002/lt.22136; Lee LA, 2001, J CLIN INVEST, V108, P367, DOI 10.1172/JCI200113650; Li N, 2009, GRAEF ARCH CLIN EXP, V247, P503, DOI 10.1007/s00417-008-1009-y; Malhi H, 2001, J Hepatobiliary Pancreat Surg, V8, P40, DOI 10.1007/s005340170049; Markus PM, 1997, CELL TRANSPLANT, V6, P455, DOI 10.1016/S0963-6897(97)00051-1; Masuhara M, 1996, HEPATOLOGY, V24, P323; Minguell JJ, 2006, EXP BIOL MED, V231, P39; Mohamadnejad M, 2007, WORLD J GASTROENTERO, V13, P3359, DOI 10.3748/wjg.v13.i24.3359; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Pan GZ, 2012, J SURG RES, V178, P935, DOI 10.1016/j.jss.2012.04.070; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Petersen BE, 1999, SCIENCE, V284, P1168, DOI 10.1126/science.284.5417.1168; Pournasr B, 2011, ARCH IRAN MED, V14, P244, DOI 0011144/AIM.004; Rajvanshi P, 1996, GASTROENTEROLOGY, V111, P1092, DOI 10.1016/S0016-5085(96)70078-1; Reyes M, 2001, BLOOD, V98, P2615, DOI 10.1182/blood.V98.9.2615; Ringden O, 2006, TRANSPLANTATION, V81, P1390, DOI 10.1097/01.tp.0000214462.63943.14; Sato Y, 2005, BLOOD, V106, P756, DOI 10.1182/blood-2005-02-0572; Shi XL, 2009, TRANSPLANTATION, V88, P1178, DOI 10.1097/TP.0b013e3181bc288b; Snykers S, 2006, TOXICOL SCI, V94, P330, DOI 10.1093/toxsci/kfl058; Thorgeirsson SS, 1996, FASEB J, V10, P1249, DOI 10.1096/fasebj.10.11.8836038; Xie C, 2009, CELL BIOL INT, V33, P493, DOI 10.1016/j.cellbi.2009.01.006; Zemel R, 2009, LIVER INT, V29, P1326, DOI 10.1111/j.1478-3231.2009.02054.x; ZHANG GQ, 2006, CHI J CLIN REHAB, V10, P183; Zhao DC, 2005, WORLD J GASTROENTERO, V11, P3431, DOI 10.3748/wjg.v11.i22.3431; ZHENG SS, 2009, ZHONG GUO XUN ZHENG, V4, P1	44	25	31	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83523	10.1371/journal.pone.0083523	http://dx.doi.org/10.1371/journal.pone.0083523			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340101	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400134
J	Yellon, SM; Dobyns, AE; Beck, HL; Kurtzman, JT; Garfield, RE; Kirby, MA				Yellon, Steven M.; Dobyns, Abigail E.; Beck, Hailey L.; Kurtzman, James T.; Garfield, Robert E.; Kirby, Michael A.			Loss of Progesterone Receptor-Mediated Actions Induce Preterm Cellular and Structural Remodeling of the Cervix and Premature Birth	PLOS ONE			English	Article							RAT UTERINE CERVIX; PRECEDES PARTURITION; LABOR INDUCTION; HUMAN-PREGNANCY; MICE LACKING; UTERUS; MIFEPRISTONE; ACTIVATION; MECHANISMS; ESTROGEN	A decline in serum progesterone or antagonism of progesterone receptor function results in preterm labor and birth. Whether characteristics of premature remodeling of the cervix after antiprogestins or ovariectomy are similar to that at term was the focus of the present study. Groups of pregnant rats were treated with vehicle, a progesterone receptor antagonist (onapristone or mifepristone), or ovariectomized on day 17 postbreeding. As expected, controls given vehicle delivered at term while rats delivered preterm after progesterone receptor antagonist treatment or ovariectomy. Similar to the cervix before term, the preterm cervix of progesterone receptor antagonist-treated rats was characterized by reduced cell nuclei density, decreased collagen content and structure, as well as a greater presence of macrophages per unit area. Thus, loss of nuclear progesterone receptor-mediated actions promoted structural remodeling of the cervix, increased census of resident macrophages, and preterm birth much like that found in the cervix at term. In contrast to the progesterone receptor antagonist-induced advance in characteristics associated with remodeling, ovariectomy-induced loss of systemic progesterone did not affect hypertrophy, extracellular collagen, or macrophage numbers in the cervix. Thus, the structure and macrophage census in the cervix appear sufficient for premature ripening and birth to occur well before term. With progesterone receptors predominantly localized on cells other than macrophages, the findings suggest that interactions between cells may facilitate the loss of progesterone receptor-mediated actions as part of a final common mechanism that remodels the cervix in certain etiologies of preterm and with parturition at term.	[Yellon, Steven M.; Dobyns, Abigail E.; Beck, Hailey L.; Kirby, Michael A.] Loma Linda Univ, Sch Med, Div Physiol, Dept Basic Sci, Loma Linda, CA 92350 USA; [Yellon, Steven M.; Dobyns, Abigail E.; Beck, Hailey L.; Kirby, Michael A.] Loma Linda Univ, Sch Med, Ctr Perinatal Biol, Loma Linda, CA USA; [Yellon, Steven M.; Kirby, Michael A.] Loma Linda Univ, Sch Med, Dept Pediat Pathol & Human Anat, Loma Linda, CA USA; [Yellon, Steven M.; Kurtzman, James T.] Loma Linda Univ, Sch Med, Dept Obstet & Gynecol, Loma Linda, CA USA; [Garfield, Robert E.] St Josephs Hosp, Dept Obstet & Gynecol, Phoenix, AZ USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University; St. Joseph's Hospital and Medical Center	Yellon, SM (corresponding author), Loma Linda Univ, Sch Med, Div Physiol, Dept Basic Sci, Loma Linda, CA 92350 USA.	syellon@LLU.edu		Yellon, Steven/0000-0003-4850-3590; Kirby, Ph.D., Michael/0000-0002-0859-374X	NIH [HD054931]; Loma Linda University Department of Pediatrics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD054931] Funding Source: NIH RePORTER; National Institute for Health Research [NF-SI-0510-10164] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Loma Linda University Department of Pediatrics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by NIH HD054931 and the Loma Linda University Department of Pediatrics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson S, 2008, J CLIN ENDOCR METAB, V93, P2366, DOI 10.1210/jc.2007-2813; Boyd JW, 2009, REPRODUCTION, V137, P739, DOI 10.1530/REP-08-0507; BRIDGES RS, 1984, ENDOCRINOLOGY, V114, P930, DOI 10.1210/endo-114-3-930; Brown AG, 2004, ANN NY ACAD SCI, V1034, P36, DOI 10.1196/annals.1335.004; Buhimschi IA, 2004, AM J OBSTET GYNECOL, V191, P1695, DOI 10.1016/j.ajog.2004.03.080; Chapman NR, 2006, MOL HUM REPROD, V12, P19, DOI 10.1093/molehr/gah248; CHWALISZ K, 1994, HUM REPROD, V9, P131, DOI 10.1093/humrep/9.suppl_1.131; Clyde LA, 2011, BIOL REPROD, V84, P587, DOI 10.1095/biolreprod.110.086207; Condon JC, 2006, MOL ENDOCRINOL, V20, P764, DOI 10.1210/me.2005-0242; Condon JC, 2003, P NATL ACAD SCI USA, V100, P9518, DOI 10.1073/pnas.1633616100; CSAPO A, 1956, AM J ANAT, V98, P273, DOI 10.1002/aja.1000980206; DE M, 1990, J ENDOCRINOL, V126, P417, DOI 10.1677/joe.0.1260417; Denison FC, 2000, MOL HUM REPROD, V6, P541, DOI 10.1093/molehr/6.6.541; Donath J, 2000, ANN ANAT, V182, P143, DOI 10.1016/S0940-9602(00)80073-4; Ekman-Ordeberg G, 2003, STEROIDS, V68, P837, DOI 10.1016/j.steroids.2003.08.018; Ellora D, 2012, J OBSTET GYN INDIA, V62, P47, DOI 10.1007/s13224-012-0156-6; Fang X, 1997, ENDOCRINOLOGY, V138, P2763, DOI 10.1210/en.138.7.2763; Fata JE, 2001, BIOL REPROD, V65, P680, DOI 10.1095/biolreprod65.3.680; GARFIELD RE, 1982, AM J OBSTET GYNECOL, V142, P21; GARFIELD RE, 1987, AM J OBSTET GYNECOL, V157, P1281, DOI 10.1016/S0002-9378(87)80315-0; Giacalone PL, 1998, OBSTET GYNECOL, V92, P487, DOI 10.1016/S0029-7844(98)00225-7; Golightly E, 2011, MOL CELL ENDOCRINOL, V335, P52, DOI 10.1016/j.mce.2010.08.005; Gonzalez JM, 2011, AM J PATHOL, V179, P838, DOI 10.1016/j.ajpath.2011.04.024; GRATTAN DR, 1990, ENDOCRINOLOGY, V126, P1199, DOI 10.1210/endo-126-2-1199; HEIKINHEIMO O, 1993, ANN MED, V25, P71, DOI 10.3109/07853899309147861; IKUTA Y, 1991, ENDOCRINOL JAPON, V38, P491; Kirby LS, 2005, J SOC GYNECOL INVEST, V12, P578, DOI 10.1016/j.jsgi.2005.08.006; Kurtzman J, 2011, CONT OB GYN, V9, P26; Leonhardt SA, 2002, EXP BIOL MED, V227, P969, DOI 10.1177/153537020222701104; Leppert P, 1998, AM J OBSTET GYNECOL, V178, P713, DOI 10.1016/S0002-9378(98)70481-8; LUQUE EH, 1989, ANAT REC, V223, P257, DOI 10.1002/ar.1092230304; Mackler AM, 1999, BIOL REPROD, V61, P879, DOI 10.1095/biolreprod61.4.879; Mahendroo MS, 1999, MOL ENDOCRINOL, V13, P981, DOI 10.1210/me.13.6.981; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Mesiano S, 2011, REPROD SCI, V18, P6, DOI 10.1177/1933719110382922; Mitchell BF, 2009, AM J PHYSIOL-REG I, V297, pR525, DOI 10.1152/ajpregu.00153.2009; Payne KJ, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.101840; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Sfakianaki AK, 2006, J MATERN-FETAL NEO M, V19, P763, DOI 10.1080/14767050600949829; SHERWOOD OD, 1994, PHYSL REPROD, P862; SMITH MS, 1975, ENDOCRINOLOGY, V96, P219, DOI 10.1210/endo-96-1-219; Stenlund PM, 1999, ACTA OBSTET GYN SCAN, V78, P793, DOI 10.1034/j.1600-0412.1999.780910.x; Stjernholm-Vladic Y, 2004, GYNECOL ENDOCRINOL, V18, P41, DOI 10.1080/09513590310001651777; Tan HQ, 2012, J CLIN ENDOCR METAB, V97, pE719, DOI 10.1210/jc.2011-3251; VIRGO BB, 1974, ENDOCRINOLOGY, V95, P1486, DOI 10.1210/endo-95-5-1486; Wing DA, 2000, OBSTET GYNECOL, V96, P543, DOI 10.1016/S0029-7844(00)00947-9; Word RA, 2007, SEMIN REPROD MED, V25, P69, DOI 10.1055/s-2006-956777; Yellon SA, 2008, BIOL REPROD, V78, P438, DOI 10.1095/biolreprod.107.063404; Yellon SM, 2012, REPROD SCI, V19, p303A; Yellon SM, 2011, BIOL REPROD, V85, P498, DOI 10.1095/biolreprod.111.091983	50	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81340	10.1371/journal.pone.0081340	http://dx.doi.org/10.1371/journal.pone.0081340			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339918	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400014
J	Gasparic, MB; Lenassi, M; Gostincar, C; Rotter, A; Plemenitas, A; Gunde-Cimerman, N; Gruden, K; Zel, J				Gasparic, Meti Buh; Lenassi, Metka; Gostincar, Cene; Rotter, Ana; Plemenitas, Ana; Gunde-Cimerman, Nina; Gruden, Kristina; Zel, Jana			Insertion of a Specific Fungal 3 '-phosphoadenosine-5 '-phosphatase Motif into a Plant Homologue Improves Halotolerance and Drought Tolerance of Plants	PLOS ONE			English	Article							INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; IN-VIVO TARGET; SALT TOLERANCE; 3(2),5-BISPHOSPHATE NUCLEOTIDASE; 3'(2'),5'-BISPHOSPHATE NUCLEOTIDASE; NEGATIVE REGULATOR; ABIOTIC STRESS; ABSCISIC-ACID; REAL-TIME; ARABIDOPSIS	Soil salinity and drought are among the most serious agricultural and environmental problems of today. Therefore, investigations of plant resistance to abiotic stress have received a lot of attention in recent years. In this study, we identified the complete coding sequence of a 3'-phosphoadenosine-5'-phosphatase protein, ApHal2, from the halotolerant yeast Aureobasidium pullulans. Expression of the ApHAL2 gene in a Saccharomyces cerevisiae hal2 mutant complemented the mutant auxotrophy for methionine, and rescued the growth of the hal2 mutant in media with high NaCl concentrations. A 21-amino-acids-long region of the ApHal2 enzyme was inserted into the Arabidopsis thaliana homologue of Hal2, the SAL1 phosphatase. The inserted sequence included the META motif, which has previously been implicated in increased sodium tolerance of the Hal2 homologue from a related fungal species. Transgenic Arabidopsis plants overexpressing this modified SAL1 (mSAL1) showed improved halotolerance and drought tolerance. In a medium with an elevated salt concentration, mSAL1-expressing plants were twice as likely to have roots in a higher length category in comparison with the wild-type Arabidopsis and with plants overexpressing the native SAL1, and had 5% to 10% larger leaf surface area under moderate and severe salt stress, respectively. Similarly, after moderate drought exposure, the mSAL1-expressing plants showed 14% increased dry weight after revitalisation, with no increase in dry weight of the wild-type plants. With severe drought, plants overexpressing native SAL1 had the worst rehydration success, consistent with the recently proposed role of SAL1 in severe drought. This was not observed for plants expressing mSAL1. Therefore, the presence of this fungal META motif sequence is beneficial under conditions of increased salinity and moderate drought, and shows no drawbacks for plant survival under severe drought. This demonstrates that adaptations of extremotolerant fungi should be considered as a valuable resource for improving stress-tolerance in plant breeding in the future.	[Gasparic, Meti Buh; Rotter, Ana; Gruden, Kristina; Zel, Jana] Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia; [Lenassi, Metka; Plemenitas, Ana] Univ Ljubljana, Fac Med, Inst Biochem, Ljubljana 61000, Slovenia; [Lenassi, Metka; Gostincar, Cene; Gunde-Cimerman, Nina] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia; [Gostincar, Cene] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia	National Institute of Biology - Slovenia; University of Ljubljana; University of Ljubljana	Zel, J (corresponding author), Natl Inst Biol, Dept Biotechnol & Syst Biol, Ljubljana, Slovenia.	jana.zel@nib.si	Gruden, kristina/AAI-6439-2020	Gunde-Cimerman, Nina/0000-0002-9464-3263; Rotter, Ana/0000-0002-6879-0980; Lenassi, Metka/0000-0002-9488-6855; gruden, kristina/0000-0001-5906-8569; Gostincar, Cene/0000-0002-0149-3674	Slovenian Research Agency [J4-2022, P1-170, P4-0165, Z4-5531]; Slovenian Research Agency (Infrastructural Centre Mycosmo); Slovenian Research Agency (MRIC UL); COST network [FA0804]; operation "Centre of excellence for integrated approaches in chemistry and biology of proteins" [OP13.1.1.2.02.0005]; European regional development fund; Slovenian Ministry of higher education, science and technology	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovenian Research Agency (Infrastructural Centre Mycosmo); Slovenian Research Agency (MRIC UL); COST network; operation "Centre of excellence for integrated approaches in chemistry and biology of proteins"; European regional development fund(European Commission); Slovenian Ministry of higher education, science and technology	The authors acknowledge the financial support from the state budget by the Slovenian Research Agency (grants no. J4-2022, P1-170, P4-0165, Infrastructural Centre Mycosmo, MRIC UL, and postdoctoral project Z4-5531 to CG) and COST network FA0804. The scientific work was partly financed via operation "Centre of excellence for integrated approaches in chemistry and biology of proteins" number OP13.1.1.2.02.0005, financed by European regional development fund (85% share of financing) and by the Slovenian Ministry of higher education, science and technology (15% share of financing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal M, 2005, YEAST, V22, P457, DOI 10.1002/yea.1223; Aggarwal M, 2008, ARCH BIOCHEM BIOPHYS, V469, P174, DOI 10.1016/j.abb.2007.10.011; Albert A, 2000, J MOL BIOL, V295, P927, DOI 10.1006/jmbi.1999.3408; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], [No title captured]; Arrillaga I, 1998, PLANT SCI, V136, P219, DOI 10.1016/S0168-9452(98)00122-8; Ashraf M, 2010, Biotechnol Adv, V28, P169, DOI 10.1016/j.biotechadv.2009.11.005; Ashraf M, 2009, BIOTECHNOL ADV, V27, P744, DOI 10.1016/j.biotechadv.2009.05.026; Chen H, 2011, PLOS ONE, V6; Chen H, 2011, PLANT SIGNAL BEHAV, V6, P123, DOI 10.4161/psb.6.1.14231; Chen H, 2010, PLANT CELL ENVIRON, V33, P2180, DOI 10.1111/j.1365-3040.2010.02218.x; Chen Y, 2006, J EXP BOT, V57, P2101, DOI 10.1093/jxb/erj167; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cominelli E, 2010, NEW BIOTECHNOL, V27, P473, DOI 10.1016/j.nbt.2010.08.005; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Estavillo GM, 2011, PLANT CELL, V23, P3992, DOI 10.1105/tpc.111.091033; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; Gostincar C, 2012, BIORESOURCE TECHNOL, V111, P360, DOI 10.1016/j.biortech.2012.02.039; Gostincar C, 2011, FUNGAL BIOL-UK, V115, P1008, DOI 10.1016/j.funbio.2011.03.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Harrell Jr F. E., 2012, RMS REGRESSION MODEL; Hirsch J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016724; Kim BH, 2009, PLANT J, V58, P208, DOI 10.1111/j.1365-313X.2008.03770.x; Kogovsek P, 2010, RAZLIKE IZRAZANJU GE; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lenassi M, 2013, PLOS ONE IN PRESS; Leustek T, 1999, PLANT PHYSIOL, V120, P637, DOI 10.1104/pp.120.3.637; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miyamoto R, 2000, J BACTERIOL, V182, P3619, DOI 10.1128/JB.182.13.3619-3625.2000; MURGUIA JR, 1995, SCIENCE, V267, P232; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; PENG ZH, 1995, J BIOL CHEM, V270, P29105, DOI 10.1074/jbc.270.49.29105; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; RENSDOMIANO SS, 1987, J NEUROCHEM, V48, P1411, DOI 10.1111/j.1471-4159.1987.tb05679.x; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; ROZMAN D, 1994, BIOTECHNIQUES, V16, P382; Skirycz A, 2011, NAT BIOTECHNOL, V29, P212, DOI 10.1038/nbt.1800; Somvanshi Vishal S, 2009, Recent Pat DNA Gene Seq, V3, P16; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; THOMAS D, 1992, J GEN MICROBIOL, V138, P2021, DOI 10.1099/00221287-138-10-2021; Vaupotic T, 2007, FUNGAL GENET BIOL, V44, P1109, DOI 10.1016/j.fgb.2007.02.005; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Weller SA, 2000, APPL ENVIRON MICROB, V66, P2853, DOI 10.1128/AEM.66.7.2853-2858.2000; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Xiong LM, 2004, PLANT J, V40, P536, DOI 10.1111/j.1365-313X.2004.02225.x; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Zhang J, 2011, DEV CELL, V20, P855, DOI 10.1016/j.devcel.2011.05.013	55	9	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81872	10.1371/journal.pone.0081872	http://dx.doi.org/10.1371/journal.pone.0081872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349144	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200053
J	Paduano, V; Tagliaferri, D; Falco, G; Ceccarelli, M				Paduano, Vincenzo; Tagliaferri, Daniela; Falco, Geppino; Ceccarelli, Michele			Automated Identification and Location Analysis of Marked Stem Cells Colonies in Optical Microscopy Images	PLOS ONE			English	Article							COMPUTER VISION APPROACH; MOUSE ES CELLS; SURFACE MEASUREMENTS; CELLULAR IMAGES; PLURIPOTENCY; DIFFUSION; SEGMENTATION; ZSCAN4	Embryonic stem cells (ESCs) are characterized by two remarkable peculiarities: the capacity to propagate as undifferentiated cells (sell-renewal) and the ability to differentiate in ectoderm, endoderm, and mesoderm derivatives (pluripotency). Although the majority of ESCs divide without losing the pluripotency, it has become evident that ESC cultures consists of multiple cell populations highlighted by the expression of early germ lineage markers during spontaneous differentiation. Hence, the identification and characterization of ESCs subpopulations represents an efficient approach to improve the comprehension of correlation between gene expression and cell specification status. To study markers of ESCs heterogeneity, we developed an analysis pipeline which can automatically process images of stem cell colonies in optical microscopy. The question we try to address is to find out the statistically significant preferred locations of the marked cells. We tested our algorithm on a set of images of stem cell colonies to analyze the expression pattern of the Zscan4 gene, which was an elite candidate gene to be studied because it is specifically expressed in subpopulation of ESCs. To validate the proposed method we analyzed the behavior of control genes whose pattern had been associated to biological status such as differentiation (EndoA), pluripotency (Pou5f1), and pluripotency fluctuation (Nanog). We found that Zscan4 is not uniformly expressed inside a stem cell colony, and that it tends to be expressed towards the center of the colony, moreover cells expressing Zscan4 cluster each other. This is of significant importance because it allows us to hypothesize a biological status where the cells expressing Zscan4 are preferably associated to the inner of colonies suggesting pluripotent cell status features, and the clustering between themselves suggests either a colony paracrine effect or an early phase of cell specification through proliferation. Also, the analysis on the control genes showed that they behave as expected.	[Paduano, Vincenzo; Ceccarelli, Michele] BioGeM Sca Rl, Genet Res Inst G Salvatore IRGS, Bioinformat Lab, Avellino, Italy; [Tagliaferri, Daniela; Falco, Geppino] BioGeM Sca Rl, Genet Res Inst G Salvatore IRGS, Stem Cell Res Lab, Avellino, Italy; [Paduano, Vincenzo; Falco, Geppino; Ceccarelli, Michele] Univ Sannio, Dept Sci & Technol, Benevento, Italy	University of Sannio	Falco, G (corresponding author), BioGeM Sca Rl, Genet Res Inst G Salvatore IRGS, Stem Cell Res Lab, Avellino, Italy.	geppino.falco@unisannio.it; michele.ceccarelli@unisannio.it	Ceccarelli, Michele/AGP-1739-2022	falco, geppino/0000-0001-6193-7233; Ceccarelli, Michele/0000-0002-4702-6617				Black MJ, 1998, IEEE T IMAGE PROCESS, V7, P421, DOI 10.1109/83.661192; Carter MG, 2008, GENE EXPR PATTERNS, V8, P181, DOI 10.1016/j.gep.2007.10.009; Ceccarelli M, 2001, P IM PROC 2001, V3, P712; Ceccarelli M, 2010, IEEE T INSTRUM MEAS, V59, P2383, DOI 10.1109/TIM.2010.2049184; Ceccarelli M, 2009, IEEE INT WORK MED ME, P223, DOI 10.1109/MEMEA.2009.5167989; Ceccarelli M, 2009, IEEE INT WORK MED ME, P166, DOI 10.1109/MEMEA.2009.5167977; Falco G, 2007, DEV BIOL, V307, P539, DOI 10.1016/j.ydbio.2007.05.003; Haralick R.M., 1992, COMPUTER ROBOT VISIO, V1, P158; Haykin S., 2002, ADAPTIVE FILTER THEO; Held M, 2010, NAT METHODS, V7, P747, DOI 10.1038/nmeth.1486; Khairy K, 2011, GENESIS, V49, P488, DOI 10.1002/dvg.20698; Kolmogorov, 1933, GIORNALE DELLISTITUT, V4, P83; Li FH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003043; Li JY, 2012, BIOINFORMATICS, V28, pI32, DOI 10.1093/bioinformatics/bts230; Loh KM, 2011, CELL STEM CELL, V8, P363, DOI 10.1016/j.stem.2011.03.013; Lowry N, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P194, DOI 10.1109/ISBI.2012.6235517; MEYER F, 1994, SIGNAL PROCESS, V38, P113, DOI 10.1016/0165-1684(94)90060-4; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Osher S.J., 2002, LEVEL SET METHODS DY, V153; Schervish M. J., 1996, THEORY STAT; Sethian JA, 1999, CAMBRIDGE MONOGRAPHS; Soille P., 2003, MORPHOLOGICAL IMAGE, DOI [10.1007/978-3-662-05088-0, DOI 10.1007/978-3-662-05088-0]; Stryke D, 2003, NUCLEIC ACIDS RES, V31, P278, DOI 10.1093/nar/gkg064; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Truong TV, 2011, GENESIS, V49, P555, DOI 10.1002/dvg.20760; van den Boomgard R, 1992, COMPUTER VISION GRAP, V54, P254; Weeratunga SK, 2002, P SOC PHOTO-OPT INS, V4667, P279, DOI 10.1117/12.467989; Weickert J, 1998, IEEE T IMAGE PROCESS, V7, P398, DOI 10.1109/83.661190; Yan PK, 2008, IEEE T INF TECHNOL B, V12, P109, DOI 10.1109/TITB.2007.898006; Zalzman M, 2010, NATURE, V464, P858, DOI 10.1038/nature08882; Zuiderveld K.J., 1994, GRAPHICS GEMS, P474, DOI DOI 10.1016/B978-0-12-336156-1.50061-6	33	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80776	10.1371/journal.pone.0080776	http://dx.doi.org/10.1371/journal.pone.0080776			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349016	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200012
J	Ludtke, B; Moser, I; Santiago-Alarcon, D; Fischer, M; Kalko, EKV; Schaefer, HM; Suarez-Rubio, M; Tschapka, M; Renner, SC				Luedtke, Bruntje; Moser, Isabelle; Santiago-Alarcon, Diego; Fischer, Markus; Kalko, Elisabeth K. V.; Schaefer, H. Martin; Suarez-Rubio, Marcela; Tschapka, Marco; Renner, Swen C.			Associations of Forest Type, Parasitism and Body Condition of Two European Passerines, Fringilla coelebs and Sylvia atricapilla	PLOS ONE			English	Article							AVIAN BLOOD PARASITES; FLUCTUATING ASYMMETRY; PHYSIOLOGICAL STRESS; LEUKOCYTE PROFILES; TRADE-OFFS; POPULATION; PREVALENCE; DIVERSITY; BIRDS; INFECTION	Human-induced forest modification can alter parasite-host interactions and might change the persistence of host populations. We captured individuals of two widespread European passerines (Fringilla coelebs and Sylvia atricapilla) in southwestern Germany to disentangle the associations of forest types and parasitism by haemosporidian parasites on the body condition of birds. We compared parasite prevalence and parasite intensity, fluctuating asymmetries, leukocyte numbers, and the heterophil to lymphocyte ratio (H/L-ratio) among individuals from beech, mixed-deciduous and spruce forest stands. Based on the biology of bird species, we expected to find fewer infected individuals in beech or mixed-deciduous than in spruce forest stands. We found the highest parasite prevalence and intensity in beech forests for F. coelebs. Although, we found the highest prevalence in spruce forests for S. atricapilla, the highest intensity was detected in beech forests, partially supporting our hypothesis. Other body condition or health status metrics, such as the heterophil to lymphocyte ratio (H/L-ratio), revealed only slight differences between bird populations inhabiting the three different forest types, with the highest values in spruce for F. coelebs and in mixed-deciduous forests for S. atricapilla. A comparison of parasitized versus non-parasitized individuals suggests that parasite infection increased the immune response of a bird, which was detectable as high H/L-ratio. Higher infections with blood parasites for S. atricapilla in spruce forest indicate that this forest type might be a less suitable habitat than beech and mixed-deciduous forests, whereas beech forests seem to be a suboptimal habitat regarding parasitism for F. coelebs.	[Luedtke, Bruntje; Kalko, Elisabeth K. V.; Tschapka, Marco; Renner, Swen C.] Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany; [Luedtke, Bruntje; Schaefer, H. Martin] Univ Freiburg, Inst Zool, D-79106 Freiburg, Germany; [Moser, Isabelle] Univ Tubingen, Tubingen, Germany; [Fischer, Markus] Univ Bern, Inst Plant Sci, Bern, Switzerland; [Fischer, Markus] Univ Bern, Bot Garden, Bern, Switzerland; [Kalko, Elisabeth K. V.; Tschapka, Marco] Smithsonian Trop Res Inst, Bilbao, Panama; [Suarez-Rubio, Marcela] Univ Nat Resources & Life Sci, Inst Zool, Vienna, Austria; [Renner, Swen C.] Natl Zool Pk, Smithsonian Conservat Biol Ctr, Front Royal, VA USA	Ulm University; University of Freiburg; Eberhard Karls University of Tubingen; University of Bern; University of Bern; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Natural Resources & Life Sciences, Vienna; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Renner, SC (corresponding author), Univ Ulm, Inst Expt Ecol, D-89069 Ulm, Germany.	swen.renner@uni-ulm.de	Fischer, Markus/C-6411-2008; Santiago-Alarcon, Diego/G-2485-2018; Santiago-Alarcon, Diego/AAF-3641-2020	Fischer, Markus/0000-0002-5589-5900; Santiago-Alarcon, Diego/0000-0002-4914-5580; Santiago-Alarcon, Diego/0000-0002-4914-5580; /0000-0002-6893-4219; Suarez-Rubio, Marcela/0000-0002-0596-2626	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories''; A. v. Humboldt Foundation	DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories''; A. v. Humboldt Foundation(Alexander von Humboldt Foundation)	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories''. DSA has been funded through the A. v. Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anciaes M, 2000, J APPL ECOL, V37, P1013, DOI 10.1046/j.1365-2664.2000.00554.x; Battin J, 2004, CONSERV BIOL, V18, P1482, DOI 10.1111/j.1523-1739.2004.00417.x; Benning TL, 2002, P NATL ACAD SCI USA, V99, P14246, DOI 10.1073/pnas.162372399; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Brown CR, 2002, J EVOLUTION BIOL, V15, P1067, DOI 10.1046/j.1420-9101.2002.00474.x; Brunet Jorg, 2010, Ecological Bulletins, V53, P77; Campbell T. W., 2007, AVIAN EXOTIC ANIMAL; Chalfoun AD, 2007, J APPL ECOL, V44, P983, DOI 10.1111/j.1365-2664.2007.01352.x; Chasar A, 2009, MOL ECOL, V18, P4121, DOI 10.1111/j.1365-294X.2009.04346.x; Cirule D, 2012, J ORNITHOL, V153, P161, DOI 10.1007/s10336-011-0719-9; D'Amico VL, 2010, J WILDLIFE DIS, V46, P644, DOI 10.7589/0090-3558-46.2.644; Davis AK, 2008, FUNCT ECOL, V22, P760, DOI 10.1111/j.1365-2435.2008.01467.x; Davis AK, 2005, J FIELD ORNITHOL, V76, P334, DOI 10.1648/0273-8570-76.4.334; DeGroote LW, 2010, J AVIAN BIOL, V41, P147, DOI 10.1111/j.1600-048X.2009.04782.x; Dhondt AA, 2010, J ANIM ECOL, V79, P257, DOI 10.1111/j.1365-2656.2009.01624.x; Ellis RD, 2012, LANDSCAPE ECOL, V27, P1, DOI 10.1007/s10980-011-9671-6; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Fokidis HB, 2008, J AVIAN BIOL, V39, P300, DOI [10.1111/j.0908-8857.2008.04248.x, 10.1111/j.2008.0908-8857.04248.x]; Forsman JT, 2008, BEHAV ECOL, V19, P539, DOI 10.1093/beheco/arn005; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Glutz Von Blotzheim UN., 1987, HDB VOGEL MITTELEURO; GODFREY RD, 1987, J WILDLIFE DIS, V23, P558, DOI 10.7589/0090-3558-23.4.558; Green AJ, 2001, ECOLOGY, V82, P1473, DOI 10.2307/2680003; Gregory RD, 2007, IBIS, V149, P78, DOI 10.1111/j.1474-919X.2007.00698.x; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Helle S, 2011, ECOL INDIC, V11, P861, DOI 10.1016/j.ecolind.2010.11.004; Ilmonen P, 2003, OECOLOGIA, V136, P148, DOI 10.1007/s00442-003-1243-2; KAISER A, 1993, J FIELD ORNITHOL, V64, P246; Knoke T, 2008, EUR J FOREST RES, V127, P89, DOI 10.1007/s10342-007-0186-2; Knowles SCL, 2009, FUNCT ECOL, V23, P405, DOI 10.1111/j.1365-2435.2008.01507.x; Lachish S, 2011, J ANIM ECOL, V80, P1196, DOI 10.1111/j.1365-2656.2011.01836.x; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; Lens L, 2002, BIOL REV, V77, P27, DOI 10.1017/S1464793101005796; Lens L, 2008, BIRD CONSERV INT, V18, pS125, DOI 10.1017/S0959270908000336; Lindstrom KM, 2005, GEN COMP ENDOCR, V143, P231, DOI 10.1016/j.ygcen.2005.04.005; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Loiseau C, 2010, J PARASITOL, V96, P21, DOI 10.1645/GE-2123.1; Martin TE, 1998, ECOLOGY, V79, P656, DOI 10.1890/0012-9658(1998)079[0656:AMPOCS]2.0.CO;2; Marzal A, 2013, J AVIAN BIOL, V44, P437, DOI 10.1111/j.1600-048X.2013.00178.x; Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307; MOLLER AP, 1992, J EVOLUTION BIOL, V5, P691, DOI 10.1046/j.1420-9101.1992.5040691.x; Mouritsen KN, 2005, OIKOS, V108, P344, DOI 10.1111/j.0030-1299.2005.13507.x; Norris K, 2000, BEHAV ECOL, V11, P19, DOI 10.1093/beheco/11.1.19; Oppliger A, 1998, ECOL LETT, V1, P129; Ots I, 1998, FUNCT ECOL, V12, P700, DOI 10.1046/j.1365-2435.1998.00219.x; Ots I, 1998, OECOLOGIA, V116, P441, DOI 10.1007/s004420050608; Paillet Y, 2010, CONSERV BIOL, V24, P101, DOI 10.1111/j.1523-1739.2009.01399.x; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Palinauskas V, 2011, EXP PARASITOL, V127, P527, DOI 10.1016/j.exppara.2010.10.007; Parejo D, 2009, NATURWISSENSCHAFTEN, V96, P1193, DOI 10.1007/s00114-009-0584-z; Parga ML, 2001, J AVIAN MED SURG, V15, P162, DOI 10.1647/1082-6742(2001)015[0162:TEOTOH]2.0.CO;2; Poulin R, 2006, INT J PARASITOL, V36, P877, DOI 10.1016/j.ijpara.2006.02.021; R Development Core Team, 2011, R LANG ENV STAT COMP; Ralph CJ, 1993, HDB FIELD METHODS MO; Reiczigel J., 2005, QUANTITATIVE PARASIT; Renner SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053121; Ricklefs RE, 2007, AUK, V124, P1254, DOI 10.1642/0004-8038(2007)124[1254:MPAWRT]2.0.CO;2; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Rueda M, 2013, GLOBAL ECOL BIOGEOGR, V22, P1282, DOI 10.1111/geb.12079; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Santiago-Alarcon D, 2011, PARASITOLOGY, V138, P824, DOI 10.1017/S0031182011000515; Santiago-Alarcon D, 2008, J PARASITOL, V94, P584, DOI 10.1645/GE-1351.1; Santiago-Alarcon D, 2012, STUD AVIAN BIOL, P31; Santiago-Alarcon D, 2012, BIOL REV, V87, P928, DOI 10.1111/j.1469-185X.2012.00234.x; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Sobek S, 2009, FOREST ECOL MANAG, V258, P609, DOI 10.1016/j.foreco.2009.04.026; Sobek S, 2009, DIVERS DISTRIB, V15, P660, DOI 10.1111/j.1472-4642.2009.00570.x; Sorci G, 2013, PARASITE IMMUNOL, V35, P350, DOI 10.1111/pim.12047; Suorsa P, 2004, P ROY SOC B-BIOL SCI, V271, P435, DOI 10.1098/rspb.2003.2620; Suorsa P, 2003, P ROY SOC B-BIOL SCI, V270, P963, DOI 10.1098/rspb.2002.2326; Svensson E, 1998, FUNCT ECOL, V12, P912, DOI 10.1046/j.1365-2435.1998.00271.x; Taboada A, 2010, EUR J FOREST RES, V129, P31, DOI 10.1007/s10342-008-0245-3; Valkinas G., 2005, AVIAN MALARIA PARASI; Valkiunas G, 2006, J PARASITOL, V92, P1123, DOI 10.1645/GE-3564-RN.1; Willoughby I, 2008, FOREST VEGETATION MA; Wilson K, 1996, FUNCT ECOL, V10, P592, DOI 10.2307/2390169; Wilson K, 1997, PARASITOL TODAY, V13, P33, DOI 10.1016/S0169-4758(96)40009-6; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Woodworth BL, 2005, P NATL ACAD SCI USA, V102, P1531, DOI 10.1073/pnas.0409454102	81	17	18	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81395	10.1371/journal.pone.0081395	http://dx.doi.org/10.1371/journal.pone.0081395			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339923	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100053
J	Reifenberg, K; Cheng, F; Twardowski, L; Kupper, I; Wiese, E; Bollmann, F; Kleinert, H; Blessing, M; Lackner, KJ; Torzewski, M				Reifenberg, Kurt; Cheng, Fei; Twardowski, Laura; Kuepper, Ines; Wiese, Elena; Bollmann, Franziska; Kleinert, Hartmut; Blessing, Manfred; Lackner, Karl J.; Torzewski, Michael			T Cell-Specific Overexpression of TGF beta 1 Fails to Influence Atherosclerosis in ApoE-Deficient Mice	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE CELLS; TGF-BETA; ACCELERATES ATHEROSCLEROSIS; IMMUNE-RESPONSE; IMAGE-ANALYSIS; DISEASE; INHIBITION; CANCER; PROGRESSION	Clinical data have indicated a negative correlation between plasma TGF beta 1 concentrations and the extent of atherosclerosis and have thus led to the hypothesis that the pleiotropic cytokine may have anti-atherogenic properties. T-cells are currently discussed to significantly participate in atherogenesis, but the precise role of adaptive immunity in atherogenesis remains to be elucidated. TGF beta 1 is known to strongly modulate the function of T-cells, however, inhibition of TGF beta 1 signalling in T-cells of atherosclerosis-prone knock-out mice failed to unequivocally clarify the role of the cytokine for the development of atherosclerosis. In the present study, we thus tried to specify the role of TGF beta 1 in atherogenesis by using the murine CD2-TGF beta 1 transgenic strain which represents a well characterized model of T-cell specific TGF beta 1 overexpression. The CD2-TGF beta 1 transgenic mice were crossed to ApoE knock-out mice and quantity and quality of atherosclerosis regarding number of macrophages, smooth muscle cells, CD3 positive T-cells and collagen was analyzed in CD2-TGF beta 1 ApoE double mutants as well as non-transgenic ApoE controls on both normal and atherogenic diet of a duration of 8, 16 or 24 weeks, respectively. In all experimental groups investigated, we failed to detect any influence of TGF beta 1 overexpression on disease. Total number of CD3-positive T-lymphocytes was not significantly different in atherosclerotic lesions of CD2-TGF beta 1 ApoE(-/-) females and isogenic ApoE(-/-) controls, even after 24 weeks on the atherogenic diet. The synopsis of these data and our previous study on TGF beta 1 overexpressing macrophages suggests that potential effects of TGF beta 1 on atherosclerosis are most probably mediated by macrophages rather than T-cells.	[Reifenberg, Kurt] German Canc Res Ctr, Anim Lab Serv, Heidelberg, Germany; [Cheng, Fei; Lackner, Karl J.; Torzewski, Michael] Johannes Gutenberg Univ Mainz, Inst Clin Chem & Lab Med, Univ Med Ctr, D-55122 Mainz, Germany; [Twardowski, Laura; Torzewski, Michael] Robert Bosch Krankenhaus, Dept Lab Med, Stuttgart, Germany; [Kuepper, Ines; Wiese, Elena] Johannes Gutenberg Univ Mainz, Cent Lab Anim Facil, D-55122 Mainz, Germany; [Bollmann, Franziska; Kleinert, Hartmut] Johannes Gutenberg Univ Mainz, Dept Pharmacol, Univ Med Ctr, Mainz, Germany; [Blessing, Manfred] Univ Leipzig, Fac Vet, Ctr Biotechnol & Biomed, D-04109 Leipzig, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Johannes Gutenberg University of Mainz; Bosch; Robert Bosch Krankenhaus; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Leipzig University	Torzewski, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Clin Chem & Lab Med, Univ Med Ctr, D-55122 Mainz, Germany.	michael.torzewski@rbk.de	Kleinert, Hartmut/M-2988-2018	Kleinert, Hartmut/0000-0003-2202-3548	Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine; Robert-Bosch-Hospital, Stuttgart	Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine; Robert-Bosch-Hospital, Stuttgart	The project was supported by the Foundation for Pathobiochemistry and Molecular Diagnostics of the German Society for Clinical Chemistry and Laboratory Medicine and the innovation fund of the Robert-Bosch-Hospital, Stuttgart. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2004, IMMUNITY, V21, P491, DOI 10.1016/j.immuni.2004.07.020; Becker C, 2005, CELL CYCLE, V4, P217; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Campbell KA, 2012, CIRC RES, V110, P889, DOI 10.1161/CIRCRESAHA.111.263186; Carbone F, 2013, THROMB HAEMOSTASIS, V109, P5; Dansky HM, 1997, P NATL ACAD SCI USA, V94, P4642, DOI 10.1073/pnas.94.9.4642; Daugherty A, 1997, J CLIN INVEST, V100, P1575, DOI 10.1172/JCI119681; Erren M, 1999, ARTERIOSCL THROM VAS, V19, P2355, DOI 10.1161/01.ATV.19.10.2355; Frutkin AD, 2009, ARTERIOSCL THROM VAS, V29, P1251, DOI 10.1161/ATVBAHA.109.186593; Gojova A, 2003, BLOOD, V102, P4052, DOI 10.1182/blood-2003-05-1729; GRAINGER DJ, 1995, NAT MED, V1, P74, DOI 10.1038/nm0195-74; GRAINGER DJ, 1995, NAT MED, V1, P932, DOI 10.1038/nm0995-932; HANSSON J, 1989, J BIOL CHEM, V264, P21788; Ketelhuth DFJ, 2011, THROMB HAEMOSTASIS, V106, P779, DOI 10.1160/TH11-05-0321; Klingenberg R, 2009, EUR HEART J, V30, P2838, DOI 10.1093/eurheartj/ehp477; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Lehr HA, 1999, J HISTOCHEM CYTOCHEM, V47, P119, DOI 10.1177/002215549904700113; Lehr HA, 1997, J HISTOCHEM CYTOCHEM, V45, P1559, DOI 10.1177/002215549704501112; Li MO, 2006, IMMUNITY, V25, P455, DOI 10.1016/j.immuni.2006.07.011; Lutgens E, 2002, ARTERIOSCL THROM VAS, V22, P975, DOI 10.1161/01.ATV.0000019729.39500.2F; Mach F, 1998, NATURE, V394, P200, DOI 10.1038/28204; Mallat Z, 2001, CIRC RES, V89, P930, DOI 10.1161/hh2201.099415; Mallat Z, 2001, CIRC RES, V88, P998, DOI 10.1161/hh1001.090571; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; OWENS GK, 1988, J CELL BIOL, V107, P771, DOI 10.1083/jcb.107.2.771; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; Presser K, 2008, J IMMUNOL, V181, P7751, DOI 10.4049/jimmunol.181.11.7751; Reifenberg K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040990; Robertson AKL, 2003, J CLIN INVEST, V112, P1342, DOI 10.1172/JCI200318607; Schramm C, 2004, INT IMMUNOL, V16, P1241, DOI 10.1093/intimm/dxh126; SHARPLES K, 1987, DNA-J MOLEC CELL BIO, V6, P239, DOI 10.1089/dna.1987.6.239; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Song L, 2001, J CLIN INVEST, V108, P251, DOI 10.1172/JCI11380; Tashiro H, 2002, CORONARY ARTERY DIS, V13, P139, DOI 10.1097/00019501-200205000-00001; Torzewski M, 2007, ARTERIOSCL THROM VAS, V27, P850, DOI 10.1161/01.ATV.0000258809.47285.07; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Zhou XH, 1998, J CLIN INVEST, V101, P1717, DOI 10.1172/JCI1216; Zhou XH, 1996, AM J PATHOL, V149, P359; ZHUMABEKOV T, 1995, J IMMUNOL METHODS, V185, P133, DOI 10.1016/0022-1759(95)00124-S	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81444	10.1371/journal.pone.0081444	http://dx.doi.org/10.1371/journal.pone.0081444			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339930	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566100057
J	Crescenzo-Chaigne, B; Barbezange, C; van der Werf, S				Crescenzo-Chaigne, Bernadette; Barbezange, Cyril; van der Werf, Sylvie			The Panhandle Formed by Influenza A and C Virus NS Non-Coding Regions Determines NS Segment Expression	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCES; POLYMERASE COMPLEXES; GENOME SEGMENTS; RNA-POLYMERASE; MESSENGER-RNA; VIRION RNA; VIRAL-RNA; B VIRUS; TRANSCRIPTION; REPLICATION	Exchange of the extremities of the NS segment of type A and C influenza viruses in reverse genetics systems was used to assess their putative role in type specificity. Restoration of each specific proximal panhandle was mandatory to allow the rescue of viruses with heterotypic extremities. Moreover, the transcription level of the modified segment seemed to be directly affected by the distal panhandle strength.	[Crescenzo-Chaigne, Bernadette; Barbezange, Cyril; van der Werf, Sylvie] Inst Pasteur, Unite Genet Mol Virus ARN, Paris, France; [Crescenzo-Chaigne, Bernadette; Barbezange, Cyril; van der Werf, Sylvie] CNRS, Unite Mixte Rech 3569, Paris, France; [Crescenzo-Chaigne, Bernadette; Barbezange, Cyril; van der Werf, Sylvie] Univ Paris Diderot, Unite Genet Mol Virus ARN, Sorbonne Paris Cite, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	van der Werf, S (corresponding author), Inst Pasteur, Unite Genet Mol Virus ARN, Paris, France.	sylvie.van-der-werf@pasteur.fr	Barbezange, Cyril/W-5133-2019	Barbezange, Cyril/0000-0001-9606-2983; van der WERF, Sylvie/0000-0002-1148-4456	Institut Pasteur; Centre National de la Recherche Scientifique; University Paris Diderot, Sorbonne Paris Cite, Paris, France	Institut Pasteur(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); University Paris Diderot, Sorbonne Paris Cite, Paris, France	This work was supported by institutional funds from the Institut Pasteur, the Centre National de la Recherche Scientifique and the University Paris Diderot, Sorbonne Paris Cite, Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann M, 1996, VIRUS RES, V44, P23, DOI 10.1016/0168-1702(96)01335-4; Cheong HK, 1999, NUCLEIC ACIDS RES, V27, P1392, DOI 10.1093/nar/27.5.1392; Crescenzo-Chaigne B, 2002, VIROLOGY, V303, P240, DOI 10.1006/viro.2002.1637; Crescenzo-Chaigne B, 2001, J GEN VIROL, V82, P1075, DOI 10.1099/0022-1317-82-5-1075; Crescenzo-Chaigne B, 2007, DNA J VIROL, V81, P11282, DOI [10.1128/JVI.00910-07, DOI 10.1128/JVI.00910-07]; Crescenzo-Chaigne B, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-132; Crow M, 2004, J VIROL, V78, P6263, DOI 10.1128/JVI.78.12.6263-6270.2004; DESSELBERGER U, 1980, GENE, V8, P315, DOI 10.1016/0378-1119(80)90007-4; Flick R, 1996, RNA, V2, P1046; FODOR E, 1995, J VIROL, V69, P4012, DOI 10.1128/JVI.69.7.4012-4019.1995; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Fujii K, 2009, J GEN VIROL, V90, P1734, DOI 10.1099/vir.0.010355-0; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Harris A, 2006, P NATL ACAD SCI USA, V103, P19123, DOI 10.1073/pnas.0607614103; HSU MT, 1987, P NATL ACAD SCI USA, V84, P8140, DOI 10.1073/pnas.84.22.8140; Jackson D, 2011, J GEN VIROL, V92, P1, DOI 10.1099/vir.0.026187-0; Lee JH, 2010, VIROLOGY, V397, P89, DOI 10.1016/j.virol.2009.10.041; Lee MTM, 2003, NUCLEIC ACIDS RES, V31, P1624, DOI 10.1093/nar/gkg253; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Neumann G, 2004, CURR TOP MICROBIOL, V283, P121; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; PANNEERSELVAM M, 1986, J IMMUNOL, V136, P2534; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Pritlove DC, 1999, J VIROL, V73, P2109, DOI 10.1128/JVI.73.3.2109-2114.1999; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; ROBERTSON JS, 1979, NUCLEIC ACIDS RES, V6, P3745, DOI 10.1093/nar/6.12.3745; SHIMIZU K, 1994, NUCLEIC ACIDS RES, V22, P5047, DOI 10.1093/nar/22.23.5047; STOECKLE MY, 1987, P NATL ACAD SCI USA, V84, P2703, DOI 10.1073/pnas.84.9.2703; Vendeix FAP, 2009, RNA, V15, P2278, DOI 10.1261/rna.1734309; Vignuzzi M, 2001, J GEN VIROL, V82, P1737, DOI 10.1099/0022-1317-82-7-1737; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wong SCC, 2005, J CLIN PATHOL, V58, P276, DOI 10.1136/jcp.2004.016592	34	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81550	10.1371/journal.pone.0081550	http://dx.doi.org/10.1371/journal.pone.0081550			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24348921	Green Published, gold, Green Submitted			2022-12-27	WOS:000327539800135
J	Gruber, N; Kreuzpointner, L				Gruber, Nicole; Kreuzpointner, Ludwig			Measuring the Reliability of Picture Story Exercises like the TAT	PLOS ONE			English	Article							IMPLICIT MOTIVES; ACHIEVEMENT-MOTIVATION; CONSISTENCY	As frequently reported, psychometric assessments on Picture Story Exercises, especially variations of the Thematic Apperception Test, mostly reveal inadequate scores for internal consistency. We demonstrate that the reason for this apparent shortcoming is not caused by the coding system itself but from the incorrect use of internal consistency coefficients, especially Cronbach's a. This problem could be eliminated by using the category-scores as items instead of the picture-scores. In addition to a theoretical explanation we prove mathematically why the use of category-scores produces an adequate internal consistency estimation and examine our idea empirically with the origin data set of the Thematic Apperception Test by Heckhausen and two additional data sets. We found generally higher values when using the category-scores as items instead of picture-scores. From an empirical and theoretical point of view, the estimated reliability is also superior to each category within a picture as item measuring. When comparing our suggestion with a multifaceted Rasch-model we provide evidence that our procedure better fits the underlying principles of PSE.	[Gruber, Nicole; Kreuzpointner, Ludwig] Univ Regensburg, Dept Psychol, D-93053 Regensburg, Germany	University of Regensburg	Kreuzpointner, L (corresponding author), Univ Regensburg, Dept Psychol, D-93053 Regensburg, Germany.	ludwig.kreuzpointner@ur.de	Kreuzpointner, Ludwig/K-1741-2013; Gruber, Nicole/D-3207-2017	Kreuzpointner, Ludwig/0000-0003-1391-0807; Gruber, Nicole/0000-0002-2068-8768				Atkinson J. W., 1977, MOTIV EMOTION, V1, P1, DOI [DOI 10.1007/BF00997578, 101007/BF00997578]; Atkinson J.W., 1970, DYNAMICS ACTION; Blankenship V, 2006, J PERS ASSESS, V86, P100, DOI 10.1207/s15327752jpa8601_11; Borsboom D., 2005, MEASURING MIND CONCE; Breidebach G., 2012, BILDUNGSBENACHTEILIG; Brunstein JC, 2004, J RES PERS, V38, P536, DOI 10.1016/j.jrp.2004.01.003; Coulacoglou C., 2008, EXPLORING CHILDS PER; COVINGTON MV, 1994, STUDENT MOTIVATION C, P157; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; ENTWISLE DR, 1972, PSYCHOL BULL, V77, P377, DOI 10.1037/h0020021; Fleming J., 1982, MOTIVATION SOC, P63; Heckhausen H., 1963, HOFFNUNG FURCHT LEIS; JENSEN AR, 1959, ACTA PSYCHOL, V16, P108, DOI 10.1016/0001-6918(59)90089-7; Kenney J.F., 1951, MATH STAT 2; Kreuzpointner L, 2010, BRIT J MATH STAT PSY, V63, P341, DOI 10.1348/000711009X465647; Kuder GF, 1937, PSYCHOMETRIKA, V2, P151, DOI 10.1007/BF02288391; KUHL J, 1978, ARCH PSYCHOL-GER, V130, P37; Linacre JM, 2005, USER GUIDE FACETS RA; Lord F. M., 1968, STAT THEORIES MENTAL; LUNDY A, 1985, J PERS ASSESS, V49, P141, DOI 10.1207/s15327752jpa4902_6; McClelland D.C., 1980, REV PERSONALITY SOCI, P10; McClelland D.C., 1985, HUMAN MOTIVATION; MCCLELLAND DC, 1989, PSYCHOL REV, V96, P690, DOI 10.1037/0033-295X.96.4.690; McClelland DC, 1958, MOTIVES FANTASY ACTI, P153; McDonald RP, 1999, TEST THEORY UNIFIED; McGrath R.E., 2012, APA HDB RES METHODS, V1, P329, DOI [DOI 10.1037/13619-018, 10.1037/13619-018]; MISCHEL W, 1995, PSYCHOL REV, V102, P246, DOI 10.1037/0033-295X.102.2.246; Pang JS, 2005, J PERS ASSESS, V85, P280, DOI 10.1207/s15327752jpa8503_04; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rae G, 2007, PSYCHOL METHODS, V12, P177, DOI 10.1037/1082-989X.12.2.177; REUMAN DA, 1982, J PERS SOC PSYCHOL, V43, P1098, DOI 10.1037/0022-3514.43.5.1098; Revelle W., 2013, PROCEDURES PERSONALI; Revelle W, 2009, PSYCHOMETRIKA, V74, P145, DOI 10.1007/s11336-008-9102-z; ROSENZWEIG S, 1945, J PERS, V14, P3, DOI 10.1111/j.1467-6494.1945.tb01036.x; Schultheiss OC., 2001, MANUAL ASSESSMENT HO; Schultheiss OC., 2007, HDB RES METHODS PERS, P322, DOI DOI 10.1093/ACPROF:OSO/9780195335156.001.0001; Schultheiss OC, 2008, J RES PERS, V42, P1560, DOI 10.1016/j.jrp.2008.07.008; Tuerlinckx F, 2002, J PERS SOC PSYCHOL, V82, P448, DOI 10.1037/0022-3514.82.3.448; Winter, 1994, MANUAL SCORING UNPUB; [No title captured]	40	11	11	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2013	8	11							e79450	10.1371/journal.pone.0079450	http://dx.doi.org/10.1371/journal.pone.0079450			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	247EE	24348902	gold, Green Submitted, Green Published			2022-12-27	WOS:000326597400066
J	Sellers, WI; Margetts, L; Coria, RA; Manning, PL				Sellers, William Irvin; Margetts, Lee; Coria, Rodolfo Anibal; Manning, Phillip Lars			March of the Titans: The Locomotor Capabilities of Sauropod Dinosaurs	PLOS ONE			English	Review							MUSCLE MOMENT ARMS; ELITE SPRINTING ATHLETE; PELVIC LIMB MUSCLES; FUNCTIONAL-ANATOMY; AUSTRALOPITHECUS-AFARENSIS; SENSITIVITY-ANALYSIS; BIPEDAL LOCOMOTION; GAIT; MODEL; TYRANNOSAURUS	Sauropod dinosaurs are the largest terrestrial vertebrate to have lived on Earth. This size must have posed special challenges for the musculoskeletal system. Scaling theory shows that body mass and hence the loads that must be overcome increases with body size more rapidly than either the ability of the muscles to generate force, or the ability of the skeleton to support these loads. Here we demonstrate how one of the very largest sauropods, Argentinosaurus huinculensis (40 metres long, weighing 83 tonnes), may have moved. A musculoskeletal model was generated using data captured by laser scanning a mounted skeleton and assigning muscle properties based on comparative data from living animals. Locomotion is generated using forward dynamic simulation to calculate the accelerations produced by the muscle forces, coupled with machine learning techniques to find a control pattern that minimises metabolic cost. The simulation demonstrates that at such vast body size, joint range of motion needs to be restricted to allow sufficient force generation for an achievable muscle mass. However when this is done, a perfectly plausible gait can be generated relatively easily. Whilst this model represents the best current simulation of the gait of these giant animals, it is likely that there are as yet unknown mechanical mechanisms, possibly based on passive elastic structures that should be incorporated to increase the efficiency of the animal's locomotion. It is certainly the case that these would need to be incorporated into the model to properly assess the full locomotor capabilities of the animal.	[Sellers, William Irvin] Univ Manchester, Fac Life Sci, Manchester, Greater Manches, England; [Margetts, Lee] Univ Manchester, IT Serv Res, Manchester, Greater Manches, England; [Coria, Rodolfo Anibal] Univ Nacl Rio Negro, Museo Carmen Funes, Subsecretaria Cultura Neuquen, CONICET, Neuquen, Argentina; [Manning, Phillip Lars] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Greater Manches, England	University of Manchester; University of Manchester; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Manchester	Sellers, WI (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Greater Manches, England.	William.Sellers@manchester.ac.uk	Manning, Phillip/F-9966-2011; Margetts, Lee/A-8775-2008; Sellers, William Irvin/Q-3843-2019	Manning, Phillip/0000-0002-7161-6246; Margetts, Lee/0000-0001-8239-8259; Sellers, William Irvin/0000-0002-2913-5406	BBSRC; NERC; Leverhulme Trust	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust)	Support for developing GaitSym was provided by BBSRC, NERC and the Leverhulme Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander R.M., 1989, DYNAMICS DINOSAURS O; ALEXANDER RM, 1982, J ZOOL, V198, P293, DOI 10.1111/j.1469-7998.1982.tb02077.x; Alexander RM., 2003, PRINCIPLES ANIMAL LO; AN KN, 1984, J BIOMECH ENG-T ASME, V106, P280, DOI 10.1115/1.3138494; Arnold EM, 2010, ANN BIOMED ENG, V38, P269, DOI 10.1007/s10439-009-9852-5; Bates KT, 2010, J VERTEBR PALEONTOL, V30, P458, DOI 10.1080/02724630903409329; Bates KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004532; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; BIEWENER AA, 1991, J BIOMECH, V24, P19, DOI 10.1016/0021-9290(91)90374-V; Blanco RE, 2005, P ROY SOC B-BIOL SCI, V272, P1769, DOI 10.1098/rspb.2005.3133; Bonaparte Jose F., 1993, Ameghiniana, V30, P271; BORNSTEIN MH, 1976, NATURE, V259, P557, DOI 10.1038/259557a0; Campolongo F, 2000, SENSITIVITY ANAL, P15; Carpenter K., 2006, NEW MEXICO MUSEUM NA, V36, P131; Carrano Matthew T., 2006, P225; Carrano MT, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P229; Chandler R., 1975, TECH REP; Christiansen P, 2004, ZOOL J LINN SOC-LOND, V140, P523, DOI 10.1111/j.1096-3642.2004.00113.x; COOMBS WP, 1978, Q REV BIOL, V53, P393, DOI 10.1086/410790; Cope E.D., 1896, PRIMARY FACTORS ORGA, DOI DOI 10.5962/BHL.TITLE.2068; Crompton RH, 1996, AM J PHYS ANTHROPOL, V99, P547, DOI 10.1002/(SICI)1096-8644(199604)99:4<547::AID-AJPA3>3.0.CO;2-R; Crompton RH, 1998, J HUM EVOL, V35, P55, DOI 10.1006/jhev.1998.0222; Crompton RH, 2012, J R SOC INTERFACE, V9, P707, DOI 10.1098/rsif.2011.0258; Crook TC, 2010, J ANAT, V217, P26, DOI 10.1111/j.1469-7580.2010.01241.x; Currey J, 2002, BONES STRUCTURES MEC; Falkingham PL, 2011, J R SOC INTERFACE, V8, P1142, DOI 10.1098/rsif.2010.0634; FULL RJ, 1990, J EXP BIOL, V150, P233; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; Genin JJ, 2010, J EXP BIOL, V213, P694, DOI 10.1242/jeb.035436; Riga BJG, 2011, AN ACAD BRAS CIENC, V83, P279, DOI 10.1590/S0001-37652011005000002; HANAVAN E P Jr, 1964, AMRL TR, P1; HILDEBRA.M, 1965, SCIENCE, V150, P701, DOI 10.1126/science.150.3697.701; HILDEBRAND M, 1980, AM ZOOL, V20, P255; Hill A. V., 1950, Science Progress London, V38, P209; HOKKANEN JEI, 1986, J THEOR BIOL, V118, P491, DOI 10.1016/S0022-5193(86)80167-9; Hutchinson JR, 2007, J THEOR BIOL, V246, P660, DOI 10.1016/j.jtbi.2007.01.023; Hutchinson JR, 2005, PALEOBIOLOGY, V31, P676; Hutchinson JR, 2004, J MORPHOL, V262, P441, DOI 10.1002/jmor.10240; Hutchinson JR, 2002, NATURE, V415, P1018, DOI 10.1038/4151018a; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Kramer PA, 1999, J EXP BIOL, V202, P2807; Manning PL, 2004, GEOL SOC SPEC PUBL, V228, P93, DOI 10.1144/GSL.SP.2004.228.01.06; MAREY EJ, 1887, CR HEBD ACAD SCI, V105, P149; Mazzetta Gerardo V., 2004, Historical Biology, V16, P71, DOI 10.1080/08912960410001715132; McGinnis PM, 1999, BIOMECHANICS SPORT E; Medler S, 2002, AM J PHYSIOL-REG I, V283, pR368, DOI 10.1152/ajpregu.00689.2001; MENDEZ J, 1960, METABOLISM, V9, P184; Minetti AE, 1997, J THEOR BIOL, V186, P467, DOI 10.1006/jtbi.1997.0407; Muhlenbein H., 1991, Proceedings of the Third IEEE Symposium on Parallel and Distributed Processing (Cat. No.91TH0396-2), P526, DOI 10.1109/SPDP.1991.218254; Muybridge E, 1899, ANIMALS MOTION; Nagano A, 2005, AM J PHYS ANTHROPOL, V126, P2, DOI 10.1002/ajpa.10408; Nudds RL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006927; Ogihara N, 2006, DEV PRIMATOL-PROG PR, P167, DOI 10.1007/0-387-29798-7_13; Otero A, 2008, AMEGHINIANA, V45, P333; Paul Gregory S., 1997, P129; Pierrynowski M.R., 1995, 3 DIMENSIONAL ANAL H, P215; Ren L, 2008, J EXP BIOL, V211, P2735, DOI 10.1242/jeb.018820; Sander PM, 2011, BIOL REV, V86, P117, DOI 10.1111/j.1469-185X.2010.00137.x; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Sellers WI, 2013, FOLIA PRIMATOL, V84, P180, DOI 10.1159/000351562; Sellers WI, 2012, BIOL LETTERS, V8, P842, DOI 10.1098/rsbl.2012.0263; Sellers WI, 2009, PALAEONTOL ELECTRON, V12; Sellers WI, 2005, J R SOC INTERFACE, V2, P431, DOI 10.1098/rsif.2005.0060; Sellers WI, 2004, J ANAT, V204, P343, DOI 10.1111/j.0021-8782.2004.00294.x; Sellers WI, 2007, P ROY SOC B-BIOL SCI, V274, P2711, DOI 10.1098/rspb.2007.0846; Sellers WI, 2010, INT J PRIMATOL, V31, P321, DOI 10.1007/s10764-010-9396-4; Silder A, 2007, J BIOMECH, V40, P2628, DOI 10.1016/j.jbiomech.2006.12.017; Skerritt G.C, 1984, INTRO FUNCTIONAL ANA; Smith NC, 2007, J ANAT, V211, P313, DOI 10.1111/j.1469-7580.2007.00762.x; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Stevens Kent A., 2002, Senckenbergiana Lethaea, V82, P23; Thorpe SKS, 1999, AM J PHYS ANTHROPOL, V110, P179, DOI 10.1002/(SICI)1096-8644(199910)110:2<179::AID-AJPA5>3.0.CO;2-Z; Umberger Brian R., 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P99, DOI 10.1080/1025584031000091678; Vila B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057408; Wareing K, 2011, POLAR BIOL, V34, P1571, DOI 10.1007/s00300-011-1017-y; Westneat MW, 2003, J THEOR BIOL, V223, P269, DOI 10.1016/S0022-5193(03)00058-4; Wilkie DR, 1968, I BIOL STUDIES BIOL, V11; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Wilson JA, 1999, PALEOBIOLOGY, V25, P252, DOI 10.1017/S0094837300026543; Wilson JA, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P15; Winter D., 1990, BIOMECHANICS MOTOR C, V2nd; WITMER LM, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P19; WOOD GL, 1972, ANIMAL FACTS FEATS; Yamasaki T, 2003, BIOSYSTEMS, V71, P221, DOI 10.1016/S0303-2647(03)00118-7; Yamazaki N, 1996, FOLIA PRIMATOL, V66, P253, DOI 10.1159/000157199; YEADON MR, 1990, J BIOMECH, V23, P67, DOI 10.1016/0021-9290(90)90370-I; Yokoi T, 1998, ANTHROPOL SCI, V106, P371, DOI 10.1537/ase.106.371; Zatiorski VM, 1983, BIOMECHANICS B, P1154; Zheng NQ, 1998, J BIOMECH, V31, P963, DOI 10.1016/S0021-9290(98)00056-6	89	45	46	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2013	8	10							e78733	10.1371/journal.pone.0078733	http://dx.doi.org/10.1371/journal.pone.0078733			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	243RL	24348896	gold, Green Published			2022-12-27	WOS:000326334500130
J	Pozzi, A; Kim, SE; Conrad, BP; Horodyski, M; Banks, SA				Pozzi, Antonio; Kim, Stanley E.; Conrad, Bryan P.; Horodyski, MaryBeth; Banks, Scott A.			Ex Vivo Pathomechanics of the Canine Pond-Nuki Model	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; ARTICULAR-CARTILAGE; ACL-DEFICIENT; TIBIAL SLOPE; CONTACT MECHANICS; KINEMATICS; KNEE; OSTEOARTHRITIS; MECHANOBIOLOGY; BIOMECHANICS	Background: Transection of the canine cranial cruciate ligament (CCL) is a well-established osteoarthritis (OA) model. The effect of CCL loss on contact pressure and joint alignment has not been quantified for stifle loading in standing. The purposes of the study were to measure femorotibial contact areas and stresses and joint alignment following transection of the CCL in an ex vivo model. We hypothesized that transection of the CCL would lead to abnormal kinematics, as well as alterations in contact mechanics of the femorotibial joint. Methodology/Principal Findings: Eight canine hindlimbs were tested in a servo-hydraulic materials testing machine using a custom made femoral jig. Contact area and pressure measurements, and femorotibial rotations and translations were measured in the normal and the CCL-deficient stifle in both standing and deep flexion angles. We found that at standing angle, transection of the CCL caused cranial translation and internal rotation of the tibia with a concurrent caudal shift of the contact area, an increase in peak pressure and a decrease in contact area. These changes were not noted in deep flexion. At standing, loss of CCL caused a redistribution of the joint pressure, with the caudal region of the compartment being overloaded and the rest of the joint being underloaded. Conclusion: In the Pond-Nuki model alterations in joint alignment are correlated with shifting of the contact points to infrequently loaded areas of the tibial plateau. The results of this study suggest that this cadaveric Pond-Nuki model simulates the biomechanical changes previously reported in the in-vivo Pond-Nuki model.	[Pozzi, Antonio; Kim, Stanley E.] Univ Florida, Dept Small Anim Clin Sci, Comparat Orthopaed Biomech Lab, Gainesville, FL 32610 USA; [Conrad, Bryan P.; Horodyski, MaryBeth] Univ Florida, Dept Orthopaed & Rehabil, Comparat Orthopaed Biomech Lab, Gainesville, FL USA; [Banks, Scott A.] Univ Florida, Dept Mech & Aerosp Engn, Comparat Orthopaed Biomech Lab, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Pozzi, A (corresponding author), Univ Florida, Dept Small Anim Clin Sci, Comparat Orthopaed Biomech Lab, Gainesville, FL 32610 USA.	PozziA@ufl.edu	Banks, Scott Arthur/B-6345-2008	Banks, Scott Arthur/0000-0003-0404-6826; Pozzi, Antonio/0000-0001-6780-014X				ADAMS ME, 1991, J RHEUMATOL, V18, P428; ALTMAN RD, 1984, ANN RHEUM DIS, V43, P83, DOI 10.1136/ard.43.1.83; Anderst WJ, 2009, J ORTHOP RES, V27, P71, DOI 10.1002/jor.20702; Andriacchi TP, 2004, ANN BIOMED ENG, V32, P447, DOI 10.1023/B:ABME.0000017541.82498.37; Andriacchi TP, 2005, J BIOMECH, V38, P293, DOI 10.1016/j.jbiomech.2004.02.010; Beaupre GS, 2000, J REHABIL RES DEV, V37, P145; Brandsson S, 2001, ACTA ORTHOP SCAND, V72, P372, DOI 10.1080/000164701753542032; BRANDT KD, 1991, ARTHRITIS RHEUM-US, V34, P1560; Carter DR, 2004, CLIN ORTHOP RELAT R, pS69, DOI 10.1097/01.blo.0000144970.05107.7e; Carter DR, 1998, CLIN ORTHOP RELAT R, pS41; Eckstein F, 2002, OSTEOARTHR CARTILAGE, V10, P44, DOI 10.1053/joca.2001.0480; Giffin JR, 2007, AM J SPORT MED, V35, P1443, DOI 10.1177/0363546507304665; Giffin JR, 2007, SPORTS MED ARTHROSC, V15, P23; Giffin JR, 2004, AM J SPORT MED, V32, P376, DOI 10.1177/0363546503258880; GILBERTSON EMM, 1975, ANN RHEUM DIS, V34, P12, DOI 10.1136/ard.34.1.12; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; GUILAK F, 1994, J ORTHOPAED RES, V12, P474, DOI 10.1002/jor.1100120404; JOHNSON RG, 1990, EXP PATHOL-JENA, V38, P37, DOI 10.1016/S0232-1513(11)80196-9; Jurvelin J, 1987, Eng Med, V16, P15, DOI 10.1243/EMED_JOUR_1987_016_006_02; Kim SE, 2009, VET SURG, V38, P23, DOI 10.1111/j.1532-950X.2008.00470.x; KORVICK DL, 1994, J BIOMECH, V27, P77, DOI 10.1016/0021-9290(94)90034-5; Li GA, 2006, J BONE JOINT SURG AM, V88A, P1826, DOI 10.2106/JBJS.E.00539; Lohmander LS, 1999, ARTHRITIS RHEUM, V42, P534, DOI 10.1002/1529-0131(199904)42:3<534::AID-ANR19>3.0.CO;2-J; Marshall KW, 1996, J RHEUMATOL, V23, P344; NISELL R, 1986, ACTA ORTHOP SCAND, V57, P41, DOI 10.3109/17453678608993213; Pond M J, 1973, Ann Rheum Dis, V32, P387, DOI 10.1136/ard.32.4.387; PRODROMOS CC, 1985, J BONE JOINT SURG AM, V67A, P1188, DOI 10.2106/00004623-198567080-00007; RUBIN RM, 1975, CLIN ORTHOP RELAT R, P212; Shefelbine SJ, 2006, J ORTHOP RES, V24, P1208, DOI 10.1002/jor.20139; Shelburne KB, 2011, J ORTHOP RES, V29, P223, DOI 10.1002/jor.21242; Tashman S, 2004, J ORTHOPAED RES, V22, P931, DOI 10.1016/j.orthres.2004.01.008; WANG JW, 1990, J BONE JOINT SURG AM, V72A, P905, DOI 10.2106/00004623-199072060-00017; Warzee CC, 2001, VET SURG, V30, P278, DOI 10.1053/jvet.2001.21400; Wilke VL, 2002, J AM VET MED ASSOC, V221, P1426, DOI 10.2460/javma.2002.221.1426; Wu JZ, 2000, MED ENG PHYS, V22, P1, DOI 10.1016/S1350-4533(00)00012-6	35	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81383	10.1371/journal.pone.0081383	http://dx.doi.org/10.1371/journal.pone.0081383			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349061	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200008
J	Selva, JJ; Chen, X				Selva, Jeremy John; Chen, Xin			SRComp: Short Read Sequence Compression Using Burstsort and Elias Omega Coding	PLOS ONE			English	Article							GENOMIC SEQUENCE	Next-generation sequencing (NGS) technologies permit the rapid production of vast amounts of data at low cost. Economical data storage and transmission hence becomes an increasingly important challenge for NGS experiments. In this paper, we introduce a new non-reference based read sequence compression tool called SRComp. It works by first employing a fast string-sorting algorithm called burstsort to sort read sequences in lexicographical order and then Elias omega-based integer coding to encode the sorted read sequences. SRComp has been benchmarked on four large NGS datasets, where experimental results show that it can run 5-35 times faster than current state-of-the-art read sequence compression tools such as BEETL and SCALCE, while retaining comparable compression efficiency for large collections of short read sequences. SRComp is a read sequence compression tool that is particularly valuable in certain applications where compression time is of major concern.	[Selva, Jeremy John; Chen, Xin] Nanyang Technol Univ, Sch Phys & Math Sci, Div Math Sci, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chen, X (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Math Sci, Singapore 639798, Singapore.	chenxin@ntu.edu.sg	Chen, Xin/D-8430-2011	Selva, Jeremy/0000-0002-4498-2662	Singapore Ministry of Education Academic Research Fund [MOE2012-T2-1-055]; National Medical Research Council [CBRG11nov091]; Nanyang Technological University under the Undergraduate Research Experience on CAmpus (URECA) programme	Singapore Ministry of Education Academic Research Fund(Ministry of Education, Singapore); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Nanyang Technological University under the Undergraduate Research Experience on CAmpus (URECA) programme(Nanyang Technological University)	This work was supported in part by the Singapore Ministry of Education Academic Research Fund (MOE2012-T2-1-055), National Medical Research Council grant (CBRG11nov091), and a fund from Nanyang Technological University under the Undergraduate Research Experience on CAmpus (URECA) programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonfield JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059190; CLEARY JG, 1984, IEEE T COMMUN, V32, P396, DOI 10.1109/TCOM.1984.1096090; Cox AJ, 2012, BIOINFORMATICS, V28, P1415, DOI 10.1093/bioinformatics/bts173; Deorowicz S, 2011, BIOINFORMATICS, V27, P860, DOI 10.1093/bioinformatics/btr014; ELIAS P, 1975, IEEE T INFORM THEORY, V21, P194, DOI 10.1109/TIT.1975.1055349; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Hach F, 2012, BIOINFORMATICS, V28, P3051, DOI 10.1093/bioinformatics/bts593; Jones DC, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks754; Kahn SD, 2011, SCIENCE, V331, P728, DOI 10.1126/science.1197891; Kozanitis C, 2011, J COMPUT BIOL, V18, P401, DOI 10.1089/cmb.2010.0253; Pinho AJ, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1124; Popitsch N, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks939; Sinha R., 2004, J EXP ALGORITHMICS, V9, P1; Tembe W, 2010, BIOINFORMATICS, V26, P2192, DOI 10.1093/bioinformatics/btq346; Wan R, 2010, IEEE INT C BIO BIO W, P567, DOI 10.1109/BIBMW.2010.5703863; Yanovsky V, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-23	16	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81414	10.1371/journal.pone.0081414	http://dx.doi.org/10.1371/journal.pone.0081414			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349065	gold, Green Published, Green Submitted			2022-12-27	WOS:000328734200011
J	Zhou, H; Jakobsson, E				Zhou, Hua; Jakobsson, Eric			Predicting Protein-Protein Interaction by the Mirrortree Method: Possibilities and Limitations	PLOS ONE			English	Article							COEVOLUTION; EVOLUTION; NETWORKS	Molecular co-evolution analysis as a sequence-only based method has been used to predict protein-protein interactions. In co-evolution analysis, Pearson's correlation within the mirrortree method is a well-known way of quantifying the correlation between protein pairs. Here we studied the mirrortree method on both known interacting protein pairs and sets of presumed non-interacting protein pairs, to evaluate the utility of this correlation analysis method for predicting protein-protein interactions within eukaryotes. We varied metrics for computing evolutionary distance and evolutionary span of the species analyzed. We found the differences between co-evolutionary correlation scores of the interacting and non-interacting proteins, normalized for evolutionary span, to be significantly predictive for proteins conserved over a wide range of eukaryotic clades (from mammals to fungi). On the other hand, for narrower ranges of evolutionary span, the predictive power was much weaker.	[Zhou, Hua; Jakobsson, Eric] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Jakobsson, Eric] Univ Illinois, Program Biophys & Computat Biol, Natl Ctr Supercomp Applicat, Beckman Inst,Dept Mol & Integrat Physiol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Jakobsson, E (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	jake@illinois.edu			National Center for Supercomputing Applications; National Institutes of Health [5R01NS063405-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063405] Funding Source: NIH RePORTER	National Center for Supercomputing Applications; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by the National Center for Supercomputing Applications (ncsa.illinois.edu); 5R01NS063405-03 from National Institutes of Health (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brenner S, 1999, CURR BIOL, V9, pR755, DOI 10.1016/S0960-9822(00)80001-9; Clark GW, 2011, METHODS MOL BIOL, V781, P237, DOI 10.1007/978-1-61779-276-2_11; Dayhoff M.O., 1978, ATLAS PROTEIN SEQ ST; de Juan D, 2013, NAT REV GENET, V14, P249, DOI 10.1038/nrg3414; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Free R Benjamin, 2009, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0528s46; Garcia CD, 2003, BIOTECHNOL PROGR, V19, P575, DOI 10.1021/bp025725g; George DG, 1988, CURRENT METHODS SEQU, P127; Goh CS, 2002, J MOL BIOL, V324, P177, DOI 10.1016/S0022-2836(02)01038-0; Hakes L, 2007, P NATL ACAD SCI USA, V104, P7999, DOI 10.1073/pnas.0609962104; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Herman D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-363; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kann MG, 2009, J MOL BIOL, V385, P91, DOI 10.1016/j.jmb.2008.09.078; Kiel C, 2008, ANNU REV BIOCHEM, V77, P415, DOI 10.1146/annurev.biochem.77.062706.133317; Muley VY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042057; Natarajan S, 2010, CHANNELS, V4, P355, DOI 10.4161/chan.4.5.12813; Ochoa D, 2010, BIOINFORMATICS, V26, P1370, DOI 10.1093/bioinformatics/btq137; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189; Powers D. M, 2011, ARXIV201016061; Rice JA, 1995, MATH STAT DATA ANAL, P199; Schneider A, 2007, BIOINFORMATICS, V23, P2180, DOI 10.1093/bioinformatics/btm295; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; von Mering C, 2005, NUCLEIC ACIDS RES, V33, pD433, DOI 10.1093/nar/gki005; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Xenarios I, 2002, NUCLEIC ACIDS RES, V30, P303, DOI 10.1093/nar/30.1.303; Yellaboina S, 2011, NUCLEIC ACIDS RES, V39, pD730, DOI 10.1093/nar/gkq1229; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	36	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81100	10.1371/journal.pone.0081100	http://dx.doi.org/10.1371/journal.pone.0081100			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349035	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200004
J	Kohn, NR; Reaume, CJ; Moreno, C; Burns, JG; Sokolowski, MB; Mery, F				Kohn, Nancy R.; Reaume, Christopher J.; Moreno, Celine; Burns, James G.; Sokolowski, Marla B.; Mery, Frederic			Social Environment Influences Performance in a Cognitive Task in Natural Variants of the Foraging Gene	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; LONG-TERM-MEMORY; DROSOPHILA-MELANOGASTER; BEHAVIOR POLYMORPHISM; SELECTION; NEURONS	In Drosophila melanogaster, natural genetic variation in the foraging gene affects the foraging behaviour of larval and adult flies, larval reward learning, adult visual learning, and adult aversive training tasks. Sitters (for(s)) are more sedentary and aggregate within food patches whereas rovers (for R) have greater movement within and between food patches, suggesting that these natural variants are likely to experience different social environments. We hypothesized that social context would differentially influence rover and sitter behaviour in a cognitive task. We measured adult rover and sitter performance in a classical olfactory training test in groups and alone. All flies were reared in groups, but fly training and testing were done alone and in groups. Sitters trained and tested in a group had significantly higher learning performances compared to sitters trained and tested alone. Rovers performed similarly when trained and tested alone and in a group. In other words, rovers learning ability is independent of group training and testing. This suggests that sitters may be more sensitive to the social context than rovers. These differences in learning performance can be altered by pharmacological manipulations of PKG activity levels, the foraging (for) gene's gene product. Learning and memory is also affected by the type of social interaction (being in a group of the same strain or in a group of a different strain) in rovers, but not in sitters. These results suggest that for mediates social learning and memory in D. melanogaster.	[Kohn, Nancy R.; Moreno, Celine; Mery, Frederic] CNRS, Lab Evolut Genome & Speciat, Gif Sur Yvette, France; [Reaume, Christopher J.; Burns, James G.; Sokolowski, Marla B.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada; [Kohn, Nancy R.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University of Missouri System; University of Missouri Saint Louis	Mery, F (corresponding author), CNRS, Lab Evolut Genome & Speciat, Gif Sur Yvette, France.	Frederic.Mery@legs.cnrs-gif.fr		Sokolowski, Marla/0000-0002-7462-8007	European Research Council under the European Community [209540]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes for Advanced Research; CIFAR; University of Toronto's Institute for Human Development; NSERC fellowship	European Research Council under the European Community(European Research Council (ERC)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Advanced Research; CIFAR(Canadian Institute for Advanced Research (CIFAR)); University of Toronto's Institute for Human Development; NSERC fellowship(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was supported by a grant from the European Research Council under the European Community's Seventh Frame-work Programme (FP7/2007-2013)/ERC Grant agreement no 209540 to FM and by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institutes for Advanced Research to MBS. JGB's salary was funded in part by CIFAR as part of its Junior Fellows Program and in part by a Connaught Global Challenge Fund grant from University of Toronto's Institute for Human Development. CJR was funded by an NSERC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL WJ, 1987, J INSECT PHYSIOL, V33, P51, DOI 10.1016/0022-1910(87)90103-X; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Billeter JC, 2009, NATURE, V461, P987, DOI 10.1038/nature08495; Chabaud MA, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00192; Chabaud MA, 2009, CURR BIOL, V19, P1654, DOI 10.1016/j.cub.2009.08.017; Dawson-Scully K, 2010, J EXP BIOL, V213, P2410, DOI 10.1242/jeb.041319; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Foucaud J, 2013, P ROYAL SOC B, V280; Joels M, 2006, TRENDS COGN SCI, V10, P152, DOI 10.1016/j.tics.2006.02.002; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kaun KR, 2007, LEARN MEMORY, V14, P342, DOI 10.1101/lm.505807; Kent C, 2008, CURR BIOL, V18, P1384, DOI 10.1016/j.cub.2008.07.088; Kent CF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000609; Krupp JJ, 2008, CURR BIOL, V18, P1373, DOI 10.1016/j.cub.2008.07.089; Laland KN, 2004, LEARN BEHAV, V32, P4; Leal WS, 2010, PLOS ONE, V5; Lucas C, 2009, P NATL ACAD SCI USA, V106, P6351, DOI 10.1073/pnas.0809463106; Mery F, 2005, SCIENCE, V308, P1148, DOI 10.1126/science.1111331; Mery F, 2007, EXP GERONTOL, V42, P99, DOI 10.1016/j.exger.2006.06.004; Mery F, 2007, P NATL ACAD SCI USA, V104, P13051, DOI 10.1073/pnas.0702923104; Mery F, 2009, CURR BIOL, V19, P730, DOI 10.1016/j.cub.2009.02.064; Miczek KA, 2007, J NEUROSCI, V27, P11803, DOI 10.1523/JNEUROSCI.3500-07.2007; MUELLER LD, 1991, SCIENCE, V253, P433, DOI 10.1126/science.1907401; NAGLE KJ, 1987, BEHAV GENET, V17, P386, DOI 10.1007/BF01068138; NICOL CJ, 1995, APPL ANIM BEHAV SCI, V44, P79, DOI 10.1016/0168-1591(95)00607-T; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Pascual A, 2001, SCIENCE, V294, P1115, DOI 10.1126/science.1064200; Paul C, 2008, J NEUROSCI, V28, P14202, DOI 10.1523/JNEUROSCI.2216-08.2008; PEREIRA HS, 1993, P NATL ACAD SCI USA, V90, P5044, DOI 10.1073/pnas.90.11.5044; Phelan LL, 1998, LEARN MOTIV, V29, P83, DOI 10.1006/lmot.1997.0995; Potter CJ, 2008, NAT NEUROSCI, V11, P989, DOI 10.1038/nn0908-989; Reaume CJ, 2011, PHILOS T R SOC B, V366, P2100, DOI 10.1098/rstb.2011.0028; Reaume CJ, 2011, P ROY SOC B-BIOL SCI, V278, P91, DOI 10.1098/rspb.2010.1337; Reaume CJ, 2009, J NEUROGENET, V23, pS63; Robinson GE, 2008, SCIENCE, V322, P896, DOI 10.1126/science.1159277; Schneider J, 2012, P NATL ACAD SCI USA, V109, P17174, DOI 10.1073/pnas.1121252109; Schneider J, 2012, ADV GENET, V77, P59, DOI 10.1016/B978-0-12-387687-4.00003-9; Sokal R.R., 2012, BIOMETRY; Sokolowski MB, 2010, NEURON, V65, P780, DOI 10.1016/j.neuron.2010.03.007; SOKOLOWSKI MB, 1986, ANIM BEHAV, V34, P403, DOI 10.1016/S0003-3472(86)80109-9; Stamps J, 2005, ANIM BEHAV, V70, P609, DOI 10.1016/j.anbehav.2004.11.018; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; TEMPEL BL, 1983, P NATL ACAD SCI-BIOL, V80, P1482, DOI 10.1073/pnas.80.5.1482; Tinette S, 2004, GENES BRAIN BEHAV, V3, P39, DOI 10.1046/j.1601-183x.2003.0046.x; Tinette S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-65; TORTORICI C, 1988, Journal of Insect Behavior, V1, P209, DOI 10.1007/BF01052239; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Villella A, 2008, ADV GENET, V62, P67, DOI 10.1016/S0065-2660(08)00603-2; Wang LM, 2010, NATURE, V463, P227, DOI 10.1038/nature08678; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	51	29	29	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81272	10.1371/journal.pone.0081272	http://dx.doi.org/10.1371/journal.pone.0081272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349049	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800015
J	Bret, C; Sueur, C; Ngoubangoye, B; Verrier, D; Deneubourg, JL; Petit, O				Bret, Celine; Sueur, Cedric; Ngoubangoye, Barthelemy; Verrier, Delphine; Deneubourg, Jean-Louis; Petit, Odile			Social Structure of a Semi-Free Ranging Group of Mandrills (Mandrillus sphinx): A Social Network Analysis	PLOS ONE			English	Article							GROUP-SIZE; BABOONS; FISSION; SOCIETIES; VARIABLES; BEHAVIOR; PRIMATES; RESERVE; GELADA; LIFE	The difficulty involved in following mandrills in the wild means that very little is known about social structure in this species. Most studies initially considered mandrill groups to be an aggregation of one-male/multifemale units, with males occupying central positions in a structure similar to those observed in the majority of baboon species. However, a recent study hypothesized that mandrills form stable groups with only two or three permanent males, and that females occupy more central positions than males within these groups. We used social network analysis methods to examine how a semi-free ranging group of 19 mandrills is structured. We recorded all dyads of individuals that were in contact as a measure of association. The betweenness and the eigenvector centrality for each individual were calculated and correlated to kinship, age and dominance. Finally, we performed a resilience analysis by simulating the removal of individuals displaying the highest betweenness and eigenvector centrality values. We found that related dyads were more frequently associated than unrelated dyads. Moreover, our results showed that the cumulative distribution of individual betweenness and eigenvector centrality followed a power function, which is characteristic of scale-free networks. This property showed that some group members, mostly females, occupied a highly central position. Finally, the resilience analysis showed that the removal of the two most central females split the network into small subgroups and increased the network diameter. Critically, this study confirms that females appear to occupy more central positions than males in mandrill groups. Consequently, these females appear to be crucial for group cohesion and probably play a pivotal role in this species.	[Bret, Celine; Sueur, Cedric; Verrier, Delphine; Petit, Odile] CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France; [Bret, Celine; Sueur, Cedric; Verrier, Delphine; Petit, Odile] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Bret, Celine; Sueur, Cedric; Deneubourg, Jean-Louis; Petit, Odile] Univ Libre Bruxelles, Unit Social Ecol, Brussels, Belgium; [Ngoubangoye, Barthelemy] Ctr Int Rech Med Franceville, Franceville, Gabon	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite Libre de Bruxelles	Bret, C (corresponding author), CNRS, Dept Ecol Physiol & Ethol, Strasbourg, France.	celine.bret@iphc.cnrs.fr	Sueur, Cédric/A-4020-2011	Sueur, Cédric/0000-0001-8206-2739	French ministry of higher education and research	French ministry of higher education and research	This work was supported by the French ministry of higher education and research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KA, 2002, J ZOOL, V258, P131, DOI 10.1017/S0952836902001267; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Borgatti S. P., 2006, Computational & Mathematical Organization Theory, V12, P21, DOI 10.1007/s10588-006-7084-x; Chapais B., 2004, KINSHIP BEHAV PRIMAT; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; DEVRIES H, 1995, ANIM BEHAV, V50, P1375, DOI 10.1016/0003-3472(95)80053-0; DEVRIES H, 1993, PSYCHOMETRIKA, V58, P53, DOI 10.1007/BF02294470; Disotell T, 1993, EVOL ANTHROPOL, V5, P18; DUNBAR RIM, 1980, J ANIM ECOL, V49, P485, DOI 10.2307/4259; DUNBAR RIM, 1983, ANIM BEHAV, V31, P556, DOI 10.1016/S0003-3472(83)80079-7; ERDOS P, 1960, B INT STATIST INST, V38, P343; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; Fox J., 2002, R S PLUS COMPANION A; Fruteau C, 2010, BEHAV PROCESS, V83, P113, DOI 10.1016/j.beproc.2009.11.004; Grueter CC, 2012, INT J PRIMATOL, V33, P1002, DOI 10.1007/s10764-012-9618-z; Grueter CC, 2012, INT J PRIMATOL, V33, P993, DOI 10.1007/s10764-012-9614-3; Guimaraes PR, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.042901; HARRISON M J S, 1988, Oryx, V22, P218; Henzi SP, 2009, BEHAV ECOL SOCIOBIOL, V63, P1015, DOI 10.1007/s00265-009-0720-y; Hoshino J, 1984, PRIMATES, V25, P297; Jacobs A, 2011, AM J PRIMATOL, V73, P741, DOI 10.1002/ajp.20932; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Jouventin P, 1975, TERRE VIE, V29, P439; Kanngiesser P, 2011, AM J PRIMATOL, V73, P758, DOI 10.1002/ajp.20914; Kapsalis E, 2004, KINSHIP AND BEHAVIOR IN PRIMATES, P153; Kasper C, 2009, PRIMATES, V50, P343, DOI 10.1007/s10329-009-0153-2; Krause J, 2002, LIVING GROUPS; Kummer H, 1995, QUEST SACRED BABOONS; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Manno TG, 2008, ANIM BEHAV, V75, P1221, DOI 10.1016/j.anbehav.2007.09.025; Matsuda I, 2012, INT J PRIMATOL, V33, P1038, DOI 10.1007/s10764-012-9616-1; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; McCowan B, 2008, APPL ANIM BEHAV SCI, V109, P396, DOI 10.1016/j.applanim.2007.02.009; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ramos-Fernandez G, 2009, BEHAV ECOL SOCIOBIOL, V63, P999, DOI 10.1007/s00265-009-0719-4; Rogers ME, 1996, AM J PRIMATOL, V40, P297, DOI 10.1002/(SICI)1098-2345(1996)40:4<297::AID-AJP1>3.0.CO;2-T; Setchell JM, 2001, AM J PHYS ANTHROPOL, V115, P349, DOI 10.1002/ajpa.1091; Setchell JM, 2002, AM J PRIMATOL, V56, P9, DOI 10.1002/ajp.1060; Setchell JM, 2003, ADV STUD BEHAV, V33, P87, DOI 10.1016/S0065-3454(03)33003-7; Setchell JM, 2002, INT J PRIMATOL, V23, P51, DOI 10.1023/A:1013245707228; Setchell JM, 1999, THESIS U CAMBRIDGE; Silk JB, 1999, BEHAVIOUR, V136, P679, DOI 10.1163/156853999501522; Silk JB, 2006, BEHAV ECOL SOCIOBIOL, V61, P197, DOI 10.1007/s00265-006-0250-9; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Sueur C, 2011, ANIM BEHAV, V82, P845, DOI 10.1016/j.anbehav.2011.07.020; Sueur C, 2010, J EXP BIOL, V213, P1338, DOI 10.1242/jeb.039016; Sueur C, 2012, LEC NOTES C IN PRESS; Sueur C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032566; Sueur C, 2011, J THEOR BIOL, V273, P156, DOI 10.1016/j.jtbi.2010.12.035; Sueur C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016131; Sueur C, 2011, AM J PRIMATOL, V73, P703, DOI 10.1002/ajp.20915; Sueur C, 2010, BEHAV ECOL SOCIOBIOL, V64, P1875, DOI 10.1007/s00265-010-0999-8; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Watts DP, 2000, ON THE MOVE: HOW AND WHY ANIMALS TRAVEL IN GROUPS, P351; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Wey TW, 2010, ANIM BEHAV, V79, P1343, DOI 10.1016/j.anbehav.2010.03.008; Whitehead H., 2008, ANAL ANIMAL SOC; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; WICKINGS EJ, 1992, J REPROD FERTIL, V95, P129	67	25	27	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83015	10.1371/journal.pone.0083015	http://dx.doi.org/10.1371/journal.pone.0083015			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340074	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400110
J	Garcia-Gonzalez, L; Moreno, MP; Moreno, A; Gil, A; del Villar, F				Garcia-Gonzalez, Luis; Perla Moreno, M.; Moreno, Alberto; Gil, Alexander; del Villar, Fernando			Effectiveness of a Video-Feedback and Questioning Programme to Develop Cognitive Expertise in Sport	PLOS ONE			English	Article							DECISION-MAKING; NOVICE DIFFERENCES; PROBLEM REPRESENTATIONS; TACTICAL KNOWLEDGE; EXECUTION SKILLS; TENNIS; PERFORMANCE; PROFESSIONALS; THINKING; ELITE	The importance within sport expertise of cognitive factors has been emphasised in many research studies. Adaptations that take place in athletes' long-term memories are going to condition their decision-making and performance, and training programmes must be developed that improve these adaptations. In our study, we provide a tactical-cognitive training programme based on video-feedback and questioning in order to improve tactical knowledge in tennis players and verify its effect when transferred to athletes' decision-making. 11 intermediate tennis players participated in this study (12.9+/-0.7 years old), distributed into two groups (experimental, n = 5; control, n = 6). Tactical knowledge was measured by problem representation and strategy planning with a verbal protocol. Decision-making was measured by a systematic observation instrument. Results confirm the effectiveness of a combination of video-feedback and questioning on cognitive expertise, developing adaptations in long-term memory that produce an improvement in the quality of tactical knowledge (content, sophistication and structure). This, in turn, is transferred to the athletes' decision-making capacity, leading to a higher percentage of successful decisions made during game play. Finally, we emphasise the need to develop effective programmes to develop cognitive expertise and improve athletes' performance, and include it in athletes' formative stages.	[Garcia-Gonzalez, Luis] Univ Zaragoza, Fac Hlth & Sport Sci, Huesca, Spain; [Perla Moreno, M.; Moreno, Alberto; Gil, Alexander; del Villar, Fernando] Univ Extremadura, Fac Sport Sci, Caceres, Spain	University of Zaragoza; Universidad de Extremadura	Garcia-Gonzalez, L (corresponding author), Univ Zaragoza, Fac Hlth & Sport Sci, Huesca, Spain.	lgarciag@unizar.es	Gil Arias, Alexander/N-2680-2014; Moreno, Alberto/J-4326-2017; Garcia-Gonzalez, Luis/D-3096-2013; Moreno, Alberto/AAQ-3559-2020	Gil Arias, Alexander/0000-0002-5814-1100; Moreno, Alberto/0000-0003-0112-9394; Garcia-Gonzalez, Luis/0000-0001-8115-0649; Moreno, Alberto/0000-0003-0112-9394; Del Villar, Fernando/0000-0001-8724-8006; Moreno, M. Perla/0000-0003-0405-2409	Ministry of Science and Innovation (Spain) [DEP2011-29527]	Ministry of Science and Innovation (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Funded by Ministry of Science and Innovation (Spain) with the research project DEP2011-29527 "Thinking and action. Development of a knowledge-stimulation programme during competition, to improve individual tactical performance of athletes" (http://www.idi.mineco.gob.es/portal/site/MICINN/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso J, 2012, J SPORT SCI MED, V11, P339; Baker J, 2003, RES Q EXERCISE SPORT, V74, P342, DOI 10.1080/02701367.2003.10609101; Bar-Eli M., 2011, JUDGEMENT DECISION M; Calmeiro L, 2011, J CLIN SPORT PSYCHOL, V5, P223, DOI 10.1123/jcsp.5.3.223; Carvalho J, 2011, REV PSICOL DEPORTE, V20, P767; Deakin JM., 2003, EXPERT PERFORMANCE S, P115; Del Villar F, 2007, PERCEPT MOTOR SKILL, V104, P355, DOI 10.2466/PMS.104.2.355-365; Elferink-Gemser MT, 2010, J SPORT SCI, V28, P521, DOI 10.1080/02640410903582743; ERICSSON KA, 1995, PSYCHOL REV, V102, P211, DOI 10.1037/0033-295X.102.2.211; Ericsson KA, 2000, PSYCHOL REV, V107, P578, DOI 10.1037/0033-295X.107.3.578; Fleiss JL, 2004, STAT METHODS RATES P, P598, DOI DOI 10.1002/0471445428.CH18; Garcia-Gonzalez L, 2012, PERCEPT MOTOR SKILL, V115, P567, DOI 10.2466/30.10.25.PMS.115.5.567-580; Goldberg Elkhonon, 2005, WISDOM PARADOX YOUR; Gorecki JJ, 2003, RES Q EXERCISE SPORT, V74, pA100; Harteis C., 2008, US CHINA ED REV, V5, P68; Hodges NJ, 2006, CAMBRIDGE HANDBOOK OF EXPERTISE AND EXPERT PERFORMANCE, P471; Hodges NJ, 2003, J MOTOR BEHAV, V35, P247, DOI 10.1080/00222890309602138; Hogarth R., 2001, ED INTUITION; Hogarth RM, 2008, INTUITION IN JUDGMENT AND DECISION MAKING, P91; KOPPEN J., 2009, PERSPECTIVES COGNITI, P108; Lorains M, 2013, PSYCHOL SPORT EXERC, V14, P293, DOI 10.1016/j.psychsport.2012.11.004; MacMahon C, 2009, INT J SPORT PSYCHOL, V40, P565; Mann DTY, 2007, J SPORT EXERCISE PSY, V29, P457, DOI 10.1123/jsep.29.4.457; McPherson S. L., 2008, DEVELOPING SPORT EXP, P155; McPherson S.L., 2003, EXPERT PERFORMANCE S, P137; McPherson SL, 1999, RES Q EXERCISE SPORT, V70, P369, DOI 10.1080/02701367.1999.10608057; McPherson SL, 1999, RES Q EXERCISE SPORT, V70, P233, DOI 10.1080/02701367.1999.10608043; MCPHERSON SL, 1994, QUEST, V46, P223, DOI 10.1080/00336297.1994.10484123; MCPHERSON SL, 1989, J EXP CHILD PSYCHOL, V48, P190, DOI 10.1016/0022-0965(89)90002-7; MCPHERSON SL, 1993, J SPORT EXERCISE PSY, V15, P304, DOI 10.1123/jsep.15.3.304; McPherson SL, 2000, J SPORT EXERCISE PSY, V22, P39, DOI 10.1123/jsep.22.1.39; McPherson SL, 2007, J SPORT SCI, V25, P945, DOI 10.1080/02640410600908035; McRobert AP, 2011, BRIT J PSYCHOL, V102, P519, DOI 10.1111/j.2044-8295.2010.02013.x; Ruiz LM, 2006, AN PSICOL-SPAIN, V22, P132; Moran A, 2012, THINK SKILLS CREAT, V7, P85, DOI 10.1016/j.tsc.2012.03.005; Dominguez AM, 2011, REV PSICOL DEPORTE, V20, P785; Moreno MP, 2008, INT J SPORT PSYCHOL, V39, P59; Nelson LJ, 2014, SPORT EDUC SOC, V19, P19, DOI 10.1080/13573322.2011.613925; Nielsen TM, 2001, PERCEPT MOTOR SKILL, V93, P541, DOI 10.2466/PMS.93.6.541-555; Overney LS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002380; Puri ML., 1985, NONPARAMETRIC METHOD; Raab M, 2005, HUM MOVEMENT SCI, V24, P326, DOI 10.1016/j.humov.2005.06.004; Raab M, 2003, INT J SPORT PSYCHOL, V34, P273; Raab M., 2007, PHYS EDUC SPORT PEDA, V12, P1, DOI DOI 10.1080/17408980601060184; Raab M, 2008, INTUITION IN JUDGMENT AND DECISION MAKING, P119; Rulence-Paques P., 2005, EUR REV APPL PSYCHOL, V55, P131, DOI [10.1016/j.erap.2004.05.003, DOI 10.1016/J.ERAP.2004.05.003]; Schack T, 2006, NEUROSCI LETT, V391, P77, DOI 10.1016/j.neulet.2005.10.009; Starkes JL, 2001, HDB SPORT PSYCHOL, P174; Thomas J.R., 2011, RES METHODS PHYS ACT, Vsixth; Thomas JR, 1999, RES Q EXERCISE SPORT, V70, P11, DOI 10.1080/02701367.1999.10607726; Thomas JR, 2002, PHYS ACTIVITY ASSESS, P73; Travassos B, 2013, PSYCHOL SPORT EXERC, V14, P211, DOI 10.1016/j.psychsport.2012.11.002; Vickers J.N., 2007, HUMAN KINETICS; Vickers J. N., 2004, SKILL ACQUISITION SP, P103; Vickers JN, 1999, J SPORT SCI, V17, P357, DOI 10.1080/026404199365876; Williams A. M., 1999, VISUAL PERCEPTION AC; Williams AM, 2011, APPL COGNITIVE PSYCH, V25, P432, DOI 10.1002/acp.1710; Williams AM, 2008, J SPORT EXERCISE PSY, V30, P653, DOI 10.1123/jsep.30.6.653; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; Williams AM, 2009, PERSPECTIVES COGNITI, P95	60	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82270	10.1371/journal.pone.0082270	http://dx.doi.org/10.1371/journal.pone.0082270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VW	24340012	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400068
J	Shem-Ad, T; Irit, O; Yifrach, O				Shem-Ad, Tzilhav; Irit, Orr; Yifrach, Ofer			Inter-Subunit Interactions across the Upper Voltage Sensing-Pore Domain Interface Contribute to the Concerted Pore Opening Transition of Kv Channels	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GATING CHARGE; ION CHANNELS; K+ CHANNEL; POTASSIUM; SENSOR; COOPERATIVITY; INACTIVATION; MECHANISMS; KV1.2	The tight electro-mechanical coupling between the voltage-sensing and pore domains of Kv channels lies at the heart of their fundamental roles in electrical signaling. Structural data have identified two voltage sensor pore inter-domain interaction surfaces, thus providing a framework to explain the molecular basis for the tight coupling of these domains. While the contribution of the intra-subunit lower domain interface to the electro-mechanical coupling that underlies channel opening is relatively well understood, the contribution of the inter-subunit upper interface to channel gating is not yet clear. Relying on energy perturbation and thermodynamic coupling analyses of tandem-dimeric Shaker Kv channels, we show that mutation of upper interface residues from both sides of the voltage sensor-pore domain interface stabilizes the closed channel state. These mutations, however, do not affect slow inactivation gating. We, moreover, find that upper interface residues form a network of state-dependent interactions that stabilize the open channel state. Finally, we note that the observed residue interaction network does not change during slow inactivation gating. The upper voltage sensing-pore interaction surface thus only undergoes conformational rearrangements during channel activation gating. We suggest that inter-subunit interactions across the upper domain interface mediate allosteric communication between channel subunits that contributes to the concerted nature of the late pore opening transition of Kv channels.	[Yifrach, Ofer] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Yifrach, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	ofery@bgu.ac.il			Israel Science Foundation [488/12]	Israel Science Foundation(Israel Science Foundation)	The study was funded by a Israel Science Foundation grant # 488/12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], P NATL ACAD SCI US, V104, P19813; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bocksteins E, 2011, EUR BIOPHYS J BIOPHY, V40, P783, DOI 10.1007/s00249-011-0694-3; Chanda B, 2005, NATURE, V436, P852, DOI 10.1038/nature03888; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Chowdhury S, 2012, J GEN PHYSIOL, V140, P613, DOI 10.1085/jgp.201210840; Chowdhury S, 2012, J GEN PHYSIOL, V139, P3, DOI 10.1085/jgp.201110722; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cuello LG, 2010, NATURE, V466, P203, DOI 10.1038/nature09153; Faiman GA, 1996, PROTEIN ENG, V9, P315, DOI 10.1093/protein/9.3.315; Full Y, 2013, PFLUG ARCH EUR J PHY, V465, P797, DOI 10.1007/s00424-012-1184-x; Haitin Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001935; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HOROVITZ A, 1990, J MOL BIOL, V214, P613, DOI 10.1016/0022-2836(90)90275-Q; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 2000, NEURON, V27, P573, DOI 10.1016/S0896-6273(00)00067-2; Lee SY, 2009, PLOS BIOL, V7, P676, DOI 10.1371/journal.pbio.1000047; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Mckeown L, 2008, J BIOL CHEM, V283, P30421, DOI 10.1074/jbc.M708921200; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; PERUTZ MF, 1989, Q REV BIOPHYS, V22, P139, DOI 10.1017/S0033583500003826; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips LR, 2010, J GEN PHYSIOL, V136, P629, DOI 10.1085/jgp.201010517; Shem-Ad T, 2013, J GEN PHYSIOL, V141, P507, DOI 10.1085/jgp.201310976; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Vargas E, 2012, J GEN PHYSIOL, V140, P587, DOI 10.1085/jgp.201210873; Yang YS, 1997, J GEN PHYSIOL, V109, P779, DOI 10.1085/jgp.109.6.779; Yellen G, 1998, Q REV BIOPHYS, V31, P239, DOI 10.1017/S0033583598003448; Yifrach O, 2004, BIOPHYS J, V87, P822, DOI 10.1529/biophysj.104.040410; Yifrach O, 2009, METHOD ENZYMOL, V466, P179, DOI 10.1016/S0076-6879(09)66008-0; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	39	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82253	10.1371/journal.pone.0082253	http://dx.doi.org/10.1371/journal.pone.0082253			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340010	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400067
J	Warsow, G; Struckmann, S; Kerkhoff, C; Reimer, T; Engel, N; Fuellen, G				Warsow, Gregor; Struckmann, Stephan; Kerkhoff, Claus; Reimer, Toralf; Engel, Nadja; Fuellen, Georg			Differential Network Analysis Applied to Preoperative Breast Cancer Chemotherapy Response	PLOS ONE			English	Article							LEUCINE-ZIPPER KINASE; B-MYB; IN-VIVO; EXPRESSION; PROTEIN; CELLS; SUBTYPES; REGULATOR; MELK; CLASSIFICATION	In silico approaches are increasingly considered to improve breast cancer treatment. One of these treatments, neoadjuvant TFAC chemotherapy, is used in cases where application of preoperative systemic therapy is indicated. Estimating response to treatment allows or improves clinical decision-making and this, in turn, may be based on a good understanding of the underlying molecular mechanisms. Ever increasing amounts of high throughput data become available for integration into functional networks. In this study, we applied our software tool ExprEssence to identify specific mechanisms relevant for TFAC therapy response, from a gene/protein interaction network. We contrasted the resulting active subnetwork to the subnetworks of two other such methods, OptDis and KeyPathwayMiner. We could show that the ExprEssence subnetwork is more related to the mechanistic functional principles of TFAC therapy than the subnetworks of the other two methods despite the simplicity of ExprEssence. We were able to validate our method by recovering known mechanisms and as an application example of our method, we identified a mechanism that may further explain the synergism between paclitaxel and doxorubicin in TFAC treatment: Paclitaxel may attenuate MELK gene expression, resulting in lower levels of its target MYBL2, already associated with doxorubicin synergism in hepatocellular carcinoma cell lines. We tested our hypothesis in three breast cancer cell lines, confirming it in part. In particular, the predicted effect on MYBL2 could be validated, and a synergistic effect of paclitaxel and doxorubicin could be demonstrated in the breast cancer cell lines SKBR3 and MCF-7.	[Warsow, Gregor; Struckmann, Stephan; Fuellen, Georg] Univ Rostock, Sch Med, Inst Biostat & Informat Med & Ageing Res, D-18055 Rostock, Germany; [Warsow, Gregor] Ernst Moritz Arndt Univ Greifswald, Dept Math & Informat, Greifswald, Germany; [Warsow, Gregor] Univ Med Greifswald, Dept Anat & Cell Biol, Greifswald, Germany; [Kerkhoff, Claus] Univ Osnabruck, Dept Biomed Sci, Sch Human Sci, D-49069 Osnabruck, Germany; [Reimer, Toralf] Univ Rostock, Sch Med, Dept Obstet & Gynecol, D-18055 Rostock, Germany; [Engel, Nadja] Univ Rostock, Sch Med, Dept Cell Biol, D-18055 Rostock, Germany	University of Rostock; Ernst Moritz Arndt Universitat Greifswald; Greifswald Medical School; University Osnabruck; University of Rostock; University of Rostock	Engel, N (corresponding author), Univ Rostock, Sch Med, Dept Cell Biol, D-18055 Rostock, Germany.	nadja.engel-lutz@uni-rostock.de; fuellen@uni-rostock.de	Reimer, Toralf/R-8199-2019	Struckmann, Stephan/0000-0002-8565-7962; Engel, Nadja/0000-0002-6362-9282	BMBF [01GN0901]; DFG [FU583/2-1, FU583/2-2]	BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG))	ExprEssence development is funded by the BMBF (01GN0901) and the DFG (FU583/2-1, FU583/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1617; Alcaraz N, 2012, INTEGR BIOL-UK, V4, P756, DOI 10.1039/c2ib00133k; Baumbach J, 2012, PROCEEDINGS OF THE FOURTEENTH INTERNATIONAL CONFERENCE ON GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P169, DOI 10.1145/2330163.2330188; BLAGOSKLONNY MV, 1995, CANCER RES, V55, P4623; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breitling R, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-100; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Cabusora L, 2005, BIOINFORMATICS, V21, P2898, DOI 10.1093/bioinformatics/bti440; Calvisi DF, 2011, HEPATOLOGY, V53, P1226, DOI 10.1002/hep.24174; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chou J, 2010, J CELL PHYSIOL, V222, P42, DOI 10.1002/jcp.21943; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Dao P, 2011, BIOINFORMATICS, V27, pI205, DOI 10.1093/bioinformatics/btr245; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Engel N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047833; Gevaert O, 2006, BIOINFORMATICS, V22, pE184, DOI 10.1093/bioinformatics/btl230; Hannemann J, 2006, BRIT J CANCER, V95, P1334, DOI 10.1038/sj.bjc.6603449; Hebbard LW, 2010, CANCER RES, V70, P8863, DOI 10.1158/0008-5472.CAN-10-1295; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Ideker T, 2008, GENOME RES, V18, P644, DOI 10.1101/gr.071852.107; Ideker T, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2011.99; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Joaquin M, 2003, J BIOL CHEM, V278, P44255, DOI 10.1074/jbc.M308953200; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Liekens AML, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r57; LIN D, 1994, P NATL ACAD SCI USA, V91, P10079, DOI 10.1073/pnas.91.21.10079; LONG BH, 1994, CANCER RES, V54, P4355; Lund MJ, 2010, CANCER-AM CANCER SOC, V116, P2549, DOI 10.1002/cncr.25016; Mannefeld M, 2009, CANCER RES, V69, P4073, DOI 10.1158/0008-5472.CAN-08-4156; Nacu S, 2007, BIOINFORMATICS, V23, P850, DOI 10.1093/bioinformatics/btm019; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Pickard MR, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2350; Popovici V, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2468; Raschella G, 1999, CANCER RES, V59, P3365; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Sala A, 1996, J BIOL CHEM, V271, P9363, DOI 10.1074/jbc.271.16.9363; Seong HA, 2002, BIOCHEM J, V361, P597, DOI 10.1042/0264-6021:3610597; Seong HA, 2003, J BIOL CHEM, V278, P9655, DOI 10.1074/jbc.M207478200; Staiger C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034796; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tegze B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030804; Thorner AR, 2009, ONCOGENE, V28, P742, DOI 10.1038/onc.2008.430; Ulitsky I, 2008, LECT N BIOINFORMAT, V4955, P347; Vantieghem K, 2006, ACTA BIOMEDICA LOVAN, V371; Verlinden L, 2005, J BIOL CHEM, V280, P37319, DOI 10.1074/jbc.M503587200; Warsow G, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-164; Yang XR, 2011, JNCI-J NATL CANCER I, V103, P250, DOI 10.1093/jnci/djq526	48	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81784	10.1371/journal.pone.0081784	http://dx.doi.org/10.1371/journal.pone.0081784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349128	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200050
J	Yu, NW; Fu, S; Liu, YB; Fu, ZH; Meng, JZ; Xu, ZH; Wang, BC; Zhang, AM				Yu, Nengwang; Fu, Shuai; Liu, Yibao; Fu, Zhihou; Meng, Jianzhong; Xu, Zhonghua; Wang, Baocheng; Zhang, Aimin			Benign and Malignant Renal Cells Are Differentially Inhibited during Prolonged Organ Preservation	PLOS ONE			English	Article							TUMOR NECROSIS; TRANSPLANTATION; KIDNEY; CARCINOMA; SURVIVAL; DIALYSIS; DONORS; IMPACT; GRAFT	The worry of potential residual renal cancer cells in donor kidney after resection of small renal cancer impedes the extensive use of such controversial donor source. To explore the impacts of organ preservation process on the survival of renal cancer cells, we detected cell proliferation and viability of benign and malignant renal cell lines and clinical renal samples after treated with simulated organ preservation process. It was found that the viability and proliferation of malignant renal cells are inhibited much more than that of benign renal cells during prolonged organ preservation. The inhibition of proliferation in benign renal cells is fully reversible, while in malignant renal cancer cells is not fully reversible after a certain time. So potential residual renal cancer cells could be partly inhibited and eliminated by organ preservation process.	[Yu, Nengwang; Liu, Yibao; Zhang, Aimin] Jinan Mil Command, Gen Hosp, Dept Urol, Jinan, Shandong, Peoples R China; [Fu, Shuai] Beijing Canc Hosp, Dept Thorac Med Oncol, Beijing, Peoples R China; [Fu, Zhihou] Jinan Mil Command, Gen Hosp, Dept Orthoped, Jinan, Shandong, Peoples R China; [Meng, Jianzhong] Jinan Mil Command, Gen Hosp, Blood Purificat Dept, Jinan, Shandong, Peoples R China; [Xu, Zhonghua] Qilu Hosp, Dept Urol, Jinan, Shandong, Peoples R China; [Wang, Baocheng] Jinan Mil Command, Gen Hosp, Dept Oncol, Jinan, Shandong, Peoples R China	Peking University; Shandong University	Yu, NW (corresponding author), Jinan Mil Command, Gen Hosp, Dept Urol, Jinan, Shandong, Peoples R China.	yunengwang@hotmail.com			China Postdoctoral Science Foundation [2012M521931]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was supported by a grant from China Postdoctoral Science Foundation (No. 2012M521931). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Brook NR, 2010, TRANSPL INT, V23, P476, DOI 10.1111/j.1432-2277.2009.01002.x; Buell JF, 2005, TRANSPL P, V37, P581, DOI 10.1016/j.transproceed.2004.12.118; Buell Joseph F, 2004, Ann Transplant, V9, P53; Cohn JA, 2008, UROL ONCOL-SEMIN ORI, V26, P573, DOI 10.1016/j.urolonc.2008.08.007; Dainys Balys, 2007, Medicina (Kaunas), V43 Suppl 1, P145; Ghafari A, 2007, TRANSPL P, V39, P1660, DOI 10.1016/j.transproceed.2007.02.089; Gurova KV, 2004, CANCER RES, V64, P1951, DOI 10.1158/0008-5472.CAN-03-1541; He B, 2012, TRANSPLANTATION, V94, P1093, DOI 10.1097/00007890-201211271-02166; Johnson DW, 2000, TRANSPLANTATION, V69, P794; Kalble T, 2005, EUR UROL, V47, P156, DOI 10.1016/j.eururo.2004.02.009; Khurram MA, 2011, INT J NEPHROL, V2010; Mannami M, 2008, AM J TRANSPLANT, V8, P811, DOI 10.1111/j.1600-6143.2007.02145.x; Matijasevic Z, 2002, ANTICANCER RES, V22, P3267; Hijosa MM, 2012, PEDIATR NEPHROL, V27, P2319, DOI 10.1007/s00467-012-2255-0; PENN I, 1995, TRANSPLANTATION, V59, P480; Pflanz S, 2008, SCAND J UROL NEPHROL, V42, P507, DOI 10.1080/00365590802460633; Pichler M, 2012, AM J CLIN PATHOL, V137, P283, DOI 10.1309/AJCPLBK9L9KDYQZP; Richstone L, 2004, J UROLOGY, V171, P615, DOI 10.1097/01.ju.0000106955.19813.f6; Sener A, 2009, BJU INT, V104, P1655, DOI 10.1111/j.1464-410X.2009.08681.x; Southard JH, 1999, TRANSPLANTATION, P271; STUBENBORD WT, 1982, TRANSPLANT P, V14, P775; TORIGOE S, 1992, ONCOL RES, V4, P467; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Valente M, 2012, TRANSPL P, V44, P1846, DOI 10.1016/j.transproceed.2012.06.036; Whitson JM, 2007, UROLOGY, V70, DOI 10.1016/j.urology.2007.07.070; Yu N, 2013, CLIN TRANSP IN PRESS	26	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81745	10.1371/journal.pone.0081745	http://dx.doi.org/10.1371/journal.pone.0081745			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349123	Green Submitted, gold, Green Published			2022-12-27	WOS:000328705200047
J	Larsen, MD; Hallas, J				Larsen, Michael Due; Hallas, Jesper			Hospital Physicians' Influence on Gastrointestinal Protection during Treatment with Non-Steroidal Anti-Inflammatory Drugs and Acetylsalicylic Acid and the Impact on Prescribing in Primary Care	PLOS ONE			English	Article							EXPERT CONSENSUS DOCUMENT; PEPTIC-ULCER DISEASE; LOW-DOSE ASPIRIN; ANTIPLATELET THERAPY; NSAID USE; RISK; COMPLICATIONS; COMMUNICATION; PREVENTION; CONTINUITY	Background: The aim of this study was to describe the use of gastrointestinal (GI) protection before, during and after hospitalisation for elderly patients using NSAID or low-dose ASA. Methods: This study included all elderly patients (75+) admitted to hospital in the period of 1st April 2010 to 31st March 2011 at Odense University Hospital, Denmark, who were regular users of NSAID or low-dose ASA before hospital admission, or had one of these drugs initiated during hospital stay. By using pharmacy dispensing data and a hospital-based pharmacoepidemiological database, the treatment strategy for the individual patients was followed across hospital stay. Results: In total, 3,587 patients were included. Before hospital admission, 93 of 245 NSAID users (38.0%) and 597 of 1994 user of low-dose ASA (29.9%) had used GI protection. During hospital stay, use of GI protection increased to 75% and 33.9%, respectively. When hospital physicians initiated new treatment with NSAID or with low-dose ASA, 305 of 555 (55.0%) and 647 of 961 (67.3%) were initiated without concomitant use of GI protection. When hospital physicians initiated GI protection, 26.8-51.0% were continued in primary care after discharge. Conclusions: During hospital stay, the use of GI protection increases, but when new treatment with NSAIDs or low-dose ASA is initiated in hospital, the use of gastrointestinal protection is low. The low use of GI protection is carried on in primary care after discharge.	[Larsen, Michael Due; Hallas, Jesper] Univ So Denmark, Odense M, Denmark	University of Southern Denmark	Larsen, MD (corresponding author), Univ So Denmark, Odense M, Denmark.	mdlarsen@health.sdu.dk		Larsen, Michael Due/0000-0002-0623-2481; Hallas, Jesper/0000-0002-8097-8708				Abraham NS, 2010, AM J GASTROENTEROL, V105, P2533, DOI 10.1038/ajg.2010.445; Andrade SE, 2006, PHARMACOEPIDEM DR S, V15, P565, DOI 10.1002/pds.1230; [Anonymous], 2005, ESSENTIAL MED STAT; Bhatt DL, 2008, AM J GASTROENTEROL, V103, P2890, DOI 10.1111/j.1572-0241.2008.02216.x; CHAN KWA, 1993, J CLIN EPIDEMIOL, V46, P113, DOI 10.1016/0895-4356(93)90016-T; Danish State Serum Institute, 2013, DISTR OV THE COUNT A; Federman Alex D, 2006, Am J Geriatr Pharmacother, V4, P306; Fosbol EL, 2008, PHARMACOEPIDEM DR S, V17, P822, DOI 10.1002/pds.1592; Gaist D, 1997, DAN MED BULL, V44, P445; Glintborg B, 2007, QUAL SAF HEALTH CARE, V16, P34, DOI 10.1136/qshc.2006.019828; GRIFFIN MR, 1991, ANN INTERN MED, V114, P257, DOI 10.7326/0003-4819-114-4-257; Hernandez-Diaz S, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-22; Himmel W, 2004, INT J CLIN PHARM TH, V42, P103; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P13, DOI 10.2147/CLEP.S26958; Krag A, 2006, ALIMENT PHARM THER, V23, P1713, DOI 10.1111/j.1365-2036.2006.02950.x; Kripalani S, 2007, JAMA-J AM MED ASSOC, V297, P831, DOI 10.1001/jama.297.8.831; Laine L, 2006, ALIMENT PHARM THER, V24, P897, DOI 10.1111/j.1365-2036.2006.03077.x; Mahe I, 2003, DRUG AGING, V20, P999; Mansur N, 2008, DRUG AGING, V25, P861, DOI 10.2165/00002512-200825100-00005; Ng FH, 2010, GASTROENTEROLOGY, V138, P82, DOI 10.1053/j.gastro.2009.09.063; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Rostom A, 2002, COCHRANE DATABASE SY; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Serrano P, 2002, ALIMENT PHARM THER, V16, P1945, DOI 10.1046/j.1365-2036.2002.01355.x; SILVERSTEIN FE, 1995, ANN INTERN MED, V123, P241, DOI 10.7326/0003-4819-123-4-199508150-00001; The Danish College of General Practitioners, 2013, DYSP; The Danish College of General Practitioners, AELDR PAT; The Danish Society of Cardiology, FARM KARD KOMPL; Visser LE, 2002, BRIT J CLIN PHARMACO, V53, P183, DOI 10.1046/j.0306-5251.2001.01190.x; Wettermark B, 2013, PHARMACOEPIDEMIOLOGY; WHO Collaborating Centre for Drug Statistics Methodology, 2010, GUID ATC CLASS DDD A; Yeomans ND, 2005, ALIMENT PHARM THER, V22, P795, DOI 10.1111/j.1365-2036.2005.02649.x	32	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e81845	10.1371/journal.pone.0081845	http://dx.doi.org/10.1371/journal.pone.0081845			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24349137	gold, Green Submitted, Green Published			2022-12-27	WOS:000328566700052
J	Christensen, T; Jensen, L; Bouzinova, EV; Wiborg, O				Christensen, Trine; Jensen, Line; Bouzinova, Elena V.; Wiborg, Ove			Molecular Profiling of the Lateral Habenula in a Rat Model of Depression	PLOS ONE			English	Article							CHRONIC MILD STRESS; ENDOTHELIAL GROWTH-FACTOR; ANIMAL-MODEL; BEHAVIORAL ACTIONS; VEGF; ESCITALOPRAM; RESILIENCE; HIPPOCAMPUS; RESISTANCE; SEROTONIN	Objective: This study systematically investigated the effect of chronic mild stress and response to antidepressant treatment in the lateral habenula at the whole genome level. Methods: Rat whole genome expression chips (Affymetrix) were used to detect gene expression regulations in the lateral habenula of rats subjected to chronic mild stress (mild stressors exchanged twice a day for 8 weeks). Some rats received antidepressant treatment during fifth to eights week of CMS. The lateral habenula gene expression profile was studied through the gene ontology and signal pathway analyses using bioinformatics. Real-time quantitative polymerase chain reaction (RT-PCR) was used to verify the microarray results and determine the expression of the Fcrla, Eif3k, Sec3l1, Ubr5, Abca8a, Ankrd49, Cyp2j10, Frs3, Syn2, and Znf503 genes in the lateral habenula tissue. Results: In particular we found that stress and antidepressant treatment affected intracellular cascades like growth factor receptor signaling, G-protein-coupled receptor signaling, and Wnt signaling - processes involved in the neuroplastic changes observed during the progression of depression and antidepressant treatment. Conclusion: The present study suggests an important role of the lateral habenula in the development of depression-like conditions and correlates to previous studies demonstrating a significant role of the lateral habenula in depressive-like conditions and antidepressant treatment.	[Christensen, Trine; Jensen, Line; Bouzinova, Elena V.; Wiborg, Ove] Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark	Aarhus University	Bouzinova, EV (corresponding author), Aarhus Univ, Dept Clin Med, Translat Neuropsychiat Unit, Risskov, Denmark.	elena_bouz@hotmail.com		Bouzinova, Elena V./0000-0001-9511-8009	Lundbeck Foundation [R77-A7085]; Familien Hede Nielsens Fond; Augustinus Fonden; Direktor Jacob Madsen & Hustru Olga Madsens Fond; Soster og Verner Lipperts Fond; Gross. L.F. Foghts Fond; Civilingenior Frode V. Nyegaard og Hustrus Fond	Lundbeck Foundation(Lundbeckfonden); Familien Hede Nielsens Fond; Augustinus Fonden; Direktor Jacob Madsen & Hustru Olga Madsens Fond; Soster og Verner Lipperts Fond; Gross. L.F. Foghts Fond; Civilingenior Frode V. Nyegaard og Hustrus Fond	This study was supported by the Lundbeck Foundation (R77-A7085) - Lundbeckfonden.com, and Familien Hede Nielsens Fond, Augustinus Fonden, Direktor Jacob Madsen & Hustru Olga Madsens Fond, Soster og Verner Lipperts Fond, Gross. L.F. Foghts Fond, and Civilingenior Frode V. Nyegaard og Hustrus Fond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banasr M, 2010, MOL PSYCHIATR, V15, P501, DOI 10.1038/mp.2008.106; Bath KG, 2013, NEUROSCIENCE, V239, P149, DOI 10.1016/j.neuroscience.2013.01.074; Bergstrom A, 2007, J MOL NEUROSCI, V33, P201, DOI 10.1007/s12031-007-0065-9; Berman R M, 1997, Depress Anxiety, V5, P154, DOI 10.1002/(SICI)1520-6394(1997)5:4<154::AID-DA2>3.0.CO;2-D; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Bisgaard CF, 2007, J MOL NEUROSCI, V32, P132, DOI 10.1007/s12031-007-0025-4; Bisgaard CF, 2012, J PSYCHOPHARMACOL, V26, P1569, DOI 10.1177/0269881112460110; Brockington A, 2004, NEUROPATH APPL NEURO, V30, P427, DOI 10.1111/j.1365-2990.2004.00600.x; CALDECOTTHAZARD S, 1988, J NEUROSCI, V8, P1951; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Christensen T, 2011, NEUROSCIENCE, V196, P66, DOI 10.1016/j.neuroscience.2011.08.024; Christensen T, 2010, NEUROSCIENCE, V170, P731, DOI 10.1016/j.neuroscience.2010.07.016; Christiansen S, 2012, STRESS, V15, P647, DOI 10.3109/10253890.2011.654370; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Dwivedi Yogesh, 2008, Neuropsychiatr Dis Treat, V4, P161; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fava M, 2003, BIOL PSYCHIAT, V53, P649, DOI 10.1016/S0006-3223(03)00231-2; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Fournier NM, 2012, BEHAV BRAIN RES, V227, P440, DOI 10.1016/j.bbr.2011.04.022; Greene J, 2009, NEUROPSYCHOPHARMACOL, V34, P2459, DOI 10.1038/npp.2009.68; Grippo AJ, 2005, PHYSIOL BEHAV, V84, P697, DOI 10.1016/j.physbeh.2005.02.011; Gronli J, 2007, BEHAV BRAIN RES, V181, P42, DOI 10.1016/j.bbr.2007.03.018; Heine VM, 2005, EUR J NEUROSCI, V21, P1304, DOI 10.1111/j.1460-9568.2005.03951.x; Henningsen K, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.016428; Henningsen K, 2009, BEHAV BRAIN RES, V198, P136, DOI 10.1016/j.bbr.2008.10.039; Hikosaka O, 2008, J NEUROSCI, V28, P11825, DOI 10.1523/JNEUROSCI.3463-08.2008; Hikosaka O, 2010, NAT REV NEUROSCI, V11, P503, DOI 10.1038/nrn2866; Holm MM, 2011, HIPPOCAMPUS, V21, P422, DOI 10.1002/hipo.20758; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Krishnan V, 2008, NATURE, V455, P894, DOI 10.1038/nature07455; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Meng HM, 2011, BRAIN RES, V1422, P32, DOI 10.1016/j.brainres.2011.08.041; Mirnics K, 2001, TRENDS NEUROSCI, V24, P479, DOI 10.1016/S0166-2236(00)01862-2; Morris JS, 1999, NEUROIMAGE, V10, P163, DOI 10.1006/nimg.1999.0455; Newton SS, 2003, J NEUROSCI, V23, P10841; Nowacka MM, 2012, NEUROPEPTIDES, V46, P1, DOI 10.1016/j.npep.2011.05.005; Ou JJ, 2011, PSYCHOPHARMACOLOGY, V213, P639, DOI 10.1007/s00213-010-1822-y; Paxinos G., 1998, RAT BRAIN STEREOTACT; Pittenger C, 2008, NEUROPSYCHOPHARMACOL, V33, P88, DOI 10.1038/sj.npp.1301574; Quitkin FM, 2000, AM J PSYCHIAT, V157, P327, DOI 10.1176/appi.ajp.157.3.327; Roiser JP, 2009, BIOL PSYCHIAT, V66, P441, DOI 10.1016/j.biopsych.2009.05.002; Sartorius A, 2010, BIOL PSYCHIAT, V67, pE9, DOI 10.1016/j.biopsych.2009.08.027; Shumake J, 2003, BRAIN RES, V963, P274, DOI 10.1016/S0006-8993(02)04048-9; Ventura D, 2007, CURR MED RES OPIN, V23, P245, DOI 10.1185/030079906X167273; Voleti B, 2012, CLIN PHARMACOL THER, V91, P333, DOI 10.1038/clpt.2011.296; Warner-Schmidt JL, 2008, CURR OPIN PHARMACOL, V8, P14, DOI 10.1016/j.coph.2007.10.013; Warner-Schmidt JL, 2007, P NATL ACAD SCI USA, V104, P4647, DOI 10.1073/pnas.0610282104; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; Winter C, 2011, BEHAV BRAIN RES, V216, P463, DOI 10.1016/j.bbr.2010.07.034; WIRTSHAFTER D, 1994, BRAIN RES, V633, P21, DOI 10.1016/0006-8993(94)91517-2; Wu X, 2012, PHARMACOL THERAPEUT, V134, P68, DOI 10.1016/j.pharmthera.2011.12.008; Yang LM, 2008, BEHAV BRAIN RES, V188, P84, DOI 10.1016/j.bbr.2007.10.022	57	26	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80666	10.1371/journal.pone.0080666	http://dx.doi.org/10.1371/journal.pone.0080666			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339877	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100016
J	Dominguez-Rodrigo, M; Pickering, TR; Baquedano, E; Mabulla, A; Mark, DF; Musiba, C; Bunn, HT; Uribelarrea, D; Smith, V; Diez-Martin, F; Perez-Gonzalez, A; Sanchez, P; Santonja, M; Barboni, D; Gidna, A; Ashley, G; Yravedra, J; Heaton, JL; Arriaza, MC				Dominguez-Rodrigo, Manuel; Pickering, Travis Rayne; Baquedano, Enrique; Mabulla, Audax; Mark, Darren F.; Musiba, Charles; Bunn, Henry T.; Uribelarrea, David; Smith, Victoria; Diez-Martin, Fernando; Perez-Gonzalez, Alfredo; Sanchez, Policarpo; Santonja, Manuel; Barboni, Doris; Gidna, Agness; Ashley, Gail; Yravedra, Jose; Heaton, Jason L.; Carmen Arriaza, Maria			First Partial Skeleton of a 1.34-Million-Year-Old Paranthropus boisei from Bed II, Olduvai Gorge, Tanzania	PLOS ONE			English	Article							EARLY HOMO; POSTCRANIAL REMAINS; LAKE TURKANA; SWARTKRANS; BONE; PROPORTIONS; DISCOVERIES; MORPHOLOGY; ERECTUS; RADIUS	Recent excavations in Level 4 at BK (Bed II, Olduvai Gorge, Tanzania) have yielded nine hominin teeth, a distal humerus fragment, a proximal radius with much of its shaft, a femur shaft, and a tibia shaft fragment (cataloged collectively as OH 80). Those elements identified more specifically than to simply Hominidae gen. et sp. indet are attributed to Paranthropus boisei. Before this study, incontrovertible P. boisei partial skeletons, for which postcranial remains occurred in association with taxonomically diagnostic craniodental remains, were unknown. Thus, OH 80 stands as the first unambiguous, dentally associated Paranthropus partial skeleton from East Africa. The morphology and size of its constituent parts suggest that the fossils derived from an extremely robust individual who, at 1.338 +/- 60.024 Ma (1 sigma), represents one of the most recent occurrences of Paranthropus before its extinction in East Africa.	[Dominguez-Rodrigo, Manuel; Baquedano, Enrique; Gidna, Agness] Museo Origenes, Inst Evoluc Africa, Madrid, Spain; [Dominguez-Rodrigo, Manuel; Yravedra, Jose; Carmen Arriaza, Maria] Univ Complutense, Dept Prehist, E-28040 Madrid, Spain; [Pickering, Travis Rayne; Bunn, Henry T.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA; [Pickering, Travis Rayne] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Pickering, Travis Rayne; Heaton, Jason L.] Transvaal Museum, Ditsong Natl Museum Nat Hist, Dept Vertebrates, Pliopleistocene Palaeontol Sect, Pretoria, South Africa; [Baquedano, Enrique] Museo Arqueol Reg, Madrid, Spain; [Mabulla, Audax] Univ Dar Es Salaam, Archaeol Unit, Dar Es Salaam, Tanzania; [Mark, Darren F.] Scottish Univ, Environm Res Ctr, Nat Environm Res Council, Argon Isotope Facil, E Kilbride, Lanark, Scotland; [Musiba, Charles] Univ Colorado, Dept Anthropol, Denver, CO 80202 USA; [Uribelarrea, David] Univ Complutense, Dept Geodynam, E-28040 Madrid, Spain; [Smith, Victoria] Univ Oxford, Res Lab Archaeol & Hist Art, Oxford, England; [Diez-Martin, Fernando; Sanchez, Policarpo] Univ Valladolid, Dept Prehist & Archaeol, Valladolid, Spain; [Perez-Gonzalez, Alfredo; Santonja, Manuel] Ctr Nacl Invest Evoluc Humana, Burgos, Spain; [Barboni, Doris] Aix Marseille Univ, Ctr Europeen Rech & Enseignement Geosci Environm, Aix En Provence, France; [Gidna, Agness] Natl Museum Tanzania, Paleontol Unit, Dar Es Salaam, Tanzania; [Ashley, Gail] Rutgers State Univ, Dept Earth & Planetary Sci, Piscataway, NJ USA; [Heaton, Jason L.] Birmingham Southern Coll, Dept Biol, Birmingham, AL USA	Complutense University of Madrid; University of Wisconsin System; University of Wisconsin Madison; University of Witwatersrand; University of Dar es Salaam; Scottish Universities Research & Reactor Center; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Colorado System; University of Colorado Denver; Complutense University of Madrid; University of Oxford; Universidad de Valladolid; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); UDICE-French Research Universities; Aix-Marseille Universite; Rutgers State University New Brunswick	Dominguez-Rodrigo, M (corresponding author), Museo Origenes, Inst Evoluc Africa, Madrid, Spain.	m.dominguez.rodrigo@gmail.com	Manuel, Santonja/F-1698-2018; Yravedra, Jose/E-9815-2016; Diez-Martin, Fernando/D-6158-2016; Smith, Victoria C/P-6317-2016; Baquedano, Enrique/ABE-9997-2020; Smith, Victoria/AAA-4152-2021; Mabulla, Audax ZP/ABE-2455-2020; Yravedra, Jose/AAC-2073-2019; Barboni, Doris/A-6908-2010; del Carmen Arriaza Dorado, María/AAB-3468-2021; URIBELARREA, DAVID/K-2446-2019; DEL VAL, DAVID URIBELARREA/J-4750-2017	Diez-Martin, Fernando/0000-0001-7284-362X; Smith, Victoria C/0000-0003-0878-5060; Smith, Victoria/0000-0003-0878-5060; Yravedra, Jose/0000-0002-4323-3379; Barboni, Doris/0000-0001-7753-1254; del Carmen Arriaza Dorado, María/0000-0003-1393-4323; URIBELARREA, DAVID/0000-0001-9769-3445; DEL VAL, DAVID URIBELARREA/0000-0001-9769-3445; Santonja, Manuel/0000-0001-5848-9011	Spanish Ministry of Science and Technology through the HAR2010-18952-C02-01 Project; Comunidad de Madrid through the S2010/BMD-2330 I+D project; Ministry of Culture through the Archaeological Research Abroad program; LSB Leakey Foundation for a Baldwin Fellowship; NERC; Natural Environment Research Council [aif10001] Funding Source: researchfish; NERC [aif10001] Funding Source: UKRI	Spanish Ministry of Science and Technology through the HAR2010-18952-C02-01 Project; Comunidad de Madrid through the S2010/BMD-2330 I+D project; Ministry of Culture through the Archaeological Research Abroad program; LSB Leakey Foundation for a Baldwin Fellowship; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Spanish Ministry of Science and Technology for funding this research through the HAR2010-18952-C02-01 Project, the Comunidad de Madrid through the S2010/BMD-2330 I+D project, and the Ministry of Culture through the Archaeological Research Abroad program. We thank the LSB Leakey Foundation for a Baldwin Fellowship granted to AOG to conduct this research. The Argon Isotope Facility at SUERC thanks NERC for continued funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello L, 1991, INTRO HUMAN EVOLUTIO; AIELLO LC, 1994, AM J PHYS ANTHROPOL, V95, P409, DOI 10.1002/ajpa.1330950405; Aiello LC, 1999, AM J PHYS ANTHROPOL, V109, P89, DOI 10.1002/(SICI)1096-8644(199905)109:1<89::AID-AJPA8>3.0.CO;2-4; Alcantara V., 2006, TRABAJOS PREHIST, V63, P25; BEHRENSMEYER AK, 1978, PALEOBIOLOGY, V4, P150, DOI 10.1017/S0094837300005820; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; BROOM R, 1949, NATURE, V164, P322, DOI 10.1038/164322a0; BROWN F, 1985, NATURE, V316, P788, DOI 10.1038/316788a0; Carretero JM, 1994, THESIS COMPLUTENSE U; CLARKE RJ, 1977, S AFR J SCI, V73, P46; Clarke RJ, 1998, S AFR J SCI, V94, P460; DARLINGTON RB, 1973, REV EDUC RES, V43, P433, DOI 10.3102/00346543043004433; DAY MH, 1971, NATURE, V232, P383, DOI 10.1038/232383a0; Diederichs G, 2009, J SHOULDER ELB SURG, V18, P399, DOI 10.1016/j.jse.2008.11.001; Dominguez-Rodrigo M, 2009, J HUM EVOL, V57, P260, DOI 10.1016/j.jhevol.2009.04.006; Egeland C.P, 2007, THESIS INDIANA U; Egeland CP, 2008, J HUM EVOL, V55, P1031, DOI 10.1016/j.jhevol.2008.05.021; Gilbert WH., 2009, HOMOERECTUS PLEISTOC; Gower J., 2011, UNDERSTANDING BIPLOT; Grausz H.M., 1988, P127; Grime F.E., 1984, THESIS U WITWATERSRA; Grine F.E., 1985, P153; GRINE FE, 1989, AM J PHYS ANTHROPOL, V79, P409, DOI 10.1002/ajpa.1330790402; Grine FE, 2005, S AFR J SCI, V101, P43; Hay R.L., 1976, GEOLOGY OLDUVAI GORG; HEINRICH RE, 1993, AM J PHYS ANTHROPOL, V92, P139, DOI 10.1002/ajpa.1330920203; Howell F.C., 1978, P154; JOHANSON DC, 1987, NATURE, V327, P205, DOI 10.1038/327205a0; JOHANSON DC, 1976, AM J PHYS ANTHROPOL, V45, P217, DOI 10.1002/ajpa.1330450209; Jungers W.L., 1988, P115; Kappelman J, 1996, J HUM EVOL, V30, P243, DOI 10.1006/jhev.1996.0021; la Grange A, 2009, J STAT SOFTW, V30, P1; LEAKEY LSB, 1958, NATURE, V181, P1099, DOI 10.1038/1811099a0; Leakey M.D., 1971, OLDUVAI GORGE; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; MCHENRY HM, 1994, J HUM EVOL, V27, P77, DOI 10.1006/jhev.1994.1036; MCHENRY HM, 1978, AM J PHYS ANTHROPOL, V49, P15, DOI 10.1002/ajpa.1330490104; O'Neill MC, 2004, J HUM EVOL, V47, P221, DOI 10.1016/j.jhevol.2004.07.002; Gidna AO, 2013, HOMO, V64, P29, DOI 10.1016/j.jchb.2012.09.006; Patel BA, 2005, J HUM EVOL, V48, P415, DOI 10.1016/j.jhevol.2005.01.001; Pickering TR, 2013, J ARCHAEOL SCI, V40, P1295, DOI 10.1016/j.jas.2012.09.025; Renne PR, 2011, GEOCHIM COSMOCHIM AC, V75, P5097, DOI 10.1016/j.gca.2011.06.021; Robinson JT, 1953, AM J PHYS ANTHROP-NE, V11, P445, DOI 10.1002/ajpa.1330110402; Robinson JT, 1956, DENTITION AUSTRALOPI; Ruff CB, 1999, AM J PHYS ANTHROPOL, V109, P509, DOI 10.1002/(SICI)1096-8644(199908)109:4<509::AID-AJPA7>3.0.CO;2-X; Ruff C, 2008, J HUM EVOL, V54, P383, DOI 10.1016/j.jhevol.2007.09.001; Senut B, 1981, CAHIERS PALEONTOLOGI; Silverman N, 2001, AM J PHYS ANTHROPOL, V115, P167, DOI 10.1002/ajpa.1066; Susman R.L., 1988, P149; Susman RL, 2001, J HUM EVOL, V41, P607, DOI 10.1006/jhev.2001.0510; Suwa G, 1997, NATURE, V389, P489, DOI 10.1038/39037; Suwa G, 1996, AM J PHYS ANTHROPOL, V101, P247, DOI 10.1002/(SICI)1096-8644(199610)101:2<247::AID-AJPA9>3.0.CO;2-Z; Tobias P. V., 1965, South African Archaeological Bulletin, V20, P167, DOI 10.2307/3887824; Tobias P.V, 1967, OLDUVAI GORGE, V2; Trinkaus E, 1988, AM J PHYS ANTHROPOL, V83, P147; Walker A., 1993, NARIOKOTOME HOMO ERE; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802; WOLPOFF MH, 1976, NATURE, V264, P812, DOI 10.1038/264812a0; Wood BA, 1991, HOMINID CRANIAL REMA, P4; Wood B, 2007, YEARB PHYS ANTHROPOL, V50, P106, DOI 10.1002/ajpa.20732	60	63	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80347	10.1371/journal.pone.0080347	http://dx.doi.org/10.1371/journal.pone.0080347			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339873	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000328566100011
J	Lane, TJ; Pande, VS				Lane, Thomas J.; Pande, Vijay S.			Inferring the Rate-Length Law of Protein Folding	PLOS ONE			English	Article							CONTACT ORDER; SIMPLE-MODEL; SIZE; DOMAIN; TIMES; FLOW	We investigate the rate-length scaling law of protein folding, a key undetermined scaling law in the analytical theory of protein folding. Available data yield statistically significant evidence for the existence of a rate-length law capable of predicting folding times to within about two orders of magnitude (over 9 decades of variation). Unambiguous determination of the functional form of such a law could provide key mechanistic insight into folding. Four proposed laws from literature (power law, exponential, and two stretched exponentials) are tested against one another, and it is found that the power law best explains the data by a modest margin. We conclude that more data is necessary to unequivocally infer the rate-length law. Such data could be obtained through a small number of protein folding experiments on large protein domains.	[Lane, Thomas J.; Pande, Vijay S.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Pande, Vijay S.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Pande, Vijay S.] Stanford Univ, Dept Biophys, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pande, VS (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.	pande@stanford.edu	Pande, Vijay/ABE-8145-2020	Lane, Thomas/0000-0003-2627-4432	National Science Foundation GRF	National Science Foundation GRF(National Science Foundation (NSF))	TJL was supported by a National Science Foundation GRF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogatyreva NS, 2009, NUCLEIC ACIDS RES, V37, pD342, DOI 10.1093/nar/gkn696; Cieplak M, 2003, BIOPHYS J, V84, P475, DOI 10.1016/S0006-3495(03)74867-X; Cieplak M, 1999, PHYS REV LETT, V83, P1684, DOI 10.1103/PhysRevLett.83.1684; De Sancho D, 2011, PHYS CHEM CHEM PHYS, V13, P17030, DOI 10.1039/c1cp20402e; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Finkelstein AV, 2007, CURR PROTEIN PEPT SC, V8, P521, DOI 10.2174/138920307783018695; Fukuda I, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046708; Grosberg A.Y., 1994, STAT PHYS MACROMOLEC; Gutin AM, 1996, PHYS REV LETT, V77, P5433, DOI 10.1103/PhysRevLett.77.5433; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Horwich AL, 2009, Q REV BIOPHYS, V42, P83, DOI 10.1017/S0033583509004764; Ivankov DN, 2010, J PHYS CHEM B, V114, P7930, DOI 10.1021/jp912187w; Ivankov DN, 2003, PROTEIN SCI, V12, P2057, DOI 10.1110/ps.0302503; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Koga N, 2001, J MOL BIOL, V313, P171, DOI 10.1006/jmbi.2001.5037; Lane TJ, 2012, J PHYS CHEM B, V116, P6764, DOI 10.1021/jp212332c; Lawrence C, 2010, J MOL BIOL, V403, P446, DOI 10.1016/j.jmb.2010.08.049; Levinthal C., 1969, MOSSBAUER SPECTROSC, P22; Li MS, 2002, J PHYS CHEM B, V106, P8302, DOI 10.1021/jp025837q; Naganathan AN, 2005, J AM CHEM SOC, V127, P480, DOI 10.1021/ja044449u; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; ROUSE PE, 1953, J CHEM PHYS, V21, P1272, DOI 10.1063/1.1699180; Shen MY, 2005, CHEM PHYS LETT, V405, P224, DOI 10.1016/j.cplett.2005.02.029; THIRUMALAI D, 1995, J PHYS I, V5, P1457, DOI 10.1051/jp1:1995209; Wolynes PG, 1997, P NATL ACAD SCI USA, V94, P6170, DOI 10.1073/pnas.94.12.6170; Xu D, 1998, FOLD DES, V3, P11, DOI 10.1016/S1359-0278(98)00004-2; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Zheng OY, 2008, PROTEIN SCI, V17, P1256, DOI 10.1110/ps.034660.108; ZIMM BH, 1956, J CHEM PHYS, V24, P269, DOI 10.1063/1.1742462; ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20; ZWANZIG R, 1995, P NATL ACAD SCI USA, V92, P9801, DOI 10.1073/pnas.92.21.9801	31	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e78606	10.1371/journal.pone.0078606	http://dx.doi.org/10.1371/journal.pone.0078606			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339865	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100004
J	Kost'ak, M; Jagt, JWM; Speijer, RP; Stassen, P; Steurbaut, E				Kost'ak, Martin; Jagt, John W. M.; Speijer, Robert P.; Stassen, Peter; Steurbaut, Etienne			New Paleocene Sepiid Coleoids (Cephalopoda) from Egypt: Evolutionary Significance and Origin of the Sepiid 'Rostrum'	PLOS ONE			English	Article							BENTHIC FORAMINIFERAL ASSEMBLAGES; ORGANIC SKELETAL STRUCTURE; MIDDLE PALEOCENE; EARLY EOCENE; BELEMNITE; HAKKARI; RECORD; TURKEY; GENUS	New coleoid cephalopods, assignable to the order Sepiida, are recorded from the Selandian/Thanetian boundary interval (Middle to Upper Paleocene transition, c. 59.2 Ma) along the southeastern margin (Toshka Lakes) of the Western Desert in Egypt. The two genera recognised, Aegyptosaepia n. gen. and ?Anomalosaepia Weaver and Ciampaglio, are placed in the families Belosaepiidae and ?Anomalosaepiidae, respectively. They constitute the oldest record to date of sepiids with a 'rostrum-like' prong. In addition, a third, generically and specifically indeterminate coleoid is represented by a single rostrum-like find. The taxonomic assignment of the material is based on apical parts (as preserved), i.e., guard, apical prong (or 'rostrum-like' structure), phragmocone and (remains of) protoconch, plus shell mineralogy. We here confirm the shell of early sepiids to have been bimineralic, i.e., composed of both calcite and aragonite. Aegyptosaepia lugeri n. gen., n. sp. reveals some similarities to later species of Belosaepia, in particular the possession of a distinct prong. General features of the phragmocone and protoconch of the new form are similar to both Belocurta (Middle Danian [Lower Paleocene]) and Belosaepia (Eocene). However, breviconic coiling and the presence of a longer ventral conotheca indicate closer ties with late Maastrichtian-Middle Danian Ceratisepia. In this respect, Aegyptosaepia n. gen. constitutes a link between Ceratisepia and the Eocene Belosaepia. The occurrence of the new genus near the Selandian/Thanetian boundary suggests an earlier origin of belosaepiids, during the early to Middle Paleocene. These earliest known belosaepiids may have originated in the Tethyan Realm. From northeast Africa, they subsequently spread to western India, the Arabian Plate and, probably via the Mediterranean region, to Europe and North America.	[Kost'ak, Martin] Charles Univ Prague, Fac Sci, Inst Geol & Palaeontol, Prague, Czech Republic; [Jagt, John W. M.] Nat Hist Museum Maastricht, Maastricht, Netherlands; [Speijer, Robert P.; Stassen, Peter; Steurbaut, Etienne] Katholieke Univ Leuven, Louvain, Belgium; [Steurbaut, Etienne] Royal Belgian Inst Nat Sci, Brussels, Belgium	Charles University Prague; KU Leuven; Royal Belgian Institute of Natural Sciences	Kost'ak, M (corresponding author), Charles Univ Prague, Fac Sci, Inst Geol & Palaeontol, Prague, Czech Republic.	martin.kostak@natur.cuni.cz	Speijer, Robert/H-5073-2016; Stassen, Peter/P-8837-2015; Kostak, Martin/I-6006-2017	Speijer, Robert/0000-0002-5873-7203; Stassen, Peter/0000-0002-2663-2781; Kostak, Martin/0000-0002-0818-3505	PRVOUK [P44 / MSM 0021620855]; KU Leuven Research Fund [OT/08/18]	PRVOUK; KU Leuven Research Fund(KU Leuven)	PRVOUK P44 / MSM 0021620855; KU Leuven Research Fund (OT/08/18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnini C, 2007, MAR MICROPALEONTOL, V64, P215, DOI 10.1016/j.marmicro.2007.05.003; Akkerman H, 2012, STARINGIA, V13, P184; Allen J. E., 1968, Tulane Studies in Geology, V6, P33; Avnimele'ch M., 1958, Bulletin of the Research Council of Israel, V7G, P61; Bassiouni M.A.A., 1990, Berliner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V120, P755; Bather F. A., 1888, Annals of Natural History, V(6), P298; Berggren WA, 2005, J FORAMIN RES, V35, P279, DOI 10.2113/35.4.279; Blainville HM, 1825, MANUEL MALACOLOGIE C, P664; Briart A, 1877, MEM ACAD ROY SCI LET, P1; Bulow-Trummer EU, 1920, FOSSILIUM CATALOGUS, V11, P313; Ciampaglio CN, 2008, NEUES JAHRB GEOL P-A, V250, P103, DOI 10.1127/0077-7749/2008/0250-0103; Cossmann M, 1909, PALEONTOLOGIA INDICA, V3, P1; Cossmann M, 1910, ICONOGRAPHIE COMPLET, P22; CUVILLIER JEAN, 1930, MEM INST EGYPTE, V16, P1; DEGEYTER G, 2006, GEOL BELG, V9, P203; Deshayes GP, 1835, DESCRIPTION COQUILLE, P435; DIXON F., 1850, GEOLOGY FOSSILS TERT; Doguzhaeva LA, 2014, ACTA PALAEONTOL POL, V59, P147, DOI 10.4202/app.2011.0208; Doguzhaeva LA, 2012, GEOBIOS-LYON, V45, P13, DOI 10.1016/j.geobios.2011.11.008; Doguzhaeva LA, 2011, PALAEONTOLOGY, V54, P397, DOI 10.1111/j.1475-4983.2010.01027.x; dOrbigny A. D., 1842, ANN SOCIETE SCI NATU, V17, P362; Doyle P., 1994, PALEONTOLOGICAL CONT, V5, P1; Dupuis C, 2003, MICROPALEONTOLOGY, V49, P41, DOI 10.2113/49.Suppl_1.41; Edwards F.E., 1849, MONOGRAPH PALAEONTOG, V1, P1; Fuchs D, 2012, GEOBIOS-LYON, V45, P29, DOI 10.1016/j.geobios.2011.11.014; Fuchs D, 2012, CRETACEOUS RES, V34, P200, DOI 10.1016/j.cretres.2011.10.018; Gabb W.M., 1860, J ACAD NATURAL SCI P, V4, P375; Gray J. E., 1849, CATALOGUE MOLLUSCA C; Guiraud R, 1999, TECTONOPHYSICS, V315, P73, DOI 10.1016/S0040-1951(99)00293-0; Haas W., 2003, Berliner Palaeobiologische Abhandlungen, V3, P113; Hewitt RA, 1999, ACTA PALAEONTOL POL, V44, P305; Hosgor I, 2012, CRETACEOUS RES, V37, P35, DOI 10.1016/j.cretres.2012.02.014; Iba Y, 2011, GEOLOGY, V39, P483, DOI 10.1130/G31724.1; Jagt J. W. M., 2012, Scripta Geologica, P1; Jeletzky, 1966, PALEONTOLOGICAL CONT, V7, P1; Kostak M, 2012, NEUES JAHRB GEOL P-A, V266, P59, DOI 10.1127/0077-7749/2012/0260; Kostak M, 2008, ACTA PALAEONTOL POL, V53, P669, DOI 10.4202/app.2008.0411; Linnaeus C., 1758, IMPENSIS DIRECT, VI; Luger P., 1985, BERL GEOWISS ABH A, V63, P1; MARTINI E., 1970, P 2 PLANKT C ROM, V2, P739; Meyer C, 1993, GEOBIOS MEMOIRE SPEC, V15, P287; NAEF A, 1922, FOSSILEN TINTENFISCH, P322; Naidin D. P., 1964, Byulleten Moskovskogo Obshchestva Ispytatelei Prirody (Geol), V39, P85; Naidin DP, 1952, T MOSKOVSKOGO GEOLOG, V27, P1; Newton R. B., 1894, Proceedings of the Malacological Society of London, Vi, P119; Newton R. B., 1922, Geol Surv Nigeria bul, V3, P1; NOWAK J., 1913, B INT ACAD SCI CRA B, V1913, P335; Palmer K. vw., 1937, Bulletin of American Paleontology Ithaca, V7, P1; Pavlow A.P., 1914, ZAPISKI IMPERATORSKO, V21, P1; Riegraf W, 1998, FOSSILIUM CATALOGUS, V135, P1; Schmitz B, 2011, EPISODES, V34, P220, DOI 10.18814/epiiugs/2011/v34i4/002; Speijer Robert P., 2003, Geological Society of America Special Paper, V369, P275; Speijer RP, 1996, MAR MICROPALEONTOL, V28, P99, DOI 10.1016/0377-8398(95)00079-8; Sprong J, 2012, MAR MICROPALEONTOL, V86-87, P15, DOI 10.1016/j.marmicro.2012.01.001; SQUIRES RL, 1988, J PALEONTOL, V62, P76, DOI 10.1017/S0022336000018023; STEURBAUT E., 2002, R MICROPALEONTOL, V45, P195, DOI DOI 10.1016/S0035-1598(02)90022-X; Strugnell J, 2006, CLADISTICS, V22, P89, DOI 10.1111/j.1096-0031.2006.00086.x; Vandenberghe N, 2012, GEOLOGIC TIME SCALE 2012, VOLS 1 & 2, P855, DOI 10.1016/B978-0-444-59425-9.00028-7; Vincent E, 1901, ANN SOC ROY ZOOL BEL, V35, P1; Voltz P.-L., 1830, MEMOIRES SOCIETE MUS, V1, P1; Wagner H, 1938, ANN HIST NATURALES M, V31, P179; Warnke KM, 2011, MOL PHYLOGENET EVOL, V58, P390, DOI 10.1016/j.ympev.2010.11.024; Weaver Patricia G., 2010, Ferrantia, V59, P202; Weaver PG, 2010, PALAEONTOGR ABT A, V292, P53; Weaver PG, 2003, J PALEONTOL, V77, P1103, DOI 10.1666/0022-3360(2003)077<1103:ANGOBC>2.0.CO;2; Yancey TE, 2011, J PALEONTOL, V85, P904, DOI 10.1666/10-067.1; Yancey TE, 2010, J PALEONTOL, V84, P267, DOI 10.1666/09-018R.1; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	68	13	13	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e81180	10.1371/journal.pone.0081180	http://dx.doi.org/10.1371/journal.pone.0081180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24348918	gold, Green Submitted, Green Published			2022-12-27	WOS:000327539800108
J	Schroeter, R; Hoffmann, T; Voigt, B; Meyer, H; Bleisteiner, M; Muntel, J; Jurgen, B; Albrecht, D; Becher, D; Lalk, M; Evers, S; Bongaerts, J; Maurer, KH; Putzer, H; Hecker, M; Schweder, T; Bremer, E				Schroeter, Rebecca; Hoffmann, Tamara; Voigt, Birgit; Meyer, Hanna; Bleisteiner, Monika; Muntel, Jan; Juergen, Britta; Albrecht, Dirk; Becher, Doerte; Lalk, Michael; Evers, Stefan; Bongaerts, Johannes; Maurer, Karl-Heinz; Putzer, Harald; Hecker, Michael; Schweder, Thomas; Bremer, Erhard			Stress Responses of the Industrial Workhorse Bacillus licheniformis to Osmotic Challenges	PLOS ONE			English	Article							OSMOPROTECTANT GLYCINE BETAINE; COMPATIBLE SOLUTE PROLINE; COMPLETE GENOME SEQUENCE; SUBTILIS CHARACTERIZATION; MECHANOSENSITIVE CHANNELS; STARVATION RESPONSE; GENETIC-ANALYSIS; CELL PHYSIOLOGY; RNA-POLYMERASE; COMPLEX	The Gram-positive endospore-forming bacterium Bacillus licheniformis can be found widely in nature and it is exploited in industrial processes for the manufacturing of antibiotics, specialty chemicals, and enzymes. Both in its varied natural habitats and in industrial settings, B. licheniformis cells will be exposed to increases in the external osmolarity, conditions that trigger water efflux, impair turgor, cause the cessation of growth, and negatively affect the productivity of cell factories in biotechnological processes. We have taken here both systems-wide and targeted physiological approaches to unravel the core of the osmostress responses of B. licheniformis. Cells were suddenly subjected to an osmotic upshift of considerable magnitude (with 1 M NaCl), and their transcriptional profile was then recorded in a time-resolved fashion on a genome-wide scale. A bioinformatics cluster analysis was used to group the osmotically up-regulated genes into categories that are functionally associated with the synthesis and import of osmostress-relieving compounds (compatible solutes), the SigB-controlled general stress response, and genes whose functional annotation suggests that salt stress triggers secondary oxidative stress responses in B. licheniformis. The data set focusing on the transcriptional profile of B. licheniformis was enriched by proteomics aimed at identifying those proteins that were accumulated by the cells through increased biosynthesis in response to osmotic stress. Furthermore, these global approaches were augmented by a set of experiments that addressed the synthesis of the compatible solutes proline and glycine betaine and assessed the growth-enhancing effects of various osmoprotectants. Combined, our data provide a blueprint of the cellular adjustment processes of B. licheniformis to both sudden and sustained osmotic stress.	[Schroeter, Rebecca; Juergen, Britta; Schweder, Thomas] Univ Greifswald, Inst Pharm, Greifswald, Germany; [Hoffmann, Tamara; Bleisteiner, Monika; Bremer, Erhard] Univ Marburg, Dept Biol, Microbiol Lab, Marburg, Germany; [Hoffmann, Tamara; Bremer, Erhard] Univ Marburg, LOEWE Ctr Synthet Microbiol, Marburg, Germany; [Voigt, Birgit; Muntel, Jan; Albrecht, Dirk; Becher, Doerte; Hecker, Michael] Univ Greifswald, Inst Microbiol, Greifswald, Germany; [Meyer, Hanna; Lalk, Michael] Univ Greifswald, Inst Biochem, Greifswald, Germany; [Evers, Stefan; Bongaerts, Johannes] Henkel AG & Co KGaA, Dusseldorf, Germany; [Maurer, Karl-Heinz] AB Enzymes GmbH, Darmstadt, Germany; [Putzer, Harald] Univ Paris Diderot, CNRS UPR 9073, Inst Biol Physicochim, Sorbonne Paris Cite, Paris, France	Ernst Moritz Arndt Universitat Greifswald; Philipps University Marburg; Philipps University Marburg; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Henkel; UDICE-French Research Universities; Universite Paris Cite	Schweder, T (corresponding author), Univ Greifswald, Inst Pharm, Greifswald, Germany.	schweder@uni-greifswald.de; bremer@staff.uni-marburg.de	Putzer, Harald/GRY-6203-2022; Becher, Doerte/B-4454-2015; Lalk, Michael/C-1618-2010	Becher, Doerte/0000-0002-9630-5735; Lalk, Michael/0000-0002-9230-0267; Schweder, Thomas/0000-0002-7213-3596	German Ministry of Education and Research via the Bacell-SysMo2 consortium; competence network "Genome Research in Bacteria"; LOEWE program of the State of Hessen (via the Centre for Synthetic Microbiology; SynMicro, Marburg); Fonds der Chemischen Industrie; French National Centre for Scientific Research [UPR 9073]; Universite Paris VII-Denis Diderot	German Ministry of Education and Research via the Bacell-SysMo2 consortium; competence network "Genome Research in Bacteria"; LOEWE program of the State of Hessen (via the Centre for Synthetic Microbiology; SynMicro, Marburg); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); French National Centre for Scientific Research; Universite Paris VII-Denis Diderot	This study was financially supported by grants from the German Ministry of Education and Research via the Bacell-SysMo2 consortium (to ML, MH and EB) and the competence network "Genome Research in Bacteria" (to ML, MH, KHM and TS). Additional Funds were provided through the LOEWE program of the State of Hessen (via the Centre for Synthetic Microbiology; SynMicro, Marburg) (to EB), the Fonds der Chemischen Industrie (to EB) and the French National Centre for Scientific Research (UPR 9073), Universite Paris VII-Denis Diderot (to HP). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht AG, 2010, J BACTERIOL, V192, P1643, DOI 10.1128/JB.01536-09; Alexopoulos C, 2004, J VET MED A, V51, P306, DOI 10.1111/j.1439-0442.2004.00637.x; Belitsky BR, 2011, J MOL BIOL, V413, P321, DOI 10.1016/j.jmb.2011.08.003; Belitsky BR, 2001, J BACTERIOL, V183, P4389, DOI 10.1128/JB.183.14.4389-4392.2001; BOCH J, 1994, J BACTERIOL, V176, P5364; Boch J, 1996, J BACTERIOL, V178, P5121, DOI 10.1128/jb.178.17.5121-5129.1996; Booth IR, 2012, J BACTERIOL, V194, P4802, DOI 10.1128/JB.00576-12; Borgmeier C, 2012, J BIOTECHNOL, V159, P12, DOI 10.1016/j.jbiotec.2012.02.011; Bremer E, 2000, BACTERIAL STRESS RESPONSES, P79; Bremer E., 2002, BACILLUS SUBTILIS IT, P385, DOI DOI 10.1128/9781555817992.CH27; Brill J, 2011, J BACTERIOL, V193, P5335, DOI 10.1128/JB.05490-11; Brill J, 2011, MICROBIOL-SGM, V157, P977, DOI 10.1099/mic.0.047357-0; Brody MS, 1998, GENE, V212, P111, DOI 10.1016/S0378-1119(98)00140-1; Bursy J, 2007, J BIOL CHEM, V282, P31147, DOI 10.1074/jbc.M704023200; Buttner K, 2001, ELECTROPHORESIS, V22, P2908, DOI 10.1002/1522-2683(200108)22:14<2908::AID-ELPS2908>3.0.CO;2-M; Bylund F, 1998, BIOPROCESS ENG, V18, P171, DOI 10.1007/s004490050427; Chauhan K, 2013, INT J FOOD MICROBIOL, V165, P175, DOI 10.1016/j.ijfoodmicro.2013.05.007; Csonka L.N., 2007, ECOSALESCHERICHIA CO; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Cutting S., 1990, MOL BIOL METHODS BAC; de Been M, 2011, MICROBIOL-SGM, V157, P3, DOI 10.1099/mic.0.045740-0; den Besten HMW, 2009, APPL ENVIRON MICROB, V75, P4111, DOI 10.1128/AEM.02891-08; Enfors SO, 2001, J BIOTECHNOL, V85, P175, DOI 10.1016/S0168-1656(00)00365-5; Eppinger M, 2011, J BACTERIOL, V193, P4199, DOI 10.1128/JB.00449-11; FROYSHOV O, 1974, EUR J BIOCHEM, V46, P235, DOI 10.1111/j.1432-1033.1974.tb03616.x; George S, 1998, BIOPROCESS ENG, V18, P135, DOI 10.1007/PL00008979; Gioia J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000928; GOTSCHE S, 1995, J BACTERIOL, V177, P2721, DOI 10.1128/jb.177.10.2721-2726.1995; Gutierrez-Preciado A, 2009, MICROBIOL MOL BIOL R, V73, P36, DOI 10.1128/MMBR.00026-08; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Harwood C., 1990, MOL BIOL METHODS BAC, P1; HARWOOD CR, 1992, TRENDS BIOTECHNOL, V10, P247, DOI 10.1016/0167-7799(92)90233-L; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Hecker M, 2007, ANNU REV MICROBIOL, V61, P215, DOI 10.1146/annurev.micro.61.080706.093445; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; HELMANN JD, 1995, NUCLEIC ACIDS RES, V23, P2351, DOI 10.1093/nar/23.13.2351; Hoffmann K, 2010, APPL ENVIRON MICROB, V76, P8211, DOI 10.1128/AEM.01404-10; Hoffmann K, 2010, APPL ENVIRON MICROB, V76, P5046, DOI 10.1128/AEM.00660-10; Hoffmann T, 2008, APPL ENVIRON MICROB, V74, P2454, DOI 10.1128/AEM.01573-07; Hoffmann T, 2013, J BACTERIOL, V195, P510, DOI 10.1128/JB.01505-12; Hoffmann T, 2012, APPL ENVIRON MICROB, V78, P5753, DOI 10.1128/AEM.01040-12; Hoffmann T, 2011, J BACTERIOL, V193, P1552, DOI 10.1128/JB.01319-10; Hoi LT, 2006, PROTEOMICS, V6, P3582, DOI 10.1002/pmic.200500842; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Holtmann G, 2004, J BACTERIOL, V186, P1683, DOI 10.1128/JB.186.6.1683-1693.2004; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Hoper D, 2006, PROTEOMICS, V6, P1550, DOI 10.1002/pmic.200500197; Hoper D, 2005, J BACTERIOL, V187, P2810, DOI 10.1128/JB.187.8.2810-2826.2005; Horsburgh MJ, 1999, MOL MICROBIOL, V32, P41, DOI 10.1046/j.1365-2958.1999.01323.x; Huang SC, 2011, MICROBIOL-SGM, V157, P3370, DOI 10.1099/mic.0.054197-0; Kappes RM, 1999, MOL MICROBIOL, V32, P203, DOI 10.1046/j.1365-2958.1999.01354.x; Kappes RM, 1996, J BACTERIOL, V178, P5071, DOI 10.1128/jb.178.17.5071-5079.1996; KEMPF B, 1995, J BIOL CHEM, V270, P16701, DOI 10.1074/jbc.270.28.16701; Kempf B, 1998, ARCH MICROBIOL, V170, P319, DOI 10.1007/s002030050649; Kim L, 1996, GENE, V181, P71, DOI 10.1016/S0378-1119(96)00466-0; Knap I, 2010, AVIAN DIS, V54, P931, DOI 10.1637/9106-101509-ResNote.1; KRUGER E, 1994, J BACTERIOL, V176, P3360; Kuhlmann AU, 2002, APPL ENVIRON MICROB, V68, P772, DOI 10.1128/AEM.68.2.772-783.2002; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Liebeke M, 2011, MOL BIOSYST, V7, P1241, DOI 10.1039/c0mb00315h; Liedert C, 2010, PROTEOMICS, V10, P555, DOI 10.1002/pmic.200800657; Logan N.A., 2009, BERGEYS MANUAL SYSTE; Lundberg ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060993; Madslien EH, 2013, J APPL MICROBIOL, V115, P1068, DOI 10.1111/jam.12299; MAJUMDAR D, 1991, BIOTECHNIQUES, V11, P94; Palomino MM, 2009, RES MICROBIOL, V160, P117, DOI 10.1016/j.resmic.2008.10.011; Meyer H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-69; Meyer H, 2010, ANAL BIOCHEM, V401, P250, DOI 10.1016/j.ab.2010.03.003; Moses S, 2012, J BACTERIOL, V194, P745, DOI 10.1128/JB.06380-11; Nannapaneni P, 2012, MICROBIOL-SGM, V158, P696, DOI 10.1099/mic.0.055434-0; Nau-Wagner G, 2012, J BACTERIOL, V194, P2703, DOI 10.1128/JB.06642-11; Nielsen AK, 2010, J MOL MICROB BIOTECH, V18, P162, DOI 10.1159/000315457; Oren A, 2011, ENVIRON MICROBIOL, V13, P1908, DOI 10.1111/j.1462-2920.2010.02365.x; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Pioch D, 2008, APPL MICROBIOL BIOT, V78, P719, DOI 10.1007/s00253-008-1347-z; Price CW, 2011, BACTERIAL STRESS RESPONSES, 2ND EDITION, P301; PUTZER H, 1995, MOL MICROBIOL, V16, P709, DOI 10.1111/j.1365-2958.1995.tb02432.x; Putzer H, 2002, NUCLEIC ACIDS RES, V30, P3026, DOI 10.1093/nar/gkf415; Reder A, 2008, MOL MICROBIOL, V69, P1104, DOI 10.1111/j.1365-2958.2008.06332.x; Reder A, 2012, J BACTERIOL, V194, P3601, DOI 10.1128/JB.00528-12; Rey MW, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r77; Schallmey M, 2004, CAN J MICROBIOL, V50, P1, DOI 10.1139/W03-076; Schock F, 1996, GENE, V170, P77, DOI 10.1016/0378-1119(95)00860-8; Schroeter R, 2011, PROTEOMICS, V11, P2851, DOI 10.1002/pmic.201000461; Schwalbach MS, 2012, APPL ENVIRON MICROB, V78, P3442, DOI 10.1128/AEM.07329-11; Schweder T, 1999, BIOTECHNOL BIOENG, V65, P151, DOI 10.1002/(SICI)1097-0290(19991020)65:2&lt;151::AID-BIT4&gt;3.0.CO;2-V; Schweder T, 2011, BIOTECHNOL J, V6, P926, DOI 10.1002/biot.201100248; Spiegelhalter F, 1998, MOL MICROBIOL, V29, P285, DOI 10.1046/j.1365-2958.1998.00929.x; Srivatsan A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000139; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; STULKE J, 1993, J GEN MICROBIOL, V139, P2041, DOI 10.1099/00221287-139-9-2041; Tanghe A, 2006, TRENDS MICROBIOL, V14, P78, DOI 10.1016/j.tim.2005.12.001; Underwood SA, 2004, APPL ENVIRON MICROB, V70, P2734, DOI 10.1128/AEM.70.5.2734-2740.2004; Veith B, 2004, J MOL MICROB BIOTECH, V7, P204, DOI 10.1159/000079829; Voigt B, 2006, PROTEOMICS, V6, P268, DOI 10.1002/pmic.200500091; Voigt B, 2004, PROTEOMICS, V4, P1465, DOI 10.1002/pmic.200300684; Voigt B, 2009, J MOL MICROB BIOTECH, V16, P53, DOI 10.1159/000142894; Voigt B, 2007, PROTEOMICS, V7, P413, DOI 10.1002/pmic.200600556; Voigt B, 2013, PROTEOMICS, V13, P2140, DOI 10.1002/pmic.201200297; vonBlohn C, 1997, MOL MICROBIOL, V25, P175, DOI 10.1046/j.1365-2958.1997.4441809.x; Waldeck J, 2007, J BIOTECHNOL, V130, P124, DOI 10.1016/j.jbiotec.2007.03.011; Waldeck J, 2007, APPL MICROBIOL BIOT, V73, P1340, DOI 10.1007/s00253-006-0602-4; Wecke T, 2006, J BACTERIOL, V188, P7500, DOI 10.1128/JB.01110-06; Wels M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-330; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; Whitaker JM, 2005, J FIELD ORNITHOL, V76, P264, DOI 10.1648/0273-8570-76.3.264; Wood JM, 2011, ANNU REV MICROBIOL, V65, P215, DOI 10.1146/annurev-micro-090110-102815; YAKIMOV MM, 1995, APPL ENVIRON MICROB, V61, P1706, DOI 10.1128/AEM.61.5.1706-1713.1995; Young JW, 2013, P NATL ACAD SCI USA, V110, P4140, DOI 10.1073/pnas.1213060110; Zaprasis A, 2013, ENVIRON MICROBIOL, DOI [10.1111/1462-2920.12193, DOI 10.1111/1462-2920.12193.PUBMED:23869754]; Zaprasis A, 2013, APPL ENVIRON MICROB, V79, P576, DOI 10.1128/AEM.01934-12; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	114	37	39	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80956	10.1371/journal.pone.0080956	http://dx.doi.org/10.1371/journal.pone.0080956			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24348917	gold, Green Published, Green Submitted			2022-12-27	WOS:000327258600105
J	Fujita, S; Okamoto, Y; Shibata, K; Morita, H; Ito, T; Sohmiya, K; Hoshiga, M; Ishizaka, N				Fujita, Shu-ichi; Okamoto, Yusuke; Shibata, Kensaku; Morita, Hideaki; Ito, Takahide; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu			Serum Uric Acid Is Associated with Left Ventricular Hypertrophy Independent of Serum Parathyroid Hormone in Male Cardiac Patients	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; POPULATION; MASS; HYPERPARATHYROIDISM; ABNORMALITIES; HYPERURICEMIA; MORTALITY; GEOMETRY; OBESITY	Background: Several studies have shown that serum uric acid (UA) is associated with left ventricular (LV) hypertrophy. Serum levels of parathyroid hormone (PTH), which has bbe shown to be correlated with UA, is also known to be associated with cardiac hypertrophy; however, whether the association between UA and cardiac hypertrophy is independent of PTH remains unknown. Purpose: We investigated whether the relationship between serum uric acid (UA) and LV hypertrophy is independent of intact PTH and other calcium-phosphate metabolism-related factors in cardiac patients. Methods and Results: In a retrospective study, the association between UA and left ventricular mass index was assessed among 116 male cardiac patients (mean age 65 +/- 12 years) who were not taking UA lowering drugs. The median UA value was 5.9 mg/dL. Neither age nor body mass index differed significantly among the UA quartile groups. Patients with higher UA levels were more likely to be taking loop diuretics. UA showed a significant correlation with intact PTH (R = 0.34, P<0.001) but not with other calcium-phosphate metabolism-related factors. Linear regression analysis showed that log-transformed UA showed a significant association with left ventricular mass index, and this relationship was found to be significant exclusively in patients who were not taking loop and/or thiazide diuretics. Multivariate logistic regression analysis showed that log-transformed UA was independently associated with LV hypertrophy with an odds ratio of 2.79 (95% confidence interval 1.48-5.28, P = 0.002 per one standard deviation increase). Conclusions: Among cardiac patients, serum UA was associated with LV hypertrophy, and this relationship was, at least in part, independent of intact PTH levels, which showed a significant correlation with UA in the same population.	[Fujita, Shu-ichi; Okamoto, Yusuke; Shibata, Kensaku; Morita, Hideaki; Ito, Takahide; Sohmiya, Koichi; Hoshiga, Masaaki; Ishizaka, Nobukazu] Osaka Med Coll, Dept Cardiol, Osaka, Japan	Osaka Medical College	Ishizaka, N (corresponding author), Osaka Med Coll, Dept Cardiol, Osaka, Japan.	ishizaka@poh.osaka-med.ac.jp			Ministry of Education, Science, and Culture of Japan; Mitsui Life Social Welfare Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitsui Life Social Welfare Foundation	This work was supported in part by Grants in Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan, Mitsui Life Social Welfare Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agabiti-Rosei E, 1998, CURR OPIN NEPHROL HY, V7, P211, DOI 10.1097/00041552-199803000-00011; Broulik PD, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/309068; Chen CC, 2011, AM J PHYSIOL-HEART C, V301, pH1107, DOI 10.1152/ajpheart.01071.2010; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; Eguchi K, 2008, AM J CARDIOL, V101, P1787, DOI 10.1016/j.amjcard.2008.02.082; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fujii H, 2007, INTERNAL MED, V46, P1507, DOI 10.2169/internalmedicine.46.0269; Hui JY, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3769; Ishay A, 2011, ENDOCR PRACT, V17, P584, DOI 10.4158/EP10321.OR; Iwashima Y, 2006, HYPERTENSION, V47, P195, DOI 10.1161/01.HYP.0000200033.14574.14; KOREN MJ, 1991, ANN INTERN MED, V114, P345, DOI 10.7326/0003-4819-114-5-345; Krishnan Eswar, 2012, Congest Heart Fail, V18, P138, DOI 10.1111/j.1751-7133.2011.00259.x; Liu X, 2008, J INT MED RES, V36, P942, DOI 10.1177/147323000803600510; Matsumura K, 2006, CIRC J, V70, P885, DOI 10.1253/circj.70.885; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Mitsuhashi H, 2009, CIRC J, V73, P667, DOI 10.1253/circj.CJ-08-0626; Nabipour I, 2011, J BONE MINER RES, V26, P955, DOI 10.1002/jbmr.286; Pilz S, 2010, EUR HEART J, V31, P1591, DOI 10.1093/eurheartj/ehq109; Randon RB, 2005, BRAZ J MED BIOL RES, V38, P1409, DOI 10.1590/S0100-879X2005000900016; Rekhraj S, 2013, J AM COLL CARDIOL, V61, P926, DOI 10.1016/j.jacc.2012.09.066; Roman MJ, 1996, J AM COLL CARDIOL, V28, P751, DOI 10.1016/0735-1097(96)00225-2; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; SAVAGE DD, 1987, CIRCULATION, V75, P26; Shibata K, 2013, PLOS ONE IN PRESS; Szwejkowski BR, 2013, J AM COLL CARDIOL; Taddei S, 2011, HEART FAIL REV, V16, P615, DOI 10.1007/s10741-010-9197-z; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Tomaschitz A, 2012, CARDIOVASC RES, V94, P10, DOI 10.1093/cvr/cvs092; Valdemarsson S, 1998, J INTERN MED, V244, P241; van Ballegooijen AJ, 2013, J CLIN ENDOCR METAB, V98, P2544, DOI 10.1210/jc.2012-4252; Vernooij JWP, 2012, AM J CARDIOL, V110, P227, DOI 10.1016/j.amjcard.2012.03.016; Viazzi F, 2005, HYPERTENSION, V45, P991, DOI 10.1161/01.HYP.0000161184.10873.ea; Wachtell K, 2000, HYPERTENSION, V35, P6, DOI 10.1161/01.HYP.35.1.6; Walker MD, 2010, J CLIN ENDOCR METAB, V95, P2172, DOI 10.1210/jc.2009-2072; Woodiwiss AJ, 2008, AM J HYPERTENS, V21, P1144, DOI 10.1038/ajh.2008.252; Yoneda M, 1983, Nihon Naibunpi Gakkai Zasshi, V59, P1738; Yoshitomi R, 2013, HYPERTENS RES; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d	38	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82735	10.1371/journal.pone.0082735	http://dx.doi.org/10.1371/journal.pone.0082735			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340056	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400093
J	Heymann, EW; Zinner, D; Ganzhorn, JU				Heymann, Eckhard W.; Zinner, Dietmar; Ganzhorn, Joerg U.			Disproportional Representation of Primates in the Ecological Literature	PLOS ONE			English	Article							FIELD EXPERIMENT; CEBUS-APELLA; RESPONSES; MONKEYS; INFORMATION; CALLICEBUS; TRADITIONS; EVOLUTION; BABOONS; LEMURS	We address the question why papers dealing with the ecology of primates are so sparsely represented in the general ecological literature. A literature analyses based on entries in Web of Science and PrimateLit reveals that despite a large number of papers published on primates in general and on the ecology of primates, only a very small fraction of these papers is published in high-ranking international ecological journals. We discuss a number of potential reasons for the disproportion and highlight the problems associated with experimental research on wild primates and constraints on sample size as major issues.	[Heymann, Eckhard W.] Deutsch Primatenzentrum GmbH, Abt Verhaltensokol & Soziobiol, Gottingen, Germany; [Zinner, Dietmar] Deutsch Primatenzentrum GmbH, Abt Kognit Ethol, Gottingen, Germany; [Ganzhorn, Joerg U.] Univ Hamburg, Inst Zool, Abt Tierokol, Hamburg, Germany	Deutsches Primatenzentrum (DPZ); Deutsches Primatenzentrum (DPZ); University of Hamburg	Heymann, EW (corresponding author), Deutsch Primatenzentrum GmbH, Abt Verhaltensokol & Soziobiol, Gottingen, Germany.	eheyman@gwdg.de	Ganzhorn, Joerg/AAO-6955-2020; Heymann, Eckhard W./I-2422-2014	Ganzhorn, Joerg/0000-0003-1395-9758; Heymann, Eckhard W./0000-0002-4259-8018				Bicca-Marques JC, 2004, AM J PRIMATOL, V62, P171, DOI 10.1002/ajp.20014; Boos M, 2011, COORDINATION IN HUMAN AND PRIMATE GROUPS, P1, DOI 10.1007/978-3-642-15355-6; Carmel Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059813; CHAPMAN CA, 1990, FOLIA PRIMATOL, V54, P177, DOI 10.1159/000156442; Clutton-Brock TH, 1977, PRIMATE ECOLOGY STUD; CLUTTONB.TH, 1974, NATURE, V250, P539, DOI 10.1038/250539a0; Codron D, 2006, AM J PHYS ANTHROPOL, V129, P204, DOI 10.1002/ajpa.20253; Crook J. H., 1965, Symposia of the Zoological Society of London, VNo. 14, P181; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; Effiom EO, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0246; Fragaszy D, 2010, ANIM BEHAV, V79, P321, DOI 10.1016/j.anbehav.2009.11.004; Goerlitz HR, 2007, FUNCT ECOL, V21, P143, DOI 10.1111/j.1365-2435.2006.01212.x; Janson CH, 1998, ANIM BEHAV, V55, P1229, DOI 10.1006/anbe.1997.0688; Janson C, 2012, INT J PRIMATOL, V33, P520, DOI 10.1007/s10764-011-9550-7; Jones CB., 2005, BEHAV FLEXIBILITY PR, DOI [10.1007/978-0-387-23327-7, DOI 10.1007/978-0-387-23327-7]; Kappeler PM, 2012, LONG TERM FIELD STUD; Kawai M., 1960, Primates, V2, P181, DOI 10.1007/BF01659168; King AJ, 2009, ANIM BEHAV, V78, P1381, DOI 10.1016/j.anbehav.2009.09.009; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Matsuzawa Tetsuro, 1994, P351; MILTON K, 1976, NATURE, V259, P459, DOI 10.1038/259459a0; Mitani J., 2012, EVOLUTION PRIMATE SO; Nowell AA, 2008, BEHAVIOUR, V145, P171, DOI 10.1163/156853907783244747; Peres CA, 2000, OECOLOGIA, V122, P175, DOI 10.1007/PL00008845; Pesendorfer MB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004472; RAEMAEKERS JJ, 1985, ANIM BEHAV, V33, P481, DOI 10.1016/S0003-3472(85)80071-3; Riba-Hernandez P, 2005, BIOTROPICA, V37, P274, DOI 10.1111/j.1744-7429.2005.00037.x; ROBINSON JG, 1979, BEHAV ECOL SOCIOBIOL, V5, P1, DOI 10.1007/BF00302691; Schnoell AV, 2012, ANIM COGN, V15, P505, DOI 10.1007/s10071-012-0477-y; StatSoft Inc, 2011, STATISTICA WIND SOFT; Thoren S, 2011, AM J PHYS ANTHROPOL, V145, P156, DOI 10.1002/ajpa.21516; VITALE AF, 1991, INT J PRIMATOL, V12, P277, DOI 10.1007/BF02547588; Wolf M, 2012, TRENDS ECOL EVOL, V27, P452, DOI 10.1016/j.tree.2012.05.001; Zuberbuhler K, 2000, P ROY SOC B-BIOL SCI, V267, P713, DOI 10.1098/rspb.2000.1061	34	0	0	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e80763	10.1371/journal.pone.0080763	http://dx.doi.org/10.1371/journal.pone.0080763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339882	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400005
J	Jiang, J; Jin, MS; Kong, F; Cao, DH; Ma, HX; Jia, ZF; Wang, YP; Suo, J; Cao, XY				Jiang, Jing; Jin, Mei-Shan; Kong, Fei; Cao, Donghui; Ma, Hong-Xi; Jia, Zhifang; Wang, Yin-Ping; Suo, Jian; Cao, Xueyuan			Decreased Galectin-9 and Increased Tim-3 Expression Are Related to Poor Prognosis in Gastric Cancer	PLOS ONE			English	Article							T-CELLS; POPULATION; SUPPRESSES; INDUCTION; APOPTOSIS; FAMILY	Introduction: Galectin-9 (Gal-9) induces adhesion and aggregation of certain cell types and inhibits the metastasis of tumor cells. T-cell immunoglobulin-and mucin domain-3-containing molecule 3 (TIM-3) plays a pivotal role in immune regulation. The aim of this study is to investigate Gal-9 and TIM-3 alterations in gastric cancer and their prognostic values. Methods: Gal-9 and Tim-3 expression was evaluated using a tissue microarray immunohistochemistry method in 305 gastric cancers, of which 84 had paired adjacent normal samples. Cell lines SGC-7901, BGC-823, MGC-803, MKN45 and GES-1 were also stained. Correlations were analyzed between expression levels of Gal-9 and Tim-3 protein and tumor parameters or clinical outcomes. Results: Gal-9 and Tim-3 stained positive on tumor cells in 86.2% (263/305), and 60.0% (183/305) patients with gastric cancer, respectively. Gal-9 expression was significantly higher in cancer than in normal mucosa (P<0.001). Reduced Gal-9 expression was associated with lymph-vascular invasion, lymph node metastasis, distant metastasis and worse TNM staging (P = 0.034, P = 0.009, P = 0.002 and P = 0.043, respectively). In contrast, Tim-3 expression was significantly lower in cancer than in control mucosa (P<0.001). Patients with lymph-vascular invasion had higher expression levels of Tim-3 (P<0.001). Moreover, multivariate analysis shows that both high Gal-9 expression and low Tim-3 expression were significantly associated with long overall survival (P = 0.002, P = 0.010, respectively); the combination of Gal-9 and Tim-3 expression was an independent prognostic predictor for patients with gastric cancer (RR: 0.43; 95% CI: 0.20-0.93). H. pylori infection status was not associated with Gal-9 and Tim-3 expression (P = 0.102, P = 0.565). Conclusion: The results suggest that expression of Gal-9 and Tim-3 in tumor cells may be a potential, independent prognostic factor for patients with gastric cancer. Gal-9 and TIM-3 may play an important part in the gastric carcinogenesis.	[Jiang, Jing; Kong, Fei; Cao, Donghui; Jia, Zhifang] Jilin Univ, Hosp 1, Div Clin Epidemiol, Changchun 130023, Peoples R China; [Jin, Mei-Shan; Ma, Hong-Xi; Wang, Yin-Ping] Jilin Univ, Hosp 1, Div Pathol, Changchun 130023, Peoples R China; [Suo, Jian; Cao, Xueyuan] Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130023, Peoples R China	Jilin University; Jilin University; Jilin University	Cao, XY (corresponding author), Jilin Univ, Hosp 1, Dept Gastr & Colorectal Surg, Changchun 130023, Peoples R China.	ccmzc32jdyycao@yahoo.com.cn			National Natural Science Foundation of China [81072369, 81273065]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study has been supported by National Natural Science Foundation of China (81072369 and 81273065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Baldus SE, 2000, TUMOR BIOL, V21, P258, DOI 10.1159/000030131; BARONDES SH, 1994, CELL, V76, P597, DOI 10.1016/0092-8674(94)90498-7; Bray F, 2012, LANCET ONCOL, V13, P790, DOI 10.1016/S1470-2045(12)70211-5; Cao Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053834, 10.1371/journal.pone.0055021]; CARON M, 1990, INT J BIOCHEM, V22, P1379, DOI 10.1016/0020-711X(90)90226-S; Fujihara S, 2013, RECENT PATENTS ENDOC, V7, P130, DOI 10.2174/1872214811307020006; Hafler DA, 2008, J EXP MED, V205, P2699, DOI 10.1084/jem.20082429; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Pharmaceuticals, 2012, IARC MONOGR EVAL CAR, V100, P1; Irie A, 2005, CLIN CANCER RES, V11, P2962, DOI 10.1158/1078-0432.CCR-04-0861; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kadowaki T, 2012, CLIN IMMUNOL, V142, P296, DOI 10.1016/j.clim.2011.11.006; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kashio Y, 2003, J IMMUNOL, V170, P3631, DOI 10.4049/jimmunol.170.7.3631; Keryer-Bibens C, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-283; Kim SJ, 2010, GASTROENTEROLOGY, V138, P1035, DOI 10.1053/j.gastro.2009.09.061; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Liang M, 2008, J CANCER RES CLIN, V134, P899, DOI 10.1007/s00432-008-0352-z; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Lv K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048379; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Ngiow SF, 2011, CANCER RES, V71, P6567, DOI 10.1158/0008-5472.CAN-11-1487; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sehrawat S, 2009, J IMMUNOL, V182, P3191, DOI 10.4049/jimmunol.0803673; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Vaitaitis GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038708; Veenstra RG, 2012, BLOOD, V120, P682, DOI 10.1182/blood-2011-10-387977; Wada J, 1997, J BIOL CHEM, V272, P6078, DOI 10.1074/jbc.272.9.6078; Wiener Z, 2007, J INVEST DERMATOL, V127, P906, DOI 10.1038/sj.jid.5700616; Wiersma VR, 2012, J INVEST DERMATOL, V132, P2302, DOI 10.1038/jid.2012.133; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Yamauchi A, 2006, BREAST J, V12, pS196, DOI 10.1111/j.1075-122X.2006.00334.x; Yan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058006; Zhang Y, 2012, J LEUKOCYTE BIOL, V91, P189, DOI 10.1189/jlb.1010591; Zhang ZY, 2012, ASIAN PAC J CANCER P, V13, P2503, DOI 10.7314/APJCP.2012.13.6.2503; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhuang XW, 2012, AM J CLIN PATHOL, V137, P978, DOI 10.1309/AJCP9Q6OVLVSHTMY	39	73	83	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81799	10.1371/journal.pone.0081799	http://dx.doi.org/10.1371/journal.pone.0081799			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339967	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400043
J	Murakami, K; Bhandari, H; Lucas, ES; Takeda, S; Gargett, CE; Quenby, S; Brosens, JJ; Tan, BK				Murakami, Keisuke; Bhandari, Harish; Lucas, Emma S.; Takeda, Satoru; Gargett, Caroline E.; Quenby, Siobhan; Brosens, Jan J.; Tan, Bee K.			Deficiency in Clonogenic Endometrial Mesenchymal Stem Cells in Obese Women with Reproductive Failure - a Pilot Study	PLOS ONE			English	Article							BODY-MASS INDEX; PREGNANCY; AGE; REGENERATION	Objectives: The mechanisms of obesity associated reproductive complications remain poorly understood. Endometrial mesenchymal stem-cells are critical for cyclic renewal and uterine function. Recently, W5C5(+) cells, with high clonogenicity, capable of producing endometrial stroma in vivo, have been described. We sought to investigate the abundance and cloning efficiency of W5C5(+) and W5C5(-) endometrial cells in relation to Body Mass Index, age and reproductive outcome. Design: W5C5(+) and W5C5(-) cells were purified from mid-luteal endometrial biopsies (n = 54) by magnetic bead separation and subjected to in vitro colony-forming assays. Results: First trimester pregnancy losses were significantly higher in obese subjects (n = 12) compared to overweight (n = 20) and subjects with normal Body Mass Index (n = 22) (P<0.05, P<0.01, respectively). W5C5(+) cells (%) were significantly lower in obese subjects compared to subjects with normal Body Mass Index (P<0.05). W5C5(+) cloning efficiency was significantly lower in obese subjects compared to overweight and subjects with normal Body Mass Index (P<0.05, respectively). W5C5(-) cloning efficiency was significantly lower in obese subjects compared to subjects with normal Body Mass Index (P<0.05). Body Mass Index was significantly negatively correlated with W5C5(+) cloning efficiency and W5C5(-) cloning efficiency (P<0.01, respectively), and positively correlated with first trimester loss (P<0.01). We found no significant results with age (P>0.05). Conclusions: Our observations suggest that the regenerative capacity and plasticity of the endometrium of obese women is suboptimal, which in turn may account for the increased risk of reproductive complications associated with obesity.	[Murakami, Keisuke; Bhandari, Harish; Lucas, Emma S.; Quenby, Siobhan; Brosens, Jan J.; Tan, Bee K.] Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Reprod Hlth, Coventry CV4 7AL, W Midlands, England; [Murakami, Keisuke; Takeda, Satoru] Juntendo Univ, Fac Med, Dept Obstet & Gynecol, Tokyo, Japan; [Gargett, Caroline E.] Monash Univ, Monash Inst Med Res, Ritchie Ctr, Clayton, Vic, Australia; [Gargett, Caroline E.] Monash Univ, Dept Obstet & Gynecol, Clayton, Vic, Australia; [Tan, Bee K.] Heart England NHS Fdn Trust, Birmingham Heartlands Hosp, Dept Obstet & Gynecol, Birmingham, W Midlands, England	University of Warwick; Juntendo University; Monash University; Monash University; Heart of England NHS Foundation Trust; University of Birmingham	Tan, BK (corresponding author), Univ Warwick, Warwick Med Sch, Clin Sci Res Labs, Div Reprod Hlth, Coventry CV4 7AL, W Midlands, England.	B.K.Tan@warwick.ac.uk	Lucas, Emma S/I-2719-2013; Gargett, Caroline E/Q-7911-2019; Murakami, Keisuke/Q-1257-2019; Gargett, Caroline Eve/I-4895-2019	Lucas, Emma S/0000-0002-8571-8921; Gargett, Caroline E/0000-0002-3590-2077; Quenby, Siobhan/0000-0003-3221-5471; Brosens, Jan/0000-0003-0116-9329; Takeda, Satoru/0000-0001-9547-1435	Biomedical Research Unit in Reproductive Health; Australian National Health and Medical Research Council [1042298]; Victorian Government	Biomedical Research Unit in Reproductive Health; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government	This work was supported by the Biomedical Research Unit in Reproductive Health, a joint initiative between the University Hospitals Coventry and Warwickshire NHS Trust and Warwick Medical School. Dr Caroline Gargett also received funding from The Australian National Health and Medical Research Council for a Senior Research Fellowship 1042298 (CEG) and the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDALLA HI, 1993, HUM REPROD, V8, P1512, DOI 10.1093/oxfordjournals.humrep.a138289; Alanis MC, 2010, ACTA OBSTET GYN SCAN, V89, P924, DOI 10.3109/00016341003657884; Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Brewer CJ, 2010, REPRODUCTION, V140, P347, DOI 10.1530/REP-09-0568; Brosens JJ, 1999, ENDOCRINOLOGY, V140, P4809, DOI 10.1210/en.140.10.4809; Burton GJ, 2011, BEST PRACT RES CL OB, V25, P287, DOI 10.1016/j.bpobgyn.2010.10.016; Denison FC, 2010, REPRODUCTION, V140, P373, DOI 10.1530/REP-10-0074; Du HL, 2012, STEM CELLS DEV, V21, P3324, DOI 10.1089/scd.2011.0193; Dunson DB, 2004, OBSTET GYNECOL, V103, P51, DOI 10.1097/01.AOG.0000100153.24061.45; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9; Lam EWF, 2012, J ENDOCRINOL, V212, P13, DOI 10.1530/JOE-10-0480; Lo W, 2012, J FAM COMMUNITY MED, V19, P167, DOI 10.4103/2230-8229.102316; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Santamaria X, 2011, MOL THER, V19, P2065, DOI 10.1038/mt.2011.173; Ulrich D, 2013, EXPERT OPIN BIOL TH, V13, P1387, DOI 10.1517/14712598.2013.826187; Wolff EF, 2011, J CELL MOL MED, V15, P747, DOI 10.1111/j.1582-4934.2010.01068.x	18	26	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82582	10.1371/journal.pone.0082582	http://dx.doi.org/10.1371/journal.pone.0082582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340046	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400086
J	Peng, H; Zhang, MZ; Cai, XQ; Olofindayo, J; Tan, AN; Zhang, YH				Peng, Hao; Zhang, Mingzhi; Cai, Xiaoqin; Olofindayo, Jennifer; Tan, Anna; Zhang, Yonghong			Association between Human Urotensin II and Essential Hypertension-A 1:1 Matched Case-Control Study	PLOS ONE			English	Article							CAROTID ATHEROSCLEROSIS; VASCULAR-TONE	Objective: We aimed to evaluate the controversial association between human urotensin II and essential hypertension in untreated hypertensive cases and normotensive controls. Methods: 197 newly diagnosed hypertensive patients and 197 age-and sex-matched normotensive controls were studied. Plasma urotensin II, nitric oxide metabolites, and other traditional biomarkers were examined. Results: Hypertensive patients had higher urotensin II [median (interquartile rang): 9.32 (7.86-11.52) ng/mL vs 8.52 (7.07-10.41) ng/mL] and lower nitric oxide metabolites [19.19 (2.55-38.48) mmol/L vs 23.83 (11.97-43.40) mmol/L] than normotensive controls. Urotensin II was positively correlated with systolic blood pressure (r = 0.169, P<0.001) and diastolic blood pressure (r = 0.113, P = 0.024) while negatively correlated with nitric oxide metabolites (r = 20.112, P = 0.027). In multivariate regression analysis, subjects in the highest quartile of urotensin II were more likely to have hypertension than those in the lowest quartile (OR, 2.58; 95% CI, 1.21-5.49). Sub-group analyses in 106 pairs of cases and controls with either both normal or both abnormal nitric oxide metabolites levels showed that the association between urotensin II levels and hypertension persisted (P value for trend = 0.039). Conclusion: Human urotensin II is markedly associated with essential hypertension, and the association is independent of nitric oxide metabolites. Our results indicated that urotensin II might be an independent risk factor for essential hypertension.	[Peng, Hao; Zhang, Mingzhi; Zhang, Yonghong] Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China; [Cai, Xiaoqin] Nanjing Univ Tradit Chinese Med, Kunshan Affiliated Hosp, Dept Diagnost Ctr, Suzhou, Peoples R China; [Olofindayo, Jennifer] Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA USA; [Tan, Anna] Tulane Univ, Dept Publ Hlth, New Orleans, LA 70118 USA	Soochow University - China; Nanjing University of Chinese Medicine; Tulane University; Tulane University	Zhang, YH (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Dept Epidemiol, Suzhou, Peoples R China.	yhzhang@suda.edu.cn	Peng, Hao/I-1134-2014; Peng, Hao/AAB-4759-2022	Peng, Hao/0000-0001-6277-662X; 	Youth Found of the National Natural Science Foundation of China [81202271]; Priority Academic Program Development of Jiangsu Higher Education Institutions of China; National Institute on Minority Health and Health Disparities [T37MD001424] Funding Source: NIH RePORTER	Youth Found of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions of China; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study is supported by Youth Found of the National Natural Science Foundation of China (Grant No. 81202271) and partially supported by a Project of the Priority Academic Program Development of Jiangsu Higher Education Institutions of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ban Y, 2009, J ATHEROSCLER THROMB, V16, P179, DOI 10.5551/jat.E608; BERN HA, 1969, J ENDOCRINOL, V45, pR11; Bohm F, 2002, BRIT J PHARMACOL, V135, P25, DOI 10.1038/sj.bjp.0704448; Cheung BMY, 2004, J HYPERTENS, V22, P1341, DOI 10.1097/01.hjh.0000125452.28861.f1; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Coulouarn Y, 1998, P NATL ACAD SCI USA, V95, P15803, DOI 10.1073/pnas.95.26.15803; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Ghasemi A, 2010, CLIN BIOCHEM, V43, P89, DOI 10.1016/j.clinbiochem.2009.09.011; Giachini FRC, 2008, EXPERT OPIN THER TAR, V12, P327, DOI 10.1517/14728222.12.3.327; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kelly AS, 2012, J CLIN HYPERTENS, V14, P85, DOI 10.1111/j.1751-7176.2011.00569.x; Kemp William, 2005, Current Vascular Pharmacology, V3, P159, DOI 10.2174/1570161053586930; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim M, 2004, CIRCULATION, V109, P1212, DOI 10.1161/01.CIR.0000121326.69153.98; Mosenkis A, 2011, NEPHROL DIAL TRANSPL, V26, P609, DOI 10.1093/ndt/gfq416; Ong KL, 2008, PEPTIDES, V29, P859, DOI 10.1016/j.peptides.2007.06.003; Rdzanek A, 2006, INT J CARDIOL, V110, P175, DOI 10.1016/j.ijcard.2005.07.008; Russell FD, 2004, PHARMACOL THERAPEUT, V103, P223, DOI 10.1016/j.pharmthera.2004.07.004; Sondermeijer B, 2005, AM J HYPERTENS, V18, P1195, DOI 10.1016/j.amjhyper.2005.03.748; Stirrat A, 2001, AM J PHYSIOL-HEART C, V280, pH925, DOI 10.1152/ajpheart.2001.280.2.H925; Suguro T, 2007, AM J HYPERTENS, V20, P211, DOI 10.1016/j.amjhyper.2006.08.001; Thompson JP, 2003, ANESTH ANALG, V97, P1501, DOI 10.1213/01.ANE.0000086723.97421.BC; Tsoukas P, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00038; Vogt L, 2005, J HYPERTENS, V23, P2055, DOI 10.1097/01.hjh.0000186829.56372.04; Watanabe T, 2009, CURR MED CHEM, V16, P550, DOI 10.2174/092986709787458515; Zomer E, 2008, CLIN EXP PHARMACOL P, V35, P1147, DOI 10.1111/j.1440-1681.2008.04960.x	26	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81764	10.1371/journal.pone.0081764	http://dx.doi.org/10.1371/journal.pone.0081764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339964	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400040
J	Herzner, G; Kaltenpoth, M; Poettinger, T; Weiss, K; Koedam, D; Kroiss, J; Strohm, E				Herzner, Gudrun; Kaltenpoth, Martin; Poettinger, Theodor; Weiss, Katharina; Koedam, Dirk; Kroiss, Johannes; Strohm, Erhard			Morphology, Chemistry and Function of the Postpharyngeal Gland in the South American Digger Wasps Trachypus boharti and Trachypus elongatus	PLOS ONE			English	Article							INSECT CUTICULAR HYDROCARBONS; DIRECT BEHAVIORAL EVIDENCE; SOLITARY WASP; EUROPEAN BEEWOLF; PHILANTHUS-TRIANGULUM; NESTMATE RECOGNITION; PHYSICAL-PROPERTIES; SEX-PHEROMONE; SOCIAL GLAND; HYMENOPTERA	Microbes pose severe threats to animals as competitors or pathogens and strongly affect the evolution of life history traits like parental care. Females of the European beewolf Philanthus triangulum, a solitary digger wasp, provision their offspring with paralyzed honeybees and embalm them with the secretion from large postpharyngeal glands (PPG) that contain mainly unsaturated hydrocarbons. This coating changes the physico-chemical properties of the prey surface, causes a reduction of water condensation and retards growth of mold fungi. Here we examined the closely related South American genus Trachypus, which shows a life-history similar to Philanthus. We investigated whether Trachypus spp. also possess PPGs and embalm larval provisions. Using histological methods and 3D reconstructions we show that Trachypus boharti and T. elongatus possess PPGs that are similar to P. triangulum but somewhat smaller. The ultrastructure of the gland epithelium suggests that the gland content is at least partly sequestered from the hemolymph. Chemical analyses using gas chromatography / mass spectrometry revealed that both the cuticle and PPGs of Trachypus contain mainly unsaturated long-chain hydrocarbons. The gland of T. boharti additionally contains long-chain ketones. The hydrocarbons from the PPG of T. elongatus occurred on prey bees excavated from nests in the field but not on conspecific control bees. While the embalming only slightly elevated the amount of hydrocarbons on prey bees, the proportion of unsaturated hydrocarbons, which is crucial for the antifungal effect, was significantly increased. The Trachypus species under study possess PPGs that are very similar to the PPG of P. triangulum with regard to morphology, ultrastructure and chemistry. Moreover, we provide clear evidence that T. elongatus females embalm their prey, presumably as a means of prey preservation. The observed differences among Trachypus and Philanthus in gland size and prey embalming may have evolved in response to divergent ecological conditions.	[Herzner, Gudrun; Poettinger, Theodor; Weiss, Katharina; Strohm, Erhard] Univ Regensburg, Inst Zool, Evolutionary Ecol Grp, D-93053 Regensburg, Germany; [Kaltenpoth, Martin; Kroiss, Johannes] Max Planck Inst Chem Ecol, Res Grp Insect Symbiosis, Jena, Germany; [Koedam, Dirk] Fed Rural Univ Semiarid Reg, Dept Anim Sci, Mossoro, RN, Brazil	University of Regensburg; Max Planck Society; Universidade Federal Rural do Semi-Arido (UFERSA)	Herzner, G (corresponding author), Univ Regensburg, Inst Zool, Evolutionary Ecol Grp, Univ Str 31, D-93053 Regensburg, Germany.	gudrun.herzner@biologie.uni-regensburg.de	Poettinger, Theodor/A-8141-2015; Kaltenpoth, Martin/M-8475-2014; koedam, dirk/I-8140-2012	Poettinger, Theodor/0000-0001-7274-615X; Kaltenpoth, Martin/0000-0001-9450-0345; koedam, dirk/0000-0001-8034-4273	Systematics Research Fund (SRF); German Science Foundation (DFG) [DFG STR 532/2-2]; Max Planck Society	Systematics Research Fund (SRF); German Science Foundation (DFG)(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This study was supported by a grant of the Systematics Research Fund (SRF) jointly administered by the Council of the Linnean Society of London and the Systematics Association to Gudrun Herzner (http://www.systass.org/awards/srf.shtml), by the German Science Foundation (DFG) with a grant to Erhard Strohm and Martin Kaltenpoth (grant number: DFG STR 532/2-2) and within the funding program Open Access Publishing (http://dfg.de/en/). Martin Kaltenpoth and Johannes Kroiss gratefully acknowledge financial support from the Max Planck Society (www.mpg.de/en). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam H., 1964, ARBEITSMETHODEN MAKR; Akino T, 2004, APPL ENTOMOL ZOOL, V39, P381, DOI 10.1303/aez.2004.381; ALEXANDER BA, 1992, SYST ENTOMOL, V17, P91, DOI 10.1111/j.1365-3113.1992.tb00324.x; [Anonymous], 1976, SPHECID WASPS WORLD; BAGNERES AG, 1991, EXPERIENTIA, V47, P106, DOI 10.1007/BF02041269; CLARKE KR, 1988, MAR ECOL PROG SER, V46, P213, DOI 10.3354/meps046213; Cotter SC, 2010, ECOL LETT, V13, P1114, DOI 10.1111/j.1461-0248.2010.01500.x; Eelen D, 2006, ACTA ZOOL-STOCKHOLM, V87, P101, DOI 10.1111/j.1463-6395.2006.00212.x; FRANCIS GW, 1981, J CHROMATOGR, V219, P379, DOI 10.1016/S0021-9673(00)80381-7; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; GIBBS A, 1995, COMP BIOCHEM PHYS B, V112, P243, DOI 10.1016/0305-0491(95)00081-X; Gibbs A, 1995, COMP BIOCHEM PHYS B, V112, P667, DOI 10.1016/0305-0491(95)00119-0; Gross J, 2008, J CHEM ECOL, V34, P179, DOI 10.1007/s10886-007-9416-9; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hefetz A, 1996, J INSECT BEHAV, V9, P709, DOI 10.1007/BF02213551; HEFETZ A, 1982, J CHEM ECOL, V8, P1389, DOI 10.1007/BF01403102; Herzner G, 2008, PHYSIOL ENTOMOL, V33, P101, DOI 10.1111/j.1365-3032.2007.00603.x; Herzner G, 2007, ARTHROPOD STRUCT DEV, V36, P123, DOI 10.1016/j.asd.2006.08.006; Herzner G, 2007, J CHEM ECOL, V33, P849, DOI 10.1007/s10886-007-9263-8; Herzner G, 2007, CURR BIOL, V17, pR46, DOI 10.1016/j.cub.2006.11.060; Herzner G, 2013, P NATL ACAD SCI USA, V110, P1369, DOI 10.1073/pnas.1213384110; Herzner G, 2011, ANIM BEHAV, V82, P321, DOI 10.1016/j.anbehav.2011.05.006; Herzner G, 2011, ZOOLOGY, V114, P36, DOI 10.1016/j.zool.2010.10.002; HOWARD RW, 1993, INSECT LIPIDS: CHEMISTRY, BIOCHEMISTRY AND BIOLOGY, P179; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Kaltenpoth M, 2006, INT J SYST EVOL MICR, V56, P1403, DOI 10.1099/ijs.0.64117-0; Kaltenpoth M, 2012, APPL ENVIRON MICROB, V78, P822, DOI 10.1128/AEM.06809-11; Kaltenpoth M, 2010, PHYSIOL ENTOMOL, V35, P196, DOI 10.1111/j.1365-3032.2010.00729.x; Koedam D, 2009, GENET MOL RES, V8, P690, DOI 10.4238/vol8-2kerr032; Koedam D, 2011, PHYSIOL ENTOMOL, V36, P187, DOI 10.1111/j.1365-3032.2010.00769.x; Koehler S, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-3; Kroiss J, 2006, J CHEM ECOL, V32, P2763, DOI 10.1007/s10886-006-9198-5; Kroiss J, 2011, J CHEM ECOL, V37, P420, DOI 10.1007/s10886-011-9933-4; Kroiss J, 2010, NAT CHEM BIOL, V6, P261, DOI [10.1038/NCHEMBIO.331, 10.1038/nchembio.331]; Kudo SI, 2011, ETHOLOGY, V117, P19, DOI 10.1111/j.1439-0310.2010.01851.x; Lahav S, 1999, NATURWISSENSCHAFTEN, V86, P246, DOI 10.1007/s001140050609; Legendre P., 2012, NUMERICAL ECOLOGY; Leonhardt SD, 2009, INSECT SOC, V56, P157, DOI 10.1007/s00040-009-0007-3; Lucas C, 2004, J INSECT PHYSIOL, V50, P595, DOI 10.1016/j.jinsphys.2004.04.006; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; ONeill K. M, 1988, NATURAL HIST BEHAV N; Patricio EFLRA, 2002, J INSECT PHYSIOL, V48, P249, DOI 10.1016/S0022-1910(01)00170-6; Polidori C, 2009, STUD NEOTROP FAUNA E, V44, P55, DOI 10.1080/01650520902861531; Pulawski WJ, 2013, CATALOG SPHECIDAE; Quennedey A, 1998, MICROSCOPIC ANATOMY OF INVERTEBRATES, VOL 11 A-C, P177; Sadd BM, 2007, CURR BIOL, V17, pR1046, DOI 10.1016/j.cub.2007.11.007; Schubert R., 1984, LEHRBUCH OKOLOGIE; SOROKER V, 1994, NATURWISSENSCHAFTEN, V81, P510; Soroker V, 1995, PHYSIOL ENTOMOL, V20, P323, DOI 10.1111/j.1365-3032.1995.tb00822.x; Soroker V, 2000, J INSECT PHYSIOL, V46, P1097, DOI 10.1016/S0022-1910(99)00219-X; Strohm E, 1997, ANIM BEHAV, V54, P23, DOI 10.1006/anbe.1996.0431; Strohm E, 1997, P ROY SOC B-BIOL SCI, V264, P423, DOI 10.1098/rspb.1997.0060; Strohm E, 2010, INSECT SOC, V57, P285, DOI 10.1007/s00040-010-0083-4; Strohm E, 2001, ECOL ENTOMOL, V26, P198, DOI 10.1046/j.1365-2311.2001.00300.x; Strohm E, 2008, J CHEM ECOL, V34, P575, DOI 10.1007/s10886-008-9447-x; Strohm E, 2007, ARTHROPOD STRUCT DEV, V36, P113, DOI 10.1016/j.asd.2006.08.007; Witte V, 2009, J CHEM ECOL, V35, P355, DOI 10.1007/s10886-009-9606-8; Yasui H, 2003, ENTOMOL EXP APPL, V107, P167, DOI 10.1046/j.1570-7458.2003.00053.x	58	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82780	10.1371/journal.pone.0082780	http://dx.doi.org/10.1371/journal.pone.0082780			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324830	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566700109
J	Chang, CYY; Chen, Y; Lai, MT; Chang, HW; Cheng, J; Chan, C; Chen, CM; Lee, SC; Lin, YJ; Wan, L; Tsai, PW; Yang, SH; Chung, C; Sheu, JJC; Tsai, FJ				Chang, Cherry Yin-Yi; Chen, Yi; Lai, Ming-Tsung; Chang, Hui-Wen; Cheng, Jack; Chan, Carmen; Chen, Chih-Mei; Lee, Shan-Chih; Lin, Ying-Ju; Wan, Lei; Tsai, Pei-Wen; Yang, Su-Han; Chung, Ching; Sheu, Jim Jinn-Chyuan; Tsai, Fuu-Jen			BMPR1B Up-Regulation via a miRNA Binding Site Variation Defines Endometriosis Susceptibility and CA125 Levels	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEIN-2; OVARIAN-CARCINOMA CELLS; NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR; HAPLOTYPE RECONSTRUCTION; PERITONEAL-FLUID; EXPRESSION; CANCER; MICRORNAS; PROGNOSIS	Background: Bone morphogenetic protein receptor I B (BMPR1B) is a transmembrane receptor mediating TGF-beta signal transduction. Recent studies indicate a tumor suppressor role for BMPR1B in ovarian cancer. Polymorphism at BMPR1B 3 ' UTR within the miR-125b binding site alters its binding affinity toward the miRNA, which may result in insufficient post-transcriptional repression. Methods: Single-nucleotide polymorphisms rs1970801, rs1434536, and rs11097457 near the miR-125b binding site in BMPR1B were genotyped by Taqman assay on 193 endometriosis patients and 202 healthy controls. BMPR1B and CA125 levels in ectopic endometrial tissues were evaluated by quantitative PCR and immunohistochemistry. Luciferase reporter assay was utilized to verify regulatory roles of BMPR1B 3 ' UTR with allelic variants of rs1434536 in a cell line model. Cell proliferation and migration were recorded, while expression of BMPR1B, CA125, glucocorticoid receptor (GCCR) and IL-1 beta were measured by quantitative PCR in endometrial cells transfected with wild-type or mutated miR-125b. Results: This study found two endometriosis-associated SNPs, rs1434536 (P = 0.010) and rs1970801 (P = 0.0087), located within and next to a miR-125b binding site on BMPR1B. Interestingly, patients with homozygous variant alleles at rs1434536 showed significantly lower serum CA125 levels. Immunohistochemistry staining further confirmed inverse correlation between BMPR1B and CA125 levels in three rs1434536 genotypes. Cell assays demonstrated the variant allele of rs1434536 up-regulating BMPR1B at both mRNA and protein levels, which negatively correlated with CA125 and IL-1 beta levels. Disruption of the binding between miR-125b and BMPR1B hampered abnormal cell proliferation. Conclusions: SNPs of BMPR1B within and next to the miR-125b binding site manifested strong correlation with endometriosis development in a Taiwanese cohort. Disrupting the binding of miR-125b toward BMPR1B would increase protein expression, diminishing abnormal cell proliferation as well as serum and cellular CA125 levels. Genetic variation at the miR-125b binding site may play functional roles to protect against endometriosis progression.	[Chang, Cherry Yin-Yi] China Med Univ Hosp, Dept Obstet & Gynecol, Taichung, Taiwan; [Chang, Cherry Yin-Yi] China Med Univ, Dept Publ Hlth, Taichung, Taiwan; [Chang, Cherry Yin-Yi; Chang, Hui-Wen] China Med Univ, Sch Med, Taichung, Taiwan; [Chen, Yi; Cheng, Jack; Chan, Carmen; Chen, Chih-Mei; Lin, Ying-Ju; Wan, Lei; Tsai, Pei-Wen; Yang, Su-Han; Chung, Ching; Sheu, Jim Jinn-Chyuan; Tsai, Fuu-Jen] China Med Univ Hosp, Ctr Human Genet, Taichung, Taiwan; [Lai, Ming-Tsung] Chung Shan Med Univ Hosp, Dept Pathol, Taichung, Taiwan; [Lai, Ming-Tsung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Lee, Shan-Chih] Chung Shan Med Univ, Coll Med Sci & Technol, Taichung, Taiwan; [Lin, Ying-Ju; Wan, Lei; Sheu, Jim Jinn-Chyuan] China Med Univ, Sch Chinese Med, Taichung, Taiwan; [Sheu, Jim Jinn-Chyuan] Asia Univ, Dept Hlth & Nutr Biotechnol, Taichung, Taiwan; [Tsai, Fuu-Jen] China Med Univ, Sch Postbaccalaureate Chinese Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University; China Medical University Taiwan; Asia University Taiwan; China Medical University Taiwan	Sheu, JJC (corresponding author), China Med Univ Hosp, Ctr Human Genet, Taichung, Taiwan.	jimsheu@mail.cmu.edu.tw; d0704@mail.cmuh.org.tw	Tsai, Fuu-Jen/J-4140-2015; Wan, Lei/F-4719-2010	Lee, Shan-Chih/0000-0001-6583-1575; Wan, Lei/0000-0002-9525-3232; Chung, Ching/0000-0002-4834-4406; Cheng, Jack/0000-0002-9305-0781	China Medical University Hospital, Taichung, Taiwan [DMR-100-093, DMR-101-071]	China Medical University Hospital, Taichung, Taiwan	This work was funded by grants DMR-100-093 and DMR-101-071 from China Medical University Hospital, Taichung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo AA, 2010, SCIENCE, V329, P817, DOI 10.1126/science.1192537; Arici A, 1996, BIOL REPROD, V54, P463, DOI 10.1095/biolreprod54.2.463; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Ballard K, 2006, FERTIL STERIL, V86, P1296, DOI 10.1016/j.fertnstert.2006.04.054; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bhattacharya S, 2009, HUM REPROD, V24, P3096, DOI 10.1093/humrep/dep287; Bokobza Sivan M., 2009, Cancer Genomics & Proteomics, V6, P101; Brinton LA, 2004, FERTIL STERIL, V82, P405, DOI 10.1016/j.fertnstert.2004.02.109; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Chambers CP, 2009, MATH FINANC, V19, P335, DOI 10.1111/j.1467-9965.2009.00369.x; Chegini N, 2008, SEMIN REPROD MED, V26, P298, DOI 10.1055/s-0028-1082388; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Dinulescu DM, 2005, NAT MED, V11, P63, DOI 10.1038/nm1173; Donnez J, 2002, GYNECOL OBSTET INVES, V54, P52, DOI 10.1159/000066295; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Guo SW, 2009, MOL HUM REPROD, V15, P587, DOI 10.1093/molehr/gap064; Hadfield RM, 1997, FERTIL STERIL, V68, P941, DOI 10.1016/S0015-0282(97)00359-2; Hawkins SM, 2011, MOL ENDOCRINOL, V25, P821, DOI 10.1210/me.2010-0371; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; KARLAN BY, 1988, CANCER RES, V48, P3502; Keita M, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-3; KENNEDY S, 1995, J ASSIST REPROD GEN, V12, P32, DOI 10.1007/BF02214126; Komiyama S, 1999, GYNECOL ONCOL, V72, P342, DOI 10.1006/gyno.1998.5284; Lee GT, 2011, MOL IMMUNOL, V48, P1540, DOI 10.1016/j.molimm.2011.04.019; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu S, 2009, CANCER INVEST, V27, P734, DOI 10.1080/07357900802620786; Liu YG, 2009, MOL HUM REPROD, V15, P665, DOI 10.1093/molehr/gap043; LUYTEN FP, 1989, J BIOL CHEM, V264, P13377; Ma Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-85; Mandai M, 2009, INT J CLIN ONCOL, V14, P383, DOI 10.1007/s10147-009-0935-y; Matsumoto Y, 2010, MOL CELL ENDOCRINOL, V325, P118, DOI 10.1016/j.mce.2010.05.004; Moore RG, 2010, GYNECOL ONCOL, V116, P240, DOI 10.1016/j.ygyno.2009.09.041; Nap AW, 2004, J CLIN ENDOCR METAB, V89, P1089, DOI 10.1210/jc.2003-031406; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; OOSTERLYNCK DJ, 1994, OBSTET GYNECOL, V83, P287; Pi XC, 2007, J CELL BIOL, V179, P1569, DOI 10.1083/jcb.200704010; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Schenken RS, 1998, J REPROD MED, V43, P269; Scholl B, 2009, GYNECOL ENDOCRINOL, V25, P701, DOI 10.3109/09513590903159680; Sikora J, 2012, AM J REPROD IMMUNOL, V68, P138, DOI 10.1111/j.1600-0897.2012.01147.x; Sillem M, 1999, EUR J OBSTET GYN R B, V87, P123, DOI 10.1016/S0301-2115(99)00114-1; Stadlmann S, 2005, GYNECOL ONCOL, V97, P784, DOI 10.1016/j.ygyno.2005.02.017; Stefanson H, 2002, HUM REPROD, V17, P555, DOI 10.1093/humrep/17.3.555; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Teague EMCO, 2009, MOL ENDOCRINOL, V23, P265, DOI 10.1210/me.2008-0387; Trukhacheva E, 2009, J CLIN ENDOCR METAB, V94, P615, DOI 10.1210/jc.2008-1466; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; YAMAJI N, 1994, BIOCHEM BIOPH RES CO, V205, P1944, DOI 10.1006/bbrc.1994.2898	54	6	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80630	10.1371/journal.pone.0080630	http://dx.doi.org/10.1371/journal.pone.0080630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339876	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100015
J	Schneider, D; Baronsky, T; Pietuch, A; Rother, J; Oelkers, M; Fichtner, D; Wedlich, D; Janshoff, A				Schneider, David; Baronsky, Thilo; Pietuch, Anna; Rother, Jan; Oelkers, Marieelen; Fichtner, Dagmar; Wedlich, Doris; Janshoff, Andreas			Tension Monitoring during Epithelial-to-Mesenchymal Transition Links the Switch of Phenotype to Expression of Moesin and Cadherins in NMuMG Cells	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; SURFACE-AREA REGULATION; MEMBRANE TENSION; ACTIN DYNAMICS; LIVING CELLS; MECHANICS; INHIBITION; PROTEINS; ADHESION; MODULUS	Structural alterations during epithelial-to-mesenchymal transition (EMT) pose a substantial challenge to the mechanical response of cells and are supposed to be key parameters for an increased malignancy during metastasis. Herein, we report that during EMT, apical tension of the epithelial cell line NMuMG is controlled by cell-cell contacts and the architecture of the underlying actin structures reflecting the mechanistic interplay between cellular structure and mechanics. Using force spectroscopy we find that tension in NMuMG cells slightly increases 24 h after EMT induction, whereas upon reaching the final mesenchymal-like state characterized by a complete loss of intercellular junctions and a concerted down-regulation of the adherens junction protein E-cadherin, the overall tension becomes similar to that of solitary adherent cells and fibroblasts. Interestingly, the contribution of the actin cytoskeleton on apical tension increases significantly upon EMT induction, most likely due to the formation of stable and highly contractile stress fibers which dominate the elastic properties of the cells after the transition. The structural alterations lead to the formation of single, highly motile cells rendering apical tension a good indicator for the cellular state during phenotype switching. In summary, our study paves the way towards a more profound understanding of cellular mechanics governing fundamental morphological programs such as the EMT.	[Schneider, David; Baronsky, Thilo; Pietuch, Anna; Rother, Jan; Oelkers, Marieelen; Janshoff, Andreas] Univ Gottingen, Inst Phys Chem, Gottingen, Germany; [Fichtner, Dagmar; Wedlich, Doris] Karlsruhe Inst Technol, Inst Cell & Dev Biol, D-76021 Karlsruhe, Germany	University of Gottingen; Helmholtz Association; Karlsruhe Institute of Technology	Janshoff, A (corresponding author), Univ Gottingen, Inst Phys Chem, Tammannstr 6, Gottingen, Germany.	ajansho@gwdg.de	Janshoff, Andreas/B-8711-2009	Janshoff, Andreas/0000-0002-0773-2963	Dorothea Schlozer Scholarship program of the Georg-August-University of Gottingen; Boehringer Ingelheim Fond; SFB [937]	Dorothea Schlozer Scholarship program of the Georg-August-University of Gottingen; Boehringer Ingelheim Fond(Boehringer Ingelheim); SFB(Austrian Science Fund (FWF))	This work is financially supported by the Dorothea Schlozer Scholarship program (A.P.) of the Georg-August-University of Gottingen, the Boehringer Ingelheim Fond (J.R.) and the SFB 937 (A.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz J, 2003, BIOPHYS J, V84, P2071, DOI 10.1016/S0006-3495(03)75014-0; Alcaraz J, 2002, LANGMUIR, V18, P716, DOI 10.1021/la0110850; Nieto MA, 2009, INT J DEV BIOL, V53, P1541, DOI 10.1387/ijdb.072410mn; Bajpai S, 2009, J BIOL CHEM, V284, P18252, DOI 10.1074/jbc.M109.000661; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583; Bianchi A, 2010, CELL CYCLE, V9, P1647, DOI 10.4161/cc.9.8.11517; Boulant S, 2011, NAT CELL BIOL, V13, P1124, DOI 10.1038/ncb2307; Brown KA, 2004, BREAST CANCER RES, V6, pR215, DOI 10.1186/bcr778; Buckley ST, 2012, NANOMED-NANOTECHNOL, V8, P355, DOI 10.1016/j.nano.2011.06.021; Cavey M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002998; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Darenfed H, 2007, CELL MOTIL CYTOSKEL, V64, P97, DOI 10.1002/cm.20168; Diz-Munoz A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000544; Engin S, 2010, LANGMUIR, V26, P6097, DOI 10.1021/la904829y; EVANS EA, 1976, BIOPHYS J, V16, P585, DOI 10.1016/S0006-3495(76)85713-X; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; Fabry B, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.041914; Fabry B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.148102; Ferrer-Vaquer A, 2010, CELL ADHES MIGR, V4, P447, DOI 10.4161/cam.4.3.10771; Fine T, 2009, SOFT MATTER, V5, P3262, DOI 10.1039/b901714c; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Groulx N, 2006, J MEMBRANE BIOL, V214, P43, DOI 10.1007/s00232-006-0080-8; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Haynes J, 2011, MOL BIOL CELL, V22, P4750, DOI 10.1091/mbc.E11-02-0119; Hills CE, 2012, DIABETOLOGIA, V55, P812, DOI 10.1007/s00125-011-2409-9; HOCHMUTH RM, 1982, BIOPHYS J, V39, P71, DOI 10.1016/S0006-3495(82)84492-5; Hochmuth RM, 1996, BIOPHYS J, V70, P358, DOI 10.1016/S0006-3495(96)79577-2; Huang RYJ, 2012, J CELL SCI, V125, P4417, DOI 10.1242/jcs.099697; Ishizaki T, 2000, MOL PHARMACOL, V57, P976; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927; Jones WR, 1999, J BIOMECH, V32, P119, DOI 10.1016/S0021-9290(98)00166-3; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kollmannsberger P, 2009, SOFT MATTER, V5, P1771, DOI 10.1039/b820228a; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Krieg M, 2008, ANGEW CHEM INT EDIT, V47, P9775, DOI 10.1002/anie.200803552; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Larson SM, 2010, MOL BIOL CELL, V21, P3182, DOI 10.1091/mbc.E10-01-0066; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Liu LH, 2011, J CELL BIOL, V194, P815, DOI 10.1083/jcb.201102090; Lomakina EB, 2004, BIOPHYS J, V87, P4246, DOI 10.1529/biophysj.103.031765; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mahaffy RE, 2000, PHYS REV LETT, V85, P880, DOI 10.1103/PhysRevLett.85.880; Marcus WD, 2002, ANN BIOMED ENG, V30, P1273, DOI 10.1114/1.1528614; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; McGrail DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033248; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Oliver WC, 2004, J MATER RES, V19, P3, DOI 10.1557/jmr.2004.19.1.3; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Paluch E, 2009, CURR BIOL, V19, pR790, DOI 10.1016/j.cub.2009.07.029; Piek E, 1999, J CELL SCI, V112, P4557; Pietuch A, 2013, SOFT MATTER, V9, P11490, DOI 10.1039/c3sm51610e; Pietuch A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130084; Pietuch A, 2013, BBA-MOL CELL RES, V1833, P712, DOI 10.1016/j.bbamcr.2012.11.006; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Roca-Cusachs P, 2006, BIOPHYS J, V91, P3508, DOI 10.1529/biophysj.106.088831; Roubinet C, 2011, J CELL BIOL, V195, P99, DOI 10.1083/jcb.201106048; Schafer E, 2013, MECH PROPERTIES GIAN; Schneider D, 2012, BIOCHEM BIOPH RES CO, V419, P221, DOI 10.1016/j.bbrc.2012.01.151; Schneider D, 2011, BBA-MOL CELL RES, V1813, P2099, DOI 10.1016/j.bbamcr.2011.07.016; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Sekyrova P, 2012, SEMIN CANCER BIOL, V22, P369, DOI 10.1016/j.semcancer.2012.05.007; Sen S, 2005, BIOPHYS J, V89, P3203, DOI 10.1529/biophysj.105.063826; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Shook D, 2003, MECH DEVELOP, V120, P1351, DOI 10.1016/j.mod.2003.06.005; SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286, DOI 10.1152/ajpcell.1995.269.1.C286; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Sun M, 2007, J CELL SCI, V120, P2223, DOI 10.1242/jcs.001370; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thoelking G, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/26/265102; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; Venkov C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025354; Wendt MK, 2011, MOL BIOL CELL, V22, P2423, DOI 10.1091/mbc.E11-04-0306; WILLIAMS TJ, 1981, ARCH BIOCHEM BIOPHYS, V209, P555, DOI 10.1016/0003-9861(81)90313-1; Zhu C, 2000, ANNU REV BIOMED ENG, V2, P189, DOI 10.1146/annurev.bioeng.2.1.189	81	41	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80068	10.1371/journal.pone.0080068	http://dx.doi.org/10.1371/journal.pone.0080068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339870	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100009
J	Suzuki, R; Ito, N; Uno, Y; Nishii, I; Kagiwada, S; Okada, S; Noguchi, T				Suzuki, Reiko; Ito, Naoko; Uno, Yuki; Nishii, Ichiro; Kagiwada, Satoshi; Okada, Sigeru; Noguchi, Tetsuko			Transformation of Lipid Bodies Related to Hydrocarbon Accumulation in a Green Alga, Botryococcus braunii (Race B)	PLOS ONE			English	Article							SINAPIS-ALBA L; TETRATERPENOID HYDROCARBON; TRITERPENOID HYDROCARBONS; SQUALENE SYNTHASE; ER MEMBRANE; OIL BODIES; BIOSYNTHESIS; STRAINS; DROPLETS; SITES	The colonial microalga Botryococcus braunii accumulates large quantities of hydrocarbons mainly in the extracellular space; most other oleaginous microalgae store lipids in the cytoplasm. Botryococcus braunii is classified into three principal races (A, B, and L) based on the types of hydrocarbons. Race B has attracted the most attention as an alternative to petroleum by its higher hydrocarbon contents than the other races and its hydrocarbon components, botryococcenes and methylsqualenes, both can be readily converted into biofuels. We studied race B using fluorescence and electron microscopy, and clarify the stage when extracellular hydrocarbon accumulation occurs during the cell cycle, in a correlation with the behavior and structural changes of the lipid bodies and discussed development of the algal colony. New accumulation of lipids on the cell surface occurred after cell division in the basolateral region of daughter cells. While lipid bodies were observed throughout the cell cycle, their size and inclusions were dynamically changing. When cells began dividing, the lipid bodies increased in size and inclusions until the extracellular accumulation of lipids started. Most of the lipids disappeared from the cytoplasm concomitant with the extracellular accumulation, and then reformed. We therefore hypothesize that lipid bodies produced during the growth of B. braunii are related to lipid secretion. New lipids secreted at the cell surface formed layers of oil droplets, to a maximum depth of six layers, and fused to form flattened, continuous sheets. The sheets that combined a pair of daughter cells remained during successive cellular divisions and the colony increased in size with increasing number of cells.	[Suzuki, Reiko; Ito, Naoko; Uno, Yuki; Kagiwada, Satoshi; Noguchi, Tetsuko] Nara Womens Univ, Dept Biol Sci, Nara 630, Japan; [Nishii, Ichiro] Temasek Life Sci Lab, Singapore, Singapore; [Nishii, Ichiro] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Okada, Sigeru] Univ Tokyo, Dept Aquat Biosci, Bunkyo Ku, Tokyo, Japan; [Suzuki, Reiko; Nishii, Ichiro; Kagiwada, Satoshi; Okada, Sigeru; Noguchi, Tetsuko] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan	Nara Womens University; National University of Singapore; University of Tokyo; Japan Science & Technology Agency (JST)	Noguchi, T (corresponding author), Nara Womens Univ, Dept Biol Sci, Nara 630, Japan.	noguchi@cc.nara-wu.ac.jp	Okada, Shigeru/U-8305-2017	Okada, Shigeru/0000-0003-3663-7778	CREST project of the Japan Science and Technology Agency	CREST project of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST))	This work was supported by the CREST project of the Japan Science and Technology Agency http://www.jst.go.jp/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achitouv E, 2004, PHYTOCHEMISTRY, V65, P3159, DOI 10.1016/j.phytochem.2004.09.015; [Anonymous], 1998, [No title captured]; BERGFELD R, 1978, PLANTA, V143, P297, DOI 10.1007/BF00392002; BERKALOFF C, 1984, J PHYCOL, V20, P377, DOI 10.1111/j.0022-3646.1984.00377.x; CASADEVALL E, 1984, TETRAHEDRON LETT, V25, P4123, DOI 10.1016/S0040-4039(01)90198-4; Chapman KD, 2012, J LIPID RES, V53, P215, DOI 10.1194/jlr.R021436; Cheng JL, 2009, HISTOCHEM CELL BIOL, V132, P281, DOI 10.1007/s00418-009-0615-z; Davidi L, 2012, PLANTA, V236, P19, DOI 10.1007/s00425-011-1585-7; Eroglu E, 2011, J APPL PHYCOL, V23, P763, DOI 10.1007/s10811-010-9577-8; Furuhashi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066483; Goodson C, 2011, EUKARYOT CELL, V10, P1592, DOI 10.1128/EC.05242-11; HILLEN LW, 1982, BIOTECHNOL BIOENG, V24, P193, DOI 10.1002/bit.260240116; Hirose M, 2013, EUKARYOT CELL, V12, P1132, DOI 10.1128/EC.00088-13; Hu Q, 2008, PLANT J, V54, P621, DOI 10.1111/j.1365-313X.2008.03492.x; Huang AHC, 1996, PLANT PHYSIOL, V110, P1055, DOI 10.1104/pp.110.4.1055; Kanda H, 2013, FUEL, V105, P535, DOI 10.1016/j.fuel.2012.08.032; Kita K, 2010, APPL ENERG, V87, P2420, DOI 10.1016/j.apenergy.2009.11.036; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1081, DOI 10.1016/0031-9422(80)83060-3; LARGEAU C, 1980, PHYTOCHEMISTRY, V19, P1043, DOI 10.1016/0031-9422(80)83054-8; Magota A, 2012, BIORESOURCE TECHNOL, V123, P195, DOI 10.1016/j.biortech.2012.07.095; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Matsushima D, 2012, PLANT SCI, V185, P309, DOI 10.1016/j.plantsci.2012.01.002; Metzger P, 2005, APPL MICROBIOL BIOT, V66, P486, DOI 10.1007/s00253-004-1779-z; METZGER P, 1987, PHYTOCHEMISTRY, V26, P129; METZGER P, 1989, PHYTOCHEMISTRY, V28, P2349, DOI 10.1016/S0031-9422(00)97982-2; METZGER P, 1987, TETRAHEDRON LETT, V28, P3931, DOI 10.1016/S0040-4039(00)96423-2; METZGER P, 1990, J PHYCOL, V26, P258, DOI 10.1111/j.0022-3646.1990.00258.x; METZGER P, 1985, PHYTOCHEMISTRY, V24, P2305, DOI 10.1016/S0031-9422(00)83032-0; Metzger P, 2007, ORG GEOCHEM, V38, P566, DOI 10.1016/j.orggeochem.2006.12.003; Moellering ER, 2011, TRENDS PLANT SCI, V16, P98, DOI 10.1016/j.tplants.2010.11.004; Murphy DJ, 1999, TRENDS BIOCHEM SCI, V24, P109, DOI 10.1016/S0968-0004(98)01349-8; Niehaus TD, 2011, P NATL ACAD SCI USA, V108, P12260, DOI 10.1073/pnas.1106222108; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Okada S, 2004, ARCH BIOCHEM BIOPHYS, V422, P110, DOI 10.1016/j.abb.2003.12.004; Okada S, 1995, J APPL PHYCOL, V7, P555, DOI 10.1007/BF00003942; Okada S, 2000, ARCH BIOCHEM BIOPHYS, V373, P307, DOI 10.1006/abbi.1999.1568; REST JA, 1972, PLANTA, V105, P245, DOI 10.1007/BF00385396; Robenek H, 2006, J CELL SCI, V119, P4215, DOI 10.1242/jcs.03191; Sato Y, 2003, TETRAHEDRON LETT, V44, P7035, DOI 10.1016/S0040-4039(03)01784-2; SCHNEPF E, 1978, Botanische Jahrbuecher fuer Systematik Pflanzengeschichte und Pflanzengeographie, V99, P370; SCHWARZENBACH A M, 1971, Cytobiologie, V4, P145; Suzuki M, 2011, J ELECTRON MICROSC, V60, pS101, DOI 10.1093/jmicro/dfr016; TEMPLIER J, 1984, PHYTOCHEMISTRY, V23, P1017, DOI 10.1016/S0031-9422(00)82602-3; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wang ZT, 2009, EUKARYOT CELL, V8, P1856, DOI 10.1128/EC.00272-09; WANNER G, 1981, PLANTA, V151, P109, DOI 10.1007/BF00387812; Weiss TL, 2012, EUKARYOT CELL, V11, P1424, DOI 10.1128/EC.00184-12; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; WOLF FR, 1981, J PHYCOL, V17, P395, DOI 10.1111/j.1529-8817.1981.tb00868.x; YATSU LY, 1972, PLANT PHYSIOL, V49, P937, DOI 10.1104/pp.49.6.937	50	24	24	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81626	10.1371/journal.pone.0081626	http://dx.doi.org/10.1371/journal.pone.0081626			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339948	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100069
J	Bled, F; Sauer, J; Pardieck, K; Doherty, P; Royle, JA				Bled, Florent; Sauer, John; Pardieck, Keith; Doherty, Paul; Royle, J. Andrew			Modeling Trends from North American Breeding Bird Survey Data: A Spatially Explicit Approach	PLOS ONE			English	Article							POPULATION-CHANGE; FOREST BIRDS; ABUNDANCE; NEEDS	Population trends, defined as interval-specific proportional changes in population size, are often used to help identify species of conservation interest. Efficient modeling of such trends depends on the consideration of the correlation of population changes with key spatial and environmental covariates. This can provide insights into causal mechanisms and allow spatially explicit summaries at scales that are of interest to management agencies. We expand the hierarchical modeling framework used in the North American Breeding Bird Survey (BBS) by developing a spatially explicit model of temporal trend using a conditional autoregressive (CAR) model. By adopting a formal spatial model for abundance, we produce spatially explicit abundance and trend estimates. Analyses based on large-scale geographic strata such as Bird Conservation Regions (BCR) can suffer from basic imbalances in spatial sampling. Our approach addresses this issue by providing an explicit weighting based on the fundamental sample allocation unit of the BBS. We applied the spatial model to three species from the BBS. Species have been chosen based upon their well-known population change patterns, which allows us to evaluate the quality of our model and the biological meaning of our estimates. We also compare our results with the ones obtained for BCRs using a nonspatial hierarchical model (Sauer and Link 2011). Globally, estimates for mean trends are consistent between the two approaches but spatial estimates provide much more precise trend estimates in regions on the edges of species ranges that were poorly estimated in non-spatial analyses. Incorporating a spatial component in the analysis not only allows us to obtain relevant and biologically meaningful estimates for population trends, but also enables us to provide a flexible framework in order to obtain trend estimates for any area.	[Bled, Florent; Sauer, John; Pardieck, Keith; Royle, J. Andrew] US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA; [Bled, Florent; Doherty, Paul] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA	United States Department of the Interior; United States Geological Survey; Colorado State University	Bled, F (corresponding author), US Geol Survey, Patuxent Wildlife Res Ctr, Laurel, MD USA.	florent.bled@gmail.com		Royle, Jeffrey/0000-0003-3135-2167	United States Geological Survey (USGS)	United States Geological Survey (USGS)(United States Geological Survey)	This research was supported by the United States Geological Survey (USGS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; Andrle R. F., 1988, ATLAS BREEDING BIRDS; [Anonymous], 2010, R LANG ENV STAT COMP; Askins Robert A., 1993, Current Ornithology, V11, P1; Bahn V, 2006, ECOGRAPHY, V29, P835, DOI 10.1111/j.2006.0906-7590.04621.x; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Best N, 2005, STAT METHODS MED RES, V14, P35, DOI 10.1191/0962280205sm388oa; BirdLife International, 2008, IUCN 2010 IUCN RED L; Bohlen H. D., 1989, BIRDS ILLINOIS; Bystrak D, 1979, SIALIA, V1, P74; Coleman DC, 2010, BIG ECOLOGY: THE EMERGENCE OF ECOSYSTEM SCIENCE, P1; Costanza R, 2001, DYNAMIC SYSTEMS MODE, P21; DesGranges JL, 2010, AVIAN CONSERV ECOL, V5; Dinsmore J.J., 1984, IOWA BIRDS; Dunn EH, 2002, CONSERV BIOL, V16, P1632, DOI 10.1046/j.1523-1739.2002.01250.x; Dunn J. L., 1997, FIELD GUIDE WARBLERS; Ellner SP, 2002, J COMPUT GRAPH STAT, V11, P348; EMLEN JT, 1986, AUK, V103, P791, DOI 10.1093/auk/103.4.791; GHOSH M, 1994, STAT SCI, V9, P55, DOI 10.1214/ss/1177010647; GRABER JW, 1979, WILSON BULL, V91, P88; Haggerty TM, 1995, BIRDS N AM ONLINE; Hamel P.B., 2000, CERULEAN WARBLER STA; He ZQ, 2000, BIOMETRICS, V56, P360, DOI 10.1111/j.0006-341X.2000.00360.x; HERKERT JR, 1995, AM MIDL NAT, V134, P41, DOI 10.2307/2426481; Hess P, 1992, PENNSYLVANIA BIRDS, V6, P15; Jackson Jerome A., 1998, Bird Observer (Arlington), V26, P4; JAMES DA, 1986, ARKANSAS BIRDS THEIR; Keitt TH, 2002, ECOGRAPHY, V25, P616, DOI 10.1034/j.1600-0587.2002.250509.x; Keller M, 2008, FRONT ECOL ENVIRON, V6, P282, DOI 10.1890/1540-9295(2008)6[282:ACSFTN]2.0.CO;2; Krebs J.R., 1978, P23; Law J, 2004, GEOGR ANAL, V36, P197, DOI 10.1111/j.1538-4632.2004.tb01132.x; Lawson A. B., 2003, DIS MAPPING WINBUGS; Lennon JJ, 2000, ECOGRAPHY, V23, P101, DOI 10.1034/j.1600-0587.2000.230111.x; Link WA, 1998, ECOL APPL, V8, P258, DOI 10.1890/1051-0761(1998)008[0258:EPCFCD]2.0.CO;2; Link WA, 2002, ECOLOGY, V83, P2832, DOI 10.1890/0012-9658(2002)083[2832:AHAOPC]2.0.CO;2; Link WA, 2007, ECOLOGY, V88, P49, DOI 10.1890/0012-9658(2007)88[49:SCOAPC]2.0.CO;2; Lovett GM, 2007, FRONT ECOL ENVIRON, V5, P253, DOI 10.1890/1540-9295(2007)5[253:WNEM]2.0.CO;2; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Meade GM, 1988, ATLAS BREEDING BIRDS, P228; Moseley Edwin L., 1947, AUK, V64, P15; Peterjohn Bruce G., 1995, P3; PETERJOHN PG, 1994, WILDLIFE SOC B, V22, P155; Petersen, 1993, BIRDS MASSACHUSETTS; Rao J.N.K., 2003, SMALL AREA ESTIMATIO; Rao JNK, 2004, AGR SURVEY METHODS, V9, P139; Rich TD, 2004, PARTNERS FLIGHT; ROBBINS C. S., 1986, RESOURCE PUBLICATION, V157, piii; ROBBINS CS, 1992, ECOLOGY AND CONSERVATION OF NEOTROPICAL MIGRANT LANDBIRDS, P549; ROBBINS CS, 1989, WILDLIFE MONOGR, P1; Robinson L. J., 1977, BIRD OBSERVER E MASS, V5, P195; Royle J. A., 2008, HIERARCHICAL MODELIN; Sauer J.R, 2002, N AM BREEDING BIRD S; Sauer JR, 2008, J WILDLIFE MANAGE, V72, P204, DOI 10.2193/2006-534; Sauer JR, 2011, AUK, V128, P87, DOI 10.1525/auk.2010.09220; Sauer JR, 2002, ECOLOGY, V83, P1743, DOI 10.2307/3071992; Sauer JR, 2010, N AM BREEDING BIRD S; Scott JM, 1997, GAP ANAL BIODIVERSIT, P321; Shackelford CE, 2000, RED BELLIED WOODPECK; Shaddick G, 2008, WORKSH BAYES HIER MO; Siriwardena GM, 1998, J APPL ECOL, V35, P24, DOI 10.1046/j.1365-2664.1998.00275.x; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Sullivan E., 1992, Connecticut Warbler, V12, P24; Tamar H, 1978, INDIANA AUDUBON Q, V56, P9; Thogmartin WE, 2004, ECOL APPL, V14, P1766, DOI 10.1890/03-5247; Thomas A., 2004, GEOBUGS USER MANUAL; Thomas L, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P71; Townsend Charles W. A, 1909, Auk Cambridge Mass, V26; U.S. Fish and Wildlife Service Division of Migratory Bird Management, 2008, BIRDS CONS 2008	69	26	26	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81867	10.1371/journal.pone.0081867	http://dx.doi.org/10.1371/journal.pone.0081867			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349141	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200016
J	Shi, L; Wang, DF; Chu, WCW; Liu, SP; Xiong, YY; Wang, YL; Wang, YJ; Wong, LKS; Mok, VCT				Shi, Lin; Wang, Defeng; Chu, Winnie C. W.; Liu, Shangping; Xiong, Yunyun; Wang, Yilong; Wang, Yongjun; Wong, Lawrence K. S.; Mok, Vincent C. T.			Abnormal Organization of White Matter Network in Patients with No Dementia after Ischemic Stroke	PLOS ONE			English	Article							VASCULAR COGNITIVE IMPAIRMENT; STRUCTURAL CORTICAL NETWORKS; SMALL-WORLD; BRAIN NETWORKS; FUNCTIONAL REORGANIZATION; CONNECTIVITY PATTERNS; ANATOMICAL NETWORK; DIFFUSION; TRACTOGRAPHY; DYSFUNCTION	Structural changes after ischemic stroke could affect information communication extensively in the brain network. It is likely that the defects in the white matter (WM) network play a key role in information interchange. In this study, we used graph theoretical analysis to examine potential organization alteration in the WM network architecture derived from diffusion tensor images from subjects with no dementia and experienced stroke in the past 5.4-14.8 months (N = 47, Mini-Mental Screening Examination, MMSE range 18-30), compared with a normal control group with 44 age and gender-matched healthy volunteers (MMSE range 26-30). Region-wise connectivity was derived from fiber connection density of 90 different cortical and subcortical parcellations across the whole brain. Both normal controls and patients with chronic stroke exhibited efficient small-world properties in their WM structural networks. Compared with normal controls, topological efficiency was basically unaltered in the patients with chronic stroke, as reflected by unchanged local and global clustering coefficient, characteristic path length, and regional efficiency. No significant difference in hub distribution was found between normal control and patient groups. Patients with chronic stroke, however, were found to have reduced betweenness centrality and predominantly located in the orbitofrontal cortex, whereas increased betweenness centrality and vulnerability were observed in parietal-occipital cortex. The National Institutes of Health Stroke Scale (NIHSS) score of patient is correlated with the betweenness centrality of right pallidum and local clustering coefficient of left superior occipital gyrus. Our findings suggest that patients with chronic stroke still exhibit efficient small-world organization and unaltered topological efficiency, with altered topology at orbitofrontal cortex and parietal-occipital cortex in the overall structural network. Findings from this study could help in understanding the mechanism of cognitive impairment and functional compensation occurred in patients with chronic stroke.	[Shi, Lin; Wang, Defeng; Chu, Winnie C. W.; Liu, Shangping] Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Shi, Lin] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China; [Wang, Defeng] CUHK Shenzhen Res Inst, Shenzhen, Peoples R China; [Xiong, Yunyun; Wong, Lawrence K. S.; Mok, Vincent C. T.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Wang, Yilong; Wang, Yongjun] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China	Chinese University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS; Chinese University of Hong Kong; Capital Medical University	Wang, DF (corresponding author), Chinese Univ Hong Kong, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	dfwang@cuhk.edu.hk; vctmok@cuhk.edu.hk	Chu, Winnie CW/F-8449-2014; Wong, Ka Sing Lawrence/N-3434-2015; Mok, Vincent/N-6421-2015; Shi, Lin/K-5241-2014; Xiong, Yunyun/B-3658-2014	Chu, Winnie CW/0000-0003-4962-4132; Wong, Ka Sing Lawrence/0000-0002-2031-9866; Mok, Vincent/0000-0002-8102-8835; Shi, Lin/0000-0003-2318-4669; Xiong, Yunyun/0000-0003-1353-2295	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 411811, 475711, 416712, 473012]; Shenzhen Science and Technology Innovation Committee [JC201005250030A, JCYJ20120619152326449]; National Natural Science Foundation of China [81101111, 81201157, 81271653]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Shenzhen Science and Technology Innovation Committee; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work described in this paper was supported by grants from the Research Grants Council of the Hong Kong Special Administrative Region, China (Project No. CUHK 411811, 475711, 416712, 473012), grants from Shenzhen Science and Technology Innovation Committee (Project No. JC201005250030A and JCYJ20120619152326449), and grants from the National Natural Science Foundation of China (Project No. 81101111, 81201157, 81271653). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Andersson J.L.R., 2007, TR07JA2 FMRIB; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black S, 2009, STROKE, V40, pS48, DOI 10.1161/STROKEAHA.108.537704; Breier JI, 2008, AM J NEURORADIOL, V29, P483, DOI 10.3174/ajnr.A0846; Brodtmann A, 2012, J NEUROL SCI, V322, P122, DOI 10.1016/j.jns.2012.07.019; Buch ER, 2012, BRAIN, V135, P596, DOI 10.1093/brain/awr331; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carter AR, 2010, ANN NEUROL, V67, P365, DOI 10.1002/ana.21905; Cha J, 2013, EUR J NEUROSCI, V37, P1916, DOI 10.1111/ejn.12177; Chen YK, 2009, CLIN NEUROL NEUROSUR, V111, P852, DOI 10.1016/j.clineuro.2009.08.019; Cheng H, 2012, J NEUROSCI METH, V203, P264, DOI 10.1016/j.jneumeth.2011.09.021; Cloutman LL, 2011, BRAIN LANG, V116, P14, DOI 10.1016/j.bandl.2010.09.002; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Crofts JJ, 2011, NEUROIMAGE, V54, P161, DOI 10.1016/j.neuroimage.2010.08.032; del Ser T, 2005, STROKE, V36, P2670, DOI 10.1161/01.STR.0000189626.71033.35; Duarte-Carvajalino JM, 2012, NEUROIMAGE, V59, P3784, DOI 10.1016/j.neuroimage.2011.10.096; Dudink J, 2012, ARCH DIS CHILD-FETAL, V97, pF362, DOI 10.1136/archdischild-2011-300121; Eaton KP, 2008, NEUROIMAGE, V41, P311, DOI 10.1016/j.neuroimage.2008.02.033; Fan FM, 2013, HUM BRAIN MAPP, V34, P1872, DOI 10.1002/hbm.22034; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; FOULKES MA, 1988, STROKE, V19, P547, DOI 10.1161/01.STR.19.5.547; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hanggi J, 2011, J NEUROSCI, V31, P5816, DOI 10.1523/JNEUROSCI.0964-10.2011; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Indefrey P, 2001, P NATL ACAD SCI USA, V98, P5933, DOI 10.1073/pnas.101118098; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jiang L, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/924192; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Kim DJ, 2011, BRAIN CONNECT, V1, P473, DOI 10.1089/brain.2011.0053; Kramer JH, 2002, J NEUROL NEUROSUR PS, V72, P217, DOI 10.1136/jnnp.72.2.217; Lassalle-Lagadec S, 2012, RADIOLOGY, V264, P218, DOI 10.1148/radiol.12111718; Lazar M, 2010, NMR BIOMED, V23, P821, DOI 10.1002/nbm.1579; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Leys D, 2005, LANCET NEUROL, V4, P752, DOI 10.1016/S1474-4422(05)70221-0; Lo CY, 2010, J NEUROSCI, V30, P16876, DOI 10.1523/JNEUROSCI.4136-10.2010; Mok V, 2005, DEMENT GERIATR COGN, V20, P225, DOI 10.1159/000087310; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Nakamura T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008220; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nitkunan A, 2006, NMR BIOMED, V19, P610, DOI 10.1002/nbm.1052; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P963, DOI 10.1001/archneur.65.7.963; Onnela JP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.065103; Ramos-Estebanez C, 2008, DEMENT GERIATR COGN, V25, P451, DOI 10.1159/000124753; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Seo SW, 2010, J NEUROIMAGING, V20, P37, DOI 10.1111/j.1552-6569.2008.00293.x; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shu N, 2011, CEREB CORTEX, V21, P2565, DOI 10.1093/cercor/bhr039; Shu N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007228; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Specht K, 2009, NEUROIMAGE, V47, P2057, DOI 10.1016/j.neuroimage.2009.06.011; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Stebbins GT, 2008, STROKE, V39, P785, DOI 10.1161/STROKEAHA.107.507392; TATEMICHI TK, 1994, J NEUROL NEUROSUR PS, V57, P202, DOI 10.1136/jnnp.57.2.202; Tian LX, 2011, NEUROIMAGE, V54, P191, DOI 10.1016/j.neuroimage.2010.07.066; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vaessen MJ, 2012, CEREB CORTEX, V22, P2139, DOI 10.1093/cercor/bhr298; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Meer MPA, 2012, J NEUROSCI, V32, P4495, DOI 10.1523/JNEUROSCI.3662-11.2012; Varoquaux G, 2010, LECT NOTES COMPUT SC, V6361, P200; Wang CS, 2006, NEUROBIOL AGING, V27, P1827, DOI 10.1016/j.neurobiolaging.2005.10.008; Wang JY, 2012, NEUROIMAGE, V60, P1127, DOI 10.1016/j.neuroimage.2011.12.062; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Watkins KE, 2008, BRAIN, V131, P50, DOI 10.1093/brain/awm241; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wen W, 2004, STROKE, V35, P2813, DOI 10.1161/01.STR.0000147034.25760.3d; Wen W, 2011, J NEUROSCI, V31, P1204, DOI 10.1523/JNEUROSCI.4085-10.2011; Williamson J, 2010, J CLIN EXP NEUROPSYC, V32, P673, DOI 10.1080/13803390903427406; Wong A, 2013, J NEUROL NEUROSUR PS, V84, P499, DOI 10.1136/jnnp-2012-304041; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	87	14	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81388	10.1371/journal.pone.0081388	http://dx.doi.org/10.1371/journal.pone.0081388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349063	Green Submitted, Green Published, gold			2022-12-27	WOS:000328734200010
J	Bouwland-Both, MI; van Mil, NH; Stolk, L; Eilers, PHC; Verbiest, MMPJ; Heijmans, BT; Tiemeier, H; Hofman, A; Steegers, EAP; Jaddoe, VWV; Steegers-Theunissen, RPM				Bouwland-Both, Marieke I.; van Mil, Nina H.; Stolk, Lisette; Eilers, Paul H. C.; Verbiest, Michael M. P. J.; Heijmans, Bastiaan T.; Tiemeier, Henning; Hofman, Albert; Steegers, Eric A. P.; Jaddoe, Vincent W. V.; Steegers-Theunissen, Regine P. M.			DNA Methylation of IGF2DMR and H19 Is Associated with Fetal and Infant Growth: The Generation R Study	PLOS ONE			English	Article							FOR-GESTATIONAL-AGE; DEVELOPMENTAL ORIGINS; LONGITUDINAL DATA; GENE; PREGNANCY; HEALTH; EXPRESSION; STATEMENT; PATTERNS; CHILDREN	Changes in epigenetic programming of embryonic growth genes during pregnancy seem to affect fetal growth. Therefore, in a population-based prospective birth cohort in the Netherlands, we examined associations between fetal and infant growth and DNA methylation of IGF2DMR, H19 and MTHFR. For this study, we selected 69 case children born small-for-gestational age (SGA, birth weight,<-2SDS) and 471 control children. Fetal growth was assessed with serial ultrasound measurements. Information on birth outcomes was retrieved from medical records. Infant weight was assessed at three and six months. Methylation was assessed in DNA extracted from umbilical cord white blood cells. Analyses were performed using linear mixed models with DNA methylation as dependent variable. The DNA methylation levels of IGF2DMR and H19 in the control group were, median (90% range), 53.6% (44.5-61.6) and 30.0% (25.6-34.2) and in the SGA group 52.0% (43.9-60.9) and 30.5% (23.9-32.9), respectively. The MTHFR region was found to be hypomethylated with limited variability in the control and SGA group, 2.5% (1.4-4.0) and 2.4% (1.5-3.8), respectively. SGA was associated with lower IGF2DMR DNA methylation (beta = -1.07, 95% CI -1.93; -0.21, P-value = 0.015), but not with H19 methylation. A weight gain in the first three months after birth was associated with lower IGF2DMR DNA methylation (beta = -0.53, 95% CI -0.91; -0.16, P-value = 0.005). Genetic variants in the IGF2/H19 locus were associated with IGF2DMR DNA methylation (P-value < 0.05), but not with H19 methylation. Furthermore, our results suggest a possibility of mediation of DNA methylation in the association between the genetic variants and SGA. To conclude, IGF2DMR and H19 DNA methylation is associated with fetal and infant growth.	[Bouwland-Both, Marieke I.; van Mil, Nina H.; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, Rotterdam, Netherlands; [Bouwland-Both, Marieke I.; van Mil, Nina H.; Steegers, Eric A. P.; Steegers-Theunissen, Regine P. M.] Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands; [van Mil, Nina H.; Tiemeier, Henning] Erasmus MC, Dept Child & Adolescent Psychiat Psychol, Rotterdam, Netherlands; [Stolk, Lisette; Verbiest, Michael M. P. J.] Erasmus MC, Dept Internal Med, Rotterdam, Netherlands; [Stolk, Lisette; Heijmans, Bastiaan T.] Netherlands Consortium Hlth Aging, Rotterdam, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Dept Biostat, Rotterdam, Netherlands; [Heijmans, Bastiaan T.] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Tiemeier, Henning; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, Rotterdam, Netherlands; [Steegers-Theunissen, Regine P. M.] Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Steegers-Theunissen, RPM (corresponding author), Erasmus MC, Dept Obstet & Gynecol, Rotterdam, Netherlands.	r.steegers@erasmusmc.nl	Tiemeier, Henning/H-6534-2019	Tiemeier, Henning/0000-0002-4395-1397	Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development [ZonMw 21000074]; Bo Hjelt Foundation [2009]	Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Bo Hjelt Foundation	The first phase of the Generation R study was made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, and the Netherlands Organization for Health Research and Development (ZonMw 21000074). M. I. Bouwland-Both is financially supported by the Bo Hjelt Foundation (Grant 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amero S, 2008, J MED GENET, V45, P193, DOI 10.1136/jmg.2007.053017; Adkins RM, 2010, PEDIATR RES, V68, P429, DOI 10.1203/PDR.0b013e3181f1ca99; Ally MS, 2009, CANCER EPIDEM BIOMAR, V18, P922, DOI 10.1158/1055-9965.EPI-08-0703; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Bergen NE, 2012, BJOG-INT J OBSTET GY, V119, P739, DOI 10.1111/j.1471-0528.2012.03321.x; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Coolman M, 2010, J CLIN EPIDEMIOL, V63, P932, DOI 10.1016/j.jclinepi.2009.10.010; de Graaf JP, 2013, CURR OPIN OBSTET GYN, V25, P98, DOI 10.1097/GCO.0b013e32835ec9b0; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Dominguez-Salas P, 2012, P NUTR SOC, V71, P154, DOI 10.1017/S0029665111003338; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Friso S, 2002, P NATL ACAD SCI USA, V99, P5606, DOI 10.1073/pnas.062066299; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Guo L, 2008, DEV BIOL, V320, P79, DOI 10.1016/j.ydbio.2008.04.025; HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Herzog E, 2012, REPROD SCI, V19, p164A; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2012, EUR J EPIDEMIOL, V27, P739, DOI 10.1007/s10654-012-9735-1; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; McKay JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033290; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Nafee TM, 2008, BJOG-INT J OBSTET GY, V115, P158, DOI 10.1111/j.1471-0528.2007.01528.x; NIKLASSON A, 1991, ACTA PAEDIATR SCAND, V80, P756, DOI 10.1111/j.1651-2227.1991.tb11945.x; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Smerieri A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029562; St-Pierre J, 2012, EPIGENETICS-US, V7, P1125, DOI 10.4161/epi.21855; Steegers-Theunissen RP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007845; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; Talens RP, 2012, AGING CELL, V11, P694, DOI 10.1111/j.1474-9726.2012.00835.x; Talens RP, 2010, FASEB J, V24, P3135, DOI 10.1096/fj.09-150490; Tobi EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037933; Tobi EW, 2011, EPIGENETICS-US, V6, P171, DOI 10.4161/epi.6.2.13516; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Yanney Michael, 2004, Semin Fetal Neonatal Med, V9, P411, DOI 10.1016/j.siny.2004.03.005	39	42	43	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81731	10.1371/journal.pone.0081731	http://dx.doi.org/10.1371/journal.pone.0081731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349121	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800025
J	Hsieh, YF; Liu, GY; Lee, YJ; Yang, JJ; Sandor, K; Sarang, Z; Bononi, A; Pinton, P; Tretter, L; Szondy, Z; Tsay, GJ				Hsieh, Yu-Fan; Liu, Guang-Yaw; Lee, Yi-Ju; Yang, Jiann-Jou; Sandor, Katalin; Sarang, Zsolt; Bononi, Angela; Pinton, Paolo; Tretter, Laszlo; Szondy, Zsuzsa; Tsay, Gregory J.			Transglutaminase 2 Contributes to Apoptosis Induction in Jurkat T Cells by Modulating Ca2+ Homeostasis via Cross-Linking RAP1GDS1	PLOS ONE			English	Article							MITOCHONDRIA-ASSOCIATED MEMBRANES; TISSUE TRANSGLUTAMINASE; ENDOPLASMIC-RETICULUM; PHOSPHOLIPASE-C; CALCIUM; DIFFERENTIATION; ACTIVATION; EXPRESSION; MECHANISM; PROTEIN	Background: Transglutaminase 2 (TG2) is a protein cross-linking enzyme known to be associated with the in vivo apoptosis program of T cells. However, its role in the T cell apoptosis program was not investigated yet. Results: Here we report that timed overexpression of both the wild type (wt) and the cross-linking mutant of TG2 induced apoptosis in Jurkat T cells, the wt being more effective. Part of TG2 colocalised with mitochondria. WtTG2-induced apoptosis was characterized by enhanced mitochondrial Ca2+ uptake. Ca2+-activated wtTG2 cross-linked RAP1, GTP-GDP dissociation stimulator 1, an unusual guanine exchange factor acting on various small GTPases, to induce a yet uncharacterized signaling pathway that was able to promote the Ca2+ release from the endoplasmic reticulum via both Ins(3)P and ryanodine sensitive receptors leading to a consequently enhanced mitochondrial Ca2+ uptake. Conclusions: Our data indicate that TG2 might act as a Ca2+ sensor to amplify endoplasmic reticulum-derived Ca2+ signals to enhance mitochondria Ca2+ uptake. Since enhanced mitochondrial Ca2+ levels were previously shown to sensitize mitochondria for various apoptotic signals, our data demonstrate a novel mechanism through which TG2 can contribute to the induction of apoptosis in certain cell types. Since, as compared to knock out cells, physiological levels of TG2 affected Ca2+ signals in mouse embryonic fibroblasts similar to Jurkat cells, our data might indicate a more general role of TG2 in the regulation of mitochondrial Ca2+ homeostasis.	[Hsieh, Yu-Fan; Liu, Guang-Yaw; Lee, Yi-Ju; Tsay, Gregory J.] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Yang, Jiann-Jou] Chung Shan Med Univ, Dept Biomed Sci, Taichung, Taiwan; [Sandor, Katalin; Sarang, Zsolt; Szondy, Zsuzsa] Univ Debrecen, Dept Biochem & Mol Biol, Res Ctr Mol Med, Debrecen, Hungary; [Bononi, Angela; Pinton, Paolo] Univ Ferrara, Dept Expt & Diagnost Med, Sect Gen Pathol, ICSI,LTTA, I-44100 Ferrara, Italy; [Tretter, Laszlo] Semmelweis Univ, Dept Med Biochem, Neurobiochem Grp, Hungarian Acad Sci, H-1085 Budapest, Hungary; [Tsay, Gregory J.] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; University of Debrecen; University of Ferrara; Hungarian Academy of Sciences; Semmelweis University; Chung Shan Medical University; Chung Shan Medical University Hospital	Szondy, Z (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Res Ctr Mol Med, Debrecen, Hungary.	szondy@med.unideb.hu; gjt@csmu.edu.tw	Sandor, Katalin Danielne/E-6791-2017; Pinton, Paolo/J-8025-2012; Yang, Jiann-Jou/E-9502-2011; Sarang, Zsolt/A-7513-2012; Tretter, Laszlo/ACI-2689-2022	Sandor, Katalin Danielne/0000-0002-3153-617X; Pinton, Paolo/0000-0001-7108-6508; Sandor, Katalin/0000-0003-2892-4865; Yang, Jiann-Jou/0000-0002-9019-2178	National Science Council (NSC) [NSC 95-2745-B-040-007, NSC 96-2314-B-040-013-MY3, NSC97-29111-I-040-001, NSC 96-2911-I-040-002, NSC98-2811-B-040-004, NS99-2314-B-040-006-MY3, NSC99-2911-I-040-001, NSC 99-2811-B-040-005]; Chung Shan Medical University Hospital grand [CSH-2010-D-2002, CSH-2012-D-001]; Hungarian National Research Fund [OTKA K 77587, 83865, 104228, NK105046]; European Social Fund; European Regional Development Fund; Hungarian Taiwanese bilateral agreement; Italian Association for Cancer Research (AIRC); Telethon [GGP09128, GGP11139B]; University of Ferrara; Italian Ministry of Education, University and Research (COFIN); Italian Ministry of Education, University and Research (FIRB); Italian Ministry of Education, University and Research (Futuro in Ricerca); Italian Ministry of Health;  [TAMOP 4.2.2. A-11/1/KONV-2012-0023]	National Science Council (NSC)(Ministry of Science and Technology, Taiwan); Chung Shan Medical University Hospital grand; Hungarian National Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission); Hungarian Taiwanese bilateral agreement; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon); University of Ferrara; Italian Ministry of Education, University and Research (COFIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Italian Ministry of Education, University and Research (FIRB)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Education, University and Research (Futuro in Ricerca)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health(Ministry of Health, Italy); 	This study was supported by National Science Council (NSC) (NSC 95-2745-B-040-007, NSC 96-2314-B-040-013-MY3, NSC97-29111-I-040-001, NSC 96-2911-I-040-002, NSC98-2811-B-040-004, NS99-2314-B-040-006-MY3, NSC99-2911-I-040-001, NSC 99-2811-B-040-005) and Chung Shan Medical University Hospital grand (CSH-2010-D-2002 and CSH-2012-D-001), Hungarian National Research Fund (OTKA K 77587, 83865, 104228, NK105046), TAMOP 4.2.2. A-11/1/KONV-2012-0023 "VED-ELEM" project (implemented through the New Hungary Development Plan co-financed by the European Social Fund and the European Regional Development Fund), a Hungarian Taiwanese bilateral agreement, the Italian Association for Cancer Research (AIRC), Telethon (GGP09128 and GGP11139B), local funds from the University of Ferrara, the Italian Ministry of Education, University and Research (COFIN, FIRB and Futuro in Ricerca), and Italian Ministry of Health to PP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amendola A, 1996, P NATL ACAD SCI USA, V93, P11057, DOI 10.1073/pnas.93.20.11057; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bernassola F, 2002, FASEB J, V16, P1371, DOI 10.1096/fj.01-0689com; BOYER JL, 1989, J BIOL CHEM, V264, P884; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; D'Eletto M, 2009, AUTOPHAGY, V5, P1145, DOI 10.4161/auto.5.8.10040; Fesus L, 2005, FEBS LETT, V579, P3297, DOI 10.1016/j.febslet.2005.03.063; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Flourakis M, 2006, FASEB J, V20, P1215, DOI 10.1096/fj.05-5254fje; FOLK JE, 1985, METHOD ENZYMOL, V113, P358; Garabuczi E, 2013, AMINO ACIDS, V44, P235, DOI 10.1007/s00726-011-1119-4; Holz GG, 2004, DIABETES, V53, P5, DOI 10.2337/diabetes.53.1.5; Hoth M, 1997, J CELL BIOL, V137, P633, DOI 10.1083/jcb.137.3.633; Hutchinson JP, 2000, METHOD ENZYMOL, V325, P71; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Khan AA, 1996, SCIENCE, V273, P503, DOI 10.1126/science.273.5274.503; Kiraly R, 2011, FEBS J, V278, P4717, DOI 10.1111/j.1742-4658.2011.08345.x; LEE KN, 1993, BIOCHIM BIOPHYS ACTA, V1202, P1, DOI 10.1016/0167-4838(93)90055-V; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; MAGNIER C, 1994, BIOCHEM J, V297, P343, DOI 10.1042/bj2970343; MELINO G, 1994, MOL CELL BIOL, V14, P6584, DOI 10.1128/MCB.14.10.6584; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Mishra S, 2006, BIOCHEM BIOPH RES CO, V339, P726, DOI 10.1016/j.bbrc.2005.11.071; Oliverio S, 1997, MOL CELL BIOL, V17, P6040, DOI 10.1128/MCB.17.10.6040; PALADE P, 1989, MOL PHARMACOL, V36, P673; Patergnani S, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-19; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pinton P, 2001, EMBO J, V20, P2690, DOI 10.1093/emboj/20.11.2690; Rizzuto R, 1998, SCIENCE, V280, P1763, DOI 10.1126/science.280.5370.1763; Rodolfo C, 2004, J BIOL CHEM, V279, P54783, DOI 10.1074/jbc.M410938200; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Singh US, 2003, J BIOL CHEM, V278, P391, DOI 10.1074/jbc.M206361200; Smaili SS, 2003, BRAZ J MED BIOL RES, V36, P183, DOI 10.1590/S0100-879X2003000200004; Szalai G, 1999, EMBO J, V18, P6349, DOI 10.1093/emboj/18.22.6349; Szondy Z, 1997, FEBS LETT, V404, P307, DOI 10.1016/S0014-5793(97)00140-3; Szondy Z, 2006, CELL DEATH DIFFER, V13, P1827, DOI 10.1038/sj.cdd.4401889; Taylor CW, 2012, MOL CELL ENDOCRINOL, V353, P21, DOI 10.1016/j.mce.2011.08.028; Vaux DL, 2011, BBA-MOL CELL RES, V1813, P546, DOI 10.1016/j.bbamcr.2010.08.002; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Yi SJ, 2009, J BIOL CHEM, V284, P35645, DOI 10.1074/jbc.M109.062240	44	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81516	10.1371/journal.pone.0081516	http://dx.doi.org/10.1371/journal.pone.0081516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349085	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000328730300035
J	Mekonnen, TA; Odden, MC; Coxson, PG; Guzman, D; Lightwood, J; Wang, YC; Bibbins-Domingo, K				Mekonnen, Tekeshe A.; Odden, Michelle C.; Coxson, Pamela G.; Guzman, David; Lightwood, James; Wang, Y. Claire; Bibbins-Domingo, Kirsten			Health Benefits of Reducing Sugar-Sweetened Beverage Intake in High Risk Populations of California: Results from the Cardiovascular Disease (CVD) Policy Model	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ADOLESCENT OVERWEIGHT; BODY-WEIGHT; CONSUMPTION; OBESITY; IMPACT; TROMSO; COST; SEX	Background: Consumption of sugar-sweetened beverage (SSB) has risen over the past two decades, with over 10 million Californians drinking one or more SSB per day. High SSB intake is associated with risk of type 2 diabetes, obesity, hypertension, and coronary heart disease (CHD). Reduction of SSB intake and the potential impact on health outcomes in California and among racial, ethnic, and low-income sub-groups has not been quantified. Methods: We projected the impact of reduced SSB consumption on health outcomes among all Californians and California subpopulations from 2013 to 2022. We used the CVD Policy Model - CA, an established computer simulation of diabetes and heart disease adapted to California. We modeled a reduction in SSB intake by 10-20% as has been projected to result from proposed penny-per-ounce excise tax on SSB and modeled varying effects of this reduction on health parameters including body mass index, blood pressure, and diabetes risk. We projected avoided cases of diabetes and CHD, and associated health care cost savings in 2012 US dollars. Results: Over the next decade, a 10-20% SSB consumption reduction is projected to result in a 1.8-3.4% decline in the new cases of diabetes and an additional drop of 0.5-1% in incident CHD cases and 0.5-0.9% in total myocardial infarctions. The greatest reductions are expected in African Americans, Mexican Americans, and those with limited income regardless of race and ethnicity. This reduction in SSB consumption is projected to yield $320-620 million in medical cost savings associated with diabetes cases averted and an additional savings of $14-27 million in diabetes-related CHD costs avoided. Conclusions: A reduction of SSB consumption could yield substantial population health benefits and cost savings for California. In particular, racial, ethnic, and low-income subgroups of California could reap the greatest health benefits.	[Mekonnen, Tekeshe A.; Coxson, Pamela G.; Guzman, David; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Mekonnen, Tekeshe A.; Coxson, Pamela G.; Guzman, David; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Div Gen Internal Med, San Francisco Gen Hosp, San Francisco, CA 94143 USA; [Mekonnen, Tekeshe A.; Coxson, Pamela G.; Guzman, David; Bibbins-Domingo, Kirsten] San Francisco Gen Hosp, UCSF Ctr Vulnerable Populat, San Francisco, CA 94110 USA; [Odden, Michelle C.] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Lightwood, James] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Wang, Y. Claire] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; Oregon State University; University of California System; University of California San Francisco; Columbia University; University of California System; University of California San Francisco	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	kdomingo@medsfgh.ucsf.edu			National Institute on Minority Health and Health Disparities (NIMHD), Comprehensive Centers of Excellence [1P60MD006902]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30-DK092924]; Clinical and Translational Science Institute, Resource Allocation Program [UL1 RR024131]; American Heart Association, Western State Affiliates [09GRNT2060096, 11CRP7210088]; Ruth L. Kirschstein National Research Service Award [T32HP19025]; Robert Wood Johnson Foundation [68162]; National Institute on Minority Health and Health Disparities [P60MD006902] Funding Source: NIH RePORTER	National Institute on Minority Health and Health Disparities (NIMHD), Comprehensive Centers of Excellence; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Clinical and Translational Science Institute, Resource Allocation Program; American Heart Association, Western State Affiliates(American Heart Association); Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This project and Dr. Bibbins-Domingo were in part supported by grant 1P60MD006902 from the National Institute on Minority Health and Health Disparities (NIMHD), Comprehensive Centers of Excellence (http://www.nimhd.nih.gov/our_programs/centerOfExcellence.asp); by grant P30-DK092924 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (http://diabetestranslation.org/); by grant UL1 RR024131 from the Clinical and Translational Science Institute, Resource Allocation Program; and by grant 09GRNT2060096 from the American Heart Association, Western State Affiliates (http://tinyurl.com/allq24j). Dr. Odden was supported by a Ruth L. Kirschstein National Research Service Award (T32HP19025) (http://grants.nih.gov/training/nrsa.htm) and by grant 11CRP7210088 from the American Heart Association, Western State Affiliates (http://tinyurl.com/allq24j). Dr. Wang was support in part by grant #68162 from the Robert Wood Johnson Foundation (http://www.rwjf.org/en/grants.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2004, MED EXP PAN SURV PUB; Andreyeva T, 2010, AM J PUBLIC HEALTH, V100, P216, DOI 10.2105/AJPH.2008.151415; [Anonymous], 2012, NY TIMES; Babey Susan H, 2009, Policy Brief UCLA Cent Health Policy Res, P1; Bibbins-Domingo K, N ENGL J MED, V362, P590; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Brownell KD, 2010, HEALTH AFFAIR, V29, P379, DOI 10.1377/hlthaff.2009.0739; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; California Health Interview Survey (CHIS), 2001, CAL HLTH INT SURV CH; California Health Interview Survey (CHIS), 2005, CAL HLTH INT SURV CH; Chen LW, 2010, CIRCULATION, V121, P2398, DOI 10.1161/CIRCULATIONAHA.109.911164; Dhingra R, 2007, CIRCULATION, V116, P480, DOI 10.1161/CIRCULATIONAHA.107.689935; Diamant Allison L, 2003, Policy Brief UCLA Cent Health Policy Res, P1; Diamant Allison L, 2010, Policy Brief UCLA Cent Health Policy Res, P1; Division of Nutrition and Physical Activity, 2006, DOES DRINK BEV ADD S; Duffey KJ, 2007, OBESITY, V15, P2739, DOI 10.1038/oby.2007.326; Elbel B, 2012, NEW ENGL J MED, V367, P680, DOI 10.1056/NEJMc1208318; Fagherazzi G, 2013, AM J CLIN NUTR, V97, P517, DOI 10.3945/ajcn.112.050997; Finkelstein EA, 2012, J HLTH EC, V32, P219; Finkelstein EA, 2010, ARCH INTERN MED, V170, P2028, DOI 10.1001/archinternmed.2010.449; Fung TT, 2009, AM J CLIN NUTR, V89, P1037, DOI 10.3945/ajcn.2008.27140; Grynabaum M, 2013, NY TIMES; Guthrie A, 2013, WALL STREET J; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Kim D, 2006, AM J PREV MED, V30, P430, DOI 10.1016/j.amepre.2005.12.007; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; KQED-Public Media for Northern California, 2012, RICHMOND RESIDENTS W; Lightwood J, 2009, AM J PUBLIC HEALTH, V99, P2230, DOI 10.2105/AJPH.2008.152595; Ludwig DS, 2009, JAMA-J AM MED ASSOC, V302, P2477, DOI 10.1001/jama.2009.1822; Lustig RH, 2010, J AM DIET ASSOC, V110, P1307, DOI 10.1016/j.jada.2010.06.008; Malik VS, 2010, CIRCULATION, V121, P1356, DOI 10.1161/CIRCULATIONAHA.109.876185; National Heart Lung Blood Institute (NHLBI), 2000, NIH PUBLICATION; National Institutes of Health National Heart Lung Blood Institute (NHLBI), 2005, 055213 NHLBI; Odden MC, 2011, AM J MED, V124, P827, DOI 10.1016/j.amjmed.2011.04.010; Ogden C. L., 2011, NCHS Data Briefs; Petersen M, 2008, DIABETES CARE, V31, P1271, DOI 10.2337/dc08-9017; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Reynen DJ, 2011, BURDEN CARDIOVASCULA; Rudd Center for Food Policy and Obesity, 2009, RUDD REP SOFT DRINK; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Stookey JD, 2007, OBESITY, V15, P3013, DOI 10.1038/oby.2007.359; Swithers SE, 2013, TRENDS ENDOCRINOL ME; The California Endowment The Field Poll, 2013, 2012 FIELD TCE CHILD; United States Department of Labor Division of Consumer Prices and Price Indexes, 2010, CONS PRIC IND; Wang YC, 2012, HEALTH AFFAIR, V31, P199, DOI 10.1377/hlthaff.2011.0410; Wang YC, 2010, POTENTIAL IMPACT SUG; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Wilsgaard T, 2000, ARCH INTERN MED, V160, P2847, DOI 10.1001/archinte.160.18.2847; Wilsgaard T, 2004, ANN EPIDEMIOL, V14, P265, DOI 10.1016/j.annepidem.2003.08.004	49	40	41	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81723	10.1371/journal.pone.0081723	http://dx.doi.org/10.1371/journal.pone.0081723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349119	Green Submitted, gold, Green Published			2022-12-27	WOS:000328730300048
J	Nakamura, M; Kanda, T; Nakamoto, S; Miyamura, T; Jiang, X; Wu, S; Yokosuka, O				Nakamura, Masato; Kanda, Tatsuo; Nakamoto, Shingo; Miyamura, Tatsuo; Jiang, Xia; Wu, Shuang; Yokosuka, Osamu			No Correlation between PNPLA3 rs738409 Genotype and Fatty Liver and Hepatic Cirrhosis in Japanese Patients with HCV	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; NONALCOHOLIC STEATOHEPATITIS; HISTOLOGICAL SEVERITY; STEATOSIS; DISEASE; ASSOCIATION; PROGRESSION; FIBROSIS; IL28B; POLYMORPHISMS	Background: Hepatitis C virus (HCV) infection is associated with the development of cirrhosis and hepatocellular carcinoma and is also related to fatty change of the liver. Variation in patatin-like phospholipase domain-containing 3 (PNPLA3) gene is associated with disease progression in nonalcoholic fatty liver disease (NAFLD). Recent reports have suggested that PNPLA3, IL28B and TLR4-associated single nucleotide polymorphisms (SNPs) may have an impact on hepatic steatosis or fibrosis in patients with chronic HCV infection. Methods and Findings: Four SNPs (PNPLA3 rs738409, TLR4 rs4986790, TLR4 rs4986791, IL28B rs8099917) were identified in Japanese patients infected with HCV. We examined the association between the distribution of these SNP alleles and fatty change of the liver or existence of hepatic cirrhosis diagnosed by ultrasonography, one of the widely accessible and easy-to-use methods. PNPLA3 rs738409 G-allele and IL28B rs 8099917 minor allele were found in 70.0% and 31.1%, respectively. These two TLR4 SNPs were uniform in Japanese. Fatty change of the liver developed independent of the abscence of hepatic cirrhosis on sonographic findings and younger age. Hepatic cirrhosis was associated with a higher aspartate aminotransferase/platelet ratio index (APRI), no fatty change of the liver, higher BMI and higher AFP levels. No association between PNPLA3 rs738409/IL28B rs8099917 genotypes and hepatic steatosis or liver fibrosis was observed. Conclusions: According to ultrasound examinations, no association between PNPLA3 rs738409 genotype and fatty change of the liver or hepatic cirrhosis was found in Japanese patients infected with HCV. Together, our results suggested that the mechanism of hepatic steatosis underlying HCV infection might differ from that of NAFLD and should be explored.	[Nakamura, Masato; Kanda, Tatsuo; Nakamoto, Shingo; Miyamura, Tatsuo; Jiang, Xia; Wu, Shuang; Yokosuka, Osamu] Chiba Univ, Dept Gastroenterol & Nephrol, Grad Sch Med, Chiba, Japan; [Nakamoto, Shingo] Chiba Univ, Dept Mol Virol, Grad Sch Med, Chiba, Japan	Chiba University; Chiba University	Kanda, T (corresponding author), Chiba Univ, Dept Gastroenterol & Nephrol, Grad Sch Med, Chiba, Japan.	kandat@aol.com	Jiang, Xia/P-4220-2014	Jiang, Xia/0000-0003-4572-0039; Kanda, Tatsuo/0000-0002-1654-5385	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by grants for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (TK and SN), and grants from the Ministry of Health, Labour and Welfare of Japan (TK and OY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Bacon Bruce R, 2011, Mo Med, V108, P255; Brunt EM, 2004, SEMIN LIVER DIS, V24, P3; DiBisceglie AM, 1997, HEPATOLOGY, V26, pS34, DOI 10.1002/hep.510260706; Fabris C, 2011, J HEPATOL, V54, P716, DOI 10.1016/j.jhep.2010.07.019; Gaia S, 2011, J HEPATOL, V54, P64, DOI 10.1016/j.jhep.2010.06.022; Guo JS, 2009, HEPATOLOGY, V49, P960, DOI 10.1002/hep.22697; Harrison SA, 2005, CLIN GASTROENTEROL H, V3, P604, DOI 10.1016/S1542-3565(05)00246-6; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; Hotta K, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-172; Hu KQ, 2004, J HEPATOL, V40, P147, DOI 10.1016/S0168-8278(03)00479-3; Huang HJ, 2006, GASTROENTEROLOGY, V130, P1679, DOI 10.1053/j.gastro.2006.02.032; Hwang SJ, 2011, J GASTROEN HEPATOL, V26, P96, DOI 10.1111/j.1440-1746.2010.06542.x; Jiang X, 2013, IMMUNOL LETT, V152, P8, DOI 10.1016/j.imlet.2013.03.006; Kanayama Y, 2013, ULTRASOUND MED BIOL, V39, P692, DOI 10.1016/j.ultrasmedbio.2012.10.021; Kanda T, 2005, EUR J PEDIATR, V164, P212, DOI 10.1007/s00431-004-1584-9; Kanda T, 2005, HEPATO-GASTROENTEROL, V52, P180; Kanda T, 2007, HEPATO-GASTROENTEROL, V54, P1758; Kanda T, 2010, HEPATOL INT, V4, P548, DOI 10.1007/s12072-010-9193-3; Kawaguchi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038322; Kitamoto T, 2013, HUM GENET, V132, P783, DOI 10.1007/s00439-013-1294-3; KONDO F, 1990, HEPATOLOGY, V12, P592, DOI 10.1002/hep.1840120324; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Lavanchy D, 2011, CLIN MICROBIOL INFEC, V17, P107, DOI 10.1111/j.1469-0691.2010.03432.x; Leandro G, 2006, GASTROENTEROLOGY, V130, P1636, DOI 10.1053/j.gastro.2006.03.014; Li YH, 2009, J HEPATOL, V51, P750, DOI 10.1016/j.jhep.2009.04.027; Lorenz E, 2002, ARCH INTERN MED, V162, P1028, DOI 10.1001/archinte.162.9.1028; Miyamura T, 2012, VIRUSES-BASEL, V4, P1264, DOI 10.3390/v4081264; Miyamura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028617; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Nakamoto S, 2011, SCAND J GASTROENTERO, V46, P955, DOI 10.3109/00365521.2011.574731; Nakamura M, 2013, INT J MED SCI, V10, P1015, DOI 10.7150/ijms.6402; Nishina S, 2010, LIVER INT, V30, P683, DOI 10.1111/j.1478-3231.2010.02210.x; Patton HM, 2004, J HEPATOL, V40, P484, DOI 10.1016/j.jhep.2003.11.004; Poynard T, 2003, HEPATOLOGY, V38, P75, DOI 10.1053/jhep.2003.50267; Romeo S, 2010, INT J OBESITY, V34, P190, DOI 10.1038/ijo.2009.216; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; Rotman Y, 2010, HEPATOLOGY, V52, P894, DOI 10.1002/hep.23759; Rubbia-Brandt L, 2000, J HEPATOL, V33, P106, DOI 10.1016/S0168-8278(00)80166-X; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Sanyal AJ, 2011, HEPATOL RES, V41, P670, DOI 10.1111/j.1872-034X.2011.00824.x; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Sookoian S, 2011, HEPATOLOGY, V53, P1883, DOI 10.1002/hep.24283; Tamura R, 2011, J INFECT DIS, V204, P793, DOI 10.1093/infdis/jir381; TANAKA T, 1994, HEPATOLOGY, V19, P1347, DOI 10.1016/0270-9139(94)90226-7; Tanaka Y, 2009, NAT GENET, V41, P1105, DOI 10.1038/ng.449; Tillmann HL, 2011, J HEPATOL, V55, P1195, DOI 10.1016/j.jhep.2011.03.015; Trepo E, 2011, HEPATOLOGY, V54, P60, DOI 10.1002/hep.24350; Valenti L, 2011, HEPATOLOGY, V53, P791, DOI 10.1002/hep.24123; Wang AP, 2005, J AUTOIMMUN, V25, P85, DOI 10.1016/j.jaut.2005.05.003; Wu S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073615; Yoshioka Y, 2004, J GASTROENTEROL, V39, P1215, DOI 10.1007/s00535-004-1475-x	53	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81312	10.1371/journal.pone.0081312	http://dx.doi.org/10.1371/journal.pone.0081312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349054	gold, Green Published, Green Submitted			2022-12-27	WOS:000328730300025
J	Novitsky, V; Bussmann, H; Logan, A; Moyo, S; van Widenfelt, E; Okui, L; Mmalane, M; Baca, J; Buck, L; Phillips, E; Tim, D; McLane, MF; Lei, QH; Wang, R; Makhema, J; Lockman, S; DeGruttola, V; Essex, M				Novitsky, Vladimir; Bussmann, Hermann; Logan, Andrew; Moyo, Sikhulile; van Widenfelt, Erik; Okui, Lillian; Mmalane, Mompati; Baca, Jeannie; Buck, Lauren; Phillips, Eleanor; Tim, David; McLane, Mary Fran; Lei, Quanhong; Wang, Rui; Makhema, Joseph; Lockman, Shahin; DeGruttola, Victor; Essex, M.			Phylogenetic Relatedness of Circulating HIV-1C Variants in Mochudi, Botswana	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SUBTYPE B; TRANSMISSION NETWORKS; SEQUENCE ALIGNMENT; MOLECULAR EVIDENCE; ENV; RECOMBINATION; PHYLODYNAMICS; INDIVIDUALS; EVOLUTION	Background: Determining patterns of HIV transmission is increasingly important for the most efficient use of modern prevention interventions. HIV phylogeny can provide a better understanding of the mechanisms underlying HIV transmission networks in communities. Methods: To reconstruct the structure and dynamics of a local HIV/AIDS epidemic, the phylogenetic relatedness of HIV-1 subtype C env sequences obtained from 785 HIV-infected community residents in the northeastern sector of Mochudi, Botswana, during 2010-2013 was estimated. The genotyping coverage was estimated at 44%. Clusters were defined based on relatedness of HIV-1C env sequences and bootstrap support of splits. Results: The overall proportion of clustered HIV-1C env sequences was 19.1% (95% CI 17.5% to 20.8%). The proportion of clustered sequences from Mochudi was significantly higher than the proportion of non-Mochudi sequences that clustered, 27.0% vs. 14.7% (p = 5.8E-12; Fisher exact test). The majority of clustered Mochudi sequences (90.1%; 95% CI 85.1% to 93.6%) were found in the Mochudi-unique clusters. None of the sequences from Mochudi clustered with any of the 1,244 non-Botswana HIV-1C sequences. At least 83 distinct HIV-1C variants, or chains of HIV transmission, in Mochudi were enumerated, and their sequence signatures were reconstructed. Seven of 20 genotyped seroconverters were found in 7 distinct clusters. Conclusions: The study provides essential characteristics of the HIV transmission network in a community in Botswana, suggests the importance of high sampling coverage, and highlights the need for broad HIV genotyping to determine the spread of community-unique and community-mixed viral variants circulating in local epidemics. The proposed methodology of cluster analysis enumerates circulating HIV variants and can work well for surveillance of HIV transmission networks. HIV genotyping at the community level can help to optimize and balance HIV prevention strategies in trials and combined intervention packages.	[Novitsky, Vladimir; Baca, Jeannie; Buck, Lauren; Phillips, Eleanor; Tim, David; McLane, Mary Fran; Lockman, Shahin; Essex, M.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Bussmann, Hermann; Logan, Andrew; Moyo, Sikhulile; van Widenfelt, Erik; Okui, Lillian; Mmalane, Mompati; Makhema, Joseph] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Lei, Quanhong; Wang, Rui; DeGruttola, Victor] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health	Essex, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	messex@hsph.harvard.edu	Wang, Rui/X-1699-2019; Moyo, Sikhulile/E-1464-2015	Wang, Rui/0000-0001-5007-193X; Moyo, Sikhulile/0000-0003-3821-4592	National Institutes of Health (NIH) [R01 AI083036]; NIH [RC4 AI092715, D43 TW000004, R37 AI24643, R37 51164]; FOGARTY INTERNATIONAL CENTER [D43TW000004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024643, R01AI083036, R37AI051164, R37AI024643, RC4AI092715] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Mochudi Prevention Project in Botswana was supported and funded by National Institutes of Health (NIH) grant R01 AI083036, An HIV Prevention Program for Mochudi, Botswana. The HIV genotyping of samples in the GWAS study was supported by NIH grant RC4 AI092715. The presented work was supported in part by NIH grants D43 TW000004, R37 AI24643, and R37 51164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alix B, 2012, NUCLEIC ACIDS RES, V40, pW573, DOI 10.1093/nar/gks485; ARNOLD C, 1995, VIROLOGY, V211, P198, DOI 10.1006/viro.1995.1391; Bello G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-22; Beyrer C, 2013, CURR OPIN HIV AIDS, V8, P306, DOI 10.1097/COH.0b013e328361f53a; Blanchard A, 1998, J VIROL, V72, P4537, DOI 10.1128/JVI.72.5.4537-4540.1998; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brenner BG, 2011, J INFECT DIS, V204, P1115, DOI 10.1093/infdis/jir468; Brenner BG, 2008, AIDS, V22, P2509, DOI 10.1097/QAD.0b013e3283121c90; Brown AJL, 2011, J INFECT DIS, V204, P1463, DOI 10.1093/infdis/jir550; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Buskin SE, 2008, JAIDS-J ACQ IMM DEF, V49, P205, DOI 10.1097/QAI.0b013e318185727e; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Cho YK, 2011, AIDS RES HUM RETROV, V27, P613, DOI [10.1089/AID.2010.0174, 10.1089/aid.2010.0174]; Ciccozzi M, 2007, AIDS, V21, P1213, DOI 10.1097/QAD.0b013e32813aee1a; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DELWART EL, 1993, SCIENCE, V262, P1257, DOI 10.1126/science.8235655; Deng W, 2009, AIDS, V23, P977, DOI 10.1097/QAD.0b013e328329217d; Dennis AM, 2013, JAIDS-J ACQ IMM DEF, V63, P135, DOI 10.1097/QAI.0b013e318288b246; Dennis AM, 2012, AIDS, V26, P1813, DOI 10.1097/QAD.0b013e3283573244; Dugan KA, 2002, J FORENSIC SCI, V47, P811; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eshleman SH, 2011, J INFECT DIS, V204, P1918, DOI 10.1093/infdis/jir651; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Goujon CP, 2000, J VIROL, V74, P2525, DOI 10.1128/JVI.74.6.2525-2532.2000; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han ZG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-148; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; Heath TA, 2008, SYST BIOL, V57, P160, DOI 10.1080/10635150701884640; HILLIS DM, 1994, SCIENCE, V264, P671, DOI 10.1126/science.8171318; HILLIS DM, 1994, NATURE, V369, P24, DOI 10.1038/369024a0; HOLMES EC, 1993, J INFECT DIS, V167, P1411, DOI 10.1093/infdis/167.6.1411; Hughes GJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000590; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jafa K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005416; JAFFE HW, 1994, ANN INTERN MED, V121, P855, DOI 10.7326/0003-4819-121-11-199412010-00005; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kumar SB, 2011, J VIROL, V85, P7142, DOI 10.1128/JVI.01955-10; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lewis F, 2008, PLOS MED, V5, P392, DOI 10.1371/journal.pmed.0050050; Li Y, 2010, VIROLOGY, V402, P223, DOI 10.1016/j.virol.2010.03.048; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Metzker ML, 2002, P NATL ACAD SCI USA, V99, P14292, DOI 10.1073/pnas.222522599; Murillo W, 2013, J VIROL, V87, P7463, DOI 10.1128/JVI.01602-12; Nei M., 2000, MOL EVOLUTION PHYLOG; Novitsky V, 2008, AIDS CARE, V20, P806, DOI 10.1080/09540120701694055; Novitsky V, 2013, INFECT GENET EVOL, V19, P361, DOI 10.1016/j.meegid.2013.02.023; Novitsky V, 2010, VIRUSES-BASEL, V2, P33, DOI 10.3390/v2010033; Novitsky V, 2009, JAIDS-J ACQ IMM DEF, V50, P65, DOI 10.1097/QAI.0b013e3181900141; Novitsky V, 2009, VIROLOGY, V383, P47, DOI 10.1016/j.virol.2008.09.017; Novitsky V, 2011, AIDS, V25, P1515, DOI 10.1097/QAD.0b013e3283471eb2; Novitsky V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016714; OU CY, 1992, SCIENCE, V256, P1165, DOI 10.1126/science.256.5060.1165; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Paraskevis D, 2011, EURO SURVEILL, V16; Perez-Losada M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016902; Perez-Losada M, 2010, MOL BIOL EVOL, V27, P417, DOI 10.1093/molbev/msp254; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Prosperi MCF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1325; Russell ES, 2011, J VIROL, V85, P8253, DOI 10.1128/JVI.00197-11; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; Shapiro RL, 2006, AIDS, V20, P1281, DOI 10.1097/01.aids.0000232236.26630.35; Skar H, 2011, J VIROL, V85, P510, DOI 10.1128/JVI.01413-10; SMITH JM, 1992, J MOL EVOL, V34, P126; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telan EFO, 2011, J MED VIROL, V83, P941, DOI 10.1002/jmv.22070; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; UNAIDS, 2012, GLOBAL REPORT UNAIDS; Volz EM, 2009, GENETICS GENETICS, V109; Wester C. William, 2009, HIV Therapy, V3, P501, DOI 10.2217/HIV.09.35; Yirrell DI, 1997, BRIT MED J, V314, P1446, DOI 10.1136/bmj.314.7092.1446; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	83	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80589	10.1371/journal.pone.0080589	http://dx.doi.org/10.1371/journal.pone.0080589			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349005	Green Submitted, gold, Green Published			2022-12-27	WOS:000328730300011
J	Ito, H; Mo, QX; Qin, LX; Viale, A; Maithel, SK; Maker, AV; Shia, J; Kingham, P; Allen, P; DeMatteo, RP; Fong, YM; Jarnagin, WR; D'Angelica, M				Ito, Hiromichi; Mo, Qianxing; Qin, Li-Xuan; Viale, Agnes; Maithel, Shishir K.; Maker, Ajay V.; Shia, Jinru; Kingham, Peter; Allen, Peter; DeMatteo, Ronald P.; Fong, Yuman; Jarnagin, William R.; D'Angelica, Michael			Gene Expression Profiles Accurately Predict Outcome Following Liver Resection in Patients with Metastatic Colorectal Cancer	PLOS ONE			English	Article							HEPATIC RESECTION; SURGICAL RESECTION; SURVIVAL; RECURRENCE; CHEMOTHERAPY; SIGNATURE; CARCINOMA; INFUSION; TISSUES; SYSTEM	Purpose: The aim of this study was to build a molecular prognostic model based on gene signatures for patients with completely resected hepatic metastases from colorectal cancer (MCRC). Methods: Using the Illumina HumanHT-12 gene chip, RNA samples from the liver metastases of 96 patients who underwent R0 liver resection were analyzed. Patients were randomly assigned to a training (n = 60) and test (n = 36) set. The genes associated with disease-specific survival (DSS) and liver-recurrence-free survival (LRFS) were identified by Cox-regression and selected to construct a molecular risk score (MRS) using the supervised principle component method on the training set. The MRS was then evaluated in the independent test set. Results: Nineteen and 115 genes were selected to construct the MRS for DSS and LRFS, respectively. Each MRS was validated in the test set; 3-year DSS/LRFS rates were 42/32% and 79/80% for patients with high and low MRS, respectively (p = 0.007 for DSS and p = 0.046 for LRFS). In a multivariate model controlling for a previously validated clinical risk score (CRS), the MRS remained a significant predictor of DSS (p = 0.001) and LRFS (p = 0.03). When CRS and MRS were combined, the patients were discriminated better with 3-year DSS/LRFS rates of 90/89% in the low risk group (both risk scores low) vs 42/26% in the high risk group (both risk scores high), respectively (p = 0.002/0.004 for DSS/LRFS). Conclusion: MRS based on gene expression profiling has high prognostic value and is independent of CRS. This finding provides a potential strategy for better risk-stratification of patients with liver MCRC.	[Ito, Hiromichi; Maithel, Shishir K.; Maker, Ajay V.; Kingham, Peter; Allen, Peter; DeMatteo, Ronald P.; Fong, Yuman; Jarnagin, William R.; D'Angelica, Michael] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA; [Mo, Qianxing; Qin, Li-Xuan] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10021 USA; [Shia, Jinru] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Ito, Hiromichi] Michigan State Univ, Dept Surg, E Lansing, MI 48824 USA; [Mo, Qianxing] Baylor Coll Med, Dept Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Michigan State University; Baylor College of Medicine	D'Angelica, M (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, 1275 York Ave, New York, NY 10021 USA.	dangelim@mskcc.org	Ito, Hiromichi/AAV-8369-2020	Kingham, T Peter/0000-0002-3359-3186; Shia, Jinru/0000-0002-4351-2511				Ammirante M, 2010, P NATL ACAD SCI USA, V107, P7497, DOI 10.1073/pnas.0907696107; Arango D, 2005, GASTROENTEROLOGY, V129, P874, DOI 10.1053/j.gastro.2005.06.066; Ayez N, 2011, ANN SURG ONCOL, V18, P2757, DOI 10.1245/s10434-011-1819-8; Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Cady B, 1998, ANN SURG, V227, P566, DOI 10.1097/00000658-199804000-00019; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; COX DR, 1972, J R STAT SOC B, V34, P187; Czubayko F, 1997, NAT MED, V3, P1137, DOI 10.1038/nm1097-1137; D'Arrigo A, 2005, INT J CANCER, V115, P256, DOI 10.1002/ijc.20883; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Farid SG, 2010, ANN SURG, V251, P91, DOI 10.1097/SLA.0b013e3181bfda3c; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; House MG, 2010, J AM COLL SURGEONS, V210, P744, DOI 10.1016/j.jamcollsurg.2009.12.040; Ito H, 2008, ANN SURG, V247, P994, DOI 10.1097/SLA.0b013e31816c405f; Ito K, 2011, ANN SURG ONCOL; Iwatsuki S, 1999, J AM COLL SURGEONS, V189, P291, DOI 10.1016/S1072-7515(99)00089-7; Jansen MPHM, 2005, J CLIN ONCOL, V23, P732, DOI 10.1200/JCO.2005.05.145; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kemeny MM, 2002, J CLIN ONCOL, V20, P1499, DOI 10.1200/JCO.20.6.1499; Kemeny N, 1999, NEW ENGL J MED, V341, P2039, DOI 10.1056/NEJM199912303412702; Koehler A, 2004, J PATHOL, V204, P65, DOI 10.1002/path.1606; Nordlinger B, 1996, CANCER, V77, P1254, DOI 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R; OAKES D, 1982, BIOMETRICS, V38, P451, DOI 10.2307/2530458; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Poston GJ, 2008, J CLIN ONCOL, V26, P4828, DOI 10.1200/JCO.2008.17.6453; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; Satagopan JM, 2004, BRIT J CANCER, V91, P1229, DOI 10.1038/sj.bjc.6602102; Tomlinson JS, 2007, J CLIN ONCOL, V25, P4575, DOI 10.1200/JCO.2007.11.0833; Tsunoda Y, 2008, JPN J CLIN ONCOL, V38, P347, DOI 10.1093/jjco/hyn032; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zakaria S, 2007, ANN SURG, V246, P183, DOI 10.1097/SLA.0b013e3180603039	36	25	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81680	10.1371/journal.pone.0081680	http://dx.doi.org/10.1371/journal.pone.0081680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339954	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400030
J	Liu, ZG; Ji, T; Yin, L; Shen, J; Shen, F; Chen, GH				Liu, Zhenguo; Ji, Ting; Yin, Ling; Shen, Jie; Shen, Fang; Chen, Guohong			Transcriptome Sequencing Analysis Reveals the Regulation of the Hypopharyngeal Glands in the Honey Bee, Apis mellifera carnica Pollmann	PLOS ONE			English	Article							DIVISION-OF-LABOR; DEPENDENT ROLE CHANGE; ROYAL JELLY PROTEINS; GENE-EXPRESSION; PROTEOME COMPLEMENT; SOCIAL-BEHAVIOR; MESSENGER-RNAS; AGE POLYETHISM; POLLEN; IDENTIFICATION	Transcriptome sequencing has become the main methodology for analyzing the relationship between genes and characteristics of interests, particularly those associated with diseases and economic traits. Because of its role of functional food for humans, commercial royal jelly (RJ) and its production are major research focuses in the field of apiculture. Multiple lines of evidence have demonstrated that many factors affect RJ output by activating or inhibiting various target genes and signaling pathways. Available coding sequences from the Honey Bee Genome Sequencing Consortium have permitted a pathway-based approach for investigating the development of the hypopharyngeal glands (HGs). In the present study, 3573941, 3562730, 3551541, 3524453, and 3615558 clean reads were obtained from the HGs of five full-sister honey bee samples using Solexa RNA sequencing technology. These reads were then assembled into 18378, 17785, 17065, 17105, and 17995 unigenes, respectively, and aligned to the DFCI Honey Bee Gene Index database. The differentially expressed genes (DEGs) data were also correlated with detailed morphological data for HGs acini.	[Liu, Zhenguo; Ji, Ting; Yin, Ling; Shen, Jie; Shen, Fang; Chen, Guohong] Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China	Yangzhou University	Ji, T (corresponding author), Yangzhou Univ, Coll Anim Sci & Technol, Yangzhou, Jiangsu, Peoples R China.	tji@yzu.edu.cn			National Natural Science Foundation of China [31172272]; China Agriculture Research System [CARS-45-SYZ6]; Priority Academic Program Development (PAPD) of the Jiangsu Higher Education Institutions, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; Priority Academic Program Development (PAPD) of the Jiangsu Higher Education Institutions, China	This work is supported by the National Natural Science Foundation of China (number 31172272)(http://isisn.nsfc.gov.cn/egrantweb/main?datetimestamp=1362108445508), the China Agriculture Research System (CARS-45-SYZ6) (http://119.253.58.231/), and the Priority Academic Program Development (PAPD) of the Jiangsu Higher Education Institutions, China (http://jsycw.ec.js.edu.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Ament SA, 2008, P NATL ACAD SCI USA, V105, P4226, DOI 10.1073/pnas.0800630105; Ament SA, 2010, WIRES SYST BIOL MED, V2, P566, DOI 10.1002/wsbm.73; Babendreier D, 2005, APIDOLOGIE, V36, P585, DOI 10.1051/apido:2005049; Benjamini Y, 2001, ANNEALS STAT, V29, P1185; Blackiston H, 2009, BEEKEEPING DUMMIES, P21; Britto FB, 2006, MICRON, V37, P742, DOI 10.1016/j.micron.2006.03.002; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; BROUWERS EVM, 1982, J APICULT RES, V21, P193, DOI 10.1080/00218839.1982.11100541; Buttstedt A, 2014, BIOL REV, V89, P255, DOI 10.1111/brv.12052; Chanchao Chanpen, 2006, Journal of Apicultural Science, V50, P5; Chen GH, 2010, BEES GENETICS BREEDI, P56; Chen X, 2012, INSECT BIOCHEM MOLEC, V5, P9; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; CRAILSHEIM K, 1992, J INSECT PHYSIOL, V38, P409, DOI 10.1016/0022-1910(92)90117-V; CRAILSHEIM K, 1986, J INSECT PHYSIOL, V32, P629, DOI 10.1016/0022-1910(86)90092-2; Crailsheim K, 1998, J INSECT PHYSL, V34, P1093; CUI Y, 1995, GENE DEV, V9, P423, DOI 10.1101/gad.9.4.423; Deseyn J, 2005, APIDOLOGIE, V36, P49, DOI 10.1051/apido:2004068; Drapeau MD, 2006, GENOME RES, V16, P1385, DOI 10.1101/gr.5012006; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; Feng M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-645; Fields S, 2005, SCIENCE, V307, P1885, DOI 10.1126/science.1108872; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Graham J.M., 1999, HIVE HONEY BEE; Hassanein MH, 1952, EFFECTS INFECT NOSEM; Herb BR, 2012, NAT NEUROSCI, V15, P1371, DOI 10.1038/nn.3218; Huang SK, 2011, PHYSL HONEYBEE CHINA, P177; HUANG ZY, 1989, APIDOLOGIE, V20, P455, DOI 10.1051/apido:19890601; HUANG ZY, 1990, J APICULT RES, V29, P75, DOI 10.1080/00218839.1990.11101200; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Jung-Hoffmann I., 1966, BIENENFORSCH, V8, P296; Kamakura M, 2006, PROTEIN EXPRES PURIF, V45, P307, DOI 10.1016/j.pep.2005.08.004; Kamakura M, 2011, NATURE, V473, P478, DOI 10.1038/nature10093; KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Krell R, 1996, FAO AGR SERVICES B, V124; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291, DOI 10.1093/oxfordjournals.jbchem.a021237; Kunieda T, 2006, INSECT MOL BIOL, V15, P563, DOI 10.1111/j.1365-2583.2006.00677.x; LABEIT S, 1990, NATURE, V345, P273, DOI 10.1038/345273a0; Li JK, 2008, APIDOLOGIE, V39, P199, DOI 10.1051/apido:2007059; Li JK, 2010, J PROTEOME RES, V9, P6578, DOI 10.1021/pr100768t; Liu F, 2011, J INSECT PHYSIOL, V57, P274, DOI 10.1016/j.jinsphys.2010.11.015; Liu XJ, 2010, CURR MICROBIOL, V61, P422, DOI 10.1007/s00284-010-9633-2; Maurizio A., 1954, LANDWIRTSCH JB SCHWE, V68, P115, DOI DOI 10.1051/APIDO/2010012; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Naiem ES, 1999, J COMP PHYSIOL B, V169, P271, DOI 10.1007/s003600050221; Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Ohashi K, 2000, ZOOL SCI, V17, P1089, DOI 10.2108/zsj.17.1089; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509; Pernal SF, 2000, APIDOLOGIE, V31, P387, DOI 10.1051/apido:2000130; ROBINSON GE, 1992, ANNU REV ENTOMOL, V37, P637, DOI 10.1146/annurev.en.37.010192.003225; ROBINSON GE, 1987, BEHAV ECOL SOCIOBIOL, V20, P329, DOI 10.1007/BF00300679; Sano O, 2004, J AGR FOOD CHEM, V52, P15, DOI 10.1021/jf030340e; Santos KS, 2005, INSECT BIOCHEM MOLEC, V35, P85, DOI 10.1016/j.ibmb.2004.10.003; Scarselli R, 2005, PROTEOMICS, V5, P769, DOI 10.1002/pmic.200401149; Schmitzova J, 1998, CELL MOL LIFE SCI, V54, P1020, DOI 10.1007/s000180050229; Schulz DJ, 2002, HORM BEHAV, V42, P222, DOI 10.1006/hbeh.2002.1806; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Suwannapong Guntima, 2010, Psyche (Cambridge), V2010, P1, DOI 10.1155/2010/181025; Takenaka T, 1990, B FAC AGR TAMAGAWA U, V30, P8; Ueno T, 2009, ZOOL SCI, V26, P557, DOI 10.2108/zsj.26.557; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000896; Wang Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004899; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; Winnebeck EC, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.14119; Xue QZ, 2012, TOOLS ANAL DNA PROTE, P187; YAMAGUCHI M, 1992, MOL CELL BIOCHEM, V110, P25, DOI 10.1007/BF02385002; Yang HJ, 2013, NATURE, V497, P217, DOI 10.1038/nature12122; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Zeng ZJ, 2009, APIOLOGY, P123; Zeng ZJ, 2007, BIOL HONEYBEE, P36; Zheng AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020428; Zheng Huo-Qing, 2009, Acta Entomologica Sinica, V52, P210	79	19	24	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81001	10.1371/journal.pone.0081001	http://dx.doi.org/10.1371/journal.pone.0081001			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339892	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400009
J	Wang, J; Kang, QS; Lv, XG; Song, J; Zhan, N; Dong, WG; Huang, WH				Wang, Jing; Kang, Qin-shu; Lv, Xiao-guang; Song, Jia; Zhan, Na; Dong, Wei-guo; Huang, Wei-hua			Simple Patterned Nanofiber Scaffolds and Its Enhanced Performance in Immunoassay	PLOS ONE			English	Article							PROSTATE-CANCER; TUMOR-MARKERS; BIOMARKERS; SERUM; FABRICATION	Cancer has become the leading cause of death worldwide; early diagnosis and treatment of cancers is critical for the survival of the patients. The concentration of cancer markers in easy-to-access biological fluids can provide great assistance in screening for occult primary cancers, distinguishing malignant from benign findings, determining prognosis and prediction for cancer patients. The multiplex detection technology of a panel of cancer markers can greatly increase the accuracy of disease diagnosis. Herein, we briefly fabricate a high-throughput micro-immunoassay based on the electrospun polystyrene (PS) substrates to improve detection sensitivity. The immunoassay was evaluated by analyzing three different cancer biomarkers (AFP, CEA, VEGF). For AFP, CEA, VEGF immunofluorescence assay, the LOD of assay conducted on electrospun PS substrates before or after plasma and the conventional PS substrates were 0.42, 0.10, 1.12 ng/mL, 0.57, 0.09, 1.24 ng/mL, and 159.75, 26.19, 385.59 pg/mL, respectively (P < 0.05). Due to the high porosity and large surface area-to-volume ratio which is the foremost merit of nanostructures, and the plasma treatment which make the hydrophobic PS nanofibers hydropholic, the nanofibers substrates showed sufficient retention of immunoassay functionality and high potential for capture molecules immobilization. Consequently, the immunofluorescence assay conducted on electrospun PS substrates could significantly enhance the sensitivity and limits of detection.	[Wang, Jing; Lv, Xiao-guang; Song, Jia; Dong, Wei-guo] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China; [Kang, Qin-shu; Huang, Wei-hua] Wuhan Univ, Key Lab Analyt Chem Biol & Med, Minist Educ, Coll Chem & Mol Sci, Wuhan 430072, Peoples R China; [Kang, Qin-shu] Huazhong Agr Univ, Coll Sci, Wuhan, Peoples R China; [Zhan, Na] Wuhan Univ, Renmin Hosp, Dept Pathol, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University; Huazhong Agricultural University; Wuhan University	Dong, WG (corresponding author), Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430072, Peoples R China.	dwg@whu.edu.cn; whhuang@whu.edu.cn			Wuhan Planning Project of Science and Technology [200760423153, 201260523178-5]	Wuhan Planning Project of Science and Technology	This work was supported by Wuhan Planning Project of Science and Technology (200760423153, 201260523178-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Camarero JA, 2008, BIOPOLYMERS, V90, P450, DOI 10.1002/bip.20803; Chantasirichot S, 2012, BIOSENS BIOELECTRON, V38, P209, DOI 10.1016/j.bios.2012.05.029; Choi YE, 2010, SENSORS-BASEL, V10, P428, DOI 10.3390/s100100428; Creeden J, 2011, MOL DIAGN THER, V15, P129, DOI 10.2165/11591300-000000000-00000; Dong WG, 2003, WORLD J GASTROENTERO, V9, P2596; Duffy MJ, 2013, MED PRIN PRACT, V22, P4, DOI 10.1159/000338393; Garg K, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3567097; Henry NL, 2012, MOL ONCOL, V6, P140, DOI 10.1016/j.molonc.2012.01.010; Hermle J, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-32; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim BK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2247; Kotek R, 2008, POLYM REV, V48, P221, DOI 10.1080/15583720802020038; Li XH, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001087; Li ZY, 2008, J AM CHEM SOC, V130, P5036, DOI 10.1021/ja800176s; Lilja H, 2008, NAT REV CANCER, V8, P268, DOI 10.1038/nrc2351; Liu N, 2013, BIOSENS BIOELECTRON, V47, P92, DOI 10.1016/j.bios.2013.02.052; Long Y, 2010, ANAL CHIM ACTA, V665, P63, DOI 10.1016/j.aca.2010.03.009; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Siqueira JR, 2010, BIOSENS BIOELECTRON, V25, P1254, DOI 10.1016/j.bios.2009.09.043; Subbiah T, 2005, J APPL POLYM SCI, V96, P557, DOI 10.1002/app.21481; Wang G, 2006, J PHYS CHEM B, V110, P23777, DOI 10.1021/jp0635819; Wang XY, 2004, NANO LETT, V4, P331, DOI 10.1021/nl034885z; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu DP, 2010, ACS APPL MATER INTER, V2, P252, DOI 10.1021/am900664v; Yang DY, 2009, BIOMACROMOLECULES, V10, P3335, DOI 10.1021/bm900955p; Yang ZX, 2013, BIOSENS BIOELECTRON, V48, P153, DOI 10.1016/j.bios.2013.04.014	26	1	1	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82888	10.1371/journal.pone.0082888	http://dx.doi.org/10.1371/journal.pone.0082888			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340065	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400101
J	Zhou, ZY; Guo, C; Meng, H				Zhou, Zhiyong; Guo, Chao; Meng, He			Temperature Sensitivity and Basal Rate of Soil Respiration and Their Determinants in Temperate Forests of North China	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; PLANT; LITTER; DECOMPOSITION; VEGETATION; CLIMATE; ROOTS; Q(10)	The basal respiration rate at 10 degrees C (R-10) and the temperature sensitivity of soil respiration (Q(10)) are two premier parameters in predicting the instantaneous rate of soil respiration at a given temperature. However, the mechanisms underlying the spatial variations in R-10 and Q(10) are not quite clear. R-10 and Q(10) were calculated using an exponential function with measured soil respiration and soil temperature for 11 mixed conifer-broadleaved forest stands and nine broadleaved forest stands at a catchment scale. The mean values of R-10 were 1.83 mu mol CO2 m(-2) s(-1) and 2.01 mmol CO2 m 22 s(-1), the mean values of Q(10) were 3.40 and 3.79, respectively, for mixed and broadleaved forest types. Forest type did not influence the two model parameters, but determinants of R-10 and Q(10) varied between the two forest types. In mixed forest stands, R-10 decreased greatly with the ratio of coniferous to broadleaved tree species; whereas it sharply increased with the soil temperature range and the variations in soil organic carbon (SOC), and soil total nitrogen (TN). Q(10) was positively correlated with the spatial variances of herb-layer carbon stock and soil bulk density, and negatively with soil C/N ratio. In broadleaved forest stands, R-10 was markedly affected by basal area and the variations in shrub carbon stock and soil phosphorus (P) content; the value of Q(10) largely depended on soil pH and the variations of SOC and TN. 51% of variations in both R-10 and Q(10) can be accounted for jointly by five biophysical variables, of which the variation in soil bulk density played an overwhelming role in determining the amplitude of variations in soil basal respiration rates in temperate forests. Overall, it was concluded that soil respiration of temperate forests was largely dependent on soil physical properties when temperature kept quite low.	[Zhou, Zhiyong; Guo, Chao] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Zhou, Zhiyong; Guo, Chao] Beijing Forestry Univ, Inst Forestry & Climate Change Res, Beijing, Peoples R China; [Meng, He] Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Peoples R China	Beijing Forestry University; Beijing Forestry University; Inner Mongolia Agricultural University	Zhou, ZY (corresponding author), Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	zhiyong@bjfu.edu.cn			National Foundation of Natural Science of China [41003029]; Special Research Program for Public-Welfare Forestry of the State Forestry Administration of China [201104008]	National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Special Research Program for Public-Welfare Forestry of the State Forestry Administration of China	This study was jointly funded by the National Foundation of Natural Science of China (Grant No. 41003029) and by the Special Research Program for Public-Welfare Forestry of the State Forestry Administration of China (Grant No. 201104008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, MULTIVARIATE ANAL EC; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Brechet L, 2009, PLANT SOIL, V319, P235, DOI 10.1007/s11104-008-9866-z; Cheng F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067353; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Dupuis EM, 2007, CAN J SOIL SCI, V87, P479, DOI 10.4141/CJSS07001; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; GALLAHER RN, 1976, SOIL SCI SOC AM J, V40, P887, DOI 10.2136/sssaj1976.03615995004000060026x; Guo J, 1992, J BEIJING FORESTRY U, V14, P134; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; Hanson PJ, 2000, BIOGEOCHEMISTRY, V48, P115, DOI 10.1023/A:1006244819642; Janssens IA, 2003, GLOBAL CHANGE BIOL, V9, P911, DOI 10.1046/j.1365-2486.2003.00636.x; Jenkins M, 2010, GLOBAL CHANGE BIOL, V16, P209, DOI 10.1111/j.1365-2486.2009.01954.x; Jiang YM, 2012, J SOIL SEDIMENT, V12, P228, DOI 10.1007/s11368-011-0442-4; JOHN MK, 1970, SOIL SCI, V109, P214, DOI 10.1097/00010694-197004000-00002; Kang SY, 2003, GLOBAL CHANGE BIOL, V9, P1427, DOI 10.1046/j.1365-2486.2003.00668.x; Katayama A, 2009, AGR FOREST METEOROL, V149, P1666, DOI 10.1016/j.agrformet.2009.05.007; Keeney R.D., 1982, METHODS SOIL ANAL, P101; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Levy-Varon JH, 2012, OECOLOGIA, V169, P211, DOI 10.1007/s00442-011-2182-y; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Ma QY., 1983, J BEIJING FORESTRY C, V4, P1; Malcolm GM, 2009, SOIL BIOL BIOCHEM, V41, P1075, DOI 10.1016/j.soilbio.2009.02.011; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Resat H, 2012, MICROB ECOL, V63, P883, DOI 10.1007/s00248-011-9965-x; Rodeghiero M, 2005, GLOBAL CHANGE BIOL, V11, P1024, DOI 10.1111/j.1365-2486.2005.00963.x; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Soe ARB, 2005, TREE PHYSIOL, V25, P1427, DOI 10.1093/treephys/25.11.1427; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; van't Hoff JH, 1898, CHEM DYNAMICS 1, P224; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Xing SH, 2010, J SOIL SEDIMENT, V10, P748, DOI 10.1007/s11368-009-0159-9; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zheng ZM, 2009, SOIL BIOL BIOCHEM, V41, P1531, DOI 10.1016/j.soilbio.2009.04.013; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010	38	21	25	3	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81793	10.1371/journal.pone.0081793	http://dx.doi.org/10.1371/journal.pone.0081793			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339966	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400042
J	Wang, ZM; Mao, Y; Cui, TX; Tang, DQ; Wang, XL				Wang, Zemin; Mao, Yun; Cui, Taixing; Tang, Dongqi; Wang, Xing Li			Impact of a Combined High Cholesterol Diet and High Glucose Environment on Vasculature	PLOS ONE			English	Article							CONTROLLED-TRIAL; ZEBRAFISH; BLOOD; METABOLISM; EXPRESSION; MODEL; FLOW	Aims: Vascular complications are the leading cause of mortality and morbidity in patients with diabetes. However, proper animal models of diabetic vasculopathy that recapitulate the accelerated progression of vascular lesions in human are unavailable. In the present study, we developed a zebrafish model of diabetic vascular complications and the methodology for quantifying vascular lesion formation real-time in the living diabetic zebrafish. Methods and Results: Wild type zebrafish (AB) and transgenic zebrafish lines of fli1:EGFP, lyz:EGFP, gata1:dsRed, double transgenic zebrafish of gata1: dsRed/fli1:EGFP were exposed to high cholesterol diet and 3% glucose (HCD-HG) for 10 days. The zebrafish model with HCD-HG treatment was characterized by significantly increased tissue levels of insulin, glucagon, glucose, total triglyceride and cholesterol. Confocal microscopic analysis further revealed that the diabetic larvae developed clearly thickened endothelial layers, distinct perivascular lipid depositions, substantial accumulations of inflammatory cells in the injured vasculature, and a decreased velocity of blood flow. Moreover, the vascular abnormalities were improved by the treatment of pioglitazone and metformin. Conclusion: A combination of high cholesterol diet and high glucose exposure induces a rapid onset of vascular complications in zebrafish similar to the early atherosclerotic vascular injuries in mammalian diabetic models, suggesting that zebrafish may be used as a novel animal model for diabetic vasculopathy.	[Wang, Zemin; Mao, Yun; Cui, Taixing; Tang, Dongqi; Wang, Xing Li] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Res Ctr Cell Therapy, Jinan 250100, Peoples R China; [Cui, Taixing] Univ S Carolina, Dept Cell Biol & Anat, Columbus, SC USA; [Tang, Dongqi] Shandong Univ, Hosp 2, Ctr Stem Cell & Regenerat Med, Jinan 250100, Peoples R China	Shandong University; University of South Carolina; Shandong University	Cui, TX (corresponding author), Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Res Ctr Cell Therapy, Jinan 250100, Peoples R China.	Taixing.Cui@uscmed.sc.edu; tangdq@sdu.edu.cn; xingliwang@sdu.edu.cn		Cui, Taixing/0000-0002-9528-7299; Tang, Dongqi/0000-0002-1429-9467	Shandong University National Qianren Scholar Fund; Taishan Scholar Fund; National 973 Program Grant [2014CB542401]	Shandong University National Qianren Scholar Fund; Taishan Scholar Fund; National 973 Program Grant	This work was supported by the Shandong University National Qianren Scholar Fund (XLW) and Taishan Scholar Fund (TC and DT), and by the National 973 Program Grant (2014CB542401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Cefalu WT, 2006, ILAR J, V47, P186, DOI 10.1093/ilar.47.3.186; Collins R, 2003, LANCET, V361, P2005; Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Elo B, 2007, J MOL ENDOCRINOL, V38, P433, DOI 10.1677/JME-06-0037; Fang LH, 2010, J BIOL CHEM, V285, P32343, DOI 10.1074/jbc.M110.137257; Foley JE, 2009, NAT PROTOC, V4, P1855, DOI 10.1038/nprot.2009.209; Force A, 1999, GENETICS, V151, P1531; Gleeson M, 2007, ACTA DIABETOL, V44, P157, DOI 10.1007/s00592-007-0257-3; Gnugge L, 2004, METHOD CELL BIOL, V76, P531; Hansen A, 2002, DIABETES, V51, P3077, DOI 10.2337/diabetes.51.10.3077; Jiang GQ, 2003, AM J PHYSIOL-ENDOC M, V284, pE671, DOI 10.1152/ajpendo.00492.2002; Jurczyk A, 2011, GEN COMP ENDOCR, V170, P334, DOI 10.1016/j.ygcen.2010.10.010; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Liang JT, 2010, BIRTH DEFECTS RES A, V88, P480, DOI 10.1002/bdra.20654; Liu X, 2009, AM J PHYSIOL-HEART C, V297, pH163, DOI 10.1152/ajpheart.00266.2009; Murphey RD, 2006, METHODS, V39, P255, DOI 10.1016/j.ymeth.2005.09.019; Murphy S. L., 2012, NATL VITAL STAT REP, V60, P4; Olsen AS, 2010, WOUND REPAIR REGEN, V18, P532, DOI 10.1111/j.1524-475X.2010.00613.x; Powers JW, 2010, MOL GENET METAB, V101, P421, DOI 10.1016/j.ymgme.2010.09.012; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; Stoletov K, 2009, CIRC RES, V104, P952, DOI 10.1161/CIRCRESAHA.108.189803; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Watkins SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044018; Westerfield M, 1995, ZEBRAFISH BOOK	28	11	12	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81485	10.1371/journal.pone.0081485	http://dx.doi.org/10.1371/journal.pone.0081485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349075	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200030
J	Ding, ZH; Newton, AT; Xu, R; Anderson, AW; Morgan, VL; Gore, JC				Ding, Zhaohua; Newton, Allen T.; Xu, Ran; Anderson, Adam W.; Morgan, Victoria L.; Gore, John C.			Spatio-Temporal Correlation Tensors Reveal Functional Structure in Human Brain	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; CONNECTIVITY; FMRI; MRI; FLUCTUATIONS; ACTIVATION; CORTEX; DTI	Resting state functional magnetic resonance imaging (fMRI) has been commonly used to measure functional connectivity between cortical regions, while diffusion tensor imaging (DTI) can be used to characterize structural connectivity of white matter tracts. In principle combining resting state fMRI and DTI data could allow characterization of structure-function relations of distributed neural networks. However, due to differences in the biophysical origins of their signals and in the tissues to which they apply, there has been no direct integration of these techniques to date. We demonstrate that MRI signal variations and power spectra in a resting state are largely comparable between gray matter and white matter, that there are temporal correlations of fMRI signals that persist over long distances within distinct white matter structures, and that neighboring intervoxel correlations of low frequency resting state signals showed distinct anisotropy in many regions. These observations suggest that MRI signal variations from within white matter in a resting state may convey similar information as their corresponding fluctuations of MRI signals in gray matter. We thus derive a local spatio-temporal correlation tensor which captures directional variations of resting-state correlations and which reveals distinct structures in both white and gray matter. This novel concept is illustrated with in vivo experiments in a resting state, which demonstrate the potential of the technique for mapping the functional structure of neural networks and for direct integration of structure-function relations in the human brain.	[Ding, Zhaohua; Newton, Allen T.; Xu, Ran; Anderson, Adam W.; Morgan, Victoria L.; Gore, John C.] Vanderbilt Univ, Inst Imaging Sci, Nashville, TN 37235 USA; [Ding, Zhaohua; Xu, Ran; Anderson, Adam W.; Morgan, Victoria L.; Gore, John C.] Vanderbilt Univ, Dept Radiol & Radiol Sci, Nashville, TN 37235 USA; [Ding, Zhaohua; Anderson, Adam W.; Morgan, Victoria L.; Gore, John C.] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Ding, Zhaohua] Vanderbilt Univ, Dept Elect Engn & Comp Sci, Nashville, TN 37235 USA; [Ding, Zhaohua; Gore, John C.] Vanderbilt Univ, Chem & Phys Biol Program, Nashville, TN 37235 USA; [Newton, Allen T.] Vanderbilt Univ, Monroe Carell Jr Childrens Hosp, Nashville, TN 37235 USA; [Gore, John C.] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Gore, John C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Ding, ZH (corresponding author), Vanderbilt Univ, Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	zhaohua.ding@vanderbilt.edu	Ding, Zhaohua/AHC-7551-2022	Ding, Zhaohua/0000-0002-1805-2955	NIH [EB000461, NS078680, NS058639, NS075270]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001628, R01EB000461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058639, R01NS078680, R01NS075270] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funders: NIH grant EB000461 (JCG), NIH grant NS078680 (JCG), NIH grant NS058639 (AWA), NIH grant NS075270 (VLM) (url: http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Birn RM, 2008, HUM BRAIN MAPP, V29, P740, DOI 10.1002/hbm.20577; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Clatworthy PL, 2010, NEUROIMAGE, V49, P2001, DOI 10.1016/j.neuroimage.2009.10.083; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Cordes D, 2002, MAGN RESON IMAGING, V20, P305, DOI 10.1016/S0730-725X(02)00503-9; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damoiseaux JS, 2009, BRAIN STRUCT FUNCT, V213, P525, DOI 10.1007/s00429-009-0208-6; Ding Z, 2013, 19 ANN C ORG HUM BRA; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Goebel R, 2003, MAGN RESON IMAGING, V21, P1251, DOI 10.1016/j.mri.2003.08.026; Gore JC, 2003, J CLIN INVEST, V112, P4, DOI 10.1172/JCI200319010; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Guye M, 2008, CURR OPIN NEUROL, V21, P393, DOI 10.1097/WCO.0b013e3283065cfb; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Kim M, 2006, MAGN RESON IMAGING, V24, P583, DOI 10.1016/j.mri.2005.12.005; Kiviniemi V, 2003, NEUROIMAGE, V19, P253, DOI 10.1016/S1053-8119(03)00097-1; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Macey PM, 2004, NEUROIMAGE, V22, P360, DOI 10.1016/j.neuroimage.2003.12.042; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mazerolle EL, 2010, NEUROIMAGE, V50, P616, DOI 10.1016/j.neuroimage.2009.12.102; Morgan VL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006660; OGAWA S, 1990, P NATL ACAD SCI USA, V87, P9868, DOI 10.1073/pnas.87.24.9868; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Purves D., 2007, NEUROSCIENCE; Rodrigo S, 2008, EPILEPSIA, V49, P1367, DOI 10.1111/j.1528-1167.2008.01607.x; Schlosser RGM, 2007, SCHIZOPHR RES, V89, P1, DOI 10.1016/j.schres.2006.09.007; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Smith T.B., 2010, IMAGING MED, V2, P445, DOI [10.2217/iim.10.33, DOI 10.2217/IIM.10.33]; Toosy AT, 2004, NEUROIMAGE, V21, P1452, DOI 10.1016/j.neuroimage.2003.11.022; Zhong Y, 2009, BRAIN TOPOGR, V22, P134, DOI 10.1007/s10548-009-0095-4	35	62	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82107	10.1371/journal.pone.0082107	http://dx.doi.org/10.1371/journal.pone.0082107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339997	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100086
J	Stefanic, PP; Koffler, T; Adler, G; Bar-Zvi, D				Stefanic, Petra Peharec; Koffler, Tal; Adler, Guy; Bar-Zvi, Dudy			Chloroplasts of Salt-Grown Arabidopsis Seedlings Are Impaired in Structure, Genome Copy Number and Transcript Levels	PLOS ONE			English	Article							GENE-EXPRESSION; PLASTID ULTRASTRUCTURE; ABSCISIC-ACID; DNA; SALINITY; STRESS; PLANT; DIFFERENTIATION; DROUGHT; CHLOROPHYLL	The chloroplast is the most prominent and metabolically active plastid in photosynthetic plants. Chloroplasts differentiate from proplastids in the plant meristem. Plant plastids contain multiple copies of a small circular genome. The numbers of chloroplasts per mesophyll cell and of plastid genome copies are affected by developmental stage and environmental signals. We compared chloroplast structure, gene expression and genome copy number in Arabidopsis seedlings germinated and grown under optimal conditions to those in seedlings germinated and grown in the presence of NaCl. Chloroplasts of the NaCl-grown seedlings were impaired, with less developed thylakoid and granum membranes than control seedlings. In addition, chloroplasts of salt-grown Arabidopsis seedlings accumulated more starch grains than those in the respective control plants. Steady-state transcript levels of chloroplast-encoded genes and of nuclear genes encoding chloroplast proteins were reduced in salt-grown seedlings. This reduction did not result from a global decrease in gene expression, since the expression of other nuclear genes was induced or not affected. Average cellular chloroplast genome copy number was reduced in salt-grown seedlings, suggesting that the reduction in steady-state transcript levels of chloroplast-encoded genes might result from a decrease in template DNA.	[Stefanic, Petra Peharec; Koffler, Tal; Adler, Guy; Bar-Zvi, Dudy] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Stefanic, Petra Peharec; Koffler, Tal; Adler, Guy; Bar-Zvi, Dudy] Ben Gurion Univ Negev, Doris & Bertie Black Ctr Bioenerget Life Sci, IL-84105 Beer Sheva, Israel; [Stefanic, Petra Peharec] Univ Zagreb, Fac Sci, Dept Mol Biol, Div Biol, Zagreb 41000, Croatia	Ben Gurion University; Ben Gurion University; University of Zagreb	Bar-Zvi, D (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	barzvi@bgu.ac.il	Stefanic, Petra peharec/AAC-8128-2019	Stefanic, Petra peharec/0000-0003-4889-6910; Bar-Zvi, Dudy/0000-0003-1546-1726	Israel Science Foundation [757]; I-CORE Program of the Planning and Budgeting Committee; National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia; Ben-Gurion University	Israel Science Foundation(Israel Science Foundation); I-CORE Program of the Planning and Budgeting Committee; National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia; Ben-Gurion University	This study was supported in part by The Israel Science Foundation Grant to DBZ and by the I-CORE Program of the Planning and Budgeting Committee and the Israel Science Foundation (Center No. 757). PPS was supported by the National Foundation for Science, Higher Education and Technological Development of the Republic of Croatia (HRZZ). GA was supported by Ben-Gurion University Kreitman post-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler G, 2010, PLANTA, V232, P187, DOI 10.1007/s00425-010-1160-7; BAUMGARTNER BJ, 1989, PLANT PHYSIOL, V89, P1011, DOI 10.1104/pp.89.3.1011; Charuvi D, 2012, PLANT CELL, V24, P1143, DOI 10.1105/tpc.111.094458; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen WR, 2008, PHYSIOL PLANTARUM, V132, P89, DOI 10.1111/j.1399-3054.2007.00992.x; DENG XW, 1987, CELL, V49, P379, DOI 10.1016/0092-8674(87)90290-X; Djebali W, 2005, PLANT BIOLOGY, V7, P358, DOI 10.1055/s-2005-837696; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fleming A, 2006, J EXP BOT, V57, P1863, DOI 10.1093/jxb/erj178; Fleming AJ, 2006, J EXP BOT, V57, P25, DOI 10.1093/jxb/eri268; FREEMAN TP, 1975, PROTOPLASMA, V83, P131, DOI 10.1007/BF01289336; Fujita M, 2004, PLANT J, V39, P863, DOI 10.1111/j.1365-313X.2004.02171.x; Green BR, 2011, PLANT J, V66, P34, DOI 10.1111/j.1365-313X.2011.04541.x; Guo YH, 2012, ACTA PHYSIOL PLANT, V34, P1287, DOI 10.1007/s11738-012-0925-y; Jamil A, 2011, CRIT REV PLANT SCI, V30, P435, DOI 10.1080/07352689.2011.605739; Kaddour R, 2011, ACTA PHYSIOL PLANT, V33, P2083, DOI 10.1007/s11738-011-0747-3; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kratsch HA, 2000, PLANT CELL ENVIRON, V23, P337, DOI 10.1046/j.1365-3040.2000.00560.x; KUROIWA T, 1991, INT REV CYTOL, V128, P1; LAMPPA GK, 1980, PLANTA, V148, P437, DOI [10.1007/BF00552656, 10.1007/BF02395311]; LICHTENTHALER HK, 1987, METHOD ENZYMOL, V148, P350; Lopez-Juez E, 2005, INT J DEV BIOL, V49, P557, DOI 10.1387/ijdb.051997el; Lu PT, 2013, PLANTA, V237, P1547, DOI 10.1007/s00425-013-1867-3; Martinez-Penalver A, 2012, RUSS J PLANT PHYSL+, V59, P640, DOI 10.1134/S1021443712030119; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Naeem MS, 2012, PLANT PHYSIOL BIOCH, V57, P84, DOI 10.1016/j.plaphy.2012.05.018; Oldenburg DJ, 2006, PLANTA, V225, P41, DOI 10.1007/s00425-006-0329-6; Oldenburg DJ, 2004, J MOL BIOL, V344, P1311, DOI 10.1016/j.jmb.2004.10.001; Papadakis IE, 2007, J PLANT PHYSIOL, V164, P100, DOI 10.1016/j.jplph.2006.04.011; PLATTALOIA KA, 1983, PROTOPLASMA, V114, P85, DOI 10.1007/BF01279871; Rowan BA, 2009, J EXP BOT, V60, P3005, DOI 10.1093/jxb/erp158; Sakamoto W., 2008, ARABIDOPSIS BOOK, V6, pe0110; Sakamoto W, 2009, PLANT CELL PHYSIOL, V50, P2069, DOI 10.1093/pcp/pcp127; SCOTT NS, 1980, J EXP BOT, V31, P1081, DOI 10.1093/jxb/31.4.1081; Shkolnik D, 2008, PLANT BIOTECHNOL J, V6, P368, DOI 10.1111/j.1467-7652.2008.00328.x; Shkolnik-Inbar D, 2013, PLANT J, V73, P993, DOI 10.1111/tpj.12091; Shkolnik-Inbar D, 2010, PLANT CELL, V22, P3560, DOI 10.1105/tpc.110.074641; Udy DB, 2012, PLANT PHYSIOL, V160, P1420, DOI 10.1104/pp.112.204198; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Waters MT, 2009, EMBO J, V28, P2861, DOI 10.1038/emboj.2009.264; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Zayed MA, 1998, BIOL PLANTARUM, V40, P351, DOI 10.1023/A:1001057728794; Zhang R, 2010, PHOTOSYNTH RES, V105, P123, DOI 10.1007/s11120-010-9572-6; Zoschke R, 2007, PLANT J, V50, P710, DOI 10.1111/j.1365-313X.2007.03084.x	44	20	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82548	10.1371/journal.pone.0082548	http://dx.doi.org/10.1371/journal.pone.0082548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340039	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100118
J	Tsukuba, T; Yanagawa, M; Kadowaki, T; Takii, R; Okamoto, Y; Sakai, E; Okamoto, K; Yamamoto, K				Tsukuba, Takayuki; Yanagawa, Michiyo; Kadowaki, Tomoko; Takii, Ryosuke; Okamoto, Yoshiko; Sakai, Eiko; Okamoto, Kuniaki; Yamamoto, Kenji			Cathepsin E Deficiency Impairs Autophagic Proteolysis in Macrophages	PLOS ONE			English	Article							MITOCHONDRIAL OXIDATIVE STRESS; ACCUMULATION; DISEASE; PROTEIN; STORAGE; ROLES; LC3; PATHOGENESIS; DYSFUNCTION; TURNOVER	Cathepsin E is an endosomal aspartic proteinase that is predominantly expressed in immune-related cells. Recently, we showed that macrophages derived from cathepsin E-deficient (CatE(-/-)) mice display accumulation of lysosomal membrane proteins and abnormal membrane trafficking. In this study, we demonstrated that CatE(-/-) macrophages exhibit abnormalities in autophagy, a bulk degradation system for aggregated proteins and damaged organelles. CatE(-/-) macrophages showed increased accumulation of autophagy marker proteins such as LC3 and p62, and polyubiquitinated proteins. Cathepsin E deficiency also altered autophagy-related signaling pathways such as those mediated by the mammalian target of rapamycin (mTOR), Akt, and extracellular signal-related kinase (ERK). Furthermore, immunofluorescence microscopy analyses showed that LC3-positive vesicles were merged with acidic compartments in wild-type macrophages, but not in CatE(-/-) macrophages, indicating inhibition of fusion of autophagosome with lysosomes in CatE(-/-) cells. Delayed degradation of LC3 protein was also observed under starvation-induced conditions. Since the autophagy system is involved in the degradation of damaged mitochondria, we examined the accumulation of damaged mitochondria in CatE(-/-) macrophages. Several mitochondrial abnormalities such as decreased intracellular ATP levels, depolarized mitochondrial membrane potential, and decreased mitochondrial oxygen consumption were observed. Such mitochondrial dysfunction likely led to the accompanying oxidative stress. In fact, CatE(-/-) macrophages showed increased reactive oxygen species (ROS) production and up-regulation of oxidized peroxiredoxin-6, but decreased antioxidant glutathione. These results indicate that cathepsin E deficiency causes autophagy impairment concomitantly with increased aberrant mitochondria as well as increased oxidative stress.	[Tsukuba, Takayuki; Kadowaki, Tomoko; Sakai, Eiko; Okamoto, Kuniaki] Nagasaki Univ, Div Oral Pathopharmacol, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Yanagawa, Michiyo] Yamaguchi Univ, Dept Oral Surg, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Takii, Ryosuke] Yamaguchi Univ, Dept Biochem & Mol Biol, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Okamoto, Yoshiko] Daiichi Univ, Dept Biochem, Coll Pharmaceut Sci, Fukuoka, Japan; [Yamamoto, Kenji] Kyushu Univ, Proteolysis Res Lab, Grad Sch Pharmaceut Sci, Fukuoka 812, Japan	Nagasaki University; Yamaguchi University; Yamaguchi University; Kyushu University	Tsukuba, T (corresponding author), Nagasaki Univ, Div Oral Pathopharmacol, Grad Sch Biomed Sci, Nagasaki 852, Japan.	tsuta@nagasaki-u.ac.jp	Tsukuba, Takayuki/I-9542-2018	Tsukuba, Takayuki/0000-0003-3322-1339; sakai, eiko/0000-0002-6776-6540	Cosmetology Research Foundation	Cosmetology Research Foundation	This work was supported in part by a Cosmetology Research Foundation Grant and a Grant-in-Aid for Scientific Research (T. T.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT K, 1992, EUR J IMMUNOL, V22, P1519, DOI 10.1002/eji.1830220626; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; KADOWAKI T, 1994, J BIOL CHEM, V269, P21371; Kakehashi H, 2007, J IMMUNOL, V179, P5728, DOI 10.4049/jimmunol.179.9.5728; Koike M, 2005, AM J PATHOL, V167, P1713, DOI 10.1016/S0002-9440(10)61253-9; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Liao GH, 2007, AM J PATHOL, V171, P962, DOI 10.2353/ajpath.2007.070052; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Manevich Y, 2005, FREE RADICAL BIO MED, V38, P1422, DOI 10.1016/j.freeradbiomed.2005.02.011; Vidal-Donet JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055526; McCurley N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011949; McEligot AJ, 2005, ANNU REV NUTR, V25, P261, DOI 10.1146/annurev.nutr.25.050304.092633; Meijer AJ, 2004, INT J BIOCHEM CELL B, V36, P2445, DOI 10.1016/j.biocel.2004.02.002; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; Nishioku T, 2002, J BIOL CHEM, V277, P4816, DOI 10.1074/jbc.M108382200; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Pamplona R, 2006, BBA-BIOENERGETICS, V1757, P496, DOI 10.1016/j.bbabio.2006.01.009; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; SAKAI H, 1989, BIOCHIM BIOPHYS ACTA, V991, P367, DOI 10.1016/0304-4165(89)90130-X; SAKU T, 1990, GUT, V31, P1250, DOI 10.1136/gut.31.11.1250; Sastradipura DF, 1998, J NEUROCHEM, V70, P2045; Schmid D, 2007, IMMUNITY, V27, P11, DOI 10.1016/j.immuni.2007.07.004; Settembre C, 2008, HUM MOL GENET, V17, P119, DOI 10.1093/hmg/ddm289; Shibata M, 2006, J BIOL CHEM, V281, P14474, DOI 10.1074/jbc.M600364200; Shinojima N, 2007, AUTOPHAGY, V3, P635, DOI 10.4161/auto.4916; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tsukuba T, 2006, FEBS J, V273, P219, DOI 10.1111/j.1742-4658.2005.05062.x; Tsukuba T, 2003, J BIOCHEM, V134, P893, DOI 10.1093/jb/mvg216; TSUKUBA T, 1993, J BIOL CHEM, V268, P7276; Tsukuba T, 2006, J BIOCHEM, V140, P57, DOI 10.1093/jb/mvj132; Tsukuba T, 2009, J BIOCHEM, V145, P565, DOI 10.1093/jb/mvp016; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Yamamoto K, 2012, BBA-PROTEINS PROTEOM, V1824, P105, DOI 10.1016/j.bbapap.2011.05.022; Yanagawa M, 2007, J BIOL CHEM, V282, P1851, DOI 10.1074/jbc.M604143200	44	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82415	10.1371/journal.pone.0082415	http://dx.doi.org/10.1371/journal.pone.0082415			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340026	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100105
J	Yoshioka, Y; Ye, YQ; Okada, K; Taniguchi, K; Yoshida, A; Sugaya, K; Onose, JI; Koshino, H; Takahashi, S; Yajima, A; Yajima, S; Abe, N				Yoshioka, Yasukiyo; Ye, Yue Qi; Okada, Kiyoshi; Taniguchi, Kayoko; Yoshida, Ayaka; Sugaya, Kouichi; Onose, Jun-ichi; Koshino, Hiroyuki; Takahashi, Shunya; Yajima, Arata; Yajima, Shunsuke; Abe, Naoki			Ubiquitin-Specific Peptidase 5, a Target Molecule of Vialinin A, Is a Key Molecule of TNF-alpha Production in RBL-2H3 Cells	PLOS ONE			English	Article							MAST-CELL; MAMMALIAN-CELLS; DEGRANULATION; ACTIVATION; INHIBITOR; RELEASE	Tumor necrosis factor alpha (TNF-alpha), a central mediator of the inflammatory response, is released from basophilic cells and other cells in response to a variety of proinflammatory stimuli. Vialinin A is a potent inhibitor of TNF-alpha production and is released from RBL-2H3 cells. Ubiquitin-specific peptidase 5 (USP5), a deubiquitinating enzyme, was identified as a target molecule of vialinin A and its enzymatic activity was inhibited by vialinin A. Here we report production of TNF-alpha is decreased in USP5 siRNA-knockdown RBL-2H3 cells, compared with control cells. The finding of the present study strongly suggests that USP5 is one of the essential molecules for the production of TNF-alpha in RBL-2H3.	[Yoshioka, Yasukiyo; Ye, Yue Qi; Sugaya, Kouichi; Onose, Jun-ichi; Abe, Naoki] Tokyo Univ Agr, Dept Nutr Sci, Fac Appl Biosci, Tokyo, Japan; [Okada, Kiyoshi; Yajima, Shunsuke] Tokyo Univ Agr, Dept Biosci, Fac Appl Biosci, Tokyo, Japan; [Taniguchi, Kayoko; Yajima, Arata] Tokyo Univ Agr, Dept Fermentat Sci, Fac Appl Biosci, Tokyo, Japan; [Yoshida, Ayaka; Koshino, Hiroyuki; Takahashi, Shunya] RIKEN, Inst Phys & Chem Res, Wako, Saitama 35101, Japan	Tokyo University of Agriculture; Tokyo University of Agriculture; Tokyo University of Agriculture; RIKEN	Abe, N (corresponding author), Tokyo Univ Agr, Dept Nutr Sci, Fac Appl Biosci, Tokyo, Japan.	abe@nodai.ac.jp	Koshino, Hiroyuki/N-7948-2015; Koshino, Hiroyuki/ABF-4899-2021	Koshino, Hiroyuki/0000-0002-0954-9839; Koshino, Hiroyuki/0000-0002-0954-9839; Sugaya, Kiminobu/0000-0002-2788-5457	Advanced Research Project of the Tokyo University of Agriculture; Chemical Genomics Project of RIKEN	Advanced Research Project of the Tokyo University of Agriculture; Chemical Genomics Project of RIKEN	This work was supported by the Advanced Research Project of the Tokyo University of Agriculture and the Chemical Genomics Project of RIKEN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerik AY, 1997, EMBO J, V16, P4826; Angot A, 2007, PLOS PATHOG, V3, P1, DOI 10.1371/journal.ppat.0030003; BARUSUMIAN EL, 1981, EUR J IMMUNOL, V11, P317; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Dayal S, 2009, J BIOL CHEM, V284, P5030, DOI 10.1074/jbc.M805871200; Falvo JV, 2010, CURR DIR AUTOIMMUN, V11, P27, DOI 10.1159/000289196; GALLI SJ, 1993, NEW ENGL J MED, V328, P257; Holgate ST, 1999, NATURE, V402, pB2, DOI 10.1038/35037000; Ishizuka T, 1999, J IMMUNOL, V162, P2087; Kattenhorn LM, 2005, MOL CELL, V19, P547, DOI 10.1016/j.molcel.2005.07.003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Marchand F, 2003, ALLERGY, V58, P1037, DOI 10.1034/j.1398-9995.2003.00251.x; Marquardt DL, 2000, J ALLERGY CLIN IMMUN, V105, P500, DOI 10.1067/mai.2000.104942; Matsuda H, 2004, BIOORGAN MED CHEM, V12, P4871, DOI 10.1016/j.bmc.2004.07.007; McDermott RA, 2007, CLIN EXP ALLERGY, V37, P752, DOI 10.1111/j.1365-2222.2007.02701.x; Misaghi S, 2006, MOL MICROBIOL, V61, P142, DOI 10.1111/j.1365-2958.2006.05199.x; Okada K, 2013, BIOORG MED CHEM LETT, V23, P4328, DOI 10.1016/j.bmcl.2013.05.093; Onose JI, 2008, BIOL PHARM BULL, V31, P831, DOI 10.1248/bpb.31.831; Onose J, 2012, CELL IMMUNOL, V279, P140, DOI 10.1016/j.cellimm.2012.10.008; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Reyes-Turcu FE, 2008, J BIOL CHEM, V283, P19581, DOI 10.1074/jbc.M800947200; Scortegagna M, 2011, J BIOL CHEM, V286, P27333, DOI 10.1074/jbc.M111.218214; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Xie C, 2005, BIOSCI BIOTECH BIOCH, V69, P2326, DOI 10.1271/bbb.69.2326; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zhao M, 2008, MOL BIOTECHNOL, V40, P19, DOI 10.1007/s12033-008-9043-x	26	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80931	10.1371/journal.pone.0080931	http://dx.doi.org/10.1371/journal.pone.0080931			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349023	Green Published, Green Submitted, gold			2022-12-27	WOS:000327949300058
J	Gomes, ALC; Galagan, JE; Segre, D				Gomes, Antonio L. C.; Galagan, James E.; Segre, Daniel			Resource Competition May Lead to Effective Treatment of Antibiotic Resistant Infections	PLOS ONE			English	Article							INTENSIVE-CARE UNITS; ANTIMICROBIAL RESISTANCE; DRUG-RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; ROTATING ANTIBIOTICS; BACTERIAL-RESISTANCE; MATHEMATICAL-MODELS; ESCHERICHIA-COLI; EVOLUTION	Drug resistance is a common problem in the fight against infectious diseases. Recent studies have shown conditions (which we call antiR) that select against resistant strains. However, no specific drug administration strategies based on this property exist yet. Here, we mathematically compare growth of resistant versus sensitive strains under different treatments (no drugs, antibiotic, and antiR), and show how a precisely timed combination of treatments may help defeat resistant strains. Our analysis is based on a previously developed model of infection and immunity in which a costly plasmid confers antibiotic resistance. As expected, antibiotic treatment increases the frequency of the resistant strain, while the plasmid cost causes a reduction of resistance in the absence of antibiotic selection. Our analysis suggests that this reduction occurs under competition for limited resources. Based on this model, we estimate treatment schedules that would lead to a complete elimination of both sensitive and resistant strains. In particular, we derive an analytical expression for the rate of resistance loss, and hence for the time necessary to turn a resistant infection into sensitive (t(clear)). This time depends on the experimentally measurable rates of pathogen division, growth and plasmid loss. Finally, we estimated t(clear) for a specific case, using available empirical data, and found that resistance may be lost up to 15 times faster under antiR treatment when compared to a no treatment regime. This strategy may be particularly suitable to treat chronic infection. Finally, our analysis suggests that accounting explicitly for a resistance-decaying rate may drastically change predicted outcomes in host-population models.	[Gomes, Antonio L. C.; Galagan, James E.; Segre, Daniel] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Galagan, James E.; Segre, Daniel] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Galagan, James E.] Broad Inst MIT & Harvard, Cambridge, MA USA; [Segre, Daniel] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University; Boston University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University	Segre, D (corresponding author), Boston Univ, Bioinformat Program, Boston, MA 02215 USA.	dsegre@bu.edu	; Segre, Daniel/A-1993-2009	Gomes, Antonio LC/0000-0003-3790-3724; Segre, Daniel/0000-0003-4859-1914; Galagan, James/0000-0003-0542-3291				Ankomah P, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002487; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P923, DOI 10.3934/mbe.2010.7.923; Beardmore RE, 2010, MATH BIOSCI ENG, V7, P527, DOI 10.3934/mbe.2010.7.527; Bergstrom CT, 2004, P NATL ACAD SCI USA, V101, P13285, DOI 10.1073/pnas.0402298101; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bollenbach T, 2009, CELL, V139, P707, DOI 10.1016/j.cell.2009.10.025; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Bonhoeffer S, 2010, MATH BIOSCI ENG, V7, P919, DOI 10.3934/mbe.2010.7.919; Bonten MJM, 2006, CRIT CARE MED, V34, P549, DOI 10.1097/01.CCM.0000196090.92997.A7; Brown EM, 2005, J ANTIMICROB CHEMOTH, V55, P6, DOI 10.1093/jac/dkh482; Cadena J, 2007, BONE MARROW TRANSPL, V40, P151, DOI 10.1038/sj.bmt.1705704; Canton R, 2003, CURR OPIN INFECT DIS, V16, P315, DOI 10.1097/00001432-200308000-00003; Chait R, 2007, NATURE, V446, P668, DOI 10.1038/nature05685; Chait R, 2012, NAT CHEM BIOL, V8, P2, DOI 10.1038/nchembio.745; Chow Karen, 2011, Journal of Biological Dynamics, V5, P27, DOI 10.1080/17513758.2010.488300; Colomer-Lluch M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017549; Control ECfDPa, 2010, ANN REP EUR ANT RES; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; Dagan R, 2008, J INFECT DIS, V197, P1094, DOI 10.1086/528995; Dall'Antonia M, 2005, J HOSP INFECT, V61, P62, DOI 10.1016/j.jhin.2005.01.008; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; Deurenberg RH, 2007, CLIN MICROBIOL INFEC, V13, P222, DOI 10.1111/j.1469-0691.2006.01573.x; Diard M, 2013, NATURE, V494, P353, DOI 10.1038/nature11913; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Ehrlich P, 1913, BRIT MED J, V1913, P353; Enne VI, 2001, LANCET, V357, P1325, DOI 10.1016/S0140-6736(00)04519-0; Francetic I, 2008, CROAT MED J, V49, P207, DOI 10.3325/cmj.2008.2.207; Frost LS, 2005, NAT REV MICROBIOL, V3, P722, DOI 10.1038/nrmicro1235; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Gottesman BS, 2009, CLIN INFECT DIS, V49, P869, DOI 10.1086/605530; GRECO WR, 1995, PHARMACOL REV, V47, P331; Gubareva LV, 2004, VIRUS RES, V103, P199, DOI 10.1016/j.virusres.2004.02.034; Hannan TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001042; Hedrick TL, 2008, SURG INFECT, V9, P139, DOI 10.1089/sur.2006.102; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Hegreness M, 2008, P NATL ACAD SCI USA, V105, P13977, DOI 10.1073/pnas.0805965105; Hoiby N, 2010, INT J ANTIMICROB AG, V35, P322, DOI 10.1016/j.ijantimicag.2009.12.011; Imran M, 2007, DISCRETE CONT DYN-B, V8, P127; Jiang JR, 2011, RESPIROLOGY, V16, P308, DOI 10.1111/j.1440-1843.2010.01902.x; Katial R, 2008, PRIMARY CARE, V35, P11, DOI 10.1016/j.pop.2007.09.002; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Klokouzas A, 2003, INT J ANTIMICROB AG, V22, P301, DOI 10.1016/S0924-8579(03)00210-3; Kollef MH, 2006, CLIN INFECT DIS, V43, pS82, DOI 10.1086/504484; Kollef MH, 2005, CRIT CARE, V9, P459, DOI 10.1186/cc3757; Koul A, 2011, NATURE, V469, P483, DOI 10.1038/nature09657; Kouyos RD, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001094; Levin BR, 1997, CLIN INFECT DIS, V24, pS9, DOI 10.1093/clinids/24.Supplement_1.S9; Lindsay Jodi A., 2006, Functional & Integrative Genomics, V6, P186, DOI 10.1007/s10142-005-0019-7; Lipsitch M, 2000, VACCINE, V18, P2895, DOI 10.1016/S0264-410X(00)00046-3; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725, DOI 10.1128/MMBR.62.3.725-774.1998; Martinez J. A., 2007, Antibiotiques, V9, P25, DOI 10.1016/S1294-5501(07)88764-4; Martinez JA, 2006, CRIT CARE MED, V34, P329, DOI 10.1097/01.CCM.0000195010.63855.45; Masterton RG, 2005, J ANTIMICROB CHEMOTH, V55, P1, DOI 10.1093/jac/dkh506; Michel JB, 2008, P NATL ACAD SCI USA, V105, P14918, DOI 10.1073/pnas.0800944105; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; OSMAN AS, 1992, ACTA TROP, V50, P249, DOI 10.1016/0001-706X(92)90081-8; Palmer AC, 2010, NAT CHEM BIOL, V6, P105, DOI [10.1038/NCHEMBIO.289, 10.1038/nchembio.289]; Pena-Miller R, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001540; Quale J, 1996, CLIN INFECT DIS, V23, P1020, DOI 10.1093/clinids/23.5.1020; Recchia GD, 1997, TRENDS MICROBIOL, V5, P389, DOI 10.1016/S0966-842X(97)01123-2; Rieux V, 2001, J INFECT DIS, V184, P66, DOI 10.1086/320992; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Rupp ME, 2003, DRUGS, V63, P353, DOI 10.2165/00003495-200363040-00002; Smith VH, 1996, TRENDS ECOL EVOL, V11, P386, DOI 10.1016/0169-5347(96)20067-9; Snitkin ES, 2011, P NATL ACAD SCI USA, V108, P13758, DOI 10.1073/pnas.1104404108; Sorensen SJ, 2005, NAT REV MICROBIOL, V3, P700, DOI 10.1038/nrmicro1232; SYVANEN M, 1984, ANNU REV GENET, V18, P271, DOI 10.1146/annurev.ge.18.120184.001415; Tenover FC, 2006, AM J MED, V119, pS3, DOI 10.1016/j.amjmed.2006.03.011; Torella JP, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000796; Welch TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000309; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yeh P, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100133; Yeh PJ, 2009, NAT REV MICROBIOL, V7, P460, DOI 10.1038/nrmicro2133; zur Wiesch PA, 2011, LANCET INFECT DIS, V11, P236, DOI 10.1016/S1473-3099(10)70264-4	76	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e80775	10.1371/journal.pone.0080775	http://dx.doi.org/10.1371/journal.pone.0080775			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349015	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200002
J	Brandt, KJ; Fickentscher, C; Kruithof, EKO; de Moerloose, P				Brandt, Karim J.; Fickentscher, Celine; Kruithof, Egbert. K. O.; de Moerloose, Philippe			TLR2 Ligands Induce NF-kappa B Activation from Endosomal Compartments of Human Monocytes	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; LIPOTEICHOIC ACID; STAPHYLOCOCCUS-AUREUS; CD14; CD36; INTERNALIZATION; PATHWAY; COMPLEX; TRAM; TOLL-LIKE-RECEPTOR-2	Localization of Toll-like receptors (TLR) in subcellular organelles is a major strategy to regulate innate immune responses. While TLR4, a cell-surface receptor, signals from both the plasma membrane and endosomal compartments, less is known about the functional role of endosomal trafficking upon TLR2 signaling. Here we show that the bacterial TLR2 ligands Pam(3)CSK(4) and LTA activate NF-kappa B-dependent signaling from endosomal compartments in human monocytes and in a NF-kappa B sensitive reporter cell line, despite the expression of TLR2 at the cell surface. Further analyses indicate that TLR2-induced NF-kappa B activation is controlled by a clathrin/dynamin-dependent endocytosis mechanism, in which CD14 serves as an important upstream regulator. These findings establish that internalization of cell-surface TLR2 into endosomal compartments is required for NF-kappa B activation. These observations further demonstrate the need of endocytosis in the activation and regulation of TLR2-dependent signaling pathways.	[Brandt, Karim J.; Fickentscher, Celine; Kruithof, Egbert. K. O.; de Moerloose, Philippe] Univ Hosp Geneva & Fac Med, Div Angiol & Hemostasis, Geneva, Switzerland	University of Geneva	de Moerloose, P (corresponding author), Univ Hosp Geneva & Fac Med, Div Angiol & Hemostasis, Geneva, Switzerland.	philippe.demoerloose@hcuge.ch	Kruithof, Egbert/AGR-4755-2022	Brandt, Karim J./0000-0003-1042-5283	Swiss National Fonds [310030-127639]; ISTH Presidential Fund	Swiss National Fonds(Swiss National Science Foundation (SNSF)); ISTH Presidential Fund	This work was supported by two grants: the Swiss National Fonds (no310030-127639) and the ISTH2007 Presidential Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbalat R, 2009, NAT IMMUNOL, V10, P1200, DOI 10.1038/ni.1792; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Baumann CL, 2010, J EXP MED, V207, P2689, DOI 10.1084/jem.20101111; Brandt KJ, 2010, J LEUKOCYTE BIOL, V88, P1191, DOI 10.1189/jlb.0510312; Bunk S, 2010, J IMMUNOL, V185, P3708, DOI 10.4049/jimmunol.0901660; CLAGUE MJ, 1994, J BIOL CHEM, V269, P21; COLLART MA, 1990, MOL CELL BIOL, V10, P1498, DOI 10.1128/MCB.10.4.1498; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; Etokebe GE, 2010, SCAND J IMMUNOL, V71, P369, DOI 10.1111/j.1365-3083.2010.02379.x; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Ip WKE, 2010, J IMMUNOL, V184, P7071, DOI 10.4049/jimmunol.1000110; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Manukyan M, 2005, EUR J IMMUNOL, V35, P911, DOI 10.1002/eji.200425336; Marre ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012871; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Sadowski L, 2009, EXP CELL RES, V315, P1601, DOI 10.1016/j.yexcr.2008.09.021; Satta Nathalie, 2011, Blood, V117, P5523, DOI 10.1182/blood-2010-11-316158; Shamsul HM, 2010, IMMUNOLOGY, V130, P262, DOI 10.1111/j.1365-2567.2009.03232.x; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Triantafilou M, 2007, CELL MICROBIOL, V9, P2030, DOI 10.1111/j.1462-5822.2007.00935.x; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Udalova IA, 1998, J BIOL CHEM, V273, P21178, DOI 10.1074/jbc.273.33.21178; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	35	39	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80743	10.1371/journal.pone.0080743	http://dx.doi.org/10.1371/journal.pone.0080743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349012	Green Published, gold, Green Submitted			2022-12-27	WOS:000328731800007
J	Niemi, L; Young, L				Niemi, Laura; Young, Liane			Caring across Boundaries versus Keeping Boundaries Intact: Links between Moral Values and Interpersonal Orientations	PLOS ONE			English	Article							SOCIAL-DOMINANCE ORIENTATION; META-ETHICS; MACHIAVELLIANISM; PERSONALITY; PSYCHOLOGY; RESPONSES; TACTICS; IMPACT; DARK	Prior work has established robust diversity in the extent to which different moral values are endorsed. Some people focus on values related to caring and fairness, whereas others assign additional moral weight to ingroup loyalty, respect for authority and established hierarchies, and purity concerns. Five studies explore associations between endorsement of distinct moral values and a suite of interpersonal orientations: Machiavellianism, prosocial resource distribution, Social Dominance Orientation, and reported likelihood of helping and not helping kin and close friends versus acquaintances and neighbors. We found that Machiavellianism (Studies 1, 3, 4, 5) (e. g., amorality, controlling and status-seeking behaviors) and Social Dominance Orientation (Study 4) were negatively associated with caring values, and positively associated with valuation of authority. Those higher in caring values were more likely to choose prosocial resource distributions (Studies 2, 3, 4) and to report reduced likelihood of failing to help kin/close friends or acquaintances (Study 4). Finally, greater likelihood of helping acquaintances was positively associated with all moral values tested except authority values (Study 4). The current work offers a novel approach to characterizing moral values and reveals a striking divergence between two kinds of moral values in particular: caring values and authority values. Caring values were positively linked with prosociality and negatively associated with Machiavellianism, whereas authority values were positively associated with Machiavellianism and Social Dominance Orientation.	[Niemi, Laura; Young, Liane] Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA	Boston College	Niemi, L (corresponding author), Boston Coll, Dept Psychol, Chestnut Hill, MA 02167 USA.	laura.niemi@bc.edu			John Templeton Foundation; Alfred P. Sloan Foundation	John Templeton Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation)	This project was made possible through the support of the John Templeton Foundation and the Alfred P. Sloan Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvan M, 2013, NEUROETHICS-NETH, V6, P307, DOI 10.1007/s12152-011-9140-6; Bartels DM, 2011, COGNITION, V121, P154, DOI 10.1016/j.cognition.2011.05.010; Birbaumer N, 2005, ARCH GEN PSYCHIAT, V62, P799, DOI 10.1001/archpsyc.62.7.799; Bloom Paul, 2004, DESCARTES BABY SCI C; Cohen TR, 2006, PERS SOC PSYCHOL B, V32, P1559, DOI 10.1177/0146167206291673; Czibor A, 2012, PERS INDIV DIFFER, V53, P202, DOI 10.1016/j.paid.2012.03.005; Dahling J. J., 2012, HDB UNETHICAL WORK B, P183; Dahling JJ, 2009, J MANAGE, V35, P219, DOI 10.1177/0149206308318618; DeScioli P, 2009, COGNITION, V112, P281, DOI 10.1016/j.cognition.2009.05.008; Dovidio JF, 2009, PERS SOC PSYCHOL REV, V13, P3, DOI 10.1177/1088868308326751; Duriez B, 2002, PERS INDIV DIFFER, V32, P1199, DOI 10.1016/S0191-8869(01)00086-1; Feinberg M, 2012, J PERS SOC PSYCHOL, V102, P1015, DOI 10.1037/a0026650; Feinberg M, 2012, J PERS SOC PSYCHOL, V102, P81, DOI 10.1037/a0025403; GEIS FL, 1981, J PERS SOC PSYCHOL, V41, P766, DOI 10.1037/0022-3514.41.4.766; Goodwin GP, 2008, COGNITION, V106, P1339, DOI 10.1016/j.cognition.2007.06.007; Goodwin GP, 2012, J EXP SOC PSYCHOL, V48, P250, DOI 10.1016/j.jesp.2011.08.006; Graham J, 2011, J PERS SOC PSYCHOL, V101, P366, DOI 10.1037/a0021847; Graham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050092; Graham J, 2010, PERS SOC PSYCHOL REV, V14, P140, DOI 10.1177/1088868309353415; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; Gunnthorsdottir A, 2002, J ECON PSYCHOL, V23, P49, DOI 10.1016/S0167-4870(01)00067-8; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; Haidt J., 2012, RIGHTEOUS MIND WHY G; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Hardy CL, 2006, PERS SOC PSYCHOL B, V32, P1402, DOI 10.1177/0146167206291006; HARRELL WA, 1976, SOCIOMETRY, V39, P157, DOI 10.2307/2786216; Hawley PH, 2003, MERRILL PALMER QUART, V49, P279, DOI 10.1353/mpq.2003.0013; Hirsh JB, 2011, PERSPECT PSYCHOL SCI, V6, P415, DOI 10.1177/1745691611416992; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Janoff-Bulman R, 2009, PSYCHOL INQ, V20, P120, DOI 10.1080/10478400903028581; Janoff-Bulman R, 2009, J PERS SOC PSYCHOL, V96, P521, DOI 10.1037/a0013779; Jost JT, 2012, SCIENCE, V337, P525, DOI 10.1126/science.1222565; Jost JT, 2012, MOTIV EMOTION, V36, P55, DOI 10.1007/s11031-011-9260-7; Jost JT, 2009, ANNU REV PSYCHOL, V60, P307, DOI 10.1146/annurev.psych.60.110707.163600; Jost JT, 2005, CURR DIR PSYCHOL SCI, V14, P260, DOI 10.1111/j.0963-7214.2005.00377.x; Kiazad K, 2010, J RES PERS, V44, P512, DOI 10.1016/j.jrp.2010.06.004; KylHeku LM, 1996, PERS INDIV DIFFER, V21, P497, DOI 10.1016/0191-8869(96)00103-1; Leidner B, 2010, PERS SOC PSYCHOL B, V36, P1115, DOI 10.1177/0146167210376391; Lipsey M. W., 2001, PRACTICAL METAANALYS, V49; Liu BS, 2013, SOC PSYCHOL PERS SCI, V4, P316, DOI 10.1177/1948550612456045; Lund OCH, 2007, J RES PERS, V41, P25, DOI 10.1016/j.jrp.2006.01.002; McIlwain D, 2012, EMOTIONS IMAGINATION, P119; Niemi L, CONTAMINATION UNPUB; PANDEY J, 1979, J SOC PSYCHOL, V108, P221, DOI 10.1080/00224545.1979.9711635; Park JH, 2011, J SOC PSYCHOL, V151, P391, DOI 10.1080/00224545.2010.481692; Paulhus DL, 2002, J RES PERS, V36, P556, DOI 10.1016/S0092-6566(02)00505-6; Piff PK, 2010, J PERS SOC PSYCHOL, V99, P771, DOI 10.1037/a0020092; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Rock MS, 2013, THESIS; Rozin P, 1997, PSYCHOL SCI, V8, P67, DOI 10.1111/j.1467-9280.1997.tb00685.x; Rozin P, 1999, PSYCHOL SCI, V10, P218, DOI 10.1111/1467-9280.00139; Rozin P., 1997, MORALITY HLTH, P379; Sinn JS, 2012, ISPP 35 ANN SCI M MA; Skitka LJ, 2005, J PERS SOC PSYCHOL, V88, P895, DOI 10.1037/0022-3514.88.6.895; Sosis R, 2003, CROSS-CULT RES, V37, P211, DOI 10.1177/1069397103037002003; Spitzer M, 2007, NEURON, V56, P185, DOI 10.1016/j.neuron.2007.09.011; Suhler CL, 2011, J COGNITIVE NEUROSCI, V23, P2013; van Leeuwen F, 2012, EVOL HUM BEHAV, V33, P429, DOI 10.1016/j.evolhumbehav.2011.12.005; van Prooijen JW, 2012, PERS SOC PSYCHOL B, V38, P1247, DOI 10.1177/0146167212448826; VanLange PAM, 1997, J PERS SOC PSYCHOL, V73, P733, DOI 10.1037/0022-3514.73.4.733; Wakslak CJ, 2007, PSYCHOL SCI, V18, P267, DOI 10.1111/j.1467-9280.2007.01887.x; Whitley BE, 1999, J PERS SOC PSYCHOL, V77, P126, DOI 10.1037/0022-3514.77.1.126; Wilson DS, 1996, PSYCHOL BULL, V119, P285, DOI 10.1037/0033-2909.119.2.285; Young L, 2013, J EXP SOC PSYCHOL, V49, P302, DOI 10.1016/j.jesp.2012.11.013	65	17	17	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81605	10.1371/journal.pone.0081605	http://dx.doi.org/10.1371/journal.pone.0081605			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349095	Green Submitted, gold, Green Published			2022-12-27	WOS:000328731800023
J	Pilcher, CD; Louie, B; Facente, S; Keating, S; Hackett, J; Vallari, A; Hall, C; Dowling, T; Busch, MP; Klausner, JD; Hecht, FM; Liska, S; Pandori, MW				Pilcher, Christopher D.; Louie, Brian; Facente, Shelley; Keating, Sheila; Hackett, John, Jr.; Vallari, Ana; Hall, Chris; Dowling, Teri; Busch, Michael P.; Klausner, Jeffrey D.; Hecht, Frederick M.; Liska, Sally; Pandori, Mark W.			Performance of Rapid Point-of-Care and Laboratory Tests for Acute and Established HIV Infection in San Francisco	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; NUCLEIC-ACID; P24 ANTIGEN; DIAGNOSIS; ANTIBODY	Background: Current laboratory and point-of-care tests for HIV detect different analytes and use different sample types. Some have fast turnaround times (< 1 hour). We investigated how HIV test choice could impact case finding by testing programs. Methods: We analyzed 21,234 consecutive HIV tests with venous blood obtained by San Francisco HIV testing programs from 2003 to 2008. For a subset, oral fluid (n = 6446) or fingerstick blood (n = 8127) samples were also obtained for rapid testing. In all cases, HIV status was determined using an HIV antibody-plus-RNA test algorithm. We assessed how the screening antibody tests performed individually versus the gold standard of the full algorithm. We then evaluated the potential ability of other tests (including new tests) to detect more cases, by re-testing all specimens that had negative/discrepant antibody results on initial screening. Findings: The antibody-RNA algorithm identified 58 acute and 703 established HIV infection cases. 1st-generation (Vironostika) and 3rd-generation (Genetic Systems) immunoassays had 92 and 96 percent sensitivity, respectively. The Oraquick rapid test had clinical sensitivity of only 86 percent on oral fluid samples, but 92 percent on finger-stick blood. Newer 4th-generation, antigen-antibody combo rapid immunoassay (ARCHITECT) detected HIV in 87 percent of all the acute cases that had been missed by one of the previous screening assays. A point-of-care 4th generation antigen-antibody combo rapid test (Determine) detected about 54 percent of such acute cases. Conclusions: Our study suggests that some rapid antibody blood tests will give similar case detection to laboratory antibody tests, but that oral fluid testing greatly reduces ability to detect HIV. New 4th-generation combo tests can detect the majority of acute infections detectable by HIV RNA but with rapid results. Using these tests as a primary screening assay in high-risk HIV testing programs could reduce or eliminate the need for HIV RNA testing.	[Pilcher, Christopher D.; Facente, Shelley; Klausner, Jeffrey D.; Hecht, Frederick M.] Univ Calif San Francisco, Div HIV AIDS, San Francisco, CA 94143 USA; [Louie, Brian; Liska, Sally; Pandori, Mark W.] San Francisco Dept Publ Hlth, Publ Hlth Lab, San Francisco, CA USA; [Facente, Shelley; Dowling, Teri] San Francisco Dept Publ Hlth, HIV Prevent Sect, San Francisco, CA USA; [Klausner, Jeffrey D.] San Francisco Dept Publ Hlth, STD Prevent & Control Serv Sect, San Francisco, CA USA; [Keating, Sheila; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Hackett, John, Jr.; Vallari, Ana] Abbott Diagnost, Abbott Pk, IL USA; [Hall, Chris] Magnet Community Hlth Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; San Francisco Department of Public Health; San Francisco Department of Public Health; San Francisco Department of Public Health; Vitalant; Vitalant Research Institute	Pilcher, CD (corresponding author), Univ Calif San Francisco, Div HIV AIDS, San Francisco, CA 94143 USA.	cpilcher@php.ucsf.edu	Facente, Shelley/M-1147-2019	Facente, Shelley N./0000-0002-7266-352X; Keating, Sheila/0000-0002-8324-3694; Hecht, Frederick/0000-0002-5782-1171	National Institutes of Health/National Institute of Mental Health [R34MH096606, R01MH068686]; California HIV Research Program [CH05-SMCHC-612, RN07-SF-722]; Peninsula AIDS Research Center, Klausner; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT007827] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH096606, P30MH058107, R01MH068686] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California HIV Research Program; Peninsula AIDS Research Center, Klausner; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was supported by National Institutes of Health/National Institute of Mental Health grants R34MH096606 and R01MH068686 (Pilcher), the California HIV Research Program CH05-SMCHC-612 (Peninsula AIDS Research Center, Klausner) and the California HIV Research Program RN07-SF-722 (Klausner and Pilcher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HIV TESTING NEW HIV; [Anonymous], HIV TEST ALG STAT RE; Bebell LM, 2010, AIDS, V24, P1945, DOI 10.1097/QAD.0b013e32833bb732; Branson B, 2006, P 13 C RETR OPP INF; Branson BM, 2007, CLIN INFECT DIS, V45, pS221, DOI 10.1086/522541; Brooks JT, 2006, AIDS, V20, P923, DOI 10.1097/01.aids.0000218558.82402.59; Centers for Disease Control and Prevention, 1992, MMWR            1218, V41; Christopoulos KA, 2013, JAIDS-J ACQ IMM DEF, V62, pE30, DOI 10.1097/QAI.0b013e31827a0b0d; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Eshleman SH, 2009, JAIDS-J ACQ IMM DEF, V52, P121, DOI 10.1097/QAI.0b013e3181ab61e1; Facente SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008217; Hutchinson AB, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000342; Kilembe W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037154; Klausner JD, 2005, NEW ENGL J MED, V353, P631; Le T, 2013, NEW ENGL J MED, V368, P218, DOI 10.1056/NEJMoa1110187; Ly TD, 2001, J CLIN MICROBIOL, V39, P3122, DOI 10.1128/JCM.39.9.3122-3128.2001; Owen SM, 2008, J CLIN MICROBIOL, V46, P1588, DOI 10.1128/JCM.02196-07; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; Patel P, 2006, JAIDS-J ACQ IMM DEF, V42, P75, DOI 10.1097/01.qai.0000218363.21088.ad; Patel P, 2010, ARCH INTERN MED, V170, P66, DOI 10.1001/archinternmed.2009.445; Pilcher CD, 2005, NEW ENGL J MED, V352, P1873, DOI 10.1056/NEJMoa042291; Pilcher CD, 2002, JAMA-J AM MED ASSOC, V288, P216, DOI 10.1001/jama.288.2.216; Pilcher CD, 2006, 13 C RETR OPP INF DE; Pilcher CD, 2008, ANN INTERN MED, V149, P204, DOI 10.7326/0003-4819-149-3-200808050-00011; Pilcher CD, 2010, J INFECT DIS, V201, pS7, DOI 10.1086/650393; Pincus JM, 2003, CLIN INFECT DIS, V37, P1699, DOI 10.1086/379772; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Stekler J, 2005, AIDS, V19, P1323, DOI 10.1097/01.aids.0000180105.73264.81; Stekler JD, 2009, CLIN INFECT DIS, V49, P444, DOI 10.1086/600043; Walensky RP, 2008, ANN INTERN MED, V149, P153, DOI 10.7326/0003-4819-149-3-200808050-00003; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Zetola NM, 2007, INFECT DIS CLIN N AM, V21, P19, DOI 10.1016/j.idc.2007.01.008	32	54	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80629	10.1371/journal.pone.0080629	http://dx.doi.org/10.1371/journal.pone.0080629			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349007	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800005
J	Marmolejo-Ramos, F; Elosua, MR; Yamada, Y; Hamm, NF; Noguchi, K				Marmolejo-Ramos, Fernando; Rosa Elosua, Maria; Yamada, Yuki; Hamm, Nicholas Francis; Noguchi, Kimihiro			Appraisal of Space Words and Allocation of Emotion Words in Bodily Space	PLOS ONE			English	Article							VERTICAL MERIDIAN ASYMMETRY; DISTRACTOR DEVALUATION; GROUNDED COGNITION; LANGUAGE; EMBODIMENT; METAPHORS; ATTENTION; COMPREHENSION; PERCEPTION; LOCATION	The body-specificity hypothesis (BSH) predicts that right-handers and left-handers allocate positive and negative concepts differently on the horizontal plane, i.e., while left-handers allocate negative concepts on the right-hand side of their bodily space, right-handers allocate such concepts to the left-hand side. Similar research shows that people, in general, tend to allocate positive and negative concepts in upper and lower areas, respectively, in relation to the vertical plane. Further research shows a higher salience of the vertical plane over the horizontal plane in the performance of sensorimotor tasks. The aim of the paper is to examine whether there should be a dominance of the vertical plane over the horizontal plane, not only at a sensorimotor level but also at a conceptual level. In Experiment 1, various participants from diverse linguistic backgrounds were asked to rate the words "up", "down", "left", and "right". In Experiment 2, right-handed participants from two linguistic backgrounds were asked to allocate emotion words into a square grid divided into four boxes of equal areas. Results suggest that the vertical plane is more salient than the horizontal plane regarding the allocation of emotion words and positively-valenced words were placed in upper locations whereas negatively-valenced words were placed in lower locations. Together, the results lend support to the BSH while also suggesting a higher saliency of the vertical plane over the horizontal plane in the allocation of valenced words.	[Marmolejo-Ramos, Fernando; Hamm, Nicholas Francis] Univ Adelaide, Fac Hlth Sci, Sch Psychol, Adelaide, SA, Australia; [Rosa Elosua, Maria] Univ Nacl Educ Distancia, Dept Psychol, Madrid, Spain; [Yamada, Yuki] Kyushu Univ, Fac Arts & Sci, Fukuoka 812, Japan; [Noguchi, Kimihiro] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA	University of Adelaide; Universidad Nacional de Educacion a Distancia (UNED); Kyushu University; Colorado State University	Marmolejo-Ramos, F (corresponding author), Univ Adelaide, Fac Hlth Sci, Sch Psychol, Adelaide, SA, Australia.	fernando.marmolejoramos@adelaide.edu.au	Elosúa, M. Rosa/E-3449-2018; Yamada, Yuki/B-2671-2008; Marmolejo-Ramos, Fernando/D-9826-2012	Elosúa, M. Rosa/0000-0003-0122-6231; Yamada, Yuki/0000-0003-1431-568X; Marmolejo-Ramos, Fernando/0000-0003-4680-1287	Spanish Ministry of Education and Science [BSO2003-02103, SEJ2004-07398/PSIC, PSI2008-00754/PSIC, CSD2008-00048]; Japan Society for Promotion of Science	Spanish Ministry of Education and Science(Spanish Government); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Maria Rosa Elosua was supported by the Spanish Ministry of Education and Science BSO2003-02103, SEJ2004-07398/PSIC, PSI2008-00754/PSIC, and CONSOLIDER-INGENIO 2010 CSD2008-00048. Yuki Yamada was supported by the Japan Society for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON NH, 1968, J PERS SOC PSYCHOL, V9, P272, DOI 10.1037/h0025907; Ansorge U, 2010, COGNITION, V116, P303, DOI 10.1016/j.cognition.2010.05.010; Ballesteros S, 1998, PERCEPT PSYCHOPHYS, V60, P389, DOI 10.3758/BF03206862; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Bates E, 2001, ANNU REV PSYCHOL, V52, P369, DOI 10.1146/annurev.psych.52.1.369; Brookshire G, 2010, P 32 ANN C COGN SCI, P1940; Brunner E, 2000, BIOMETRICAL J, V42, P17, DOI 10.1002/(SICI)1521-4036(200001)42:1<17::AID-BIMJ17>3.0.CO;2-U; Campanella F, 2011, EXP BRAIN RES, V208, P369, DOI 10.1007/s00221-010-2489-7; Casasanto D, 2010, COGNITION, V115, P179, DOI 10.1016/j.cognition.2009.11.002; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; Cattaneo Z, 2010, ACTA PSYCHOL, V134, P398, DOI 10.1016/j.actpsy.2010.04.002; Chatterjee A, 2010, LANG COGN, V2, P79, DOI 10.1515/LANGCOG.2010.004; Corbett JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024470; COREN S, 1993, PERCEPT MOTOR SKILL, V76, P1035, DOI 10.2466/pms.1993.76.3.1035; Courvoisier DS, 2010, INT J PSYCHOL RES, V3, P78; Crawford LE, 2006, COGNITION EMOTION, V20, P1153, DOI 10.1080/02699930500347794; Crawford LE, 2009, EMOT REV, V1, P129, DOI 10.1177/1754073908100438; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; de la Vega I, 2012, J EXP PSYCHOL HUMAN, V38, P375, DOI 10.1037/a0024979; Desai RH, 2011, J COGNITIVE NEUROSCI, V23, P2376, DOI 10.1162/jocn.2010.21596; Dijkstra K, 2007, COGNITION, V102, P139, DOI 10.1016/j.cognition.2005.12.009; Ducrot O., 1998, NUEVO DICCIONARIO EN; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Freeman J., 1975, COMPUT VISION GRAPH, V4, P156, DOI [DOI 10.1016/S0146-664X(75)80007-4, 10.1016/S0146-664X(75)80007-4]; Fuller S, 2008, J VISION, V8, DOI 10.1167/8.1.16; Gadea M, 2011, BRAIN COGNITION, V76, P294, DOI 10.1016/j.bandc.2011.03.003; Gallese V, 2009, PSYCHOL RES-PSYCH FO, V73, P486, DOI 10.1007/s00426-009-0232-4; Getzmann S, 2003, EXP PSYCHOL, V50, P131, DOI 10.1026//1618-3169.50.2.131; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Glenberg AM, 2008, Q J EXP PSYCHOL, V61, P905, DOI 10.1080/17470210701625550; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; Imada T, 2011, EMOTION, V11, P329, DOI 10.1037/a0022855; Ionta S, 2009, EXP BRAIN RES, V195, P207, DOI 10.1007/s00221-009-1770-0; Kihara K, 2011, J EXP PSYCHOL HUMAN, V37, P168, DOI 10.1037/a0019948; Kiss M, 2007, J COGNITIVE NEUROSCI, V19, P1316, DOI 10.1162/jocn.2007.19.8.1316; Liu TH, 2006, J VISION, V6, P1294, DOI 10.1167/6.11.12; Louwerse MM, 2008, PSYCHON B REV, V15, P838, DOI 10.3758/PBR.15.4.838; Mahon BZ, 2008, J PHYSIOL-PARIS, V102, P59, DOI 10.1016/j.jphysparis.2008.03.004; Mahon BZ, 2008, CURR BIOL, V18, pR1068, DOI 10.1016/j.cub.2008.10.001; Mark D.M., 1989, P 9 INT S COMP ASS C, V9, P538; Marmolejo-Ramos F, U PSYCHO IN PRESS; Marmolejo-Ramos F, 2009, PRAGMAT COGN, V17, P77, DOI 10.1075/pc.17.1.03mar; Martin RL, 2011, J ACOUST SOC AM, V129, P3873, DOI 10.1121/1.3589254; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Meier BP, 2011, SOC PSYCHOL PERS SCI, V2, P547, DOI 10.1177/1948550611401042; Meteyard L, 2012, CORTEX, V48, P788, DOI 10.1016/j.cortex.2010.11.002; Mishra RK, 2010, COGN PROCESS, V11, P295, DOI 10.1007/s10339-010-0363-y; Miyauchi S, 2004, J PHYSIOL-PARIS, V98, P207, DOI 10.1016/j.jphysparis.2004.03.014; Munzel U, 1999, STAT NEERL, V53, P277, DOI 10.1111/1467-9574.00112; Ni Choisdealbha A, 2011, EXP BRAIN RES, V211, P73, DOI 10.1007/s00221-011-2652-9; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Rangel Maria Luiza, 2010, Psychol. Neurosci., V3, P135, DOI 10.3922/j.psns.2010.2.002; Raymond JE, 2003, PSYCHOL SCI, V14, P537, DOI 10.1046/j.0956-7976.2003.psci_1462.x; Rosenberger J.L., 1983, UNDERSTANDING ROBUST, P297; Rueschemeyer SA, 2010, EXP PSYCHOL, V57, P260, DOI 10.1027/1618-3169/a000031; Stins JF, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-83; Talgar CP, 2002, PSYCHON B REV, V9, P714, DOI 10.3758/BF03196326; Thomas LE, 2009, PSYCHON B REV, V16, P719, DOI 10.3758/PBR.16.4.719; Ulrich R, 2010, COGNITION, V117, P126, DOI 10.1016/j.cognition.2010.08.001; Vargha A, 2000, J EDUC BEHAV STAT, V25, P101, DOI 10.3102/10769986025002101; Wilcox R. R., 2011, INTRO ROBUST ESTIMAT; Wilson NL, 2007, COGNITIVE SCI, V31, P721, DOI 10.1080/15326900701399962; Yamada Y, 2008, PSYCHOL RES-PSYCH FO, V72, P273, DOI 10.1007/s00426-007-0109-3; Yamada Y, 2012, NEUROSCI LETT, V531, P96, DOI 10.1016/j.neulet.2012.10.028; Yamada Y, 2011, J VISION, V11, DOI 10.1167/11.6.6; Yeh WC, 2006, AM J PSYCHOL, V119, P349, DOI 10.2307/20445349; Zanolie K, 2012, BRAIN COGNITION, V78, P50, DOI 10.1016/j.bandc.2011.10.006	71	24	24	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81688	10.1371/journal.pone.0081688	http://dx.doi.org/10.1371/journal.pone.0081688			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349112	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300045
J	Bossert, S; Pfaffelhuber, P				Bossert, Sebastian; Pfaffelhuber, Peter			The Yule Approximation for the Site Frequency Spectrum after a Selective Sweep	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; GENETIC HITCHHIKING; POSITIVE SELECTION; GENEALOGIES; SIGNATURE	In the area of evolutionary theory, a key question is which portions of the genome of a species are targets of natural selection. Genetic hitchhiking is a theoretical concept that has helped to identify various such targets in natural populations. In the presence of recombination, a severe reduction in sequence diversity is expected around a strongly beneficial allele. The site frequency spectrum is an important tool in genome scans for selection and is composed of the numbers S1,:::, Sn-1 where Sk is the number of single nucleotide polymorphisms (SNPs) present in k from n individuals. Previous work has shown that both the number of low-and high-frequency variants are elevated relative to neutral evolution when a strongly beneficial allele fixes. Here, we follow a recent investigation of genetic hitchhiking using a marked Yule process to obtain an analytical prediction of the site frequency spectrum in a panmictic population at the time of fixation of a highly beneficial mutation. We combine standard results from the neutral case with the effects of a selective sweep. As simulations show, the resulting formula produces predictions that are more accurate than previous approaches for the whole frequency spectrum. In particular, the formula correctly predicts the elevation of low-and high-frequency variants and is significantly more accurate than previously derived formulas for intermediate frequency variants.	[Bossert, Sebastian; Pfaffelhuber, Peter] Univ Freiburg, Dept Math Stochast, D-79106 Freiburg, Germany	University of Freiburg	Bossert, S (corresponding author), Univ Freiburg, Dept Math Stochast, Hugstetter Str 55, D-79106 Freiburg, Germany.	sebastian.bossert@stochastik.uni-freiburg.de			Deutsche Forschungsgemeinschaft (DFG) [PP672/3-1, Hu1889/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the project PP672/3-1 and Hu1889/1-1 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton NH, 1998, GENET RES, V72, P123, DOI 10.1017/S0016672398003462; Barton NH, 2004, ANN APPL PROBAB, V14, P754, DOI 10.1214/105051604000000099; Durrett R, 2004, THEOR POPUL BIOL, V66, P129, DOI 10.1016/j.tpb.2004.04.002; Durrett R, 2008, PROBAB APPL SER, P1, DOI 10.1007/978-0-387-78168-6_1; Etheridge A, 2006, ANN APPL PROBAB, V16, P685, DOI 10.1214/105051606000000114; EVANS SN, 1994, CAN MATH BULL, V37, P187, DOI 10.4153/CMB-1994-028-3; Ewens W.J, 2004, INTERDISCIPLINARY AP, V27; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fay JC, 2000, GENETICS, V155, P1405; Fisher RA, 1930, GENETICAL THEORY NAT; Jensen JD, 2007, GENETICS, V176, P2371, DOI 10.1534/genetics.106.069450; KAPLAN NL, 1989, GENETICS, V123, P887; Kim Y, 2004, GENETICS, V167, P1513, DOI 10.1534/genetics.103.025387; Kim Y, 2002, GENETICS, V160, P765; KIMURA M, 1969, GENETICS, V61, P893; Nielsen R, 2005, GENOME RES, V15, P1566, DOI 10.1101/gr.4252305; Pavlidis P, 2010, GENETICS, V185, P907, DOI 10.1534/genetics.110.116459; Pfaffelhuber P, 2007, J MATH BIOL, V55, P299, DOI 10.1007/s00285-007-0085-7; Pfaffelhuber P, 2006, GENETICS, V174, P1995, DOI 10.1534/genetics.106.061887; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stephan W, 2010, PHILOS T R SOC B, V365, P1245, DOI 10.1098/rstb.2009.0278	21	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81738	10.1371/journal.pone.0081738	http://dx.doi.org/10.1371/journal.pone.0081738			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339959	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400035
J	Bu, YY; Sun, B; Zhou, AM; Zhang, XX; Lee, I; Liu, SK				Bu, Yuanyuan; Sun, Bo; Zhou, Aimin; Zhang, Xinxin; Lee, Imshik; Liu, Shenkui			Identification and Characterization of a PutAMT1;1 Gene from Puccinellia tenuiflora	PLOS ONE			English	Article							AFFINITY AMMONIUM TRANSPORTER; PLASMA-MEMBRANE; ARABIDOPSIS-THALIANA; NH4+ UPTAKE; EXPRESSION; NITROGEN; ROOTS; TRANSFORMATION; TOXICITY; MEMBERS	Nitrogen is one of the most important limiting factors for plant growth. However, as ammonium is readily converted into ammonia (NH3) when soil pH rises above 8.0, this activity depletes the availability of ammonium (NH4+) in alkaline soils, consequently preventing the growth of most plant species. The perennial wild grass Puccinellia tenuiflora is one of a few plants able to grow in soils with extremely high salt and alkaline pH (>9.0) levels. Here, we assessed how this species responds to ammonium under such conditions by isolating and analyzing the functions of a putative ammonium transporter (PutAMT1;1). PutAMT1;1 is the first member of the AMT1 (ammonium transporter) family that has been identified in P. tenuiflora. This gene (1) functionally complemented a yeast mutant deficient in ammonium uptake (2), is preferentially expressed in the anther of P. tenuiflora, and (3) is significantly upregulated by ammonium ions in both the shoot and roots. The PutAMT1;1 protein is localized in the plasma membrane and around the nuclear periphery in yeast cells and P. tenuiflora suspension cells. Immunoelectron microscopy analysis also indicated that PutAMT1;1 is localized in the endomembrane. The overexpression of PutAMT1;1 in A. thaliana enhanced plant growth, and increased plant susceptibility to toxic methylammonium (MeA). Here, we confirmed that PutAMT1;1 is an ammonium-inducible ammonium transporter in P. tenuiflora. On the basis of the results of PutAMT1;1 overexpression in A. thaliana, this gene might be useful for improving the root to shoot mobilization of MeA (or NH4+).	[Bu, Yuanyuan; Sun, Bo; Zhou, Aimin; Zhang, Xinxin; Lee, Imshik; Liu, Shenkui] Northeast Forestry Univ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Alkali Soil Nat Environm Sci Ctr, Harbin, Peoples R China	Northeast Forestry University - China	Liu, SK (corresponding author), Northeast Forestry Univ, Key Lab Saline Alkali Vegetat Ecol Restorat Oil F, Minist Educ, Alkali Soil Nat Environm Sci Ctr, Harbin, Peoples R China.	shenkuiliu@nefu.edu.cn	Lee, Imshik/G-6129-2010; Liu, Shenkui/AAC-5405-2019	Lee, Imshik/0000-0002-0098-392X; Liu, Shenkui/0000-0001-5294-4765	Fundamental Research Funds for the Central Universities [DL13BAX13]; State Forestry Administration 948 Program of PR China [2008429]; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Forestry Administration 948 Program of PR China; Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT)(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the Fundamental Research Funds for the Central Universities (No. DL13BAX13) awarded to YB; State Forestry Administration 948 Program of PR China (No. 2008429) and Program for Changjiang Scholars and Innovative Research Team in University (PCSIRT) awarded to SL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLOOM AJ, 1992, PLANT PHYSIOL, V99, P1294, DOI 10.1104/pp.99.4.1294; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; D'Apuzzo E, 2004, PLANT PHYSIOL, V134, P1763, DOI 10.1104/pp.103.034322; Duan YH, 2007, PEDOSPHERE, V17, P697, DOI 10.1016/S1002-0160(07)60084-8; Gaur VS, 2012, MOL BIOL REP, V39, P8035, DOI 10.1007/s11033-012-1650-8; Gazzarrini S, 1999, PLANT CELL, V11, P937, DOI 10.1105/tpc.11.5.937; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; Holm LM, 2005, PFLUG ARCH EUR J PHY, V450, P415, DOI 10.1007/s00424-005-1399-1; Hoque MS, 2006, FUNCT PLANT BIOL, V33, P153, DOI 10.1071/FP05165; Howitt SM, 2000, BBA-BIOMEMBRANES, V1465, P152, DOI 10.1016/S0005-2736(00)00136-X; Jahn TP, 2004, FEBS LETT, V574, P31, DOI 10.1016/j.febslet.2004.08.004; Judkins G, 2012, ENVIRON MANAGE, V50, P478, DOI 10.1007/s00267-012-9889-3; Kronzucker HJ, 2001, TRENDS PLANT SCI, V6, P335, DOI 10.1016/S1360-1385(01)02022-2; Kumar A, 2003, PLANT CELL ENVIRON, V26, P907, DOI 10.1046/j.1365-3040.2003.01023.x; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Loque D, 2005, PLANT PHYSIOL, V137, P671, DOI 10.1104/pp.104.051268; Loque D, 2004, J EXP BOT, V55, P1293, DOI 10.1093/jxb/erh147; Loque D, 2006, PLANT J, V48, P522, DOI 10.1111/j.1365-313X.2006.02887.x; Ludewig U, 2003, J BIOL CHEM, V278, P45603, DOI 10.1074/jbc.M307424200; Ludewig U, 2002, J BIOL CHEM, V277, P13548, DOI 10.1074/jbc.M200739200; Marini AM, 1997, MOL CELL BIOL, V17, P4282, DOI 10.1128/MCB.17.8.4282; Mayer M, 2006, BIOCHEM J, V396, P431, DOI 10.1042/BJ20060051; Nakhoul NL, 2001, AM J PHYSIOL-RENAL, V281, pF255, DOI 10.1152/ajprenal.2001.281.2.F255; NINNEMANN O, 1994, EMBO J, V13, P3464, DOI 10.1002/j.1460-2075.1994.tb06652.x; Rawat SR, 1999, PLANT J, V19, P143, DOI 10.1046/j.1365-313X.1999.00505.x; Salvemini F, 2001, GENE, V270, P237, DOI 10.1016/S0378-1119(01)00470-X; Sambrook J, 1989, MOL CLONING LAB MANU, P1566; SCHACHTMAN DP, 1992, SCIENCE, V258, P1654, DOI 10.1126/science.8966547; Sheen J., 2002, TRANSIENT EXPRESSION; Shi De-Cheng, 1993, Acta Botanica Sinica, V35, P144; Simon-Rosin U, 2003, PLANT MOL BIOL, V51, P99, DOI 10.1023/A:1020710222298; Sohlenkamp C, 2000, FEBS LETT, V467, P273, DOI 10.1016/S0014-5793(00)01153-4; Sohlenkamp C, 2002, PLANT PHYSIOL, V130, P1788, DOI 10.1104/pp.008599; Sonoda Y, 2003, PLANT CELL PHYSIOL, V44, P726, DOI 10.1093/pcp/pcg083; Vinod KK, 2012, AOB PLANTS, DOI 10.1093/aobpla/pls028; von Wiren N, 2000, PLANT J, V21, P167, DOI 10.1046/j.1365-313x.2000.00665.x; Wang H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037817; WANG MY, 1993, PLANT PHYSIOL, V103, P1259, DOI 10.1104/pp.103.4.1463; Wang Z.Q., 1993, SALINE ALKALI SOIL C; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Yuan LX, 2009, PLANT CELL PHYSIOL, V50, P13, DOI 10.1093/pcp/pcn186; Yuan ZQ, 2010, THESIS NE NORMAL U C; Zhang XX, 2011, BIOCHEM BIOPH RES CO, V414, P96, DOI 10.1016/j.bbrc.2011.09.030; Zhao XQ, 2008, PEDOSPHERE, V18, P86, DOI 10.1016/S1002-0160(07)60106-4	47	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83111	10.1371/journal.pone.0083111	http://dx.doi.org/10.1371/journal.pone.0083111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340088	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400123
J	El-Zein, O; Kreydiyyeh, SI				El-Zein, Ola; Kreydiyyeh, Sawsan Ibrahim			Leptin Inhibits Glucose Intestinal Absorption via PKC, p38MAPK, PI3K and MEK/ERK	PLOS ONE			English	Article							RAT SMALL-INTESTINE; LUMINAL LEPTIN; BRUSH-BORDER; PHOSPHOINOSITIDE 3-KINASE; PERIPHERAL-TISSUES; SPLICE VARIANTS; OB-R; ACTIVATION; TRANSPORT; RECEPTOR	The role of leptin in controlling food intake and body weight is well recognized, but whether this is achieved by modulating nutrient absorption is still a controversial issue. The aim of this work was to investigate the direct effect of luminal leptin on glucose intestinal absorption and elucidate for the first time its signaling pathway. Fully differentiated Caco-2 cells grown on transwell filters were used for glucose transport studies. Leptin caused a significant reduction in glucose absorption. Individual and simultaneous inhibition of ERK, p38MAPK, PI3K or PKC abrogated completely the inhibitory effect of leptin. Activating PKC, lead to a stimulatory effect that appeared only when ERK, p38MAPK, or PI3K was inactive. Moreover, leptin increased the phosphorylation of ERK, Akt and p38MAPK. This increase changed into a decrease when p38MAPK and PKC were inactivated individually. Inhibiting ERK maintained the leptin-induced up-regulation of p-Akt and p-p38MAPK while inhibiting PI3K reduced the level of p-ERK and p-Akt but maintained the increase in p-p38MAPK. These results suggest that leptin reduces glucose absorption by activating PKC. Although the latter modulates glucose absorption via a stimulatory and an inhibitory pathway, only the latter is involved in leptin's action. Active PKC leads to a sequential activation of p38MAPK, PI3K and ERK which exerts an inhibitory effect on glucose absorption. The results reveal a modulatory role of leptin in nutrient absorption in addition to its known satiety inducing effect.	[El-Zein, Ola; Kreydiyyeh, Sawsan Ibrahim] Amer Univ Beirut, Dept Biol, Beirut, Lebanon	American University of Beirut	Kreydiyyeh, SI (corresponding author), Amer Univ Beirut, Dept Biol, Beirut, Lebanon.	Sawkreyd@aub.edu.lb		El Zein, Ola/0000-0001-7233-3291	Lebanese National Council for Scientific Research	Lebanese National Council for Scientific Research	Funding provided by Lebanese National Council for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Attoub S, 2000, FASEB J, V14, P2329, DOI 10.1096/fj.00-0162; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; Barness LA, 2007, AM J MED GENET A, V143A, P3016, DOI 10.1002/ajmg.a.32035; Barrenetxe J, 2002, GUT, V50, P797, DOI 10.1136/gut.50.6.797; Barrenetxe J, 2001, J PHYSIOL BIOCHEM, V57, P345, DOI 10.1007/BF03179829; Barros LF, 1997, J PHYSIOL-LONDON, V504, P517, DOI 10.1111/j.1469-7793.1997.517bd.x; Berti L, 1999, MOL CELL ENDOCRINOL, V157, P121, DOI 10.1016/S0303-7207(99)00154-9; Berti L, 1997, DIABETOLOGIA, V40, P606, DOI 10.1007/s001250050722; Buyse M, 2002, J BIOL CHEM, V277, P28182, DOI 10.1074/jbc.M203281200; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Cammisotto PG, 2005, J HISTOCHEM CYTOCHEM, V53, P851, DOI 10.1369/jhc.5A6620.2005; CAMMISOTTO PG, 2010, INT J CELL BIOL, V2010; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; De Matteis R, 2002, J ANAT, V201, P363, DOI 10.1046/j.0021-8782.2002.00106.x; De Matteis R, 1998, P NUTR SOC, V57, P441, DOI 10.1079/PNS19980063; Ducroc R, 2005, DIABETES, V54, P348, DOI 10.2337/diabetes.54.2.348; Ducroc R, 2010, AM J PHYSIOL-GASTR L, V299, pG179, DOI 10.1152/ajpgi.00048.2010; Fanjul C, 2012, ACTA PHYSIOL, V205, P82, DOI 10.1111/j.1748-1716.2012.02412.x; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; GOULD GW, 1995, BIOCHEM J, V311, P735, DOI 10.1042/bj3110735; GREGREEN ED, 1995, GENOME RES, V5, P5, DOI DOI 10.1101/GR.5.1; Guilmeau S, 2003, DIABETES, V52, P1664, DOI 10.2337/diabetes.52.7.1664; HALAAS JL, 1995, SCIENCE, V269, P543, DOI 10.1126/science.7624777; Hansen GH, 2008, J HISTOCHEM CYTOCHEM, V56, P677, DOI 10.1369/jhc.2008.950782; Harvey J, 2000, J BIOL CHEM, V275, P4660, DOI 10.1074/jbc.275.7.4660; Hegyi K, 2004, CELL BIOL INT, V28, P159, DOI 10.1016/j.cellbi.2003.12.003; Helliwell PA, 2000, BIOCHEM J, V350, P163, DOI 10.1042/0264-6021:3500163; Helliwell PA, 2000, BIOCHEM J, V350, P149, DOI 10.1042/0264-6021:3500149; Hoggard N, 1997, BIOCHEM BIOPH RES CO, V232, P383, DOI 10.1006/bbrc.1997.6245; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Inigo C, 2007, ACTA PHYSIOL, V190, P303, DOI 10.1111/j.1748-1716.2007.01707.x; Kellett GL, 2000, BIOCHEM J, V350, P155, DOI 10.1042/0264-6021:3500155; Lostao MP, 1998, FEBS LETT, V423, P302, DOI 10.1016/S0014-5793(98)00110-0; Martinez-Anso E, 1999, KIDNEY INT, V55, P1129; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Morton NM, 1998, J BIOL CHEM, V273, P26194, DOI 10.1074/jbc.273.40.26194; O'Rourke L, 2001, DIABETES, V50, P955, DOI 10.2337/diabetes.50.5.955; Sakar Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007935; Sinha MK, 1996, J CLIN INVEST, V98, P1277, DOI 10.1172/JCI118913; Sobhani I, 2000, GUT, V47, P178, DOI 10.1136/gut.47.2.178; Stan S, 2001, FEBS LETT, V508, P80, DOI 10.1016/S0014-5793(01)03032-0; Sweeney G, 2002, CELL SIGNAL, V14, P655, DOI 10.1016/S0898-6568(02)00006-2; Sweeney G, 2000, ENDOCRINOLOGY, V141, P1277, DOI 10.1210/en.141.3.1277; van den Brink Gijs R., 2000, Molecular Cell Biology Research Communications, V4, P144, DOI 10.1006/mcbr.2001.0270; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zhao AZ, 1998, J CLIN INVEST, V102, P869, DOI 10.1172/JCI3920	48	9	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83360	10.1371/journal.pone.0083360	http://dx.doi.org/10.1371/journal.pone.0083360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340098	gold, Green Submitted, Green Published			2022-12-27	WOS:000328707400131
J	Haagensen, EJ; Thomas, HD; Wilson, I; Harnor, SJ; Payne, SL; Rennison, T; Smith, KM; Maxwell, RJ; Newell, DR				Haagensen, Emma J.; Thomas, Huw D.; Wilson, Ian; Harnor, Suzannah J.; Payne, Sara L.; Rennison, Tommy; Smith, Kate M.; Maxwell, Ross J.; Newell, David R.			The Enhanced In Vivo Activity of the Combination of a MEK and a PI3K Inhibitor Correlates with [F-18]-FLT PET in Human Colorectal Cancer Xenograft Tumour-Bearing Mice	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; CARCINOMA-CELLS; KINASE; PROLIFERATION; GDC-0941; PATHWAY; GROWTH; BAD; PHOSPHORYLATION; TRANSCRIPTION	Combined targeting of the MAPK and PI3K signalling pathways in cancer may be necessary for optimal therapeutic activity. To support clinical studies of combination therapy, 39-deoxy-39-[F-18]-fluorothymidine ([F-18]-FLT) uptake measured by Positron Emission Tomography (PET) was evaluated as a non-invasive surrogate response biomarker in pre-clinical models. The in vivo anti-tumour efficacy and PK-PD properties of the MEK inhibitor PD 0325901 and the PI3K inhibitor GDC-0941, alone and in combination, were evaluated in HCT116 and HT29 human colorectal cancer xenograft tumour-bearing mice, and [F-18]-FLT PET investigated in mice bearing HCT116 xenografts. Dual targeting of PI3K and MEK induced marked tumour growth inhibition in vivo, and enhanced anti-tumour activity was predicted by [18 F]-FLT PET scanning after 2 days of treatment. Pharmacodynamic analyses using the combination of the PI3K inhibitor GDC-0941 and the MEK inhibitor PD 0325901 revealed that increased efficacy is associated with an enhanced inhibition of the phosphorylation of ERK1/2, S6 and 4EBP1, compared to that observed with either single agent, and maintained inhibition of AKT phosphorylation. Pharmacokinetic studies indicated that there was no marked PK interaction between the two drugs. Together these results indicate that the combination of PI3K and MEK inhibitors can result in significant efficacy, and demonstrate for the first time that [F-18]-FLT PET can be correlated to the improved efficacy of combined PI3K and MEK inhibitor treatment.	[Haagensen, Emma J.; Thomas, Huw D.; Wilson, Ian; Maxwell, Ross J.; Newell, David R.] Newcastle Univ, Sch Med, Northern Inst Canc Res, Newcastle Canc Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Harnor, Suzannah J.; Payne, Sara L.; Rennison, Tommy; Smith, Kate M.] Newcastle Univ, Sch Chem, Northern Inst Canc Res, Newcastle Canc Ctr, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Newell, DR (corresponding author), Newcastle Univ, Sch Med, Northern Inst Canc Res, Newcastle Canc Ctr, Paul OGorman Bldg,Framlington Pl, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	herbie.newell@ncl.ac.uk	Harnor, Suzannah/AAK-6041-2021	Haagensen, Emma/0000-0001-7420-9809	Cancer Research United Kingdom (CRUK) Drug Discovery; Imaging and Medicinal Chemistry Training Programmes [C240/A15751, C29821/A10348]; EJH; UCB Celltech, Slough, UK; Cancer Research UK [10348] Funding Source: researchfish; Medical Research Council [MC_G0902167] Funding Source: researchfish; MRC [MC_G0902167] Funding Source: UKRI	Cancer Research United Kingdom (CRUK) Drug Discovery; Imaging and Medicinal Chemistry Training Programmes; EJH; UCB Celltech, Slough, UK; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	HDT, IW, SJH, SLP, TR, KMS, RJM and DRN are funded by Cancer Research United Kingdom (CRUK) Drug Discovery, Imaging and Medicinal Chemistry Training Programmes (C240/A15751 and C29821/A10348) & EJH was a Medical Research Council (MRC) CASE Award PhD Student supported by UCB Celltech, Slough, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SJ, 2007, PREPARATION THIENOPY, V2007; Barrett SD, 2008, BIOORG MED CHEM LETT, V18, P6501, DOI 10.1016/j.bmcl.2008.10.054; Barthel H, 2003, CANCER RES, V63, P3791; Baudy AR, 2012, EJNMMI RES, V2, DOI 10.1186/2191-219X-2-22; Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brown AP, 2007, CANCER CHEMOTH PHARM, V59, P671, DOI 10.1007/s00280-006-0323-5; Buck AK, 2002, CANCER RES, V62, P3331; Buck AK, 2009, METHODS, V48, P205, DOI 10.1016/j.ymeth.2009.03.009; Cawthorne C, 2013, MOL CANCER THER, V12, P819, DOI 10.1158/1535-7163.MCT-12-0905; Chalkidou A, 2012, EUR J CANCER, V48, P3499, DOI 10.1016/j.ejca.2012.05.001; Cobben DCP, 2004, CLIN CANCER RES, V10, P1685, DOI 10.1158/1078-0432.CCR-03-0040; Desar Ingrid M E, 2012, World J Nucl Med, V11, P65, DOI 10.4103/1450-1147.103413; Duong HQ, 2012, ONCOL REP, V27, P182, DOI 10.3892/or.2011.1503; Ebenhan T, 2009, MOL IMAGING BIOL, V11, P308, DOI 10.1007/s11307-009-0216-1; Edgar KA, 2010, CANCER RES, V70, P1164, DOI 10.1158/0008-5472.CAN-09-2525; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Faber AC, 2009, P NATL ACAD SCI USA, V106, P19503, DOI 10.1073/pnas.0905056106; Folkes AJ, 2008, J MED CHEM, V51, P5522, DOI 10.1021/jm800295d; Fuereder T, 2011, CLIN CANCER RES, V17, P5322, DOI 10.1158/1078-0432.CCR-10-1659; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Haagensen EJ, 2012, BRIT J CANCER, V106, P1386, DOI 10.1038/bjc.2012.70; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Harada H, 1999, MOL CELL, V3, P413, DOI 10.1016/S1097-2765(00)80469-4; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Henderson YC, 2010, MOL CANCER THER, V9, P1968, DOI 10.1158/1535-7163.MCT-10-0062; Hoeben BAW, 2013, J NUCL MED, V54, P532, DOI 10.2967/jnumed.112.105999; Hoeflich KP, 2012, CANCER RES, V72, P210, DOI 10.1158/0008-5472.CAN-11-1515; Kelly CJ, 2012, NUCL MED BIOL, V39, P986, DOI 10.1016/j.nucmedbio.2012.04.006; Kenny L, 2007, EUR J NUCL MED MOL I, V34, P1339, DOI 10.1007/s00259-007-0379-4; Kinross KM, 2011, MOL CANCER THER, V10, P1440, DOI 10.1158/1535-7163.MCT-11-0240; Leyton J, 2008, MOL CANCER THER, V7, P3112, DOI 10.1158/1535-7163.MCT-08-0264; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Markman B, 2013, CURR PHARM DESIGN, V19, P895, DOI 10.2174/138161213804547213; McKinley Eliot T., 2013, PLOS ONE, V8; Moreno Garcia V, 2011, J CLIN ONCOL, V29, P3021; O'Brien C, 2010, CLIN CANCER RES, V16, P3670, DOI 10.1158/1078-0432.CCR-09-2828; Pantaleo MA, 2008, CANCER TREAT REV, V34, P103, DOI 10.1016/j.ctrv.2007.10.001; Paproski RJ, 2008, MOL PHARMACOL, V74, P1372, DOI 10.1124/mol.108.048900; Pio BS, 2006, MOL IMAGING BIOL, V8, P36, DOI 10.1007/s11307-005-0029-9; Nguyen QD, 2011, TRANSL ONCOL, V4, P241, DOI 10.1593/tlo.11118; Rasey JS, 2002, J NUCL MED, V43, P1210; Rexer BN, 2009, CLIN CANCER RES, V15, P4518, DOI 10.1158/1078-0432.CCR-09-0872; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Salphati L, 2011, XENOBIOTICA, V41, P1088, DOI [10.3109/00498254.2011.603386, 10.3109/00498254.2011.603384]; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; She QB, 2005, CANCER CELL, V8, P287, DOI 10.1016/j.ccr.2005.09.006; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Shields AF, 1998, NAT MED, V4, P1334, DOI 10.1038/3337; Solit DB, 2007, CANCER RES, V67, P11463, DOI 10.1158/0008-5472.CAN-07-2976; Sos ML, 2009, P NATL ACAD SCI USA, V106, P18351, DOI 10.1073/pnas.0907325106; Tan Y, 1999, J BIOL CHEM, V274, P34859, DOI 10.1074/jbc.274.49.34859; Wallin JJ, 2012, CLIN CANCER RES, V18, P3901, DOI 10.1158/1078-0432.CCR-11-2088; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Zhang CC, 2012, CLIN CANCER RES, V18, P1303, DOI 10.1158/1078-0432.CCR-11-1433; Zhu JD, 2008, P NATL ACAD SCI USA, V105, P6584, DOI 10.1073/pnas.0802785105	57	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81763	10.1371/journal.pone.0081763	http://dx.doi.org/10.1371/journal.pone.0081763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339963	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400039
J	Werner, I; Guo, FW; Bogert, NV; Stock, UA; Meybohm, P; Moritz, A; Beiras-Fernandez, A				Werner, Isabella; Guo, Fengwei; Bogert, Nicolai V.; Stock, Ulrich A.; Meybohm, Patrick; Moritz, Anton; Beiras-Fernandez, Andres			Methylene Blue Modulates Transendothelial Migration of Peripheral Blood Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; VASOPLEGIC SYNDROME; MONOCYTE CHEMOTAXIS; SEPTIC SHOCK; VASOPRESSIN; ADHESION; HEMODYNAMICS; INHIBITION; EXPRESSION; MANAGEMENT	Vasoplegia is a severe complication after cardiac surgery. Within the last years the administration of nitric oxide synthase inhibitor methylene blue (MB) became a new therapeutic strategy. Our aim was to investigate the role of MB on transendothelial migration of circulating blood cells, the potential role of cyclic cGMP, eNOS and iNOS in this process, and the influence of MB on endothelial cell apoptosis. Human vascular endothelial cells (HuMEC-1) were treated for 30 minutes or 2 hours with different concentrations of MB. Inflammation was mimicked by LPS stimulation prior and after MB. Transmigration of PBMCs and T-Lymphocytes through the treated endothelial cells was investigated. The influence of MB upon the different subsets of PBMCs (Granulocytes, T-and B-Lymphocytes, and Monocytes) was assessed after transmigration by means of flow-cytometry. The effect of MB on cell apoptosis was evaluated using Annexin-V and Propidium Iodide stainings. Analyses of the expression of cyclic cGMP, eNOS and iNOS were performed by means of RT-PCR and Western Blot. Results were analyzed using unpaired Students T-test. Analysis of endothelial cell apoptosis by MB indicated a dose-dependent increase of apoptotic cells. We observed time-and dose-dependent effects of MB on transendothelial migration of PBMCs. The prophylactic administration of MB led to an increase of transendothelial migration of PBMCs but not Jurkat cells. Furthermore, HuMEC-1 secretion of cGMP correlated with iNOS expression after MB administration but not with eNOS expression. Expression of these molecules was reduced after MB administration at protein level. This study clearly reveals that endothelial response to MB is dose-and especially time-dependent. MB shows different effects on circulating blood cell-subtypes, and modifies the release patterns of eNOS, iNOS, and cGMP. The transendothelial migration is modulated after treatment with MB. Furthermore, MB provokes apoptosis of endothelial cells in a dose/time-dependent manner.	[Werner, Isabella; Guo, Fengwei; Bogert, Nicolai V.; Stock, Ulrich A.; Moritz, Anton; Beiras-Fernandez, Andres] Johann Wolfgang Goethe Univ Hosp, Dept Thorac & Cardiovasc Surg, Frankfurt, Germany; [Meybohm, Patrick] Johann Wolfgang Goethe Univ Hosp, Clin Anaesthesiol Intens Care Med & Pain Therapy, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Beiras-Fernandez, A (corresponding author), Johann Wolfgang Goethe Univ Hosp, Dept Thorac & Cardiovasc Surg, Frankfurt, Germany.	andres.beiras@kgu.de	Stock, Ulrich/CAH-2487-2022; Meybohm, Patrick/K-4066-2017; Beiras, Andres/AAE-4864-2020	Meybohm, Patrick/0000-0002-2666-8696; 				ADES EW, 1992, J INVEST DERMATOL, V99, P683, DOI 10.1111/1523-1747.ep12613748; Evora PRB, 2009, REV BRAS CIR CARDIOV, V24, P279, DOI 10.1590/S0102-76382009000400005; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; BATH PMW, 1993, EUR J CLIN PHARMACOL, V45, P53, DOI 10.1007/BF00315350; BELENKY SN, 1993, J LEUKOCYTE BIOL, V53, P498, DOI 10.1002/jlb.53.5.498; Bruno MJ, 2003, GUT, V52, P7; BUSSE R, 1990, FEBS LETT, V275, P87, DOI 10.1016/0014-5793(90)81445-T; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Carreau A, 2011, EXP CELL RES, V317, P29, DOI 10.1016/j.yexcr.2010.08.011; Chang YS, 2005, J CATARACT REFR SURG, V31, P792, DOI 10.1016/j.jcrs.2004.07.020; Cho JS, 2012, KOREAN J ANESTHESIOL, V63, P142, DOI 10.4097/kjae.2012.63.2.142; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Evora PRB, 2012, CURR DRUG TARGETS, V13, P1207; Evora PRB, 2000, J THORAC CARDIOV SUR, V119, P632, DOI 10.1016/S0022-5223(00)70152-8; Harbrecht BG, 1997, SHOCK, V8, P415, DOI 10.1097/00024382-199712000-00004; Holmes CL, 2001, INTENS CARE MED, V27, P1416, DOI 10.1007/s001340101014; Kanzler I, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-012-0310-4; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kiesslich R, 2004, J CLIN GASTROENTEROL, V38, P7, DOI 10.1097/00004836-200401000-00004; Kirszberg C, 2005, CANCER CHEMOTH PHARM, V56, P659, DOI 10.1007/s00280-005-1014-3; Klinzing S, 2003, CRIT CARE MED, V31, P2646, DOI 10.1097/01.CCM.0000094260.05266.F4; Lange M, 2010, CRIT CARE, V14, DOI 10.1186/cc9097; Lenglet S, 2011, EXPERT REV CARDIOVAS, V9, P1519, DOI [10.1586/ERC.11.160, 10.1586/erc.11.160]; Levin MA, 2009, CIRCULATION, V120, P1664, DOI 10.1161/CIRCULATIONAHA.108.814533; Levin RL, 2004, ANN THORAC SURG, V77, P496, DOI 10.1016/S0003-4975(03)01510-8; Lomniczi A, 2000, NEUROIMMUNOMODULAT, V8, P122, DOI 10.1159/000054271; Martikainen TJ, 2003, ANESTH ANALG, V97, P1756, DOI 10.1213/01.ANE.0000087039.60041.2E; MAYER B, 1993, EUR HEART J, V14, P22; Mebazaa A, 2010, CRIT CARE, V14, DOI 10.1186/cc8153; MILLER J, 1995, J EXP MED, V182, P1231, DOI 10.1084/jem.182.5.1231; MITSUHATA H, 1995, J CLIN IMMUNOL, V15, P277, DOI 10.1007/BF01541317; MONCADA S, 1991, PHARMACOL REV, V43, P109; Ozal E, 2005, ANN THORAC SURG, V79, P1615, DOI 10.1016/j.athoracsur.2004.10.038; Peter C, 2000, EUR J CLIN PHARMACOL, V56, P247, DOI 10.1007/s002280000124; Polito A, 2012, INTENS CARE MED, V38, P9, DOI 10.1007/s00134-011-2407-x; Ramsay RR, 2007, BRIT J PHARMACOL, V152, P946, DOI 10.1038/sj.bjp.0707430; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; REICHERT T, 1991, CLIN IMMUNOL IMMUNOP, V60, P190, DOI 10.1016/0090-1229(91)90063-G; Scalia R, 1999, J EXP MED, V189, P931, DOI 10.1084/jem.189.6.931; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; SCHULZ R, 1992, BRIT J PHARMACOL, V105, P575, DOI 10.1111/j.1476-5381.1992.tb09021.x; Shanmugam G, 2005, EUR J CARDIO-THORAC, V28, P705, DOI 10.1016/j.ejcts.2005.07.011; Taylor KM, 1996, ANN THORAC SURG, V61, P1607, DOI 10.1016/0003-4975(96)00225-1; THELEN KI, 1992, N-S ARCH PHARMACOL, V345, P93; THIEMERMANN C, 1993, P NATL ACAD SCI USA, V90, P267, DOI 10.1073/pnas.90.1.267; Vutskits L, 2008, ANESTHESIOLOGY, V108, P684, DOI 10.1097/ALN.0b013e3181684be4; Wang W, 2009, CHINESE J PHYSIOL, V52, P99, DOI 10.4077/CJP.2009.AMH006; Wright RO, 1999, ANN EMERG MED, V34, P646, DOI 10.1016/S0196-0644(99)70167-8; Xu PB, 2012, J INFECTION, V65, P380, DOI 10.1016/j.jinf.2012.08.001; Yang L, 2006, J IMMUNOL, V177, P6440, DOI 10.4049/jimmunol.177.9.6440	50	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82214	10.1371/journal.pone.0082214	http://dx.doi.org/10.1371/journal.pone.0082214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340007	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400065
J	Acosta, SA; Diamond, DM; Wolfe, S; Tajiri, N; Shinozuka, K; Ishikawa, H; Hernandez, DG; Sanberg, PR; Kaneko, Y; Borlongan, CV				Acosta, Sandra A.; Diamond, David M.; Wolfe, Steven; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Hernandez, Diana G.; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesar V.			Influence of Post-Traumatic Stress Disorder on Neuroinflammation and Cell Proliferation in a Rat Model of Traumatic Brain Injury	PLOS ONE			English	Article							MAGNETIC-RESONANCE SPECTROSCOPY; MEDIAL TEMPORAL-LOBES; HIPPOCAMPAL VOLUME; ANIMAL-MODEL; MEMORY; PERFORMANCE; SURVIVORS; EXPOSURE; ABSENCE; CORTEX	Long-term consequences of traumatic brain injury (TBI) are closely associated with the development of severe psychiatric disorders, such as post-traumatic stress disorder (PTSD), yet preclinical studies on pathological changes after combined TBI with PTSD are lacking. In the present in vivo study, we assessed chronic neuroinflammation, neuronal cell loss, cell proliferation and neuronal differentiation in specific brain regions of adult Sprague-Dawley male rats following controlled cortical impact model of moderate TBI with or without exposure to PTSD. Eight weeks post-TBI, stereology-based histological analyses revealed no significant differences between sham and PTSD alone treatment across all brain regions examined, whereas significant exacerbation of OX6-positive activated microglial cells in the striatum, thalamus, and cerebral peduncle, but not cerebellum, in animals that received TBI alone and combined TBI-PTSD compared with PTSD alone and sham treatment. Additional immunohistochemical results revealed a significant loss of CA3 pyramidal neurons in the hippocampus of TBI alone and TBI-PTSD compared to PTSD alone and sham treatment. Further examination of neurogenic niches revealed a significant downregulation of Ki67-positive proliferating cells, but not DCX-positive neuronally migrating cells in the neurogenic subgranular zone and subventricular zone for both TBI alone and TBI-PTSD compared to PTSD alone and sham treatment. Comparisons of levels of neuroinflammation and neurogenesis between TBI alone and TBI+PTSD revealed that PTSD did not exacerbate the neuropathological hallmarks of TBI. These results indicate a progressive deterioration of the TBI brain, which, under the conditions of the present approach, was not intensified by PTSD, at least within our time window and within the examined areas of the brain. Although the PTSD manipulation employed here did not exacerbate the pathological effects of TBI, the observed long-term inflammation and suppressed cell proliferation may evolve into more severe neurodegenerative diseases and psychiatric disorders currently being recognized in traumatized TBI patients.	[Acosta, Sandra A.; Tajiri, Naoki; Shinozuka, Kazutaka; Ishikawa, Hiroto; Hernandez, Diana G.; Sanberg, Paul R.; Kaneko, Yuji; Borlongan, Cesar V.] Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA; [Diamond, David M.; Wolfe, Steven] James A Haley Vet Affairs Med Ctr, Tampa, FL USA; [Diamond, David M.; Wolfe, Steven] Univ S Florida, Dept Psychol, Ctr Preclin & Clin Res PTSD, Dept Mol Pharmacol & Physiol, Tampa, FL 33620 USA; [Sanberg, Paul R.] Univ S Florida, Off Res & Innovat, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; US Department of Veterans Affairs; Veterans Health Administration (VHA); James A. Haley Veterans Hospital; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33620 USA.	cborlong@health.usf.edu	Tajiri, Naoki/K-1230-2012; Borlongan, Cesar/I-5696-2012	Tajiri, Naoki/0000-0003-2189-662X; Borlongan, Cesar/0000-0002-2966-9782; Ishikawa, Hiroto/0000-0003-0760-7203; Shinozuka, Kazutaka/0000-0002-6435-4460; Sanberg, Paul/0000-0001-9130-4592	USF Veterans Reintegration Research Funds; Department of Defense [W81XWH-11-1-0634]	USF Veterans Reintegration Research Funds; Department of Defense(United States Department of Defense)	Supported by USF Veterans Reintegration Research Funds and Department of Defense W81XWH-11-1-0634. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bremner JD, 2003, AM J PSYCHIAT, V160, P924, DOI 10.1176/appi.ajp.160.5.924; Brown S, 2003, J NEUROPSYCH CLIN N, V15, P367, DOI 10.1176/appi.neuropsych.15.3.367; Carrion VG, 2001, BIOL PSYCHIAT, V50, P943, DOI 10.1016/S0006-3223(01)01218-5; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; De Bellis MD, 1999, BIOL PSYCHIAT, V45, P1271, DOI 10.1016/S0006-3223(99)00045-1; De Bellis MD, 2002, BIOL PSYCHIAT, V52, P1066, DOI 10.1016/S0006-3223(02)01459-2; De Bellis MD, 2001, BIOL PSYCHIAT, V50, P305, DOI 10.1016/S0006-3223(01)01105-2; Diamond DM, 1999, HIPPOCAMPUS, V9, P542, DOI 10.1002/(SICI)1098-1063(1999)9:5<542::AID-HIPO8>3.3.CO;2-E; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Faul M, 2010, TRAUMATIC BRAIN INJU, DOI DOI 10.15620/CDC.5571; Fennema-Notestine C, 2002, BIOL PSYCHIAT, V52, P1089, DOI 10.1016/S0006-3223(02)01413-0; Freeman TW, 1998, MAGNET RESON MED, V40, P66, DOI 10.1002/mrm.1910400110; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Gilbertson MW, 2002, NAT NEUROSCI, V5, P1242, DOI 10.1038/nn958; Glaesser J, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-5; Glover LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033646; Golier JA, 2005, PSYCHIAT RES-NEUROIM, V139, P53, DOI 10.1016/j.pscychresns.2005.02.007; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Harting MT, 2008, SURGERY, V144, P803, DOI 10.1016/j.surg.2008.05.017; Hayashi T, 2009, BRAIN RES, V1280, P172, DOI 10.1016/j.brainres.2009.05.040; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Holschneider DP, 2011, J NEUROTRAUM, V28, P1909, DOI 10.1089/neu.2011.1978; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kraus JF, 1993, HEAD INJURY, P1; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Little DM, 2010, NEUROLOGY, V74, P558, DOI 10.1212/WNL.0b013e3181cff5d5; MAYHEW TM, 1991, EXP PHYSIOL, V76, P639, DOI 10.1113/expphysiol.1991.sp003533; Menon PM, 2003, PSYCHIAT RES-NEUROIM, V123, P101, DOI 10.1016/S0925-4927(03)00044-1; Pardini M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.1; Park CR, 2001, BIOL PSYCHIAT, V50, P994, DOI 10.1016/S0006-3223(01)01255-0; Pederson CL, 2004, J TRAUMA STRESS, V17, P37, DOI 10.1023/B:JOTS.0000014674.84517.46; Potts MB, 2009, CEREBELLUM, V8, P211, DOI 10.1007/s12311-009-0114-8; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Roth TL, 2011, J PSYCHIATR RES, V45, P919, DOI 10.1016/j.jpsychires.2011.01.013; Sapolsky RM, 1999, EXP GERONTOL, V34, P721, DOI 10.1016/S0531-5565(99)00047-9; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schuff N, 2001, BIOL PSYCHIAT, V50, P952, DOI 10.1016/S0006-3223(01)01245-8; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; SOSIN DM, 1995, JAMA-J AM MED ASSOC, V273, P1778, DOI 10.1001/jama.273.22.1778; Strangman GE, 2009, NEUROREHAB NEURAL RE, V23, P226, DOI 10.1177/1545968308324225; Tanielian T. L., 2008, INVISIBLE WOUNDS WAR, V1; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Villarreal G, 2002, CAN J PSYCHIAT, V47, P666, DOI 10.1177/070674370204700709; Wagner AK, 2007, BEHAV BRAIN RES, V181, P200, DOI 10.1016/j.bbr.2007.04.006; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067; Zoladz P.R., 2010, CULTURE PSY NEUROSCI, V15, P6; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007; Zoladz PR, 2008, STRESS, V11, P259, DOI 10.1080/10253890701768613	53	36	36	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81585	10.1371/journal.pone.0081585	http://dx.doi.org/10.1371/journal.pone.0081585			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	275VD	24349091	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200035
J	Reichert, S; Criscuolo, F; Verinaud, E; Zahn, S; Massemin, S				Reichert, Sophie; Criscuolo, Francois; Verinaud, Elodie; Zahn, Sandrine; Massemin, Sylvie			Telomere Length Correlations among Somatic Tissues in Adult Zebra Finches	PLOS ONE			English	Article							LONG-LIVED BIRDS; LIFE-SPAN; HUMAN FIBROBLASTS; QUANTITATIVE PCR; DYNAMICS; AGE; SURVIVAL; SHORTEN; STRESS; MODEL	Telomeres are repetitive non coding DNA sequences located at the end of eukaryotic chromosomes, which maintain the integrity of the genome by hiding the chromosome ends from being recognised as double stranded breaks. Telomeres are emerging as biomarkers for ageing and survival, and are susceptible to reflect different individual life history trajectories. In particular, the telomere length with which one starts in life has been shown to be linked with individual life-long survival, suggesting that telomere dynamics can be a proxy for individual fitness and thereby be implicated in evolutionary trade-offs. As a consequence, an increasing number of studies were conducted on telomeres in the fields of ecology and evolutionary biology, in which telomere length was almost exclusively measured from blood samples. However, not only do the number of repeats of the telomeric sequences vary among species, but also within species with great inter-individual telomere lengths variability with age, tissues, and chromosomes. This raises the issue of the exact biological meaning of telomere measurement in blood cells and stimulated the study of the correlation of telomere lengths among tissues over age. By measuring telomere length in adult zebra finches (Taeniopygia guttata) in different somatic tissues displaying variable cell turnovers (bone marrow, brain, spleen, pectoral muscle, heart, liver and in red blood cells), we checked that the measure of telomere length in red blood cells is related to telomere lengths in the other tissues. Here we show significant relationships between the telomere lengths of red blood cells and several somatic tissues at adulthood. As red blood cells are easily accessible and suitable for the longitudinal monitoring of the individual rate of telomere loss, our study confirms that telomere length measured in red blood cells could serve as a surrogate for telomere length in the whole avian organism.	[Reichert, Sophie; Criscuolo, Francois; Verinaud, Elodie; Zahn, Sandrine; Massemin, Sylvie] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France; [Reichert, Sophie; Criscuolo, Francois; Verinaud, Elodie; Zahn, Sandrine; Massemin, Sylvie] CNRS, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Reichert, S (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Dept Ecol Physiol & Ethol, Strasbourg, France.	reichert.sophie@gmail.com		Reichert, Sophie/0000-0001-7151-2773	Centre national de la recherche scientifique (CNRS); PhD grant from the Region Alsace	Centre national de la recherche scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); PhD grant from the Region Alsace(Region Grand-Est)	This work was entirely supported by Centre national de la recherche scientifique (CNRS) funding and a PhD grant from the Region Alsace. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Bauch C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2540; Benetos A, 2011, AGING CELL, V10, P991, DOI 10.1111/j.1474-9726.2011.00744.x; Bize P, 2009, P R SOC B, V276, P1679, DOI 10.1098/rspb.2008.1817; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Criscuolo F, 2009, J AVIAN BIOL, V40, P342, DOI 10.1111/j.1600-048X.2008.04623.x; Daniali L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2602; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Forsyth NR, 2002, DIFFERENTIATION, V69, P188, DOI 10.1046/j.1432-0436.2002.690412.x; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Gardner JP, 2007, J GERONTOL A-BIOL, V62, P367, DOI 10.1093/gerona/62.4.367; Granick Mark, 2011, Eplasty, V11, pe15; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hartmann N, 2009, MECH AGEING DEV, V130, P290, DOI 10.1016/j.mad.2009.01.003; Haussmann MF, 2007, EXP GERONTOL, V42, P610, DOI 10.1016/j.exger.2007.03.004; Haussmann MF, 2010, CURR ZOOL, V56, P714, DOI 10.1093/czoolo/56.6.714; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Heidinger BJ, 2012, P NATL ACAD SCI USA, V109, P1743, DOI 10.1073/pnas.1113306109; Lund TC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007688; Monaghan P, 2006, TRENDS ECOL EVOL, V21, P47, DOI 10.1016/j.tree.2005.11.007; Monaghan P, 2010, ANN NY ACAD SCI, V1206, P130, DOI 10.1111/j.1749-6632.2010.05705.x; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Olsson M, 2011, MOL ECOL, V20, P2085, DOI 10.1111/j.1365-294X.2011.05085.x; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Pauliny A, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-257; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Salomons HM, 2009, P ROY SOC B-BIOL SCI, V276, P3157, DOI 10.1098/rspb.2009.0517; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Sidorov IA, 2004, J THEOR BIOL, V226, P169, DOI 10.1016/j.jtbi.2003.08.009; Takubo K, 2002, EXP GERONTOL, V37, P523, DOI 10.1016/S0531-5565(01)00218-2; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vera E, 2012, CELL REP, V2, P732, DOI 10.1016/j.celrep.2012.08.023; Vera E, 2012, AGING-US, V4, P379, DOI 10.18632/aging.100462; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wright WE, 1996, DEV GENET, V18, P173; Youngren K, 1998, HUM GENET, V102, P640, DOI 10.1007/s004390050755	45	54	54	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81496	10.1371/journal.pone.0081496	http://dx.doi.org/10.1371/journal.pone.0081496			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349076	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200031
J	Waller-Evans, H; Hue, C; Fearnside, J; Rothwell, AR; Lockstone, HE; Calderari, S; Wilder, SP; Cazier, JB; Scott, J; Gauguier, D				Waller-Evans, Helen; Hue, Christophe; Fearnside, Jane; Rothwell, Alice R.; Lockstone, Helen E.; Calderari, Sophie; Wilder, Steven P.; Cazier, Jean-Baptiste; Scott, James; Gauguier, Dominique			Nutrigenomics of High Fat Diet Induced Obesity in Mice Suggests Relationships between Susceptibility to Fatty Liver Disease and the Proteasome	PLOS ONE			English	Article							HEPATIC GENE-EXPRESSION; ELEMENT-BINDING PROTEIN-1C; RECEPTOR-GAMMA ACTIVATION; INSULIN-RESISTANT MICE; METABOLIC SYNDROME; NONALCOHOLIC STEATOHEPATITIS; MOUSE; PATHWAY; STEATOSIS; GLUCOSE	Nutritional factors play important roles in the etiology of obesity, type 2 diabetes mellitus and their complications through genotype x environment interactions. We have characterised molecular adaptation to high fat diet (HFD) feeding in inbred mouse strains widely used in genetic and physiological studies. We carried out physiological tests, plasma lipid assays, obesity measures, liver histology, hepatic lipid measurements and liver genome-wide gene transcription profiling in C57BL/6J and BALB/c mice fed either a control or a high fat diet. The two strains showed marked susceptibility (C57BL/6J) and relative resistance (BALB/c) to HFD-induced insulin resistance and non alcoholic fatty liver disease (NAFLD). Global gene set enrichment analysis (GSEA) of transcriptome data identified consistent patterns of expression of key genes (Srebf1, Stard4, Pnpla2, Ccnd1) and molecular pathways in the two strains, which may underlie homeostatic adaptations to dietary fat. Differential regulation of pathways, including the proteasome, the ubiquitin mediated proteolysis and PPAR signalling in fat fed C57BL/6J and BALB/c suggests that altered expression of underlying diet-responsive genes may be involved in contrasting nutrigenomic predisposition and resistance to insulin resistance and NAFLD in these models. Collectively, these data, which further demonstrate the impact of gene x environment interactions on gene expression regulations, contribute to improved knowledge of natural and pathogenic adaptive genomic regulations and molecular mechanisms associated with genetically determined susceptibility and resistance to metabolic diseases.	[Waller-Evans, Helen; Fearnside, Jane; Rothwell, Alice R.; Lockstone, Helen E.; Wilder, Steven P.; Cazier, Jean-Baptiste] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Hue, Christophe; Calderari, Sophie; Gauguier, Dominique] Univ Paris 06, INSERM, Cordeliers Res Ctr, UMRS872, Paris, France; [Hue, Christophe; Calderari, Sophie; Gauguier, Dominique] Univ Paris 06, Inst Cardiometab & Nutr, Paris, France; [Scott, James] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Dept Vasc Sci, London, England	University of Oxford; Wellcome Centre for Human Genetics; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Imperial College London	Gauguier, D (corresponding author), Univ Paris 06, INSERM, Cordeliers Res Ctr, UMRS872, Paris, France.	dominique.gauguier@crc.jussieu.fr	Gauguier, Dominique/G-2190-2016; Cazier, Jean-Baptiste/GLR-2949-2022; Cazier, Jean-Baptiste/F-2369-2010	Gauguier, Dominique/0000-0001-6156-9530; Cazier, Jean-Baptiste/0000-0001-7581-9051; Cazier, Jean-Baptiste/0000-0001-7581-9051; Waller-Evans, Helen/0000-0003-4133-6064; Calderari, Sophie/0000-0002-9669-681X; Wilder, Steven/0000-0001-8049-2559	Wellcome Trust Functional Genomics Initiative grant Biological Atlas of Insulin Resistance (BAIR) [066786]; European Commission [LSHG-CT-2006-037683]; Institute of Cardiometabolism and Nutrition [ANR-10-IAHU-05]; Wellcome Trust [090532/Z/09/Z]; Wellcome Prize Studentship in Bioinformatics and Statistical Genetics; Wellcome Senior Fellowship in Basic Biomedical Science [057733]	Wellcome Trust Functional Genomics Initiative grant Biological Atlas of Insulin Resistance (BAIR)(Wellcome Trust); European Commission(European CommissionEuropean Commission Joint Research Centre); Institute of Cardiometabolism and Nutrition; Wellcome Trust(Wellcome TrustEuropean Commission); Wellcome Prize Studentship in Bioinformatics and Statistical Genetics; Wellcome Senior Fellowship in Basic Biomedical Science	This work was supported by the Wellcome Trust Functional Genomics Initiative grant Biological Atlas of Insulin Resistance (BAIR) (066786) and a grant from the European Commission (Functional genomic diagnostic tools for coronary artery disease, FGENTCARD, LSHG-CT-2006-037683). The authors acknowledge support from the Institute of Cardiometabolism and Nutrition (ANR-10-IAHU-05). H. Lockstone and J.B. Cazier were funded by the Wellcome Trust Core Award 090532/Z/09/Z. S. P. Wilder was the recipient of a Wellcome Prize Studentship in Bioinformatics and Statistical Genetics. D. Gauguier held a Wellcome Senior Fellowship in Basic Biomedical Science (057733). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; Anstee QM, 2011, BBA-MOL BASIS DIS, V1812, P1557, DOI 10.1016/j.bbadis.2011.07.017; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biddinger SB, 2005, DIABETES, V54, P1314, DOI 10.2337/diabetes.54.5.1314; Bouchard C, 2008, OBESITY, V16, pS5, DOI 10.1038/oby.2008.528; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Ciechanover A, 2000, J CELL BIOCHEM, P40; Clapper JR, 2013, AM J PHYSL GASTROINT; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Fearnside JF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001668; Fernandez MA, 2006, SCIENCE, V313, P1628, DOI 10.1126/science.1130773; Foufelle F, 2002, BIOCHEM J, V366, P377, DOI 10.1042/BJ20020430; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Harizi H, 2007, J NEUROIMMUNOL, V189, P59, DOI 10.1016/j.jneuroim.2007.06.019; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Kahn R, 2005, LANCET, V366, P1921, DOI 10.1016/S0140-6736(05)67778-1; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Lefebvre B, 2010, J CLIN INVEST, V120, P1454, DOI 10.1172/JCI38606; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Mann JI, 2006, NUTR REV, V64, P422, DOI 10.1111/j.1753-4887.2006.tb00227.x; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; McGillicuddy FC, 2009, J BIOL CHEM, V284, P31936, DOI 10.1074/jbc.M109.061655; Montgomery MK, 2013, DIABETOLOGIA, V56, P1129, DOI 10.1007/s00125-013-2846-8; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Nishikawa S, 2012, TOXICOL PATHOL, V40, P71, DOI 10.1177/0192623311422078; Nojima K, 2013, ENDOCR J, V60, P261, DOI 10.1507/endocrj.EJ12-0258; Riserus U, 2008, CURR OPIN CLIN NUTR, V11, P100, DOI 10.1097/MCO.0b013e3282f52708; Rossmeisl M, 2003, DIABETES, V52, P1958, DOI 10.2337/diabetes.52.8.1958; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Sato M, 2010, FASEB J, V24, P2375, DOI 10.1096/fj.09-145466; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Sreekumar R, 2003, HEPATOLOGY, V38, P244, DOI 10.1053/jhep.2003.50290; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; Toye AA, 2007, DIABETOLOGIA, V50, P1867, DOI 10.1007/s00125-007-0738-5; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Vignati S, 2006, NEOPLASIA, V8, P851, DOI 10.1593/neo.06433; Wilder SP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-63; Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200; Younossi ZM, 2005, LIVER INT, V25, P760, DOI 10.1111/j.1478-3231.2005.01117.x	42	32	32	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82825	10.1371/journal.pone.0082825	http://dx.doi.org/10.1371/journal.pone.0082825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324835	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566700114
J	Chihara, Y; Egawa, H; Oga, T; Tsuboi, T; Handa, T; Yagi, S; Iida, T; Yoshizawa, A; Yamamoto, K; Mishima, M; Tanaka, K; Uemoto, S; Chin, K				Chihara, Yuichi; Egawa, Hiroto; Oga, Toru; Tsuboi, Tomomasa; Handa, Tomohiro; Yagi, Shintaro; Iida, Taku; Yoshizawa, Atsushi; Yamamoto, Kazuhiko; Mishima, Michiaki; Tanaka, Koichi; Uemoto, Shinji; Chin, Kazuo			Predictive Factors for Reintubation following Noninvasive Ventilation in Patients with Respiratory Complications after Living Donor Liver Transplantation	PLOS ONE			English	Article							POSITIVE-PRESSURE VENTILATION; PEDIATRIC-PATIENTS; PULMONARY COMPLICATIONS; FAILURE; TRIAL; RECIPIENTS; DISEASE; HELMET	Background: Postoperative respiratory complications are a major cause of mortality following liver transplantation (LT). Noninvasive ventilation (NIV) appears to be effective for respiratory complications in patients undergoing solid organ transplantation; however, mortality has been high in patients who experienced reintubation in spite of NIV therapy. The predictors of reintubation following NIV therapy after LT are not exactly known. Methods: Of 511 adult patients who received living-donor LT, data on the 179 who were treated by NIV were retrospectively examined. Results: Forty-three (24%) of the 179 patients who received NIV treatment required reintubation. Independent factors associated with reintubation by multivariate logistic regression analysis were controlled preoperative infections (odds ratio [OR] 8.88; 95% confidence interval (CI) 1.64 to 48.11; p = 0.01), ABO-incompatibility (OR 4.49; 95% CI, 1.50 to 13.38; p = 0.007), and presence of postoperative pneumonia at the time of starting NIV (OR 3.28; 95% CI, 1.02 to 11.01; p = 0.04). The reintubated patients had a significant higher rate of postoperative infectious complications and a significantly longer intensive care unit stay than those in whom NIV was successful (p<0.0001). Of the 43 reintubated patients, 22 (51.2%) died during hospitalization following LT vs. 8 (5.9%) of the 136 patients in whom NIV was successful (p<0.0001). Conclusions: Because controlled preoperative infection, ABO-incompatibility or pneumonia prior to the start of NIV were independent risk factors for reintubation following NIV, caution should be used in applying NIV in patients with these conditions considering the high rate of mortality in patients requiring reintubation following NIV.	[Chihara, Yuichi; Mishima, Michiaki] Kyoto Univ Hosp, Dept Resp Med, Kyoto 606, Japan; [Egawa, Hiroto] Tokyo Womens Med Univ Hosp, Dept Surg Gastroenterol, Tokyo, Japan; [Oga, Toru; Tsuboi, Tomomasa; Chin, Kazuo] Kyoto Univ, Dept Resp Care, Grad Sch Med, Kyoto, Japan; [Oga, Toru; Tsuboi, Tomomasa; Chin, Kazuo] Kyoto Univ, Dept Sleep Control Med, Grad Sch Med, Kyoto, Japan; [Handa, Tomohiro] Kyoto Univ Hosp, Dept Rehabil, Kyoto 606, Japan; [Yagi, Shintaro; Iida, Taku; Yoshizawa, Atsushi; Uemoto, Shinji] Kyoto Univ Hosp, Dept Transplant Surg, Kyoto 606, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy, Tokyo, Japan; [Yamamoto, Kazuhiko] Univ Tokyo, Dept Rheumatol, Grad Sch Med, Tokyo, Japan; [Tanaka, Koichi] Fdn Kobe Int Med Alliance, Kobe, Hyogo, Japan	Kyoto University; Tokyo Women's Medical University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; University of Tokyo; University of Tokyo	Chin, K (corresponding author), Kyoto Univ, Dept Resp Care, Grad Sch Med, Kyoto, Japan.	hink@kuhp.kyoto-u.ac.jp	Chihara, Yuichi/AAK-3397-2020; Yagi, Shintaro/O-4403-2016	Yagi, Shintaro/0000-0001-7465-5761	Japanese Ministry of Education, Culture, Sports, Science and Technology [20590921, 22590860]; Ministry of Health, Labor and Welfare of Japan; Japan Vascular Disease Research Foundation	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Vascular Disease Research Foundation(Japan Vascular Disease Research Foundation)	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (nos. 20590921 and 22590860), Respiratory Failure Research Group and Health science Research Grants (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus from the Ministry of Health, Labor and Welfare of Japan, and the Japan Vascular Disease Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda M, 2008, CRIT CARE MED, V36, P2766, DOI 10.1097/CCM.0b013e31818699f6; Ambrosino N, 2008, EUR RESPIR J, V31, P874, DOI 10.1183/09031936.00143507; AMBROSINO N, 1995, THORAX, V50, P755, DOI 10.1136/thx.50.7.755; Antonelli M, 2001, INTENS CARE MED, V27, P1718, DOI 10.1007/s00134-001-1114-4; Antonelli M, 2002, CRIT CARE MED, V30, P602, DOI 10.1097/00003246-200203000-00019; Antonelli M, 2000, JAMA-J AM MED ASSOC, V283, P235, DOI 10.1001/jama.283.2.235; Barry A, 1985, CLIN APPL RESP CARE, P180; Chihara Y, 2011, LIVER TRANSPLANT, V17, P144, DOI 10.1002/lt.22207; Chin K, 2005, LIVER TRANSPLANT, V11, P188, DOI 10.1002/lt.20297; Chin K, 2007, J THORAC CARDIOV SUR, V134, P260, DOI 10.1016/j.jtcvs.2007.03.002; Confalonieri M, 2002, INTENS CARE MED, V28, P1233, DOI 10.1007/s00134-002-1395-2; Duran F G, 1998, Transpl Int, V11 Suppl 1, pS255, DOI 10.1111/j.1432-2277.1998.tb01127.x; Feltracco P, 2008, TRANSPL P, V40, P1979, DOI 10.1016/j.transproceed.2008.05.006; Ferrer M, 2003, AM J RESP CRIT CARE, V168, P1438, DOI 10.1164/rccm.200301-072OC; Golfieri R, 2000, EUR RADIOL, V10, P1169, DOI 10.1007/s003309900268; Gristina GR, 2011, CRIT CARE MED, V39, P2232, DOI 10.1097/CCM.0b013e3182227a27; Hasegawa S, 1996, TRANSPLANTATION, V62, P943, DOI 10.1097/00007890-199610150-00012; Hilbert G, 2001, NEW ENGL J MED, V344, P481, DOI 10.1056/NEJM200102153440703; Hong SK, 2006, TRANSPLANT P, V38, P2979, DOI 10.1016/j.transproceed.2006.08.090; Huang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022689; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lin CC, 2004, TRANSPL P, V36, P2338, DOI 10.1016/j.transproceed.2004.07.044; Mullhaupt B, 2008, J HEPATOL, V48, pS58, DOI 10.1016/j.jhep.2008.01.013; Murase K, 2012, LIVER TRANSPLANT, V18, P1217, DOI 10.1002/lt.23491; Narita M, 2009, SURG TODAY, V39, P172, DOI 10.1007/s00595-008-3815-6; Nava S, 2009, LANCET, V374, P250, DOI 10.1016/S0140-6736(09)60496-7; Rocco M, 2004, CHEST, V126, P1508, DOI 10.1378/chest.126.5.1508; Singh N, 1999, TRANSPLANTATION, V67, P1138, DOI 10.1097/00007890-199904270-00009; Takahashi K, 2005, RESP MED, V99, P262, DOI 10.1016/j.rmed.2004.08.001; Takahashi KI, 2005, LIVER TRANSPLANT, V11, P570, DOI 10.1002/lt.20400; Tanaka K, 2004, HPB (Oxford), V6, P88, DOI 10.1080/13651820310020765; Wu JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016521	32	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81417	10.1371/journal.pone.0081417	http://dx.doi.org/10.1371/journal.pone.0081417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339926	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100054
J	Guo, HJ; Sun, YC; Li, YF; Liu, XH; Ren, Q; Zhu-Salzman, K; Ge, F				Guo, Huijuan; Sun, Yucheng; Li, Yuefei; Liu, Xianghui; Ren, Qin; Zhu-Salzman, Keyan; Ge, Feng			Elevated CO2 Modifies N Acquisition of Medicago truncatula by Enhancing N Fixation and Reducing Nitrate Uptake from Soil	PLOS ONE			English	Article							SYMBIOTIC N-2 FIXATION; CARBON-DIOXIDE CONCENTRATION; NITROGEN NUTRITION; ATMOSPHERIC PCO(2); FERTILE GRASSLAND; PLANT; ASSIMILATION; PHOTOSYNTHESIS; AVAILABILITY; STIMULATION	The effects of elevated CO2 (750 ppm vs. 390 ppm) were evaluated on nitrogen were evaluated (N) acquisition and assimilation by three medicago truncatula genotypes, including two N-fixing-deficient mutants (dn and dni1-2) and their wild -type (jemalong). The proportion of N acquisition from atmosphere and soil were quantified by N-15 stable isotope, and N transportation and assimilation-related genes and enzymes were determined by qPCR and biochemical analysis. Elevated CO2 decreased nitrate uptake from soil in all three plant genotypes by down-regulating nitrate reductase (NR), nitrate transporter NR7-1.1 and NR activity. Jemalong plant, however, produced more nodules, up-regulated N-fixation-related genes and enhanced percentage of N derived from fixation (%Ndf) to increase foliar N concentration and N content in whole plant (Ntotal Yield) to satisfy he requirement of larger biomass under elevated CO2. In contrast, both dnfi mutants deficient in N fixation consequently decreased activity of glutamine synthetaseiglutarriate synthase (GS/GOGAT) and N concentration under evated CO2. Our results suggest that elevated CO2 is likely to modify N acquisition of M. truncatula by simultaneously increasing N fixation and reducing nitrate uptake from soil. We propose that I vated CO2 causes legumes to rely more on N fixation than on N uptake from soil to satisfy N requirements.	[Guo, Huijuan; Sun, Yucheng; Li, Yuefei; Liu, Xianghui; Ge, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Guo, Huijuan] Univ Chinese Acad Sci, Beijing, Peoples R China; [Li, Yuefei; Ren, Qin] Jining Normal Coll, Jining, Peoples R China; [Zhu-Salzman, Keyan] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Texas A&M University System; Texas A&M University College Station	Sun, YC (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunyc@ioz.ac.cn; gef@ioz.ac.cn		Sun, Yucheng/0000-0003-2353-0218	"National Basic Research Program of China" (973 Program) [2012CB114103]; National Nature Science Fund of China [31000854, 31170390]	"National Basic Research Program of China" (973 Program)(National Basic Research Program of China); National Nature Science Fund of China(National Natural Science Foundation of China (NSFC))	This project was supported by the "National Basic Research Program of China" (973 Program) (No. 2012CB114103), and the National Nature Science Fund of China (No. 31000854, No. 31170390). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Ainsworth EA, 2002, GLOBAL CHANGE BIOL, V8, P695, DOI 10.1046/j.1365-2486.2002.00498.x; Ainsworth EA, 2007, PLANT CELL ENVIRON, V30, P258, DOI 10.1111/j.1365-3040.2007.01641.x; Bagchi R, 2012, PLANT PHYSIOL, V160, P906, DOI 10.1104/pp.112.196444; Baggs EM, 2003, GLOBAL CHANGE BIOL, V9, P1214, DOI 10.1046/j.1365-2486.2003.00654.x; Barbulova A, 2007, MOL PLANT MICROBE IN, V20, P994, DOI 10.1094/MPMI-20-8-0994; Betti M, 2012, INT J MOL SCI, V13, P7994, DOI 10.3390/ijms13077994; Bloom AJ, 2002, P NATL ACAD SCI USA, V99, P1730, DOI 10.1073/pnas.022627299; Bloom AJ, 2010, SCIENCE, V328, P899, DOI 10.1126/science.1186440; Cabrerizo PM, 2001, PHYSIOL PLANTARUM, V113, P33, DOI 10.1034/j.1399-3054.2001.1130105.x; [陈法军 Chen Fajun], 2005, [生态学杂志, Chinese Journal of Ecology], V24, P585; Curatti L, 2005, P NATL ACAD SCI USA, V102, P6291, DOI 10.1073/pnas.0501216102; Daepp M, 2000, GLOB CHANGE BIOL, V6, P805, DOI 10.1046/j.1365-2486.2000.00359.x; Fei H, 2009, PHYSIOL PLANTARUM, V135, P317, DOI 10.1111/j.1399-3054.2008.01192.x; Geiger M, 1998, PLANT CELL ENVIRON, V21, P253, DOI 10.1046/j.1365-3040.1998.00277.x; Glevarec G, 2004, PLANTA, V219, P286, DOI 10.1007/s00425-004-1214-9; Gubsch M, 2011, PLANT CELL ENVIRON, V34, P895, DOI 10.1111/j.1365-3040.2011.02287.x; Intergovernmental Panel on Climate Change. & Intergovernmental Panel on Climate Change. Working Group I, 2007, CLIMATE CHANGE 2007; KEENEY DR, 1966, NATURE, V211, P892, DOI 10.1038/211892a0; KEYS AJ, 1978, NATURE, V275, P741, DOI 10.1038/275741a0; Lam SK, 2012, GLOBAL CHANGE BIOL, V18, P2853, DOI 10.1111/j.1365-2486.2012.02758.x; LARUE TA, 1981, ADV AGRON, V34, P15, DOI 10.1016/S0065-2113(08)60883-4; Limami AM, 2008, J EXP BOT, V59, P2325, DOI 10.1093/jxb/ern102; Luscher A, 2000, GLOB CHANGE BIOL, V6, P655, DOI 10.1046/j.1365-2486.2000.00345.x; McDonald EP, 2002, FUNCT PLANT BIOL, V29, P1115, DOI 10.1071/FP02007; Montealegre CM, 2002, PLANT SOIL, V243, P197, DOI 10.1023/A:1019901828483; Munier-Jolain NG, 2005, PLANT CELL ENVIRON, V28, P1388, DOI 10.1111/j.1365-3040.2005.01371.x; Norby RJ, 2010, P NATL ACAD SCI USA, V107, P19368, DOI 10.1073/pnas.1006463107; Pang J, 2006, ENVIRON EXP BOT, V57, P98, DOI 10.1016/j.envexpbot.2005.04.004; Pausch RC, 1996, AGR ECOSYST ENVIRON, V60, P61, DOI 10.1016/S0167-8809(96)01062-6; Rachmilevitch S, 2004, P NATL ACAD SCI USA, V101, P11506, DOI 10.1073/pnas.0404388101; Rogers A, 1998, PLANT PHYSIOL, V118, P683, DOI 10.1104/pp.118.2.683; Rogers A, 2006, PLANT CELL ENVIRON, V29, P1651, DOI 10.1111/j.1365-3040.2006.01549.x; SILSBURY JH, 1977, NATURE, V267, P149, DOI 10.1038/267149a0; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Stitt M, 1999, PLANT CELL ENVIRON, V22, P583, DOI 10.1046/j.1365-3040.1999.00386.x; Sun YC, 2010, PLANT CELL ENVIRON, V33, P729, DOI 10.1111/j.1365-3040.2009.02098.x; Suzuki A, 2001, PHYSIOL PLANTARUM, V112, P524, DOI 10.1034/j.1399-3054.2001.1120409.x; Taub DR, 2008, J INTEGR PLANT BIOL, V50, P1365, DOI 10.1111/j.1744-7909.2008.00754.x; Taub DR, 2008, GLOBAL CHANGE BIOL, V14, P565, DOI 10.1111/j.1365-2486.2007.01511.x; TISSUE DT, 1995, FUNCT ECOL, V9, P518, DOI 10.2307/2390018; Valentine AJ, 2010, ANN PLANT REV, V42, P207; van Groenigen KJ, 2006, P NATL ACAD SCI USA, V103, P6571, DOI 10.1073/pnas.0509038103; Vernie T, 2008, PLANT CELL, V20, P2696, DOI 10.1105/tpc.108.059857; Voisin AS, 2003, J EXP BOT, V54, P2733, DOI 10.1093/jxb/erg290; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; West JB, 2005, NEW PHYTOL, V167, P523, DOI 10.1111/j.1469-8137.2005.01444.x; Zanetti S, 1998, PLANT CELL ENVIRON, V21, P623, DOI 10.1046/j.1365-3040.1998.00307.x; Zanetti S, 1996, PLANT PHYSIOL, V112, P575, DOI 10.1104/pp.112.2.575; Zanetti S, 1997, OECOLOGIA, V112, P17, DOI 10.1007/s004420050278	50	20	22	2	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81373	10.1371/journal.pone.0081373	http://dx.doi.org/10.1371/journal.pone.0081373			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339920	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100050
J	Krishna, SN; Luan, CH; Mishra, RK; Xu, L; Scheidt, KA; Anderson, WF; Bergan, RC				Krishna, Sankar N.; Luan, Chi-Hao; Mishra, Rama K.; Xu, Li; Scheidt, Karl A.; Anderson, Wayne F.; Bergan, Raymond C.			A Fluorescence-Based Thermal Shift Assay Identifies Inhibitors of Mitogen Activated Protein Kinase Kinase 4	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; METALLOPROTEINASE TYPE-2 ACTIVATION; DIFFERENTIAL SCANNING FLUOROMETRY; CELL INVASION; DRUG DISCOVERY; DOCKING SITE; GENISTEIN; MKK4; SELECTIVITY; ESTROGEN	Prostate cancer (PCa) is the second highest cause of cancer death in United States males. If the metastatic movement of PCa cells could be inhibited, then mortality from PCa could be greatly reduced. Mitogen-activated protein kinase kinase 4 (MAP2K4) has previously been shown to activate pro-invasion signaling pathways in human PCa. Recognizing that MAP2K4 represents a novel and validated therapeutic target, we sought to develop and characterize an efficient process for the identification of small molecules that target MAP2K4. Using a fluorescence-based thermal shift assay (FTS) assay, we first evaluated an 80 compound library of known kinase inhibitors, thereby identifying 8 hits that thermally stabilized MAP2K4 in a concentration dependent manner. We then developed an in vitro MAP2K4 kinase assay employing the biologically relevant downstream substrates, JNK1 and p38 MAPK, to evaluate kinase inhibitory function. In this manner, we validated the performance of our initial FTS screen. We next applied this approach to a 2000 compound chemically diverse library, identified 7 hits, and confirmed them in the in vitro kinase assay. Finally, by coupling our structure-activity relationship data to MAP2K4's crystal structure, we constructed a model for ligand binding. It predicts binding of our identified inhibitory compounds to the ATP binding pocket. Herein we report the creation of a robust inhibitor-screening platform with the ability to inform the discovery and design of new and potent MAP2K4 inhibitors.	[Krishna, Sankar N.; Xu, Li; Bergan, Raymond C.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Luan, Chi-Hao] Northwestern Univ, Dept Mol Biosci, Chicago, IL 60611 USA; [Scheidt, Karl A.] Northwestern Univ, Dept Chem, Chicago, IL 60611 USA; [Anderson, Wayne F.] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Luan, Chi-Hao] Northwestern Univ, High Throughput Anal Lab, Chicago, IL 60611 USA; [Mishra, Rama K.; Scheidt, Karl A.; Anderson, Wayne F.; Bergan, Raymond C.] Northwestern Univ, Ctr Mol Innovat & Drug Discovery, Chicago, IL 60611 USA; [Luan, Chi-Hao; Scheidt, Karl A.; Anderson, Wayne F.; Bergan, Raymond C.] Northwestern Univ, Robert H Lurie Canc Ctr, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Bergan, RC (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.	r-bergan@northwestern.edu		Scheidt, Karl/0000-0003-4856-3569	CMU [CMU100-S-01]; CMUH [DMR-102-034]; Republic of China National Science Council [NSC100-2320-B-039-012-MY3, NSC101-2314-B-039-008-MY3]; NATIONAL CANCER INSTITUTE [R01CA122985, P50CA090386] Funding Source: NIH RePORTER	CMU; CMUH; Republic of China National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Support for this research was provided by CMU (CMU100-S-01), CMUH (DMR-102-034), and the Republic of China National Science Council (NSC100-2320-B-039-012-MY3; NSC101-2314-B-039-008-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA T, 1987, J BIOL CHEM, V262, P5592; Bamborough P, 2011, J MED CHEM, V54, P5131, DOI 10.1021/jm200349b; Boly R, 2011, INT J ONCOL, V38, P833, DOI 10.3892/ijo.2010.890; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Cuenda A, 2000, INT J BIOCHEM CELL B, V32, P581, DOI 10.1016/S1357-2725(00)00003-0; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Fedorov O, 2012, METHODS MOL BIOL, V795, P109, DOI 10.1007/978-1-61779-337-0_7; Ho DT, 2003, J BIOL CHEM, V278, P32662, DOI 10.1074/jbc.M304229200; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Lakshman M, 2008, CANCER RES, V68, P2024, DOI 10.1158/0008-5472.CAN-07-1246; LIN AN, 1995, SCIENCE, V268, P286, DOI 10.1126/science.7716521; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Lotan TL, 2007, J PATHOL, V212, P386, DOI 10.1002/path.2194; Manas ES, 2004, STRUCTURE, V12, P2197, DOI 10.1016/j.str.2004.09.015; Matsumoto T, 2010, BIOCHEM BIOPH RES CO, V400, P369, DOI 10.1016/j.bbrc.2010.08.071; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Patel D, 2007, INT J ONCOL, V30, P233; Pavese JM, 2010, CANCER METAST REV, V29, P465, DOI 10.1007/s10555-010-9238-z; Peterson G, 1996, CELL GROWTH DIFFER, V7, P1345; Rouslathi E, 1996, SCI AM, P42; Sherman W, 2006, CHEM BIOL DRUG DES, V67, P83, DOI 10.1111/j.1747-0285.2005.00327.x; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stearns ME, 1996, ONCOL RES, V8, P63; STEARNS ME, 1993, CANCER RES, V53, P878; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Takekawa M, 2005, MOL CELL, V18, P295, DOI 10.1016/j.molcel.2005.04.001; Wang L, 2004, ONCOGENE, V23, P5978, DOI 10.1038/sj.onc.1207802; Wang TTY, 1996, CARCINOGENESIS, V17, P271, DOI 10.1093/carcin/17.2.271; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Weisman JL, 2006, CHEM BIOL DRUG DES, V67, P409, DOI 10.1111/j.1747-0285.2006.00391.x; Xu L, 2006, ONCOGENE, V25, P2987, DOI 10.1038/sj.onc.1209337; Xu L, 2006, MOL PHARMACOL, V70, P869, DOI 10.1124/mol.106.023861; Xu L, 2009, JNCI-J NATL CANCER I, V101, P1141, DOI 10.1093/jnci/djp227	37	36	38	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81504	10.1371/journal.pone.0081504	http://dx.doi.org/10.1371/journal.pone.0081504			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339940	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100064
J	Kwon, M; Lee, SJ; Reddy, S; Rybak, Y; Adem, A; Libutti, SK				Kwon, Mijung; Lee, Soo Jin; Reddy, Srilakshmi; Rybak, Yevangelina; Adem, Asha; Libutti, Steven K.			Down-Regulation of Filamin Ainteracting protein 1-like Is Associated with Promoter Methylation and an Invasive Phenotype in Breast, Colon, Lung and Pancreatic Cancers	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CANCER; GENE-EXPRESSION; PROSTATE-CANCER; ENDOTHELIAL-CELLS; CANDIDATE GENES; MESSENGER-RNA; MASS ARRAY; HYPERMETHYLATION; SENESCENCE; RISK	Identifying key mediators of cancer cell invasion and metastasis is critical to the development of more effective cancer therapies. We previously identified Filamin A interacting protein 1-like (FILIP1L) as an important inhibitor of cell migration and invasion in ovarian cancer. FILIP1L expression was inversely correlated with the invasive potential of ovarian cancer cell lines and ovarian cancer specimens. We also demonstrated that DNA methylation in the FILIP1L promoter was a mechanism by which FILIP1L was down-regulated in ovarian cancer. In our present study, we tested this observation in other cancer histologies: breast, colon, lung and pancreatic cancers. Both mRNA and protein expression of FILIP1L were down-regulated in these cancer cells compared with their normal epithelial cells. As in ovarian cancer, DNA methylation is a mechanism by which FILIP1L is down-regulated in these cancer histologies. Methylation status of the FILIP1L promoter was inversely correlated with FILIP1L expression. Reduced methylation in the FILIP1L promoter following treatment with a DNA demethylating agent was associated with restoration of FILIP1L expression in these cancer cells. Further, FILIP1L expression was inversely correlated with the invasive potential of these cancer cells. Re-expression of FILIP1L in FILIP1L-low expressing, highly-invasive cancer cell lines resulted in inhibition of cell invasion. Correspondingly, knockdown of FILIP1L in FILIP1L-high expressing, low-invasive cancer cell lines resulted in increase of cell invasion. Overall, these findings suggest that down-regulation of FILIP1L associated with DNA methylation is related with the invasive phenotype in various cancers. Thus, modulation of FILIP1L expression has the potential to be a target for cancer therapy.	[Kwon, Mijung; Lee, Soo Jin; Reddy, Srilakshmi; Rybak, Yevangelina; Adem, Asha; Libutti, Steven K.] Yeshiva Univ, Dept Surg, Albert Einstein Coll Med, Bronx, NY 10033 USA	Yeshiva University; Albert Einstein College of Medicine	Libutti, SK (corresponding author), Yeshiva Univ, Dept Surg, Albert Einstein Coll Med, Bronx, NY 10033 USA.	slibutti@montefiore.org		Lee, Soojin/0000-0002-0383-5025				Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Burton ER, 2011, MOL CANCER RES, V9, P1126, DOI 10.1158/1541-7786.MCR-11-0162; Conne B, 2000, NAT MED, V6, P637, DOI 10.1038/76211; Desotelle J, 2013, J UROLOGY, V189, P329, DOI 10.1016/j.juro.2012.08.188; Ehrich M, 2008, P NATL ACAD SCI USA, V105, P4844, DOI 10.1073/pnas.0712251105; Khumalo T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066297; Kwon M, 2008, CANCER RES, V68, P7332, DOI 10.1158/0008-5472.CAN-08-1087; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Mazzanti CM, 2004, GENOME RES, V14, P1585, DOI 10.1101/gr.2552804; MOK SC, 1994, GYNECOL ONCOL, V52, P247, DOI 10.1006/gyno.1994.1040; Nagamine Y, 2005, THROMB HAEMOSTASIS, V93, P661, DOI 10.1160/TH04-12-0814; Notaridou M, 2011, INT J CANCER, V128, P2063, DOI 10.1002/ijc.25554; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Quaye L, 2009, HUM MOL GENET, V18, P1869, DOI 10.1093/hmg/ddp107; Radpour R, 2009, ONCOGENE, V28, P2969, DOI 10.1038/onc.2009.149; Radpour R, 2008, MOL CANCER RES, V6, P1702, DOI 10.1158/1541-7786.MCR-08-0262; Salari R, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002644; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Schwarze SR, 2002, J BIOL CHEM, V277, P14877, DOI 10.1074/jbc.M200373200; Tandle AT, 2005, CYTOKINE, V30, P347, DOI 10.1016/j.cyto.2005.01.020; Vanaja DK, 2009, CANCER INVEST, V27, P549, DOI 10.1080/07357900802620794; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Xie C, 2011, HUM GENE THER, V22, P1413, DOI 10.1089/hum.2011.047	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82620	10.1371/journal.pone.0082620	http://dx.doi.org/10.1371/journal.pone.0082620			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340050	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100121
J	Riddell, MR; Winkler-Lowen, B; Jiang, YY; Davidge, ST; Guilbert, LJ				Riddell, Meghan R.; Winkler-Lowen, Bonnie; Jiang, Yanyan; Davidge, Sandra T.; Guilbert, Larry J.			Pleiotropic Actions of Forskolin Result in Phosphatidylserine Exposure in Primary Trophoblasts	PLOS ONE			English	Article							INTERCELLULAR FUSION; GLYCOPROTEIN; CYCLASE; LINE	Forskolin is an extract of the Coleus forskholii plant that is widely used in cell physiology to raise intracellular cAMP levels. In the field of trophoblast biology, forskolin is one of the primary treatments used to induce trophoblastic cellular fusion. The syncytiotrophoblast (ST) is a continuous multinucleated cell in the human placenta that separates maternal from fetal circulations and can only expand by fusion with its stem cell, the cytotrophoblast (CT). Functional investigation of any aspect of ST physiology requires in vitro differentiation of CT and de novo ST formation, thus selecting the most appropriate differentiation agent for the hypothesis being investigated is necessary as well as addressing potential off-target effects. Previous studies, using forskolin to induce fusion in trophoblastic cell lines, identified phosphatidylserine (PS) externalization to be essential for trophoblast fusion and showed that widespread PS externalization is present even after fusion has been achieved. PS is a membrane phospholipid that is primarily localized to the inner-membrane leaflet. Externalization of PS is a hallmark of early apoptosis and is involved in cellular fusion of myocytes and macrophages. We were interested to examine whether PS externalization was also involved in primary trophoblast fusion. We show widespread PS externalization occurs after 72 hours when fusion was stimulated with forskolin, but not when stimulated with the cell permeant cAMP analog Br-cAMP. Using a forskolin analog, 1,9-dideoxyforskolin, which stimulates membrane transporters but not adenylate cyclase, we found that widespread PS externalization required both increased intracellular cAMP levels and stimulation of membrane transporters. Treatment of primary trophoblasts with Br-cAMP alone did not result in widespread PS externalization despite high levels of cellular fusion. Thus, we concluded that widespread PS externalization is independent of trophoblast fusion and, importantly, provide evidence that the common differentiation agent forskolin has previously unappreciated pleiotropic effects on trophoblastic cells.	[Riddell, Meghan R.; Davidge, Sandra T.] Univ Alberta, Dept Physiol, Edmonton, AB, Canada; [Winkler-Lowen, Bonnie; Guilbert, Larry J.] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Jiang, Yanyan; Davidge, Sandra T.] Univ Alberta, Dept Obstet & Gynecol, Edmonton, AB, Canada; [Riddell, Meghan R.; Davidge, Sandra T.] Univ Alberta, Women & Childrens Hlth Res Inst, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Davidge, ST (corresponding author), Univ Alberta, Dept Physiol, Edmonton, AB, Canada.	sandra.davidge@ualberta.ca		Riddell, Meghan/0000-0002-3203-2897; Davidge, Sandra/0000-0002-5559-4905	Canadian Institute for Health Research [MOP-82892]; Alberta Innovates - Health Solutions; Women and Children's Research Institute; Mazankowski Heart Institute	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions; Women and Children's Research Institute; Mazankowski Heart Institute	This work was supported by a grant from the Canadian Institute for Health Research (grant number MOP-82892) (http://www.cihr.gc.ca). SD is a Canada Research Chair (Tier 1) in Women's Cardiovascular Health, and an Alberta Innovates - Health Solutions/Alberta Heritage Foundation for Medical Research Scientist. M.R. was supported by studentships from Alberta Innovates - Health Solutions (http://www.aihealthsolutions.ca), the Women and Children's Research Institute (http://wchri.srv.ualberta.ca), and the Mazankowski Heart Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER RR, 1995, BIOL REPROD, V53, P905, DOI 10.1095/biolreprod53.4.905; Benaitreau D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-128; Benirschke KKP., 2006, PATHOLOGY HUMAN PLAC, Vvol XX, P1050; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Burton GJ, 2011, PLACENTA HUMAN DEV P, P246; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Chen YX, 2011, INT J BIOCHEM CELL B, V43, P821, DOI 10.1016/j.biocel.2011.02.007; Das M, 2004, PLACENTA, V25, P396, DOI 10.1016/j.placenta.2003.11.004; Drewlo Sascha, 2008, V475, P363, DOI 10.1007/978-1-59745-250-2_21; Dunk CE, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096925; Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003; Guilbert LJ, 2010, PLACENTA, V31, P982, DOI 10.1016/j.placenta.2010.08.012; Helming L, 2009, TRENDS CELL BIOL, V19, P514, DOI 10.1016/j.tcb.2009.07.005; HOSHI T, 1988, SCIENCE, V240, P1652, DOI 10.1126/science.2454506; Huppertz B, 2008, J CLIN PATHOL, V61, P1296, DOI 10.1136/jcp.2008.055277; Jeong J, 2011, BIOCHEM BIOPH RES CO, V414, P9, DOI 10.1016/j.bbrc.2011.08.128; Johnstone ED, 2005, PLACENTA, V26, P548, DOI 10.1016/j.placenta.2004.08.012; Krijnen PAJ, 2010, J MOL CELL CARDIOL, V49, P781, DOI 10.1016/j.yjmcc.2010.07.017; LYDEN TW, 1992, J REPROD IMMUNOL, V22, P1, DOI 10.1016/0165-0378(92)90002-L; Malassine A, 2010, INT J DEV BIOL, V54, P475, DOI 10.1387/ijdb.082766am; MORRIS DI, 1991, J BIOL CHEM, V266, P13377; MORRIS DI, 1991, BIOCHEMISTRY-US, V30, P8371, DOI 10.1021/bi00098a014; Riddell MR, 2012, PLACENTA, V33, P88, DOI 10.1016/j.placenta.2011.11.008; Tang XJ, 1996, SCIENCE, V272, P1495, DOI 10.1126/science.272.5267.1495; van den Eijnde SM, 2001, J CELL SCI, V114, P3631; WICE B, 1990, EXP CELL RES, V186, P306, DOI 10.1016/0014-4827(90)90310-7; YUI J, 1994, PLACENTA, V15, P231, DOI 10.1016/0143-4004(94)90015-9	27	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81273	10.1371/journal.pone.0081273	http://dx.doi.org/10.1371/journal.pone.0081273			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339915	Green Submitted, gold, Green Published			2022-12-27	WOS:000328566100047
J	Singh, K; Haydari, N; Brunette, I; Costantino, S				Singh, Kanwarpal; Haydari, Nour; Brunette, Isabelle; Costantino, Santiago			Preparing Uniform-Thickness Corneal Endothelial Grafts from Donor Tissues Using a Non-Amplified Femtosecond Laser	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; POSTERIOR LAMELLAR KERATOPLASTY; PENETRATING KERATOPLASTY; ANTERIOR SEGMENT; VISUAL-ACUITY; MICROKERATOME; DSAEK; EYES; STORAGE; SHIFT	Corneal grafts for Descemet's Stripping Automated Endothelial Keratoplasty are commonly prepared using mechanical microkeratomes. However, the cuts produced in such way render corneal lenticules that are thinner centrally than peripherally, thus inducing a hyperopic shift. Here we describe a novel device for preparing donor corneal grafts, in which a single low-energy femtosecond laser system is used as both a light source for optical coherence tomography and for cutting the graft illuminating from the endothelial side. The same laser is first utilized to obtain three-dimensional optical coherence tomography images of the donor tissue for guiding the dissection and obtaining grafts of uniform thickness with no applanation or contact. This device allows an optimal procedure for preparing consistently thin posterior grafts for transplantation.	[Singh, Kanwarpal; Haydari, Nour; Brunette, Isabelle; Costantino, Santiago] Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada; [Singh, Kanwarpal; Haydari, Nour; Brunette, Isabelle; Costantino, Santiago] Univ Montreal, Fac Med, Dept Ophthalmol, Montreal, PQ H3C 3J7, Canada; [Costantino, Santiago] Univ Montreal, Inst Biomed Engn, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal	Costantino, S (corresponding author), Hop Maison Neuve Rosemont, Ctr Rech, Montreal, PQ H1T 2M4, Canada.	santiago.costantino@umontreal.ca	Costantino, Santiago/ABD-5472-2020; Singh, Kanwarpal/P-3789-2019	Costantino, Santiago/0000-0002-2454-2635; Singh, Kanwarpal/0000-0002-6884-8089	Canadian Institutes of Health Research; Charles-Albert Poissant Research chair in Corneal Transplantation, University of Montreal, QC, Canada; FRQS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Charles-Albert Poissant Research chair in Corneal Transplantation, University of Montreal, QC, Canada; FRQS	This research was supported by a grant from the Canadian Institutes of Health Research to IB and SC. IB is the recipient of the Charles-Albert Poissant Research chair in Corneal Transplantation, University of Montreal, QC, Canada. SC holds an FRQS Chercheur Junior 2 award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahar I, 2008, OPHTHALMOLOGY, V115, P1525, DOI 10.1016/j.ophtha.2008.02.010; Buratto L, 2007, AM J OPHTHALMOL, V143, P737, DOI 10.1016/j.ajo.2007.01.056; Busin M, 2013, OPHTHALMOLOGY, V120, P1186, DOI 10.1016/j.ophtha.2012.11.030; Busin M, 2012, INVEST OPHTH VIS SCI, V53, P521, DOI 10.1167/iovs.11-7753; Cheng YYY, 2007, J CATARACT REFR SURG, V33, P152, DOI 10.1016/j.jcrs.2006.07.044; Covert DJ, 2007, CORNEA, V26, P692, DOI 10.1097/ICO.0b013e31805fc38f; Di Pascuale MA, 2009, AM J OPHTHALMOL, V148, P32, DOI 10.1016/j.ajo.2009.01.016; Dupps WJ, 2008, J CATARACT REFR SURG, V34, P578, DOI 10.1016/j.jcrs.2007.11.045; FERCHER AF, 1995, OPT COMMUN, V117, P43, DOI 10.1016/0030-4018(95)00119-S; Guell JL, 1996, J REFRACT SURG, V12, P222; Hjortdal J, 2012, OPEN OPHTHALMOL J, V6, P19, DOI 10.2174/1874364101206010019; Holz HA, 2008, J CATARACT REFR SURG, V34, P211, DOI 10.1016/j.jcrs.2007.09.030; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Ide T, 2010, CORNEA, V29, P93, DOI 10.1097/ICO.0b013e3181967052; Jeng BH, 2006, CURR OPIN OPHTHALMOL, V17, P332, DOI 10.1097/01.icu.0000233950.63853.88; Jun B, 2009, CORNEA, V28, P19, DOI 10.1097/ICO.0b013e318182a4c1; Koenig SB, 2007, CORNEA, V26, P670, DOI 10.1097/ICO.0b013e3180544902; Mehta JS, 2008, J CATARACT REFR SURG, V34, P1970, DOI 10.1016/j.jcrs.2008.07.028; Melles GRJ, 2006, CORNEA, V25, P987, DOI 10.1097/01.ico.0000248385.16896.34; Meltendorf C, 2006, CORNEA, V25, P1090, DOI 10.1097/01.ico.0000228784.46463.e9; Monterosso C, 2011, CORNEA, V30, P189, DOI 10.1097/ICO.0b013e3181ead924; Mootha VV, 2011, CORNEA, V30, P320, DOI 10.1097/ICO.0b013e3181f22cc3; Neff KD, 2011, CORNEA, V30, P388, DOI 10.1097/ICO.0b013e3181f236c6; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Peyrot DA, 2010, J REFRACT SURG, V26, P786, DOI 10.3928/1081597X-20100921-04; Price FW, 2006, J CATARACT REFR SURG, V32, P411, DOI 10.1016/j.jcrs.2005.12.078; Price MO, 2008, J CATARACT REFR SURG, V34, P1423, DOI 10.1016/j.jcrs.2008.05.044; Price MO, 2006, OPHTHALMOLOGY, V113, P1936, DOI 10.1016/j.ophtha.2006.05.034; Price MO, 2009, OPHTHALMOLOGY, V116, P2361, DOI 10.1016/j.ophtha.2009.07.010; Radhakrishnan S, 2001, ARCH OPHTHALMOL-CHIC, V119, P1179, DOI 10.1001/archopht.119.8.1179; Rao SK, 2008, AM J OPHTHALMOL, V145, P991, DOI 10.1016/j.ajo.2008.01.017; Scorcia V, 2009, OPHTHALMOLOGY, V116, P1651, DOI 10.1016/j.ophtha.2009.04.035; Singh K, 2012, INVEST OPHTH VIS SCI, V53, P7819, DOI 10.1167/iovs.12-9834; Singh K, 2011, INVEST OPHTH VIS SCI, V52, P8927, DOI 10.1167/iovs.11-7854; Soong HK, 2005, OPHTHALMOLOGY, V112, P44, DOI 10.1016/j.ophtha.2004.06.037; TAYLOR MJ, 1981, BRIT J OPHTHALMOL, V65, P815, DOI 10.1136/bjo.65.12.815; Terry MA, 2012, OPHTHALMOLOGY, V119, P1988, DOI 10.1016/j.ophtha.2012.05.021; Wagoner MD, 2005, CORNEA, V24, P976, DOI 10.1097/01.ico.0000159731.52801.b6; Wojtkowski M, 2004, OPT EXPRESS, V12, P2404, DOI 10.1364/OPEX.12.002404; Woodward MA, 2013, CORNEA, V32, pE69, DOI 10.1097/ICO.0b013e318271fc99; Yoo SH, 2008, ARCH OPHTHALMOL-CHIC, V126, P1052, DOI 10.1001/archopht.126.8.1052	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e83185	10.1371/journal.pone.0083185	http://dx.doi.org/10.1371/journal.pone.0083185			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340090	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100134
J	Barbieri, E; De Preter, K; Capasso, M; Johansson, P; Man, TK; Chen, ZW; Stowers, P; Tonini, GP; Speleman, F; Shohet, JM				Barbieri, Eveline; De Preter, Katleen; Capasso, Mario; Johansson, Peter; Man, Tsz-Kwong; Chen, Zaowen; Stowers, Paris; Tonini, Gian Paolo; Speleman, Frank; Shohet, Jason M.			A p53 Drug Response Signature Identifies Prognostic Genes in High-Risk Neuroblastoma	PLOS ONE			English	Article							CHROMATIN ASSEMBLY FACTOR-1; RIBONUCLEOTIDE REDUCTASE INHIBITORS; MDM2 ANTAGONIST NUTLIN-3; QUANTITATIVE PCR DATA; WILD-TYPE P53; IN-VIVO; TRANSCRIPTIONAL REPRESSION; P53/MDM2/P14(ARF) PATHWAY; FUNCTIONAL-ANALYSIS; TARGET GENES	Chemotherapy induces apoptosis and tumor regression primarily through activation of p53-mediated transcription. Neuroblastoma is a p53 wild type malignancy at diagnosis and repression of p53 signaling plays an important role in its pathogenesis. Recently developed small molecule inhibitors of the MDM2-p53 interaction are able to overcome this repression and potently activate p53 dependent apoptosis in malignancies with intact p53 downstream signaling. We used the small molecule MDM2 inhibitor, Nutlin-3a, to determine the p53 drug response signature in neuroblastoma cells. In addition to p53 mediated apoptotic signatures, GSEA and pathway analysis identified a set of p53-repressed genes that were reciprocally over-expressed in neuroblastoma patients with the worst overall outcome in multiple clinical cohorts. Multifactorial regression analysis identified a subset of four genes (CHAF1A, RRM2, MCM3, and MCM6) whose expression together strongly predicted overall and event-free survival (p < 0.0001). The expression of these four genes was then validated by quantitative PCR in a large independent clinical cohort. Our findings further support the concept that oncogene-driven transcriptional networks opposing p53 activation are essential for the aggressive behavior and poor response to therapy of high-risk neuroblastoma.	[Barbieri, Eveline; Man, Tsz-Kwong; Chen, Zaowen; Stowers, Paris; Shohet, Jason M.] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA; [Barbieri, Eveline; Man, Tsz-Kwong; Chen, Zaowen; Stowers, Paris; Shohet, Jason M.] Baylor Coll Med, Dept Pediat, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [De Preter, Katleen] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Capasso, Mario] Univ Naples Federico II, Dept Biochem & Med Biotechnol, CEINGE Biotecnol Avanzate, Naples, Italy; [Johansson, Peter] NCI, Oncogen Sect, Pediat Oncol Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Tonini, Gian Paolo] Univ Padua, Pediat Res Inst, Padua, Italy	Baylor College of Medicine; Texas Children's Cancer Center; Baylor College of Medicine; Ghent University; CEINGE Biotecnologie Avanzate; University of Naples Federico II; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Padua	Shohet, JM (corresponding author), Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA.	jmshohet@txch.org	De Preter, Katleen/I-7135-2013; Capasso, Mario/D-1617-2014; Johansson, Peter A/K-1053-2014; speleman, frank/AAR-5184-2020	De Preter, Katleen/0000-0002-7726-5096; Johansson, Peter A/0000-0001-7015-5452; speleman, frank/0000-0002-6628-8559; Capasso, Mario/0000-0003-3306-1259; Man, Tsz-Kwong/0000-0001-5920-5746	Ale's Lemonade Stand Foundation; Children's Cancer Research Foundation; American Cancer Society; Flemish Fund for Scientific Research; Associazione Italiana per la Lotta al Neuroblastoma; MIUR - FIRB Ricerca in Futuro	Ale's Lemonade Stand Foundation; Children's Cancer Research Foundation; American Cancer Society(American Cancer Society); Flemish Fund for Scientific Research(FWO); Associazione Italiana per la Lotta al Neuroblastoma(Fondazione AIRC per la ricerca sul cancro); MIUR - FIRB Ricerca in Futuro(Ministry of Education, Universities and Research (MIUR))	This work was supported by Ale's Lemonade Stand Foundation (EB, JMS), the Children's Cancer Research Foundation (EB) and a Research Scholar Grant from the American Cancer Society (JMS). KDP is supported by the Flemish Fund for Scientific Research. MC is supported by Associazione Italiana per la Lotta al Neuroblastoma and MIUR - FIRB Ricerca in Futuro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri E, 2006, MOL CANCER THER, V5, P2358, DOI 10.1158/1535-7163.MCT-06-0305; Bhutia YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053436; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Carol H, 2013, PEDIATR BLOOD CANCER, V60, P633, DOI 10.1002/pbc.24235; Carr J, 2006, CANCER RES, V66, P2138, DOI 10.1158/0008-5472.CAN-05-2623; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Cerqueira NMFSA, 2005, CURR MED CHEM, V12, P1283, DOI 10.2174/0929867054020981; Chen YY, 2008, NATURE, V455, P971, DOI 10.1038/nature07399; Chen ZW, 2009, NEOPLASIA, V11, P753, DOI 10.1593/neo.09466; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Davis ME, 2010, NATURE, V464, P1067, DOI 10.1038/nature08956; De Preter K, 2010, CLIN CANCER RES, V16, P1532, DOI 10.1158/1078-0432.CCR-09-2607; Ding Q, 2013, J MED CHEM; Fredlund E, 2008, P NATL ACAD SCI USA, V105, P14094, DOI 10.1073/pnas.0804455105; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hellemans J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r19; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Houlard M, 2006, PLOS GENET, V2, P1686, DOI 10.1371/journal.pgen.0020181; Janoueix-Lerosey I, 2008, NATURE, V455, P967, DOI 10.1038/nature07398; Jiao RJ, 2004, MOL CELL BIOL, V24, P4710, DOI 10.1128/MCB.24.11.4710-4719.2004; Kim E, 2009, JNCI-J NATL CANCER I, V101, P1527, DOI 10.1093/jnci/djp376; Koeppel M, 2011, NUCLEIC ACIDS RES, V39, P6069, DOI 10.1093/nar/gkr028; Koppen A, 2007, EUR J CANCER, V43, P2413, DOI 10.1016/j.ejca.2007.07.024; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; Lefever S, 2009, NUCLEIC ACIDS RES, V37, pD942, DOI 10.1093/nar/gkn777; Lefever S, 2009, NUCLEIC ACIDS RES, V37, P2065, DOI 10.1093/nar/gkp056; Lozano G, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001115; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Majid S, 2010, CANCER RES, V70, P2809, DOI 10.1158/0008-5472.CAN-09-4176; Manalo DJ, 2005, BLOOD, V105, P659, DOI 10.1182/blood-2004-07-2958; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Meng MV, 2001, CLIN CANCER RES, V7, P2712; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Molenaar JJ, 2012, GENE CHROMOSOME CANC, V51, P10, DOI 10.1002/gcc.20926; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Qing GL, 2010, CANCER RES, V70, P10351, DOI 10.1158/0008-5472.CAN-10-0740; Rahman MA, 2013, CLIN CANCER RES, V19, P3416, DOI 10.1158/1078-0432.CCR-13-0073; Ramnath N, 2001, J CLIN ONCOL, V19, P4259, DOI 10.1200/JCO.2001.19.22.4259; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; Schmid T, 2004, BIOCHEM J, V380, P289, DOI 10.1042/BJ20031299; Shao J, 2006, CURR CANCER DRUG TAR, V6, P409, DOI 10.2174/156800906777723949; Shohet JM, 2002, CANCER RES, V62, P1123; Speleman F, 2011, SEMIN CANC BIOL; Spurgers KB, 2006, J BIOL CHEM, V281, P25134, DOI 10.1074/jbc.M513901200; Statnikov A, 2005, INT J MED INFORM, V74, P491, DOI 10.1016/j.ijmedinf.2005.05.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swarbrick A, 2010, NAT MED, V16, P1134, DOI 10.1038/nm.2227; Van Maerken T, 2011, MOL CANCER THER, V10, P983, DOI 10.1158/1535-7163.MCT-10-1090; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vermeulen J, 2009, LANCET ONCOL, V10, P1030, DOI 10.1016/S1470-2045(09)70325-0; Wang Q, 2006, CANCER RES, V66, P6050, DOI 10.1158/0008-5472.CAN-05-4618; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Xue LJ, 2003, CANCER RES, V63, P980	58	27	32	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e79843	10.1371/journal.pone.0079843	http://dx.doi.org/10.1371/journal.pone.0079843			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24348903	Green Published, Green Submitted, gold			2022-12-27	WOS:000327311900048
J	Nakamoto, K; Nishinaka, T; Sato, N; Mankura, M; Koyama, Y; Kasuya, F; Tokuyama, S				Nakamoto, Kazuo; Nishinaka, Takashi; Sato, Naoya; Mankura, Mitsumasa; Koyama, Yutaka; Kasuya, Fumiyo; Tokuyama, Shogo			Hypothalamic GPR40 Signaling Activated by Free Long Chain Fatty Acids Suppresses CFA-Induced Inflammatory Chronic Pain	PLOS ONE			English	Article							RECEPTOR GPR40; BETA-ENDORPHIN; DOCOSAHEXAENOIC ACID; NEUROPATHIC PAIN; INSULIN-SECRETION; NERVOUS-SYSTEM; EXPRESSION; BRAIN; CELLS; ASTROCYTES	GPR40 has been reported to be activated by long-chain fatty acids, such as docosahexaenoic acid (DHA). However, reports studying functional role of GPR40 in the brain are lacking. The present study focused on the relationship between pain regulation and GPR40, investigating the functional roles of hypothalamic GPR40 during chronic pain caused using a complete Freund's adjuvant (CFA)-induced inflammatory chronic pain mouse model. GPR40 protein expression in the hypothalamus was transiently increased at day 7, but not at days 1, 3 and 14, after CFA injection. GPR40 was co-localized with NeuN, a neuron marker, but not with glial fibrillary acidic protein (GFAP), an astrocyte marker. At day 1 after CFA injection, GFAP protein expression was markedly increased in the hypothalamus. These increases were significantly inhibited by the intracerebroventricular injection of flavopiridol (15 nmol), a cyclin-dependent kinase inhibitor, depending on the decreases in both the increment of GPR40 protein expression and the induction of mechanical allodynia and thermal hyperalgesia at day 7 after CFA injection. Furthermore, the level of DHA in the hypothalamus tissue was significantly increased in a flavopiridol reversible manner at day 1, but not at day 7, after CFA injection. The intracerebroventricular injection of DHA (50 mu g) and GW9508 (1.0 mu g), a GPR40-selective agonist, significantly reduced mechanical allodynia and thermal hyperalgesia at day 7, but not at day 1, after CFA injection. These effects were inhibited by intracerebroventricular pretreatment with GW1100 (10 mg), a GPR40 antagonist. The protein expression of GPR40 was colocalized with that of beta-endorphin and proopiomelanocortin, and a single intracerebroventricular injection of GW9508 (1.0 mg) significantly increased the number of neurons double-stained for c-Fos and proopiomelanocortin in the arcuate nucleus of the hypothalamus. Our findings suggest that	[Nakamoto, Kazuo; Nishinaka, Takashi; Sato, Naoya; Tokuyama, Shogo] Kobe Gakuin Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Kobe, Hyogo 65121, Japan; [Mankura, Mitsumasa] Bizen Kasei Chem Co Ltd, Okayama, Japan; [Koyama, Yutaka] Osaka Ohtani Univ, Fac Pharm, Pharmacol Lab, Osaka, Japan; [Kasuya, Fumiyo] Kobe Gakuin Univ, Fac Pharmaceut Sci, Biochem Toxicol Lab, Kobe, Hyogo, Japan	Kobe Gakuin University; Kobe Gakuin University	Tokuyama, S (corresponding author), Kobe Gakuin Univ, Sch Pharmaceut Sci, Dept Clin Pharm, Kobe, Hyogo 65121, Japan.	stoku@pharm.kobegakuin.ac.jp	Nishinaka, Takashi/AAR-4332-2020	Nishinaka, Takashi/0000-0001-7500-7889	Ministry of Education, Culture, Sports, Science and Technology, Japan [24592364]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (C) (24592364) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NJ, 2005, CURR OPIN NEUROBIOL, V15, P542, DOI 10.1016/j.conb.2005.08.006; Arita M, 2012, J BIOCHEM, V152, P313, DOI 10.1093/jb/mvs092; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Boneva NB, 2012, HIPPOCAMPUS, V22, P896, DOI 10.1002/hipo.20951; Boneva NB, 2010, J PHARM SCI, V116, P163; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; BRONSTEIN DM, 1992, BRAIN RES, V587, P269, DOI 10.1016/0006-8993(92)91007-2; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Bruehl S, 2007, PAIN, V130, P208, DOI 10.1016/j.pain.2006.11.013; Calder PC, 2003, LIPIDS, V38, P343, DOI 10.1007/s11745-003-1068-y; Calder PC, 2009, BIOFACTORS, V35, P266, DOI 10.1002/biof.42; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Di Giovanni S, 2005, P NATL ACAD SCI USA, V102, P8333, DOI 10.1073/pnas.0500989102; Farooqui AA, 2012, CURR MED CHEM, V19, P532; Goldberg RJ, 2007, PAIN, V129, P210, DOI 10.1016/j.pain.2007.01.020; HALEY TJ, 1957, BRIT J PHARM CHEMOTH, V12, P12, DOI 10.1111/j.1476-5381.1957.tb01354.x; Harel Z, 1996, AM J OBSTET GYNECOL, V174, P1335, DOI 10.1016/S0002-9378(96)70681-6; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Huang LA, 2011, PAIN, V152, P557, DOI 10.1016/j.pain.2010.11.021; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Kidd PM, 2007, ALTERN MED REV, V12, P207; Kiguchi N, 2010, PAIN, V149, P305, DOI 10.1016/j.pain.2010.02.025; Ko GD, 2010, CLIN J PAIN, V26, P168, DOI 10.1097/AJP.0b013e3181bb8533; Ma D, 2008, HIPPOCAMPUS, V18, P326, DOI 10.1002/hipo.20393; Ma D, 2007, NEUROSCI RES, V58, P394, DOI 10.1016/j.neures.2007.05.001; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Mechlin B, 2007, PAIN, V131, P142, DOI 10.1016/j.pain.2006.12.027; Melillo G, 1999, CANCER RES, V59, P5433; Millan MJ, 2002, PROG NEUROBIOL, V66, P355, DOI 10.1016/S0301-0082(02)00009-6; MOORE SA, 1991, J NEUROCHEM, V56, P518, DOI 10.1111/j.1471-4159.1991.tb08180.x; Moore SA, 2001, J MOL NEUROSCI, V16, P195, DOI 10.1385/JMN:16:2-3:195; MOORE SA, 1993, ADV EXP MED BIOL, V331, P229; Nakamoto Kazuo, 2012, JAPANESE JOURNAL OF NEUROPSYCHOPHARMACOLOGY, V32, P233; Nakamoto K, 2012, BRAIN RES, V1432, P74, DOI 10.1016/j.brainres.2011.11.012; Nakamoto K, 2011, EUR J PHARMACOL, V666, P100, DOI 10.1016/j.ejphar.2011.05.047; Nakamoto K, 2010, BIOL PHARM BULL, V33, P1070, DOI 10.1248/bpb.33.1070; Ohira H, 2013, J ATHEROSCLER THROMB, V20, P425, DOI 10.5551/jat.15065; Riediger ND, 2009, J AM DIET ASSOC, V109, P668, DOI 10.1016/j.jada.2008.12.022; Saravanan P, 2010, LANCET, V376, P540, DOI 10.1016/S0140-6736(10)60445-X; Seo YJ, 2008, NEUROSCIENCE, V152, P1054, DOI 10.1016/j.neuroscience.2007.06.047; Shahidi F, 2004, J MED FOOD, V7, P387, DOI 10.1089/jmf.2004.7.387; Strokin M, 2003, BRIT J PHARMACOL, V139, P1014, DOI 10.1038/sj.bjp.0705326; Swanton C, 2004, LANCET ONCOL, V5, P27, DOI 10.1016/S1470-2045(03)01321-4; Tokuyama S, 2011, BIOL PHARM BULL, V34, P1174, DOI 10.1248/bpb.34.1174; Tseng LF, 2001, TRENDS PHARMACOL SCI, V22, P623, DOI 10.1016/S0165-6147(00)01843-5; Tsuda M, 2011, BRAIN, V134, P1127, DOI 10.1093/brain/awr025; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Wang KQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030128; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yamashima T, 2012, PROG LIPID RES, V51, P221, DOI 10.1016/j.plipres.2012.02.001; Zhu Z, 2007, GLIA, V55, P546, DOI 10.1002/glia.20476	55	64	68	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81563	10.1371/journal.pone.0081563	http://dx.doi.org/10.1371/journal.pone.0081563			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349089	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800022
J	Hoang, T; Aagaard, C; Dietrich, J; Cassidy, JP; Dolganov, G; Schoolnik, GK; Lundberg, CV; Agger, EM; Andersen, P				Truc Hoang; Aagaard, Claus; Dietrich, Jes; Cassidy, Joseph P.; Dolganov, Gregory; Schoolnik, Gary K.; Lundberg, Carina Vingsbo; Agger, Else Marie; Andersen, Peter			ESAT-6 (EsxA) and TB10.4 (EsxH) Based Vaccines for Pre-and Post-Exposure Tuberculosis Vaccination	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; CD4 T-CELLS; EFFICIENT PROTECTION; SUBUNIT VACCINATION; IMMUNE-RESPONSES; SECRETED PROTEIN; ANTIGENS; GENE; PERSISTENCE; EXPRESSION	The ESX systems from Mycobacterium tuberculosis are responsible for the secretion of highly immunogenic proteins of key importance for bacterial survival and growth. The two prototypic proteins, ESAT-6 (EsxA from ESX-1) and TB10.4 (EsxH from ESX-3) share a lot of characteristics regarding genome organization, size, antigenic properties, and vaccine potential but the two molecules clearly have very different roles in bacterial physiology. To further investigate the role of ESAT-6 and TB10.4 as preventive and post-exposure tuberculosis vaccines, we evaluated four different fusion-protein vaccines; H1, H4, H56 and H28, that differ only in these two components. We found that all of these vaccines give rise to protection in a conventional prophylactic vaccination model. In contrast, only the ESAT-6-containing vaccines resulted in significant protection against reactivation, when administered post-exposure. This difference in post-exposure activity did not correlate with a difference in gene expression during infection or a differential magnitude or quality of the vaccine-specific CD4 T cells induced by ESAT-6 versus TB10.4-containing vaccines. The post-exposure effect of the ESAT-6 based vaccines was found to be influenced by the infectious load at the time-point of vaccination and was abolished in chronically infected animals with high bacterial loads at the onset of vaccination. Our data demonstrate that there are specific requirements for the immune system to target an already established tuberculosis infection and that ESAT-6 has a unique potential in post-exposure vaccination strategies.	[Truc Hoang; Aagaard, Claus; Dietrich, Jes; Agger, Else Marie; Andersen, Peter] Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark; [Cassidy, Joseph P.] Univ Coll Dublin, Vet Sci Ctr, Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Dolganov, Gregory; Schoolnik, Gary K.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA; [Lundberg, Carina Vingsbo] Statens Serum Inst, Dept Microbiol & Infect Control, DK-2300 Copenhagen, Denmark	Statens Serum Institut; University College Dublin; Stanford University; Statens Serum Institut	Andersen, P (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol, DK-2300 Copenhagen, Denmark.	PA@ssi.dk		Andersen, Peter/0000-0002-5869-2551; Cassidy, Joseph/0000-0002-9229-1831	Bill and Melinda Gates Foundation (GC12) [37885]; Danish Strategic Research council (Centre for Nanovaccines)	Bill and Melinda Gates Foundation (GC12); Danish Strategic Research council (Centre for Nanovaccines)	This work was supported by the Bill and Melinda Gates Foundation (GC12 # 37885) and the Danish Strategic Research council (Centre for Nanovaccines). We thank Sanofi Aventis for supporting the pre-clinical development of H4 (Ag85B-TB10.4) and H28 (Ag85B-TB10.4-Rv2660c) in addition to the clinical development of H4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2011, NAT MED, V17, P189, DOI 10.1038/nm.2285; Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Ahn SS, 2012, GENE THER, V19, P570, DOI 10.1038/gt.2011.140; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brandt L, 2000, INFECT IMMUN, V68, P791, DOI 10.1128/IAI.68.2.791-795.2000; Cardona PJ, 2005, VACCINE, V23, P1393, DOI 10.1016/j.vaccine.2004.09.008; Coler RN, 2013, J INFECT DIS, V207, P1242, DOI 10.1093/infdis/jis425; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; Demissie A, 2006, CLIN VACCINE IMMUNOL, V13, P179, DOI 10.1128/CVI.13.2.179-186.2006; Dey B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023360; Dietrich J, 2006, VET MICROBIOL, V112, P163, DOI 10.1016/j.vetmic.2005.11.030; Dietrich J, 2005, J IMMUNOL, V174, P6332, DOI 10.4049/jimmunol.174.10.6332; Dolganov GM, 2001, GENOME RES, V11, P1473, DOI 10.1101/gr.191301; Ernst JD, 2012, NAT REV IMMUNOL, V12, P581, DOI 10.1038/nri3259; Feltcher ME, 2010, FUTURE MICROBIOL, V5, P1581, DOI [10.2217/fmb.10.112, 10.2217/FMB.10.112]; Gideon HP, 2012, J IMMUNOL, V189, P5867, DOI 10.4049/jimmunol.1202281; Gideon HP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001237; Gill WP, 2009, NAT MED, V15, P211, DOI 10.1038/nm.1915; Grewal A, 2007, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0701S17; Harding CV, 2010, NAT REV MICROBIOL, V8, P296, DOI 10.1038/nrmicro2321; Hoang TTKT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005928; Ilghari D, 2011, J BIOL CHEM, V286, P29993, DOI 10.1074/jbc.M111.248732; Kassa D, 2012, CLIN VACCINE IMMUNOL, V19, P1907, DOI 10.1128/CVI.00482-12; Lewis KN, 2003, J INFECT DIS, V187, P117, DOI 10.1086/345862; Leyten EMS, 2006, MICROBES INFECT, V8, P2052, DOI 10.1016/j.micinf.2006.03.018; Ligon LS, 2012, TUBERCULOSIS, V92, P121, DOI 10.1016/j.tube.2011.11.005; Lin MY, 2007, INFECT IMMUN, V75, P3523, DOI 10.1128/IAI.01999-06; Lindenstrom T, 2012, INFECT IMMUN, V80, P3533, DOI 10.1128/IAI.00550-12; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; MCCUNE RM, 1956, J EXP MED, V104, P763, DOI 10.1084/jem.104.5.763; MCCUNE RM, 1956, J EXP MED, V104, P737, DOI 10.1084/jem.104.5.737; Munoz-Elias EJ, 2005, INFECT IMMUN, V73, P546, DOI 10.1128/IAI.73.1.546-551.2005; Olsen AW, 2001, INFECT IMMUN, V69, P2773, DOI 10.1128/IAI.69.5.2773-2778.2001; Orme IM, 2006, VACCINE, V24, P2, DOI 10.1016/j.vaccine.2005.07.078; Ottenhoff THM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002607; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Romano M, 2012, EXPERT OPIN BIOL TH, V12, P1601, DOI 10.1517/14712598.2012.721768; Samten B, 2009, TUBERCULOSIS, V89, pS74, DOI 10.1016/S1472-9792(09)70017-4; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi L, 2004, INFECT IMMUN, V72, P2420, DOI 10.1128/IAI.72.4.2420-2424.2004; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Simeone R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002507; Skjot RLV, 2002, INFECT IMMUN, V70, P5446, DOI 10.1128/IAI.70.10.5446-5453.2002; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Smith J, 2008, INFECT IMMUN, V76, P5478, DOI 10.1128/IAI.00614-08; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Taylor JL, 2012, IMMUNOL CELL BIOL, V90, P945, DOI 10.1038/icb.2012.34; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Verreck FAW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005264; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wayne LG, 1996, INFECT IMMUN, V64, P2062, DOI 10.1128/IAI.64.6.2062-2069.1996; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Winslow GM, 2003, J IMMUNOL, V170, P2046, DOI 10.4049/jimmunol.170.4.2046	57	62	62	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80579	10.1371/journal.pone.0080579	http://dx.doi.org/10.1371/journal.pone.0080579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349004	Green Submitted, Green Published, gold			2022-12-27	WOS:000328731800004
J	Al Mamun, A; Mannan, M; O'Callaghan, MJ; Williams, GM; Najman, JM; Callaway, LK				Al Mamun, Abdullah; Mannan, Munim; O'Callaghan, Michael J.; Williams, Gail M.; Najman, Jake M.; Callaway, Leonie K.			Association between Gestational Weight Gain and Postpartum Diabetes: Evidence from a Community Based Large Cohort Study	PLOS ONE			English	Article							RISK-FACTOR; PREGNANCY; OBESITY; CHILDBEARING; MELLITUS; DISEASE; WOMEN	We have investigated the prospective association between excess gestational weight gain (GWG) and development of diabetes by 21 years post-partum using a community-based large prospective cohort study in Brisbane, Australia. There were 3386 mothers for whom complete data were available on GWG, pre-pregnancy BMI and self-reported diabetes 21 years post-partum. We used The Institute of Medicine (IOM) definition to categorize GWG as inadequate, adequate and excessive. We found 839 (25.78%) mothers gained inadequate weight, 1,353 (39.96%) had adequate weight gain and 1,194 (35.26%) had gained excessive weight during pregnancy. At 21 years post-partum, 8.40% of mothers self-reported a diagnosis of diabetes made by their doctor. In the age adjusted model, we found mothers who gained excess weight during pregnancy were 1.47(1.11,1.94) times more likely to experience diabetes at 21 years post-partum compared to the mothers who gained adequate weight. This association was not explained by the potential confounders including maternal age, parity, education, race, smoking, TV watching and exercise. However, this association was mediated by the current BMI. There was no association for the women who had normal BMI before pregnancy and gained excess weight during pregnancy. The findings of this study suggest that women who gain excess weight during pregnancy are at greater risk of being diagnosed with diabetes in later life. This relationship is likely mediated through the pathway of post-partum weight-retention and obesity. This study adds evidence to the argument that excessive GWG during pregnancy for overweight mothers has long term maternal health implications.	[Al Mamun, Abdullah; Mannan, Munim; Williams, Gail M.; Najman, Jake M.] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [O'Callaghan, Michael J.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [O'Callaghan, Michael J.; Callaway, Leonie K.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Callaway, Leonie K.] Univ Queensland, Mater Childrens Hosp, Brisbane, Qld 4101, Australia; [Callaway, Leonie K.] Univ Queensland, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; University of Queensland	Al Mamun, A (corresponding author), Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia.	mamun@sph.uq.edu.au	Najman, Jackob M./B-1527-2008; Williams, Gail/S-8833-2019; Mamun, Abdullah A/A-4673-2011; Mamun, Abdullah/HHM-9898-2022	Najman, Jackob M./0000-0001-7079-2080; Williams, Gail/0000-0002-4822-5263; Mamun, Abdullah A/0000-0002-1535-8086; Callaway, Leonie/0000-0002-0137-9935	National Health and Medical Research Council (NHMRC) of Australia; NHMRC [519756]; National Heart Foundation of Australia [G07B3135]	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); National Heart Foundation of Australia(National Heart Foundation of Australia)	The core study was funded by the National Health and Medical Research Council (NHMRC) of Australia. AAM is supported by a Career Development Fellowship from the NHMRC (ID 519756). For the work in this paper AAM has a grant from the National Heart Foundation of Australia (ID G07B3135). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in the paper are those of the authors and not necessarily those of any funding body and no funding body influenced the way in which the data were analysed and presented.	Cai ZJ, 1999, WHO TECH REP SER, V887, P1; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Gunderson EP, 2004, INT J OBESITY, V28, P525, DOI 10.1038/sj.ijo.0802551; Gunderson EP, 2000, EPIDEMIOL REV, V22, P261, DOI 10.1093/oxfordjournals.epirev.a018038; Gunderson EP, 2008, OBESITY, V16, P1078, DOI 10.1038/oby.2008.40; Hernan MA, 2002, AM J EPIDEMIOL, V155, P176, DOI 10.1093/aje/155.2.176; Hoffman L, 1998, MED J AUSTRALIA, V169, P93, DOI 10.5694/j.1326-5377.1998.tb140192.x; Horwood LJ, 2010, DRUG ALCOHOL DEPEN, V110, P247, DOI 10.1016/j.drugalcdep.2010.03.008; HUBERT HB, 1983, CIRCULATION, V67, P968, DOI 10.1161/01.CIR.67.5.968; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; KEEPING JD, 1989, BRIT J OBSTET GYNAEC, V96, P289, DOI 10.1111/j.1471-0528.1989.tb02388.x; Lim S, 2007, DIABETES CARE, V30, P348, DOI 10.2337/dc06-1405; Linne Y, 2002, Obes Rev, V3, P75, DOI 10.1046/j.1467-789X.2002.00061.x; Little R.J.A., 2002, STAT ANAL MISSING DA; Mamun AA, 2010, AM J CLIN NUTR, V91, P1336, DOI 10.3945/ajcn.2009.28950; Mamun AA, 2009, CIRCULATION, V119, P1720, DOI 10.1161/CIRCULATIONAHA.108.813436; Margolis KL, 2008, CLIN TRIALS, V5, P240, DOI 10.1177/1740774508091749; Najman JM, 2005, INT J EPIDEMIOL, V34, P992, DOI 10.1093/ije/dyi119; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461	21	35	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e75679	10.1371/journal.pone.0075679	http://dx.doi.org/10.1371/journal.pone.0075679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348988	Green Submitted, gold, Green Published			2022-12-27	WOS:000328730300004
J	Brien, ML; Lang, JW; Webb, GJ; Stevenson, C; Christian, KA				Brien, Matthew L.; Lang, Jeffrey W.; Webb, Grahame J.; Stevenson, Colin; Christian, Keith A.			The Good, the Bad, and the Ugly: Agonistic Behaviour in Juvenile Crocodilians	PLOS ONE			English	Article							FRESH-WATER CROCODILES; CRAYFISH; COOPERATION; COMPETITION; INITIATION; PATTERNS; DECAPODA; ONTOGENY; SIZE; TIME	We examined agonistic behaviour in seven species of hatchling and juvenile crocodilians held in small groups (N=4) under similar laboratory conditions. Agonistic interactions occurred in all seven species, typically involved two individuals, were short in duration (5-15 seconds), and occurred between 1600-2200 h in open water. The nature and extent of agonistic interactions, the behaviours displayed, and the level of conspecific tolerance varied among species. Discrete postures, non-contact and contact movements are described. Three of these were species-specific: push downs by C. johnstoni; inflated tail sweeping by C. novaeguineae; and, side head striking combined with tail wagging by C. porosus. The two long-snouted species (C. johnstoni and G. gangeticus) avoided contact involving the head and often raised the head up out of the way during agonistic interactions. Several behaviours not associated with aggression are also described, including snout rubbing, raising the head up high while at rest, and the use of vocalizations. The two most aggressive species (C. porosus, C. novaeguineae) appeared to form dominance hierarchies, whereas the less aggressive species did not. Interspecific differences in agonistic behaviour may reflect evolutionary divergence associated with morphology, ecology, general life history and responses to interspecific conflict in areas where multiple species have co-existed. Understanding species-specific traits in agonistic behaviour and social tolerance has implications for the controlled raising of different species of hatchlings for conservation, management or production purposes.	[Brien, Matthew L.; Webb, Grahame J.; Christian, Keith A.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia; [Brien, Matthew L.; Webb, Grahame J.] Wildlife Management Int Pty Ltd, Karama, NT, Australia; [Lang, Jeffrey W.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Stevenson, Colin] Madras Crocodile Bank Trust, Dept Wildlife, Mamallapuram, Tamil Nadu, India; [Stevenson, Colin] Ctr Herpetol, Mamallapuram, Tamil Nadu, India	Charles Darwin University; University of Minnesota System; University of Minnesota Twin Cities	Brien, ML (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT 0909, Australia.	matthew_brien@hotmail.com		Christian, Keith/0000-0001-6135-1670	WMI through the Rural Industries Research and Development Corporation; Holsworth Wildlife Research Endowment (ANZ Trustees Foundation); Northern Territory Research and Innovation Board student grant; IUCN Crocodile Specialist Group student grant; Charles Darwin University	WMI through the Rural Industries Research and Development Corporation; Holsworth Wildlife Research Endowment (ANZ Trustees Foundation); Northern Territory Research and Innovation Board student grant; IUCN Crocodile Specialist Group student grant; Charles Darwin University	WMI funding through the Rural Industries Research and Development Corporation is gratefully acknowledged. Funding for equipment (cameras, digital video recorders) was provided through a Holsworth Wildlife Research Endowment (ANZ Trustees Foundation), a Northern Territory Research and Innovation Board student grant, an IUCN Crocodile Specialist Group student grant, and Charles Darwin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ECOLOGY, V85, P2664, DOI 10.1890/04-0648; ALLEE WC, 1948, J EXP ZOOL, V108, P1, DOI 10.1002/jez.1401080102; [Anonymous], 1953, SOCIAL BEHAV ANIMALS; BARKER DG, 1979, COPEIA, P466; BEKOFF M, 1981, AGGRESSIVE BEHAV, V7, P225, DOI 10.1002/1098-2337(1981)7:3<225::AID-AB2480070306>3.0.CO;2-I; Bergman DA, 2003, BIOL BULL-US, V205, P26, DOI 10.2307/1543442; Bergman VH-H, 1968, Z TIERPSYCHOL, V25, P559; BOVBJERG RV, 1970, ECOLOGY, V51, P225, DOI 10.2307/1933658; Brazaitis P, 2011, HIST BIOL, V23, P73, DOI 10.1080/08912963.2011.560723; Brien ML, 2013, AUST J ZOOL, V61, P196, DOI 10.1071/ZO13035; Brien ML, 2013, BEHAVIOUR, V150, P737, DOI 10.1163/1568539X-00003078; Britton A, 2001, REV CLASSIFICATION C, P364; Brochu CA, 2001, AM ZOOL, V41, P564, DOI 10.1668/0003-1569(2001)041[0564:CSISAT]2.0.CO;2; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Campos Z, 2012, J NAT HIST, V46, P2979, DOI 10.1080/00222933.2012.724723; Carpenter C.C., 1984, University of Kansas Publications of the Museum of Natural History, P195; Carpenter C.C., 1977, P335; Christian K, 1996, J HERPETOL, V30, P1, DOI 10.2307/1564699; Di-Poi N, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-19; Dinets V, 2013, ETHOL ECOL EVOL, V25, P174, DOI 10.1080/03949370.2012.744358; Dinetz V, 2011, THESIS U MIAMI US; Drummond H, 2006, Q REV BIOL, V81, P3, DOI 10.1086/503922; DRUMMOND H, 1986, BEHAV ECOL SOCIOBIOL, V19, P365, DOI 10.1007/BF00295710; Drummond H, 2001, ADV STUD BEHAV, V30, P261, DOI 10.1016/S0065-3454(01)80009-7; FROESE AD, 1974, ANIM BEHAV, V22, P735, DOI 10.1016/S0003-3472(74)80025-4; Garrick L. D., 1978, B AM MUS NAT HIST, V160, P153; GARRICK LD, 1977, AM ZOOL, V17, P225; Genner MJ, 1999, ECOL LETT, V2, P185; Gherardi F, 2004, BEHAV PROCESS, V65, P163, DOI 10.1016/j.beproc.2003.09.002; GREENBERG B, 1947, PHYSIOL ZOOL, V20, P267, DOI 10.1086/physzool.20.3.30151959; Groombridge B., 1987, P9; Guiasu RC, 1997, CRUSTACEANA, V70, P480; Hoogmartens I., 2010, AGFA GRAPHICS NV US7; HUBER R, 1995, BRAIN BEHAV EVOLUT, V46, P72, DOI 10.1159/000113260; HUNTINGTON F, 1987, ANIMAL CONFLICT; Jelden D, 2008, CROCODILE CONSERVATI; Ladich F, 1997, MAR FRESHW BEHAV PHY, V29, P87, DOI 10.1080/10236249709379002; Lang J.W., 1987, P273; Lang JW, 2013, CROC P 22 WORK M SSC; Lang T.W., 1987, P301; Leitch DB, 2012, J EXP BIOL, V215, P4217, DOI 10.1242/jeb.076836; Manolis S. C., 2010, CROCODILES STATUS SU; MOCK DW, 1991, AM NAT, V138, P1015, DOI 10.1086/285265; Morafka DJ, 2000, HERPETOL MONOGR, V14, P353, DOI 10.2307/1467050; NEWMAN MURRAY A., 1956, PHYSIOL ZOOL, V29, P64; Oaks JR, 2011, EVOLUTION, V65, P3285, DOI 10.1111/j.1558-5646.2011.01373.x; Pahl KR, 2012, NATURAL HIST SIAMESE, P1; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Pavey CR, 1996, J ZOOL, V238, P445, DOI 10.1111/j.1469-7998.1996.tb05405.x; PHILLIPS JA, 1993, PHYSIOL BEHAV, V53, P81, DOI 10.1016/0031-9384(93)90014-7; Pierce SE, 2008, J MORPHOL, V269, P840, DOI 10.1002/jmor.10627; Sanchez-Hernandez P, 2012, ACTA ETHOL, V15, P65, DOI 10.1007/s10211-011-0109-6; Senter P, 2008, J HERPETOL, V42, P354, DOI 10.1670/07-150.1; SIMPSON B. K., 2006, CROCODILES, P293; SMALE L, 1995, ANIM BEHAV, V50, P671, DOI 10.1016/0003-3472(95)80128-6; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; STAUB NL, 1993, HERPETOLOGICA, V49, P271; Targarona R.R., 2010, CROCODILES STATUS SU, P114; TERRANOVA ML, 1993, DEV PSYCHOBIOL, V26, P467, DOI 10.1002/dev.420260805; Thorbjarnarson JB, 1992, CROCODILES STATUS SU; Tierney AJ, 2000, J CRUSTACEAN BIOL, V20, P54, DOI 10.1651/0278-0372(2000)020[0054:CAOABI]2.0.CO;2; Torr Geordie A., 1994, Amphibia-Reptilia, V15, P21, DOI 10.1163/156853894X00524; Usio Nisikawa, 2001, Biological Invasions, V3, P179, DOI 10.1023/A:1014573915464; van Weerd M, 2010, CROCODILES STATUS SU, P71; Varona L. S., 1966, SERIE A, V16, P1; Vergne AL, 2012, ANIM COGN, V15, P1095, DOI 10.1007/s10071-012-0533-7; VLIET KA, 1989, AM ZOOL, V29, P1019; Vliet KA, 1987, THESIS U FLORIDA US; Walmsley CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053873; Webb G., 1989, CROCODILES AUSTR; WEBB GJW, 1977, COPEIA, P238; Weldon PJ, 2008, NAT PROD REP, V25, P738, DOI 10.1039/b509854h; WELDON PJ, 1993, BRAIN BEHAV EVOLUT, V41, P239, DOI 10.1159/000113845; Worner LLB, 2009, THESIS VICTORIA U NZ	74	23	26	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80872	10.1371/journal.pone.0080872	http://dx.doi.org/10.1371/journal.pone.0080872			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349018	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300013
J	Fraschetti, S; Guarnieri, G; Bevilacqua, S; Terlizzi, A; Boero, F				Fraschetti, Simonetta; Guarnieri, Giuseppe; Bevilacqua, Stanislao; Terlizzi, Antonio; Boero, Ferdinando			Protection Enhances Community and Habitat Stability: Evidence from a Mediterranean Marine Protected Area	PLOS ONE			English	Article							ECOSYSTEM FUNCTION; BIODIVERSITY LOSS; REGIME SHIFTS; TEMPORAL VARIABILITY; TROPHIC CASCADES; RESERVES; PATTERNS; RESILIENCE; RECOVERY; IMPACTS	Rare evidences support that Marine Protected Areas (MPAs) enhance the stability of marine habitats and assemblages. Based on nine years of observation (2001-2009) inside and outside a well managed MPA, we assessed the potential of conservation and management actions to modify patterns of spatial and/or temporal variability of Posidonia oceanica meadows, the lower midlittoral and the shallow infralittoral rock assemblages. Significant differences in both temporal variations and spatial patterns were observed between protected and unprotected locations. A lower temporal variability in the protected vs. unprotected assemblages was found in the shallow infralittoral, demonstrating that, at least at local scale, protection can enhance community stability. Macrobenthos with long-lived and relatively slow-growing invertebrates and structurally complex algal forms were homogeneously distributed in space and went through little fluctuations in time. In contrast, a mosaic of disturbed patches featured unprotected locations, with small-scale shifts from macroalgal stands to barrens, and harsh temporal variations between the two states. Opposite patterns of spatial and temporal variability were found for the midlittoral assemblages. Despite an overall clear pattern of seagrass regression through time, protected meadows showed a significantly higher shoot density than unprotected ones, suggesting a higher resistance to local human activities. Our results support the assumption that the exclusion/management of human activities within MPAs enhance the stability of the structural components of protected marine systems, reverting or arresting threat-induced trajectories of change.	[Fraschetti, Simonetta; Guarnieri, Giuseppe; Bevilacqua, Stanislao; Terlizzi, Antonio; Boero, Ferdinando] Univ Salento, Dept Biol & Environm Sci & Technol, Consorzio Nazl Interuniv Sci Mare, Lecce, Italy; [Boero, Ferdinando] Inst Marine Sci, Natl Res Council, Genoa, Italy	University of Salento; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze Marine (ISMAR-CNR)	Fraschetti, S (corresponding author), Univ Salento, Dept Biol & Environm Sci & Technol, Consorzio Nazl Interuniv Sci Mare, Lecce, Italy.	simona.fraschetti@unisalento.it	Bevilacqua, Stanislao/I-1393-2019; Fraschetti, Simonetta/R-8716-2019; Terlizzi, Antonio/B-6131-2015; CNR, Ismar/P-1247-2014	Bevilacqua, Stanislao/0000-0002-6417-7134; Fraschetti, Simonetta/0000-0002-1780-1651; Terlizzi, Antonio/0000-0001-5968-4548; Boero, Ferdinando/0000-0002-6317-2710; Guarnieri, Giuseppe/0000-0002-7334-9030; CNR, Ismar/0000-0001-5351-1486	Italian Ministry of the Environment (Afrodite project); European Community's 7th Framework Programmes [287844, 287600]; European Union from VECTORS; Italian Ministry of the Research PRIN TETRIS	Italian Ministry of the Environment (Afrodite project); European Community's 7th Framework Programmes; European Union from VECTORS; Italian Ministry of the Research PRIN TETRIS	The research leading to these results also received funding from the Italian Ministry of the Environment (Afrodite project), the European Community's 7th Framework Programmes (FP7/2007-2013) for the project COCONET (Grant agreement No. 287844, http://www.coconet-fp7.eu/) and PERSEUS (Grant agreement No. 287600, http://www.perseus-net.eu/site/content.php). The support by the European Union from VECTORS (http://www.marine-vectors.eu/) and from the Italian Ministry of the Research PRIN TETRIS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguado-Gimenez F, 2012, MAR POLLUT BULL, V64, P729, DOI 10.1016/j.marpolbul.2012.02.012; Allison GW, 1998, ECOL APPL, V8, pS79, DOI 10.1890/1051-0761(1998)8[S79:MRANBN]2.0.CO;2; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Anderson MJ, 2001, CAN J FISH AQUAT SCI, V58, P626, DOI 10.1139/cjfas-58-3-626; Babcock RC, 2010, P NATL ACAD SCI USA, V107, P18256, DOI 10.1073/pnas.0908012107; Badalamenti F, 2006, HYDROBIOLOGIA, V555, P253, DOI 10.1007/s10750-005-1121-5; Bellan G, 1999, WATER ENVIRON RES, V71, P483, DOI 10.2175/106143097X122167; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bertocci I, 2012, MAR ENVIRON RES, V77, P60, DOI 10.1016/j.marenvres.2012.02.003; Bevilacqua S, 2006, J ANIM ECOL, V75, P908, DOI 10.1111/j.1365-2656.2006.01108.x; Bevilacqua S, 2012, ECOL INDIC, V18, P140, DOI 10.1016/j.ecolind.2011.11.006; BOERO F, 1994, MAR ECOL-P S Z N I, V15, P3, DOI 10.1111/j.1439-0485.1994.tb00038.x; Boero F, 2007, MAR ECOL-EVOL PERSP, V28, P134, DOI 10.1111/j.1439-0485.2007.00171.x; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Bulleri F, 2011, MAR ECOL PROG SER, V431, P55, DOI 10.3354/meps09137; Bustamante M, 2012, MAR ENVIRON RES, V80, P27, DOI 10.1016/j.marenvres.2012.06.007; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Carpenter SR, 2011, SCIENCE, V332, P1079, DOI 10.1126/science.1203672; Ceccherelli G, 2006, MAR ENVIRON RES, V61, P171, DOI 10.1016/j.marenvres.2005.09.002; Claudet J, 2010, BIOL CONSERV, V143, P2195, DOI 10.1016/j.biocon.2010.06.004; Claudet J, 2010, AQUAT CONSERV, V20, P239, DOI 10.1002/aqc.1087; Coleman RA, 2006, OECOLOGIA, V147, P556, DOI 10.1007/s00442-005-0296-9; Coll M, 2012, GLOBAL ECOL BIOGEOGR, V21, P465, DOI 10.1111/j.1466-8238.2011.00697.x; DETHIER MN, 1993, MAR ECOL PROG SER, V96, P93, DOI 10.3354/meps096093; Deyoung B, 2008, TRENDS ECOL EVOL, V23, P402, DOI 10.1016/j.tree.2008.03.008; Dominguez M, 2012, RESTOR ECOL, V20, P180, DOI 10.1111/j.1526-100X.2010.00762.x; Fauchald P, 2010, ECOLOGY, V91, P2191, DOI 10.1890/09-1500.1; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; FRANCOUR P, 1994, OCEANOL ACTA, V17, P309; Fraschetti S, 2005, MAR ENVIRON RES, V59, P309, DOI 10.1016/j.marenvres.2004.05.007; Fraschetti S., 2011, MARINE PROTECTED ARE, P11, DOI DOI 10.1017/CBO9781139049382.003; Fraschetti S, 2006, J EXP MAR BIOL ECOL, V339, P148, DOI 10.1016/j.jembe.2006.07.007; Fraschetti S, 2012, MAR ECOL PROG SER, V466, P21, DOI 10.3354/meps09937; Fraterrigo JM, 2008, ECOL LETT, V11, P756, DOI 10.1111/j.1461-0248.2008.01191.x; Garcia-Charton JA, 2008, J NAT CONSERV, V16, P193, DOI 10.1016/j.jnc.2008.09.007; GASTON KJ, 1994, PHILOS T R SOC B, V345, P335, DOI 10.1098/rstb.1994.0114; Goni R, 2006, MAR ECOL PROG SER, V308, P207, DOI 10.3354/meps308207; Gonzalez-Correa JM, 2008, ESTUAR COAST SHELF S, V76, P834, DOI 10.1016/j.ecss.2007.08.012; Gorman D, 2009, J APPL ECOL, V46, P1258, DOI 10.1111/j.1365-2664.2009.01711.x; Grman E, 2010, ECOL LETT, V13, P1400, DOI 10.1111/j.1461-0248.2010.01533.x; Guarnieri G, 2012, MAR BIOL, V159, P1155, DOI 10.1007/s00227-012-1895-8; Guarnieri G, 2009, BIOFOULING, V25, P593, DOI 10.1080/08927010903013656; Guidetti P, 2008, BIOL CONSERV, V141, P699, DOI 10.1016/j.biocon.2007.12.013; Guidetti P, 2007, CONSERV BIOL, V21, P540, DOI 10.1111/j.1523-1739.2007.00657.x; Guidetti P, 2006, ECOL APPL, V16, P963, DOI 10.1890/1051-0761(2006)016[0963:MRRLPI]2.0.CO;2; Halpern BS, 2011, BIOL CONSERV, V144, P1499, DOI 10.1016/j.biocon.2011.01.019; Halpern BS, 2010, P NATL ACAD SCI USA, V107, P18312, DOI 10.1073/pnas.0908503107; Hereu B, 2008, EUR J PHYCOL, V43, P263, DOI 10.1080/09670260801930330; Hereu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036901; Hereu B, 2008, ECOLOGY, V89, P3423, DOI 10.1890/07-0613.1; Hewitt J.E., 2009, Open Ecology Journal, V2, P37; Hewitt J, 2010, BIODIVERS CONSERV, V19, P1315, DOI 10.1007/s10531-009-9763-7; Hoey AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025824; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hsieh CH, 2006, NATURE, V443, P859, DOI 10.1038/nature05232; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Linares C, 2012, CONSERV BIOL, V26, P88, DOI 10.1111/j.1523-1739.2011.01795.x; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Milazzo M, 2002, MAR ECOL-P S Z N I, V23, P280, DOI 10.1111/j.1439-0485.2002.tb00026.x; Montefalcone M, 2007, MAR POLLUT BULL, V54, P206, DOI 10.1016/j.marpolbul.2006.10.005; Montefalcone M, 2009, MAR POLLUT BULL, V58, P515, DOI 10.1016/j.marpolbul.2008.12.001; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, SCIENCE, V311, P98, DOI 10.1126/science.1121129; Navarrete SA, 2010, REV CHIL HIST NAT, V83, P143; O'Sullivan D, 2011, MAR ECOL PROG SER, V440, P115, DOI 10.3354/meps09294; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pergent G., 1995, M SOG E MARSEILLE, V54, P3; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Petraitis PS, 2009, OECOLOGIA, V161, P139, DOI 10.1007/s00442-009-1350-9; Polley HW, 2007, OIKOS, V116, P2044, DOI 10.1111/j.2007.0030-1299.16080.x; SALA E, 2011, PLOS ONE, V6; Sala E, 2012, PLOS ONE, V7; Sales M, 2011, ESTUAR COAST SHELF S, V92, P347, DOI 10.1016/j.ecss.2011.01.008; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Schwartz MW, 2000, OECOLOGIA, V122, P297, DOI 10.1007/s004420050035; Shears NT, 2012, ENVIRON CONSERV, V39, P225, DOI 10.1017/S0376892912000082; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; STENECK RS, 1994, OIKOS, V69, P476, DOI 10.2307/3545860; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; WARWICK RM, 1993, J EXP MAR BIOL ECOL, V172, P215, DOI 10.1016/0022-0981(93)90098-9; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	88	31	32	0	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81838	10.1371/journal.pone.0081838	http://dx.doi.org/10.1371/journal.pone.0081838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349135	Green Published, gold			2022-12-27	WOS:000328730300054
J	Brown, AG; Basell, LS; Robinson, S; Burdge, GC				Brown, Antony G.; Basell, Laura S.; Robinson, Sian; Burdge, Graham C.			Site Distribution at the Edge of the Palaeolithic World: A Nutritional Niche Approach	PLOS ONE			English	Article							SHALLOW-WATER HABITATS; HUNTER-GATHERER DIETS; ALPHA-LINOLENIC ACID; MIDDLE-PLEISTOCENE; ISOTOPIC EVIDENCE; FORAGING THEORY; FALLBACK FOODS; HUMAN-BEHAVIOR; THAMES-MEDWAY; EVOLUTION	This paper presents data from the English Channel area of Britain and Northern France on the spatial distribution of Lower to early Middle Palaeolithic pre-MIS5 interglacial sites which are used to test the contention that the pattern of the richest sites is a real archaeological distribution and not of taphonomic origin. These sites show a marked concentration in the middle-lower reaches of river valleys with most being upstream of, but close to, estimated interglacial tidal limits. A plant and animal database derived from Middle-Late Pleistocene sites in the region is used to estimate the potentially edible foods and their distribution in the typically undulating landscape of the region. This is then converted into the potential availability of macronutrients (proteins, carbohydrates, fats) and selected micronutrients. The floodplain is shown to be the optimum location in the nutritional landscape (nutriscape). In addition to both absolute and seasonal macronutrient advantages the floodplains could have provided foods rich in key micronutrients, which are linked to better health, the maintenance of fertility and minimization of infant mortality. Such places may have been seen as 'good (or healthy) places' explaining the high number of artefacts accumulated by repeated visitation over long periods of time and possible occupation. The distribution of these sites reflects the richest aquatic and wetland successional habitats along valley floors. Such locations would have provided foods rich in a wide range of nutrients, importantly including those in short supply at these latitudes. When combined with other benefits, the high nutrient diversity made these locations the optimal niche in northwest European mixed temperate woodland environments. It is argued here that the use of these nutritionally advantageous locations as nodal or central points facilitated a healthy variant of the Palaeolithic diet which permitted habitation at the edge of these hominins' range.	[Brown, Antony G.] Univ Southampton, Palaeoenvironm Labs PLUS, Southampton, Hants, England; [Basell, Laura S.] Queens Univ Belfast, Sch Geog Archaeol & Palaeoecol, Belfast, Antrim, North Ireland; [Robinson, Sian] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Burdge, Graham C.] Univ Southampton, Fac Med, Inst Dev Sci Bldg, Southampton SO9 5NH, Hants, England	University of Southampton; Queens University Belfast; University of Southampton; University of Southampton	Brown, AG (corresponding author), Univ Southampton, Palaeoenvironm Labs PLUS, Southampton, Hants, England.	Tony.Brown@soton.ac.uk	Burdge, Graham/A-2370-2014; Brown, Antony/G-4498-2014	Burdge, Graham/0000-0002-7665-2967; Robinson, Sian/0000-0003-1766-7269; Brown, Antony/0000-0002-1990-4654	English Heritage [PNUM 5696]; MRC [MC_UP_A620_1015, MC_UU_12011/2, MC_UU_12011/4, MC_UP_A620_1017] Funding Source: UKRI; Medical Research Council [U1475000002, MC_UP_A620_1015, MC_UU_12011/2, MC_UP_A620_1017, MC_UU_12011/4] Funding Source: researchfish	English Heritage; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The data collection and analysis from SW England was funded by English Heritage (Project PNUM 5696 URL http://www.english-heritage.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Ambrose SH, 2003, J ANTHROPOL ARCHAEOL, V22, P217, DOI 10.1016/S0278-4165(03)00036-9; Antoine Pierre, 2006, Quaternaire, V17, P281; Antoine P, 2010, QUATERN INT, V223, P456, DOI 10.1016/j.quaint.2009.07.014; Ashton N, 2008, QUATERNARY SCI REV, V27, P652, DOI 10.1016/j.quascirev.2008.01.003; Ashton N, 2010, J QUATERNARY SCI, V25, P737, DOI 10.1002/jqs.1350; Basell LS, 2011, GEOL SOC AM SPEC PAP, V476, P23, DOI 10.1130/2011.2476(03); Basell LS, 2011, QUATERNARY EXE VALLE, P2; Basell LS, 2012, PAST, V71, P3; Bocherens H, 2005, J HUM EVOL, V49, P71, DOI 10.1016/j.jhevol.2005.03.003; Briant RM, 2012, P GEOLOGIST ASSOC, V123, P87, DOI 10.1016/j.pgeola.2011.07.008; Briant R. M., 2009, QUATERNARY SOLENT BA, P161; Bridgland David, 2004, Quaternaire, V15, P29; Bridgland DR, 1999, QUATERNARY SCI REV, V18, P109, DOI 10.1016/S0277-3791(97)00092-9; Brown AG, 2010, QUATERNARY SCI REV, V29, P897, DOI 10.1016/j.quascirev.2009.12.007; Brown AG, 2009, P GEOLOGIST ASSOC, V120, P275, DOI 10.1016/j.pgeola.2009.08.012; Brown A.G., 1997, ALLUVIAL GEOARCHAEOL; Brown AG, 2013, GEOSCIENCES S W ENGL, V13, P1; Burdge G, 2004, CURR OPIN CLIN NUTR, V7, P137, DOI 10.1097/00075197-200403000-00006; Burdge GC, 2006, NUTR RES REV, V19, P26, DOI 10.1079/NRR2005113; Butzer KW, 1982, ARCHAEOLOGY HUMAN EC; Carpenter K. J., 1986, HIST SCURVY VITAMIN; Chase J.M., 2009, ECOLOGICAL NICHES LI; Cohen KM, 2012, QUATERN INT, V271, P70, DOI 10.1016/j.quaint.2011.11.003; Coles B.J, 2006, BEAVERS BRITAINS; Conway B., 1996, 94 BRIT MUS; Coope GR, 2010, QUATERNARY SCI REV, V29, P1507, DOI 10.1016/j.quascirev.2009.12.017; Cordain L, 2001, WORLD REV NUTR DIET, V90, P144; Cordain L, 2000, AM J CLIN NUTR, V71, P682, DOI 10.1093/ajcn/71.3.682; Couplan F, 1984, ENCY PLANTES COMESTI, V2; Crawford MA, 1999, LIPIDS, V34, pS39, DOI 10.1007/BF02562227; Cunnane SC, 2005, AM J CLIN NUTR, V82, P483, DOI 10.1093/ajcn/82.2.483; Cunnane Stephen C., 1993, Nutrition and Health (Bicester), V9, P219; Daujeard C, 2012, QUATERN INT, V252, P32, DOI 10.1016/j.quaint.2011.01.047; Davis J, 1986, STAT DATA ANAL GEOLO; Draper C J, 1951, ARCHAEOLOGICAL NEWSL, V3, P147; EATON SB, 1985, NEW ENGL J MED, V312, P283, DOI 10.1056/NEJM198501313120505; Erlandson JM, 2001, J ARCHAEOL RES, V9, P287, DOI 10.1023/A:1013062712695; Fa JE, 2013, J HUM EVOL, V64, P233, DOI 10.1016/j.jhevol.2013.01.002; Fiorenza L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014769; Gamble Clive, 1999, P396; Godfrey KM, 2007, PEDIATR RES, V61, p5R, DOI 10.1203/pdr.0b013e318045bedb; Godwin H., 1975, HIST BRIT FLORA; Gowlett J.A.J., 2005, P50; Grove M, 2011, J HUM EVOL, V61, P306, DOI 10.1016/j.jhevol.2011.04.005; Harding P, 2012, P GEOLOGIST ASSOC, V123, P584, DOI 10.1016/j.pgeola.2012.03.003; Hardy BL, 2010, QUATERNARY SCI REV, V29, P662, DOI 10.1016/j.quascirev.2009.11.016; Harrison CJO, 1999, BOXGROVE MIDDLE PLEI, P181; Hayden B., 1981, OMNIVOROUS PRIMATES, P344, DOI DOI 10.7312/HARD92188-011; Henry AG, 2011, P NATL ACAD SCI USA, V108, P486, DOI 10.1073/pnas.1016868108; Herries AIR, 2010, AM J PHYS ANTHROPOL, V143, P640, DOI 10.1002/ajpa.21389; Hockett B, 2003, EVOL ANTHROPOL, V12, P211, DOI 10.1002/evan.10116; Hoile SP, 2013, J NUTR BIOCHEM, V24, P1213, DOI 10.1016/j.jnutbio.2012.09.005; HOLLOWAY RL, 1967, GEN SYST, V12, P3; Holmes JA, 2010, QUATERNARY SCI REV, V29, P1515, DOI 10.1016/j.quascirev.2009.02.024; Hosfield R, QUATERNARY HIST PALA; Hosfield R. T., 2001, PALAEOLITHIC ARCHAEO, P85; Hosfield RT, 2011, QUATERNARY EXE ADJOI, P103; Hunn E. S, 1981, J ETHNOBIOLOGY, V1, P124; Hunt R., 1990, ABRIDGED COMP PLANT; Irving B, 1996, EXCAVATIONS BARNFIEL, P145; Johnston B, 2010, INVESTIGATION DISTRI; Kuipers RS, 2012, NUTR RES REV, V25, P96, DOI 10.1017/S0954422412000017; Kuipers RS, 2010, BRIT J NUTR, V104, P1666, DOI 10.1017/S0007114510002679; Laland KN, 2010, J ARCHAEOL METHOD TH, V17, P303, DOI 10.1007/s10816-010-9096-6; Lewin J, 2002, EARTH SURF PROC LAND, V27, P145, DOI 10.1002/esp.306; Lewontin RC, 1983, SCIENTIA, V118, P68; Li D, 2000, ASIA PAC J CLIN NUTR, V9, P18, DOI 10.1046/j.1440-6047.2000.00129.x; Limondin-Lozouet N, 2010, QUATERN INT, V223, P299, DOI 10.1016/j.quaint.2009.10.013; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001071; MAILER CM, 1964, NATURE, V201, P403, DOI 10.1038/201403a0; MAYHEW DF, 1978, PHILOS T ROY SOC B, V281, P407, DOI 10.1098/rstb.1978.0004; McNabb J., 2012, DISSENT MODIFICATION; Mihlbachler MC, 2011, SCIENCE, V331, P1178, DOI 10.1126/science.1196166; Milton K, 2000, AM J CLIN NUTR, V71, P665, DOI 10.1093/ajcn/71.3.665; Navarrete A, 2011, NATURE, V480, P91, DOI 10.1038/nature10629; Niethammer J, 2013, HDB SAUGETIERE EUROP; OBRIEN JS, 1965, J LIPID RES, V6, P537; Owen L. R., 2005, DISTORTING GENDER DI; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Parfitt S.A., 1999, P197; Parfitt SA, 2010, NATURE, V466, P229, DOI 10.1038/nature09117; Penkman KEH, 2011, NATURE, V476, P446, DOI 10.1038/nature10305; Pontzer H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040503; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Potts R, 1996, SCIENCE, V273, P922, DOI 10.1126/science.273.5277.922; Potts R, 2011, NATURE, V480, P43, DOI 10.1038/480043a; Powell A, 2009, SCIENCE, V324, P1298, DOI 10.1126/science.1170165; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Richards MP, 2000, J ARCHAEOL SCI, V27, P1, DOI 10.1006/jasc.1999.0520; Roberts M.B., 1999, 17 ENGL HER; Roberts MB, 1999, BOXGROVE MIDDLE PLEI, P309; Robinson J. E., 1996, EXCAVATIONS SWANSCOM, V94, P187; Roe D, 1968, GAZETTER BRIT LOWER; ROSE J, 1994, TERRA NOVA, V6, P435, DOI 10.1111/j.1365-3121.1994.tb00887.x; Schick K. D., 1993, MAKING SILENT STONES; Schreve DC, 2002, QUATERNARY SCI REV, V21, P1423, DOI 10.1016/S0277-3791(01)00100-7; Schreve DC, 2001, QUATERNARY SCI REV, V20, P1693, DOI 10.1016/S0277-3791(01)00033-6; Schreve DC, 2001, QUATERN INT, V79, P65, DOI 10.1016/S1040-6182(00)00123-3; Scott-Jackson JE, 2008, ALTERNATIVE LOCATION; SHICK KD, 1987, J HUM EVOL, V16, P789, DOI 10.1016/0047-2484(87)90024-8; Smith R. A., 1926, GUIDE ANTIQUITIES ST; SPETH JD, 1983, J ANTHROPOL ARCHAEOL, V2, P1, DOI 10.1016/0278-4165(83)90006-5; Sponheimer M, 1999, SCIENCE, V283, P368, DOI 10.1126/science.283.5400.368; Stemerdink C, 2010, J QUATERNARY SCI, V25, P447, DOI 10.1002/jqs.1375; Stiner MC, 1994, HONOR THEIVES ZOOLOG; Stuart AJ., 1993, LOWER PALEOLITHIC SI, P163; Torres RT, 2011, ECOL RES, V26, P781, DOI 10.1007/s11284-011-0837-0; Tuffreau A, 1995, EARLIEST OCCUPATION, P147; Turner C., 1968, EISZEITALTER GEGENWA, V19, P93; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; Wenban-Smith F., 2000, P PREHIST SOC, V66, P209, DOI DOI 10.1017/S0079497X0000181X; Wenban-Smith FF, 2009, QUATERNARY SOLENT BA, P123; Westaway R, 2011, QUATERNARY EXE VALLE, P27; White M, 2006, J QUATERNARY SCI, V21, P525, DOI 10.1002/jqs.1034; Wilkinson K, 2007, LOWER MIDDLE PALAEOL; Winton V, 2004, BRIT ARCHAEOLOGICAL, V360; Wood B, 1999, NATURE, V400, P219, DOI 10.1038/22227; Wrangham R, 2009, AM J PHYS ANTHROPOL, V140, P630, DOI 10.1002/ajpa.21122; Wymer J.J., 1999, LOWER PALAEOLITHIC O; Wymer J.J., 1993, LOWER PALEOLITHIC SI, P169; Xu G, 2011, QUATERN INT, V281, P10; ZAGWIJN WH, 1978, REV PALAEOBOT PALYNO, V26, P243, DOI 10.1016/0034-6667(78)90014-3	124	16	16	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81476	10.1371/journal.pone.0081476	http://dx.doi.org/10.1371/journal.pone.0081476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339935	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000328707400020
J	Friedjung, AY; Choudhary, SP; Dudai, N; Rachmilevitch, S				Friedjung, Avital Yosef; Choudhary, Sikander Pal; Dudai, Nativ; Rachmilevitch, Shimon			Physiological Conjunction of Allelochemicals and Desert Plants	PLOS ONE			English	Article							ARTEMISIA-HERBA-ALBA; ESSENTIAL OILS; ALLELOPATHY; GERMINATION; GROWTH	Plants exchange signals with other physical and biological entities in their habitat, a form of communication termed allelopathy. The underlying principles of allelopathy and secondary-metabolite production are still poorly understood, especially in desert plants. The coordination and role of secondary metabolites were examined as a cause of allelopathy in plants thriving under arid and semiarid soil conditions. Desert plant species, Origanum dayi, Artemisia sieberi and Artemisia judaica from two different sources (cultivar cuttings and wild seeds) were studied in their natural habitats. Growth rate, relative water content, osmotic potential, photochemical efficiency, volatile composition and vital factors of allelopathy were analyzed at regular intervals along four seasons with winter showing optimum soil water content and summer showing water deficit conditions. A comprehensive analysis of the volatile composition of the leaves, ambient air and soil in the biological niche of the plants under study was carried out to determine the effects of soil water conditions and sample plants on the surrounding flora. Significant morpho-physiological changes were observed across the seasons and along different soil water content. Metabolic analysis showed that water deficit was the key for driving selective metabolomic shifts. A. judaica showed the least metabolic shifts, while A. sieberi showed the highest shifts. All the species exhibited high allelopathic effects; A. judaica displayed relatively higher growth-inhibition effects, while O. dayi showed comparatively higher germination-inhibition effects in germination assays. The current study may help in understanding plant behavior, mechanisms underlying secondary-metabolite production in water deficit conditions and metabolite-physiological interrelationship with allelopathy in desert plants, and can help cull economic benefits from the produced volatiles.	[Friedjung, Avital Yosef; Choudhary, Sikander Pal; Rachmilevitch, Shimon] Ben Gurion Univ Negev, French Associates Inst Agr & Biotechnol Drylands, Jacob Blaustein Inst Desert Res, Midreshet Ben Gurion, Israel; [Dudai, Nativ] Newe Yaar Res Ctr, Unit Med & Aromat Plants, Agr Res Org, Ramat Yishay, Israel; [Choudhary, Sikander Pal] Univ Jammu, Dept Bot, Jammu 180004, India	Ben Gurion University; University of Jammu	Dudai, N (corresponding author), Newe Yaar Res Ctr, Unit Med & Aromat Plants, Agr Res Org, Ramat Yishay, Israel.	nativdud@gmail.com; rshimon@bgu.ac.il	Rachmilevitch, Shimon/F-1329-2012	Rachmilevitch, Shimon/0000-0003-3600-5949; PAL, SIKANDER/0000-0002-3827-466X	Albert Katz International School for Desert Studies	Albert Katz International School for Desert Studies	This work was supported by the Albert Katz International School for Desert Studies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barney JN, 2005, J CHEM ECOL, V31, P247, DOI 10.1007/s10886-005-1339-8; Belz RG, 2007, PEST MANAG SCI, V63, P308, DOI 10.1002/ps.1320; BHOWMIK PC, 1984, AGRON J, V76, P383, DOI 10.2134/agronj1984.00021962007600030008x; Blum U, 2011, PLANT-PLANT ALLELOPATHI INTERACTIONS: PHENOLIC ACIDS, COVER CROPS AND WEED EMERGENCE, P1, DOI 10.1007/978-94-007-0683-5_1; Cheng H. H., 1992, Allelopathy: basic and applied aspects., P21; Chon S.-U., 2013, ALLELOPATHY, P81, DOI [DOI 10.1007/978-3-642-30595-5_, 10.1007/978-3-642-30595-5_5, DOI 10.1007/978-3-642-30595-5_5]; Couso LL, 2012, ANN BOT-LONDON, V110, P849, DOI 10.1093/aob/mcs147; Danin A, 1983, DESERT VEGETATION IS, P98; Dudai N, 1999, J CHEM ECOL, V25, P1079, DOI 10.1023/A:1020881825669; Dudai N, 2003, FLAVOUR FRAG J, V18, P334, DOI 10.1002/ffj.1237; DUDAI N, 1992, PHYSIOL PLANTARUM, V84, P453, DOI 10.1034/j.1399-3054.1992.840320.x; Dudai N, 2009, KOL HAZMACHIM, V10, P25; DUKE SO, 1987, WEED SCI, V35, P499, DOI 10.1017/S0043174500060458; Einhellig FA, 1987, ACS SYM SER, P343; Escudero A, 2000, PLANT ECOL, V148, P71, DOI 10.1023/A:1009848215019; FEUERSTEIN I, 1986, PHYTOCHEMISTRY, V25, P2343, DOI 10.1016/S0031-9422(00)81692-1; Fleisher Z, 2002, J ESSENT OIL RES, V14, P156, DOI 10.1080/10412905.2002.9699809; Hussain M, 2013, ALLELOPATHY, P469; Larkov O, 2005, FLAVOUR FRAG J, V20, P109, DOI 10.1002/ffj.1386; Lorenzo P, 2013, ALLELOPATHY, P3, DOI [10.1007/978-3-642-30595-5_1, DOI 10.1007/978-3-642-30595-51]; Miranda JD, 2011, J ARID ENVIRON, V75, P1302, DOI 10.1016/j.jaridenv.2011.04.022; Mohamed AEHH, 2010, REC NAT PROD, V4, P1; MULLER CH, 1964, SCIENCE, V143, P471, DOI 10.1126/science.143.3605.471; Narwal SS, 2013, ALLELOPATHY, P217, DOI DOI 10.1007/978-3-642-30595-5_10; Poonpaiboonpipat T, 2013, IND CROP PROD, V41, P403, DOI 10.1016/j.indcrop.2012.04.057; Preston CA, 2002, J CHEM ECOL, V28, P2343, DOI 10.1023/A:1021065703276; Qian HF, 2009, CHEMOSPHERE, V75, P368, DOI 10.1016/j.chemosphere.2008.12.040; Rachmilevitch S, 2006, NEW PHYTOL, V170, P479, DOI 10.1111/j.1469-8137.2006.01684.x; Ravid U., 1992, Flavour and Fragrance Journal, V7, P69, DOI 10.1002/ffj.2730070204; Ravid U, 1992, FLAVOUR FRAG J, V7, P235, DOI [10.1002/ffj.2730070413, 10.1002/ffj.2730070511]; Reinhardt CF, 1996, 1 WORLD C ALL CAD SP, P133; Sardans J, 2012, PLANT PHYSIOL, V160, P1741, DOI 10.1104/pp.112.208785; Schulz M, 2013, J CHEM ECOL, V39, P154, DOI 10.1007/s10886-013-0235-x; Smethurst JA, 2012, GEOTECHNIQUE, V62, P429, DOI [10.1680/geot.11.D.097, 10.1680/geot.10.P.097]; Soleiman E, 2010, REC NAT PROD, V4, P1; Teerarak M., 2012, African Journal of Biotechnology, V11, P7850; Thorpe AS, 2011, J ECOL, V99, P729, DOI 10.1111/j.1365-2745.2011.01802.x; Uesugi A, 2013, NEW PHYTOL, V198, P916, DOI 10.1111/nph.12172; Verhoeven AS, 2013, PHYSIOL PLANTARUM, V147, P147, DOI 10.1111/j.1399-3054.2012.01644.x; Weston LA, 2013, J CHEM ECOL, V39, P283, DOI 10.1007/s10886-013-0248-5; Wu H, 2001, BOT REV, V67, P403, DOI 10.1007/BF02858100; Xu MM, 2012, NEW PHYTOL, V193, P570, DOI 10.1111/j.1469-8137.2011.04005.x; Zeng QP, 2011, BIOL PLANTARUM, V55, P669, DOI 10.1007/s10535-011-0166-8	44	12	12	7	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81580	10.1371/journal.pone.0081580	http://dx.doi.org/10.1371/journal.pone.0081580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339945	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400024
J	Legros, M; Xu, CG; Morrison, A; Scott, TW; Lloyd, AL; Gould, F				Legros, Mathieu; Xu, Chonggang; Morrison, Amy; Scott, Thomas W.; Lloyd, Alun L.; Gould, Fred			Modeling the Dynamics of a Non- Limited and a Self-Limited Gene Drive System in Structured Aedes aegypti Populations	PLOS ONE			English	Article							ENGINEERED UNDERDOMINANCE; CULICIDAE PRODUCTION; RNA INTERFERENCE; VIRUS-RESISTANCE; MEIOTIC DRIVE; MOSQUITO; TRANSGENES; DIPTERA; REPLACEMENT; WOLBACHIA	Recently there have been significant advances in research on genetic strategies to control populations of disease-vectoring insects. Some of these strategies use the gene drive properties of selfish genetic elements to spread physically linked anti-pathogen genes into local vector populations. Because of the potential of these selfish elements to spread through populations, control approaches based on these strategies must be carefully evaluated to ensure a balance between the desirable spread of the refractoriness-conferring genetic cargo and the avoidance of potentially unwanted outcomes such as spread to non-target populations. There is also a need to develop better estimates of the economics of such releases. We present here an evaluation of two such strategies using a biologically realistic mathematical model that simulates the resident Aedes aegypti mosquito population of Iquitos, Peru. One strategy uses the selfish element Medea, a non-limited element that could permanently spread over a large geographic area; the other strategy relies on Killer-Rescue genetic constructs, and has been predicted to have limited spatial and temporal spread. We simulate various operational approaches for deploying these genetic strategies, and quantify the optimal number of released transgenic mosquitoes needed to achieve definitive spread of Medea-linked genes and/or high frequencies of Killer-Rescue-associated elements. We show that for both strategies the most efficient approach for achieving spread of anti-pathogen genes within three years is generally to release adults of both sexes in multiple releases over time. Even though females in these releases should not transmit disease, there could be public concern over such releases, making the less efficient male-only release more practical. This study provides guidelines for operational approaches to population replacement genetic strategies, as well as illustrates the use of detailed spatial models to assist in safe and efficient implementation of such novel genetic strategies.	[Legros, Mathieu; Xu, Chonggang; Gould, Fred] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Legros, Mathieu; Morrison, Amy; Scott, Thomas W.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Legros, Mathieu] ETH, Inst Integrat Biol, Zurich, Switzerland; [Xu, Chonggang] Los Alamos Natl Lab, Div Earth & Environm Sci, Los Alamos, NM 87545 USA; [Morrison, Amy; Scott, Thomas W.; Lloyd, Alun L.; Gould, Fred] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Lloyd, Alun L.] N Carolina State Univ, Dept Math, Raleigh, NC 27695 USA; [Lloyd, Alun L.] N Carolina State Univ, Biomath Grad Program, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of California System; University of California Davis; Swiss Federal Institutes of Technology Domain; ETH Zurich; United States Department of Energy (DOE); Los Alamos National Laboratory; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Legros, M (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	legros.mathieu@gmail.com	Morrison, Amy/AAU-6511-2020; Lloyd, Alun/AAN-6639-2020; Lloyd, Alun L/H-4944-2012; Legros, Mathieu/E-6767-2011	Lloyd, Alun/0000-0002-6389-6321; Legros, Mathieu/0000-0003-3807-8594; Xu, Chonggang/0000-0002-0937-5744; Morrison, Amy/0000-0001-6224-5984	National Institutes of Health [R01-AI54954-0IA2]; Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091980, R01AI054954] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant R01-AI54954-0IA2, and through the Regents of the University of California from the Foundation for the National Institutes of Health Grand Challenges in Global Health initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; BEEMAN RW, 1992, SCIENCE, V256, P89, DOI 10.1126/science.1566060; Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319; Chen CH, 2007, SCIENCE, V316, P597, DOI [10.1126/science. 1138595, 10.1126/science.1138595]; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357; Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037; Franz AWE, 2009, INSECT MOL BIOL, V18, P661, DOI 10.1111/j.1365-2583.2009.00908.x; Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103; GILPIN ME, 1979, FORTS ZOOL, V25, P355; Gould F, 2006, AM SCI, V94, P238, DOI 10.1511/2006.3.238; Gould F, 2008, P ROY SOC B-BIOL SCI, V275, P2823, DOI 10.1098/rspb.2008.0846; Gubler DJ, 1997, DENGUE DENGUE HEMORR; Heinrich JC, 2000, P NATL ACAD SCI USA, V97, P8229, DOI 10.1073/pnas.140142697; Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356; Huang YX, 2007, EVOLUTION, V61, P717, DOI 10.1111/j.1558-5646.2007.00075.x; James AA, 2005, TRENDS PARASITOL, V21, P64, DOI 10.1016/j.pt.2004.11.004; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Legros M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052235; Legros M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022701; Magori K, 2006, GENETICS, V172, P2613, DOI 10.1534/genetics.105.051789; Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508; Mori A, 2004, J MED ENTOMOL, V41, P1027, DOI 10.1603/0022-2585-41.6.1027; Morrison AC, 2006, ANN TROP MED PARASIT, V100, pS73, DOI 10.1179/136485906X105534; Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123; Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068; PAA S, 2010, CREATING STRAIN DROS; SCOTT TW, 2008, LONGITUDINAL FIELD S, P132; SHARPE PJH, 1977, J THEOR BIOL, V64, P649, DOI 10.1016/0022-5193(77)90265-X; Sinkins SP, 2004, P ROY SOC B-BIOL SCI, V271, P1421, DOI 10.1098/rspb.2004.2740; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Travanty EA, 2004, INSECT BIOCHEM MOLEC, V34, P607, DOI 10.1016/j.ibmb.2004.03.013; Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x; WADE MJ, 1994, GENETICS, V138, P1309; Ward CM, 2011, EVOLUTION, V65, P1149, DOI 10.1111/j.1558-5646.2010.01186.x	36	13	13	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83354	10.1371/journal.pone.0083354	http://dx.doi.org/10.1371/journal.pone.0083354			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340097	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400130
J	Yeo, D; Kiparissides, A; Cha, JM; Aguilar-Gallardo, C; Polak, JM; Tsiridis, E; Pistikopoulos, EN; Mantalaris, A				Yeo, David; Kiparissides, Alexandros; Cha, Jae Min; Aguilar-Gallardo, Cristobal; Polak, Julia M.; Tsiridis, Elefterios; Pistikopoulos, Efstratios N.; Mantalaris, Athanasios			Improving Embryonic Stem Cell Expansion through the Combination of Perfusion and Bioprocess Model Design	PLOS ONE			English	Article							SELF-RENEWAL; DIFFERENTIATION; METABOLISM; DERIVATION; GROWTH; LIF; ENCAPSULATION; PLURIPOTENCY; EQUILIBRIUM; CULTURES	Background: High proliferative and differentiation capacity renders embryonic stem cells (ESCs) a promising cell source for tissue engineering and cell-based therapies. Harnessing their potential, however, requires well-designed, efficient and reproducible expansion and differentiation protocols as well as avoiding hazardous by-products, such as teratoma formation. Traditional, standard culture methodologies are fragmented and limited in their fed-batch feeding strategies that afford a sub-optimal environment for cellular metabolism. Herein, we investigate the impact of metabolic stress as a result of inefficient feeding utilizing a novel perfusion bioreactor and a mathematical model to achieve bioprocess improvement. Methodology/Principal Findings: To characterize nutritional requirements, the expansion of undifferentiated murine ESCs (mESCs) encapsulated in hydrogels was performed in batch and perfusion cultures using bioreactors. Despite sufficient nutrient and growth factor provision, the accumulation of inhibitory metabolites resulted in the unscheduled differentiation of mESCs and a decline in their cell numbers in the batch cultures. In contrast, perfusion cultures maintained metabolite concentration below toxic levels, resulting in the robust expansion (> 16-fold) of high quality 'naive' mESCs within 4 days. A multi-scale mathematical model describing population segregated growth kinetics, metabolism and the expression of selected pluripotency (stemness) genes was implemented to maximize information from available experimental data. A global sensitivity analysis (GSA) was employed that identified significant (6/29) model parameters and enabled model validation. Predicting the preferential propagation of undifferentiated ESCs in perfusion culture conditions demonstrates synchrony between theory and experiment. Conclusions/Significance: The limitations of batch culture highlight the importance of cellular metabolism in maintaining pluripotency, which necessitates the design of suitable ESC bioprocesses. We propose a novel investigational framework that integrates a novel perfusion culture platform (controlled metabolic conditions) with mathematical modeling (information maximization) to enhance ESC bioprocess productivity and facilitate bioprocess optimization.	[Tsiridis, Elefterios] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London, England; [Yeo, David; Kiparissides, Alexandros; Cha, Jae Min; Aguilar-Gallardo, Cristobal; Polak, Julia M.; Pistikopoulos, Efstratios N.; Mantalaris, Athanasios] Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England	Imperial College London; Imperial College London	Mantalaris, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Chem Engn, London SW7 2AZ, England.	a.mantalaris@imperial.ac.uk	Kiparissides, Alexandros/N-4970-2014; Aguilar-Gallardo, Cristobal/I-1841-2017; Kiparissides, Alexandros/ABH-5729-2020	Kiparissides, Alexandros/0000-0003-2923-2481; Aguilar-Gallardo, Cristobal/0000-0002-1594-3648; Kiparissides, Alexandros/0000-0003-2923-2481; Tsiridis, Eleftherios/0000-0001-8278-1653; Pistikopoulos, Stratos/0000-0001-6220-818X	Rosetrees Trust	Rosetrees Trust(Rosetrees Trust)	The authors wish to acknowledge support from the Rosetrees Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches E, 2007, BIOTECHNOL BIOENG, V96, P1211, DOI 10.1002/bit.21191; Blin G, 2010, BIOMATERIALS, V31, P1742, DOI 10.1016/j.biomaterials.2009.11.055; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chaudhry MA, 2009, BIOCHEM ENG J, V45, P126, DOI 10.1016/j.bej.2009.03.005; Chen XL, 2010, STEM CELLS DEV, V19, P1781, DOI 10.1089/scd.2010.0077; Chowdhury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015655; Csaszar E, 2012, CELL STEM CELL, V10, P218, DOI 10.1016/j.stem.2012.01.003; Davey RE, 2007, FASEB J, V21, P2020, DOI 10.1096/fj.06-7852com; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Discher DE, 2009, SCIENCE, V324, P1673, DOI 10.1126/science.1171643; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Ernst M, 1996, J BIOL CHEM, V271, P30136, DOI 10.1074/jbc.271.47.30136; Fauzi I, 2012, STEM CELLS DEV, V21, P3152, DOI 10.1089/scd.2012.0030; Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031; Fluri DA, 2012, NAT METHODS, V9, P509, DOI [10.1038/NMETH.1939, 10.1038/nmeth.1939]; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; HILTON DJ, 1992, J BIOL CHEM, V267, P10238; Hwang YS, 2009, BIOMATERIALS, V30, P499, DOI 10.1016/j.biomaterials.2008.07.028; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kiparissides A, 2011, AUTOMATICA, V47, P1147, DOI 10.1016/j.automatica.2011.01.013; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Leung HW, 2011, TISSUE ENG PART C-ME, V17, P165, DOI 10.1089/ten.TEC.2010.0320; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mager DE, 2005, PHARM RES-DORDR, V22, P1589, DOI 10.1007/s11095-005-6650-0; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Onishi K, 2012, INTEGR BIOL-UK, V4, P1367, DOI 10.1039/c2ib20098h; Ouyang A, 2007, STEM CELLS, V25, P447, DOI 10.1634/stemcells.2006-0322; Ozturk SS, 1997, BIOTECHNOL BIOENG, V53, P372, DOI 10.1002/(SICI)1097-0290(19970220)53:4<372::AID-BIT3>3.0.CO;2-K; OZTURK SS, 1990, BIOTECHNOL PROGR, V6, P121, DOI 10.1021/bp00002a005; OZTURK SS, 1992, BIOTECHNOL BIOENG, V39, P418, DOI 10.1002/bit.260390408; Panopoulos AD, 2012, CELL RES, V22, P168, DOI 10.1038/cr.2011.177; Pelton TA, 2002, J CELL SCI, V115, P329; Placzek MR, 2009, J R SOC INTERFACE, V6, P209, DOI 10.1098/rsif.2008.0442; Randle WL, 2007, TISSUE ENG, V13, P2957, DOI 10.1089/ten.2007.0072; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Shafa M, 2012, NAT METHODS, V9, P465, DOI [10.1038/NMETH.1973, 10.1038/nmeth.1973]; Siti-Ismail N, 2008, BIOMATERIALS, V29, P3946, DOI 10.1016/j.biomaterials.2008.04.027; Suzuki S, 2000, J INVEST DERMATOL, V114, P456, DOI 10.1046/j.1523-1747.2000.00912.x; Taiani JT, 2010, STEM CELLS DEV, V19, P989, DOI 10.1089/scd.2009.0297; Thomson H, 2007, TRENDS BIOTECHNOL, V25, P224, DOI 10.1016/j.tibtech.2007.03.003; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Viswanathan S, 2002, STEM CELLS, V20, P119, DOI 10.1634/stemcells.20-2-119; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Washington JM, 2010, AM J PHYSIOL-CELL PH, V298, pC982, DOI 10.1152/ajpcell.00498.2009; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yanes O, 2010, NAT CHEM BIOL, V6, P411, DOI 10.1038/nchembio.364; Yeo D, 2012, J TISSUE ENG REGEN M, V6, P253; Yeo D, 2011, COMPUT-AIDED CHEM EN, V29, P1326; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhou WC, 1997, CYTOTECHNOLOGY, V24, P99, DOI 10.1023/A:1007945826228; Zwi-Dantsis L, 2011, TISSUE ENG A	57	22	22	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81728	10.1371/journal.pone.0081728	http://dx.doi.org/10.1371/journal.pone.0081728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339957	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400033
J	Ashcroft, KJ; Syed, F; Bayat, A				Ashcroft, Kevin J.; Syed, Farhatullah; Bayat, Ardeshir			Site-Specific Keloid Fibroblasts Alter the Behaviour of Normal Skin and Normal Scar Fibroblasts through Paracrine Signalling	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; COLLAGEN GENE-EXPRESSION; CONNECTIVE-TISSUE; FACTOR-BETA; UP-REGULATION; HYPERTROPHIC SCAR; FACTOR CTGF; IN-VITRO; PATHWAY	Keloid disease (KD) is an abnormal cutaneous fibroproliferative disorder of unknown aetiopathogenesis. Keloid fibroblasts (KF) are implicated as mediators of elevated extracellular matrix deposition. Aberrant secretory behaviour by KF relative to normal skin fibroblasts (NF) may influence the disease state. To date, no previous reports exist on the ability of site-specific KF to induce fibrotic-like phenotypic changes in NF or normal scar fibroblasts (NS) by paracrine mechanisms. Therefore, the aim of this study was to investigate the influence of conditioned media from site-specific KF on the cellular and molecular behaviour of both NF and NS enabled by paracrine mechanisms. Conditioned media was collected from cultured primary fibroblasts during a proliferative log phase of growth including: NF, NS, peri-lesional keloid fibroblasts (PKF) and intralesional keloid fibroblasts (IKF). Conditioned media was used to grow NF, NS, PKF and IKF cells over 240 hrs. Cellular behavior was monitored through real time cell analysis (RTCA), proliferation rates and migration in a scratch wound assay. Fibrosis-associated marker expression was determined at both protein and gene level. PKF conditioned media treatment of both NF and NS elicited enhanced cell proliferation, spreading and viability as measured in real time over 240 hrs versus control conditioned media. Following PKF and IKF media treatments up to 240 hrs, both NF and NS showed significantly elevated proliferation rates (p<0.03) and migration in a scratch wound assay (p<0.04). Concomitant up-regulation of collagen I, fibronectin, alpha-SMA, PAI-1, TGF-beta and CTGF (p<0.03) protein expression were also observed. Corresponding qRT-PCR analysis supported these findings (P<0.03). In all cases, conditioned media from growing marginal PKF elicited the strongest effects. In conclusion, primary NF and NS cells treated with PKF or IKF conditioned media exhibit enhanced expression of fibrosis-associated molecular markers and increased cellular activity as a result of keloid fibroblast-derived paracrine factors.	[Ashcroft, Kevin J.; Syed, Farhatullah; Bayat, Ardeshir] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Ashcroft, Kevin J.; Syed, Farhatullah; Bayat, Ardeshir] Univ Manchester, Inst Inflammat & Repair, Manchester, Lancs, England; [Bayat, Ardeshir] Univ Hosp South Manchester Fdn Trust, Wythenshawe Hosp, Dept Plast & Reconstruct Surg, Manchester, Lancs, England; [Bayat, Ardeshir] Univ Manchester, Wythenshawe Hosp, Manchester Acad Hlth Sci Ctr, Univ Hosp South Manchester Fdn Trust, Manchester, Lancs, England	University of Manchester; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Bayat, A (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	Ardeshir.bayat@manchester.ac.uk		BAYAT, ARDESHIR/0000-0002-4116-6491	NIHR; GAT family foundation	NIHR(National Institute for Health Research (NIHR)); GAT family foundation	This study was supported in part by grants from NIHR to AB. In addition, we specially thank the GAT family foundation for their generous funding and support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERGEL RP, 1985, J INVEST DERMATOL, V84, P384, DOI 10.1111/1523-1747.ep12265471; ALAISH SM, 1995, J PEDIATR SURG, V30, P949, DOI 10.1016/0022-3468(95)90319-4; BABU M, 1992, J INVEST DERMATOL, V99, P650, DOI 10.1111/1523-1747.ep12668146; BABU M, 1989, MOL CELL BIOL, V9, P1642, DOI 10.1128/MCB.9.4.1642; Bagabir R, 2012, EXP DERMATOL, V21, P376, DOI 10.1111/j.1600-0625.2012.01476.x; Bagabir RA, 2011, J INVEST DERMATOL, V131, P2128, DOI 10.1038/jid.2011.163; Clark RAF, 1997, J CELL PHYSIOL, V170, P69; Daian T, 2003, J INVEST DERMATOL, V120, P956, DOI 10.1046/j.1523-1747.2003.12143.x; Duncan MR, 1999, FASEB J, V13, P1774, DOI 10.1096/fasebj.13.13.1774; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; FRIEDMAN DW, 1993, J SURG RES, V55, P214, DOI 10.1006/jsre.1993.1132; Fujiwara M, 2005, ARCH DERMATOL RES, V297, P161, DOI 10.1007/s00403-005-0596-2; Ghazizadeh M, 2007, J INVEST DERMATOL, V127, P98, DOI 10.1038/sj.jid.5700564; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; Hanasono Matthew M, 2003, Arch Facial Plast Surg, V5, P26; He S, 2010, BRIT J DERMATOL, V162, P538, DOI 10.1111/j.1365-2133.2009.09511.x; Higgins PJ, 1999, EXP CELL RES, V248, P634, DOI 10.1006/excr.1999.4466; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Khoo YT, 2006, J CELL PHYSIOL, V208, P336, DOI 10.1002/jcp.20668; Koskela A, 2010, WOUND REPAIR REGEN, V18, P452, DOI 10.1111/j.1524-475X.2010.00605.x; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Lim CP, 2009, J INVEST DERMATOL, V129, P851, DOI 10.1038/jid.2008.337; Lim IJ, 2002, AM J PHYSIOL-CELL PH, V283, pC212, DOI 10.1152/ajpcell.00555.2001; Luo SK, 2001, PLAST RECONSTR SURG, V107, P87, DOI 10.1097/00006534-200101000-00014; Mukhopadhyay A, 2005, BRIT J DERMATOL, V152, P639, DOI 10.1111/j.1365-2133.2005.06545.x; Nirodi CS, 2000, WOUND REPAIR REGEN, V8, P371, DOI 10.1046/j.1524-475x.2000.00371.x; Park G, 2008, J INVEST DERMATOL, V128, P2429, DOI 10.1038/jid.2008.103; Pedroja BS, 2009, J BIOL CHEM, V284, P20708, DOI 10.1074/jbc.M109.018804; PELTONEN J, 1991, J INVEST DERMATOL, V97, P240, DOI 10.1111/1523-1747.ep12480289; Peura M, 2010, J BIOMED MATER RES A, V95A, P658, DOI 10.1002/jbm.a.32881; Robles DT, 2007, CLIN DERMATOL, V25, P26, DOI 10.1016/j.clindermatol.2006.09.009; Russell SB, 2010, J INVEST DERMATOL, V130, P2489, DOI 10.1038/jid.2010.162; Satish L, 2006, WOUND REPAIR REGEN, V14, P463, DOI 10.1111/j.1743-6109.2006.00135.x; Seifert O, 2008, WOUND REPAIR REGEN, V16, P254, DOI 10.1111/j.1524-475X.2007.00343.x; Shi-Wen X, 2000, EXP CELL RES, V259, P213, DOI 10.1006/excr.2000.4972; Shih Barbara, 2010, Eplasty, V10, pe24; Shih B, 2010, WOUND REPAIR REGEN, V18, P139, DOI 10.1111/j.1524-475X.2009.00553.x; Smith JC, 2008, J INVEST DERMATOL, V128, P1298, DOI 10.1038/sj.jid.5701149; Steffen CL, 1998, GROWTH FACTORS, V15, P199, DOI 10.3109/08977199809002117; Syed F, 2011, BRIT J DERMATOL, V164, P83, DOI 10.1111/j.1365-2133.2010.10048.x; Syed F, 2013, J INVEST DERMATOL, V133, P1340, DOI 10.1038/jid.2012.483; Syed F, 2012, AM J PATHOL, V181, P1642, DOI 10.1016/j.ajpath.2012.08.006; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430; Tuan TL, 2008, AM J PATHOL, V173, P1311, DOI 10.2353/ajpath.2008.080272; Tuan TL, 1996, J INVEST DERMATOL, V106, P1007, DOI 10.1111/1523-1747.ep12338552; Twigg SM, 2002, ENDOCRINOLOGY, V143, P1260, DOI 10.1210/en.143.4.1260; UITTO J, 1985, P NATL ACAD SCI USA, V82, P5935, DOI 10.1073/pnas.82.17.5935; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Xue H, 2000, J SURG RES, V89, P74, DOI 10.1006/jsre.1999.5805; YOUNAI S, 1994, ANN PLAS SURG, V33, P148, DOI 10.1097/00000637-199408000-00005; Yu HY, 2006, J PLAST RECONSTR AES, V59, P221, DOI 10.1016/j.bjps.2005.06.010	53	60	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e75600	10.1371/journal.pone.0075600	http://dx.doi.org/10.1371/journal.pone.0075600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24348987	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200003
J	Lloyd, DA; Abrahamyan, A; Harris, JA				Lloyd, David A.; Abrahamyan, Arman; Harris, Justin A.			Brain-Stimulation Induced Blindsight: Unconscious Vision or Response Bias?	PLOS ONE			English	Article							STRIATE CORTEX; AREA MT; ABSENCE; V1	A dissociation between visual awareness and visual discrimination is referred to as "blindsight". Blindsight results from loss of function of the primary visual cortex (V1) which can occur due to cerebrovascular accidents (i.e. stroke-related lesions). There are also numerous reports of similar, though reversible, effects on vision induced by transcranial Magnetic Stimulation (TMS) to early visual cortex. These effects point to V1 as the "gate" of visual awareness and have strong implications for understanding the neurological underpinnings of consciousness. It has been argued that evidence for the dissociation between awareness of, and responses to, visual stimuli can be a measurement artifact of the use of a high response criterion under yes-no measures of visual awareness when compared with the criterion free forced-choice responses. This difference between yes-no and forced-choice measures suggests that evidence for a dissociation may actually be normal near-threshold conscious vision. Here we describe three experiments that tested visual performance in normal subjects when their visual awareness was suppressed by applying TMS to the occipital pole. The nature of subjects' performance whilst undergoing occipital TMS was then verified by use of a psychophysical measure (d') that is independent of response criteria. This showed that there was no genuine dissociation in visual sensitivity measured by yes-no and forced-choice responses. These results highlight that evidence for visual sensitivity in the absence of awareness must be analysed using a bias-free psychophysical measure, such as d', In order to confirm whether or not visual performance is truly unconscious.	[Lloyd, David A.; Abrahamyan, Arman; Harris, Justin A.] Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia	University of Sydney	Lloyd, DA (corresponding author), Univ Sydney, Sch Psychol, Sydney, NSW 2006, Australia.	dllo2792@uni.sydney.edu.au		Harris, Justin/0000-0003-3865-8097	Australian Research Council [DP0986137]	Australian Research Council(Australian Research Council)	This research was funded by the Australian Research Council Grant DP0986137. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamyan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022342; Alexander I, 2010, CONSCIOUS COGN, V19, P520, DOI 10.1016/j.concog.2010.01.008; Azzopardi P, 1998, CONSCIOUS COGN, V7, P292, DOI 10.1006/ccog.1998.0358; Azzopardi P, 1997, P NATL ACAD SCI USA, V94, P14190, DOI 10.1073/pnas.94.25.14190; BARBUR JL, 1980, BRAIN, V103, P905, DOI 10.1093/brain/103.4.905; BLYTHE IM, 1987, BRAIN, V110, P887, DOI 10.1093/brain/110.4.887; Boyer JL, 2005, P NATL ACAD SCI USA, V102, P16875, DOI 10.1073/pnas.0505332102; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMPION J, 1983, BEHAV BRAIN SCI, V6, P423, DOI 10.1017/S0140525X00016861; Christensen MS, 2008, P NATL ACAD SCI USA, V105, P1353, DOI 10.1073/pnas.0705858105; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; GROSS CG, 1991, NEUROPSYCHOLOGIA, V29, P497, DOI 10.1016/0028-3932(91)90007-U; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; HOLMES G, 1945, PROC R SOC SER B-BIO, V132, P348, DOI 10.1098/rspb.1945.0002; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Ko Y, 2012, PHILOS T R SOC B, V367, P1401, DOI 10.1098/rstb.2011.0380; Kontsevich LL, 1999, VISION RES, V39, P2729, DOI 10.1016/S0042-6989(98)00285-5; Lamme VAF, 2006, TRENDS COGN SCI, V10, P193, DOI 10.1016/j.tics.2006.03.002; McNicol D., 1972, PRIMER SIGNAL DETECT; Milner A. D., 1995, VISUAL BRAIN ACTION; Morgan MJ, 1997, NATURE, V385, P401, DOI 10.1038/385401b0; Overgaard M, 2004, J CONSCIOUSNESS STUD, V11, P77; Overgaard M, 2004, BRAIN COGNITION, V54, P58, DOI 10.1016/S0278-2626(03)00260-4; Overgaard M, 2012, PHILOS T R SOC B, V367, P1287, DOI 10.1098/rstb.2011.0425; Overgaard M, 2011, EXP BRAIN RES, V209, P473, DOI 10.1007/s00221-011-2578-2; Overgaard M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003028; Persaud N, 2008, CONSCIOUS COGN, V17, P1046, DOI 10.1016/j.concog.2007.10.001; Pinker Steven, 2007, Time, V169, P58; POPPEL E, 1973, NATURE, V243, P295, DOI 10.1038/243295a0; Radoeva PD, 2008, J COGNITIVE NEUROSCI, V20, P1927, DOI 10.1162/jocn.2008.20139; Ramsoy T.Z., 2004, PHENOMENOL COGNIT SC, V3, P1, DOI [10.1023/b:phen.0000041900.30172.e8, DOI 10.1023/B:PHEN.0000041900.30172.E8, 10.1023/B:PHEN.0000041900.30172.e8]; Ro T, 2004, P NATL ACAD SCI USA, V101, P9933, DOI 10.1073/pnas.0403061101; RODMAN HR, 1989, J NEUROSCI, V9, P2033; SANDERS MD, 1974, LANCET, V1, P707; Schiller PH, 2001, PROG BRAIN RES, V134, P127; Stoerig P, 2010, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.074.2009; Trevethan CT, 2007, NEUROPSYCHOLOGIA, V45, P2092, DOI 10.1016/j.neuropsychologia.2007.01.022; Weiskrantz L., 1986, BLINDSIGHT CASE STUD; Weiskrantz L, 2009, EXP BRAIN RES, V192, P413, DOI 10.1007/s00221-008-1388-7	39	24	24	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82828	10.1371/journal.pone.0082828	http://dx.doi.org/10.1371/journal.pone.0082828			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WJ	24324837	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566700116
J	Forty, EJ; Ashton, N				Forty, Ellen J.; Ashton, Nick			The Urotensin System Is Up-Regulated in the Pre-Hypertensive Spontaneously Hypertensive Rat	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PHARMACOLOGICAL CHARACTERIZATION; ANGIOTENSIN-II; BLOOD-PRESSURE; IDENTIFICATION; IMPAIRMENT	Urotensin II (UII) concentrations are raised both in humans with hypertension and in spontaneously hypertensive rats (SHR). Since the urotensin system acts to regulate glomerular filtration in the kidney it may play a greater role in the pre-hypertensive SHR in which renal dysfunction is known to precede the onset of severe hypertension. This study aimed to determine the renal actions and expression of the urotensin system in the young SHR. Intravenous rat UII (6 pmol. min(-1). 100 g body weight(-1)) had no significant effect on GFR; however urotensin-related peptide (URP) reduced GFR (P<0.05) in 4-5 week old SHR. Administration of the UT antagonist SB-706375 evoked marked increases in GFR (baseline 0.38 +/- 0.07 vs antagonist 0.76 +/- 0.05 ml. min(-1). 100 g body weight(-1), P<0.05), urine flow and sodium excretion (baseline 2.5 +/- 0.4 vs antagonist 9.1 +/- 2.1 mu mol. min(-1). 100 g body weight(-1), P<0.05) in the SHR. Normotensive Wistar-Kyoto rats showed little response to UT antagonism. Quantitative RT-PCR showed that neither UII nor UT mRNA expression differed between the kidneys of young SHR and WKY rats; however expression of URP was 4-fold higher in the SHR kidney. Renal transcriptional up-regulation indicates that URP is the major UT ligand in young SHR and WKY rats. Enhanced tonic UT activation may contribute to known renal dysfunction in pre-hypertensive SHR.	[Forty, Ellen J.; Ashton, Nick] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Ashton, N (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	nick.ashton@manchester.ac.uk		Ashton, Nick/0000-0003-3366-1617	Capacity Building Award in Integrative Mammalian Biology; BBSRC; BPS; HEFCE; KTN; MRC	Capacity Building Award in Integrative Mammalian Biology; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BPS; HEFCE(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); KTN; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	These studies were supported by a Capacity Building Award in Integrative Mammalian Biology funded by the BBSRC, BPS, HEFCE, KTN and MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Razik AES, 2008, J ENDOCRINOL, V198, P617, DOI 10.1677/JOE-08-0260; Abdel-Razik AES, 2008, AM J PHYSIOL-RENAL, V295, pF1239, DOI 10.1152/ajprenal.90374.2008; BEIERWALTES WH, 1982, HYPERTENSION, V4, P908, DOI 10.1161/01.HYP.4.6.908; Chatenet D, 2013, BRIT J PHARMACOL, V168, P807, DOI 10.1111/j.1476-5381.2012.02217.x; Cheung BMY, 2004, J HYPERTENS, V22, P1341, DOI 10.1097/01.hjh.0000125452.28861.f1; Disa J, 2006, PEPTIDES, V27, P1532, DOI 10.1016/j.peptides.2005.10.004; Douglas SA, 2005, BRIT J PHARMACOL, V145, P620, DOI 10.1038/sj.bjp.0706229; Douglas SA, 2004, TRENDS PHARMACOL SCI, V25, P76, DOI 10.1016/j.tips.2003.12.005; Elshourbagy NA, 2002, BRIT J PHARMACOL, V136, P9, DOI 10.1038/sj.bjp.0704671; Forty EJ, 2012, EXP PHYSIOL, V97, P785, DOI 10.1113/expphysiol.2011.063172; Gendron G, 2004, CLIN EXP HYPERTENS, V26, P511, DOI 10.1081/CEH-200031826; Gouldsborough I, 2001, CLIN EXP PHARMACOL P, V28, P504, DOI 10.1046/j.1440-1681.2001.03480.x; HARRAP SB, 1986, CLIN EXP PHARMACOL P, V13, P753, DOI 10.1111/j.1440-1681.1986.tb02379.x; KOPF D, 1993, AM J PHYSIOL, V265, pF104, DOI 10.1152/ajprenal.1993.265.1.F104; Matsushita M, 2001, J HYPERTENS, V19, P2185, DOI 10.1097/00004872-200112000-00011; Mosenkis A, 2011, NEPHROL DIAL TRANSPL, V26, P609, DOI 10.1093/ndt/gfq416; RETTIG R, 1991, KLIN WOCHENSCHR, V69, P597, DOI 10.1007/BF01649322; ROMAN RJ, 1987, HYPERTENSION, V9, P130; Shi Y, 2008, PEPTIDES, V29, P783, DOI 10.1016/j.peptides.2008.02.015; Song W, 2006, KIDNEY INT, V69, P1360, DOI 10.1038/sj.ki.5000290; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Suguro T, 2007, AM J HYPERTENS, V20, P211, DOI 10.1016/j.amjhyper.2006.08.001; Thompson JP, 2003, ANESTH ANALG, V97, P1501, DOI 10.1213/01.ANE.0000086723.97421.BC; UYEHARA CFT, 1993, AM J PHYSIOL, V265, pR943, DOI 10.1152/ajpregu.1993.265.4.R943; VYAS SJ, 1995, J PHARMACOL EXP THER, V273, P768; Winter MJ, 1999, GEN COMP ENDOCR, V114, P249, DOI 10.1006/gcen.1998.7245; Yi L, 2006, J INT MED RES, V34, P272, DOI 10.1177/147323000603400306; Zoccali C, 2006, KIDNEY INT, V69, P1253, DOI 10.1038/sj.ki.5000114; Zoccali C, 2008, HYPERTENSION, V51, P326, DOI 10.1161/HYPERTENSIONAHA.107.101188	29	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e83317	10.1371/journal.pone.0083317	http://dx.doi.org/10.1371/journal.pone.0083317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340095	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100135
J	Rosa, BV; Blair, HT; Vickers, MH; Dittmer, KE; Morel, PCH; Knight, CG; Firth, EC				Rosa, Brielle V.; Blair, Hugh T.; Vickers, Mark H.; Dittmer, Keren E.; Morel, Patrick C. H.; Knight, Cameron G.; Firth, Elwyn C.			Moderate Exercise during Pregnancy in Wistar Rats Alters Bone and Body Composition of the Adult Offspring in a Sex-Dependent Manner	PLOS ONE			English	Article							PHYSIOLOGICAL STRESS-RESPONSE; MATERNAL EXERCISE; FETOPLACENTAL GROWTH; VOLUNTARY EXERCISE; HYPERCALORIC NUTRITION; DEVELOPMENTAL ORIGINS; GLUCOSE-METABOLISM; ENERGY-METABOLISM; REGULAR EXERCISE; GENE-EXPRESSION	Exercise during pregnancy may have long-lasting effects on offspring health. Musculoskeletal growth and development, metabolism, and later-life disease risk can all be impacted by the maternal environment during pregnancy. The skeleton influences glucose handling through the actions of the bone-derived hormone osteocalcin. The purpose of this study was to test the effects of moderate maternal exercise during pregnancy on the bone and body composition of the offspring in adult life, and to investigate the role of osteocalcin in these effects. Groups of pregnant Wistar rats either performed bipedal standing exercise to obtain food/water throughout gestation but not lactation, or were fed conventionally. Litters were reduced to 8/dam and pups were raised to maturity under control conditions. Whole body dual-energy x-ray absorptiometry, and ex vivo peripheral quantitative computed tomography scans of the right tibia were performed. At study termination blood and tissue samples were collected. Serum concentrations of fully and undercarboxylated osteocalcin were measured, and the relative expression levels of osteocalcin, insulin receptor, Forkhead box transcription factor O1, and osteotesticular protein tyrosine phosphatase mRNA were quantified. Body mass did not differ between the offspring of exercised and control dams, but the male offspring of exercised dams had a greater % fat and lower % lean than controls (p=0.001 and p=0.0008, respectively). At the mid-tibial diaphysis, offspring of exercised dams had a lower volumetric bone mineral density than controls (p=0.01) and in the male offspring of exercised dams the bone: muscle relationship was fundamentally altered. Serum concentrations of undercarboxylated osteocalcin were significantly greater in the male offspring of exercised dams than in controls (p=0.02); however, the relative expression of the measured genes did not differ between groups. These results suggest that moderate exercise during pregnancy can result in lasting changes to the musculoskeletal system and adiposity in offspring, in a sex-specific manner.	[Rosa, Brielle V.; Blair, Hugh T.; Firth, Elwyn C.] Massey Univ, GRAVIDA Natl Ctr Growth & Dev, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Vickers, Mark H.] Univ Auckland, Liggins Inst, GRAVIDA Natl Ctr Growth & Dev, Auckland 1, New Zealand; [Dittmer, Keren E.; Morel, Patrick C. H.] Massey Univ, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand; [Knight, Cameron G.] Univ Calgary, Dept Ecosyst & Publ Hlth, Fac Vet Med, Calgary, AB, Canada	Massey University; University of Auckland; Massey University; University of Calgary	Rosa, BV (corresponding author), Massey Univ, GRAVIDA Natl Ctr Growth & Dev, Inst Vet Anim & Biomed Sci, Palmerston North, New Zealand.	B.V.Rosa@massey.ac.nz	Blair, Hugh/C-5569-2014; Dittmer, Keren/AAR-3148-2021	Blair, Hugh/0000-0003-4415-4282; Dittmer, Keren/0000-0002-1813-2197; Vickers, Mark/0000-0003-4876-9356	Gravida: National Research Centre for Growth and Development, New Zealand; Institute of Veterinary, Animal and Biomedical Sciences Postgraduate Research Fund, Massey University, New Zealand	Gravida: National Research Centre for Growth and Development, New Zealand; Institute of Veterinary, Animal and Biomedical Sciences Postgraduate Research Fund, Massey University, New Zealand	This study was supported by Gravida: National Research Centre for Growth and Development, New Zealand (www.gravida.org.nz) and by the Institute of Veterinary, Animal and Biomedical Sciences Postgraduate Research Fund, Massey University, New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan MM, 2008, NEUROSCIENCE, V151, P1173, DOI 10.1016/j.neuroscience.2007.10.051; Booth SL, 2013, NAT REV ENDOCRINOL, V9, P43, DOI 10.1038/nrendo.2012.201; Carter LG, 2013, MED SCI SPORT EXER, V45, P832, DOI 10.1249/MSS.0b013e31827de953; Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096; Clapp JF, 2003, EUR J OBSTET GYN R B, V110, pS80, DOI 10.1016/S0301-2115(03)00176-3; Clapp JF, 1996, J PEDIATR-US, V129, P856, DOI 10.1016/S0022-3476(96)70029-X; Clapp JF, 2002, AM J OBSTET GYNECOL, V186, P142, DOI 10.1067/mob.2002.119109; Clapp JF, 1998, AM J OBSTET GYNECOL, V178, P594, DOI 10.1016/S0002-9378(98)70444-2; Clemens TL, 2011, J BONE MINER RES, V26, P677, DOI 10.1002/jbmr.321; Confavreux CB, 2009, MOL CELL ENDOCRINOL, V310, P21, DOI 10.1016/j.mce.2009.04.004; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; DENADAI BS, 1994, COMP BIOCHEM PHYS A, V109, P727, DOI 10.1016/0300-9629(94)90216-X; Donovan EL, 2013, J DEV ORIG HLTH DIS, V4, P296, DOI 10.1017/S2040174413000214; Ducy P, 2011, DIABETOLOGIA, V54, P1291, DOI 10.1007/s00125-011-2155-z; Ferron M, 2012, BONE, V50, P568, DOI 10.1016/j.bone.2011.04.017; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; Firth EC, 2008, AM J PHYSIOL-REG I, V294, pR1890, DOI 10.1152/ajpregu.00805.2007; Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049; Gabory A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047986; Gilbert JS, 2008, AM J PHYSIOL-REG I, V295, pR1941, DOI 10.1152/ajpregu.90724.2008; GLUCKMAN PD, 2006, MISMATCH OUR WORLD N; Hard GC, 2004, TOXICOL PATHOL, V32, P171, DOI 10.1080/01926230490422574; Houghton PE, 2000, CAN J APPL PHYSIOL, V25, P443, DOI 10.1139/h00-029; Ivaska KK, 2004, J BIOL CHEM, V279, P18361, DOI 10.1074/jbc.M314324200; Karsenty G, 2012, ANNU REV PHYSIOL, V74, P87, DOI 10.1146/annurev-physiol-020911-153233; Kwong WY, 2004, REPROD BIOMED ONLINE, V8, P574, DOI 10.1016/S1472-6483(10)61105-4; Lee AJ, 2000, ANN CLIN BIOCHEM, V37, P432, DOI 10.1258/0004563001899573; Lee HH, 2006, BRAIN DEV-JPN, V28, P147, DOI 10.1016/j.braindev.2005.05.007; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Low FM, 2012, EVOL BIOL, V39, P650, DOI 10.1007/s11692-011-9157-0; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Monteiro ACT, 2010, J PEDIAT-BRAZIL, V86, P233, DOI 10.2223/JPED.1996; Moritz KM, 2009, AM J PHYSIOL-RENAL, V296, pF1, DOI 10.1152/ajprenal.00049.2008; Mottola M, 1983, Br J Sports Med, V17, P117; Mottola MF, 1996, SEMIN PERINATOL, V20, P222, DOI 10.1016/S0146-0005(96)80015-2; Motyl KJ, 2010, ARCH BIOCHEM BIOPHYS, V503, P2, DOI 10.1016/j.abb.2010.07.030; Pivarnik JM, 2006, MED SCI SPORT EXER, V38, P989, DOI 10.1249/01.mss.0000218147.51025.8a; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Rosa BV, 2012, J MUSCULOSKEL NEURON, V12, P199; Rosa BV, 2013, ENDOCRINE, V44, P809, DOI 10.1007/s12020-013-0008-x; Rosa BV, 2011, AM J PHYSIOL-REG I, V300, pR1134, DOI 10.1152/ajpregu.00683.2010; Rosa BV, 2010, AM J PHYSIOL-REG I, V299, pR1037, DOI 10.1152/ajpregu.00112.2010; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; TREADWAY J, 1986, J APPL PHYSIOL, V60, P1700, DOI 10.1152/jappl.1986.60.5.1700; Vermeer C, 1996, J NUTR, V126, pS1187, DOI 10.1093/jn/126.suppl_4.1187S; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Vickers MH, 2003, AM J PHYSIOL-REG I, V285, pR271, DOI 10.1152/ajpregu.00051.2003; Yao W., 2001, Journal of Musculoskeletal & Neuronal Interactions, V1, P241	50	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82378	10.1371/journal.pone.0082378	http://dx.doi.org/10.1371/journal.pone.0082378			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340022	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100101
J	Braga, JCT; Macedo, MP; Pinto, C; Duprat, J; Begnami, MD; Pellacani, G; Rezze, GG				Tavoloni Braga, Juliana Casagrande; Macedo, Mariana Petaccia; Pinto, Clovis; Duprat, Joao; Begnami, Maria Dirlei; Pellacani, Giovanni; Rezze, Gisele Gargantini			Learning Reflectance Confocal Microscopy of Melanocytic Skin Lesions through Histopathologic Transversal Sections	PLOS ONE			English	Article							SCANNING LASER MICROSCOPY; EPILUMINESCENCE MICROSCOPY; DERMOSCOPIC FEATURES; MELANOMAS; NEVI; DIAGNOSIS; CRITERIA; IMAGES	Histopathologic interpretation of dermoscopic and reflectance confocal microscopy (RCM) features of cutaneous melanoma was timidly carried out using perpendicular histologic sections, which does not mimic the same plane of the image achieved at both techniques (horizontal plane). The aim of this study was to describe the transverse histologic sections research technique and correlate main dermoscopic features characteristic of cutaneous melanoma (atypical network, irregular globules and pseudopods) with RCM and histopathology in perpendicular and transverse sections in order to offer a more precise interpretation of in vivo detectable features. Four melanomas and 2 nevi with different dermoscopic clues have been studied. Lesion areas that showed characteristic dermoscopic features were imaged by dermoscopy and confocal microscopy and directly correlated with histopathology in perpendicular and transverse sections. We presented the possibility to perform transverse sections as a new approach to understand RCM features. Atypical network showed different aspects in the 2 melanomas: in one case it was characterized by pleomorphic malignant melanocytes with tendency to form aggregates, whereas in the other elongated dendritic cells crowded around dermal papillae, some of them forming bridges that resembled the mitochondrial aspect at confocal and histopathology transversal sections. Pigment globules in melanomas and nevi differed for the presence of large atypical cells in the former, and pseudopods showed up as elongated nests protruded toward the periphery of the lesion. Transverse histologic research sections have a consistent dermoscopic and confocal correlate, and it may represent an help in confocal feature interpretation and an advance in improving melanoma diagnosis and knowledge of the biology of melanocytic lesions.	[Tavoloni Braga, Juliana Casagrande; Duprat, Joao; Rezze, Gisele Gargantini] AC Camargo Hosp, Cutaneous Oncol Dept, Sao Paulo, Brazil; [Macedo, Mariana Petaccia; Pinto, Clovis; Begnami, Maria Dirlei] AC Camargo Hosp, Dept Anat Pathol, Sao Paulo, Brazil; [Pellacani, Giovanni] Univ Modena & Reggio Emilia, Dept Dermatol, Modena, Italy	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universita di Modena e Reggio Emilia	Rezze, GG (corresponding author), AC Camargo Hosp, Cutaneous Oncol Dept, Sao Paulo, Brazil.	ggrezze@hotmail.com	pellacani, giovanni/E-8573-2011; Begnami, Maria/D-9663-2012; Duprat, Joao P/I-4198-2015; Braga, Juliana/M-2997-2014; Duprat Neto, Joao/F-7563-2012; Rezze, Gisele/B-5479-2014; Pinto, Clovis/P-5629-2014	pellacani, giovanni/0000-0002-7222-2951; Begnami, Maria/0000-0003-0848-7813; Duprat, Joao P/0000-0001-8968-4506; Braga, Juliana/0000-0002-1378-6992; Duprat Neto, Joao/0000-0002-3873-6473; Pinto, Clovis/0000-0003-1711-0081; Petaccia de Macedo, mariana/0000-0002-0434-7605	FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo) [2010/06455-1]	FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The study was supported by FAPESP (Fundacao de Amparo a Pesquisa no Estado de Sao Paulo - grant 2010/06455-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Busam KJ, 2001, MODERN PATHOL, V14, P862, DOI 10.1038/modpathol.3880402; Corona R, 1996, J CLIN ONCOL, V14, P1218, DOI 10.1200/JCO.1996.14.4.1218; Guitera P, 2012, J INVEST DERMATOL, V132, P2386, DOI 10.1038/jid.2012.172; Guitera P, 2009, J INVEST DERMATOL, V129, P131, DOI 10.1038/jid.2008.193; HEADINGTON JT, 1984, ARCH DERMATOL, V120, P449, DOI 10.1001/archderm.120.4.449; KENET RO, 1993, ARCH DERMATOL, V129, P157, DOI 10.1001/archderm.129.2.157; Langley RGB, 2001, J AM ACAD DERMATOL, V45, P365, DOI 10.1067/mjd.2001.117395; Longo C, 2012, DERMATOL CLIN, V30, P799, DOI 10.1016/j.det.2012.06.012; MENZIES SW, 1995, ARCH DERMATOL, V131, P436, DOI 10.1001/archderm.131.4.436; PEHAMBERGER H, 1987, J AM ACAD DERMATOL, V17, P571, DOI 10.1016/S0190-9622(87)70239-4; Pehamberger H, 1993, J INVEST DERMATOL, V100, P356; Pellacani G, 2005, J INVEST DERMATOL, V125, P532, DOI 10.1111/j.0022-202X.2005.23813.x; Pellacani G, 2005, ARCH DERMATOL, V141, P147, DOI 10.1001/archderm.141.2.147; Pellacani G, 2005, MODERN PATHOL, V18, P469, DOI 10.1038/modpathol.3800330; Pellacani G, 2004, J AM ACAD DERMATOL, V51, P371, DOI 10.1016/j.jaad.2003.12.041; Pellacani G, 2007, J INVEST DERMATOL, V127, P2759, DOI 10.1038/sj.jid.5700993; Pellacani G, 2007, J AM ACAD DERMATOL, V57, P96, DOI 10.1016/j.jaad.2006.11.006; Pellacani G, 2009, J AM ACAD DERMATOL, V61, P1001, DOI 10.1016/j.jaad.2009.04.018; Pellacani G, 2008, ARCH DERMATOL, V144, P1597, DOI 10.1001/archderm.144.12.1597; Pellicani G, 2005, J AM ACAD DERMATOL, V53, P979, DOI 10.1016/j.jaad.2005.08.022; RAJADHYAKSHA M, 1995, J INVEST DERMATOL, V104, P946, DOI 10.1111/1523-1747.ep12606215; Rezze GG, 2006, AM J DERMATOPATH, V28, P13, DOI 10.1097/01.dad.0000181545.89077.8c; Scope A, 2007, J AM ACAD DERMATOL, V57, P644, DOI 10.1016/j.jaad.2007.05.044; Scope A, 2007, ARCH DERMATOL, V143, P727, DOI 10.1001/archderm.143.6.727; Scope A, 2007, ARCH DERMATOL, V143, P176, DOI 10.1001/archderm.143.2.176; Soyer HP, 2000, EUR J DERMATOL, V10, P22; STEINER A, 1993, J AM ACAD DERMATOL, V29, P581, DOI 10.1016/0190-9622(93)70225-I; YADAV S, 1993, AM J DERMATOPATH, V15, P297, DOI 10.1097/00000372-199308000-00001	29	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81205	10.1371/journal.pone.0081205	http://dx.doi.org/10.1371/journal.pone.0081205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339910	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100042
J	Wu, YR; Chang, KH; Chang, WT; Hsiao, YC; Hsu, HC; Jiang, PR; Chen, YC; Chao, CY; Chang, YC; Lee, BH; Hu, FJ; Chen, WL; Lee-Chen, GJ; Chen, CM				Wu, Yih-Ru; Chang, Kuo-Hsuan; Chang, Wen-Teng; Hsiao, Ya-Chin; Hsu, Hsuan-Chu; Jiang, Pei-Ru; Chen, Yi-Chun; Chao, Chih-Ying; Chang, Yi-Chung; Lee, Bo-Hsun; Hu, Fen-Ju; Chen, Wan-Ling; Lee-Chen, Guey-Jen; Chen, Chiung-Mei			Genetic Variants of LRRK2 in Taiwanese Parkinson's Disease	PLOS ONE			English	Article							AUTOSOMAL-DOMINANT PARKINSONISM; REPEAT KINASE 2; RISK-FACTOR; GLY2385ARG VARIANT; MUTATION; CHINESE; POPULATION; G2019S; ASSOCIATION; PREVALENCE	Genetic variants of leucine-rich repeat kinase 2 (LRRK2) were reported to alter the risk for Parkinson's disease (PD). However, the genetic spectrum of LRRK2 variants has not been clearly disclosed yet in Taiwanese population. Herein, we sequenced LRRK2 coding region in 70 Taiwanese early onset PD patients (age at onset <= 50), and found six amino acid-changing single nucleotide polymorphisms (SNPs, N551K, R1398H, R1628P, S1647T, G2385R and M2397T), one reported (R1441H) and 2 novel missense (R767H and S885N) mutations. We examined the frequency of identified LRRK2 variants by genotyping 573 Taiwanese patients with PD and 503 age-matched control subjects. The results showed that PD patients demonstrated a higher frequency of G2385R A allele (4.6%) than control subjects (2.1%; odds ratio = 2.27, 95% confidence interval: 1.38-3.88, P = 0.0017). Fewer PD patients (27.7%) carried the 1647T-2397T haplotype as compared with the control subjects (33.0%; odds ratio = 0.80, 95% confidence interval: 0.65-0.97, P = 0.0215). However, the frequency of 1647T-2385R-2397T haplotype (4.3%) in PD patients was still higher than in control subjects (1.9%, odds ratio: 2.15, 95% confidence interval: 1.27-3.78, P = 0.0058). While no additional subject was found to carry R767H and R1441H, one more patient was observed to carry the S885N variant. Our results indicate a robust risk association regarding G2385R and a new possible protective haplotype (1647T-2397T). Gene-environmental interaction and a larger cohort study are warranted to validate our findings. Additionally, two new missense mutations (R767H and S885N) regarding LRRK2 in PD patients were identified. Functional studies are needed to elucidate the effects of these LRRK2 variants on protein function.	[Wu, Yih-Ru; Chang, Kuo-Hsuan; Chen, Yi-Chun; Chao, Chih-Ying; Hu, Fen-Ju; Chen, Wan-Ling; Chen, Chiung-Mei] Chang Gung Univ, Dept Neurol, Chang Gung Mem Hosp, Coll Med, Taipei, Taiwan; [Chang, Wen-Teng; Hsiao, Ya-Chin; Hsu, Hsuan-Chu; Jiang, Pei-Ru; Chang, Yi-Chung; Lee, Bo-Hsun; Lee-Chen, Guey-Jen] Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Taiwan Normal University	Lee-Chen, GJ (corresponding author), Natl Taiwan Normal Univ, Dept Life Sci, Taipei, Taiwan.	t43019@ntnu.edu.tw; cmchen@adm.cgmh.org.tw	Wang, Pa-Chun/AAD-4094-2019; Chen, Chiung-Mei/AAL-6260-2020		National Science Council, Executive Yuan [NSC98-2628-B-182A-001-MY3, NSC 99-2811-B-182A-007, NSC100-2811-B-182A-003]; Chang Gung Memorial Hospital, Taipei, Taiwan [CMRPG3B138]	National Science Council, Executive Yuan(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital, Taipei, Taiwan(Chang Gung Memorial Hospital)	This work was supported by grants NSC98-2628-B-182A-001-MY3, NSC 99-2811-B-182A-007 and NSC100-2811-B-182A-003 from National Science Council, Executive Yuan, and CMRPG3B138 from Chang Gung Memorial Hospital, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; An XK, 2008, EUR J NEUROL, V15, P301, DOI 10.1111/j.1468-1331.2007.02052.x; Cheverud JM, 2001, HEREDITY, V87, P52, DOI 10.1046/j.1365-2540.2001.00901.x; Di Fonzo A, 2005, LANCET, V365, P412; Di Fonzo A, 2006, NEUROGENETICS, V7, P133, DOI 10.1007/s10048-006-0041-5; Farrer MJ, 2007, PARKINSONISM RELAT D, V13, P89, DOI 10.1016/j.parkreldis.2006.12.001; Funayama M, 2007, NEUROREPORT, V18, P273, DOI 10.1097/WNR.0b013e32801254b6; Fung HC, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-47; Fung HC, 2006, MOVEMENT DISORD, V21, P880, DOI 10.1002/mds.20814; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goldwurm S, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.035568; Guo LX, 2006, INT J BIOCHEM CELL B, V38, P1469, DOI 10.1016/j.biocel.2006.02.009; Huang Y, 2007, MOVEMENT DISORD, V22, P982, DOI 10.1002/mds.21477; Hulihan MM, 2008, LANCET NEUROL, V7, P591, DOI 10.1016/S1474-4422(08)70116-9; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kay DM, 2006, MOVEMENT DISORD, V21, P519, DOI 10.1002/mds.20751; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lesage S, 2006, NEW ENGL J MED, V354, P422, DOI 10.1056/NEJMc055540; Li C, 2007, MOVEMENT DISORD, V22, P2439, DOI 10.1002/mds.21763; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; Lin CH, 2008, J BIOMED SCI, V15, P661, DOI 10.1007/s11373-008-9260-0; Lin CH, 2011, PARKINSONISM RELAT D, V17, P84, DOI 10.1016/j.parkreldis.2010.11.011; Liu ZH, 2012, CELL RES, V22, P1092, DOI 10.1038/cr.2012.42; Liu ZH, 2011, NAT IMMUNOL, V12, P1063, DOI 10.1038/ni.2113; Lu CS, 2008, NEUROGENETICS, V9, P271, DOI 10.1007/s10048-008-0140-6; Mata IF, 2005, NEUROGENETICS, V6, P171, DOI 10.1007/s10048-005-0005-1; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Ross OA, 2011, LANCET NEUROL, V10, P898, DOI 10.1016/S1474-4422(11)70175-2; Rudenko IN, 2012, BIOCHEM J, V446, P99, DOI 10.1042/BJ20120637; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Spanaki C, 2006, NEUROLOGY, V67, P1518, DOI 10.1212/01.wnl.0000239829.33936.73; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Tan EK, 2007, HUM GENET, V120, P857, DOI 10.1007/s00439-006-0268-0; Tan EK, 2010, HUM MUTAT, V31, P561, DOI 10.1002/humu.21225; von Bohlen und Halbach O, 2004, PROG NEUROBIOL, V73, P151, DOI 10.1016/j.pneurobio.2004.05.002; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Zabetian CP, 2005, NEUROLOGY, V65, P741, DOI 10.1212/01.WNL.0000172630.22804.73; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	44	41	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82001	10.1371/journal.pone.0082001	http://dx.doi.org/10.1371/journal.pone.0082001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339985	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100078
J	Schucht, P; Murek, M; Jilch, A; Seidel, K; Hewer, E; Wiest, R; Raabe, A; Beck, J				Schucht, Philippe; Murek, Michael; Jilch, Astrid; Seidel, Kathleen; Hewer, Ekkehard; Wiest, Roland; Raabe, Andreas; Beck, Juergen			Early Re-Do Surgery for Glioblastoma Is a Feasible and Safe Strategy to Achieve Complete Resection of Enhancing Tumor	PLOS ONE			English	Article							5-AMINOLEVULINIC ACID; MALIGNANT GLIOMA; CONTROLLED-TRIAL; FLUORESCENCE; EXTENT; MULTIFORME; PROGNOSIS; SURVIVAL; NEURONAVIGATION; GUIDANCE	Background: Complete resection of enhancing tumor as assessed by early (<72 hours) postoperative MRI is regarded as the optimal result in glioblastoma surgery. As yet, there is no consensus on standard procedure if postoperative imaging reveals unintended tumor remnants. Objective: The current study evaluated the feasibility and safety of an early re-do surgery aimed at completing resections with the aid of 5-ALA fluorescence and neuronavigation after detection of enhancing tumor remnants on post-operative MRI. Methods: From October 2008 to October 2012 a single center institutional protocol offered a second surgery within one week to patients with unintentional incomplete glioblastoma resection. We report on the feasibility of the use 5-ALA fluorescence guidance, the extent of resection (EOR) rates and complications of early re-do surgery. Results: Nine of 151 patients (6%) with glioblastoma resections had an unintentional tumor remnant with a volume >0.175 cm(3). 5-ALA guided re-do surgery completed the resection (CRET) in all patients without causing neurological deficits, infections or other complications. Patients who underwent a re-do surgery remained hospitalized between surgeries, resulting in a mean length of hospital stay of 11 days (range 7-15), compared to 9 days for single surgery (range 3-23; p=0.147). Conclusion: Our early re-do protocol led to complete resection of all enhancing tumor in all cases without any new neurological deficits and thus provides a similar oncological result as intraoperative MRI (iMRI). The repeated use of 5-ALA induced fluorescence, used for identification of small remnants, remains highly sensitive and specific in the setting of re-do surgery. Early re-do surgery is a feasible and safe strategy to complete unintended subtotal resections.	[Schucht, Philippe; Murek, Michael; Jilch, Astrid; Seidel, Kathleen; Raabe, Andreas; Beck, Juergen] Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland; [Wiest, Roland] Univ Hosp Bern, Inst Diagnost & Intervent Neuroradiol, CH-3010 Bern, Switzerland; [Hewer, Ekkehard] Univ Hosp Bern, Dept Neuropathol, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Schucht, P (corresponding author), Univ Hosp Bern, Dept Neurosurg, CH-3010 Bern, Switzerland.	philippe.schucht@insel.ch	Hewer, Ekkehard/W-8670-2019	Hewer, Ekkehard/0000-0002-9128-0364; Beck, Jurgen/0000-0002-7687-6098; Seidel, Kathleen/0000-0002-7360-3852				ALBERT FK, 1994, NEUROSURGERY, V34, P45, DOI 10.1097/00006123-199401000-00008; Black PM, 1999, NEUROSURGERY, V45, P423, DOI 10.1097/00006123-199909000-00001; Chang SM, 2003, J NEUROSURG, V98, P1175, DOI 10.3171/jns.2003.98.6.1175; den Boogert J, 1998, J PHOTOCH PHOTOBIO B, V44, P29, DOI [10.1016/S1011-1344(98)00102-X, DOI 10.1016/S1011-1344(98)00102-X]; Duffau H, 2005, J NEUROL NEUROSUR PS, V76, P845, DOI 10.1136/jnnp.2004.048520; Eyupoglu IY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044885; Gras-Combe G, 2012, J NEUROSURG, V117, P466, DOI 10.3171/2012.6.JNS111981; Hall WA, 2000, NEUROSURGERY, V46, P632, DOI 10.1097/00006123-200003000-00022; Kowalczuk A, 1997, NEUROSURGERY, V41, P1028, DOI 10.1097/00006123-199711000-00004; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Nimsky C, 2004, NEUROSURGERY, V55, P358, DOI 10.1227/01.NEU.0000129694.64671.91; Panciani PP, 2012, NEUROCIRUGIA, V23, P23, DOI 10.1016/j.neucir.2012.04.003; Schucht P, 2012, NEUROSURGERY, V71, P927, DOI 10.1227/NEU.0b013e31826d1e6b; Schucht P, 2011, ACTA NEUROCHIR, V153, P1497, DOI 10.1007/s00701-011-0991-8; Schulder Michael, 2003, Cancer Control, V10, P115; Seidel K, 2012, NEUROSURGERY, V71, P104, DOI 10.1227/NEU.0b013e31824c02a0; Senft C, 2011, LANCET ONCOL, V12, P997, DOI 10.1016/S1470-2045(11)70196-6; Stroka R, 1996, J PHOTOCH PHOTOBIO B, V34, P13, DOI [10.1016/1011-1344(95)07265-9, DOI 10.1016/1011-1344(95)07265-9]; Stummer W, 2006, LANCET ONCOL, V7, P392, DOI 10.1016/S1470-2045(06)70665-9; Stummer W, 2000, J NEUROSURG, V93, P1003, DOI 10.3171/jns.2000.93.6.1003; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.NEU.0000297118.47076.5F, 10.1227/01.NEU.0000346230.80425.3A, 10.1227/01.neu.0000317304.31579.17]; Utsuki S, 2007, NEUROL MED-CHIR, V47, P210, DOI 10.2176/nmc.47.210; VECHT CJ, 1990, J NEUROL NEUROSUR PS, V53, P466, DOI 10.1136/jnnp.53.6.466; Willems PWA, 2006, J NEUROSURG, V104, P360, DOI 10.3171/jns.2006.104.3.360	24	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2013	8	11							e79846	10.1371/journal.pone.0079846	http://dx.doi.org/10.1371/journal.pone.0079846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255QK	24348904	Green Submitted, Green Published, gold			2022-12-27	WOS:000327254700163
J	Aydin, A; Adsay, BA; Sheikhzadeh, S; Keyser, B; Rybczynski, M; Sondermann, C; Detter, C; Steven, D; Robinson, PN; Berger, J; Schmidtke, J; Blankenberg, S; Willems, S; von Kodolitsch, Y; Hoffmann, BA				Aydin, Ali; Adsay, Baran A.; Sheikhzadeh, Sara; Keyser, Britta; Rybczynski, Meike; Sondermann, Claudia; Detter, Christian; Steven, Daniel; Robinson, Peter N.; Berger, Juergen; Schmidtke, Joerg; Blankenberg, Stefan; Willems, Stephan; von Kodolitsch, Yskert; Hoffmann, Boris A.			Observational Cohort Study of Ventricular Arrhythmia in Adults with Marfan Syndrome Caused by FBN1 Mutations	PLOS ONE			English	Article							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; AMERICAN-COLLEGE; HEART-DISEASE; MOUSE MODEL; SOCIETY; PATHOGENESIS; MANAGEMENT; GENETICS; CHILDREN	Background: Marfan syndrome is associated with ventricular arrhythmia but risk factors including FBN1 mutation characteristics require elucidation. Methods and Results: We performed an observational cohort study of 80 consecutive adults (30 men, 50 women aged 42 +/- 15 years) with Marfan syndrome caused by FBN1 mutations. We assessed ventricular arrhythmia on baseline ambulatory electrocardiography as >10 premature ventricular complexes per hour (>10 PVC/h), as ventricular couplets (Couplet), or as non-sustained ventricular tachycardia (nsVT), and during 31 +/- 18 months of follow-up as ventricular tachycardia (VT) events (VTE) such as sudden cardiac death (SCD), and sustained ventricular tachycardia (sVT). We identified >10 PVC/h in 28 (35%), Couplet/nsVT in 32 (40%), and VTE in 6 patients (8%), including 3 with SCD (4%). PVC>10/h, Couplet/nsVT, and VTE exhibited increased N-terminal pro-brain natriuretic peptide serum levels(P<.001). All arrhythmias related to increased NT-proBNP (P<.001), where PVC>10/h and Couplet/nsVT also related to increased indexed end-systolic LV diameters (P = .024 and P = .020), to moderate mitral valve regurgitation (P = .018 and P = .003), and to prolonged QTc intervals (P = .001 and P = .006), respectively. Moreover, VTE related to mutations in exons 24-32 (P = .021). Kaplan-Meier analysis corroborated an association of VTE with increased NT-proBNP (P<.001) and with mutations in exons 24-32 (P<.001). Conclusions: Marfan syndrome with causative FBN1 mutations is associated with an increased risk for arrhythmia, and affected persons may require life-long monitoring. Ventricular arrhythmia on electrocardiography, signs of myocardial dysfunction and mutations in exons 24-32 may be risk factors of VTE.	[Adsay, Baran A.; Sheikhzadeh, Sara; Rybczynski, Meike; Sondermann, Claudia; Detter, Christian; Blankenberg, Stefan; von Kodolitsch, Yskert] Univ Hosp Eppendorf, Univ Heart Ctr, Dept Cardiol, Hamburg, Germany; [Aydin, Ali; Steven, Daniel; Willems, Stephan; Hoffmann, Boris A.] Univ Hosp Eppendorf, Dept Cardiol Electrophysiol, Univ Heart Ctr, Hamburg, Germany; [Berger, Juergen] Univ Hosp Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Keyser, Britta; Schmidtke, Joerg] Charite, Hannover Med Sch, Inst Human Genet, D-13353 Berlin, Germany; [Robinson, Peter N.] Charite, Inst Human Genet & Med Genet, D-13353 Berlin, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	von Kodolitsch, Y (corresponding author), Univ Hosp Eppendorf, Univ Heart Ctr, Dept Cardiol, Hamburg, Germany.	kodolitsch@uke.de	Adsay, Volkan/N-7130-2017	Adsay, Volkan/0000-0002-1308-3701				Biaggi P, 2009, J AM SOC ECHOCARDIOG, V22, P720, DOI 10.1016/j.echo.2009.03.012; CHEN SC, 1985, AM J DIS CHILD, V139, P273, DOI 10.1001/archpedi.1985.02140050067024; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Crawford MH, 1999, J AM COLL CARDIOL, V34, P912, DOI 10.1016/S0735-1097(99)00354-X; Du Bois D, 1989, Nutrition, V5, P303; Faivre L, 2007, AM J HUM GENET, V81, P454, DOI 10.1086/520125; Freed LA, 1999, NEW ENGL J MED, V341, P1, DOI 10.1056/NEJM199907013410101; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hiratzka Loren F, 2010, Catheter Cardiovasc Interv, V76, pE43; Hoffmann BA, 2012, INT J CARDIOL; Kuhne K, 2012, INT J CARDIOL; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Maron BJ, 2000, CIRCULATION, V102, P858; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ng CM, 2004, J CLIN INVEST, V114, P1586, DOI 10.1172/JCI22715; NIJBROEK G, 1995, AM J HUM GENET, V57, P8; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Robinson PN, 2006, J MED GENET, V43, P769, DOI 10.1136/jmg.2005.039669; ROMAN MJ, 1989, AM J CARDIOL, V64, P507, DOI 10.1016/0002-9149(89)90430-X; Rybczynski M, 2010, AM J CARDIOL, V105, P1836, DOI 10.1016/j.amjcard.2010.01.369; Rybczynski M, 2008, AM J MED GENET A, V146A, P3157, DOI 10.1002/ajmg.a.32595; Savolainen A, 1997, J INTERN MED, V241, P221; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Sheikhzadeh S, 2012, CLIN GENET, V82, P240, DOI 10.1111/j.1399-0004.2011.01771.x; Sheldon R, 2010, J CARDIOVASC ELECTR, V21, P1358, DOI 10.1111/j.1540-8167.2010.01835.x; SILVERMAN DI, 1995, AM J CARDIOL, V75, P157, DOI 10.1016/S0002-9149(00)80066-1; Silversides CK, 2010, CAN J CARDIOL, V26, pE80, DOI 10.1016/S0828-282X(10)70355-X; STEVENSON WG, 1993, CIRCULATION, V88, P2953, DOI 10.1161/01.CIR.88.6.2953; Tikkanen JT, 2009, NEW ENGL J MED, V361, P2529, DOI 10.1056/NEJMoa0907589; Tseng ZH, 2009, HEART RHYTHM, V6, P1745, DOI 10.1016/j.hrthm.2009.08.031; VAUGHANWILLIAMS EM, 1975, PHARMACOL THER PT B, V1, P115; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; von Kodolitsch Y, 2007, HEART, V93, P755, DOI 10.1136/hrt.2006.098798; WILLIAMS EMV, 1984, J CLIN PHARMACOL, V24, P129, DOI 10.1002/j.1552-4604.1984.tb01822.x; Yetman AT, 2003, J AM COLL CARDIOL, V41, P329, DOI 10.1016/S0735-1097(02)02699-2; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	36	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81281	10.1371/journal.pone.0081281	http://dx.doi.org/10.1371/journal.pone.0081281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349050	gold, Green Submitted, Green Published			2022-12-27	WOS:000328734200007
J	Zhi, H; Luptak, I; Alreja, G; Shi, JR; Guan, J; Metes-Kosik, N; Joseph, J				Zhi, Hui; Luptak, Ivan; Alreja, Gaurav; Shi, Jianru; Guan, Jian; Metes-Kosik, Nicole; Joseph, Jacob			Effects of Direct Renin Inhibition on Myocardial Fibrosis and Cardiac Fibroblast Function	PLOS ONE			English	Article							PRESERVED EJECTION FRACTION; MUSCLE-CELL PROLIFERATION; CHRONIC HEART-FAILURE; ANGIOTENSIN-II; HYPERTENSIVE-RATS; INDUCED HYPERHOMOCYSTEINEMIA; ENDOTHELIAL DYSFUNCTION; MESANGIAL CELLS; BLOOD-PRESSURE; HOMOCYSTEINE	Myocardial fibrosis, a major pathophysiologic substrate of heart failure with preserved ejection fraction (HFPEF), is modulated by multiple pathways including the renin-angiotensin system. Direct renin inhibition is a promising anti-fibrotic therapy since it attenuates the pro-fibrotic effects of renin in addition to that of other effectors of the renin-angiotensin cascade. Here we show that the oral renin inhibitor aliskiren has direct effects on collagen metabolism in cardiac fibroblasts and prevented myocardial collagen deposition in a non-hypertrophic mouse model of myocardial fibrosis. Adult mice were fed hyperhomocysteinemia-inducing diet to induce myocardial fibrosis and treated concomitantly with either vehicle or aliskiren for 12 weeks. Blood pressure and plasma angiotensin II levels were normal in control and hyperhomocysteinemic mice and reduced to levels lower than observed in the control group in the groups treated with aliskiren. Homocysteine-induced myocardial matrix gene expression and fibrosis were also prevented by aliskiren. In vitro studies using adult rat cardiac fibroblasts also showed that aliskiren attenuated the pro-fibrotic pattern of matrix gene and protein expression induced by D, L, homocysteine. Both in vivo and in vitro studies demonstrated that the Akt pathway was activated by homocysteine, and that treatment with aliskiren attenuated Akt activation. In conclusion, aliskiren as mono-therapy has potent and direct effects on myocardial matrix turnover and beneficial effects on diastolic function.	[Metes-Kosik, Nicole; Joseph, Jacob] VA Boston Healthcare Syst, West Roxbury, MA USA; [Luptak, Ivan; Alreja, Gaurav; Joseph, Jacob] Boston Univ, Sch Med, Boston, MA 02118 USA; [Zhi, Hui; Shi, Jianru; Guan, Jian; Joseph, Jacob] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Joseph, J (corresponding author), VA Boston Healthcare Syst, West Roxbury, MA USA.	jjoseph16@partners.org	Joseph, Jacob/GYR-1361-2022	Joseph, Jacob/0000-0002-7279-4896; Luptak, Ivan/0000-0001-7498-7694	Novartis Pharmaceuticals	Novartis Pharmaceuticals(Novartis)	The work was supported by a resarch grant from Novartis Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abekhoukh S, 2013, MOL NEUROBIOL, V47, P105, DOI 10.1007/s12035-012-8326-1; Ahmed SH, 2006, CIRCULATION, V113, P2089, DOI 10.1161/CIRCULATIONAHA.105.573865; Bonaventura D, 2004, PHARMACOLOGY, V70, P91, DOI 10.1159/000074673; Chao CL, 2000, STROKE, V31, P2907, DOI 10.1161/01.STR.31.12.2907; Chen K, 2004, CIRC RES, V95, P1167, DOI 10.1161/01.RES.0000150369.68826.2f; Chiang JK, 2011, J CELL PHYSIOL, V226, P1017, DOI 10.1002/jcp.22415; Cleland JGF, 2006, EUR HEART J, V27, P2338, DOI 10.1093/eurheartj/ehl250; da Cunha AA, 2012, INT J DEV NEUROSCI, V30, P369, DOI 10.1016/j.ijdevneu.2012.04.001; Devi S, 2006, CARDIOVASC PATHOL, V15, P75, DOI 10.1016/j.carpath.2005.11.001; Doronzo G, 2010, THROMB RES, V125, pE23, DOI 10.1016/j.thromres.2009.08.015; EMANUEL RL, 1973, J LAB CLIN MED, V81, P632; Fu YF, 2005, EUR J PHARMACOL, V508, P167, DOI 10.1016/j.ejphar.2004.11.063; Fu YF, 2003, J CARDIOVASC PHARM, V42, P566, DOI 10.1097/00005344-200310000-00016; Gross O, 2011, AM J HYPERTENS, V24, P355, DOI 10.1038/ajh.2010.231; He M, 2009, EUR J PHARMACOL, V606, P155, DOI 10.1016/j.ejphar.2008.12.050; Higashikuni Y, 2012, HYPERTENS RES, V35, P62, DOI 10.1038/hr.2011.136; Huang Y, 2006, KIDNEY INT, V69, P105, DOI 10.1038/sj.ki.5000011; Joseph J, 2002, AM J PHYSIOL-HEART C, V283, pH2567, DOI 10.1152/ajpheart.00475.2002; Joseph J, 2008, J HEART LUNG TRANSPL, V27, P1237, DOI 10.1016/j.healun.2008.07.024; Joseph J, 2009, J HYPERTENS, V27, P1317, DOI 10.1097/HJH.0b013e328329fc20; Joseph J, 2009, CARDIOVASC TOXICOL, V9, P53, DOI 10.1007/s12012-009-9042-6; Kaneshiro Y, 2007, J AM SOC NEPHROL, V18, P1789, DOI 10.1681/ASN.2006091062; Kennedy RH, 2006, AM J HYPERTENS, V19, P94, DOI 10.1016/j.amjhyper.2005.07.008; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lee SJ, 2012, TOXICOL APPL PHARM, V260, P89, DOI 10.1016/j.taap.2012.01.026; Liu G, 2011, J HYPERTENS, V29, P696, DOI 10.1097/HJH.0b013e328343c62b; Massie BM, 2008, NEW ENGL J MED, V359, P2456, DOI 10.1056/NEJMoa0805450; Miller A, 2002, AM J HYPERTENS, V15, P157, DOI 10.1016/S0895-7061(01)02286-5; Montes E, 2012, EUR RESPIR J, V39, P141, DOI 10.1183/09031936.00130310; Neves MF, 2004, J HYPERTENS, V22, P959, DOI 10.1097/00004872-200405000-00018; Nguyen G, 1996, KIDNEY INT, V50, P1897, DOI 10.1038/ki.1996.511; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Peters H, 1998, KIDNEY INT, V54, P1570, DOI 10.1046/j.1523-1755.1998.00164.x; Shastry S, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-27; Suzuki YJ, 1999, ANTIOXID REDOX SIGN, V1, P233, DOI 10.1089/ars.1999.1.2-233; Vasan RS, 2003, JAMA-J AM MED ASSOC, V289, P1251, DOI 10.1001/jama.289.10.1251; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; Westermann D, 2008, HYPERTENSION, V52, P1068, DOI 10.1161/HYPERTENSIONAHA.108.116350; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7; Zou CG, 2009, J MOL MED, V87, P75, DOI 10.1007/s00109-008-0407-2	40	25	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81612	10.1371/journal.pone.0081612	http://dx.doi.org/10.1371/journal.pone.0081612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349097	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300039
J	Beard, H; Cholleti, A; Pearlman, D; Sherman, W; Loving, KA				Beard, Hege; Cholleti, Anuradha; Pearlman, David; Sherman, Woody; Loving, Kathryn A.			Applying Physics-Based Scoring to Calculate Free Energies of Binding for Single Amino Acid Mutations in Protein-Protein Complexes	PLOS ONE			English	Article							ALANINE-SCANNING MUTAGENESIS; INTERFERON-GAMMA RECEPTOR; COMPUTATIONAL DESIGN; FORCE-FIELD; SIDE-CHAIN; AFFINITY; ANTIBODY; SPECIFICITY; RECOGNITION; PREDICTION	Predicting changes in protein binding affinity due to single amino acid mutations helps us better understand the driving forces underlying protein-protein interactions and design improved biotherapeutics. Here, we use the MM-GBSA approach with the OPLS2005 force field and the VSGB2.0 solvent model to calculate differences in binding free energy between wild type and mutant proteins. Crucially, we made no changes to the scoring model as part of this work on protein-protein binding affinity-the energy model has been developed for structure prediction and has previously been validated only for calculating the energetics of small molecule binding. Here, we compare predictions to experimental data for a set of 418 single residue mutations in 21 targets and find that the MM-GBSA model, on average, performs well at scoring these single protein residue mutations. Correlation between the predicted and experimental change in binding affinity is statistically significant and the model performs well at picking "hotspots," or mutations that change binding affinity by more than 1 kcal/mol. The promising performance of this physics-based method with no tuned parameters for predicting binding energies suggests that it can be transferred to other protein engineering problems.	[Beard, Hege; Pearlman, David; Sherman, Woody; Loving, Kathryn A.] Schrodinger, New York, NY USA; [Cholleti, Anuradha] Schrodinger, Hyderabad, Andhra Pradesh, India		Pearlman, D (corresponding author), Schrodinger, New York, NY USA.	david.pearlman@schrodinger.com; woody.sherman@schrodinger.com; kathryn_armstrong@alum.mit.edu	Sherman, Woody/AAF-6952-2020	Sherman, Woody/0000-0001-9079-1376; Pearlman, David/0000-0002-2574-6066	Schrodinger	Schrodinger(Austrian Science Fund (FWF))	Schrodinger was the only funder of our study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel R, 2011, CHEMMEDCHEM, V6, P1049, DOI 10.1002/cmdc.201000533; Armstrong KA, 2008, BIOTECHNOL PROGR, V24, P62, DOI 10.1021/bp070134h; Baker D, 2010, PROTEIN SCI, V19, P1817, DOI 10.1002/pro.481; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Beuming T, 2009, PROTEIN SCI, V18, P1609, DOI 10.1002/pro.177; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; Bosch DE, 2011, J BIOL CHEM, V286, P3351, DOI 10.1074/jbc.M110.190496; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Clackson T, 1998, J MOL BIOL, V277, P1111, DOI 10.1006/jmbi.1998.1669; Clark LA, 2006, PROTEIN SCI, V15, P949, DOI 10.1110/ps.052030506; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Dai LA, 2010, PROTEINS, V78, P2338, DOI 10.1002/prot.22746; DeLano WL, 2000, SCIENCE, V287, P1279, DOI 10.1126/science.287.5456.1279; Diller DJ, 2010, PROTEINS, V78, P2329, DOI 10.1002/prot.22745; Dougan DA, 1998, PROTEIN ENG, V11, P65, DOI 10.1093/protein/11.1.65; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hendsch ZS, 2001, J AM CHEM SOC, V123, P1264, DOI 10.1021/ja0032273; Hofstadter K, 1999, J MOL BIOL, V285, P805, DOI 10.1006/jmbi.1998.2343; Jacobson MP, 2002, J PHYS CHEM B, V106, P11673, DOI 10.1021/jp021564n; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KELLEY RF, 1995, BIOCHEMISTRY-US, V34, P10383, DOI 10.1021/bi00033a009; Korkegian A, 2005, SCIENCE, V308, P857, DOI 10.1126/science.1107387; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lang S, 2000, BIOCHEMISTRY-US, V39, P15674, DOI 10.1021/bi000838z; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li JN, 2011, PROTEINS, V79, P2794, DOI 10.1002/prot.23106; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lippow SM, 2007, CURR OPIN BIOTECH, V18, P305, DOI 10.1016/j.copbio.2007.04.009; Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Oberlin M, 2012, J CHEM INF MODEL, V52, P2204, DOI [10.1021/ci3001474, 10.1021/ci30014741]; Pons J, 1999, PROTEIN SCI, V8, P958, DOI 10.1110/ps.8.5.958; Powers D. M, 2011, ARXIV201016061; Ripoll DR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002665; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sammond DW, 2010, PROTEINS, V78, P1055, DOI 10.1002/prot.22631; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; Sloan DJ, 1999, PROTEIN SCI, V8, P1643, DOI 10.1110/ps.8.8.1643; Snyder PW, 2011, P NATL ACAD SCI USA, V108, P17889, DOI 10.1073/pnas.1114107108; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Tracewell CA, 2009, CURR OPIN CHEM BIOL, V13, P3, DOI 10.1016/j.cbpa.2009.01.017; Voigt CA, 2001, P NATL ACAD SCI USA, V98, P3778, DOI 10.1073/pnas.051614498; Wallis R, 1998, BIOCHEMISTRY-US, V37, P476, DOI 10.1021/bi971884a; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Wright CS, 2005, BIOCHEMISTRY-US, V44, P13510, DOI 10.1021/bi050668w; Xia Y, 2002, P NATL ACAD SCI USA, V99, P10382, DOI 10.1073/pnas.162097799; Zhu K, 2007, J CHEM THEORY COMPUT, V3, P640, DOI 10.1021/ct600129f; Zhu K, 2007, J CHEM THEORY COMPUT, V3, P2108, DOI 10.1021/ct700166f	58	123	126	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82849	10.1371/journal.pone.0082849	http://dx.doi.org/10.1371/journal.pone.0082849			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340062	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400098
J	Chang, LW; Fu, A; Wozniak, E; Chow, M; Duke, DG; Green, L; Kelley, K; Hernandez, JA; Jacobson, ER				Chang, Li-Wen; Fu, Ann; Wozniak, Edward; Chow, Marjorie; Duke, Diane G.; Green, Linda; Kelley, Karen; Hernandez, Jorge A.; Jacobson, Elliott R.			Immunohistochemical Detection of a Unique Protein within Cells of Snakes Having Inclusion Body Disease, a World-Wide Disease Seen in Members of the Families Boidae and Pythonidae	PLOS ONE			English	Article							BOA CONSTRICTORS; FORMALIN FIXATION; IDENTIFICATION; RETROVIRUSES; DIAGNOSIS	Inclusion body disease (IBD) is a worldwide disease in captive boa constrictors (boa constrictor) and occasionally in other snakes of the families Boidae and Pythonidae. The exact causative agent(s) and pathogenesis are not yet fully understood. Currently, diagnosis of IBD is based on the light microscopic identification of eosinophilic intracytoplasmic inclusion bodies in hematoxylin and eosin stained tissues or blood smears. An antigenically unique 68 KDa protein was identified within the IBD inclusion bodies, called IBD protein. A validated immuno-based antemortem diagnostic test is needed for screening snakes that are at risk of having IBD. In this study, despite difficulties in solubilizing semi-purified inclusion bodies, utilizing hybridoma technology a mouse anti-IBD protein monoclonal antibody (MAB) was produced. The antigenic specificity of the antibody was confirmed and validated by western blots, enzyme-linked immunosorbent assay, immuno-transmission electron microscopy, and immunohistochemical staining. Paraffin embedded tissues of IBD positive and negative boa constrictors (n=94) collected from 1990 to 2011 were tested with immunohistochemical staining. In boa constrictors, the anti-IBDP MAB had a sensitivity of 83% and specificity of 100% in detecting IBD. The antibody also cross-reacted with IBD inclusion bodies in carpet pythons (Morelia spilota) and a ball python (python regius). This validated antibody can serve as a tool for the development of ante-mortem immunodiagnostic tests for IBD.	[Chang, Li-Wen; Jacobson, Elliott R.] Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA; [Fu, Ann] Univ Florida, Coll Med, Dept Pathol, Mol Pathol Core, Gainesville, FL USA; [Wozniak, Edward] Texas Dept State Hlth Serv, Zoonosis Control Unit, Uvalde, TX USA; [Chow, Marjorie] Univ Florida, Prot Biomarkers Lab, Prote Div, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Duke, Diane G.; Green, Linda] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Hybridoma Lab, Cell Div, Gainesville, FL USA; [Kelley, Karen] Univ Florida, Electron Microscopy & Bioimaging Core Lab, Cell Div, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL USA; [Hernandez, Jorge A.] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Texas Department of State Health Services; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jacobson, ER (corresponding author), Univ Florida, Coll Vet Med, Dept Small Anim Clin Sci, Gainesville, FL 32610 USA.	jacobsone@ufl.edu			Morris Animal Foundation [D10ZO-045]	Morris Animal Foundation	The validation of the monoclonal mouse anti-IBDP antibody was funded by Morris Animal Foundation (www.MorrisAnimalFoundation.org) under project "Diagnosing Inclusion Body Disease (IBD), A Worldwide Infectious Disease of Boid Snakes" (Grant ID D10ZO-045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banajee KH, 2012, VET CLIN PATH, V41, P158, DOI 10.1111/j.1939-165X.2011.00393.x; Bodewes R, 2013, J GEN VIROL, V94, P1206, DOI 10.1099/vir.0.051995-0; Boenisch T, 2005, APPL IMMUNOHISTO M M, V13, P283, DOI 10.1097/01.0000146524.74402.a4; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carlisle-Nowak MS, 1998, AUST VET J, V76, P98, DOI 10.1111/j.1751-0813.1998.tb14535.x; Chang LW, 2010, J EXOT PET MED, V19, P216, DOI 10.1053/j.jepm.2010.07.014; DOHOO I, 2003, VET EPIDEMIOLOGIC RE, P121; Dohoo I., 2003, VET EPIDEMIOLOGIC RE, P85; Fleming Gregory J., 2003, Journal of Herpetological Medicine and Surgery, V13, P18; FRENCH SW, 1972, LAB INVEST, V26, P240; Hazeki N, 2000, BIOCHEM BIOPH RES CO, V277, P386, DOI 10.1006/bbrc.2000.3682; Hetzel U, 2013, J VIROL, V87, P10918, DOI 10.1128/JVI.01123-13; Huder JB, 2002, J VIROL, V76, P7607, DOI 10.1128/JVI.76.15.7607-7615.2002; Jacobson ER, 2001, AM J VET RES, V62, P217, DOI 10.2460/ajvr.2001.62.217; Leong ASY, 2011, METHODS MOL BIOL, V724, P37, DOI 10.1007/978-1-61779-055-3_3; Lock BA, 2003, AM J VET RES, V64, P388, DOI 10.2460/ajvr.2003.64.388; Miller MA, 2005, J VET DIAGN INVEST, V17, P461, DOI 10.1177/104063870501700509; Pees M, 2010, VET REC, V166, P422, DOI 10.1136/vr.b4819; Ramos-Vara JA, 2011, METHODS MOL BIOL, V691, P83, DOI 10.1007/978-1-60761-849-2_5; Ramos-Vara JA, 2008, J VET DIAGN INVEST, V20, P393, DOI 10.1177/104063870802000401; Raymond JT, 2001, J VET DIAGN INVEST, V13, P82, DOI 10.1177/104063870101300118; Schilliger L, 2011, J VET DIAGN INVEST, V23, P159, DOI 10.1177/104063871102300131; SCHUMACHER J, 1994, J ZOO WILDLIFE MED, V25, P511; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; Stenglein MD, 2012, MBIO, V3, DOI 10.1128/mBio.00180-12; Vancraeynest D, 2006, VET REC, V158, P757, DOI 10.1136/vr.158.22.757; Webster JD, 2009, J HISTOCHEM CYTOCHEM, V57, P753, DOI 10.1369/jhc.2009.953877; Wozniak E, 2000, VET PATHOL, V37, P449, DOI 10.1354/vp.37-5-449	29	23	23	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82916	10.1371/journal.pone.0082916	http://dx.doi.org/10.1371/journal.pone.0082916			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340066	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400102
J	Alexander, D; Rieger, M; Klein, C; Ardjomandi, N; Reinert, S				Alexander, Dorothea; Rieger, Melanie; Klein, Christian; Ardjomandi, Nina; Reinert, Siegmar			Selection of Osteoprogenitors from the Jaw Periosteum by a Specific Animal-Free Culture Medium	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; T-CELLS; DIFFERENTIATION; PROLIFERATION; INHIBIT; OSTEOGENESIS; INVOLVEMENT; CAPACITY; INDUCE; NICHES	The goal of our research work is to establish mesenchymal osteoprogenitors derived from human jaw periosteum for tissue engineering applications in oral and maxillofacial surgery. For future autologous and/or allogeneic transplantations, some issues must be addressed. On the one hand, animal-free culture conditions have yet to be established. On the other hand, attempts should be undertaken to shorten the in vitro culturing process efficiently. The aim of the present study is to compare and analyze the phenotype of osteoprogenitors from the jaw periosteum under normal FCS-containing and animal-free culture conditions. Therefore, we analyzed the proliferation rates of MesenCult-XF medium (MC-) in comparison to DMEM-cultured JPCs. Whereas jaw periosteal cells (JPCs) show relatively slow proliferation rates and a fibroblastoid shape under DMEM culture conditions, MC-cultured JPCs diminished their cell size significantly and proliferated rapidly. By live-monitoring measurements of adhesion and proliferation, we made an interesting observation: whereas the proliferation of the MSCA-1(+) subpopulation and the unseparated cell fraction were favored by the animal-free culture medium, the proliferation of the MSCA-1(-) subpopulation seemed to be repressed under these conditions. The alkaline phosphatase expression pattern showed similar results under both culture conditions. Comparison of the mineralization capacity revealed an earlier formation of calcium-phosphate precipitates under MC culture conditions; however, the mineralization capacity of the DMEM-cultured cells seemed to be higher. We conclude that the tested animal-free medium is suitable for the in vitro expansion and even for the specific selection of osteoprogenitor cells derived from the jaw periosteum.	[Alexander, Dorothea; Rieger, Melanie; Ardjomandi, Nina; Reinert, Siegmar] Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Tubingen, Germany; [Klein, Christian] Univ Tubingen Hosp, Dept Conservat Dent, Tubingen, Germany; [Klein, Christian] Dent Practice Zahngesundheit Waiblingen, Waiblingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Alexander, D (corresponding author), Univ Tubingen Hosp, Dept Oral & Maxillofacial Surg, Tubingen, Germany.	dorothea.alexander@med.uni-tuebingen.de			BMBF in the framework of REGiNA [FKZO1KQ0902A]; BMBF	BMBF in the framework of REGiNA; BMBF(Federal Ministry of Education & Research (BMBF))	This study was sponsored in part by BMBF (funder's website:www.bmbf.de) in the framework of REGiNA (grant number: FKZO1KQ0902A). MR was financed by BMBF. No additional external funding received for this study. We financed in part this study from the departments' own budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D, 2008, J MATER SCI-MATER M, V19, P965, DOI 10.1007/s10856-007-3351-8; Alexander D, 2011, CELL BIOL INT, V35, P973, DOI 10.1042/CBI20100836; Alexander D, 2010, CELL PHYSIOL BIOCHEM, V26, P1073, DOI 10.1159/000323985; Alexander D, 2009, CELL PHYSIOL BIOCHEM, V24, P283, DOI 10.1159/000233253; Ardjomandi N, 2012, J BIOMED MATER RES A, V100A, P2034, DOI 10.1002/jbm.a.34062; Ardjomandi N, 2013, NUCLEIC ACID THER, V23, P44, DOI 10.1089/nat.2012.0349; Bonewald LF, 2003, CALCIFIED TISSUE INT, V72, P537, DOI 10.1007/s00223-002-1057-y; Crapnell K, 2013, EXP CELL RES, V319, P1409, DOI 10.1016/j.yexcr.2013.04.004; Dazzi F, 2011, BEST PRACT RES CL HA, V24, P49, DOI 10.1016/j.beha.2011.01.002; Dimarakis I, 2006, STEM CELLS, V24, P1407, DOI 10.1634/stemcells.2005-0577; Dolley-Sonneville PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070263; Ema H, 2012, BLOOD, V120, P2174, DOI 10.1182/blood-2012-04-424507; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Olbrich M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047176; Prigione I, 2009, STEM CELLS, V27, P693, DOI 10.1634/stemcells.2008-0687; Shahdadfar A, 2005, STEM CELLS, V23, P1357, DOI 10.1634/stemcells.2005-0094; Sioud M, 2010, SCAND J IMMUNOL, V71, P267, DOI 10.1111/j.1365-3083.2010.02378.x; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Spees JL, 2004, MOL THER, V9, P747, DOI 10.1016/j.ymthe.2004.02.012; Tseng FW, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/234179; Wang YH, 2006, BIOTECHNOL PROGR, V22, P1697, DOI 10.1021/bp060274b	27	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81674	10.1371/journal.pone.0081674	http://dx.doi.org/10.1371/journal.pone.0081674			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349108	Green Submitted, gold, Green Published			2022-12-27	WOS:000328705200042
J	Li, MY; Niu, LL; Qin, B; Zhou, ZM; Ni, K; Le, QH; Xiang, J; Wei, AJ; Ma, WP; Zhou, XT				Li, Meiyan; Niu, Lingling; Qin, Bing; Zhou, Zimei; Ni, Katherine; Le, Qihua; Xiang, Jun; Wei, Anji; Ma, Weiping; Zhou, Xingtao			Confocal Comparison of Corneal Reinnervation after Small Incision Lenticule Extraction (SMILE) and Femtosecond Laser In Situ Keratomileusis (FS-LASIK)	PLOS ONE			English	Article							SUBBASAL NERVE DENSITY; DRY EYE; KERATOCYTE DEFICITS; SENSITIVITY; REGENERATION	Purpose: To evaluate corneal reinnervation, and the corresponding corneal sensitivity and keratocyte density after small incision lenticule extraction (SMILE) and femtosecond laser in situ keratomileusis (FS-LASIK). Methods: In this prospective, non-randomized observational study, 18 patients (32 eyes) received SMILE surgery, and 22 patients (42 eyes) received FS-LASIK surgery to correct myopia. The corneal subbasal nerve density and microscopic morphological changes in corneal architecture were evaluated by confocal microscopy prior to surgery and at 1 week, 1 month, 3 months, and 6 months after surgery. A correlation analysis was performed between subbasal corneal nerve density and the corresponding keratocyte density and corneal sensitivity. Results: The decrease in subbasal nerve density was less severe in SMILE-treated eyes than in FS-LASIK-treated eyes at 1 week (P=0.0147), 1 month (P=0.0243), and 3 months (P=0.0498), but no difference was detected at the 6-month visit (P=0.5277). The subbasal nerve density correlated positively with central corneal sensitivity in both groups (r=0.416, P < 0.0001, and r=0.2567, P=0.0038 for SMILE group and FS-LASIK group, respectively). The SMILE-treated eyes have a lower risk of developing peripheral empty space with epithelial cells filling in (P=0.0005). Conclusions: The decrease in subbasal nerve fiber density was less severe in the SMILE group than the FS-LASIK group in the first 3 months following the surgeries. The subbasal nerve density was correlated with central corneal sensitivity.	[Li, Meiyan; Niu, Lingling; Qin, Bing; Le, Qihua; Xiang, Jun; Wei, Anji; Zhou, Xingtao] Fudan Univ, EYE & ENT Hosp, Key Lab Myopia, Minist Hlth,Dept Ophthalmol, Shanghai 200433, Peoples R China; [Zhou, Zimei] Bronx Lebanon Hosp Ctr, Albert Einstein Coll Med, Dept Ophthalmol, Bronx, NY 10456 USA; [Ni, Katherine] Duke Univ, Durham, NC USA; [Ma, Weiping] Fudan Univ, Sch Publ Hlth, Dept Biostat, Shanghai 200433, Peoples R China	Fudan University; BronxCare Health System; Yeshiva University; Albert Einstein College of Medicine; Duke University; Fudan University	Zhou, XT (corresponding author), Fudan Univ, EYE & ENT Hosp, Key Lab Myopia, Minist Hlth,Dept Ophthalmol, Shanghai 200433, Peoples R China.	doctzhouxingtao@163.com	zhou, xt/GWZ-9212-2022		Natural Science Foundation of China [11074052]; The Key Project of Science and Technology of Shanghai [11JC1402000]; Scholarship Award for Excellent Doctoral Student granted by Ministry of Education	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); The Key Project of Science and Technology of Shanghai; Scholarship Award for Excellent Doctoral Student granted by Ministry of Education	1) Natural Science Foundation of China (Grant No. 11074052); http://www.nsfc.gov.cn/Portal0/default152.htm. 2) The Key Project of Science and Technology of Shanghai (Grant No. 11JC1402000); http://www.stcsm.gov.cn/.3) Scholarship Award for Excellent Doctoral Student granted by Ministry of Education; http://www.moe.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosio R, 2008, J REFRACT SURG, V24, P396, DOI 10.3928/1081597X-20080401-14; Darwish T, 2007, J REFRACT SURG, V23, P709, DOI 10.3928/1081-597X-20070901-10; Donnenfeld ED, 2003, OPHTHALMOLOGY, V110, P1023, DOI 10.1016/S0161-6420(03)00100-3; Erie JC, 2005, AM J OPHTHALMOL, V140, P1059, DOI 10.1016/j.ajo.2005.07.027; Erie JC, 2006, AM J OPHTHALMOL, V141, P799, DOI 10.1016/j.ajo.2005.12.014; Erie JC, 2004, OPHTHALMOLOGY, V111, P1356, DOI 10.1016/j.ophtha.2003.10.027; Konomi K, 2008, INVEST OPHTH VIS SCI, V49, P168, DOI 10.1167/iovs.07-0337; Lee BH, 2002, INVEST OPHTH VIS SCI, V43, P3660; Lee SJ, 2006, AM J OPHTHALMOL, V141, P1009, DOI 10.1016/j.ajo.2006.01.048; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; Patel SV, 2010, ARCH OPHTHALMOL-CHIC, V128, P1413, DOI 10.1001/archophthalmol.2010.253; Salomao MQ, 2009, J CATARACT REFR SURG, V35, P1756, DOI 10.1016/j.jcrs.2009.05.032; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Tuisku IS, 2007, J REFRACT SURG, V23, P338; Vestergaard AH, 2013, GRAEFES ARC IN PRESS; Vestergaard A, 2013, ACTA OPHTHALMOL, V91, P355, DOI 10.1111/j.1755-3768.2012.02406.x; Wei SS, 2013, GRAEF ARCH CLIN EXP, V251, P1645, DOI 10.1007/s00417-013-2272-0; Zhang FJ, 2012, INVEST OPHTH VIS SCI, V53, P5536, DOI 10.1167/iovs.11-8786	19	71	81	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81435	10.1371/journal.pone.0081435	http://dx.doi.org/10.1371/journal.pone.0081435			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349069	gold, Green Submitted, Green Published			2022-12-27	WOS:000328705200029
J	Lin, JN; Chang, LL; Lai, CH; Lin, HH; Chen, YH				Lin, Jiun-Nong; Chang, Lin-Li; Lai, Chung-Hsu; Lin, Hsi-Hsun; Chen, Yen-Hsu			Emergence of Streptococcus pyogenes emm102 Causing Toxic Shock Syndrome in Southern Taiwan during 2005-2012	PLOS ONE			English	Article							GROUP-A STREPTOCOCCUS; BACTERIAL SUPERANTIGEN; TISSUE INFECTIONS; RISK-FACTORS; DISEASE; VACCINE; EPIDEMIOLOGY; SEQUENCE; GENES; PATHOGENESIS	Background: Streptococcal toxic shock syndrome (STSS) is an uncommon but life-threatening disease caused by Streptococcus pyogenes. Methods: To understand the clinical and molecular characteristics of STSS, we analyzed clinical data and explored the emm types, superantigen genes, and pulsed-field gel electrophoresis of causative S. pyogenes isolates obtained between 2005 and 2012. Results: In total, 53 patients with STSS were included in this study. The median age of the patients was 57 years (range: 9-83 years), and 81.1% were male. The most prevalent underlying disease was diabetes mellitus (45.3%). Skin and soft-tissue infection accounted for 86.8% of STSS. The overall mortality rate was 32.1%. Underlying diseases had no statistical impact on mortality. A total of 19 different emm types were identified. The most prevalent emm type was emm102 (18.9%), followed by emm11 (17%), emm1 (11.3%), emm87 (9.4%), and emm89 (7.5%). There was no statistically significant association between emm type and a fatal outcome. Among the superantigen genes, speB was the most frequently detected one (92.5%), followed by smeZ (90.6%), speG (81.1%), speC (39.6%), and speF (39.6%). The majority of emm102 strains were found to have speB, speC, speG, and smeZ. The presence of speG was negatively associated with a fatal outcome (P = 0.045). Conclusions: Our surveillance revealed the emergence of uncommon emm types, particularly emm102, causing STSS in southern Taiwan. Characterization of clinical, epidemiological, and molecular characteristics of STSS will improve our understanding of this life-threatening disease.	[Lin, Jiun-Nong; Lai, Chung-Hsu; Chen, Yen-Hsu] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Lin, Jiun-Nong] I Shou Univ, Dept Crit Care Med, E Da Hosp, Kaohsiung, Taiwan; [Lin, Jiun-Nong; Lai, Chung-Hsu; Lin, Hsi-Hsun] I Shou Univ, Dept Internal Med, E Da Hosp, Div Infect Dis, Kaohsiung, Taiwan; [Chang, Lin-Li] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Microbiol, Kaohsiung, Taiwan; [Lin, Hsi-Hsun] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chen, Yen-Hsu] Kaohsiung Med Univ Hosp, Div Infect Dis, Dept Internal Med, Kaohsiung, Taiwan	Kaohsiung Medical University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Kaohsiung Medical University; National Yang Ming Chiao Tung University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chen, YH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.	infchen@gmail.com		Chen, Yen-hsu/0000-0002-8667-4844	E-Da Hospital [EDAHI102002]	E-Da Hospital	This work was supported by grant EDAHI102002 from the E-Da Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall B, 2000, MICROBIOL-SGM, V146, P1195, DOI 10.1099/00221287-146-5-1195; Bessen DE, 1999, J INFECT DIS, V179, P627, DOI 10.1086/314631; BRAUN MA, 1993, J IMMUNOL, V150, P2457; Brosnahan AJ, 2011, FEBS J, V278, P4649, DOI 10.1111/j.1742-4658.2011.08151.x; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Centers for Disease Control and Prevention, 2010, STREPT LAB PROT; Centers for Disease Control and Prevention, 2011, CDC STREPT LAB; Chiang-Ni C, 2011, J MICROBIOL IMMUNOL, V44, P424, DOI 10.1016/j.jmii.2011.04.005; Chiou CS, 2004, J CLIN MICROBIOL, V42, P3998, DOI 10.1128/JCM.42.9.3998-4006.2004; Commons R, 2008, J MED MICROBIOL, V57, P1238, DOI 10.1099/jmm.0.2008/001156-0; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Dale JB, 2013, VACCINE, V31, P1576, DOI 10.1016/j.vaccine.2013.01.019; Dale JB, 2011, VACCINE, V29, P8175, DOI 10.1016/j.vaccine.2011.09.005; Darenberg J, 2007, CLIN INFECT DIS, V45, P450, DOI 10.1086/519936; Defining the group A streptococcal toxic shock syndrome, 1993, JAMA, V269, P390; DEMERS B, 1993, CLIN INFECT DIS, V16, P792, DOI 10.1093/clind/16.6.792; Factor SH, 2005, EMERG INFECT DIS, V11, P1062, DOI 10.3201/eid1107.040900; Factor SH, 2003, EMERG INFECT DIS, V9, P970; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fraser JD, 2008, IMMUNOL REV, V225, P226, DOI 10.1111/j.1600-065X.2008.00681.x; Friaes A, 2013, EUR J CLIN MICROBIOL, V32, P115, DOI 10.1007/s10096-012-1726-3; Gerlach D, 2001, FEMS IMMUNOL MED MIC, V30, P209, DOI 10.1111/j.1574-695X.2001.tb01572.x; HOLM SE, 1992, J INFECT DIS, V166, P31, DOI 10.1093/infdis/166.1.31; Hsueh PR, 1998, CLIN INFECT DIS, V26, P584, DOI 10.1086/514567; Huang Yi-Chuan, 2001, Journal of Microbiology Immunology and Infection, V34, P195; Ikebe T, 2007, EPIDEMIOL INFECT, V135, P1227, DOI 10.1017/S0950268807007984; Lamagni TL, 2008, J CLIN MICROBIOL, V46, P2359, DOI 10.1128/JCM.00422-08; Lappin E, 2009, LANCET INFECT DIS, V9, P281, DOI 10.1016/S1473-3099(09)70066-0; Lepoutre A, 2011, J CLIN MICROBIOL, V49, P4094, DOI 10.1128/JCM.00070-11; Li ZY, 2003, J INFECT DIS, V188, P1587, DOI 10.1086/379050; Lin JN, 2011, J CLIN MICROBIOL, V49, P3632, DOI 10.1128/JCM.00531-11; Lin JN, 2013, AM J EMERG MED, V31; Luca-Harari B, 2008, J CLIN MICROBIOL, V46, P79, DOI 10.1128/JCM.01626-07; Maripuu L, 2008, FEMS IMMUNOL MED MIC, V54, P236, DOI 10.1111/j.1574-695X.2008.00469.x; McMillan DJ, 2007, MICROBES INFECT, V9, P259, DOI 10.1016/j.micinf.2006.11.014; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; Meisal R, 2010, J CLIN MICROBIOL, V48, P842, DOI 10.1128/JCM.01312-09; Nooh MM, 2007, J IMMUNOL, V178, P3076, DOI 10.4049/jimmunol.178.5.3076; Norrby-Teglund A, 2001, J INFECT DIS, V184, P853, DOI 10.1086/323443; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Plainvert C, 2012, CLIN MICROBIOL INFEC, V18, P702, DOI 10.1111/j.1469-0691.2011.03624.x; Proft T, 2000, J EXP MED, V191, P1765, DOI 10.1084/jem.191.10.1765; Proft T, 2003, INFECT IMMUN, V71, P1361, DOI 10.1128/IAI.71.3.1361-1369.2003; Rantala S, 2012, EUR J CLIN MICROBIOL, V31, P859, DOI 10.1007/s10096-011-1385-9; Ruoff KL, 2003, STREPTOCOCCUS, P405; Schmitz FJ, 2003, J INFECT DIS, V188, P1578, DOI 10.1086/379230; SCOTT JR, 1985, P NATL ACAD SCI USA, V82, P1822, DOI 10.1073/pnas.82.6.1822; Shah SS, 2009, CLIN INFECT DIS, V49, P1369, DOI 10.1086/606048; Silva-Costa C, 2006, CLIN MICROBIOL INFEC, V12, P513, DOI 10.1111/j.1469-0691.2006.01408.x; Smoot LM, 2002, INFECT IMMUN, V70, P7095, DOI 10.1128/IAI.70.12.7095-7104.2002; Steer AC, 2009, LANCET INFECT DIS, V9, P611, DOI 10.1016/S1473-3099(09)70178-1; Su YF, 2009, J CLIN MICROBIOL, V47, P2658, DOI 10.1128/JCM.01078-09; Vlaminckx BJM, 2003, J CLIN MICROBIOL, V41, P4941, DOI 10.1128/JCM.41.11.4941-4949.2003	53	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81700	10.1371/journal.pone.0081700	http://dx.doi.org/10.1371/journal.pone.0081700			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349115	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200045
J	Pan, YJ; Lin, TL; Chen, YH; Hsu, CR; Hsieh, PF; Wu, MC; Wang, JT				Pan, Yi-Jiun; Lin, Tzu-Lung; Chen, Yen-Hua; Hsu, Chun-Ru; Hsieh, Pei-Fang; Wu, Meng-Chuan; Wang, Jin-Town			Capsular Types of Klebsiella pneumoniae Revisited by wzc Sequencing	PLOS ONE			English	Article							PYOGENIC LIVER-ABSCESS; ESCHERICHIA-COLI; VACCINE DEVELOPMENT; VIRULENCE GENE; NORTH-AMERICA; SEROTYPE K1; POLYSACCHARIDE; TAIWAN; SEROEPIDEMIOLOGY; BACTEREMIA	Capsule is an important virulence factor in bacteria. A total of 78 capsular types have been identified in Klebsiella pneumoniae. However, there are limitations in current typing methods. We report here the development of a new genotyping method based on amplification of the variable regions of the wzc gene. Fragments corresponding to the variable region of wzc were amplified and sequenced from 76 documented capsular types of reference or clinical strains. The remaining two capsular types (reference strains K15 and K50) lacked amplifiable wzc genes and were proven to be acapsular. Strains with the same capsular type exhibited >= 94% DNA sequence identity across the variable region (CD1-VR2-CD2) of wzc. Strains with distinct K types exhibited <80% DNA sequence identity across this region, with the exception of three pairs of strains: K22/K37, K9/K45, and K52/K79. Strains K22 and K37 shared identical capsular polysaccharide synthesis (cps) genes except for one gene with a difference at a single base which resulted in frameshift mutation. The wzc sequences of K9 and K45 exhibited high DNA sequence similarity but possessed different genes in their cps clusters. K52 and K79 exhibited 89% wzc DNA sequence identity but were readily distinguished from each other at the DNA level; in contrast, strains with the same capsular type as K52 exhibited 100% wzc sequence identity. A total of 29 strains from patients with bacteremia were typed by the wzc system. wzc DNA sequences confirmed the documented capsular type for twenty-eight of these clinical isolates; the remaining strain likely represents a new capsular type. Thus, the wzc genotyping system is a simple and useful method for capsular typing of K. pneumoniae.	[Pan, Yi-Jiun; Lin, Tzu-Lung; Chen, Yen-Hua; Hsu, Chun-Ru; Hsieh, Pei-Fang; Wu, Meng-Chuan; Wang, Jin-Town] Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan; [Wang, Jin-Town] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital	Wang, JT (corresponding author), Natl Taiwan Univ, Coll Med, Dept Microbiol, Taipei 10764, Taiwan.	wangjt@ntu.edu.tw	Hsu, Chun-Ru/ABF-8475-2020	Chen, Yen-Hua/0000-0002-5794-3769; Pan, Yi-Jiun/0000-0002-2522-7805	National Science Council; National Taiwan University; National Taiwan University Hospital; Liver Disease Prevention and Treatment Research Foundation in Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); National Taiwan University(National Taiwan University); National Taiwan University Hospital(National Taiwan University); Liver Disease Prevention and Treatment Research Foundation in Taiwan	This study was supported by grants from the National Science Council, National Taiwan University, National Taiwan University Hospital and the Liver Disease Prevention and Treatment Research Foundation in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbot S.L., 2003, MANUAL CLIN MICROBIO, P684; ALTMAN E, 1983, CARBOHYD RES, V118, P183, DOI 10.1016/0008-6215(83)88046-X; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Brisse S, 2004, J CLIN MICROBIOL, V42, P3388, DOI 10.1128/JCM.42.8.3388-3398.2004; Chang CM, 2008, INFECTION, V36, P328, DOI 10.1007/s15010-008-7272-3; CHENG DL, 1991, ARCH INTERN MED, V151, P1557; Chuang YP, 2006, J INFECT DIS, V193, P645, DOI 10.1086/499968; Chung DR, 2007, J INFECTION, V54, P578, DOI 10.1016/j.jinf.2006.11.008; Cortes G, 2002, INFECT IMMUN, V70, P2583, DOI 10.1128/IAI.70.5.2583-2590.2002; CRYZ SJ, 1986, J CLIN MICROBIOL, V23, P687, DOI 10.1128/JCM.23.4.687-690.1986; Drummelsmith J, 2000, EMBO J, V19, P57, DOI 10.1093/emboj/19.1.57; Fang CT, 2007, CLIN INFECT DIS, V45, P284, DOI 10.1086/519262; Fang CT, 2004, J EXP MED, V199, P697, DOI 10.1084/jem.20030857; Fang FC, 2005, J CLIN MICROBIOL, V43, P991, DOI 10.1128/JCM.43.2.991-992.2005; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Hsieh PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033155; Jenney AW, 2006, J CLIN MICROBIOL, V44, P102, DOI 10.1128/JCM.44.1.102-107.2006; Julianelle LA, 1926, J EXP MED, V44, P113, DOI 10.1084/jem.44.1.113; Keynan Y, 2007, SCAND J INFECT DIS, V39, P828, DOI 10.1080/00365540701266763; Ko WC, 2002, EMERG INFECT DIS, V8, P160, DOI 10.3201/eid0802.010025; Lin MH, 2009, MOL CELL PROTEOMICS, V8, P2613, DOI 10.1074/mcp.M900276-MCP200; Lin WH, 2010, INFECTION, V38, P459, DOI 10.1007/s15010-010-0049-5; MIZUTA K, 1983, INFECT IMMUN, V40, P56, DOI 10.1128/IAI.40.1.56-61.1983; MOLLER HJ, 1993, ANAL BIOCHEM, V209, P169, DOI 10.1006/abio.1993.1098; Nadasy KA, 2007, CLIN INFECT DIS, V45, pE25, DOI 10.1086/519424; Ohmori S, 2002, HEPATOL RES, V22, P307, DOI 10.1016/S1386-6346(01)00153-X; Okano H, 2002, INT J MOL MED, V10, P627; ORSKOV I, 1984, METHOD MICROBIOL, V14, P143, DOI 10.1016/S0580-9517(08)70449-5; Pan YJ, 2008, J CLIN MICROBIOL, V46, P2231, DOI 10.1128/JCM.01716-07; PAROLIS H, 1992, CARBOHYD RES, V231, P93, DOI 10.1016/0008-6215(92)84011-G; PAROLIS LAS, 1988, CARBOHYD RES, V179, P301, DOI 10.1016/0008-6215(88)84126-0; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Rahn A, 1999, J BACTERIOL, V181, P2307, DOI 10.1128/JB.181.7.2307-2313.1999; Struve C, 2005, J MED MICROBIOL, V54, P1111, DOI 10.1099/jmm.0.46165-0; Tsai FC, 2008, EMERG INFECT DIS, V14, P1592, DOI 10.3201/eid1410.071254; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; Wang JH, 1998, CLIN INFECT DIS, V26, P1434, DOI 10.1086/516369; Wang JL, 2005, CLIN INFECT DIS, V40, P915, DOI 10.1086/428574; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Wugeditsch T, 2001, J BIOL CHEM, V276, P2361, DOI 10.1074/jbc.M009092200; Yu WL, 2008, DIAGN MICR INFEC DIS, V62, P1, DOI 10.1016/j.diagmicrobio.2008.04.007; Yu WL, 2007, J INFECT DIS, V195, P1235, DOI 10.1086/512686; Zamze S, 2002, J BIOL CHEM, V277, P41613, DOI 10.1074/jbc.M207057200	45	85	92	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80670	10.1371/journal.pone.0080670	http://dx.doi.org/10.1371/journal.pone.0080670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349011	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200010
J	Stein, A; Engell, A; Okamoto, H; Wollbrink, A; Lau, P; Wunderlich, R; Rudack, C; Pantev, C				Stein, Alwina; Engell, Alva; Okamoto, Hidehiko; Wollbrink, Andreas; Lau, Pia; Wunderlich, Robert; Rudack, Claudia; Pantev, Christo			Modulatory Effects of Spectral Energy Contrasts on Lateral Inhibition in the Human Auditory Cortex: An MEG Study	PLOS ONE			English	Article							TONOTOPIC ORGANIZATION; COCHLEAR NUCLEUS; TINNITUS; RESPONSES; MUSIC; NOISE; NEUROSCIENCE; DEPENDENCE; PATTERNS; RECOVERY	We investigated the modulation of lateral inhibition in the human auditory cortex by means of magnetoencephalography (MEG). In the first experiment, five acoustic masking stimuli (MS), consisting of noise passing through a digital notch filter which was centered at 1 kHz, were presented. The spectral energy contrasts of four MS were modified systematically by either amplifying or attenuating the edge-frequency bands around the notch (EFB) by 30 dB. Additionally, the width of EFB amplification/attenuation was varied (3/8 or 7/8 octave on each side of the notch). N1m and auditory steady state responses (ASSR), evoked by a test stimulus with a carrier frequency of 1 kHz, were evaluated. A consistent dependence of N1m responses upon the preceding MS was observed. The minimal NI m source strength was found in the narrowest amplified EFB condition, representing pronounced lateral inhibition of neurons with characteristic frequencies corresponding to the center frequency of the notch (NOTCH CF) in secondary auditory cortical areas. We tested in a second experiment whether an even narrower bandwidth of EFB amplification would result in further enhanced lateral inhibition of the NOTCH CF. Here three MS were presented, two of which were modified by amplifying 1/8 or 1/24 octave EFB width around the notch. We found that N1m responses were again significantly smaller in both amplified EFB conditions as compared to the NFN condition. To our knowledge, this is the first study demonstrating that the energy and width of the EFB around the notch modulate lateral inhibition in human secondary auditory cortical areas. Because it is assumed that chronic tinnitus is caused by a lack of lateral inhibition, these new insights could be used as a tool for further improvement of tinnitus treatments focusing on the lateral inhibition of neurons corresponding to the tinnitus frequency, such as the tailor-made notched music training.	[Stein, Alwina; Engell, Alva; Wollbrink, Andreas; Lau, Pia; Wunderlich, Robert; Pantev, Christo] Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Okamoto, Hidehiko] Natl Inst Physiol Sci, Dept Integrat Physiol, Okazaki, Aichi 444, Japan; [Rudack, Claudia] Univ Hosp, Dept Otolaryngol, Munster, Germany	University of Munster; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Munster	Pantev, C (corresponding author), Univ Hosp, Inst Biomagnetism & Biosignalanal, Munster, Germany.	pantev@uni-muenster.de	Okamoto, Hidehiko/A-7934-2008	Okamoto, Hidehiko/0000-0003-2799-3340; Stein, Alwina/0000-0002-1647-680X	IZKF [CRA05]; Deutsche Forschungsgemeinschaft [PA 392/14-1]; Japan Society for the Promotion of Science for Young Scientists [23689070]	IZKF; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by IZKF (CRA05) and Deutsche Forschungsgemeinschaft (PA 392/14-1). Hidehiko Okamoto was supported by the Japan Society for the Promotion of Science for Young Scientists (23689070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajima A, 2006, CEREB CORTEX, V16, P1202, DOI 10.1093/cercor/bhj061; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Catz N, 2013, FRONTIERS SYSTEMS NE; Chevillet M, 2011, J NEUROSCI, V31, P9345, DOI 10.1523/JNEUROSCI.1448-11.2011; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Engelien A, 2000, HEARING RES, V148, P153, DOI 10.1016/S0378-5955(00)00148-9; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; May P, 1999, J COMPUT NEUROSCI, V6, P99, DOI 10.1023/A:1008896417606; Norena A, 2000, HEARING RES, V149, P24, DOI 10.1016/S0378-5955(00)00158-1; Norena A, 1999, CLIN NEUROPHYSIOL, V110, P666, DOI 10.1016/S1388-2457(98)00034-0; Norena AJ, 2011, NEUROSCI BIOBEHAV R, V35, P1089, DOI 10.1016/j.neubiorev.2010.11.003; Okamoto H, 2005, EUR J NEUROSCI, V21, P1957, DOI 10.1111/j.1460-9568.2005.04022.x; Okamoto H, 2004, HEARING RES, V196, P77, DOI 10.1016/j.heares.2004.04.017; Okamoto H., 2009, LISTENING TAILOR MAD, DOI [10.1073/pnas.0911268107, DOI 10.1073/PNAS.0911268107]; Okamoto H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-52; Okamoto H, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-33; Okamoto H, 2010, P NATL ACAD SCI USA, V107, P1207, DOI 10.1073/pnas.0911268107; Okamoto H, 2009, CEREB CORTEX, V19, P2290, DOI 10.1093/cercor/bhn245; Pantev C, 1999, BRAIN RES, V842, P192, DOI 10.1016/S0006-8993(99)01835-1; PANTEV C, 1988, ELECTROEN CLIN NEURO, V69, P160, DOI 10.1016/0013-4694(88)90211-8; Pantev C, 2004, EUR J NEUROSCI, V19, P2337, DOI 10.1111/j.0953-816X.2004.03296.x; PANTEV C, 1995, ELECTROEN CLIN NEURO, V94, P26, DOI 10.1016/0013-4694(94)00209-4; RHODE WS, 1994, J NEUROPHYSIOL, V71, P493, DOI 10.1152/jn.1994.71.2.493; Roberts LE, 2010, J NEUROSCI, V30, P14972, DOI 10.1523/JNEUROSCI.4028-10.2010; ROMANI GL, 1982, SCIENCE, V216, P1339, DOI 10.1126/science.7079770; Ross B, 2005, CEREB CORTEX, V15, P2029, DOI 10.1093/cercor/bhi078; Ross B, 2002, HEARING RES, V165, P68, DOI 10.1016/S0378-5955(02)00285-X; Shamma S, 2001, TRENDS COGN SCI, V5, P340, DOI 10.1016/S1364-6613(00)01704-6; SHAMMA SA, 1985, HEARING RES, V19, P1, DOI 10.1016/0378-5955(85)90094-2; SHORE SE, 1995, HEARING RES, V82, P31, DOI 10.1016/0378-5955(94)00160-R; Soeta Y, 2009, NEUROREPORT, V20, P548, DOI 10.1097/WNR.0b013e32832a6f15; SUGA N, 1995, NEUROSCI RES, V21, P287, DOI 10.1016/0168-0102(94)00868-G; Tanji K, 2010, NEUROIMAGE, V49, P150, DOI 10.1016/j.neuroimage.2009.07.029; Teismann H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024685; TESCHE CD, 1995, ELECTROEN CLIN NEURO, V95, P189, DOI 10.1016/0013-4694(95)00064-6; Thaerig S, 2008, INT J PSYCHOPHYSIOL, V67, P235, DOI 10.1016/j.ijpsycho.2007.06.007; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Zatorre RJ, 2002, TRENDS COGN SCI, V6, P37, DOI 10.1016/S1364-6613(00)01816-7	38	13	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80899	10.1371/journal.pone.0080899	http://dx.doi.org/10.1371/journal.pone.0080899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349019	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200013
J	Williams, PS; Hoffman, RL; Clark, BC				Williams, Petra S.; Hoffman, Richard L.; Clark, Brian C.			Preliminary Evidence That Anodal Transcranial Direct Current Stimulation Enhances Time to Task Failure of a Sustained Submaximal Contraction	PLOS ONE			English	Article							HUMAN MOTOR CORTEX; NONINVASIVE BRAIN-STIMULATION; MAGNETIC STIMULATION; BICEPS-BRACHII; MUSCLE FATIGUE; ISOMETRIC CONTRACTION; CORTICAL EXCITABILITY; SUPRASPINAL FACTORS; ACTIVATION; PLASTICITY	The purpose of this study was to determine whether anodal transcranial direct current stimulation (tDCS) delivered while performing a sustained submaximal contraction would increase time to task failure (TTF) compared to sham stimulation. Healthy volunteers (n = 18) performed two fatiguing contractions at 20% of maximum strength with the elbow flexors on separate occasions. During fatigue task performance, either anodal or sham stimulation was delivered to the motor cortex for up to 20 minutes. Transcranial magnetic stimulation (TMS) was used to assess changes in cortical excitability during stimulation. There was no systematic effect of the anodal tDCS stimulation on TTF for the entire subject set (n = 18; p = 0.64). Accordingly, a posteriori subjects were divided into two tDCS-time groups: Full-Time (n = 8), where TTF occurred prior to the termination of tDCS, and Part-Time (n = 10), where TTF extended after tDCS terminated. The TTF for the Full-Time group was 31% longer with anodal tDCS compared to sham (p = 0.04), whereas TTF for the Part-Time group did not differ (p = 0.81). Therefore, the remainder of our analysis addressed the Full-Time group. With anodal tDCS, the amount of muscle fatigue was 6% greater at task failure (p = 0.05) and the amount of time the Full-Time group performed the task at an RPE between 8-10 ("very hard'') increased by 38% (p = 0.04) compared to sham. There was no difference in measures of cortical excitability between stimulation conditions (p = 0.90). That the targeted delivery of anodal tDCS during task performance both increased TTF and the amount of muscle fatigue in a subset of subjects suggests that augmenting cortical excitability with tDCS enhanced descending drive to the spinal motorpool to recruit more motor units. The results also suggest that the application of tDCS during performance of fatiguing activity has the potential to bolster the capacity to exercise under conditions required to derive benefits due to overload.	[Williams, Petra S.; Hoffman, Richard L.; Clark, Brian C.] Ohio Univ, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA; [Williams, Petra S.] No Arizona Univ, Dept Phys Therapy & Athlet Training, Flagstaff, AZ 86011 USA; [Clark, Brian C.] Ohio Univ, Dept Biomed Sci, Athens, OH 45701 USA; [Clark, Brian C.] Ohio Univ, Dept Geriatr Med & Gerontol, Athens, OH 45701 USA	University System of Ohio; Ohio University; Northern Arizona University; University System of Ohio; Ohio University; University System of Ohio; Ohio University	Williams, PS (corresponding author), Ohio Univ, Ohio Musculoskeletal & Neurol Inst, Athens, OH 45701 USA.	petra.williams@nau.edu			National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development [R15HD065552]; Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R15HD065552] Funding Source: NIH RePORTER	National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by grant R15HD065552 from the National Institutes of Health's Eunice Kennedy Shriver National Institute of Child Health and Human Development to B. C. Clark. Additionally, internal support for this work was provided by a grant from the Research and Scholarly Affairs Committee at the Ohio University Heritage College of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Barry BK, 2007, INTEGR COMP BIOL, V47, P465, DOI 10.1093/icb/icm047; Bastani A, 2012, CLIN NEUROPHYSIOL, V123, P644, DOI 10.1016/j.clinph.2011.08.029; BIGLANDRITCHIE B, 1982, J PHYSIOL-LONDON, V330, P265, DOI 10.1113/jphysiol.1982.sp014340; BIGLANDRITCHIE B, 1984, MUSCLE NERVE, V7, P691, DOI 10.1002/mus.880070902; Boggio PS, 2007, RESTOR NEUROL NEUROS, V25, P123; Bolognini N, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BRASILNETO JP, 1992, J CLIN NEUROPHYSIOL, V9, P132, DOI 10.1097/00004691-199201000-00014; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Cogiamanian F, 2007, EUR J NEUROSCI, V26, P242, DOI 10.1111/j.1460-9568.2007.05633.x; Damron LA, 2008, J NEUROSCI METH, V173, P121, DOI 10.1016/j.jneumeth.2008.06.001; DaSilva AF, 2011, JOVE-J VIS EXP, DOI 10.3791/2744; Docherty D, 2000, SPORTS MED, V30, P385, DOI 10.2165/00007256-200030060-00001; Duchateau J, 2002, J PHYSIOL-LONDON, V541, P959, DOI 10.1113/jphysiol.2002.016790; ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631, DOI 10.1152/jappl.1992.72.5.1631; Enoka RM, 2012, J BIOMECH, V45, P427, DOI 10.1016/j.jbiomech.2011.11.047; Enoka RM, 2011, J ELECTROMYOGR KINES, V21, P208, DOI 10.1016/j.jelekin.2010.10.006; Fricke K, 2011, J NEUROPHYSIOL, V105, P1141, DOI 10.1152/jn.00608.2009; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529, DOI 10.1113/jphysiol.1996.sp021164; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; GARLAND SJ, 1994, J APPL PHYSIOL, V76, P2411, DOI 10.1152/jappl.1994.76.6.2411; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Hummel FC, 2006, LANCET NEUROL, V5, P708, DOI 10.1016/S1474-4422(06)70525-7; Hunter SK, 2003, J APPL PHYSIOL, V94, P108, DOI 10.1152/japplphysiol.00635.2002; Jones LA, 1995, ADV EXP MED BIOL, V384, P305; Kalmar JM, 2006, EXP BRAIN RES, V173, P446, DOI 10.1007/s00221-006-0383-0; Klass M, 2008, J NEUROPHYSIOL, V99, P1096, DOI 10.1152/jn.01252.2007; Lang N, 2004, EXP BRAIN RES, V156, P439, DOI 10.1007/s00221-003-1800-2; Lang N, 2005, EUR J NEUROSCI, V22, P495, DOI 10.1111/j.1460-9568.2005.04233.x; Lang N, 2011, J NEUROPHYSIOL, V105, P2802, DOI 10.1152/jn.00617.2010; Maluf KS, 2005, J APPL PHYSIOL, V99, P389, DOI 10.1152/japplphysiol.00207.2005; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; McNeil CJ, 2011, J PHYSIOL-LONDON, V589, P3533, DOI 10.1113/jphysiol.2011.207191; McNeil CJ, 2009, J PHYSIOL-LONDON, V587, P5601, DOI 10.1113/jphysiol.2009.180968; McNeil CJ., 2011, PHYSL NEWS, V82, P29; Muthalib M, 2013, ADV EXP MED BIOL, V789, P73, DOI 10.1007/978-1-4614-7411-1_11; Nitsche MA, 2007, J NEUROPHYSIOL, V97, P3109, DOI 10.1152/jn.01312.2006; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P2220, DOI 10.1016/S1388-2457(03)00235-9; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2003, CLIN NEUROPHYSIOL, V114, P600, DOI 10.1016/S1388-2457(02)00412-1; Nitsche MA, 2003, J PHYSIOL-LONDON, V553, P293, DOI 10.1113/jphysiol.2003.049916; Nitsche MA, 2005, J PHYSIOL-LONDON, V568, P291, DOI 10.1113/jphysiol.2005.092429; Nitsche MA, 2007, J NEUROSCI, V27, P3807, DOI 10.1523/JNEUROSCI.5348-06.2007; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Peterchev AV, 2012, BRAIN STIMUL, V5, P435, DOI 10.1016/j.brs.2011.10.001; Place N, 2009, CLIN EXP PHARMACOL P, V36, P334, DOI 10.1111/j.1440-1681.2008.05021.x; Poortvliet PC, 2013, CLIN NEUROPHYSIOL, V124, P732, DOI 10.1016/j.clinph.2012.09.025; Priori A, 1998, NEUROREPORT, V9, P2257, DOI 10.1097/00001756-199807130-00020; Ratamess NA, 2009, MED SCI SPORT EXER, V41, P687, DOI 10.1249/MSS.0b013e3181915670; Reis J, 2008, J PHYSIOL-LONDON, V586, P325, DOI 10.1113/jphysiol.2007.144824; Reis J, 2011, CURR OPIN NEUROL, V24, P590, DOI 10.1097/WCO.0b013e32834c3db0; Reis J, 2008, BRAIN STIMUL, V1, P363, DOI 10.1016/j.brs.2008.08.001; Rothwell JC, 2009, J PHYSIOL-LONDON, V587, P5517, DOI 10.1113/jphysiol.2009.183475; Rothwell JC, 2010, FOLIA PHONIATR LOGO, V62, P153, DOI 10.1159/000314030; Sacco P, 1997, MUSCLE NERVE, V20, P1158, DOI 10.1002/(SICI)1097-4598(199709)20:9<1158::AID-MUS11>3.0.CO;2-P; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; Taylor JL, 1997, EXP BRAIN RES, V117, P472, DOI 10.1007/s002210050243; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519, DOI 10.1113/jphysiol.1996.sp021163; Taylor JL, 2001, MUSCLE NERVE, V24, P18, DOI 10.1002/1097-4598(200101)24:1<18::AID-MUS2>3.3.CO;2-4; Thirugnanasambandam N, 2011, RESTOR NEUROL NEUROS, V29, P311, DOI 10.3233/RNN-2011-0601; Zijdewind I, 2006, EXP BRAIN RES, V175, P526, DOI 10.1007/s00221-006-0570-z	68	81	85	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81418	10.1371/journal.pone.0081418	http://dx.doi.org/10.1371/journal.pone.0081418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349067	Green Published, Green Submitted, gold			2022-12-27	WOS:000328705200027
J	Garver, KA; Mahony, AAM; Stucchi, D; Richard, J; Van Woensel, C; Foreman, M				Garver, Kyle A.; Mahony, Amelia A. M.; Stucchi, Dario; Richard, Jon; Van Woensel, Cecile; Foreman, Mike			Estimation of Parameters Influencing Waterborne Transmission of Infectious Hematopoietic Necrosis Virus (IHNV) in Atlantic Salmon (Salmo salar)	PLOS ONE			English	Article							EPC CELL-LINE; SOCKEYE-SALMON; BRITISH-COLUMBIA; RAINBOW-TROUT; SEAWATER; ESTUARINE; SURVIVAL	Understanding how pathogenic organisms spread in the environment is crucial for the management of disease, yet knowledge of propagule dispersal and transmission in aquatic environments is limited. We conducted empirical studies using the aquatic virus, infectious hematopoietic necrosis virus (IHNV), to quantify infectious dose, shedding capacity, and virus destruction rates in order to better understand the transmission of IHN virus among Atlantic salmon marine net-pen aquaculture. Transmission of virus and subsequent mortality in Atlantic salmon post-smolts was initiated with as low as 10 plaque forming units (pfu) ml(-1). Virus shedding from IHNV infected Atlantic salmon was detected before the onset of visible signs of disease with peak shed rates averaging 3.2x10(7) pfu fish(-1) hour(-1) one to two days prior to mortality. Once shed into the marine environment, the abundance of free IHNV is modulated by sunlight (UV A and B) and the growth of natural biota present in the seawater. Virus decayed very slowly in sterilized seawater while rates as high as k = 4.37 d(-1) were observed in natural seawater. Decay rates were further accelerated when exposed to sunlight with virus infectivity reduced by six orders of magnitude within 3 hours of full sunlight exposure. Coupling the IHNV transmission parameter estimates determined here with physical water circulation models, will increase the understanding of IHNV dispersal and provide accurate geospatial predictions of risk for IHNV transmission from marine salmon sites.	[Garver, Kyle A.; Mahony, Amelia A. M.; Richard, Jon; Van Woensel, Cecile] Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada; [Stucchi, Dario; Foreman, Mike] Fisheries & Oceans Canada, Inst Ocean Sci, Sidney, BC, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada	Garver, KA (corresponding author), Fisheries & Oceans Canada, Pacific Biol Stn, Nanaimo, BC V9T 6N7, Canada.	Kyle.Garver@dfo-mpo.gc.ca			Aquaculture Coordinated Research and Development Program of Fisheries and Oceans Canada [P09-03-006, P11-02-005]	Aquaculture Coordinated Research and Development Program of Fisheries and Oceans Canada	Financial support was provided through project P09-03-006 and P11-02-005 of the Aquaculture Coordinated Research and Development Program of Fisheries and Oceans Canada (http://www.dfo-mpo.gc.ca/science/enviro/aquaculture/acrdp-pcrda/index-eng.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMEND DF, 1969, T AM FISH SOC, V98, P796, DOI 10.1577/1548-8659(1969)98[796:AHVDOR]2.0.CO;2; AMEND DF, 1977, J FISH BIOL, V11, P567, DOI 10.1111/j.1095-8649.1977.tb05713.x; Barja J. L., 1983, Bulletin of the European Association of Fish Pathologists, V3, P47; Batts W. N., 1989, Journal of Aquatic Animal Health, V1, P284, DOI 10.1577/1548-8667(1989)001&lt;0284:EDOIHN&gt;2.3.CO;2; BERRY SA, 1976, WATER RES, V10, P323, DOI 10.1016/0043-1354(76)90174-3; Bootland LM, 1999, FISH DISEASES AND DISORDERS, VOL 3, P57; DROLET BS, 1994, J FISH DIS, V17, P337, DOI 10.1111/j.1365-2761.1994.tb00229.x; Emmenegger EJ, 2000, DIS AQUAT ORGAN, V40, P163, DOI 10.3354/dao040163; FIJAN N, 1983, ANN INST PASTEUR VIR, V134, P207, DOI 10.1016/S0769-2617(83)80060-4; Foreman MGG, 2012, ATMOS OCEAN, V50, P301, DOI 10.1080/07055900.2012.686900; Forester RR, 1938, J FISH RES BOARD CAN, V33, P186; Garver KA, 2006, J AQUAT ANIM HEALTH, V18, P232, DOI 10.1577/H05-038.1; GUENTHER RAYMOND W., 1959, U S FISH AND WILDLIFE SERV SPEC SCI REPT FISH, V296, P1; KAMEI Y, 1987, Bulletin of the Faculty of Fisheries Hokkaido University, V38, P271; KAMEI Y, 1987, NIPPON SUISAN GAKK, V53, P2179; KAMEI Y, 1988, Bulletin of the Faculty of Fisheries Hokkaido University, V39, P124; Kowalski W, 2009, ULTRAVIOLET GERMICIDAL IRRADIATION HANDBOOK, P1, DOI 10.1007/978-3-642-01999-9; Langhorne P., 1981, P349; LAPATRA SE, 1993, DIS AQUAT ORGAN, V16, P115, DOI 10.3354/dao016115; LaPatra SE, 1998, J AQUAT ANIM HEALTH, V10, P121, DOI 10.1577/1548-8667(1998)010&lt;0121:FAPOIH&gt;2.0.CO;2; Lytle CD, 2005, J VIROL, V79, P14244, DOI 10.1128/JVI.79.22.14244-14252.2005; McKinlay AF., 1987, EXCERPTA MED INT C S, V744, P83; Meyers TR, 2003, J AQUAT ANIM HEALTH, V15, P21, DOI 10.1577/1548-8667(2003)015&lt;0021:IHNVII&gt;2.0.CO;2; PIETSCH JP, 1977, J FISH RES BOARD CAN, V34, P1360, DOI 10.1139/f77-195; Richmond Z., 2012, J AQUACULTURE RES DE, V3, P1, DOI DOI 10.4172/2155-9546.1000120; Rudakova SL, 2007, DIS AQUAT ORGAN, V75, P1, DOI 10.3354/dao075001; Saksida SM, 2006, DIS AQUAT ORGAN, V72, P213, DOI 10.3354/dao072213; St-Hilaire S, 2002, AQUACULTURE, V212, P49, DOI 10.1016/S0044-8486(02)00201-6; SUTTLE CA, 1992, APPL ENVIRON MICROB, V58, P3721, DOI 10.1128/AEM.58.11.3721-3729.1992; TORANZO AE, 1982, J FISH DIS, V5, P223, DOI 10.1111/j.1365-2761.1982.tb00477.x; TRAXLER GS, 1993, DIS AQUAT ORGAN, V16, P111, DOI 10.3354/dao016111; Vantrepotte V, 2006, EUROPEAN COMMISSION; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; Yamamoto T., 1989, Viruses of lower vertebrates., P411	34	59	59	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82296	10.1371/journal.pone.0082296	http://dx.doi.org/10.1371/journal.pone.0082296			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340016	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100097
J	Scaiewicz, V; Nahmias, A; Chung, RT; Mueller, T; Tirosh, B; Shibolet, O				Scaiewicz, Viviana; Nahmias, Avital; Chung, Raymond T.; Mueller, Tobias; Tirosh, Boaz; Shibolet, Oren			CCAAT/Enhancer-Binding Protein Homologous (CHOP) Protein Promotes Carcinogenesis in the DEN-Induced Hepatocellular Carcinoma Model	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED APOPTOSIS; GENE-EXPRESSION; ATF6; HEPATOCARCINOGENESIS; CONTRIBUTES; PROTEOLYSIS; PROGRESSION; TUMORS; ROLES	Background and Aims: C/EBP homologous protein (CHOP) plays pro-apoptotic roles in the integrated stress response. Recently, a tumor suppressive role for CHOP was demonstrated in lung cancer via regulation of tumor metabolism. To explore the role of CHOP in hepatocarcinogenesis, we induced hepatocellular carcinoma (HCC) in wild type (wt) and CHOP knockout (KO) mice using the carcinogen N-diethylnitrosamine (DEN). Results: Analysis of tumor development showed reduced tumor load, with markedly smaller tumor nodules in the CHOP KO animals, suggesting oncogenic roles of CHOP in carcinogen-induced HCC. In wt tumors, CHOP was exclusively expressed in tumor tissue, with minimal expression in normal parenchyma. Analysis of human adenocarcinomas of various origins demonstrated scattered expression of CHOP in the tumors, pointing to relevance in human pathology. Characterization of pathways that may contribute to preferential expression of CHOP in the tumor identified ATF6 as a potential candidate. ATF6, a key member of the endoplasmic reticulum stress signaling machinery, exhibited a similar pattern of expression as CHOP and strong activation in wt but not CHOP KO tumors. Because HCC is induced by chronic inflammation, we assessed whether CHOP deficiency affects tumor-immune system crosstalk. We found that the number of macrophages and levels of IFN gamma and CCL4 mRNA were markedly reduced in tumors from CHOP KO relative to wt mice, suggesting a role for CHOP in modulating tumor microenvironment and macrophage recruitment to the tumor. Conclusion: Our data highlights a role for CHOP as a positive regulator of carcinogen-induced HCC progression through a complex mechanism that involves the immune system and modulation of stress signaling pathways.	[Scaiewicz, Viviana; Tirosh, Boaz] Hebrew Univ Jerusalem, Sch Med, Fac Med, Inst Drug Res, IL-91010 Jerusalem, Israel; [Nahmias, Avital] Hadassah Hebrew Univ Med Ctr, Liver Unit, Div Med, Jerusalem, Israel; [Chung, Raymond T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA; [Chung, Raymond T.] Harvard Univ, Sch Med, Boston, MA USA; [Mueller, Tobias] Univ Hosp Leipzig, Sect Hepatol, Dept Gastroenterol & Rheumatol, Leipzig, Germany; [Shibolet, Oren] Tel Aviv Med Ctr & Sch Med, Dept Gastroenterol, Liver Unit, Tel Aviv, Israel; [Shibolet, Oren] Tel Aviv Univ, IL-69978 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Leipzig University; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Tirosh, B (corresponding author), Hebrew Univ Jerusalem, Sch Med, Fac Med, Inst Drug Res, IL-91010 Jerusalem, Israel.	boazt@ekmd.huji.ac.il; orensh@tasmc.health.gov.il		Mueller, Tobias/0000-0003-3426-5421	Israel Science Foundation [1668/08, 78/09]; BSF [2007083]; Israel Cancer Association [20110061]	Israel Science Foundation(Israel Science Foundation); BSF(US-Israel Binational Science Foundation); Israel Cancer Association	This research was supported by the Morasha Program of Israel Science Foundation (grant No. 1668/08) to O.S, by the BSF (grant No. 2007083) to O.S and the Israel Cancer Association (20110061) to O.S, and by the Israel Science Foundation (grant 78/09) to BT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Center MM, 2011, CANCER EPIDEM BIOMAR, V20, P2362, DOI 10.1158/1055-9965.EPI-11-0643; Chen J, 2012, CANCER IMMUNOL IMMUN, V61, P101, DOI 10.1007/s00262-011-1094-3; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Chiribau CB, 2010, MOL CELL BIOL, V30, P3722, DOI 10.1128/MCB.01507-09; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DIWAN BA, 1992, CARCINOGENESIS, V13, P1893, DOI 10.1093/carcin/13.10.1893; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ghosh R, 2010, PLOS ONE, V5, pA104, DOI 10.1371/journal.pone.0009575; Gorman AM, 2012, PHARMACOL THERAPEUT, V134, P306, DOI 10.1016/j.pharmthera.2012.02.003; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hanada T, 2000, INT J UROL, V7, P263, DOI 10.1046/j.1442-2042.2000.00190.x; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520; Huber AL, 2013, MOL CELL, V49, P1049, DOI 10.1016/j.molcel.2013.01.009; Jauhiainen A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033208; Kong LQ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059771, 10.1371/journal.pone.0078275]; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Malhi H, 2013, J BIOL CHEM; Mano Y, 2013, PATHOBIOLOGY, V80, P146, DOI 10.1159/000346196; Matsuda M, 2005, LAB INVEST, V85, P655, DOI 10.1038/labinvest.3700257; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Palam LR, 2011, J BIOL CHEM, V286, P10939, DOI 10.1074/jbc.M110.216093; Pan YJ, 2004, BBA-MOL CELL RES, V1691, P41, DOI 10.1016/j.bbamcr.2003.12.003; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pereira ER, 2012, PLOS ONE, V5; Pierce RH, 2002, AM J PATHOL, V160, P1555, DOI 10.1016/S0002-9440(10)61101-7; Qiu W, 2011, HEPATOLOGY, V54, P1249, DOI 10.1002/hep.24516; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Said MM, 2009, J TOXICOL PATHOL, V22, P263, DOI 10.1293/tox.22.263; Shirabe K, 2012, SURG TODAY, V42, P1, DOI 10.1007/s00595-011-0058-8; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Teske BF, 2011, MOL BIOL CELL, V22, P4390, DOI 10.1091/mbc.E11-06-0510; Uzi D, 2013, J HEPATOL; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	40	28	32	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81065	10.1371/journal.pone.0081065	http://dx.doi.org/10.1371/journal.pone.0081065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339898	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100032
J	Shiroyama, T; Okamoto, N; Suzuki, H; Tamiya, M; Yamadori, T; Morishita, N; Otsuka, T; Morita, S; Kurata, K; Okimura, A; Kawahara, K; Sasada, S; Hirashima, T; Kawase, I				Shiroyama, Takayuki; Okamoto, Norio; Suzuki, Hidekazu; Tamiya, Motohiro; Yamadori, Tadahiro; Morishita, Naoko; Otsuka, Tomoyuki; Morita, Satomu; Kurata, Kanako; Okimura, Akira; Kawahara, Kunimitsu; Sasada, Shinji; Hirashima, Tomonori; Kawase, Ichiro			Usefulness of High Suction Pressure for Sufficient Tissue Collection During Endobronchial Ultrasound Guided Transbronchial Needle Aspiration	PLOS ONE			English	Article							CELL LUNG-CANCER; MULTICENTER; MUTATIONS; BIOPSY; TUMORS	Introduction: The optimal suction pressure during endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) remains to be determined. The aim of this study was to compare suction pressures for performance in collecting sufficient tissue specimens from mediastinal and hilar lymph nodes during EBUS-TBNA. Methods: Retrospective analysis of consecutive patients with mediastinal and hilar lymphadenopathy who underwent EBUS-TBNA over a 3-year period. Results from patients who underwent EBUS-TBNA using a dedicated 20-mL VacLoc (Merit Medical Systems, Inc, South Jordan, UT) syringe (conventional method, group C) were compared with results from patients in whom a disposable 30-mL syringe (high pressure group, group H) was used. The yield for sufficient histologic specimen retrieval and amount of tissue obtained were compared between the 2 groups. Results: Of 178 patients who underwent EBUS-TBNA, 131 had lung cancer confirmed by EBUS-TBNA: 35 in group C and 96 in group H. There were 7 patients in group C and 6 in group H who received final diagnoses by cytology alone. There were 28 in group C and 90 in group H who were diagnosed by both cytology and histology. There was a statistically significant difference between the groups in terms of the rate of sufficient sampling for histological specimens (p = 0.04). The H group revealed a tissue area approximately twice that of the C group (p = 0.003). There were no major procedure-related complications in either group. Conclusion: Higher suction pressures with larger syringe volumes during EBUS-TBNA may be useful for safely collecting sufficient tissue specimens.	[Shiroyama, Takayuki; Okamoto, Norio; Suzuki, Hidekazu; Tamiya, Motohiro; Yamadori, Tadahiro; Morishita, Naoko; Otsuka, Tomoyuki; Morita, Satomu; Kurata, Kanako; Hirashima, Tomonori; Kawase, Ichiro] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Osaka, Japan; [Kawahara, Kunimitsu] Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Pathol, Osaka, Japan; [Okimura, Akira] Steel Mem Hirohata Hosp, Dept Pathol, Kobe, Hyogo, Japan; [Sasada, Shinji] Natl Canc Ctr, Dept Endoscopy, Resp Endoscopy Div, Tokyo, Japan	Osaka Prefectural Medical Center Respiratory & Allergic Diseases; Osaka Prefectural Medical Center Respiratory & Allergic Diseases; National Cancer Center - Japan	Shiroyama, T (corresponding author), Osaka Prefectural Med Ctr Resp & Allerg Dis, Dept Thorac Malignancy, Osaka, Japan.	takayuki.s12@hotmail.co.jp	Otsuka, Tomoyuki/GRX-3302-2022	Otsuka, Tomoyuki/0000-0003-3394-0720				Casal RE, 2012, CHEST, V142, P568, DOI 10.1378/chest.11-0692; Gow CH, 2009, ANN ONCOL, V20, P696, DOI 10.1093/annonc/mdn679; Gu P, 2009, EUR J CANCER, V45, P1389, DOI 10.1016/j.ejca.2008.11.043; Lee HS, 2008, CHEST, V134, P368, DOI 10.1378/chest.07-2105; Nakajima T, 2007, CHEST, V132, P597, DOI 10.1378/chest.07-0095; Nakajima T, 2011, RESPIROLOGY, V16, P90, DOI 10.1111/j.1440-1843.2010.01871.x; Navani N, 2012, AM J RESP CRIT CARE, V185, P1316, DOI 10.1164/rccm.201202-0294OC; Navani N, 2011, J THORAC ONCOL, V6, P1505, DOI 10.1097/JTO.0b013e318223c3fe; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Sakairi Y, 2010, CLIN CANCER RES, V16, P4938, DOI 10.1158/1078-0432.CCR-10-0099; Schmid K, 2009, CLIN CANCER RES, V15, P4554, DOI 10.1158/1078-0432.CCR-09-0089; Tournoy KG, 2011, ANN ONCOL, V22, P127, DOI 10.1093/annonc/mdq311; Yarmus LB, 2013, CHEST, V143, P1036, DOI 10.1378/chest.12-1205; Yasufuku K, 2005, LUNG CANCER, V50, P347, DOI 10.1016/j.lungcan.2005.07.013	14	8	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82787	10.1371/journal.pone.0082787	http://dx.doi.org/10.1371/journal.pone.0082787			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340058	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100128
J	Zhang, H; Guan, LL; Qi, MM; Yang, J				Zhang, Hua; Guan, Lili; Qi, Mingming; Yang, Juan			Self-Esteem Modulates the Time Course of Self-Positivity Bias in Explicit Self-Evaluation	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; ENHANCEMENT; ATTENTION; STIMULI; ERP; RECOGNITION; RESPONSES; EMOTION; VALENCE	Researchers have suggested that certain individuals may show a self-positivity bias, rating themselves as possessing more positive personality traits than others. Previous evidence has shown that people evaluate self-related information in such a way as to maintain or enhance self-esteem. However, whether self-esteem would modulate the time course of self-positivity bias in explicit self-evaluation has never been explored. In the present study, 21 participants completed the Rosenberg self-esteem scale and then completed a task where they were instructed to indicate to what extent positive/negative traits described themselves. Behavioral data showed that participants endorsed positive traits as higher in self-relevance compared to the negative traits. Further, participants self-esteem levels were positively correlated with their self-positivity bias. Electrophysiological data revealed smaller N1 amplitude and larger late positive component (LPC) amplitude to stimuli consistent with the self-positivity bias (positive-high self-relevant stimuli) when compared to stimuli that were inconsistent with the self-positivity bias (positive-low self-relevant stimuli). Moreover, only in individuals with low self-esteem, the latency of P2 was more pronounced in processing stimuli that were consistent with the self-positivity bias (negative-low self-relevant stimuli) than to stimuli that were inconsistent with the self-positivity bias (positive-low self-relevant stimuli). Overall, the present study provides additional support for the view that low self-esteem as a personality variable would affect the early attentional processing.	[Zhang, Hua; Guan, Lili; Qi, Mingming; Yang, Juan] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Guan, Lili; Qi, Mingming; Yang, Juan] Southwest Univ, Dept Psychol, Chongqing, Peoples R China	Southwest University - China; Southwest University - China	Yang, J (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	valleyqq@swu.edu.cn		Qi, Mingming/0000-0002-6680-3573	Fundamental Research Funds for the Central Universities [SWU1309105]; Faculty of Psychology, Southwest University [TR201202-5]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Faculty of Psychology, Southwest University	This work was supported by the Fundamental Research Funds for the Central Universities (SWU1309105) and the Team Research Project of Faculty of Psychology, Southwest University (TR201202-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALICKE MD, 1995, J PERS SOC PSYCHOL, V68, P804, DOI 10.1037/0022-3514.68.5.804; Beck A.T., 1967, DEPRESSION CLIN EXPT; BENIGNUS VA, 1969, IEEE T ACOUST SPEECH, VAU17, P145, DOI 10.1109/TAU.1969.1162046; Bigman ZB, 2004, BIOL PSYCHOL, V66, P99, DOI 10.1016/j.biopsycho.2003.10.003; Brown JD, 2002, ASIAN J SOC PSYCHOL, V5, P145, DOI 10.1111/1467-839X.00101; BROWN JD, 1986, SOC COGNITION, V4, P353, DOI 10.1521/soco.1986.4.4.353; Brown JD, 2010, COGNITION EMOTION, V24, P1389, DOI 10.1080/02699930903504405; Burden MJ, 2009, ALCOHOL CLIN EXP RES, V33, P1994, DOI 10.1111/j.1530-0277.2009.01038.x; Campbell WK, 2002, PERS SOC PSYCHOL B, V28, P358, DOI 10.1177/0146167202286007; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Craik FIM, 1999, PSYCHOL SCI, V10, P26, DOI 10.1111/1467-9280.00102; D'Argembeau A, 2005, NEUROIMAGE, V25, P616, DOI 10.1016/j.neuroimage.2004.11.048; Dijksterhuis A, 2004, J PERS SOC PSYCHOL, V86, P345, DOI 10.1037/0022-3514.86.2.345; Edwards E, 2009, J NEUROPHYSIOL, V102, P377, DOI 10.1152/jn.90954.2008; Fields EC, 2012, NEUROIMAGE, V62, P562, DOI 10.1016/j.neuroimage.2012.05.003; Frewen PA, 2012, SOC COGN AFFECT NEUR; Gratton G., 1983, ELECTROENCEPHALOGRAP, V5, P468, DOI DOI 10.1016/0013-4694(83)90135-9; Gray HM, 2004, J EXP SOC PSYCHOL, V40, P216, DOI 10.1016/S0022-1031(03)00092-1; Heine SJ, 1999, PSYCHOL REV, V106, P766, DOI 10.1037/0033-295X.106.4.766; Herbert C, 2011, SOC COGN AFFECT NEUR, V6, P653, DOI 10.1093/scan/nsq082; Herbert C, 2011, SOC NEUROSCI-UK, V6, P277, DOI 10.1080/17470919.2010.523543; Huang X., 1992, PSYCHOL SCI, V5, P17, DOI [https://doi.org/10.16719/j.cnki.1671-6981.1992.05.004, DOI 10.1016/S0022-1031(03)00092-1]; Johnson JS, 2003, J VISION, V3, P499, DOI 10.1167/3.7.4; Johnson SC, 2002, BRAIN, V125, P1808, DOI 10.1093/brain/awf181; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Leary MR, 2007, ANNU REV PSYCHOL, V58, P317, DOI 10.1146/annurev.psych.58.110405.085658; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; Li HJ, 2012, J RES PERS, V46, P459, DOI 10.1016/j.jrp.2012.02.010; Lin YC, 2003, J CONSUM PSYCHOL, V13, P464, DOI 10.1207/S15327663JCP1304_13; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Ochsner KN, 2005, NEUROIMAGE, V28, P797, DOI 10.1016/j.neuroimage.2005.06.069; Pahl S, 2005, EXP PSYCHOL, V52, P303, DOI 10.1027/1618-3169.52.4.303; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sedikides C, 2003, J PERS SOC PSYCHOL, V84, P60, DOI 10.1037/0022-3514.84.1.60; Sinha RR, 1998, J RES PERSONALITY, V32; Tacikowski P, 2010, BIOL PSYCHOL, V84, P318, DOI 10.1016/j.biopsycho.2010.03.009; Tao R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047103; Wang G, 2005, NEUROREPORT, V16, P767, DOI 10.1097/00001756-200505120-00022; Watson LA, 2008, BRIT J PSYCHOL, V99, P143, DOI 10.1348/000712607X248689; Watson LA, 2007, BRAIN RES, V1152, P106, DOI 10.1016/j.brainres.2007.03.049; Yang J, 2012, BRAIN RES, V1471, P75, DOI 10.1016/j.brainres.2012.06.033; Yuan JJ, 2011, BIOL PSYCHOL, V87, P17, DOI 10.1016/j.biopsycho.2011.01.004	42	19	22	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81169	10.1371/journal.pone.0081169	http://dx.doi.org/10.1371/journal.pone.0081169			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	273WD	24339908	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100040
J	Huang, YP; Lin, TL; Lin, TH; Wu, HS				Huang, Yuan-Pin; Lin, Tsuey-Li; Lin, Ting-Han; Wu, Ho-Sheng			Antigenic and Genetic Diversity of Human Enterovirus 71 from 2009 to 2012, Taiwan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; CAPSID PROTEIN; PHYLOGENETIC EVIDENCE; MOUSE ADAPTATION; MOUTH-DISEASE; STRAINS; VP1; EVOLUTION; GENOGROUP; EV71	Different subgenogroups of enterovirus 71 (EV-71) have caused numerous outbreaks of hand, foot, and mouth disease worldwide, especially in the Asia-Pacific region. During the development of a vaccine against EV-71, the genetic and antigenic diversities of EV-71 isolates from Taiwan were analyzed by phylogenetic analyses and neutralization tests. The results showed that the dominant genogroups had changed twice, from B to C and from C to B, between 2009 and 2012. The subgenogroup B5 (B5b cluster) was dominant in 2008-2009 but was replaced by subgenogroup C4 in 2010-2011. From the end of 2011 to 2012, the re-emerging subgenogroup B5 (B5c cluster) was identified as the dominant subgenogroup of EV-71 outbreaks, and subgenogroups C2 and C4 were detected in sporadic cases. Interestingly, the amino acid substitution at position 145 in the VP1 gene was observed in some strains isolated from patients with acute flaccid paralysis. Furthermore, thirty-five strains and their corresponding serum samples were used to analyze the cross-protections and antigenic diversities among different subgenogroups (C4a, C5, B4, B5b, B5c, and C2-like) of EV-71. Evident antigenic diversity existed only for the C2-like subgenogroup, which was not effectively neutralized by other serum samples. In contrast, the anti-C2-like serum sample showed broad cross-reactivity against all other subgenogroups. Therefore, these results may provide valuable information for the selection of EV-71 vaccine candidates and the evolution of EV-71 subgenogroups in Taiwan from 2009 to 2012.	[Huang, Yuan-Pin; Lin, Tsuey-Li; Lin, Ting-Han; Wu, Ho-Sheng] Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Wu, Ho-Sheng] Taipei Med Univ, Sch Med Lab Sci & Biotechnol, Taipei, Taiwan	Centers For Disease Control - Taiwan; Taipei Medical University	Wu, HS (corresponding author), Minist Hlth & Welf, Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan.	wuhs@cdc.gov.tw			Taiwan CDC [DOH100-DC-2019, DOH101-DC-2401, DOH102-DC-2204, DOH102-DC-2601]; National Research Program for Genomic Medicine [98-0324-01-F-20, 99-0324-01-F-12]	Taiwan CDC; National Research Program for Genomic Medicine(Ministry of Science and Technology, Taiwan)	This study was supported financially by research grants from the Taiwan CDC (DOH100-DC-2019, DOH101-DC-2401, DOH102-DC-2204 and DOH102-DC-2601) and the National Research Program for Genomic Medicine (98-0324-01-F-20 and 99-0324-01-F-12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bible JM, 2008, J CLIN MICROBIOL, V46, P3192, DOI 10.1128/JCM.00628-08; Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang SC, 2012, J MED VIROL, V84, P931, DOI 10.1002/jmv.23287; Chen YX, 2013, VACCINE, V31, P425, DOI 10.1016/j.vaccine.2012.10.032; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; Deshpande JM, 2003, CURR SCI INDIA, V84, P1350; Foo DGW, 2008, VIRAL IMMUNOL, V21, P215, DOI 10.1089/vim.2007.0089; Guang D, 2007, VIRUS RES, V125, P61, DOI 10.1016/j.virusres.2006.12.005; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang YP, 2008, VIRUS RES, V137, P206, DOI 10.1016/j.virusres.2008.07.015; Huang YP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-277; Kung SH, 2007, CLIN MICROBIOL INFEC, V13, P782, DOI 10.1111/j.1469-0691.2007.01745.x; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Mao QY, 2012, ARCH VIROL, V157, P37, DOI 10.1007/s00705-011-1136-3; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Melnick J, 1996, FIELDS VIROLOGY, P655; Mirand A, 2010, J GEN VIROL, V91, P2263, DOI 10.1099/vir.0.021741-0; Mizuta K, 2009, VACCINE, V27, P3153, DOI 10.1016/j.vaccine.2009.03.060; Munemura T, 2003, ARCH VIROL, V148, P253, DOI 10.1007/s00705-002-0920-5; Oberste AS, 2007, VIRUS RES, V128, P34, DOI 10.1016/j.virusres.2007.04.001; Oberste MS, 2004, J GEN VIROL, V85, P1597, DOI 10.1099/vir.0.79789-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sanders SA, 2006, ARCH VIROL, V151, P1003, DOI 10.1007/s00705-005-0684-9; Seiff A, 2012, LANCET, V380, P205, DOI 10.1016/S0140-6736(12)61200-8; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan CS, 2007, ARCH VIROL, V152, P1069, DOI 10.1007/s00705-007-0941-1; van der Sanden S, 2010, J GEN VIROL, V91, P1949, DOI 10.1099/vir.0.019695-0; van der Sanden S, 2009, J CLIN MICROBIOL, V47, P2826, DOI 10.1128/JCM.00507-09; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632; Wang JR, 2002, J CLIN MICROBIOL, V40, P10, DOI 10.1128/JCM.40.1.10-15.2002; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Yu HY, 2010, VIRUS GENES, V41, P1, DOI 10.1007/s11262-010-0472-9; Zaini Z, 2012, VIRUS RES, V167, P86, DOI 10.1016/j.virusres.2012.04.009; Zhang JH, 2012, VIRUS RES, V167, P337, DOI 10.1016/j.virusres.2012.05.019; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002	40	15	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80942	10.1371/journal.pone.0080942	http://dx.doi.org/10.1371/journal.pone.0080942			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24348916	Green Submitted, Green Published, gold			2022-12-27	WOS:000327258600104
J	Xia, M; Chen, DX; Endresz, V; Faludi, I; Szabo, A; Gonczol, E; Kakkar, V; Lu, XJ				Xia, Min; Chen, Daxin; Endresz, Valeria; Faludi, Ildiko; Szabo, Andrea; Gonczol, Eva; Kakkar, Vijay; Lu, Xinjie			Immunization of Chlamydia pneumoniae (Cpn)-Infected Apob(tm2Sgy)Ldlr(tm1Her)/J Mice with a Combined Peptide of Cpn Significantly Reduces Atherosclerotic Lesion Development	PLOS ONE			English	Article							CHLAMYDOPHILA-PNEUMONIAE; T-CELLS; APO-B; INFECTION; INFLAMMATION; INHIBITION; ANTIBODIES; EPITOPES; DISEASE; IL-17A	Objective: To investigate the antigenic effect of a peptide containing two epitopes of Chlamydia pneumoniae (Cpn) on atherosclerotic lesion formation in mice infected with Cpn. Materials and Methods: Six-week-old Apob(tm2Sgy)Ldlr(tm1Her)/J mice were immunized using a repetitive immunization multiple-sites strategy with KLH-conjugated peptides derived from the major outer membrane protein and the putative outer membrane protein 5 of Cpn. Mice were fed a high-fat diet and infected with Cpn twice during the 10-week diet period. Lesions were evaluated histologically; local and systemic immune responses were analyzed by immunohistochemistry of aorta samples and cytokine measurements in plasma samples and splenocyte supernatants. Results: Mice immunized with the combined Cpn peptide showed a greater reduction in lesion size compared to mice immunized with either epitope alone [54.7% vs 39.8% or 41.72%] and was also associated with a significant decrease in lesion area in descending aortas compared with those in controls (88.9% for combined Cpn peptide, 81.9% for MOMP peptide and 75.7% for Omp5, respectively). This effect was associated with a shift in the cellular composition of plaques towards decreased inflammatory cell and increased regulatory T-cell content. Additionally, the effect was also connected with decreased secretion of proinflammatory cytokines and increased production of anti-inflammatory cytokines demonstrated in plasma and in supernatant on stimulated spleen cells. Conclusions: Atherosclerotic lesion formation may be promoted by Cpn infection in the presence of a high-fat diet, and reduced by immunization with the combined Cpn peptide. The combined peptide has more potential than either epitope alone in reducing atherosclerotic lesion development through Treg expansion.	[Xia, Min; Chen, Daxin; Kakkar, Vijay; Lu, Xinjie] Thrombosis Res Inst, Mary & Garry Weston Mol Immunol Lab, London SW3 6LR, England; [Chen, Daxin] Kings Coll London, MRC Ctr Transplantat, London WC2R 2LS, England; [Endresz, Valeria; Faludi, Ildiko] Univ Szeged, Dept Med Microbiol & Immunobiol, Szeged, Hungary; [Szabo, Andrea] Univ Szeged, Inst Surg Res, Szeged, Hungary; [Gonczol, Eva] Natl Ctr Epidemiol, Budapest, Hungary; [Gonczol, Eva] Thrombosis Res Inst, Bangalore, Karnataka, India	Thrombosis Research Institute; University of London; King's College London; Szeged University; Szeged University	Kakkar, V (corresponding author), Thrombosis Res Inst, Mary & Garry Weston Mol Immunol Lab, London SW3 6LR, England.	president@tri-kakkar.ch; xlu@tri-london.ac.uk	Szabó, Andrea/AAC-4691-2019	Szabo, Andrea/0000-0003-3139-0235	Thrombosis Research Institute London; Thrombosis Research Institute Bangalore; Garfield Weston Foundation, UK; Hungarian grant [TAMOP-4.2.1/B-09/KONV-2010-0005]	Thrombosis Research Institute London; Thrombosis Research Institute Bangalore; Garfield Weston Foundation, UK; Hungarian grant	The study was supported by grants from the Trustees of the Thrombosis Research Institute's London and Bangalore, The Garfield Weston Foundation, UK. Valeria Endresz and Ildiko Faludi were partially supported by a Hungarian grant "TAMOP-4.2.1/B-09/KONV-2010-0005". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; Blessing E, 2001, ATHEROSCLEROSIS, V158, P13, DOI 10.1016/S0021-9150(00)00758-9; Bobryshev YV, 2005, EUR HEART J, V26, P1700, DOI 10.1093/eurheartj/ehi282; Bonds RS, 2008, CURR OPIN ALLERGY CL, V8, P82, DOI 10.1097/ACI.0b013e3282f4177e; Burian K, 2003, IMMUNOL LETT, V89, P229, DOI 10.1016/S0165-2478(03)00154-8; Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784; Chen SA, 2010, J IMMUNOL, V185, P5619, DOI 10.4049/jimmunol.1001879; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Danesh J, 2002, EUR HEART J, V23, P371, DOI 10.1053/euhj.2001.2801; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Everett KDE, 1999, INT J SYST BACTERIOL, V49, P415, DOI 10.1099/00207713-49-2-415; Ezzahiri R, 2006, APMIS, V114, P117, DOI 10.1111/j.1600-0463.2006.apm_205.x; Ezzahiri R, 2002, CARDIOVASC RES, V56, P269, DOI 10.1016/S0008-6363(02)00544-8; Fredrikson GN, 2008, J INTERN MED, V264, P563, DOI 10.1111/j.1365-2796.2008.01995.x; Fredrikson GN, 2003, ARTERIOSCL THROM VAS, V23, P879, DOI 10.1161/01.ATV.0000067937.93716.DB; Gotsman I, 2008, CIRC RES, V103, P1220, DOI 10.1161/CIRCRESAHA.108.182428; Izcue A, 2006, IMMUNOL REV, V212, P256, DOI 10.1111/j.0105-2896.2006.00423.x; Joshi Rajnish, 2013, N Am J Med Sci, V5, P169, DOI 10.4103/1947-2714.109178; Kalay Nihat, 2008, Cardiol J, V15, P245; Kilpatrick KE, 1997, HYBRIDOMA, V16, P381, DOI 10.1089/hyb.1997.16.381; Kohm AP, 2003, TRENDS MICROBIOL, V11, P101, DOI 10.1016/S0966-842X(03)00006-4; Libby P, 2000, J INTERN MED, V247, P349, DOI 10.1046/j.1365-2796.2000.00654.x; LIBLAU RS, 1995, IMMUNOL TODAY, V16, P34, DOI 10.1016/0167-5699(95)80068-9; Lu XJ, 2012, ATHEROSCLEROSIS, V225, P56, DOI 10.1016/j.atherosclerosis.2012.07.021; Lu XJ, 2010, ATHEROSCLEROSIS, V212, P472, DOI 10.1016/j.atherosclerosis.2010.06.007; Maass M, 1998, ATHEROSCLEROSIS, V140, pS25, DOI 10.1016/S0021-9150(98)00117-8; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Muhlestein JB, 1998, CIRCULATION, V97, P633, DOI 10.1161/01.CIR.97.7.633; Oksjoki R, 2006, ARTERIOSCL THROM VAS, V26, P576, DOI 10.1161/01.ATV.0000201041.14438.8d; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Schiopu A, 2004, CIRCULATION, V110, P2047, DOI 10.1161/01.CIR.0000143162.56057.B5; Smith E, 2010, CIRCULATION, V121, P1746, DOI 10.1161/CIRCULATIONAHA.109.924886; TONG CYW, 1993, J CLIN PATHOL, V46, P313, DOI 10.1136/jcp.46.4.313; van Puijvelde HM, 2007, ARTERIOSCL THROM VAS, V27, P2677, DOI 10.1161/ATVBAHA.107.151274; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; Watson C, 2008, CLIN SCI, V114, P509, DOI 10.1042/CS20070298; West SK, 2009, CLIN INFECT DIS, V48, P560, DOI 10.1086/596710	38	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81056	10.1371/journal.pone.0081056	http://dx.doi.org/10.1371/journal.pone.0081056			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349031	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000328734200003
J	Fernandes, CPD; Christoforou, A; Giddaluru, S; Ersland, KM; Djurovic, S; Mattheisen, M; Lundervold, AJ; Reinvang, I; Noethen, MM; Rietschel, M; Ophoff, RA; Hofman, A; Uitterlinden, AG; Werge, T; Cichon, S; Espeseth, T; Andreassen, OA; Steen, VM; Le Hellard, S				Fernandes, Carla P. D.; Christoforou, Andrea; Giddaluru, Sudheer; Ersland, Kari M.; Djurovic, Srdjan; Mattheisen, Manuel; Lundervold, Astri J.; Reinvang, Ivar; Noethen, Markus M.; Rietschel, Marcella; Ophoff, Roel A.; Hofman, Albert; Uitterlinden, Andre G.; Werge, Thomas; Cichon, Sven; Espeseth, Thomas; Andreassen, Ole A.; Steen, Vidar M.; Le Hellard, Stephanie		GROUP	A Genetic Deconstruction of Neurocognitive Traits in Schizophrenia and Bipolar Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SET ENRICHMENT ANALYSIS; PREFRONTAL CORTEX; PSYCHIATRIC-ILLNESS; PSYCHOTIC DISORDERS; COMMON; RISK; MECHANISMS; VARIANTS; SNPS	Background: Impairments in cognitive functions are common in patients suffering from psychiatric disorders, such as schizophrenia and bipolar disorder. Cognitive traits have been proposed as useful for understanding the biological and genetic mechanisms implicated in cognitive function in healthy individuals and in the dysfunction observed in psychiatric disorders. Methods: Sets of genes associated with a range of cognitive functions often impaired in schizophrenia and bipolar disorder were generated from a genome-wide association study (GWAS) on a sample comprising 670 healthy Norwegian adults who were phenotyped for a broad battery of cognitive tests. These gene sets were then tested for enrichment of association in GWASs of schizophrenia and bipolar disorder. The GWAS data was derived from three independent single-centre schizophrenia samples, three independent single-centre bipolar disorder samples, and the multi-centre schizophrenia and bipolar disorder samples from the Psychiatric Genomics Consortium. Results: The strongest enrichments were observed for visuospatial attention and verbal abilities sets in bipolar disorder. Delayed verbal memory was also enriched in one sample of bipolar disorder. For schizophrenia, the strongest evidence of enrichment was observed for the sets of genes associated with performance in a colour-word interference test and for sets associated with memory learning slope. Conclusions: Our results are consistent with the increasing evidence that cognitive functions share genetic factors with schizophrenia and bipolar disorder. Our data provides evidence that genetic studies using polygenic and pleiotropic models can be used to link specific cognitive functions with psychiatric disorders.	[Fernandes, Carla P. D.; Christoforou, Andrea; Giddaluru, Sudheer; Ersland, Kari M.; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, KG Jebsen Ctr Psychosis Res, Bergen, Norway; [Fernandes, Carla P. D.; Christoforou, Andrea; Giddaluru, Sudheer; Ersland, Kari M.; Steen, Vidar M.; Le Hellard, Stephanie] Univ Bergen, Norwegian Ctr Mental Disorders Res NORMENT, Dept Clin Sci, Bergen, Norway; [Fernandes, Carla P. D.; Christoforou, Andrea; Giddaluru, Sudheer; Ersland, Kari M.; Steen, Vidar M.; Le Hellard, Stephanie] Haukeland Hosp, Dr Einar Martens Res Grp Biol Psychiat, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Djurovic, Srdjan; Espeseth, Thomas; Andreassen, Ole A.] Univ Oslo, Oslo Univ Hosp, Div Mental Hlth & Addict, KG Jebsen Ctr Psychosis Res,Norwegian Ctr Mental, Oslo, Norway; [Djurovic, Srdjan; Espeseth, Thomas; Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Mattheisen, Manuel; Noethen, Markus M.; Cichon, Sven] Univ Bonn, Dept Genom, Life & Brain Ctr, Bonn, Germany; [Mattheisen, Manuel] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Mattheisen, Manuel] Harvard Univ, Sch Med, Boston, MA USA; [Mattheisen, Manuel] Univ Bonn, Inst Genom Math, Bonn, Germany; [Lundervold, Astri J.] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Lundervold, Astri J.] Haraldsplass Deaconess Hosp, Kavli Res Ctr Aging & Dementia, Bergen, Norway; [Lundervold, Astri J.] Univ Bergen, KG Jebsen Ctr Res Neuropsychiatr Disorders, Bergen, Norway; [Reinvang, Ivar; Espeseth, Thomas] Univ Oslo, Dept Psychol, Oslo, Norway; [Noethen, Markus M.; Cichon, Sven] Univ Bonn, Inst Human Genet, Bonn, Germany; [Noethen, Markus M.] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Rietschel, Marcella] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Genet Epidemiol Psychiat, Heidelberg, Germany; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Psychiat, Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Ctr Neurobehavioral Genet, Los Angeles, CA USA; [Hofman, Albert; Uitterlinden, Andre G.] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Uitterlinden, Andre G.] Erasmus MC, Genet Lab, Dept Internal Med, Rotterdam, Netherlands; [Werge, Thomas] Copenhagen Univ Hosp, Res Inst Biol Psychiat, Mental Hlth Ctr Sct Hans, iPSYCH, Roskilde, Denmark; [Cichon, Sven] Res Ctr Juelich, Inst Neurosci & Med INM 1, Julich, Germany; [Andreassen, Ole A.] Univ Oslo, Oslo Univ Hosp, Div Mental Hlth & Addict, Oslo, Norway; [Andreassen, Ole A.] Univ Oslo, Inst Clin Med, Oslo, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Oslo; University of Oslo; University of Bonn; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Bonn; University of Bergen; University of Bergen; University of Oslo; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); University of Copenhagen; Helmholtz Association; Research Center Julich; University of Oslo; University of Oslo	Le Hellard, S (corresponding author), Univ Bergen, KG Jebsen Ctr Psychosis Res, Bergen, Norway.	Stephanie.hellard@med.uib.no	Andreassen, Ole A./AAY-7531-2020; Mattheisen, Manuel/B-4949-2012; Mattheisen, Manuel/S-3725-2019; Cichon, Sven/H-8803-2013; Myin-Germeys, Inez/L-5106-2014; Cichon, Sven/B-9618-2014; Lundervold, Astri/AAH-9796-2021	Mattheisen, Manuel/0000-0002-8442-493X; Mattheisen, Manuel/0000-0002-8442-493X; Cichon, Sven/0000-0002-9475-086X; Cichon, Sven/0000-0002-9475-086X; Lundervold, Astri/0000-0002-6819-6164; Myin-Germeys, Inez/0000-0002-3731-4930; Bruggeman, Richard/0000-0002-3238-8471; Djurovic, Srdjan/0000-0002-8140-8061; Le Hellard, Stephanie/0000-0002-8085-051X; Ersland, Kari Merete/0000-0003-3674-4151; Andreassen, Ole A./0000-0002-4461-3568; Nothen, Markus/0000-0002-8770-2464	Bergen Research Foundation (BFS); University of Bergen; Research Council of Norway [151904, 183327]; Psykisk Helse [175345]; Helse Vest RHF [911397, 911687]; Centre for Advanced Study (CAS) at the Norwegian Academy of Science and Letters in Oslo; NIH/NHLBI [U01 HL089856, RO1 MH087590, R01 MH081862]; German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS [01GS08144, 01GS08147]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL089856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081862, R01MH087590] Funding Source: NIH RePORTER	Bergen Research Foundation (BFS); University of Bergen; Research Council of Norway(Research Council of Norway); Psykisk Helse; Helse Vest RHF; Centre for Advanced Study (CAS) at the Norwegian Academy of Science and Letters in Oslo; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2); National Genome Research Network plus (NGFNplus); Integrated Genome Research Network (IG) MooDS; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by a grant from the Bergen Research Foundation (BFS) and the University of Bergen to S. L. H. The study was also supported by grants from the Research Council of Norway (including FUGE grant numbers 151904 and 183327, and Psykisk Helse grant number 175345), Helse Vest RHF (grant 911397 and 911687 to A. J. L.), Dr. Einar Martens Fund and in part by the Centre for Advanced Study (CAS) at the Norwegian Academy of Science and Letters in Oslo. This work was also supported by NIH/NHLBI U01 HL089856, RO1 MH087590, R01 MH081862 and by the German Federal Ministry of Education and Research (BMBF), within the context of the National Genome Research Network 2 (NGFN-2); the National Genome Research Network plus (NGFNplus); and the Integrated Genome Research Network (IG) MooDS (grant 01GS08144 to S. C. and M. M. N., grant 01GS08147 to M. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arts B, 2008, PSYCHOL MED, V38, P771, DOI 10.1017/S0033291707001675; Athanasiu L, 2010, J PSYCHIATR RES, V44, P748, DOI 10.1016/j.jpsychires.2010.02.002; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barbalat G, 2011, BIOL PSYCHIAT, V70, P73, DOI 10.1016/j.biopsych.2011.02.009; Barch DM, 2012, TRENDS COGN SCI, V16, P27, DOI 10.1016/j.tics.2011.11.015; Bora E, 2010, SCHIZOPHRENIA BULL, V36, P112, DOI 10.1093/schbul/sbp093; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Christoforou A, 2012, AM J HUM GENET, V90, P727, DOI 10.1016/j.ajhg.2012.02.025; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cichon S, 2011, AM J HUM GENET, V88, P396, DOI [10.1016/j.ajhg.2011.01.017, 10.1016/j.ajhg.2011.03.001]; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Daban C, 2006, PSYCHOTHER PSYCHOSOM, V75, P72, DOI 10.1159/000090891; Davies G, 2011, MOL PSYCHIATR, V16, P996, DOI 10.1038/mp.2011.85; Delis D. C., 2001, D KEFS EXAMINERS MAN; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Djurovic S, 2010, J AFFECT DISORDERS, V126, P312, DOI 10.1016/j.jad.2010.04.007; Egan MF, 2001, BIOL PSYCHIAT, V50, P98, DOI 10.1016/S0006-3223(01)01133-7; Ersland KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031687; Espeseth T, 2012, TWIN RES HUM GENET, V15, P442, DOI 10.1017/thg.2012.8; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GOLDBERG TE, 1995, SCHIZOPHR RES, V17, P77, DOI 10.1016/0920-9964(95)00032-H; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Guo XB, 2013, GENET EPIDEMIOL, V37, P122, DOI 10.1002/gepi.21688; Havik B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035424; Havik B, 2011, BIOL PSYCHIAT, V70, P35, DOI 10.1016/j.biopsych.2011.01.030; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Jabben N, 2010, J CLIN PSYCHIAT, V71, P764, DOI 10.4088/JCP.08m04837yel; Kahn RS, 2013, JAMA PSYCHI IN PRESS; Keefe Richard S E, 2012, Handb Exp Pharmacol, P11, DOI 10.1007/978-3-642-25758-2_2; Kohannim O, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00115; Lee SH, 2012, NAT GENET, V44, P247, DOI 10.1038/ng.1108; Lesh TA, 2011, NEUROPSYCHOPHARMACOL, V36, P316, DOI 10.1038/npp.2010.156; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; McIntosh AM, 2013, BIOL PSYCHIAT, V73, P938, DOI 10.1016/j.biopsych.2013.01.011; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; PARASURAMAN R, 1992, BRAIN, V115, P711, DOI 10.1093/brain/115.3.711; Pickard BS, 2006, ANN MED, V38, P439, DOI 10.1080/07853890600946500; PLOMIN R, 1994, SCIENCE, V264, P1733, DOI 10.1126/science.8209254; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rietschel M, 2012, MOL PSYCHIATR, V17, P906, DOI 10.1038/mp.2011.80; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rossler W, 2005, EUR NEUROPSYCHOPHARM, V15, P399, DOI 10.1016/j.euroneuro.2005.04.009; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schretlen DJ, 2007, BIOL PSYCHIAT, V62, P179, DOI 10.1016/j.biopsych.2006.09.025; Segre AV, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001058; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Simonsen C, 2011, SCHIZOPHRENIA BULL, V37, P73, DOI 10.1093/schbul/sbp034; Sklar P, 2011, NAT GENET, V43, P977, DOI 10.1038/ng.943; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sullivan PF, 2012, NAT REV GENET, V13, P537, DOI 10.1038/nrg3240; Teffer K, 2012, PROG BRAIN RES, V195, P191, DOI 10.1016/B978-0-444-53860-4.00009-X; Thurin K, 2013, MOL PSYCHIATR, V18, P852, DOI 10.1038/mp.2012.134; Torres IJ, 2007, ACTA PSYCHIAT SCAND, V116, P17, DOI 10.1111/j.1600-0447.2007.01055.x; Toulopoulou T, 2007, ARCH GEN PSYCHIAT, V64, P1348, DOI 10.1001/archpsyc.64.12.1348; Toulopoulou T, 2010, ARCH GEN PSYCHIAT, V67, P905, DOI 10.1001/archgenpsychiatry.2010.99; van den Oord EJCG, 2008, AM J MED GENET B, V147B, P637, DOI 10.1002/ajmg.b.30650; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Wang K, 2007, AM J HUM GENET, V81, P1278, DOI 10.1086/522374; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Westerhausen R, 2011, SCHIZOPHR RES, V133, P172, DOI 10.1016/j.schres.2011.08.025; Wirgenes KV, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.39; Wu JQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036351; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zhang KL, 2010, NUCLEIC ACIDS RES, V38, pW90, DOI 10.1093/nar/gkq324	71	16	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e81052	10.1371/journal.pone.0081052	http://dx.doi.org/10.1371/journal.pone.0081052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EU	24349030	Green Published, Green Submitted, gold			2022-12-27	WOS:000328731800010
J	Klein, KB; Stafinski, TD; Menon, D				Klein, Kristin B.; Stafinski, Taenia D.; Menon, Devidas			Predicting Survival after Liver Transplantation Based on Pre-Transplant MELD Score: a Systematic Review of the Literature	PLOS ONE			English	Review							MODEL; DISEASE; ALLOCATION	The model for end-stage liver disease (MELD) score is used to stratify candidates for liver transplantation based on objective measures of disease severity. MELD has been validated as a predictor of wait-list mortality in transplantation candidates and has been postulated as a predictor of post-transplant survival. The purpose of this study was to examine the predictive value of the pre-transplantation MELD score on post-transplant survival from relevant existing studies. A systematic review and critical appraisal was performed using Cochrane guidelines. PubMed, the Cochrane Library, Embase, and Web of Science were searched for articles published in the English language since 2005 using a structured search strategy. There were 3058 discrete citations identified and screened for possible inclusion. Any study examining the relationship between pre-transplant MELD and post-transplant survival in the general transplant population was included. Thirty-seven studies met these criteria and were included in the review. Studies were all case series that typically involved stratified analyses of survival by MELD. They represented 15 countries and a total of 53,691 patients. There was significant clinical heterogeneity in patient populations across studies, which precluded performance of a meta-analysis. In 15 studies, no statistically significant association between MELD and post-transplant survival was found. In the remaining 22, some association was found. Eleven studies also measured predictive ability with c-statistics. Values were below 0.7 in all but two studies, suggesting poor predictive value. In summary, while the majority of studies reported an association between pre-transplantation MELD score and post-transplant survival, they represented a low level of evidence. Therefore, their findings should be interpreted conservatively.	[Klein, Kristin B.] Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada; [Stafinski, Taenia D.; Menon, Devidas] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	University of Alberta; University of Alberta	Klein, KB (corresponding author), Univ Alberta, Fac Med & Dent, Edmonton, AB, Canada.	kristin.brooke.klein@gmail.com			Clinical Investigators program at the University of Alberta	Clinical Investigators program at the University of Alberta	Kristin Klein receives funding from the Clinical Investigators program at the University of Alberta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cholongitas E, 2006, LIVER TRANSPLANT, V12, P1049, DOI 10.1002/lt.20824; Cook NR, 2008, CLIN CHEM, V54, P17, DOI 10.1373/clinchem.2007.096529; Cywinski JB, 2011, HEPATOL INT; Freeman RB, 2005, TRANSPLANT P, V37, P585, DOI 10.1016/j.transproceed.2004.12.099; Guo ZY, 2010, SURG TODAY, V40, P38, DOI 10.1007/s00595-009-4114-6; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Oxford Centre for, 2011, EV BAS MED LEV EV; Rana A, 2008, AM J TRANSPLANT, V8, P2537, DOI 10.1111/j.1600-6143.2008.02400.x; Weismuller TJ, 2011, TRANSPL INT, V24, P91, DOI 10.1111/j.1432-2277.2010.01161.x; Yoo HY, 2005, LIVER INT, V25, P536, DOI 10.1111/j.1478-3231.2005.01011.x	10	73	76	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2013	8	12							e80661	10.1371/journal.pone.0080661	http://dx.doi.org/10.1371/journal.pone.0080661			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EU	24349010	gold, Green Submitted, Green Published			2022-12-27	WOS:000328731800006
J	Palmerini, T; Tomasi, L; Barozzi, C; Della Riva, D; Mariani, A; Taglieri, N; Leone, O; Ceccarelli, C; De Servi, S; Branzi, A; Genereux, P; Stone, GW; Ahamed, J				Palmerini, Tullio; Tomasi, Luciana; Barozzi, Chiara; Della Riva, Diego; Mariani, Andrea; Taglieri, Nevio; Leone, Ornella; Ceccarelli, Claudio; De Servi, Stefano; Branzi, Angelo; Genereux, Philippe; Stone, Gregg W.; Ahamed, Jasimuddin			Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction	PLOS ONE			English	Article							INFLAMMATORY CELLS; FACTOR EXPRESSION; PLATELETS; THROMBOGENICITY; CLOPIDOGREL; HEMOSTASIS; ANTIBODY; PATHWAY; FIBRIN	Introduction: Although ruptured atherosclerotic plaques have been extensively analyzed, the composition of thrombi causing arterial occlusion in patients with ST-segment elevation acute myocardial infarction has been less thoroughly investigated. We sought to investigate whether coagulant active tissue factor can be retrieved in thrombi of patients with STEMI undergoing primary percutaneous coronary intervention. Methods: Nineteen patients with ST-segment elevation acute myocardial infarction referred for primary percutaneous coronary intervention were enrolled in this study. Coronary thrombi aspirated from coronary arteries were routinely processed for paraffin embedding and histological evaluation (4 patients) or immediately snap frozen for evaluation of tissue factor activity using a modified aPTT test (15 patients). Immunoprecipitation followed by immunoblotting was also performed in 12 patients. Results: Thrombi aspirated from coronary arteries showed large and irregular areas of tissue factor staining within platelet aggregates, and in close contact with inflammatory cells. Some platelet aggregates stained positive for tissue factor, whereas others did not. Monocytes consistently stained strongly for tissue factor, neutrophils had a more variable and irregular tissue factor staining, and red blood cells did not demonstrate staining for tissue factor. Median clotting time of plasma samples containing homogenized thrombi incubated with a monoclonal antibody that specifically inhibits tissue factor-mediated coagulation activity (mAb 5G9) were significantly longer than their respective controls (88.9 seconds versus 76.5 seconds, respectively; p<0.001). Tissue factor was also identified by immunoprecipitation in 10 patients, with significant variability among band intensities. Conclusions: Active tissue factor is present in coronary artery thrombi of patients with ST-segment elevation acute myocardial infarction, suggesting that it contributes to activate the coagulation cascade ensuing in coronary thrombosis.	[Palmerini, Tullio; Tomasi, Luciana; Barozzi, Chiara; Della Riva, Diego; Mariani, Andrea; Taglieri, Nevio; Branzi, Angelo] Policlin S Orsola, Dipartimento Cardiovasc, Bologna, Italy; [Leone, Ornella] Policlin S Orsola, Ist Patolgia, Bologna, Italy; [Ceccarelli, Claudio] Policlin S Orsola, Dipartimento Radiol & Sci Istopatol, Bologna, Italy; [De Servi, Stefano] Osped Civile, Dipartimento Malattie Cardiovasc, Legnano, Italy; [Genereux, Philippe; Stone, Gregg W.] Columbia Univ, Med Ctr, New York, NY USA; [Genereux, Philippe; Stone, Gregg W.] Cardiovasc Res Fdn, New York, NY USA; [Ahamed, Jasimuddin] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA	IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Columbia University; Cardiovascular Research Foundation (CRF); Rockefeller University	Ahamed, J (corresponding author), Rockefeller Univ, Lab Blood & Vasc Biol, 1230 York Ave, New York, NY 10021 USA.	jahamed@rockefeller.edu	Palmerini, Tullio/K-4543-2016; ceccarelli, claudio/AAS-6105-2020; De+Servi, Stefano/AAT-2631-2021	ceccarelli, claudio/0000-0003-0743-2087; leone, ornella/0000-0001-6412-3294; Taglieri, Nevio/0000-0002-9593-4150	Dipartimento Cardiovascolare, Policlinico S. Orsola, Bologna, Italy; CTSA	Dipartimento Cardiovascolare, Policlinico S. Orsola, Bologna, Italy; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This study was funded by the Dipartimento Cardiovascolare, Policlinico S. Orsola, Bologna, Italy and an Irma-Hischl grant (JA) and fund from CTSA. The funders provided supports for buying reagents, but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed J, 2004, J BIOL CHEM, V279, P23038, DOI 10.1074/jbc.M401376200; Ahamed J, 2006, P NATL ACAD SCI USA, V103, P13932, DOI 10.1073/pnas.0606411103; ANNEX BH, 1995, CIRCULATION, V91, P619, DOI 10.1161/01.CIR.91.3.619; Ardissino D, 1997, LANCET, V349, P769, DOI 10.1016/S0140-6736(96)11189-2; Badimon JJ, 1999, CIRCULATION, V99, P1780, DOI 10.1161/01.CIR.99.14.1780; Balasubramanian V, 2002, THROMB HAEMOSTASIS, V88, P822; Balasubramanian V, 2002, BLOOD, V100, P2787, DOI 10.1182/blood-2002-03-0902; Belting M, 2005, ARTERIOSCL THROM VAS, V25, P1545, DOI 10.1161/01.ATV.0000171155.05809.bf; Camera M, 2003, ARTERIOSCL THROM VAS, V23, P1690, DOI 10.1161/01.ATV.0000085629.23209.AA; Camera M, 2012, THROMB RES, V129, P279, DOI 10.1016/j.thromres.2011.11.028; Camera M, 2010, BLOOD, V116, P5076, DOI 10.1182/blood-2010-09-307306; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Giesen PLA, 1999, P NATL ACAD SCI USA, V96, P2311, DOI 10.1073/pnas.96.5.2311; Hoffman M, 2006, J THROMB HAEMOST, V4, P2092, DOI 10.1111/j.1538-7836.2006.02085.x; Hoshiba Y, 2006, J THROMB HAEMOST, V4, P114, DOI 10.1111/j.1538-7836.2005.01701.x; Huang MD, 1998, J MOL BIOL, V275, P873, DOI 10.1006/jmbi.1997.1512; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Loubele STBG, 2009, J THROMB HAEMOST, V7, P290, DOI 10.1111/j.1538-7836.2008.03232.x; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Marmur JD, 1996, CIRCULATION, V94, P1226, DOI 10.1161/01.CIR.94.6.1226; Norledge BV, 2003, PROTEINS, V53, P640, DOI 10.1002/prot.10445; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Palmerini T, 2004, J AM COLL CARDIOL, V44, P1570, DOI 10.1016/j.jacc.2004.07.028; Palmerini T, 2002, J AM COLL CARDIOL, V40, P360, DOI 10.1016/S0735-1097(02)01951-4; Palmerini T, 2013, J AM COLL CARDIOL, V62, P496, DOI 10.1016/j.jacc.2013.05.022; Rauch U, 2000, BLOOD, V96, P170, DOI 10.1182/blood.V96.1.170.013k42_170_175; Riewald M, 2001, P NATL ACAD SCI USA, V98, P7742, DOI 10.1073/pnas.141126698; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; RUF W, 1991, BIOCHEM J, V278, P729, DOI 10.1042/bj2780729; Sakai T, 2011, THROMB RES, V127, P443, DOI 10.1016/j.thromres.2011.02.001; Toschi V, 1997, CIRCULATION, V95, P594, DOI 10.1161/01.CIR.95.3.594; Tremoli E, 1999, ATHEROSCLEROSIS, V144, P273, DOI 10.1016/S0021-9150(99)00063-5; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482	34	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81501	10.1371/journal.pone.0081501	http://dx.doi.org/10.1371/journal.pone.0081501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349079	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300032
J	Belibasakis, GN; Thurnheer, T; Bostanci, N				Belibasakis, Georgios N.; Thurnheer, Thomas; Bostanci, Nagihan			Interleukin-8 Responses of Multi-Layer Gingival Epithelia to Subgingival Biofilms: Role of the "Red Complex" Species	PLOS ONE			English	Article							PORPHYROMONAS-GINGIVALIS; TREPONEMA-DENTICOLA; TANNERELLA-FORSYTHIA; MULTISPECIES BIOFILMS; PERIODONTAL-DISEASE; CYTOKINE PRODUCTION; CELL RESPONSES; HOST RESPONSES; FIBROBLASTS; EXPRESSION	Periodontitis is an infectious inflammatory disease that results in the destruction of the tooth-supporting (periodontal) tissues. The Gram-negative anaerobic species Porphyromonas gingivalis, Tannerella forsythia and Treponema denticola, (also known as the "red complex'' species) are highly associated with subgingival biofilms at periodontitis-affected sites. A major chemokine produced by the gingival epithelium in response to biofilm challenge, is interleukin (IL)-8. The aim of this in vitro study was to investigate the relative effect of the :red complex'' species as constituents of subgingival biofilms, on the regulation of IL-8 by gingival epithelia. Multi-layered organotypic human gingival epithelial cultures were challenged with a 10-species in vitro subgingival biofilm model, or its 7-species variant, excluding the "red complex''. IL-8 gene expression and secretion analyses were performed by qPCR and ELISA, respectively. After 3 h, both biofilms up-regulated IL-8 gene expression, but the presence of the "red complex'' resulted in 3-fold greater response. IL-8 secretion was also up-regulated by both biofilms, with no differences between them. After 24 h, the 10-species biofilm reduced IL-8 secretion to 50% of the control, but this was not affected when the "red complex'' was absent. In conclusion, as part of biofilms, "red complex'' species differentially regulate IL-8 in gingival epithelia, potentially affecting the chemotactic responses of the tissue.	[Belibasakis, Georgios N.; Thurnheer, Thomas; Bostanci, Nagihan] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland	University of Zurich	Belibasakis, GN (corresponding author), Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland.	george.belibasakis@zzm.uzh.ch	Bostanci, Nagihan/ABD-5524-2020; Belibasakis, Georgios/AAL-3159-2020	Bostanci, Nagihan/0000-0002-6742-3556; Belibasakis, Georgios/0000-0002-8164-0653; Thurnheer, Thomas/0000-0002-8615-8209	Institute of Oral Biology, Center of Dental Medicine, University of Zurich; University of Zurich	Institute of Oral Biology, Center of Dental Medicine, University of Zurich; University of Zurich	This study was supported by the authors' Institute (Institute of Oral Biology, Center of Dental Medicine, University of Zurich) and a Forschungskredit Grant by the University of Zurich (NB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammann TW, 2013, J PERIODONTAL RES, V48, P517, DOI 10.1111/jre.12034; Asai Y, 2005, J DENT RES, V84, P456, DOI 10.1177/154405910508400511; Belibasakis GN, 2013, INNATE IMMUN-LONDON, V19, P3, DOI 10.1177/1753425912444767; Bodet C, 2006, MICROBES INFECT, V8, P27, DOI 10.1016/j.micinf.2005.05.015; Bostanci N, 2012, FEMS MICROBIOL LETT, V333, P1, DOI 10.1111/j.1574-6968.2012.02579.x; Bostanci N, 2011, CELL IMMUNOL, V270, P88, DOI 10.1016/j.cellimm.2011.04.002; Brissette CA, 2008, ORAL MICROBIOL IMMUN, V23, P474, DOI 10.1111/j.1399-302X.2008.00452.x; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Deng QD, 2001, ORAL MICROBIOL IMMUN, V16, P185, DOI 10.1034/j.1399-302x.2001.016003185.x; Dixon DR, 2004, PERIODONTOL 2000, V35, P53, DOI 10.1111/j.0906-6713.2004.003556.x; Ebersole JL, 2013, PERIODONTOL 2000, V62, P163, DOI 10.1111/prd.12005; Feng ZM, 2006, PERIODONTOL 2000, V40, P50, DOI 10.1111/j.1600-0757.2005.00148.x; Guggenheim B, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-280; Hajishengallis G, 2009, MICROBES INFECT, V11, P637, DOI 10.1016/j.micinf.2009.03.009; Hasegawa Y, 2008, INFECT IMMUN, V76, P2420, DOI 10.1128/IAI.00156-08; Nixon CS, 2000, INFECT IMMUN, V68, P5284, DOI 10.1128/IAI.68.9.5284-5292.2000; Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07; Peyyala R, 2013, J DENT RES, V92, P235, DOI 10.1177/0022034512472508; Peyyala R, 2013, CYTOKINE, V61, P15, DOI 10.1016/j.cyto.2012.10.006; Peyyala R, 2011, CLIN VACCINE IMMUNOL, V18, P1770, DOI 10.1128/CVI.05162-11; Peyyala R, 2012, CYTOKINE, V58, P65, DOI 10.1016/j.cyto.2011.12.016; Peyyala R, 2011, APPL ENVIRON MICROB, V77, P3413, DOI 10.1128/AEM.00039-11; Sahingur SE, 2010, MOL ORAL MICROBIOL, V25, P123, DOI 10.1111/j.2041-1014.2009.00551.x; Sandros J, 2000, J DENT RES, V79, P1808, DOI 10.1177/00220345000790101301; Schenkein HA, 2006, PERIODONTOL 2000, V40, P77, DOI 10.1111/j.1600-0757.2005.00144.x; Shin J, 2012, MOL ORAL MICROBIOL, V27, P471, DOI 10.1111/j.2041-1014.2012.00660.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tonetti MS, 1998, J PERIODONTOL, V69, P1139, DOI 10.1902/jop.1998.69.10.1139	29	38	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81581	10.1371/journal.pone.0081581	http://dx.doi.org/10.1371/journal.pone.0081581			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339946	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000328707400025
J	Christides, T; Sharp, P				Christides, Tatiana; Sharp, Paul			Sugars Increase Non-Heme Iron Bioavailability in Human Epithelial Intestinal and Liver Cells	PLOS ONE			English	Article							FRUCTOSE CORN SYRUP; SERUM-FREE MEDIUM; CACO-2 CELLS; BOUND IRON; DIETARY FRUCTOSE; PORTAL CATHETERIZATION; INTRAVENOUS IRON; UNITED-STATES; ASCORBIC-ACID; ABSORPTION	Previous studies have suggested that sugars enhance iron bioavailability, possibly through either chelation or altering the oxidation state of the metal, however, results have been inconclusive. Sugar intake in the last 20 years has increased dramatically, and iron status disorders are significant public health problems worldwide; therefore understanding the nutritional implications of iron-sugar interactions is particularly relevant. In this study we measured the effects of sugars on non-heme iron bioavailability in human intestinal Caco-2 cells and HepG2 hepatoma cells using ferritin formation as a surrogate marker for iron uptake. The effect of sugars on iron oxidation state was examined by measuring ferrous iron formation in different sugar-iron solutions with a ferrozine-based assay. Fructose significantly increased iron-induced ferritin formation in both Caco-2 and HepG2 cells. In addition, high-fructose corn syrup (HFCS-55) increased Caco-2 cell iron-induced ferritin; these effects were negated by the addition of either tannic acid or phytic acid. Fructose combined with FeCl3 increased ferrozine-chelatable ferrous iron levels by approximately 300%. In conclusion, fructose increases iron bioavailability in human intestinal Caco-2 and HepG2 cells. Given the large amount of simple and rapidly digestible sugars in the modern diet their effects on iron bioavailability may have important patho-physiological consequences. Further studies are warranted to characterize these interactions.	[Sharp, Paul] Kings Coll London, Sch Med, Diabet & Nutr Sci Div, London WC2R 2LS, England	University of London; King's College London		T.Christides@gre.ac.uk		Sharp, Paul Anthony/0000-0003-3400-6702; Christides, Tatiana/0000-0002-3160-4857	University of Greenwich School of Science	University of Greenwich School of Science	This work was supported by the University of Greenwich School of Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker E, 1998, BBA-GEN SUBJECTS, V1380, P21, DOI 10.1016/S0304-4165(97)00120-7; BATES GW, 1972, AM J CLIN NUTR, V25, P983; Beiseigel JM, 2007, AM J CLIN NUTR, V86, P388, DOI 10.1093/ajcn/86.2.388; BEYNEN AC, 1992, BIOL TRACE ELEM RES, V35, P89, DOI 10.1007/BF02786243; Boato F, 2002, J AGR FOOD CHEM, V50, P6935, DOI 10.1021/jf025832q; Brissot P, 2012, BBA-GEN SUBJECTS, V1820, P403, DOI 10.1016/j.bbagen.2011.07.014; Brodan V, 1967, Cesk Gastroenterol Vyz, V21, P521; BROUWER IA, 1993, BRIT J NUTR, V70, P171, DOI 10.1079/BJN19930114; CARO I, 1995, INT J PHARMACEUT, V116, P147, DOI 10.1016/0378-5173(94)00280-I; CARPENTER CE, 1992, CRIT REV FOOD SCI, V31, P333, DOI 10.1080/10408399209527576; CHANTRET I, 1994, J CELL SCI, V107, P213; CHARLEY PJ, 1963, BIOCHIM BIOPHYS ACTA, V69, P313, DOI 10.1016/0006-3002(63)91264-2; CHARLEY PJ, 1963, J LAB CLIN MED, V61, P397; Collings R, 2011, J NUTR, V141, P805, DOI 10.3945/jn.110.136507; DAVIS PS, 1967, AUSTRALAS ANN MED, V16, P70; DENCKER H, 1973, DIGESTION, V9, P514, DOI 10.1159/000197480; DENCKER H, 1972, SCAND J GASTROENTERO, V7, P701, DOI 10.3109/00365527209180981; DEROZO MP, 1986, ARCH LATINOAM NUTR, V36, P688; Deugnier Y, 2011, SEMIN LIVER DIS, V31, P260, DOI 10.1055/s-0031-1286057; Fleming DJ, 2002, AM J CLIN NUTR, V76, P1375, DOI 10.1093/ajcn/76.6.1375; Fleming RE, 2012, NEW ENGL J MED, V366, P348, DOI 10.1056/NEJMra1004967; Fujita N, 2011, ADV CLIN CHEM, V55, P105, DOI 10.1016/B978-0-12-387042-1.00006-X; Gangloff MB, 1996, J NUTR, V126, P3118, DOI 10.1093/jn/126.12.3118; GILLOOLY M, 1983, BRIT J NUTR, V49, P331, DOI 10.1079/BJN19830042; Gkouvatsos K, 2012, BBA-GEN SUBJECTS, V1820, P188, DOI 10.1016/j.bbagen.2011.10.013; Glahn RP, 1998, J NUTR, V128, P1555, DOI 10.1093/jn/128.9.1555; Glahn RP, 2002, J AGR FOOD CHEM, V50, P390, DOI 10.1021/jf011046u; Graham RM, 2012, NUTR HEALTH SER, P117, DOI 10.1007/978-1-60327-485-2_7; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HALLBERG L, 1982, HUM NUTR-APPL NUTR, V36, P116; Heckman MA, 2010, COMPR REV FOOD SCI F, V9, P303, DOI 10.1111/j.1541-4337.2010.00111.x; HEINRICH HC, 1974, NUTR METAB, V17, P236; Hider RC, 2002, EUR J CLIN INVEST, V32, P50, DOI 10.1046/j.1365-2362.2002.0320s1050.x; HOLBROOK JT, 1989, AM J CLIN NUTR, V49, P1290, DOI 10.1093/ajcn/49.6.1290; HOLDSWOR.CD, 1964, P SOC EXP BIOL MED, V118, P142, DOI 10.3181/00379727-118-29780; HUBERT N, 1993, J HEPATOL, V18, P301, DOI 10.1016/S0168-8278(05)80274-0; Hui HX, 2009, PANCREAS, V38, P706, DOI 10.1097/MPA.0b013e3181a7c6e5; IVATURI R, 1992, PLANT FOOD HUM NUTR, V42, P143, DOI 10.1007/BF02196467; JUMARIE C, 1991, J CELL PHYSIOL, V149, P24, DOI 10.1002/jcp.1041490105; Lung'aho MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020429; Marriott BP, 2010, CRIT REV FOOD SCI, V50, P228, DOI 10.1080/10408391003626223; MAYES PA, 1993, AM J CLIN NUTR, V58, P754; McKie AT, 2001, SCIENCE, V291, P1755, DOI 10.1126/science.1057206; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Milward EA, 2008, MAYO CLIN PROC, V83, P543, DOI 10.4065/83.5.543; Montalbetti N, 2013, MOL ASPECTS MED, V34, P270, DOI 10.1016/j.mam.2013.01.002; Moreira LM, 2012, FOOD NUTR COMPON FOC, V3, P138, DOI 10.1039/9781849734929-00138; Motulsky H., 2014, INTUITIVE BIOSTATIST, P203; NIEWOEHNER CB, 1986, J AM COLL NUTR, V5, P443; O'Brien J, 2012, HEPATOL INT, V6, P332, DOI 10.1007/s12072-011-9304-9; ODELL BL, 1993, AM J CLIN NUTR, V58, P771, DOI 10.1093/ajcn/58.5.771S; POLLACK S, 1964, BLOOD, V24, P577, DOI 10.1182/blood.V24.5.577.577; Pullakhandam R, 2011, J FOOD SCI, V76, pH38, DOI 10.1111/j.1750-3841.2010.01993.x; RIBY JE, 1993, AM J CLIN NUTR, V58, P748, DOI 10.1093/ajcn/58.5.748S; Riemer J, 2004, ANAL BIOCHEM, V331, P370, DOI 10.1016/j.ab.2004.03.049; Scheiber-Mojdehkar B, 2003, BIOCHEM PHARMACOL, V65, P1973, DOI 10.1016/S0006-2952(03)00181-3; Sharp P, 2002, FEBS LETT, V510, P71, DOI 10.1016/S0014-5793(01)03225-2; STITT C, 1962, P SOC EXP BIOL MED, V110, P70, DOI 10.3181/00379727-110-27426; Sturm B, 2005, KIDNEY INT, V67, P1161, DOI 10.1111/j.1523-1755.2005.00183.x; Sturm B, 2003, EUR J BIOCHEM, V270, P3731, DOI 10.1046/j.1432-1033.2003.03759.x; Tandy S, 2000, J BIOL CHEM, V275, P1023, DOI 10.1074/jbc.275.2.1023; Timson DJ, 2012, FOOD NUTR COMPON FOC, V3, P115, DOI 10.1039/9781849734929-00115; Tsuchiya H, 2013, METABOLISM, V62, P62, DOI 10.1016/j.metabol.2012.06.008; Verstraeten L M, 1967, Adv Carbohydr Chem Biochem, V22, P229; Wawer AA, 2012, J AGR FOOD CHEM, V60, P11318, DOI 10.1021/jf3031309; White JS, 2008, AM J CLIN NUTR, V88, p1716S, DOI 10.3945/ajcn.2008.25825B; Whitton C, 2011, BRIT J NUTR, V106, P1899, DOI 10.1017/S0007114511002340; Wood MJ, 2009, HEPATOL INT, V3, P434, DOI 10.1007/s12072-009-9144-z; WRIGHT TL, 1986, J BIOL CHEM, V261, P909; Yun SM, 2004, J NUTR, V134, P2717, DOI 10.1093/jn/134.10.2717	70	30	30	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83031	10.1371/journal.pone.0083031	http://dx.doi.org/10.1371/journal.pone.0083031			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340076	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400112
J	Clausen, A; McClanahan, T; Ji, SG; Weiss, JH				Clausen, Aaron; McClanahan, Taylor; Ji, Sung G.; Weiss, John H.			Mechanisms of Rapid Reactive Oxygen Species Generation in Response to Cytosolic Ca2+ or Zn2+ Loads in Cortical Neurons	PLOS ONE			English	Article							NMDA RECEPTOR ACTIVATION; GLOBAL CEREBRAL-ISCHEMIA; RAT HIPPOCAMPAL-NEURONS; NADPH OXIDASE; PERMEABILITY TRANSITION; SUPEROXIDE-PRODUCTION; ENERGY-PRODUCTION; CALCIUM OVERLOAD; NEURAL INJURY; ZINC RELEASE	Excessive "excitotoxic" accumulation of Ca2+ and Zn2+ within neurons contributes to neurodegeneration in pathological conditions including ischemia. Putative early targets of these ions, both of which are linked to increased reactive oxygen species (ROS) generation, are mitochondria and the cytosolic enzyme, NADPH oxidase (NOX). The present study uses primary cortical neuronal cultures to examine respective contributions of mitochondria and NOX to ROS generation in response to Ca2+ or Zn2+ loading. Induction of rapid cytosolic accumulation of either Ca2+ (via NMDA exposure) or Zn2+ (via Zn2+/ZPyrithione exposure in 0 Ca2+) caused sharp cytosolic rises in these ions, as well as a strong and rapid increase in ROS generation. Inhibition of NOX activation significantly reduced the Ca2+-induced ROS production with little effect on the Zn2+-triggered ROS generation. Conversely, dissipation of the mitochondrial electrochemical gradient increased the cytosolic Ca2+ or Zn2+ rises caused by these exposures, consistent with inhibition of mitochondrial uptake of these ions. However, such disruption of mitochondrial function markedly suppressed the Zn2+-triggered ROS, while partially attenuating the Ca2+-triggered ROS. Furthermore, block of the mitochondrial Ca2+ uniporter (MCU), through which Zn2+ as well as Ca2+ can enter the mitochondrial matrix, substantially diminished Zn2+ triggered ROS production, suggesting that the ROS generation occurs specifically in response to Zn2+ entry into mitochondria. Finally, in the presence of the sulfhydryl-oxidizing agent 2,2'-dithiodipyridine, which impairs Zn2+ binding to cytosolic metalloproteins, far lower Zn2+ exposures were able to induce mitochondrial Zn2+ uptake and consequent ROS generation. Thus, whereas rapid acute accumulation of Zn2+ and Ca2+ each can trigger injurious ROS generation, Zn2+ entry into mitochondria via the MCU may do so with particular potency. This may be of particular relevance to conditions like ischemia in which cytosolic Zn2+ buffering is impaired due to acidosis and oxidative stress.	[Clausen, Aaron; McClanahan, Taylor; Weiss, John H.] Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA; [Ji, Sung G.; Weiss, John H.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Weiss, JH (corresponding author), Univ Calif Irvine, Dept Neurol, Irvine, CA 92717 USA.	jweiss@uci.edu	weiss, john/B-4283-2008	weiss, john/0000-0001-9323-7813; Ji, Sung Goan/0000-0003-1308-2474	National Institutes of Health [R01 NS065219, T32 NS045540]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065219, T32NS045540] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants R01 NS065219 (JHW) and T32 NS045540 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Vizi V, 2010, J ALZHEIMERS DIS, V20, pS413, DOI 10.3233/JAD-2010-100465; Aizenman E, 2000, J NEUROCHEM, V75, P1878, DOI 10.1046/j.1471-4159.2000.0751878.x; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bindokas VP, 1996, J NEUROSCI, V16, P1324; Bonanni L, 2006, J NEUROSCI, V26, P6851, DOI 10.1523/JNEUROSCI.5444-05.2006; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brennan-Minnella AM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.111; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Carriedo SG, 1998, J NEUROSCI, V18, P7727; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Dineley KE, 2005, MITOCHONDRION, V5, P55, DOI 10.1016/j.mito.2004.11.001; Dineley KE, 2003, J NEUROCHEM, V85, P563, DOI 10.1046/j.1471-4159.2003.01678.x; DUGAN LL, 1995, J NEUROSCI, V15, P6377; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Gazaryan IG, 2007, J BIOL CHEM, V282, P24373, DOI 10.1074/jbc.M611376200; Gee KR, 2002, CELL CALCIUM, V31, P245, DOI 10.1016/S0143-4160(02)00053-2; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Jiang LJ, 2000, P NATL ACAD SCI USA, V97, P2503, DOI 10.1073/pnas.97.6.2503; Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034; Kim YH, 2002, EXP NEUROL, V177, P407, DOI 10.1006/exnr.2002.7990; Kim YH, 1999, NEUROSCIENCE, V89, P175, DOI 10.1016/S0306-4522(98)00313-3; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Kuznetsov AV, 2011, ANAL BIOANAL CHEM, V400, P2383, DOI 10.1007/s00216-011-4764-2; Lee JY, 2003, EXP NEUROL, V184, P337, DOI 10.1016/S0014-4886(03)00382-0; Lee JY, 2000, J NEUROSCI, V20; LINK TA, 1995, J BIOL CHEM, V270, P25001, DOI 10.1074/jbc.270.42.25001; Malaiyandi LM, 2005, J NEUROCHEM, V93, P1242, DOI 10.1111/j.1471-4159.2005.03116.x; Malaiyandi LM, 2004, GLIA, V45, P346, DOI 10.1002/glia.10332; Maret W, 1998, P NATL ACAD SCI USA, V95, P3478, DOI 10.1073/pnas.95.7.3478; Medvedeva YV, 2009, J NEUROSCI, V29, P1105, DOI 10.1523/JNEUROSCI.4604-08.2009; Noh KM, 2000, J NEUROSCI, V20; Peng TI, 2010, ANN NY ACAD SCI, V1201, P183, DOI 10.1111/j.1749-6632.2010.05634.x; REYNOLDS IJ, 1995, J NEUROSCI, V15, P3318, DOI 10.1523/jneurosci.15-05-03318.1995; SARIS NEL, 1994, FEBS LETT, V356, P195, DOI 10.1016/0014-5793(94)01256-3; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Sensi SL, 1999, P NATL ACAD SCI USA, V96, P2414, DOI 10.1073/pnas.96.5.2414; Shuttleworth CW, 2011, TRENDS PHARMACOL SCI, V32, P480, DOI 10.1016/j.tips.2011.04.001; SKULACHE.VP, 1967, BIOCHEM BIOPH RES CO, V26, P1, DOI 10.1016/0006-291X(67)90242-2; Stork CJ, 2006, J NEUROSCI, V26, P10430, DOI 10.1523/JNEUROSCI.1588-06.2006; Suh SW, 2008, ANN NEUROL, V64, P654, DOI 10.1002/ana.21511; Tang XN, 2012, NEUROL RES, V34, P338, DOI 10.1179/1743132812Y.0000000021; TONDER N, 1990, NEUROSCI LETT, V109, P247, DOI 10.1016/0304-3940(90)90002-Q; Wang GJ, 1996, J NEUROPHYSIOL, V76, P1611, DOI 10.1152/jn.1996.76.3.1611; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; WEISS JH, 1993, NEURON, V10, P43, DOI 10.1016/0896-6273(93)90240-R; WERTH JL, 1994, J NEUROSCI, V14, P348; WHITE RJ, 1995, J NEUROSCI, V15, P1318; Wudarczyk J, 1999, ARCH BIOCHEM BIOPHYS, V363, P1, DOI 10.1006/abbi.1998.1058; Yin H z, 1994, Neurobiol Dis, V1, P43, DOI 10.1006/nbdi.1994.0006; Yin HZ, 1995, NEUROREPORT, V6, P2553, DOI 10.1097/00001756-199512150-00025; Yoshioka H, 2011, J CEREBR BLOOD F MET, V31, P868, DOI 10.1038/jcbfm.2010.166	54	45	45	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83347	10.1371/journal.pone.0083347	http://dx.doi.org/10.1371/journal.pone.0083347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340096	Green Published, gold			2022-12-27	WOS:000328707400129
J	Zhang, JH; Zhang, SG; Han, SY; Li, XM; Tong, ZK; Qi, LW				Zhang, Junhong; Zhang, Shougong; Han, Suying; Li, Xinmin; Tong, Zaikang; Qi, Liwang			Deciphering Small Noncoding RNAs during the Transition from Dormant Embryo to Germinated Embryo in Larches (Larix leptolepis)	PLOS ONE			English	Article							TRAP MASS-SPECTROMETRY; ABSCISIC-ACID; SEED DORMANCY; ARABIDOPSIS-THALIANA; SOMATIC EMBRYOGENESIS; GENE-EXPRESSION; NORWAY SPRUCE; PICEA-ABIES; MICRORNAS; AUXIN	Small RNAs (sRNAs), as a key component of molecular biology, play essential roles in plant development, hormone signaling, and stress response. However, little is known about the relationships among sRNAs, hormone signaling, and dormancy regulation in gymnosperm embryos. To investigate the roles of sRNAs in embryo dormancy maintenance and release in Larix leptolepis, we deciphered the endogenous "sRNAome'' in dormant and germinated embryos. High-throughput sequencing of sRNA libraries showed that dormant embryos exhibited a length bias toward 24-nt while germinated embryos showed a bias toward 21-nt lengths. This might be associated with distinct levels of RNA-dependent RNA polymerase2 (RDR2) and/or RDR6, which is regulated by hormones. Proportions of miRNAs to nonredundant and redundant sRNAs were higher in germinated embryos than in dormant embryos, while the ratio of unknown sRNAs was higher in dormant embryos than in germinated embryos. We identified a total of 160 conserved miRNAs from 38 families, 3 novel miRNAs, and 16 plausible miRNA candidates, of which many were upregulated in germinated embryos relative to dormant embryos. These findings indicate that larches and possibly other gymnosperms have complex mechanisms of gene regulation involving miRNAs and other sRNAs operating transcriptionally and posttranscriptionally during embryo dormancy and germination. We propose that abscisic acid modulates embryo dormancy and germination at least in part through regulation of the expression level of sRNA-biogenesis genes, thus changing the sRNA components.	[Zhang, Junhong; Tong, Zaikang] Zhejiang Agr & Forestry Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China; [Zhang, Junhong; Zhang, Shougong; Li, Xinmin; Qi, Liwang] Chinese Acad Forestry, Res Inst Forestry, Cell Biol Lab, Beijing, Peoples R China; [Han, Suying] Chinese Acad Forestry, Res Inst Forest Ecol Environm & Protect, Beijing, Peoples R China; [Li, Xinmin] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA	Zhejiang A&F University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Forestry; Research Institute of Forest Ecology, Environment and Protection, CAF; University of California System; University of California Los Angeles	Tong, ZK (corresponding author), Zhejiang Agr & Forestry Univ, Nurturing Stn, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China.	zktong@zjfc.edu.cn; lwqi@caf.ac.cn			National High Technology Research and Development Program of China [2011AA100203, 2013AA102704]; National Basic Research Program of China [2009CB119106]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National High Technology Research and Development Program of China (grant nos. 2011AA100203, 2013AA102704) and the National Basic Research Program of China (grant no. 2009CB119106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; AMMIRATO PV, 1974, BOT GAZ, V135, P328, DOI 10.1086/336769; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Cairney J, 2007, NEW PHYTOL, V176, P511, DOI 10.1111/j.1469-8137.2007.02239.x; Chen WQ, 2010, J INTEGR PLANT BIOL, V52, P925, DOI 10.1111/j.1744-7909.2010.00989.x; Chen XM, 2005, FEBS LETT, V579, P5923, DOI 10.1016/j.febslet.2005.07.071; Chiwocha SDS, 2005, PLANT J, V42, P35, DOI 10.1111/j.1365-313X.2005.02359.x; Cho SH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000314; Constabel CP, 2000, PLANT PHYSIOL, V124, P285, DOI 10.1104/pp.124.1.285; Cruz-Gallardo I, 2012, FEBS LETT, V586, P646, DOI 10.1016/j.febslet.2011.08.035; Dolgosheina EV, 2008, RNA, V14, P1508, DOI 10.1261/rna.1052008; Donaire L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027916; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Filonova LH, 2000, J EXP BOT, V51, P249, DOI 10.1093/jexbot/51.343.249; Finch-Savage WE, 2006, NEW PHYTOL, V171, P501, DOI 10.1111/j.1469-8137.2006.01787.x; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400; Gutmann M, 1996, J EXP BOT, V47, P1905, DOI 10.1093/jxb/47.12.1905; Hakman I, 2009, TREE PHYSIOL, V29, P483, DOI 10.1093/treephys/tpn048; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li A, 2011, PLANT MOL BIOL REP, V29, P784, DOI 10.1007/s11105-010-0280-3; Li BS, 2011, J EXP BOT, V62, P3765, DOI 10.1093/jxb/err051; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Liu SC, 2013, ANAL BIOANAL CHEM, V405, P1257, DOI 10.1007/s00216-012-6509-2; Lu C, 2005, SCIENCE, V309, P1567, DOI 10.1126/science.1114112; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Mallory AC, 2005, PLANT CELL, V17, P1360, DOI 10.1105/tpc.105.031716; Martinez-Andujar C, 2009, 5 INT S SEED TRANSPL, V898, P53; McHale NA, 2004, PLANT CELL, V16, P1730, DOI 10.1105/tpc.021816; Morin RD, 2008, GENOME RES, V18, P571, DOI 10.1101/gr.6897308; Nambara E, 2010, SEED SCI RES, V20, P55, DOI 10.1017/S0960258510000012; Nodine MD, 2010, GENE DEV, V24, P2678, DOI 10.1101/gad.1986710; Pang MX, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r122; PAQUES LE, 1989, ANN SCI FOREST, V46, P141, DOI 10.1051/forest:19890204; Penfield S, 2009, PLANT CELL, V21, P1722, DOI 10.1105/tpc.108.064022; Rai MK, 2011, PLANT CELL TISS ORG, V106, P179, DOI 10.1007/s11240-011-9923-9; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Schwach Frank, 2009, Briefings in Functional Genomics & Proteomics, V8, P472, DOI 10.1093/bfgp/elp024; Schwarzerova K, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-89; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tahir M, 2006, TREE PHYSIOL, V26, P1257, DOI 10.1093/treephys/26.10.1257; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; von Arnold Sara, 2008, V427, P31, DOI 10.1007/978-1-59745-273-1_3; Wan LC, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-146; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Weiqi Li, 2012, 2012 IEEE 10th International Symposium on Parallel and Distributed Processing with Applications (ISPA), P1, DOI 10.1109/ISPA.2012.10; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Williams L, 2005, DEVELOPMENT, V132, P3657, DOI 10.1242/dev.01942; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yakovlev IA, 2010, NEW PHYTOL, V187, P1154, DOI 10.1111/j.1469-8137.2010.03341.x; Yamaguchi S, 1998, PLANT CELL, V10, P2115, DOI 10.1105/tpc.10.12.2115; Yang JH, 2008, NUCLEIC ACIDS RES, V36, P1220, DOI 10.1093/nar/gkm1133; Zhang JH, 2013, PLANTA, V237, P89, DOI 10.1007/s00425-012-1753-4; Zhang JH, 2012, PLANTA, V236, P647, DOI 10.1007/s00425-012-1643-9; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056	68	24	31	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81452	10.1371/journal.pone.0081452	http://dx.doi.org/10.1371/journal.pone.0081452			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339932	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400018
J	Falivelli, G; Lisabeth, EM; de la Torre, ER; Perez-Tenorio, G; Tosato, G; Salvucci, O; Pasquale, EB				Falivelli, Giulia; Lisabeth, Erika Mathes; de la Torre, Elena Rubio; Perez-Tenorio, Gizeh; Tosato, Giovanna; Salvucci, Ombretta; Pasquale, Elena B.			Attenuation of Eph Receptor Kinase Activation in Cancer Cells by Coexpressed Ephrin Ligands	PLOS ONE			English	Article							TYROSINE KINASE; LUNG-CANCER; THERAPEUTIC TARGET; A LIGANDS; CIS; SUPPRESSES; EXPRESSION; MUTATIONS; PATHWAY; GROWTH	The Eph receptor tyrosine kinases mediate juxtacrine signals by interacting "in trans" with ligands anchored to the surface of neighboring cells via a GPI-anchor (ephrin-As) or a transmembrane segment (ephrin-Bs), which leads to receptor clustering and increased kinase activity. Additionally, soluble forms of the ephrin-A ligands released from the cell surface by matrix metalloproteases can also activate EphA receptor signaling. Besides these trans interactions, recent studies have revealed that Eph receptors and ephrins coexpressed in neurons can also engage in lateral "cis" associations that attenuate receptor activation by ephrins in trans with critical functional consequences. Despite the importance of the Eph/ephrin system in tumorigenesis, Eph receptor-ephrin cis interactions have not been previously investigated in cancer cells. Here we show that in cancer cells, coexpressed ephrin-A3 can inhibit the ability of EphA2 and EphA3 to bind ephrins in trans and become activated, while ephrin-B2 can inhibit not only EphB4 but also EphA3. The cis inhibition of EphA3 by ephrin-B2 implies that in some cases ephrins that cannot activate a particular Eph receptor in trans can nevertheless inhibit its signaling ability through cis association. We also found that an EphA3 mutation identified in lung cancer enhances cis interaction with ephrin-A3. These results suggest a novel mechanism that may contribute to cancer pathogenesis by attenuating the tumor suppressing effects of Eph receptor signaling pathways activated by ephrins in trans.	[Falivelli, Giulia; Lisabeth, Erika Mathes; de la Torre, Elena Rubio; Perez-Tenorio, Gizeh; Pasquale, Elena B.] Sanford Burnham Med Res Inst, San Diego, CA 92101 USA; [Tosato, Giovanna; Salvucci, Ombretta] NCI, Cellular Oncol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA; [Falivelli, Giulia] Univ Bologna, Dept Pharmacol, Bologna, Italy	Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California San Diego; University of Bologna	Pasquale, EB (corresponding author), Sanford Burnham Med Res Inst, San Diego, CA 92101 USA.	elenap@sanfordburnham.org		Tosato, Giovanna/0000-0003-1663-3227	National Institutes of Health [P01CA138390, P01HD025938, T32CA121949]; Tobacco-Related Disease Research Program [18XT-0099, 20FT-0076]; Spanish Foundation for Science and Technology; Swedish Research Council [Dnr 2009-7360]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD025938] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA138390, T32CA121949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tobacco-Related Disease Research Program(University of California System); Spanish Foundation for Science and Technology; Swedish Research Council(Swedish Research CouncilEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health grants P01CA138390 and P01HD025938, grant 18XT-0099 from the Tobacco-Related Disease Research Program (E.B.P.), a postdoctoral fellowship from the Spanish Foundation for Science and Technology (FECYT, E. R. T.), National Institutes of Health postdoctoral training grant T32CA121949 and postdoctoral fellowship 20FT-0076 from the Tobacco-Related Disease Research Program (E.M.L.), and postdoctoral fellowship Dnr 2009-7360 from the Swedish Research Council (G. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford S, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-41; Alford SC, 2007, EXP CELL RES, V313, P4170, DOI 10.1016/j.yexcr.2007.07.019; Antion MD, 2010, MOL CELL NEUROSCI, V45, P378, DOI 10.1016/j.mcn.2010.07.011; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; BARTLEY TD, 1994, NATURE, V368, P558, DOI 10.1038/368558a0; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Beauchamp A, 2012, MOL CELL BIOL, V32, P3253, DOI 10.1128/MCB.06791-11; Carvalho RF, 2006, NAT NEUROSCI, V9, P322, DOI 10.1038/nn1655; Chen Jin, 2008, Cancer Res, V68, P10031, DOI 10.1158/0008-5472.CAN-08-3010; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Day BW, 2013, CANCER CELL, V23, P238, DOI 10.1016/j.ccr.2013.01.007; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Follenzi A, 2002, METHOD ENZYMOL, V346, P454; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Holen HL, 2011, BIOCHEM J, V433, P215, DOI 10.1042/BJ20100865; Hornberger MR, 1999, NEURON, V22, P731, DOI 10.1016/S0896-6273(00)80732-1; Ji XD, 2011, CANCER RES, V71, P1156, DOI 10.1158/0008-5472.CAN-10-0717; Kao TJ, 2011, NEURON, V71, P76, DOI 10.1016/j.neuron.2011.05.031; Keane N, 2012, EXPERT REV HEMATOL, V5, P325, DOI [10.1586/ehm.12.19, 10.1586/EHM.12.19]; Li G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1675; Lisabeth EM, 2013, COLD SPRING IN PRESS; Lisabeth EM, 2012, BIOCHEMISTRY-US, V51, P1464, DOI 10.1021/bi2014079; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Nitschke L, 2009, IMMUNOL REV, V230, P128, DOI 10.1111/j.1600-065X.2009.00801.x; Noberini R, 2012, CELL ADHES MIGR, V6, P102, DOI 10.4161/cam.19620; Noren NK, 2007, CANCER RES, V67, P3994, DOI 10.1158/0008-5472.CAN-07-0525; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Noren NK, 2004, P NATL ACAD SCI USA, V101, P5583, DOI 10.1073/pnas.0401381101; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Rong BX, 2011, CURR CANCER DRUG TAR, V11, P1082, DOI 10.2174/156800911798073050; Salvucci O, 2009, BLOOD, V114, P1707, DOI 10.1182/blood-2008-12-192294; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Stahl S, 2011, J PROTEOME RES, V10, P2566, DOI 10.1021/pr200037u; Tandon M, 2011, EXPERT OPIN THER TAR, V15, P31, DOI 10.1517/14728222.2011.538682; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79; Ware CF, 2011, CURR OPIN IMMUNOL, V23, P627, DOI 10.1016/j.coi.2011.08.008; Wykosky J, 2008, MOL CANCER RES, V6, P1795, DOI 10.1158/1541-7786.MCR-08-0244; Xi HQ, 2012, J GASTROENTEROL, V47, P785, DOI 10.1007/s00535-012-0549-4; Xi HQ, 2011, J CLIN PATHOL, V64, P498, DOI 10.1136/jcp.2010.087213; Yang NY, 2011, CELL SIGNAL, V23, P201, DOI 10.1016/j.cellsig.2010.09.004; Yaron A, 2012, TRENDS NEUROSCI, V35, P230, DOI 10.1016/j.tins.2011.12.003; Yin Y, 2004, NEUROSCI RES, V48, P285, DOI 10.1016/j.neures.2003.11.009; Zantek ND, 1999, CELL GROWTH DIFFER, V10, P629; Zhuang GL, 2012, JNCI-J NATL CANCER I, V104, P1182, DOI 10.1093/jnci/djs297	51	38	38	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2013	8	11							e81445	10.1371/journal.pone.0081445	http://dx.doi.org/10.1371/journal.pone.0081445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261MX	24348920	Green Published, Green Submitted, gold			2022-12-27	WOS:000327670300032
J	Sun, JZ; Wang, JG; Yuan, DL; Wang, S; Li, ZL; Yi, B; Mao, YP; Hou, Q; Liu, WQ				Sun, Jia-zeng; Wang, Jigui; Yuan, Daoli; Wang, Shuang; Li, Zhili; Yi, Bao; Mao, Yaping; Hou, Qiang; Liu, Weiquan			Cellular microRNA miR-181b Inhibits Replication of Mink Enteritis Virus by Repression of Non-Structural Protein 1 Translation	PLOS ONE			English	Article							FELINE PANLEUKOPENIA VIRUS; CANINE HOST-RANGE; RNA INTERFERENCE; MINUTE VIRUS; PARVOVIRUS; EXPRESSION; GENE; SEQUENCE; MICE; PROTECTION	Mink enteritis virus (MEV) is one of the most important viral pathogens in the mink industry. Recent studies have showed that microRNAs (miRNAs), small noncoding RNAs of length ranging from 18-23 nucleotides (nt) participate in host-pathogen interaction networks; however, whether or not miRNAs are involved in MEV infection has not been reported. Our study revealed that miRNA miR-181b inhibited replication of MEV in the feline kidney (F81) cell line by targeting the MEV non-structural protein 1 (NS1) messenger RNA (mRNA) coding region, resulting in NS1 translational repression, while MEV infection reduced miR-181b expression. This is the first description of cellular miRNAs modulating MEV infection in F81 cells, providing further insight into the mechanisms of viral infection, and may be useful in development of naturally-occurring miRNAs antiviral strategies.	[Sun, Jia-zeng; Wang, Jigui; Yuan, Daoli; Wang, Shuang; Li, Zhili; Yi, Bao; Mao, Yaping; Hou, Qiang; Liu, Weiquan] China Agr Univ, State Key Lab Agrobiotechnol, Dept Biochem & Mol Biol, Coll Biol Sci, Beijing 100094, Peoples R China	China Agricultural University	Liu, WQ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Dept Biochem & Mol Biol, Coll Biol Sci, Beijing 100094, Peoples R China.	weiquan8@cau.edu.cn		Yi, Bao/0000-0003-0295-3035	National Key Scientific Foundation [2009ZX08006-010B]; 863 Project [2011AA10A213]	National Key Scientific Foundation; 863 Project	This work was supported by National Key Scientific Foundation (2009ZX08006-010B) 863 Project (2011AA10A213). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; BARKER IK, 1983, CAN J COMP MED, V47, P188; Bartel DP, 2007, CELL, V131, P11, DOI 10.1016/S0092-8674(04)00045-5; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bazzini AA, 2012, SCIENCE, V336, P233, DOI 10.1126/science.1215704; BEARD C, 1989, VIROLOGY, V172, P659, DOI 10.1016/0042-6822(89)90211-0; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; BOOKOUT AL, 2006, CURR PROTOC MOL BIOL; Brown BD, 2007, NAT BIOTECHNOL, V25, P1457, DOI 10.1038/nbt1372; Cameron JE, 2008, J VIROL, V82, P1946, DOI 10.1128/JVI.02136-07; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; COTMORE SF, 1994, EMBO J, V13, P4145, DOI 10.1002/j.1460-2075.1994.tb06732.x; COTMORE SF, 1995, J VIROL, V69, P1652, DOI 10.1128/JVI.69.3.1652-1660.1995; Dalmay T, 2013, ESSAYS BIOCHEM, V54, P29, DOI [10.1042/BSE0540029, 10.1042/bse0540029]; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Djuranovic S, 2012, SCIENCE, V336, P237, DOI 10.1126/science.1215691; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; DOERIG C, 1990, J VIROL, V64, P387, DOI 10.1128/JVI.64.1.387-396.1990; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Grey F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000967; Horiuchi M, 1997, J VET MED SCI, V59, P133, DOI 10.1292/jvms.59.133; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Huang Y, 2011, J PHYSIOL BIOCHEM, V67, P129, DOI 10.1007/s13105-010-0050-6; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; KARIATSUMARI T, 1991, J GEN VIROL, V72, P867, DOI 10.1099/0022-1317-72-4-867; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kruger J, 2006, NUCLEIC ACIDS RES, V34, pW451, DOI 10.1093/nar/gkl243; LANGEVELD JPM, 1995, VACCINE, V13, P1033, DOI 10.1016/0264-410X(95)00021-R; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li BJ, 2005, NAT MED, V11, P944, DOI 10.1038/nm1280; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Lung RWM, 2009, NEOPLASIA, V11, P1174, DOI 10.1593/neo.09888; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Motsch N, 2007, RNA BIOL, V4, P131, DOI 10.4161/rna.4.3.5206; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Otsuka M, 2007, IMMUNITY, V27, P123, DOI 10.1016/j.immuni.2007.05.014; Ouyang YB, 2012, MITOCHONDRION, V12, P213, DOI 10.1016/j.mito.2011.09.001; Palliser D, 2006, NATURE, V439, P89, DOI 10.1038/nature04263; Pan Hongli, 2012, Weishengwu Xuebao, V52, P367; PARRISH CR, 1991, J VIROL, V65, P6544, DOI 10.1128/JVI.65.12.6544-6552.1991; PARRISH CR, 1982, ARCH VIROL, V72, P267, DOI 10.1007/BF01315223; PARRISH CR, 1988, VIROLOGY, V166, P293, DOI 10.1016/0042-6822(88)90500-4; Pedersen IM, 2007, NATURE, V449, P919, DOI 10.1038/nature06205; Pontius JU, 2007, J HERED, V98, P386, DOI 10.1093/jhered/esm055; Pontius JU, 2007, GENOME RES, V17, P1675, DOI 10.1101/gr.6380007; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; RIVERA E, 1987, VET MICROBIOL, V13, P371, DOI 10.1016/0378-1135(87)90068-X; Sarasin-Filipowicz M, 2009, NAT MED, V15, P31, DOI 10.1038/nm.1902; Scaria V, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-68; SCHOFIELD F. W., 1949, NORTH AMER VET, V30, P651; Song LP, 2010, J VIROL, V84, P8849, DOI 10.1128/JVI.00456-10; Tompkins SM, 2004, P NATL ACAD SCI USA, V101, P8682, DOI 10.1073/pnas.0402630101; TRUYEN U, 1995, J VIROL, V69, P4702, DOI 10.1128/JVI.69.8.4702-4710.1995; Wang B, 2010, ONCOGENE, V29, P1787, DOI 10.1038/onc.2009.468; Wang BC, 2012, BIOCHEM BIOPH RES CO, V421, P4, DOI 10.1016/j.bbrc.2012.03.025; Wang JK, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-252; Wang YY, 2012, J DIGEST DIS, V13, P366, DOI 10.1111/j.1751-2980.2012.00601.x; WILSON GM, 1991, VIROLOGY, V185, P90, DOI 10.1016/0042-6822(91)90757-3; Yang CH, 2010, CANCER RES, V70, P8108, DOI 10.1158/0008-5472.CAN-10-2579; Zeng Y, 2003, P NATL ACAD SCI USA, V100, P9779, DOI 10.1073/pnas.1630797100; Zhang DL, 1997, BIOLOGICALS, V25, P103, DOI 10.1006/biol.1996.0065; Zhu W, 2010, INT J CANCER, V127, P2520, DOI 10.1002/ijc.25260; Zuo J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-124	69	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81515	10.1371/journal.pone.0081515	http://dx.doi.org/10.1371/journal.pone.0081515			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349084	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300034
J	Jiao, BP; Liu, SR; Liu, H; Cheng, DH; Cheng, Y; Liu, YF				Jiao, Baoping; Liu, Shurong; Liu, Hao; Cheng, Donghua; Cheng, Ying; Liu, Yongfeng			Hypothermic Machine Perfusion Reduces Delayed Graft Function and Improves One-Year Graft Survival of Kidneys from Expanded Criteria Donors: A Meta-Analysis	PLOS ONE			English	Article							RENAL-TRANSPLANTATION; PULSATILE PERFUSION; COLD-STORAGE; DECEASED DONORS; ACUTE REJECTION; RISK-FACTORS; PRESERVATION; RECIPIENTS; IMPACT; ASSOCIATION	Background: Expanded criteria donors (ECDs) are currently accepted as potential sources to increase the donor pool and to provide more chances of kidney transplantation for elderly recipients who would not survive long waiting periods. Hypothermic machine perfusion (HMP) is designed to mitigate the deleterious effects of simple cold storage (CS) on the quality of preserved organs, particularly when the donor is in a marginal status. Methods: We compared the transplant outcomes in patients receiving ECD kidneys with either HMP or CS graft preservation. Articles from the MEDLINE, EMBASE and Cochrane Library databases were searched and all studies reporting outcomes from HMP versus CS methods of kidney preservation were included in this meta-analysis. The parameters analyzed included the incidence of delayed graft function (DGF), primary non-function (PNF) and one-year graft and patient survival. Results: A total of seven studies qualified for the review, involving 2374 and 8716 kidney grafts with HMP or CS preservation respectively, all from ECD donors. The incidence of delayed graft function (DGF) was significantly reduced with an odd ratio(OR) of 0.59 (95% CI 0.54-0.66, P<0.001) and one-year graft survival was significantly improved with an OR of 1.12 (95% CI 1.03-1.21, P = 0.005) in HMP preservation compared to CS. However, there was no difference in the incidence of PNF (OR 0.54, 95% CI 0.21-1.40, P = 0.20), and one-year patient survival (OR 0.98, 95% CI 0.94-1.02, P = 0.36) between HMP and CS preservation. Conclusions: HMP was associated with a reduced incidence of DGF and an with increased one-year graft survival, but it was not associated with the incidence of PNF and one-year patient survival.	[Jiao, Baoping; Liu, Shurong; Liu, Hao; Cheng, Donghua; Cheng, Ying; Liu, Yongfeng] China Med Univ, Hosp 1, Dept Gen Surg, Shenyang, Peoples R China	China Medical University	Liu, YF (corresponding author), China Med Univ, Hosp 1, Dept Gen Surg, Shenyang, Peoples R China.	yfliu@mail.cmu.edu.cn			Special Fund for Health Sector Scientific Research of the Ministry of Health [201002004]	Special Fund for Health Sector Scientific Research of the Ministry of Health	Special Fund for Health Sector Scientific Research of the Ministry of Health (No. 201002004) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Abboud I, 2011, INT J ARTIF ORGANS, V34, P513, DOI 10.5301/IJAO.2011.8458; [Anonymous], 2007, UNOS POLICY 3 5 1 DE; Barba J, 2012, WORLD J UROL; Bathini V, 2013, J UROLOGY, V189, P2214, DOI 10.1016/j.juro.2012.11.173; Bon D, 2012, NAT REV NEPHROL, V8, P339, DOI 10.1038/nrneph.2012.83; Buchanan PM, 2008, AM J TRANSPLANT, V8, P2391, DOI 10.1111/j.1600-6143.2008.02412.x; Deierhoi MH, 2007, J AM COLL SURGEONS, V204, P882; Deng RH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056368; Downs SH, 1998, J EPIDEMIOL COMMUN H, V52, P377, DOI 10.1136/jech.52.6.377; Gallinat A, 2012, NEPHROL DIAL TRANSPL; Glyda M, 2012, ANN TRANSPL, V17, P35; Gomez V, 2012, TRANSPL P, V44, P2521, DOI 10.1016/j.transproceed.2012.09.065; Kauffman HM, 2007, TRANSPLANTATION, V83, P404, DOI 10.1097/01.tp.0000251780.01031.81; Kayler LK, 2011, AM J TRANSPLANT, V11, P2647, DOI 10.1111/j.1600-6143.2011.03741.x; Kosieradzki M, 2008, TRANSPL P, V40, P3279, DOI 10.1016/j.transproceed.2008.10.004; Lam VWT, 2013, J SURG RES, V180, P176, DOI 10.1016/j.jss.2012.10.055; Matsuokaa L, 2006, AM J TRANSPLANT, V6, P1473, DOI 10.1111/j.1600-6143.2006.01323.x; McLaren AJ, 1999, CLIN TRANSPLANT, V13, P266, DOI 10.1034/j.1399-0012.1999.130308.x; Metzger RA, 2003, AM J TRANSPLANT, V3, P114, DOI 10.1034/j.1600-6143.3.s4.11.x; Moers C, 2009, NEW ENGL J MED, V360, P7, DOI 10.1056/NEJMoa0802289; Ojo AO, 2001, J AM SOC NEPHROL, V12, P589, DOI 10.1681/ASN.V123589; Pascual J, 2008, AM J KIDNEY DIS, V52, P553, DOI 10.1053/j.ajkd.2008.06.005; Polyak MMR, 2000, TRANSPLANTATION, V70, P202; Port FK, 2002, TRANSPLANTATION, V74, P1281, DOI 10.1097/00007890-200211150-00014; Schold JD, 2005, AM J TRANSPLANT, V5, P1681, DOI 10.1111/j.1600-6143.2005.00910.x; Sedigh A, 2013, TRANSPL P, V45, P1168, DOI 10.1016/j.transproceed.2012.10.017; Smits JMA, 2002, AM J TRANSPLANT, V2, P664, DOI 10.1034/j.1600-6143.2002.20713.x; Stratta RJ, 2007, J AM COLL SURGEONS, V204, P873, DOI 10.1016/j.jamcollsurg.2007.01.032; Taylor MJ, 2010, CRYOBIOLOGY, V60, pS20, DOI 10.1016/j.cryobiol.2009.10.006; TESI RJ, 1993, TRANSPLANT P, V25, P3099; Treckmann J, 2011, TRANSPL INT, V24, P548, DOI 10.1111/j.1432-2277.2011.01232.x; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667	34	51	59	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81826	10.1371/journal.pone.0081826	http://dx.doi.org/10.1371/journal.pone.0081826			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339970	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400046
J	Leo, E; Mancini, M; Aluigi, M; Luatti, S; Castagnetti, F; Testoni, N; Soverini, S; Santucci, MA; Martinelli, G				Leo, Elisa; Mancini, Manuela; Aluigi, Michela; Luatti, Simona; Castagnetti, Fausto; Testoni, Nicoletta; Soverini, Simona; Santucci, Maria Alessandra; Martinelli, Giovanni			BCR-ABL1-Associated Reduction of Beta Catenin Antagonist Chibby1 in Chronic Myeloid Leukemia	PLOS ONE			English	Article							SEQUENCE BINDING-PROTEIN; STEM-CELLS; WNT/BETA-CATENIN; SELF-RENEWAL; PROGENITOR CELLS; CML STEM; METHYLATION; GENE; BCR; EXPRESSION	Beta Catenin signaling is critical for the self-renewal of leukemic stem cells in chronic myeloid leukemia. It is driven by multiple events, enhancing beta catenin stability and promoting its transcriptional co-activating function. We investigated the impact of BCR-ABL1 on Chibby1, a beta catenin antagonist involved in cell differentiation and transformation. Relative proximity of the Chibby1 encoding gene (C22orf2) on chromosome 22q12 to the BCR breakpoint (22q11) lets assume its involvement in beta catenin activation in chronic myeloid leukemia as a consequence of deletions of distal BCR sequences encompassing one C22orf2 allele. Forty patients with chronic myeloid leukemia in chronic phase were analyzed for C22orf2 relocation and Chibby1 expression. Fluorescent in situ hybridization analyses established that the entire C22orf2 follows BCR regardless of chromosomes involved in the translocation. In differentiated hematopoietic progenitors (bone marrow mononuclear cell fractions) of 30/40 patients, the expression of Chibby1 protein was reduced below 50% of the reference value (peripheral blood mononuclear cell fractions of healthy persons). In such cell context, Chibby1 protein reduction is not dependent on C22orf2 transcriptional downmodulation; however, it is strictly dependent upon BCR-ABL1 expression because it was not observed at the moment of major molecular response under tyrosine kinase inhibitor therapy. Moreover, it was not correlated with the disease prognosis or response to therapy. Most importantly, a remarkable Chibby1 reduction was apparent in a putative BCR-ABL1+ leukemic stem cell compartment identified by a CD34+ phenotype compared to more differentiated hematopoietic progenitors. In CD34+ cells, Chibby1 reduction arises from transcriptional events and is driven by C22orf2 promoter hypermethylation. These results advance low Chibby1 expression associated with BCR-ABL1 as a component of beta catenin signaling in leukemic stem cells.	[Leo, Elisa; Mancini, Manuela; Aluigi, Michela; Luatti, Simona; Castagnetti, Fausto; Testoni, Nicoletta; Soverini, Simona; Santucci, Maria Alessandra; Martinelli, Giovanni] Univ Bologna, Sch Med, Dipartimento Med Specialist Diagnost & Sperimenta, Ist Ematol Lorenzo & Ariosto Seragnoli, Bologna, Italy	University of Bologna	Leo, E (corresponding author), Univ Bologna, Sch Med, Dipartimento Med Specialist Diagnost & Sperimenta, Ist Ematol Lorenzo & Ariosto Seragnoli, Bologna, Italy.	elisa.leo1@gmail.com	Simona, Soverini/A-3608-2016; Martinelli, Giovanni/AAK-9211-2020	Simona, Soverini/0000-0002-4508-0353; Martinelli, Giovanni/0000-0002-1025-4210; TESTONI, NICOLETTA/0000-0001-6785-5132	University of Bologna (RFO funds); Ministero della Pubblica Istruzione e della Ricerca (PRIN funds); Umberto Veronesi Foundation; AIRC; FP7 NCS-PLT project; Carisbo foundation; Fondazione del Monte di Bologna e Ravenna; BolognaAIL	University of Bologna (RFO funds); Ministero della Pubblica Istruzione e della Ricerca (PRIN funds)(Ministry of Education, Universities and Research (MIUR)); Umberto Veronesi Foundation(Fondazione Umberto Veronesi); AIRC(Fondazione AIRC per la ricerca sul cancro); FP7 NCS-PLT project; Carisbo foundation(Fondazione Carisbo); Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); BolognaAIL	University of Bologna (RFO funds), Ministero della Pubblica Istruzione e della Ricerca (PRIN funds), Umberto Veronesi Foundation, AIRC, FP7 NCS-PLT project, Carisbo foundation, Fondazione del Monte di Bologna e Ravenna and BolognaAIL are acknowledged for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Asimakopoulos FA, 1999, BLOOD, V94, P2452, DOI 10.1182/blood.V94.7.2452.419k23_2452_2460; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Coluccia AML, 2007, EMBO J, V26, P1456, DOI 10.1038/sj.emboj.7601485; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dao KHT, 2012, BLOOD, V120, P323, DOI 10.1182/blood-2011-11-388355; Della Peruta M, 2010, CANCER RES, V70, P8896, DOI 10.1158/0008-5472.CAN-10-0258; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Fischer Victoria, 2012, J Mol Signal, V7, P6, DOI 10.1186/1750-2187-7-6; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; Hu Y, 2009, LEUKEMIA, V23, P109, DOI 10.1038/leu.2008.262; Huang WQ, 2013, J BIOL CHEM, V288, P12766, DOI 10.1074/jbc.M112.429696; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Huntly BJP, 2003, BLOOD, V102, P1160, DOI 10.1182/blood-2003-01-0123; Janssen JJWM, 2010, HAEMATOL-HEMATOL J, V95, P1036, DOI 10.3324/haematol.2009.015693; Janssen JJWM, 2005, LEUKEMIA, V19, P998, DOI 10.1038/sj.leu.2403735; Jelinek J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022110; Kagita S, 2013, HEMATOLOGY; Karakoula K, 2008, GENE CHROMOSOME CANC, V47, P1005, DOI 10.1002/gcc.20607; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Lemoli RM, 2009, BLOOD, V114, P5191, DOI 10.1182/blood-2008-08-176016; Leo E, 2012, BRIT J HAEMATOL, V159, P373, DOI 10.1111/bjh.12023; Li FQ, 2008, J CELL BIOL, V181, P1141, DOI 10.1083/jcb.200709091; Liu TC, 2003, BRIT J HAEMATOL, V123, P654, DOI 10.1046/j.1365-2141.2003.04660.x; Mahon GM, 2013, BLOOD; Mancini M, 2013, CELL SIGNAL, V25, P1820, DOI 10.1016/j.cellsig.2013.05.019; Mancini M, 2010, CELL SIGNAL, V22, P1247, DOI 10.1016/j.cellsig.2010.04.002; MCWHIRTER JR, 1993, MOL CELL BIOL, V13, P7587, DOI 10.1128/MCB.13.12.7587; Minami Y, 2008, P NATL ACAD SCI USA, V105, P17967, DOI 10.1073/pnas.0808303105; Motiwala T, 2009, J BIOL CHEM, V284, P455, DOI 10.1074/jbc.M802840200; Nagy E, 2003, EUR J CANCER, V39, P2298, DOI 10.1016/S0959-8049(03)00552-5; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Neviani P, 2013, J CLIN INVEST; Pehlivan M, 2009, LEUKEMIA RES, V33, P1062, DOI 10.1016/j.leukres.2008.11.013; Perry JM, 2011, GENE DEV, V25, P1928, DOI 10.1101/gad.17421911; Qian J, 2009, EUR J HAEMATOL, V82, P119, DOI 10.1111/j.1600-0609.2008.01178.x; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Schmidt M, 2001, BLOOD, V97, P3648, DOI 10.1182/blood.V97.11.3648; Schuierer MM, 2006, WORLD J GASTROENTERO, V12, P1529, DOI 10.3748/wjg.v12.i10.1529; Sinclair PB, 2000, BLOOD, V95, P738, DOI 10.1182/blood.V95.3.738.003k21_738_743; Song JJ, 2012, INT J MOL MED, V30, P179, DOI 10.3892/ijmm.2012.970; Takemaru KI, 2003, NATURE, V422, P905, DOI 10.1038/nature01570; Testoni N, 2009, BLOOD, V114, P4939, DOI 10.1182/blood-2009-07-229864; Wang YL, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-54; Yang MY, 2003, BLOOD, V101, P3205, DOI 10.1182/blood-2002-05-1598; Zhang B, 2013, BLOOD, V121, P1824, DOI 10.1182/blood-2012-02-412890; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003	49	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81425	10.1371/journal.pone.0081425	http://dx.doi.org/10.1371/journal.pone.0081425			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339928	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400017
J	Sang, J; Han, XJ; Liu, MY; Qiao, GR; Jiang, J; Zhuo, RY				Sang, Jian; Han, Xiaojiao; Liu, Mingying; Qiao, Guirong; Jiang, Jing; Zhuo, Renying			Selection and Validation of Reference Genes for Real-Time Quantitative PCR in Hyperaccumulating Ecotype ofSedum alfredii under Different Heavy Metals Stresses	PLOS ONE			English	Article							RT-PCR; CADMIUM; NORMALIZATION; PHYTOCHELATINS; EXPRESSION; METALLOIDS; TOLERANCE	Real-time Quantitative PCR (RT-qPCR) has become an effective method for accurate analysis of gene expression in several biological systems as well as under different experimental conditions. Although with high sensitivity, specificity and broad dynamic range, this method requires suitable reference genes for transcript normalization in order to guarantee reproducible and meaningful results. In the present study, we evaluated five traditional housekeeping genes and five novel reference genes in Hyperaccumulating ecotype of Sedum alfredii, a well known hyperaccumulator for heavy metals phytoremediation, under Cd, Pb, Zn and Cu stresses of seven different durations. The expression stability of these ten candidates were determined with three programs - geNorm, NormFinder and BestKeeper. The results showed that all the selected reference genes except for SAND could be used for RT-qPCR normalization. Among them UBC9 and TUB were ranked as the most stable candidates across all samples by three programs together. For the least stable reference genes, however, BestKeeper produced different results compared with geNorm and NormFinder. Meanwhile, the expression profiles of PCS under Cd, Pb, Zn and Cu stresses were assessed using UBC9 and TUB respectively, and similar trends were obtained from the results of the two groups. The distinct expression patterns of PCS indicated that various strategies could be taken by plants in adaption to different heavy metals stresses. This study will provide appropriate reference genes for further gene expression quantification using RT-qPCR in Hyperaccumulator S. alfredii.	[Sang, Jian; Han, Xiaojiao; Liu, Mingying; Qiao, Guirong; Jiang, Jing; Zhuo, Renying] State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Sang, Jian; Han, Xiaojiao; Liu, Mingying; Qiao, Guirong; Jiang, Jing; Zhuo, Renying] Chinese Acad Forestry, Res Inst Subtrop Forestry, Key Lab Tree Genom, Fuyang, Zhejiang, Peoples R China	Chinese Academy of Forestry; Research Institute of Subtropical Forestry, CAF	Zhuo, RY (corresponding author), State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	zhuory@gmail.com		Han, Xiaojiao/0000-0001-6082-7569; zhuo, renying/0000-0002-7063-3714	National High-tech Research & Development Program of China [2013AA102701-3]; Basic Scientific Research Project of Nonprofit Central Research Institutions [CAFYBB2012040, TGB2013008]; National Natural Science Foundation of China [31200465]	National High-tech Research & Development Program of China(National High Technology Research and Development Program of China); Basic Scientific Research Project of Nonprofit Central Research Institutions; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National High-tech Research & Development Program of China (No. 2013AA102701-3), Basic Scientific Research Project of Nonprofit Central Research Institutions (No. CAFYBB2012040 and NO. TGB2013008) and the National Natural Science Foundation of China (NO. 31200465)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H, 2013, CHEMOSPHERE; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Chao YE, 2010, ENVIRON EXP BOT, V68, P107, DOI 10.1016/j.envexpbot.2009.11.013; Diels L., 2002, Re/Views in Environmental Science and Bio/Technology, V1, P75, DOI 10.1023/A:1015188708612; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Gao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064643; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kumar V, 2011, AUST J CROP SCI, V5, P1455; Li RM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053006, 10.1371/journal.pone.0058597]; Lu LL, 2008, J EXP BOT, V59, P3203, DOI 10.1093/jxb/ern174; Lu LL, 2010, J HAZARD MATER, V183, P22, DOI 10.1016/j.jhazmat.2010.06.036; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; McGrath SP, 2003, CURR OPIN BIOTECH, V14, P277, DOI 10.1016/S0958-1669(03)00060-0; McGrath SP, 2002, ADV AGRON, V75, P1, DOI 10.1016/S0065-2113(02)75002-5; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Sun Q, 2007, J PLANT PHYSIOL, V164, P1489, DOI 10.1016/j.jplph.2006.10.001; Tian SK, 2011, PLANT PHYSIOL, V157, P1914, DOI 10.1104/pp.111.183947; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visioli G, 2013, J PROTEOMICS, V79, P133, DOI 10.1016/j.jprot.2012.12.006; VOLESKY B, 1995, BIOTECHNOL PROGR, V11, P235, DOI 10.1021/bp00033a001; Yang X, 2002, CHINESE SCI BULL, V47, P1634, DOI 10.1360/02tb9359; Yang XE, 2004, PLANT SOIL, V259, P181, DOI 10.1023/B:PLSO.0000020956.24027.f2; Zhang M, 2011, FEBS LETT, V585, P2604, DOI 10.1016/j.febslet.2011.07.013; Zhang M, 2011, BIOTECHNOL LETT, V33, P1865, DOI 10.1007/s10529-011-0622-8; Zhang ZC, 2008, PHYTOCHEMISTRY, V69, P911, DOI 10.1016/j.phytochem.2007.10.012	36	32	36	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82927	10.1371/journal.pone.0082927	http://dx.doi.org/10.1371/journal.pone.0082927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340067	gold, Green Published, Green Submitted			2022-12-27	WOS:000328707400103
J	Fusco, A; Panico, L; Gorrese, M; Bianchino, G; Barone, MV; Grieco, V; Vitiello, L; D'Assante, R; Romano, R; Palamaro, L; Scalia, G; Del Vecchio, L; Pignata, C				Fusco, Anna; Panico, Luigi; Gorrese, Marisa; Bianchino, Gabriella; Barone, Maria V.; Grieco, Vitina; Vitiello, Laura; D'Assante, Roberta; Romano, Rosa; Palamaro, Loredana; Scalia, Giulia; Del Vecchio, Luigi; Pignata, Claudio			Molecular Evidence for a Thymus-Independent Partial T Cell Development in a FOXN1(-/-) Athymic Human Fetus	PLOS ONE			English	Article							BONE-MARROW-TRANSPLANTATION; INTRAEPITHELIAL LYMPHOCYTES; IMMUNE-SYSTEM; GAMMA-DELTA; EXPRESSION; MOUSE; GENE; MICE; GUT; MATURATION	The thymus is the primary organ able to support T cell ontogeny, abrogated in FOXN1(-/-) human athymia. Although evidence indicates that in animal models T lymphocytes may differentiate at extrathymic sites, whether this process is really thymus-independent has still to be clarified. In an athymic FOXN1(-/-) fetus, in which we previously described a total blockage of CD4(+) and partial blockage of CD8(+) cell development, we investigated whether intestine could play a role as extrathymic site of T-lymphopoiesis in humans. We document the presence of few extrathymically developed T lymphocytes and the presence in the intestine of CD3(+) and CD8(+), but not of CD4(+) cells, a few of them exhibiting a CD45RA(+) naive phenotype. The expression of CD3 epsilon epsilon pT alpha, RAG1 and RAG2 transcripts in the intestine and TCR gene rearrangement was also documented, thus indicating that in humans the partial T cell ontogeny occurring at extrathymic sites is a thymus- and FOXN1-independent process.	[Fusco, Anna; Barone, Maria V.; D'Assante, Roberta; Romano, Rosa; Palamaro, Loredana; Pignata, Claudio] Univ Naples Federico II, Pediat Sect, Dept Translat Med Sci, Naples, Italy; [Panico, Luigi] Natl Relevance Hosp SG Moscati, Unit Pathol, Avellino, Italy; [Gorrese, Marisa; Scalia, Giulia; Del Vecchio, Luigi] Univ Naples Federico II, Dept Biochem & Med Biotechnol CEINGE, Naples, Italy; [Bianchino, Gabriella; Grieco, Vitina] Ctr Riferimento Oncol Basilicata Rionero Vulture, Mol Oncol Unit, IRCCS, Pz, Italy; [Vitiello, Laura] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol, Naples, Italy	University of Naples Federico II; San Giuseppe Moscati Hospital; University of Naples Federico II; IRCCS CROB; University of Naples Federico II	Pignata, C (corresponding author), Univ Naples Federico II, Pediat Sect, Dept Translat Med Sci, Naples, Italy.	pignata@unina.it	Palamaro, Loredana/GRY-4382-2022; Pignata, Claudio/O-2466-2013; Grieco, Vitina/AAB-9010-2020; Vitiello, Laura/AAB-8836-2019; grieco, vitina/AAB-9532-2020; Nozza, Filomena/AAB-7861-2020; Vitiello, Laura/G-7326-2014; Fusco, Anna/N-6499-2013	Palamaro, Loredana/0000-0001-5564-1831; Pignata, Claudio/0000-0003-1568-9843; Grieco, Vitina/0000-0001-7670-4643; Vitiello, Laura/0000-0003-0776-3601; Nozza, Filomena/0000-0003-1617-1691; Vitiello, Laura/0000-0003-0776-3601; Romano, Rosa/0000-0002-1206-5165; Fusco, Anna/0000-0003-0400-1425; BARONE, Maria Vittoria/0000-0001-6190-4917	Italian Association "Un vero sorriso"	Italian Association "Un vero sorriso"	This work was supported by the Italian Association "Un vero sorriso". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriani M, 2004, ANN HUM GENET, V68, P265, DOI 10.1046/j.1529-8817.2004.00091.x; Albuquerque AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037042; BANDEIRA A, 1991, P NATL ACAD SCI USA, V88, P43, DOI 10.1073/pnas.88.1.43; Bas A, 2003, J IMMUNOL, V171, P3359, DOI 10.4049/jimmunol.171.7.3359; Blais ME, 2003, EXP HEMATOL, V31, P349, DOI 10.1016/S0301-472X(03)00026-2; BRUNO L, 1995, EUR J IMMUNOL, V25, P1877, DOI 10.1002/eji.1830250713; Bryson JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065196; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; FLANAGAN SP, 1966, GENET RES, V8, P295, DOI 10.1017/S0016672300010168; Gunther U, 2005, J IMMUNOL, V174, P5414, DOI 10.4049/jimmunol.174.9.5414; Guy-Grand D, 2003, J EXP MED, V197, P333, DOI 10.1084/jem.20021639; Hamann D, 1997, J EXP MED, V186, P1407, DOI 10.1084/jem.186.9.1407; IIAI T, 1992, IMMUNOLOGY, V77, P556; Ishikawa H, 2007, IMMUNOL REV, V215, P154, DOI 10.1111/j.1600-065X.2006.00473.x; Johansson M, 2003, J IMMUNOL, V170, P1659, DOI 10.4049/jimmunol.170.4.1659; KENNEDY JD, 1992, J IMMUNOL, V148, P1620; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luche H, 2013, J EXP MED, V210, P699, DOI 10.1084/jem.20122609; LUNDQVIST C, 1995, INT IMMUNOL, V7, P1473, DOI 10.1093/intimm/7.9.1473; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; Nonaka S, 2005, J IMMUNOL, V174, P1906, DOI 10.4049/jimmunol.174.4.1906; Oida T, 2000, J IMMUNOL, V164, P3616, DOI 10.4049/jimmunol.164.7.3616; Palamaro L, 2013, INT IMMUNOL IN PRESS; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Pignata C, 1996, AM J MED GENET, V65, P167, DOI 10.1002/(SICI)1096-8628(19961016)65:2<167::AID-AJMG17>3.0.CO;2-O; Pignata C, 2001, BLOOD, V97, P880, DOI 10.1182/blood.V97.4.880; Pignata C, 2009, ADV EXP MED BIOL, V665, P195; Rocha B, 2007, IMMUNOL REV, V215, P166, DOI 10.1111/j.1600-065X.2006.00467.x; Romano R, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/467101; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Saran N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030864; SATO K, 1995, J EXP MED, V182, P759, DOI 10.1084/jem.182.3.759; Schorpp M, 1997, IMMUNOGENETICS, V46, P509, DOI 10.1007/s002510050312; Sugahara S, 1999, IMMUNOLOGY, V96, P57; Torfadottir H, 2006, CLIN EXP IMMUNOL, V145, P407, DOI 10.1111/j.1365-2249.2006.03139.x; TORRESNAGEL N, 1992, EUR J IMMUNOL, V22, P2841, DOI 10.1002/eji.1830221113; Uss E, 2006, J IMMUNOL, V177, P2775, DOI 10.4049/jimmunol.177.5.2775; Vigliano I, 2011, J MED GENET, V48, P413, DOI 10.1136/jmg.2011.089532	39	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81786	10.1371/journal.pone.0081786	http://dx.doi.org/10.1371/journal.pone.0081786			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349129	Green Submitted, Green Published, gold			2022-12-27	WOS:000328705200051
J	Xu, L; Ping, F; Yin, JH; Xiao, XH; Xiang, HD; Ballantyne, CM; Wu, HZ; Li, M				Xu, Lu; Ping, Fan; Yin, Jinhua; Xiao, Xinhua; Xiang, Hongding; Ballantyne, Christie M.; Wu, Huaizhu; Li, Ming			Elevated Plasma SPARC Levels Are Associated with Insulin Resistance, Dyslipidemia, and Inflammation in Gestational Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; PROTEIN; ADIPONECTIN; NEPHROPATHY; SENSITIVITY; ADIPOKINES; PREGNANCY; CYTOKINES	Objective: Recent studies suggested that secreted protein acidic and rich in cysteine (SPARC), a novel adipokine, is a key player in the pathology of obesity and type 2 diabetes. We aimed to determine whether concentrations of SPARC were altered in patients with gestational diabetes mellitus (GDM) compared to normal glucose tolerance (NGT) controls and to investigate the relationships between SPARC and metabolic parameters in pregnant women. Design/Methods: Cross-sectional study of 120 pregnant women with GDM and 60 controls with NGT, in a university hospital setting. Plasma levels of SPARC, adiponectin, fibroblast growth factor 21 (FGF21), insulin and proinsulin were determined by ELISA. Results: GDM women had higher SPARC and lower adiponectin than NGT subjects; no difference was found in FGF21. SPARC levels were the lowest in subjects in the third tertile of insulin sensitivity index (ISIOGTT) and correlated positively with pre-pregnant BMI, insulin and 3 h glucose during 100-g OGTT, HOMA-IR, fasting proinsulin, hsCRP and white blood cells count, and negatively with ISIOGTT, when adjusting for gestational age. Triglyceride (TG), Apolipoprotein A1, apolipoprotein B and lipoprotein (a) correlated with SPARC in partial Pearson correlation. Correlations between SPARC with adiponectin, systolic blood pressure and TG were marginally significant in partial Spearman correlation analysis. In multivariate regression analysis, SPARC was an independent negative indicator of ISIOGTT. Conclusions: SPARC levels are correlated significantly with inflammation and may also be correlated with dyslipidemia and represent an independent determinant of insulin resistance in late pregnancy, indicating a potential role of SPARC in the pathophysiology of GDM.	[Xu, Lu; Ping, Fan; Yin, Jinhua; Xiao, Xinhua; Xiang, Hongding; Li, Ming] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Key Lab Endocrinol, Dept Endocrinol,Minist Hlth, Beijing 100730, Peoples R China; [Xu, Lu; Ping, Fan; Yin, Jinhua; Xiao, Xinhua; Xiang, Hongding; Li, Ming] Peking Union Med Coll CAMS & PUMC, Beijing, Peoples R China; [Ballantyne, Christie M.; Wu, Huaizhu] Baylor Coll Med, Dept Med, Sect Atherosclerosis & Vasc Med, Houston, TX 77030 USA; [Ballantyne, Christie M.] Methodist DeBakey Heart Ctr, Ctr Cardiovasc Dis Prevent, Houston, TX USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Baylor College of Medicine; The Methodist Hospital System; The Methodist Hospital - Houston; Methodist DeBakey Heart & Vascular Center	Li, M (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Key Lab Endocrinol, Dept Endocrinol,Minist Hlth, Beijing 100730, Peoples R China.	liming@pumch.cn	Li, Ming/I-1323-2018; Li, Ming/AAG-3644-2020; Ballantyne, Christie/A-6599-2008	Li, Ming/0000-0002-8427-605X; Li, Ming/0000-0002-8427-605X; Ballantyne, Christie/0000-0002-6432-1730	Key Laboratory of Endocrinology Ministry of Health & Peking Union Medical College Hospital, New Star Project of Beijing Science and Technology [2004A027]; Novo Nordisk Union Diabetes Research Talent Fund; National Clinical Key Projects	Key Laboratory of Endocrinology Ministry of Health & Peking Union Medical College Hospital, New Star Project of Beijing Science and Technology; Novo Nordisk Union Diabetes Research Talent Fund; National Clinical Key Projects	This work was supported by grants from Key Laboratory of Endocrinology Ministry of Health & Peking Union Medical College Hospital (http://www.pumch.cn/Category_236/index.aspx), New Star Project of Beijing Science and Technology (http://www.bjast.ac.cn/Html/List/list173.html)[2004A027], Novo Nordisk Union Diabetes Research Talent Fund and National Clinical Key Projects (http://www.novonordisk.com.cn/documents/promotion_page/document/aboutusinchinaSC.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Diabetes Association, 2007, Diabetes Care, V30 Suppl 1, pS42; Ategbo JM, 2006, J CLIN ENDOCR METAB, V91, P4137, DOI 10.1210/jc.2006-0980; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Calle MC, 2012, DIABETES METAB, V38, P183, DOI 10.1016/j.diabet.2011.11.006; Carpenter MW, 2007, DIABETES CARE, V30, pS246, DOI 10.2337/dc07-s224; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Gotto AM, 2000, CIRCULATION, V101, P477, DOI 10.1161/01.CIR.101.5.477; Greenberg AS, 2002, EUR J CLIN INVEST, V32, P24, DOI 10.1046/j.1365-2362.32.s3.4.x; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Harries LW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068253; Henegar C, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r14; Jiang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065756; Kanauchi M, 2000, DIABETOLOGIA, V43, P1076; Kautzky-Willer A, 2008, J CLIN ENDOCR METAB, V93, P1689, DOI 10.1210/jc.2007-2301; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kirwan JP, 2001, DIABETES CARE, V24, P1602, DOI 10.2337/diacare.24.9.1602; Kos K, 2009, DIABETES, V58, P1780, DOI 10.2337/db09-0211; Lee DE, 2009, AM J PHYSIOL-ENDOC M, V296, pE1210, DOI 10.1152/ajpendo.00015.2009; Li M, 2009, INT J OBESITY, V33, P424, DOI 10.1038/ijo.2009.44; Li M, 1999, CHIN J DIABETES, V7, P157; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Miehle K, 2012, CLIN ENDOCRINOL, V76, P2, DOI 10.1111/j.1365-2265.2011.04234.x; MUNJAL ID, 1994, CURR EYE RES, V13, P303, DOI 10.3109/02713689408995792; Nie J, 2009, J BIOL CHEM, V284, P1279, DOI 10.1074/jbc.M808285200; Ping F, 2012, DIABETES RES CLIN PR, V97, P283, DOI 10.1016/j.diabres.2012.02.017; Retnakaran R, 2007, DIABETIC MED, V24, P245, DOI 10.1111/j.1464-5491.2007.02077.x; Stein S, 2010, METABOLISM, V59, P33, DOI 10.1016/j.metabol.2009.07.003; Tan BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065254; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; TERMINE JD, 1981, CELL, V26, P99, DOI 10.1016/0092-8674(81)90037-4; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Wiznitzer A, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.032; Wolf M, 2004, DIABETES CARE, V27, P21, DOI 10.2337/diacare.27.1.21; Wolf M, 2003, DIABETES CARE, V26, P819, DOI 10.2337/diacare.26.3.819; Wu DD, 2011, EUR J ENDOCRINOL, V165, P597, DOI 10.1530/EJE-11-0131; Xu L, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/389108	38	28	30	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e81615	10.1371/journal.pone.0081615	http://dx.doi.org/10.1371/journal.pone.0081615			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349098	Green Published, gold, Green Submitted			2022-12-27	WOS:000328705200038
J	Gao, YH; Huang, EY; Zhang, HM; Wang, JH; Wu, NN; Chen, X; Wang, N; Wen, S; Nan, GX; Deng, F; Liao, Z; Wu, D; Zhang, BS; Zhang, JH; Haydon, RC; Luu, HH; Shi, LL; He, TC				Gao, Yanhong; Huang, Enyi; Zhang, Hongmei; Wang, Jinhua; Wu, Ningning; Chen, Xian; Wang, Ning; Wen, Sheng; Nan, Guoxin; Deng, Fang; Liao, Zhan; Wu, Di; Zhang, Bosi; Zhang, Junhui; Haydon, Rex C.; Luu, Hue H.; Shi, Lewis L.; He, Tong-Chuan			Crosstalk between Wnt/beta-Catenin and Estrogen Receptor Signaling Synergistically Promotes Osteogenic Differentiation of Mesenchymal Progenitor Cells	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; SUPPRESSES TUMOR-GROWTH; OSTEOBLAST DIFFERENTIATION; WNT; TARGET; PLAYS; EXPRESSION; INHIBITOR; BMP9	Osteogenic differentiation from mesenchymal progenitor cells (MPCs) are initiated and regulated by a cascade of signaling events. Either Wnt/beta-catenin or estrogen signaling pathway has been shown to play an important role in regulating skeletal development and maintaining adult tissue homeostasis. Here, we investigate the potential crosstalk and synergy of these two signaling pathways in regulating osteogenic differentiation of MPCs. We find that the activation of estrogen receptor (ER) signaling by estradiol (E2) or exogenously expressed ER alpha in MPCs synergistically enhances Wnt3A-induced early and late osteogenic markers, as well as matrix mineralization. The E2 or ER alpha-mediated synergy can be effectively blocked by ER alpha antagonist tamoxifen. E2 stimulation can enhance endochondral ossification of Wnt3A-transduced mouse fetal limb explants. Furthermore, exogenously expressed ER alpha significantly enhances the maturity and mineralization of Wnt3A-induced subcutaneous and intramuscular ectopic bone formation. Mechanistically, we demonstrate that E2 does not exert any detectable effect on beta-catenin/Tcf reporter activity. However, ER alpha expression is up-regulated within the first 48h in AdWnt3A-transduced MPCs, whereas ER beta expression is significantly inhibited within 24h. Moreover, the key enzyme for the biosynthesis of estrogens aromatase is modulated by Wnt3A in a biphasic manner, up-regulated at 24h but reduced after 48h. Our results demonstrate that, while ER signaling acts synergistically with Wnt3A in promoting osteogenic differentiation, Wnt3A may crosstalk with ER signaling by up-regulating ER alpha expression and down-regulating ER beta expression in MPCs. Thus, the signaling crosstalk and synergy between these two pathways should be further explored as a potential therapeutic approach to combating bone and skeletal disorders, such as fracture healing and osteoporosis.	[Gao, Yanhong] Shanghai Jiao Tong Univ, Dept Geriatr, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China; [Gao, Yanhong; Huang, Enyi; Zhang, Hongmei; Wang, Jinhua; Wu, Ningning; Chen, Xian; Wang, Ning; Wen, Sheng; Nan, Guoxin; Deng, Fang; Liao, Zhan; Wu, Di; Zhang, Bosi; Zhang, Junhui; Haydon, Rex C.; Luu, Hue H.; Shi, Lewis L.; He, Tong-Chuan] Univ Chicago, Med Ctr, Mol Oncol Lab, Dept Orthopaed Surg & Rehabil Med, Chicago, IL 60637 USA; [Huang, Enyi; Zhang, Hongmei; Wang, Jinhua; Zhang, Junhui; He, Tong-Chuan] Chongqing Med Univ, Chongqing Key Lab Oral Dis & Biomed Sci, Affiliated Hosp Stomatol, Chongqing, Peoples R China; [Wu, Ningning; Chen, Xian; Wen, Sheng; Nan, Guoxin; He, Tong-Chuan] Chongqing Med Univ, Minist Educ Key Lab Clin Diagnost Med, Affiliated Hosp, Chongqing, Peoples R China; [Wang, Ning; Deng, Fang] Third Mil Med Univ, Dept Cell Biol, Southwest Hosp, Chongqing, Peoples R China; [Wang, Ning; Deng, Fang] Third Mil Med Univ, Dept Oncol, Southwest Hosp, Chongqing, Peoples R China; [Liao, Zhan] Cent South Univ Xiang Ya Sch Med, Dept Orthopaed Surg, Xiang Ya Hosp, Changsha, Hunan, Peoples R China	Shanghai Jiao Tong University; University of Chicago; University of Chicago Medical Center; Chongqing Medical University; Chongqing Medical University; Army Medical University; Army Medical University	Gao, YH (corresponding author), Shanghai Jiao Tong Univ, Dept Geriatr, Xinhua Hosp, Sch Med, Shanghai 200030, Peoples R China.	yhgao2010@yahoo.com; tche@uchicago.edu			National Institutes of Health; North American Spine Society; Natural Science Foundation of China [81101360]; Shanghai Education Commission [12YZ053]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North American Spine Society; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Education Commission	The reported work was supported in part by research grants from the National Institutes of Health (RCH, HHL, and TCH), North American Spine Society (TCH), the Natural Science Foundation of China (#81101360 to YG), and Shanghai Education Commission (#12YZ053 to YG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Armstrong VJ, 2007, J BIOL CHEM, V282, P20715, DOI 10.1074/jbc.M703224200; Baron Roland, 2007, Curr Osteoporos Rep, V5, P73; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Burns KA, 2012, ARCH TOXICOL, V86, P1491, DOI 10.1007/s00204-012-0868-5; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Cheskis BJ, 2007, J CELL PHYSIOL, V213, P610, DOI 10.1002/jcp.21253; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; de Launoit Y, 1999, J MOL ENDOCRINOL, V22, P227, DOI 10.1677/jme.0.0220227; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Grumbach MM, 1999, J CLIN ENDOCR METAB, V84, P4677, DOI 10.1210/jc.84.12.4677; He BC, 2011, MOL PHARMACOL, V79, P211, DOI 10.1124/mol.110.068668; He BC, 2010, CLIN CANCER RES, V16, P2235, DOI 10.1158/1078-0432.CCR-09-2499; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hu N, 2013, J CELL SCI, V126, P532, DOI 10.1242/jcs.114231; Huang EY, 2012, J BONE MINER RES, V27, P1566, DOI 10.1002/jbmr.1622; Huang EY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032428; Huang JY, 2009, LIVER INT, V29, P1569, DOI 10.1111/j.1478-3231.2009.02111.x; Juul A, 2001, HUM REPROD UPDATE, V7, P303, DOI 10.1093/humupd/7.3.303; Kang Q, 2004, GENE THER, V11, P1312, DOI 10.1038/sj.gt.3302298; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Khosla S, 2012, TRENDS ENDOCRIN MET, V23, P576, DOI 10.1016/j.tem.2012.03.008; Kim JH, 2013, THER ADV MUSCULOSKEL, V5, P13, DOI 10.1177/1759720X12466608; Kouzmenko AP, 2004, J BIOL CHEM, V279, P40255, DOI 10.1074/jbc.C400331200; Li M, 2013, INT J MED SCI, V10, P1035, DOI 10.7150/ijms.6639; Liedert A, 2010, BIOCHEM BIOPH RES CO, V394, P755, DOI 10.1016/j.bbrc.2010.03.065; Liu X, 2013, J CELL MOL MED, V17, P1160, DOI 10.1111/jcmm.12097; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luo Q, 2004, J BIOL CHEM, V279, P55958, DOI 10.1074/jbc.M407810200; Luo Q, 2007, GENE, V395, P160, DOI 10.1016/j.gene.2007.02.030; Luo XJ, 2008, LAB INVEST, V88, P1264, DOI 10.1038/labinvest.2008.98; Luther G, 2011, CURR GENE THER, V11, P229; Luu HH, 2007, J ORTHOP RES, V25, P665, DOI 10.1002/jor.20359; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Monroe DG, 2012, GENE, V492, P1, DOI 10.1016/j.gene.2011.10.044; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Peng Y, 2004, J BIOL CHEM, V279, P32941, DOI 10.1074/jbc.M403344200; Peng Y, 2003, J CELL BIOCHEM, V90, P1149, DOI 10.1002/jcb.10744; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rastegar F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014182; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shi B, 2007, MOL CELL BIOL, V27, P5105, DOI 10.1128/MCB.00162-07; Si WK, 2006, MOL CELL BIOL, V26, P2955, DOI 10.1128/MCB.26.8.2955-2964.2006; Simm P J, 2008, Pediatr Endocrinol Rev, V6, P32; Su Y, 2011, ONCOGENE, V30, P3907, DOI 10.1038/onc.2011.97; Tang N, 2009, J CELL MOL MED, V13, P2448, DOI 10.1111/j.1582-4934.2008.00569.x; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Wagner Eric R, 2011, Curr Mol Pharmacol, V4, P14; Wang Y, 2013, J ORTHOP RES, V31, P1796, DOI 10.1002/jor.22427; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]; Xu DJ, 2012, BMB REP, V45, P247, DOI 10.5483/BMBRep.2012.45.4.247; Zhang WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011917; Zhao YP, 2012, CANCER, V1, P1, DOI DOI 10.1371/J0URNAL.P0NE.0043383.PUBMED:22912865; Zhou L, 2003, CANCER LETT, V193, P161, DOI 10.1016/S0304-3835(03)00013-2; Zhou L, 2002, BIOTECHNIQUES, V33, P1126, DOI 10.2144/02335dd07; Zhu GH, 2009, DIFFERENTIATION, V78, P195, DOI 10.1016/j.diff.2009.06.001	62	80	82	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82436	10.1371/journal.pone.0082436	http://dx.doi.org/10.1371/journal.pone.0082436			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340027	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100106
J	Liao, CS; Wang, SH; Pan, X; Hou, GQ; Li, DF				Liao, Congshu; Wang, Songhua; Pan, Xuan; Hou, Guoqiang; Li, Dongfeng			Dopamine Modulates the Excitability of Projection Neurons in the Robust Nucleus of the Arcopallium in Adult Zebra Finches	PLOS ONE			English	Article							MEDIAL PREOPTIC AREA; SEXUAL MOTIVATION; GENE-EXPRESSION; BRAIN; BEHAVIOR; SYSTEM; MAINTENANCE; ANTAGONISTS; SONGBIRDS; ACCUMBENS	Background: The nervous system in songbirds is an accessible system for studying vocal learning and memory in vertebrates. In the song system, the anterior forebrain pathway (AFP) is essential for song learning and the vocal motor pathway (VMP) is necessary for song production. The premotor robust nucleus of the arcopallium (RA) located in the VMP receives input from the AFP. The RA receives dopaminergic innervations from the periaqueductal gray and ventral tegmental area-substantia nigra pars compacta, but the physiological functions of this projection remain unclear. In this study, we investigated the effects of dopamine (DA) on the excitability of projection neurons (PNs) in the RA. Methodology: We recorded the electrophysiological changes from neurons in brain slices of male adult zebra finches using a whole-cell recording technique. Conclusions/Significance: We found that DA significantly increased the excitability of RA PNs. Furthermore, a D1-like receptor agonist increased the excitability of RA PNs, and a D1-like receptor antagonist suppressed the excitability induced by DA. However, a D2-like receptor agonist had no effect on the excitability of RA PNs. Moreover, the D2-like receptor agonist did not change the excitability induced by the D1 receptor agonist. These findings suggest that DA can significantly increase the excitability of RA PNs and that D1 receptors play the main role in regulating the excitability of RA PNs in response to DA, thereby providing direct evidence toward understanding the mechanism of DA signal mediation by its receptors to modulate the excitability of RA PNs.	[Liao, Congshu; Wang, Songhua; Pan, Xuan; Hou, Guoqiang; Li, Dongfeng] S China Normal Univ, Sch Life Sci, Key Lab Ecol & Environm Sci Higher Educ Guangdong, Guangzhou, Guangdong, Peoples R China	South China Normal University	Li, DF (corresponding author), S China Normal Univ, Sch Life Sci, Key Lab Ecol & Environm Sci Higher Educ Guangdong, Guangzhou, Guangdong, Peoples R China.	dfliswx@126.com	Hou, Guoqiang/S-7175-2019; LI, Dongfeng/E-4807-2013	LI, Dongfeng/0000-0001-6786-1858	National Natural Science Foundation of China [31172092]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31172092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appeltants D, 2002, NEUROREPORT, V13, P649, DOI 10.1097/00001756-200204160-00023; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; BLACKBURN JR, 1992, PROG NEUROBIOL, V39, P247, DOI 10.1016/0301-0082(92)90018-A; BOTTJER SW, 1984, J NEUROSCI, V4, P2387; Brainard MS, 2002, NATURE, V417, P351, DOI 10.1038/417351a; Ding L, 2002, J NEUROSCI, V22, P5210, DOI 10.1523/JNEUROSCI.22-12-05210.2002; Goodson JL, 2009, P NATL ACAD SCI USA, V106, P8737, DOI 10.1073/pnas.0811821106; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; HODGKIN AL, 1949, J PHYSIOL-LONDON, V108, P37, DOI 10.1113/jphysiol.1949.sp004310; HU XT, 1994, SYNAPSE, V17, P43, DOI 10.1002/syn.890170106; HULL EM, 1995, J NEUROSCI, V15, P7465; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; KEEFE KA, 1995, NEUROSCIENCE, V66, P903, DOI 10.1016/0306-4522(95)00024-D; Khaliq ZM, 2010, J NEUROSCI, V30, P7401, DOI 10.1523/JNEUROSCI.0143-10.2010; Koob GF, 1996, MOL PSYCHIATR, V1, P186; Kroner S, 2005, J NEUROPHYSIOL, V93, P1598, DOI 10.1152/jn.00843.2004; Kubikova L, 2010, J CHEM NEUROANAT, V39, P112, DOI 10.1016/j.jchemneu.2009.10.004; Kubikova L, 2010, J COMP NEUROL, V518, P741, DOI 10.1002/cne.22255; KURASHIMA M, 1995, PHARMACOL BIOCHEM BE, V52, P503, DOI 10.1016/0091-3057(95)00103-4; Marler P, 2000, P NATL ACAD SCI USA, V97, P2965, DOI 10.1073/pnas.97.7.2965; Meitzen J, 2009, J NEUROSCI, V29, P6558, DOI 10.1523/JNEUROSCI.5571-08.2009; MOSES J, 1995, PHARMACOL BIOCHEM BE, V51, P681, DOI 10.1016/0091-3057(94)00437-N; Nakajima S, 2013, EUR NEUROPSYCHOPHARM; PFAUS JG, 1991, BEHAV NEUROSCI, V105, P727, DOI 10.1037/0735-7044.105.5.727; Riters LV, 2012, FRONT NEUROENDOCRIN, V33, P194, DOI 10.1016/j.yfrne.2012.04.002; Salamone JD, 2003, J PHARMACOL EXP THER, V305, P1, DOI 10.1124/jpet.102.035063; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Spiro JE, 1999, J NEUROPHYSIOL, V81, P3007, DOI 10.1152/jn.1999.81.6.3007; vanFurth WR, 1995, BRAIN RES REV, V21, P162, DOI 10.1016/0165-0173(96)82985-7; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	31	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82497	10.1371/journal.pone.0082497	http://dx.doi.org/10.1371/journal.pone.0082497			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24340033	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100115
J	Litwak, SA; Payne, NL; Campanale, N; Ozturk, E; Lee, JY; Petratos, S; Siatskas, C; Bakhuraysah, M; Bernard, CCA				Litwak, Sara A.; Payne, Natalie L.; Campanale, Naomi; Ozturk, Ezgi; Lee, Jae Young; Petratos, Steven; Siatskas, Christopher; Bakhuraysah, Maha; Bernard, Claude C. A.			Nogo-Receptor 1 Deficiency Has No Influence on Immune Cell Repertoire or Function during Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MULTIPLE-SCLEROSIS; CNS AUTOIMMUNITY; AXONAL REGENERATION; IN-VITRO; B-CELLS; INHIBITION; DISEASE	The potential role of Nogo-66 Receptor 1 (NgR1) on immune cell phenotypes and their activation during neuroinflammatory diseases such as multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE), is unclear. To further understand the function of this receptor on haematopoietically-derived cells, phenotypic and functional analyses were performed using NgR1-deficient (ngr1-/-) animals. Flow cytometry-based phenotypic analyses performed on blood, spleen, thymus, lymph nodes, bone marrow and central nervous-system (CNS)-infiltrating blood cells revealed no immunological defects in naive ngr1-/- animals versus wild-type littermate (WTLM) controls. EAE was induced by either recombinant myelin oligodendrocyte glycoprotein (rMOG), a model in which B cells are considered to contribute pathogenically, or by MOG(35-55) peptide, a B cell-independent model. We have demonstrated that in ngr1-/- mice injected with MOG35-55, a significant reduction in the severity of EAE correlated with reduced axonal damage present in the spinal cord when compared to their WTLM controls. However, despite a reduction in axonal damage observed in the CNS of ngr1-/- mice at the chronic stage of disease, no clinical differences could be attributed to a specific genotype when rMOG was used as the encephalitogen. Following MOG(35-55)-induction of EAE, we could not derive any major changes to the immune cell populations analyzed between ngr1-/- and WTLM mice. Collectively, these data demonstrate that NgR1 has little if any effects on the repertoire of immune cells, their activation and trafficking to the CNS.	[Litwak, Sara A.; Payne, Natalie L.; Campanale, Naomi; Ozturk, Ezgi; Siatskas, Christopher; Bernard, Claude C. A.] Monash Univ, Multiple Sclerosis Res Grp, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Lee, Jae Young; Bakhuraysah, Maha] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [Petratos, Steven] Monash Univ, Cent Clin Sch, Prahran, Vic, Australia	Australian Regenerative Medicine Institute; Monash University; Monash University; Monash University	Bernard, CCA (corresponding author), Monash Univ, Multiple Sclerosis Res Grp, Australian Regenerat Med Inst, Clayton, Vic, Australia.	Claude.bernard@monash.edu		Litwak, Sara A/0000-0002-5575-3195; Bernard, Claude Charles Andre/0000-0003-2816-5328; Bakhuraysah, Maha/0000-0002-9727-650X	National Health and Medical Research Council of Australia; Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases; Cure MS Inc. Ltd; Diana Asmar fund; National Multiple Sclerosis Society of New York [RG4398A1/1]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases; Cure MS Inc. Ltd; Diana Asmar fund; National Multiple Sclerosis Society of New York(National Multiple Sclerosis Society)	This work was supported by grants from the National Health and Medical Research Council of Australia, the Eva and Les Erdi AUSiMED Fellowship in Neurological Diseases, Cure MS Inc. Ltd, the Diana Asmar fund and the National Multiple Sclerosis Society of New York (RG4398A1/1). Sara A Litwak was a Fellow of the Multiple Sclerosis International Federation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik F, 2012, EXP NEUROL, V235, P43, DOI 10.1016/j.expneurol.2011.06.006; Baranzini SE, 2012, CURR OPIN NEUROL, V25, P239, DOI 10.1097/WCO.0b013e3283533a93; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barnard AL, 2009, BLOOD, V113, P204, DOI 10.1182/blood-2008-05-156042; Bernard CCA, 1997, J MOL MED-JMM, V75, P77, DOI 10.1007/s001090050092; Castillo-Trivino T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066308; CONSTANT S, 1995, J IMMUNOL, V155, P3734; David S, 2008, TRENDS NEUROSCI, V31, P221, DOI 10.1016/j.tins.2008.02.002; De March AK, 2003, J NEUROIMMUNOL, V135, P117, DOI 10.1016/S0165-5728(02)00434-4; Domeniconi M, 2005, J NEUROL SCI, V233, P43, DOI 10.1016/j.jns.2005.03.023; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Flugel A, 2001, GLIA, V36, P125, DOI 10.1002/glia.1102; Fontoura P, 2004, J IMMUNOL, V173, P6981, DOI 10.4049/jimmunol.173.11.6981; Fournier AE, 2002, J NEUROSCI, V22, P8876; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fry EJ, 2007, NEURON, V53, P649, DOI 10.1016/j.neuron.2007.02.009; Gourraud PA, 2012, IMMUNOL REV, V248, P87, DOI 10.1111/j.1600-065X.2012.01134.x; Karnezis T, 2004, NAT NEUROSCI, V7, P736, DOI 10.1038/nn1261; Kim JE, 2004, NEURON, V44, P439, DOI 10.1016/j.neuron.2004.10.015; Lyons JA, 1999, EUR J IMMUNOL, V29, P3432, DOI 10.1002/(SICI)1521-4141(199911)29:11<3432::AID-IMMU3432>3.0.CO;2-2; McDonald CL, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-113; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; McQualter JL, 2007, J NEUROCHEM, V100, P295, DOI 10.1111/j.1471-4159.2006.04232.x; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Okuda Y, 2002, J NEUROIMMUNOL, V131, P115, DOI 10.1016/S0165-5728(02)00267-9; Payne NL, 2013, BRAIN BEHAV IMMUN, V30, P103, DOI 10.1016/j.bbi.2013.01.079; Payne NL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035093; Petratos S, 2012, BRAIN, V135, P1794, DOI 10.1093/brain/aws100; Petratos S, 2010, J NEUROPATH EXP NEUR, V69, P323, DOI 10.1097/NEN.0b013e3181d60ddb; Ponomarev ED, 2005, J NEUROSCI RES, V81, P374, DOI 10.1002/jnr.20488; Pool M, 2009, EXP NEUROL, V217, P371, DOI 10.1016/j.expneurol.2009.03.014; Satoh J, 2007, NEUROPATH APPL NEURO, V33, P99, DOI 10.1111/j.1365-2990.2006.00787.x; Satoh JI, 2005, J NEUROPATH EXP NEUR, V64, P129, DOI 10.1093/jnen/64.2.129; Schwab JM, 2005, BRAIN RES REV, V49, P295, DOI 10.1016/j.brainresrev.2004.10.007; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Short MA, 2011, CELL ADHES MIGR, V5, P373, DOI 10.4161/cam.5.5.17948; Skokowa J, 2012, NAT MED, V18, P1550, DOI 10.1038/nm.2958; Slavin A, 1998, AUTOIMMUNITY, V28, P109, DOI 10.3109/08916939809003872; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI200113360; Steinbach K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026341; Steinman L, 2007, NAT MED, V13, P139, DOI 10.1038/nm1551; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Teng FYH, 2005, J NEUROSCI RES, V79, P273, DOI 10.1002/jnr.20361; Teuscher C, 2004, AM J PATHOL, V165, P1593, DOI 10.1016/S0002-9440(10)63416-5; Theotokis P, 2012, J NEUROPATH EXP NEUR, V71, P907, DOI 10.1097/NEN.0b013e31826caebe; Trapp BD, 1999, CURR OPIN NEUROL, V12, P295, DOI 10.1097/00019052-199906000-00008; von Budingen HC, 2011, CURR OPIN IMMUNOL, V23, P713, DOI 10.1016/j.coi.2011.09.003; Wang DW, 2005, GLIA, V51, P235, DOI 10.1002/glia.20199; Wang XX, 2002, J NEUROSCI, V22, P5505; Weber MS, 2010, ANN NEUROL, V68, P369, DOI 10.1002/ana.22081; Yan J, 2012, J NEUROCHEM, V120, P721, DOI 10.1111/j.1471-4159.2011.07619.x; Yang YH, 2010, ANN NEUROL, V67, P498, DOI 10.1002/ana.21935; Zhang L, 2009, J NEUROSCI, V29, P6348, DOI 10.1523/JNEUROSCI.5040-08.2009; Zheng BH, 2005, P NATL ACAD SCI USA, V102, P1205, DOI 10.1073/pnas.0409026102	54	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e82101	10.1371/journal.pone.0082101	http://dx.doi.org/10.1371/journal.pone.0082101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339996	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100085
J	Yang, RY; Dong, J; Guo, HB; Li, HX; Wang, S; Zhao, HJ; Zhou, WY; Yu, SL; Wang, M; Chen, WX				Yang, Ruiyue; Dong, Jun; Guo, Hanbang; Li, Hongxia; Wang, Shu; Zhao, Haijian; Zhou, Weiyan; Yu, Songlin; Wang, Mo; Chen, Wenxiang			Rapid and Precise Measurement of Serum Branched-Chain and Aromatic Amino Acids by Isotope Dilution Liquid Chromatography Tandem Mass Spectrometry	PLOS ONE			English	Article							INSULIN-RESISTANCE; INHERITED DISORDERS; BIOLOGICAL INTEREST; BLOOD SPOTS; DERIVATIVES; METABOLISM; OBESE; QUANTIFICATION; QUANTITATION; DIAGNOSIS	Background: Serum branched-chain and aromatic amino acids (BCAAs and AAAs) have emerged as predictors for the future development of diabetes and may aid in diabetes risk assessment. However, the current methods for the analysis of such amino acids in biological samples are time consuming. Methods: An isotope dilution liquid chromatography tandem mass spectrometry (ID-LC/MS/MS) method for serum BCAAs and AAAs was developed. The serum was mixed with isotope-labeled BCAA and AAA internal standards and the amino acids were extracted with acetonitrile, followed by analysis using LC/MS/MS. The LC separation was performed on a reversed-phase C-18 column, and the MS/MS detection was performed via the positive electronic spray ionization in multiple reaction monitoring mode. Results:Specific analysis of the amino acids was achieved within 2 min. lntra-run and total CVs for the amino acids were less than 2% and 4%, respectively, and the analytical recoveries ranged from 99.6 to 103.6%. Conclusion: A rapid and precise method for the measurement of serum BCAAs and AAAs was developed and may serve as a quick tool for screening serum BCAAs and AAAs in studies assessing diabetes risk.	[Yang, Ruiyue; Dong, Jun; Guo, Hanbang; Li, Hongxia; Wang, Shu; Wang, Mo; Chen, Wenxiang] Minist Hlth, Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Yang, Ruiyue; Dong, Jun; Guo, Hanbang; Li, Hongxia; Wang, Shu; Wang, Mo; Chen, Wenxiang] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Zhao, Haijian; Zhou, Weiyan; Yu, Songlin; Chen, Wenxiang] Minist Hlth, Beijing Hosp, Beijing, Peoples R China; [Zhao, Haijian; Zhou, Weiyan; Yu, Songlin; Chen, Wenxiang] Minist Hlth, Natl Ctr Clin Labs, Beijing, Peoples R China	Beijing Hospital; Beijing Hospital	Chen, WX (corresponding author), Minist Hlth, Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	wchen@bjhmoh.cn	Zhou, Weiyan/GPW-9289-2022; Yang, Ruiyue/HDN-2405-2022	Zhou, Weiyan/0000-0003-4174-6047; Yang, Ruiyue/0000-0002-2304-6728	National Science & Technology Pillar Program under the Twelfth Five-year Plan of China [2012BAI37B01]; National Natural Science Foundation of China [30872413, 81171647]; National Department Public Benefit Research Foundation by Ministry of Health P. R. China [201002011]	National Science & Technology Pillar Program under the Twelfth Five-year Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Department Public Benefit Research Foundation by Ministry of Health P. R. China	This study was supported by research grants from the National Science & Technology Pillar Program under the Twelfth Five-year Plan of China (2012BAI37B01), the National Natural Science Foundation of China (30872413, 81171647) and the National Department Public Benefit Research Foundation by Ministry of Health P. R. China (No. 201002011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAYER E, 1976, ANAL CHEM, V48, P1106, DOI 10.1021/ac50002a010; Casetta B, 2000, CLIN CHEM LAB MED, V38, P391, DOI 10.1515/CCLM.2000.057; Dong J, 2012, CLIN CHIM ACTA, V413, P1071, DOI 10.1016/j.cca.2012.02.022; FELIG P, 1969, NEW ENGL J MED, V281, P811, DOI 10.1056/NEJM196910092811503; Fowler B, 1981, AMINO ACID ANAL AMIN, P313; Fraser CG, 2001, BIOL VARIATION PRINC; Hsiao G, 2011, AM J PHYSIOL-ENDOC M, V300, pE164, DOI 10.1152/ajpendo.00219.2010; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huffman KM, 2009, DIABETES CARE, V32, P1678, DOI 10.2337/dc08-2075; Laferrere B, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002043; Lu JY, 2013, FRONT MED-PRC, V7, P53, DOI 10.1007/s11684-013-0255-5; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Newgard CB, 2009, CELL METAB, V9, P311, DOI 10.1016/j.cmet.2009.02.002; Oglesbee D, 2008, CLIN CHEM, V54, P542, DOI 10.1373/clinchem.2007.098434; Pietzsch J, 1997, RAPID COMMUN MASS SP, V11, P1835; Piraud M, 2005, RAPID COMMUN MASS SP, V19, P1587, DOI 10.1002/rcm.1957; Piraud M, 2003, RAPID COMMUN MASS SP, V17, P1297, DOI 10.1002/rcm.1054; Qu J, 2002, ANAL CHEM, V74, P2034, DOI 10.1021/ac0111917; Shah SH, 2012, DIABETOLOGIA, V55, P321, DOI 10.1007/s00125-011-2356-5; SPACKMAN DH, 1958, ANAL CHEM, V30, P1190, DOI 10.1021/ac60139a006; Tai ES, 2010, DIABETOLOGIA, V53, P757, DOI 10.1007/s00125-009-1637-8; Tao L, 1998, ANAL CHEM, V70, P4015, DOI 10.1021/ac980324u; vanLeuken RGJ, 1995, J PHARMACEUT BIOMED, V13, P1459, DOI 10.1016/0731-7085(95)01580-9; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Zoppa M, 2006, J CHROMATOGR B, V831, P267, DOI 10.1016/j.jchromb.2005.12.015	26	28	28	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81144	10.1371/journal.pone.0081144	http://dx.doi.org/10.1371/journal.pone.0081144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339906	gold, Green Published, Green Submitted			2022-12-27	WOS:000328566100039
J	Schwartz, MP; Rogers, RE; Singh, SP; Lee, JY; Loveland, SG; Koepsel, JT; Witze, ES; Montanez-Sauri, SI; Sung, KE; Tokuda, EY; Sharma, Y; Everhart, LM; Nguyen, EH; Zaman, MH; Beebe, DJ; Ahn, NG; Murphy, WL; Anseth, KS				Schwartz, Michael P.; Rogers, Robert E.; Singh, Samir P.; Lee, Justin Y.; Loveland, Samuel G.; Koepsel, Justin T.; Witze, Eric S.; Montanez-Sauri, Sara I.; Sung, Kyung E.; Tokuda, Emi Y.; Sharma, Yasha; Everhart, Lydia M.; Nguyen, Eric H.; Zaman, Muhammad H.; Beebe, David J.; Ahn, Natalie G.; Murphy, William L.; Anseth, Kristi S.			A Quantitative Comparison of Human HT-1080 Fibrosarcoma Cells and Primary Human Dermal Fibroblasts Identifies a 3D Migration Mechanism with Properties Unique to the Transformed Phenotype	PLOS ONE			English	Article							AGGRESSIVE TUMOR-GROWTH; CORTICAL FLOW; GENE-EXPRESSION; CYTOSKELETAL ORGANIZATION; SIGNALING PATHWAYS; COLLAGEN SUBSTRATA; SOMATIC MUTATIONS; CANCER INVASION; P34CDC2 KINASE; FOCAL ADHESION	Here, we describe an engineering approach to quantitatively compare migration, morphologies, and adhesion for tumorigenic human fibrosarcoma cells (HT-1080s) and primary human dermal fibroblasts (hDFs) with the aim of identifying distinguishing properties of the transformed phenotype. Relative adhesiveness was quantified using self-assembled monolayer (SAM) arrays and proteolytic 3-dimensional (3D) migration was investigated using matrix metalloproteinase (MMP)-degradable poly(ethylene glycol) (PEG) hydrogels ("synthetic extracellular matrix" or "synthetic ECM"). In synthetic ECM, hDFs were characterized by vinculin-containing features on the tips of protrusions, multipolar morphologies, and organized actomyosin filaments. In contrast, HT-1080s were characterized by diffuse vinculin expression, pronounced beta 1-integrin on the tips of protrusions, a cortically-organized F-actin cytoskeleton, and quantitatively more rounded morphologies, decreased adhesiveness, and increased directional motility compared to hDFs. Further, HT-1080s were characterized by contractility-dependent motility, pronounced blebbing, and cortical contraction waves or constriction rings, while quantified 3D motility was similar in matrices with a wide range of biochemical and biophysical properties (including collagen) despite substantial morphological changes. While HT-1080s were distinct from hDFs for each of the 2D and 3D properties investigated, several features were similar to WM239a melanoma cells, including rounded, proteolytic migration modes, cortical F-actin organization, and prominent uropod-like structures enriched with beta 1-integrin, F-actin, and melanoma cell adhesion molecule (MCAM/CD146/MUC18). Importantly, many of the features observed for HT-1080s were analogous to cellular changes induced by transformation, including cell rounding, a disorganized F-actin cytoskeleton, altered organization of focal adhesion proteins, and a weakly adherent phenotype. Based on our results, we propose that HT-1080s migrate in synthetic ECM with functional properties that are a direct consequence of their transformed phenotype.	[Schwartz, Michael P.; Loveland, Samuel G.; Koepsel, Justin T.; Sung, Kyung E.; Nguyen, Eric H.; Beebe, David J.; Murphy, William L.] Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA; [Murphy, William L.] Univ Wisconsin, Dept Orthoped & Rehabil, Madison, WI USA; [Montanez-Sauri, Sara I.; Murphy, William L.] Univ Wisconsin, Mat Sci Program, Madison, WI 53706 USA; [Montanez-Sauri, Sara I.; Sung, Kyung E.; Beebe, David J.] Univ Wisconsin, Paul P Carbone Comprehens Canc Ctr, Madison, WI USA; [Beebe, David J.] Univ Wisconsin, Lab Opt & Computat Instrumentat, Madison, WI USA; [Singh, Samir P.; Lee, Justin Y.; Tokuda, Emi Y.; Anseth, Kristi S.] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA; [Ahn, Natalie G.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Ahn, Natalie G.; Anseth, Kristi S.] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Witze, Eric S.] Univ Penn, Perelman Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Sharma, Yasha; Zaman, Muhammad H.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Rogers, Robert E.] Texas A&M Hlth Sci Ctr, Coll Med, Bryan, TX USA; [Everhart, Lydia M.] Univ Dayton, Dept Chem & Mat Engn, Dayton, OH 45469 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; University of Pennsylvania; Pennsylvania Medicine; Boston University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Dayton	Schwartz, MP (corresponding author), Univ Wisconsin, Dept Biomed Engn, Madison, WI 53706 USA.	mpschwartz@wisc.edu; kristi.anseth@colorado.edu	Schwartz, Michael P/B-3417-2008; Schwartz, Michael/GNW-3991-2022; Schwartz, Mike/O-7963-2016; Murphy, William L/I-4096-2014	Schwartz, Michael P/0000-0003-3785-6606; Schwartz, Michael/0000-0003-3785-6606; Schwartz, Mike/0000-0003-3785-6606; Sung, Kyung/0000-0001-9664-6399; Rogers, Robert/0000-0001-5578-6993	Howard Hughes Medical Institute; National Institutes of Health [NIH R01CA132633, NIH R01HL093282, NIH/NCI R33CA137673, NIH R01EB010039, NIH T32 GM-065103]; National Science Foundation [0745563]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB010039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Funding was provided by the Howard Hughes Medical Institute, the National Institutes of Health (NIH R01CA132633, NIH R01HL093282, NIH/NCI R33CA137673, NIH R01EB010039, NIH T32 GM-065103), the National Science Foundation (CAREER award 0745563), and a donation in the memory of Gerald E. Whitbeck (generously provided by his family and Follett Corp.).	Anderson SB, 2011, BIOMATERIALS, V32, P3564, DOI 10.1016/j.biomaterials.2011.01.064; Anilkumar N, 1996, J CELL BIOCHEM, V61, P338, DOI 10.1002/(SICI)1097-4644(19960601)61:3<338::AID-JCB2>3.0.CO;2-U; Antonyak MA, 2011, P NATL ACAD SCI USA, V108, P4852, DOI 10.1073/pnas.1017667108; Baba A.I, 2007, COMP ONCOLOGY 2; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bardin N, 2001, BLOOD, V98, P3677, DOI 10.1182/blood.V98.13.3677; Barthel K.U., 2004, 3D SURFACE PLOT; Benton JA, 2009, BIOMATERIALS, V30, P6593, DOI 10.1016/j.biomaterials.2009.08.031; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; BOSCHEK CB, 1981, CELL, V24, P175, DOI 10.1016/0092-8674(81)90513-4; BRAY D, 1988, SCIENCE, V239, P883, DOI 10.1126/science.3277283; BROWN AF, 1982, J CELL SCI, V58, P455; BROWN R, 1984, EMBO J, V3, P1321, DOI 10.1002/j.1460-2075.1984.tb01970.x; BUBENIK J, 1979, INT J CANCER, V23, P392, DOI 10.1002/ijc.2910230318; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Coman DR, 1944, CANCER RES, V4, P625; COTTLERFOX M, 1980, INT J CANCER, V26, P689, DOI 10.1002/ijc.2910260523; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Dangi S, 2005, J BIOL CHEM, V280, P24524, DOI 10.1074/jbc.M414079200; DAVIDPFEUTY T, 1980, P NATL ACAD SCI-BIOL, V77, P6687, DOI 10.1073/pnas.77.11.6687; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Di Vizio D, 2009, CANCER RES, V69, P5601, DOI 10.1158/0008-5472.CAN-08-3860; DICKINSON RB, 1993, AICHE J, V39, P1995, DOI 10.1002/aic.690391210; ELSDALE T, 1972, J CELL BIOL, V54, P626, DOI 10.1083/jcb.54.3.626; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; Fairbanks BD, 2009, ADV MATER, V21, P5005, DOI 10.1002/adma.200901808; Fallica B, 2011, INTEGR BIOL-UK, V3, P529, DOI 10.1039/c0ib00142b; Fischbach C, 2007, NAT METHODS, V4, P855, DOI 10.1038/NMETH1085; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; FRIEDMAN E, 1984, CANCER RES, V44, P3040; GARAY T, 2013, EXP CELL RES, P14242; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Guezguez B, 2007, J IMMUNOL, V179, P6673, DOI 10.4049/jimmunol.179.10.6673; Gupta S, 2001, MOL CELL BIOL, V21, P5846, DOI 10.1128/MCB.21.17.5846-5856.2001; Gupta S, 2000, MOL CELL BIOL, V20, P9294, DOI 10.1128/MCB.20.24.9294-9306.2000; Hakkinen KM, 2011, TISSUE ENG PT A, V17, P713, DOI 10.1089/ten.TEA.2010.0273; HALL A, 1983, NATURE, V303, P396, DOI 10.1038/303396a0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HASTON WS, 1984, J CELL SCI, V68, P227; HASTON WS, 1982, J CELL BIOL, V92, P747, DOI 10.1083/jcb.92.3.747; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; HERLYN M, 1985, J NATL CANCER I, V74, P283; HIRST R, 1986, P NATL ACAD SCI USA, V83, P6470, DOI 10.1073/pnas.83.17.6470; HOFFMANN JC, 2013, INTEGR BIOL, P14242; Hoyle CE, 2010, ANGEW CHEM INT EDIT, V49, P1540, DOI 10.1002/anie.200903924; Hughes CS, 2010, PROTEOMICS, V10, P1886, DOI 10.1002/pmic.200900758; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hutmacher DW, 2010, TRENDS BIOTECHNOL, V28, P125, DOI 10.1016/j.tibtech.2009.12.001; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Johnson JP, 1999, CANCER METAST REV, V18, P345, DOI 10.1023/A:1006304806799; Juliano R, 2003, NAT CELL BIOL, V5, P589, DOI 10.1038/ncb0703-589; Kapustina M, 2013, J CELL BIOL, V200, P95, DOI 10.1083/jcb.201204157; Keller H, 1998, CELL MOTIL CYTOSKEL, V41, P181, DOI 10.1002/(SICI)1097-0169(1998)41:2<181::AID-CM8>3.3.CO;2-M; Kharkar PM, 2013, CHEM SOC REV, V42, P7335, DOI 10.1039/c3cs60040h; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; King JS, 2010, J CELL SCI, V123, P2246, DOI 10.1242/jcs.063735; Koepsel JT, 2012, INTEGR BIOL-UK, V4, P1508, DOI 10.1039/c2ib20029e; Koepsel JT, 2012, CHEMBIOCHEM, V13, P1717, DOI 10.1002/cbic.201200226; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; LAMB NJC, 1990, CELL, V60, P151, DOI 10.1016/0092-8674(90)90725-T; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lin CC, 2011, BIOMATERIALS, V32, P9685, DOI 10.1016/j.biomaterials.2011.08.083; Loessner D, 2010, BIOMATERIALS, V31, P8494, DOI 10.1016/j.biomaterials.2010.07.064; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Luo Y, 2012, ONCOGENE, V31, P306, DOI 10.1038/onc.2011.244; Lutolf MP, 2003, P NATL ACAD SCI USA, V100, P5413, DOI 10.1073/pnas.0737381100; Maddox AS, 2003, J CELL BIOL, V160, P255, DOI 10.1083/jcb.200207130; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Malawista SE, 2000, CELL MOTIL CYTOSKEL, V46, P183, DOI 10.1002/1097-0169(200007)46:3<183::AID-CM3>3.3.CO;2-U; Manes T, 2003, J CELL BIOL, V161, P817, DOI 10.1083/jcb.200212172; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1982, NATURE, V299, P171, DOI 10.1038/299171a0; MORGAN CR, 1977, J POLYM SCI POL CHEM, V15, P627, DOI 10.1002/pol.1977.170150311; Muralidharan-Chari V, 2010, J CELL SCI, V123, P1603, DOI 10.1242/jcs.064386; Nagase H, 1996, BIOPOLYMERS, V40, P399, DOI 10.1002/(SICI)1097-0282(1996)40:4<399::AID-BIP5>3.0.CO;2-R; NETZELARNETT S, 1993, BIOCHEMISTRY-US, V32, P6427, DOI 10.1021/bi00076a016; Paluch E, 2006, TRENDS CELL BIOL, V16, P5, DOI 10.1016/j.tcb.2005.11.003; Paszek MJ, 2004, J MAMMARY GLAND BIOL, V9, P325, DOI 10.1007/s10911-004-1404-x; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Pawlak G, 2001, CURR OPIN GENET DEV, V11, P41, DOI 10.1016/S0959-437X(00)00154-4; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Petroll WM, 2003, CELL MOTIL CYTOSKEL, V55, P254, DOI 10.1002/cm.10126; Pickl WF, 1997, J IMMUNOL, V158, P2107; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; PLANTEFABER LC, 1989, CELL, V56, P281, DOI 10.1016/0092-8674(89)90902-1; Poincloux R, 2011, P NATL ACAD SCI USA, V108, P1943, DOI 10.1073/pnas.1010396108; POLLACK R, 1975, P NATL ACAD SCI USA, V72, P994, DOI 10.1073/pnas.72.3.994; Provenzano PP, 2009, ONCOGENE, V28, P4326, DOI 10.1038/onc.2009.299; Provenzano PP, 2011, J CELL SCI, V124, P1195, DOI 10.1242/jcs.067009; Raeber GP, 2005, BIOPHYS J, V89, P1374, DOI 10.1529/biophysj.104.050682; Rasband W.S., 1997, IMAGE; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; RAZ A, 1982, CANCER RES, V42, P5183; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; ROOS E, 1983, INVAS METAST, V738, P263; Roubinet C, 2012, CYTOSKELETON, V69, P957, DOI 10.1002/cm.21086; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Sahai E, 2003, NAT CELL BIOL, V5, P711, DOI 10.1038/ncb1019; Sakai T, 2001, P NATL ACAD SCI USA, V98, P3808, DOI 10.1073/pnas.240456398; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; SCHLIWA M, 1984, J CELL BIOL, V99, P1045, DOI 10.1083/jcb.99.3.1045; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schwartz MP, 2010, INTEGR BIOL-UK, V2, P32, DOI 10.1039/b912438a; Scott MC, 2011, BONE, V49, P356, DOI 10.1016/j.bone.2011.05.008; SEFTON BM, 1981, CELL, V24, P165, DOI 10.1016/0092-8674(81)90512-2; SENDA N, 1975, EXP CELL RES, V91, P393, DOI 10.1016/0014-4827(75)90120-2; Shi IM, 1999, J PATHOL, V189, P4, DOI 10.1002/(SICI)1096-9896(199909)189:1<4::AID-PATH332>3.0.CO;2-P; SHRIVER K, 1981, J CELL BIOL, V89, P525, DOI 10.1083/jcb.89.3.525; Sieh S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040217; Sillman AL, 2003, EXP DERMATOL, V12, P396, DOI 10.1034/j.1600-0625.2002.120406.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; STEINBERG BM, 1980, J CELL BIOL, V87, P304, DOI 10.1083/jcb.87.1.304; Sung KE, 2011, INTEGR BIOL-UK, V3, P439, DOI 10.1039/c0ib00063a; Suzuki K, 2003, J CELL PHYSIOL, V197, P297, DOI 10.1002/jcp.10354; Tamariz E, 2002, MOL BIOL CELL, V13, P3915, DOI 10.1091/mbc.E02-05-0291; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; VOLK T, 1984, CANCER RES, V44, P811; WANG E, 1976, P NATL ACAD SCI USA, V73, P4065, DOI 10.1073/pnas.73.11.4065; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Witze ES, 2008, SCIENCE, V320, P365, DOI 10.1126/science.1151250; Witze ES, 2013, DEV CELL, V26, P645, DOI 10.1016/j.devcel.2013.08.019; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wood S, 2011, CELL CYCLE, V10, P648, DOI 10.4161/cc.10.4.14813; YAMASHIRO S, 1991, NATURE, V349, P169, DOI 10.1038/349169a0; YAMASHIRO S, 1991, BIOESSAYS, V13, P563, DOI 10.1002/bies.950131103; Yamazaki D, 2009, ONCOGENE, V28, P1570, DOI 10.1038/onc.2009.2; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Yount G, 2007, J NEURO-ONCOL, V81, P113, DOI 10.1007/s11060-006-9211-4; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215; Zaman MH, 2013, NAT REV CANCER, V13, P596, DOI 10.1038/nrc3564; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	150	24	25	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81689	10.1371/journal.pone.0081689	http://dx.doi.org/10.1371/journal.pone.0081689			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349113	gold, Green Submitted, Green Published			2022-12-27	WOS:000327947800054
J	Weis, L; Metzger, M; Haymann, JP; Thervet, E; Flamant, M; Vrtovsnik, F; Gauci, C; Houillier, P; Froissart, M; Letavernier, E; Stengel, B; Boffa, JJ				Weis, Lise; Metzger, Marie; Haymann, Jean-Philippe; Thervet, Eric; Flamant, Martin; Vrtovsnik, Francois; Gauci, Cedric; Houillier, Pascal; Froissart, Marc; Letavernier, Emmanuel; Stengel, Benedicte; Boffa, Jean-Jacques		NephroTest Study Grp	Renal Function Can Improve at Any Stage of Chronic Kidney Disease	PLOS ONE			English	Article							DOMINANT POLYCYSTIC KIDNEY; PROGRESSION; DECLINE; CKD; ASSOCIATION; DISORDERS; REMISSION; PHOSPHATE; SURVIVAL; MODERATE	Introduction: Even though renal function decline is considered relentless in chronic kidney disease (CKD), improvement has been shown in patients with hypertensive nephropathy. Whether this can occur in any type of nephropathy and at any stage is unknown as are the features of patients who improve. Methods: We identified 406 patients in the NephroTest cohort with glomerular filtration rates (mGFR) measured by Cr-51-EDTA clearance at least 3 times during at least 2 years of follow-up. Individual examination of mGFR trajectories by 4 independent nephrologists classified patients as improvers, defined as those showing a sustained mGFR increase, or nonimprovers. Twelve patients with erratic trajectories were excluded. Baseline data were compared between improvers and nonimprovers, as was the number of recommended therapeutic targets achieved over time (specifically, for systolic and diastolic blood pressure, proteinuria, and use of renin angiotensin system blockers). Results: Measured GFR improved over time in 62 patients (15.3%). Their median mGFR slope was + 1.88[IQR 1.38, 3.55] ml/min/year; it was -2.23[-3.9, -0.91] for the 332 nonimprovers. Improvers had various nephropathies, but not diabetic glomerulopathy or polycystic kidney disease. They did not differ from nonimprovers for age, sex, cardiovascular history, or CKD stage, but their urinary albumin excretion rate was lower. Improvers achieved significantly more recommended therapeutic targets (2.74 +/- 0.87) than nonimprovers (2.44 +/- 0.80, p<0.01). They also had fewer CKD-related metabolic complications and a lower prevalence of 25OH-vitamin-D deficiency. Conclusion: GFR improvement is possible in CKD patients at any CKD stage through stage 4-5. It is noteworthy that this GFR improvement is associated with a decrease in the number of metabolic complications over time.	[Weis, Lise; Boffa, Jean-Jacques] Hop Tenon, AP HP, Dept Nephrol, F-75970 Paris, France; [Metzger, Marie; Froissart, Marc; Stengel, Benedicte] INSERM, CESP, Res Ctr Epidemiol & Populat Hlth, U1018, Villejuif, France; [Metzger, Marie; Stengel, Benedicte] Univ Paris Sud, UMRS 1018, Villejuif, France; [Haymann, Jean-Philippe; Letavernier, Emmanuel] Hop Tenon, AP HP, Dept Physiol, F-75970 Paris, France; [Haymann, Jean-Philippe; Letavernier, Emmanuel; Boffa, Jean-Jacques] INSERM, U702, Paris, France; [Haymann, Jean-Philippe; Letavernier, Emmanuel; Boffa, Jean-Jacques] Univ Paris 06, UMR S 702, Paris, France; [Thervet, Eric] Hop Europeen Georges Pompidou, AP HP, Dept Nephrol, Paris, France; [Thervet, Eric; Houillier, Pascal; Froissart, Marc] Univ Paris 05, UMR S 775, Paris, France; [Flamant, Martin] Hop Bichat Claude Bernard, AP HP, Dept Physiol, F-75877 Paris, France; [Vrtovsnik, Francois] Hop Bichat Claude Bernard, AP HP, Dept Nephrol, F-75877 Paris, France; [Gauci, Cedric; Houillier, Pascal; Froissart, Marc] Hop Europeen Georges Pompidou, Dept Physiol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Boffa, JJ (corresponding author), Hop Tenon, AP HP, Dept Nephrol, F-75970 Paris, France.	jean-jacques.boffa@tnn.aphp.fr	Stengel, Benedicte/G-5730-2015; Houillier, Pascal/AAD-4903-2019; Froissart, Marc/L-7493-2014; Metzger, Marie/K-9772-2018	Stengel, Benedicte/0000-0001-9469-0804; Houillier, Pascal/0000-0003-4953-6917; Froissart, Marc/0000-0002-4010-3173; Vrtovsnik, Francois/0000-0003-1554-314X; Metzger, Marie/0000-0003-3597-5409	Inserm GIS-IReSP [AO 8113LS TGIR]; French Ministry of Health [AOM 09114]; Inserm [AO 8022LS]; Agence de la Biomedecine [R0 8156LL]; AURA; Roche [2009-152-447G]; F. Hoffman-La Roche Ltd.	Inserm GIS-IReSP; French Ministry of Health; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence de la Biomedecine; AURA; Roche(Roche Holding); F. Hoffman-La Roche Ltd.	The NephroTest CKD cohort study is supported by grants from: Inserm GIS-IReSP AO 8113LS TGIR (BS); French Ministry of Health AOM 09114 (MF); Inserm AO 8022LS (BS); Agence de la Biomedecine R0 8156LL (BS); AURA (MFr) and Roche 2009-152-447G (MFr). The Nephrotest initiative was also sponsored by unrestricted grants from F. Hoffman-La Roche Ltd. (LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamczak M, 2003, J AM SOC NEPHROL, V14, P2833, DOI 10.1097/01.ASN.0000095248.91994.D3; Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Al-Aly Z, 2010, J AM SOC NEPHROL, V21, P1961, DOI 10.1681/ASN.2009121210; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; de Boer IH, 2011, CLIN J AM SOC NEPHRO, V6, P2141, DOI 10.2215/CJN.02640311; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Ecder T, 2000, AM J KIDNEY DIS, V35, P427, DOI 10.1016/S0272-6386(00)70195-8; Eriksen BO, 2006, KIDNEY INT, V69, P375, DOI 10.1038/sj.ki.5000058; Fleiss J.L., 2013, STAT METHODS RATES P; Froissart M, 2005, J AM SOC NEPHROL, V16, P763, DOI 10.1681/ASN.2004070549; Gaardbo JC, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/161584; Hemmelgarn BR, 2006, KIDNEY INT, V69, P2155, DOI 10.1038/sj.ki.5000270; Hogan MC, 2010, J AM SOC NEPHROL, V21, P1052, DOI 10.1681/ASN.2009121291; Hsu CY, 2000, AM J KIDNEY DIS, V36, P272, DOI 10.1053/ajkd.2000.8971; Hu B, 2012, J AM SOC NEPHROL, V23, P706, DOI 10.1681/ASN.2011050456; Hunsicker LG, 1997, KIDNEY INT, V51, P1908, DOI 10.1038/ki.1997.260; IKOMA M, 1991, KIDNEY INT, V40, P195, DOI 10.1038/ki.1991.200; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kohan DE, 2011, J AM SOC NEPHROL, V22, P763, DOI 10.1681/ASN.2010080869; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Li L, 2012, AM J KIDNEY DIS, V59, P504, DOI 10.1053/j.ajkd.2011.12.009; Lorenzo V, 2010, NEPHROL DIAL TRANSPL, V25, P835, DOI 10.1093/ndt/gfp475; Melamed ML, 2009, J AM SOC NEPHROL, V20, P2631, DOI 10.1681/ASN.2009030283; Moranne O, 2009, J AM SOC NEPHROL, V20, P164, DOI 10.1681/ASN.2008020159; Pergola PE, 2011, NEW ENGL J MED, V365, P327, DOI 10.1056/NEJMoa1105351; Ravani P, 2009, KIDNEY INT, V75, P88, DOI 10.1038/ki.2008.501; Ruggenenti P, 1999, J AM SOC NEPHROL, V10, P997; Ruggenenti P, 1997, LANCET, V349, P1857; Ruggenenti P, 2001, J AM SOC NEPHROL, V12, P2832, DOI 10.1681/ASN.V12122832; Ruggenenti P, 2008, J AM SOC NEPHROL, V19, P1213, DOI 10.1681/ASN.2007090970; Schwarz S, 2006, CLIN J AM SOC NEPHRO, V1, P825, DOI 10.2215/CJN.02101205; Sharma K, 2011, J AM SOC NEPHROL, V22, P1144, DOI 10.1681/ASN.2010101049; Tanaka M, 2010, J CLIN INVEST, V120, P768, DOI 10.1172/JCI39569; Taskapan H, 2008, INT UROL NEPHROL, V40, P841, DOI 10.1007/s11255-008-9360-9; Urena-Torres P, 2011, AM J KIDNEY DIS, V58, P544, DOI 10.1053/j.ajkd.2011.04.029; Voormolen N, 2007, NEPHROL DIAL TRANSPL, V22, P2909, DOI 10.1093/ndt/gfm286; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421; Zoccali C, 2011, J AM SOC NEPHROL, V22, P1923, DOI 10.1681/ASN.2011020175	42	26	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 13	2013	8	12							e81835	10.1371/journal.pone.0081835	http://dx.doi.org/10.1371/journal.pone.0081835			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276FP	24349134	Green Published, gold, Green Submitted			2022-12-27	WOS:000328734200015
J	Lau, EHY; He, XQ; Lee, CK; Wu, JT				Lau, Eric H. Y.; He, Xiu-Qing; Lee, Cheuk-Kwong; Wu, Joseph T.			Predicting Future Blood Demand from Thalassemia Major Patients in Hong Kong	PLOS ONE			English	Article							TRANSFUSION REQUIREMENTS; BETA-THALASSEMIA; PREVALENCE; ALPHA	Background: In Hong Kong, thalassemia major (TM) patients utilized up to 9.5% of blood supply in 2009. For long-term management of blood supply, we predicted the future blood demand of TM patients for the next 10 years. Methods and Results: Annual individual transfusion data in 2005-2009 and demographic information of 381 TM patients were obtained from the Hong Kong Red Cross Blood Transfusion Service database. A generalized estimating equation (GEE) model was fitted to establish the potential relations of blood demand with age, sex, body weight, year of transfusion and splenectomy, accounted for within-patient correlation. The fitted model was used to predict future blood demand for the existing patients by accounting for expected change in body weight and mortality rate. We also predicted the number of new cases in the future based on age-and sex-specific TM incidence and official population projections. Future blood demand was predicted by combining blood demand from the existing and new patients. Female (RR = 0.94, p = 0.006) and history of splenectomy (RR = 0.85, p<0.001) were significantly associated with lower blood demand, while age and weight had an inverted U-shape relation with maximal blood demand at around 24 years of age and 71.8 kg, respectively. We predicted that the total blood demand would increase 0.81% annually from 13,459 units in 2009 to 15,183 units in 2024, with new TM cases accounting for 31.7% of the overall blood demand in 2024. Conclusions: Our results showed that future annual blood demand from TM patients would steadily increase in the next 10 years. Reducing incidence of TM cases in the future (by improving public education, antenatal care, prenatal diagnosis) and minimizing blood use among existing TM cases (e. g. with hemopoietic stem cell transplantation) can help relieve the burden on management of future blood demand.	[Lau, Eric H. Y.; He, Xiu-Qing; Wu, Joseph T.] Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China; [Lee, Cheuk-Kwong] Hong Kong Red Cross Blood Transfus Serv, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong	Lau, EHY (corresponding author), Univ Hong Kong, Pokfulam, Hong Kong, Peoples R China.	ehylau@hku.hk	Lau, Eric/AAJ-6588-2021; LEE, Cheuk Kwong/F-3950-2017; Wu, Joseph/ABD-5880-2021	Lau, Eric/0000-0002-6688-9637; LEE, Cheuk Kwong/0000-0002-3939-564X; 	National Institute of General Medical Sciences [U54GM088558]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JTW was supported by Award Number U54GM088558 from the National Institute of General Medical Sciences. The content of this paper is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au W. Y., 2011, Hong Kong Medical Journal, V17, P261; Borkent-Raven BA, 2010, TRANSFUSION, V50, P2455, DOI 10.1111/j.1537-2995.2010.02716.x; Census and Statistics Department, 2011, HONG KONG MONTHL DIG; Census and Statistics Department, 2012, HONG KONG FACTS POP; Census and Statistics Department, 2010, HONG KONG POP PROJ 2; Centers for Disease Control and Prevention, 2009, GROWTH CHARTS; Cheng MH, 2007, LANCET, V369, P981, DOI 10.1016/S0140-6736(07)60476-0; COHEN A, 1989, AM J HEMATOL, V30, P254, DOI 10.1002/ajh.2830300412; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Cunningham MJ, 2004, BLOOD, V104, P34, DOI 10.1182/blood-2003-09-3167; Currie CJ, 2004, TRANSFUSION MED, V14, P19, DOI 10.1111/j.0958-7578.2004.00475.x; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Guerin S, 2007, TRANSFUSION MED, V17, P37, DOI 10.1111/j.1365-3148.2006.00698.x; Hong Juliana, 2011, Asian J Transfus Sci, V5, P49, DOI 10.4103/0973-6247.76000; Hong Kong Red Cross, 2012, ANN REPORT; Hong Kong Red Cross, 2012, ANN REP; Kuhne CA, 2008, WORLD J SURG, V32, P1183, DOI 10.1007/s00268-007-9425-4; Kwan W. Y., 2011, Hong Kong Medical Journal, V17, P434; Lau YL, 1997, NEW ENGL J MED, V336, P1298, DOI 10.1056/NEJM199705013361805; Lee C K, 2008, Asian J Transfus Sci, V2, P47, DOI 10.4103/0973-6247.42691; Li C K, 2002, Hong Kong Med J, V8, P255; Li CG, 2009, HEMOGLOBIN, V33, P296, DOI 10.3109/03630260903211698; Modell B, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-42; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; R Development Core Team, 2010, LANG ENV STAT COMP G; REBULLA P, 1991, LANCET, V337, P277, DOI 10.1016/0140-6736(91)90881-O; Stotler B, 2011, TRANSFUSION, V51, P2627, DOI 10.1111/j.1537-2995.2011.03205.x; United Nations, 2006, POPULATION STUDIES; Valdez JM, 2011, CLIN INFECT DIS, V52, P726, DOI 10.1093/cid/ciq245; Vamvakas EC, 1996, TRANSFUS MED REV, V10, P44, DOI 10.1016/S0887-7963(96)80122-2; Xu XM, 2004, J CLIN PATHOL, V57, P517, DOI 10.1136/jcp.2003.014456; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	33	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81846	10.1371/journal.pone.0081846	http://dx.doi.org/10.1371/journal.pone.0081846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24349138	Green Published, gold, Green Submitted			2022-12-27	WOS:000328730300055
J	Nicoletti, A; Bruno, E; Nania, M; Cicero, E; Messina, S; Chisari, C; Torrisi, J; Maimone, D; Marziolo, R; Lo Fermo, S; Patti, F; Giammanco, S; Zappia, M				Nicoletti, Alessandra; Bruno, Elisa; Nania, Martina; Cicero, Edoardo; Messina, Silvia; Chisari, Clara; Torrisi, Josita; Maimone, Davide; Marziolo, Roberto; Lo Fermo, Salvatore; Patti, Francesco; Giammanco, Salvatore; Zappia, Mario			Multiple Sclerosis in the Mount Etna Region: Possible Role of Volcanogenic Trace Elements	PLOS ONE			English	Article							INCREASING FREQUENCY; TEMPORAL CLUSTER; ORGANIC-SOLVENTS; OXIDATIVE STATUS; MT-ETNA; EPIDEMIOLOGY; CATANIA; SERUM; LINGUAGLOSSA; PREVALENCE	Background: Trace elements have been hypothesised to be involved in the pathogenesis of Multiple Sclerosis and volcanic degassing is the major natural sources of trace elements. Both incidence of Multiple Sclerosis in Catania and volcanic activity of Mount Etna have been significantly increased during the last 30 years. Due to prevailing trade winds direction, volcanic gases from Etna summit craters are mostly blown towards the eastern and southern sectors of the volcano. Objective: To evaluate the possible association between Multiple Sclerosis and exposure to volcanogenic trace elements. Methods: We evaluated prevalence and incidence of Multiple Sclerosis in four communities (47,234 inhabitants) located in the eastern flank and in two communities (52,210 inhabitants) located in the western flank of Mount Etna, respectively the most and least exposed area to crater gas emissions. Results: A higher prevalence was found in the population of the eastern flank compared to the population of the western one (137.6/100,000 versus 94.3/100,000; p-value 0.04). We found a borderline significantly higher incidence risk during the incidence study period (1980-2009) in the population of the eastern flank 4.6/100,000 (95% CI 3.1-5.9), compared with the western population 3.2/100,000 (95% CI 2.4-4.2) with a RR of 1.41 (95% CI 0.97-2.05; p-value 0.06). Incidence risks have increased over the time in both populations reaching a peak of 6.4/100,000 in the eastern flank and of 4.4/100.000 in the western flank during 2000-2009. Conclusion: We found a higher prevalence and incidence of Multiple Sclerosis among populations living in the eastern flank of Mount Etna. According to our data a possible role of TE cannot be ruled out as possible co-factor in the MS pathogenesis. However larger epidemiological study are needed to confirm this hypothesis.	[Nicoletti, Alessandra; Bruno, Elisa; Nania, Martina; Cicero, Edoardo; Messina, Silvia; Chisari, Clara; Torrisi, Josita; Lo Fermo, Salvatore; Patti, Francesco; Zappia, Mario] Univ Catania, Depatment GF Ingrassia Sect Neurosci, Catania, Italy; [Maimone, Davide] Garibaldi Hosp, Neurol Unit, Catania, Italy; [Marziolo, Roberto] Cannizzaro Hosp, Neurol Unit, Catania, Italy; [Giammanco, Salvatore] Osservatorio Etneo, Ist Nazl Geofis & Vulcanol, Catania, Italy	University of Catania; Istituto Nazionale Geofisica e Vulcanologia (INGV)	Zappia, M (corresponding author), Univ Catania, Depatment GF Ingrassia Sect Neurosci, Catania, Italy.	m.zappia@isn.cnr.it	Messina, Silvia/ABC-8780-2020; Cicero, Calogero Edoardo CE/K-4055-2018; Nicoletti, Alessandra/K-4486-2018; Bruno, Elisa/P-4317-2018; Zappia, Mario/AAB-7800-2019	Cicero, Calogero Edoardo CE/0000-0002-8647-8851; Nicoletti, Alessandra/0000-0001-6757-340X; Bruno, Elisa/0000-0001-8166-1190; chisari, clara grazia/0000-0003-1607-543X; patti, francesco/0000-0002-6923-0846	AIFA- Agenzia Italiana del Farmaco; Novartis; Lundbeck; Pfizer; FISM; Bayer Schering; Biogen Idec; Merck Serono; Sanofi Aventis; TEVA	AIFA- Agenzia Italiana del Farmaco; Novartis(Novartis); Lundbeck(Lundbeck Corporation); Pfizer(Pfizer); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Bayer Schering(Bayer AG); Biogen Idec(Biogen); Merck Serono(Merck & Company); Sanofi Aventis(Sanofi-Aventis); TEVA(Teva Pharmaceutical Industries)	M. Zappia has received compensation for consulting services from Boehringer-Ingelheim, Lundbeck, Union Chimique Belge and scientific grants from AIFA- Agenzia Italiana del Farmaco, Novartis, Lundbeck. M. Zappia is the holder of the following patent, Movement Time Analyzer 01277716 issued by the Ministry of the Italian the 12 of November 1997. A. Nicoletti has received honoraria from UCB-Union Clinique Belge for medical education symposia and Lundbeck. F. Patti has received honoraria for speaking activities by Bayer Schering, Biogen Idec, Merck Serono, Novartis and Sanofi Aventis; he also served as advisory board member the following companies: Bayer Schering, Biogen Idec, Merck Serono, Novartis; he was also funded by Pfizer and FISM for epidemiological studies; finally he received grants for congress participation from Bayer Schering, Biogen Idec, Merck Serono, Novartis, Sanofi Aventis and TEVA. S. Lo Fermo received honoraria for speaking activities from Biogen Idec, Merck Serono; he also received grants for congress participation from Bayer Schering, Biogen Idec, Merck Serono and Sanofi Aventis. E. Bruno, M. Nania, E. Cicero, S. Messina, C. Chisari, J. Torrisi, D. Maimone, R. Marziolo, S. Giammanco have nothing to disclose. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Aiuppa A, 2003, APPL GEOCHEM, V18, P863, DOI 10.1016/S0883-2927(02)00182-8; Aiuppa A, 2004, GEOPH MONOG SERIES, V143, P129; Alimonti A, 2007, NEUROTOXICOLOGY, V28, P450, DOI 10.1016/j.neuro.2006.12.001; Alonso A, 2008, NEUROLOGY, V71, P129, DOI 10.1212/01.wnl.0000316802.35974.34; Behncke B, 2003, CAN J EARTH SCI, V40, P1405, DOI 10.1139/E03-052; Branca S, 2005, B VOLCANOL, V67, P732, DOI 10.1007/s00445-005-0412-z; Calabrese S, 2011, GEOCHIM COSMOCHIM AC, V75, P7401, DOI 10.1016/j.gca.2011.09.040; Cocco E, 2011, MULT SCLER J, V17, P1282, DOI 10.1177/1352458511408754; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; Dhib-Jalbut S, 2006, J NEUROIMMUNOL, V176, P198, DOI 10.1016/j.jneuroim.2006.03.027; Gauthier PJ, 1998, J VOLCANOL GEOTH RES, V81, P311, DOI 10.1016/S0377-0273(98)00002-X; Gellein K, 2008, J NEUROL SCI, V266, P70, DOI 10.1016/j.jns.2007.08.042; Giammanco S, 1998, WATER RES, V32, P9; Giovannoni G, 2007, CURR OPIN NEUROL, V20, P261, DOI 10.1097/WCO.0b013e32815610c2; Granieri E, 2007, J NEUROL, V254, P1642, DOI 10.1007/s00415-007-0560-5; GRONNING M, 1993, ACTA NEUROL SCAND, V88, P247; GUIDETTI D, 1995, NEUROEPIDEMIOLOGY, V14, P7, DOI 10.1159/000109772; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Hansell AL, 2006, OCCUP ENVIRON MED, V63, P149, DOI 10.1136/oem.2005.022459; Istituto Centrale di Statistica, 2011, 15 CENS GEN POP; Iuliano G, 2008, EUR J NEUROL, V15, P73, DOI 10.1111/j.1468-1331.2007.02006.x; Johnson S, 2000, MED HYPOTHESES, V55, P239, DOI 10.1054/mehy.2000.1051; KAPAKI E, 1989, ACTA NEUROL SCAND, V79, P373, DOI 10.1111/j.1600-0404.1989.tb03803.x; Klein R, 2006, PURE APPL CHEM, V78, P2155, DOI 10.1351/pac200678112155; Martin RS, 2009, J VOLCANOL GEOTH RES, V179, P107, DOI 10.1016/j.jvolgeores.2008.10.012; Melo TM, 2003, BIOL TRACE ELEM RES, V93, P1, DOI 10.1385/BTER:93:1-3:1; Nicoletti A, 2005, NEUROLOGY, V65, P1259, DOI 10.1212/01.wnl.0000180628.38786.85; Nicoletti A, 2005, J NEUROL, V252, P921, DOI 10.1007/s00415-005-0781-4; Nicoletti A, 2009, MULT SCLER J, V15, P129, DOI 10.1177/1352458508096873; Nicoletti A, 2001, NEUROLOGY, V56, P62, DOI 10.1212/WNL.56.1.62; Nicoletti A, 2011, MULT SCLER J, V17, P273, DOI 10.1177/1352458510386995; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; POSER CM, 1994, ANN NEUROL, V36, pS180, DOI 10.1002/ana.410360805; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Pugliatti M, 2005, NEUROEPIDEMIOLOGY, V25, P129, DOI 10.1159/000086677; Purdey M, 2004, MED HYPOTHESES, V62, P746, DOI 10.1016/j.mehy.2003.12.034; Puthenparampil M, 2013, MULT SCLER J, V19, P601, DOI 10.1177/1352458512461970; Ranzato F, 2003, MULT SCLER J, V9, P387, DOI 10.1191/1352458503ms920oa; Riise T, 2002, EPIDEMIOLOGY, V13, P718, DOI 10.1097/00001648-200211000-00018; Ristori G, 2011, NEUROLOGY, V76, P549, DOI 10.1212/WNL.0b013e31820af7de; Savettieri G, 2001, NEUROL SCI, V22, P175, DOI 10.1007/s100720170020; Sayre LM, 2000, CELL MOL BIOL, V46, P731; Schiffer RB, 2001, ARCH ENVIRON HEALTH, V56, P389, DOI 10.1080/00039890109604473	43	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e74259	10.1371/journal.pone.0074259	http://dx.doi.org/10.1371/journal.pone.0074259			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	276EG	24348986	Green Published, gold			2022-12-27	WOS:000328730300003
J	Shakeshaft, NG; Trzaskowski, M; McMillan, A; Rimfeld, K; Krapohl, E; Haworth, CMA; Dale, PS; Plomin, R				Shakeshaft, Nicholas G.; Trzaskowski, Maciej; McMillan, Andrew; Rimfeld, Kaili; Krapohl, Eva; Haworth, Claire M. A.; Dale, Philip S.; Plomin, Robert			Strong Genetic Influence on a UK Nationwide Test of Educational Achievement at the End of Compulsory Education at Age 16	PLOS ONE			English	Article							ENVIRONMENTAL-INFLUENCES; LITERACY INSTRUCTION; TWIN; ABILITIES; OVERLAP; FAMILY	We have previously shown that individual differences in educational achievement are highly heritable in the early and middle school years in the UK. The objective of the present study was to investigate whether similarly high heritability is found at the end of compulsory education (age 16) for the UK-wide examination, called the General Certificate of Secondary Education (GCSE). In a national twin sample of 11,117 16-year-olds, heritability was substantial for overall GCSE performance for compulsory core subjects (58%) as well as for each of them individually: English (52%), mathematics (55%) and science (58%). In contrast, the overall effects of shared environment, which includes all family and school influences shared by members of twin pairs growing up in the same family and attending the same school, accounts for about 36% of the variance of mean GCSE scores. The significance of these findings is that individual differences in educational achievement at the end of compulsory education are not primarily an index of the quality of teachers or schools: much more of the variance of GCSE scores can be attributed to genetics than to school or family environment. We suggest a model of education that recognizes the important role of genetics. Rather than a passive model of schooling as instruction (instruere, 'to build in'), we propose an active model of education (educare, 'to bring out') in which children create their own educational experiences in part on the basis of their genetic propensities, which supports the trend towards personalized learning.	[Shakeshaft, Nicholas G.; Trzaskowski, Maciej; McMillan, Andrew; Rimfeld, Kaili; Krapohl, Eva; Plomin, Robert] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, Med Res Council, London, England; [Haworth, Claire M. A.] Univ Warwick, Dept Psychol, Coventry CV4 7AL, W Midlands, England; [Dale, Philip S.] Univ New Mexico, Dept Speech & Hearing Sci, Albuquerque, NM 87131 USA	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; King's College London; University of Warwick; University of New Mexico	Shakeshaft, NG (corresponding author), Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, Med Res Council, London, England.	nicholas.shakeshaft@kcl.ac.uk	Dale, Philip S/A-2254-2009; Haworth, Claire M.A./C-7073-2009	Dale, Philip S/0000-0002-7697-8510; Haworth, Claire M.A./0000-0002-8608-289X; Krapohl, Eva/0000-0002-6809-7908; Plomin, Robert/0000-0002-0756-3629; Trzaskowski, Maciej/0000-0001-8559-6525; Rimfeld, Kaili/0000-0001-5139-065X	UK Medical Research Council [G0901245, G0500079]; US National Institutes of Health [HD044454, HD059215]; Medical Research Council [G19/2]; British Academy; European Research Council [295366]; MRC [G0500079, G0901245, G19/2] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044454, R01HD059215] Funding Source: NIH RePORTER; Medical Research Council [G0500079, 1427589, G0901245, 1241769] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Academy; European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The Twins Early Development Study (TEDS) is supported by a program grant to RP from the UK Medical Research Council [G0901245; and previously G0500079], with additional support from the US National Institutes of Health [HD044454; HD059215]. NGS, KR, EK, and MT are supported by Medical Research Council studentships. CMAH is supported by a research fellowship from the British Academy. RP is supported by a Medical Research Council Research Professorship award [G19/2] and a European Research Council Advanced Investigator award [295366]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbury K., 2013, G IS GENES IMPACT GE; Asbury K, 2008, TWIN RES HUM GENET, V11, P586, DOI 10.1375/twin.11.6.586; Bartels M, 2002, TWIN RES, V5, P544, DOI 10.1375/136905202762342017; Boker S, 2011, PSYCHOMETRIKA, V76, P306, DOI 10.1007/s11336-010-9200-6; Byrne B, 2009, J NEUROLINGUIST, V22, P219, DOI 10.1016/j.jneuroling.2008.09.003; Calvin CM, 2012, BEHAV GENET, V42, P699, DOI 10.1007/s10519-012-9549-7; Connor CM, 2013, PSYCHOL SCI, V24, P1408, DOI 10.1177/0956797612472204; Davis Oliver S P, 2009, Cogn Neuropsychiatry, V14, P312, DOI 10.1080/13546800902797106; Hanscombe KB, 2011, J CHILD PSYCHOL PSYC, V52, P1212, DOI 10.1111/j.1469-7610.2011.02421.x; Haworth CMA, 2008, INT J SCI EDUC, V30, P1003, DOI 10.1080/09500690701324190; Haworth CMA, 2013, TWIN RES HUM GENET, V16, P117, DOI 10.1017/thg.2012.91; Haworth CMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016006; Haworth CMA, 2011, AM PSYCHOL ASS HDB E, P529; Koeppen-Schomerus G, 2003, TWIN RES, V6, P97, DOI 10.1375/twin.6.2.97; Kovas Y, 2007, MONOGR SOC RES CHILD, V72, P1; Kovas Y, 2013, PSYCHOL SCI, V24, P2048, DOI 10.1177/0956797613486982; Loehlin J., 1976, HEREDITY ENV PERSONA, DOI DOI 10.7560/730038; MCGUE M, 1984, BEHAV GENET, V14, P325, DOI 10.1007/BF01080045; Medland SE, 2004, TWIN RES, V7, P299, DOI 10.1375/twin.7.3.299; Morrison FJ, 1996, REASON RESPONSIBILIT, P161; Neale MC, 1999, METHODOLOGY GENETIC; Nicoletti C, 2013, ECONOMICA, V80, P197, DOI 10.1111/ecca.12010; OECD, 2004, LEARN TOM WORLD 1 RE; Olson RK, 2011, SCI STUD READ, V15, P26, DOI 10.1080/10888438.2011.536128; Petrill SA, 2010, J CHILD PSYCHOL PSYC, V51, P660, DOI 10.1111/j.1469-7610.2009.02204.x; Plomin R, 2013, DEV PSYCHOP IN PRESS; Plomin R., 2013, BEHAV GENET; Plomin R, 2013, PSYCHOL SCI, V24, P562, DOI 10.1177/0956797612457952; Plomin R, 2011, INT J EPIDEMIOL, V40, P582, DOI 10.1093/ije/dyq144; Price T S, 2000, Twin Res, V3, P129, DOI 10.1375/136905200320565391; Samuelsson S, 2008, LEARN INDIVID DIFFER, V18, P289, DOI 10.1016/j.lindif.2008.03.004; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; THOMPSON LA, 1991, PSYCHOL SCI, V2, P158, DOI 10.1111/j.1467-9280.1991.tb00124.x; Trzaskowski M, 2013, BEHAV GENET, V43, P267, DOI 10.1007/s10519-013-9594-x; Tseng JCR, 2008, COMPUT EDUC, V51, P776, DOI 10.1016/j.compedu.2007.08.002; Wainwright MA, 2005, TWIN RES HUM GENET, V8, P602, DOI 10.1375/twin.8.6.602; Wooldridge A, 1994, MEASURING MIND ED PS, DOI [10.1017/CBO9780511659997, DOI 10.1017/CB09780511659997]	37	64	64	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e80341	10.1371/journal.pone.0080341	http://dx.doi.org/10.1371/journal.pone.0080341			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349000	Green Published, Green Submitted, gold			2022-12-27	WOS:000328730300009
J	Arimitsu, H; Sasaki, K; Kojima, H; Yanaka, T; Tsuji, T				Arimitsu, Hideyuki; Sasaki, Keiko; Kojima, Hiroe; Yanaka, Tadashi; Tsuji, Takao			Simple Method for Shiga Toxin 2e Purification by Affinity Chromatography via Binding to the Divinyl Sulfone Group	PLOS ONE			English	Article							PORCINE EDEMA DISEASE; ESCHERICHIA-COLI; II VARIANT; THIOPHILIC ADSORPTION; VACCINE CANDIDATE; B-SUBUNIT; RECEPTOR; GENES; SWINE; CLONING	Here we describe a simple affinity purification method for Shiga toxin 2e (Stx2e), a major causative factor of edema disease in swine. Escherichia coli strain MV1184 transformed with the expression plasmid pBSK-Stx2e produced Stx2e when cultivated in CAYE broth containing lincomycin. Stx2e bound to commercial D-galactose gel, containing a-D-galactose immobilized on agarose resin via a divinyl sulfone linker, and was eluted with phosphate-buffered saline containing 4.5 M MgCl2. A small amount of Stx2e bound to another commercial a-galactose-immobilized agarose resin, but not to beta-galactose-immobilized resin. In addition, Stx2e bound to thiophilic adsorbent resin containing beta-mercaptoethanol immobilized on agarose resin via a divinyl sulfone, and was purified in the same manner as from D-galactose gel, but the Stx2e sample contained some contamination. These results indicate that Stx2e bound to D-galactose gel mainly through the divinyl sulfone group on the resin and to a lesser extent through a-D-galactose. With these methods, the yields of Stx2e and attenuated mutant Stx2e (mStx2e) from 1 L of culture were approximately 36 mg and 27.7 mg, respectively, and the binding capacity of the D-galactose gel and thiophilic adsorbent resin for Stx2e was at least 20 mg per 1 ml of resin. In addition, using chimeric toxins with prototype Stx2 which did not bind to thiophilic adsorbent resin and some types of mutant Stx2e and Stx2 which contained inserted mutations in the B subunits, we found that, at the least, asparagine (amino acid 17 of the B subunits) was associated with Stx2e binding to the divinyl sulfone group. The mStx2e that was isolated exhibited vaccine effects in ICR mice, indicating that these methods are beneficial for large-scale preparation of Stx2e toxoid, which protects swine from edema disease.	[Arimitsu, Hideyuki; Sasaki, Keiko; Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan; [Kojima, Hiroe; Yanaka, Tadashi] Kyoritsu Seiyaku Corp, Adv Technol Dev Ctr, Tsukuba, Ibaraki, Japan	Fujita Health University	Arimitsu, H (corresponding author), Fujita Hlth Univ, Sch Med, Dept Microbiol, Toyoake, Aichi 47011, Japan.	arimitsu@fujita-hu.ac.jp			Japan Society for the Promotion of Science [24590539]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant Number 24590539. (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHESON DWK, 1993, MICROB PATHOGENESIS, V14, P57, DOI 10.1006/mpat.1993.1006; Arimitsu H, 2003, INFECT IMMUN, V71, P1599, DOI 10.1128/IAI.71.3.1599-1603.2003; Arimitsu H, 2013, MICROBIOL IMMUNOL, V57, P38, DOI 10.1111/j.1348-0421.2012.12004.x; Arimitsu H, 2009, PROTEIN EXPRES PURIF, V67, P96, DOI 10.1016/j.pep.2009.04.011; Bosworth BT, 1996, INFECT IMMUN, V64, P55, DOI 10.1128/IAI.64.1.55-60.1996; CAO CY, 1994, MICROBIOL IMMUNOL, V38, P441, DOI 10.1111/j.1348-0421.1994.tb01805.x; DEGRANDIS S, 1989, J BIOL CHEM, V264, P12520; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361, DOI 10.1128/JCM.12.3.361-366.1980; GORDON VM, 1992, INFECT IMMUN, V60, P485, DOI 10.1128/IAI.60.2.485-490.1992; GYLES CL, 1988, MICROB PATHOGENESIS, V5, P419, DOI 10.1016/0882-4010(88)90003-4; HUTCHENS TW, 1986, ANAL BIOCHEM, V159, P217, DOI 10.1016/0003-2697(86)90331-3; IMBERECHTS H, 1992, VET MICROBIOL, V31, P221, DOI 10.1016/0378-1135(92)90080-D; KEUSCH GT, 1995, INFECT IMMUN, V63, P1138, DOI 10.1128/IAI.63.3.1138-1141.1995; Lee JC, 2007, FEMS IMMUNOL MED MIC, V51, P201, DOI 10.1111/j.1574-695X.2007.00301.x; MACLEOD DL, 1990, INFECT IMMUN, V58, P1232, DOI 10.1128/IAI.58.5.1232-1239.1990; MACLEOD DL, 1991, VET PATHOL, V28, P66, DOI 10.1177/030098589102800109; Makino SI, 2001, MICROB PATHOGENESIS, V31, P1, DOI 10.1006/mpat.2001.0440; Miyake M, 2000, ANAL BIOCHEM, V281, P202, DOI 10.1006/abio.2000.4559; Moxley RA, 2000, VET CLIN N AM-FOOD A, V16, P175, DOI 10.1016/S0749-0720(15)30142-0; Pierard D, 1998, J CLIN MICROBIOL, V36, P3317; PORATH J, 1985, FEBS LETT, V185, P306, DOI 10.1016/0014-5793(85)80928-5; RYD M, 1989, FEBS LETT, V258, P320, DOI 10.1016/0014-5793(89)81684-9; SAMUEL JE, 1990, INFECT IMMUN, V58, P611, DOI 10.1128/IAI.58.3.611-618.1990; Schmidt H, 2000, APPL ENVIRON MICROB, V66, P1205, DOI 10.1128/AEM.66.3.1205-1208.2000; SCHMITT CK, 1991, INFECT IMMUN, V59, P1065, DOI 10.1128/IAI.59.3.1065-1073.1991; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Thi KNO, 2012, INFECT IMMUN, V80, P469, DOI 10.1128/IAI.05539-11; Tomoda H, 2002, ANAL BIOCHEM, V311, P50, DOI 10.1016/S0003-2697(02)00380-9; TYRRELL GJ, 1992, P NATL ACAD SCI USA, V89, P524, DOI 10.1073/pnas.89.2.524; UESAKA Y, 1994, MICROB PATHOGENESIS, V16, P71, DOI 10.1006/mpat.1994.1007; WEINSTEIN DL, 1988, J BACTERIOL, V170, P4223, DOI 10.1128/jb.170.9.4223-4230.1988	31	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83577	10.1371/journal.pone.0083577	http://dx.doi.org/10.1371/journal.pone.0083577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340102	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400135
J	Cao, HJ; Han, M; Ng, EHY; Wu, XK; Flower, A; Lewith, G; Liu, JP				Cao, Huijuan; Han, Mei; Ng, Ernest H. Y.; Wu, Xiaoke; Flower, Andrew; Lewith, George; Liu, Jian-Ping			Can Chinese Herbal Medicine Improve Outcomes of In Vitro Fertilization? A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							INFERTILITY; ACUPUNCTURE; ANOVULATION	Background: A large number of infertile couples are choosing Chinese herbal medicine (CHM) as an adjuvant therapy to improve their success when undergoing in vitro fertilization (IVF). There is no systematic review to evaluate the impact of CHM on the IVF outcomes. Objective: To evaluate the effectiveness of CHM with concurrent IVF versus IVF alone on the outcomes of IVF and its safety. Methods: The protocol of this study is registered at PROSPERO. Eligible RCTs searched from 8 databases which compared a combination of CHM and IVF with IVF alone were included. Two authors independently selected studies, extracted data and assessed methodological quality. Meta-analysis of RCTs was conducted if there was non-significant heterogeneity (evaluated by I 2 test) among trials. All statistical analysis was performed using RevMan 5.1 software. Results: Twenty trials involving 1721 women were included in the meta-analysis. Three trials were evaluated as having an unclear risk of bias. The remaining trials were evaluated as having a high risk of bias. Combination of CHM and IVF significantly increases clinical pregnancy rates (OR 2.04, 95%CI 1.67 to 2.49, p<0.00001) and ongoing pregnancy rates (OR 1.91, 95%CI 1.17 to 3.10, p = 0.009). Use of CHM after embryo transfer had no better outcome in reducing the rate of ovarian hyper stimulation syndrome (OR 0.39, 95% CI 0.14 to 1.11, p = 0.08). Conclusions: This meta-analysis showed that combination of IVF and CHM used in the included trials improve IVF success, however due to the high risk of bias observed with the trials, the significant differences found with the meta-analysis are unlikely to be accurate. No conclusion could be drawn with respect to the reproductive toxicity of CHM. Further large randomized placebo controlled trials are warranted to confirm these findings before recommending women to take CHM to improve their IVF success.	[Cao, Huijuan; Han, Mei; Liu, Jian-Ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Ng, Ernest H. Y.] Univ Hong Kong, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Wu, Xiaoke] Heilongjiang Univ Chinese Med, Affiliated Hosp 1, Dept Gynecol, Heilongjiang, Heilongjiang Pr, Peoples R China; [Flower, Andrew; Lewith, George] Univ Southampton, Sch Med, Southampton SO9 5NH, Hants, England	Beijing University of Chinese Medicine; University of Hong Kong; Heilongjiang University of Chinese Medicine; University of Southampton	Liu, JP (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	Liujp@bucm.edu.cn		Liu, Jianping/0000-0002-0320-061X; Ng, Ernest/0000-0002-7688-4557; Lewith, George/0000-0002-2364-3960	Program for Innovative Research Team of Beijing University of Chinese Medicine [2011-CXTD-09]; project on research capacity building for TCM researchers [201207007]	Program for Innovative Research Team of Beijing University of Chinese Medicine; project on research capacity building for TCM researchers	CHJ, HM, and LJP are supported by the Program for Innovative Research Team of Beijing University of Chinese Medicine (2011-CXTD-09), and the project on research capacity building for TCM researchers (201207007). The funder is the employer for main investigators of this review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[常秀峰 Chang Xiufeng], 2011, [生殖与避孕, Reproduction and Contraception], V31, P170; Cheong Y, 2010, HUM FERTIL, V13, P3, DOI 10.3109/14647270903438830; de Mouzon J, 2009, HUM REPROD, V24, P2310, DOI 10.1093/humrep/dep098; Deng W, 2011, J GUANGZHOU U TRADIT, V28:1; Deng WeiMin, 2011, Journal of Liaoning University of Traditional Chinese Medicine, V13, P5; Gao X, 2012, THESIS HEBEI U TRADI; Gao Z. Y., 2012, J CHANGCHUN U TRADIT, V28, P417; Ge M. X., 2010, J GUANGZHOU U TRADIT, V27, P457; Gui S. Q., 1997, J SHANGHAI MED U, V7, P217; Guo Jia, 2011, Zhong Xi Yi Jie He Xue Bao, V9, P1301, DOI 10.3736/jcim20111204; Higgins J., 2009, COCHRANE HDB SYSTEMA; Huang Y. Y., 2012, ZHEJIANG J TRADIT CH, V47, P734; Kalra SK, 2011, FERTIL STERIL, V95, P1887, DOI 10.1016/j.fertnstert.2011.02.044; Lei L, 2011, 11 NAT GYN TRAD CHIN; [李东 LI Dong], 2008, [中医杂志, Journal of Traditional Chinese Medicine], V49, P1084; [李东 LI Dong], 2009, [北京中医药大学学报, Journal of Beijing University of Traditional Chinese Medicine], V32, P139; Li XL, 2008, CHIN J PRACT MED, P261; Lian Fang, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P431; Lian Fang, 2008, Zhongguo Zhong Xi Yi Jie He Za Zhi, V28, P977; Lian Fang, 2007, Zhongguo Zhong Xi Yi Jie He Za Zhi, V27, P976; Lian Fang, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P685; Liu HP, 2008, SHANDONG PHARM, V48, P105; Manheimer E, 2008, BMJ-BRIT MED J, DOI 101136/bmj.39471.430451.BE; Qi G. C., 1996, LIAONING J TRADIT CH, V23, P218; Qu F, 2012, J ALTERN COMPLEM MED, V18, P429, DOI 10.1089/acm.2011.0158; Ried K, 2011, COMPLEMENT THER MED, V19, P319, DOI 10.1016/j.ctim.2011.09.003; See CJ, 2011, J ALTERN COMPLEM MED, V17, P397, DOI 10.1089/acm.2010.0254; Shannon J, 2010, IRISH J MED SCI, V179, P63, DOI 10.1007/s11845-009-0378-5; Smith JF, 2010, FERTIL STERIL, V93, P2169, DOI 10.1016/j.fertnstert.2010.02.054; Sun ZG, 2009, 9 NAT GYN TRAD CHIN; [孙振高 Sun Zhengao], 2011, [中国超声医学杂志, Chinese Journal of Ultrasonic in Medical], V27, P353; Sunderam Saswati, 2012, Morbidity and Mortality Weekly Report, V61, P1; Tan L, 2012, J ALTERN COMPLEM MED, V18, P1087, DOI 10.1089/acm.2011.0371; Teng HX, 2009, THESIS SHANDONG U CH; Teng YL, 2006, THESIS SHANDONG U CH; Wang CC, 2012, HUM REPROD, V27, P2448, DOI 10.1093/humrep/des180; Wang L, 2005, THESIS SHANDONG U CH; Yang G Y, 2001, Zhongguo Zhong Xi Yi Jie He Za Zhi, V21, P522; Zhang JW, 2007, REPROD CONTRACEPT, V27, P714; Zhu W. J., 2002, CJITWM, V22, P737; [朱文杰 Zhu Wenjie], 2002, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V22, P729; 李楠楠, 2012, [中国中医药信息杂志, Chinese Journal of Information on Traditional Chinese Medicine], V19, P79; 张明敏, 2004, [中国中西医结合杂志, Chinese Journal of Integrated Traditional and Western Medicine], V24, P1033	43	23	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81650	10.1371/journal.pone.0081650	http://dx.doi.org/10.1371/journal.pone.0081650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339951	Green Published, Green Submitted, gold			2022-12-27	WOS:000328707400027
J	Gopinath, SCB; Awazu, K; Fujimaki, M; Shimizu, K				Gopinath, Subash C. B.; Awazu, Koichi; Fujimaki, Makoto; Shimizu, Kazufumi			Evaluation of Anti-A/Udorn/307/1972 Antibody Specificity to Influenza A/H3N2 Viruses Using an Evanescent-Field Coupled Waveguide-Mode Sensor	PLOS ONE			English	Article							A VIRUS; RNA APTAMER; HEMAGGLUTININ; SENSITIVITY; PRINCIPLES; CONSTANTS	Discrimination of closely related strains is a key issue, particularly for infectious diseases whose incidence fluctuates according to variations in the season and evolutionary changes. Among infectious diseases, influenza viral infections are a worldwide cause of pandemic disease and mortality. With the emergence of different influenza strains, it is vital to develop a method using antibodies that can differentiate between viral types and subtypes. Ideally, such a system would also be user friendly. In this study, a polyclonal antibody generated against A/Udorn/307/1972 (H3N2) was used as a probe to distinguish between influenza H3N2 viruses based on the interaction between the antibody and hemagglutinin, demonstrating its applicability for viral discrimination. Clear discrimination was demonstrated using an evanescent-field-coupled waveguide-mode sensor, which has appealing characteristics over other methods in the viewpoint of improving the sensitivity, measurement time, portability and usability. Further supporting evidence was obtained using enzyme-linked immunosorbent assays, hemagglutination-inhibition assays, and infectivity neutralization assays. The results obtained indicate that the polyclonal antibody used here is a potential probe for distinguishing influenza viruses and, with the aid of a handheld sensor it could be used for influenza surveillance.	[Gopinath, Subash C. B.; Awazu, Koichi; Fujimaki, Makoto] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki, Japan; [Shimizu, Kazufumi] Nihon Univ, Sch Med, Open Res Ctr Genome & Infect Dis Control, Itabashi Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Nihon University	Gopinath, SCB (corresponding author), Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki, Japan.	gopi-subashchandrabose@aist.go.jp; k.awazu@aist.go.jp	Fujimaki, Makoto/M-3310-2018; Gopinath, Subash/D-2953-2015; Awazu, Koichi/AAY-1421-2020; Awazu, Koichi/M-8133-2018	Fujimaki, Makoto/0000-0003-4856-422X; Gopinath, Subash/0000-0002-8347-4687; Awazu, Koichi/0000-0002-1993-1708	Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan	Industrial Technology Research Grant Program from the New Energy and Industrial Technology Development Organization (NEDO) of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported by the Industrial Technology Research Grant Program 2009 from the New Energy and Industrial Technology Development Organization (NEDO) of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APPLEYARD G, 1974, J GEN VIROL, V25, P351, DOI 10.1099/0022-1317-25-3-351; Awazu K, 2007, OPT EXPRESS, V15, P2592, DOI 10.1364/OE.15.002592; Bahgat MM, 2009, J VIROL METHODS, V159, P244, DOI 10.1016/j.jviromet.2009.04.008; Biere B, 2010, J CLIN MICROBIOL, V48, P1425, DOI 10.1128/JCM.02116-09; Bolduc OR, 2009, TALANTA, V77, P1680, DOI 10.1016/j.talanta.2008.10.006; Byrne B, 2009, SENSORS-BASEL, V9, P4407, DOI 10.3390/s90604407; Chen LP, 2010, LUMINESCENCE, V25, P419, DOI 10.1002/bio.1167; de la Rica R, 2012, NAT NANOTECHNOL, V7, P821, DOI [10.1038/nnano.2012.186, 10.1038/NNANO.2012.186]; Fujimaki M, 2008, OPT EXPRESS, V16, P6408, DOI 10.1364/OE.16.006408; Fujimaki M, 2010, OPT EXPRESS, V18, P15732, DOI 10.1364/OE.18.015732; Geiger A, 1996, NUCLEIC ACIDS RES, V24, P1029, DOI 10.1093/nar/24.6.1029; Gopinath SCB, 2013, ACTA BIOMATER, V9, P5080, DOI 10.1016/j.actbio.2012.09.027; Gopinath SCB, 2006, J GEN VIROL, V87, P479, DOI 10.1099/vir.0.81508-0; Gopinath SCB, 2008, ACS NANO, V2, P1885, DOI 10.1021/nn800285p; Gopinath SCB, 2008, ANAL CHEM, V80, P6602, DOI 10.1021/ac800767s; Gopinath SCB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069121; Gopinath SCB, 2012, ANALYST, V137, P3520, DOI 10.1039/c2an35159e; Gopinath SCB, 2010, ANAL METHODS-UK, V2, P1880, DOI 10.1039/c0ay00491j; Holford TRJ, 2012, BIOSENS BIOELECTRON, V34, P12, DOI 10.1016/j.bios.2011.10.023; Imai M, 2006, J BIOL CHEM, V281, P12729, DOI 10.1074/jbc.M600902200; JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417; KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428; KURODA K, 1986, EMBO J, V5, P1359, DOI 10.1002/j.1460-2075.1986.tb04367.x; LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P215, DOI 10.1016/0956-5663(91)80006-J; Nishikawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045371; Noda T, 2006, NATURE, V439, P490, DOI 10.1038/nature04378; Schmeisser F, 2013, INFLUENZA OTHER RESP, V7, P480, DOI 10.1111/irv.12029; Schmitt K, 2010, SPRINGER SER CHEM SE, V7, P21, DOI 10.1007/978-3-540-88242-8_2; SHIMIZU K, 1985, VACCINE, V3, P207, DOI 10.1016/0264-410X(85)90107-0; Suenaga E, 2012, BIOSENS BIOELECTRON, V32, P195, DOI 10.1016/j.bios.2011.12.003; Sun C, 2013, J VIROL METHODS, V188, P57, DOI 10.1016/j.jviromet.2012.12.003; Sun XM, 2013, CELL REP, V3, P769, DOI 10.1016/j.celrep.2013.01.025; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wang RH, 2009, TALANTA, V79, P159, DOI 10.1016/j.talanta.2009.03.017; Watanabe M, 2009, PEDIATR INT, V51, P211, DOI 10.1111/j.1442-200X.2008.02696.x; Watcharatanyatip K, 2010, J VIROL METHODS, V163, P238, DOI 10.1016/j.jviromet.2009.09.027	36	47	48	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e81396	10.1371/journal.pone.0081396	http://dx.doi.org/10.1371/journal.pone.0081396			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24339924	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400015
J	Hussein, T; Yiou, E; Larue, J				Hussein, Tarek; Yiou, Eric; Larue, Jacques			Age-Related Differences in Motor Coordination during Simultaneous Leg Flexion and Finger Extension: Influence of Temporal Pressure	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; PROPRIOCEPTIVE INFORMATION; INTENSIVE PRACTICE; DYNAMIC STABILITY; BALANCE RECOVERY; MOVEMENT; PERFORMANCE; EQUILIBRIUM; ORIENTATION; CEREBELLUM	Although the effect of temporal pressure on spatio-temporal aspects of motor coordination and posture is well established in young adults, there is a clear lack of data on elderly subjects. This work examined the aging-related effects of temporal pressure on movement synchronization and dynamic stability. Sixteen young and eleven elderly subjects performed series of simultaneous rapid leg flexions in an erect posture paired with ipsilateral index-finger extensions, minimizing the difference between heel and finger movement onsets. This task was repeated ten times under two temporal conditions (self-initiated [SI] vs. reaction-time [RT]). Results showed that, first, temporal pressure modified movement synchronization; the finger extension preceded swing heel-off in RT, and inversely in SI. Synchronization error and associated standard deviation were significantly greater in elderly than in young adults in SI only, i.e. in the condition where proprioception is thought to be crucial for temporal coordination. Secondly, both groups developed a significantly shorter mediolateral (ML) anticipatory postural adjustment duration in RT (high temporal pressure) than in SI. In both groups, this shortening was compensated by an increase in the anticipatory peak of centre-of-gravity (CoG) acceleration towards the stance-leg so that ML dynamic stability at foot-off, quantified with the "extrapolated centre-of-mass", remained unchanged across temporal conditions. This increased CoG acceleration was associated with an increased anticipatory peak of ML centre-of-pressure shift towards the swing-leg in young adults only. This suggested that the ability to accelerate the CoG with the centre-of-pressure shift was degraded in elderly, probably due to weakness in the lower limb muscles. Dynamic stability at foot-off was also degraded in elderly, with a consequent increased risk of ML imbalance and falling. The present study provides new insights into the ability of elderly adults to deal with temporal pressure constraints in adapting whole-body coordination of postural and focal components of paired movement.	[Hussein, Tarek; Yiou, Eric; Larue, Jacques] Univ Paris 11, Team RIME, Lab CIAMS, Orsay, France	UDICE-French Research Universities; Universite Paris Saclay	Yiou, E (corresponding author), Univ Paris 11, Team RIME, Lab CIAMS, Orsay, France.	eric.yiou@u-psud.fr		yiou, eric/0000-0003-2535-000X	Ministere de la Recherche et de l'Enseignement Superieur	Ministere de la Recherche et de l'Enseignement Superieur	This research was funded by the Ministere de la Recherche et de l'Enseignement Superieur. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARD C, 1992, NEUROPSYCHOLOGIA, V30, P201, DOI 10.1016/0028-3932(92)90028-K; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Blouin JS, 2004, EXP BRAIN RES, V155, P63, DOI 10.1007/s00221-003-1709-9; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; BRENIERE Y, 1986, J BIOMECH, V19, P1035, DOI 10.1016/0021-9290(86)90120-X; CORDO P, 1993, PSYCHOL RES-PSYCH FO, V55, P124, DOI 10.1007/BF00419643; Dalton E, 2011, MED SCI SPORT EXER, V43, P2352, DOI 10.1249/MSS.0b013e318222bc82; Delval A, 2005, NEUROPHYSIOL CLIN, V35, P180, DOI 10.1016/j.neucli.2006.01.002; Devanne H, 1998, EXP BRAIN RES, V119, P58, DOI 10.1007/s002210050319; Do MC, 1999, EXP BRAIN RES, V129, P462, DOI 10.1007/s002210050914; DO MC, 1992, NEUROSCI LETT, V148, P181, DOI 10.1016/0304-3940(92)90834-T; Doumas M, 2010, J NEUROPHYSIOL, V104, P1969, DOI 10.1152/jn.00345.2010; Grin L, 2007, EXP BRAIN RES, V178, P62, DOI 10.1007/s00221-006-0711-4; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Horak F, 2000, BIOMECHANICS AND NEURAL CONTROL OF POSTURE AND MOVEMENT, P267; Horak FB, 2006, AGE AGEING, V35, P7, DOI 10.1093/ageing/afl077; Ilmane N, 2008, MOTOR CONTROL, V12, P330, DOI 10.1123/mcj.12.4.330; Ilmane N, 2011, ACTA PSYCHOL, V136, P1, DOI 10.1016/j.actpsy.2010.08.005; LEPERS R, 1995, EXP BRAIN RES, V107, P118; Maki BE, 2000, J GERONTOL A-BIOL, V55, pM270, DOI 10.1093/gerona/55.5.M270; Mille ML, 1998, NEUROSCI LETT, V242, P61, DOI 10.1016/S0304-3940(98)00047-0; Mille ML, 2005, CLIN BIOMECH, V20, P607, DOI 10.1016/j.clinbiomech.2005.03.004; MOUCHNINO L, 1992, J NEUROPHYSIOL, V67, P1587, DOI 10.1152/jn.1992.67.6.1587; Nougier V, 1999, NEUROSCI LETT, V260, P109, DOI 10.1016/S0304-3940(98)00961-6; PAILLARD J, 1990, REV NEUROL, V146, P600; Paillard J, 1948, ANN PSYCHOL, V47-48, P28; Ribeiro F, 2007, EUR REV AGING PHYS A, V4, P71, DOI 10.1007/s11556-007-0026-x; Singer JC, 2013, GAIT POSTURE, V38, P679, DOI 10.1016/j.gaitpost.2013.03.003; Spencer RMC, 2005, EXP BRAIN RES, V161, P383, DOI 10.1007/s00221-004-2088-6; Stenneken P, 2002, PSYCHOL RES-PSYCH FO, V66, P40, DOI 10.1007/s004260100072; Yiou E, 2005, MED SCI SPORT EXER, V37, P91, DOI 10.1249/01.MSS.0000150019.39648.01; Yiou E, 2000, INT J SPORTS MED, V21, P122; Yiou E, 2012, GAIT POSTURE, V35, P494, DOI 10.1016/j.gaitpost.2011.11.015; Yiou E, 2011, EUR J APPL PHYSIOL, V111, P611, DOI 10.1007/s00421-010-1680-7; Yiou E, 2001, EXP BRAIN RES, V137, P197, DOI 10.1007/s002210000624; Yiou E, 2007, NEUROSCI LETT, V425, P63, DOI 10.1016/j.neulet.2007.08.012; Yiou E, 2007, HUM MOVEMENT SCI, V26, P357, DOI 10.1016/j.humov.2007.03.003; Yiou E, 2011, MOTOR CONTROL, V15, P507, DOI 10.1123/mcj.15.4.507	39	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83064	10.1371/journal.pone.0083064	http://dx.doi.org/10.1371/journal.pone.0083064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340080	Green Submitted, Green Published, gold			2022-12-27	WOS:000328707400116
J	Song, S; Gao, P; Xiao, H; Xu, Y; Si, LY				Song, Shuang; Gao, Pan; Xiao, Hang; Xu, Yan; Si, Lian Yi			Klotho Suppresses Cardiomyocyte Apoptosis in Mice with Stress-Induced Cardiac Injury via Downregulation of Endoplasmic Reticulum Stress	PLOS ONE			English	Article							OXIDATIVE STRESS; HEART-FAILURE; ISCHEMIA/REPERFUSION INJURY; MYOCARDIAL-INFARCTION; MOLECULAR-MECHANISMS; INDUCED HYPERTROPHY; MYOCYTE APOPTOSIS; PROTEIN; CELLS; INHIBITION	Cardiomyocyte apoptosis is a common pathological alteration in heart disease which results in systolic dysfunction or sudden death. Klotho is a novel anti-aging hormone. We tested the effects of klotho on cell apoptosis in isoproterenol-treated cardiomyocytes. In BALB/c mice, cardiac injury was induced by subcutaneous injection of isoproterenol (5mg/kg, for 9days, sc). Klotho (0.01 mg/kg, every other day for 4days, ip) was administered to determine the changes in isoproterenol-induced apoptosis. Mouse heart was harvested at day 2, day 5, and day 9 after isoproterenol injection. Isoproterenol induced cardiac apoptosis and endoplasmic reticulum (ER) stress in a time-dependent manner. However, klotho partly reversed isoproterenol-induced cardiac apoptosis and ER stress. These same effects were observed in cultured cardiomyocytes. Furthermore, the results also showed that SB203580, a p38 inhibitor, and SP600125, a c-Jun NH2-terminal kinase (JNK) inhibitor, reduced cardiomyocyte apoptosis and ER stress, however, klotho suppressed isoproterenol-induced activation of p38 and JNK. Taken together, these results indicated that cardioprotection by klotho was related to the attenuation of ER stress and ER stress-induced apoptosis, at least partly, through suppressing activation of the p38 and JNK pathway.	[Song, Shuang; Gao, Pan; Xiao, Hang; Si, Lian Yi] Third Mil Med Univ, Southwest Hosp, Dept Geriatr, Chongqing, Peoples R China; [Xu, Yan] Third Mil Med Univ, Southwest Hosp, Dept Obstet & Gynaecol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Si, LY (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Geriatr, Chongqing, Peoples R China.	doctorsiliangyi@gmail.com		Gao, Pan/0000-0002-1510-705X	National Natural Science Foundation of China [81000132]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (No. 81000132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anestopoulos I, 2013, J NUTR BIOCHEM, V24, P586, DOI 10.1016/j.jnutbio.2012.02.009; Arumugam S, 2012, J CELL MOL MED, V16, P2176, DOI 10.1111/j.1582-4934.2012.01526.x; Arumugam S, 2012, FREE RADICAL RES, V46, P154, DOI 10.3109/10715762.2011.647010; Banerjee S, 2013, CELL PHYSIOL BIOCHEM, V31, P659, DOI 10.1159/000350085; Bloch L, 2009, FEBS LETT, V583, P3221, DOI 10.1016/j.febslet.2009.09.009; Dalal S, 2012, MOL CELL BIOCHEM, V364, P59, DOI 10.1007/s11010-011-1205-7; de Windt LJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0027294, DOI 10.1371/JOURNAL.PONE.0027294.]; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Ennis IL, 2003, HYPERTENSION, V41, P1324, DOI 10.1161/01.HYP.0000071180.12012.6E; Fu HY, 2010, CIRCULATION, V122, P361, DOI 10.1161/CIRCULATIONAHA.109.917914; Gao P, 2013, CARDIOVASC RES, V97, P533, DOI 10.1093/cvr/cvs369; George I, 2011, CARDIOVASC RES, V91, P447, DOI 10.1093/cvr/cvr106; HESCHELER J, 1991, CIRC RES, V69, P1476, DOI 10.1161/01.RES.69.6.1476; Ikushima M, 2006, BIOCHEM BIOPH RES CO, V339, P827, DOI 10.1016/j.bbrc.2005.11.094; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056695; Kuro-O M, 2008, BIOL CHEM, V389, P233, DOI 10.1515/BC.2008.028; Liu XH, 2008, SHOCK, V30, P422, DOI 10.1097/SHK.0b013e318164ca29; Mao W, 2007, AM J PHYSIOL-HEART C, V293, pH1636, DOI 10.1152/ajpheart.01377.2006; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Marutani T, 2004, J CELL SCI, V117, P5913, DOI 10.1242/jcs.01514; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nakamura K, 2000, J CELL BIOL, V150, P731, DOI 10.1083/jcb.150.4.731; Okada K, 2004, CIRCULATION, V110, P705, DOI 10.1161/01.CIR.0000137836.95625.D4; Sari FR, 2011, CELL PHYSIOL BIOCHEM, V27, P487, DOI 10.1159/000329970; Savergnini SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057757; See F, 2004, J AM COLL CARDIOL, V44, P1679, DOI 10.1016/j.jacc.2004.07.038; Somvanshi RK, 2013, INT J CARDIOL, V167, P1012, DOI 10.1016/j.ijcard.2012.03.077; Swynghedauw B, 1999, PHYSIOL REV, V79, P215, DOI 10.1152/physrev.1999.79.1.215; Takeda K, 2000, CORONARY ARTERY DIS, V11, P57, DOI 10.1097/00019501-200002000-00011; Wencker D, 2003, J CLIN INVEST, V111, P1497, DOI 10.1172/JCI200317664; Wu TT, 2011, EUR J PHARM SCI, V42, P496, DOI 10.1016/j.ejps.2011.02.005; Wu XD, 2013, APOPTOSIS, V18, P85, DOI 10.1007/s10495-012-0766-6; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200; Yang K, 2012, TOXICOL LETT, V215, P77, DOI 10.1016/j.toxlet.2012.10.004; YUE TL, 2000, HEART CIRCULATION RE, V86, P692, DOI DOI 10.1161/01.RES.86.6.692; Zhao H, 2008, HYPERTENS RES, V31, P1977, DOI 10.1291/hypres.31.1977; Zhao YH, 2011, DIABETES, V60, P1907, DOI 10.2337/db10-1262; Zhao YG, 2013, DIABETES, V62, P2545, DOI 10.2337/db12-1233; Zheng DZ, 2012, PHARMACOLOGY, V90, P78, DOI 10.1159/000339450; Zhuo XZ, 2013, APOPTOSIS, V18, P800, DOI 10.1007/s10495-013-0843-5; Zou XJ, 2012, EXP BIOL MED, V237, P1341, DOI 10.1258/ebm.2012.012041	43	51	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82968	10.1371/journal.pone.0082968	http://dx.doi.org/10.1371/journal.pone.0082968			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340070	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400106
J	Tur, C; Tintore, M; Vidal-Jordana, A; Bichuetti, D; Gonzalez, PN; Arevalo, MJ; Arrambide, G; Anglada, E; Galan, I; Castillo, J; Rio, CNJ; Martin, MI; Comabella, M; Sastre-Garriga, J; Montalban, X				Tur, Carmen; Tintore, Mar; Vidal-Jordana, Angela; Bichuetti, Denis; Nieto Gonzalez, Pablo; Jesus Arevalo, Maria; Arrambide, Georgina; Anglada, Elisenda; Galan, Ingrid; Castillo, Joaquin; Jordi Rio, Carlos Nos; Isabel Martin, Maria; Comabella, Manuel; Sastre-Garriga, Jaume; Montalban, Xavier			Risk Acceptance in Multiple Sclerosis Patients on Natalizumab Treatment	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PLACEBO-CONTROLLED TRIAL; CONTROLLED PHASE-3 TRIAL; DIAGNOSTIC-CRITERIA; INTERFERON-BETA; ORAL FINGOLIMOD; STRATIFICATION; ALEMTUZUMAB; MS; TERIFLUNOMIDE	Objective: We aimed to investigate the ability of natalizumab (NTZ)-treated patients to assume treatment-associated risks and the factors involved in such risk acceptance. Methods: From a total of 185 patients, 114 patients on NTZ as of July 2011 carried out a comprehensive survey. We obtained disease severity perception scores, personality traits' scores, and risk-acceptance scores (RAS) so that higher RAS indicated higher risk acceptance. We recorded JC virus status (JCV+/-), prior immunosuppression, NTZ treatment duration, and clinical characteristics. NTZ patients were split into subgroups (A-E), depending on their individual PML risk. Some 22 MS patients on first-line drugs (DMD) acted as controls. Results: No differences between treatment groups were observed in disease severity perception and personality traits. RAS were higher in NTZ than in DMD patients (p<0.01). Perception of the own disease as a more severe condition tended to predict higher RAS (p=0.07). Higher neuroticism scores predicted higher RAS in the NTZ group as a whole (p=0.04), and in high PML-risk subgroups (A-B) (p=0.02). In low PML-risk subgroups (C-E), higher RAS were associated with a JCV+ status (p=0.01). Neither disability scores nor pre-treatment relapse rate predicted RAS in either group. Conclusions: Risk acceptance is a multifactorial phenomenon, which might be partly explained by an adaptive process, in light of the higher risk acceptance amongst NTZ-treated patients and, especially, amongst those who are JCV seropositive but still have low PML risk, but which seems also intimately related to personality traits.	[Tur, Carmen; Tintore, Mar; Vidal-Jordana, Angela; Bichuetti, Denis; Nieto Gonzalez, Pablo; Jesus Arevalo, Maria; Arrambide, Georgina; Anglada, Elisenda; Galan, Ingrid; Castillo, Joaquin; Jordi Rio, Carlos Nos; Isabel Martin, Maria; Comabella, Manuel; Sastre-Garriga, Jaume; Montalban, Xavier] Vall dHebron Univ Hosp, Dept Neurol Neuroimmunol, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona, Spain; [Bichuetti, Denis] Univ Fed Sao Paulo, Dept Neurol & Neurosurg, Sao Paulo, Brazil; [Nieto Gonzalez, Pablo] Univ Hosp Principe de Asturias, Dept Neurol, Madrid, Spain	Hospital Universitari Vall d'Hebron; Universidade Federal de Sao Paulo (UNIFESP); Prince of Asturias University Hospital	Tur, C (corresponding author), Vall dHebron Univ Hosp, Dept Neurol Neuroimmunol, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona, Spain.	ctur@cem-cat.org	Montalban, Xavier/J-5938-2016; Bichuetti, Denis B/F-7240-2012; Sastre-Garriga, Jaume/E-8605-2018	Montalban, Xavier/0000-0002-0098-9918; Bichuetti, Denis B/0000-0002-4011-3734; Sastre-Garriga, Jaume/0000-0002-1589-2254; Arrambide, Georgina/0000-0002-2657-5510; Rio, Jordi/0000-0003-4546-7627; Vidal-Jordana, Angela/0000-0002-7270-5507; Galan, Ingrid/0000-0001-5774-4260; AREVALO, MARIA JESUS/0000-0003-0626-5555; Tintore, Mar/0000-0001-9999-5359; Comabella Lopez, Manuel/0000-0002-2373-6657; TUR, CARMEN/0000-0003-1849-3184	Bayer Health Care; Merck Serono; TEVA	Bayer Health Care(Bayer AGBayer Healthcare Pharmaceuticals); Merck Serono(Merck & Company); TEVA(Teva Pharmaceutical Industries)	CT has received honoraria and support for travel from Merk-Serono, Sanofi-Aventis, Teva, and Novartis. MT has received compensation for consulting services and speaking from Bayer-Schering, Merck-Serono, Biogen-Idec, Teva, Sanofi-Aventis, and Novartis. DB has received speaking/consulting honoraria from Bayer Health Care, Biogen Idec, Merck Serono, Sanofi and TEVA and had travel expenses to scientific meetings sponsored by Bayer Health Care, Merck Serono and TEVA. MJA has received speaking honoraria from Bayer Schering Pharma, Merck Serono and Teva Pharmaceutical Industries. IG has received compensation for speaking from Teva. CN has received lecture fees from Merck-Serono and honoraria for giving expert advice to Lilly and BaroFold. JR has received compensation for consulting services and speaking from Bayer-Schering, Merck-Serono, Biogen-Idec, and Novartis. MC has received compensation for speaking from Teva. JSG has received compensation for consulting services and speaking from Biogen, Merck-Serono, Novartis, Teva, Sanofi-Aventis, Almirall and Bayer. XM has received speaking honoraria and travel expenses for scientific meetings, has been a steering committee member of clinical trials or participated in advisory boards of clinical trials in the past years with Bayer Schering Pharma, Biogen Idec, EMD Merck Serono, Genentech, Genzyme, Novartis, Sanofi-Aventis, Teva Pharmaceuticals and Almirall. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bloomgren G, 2012, NEW ENGL J MED, V366, P1870, DOI 10.1056/NEJMoa1107829; Bodini B, 2013, HUM BRAIN MAPP, V34, P1163, DOI 10.1002/hbm.21499; Bruce JM, 2011, J PSYCHOSOM RES, V70, P479, DOI 10.1016/j.jpsychores.2010.12.010; Cohen JA, 2012, LANCET, V380, P1819, DOI 10.1016/S0140-6736(12)61769-3; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Coles AJ, 2008, NEW ENGL J MED, V359, P1786, DOI 10.1056/NEJMoa0802670; Coles AJ, 2012, LANCET, V380, P1829, DOI 10.1016/S0140-6736(12)61768-1; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; de la Hoz Antonio Pamos, 2008, NEO PI R INVENTARIO; Gourley SL, 2013, EUR J NEUROSCI, V38, P2382, DOI 10.1111/ejn.12239; Heesen C, 2010, MULT SCLER J, V16, P1507, DOI 10.1177/1352458510379819; Horga A, 2011, REV NEUROLOGIA, V52, P321, DOI 10.33588/rn.5206.2010766; Kappos L, 2011, LANCET NEUROL, V10, P745, DOI 10.1016/S1474-4422(11)70149-1; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; O'Connor P, 2011, NEW ENGL J MED, V365, P1293, DOI 10.1056/NEJMoa1014656; O'Connor PW, 2006, NEUROLOGY, V66, P894, DOI 10.1212/01.wnl.0000203121.04509.31; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Rio J, 2009, MULT SCLER, V15, P848, DOI 10.1177/1352458509104591; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; Sandrock A, 2011, NEUROLOGY, V76, pA248; Sorensen PS, 2012, MULT SCLER J, V18, P143, DOI 10.1177/1352458511435105; Taillefer SS, 2003, J PSYCHOSOM RES, V54, P331, DOI 10.1016/S0022-3999(02)00332-X; Tubridy N, 1999, NEUROLOGY, V53, P466, DOI 10.1212/WNL.53.3.466; Tur C, 2012, MULT SCLER J, V18, P1193, DOI 10.1177/1352458512439238	29	21	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e82796	10.1371/journal.pone.0082796	http://dx.doi.org/10.1371/journal.pone.0082796			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24340060	Green Submitted, gold, Green Published			2022-12-27	WOS:000328707400096
J	Zehendner, CM; Librizzi, L; Hedrich, J; Bauer, NM; Angamo, EA; de Curtis, M; Luhmann, HJ				Zehendner, Christoph M.; Librizzi, Laura; Hedrich, Jana; Bauer, Nina M.; Angamo, Eskedar A.; de Curtis, Marco; Luhmann, Heiko J.			Moderate Hypoxia Followed by Reoxygenation Results in Blood-Brain Barrier Breakdown via Oxidative Stress-Dependent Tight-Junction Protein Disruption	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NADPH-OXIDASE; MATRIX METALLOPROTEINASES; PERMEABILITY; DAMAGE; CELLS; RECEPTOR; PENUMBRA; STROKE; INJURY	Re-canalization of cerebral vessels in ischemic stroke is pivotal to rescue dysfunctional brain areas that are exposed to moderate hypoxia within the penumbra from irreversible cell death. Goal of the present study was to evaluate the effect of moderate hypoxia followed by reoxygenation (MHR) on the evolution of reactive oxygen species (ROS) and blood-brain barrier (BBB) integrity in brain endothelial cells (BEC). BBB integrity was assessed in BEC in vitro and in microvessels of the guinea pig whole brain in situ preparation. Probes were exposed to MHR (2 hours 67-70 mmHg O-2, 3 hours reoxygenation, BEC) or towards occlusion of the arteria cerebri media (MCAO) with or without subsequent reperfusion in the whole brain preparation. In vitro BBB integrity was evaluated using trans-endothelial electrical resistance (TEER) and transwell permeability assays. ROS in BEC were evaluated using 2', 7'-dichlorodihydrofluorescein diacetate (DCF), MitoSox and immunostaining for nitrotyrosine. Tight-junction protein (TJ) integrity in BEC, stainings for nitrotyrosine and FITC-albumin extravasation in the guinea pig brain preparation were assessed by confocal microscopy. Diphenyleneiodonium (DPI) was used to investigate NADPH oxidase dependent ROS evolution and its effect on BBB parameters in BEC. MHR impaired TJ proteins zonula occludens 1 (ZO-1) and claudin 5 (Cl5), decreased TEER, and significantly increased cytosolic ROS in BEC. These events were blocked by the NADPH oxidase inhibitor DPI. MCAO with or without subsequent reoxygenation resulted in extravasation of FITC-albumin and ROS generation in the penumbra region of the guinea pig brain preparation and confirmed BBB damage. BEC integrity may be impaired through ROS in MHR on the level of TJ and the BBB is also functionally impaired in moderate hypoxic conditions followed by reperfusion in a complex guinea pig brain preparation. These findings suggest that the BBB is susceptible towards MHR and that ROS play a key role in this process.	[Zehendner, Christoph M.; Hedrich, Jana; Bauer, Nina M.; Luhmann, Heiko J.] Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Mainz, Germany; [Librizzi, Laura; de Curtis, Marco] Fdn Ist Neurol Carlo Besta, Unit Expt Neurophysiol & Epileptol, Milan, Italy; [Angamo, Eskedar A.] Univ Coimbra, Ctr Neurosci & Cell Biol, Coimbra, Portugal	Johannes Gutenberg University of Mainz; IRCCS Istituto Neurologico Besta; Universidade de Coimbra	Zehendner, CM (corresponding author), Johannes Gutenberg Univ Mainz, Inst Physiol & Pathophysiol, Univ Med Ctr, Saarstr 21, Mainz, Germany.	Zehendner@uni-mainz.de	Librizzi, Laura/J-7889-2016; Luhmann, Heiko J./N-8797-2019; de Curtis, Marco M/J-8704-2016	Librizzi, Laura/0000-0002-2741-4452; Luhmann, Heiko J./0000-0002-7934-8661; de Curtis, Marco M/0000-0001-7443-6737; de Curtis, Marco/0000-0002-5608-929X; Angamo, Eskedar Ayele/0000-0002-3537-7196	"Stufe 1" grant of the University Medical Center of the Johannes Gutenberg-University of Mainz; Italian Ministry of Health; DFG; MAIFOR grant of the University Medical Center of the Johannes Gutenberg-University of Mainz; Stipendienstiftung RLP	"Stufe 1" grant of the University Medical Center of the Johannes Gutenberg-University of Mainz; Italian Ministry of Health(Ministry of Health, Italy); DFG(German Research Foundation (DFG)); MAIFOR grant of the University Medical Center of the Johannes Gutenberg-University of Mainz; Stipendienstiftung RLP	This work was supported by a "Stufe 1" grant of the University Medical Center of the Johannes Gutenberg-University of Mainz to CMZ. Italian Ministry of Health, research line 1.14 supported LL and MdC. HJL is supported by DFG grants. JH receives a MAIFOR grant of the University Medical Center of the Johannes Gutenberg-University of Mainz. NMB receives a scholarship by the Stipendienstiftung RLP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730; ASTRUP J, 1977, STROKE, V8, P51, DOI 10.1161/01.STR.8.1.51; Barber PA, 2013, SENSORS-BASEL, V13, P6981, DOI 10.3390/s130606981; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Betzen C, 2009, FREE RADICAL BIO MED, V47, P1212, DOI 10.1016/j.freeradbiomed.2009.07.034; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Breschi GL, 2012, EPILEPSIA, V53, P448, DOI 10.1111/j.1528-1167.2011.03356.x; Brown RC, 2007, BRAIN RES, V1130, P17, DOI 10.1016/j.brainres.2006.10.083; Campbell M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1852; Caso V, 2002, CLIN EXP HYPERTENS, V24, P595, DOI 10.1081/CEH-120015335; Coisne C, 2011, ANTIOXID REDOX SIGN, V15, P1285, DOI 10.1089/ars.2011.3929; DAGOSTINO RB, 1990, AM STAT, V44, P316, DOI 10.2307/2684359; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; de Curtis M, 1998, BRAIN RES PROTOC, V3, P221, DOI 10.1016/S1385-299X(98)00044-0; del Zoppo GJ, 2011, J CEREBR BLOOD F MET, V31, P1836, DOI 10.1038/jcbfm.2011.93; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Fisher M, 2013, ANN NEUROL, V73, P4, DOI 10.1002/ana.23744; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Fraser PA, 2011, FREE RADICAL BIO MED, V51, P967, DOI 10.1016/j.freeradbiomed.2011.06.003; Gladden JD, 2013, AM J PHYSIOL-HEART C, V305, pH1440, DOI 10.1152/ajpheart.00007.2013; Gu Y, 2012, J NEUROCHEM, V120, P147, DOI 10.1111/j.1471-4159.2011.07542.x; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hansel CM, 2012, P NATL ACAD SCI USA, V109, P12621, DOI 10.1073/pnas.1203885109; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Itoh Y, 2006, CLIN HEMORHEOL MICRO, V34, P163; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; KITAGAWA K, 1989, NEUROSCIENCE, V31, P401, DOI 10.1016/0306-4522(89)90383-7; Kleikers PWM, 2012, J MOL MED, V90, P1391, DOI 10.1007/s00109-012-0963-3; Kuhlmann CRW, 2008, LIFE SCI, V82, P1281, DOI 10.1016/j.lfs.2008.04.017; Kuhlmann CRW, 2009, NEUROSCI LETT, V449, P168, DOI 10.1016/j.neulet.2008.10.096; Librizzi L, 2000, NEUROSCIENCE, V101, P283, DOI 10.1016/S0306-4522(00)00365-1; Librizzi L, 2001, J NEUROSCI RES, V66, P289, DOI 10.1002/jnr.1223; Liu KH, 2005, FREE RADICAL BIO MED, V39, P71, DOI 10.1016/j.freeadbiomed.2005.03.033; Liu SM, 2004, J CEREBR BLOOD F MET, V24, P343, DOI 10.1097/01.WCB.0000110047.43905.01; Manaenko A, 2011, J NEUROSCI METH, V195, P206, DOI 10.1016/j.jneumeth.2010.12.013; Mangan PR, 2005, AM J PATHOL, V167, P1661, DOI 10.1016/S0002-9440(10)61249-7; MATSUZAWA T, 2013, IMMUNOLOGY, DOI DOI 10.1111/IMM.12168.PUBMED:24032631; Mazzetti S, 2004, BRAIN RES, V999, P81, DOI 10.1016/j.brainres.2003.11.032; Miller AA, 2006, BRAIN RES, V1111, P111, DOI 10.1016/j.brainres.2006.06.082; Molina CA, 2005, STROKE, V36, P2311, DOI 10.1161/01.STR.0000182100.65262.46; Movahedan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069113; MUHLETHALER M, 1993, EUR J NEUROSCI, V5, P915, DOI 10.1111/j.1460-9568.1993.tb00942.x; Octavia Y, 2012, FREE RADICAL BIO MED, V52, P291, DOI 10.1016/j.freeradbiomed.2011.10.482; Okuno Y, 2012, NAT MED, V18, P1208, DOI 10.1038/nm.2846; Riganti C, 2008, TOXICOL APPL PHARM, V228, P277, DOI 10.1016/j.taap.2007.12.013; Riganti C, 2006, TOXICOL APPL PHARM, V212, P179, DOI 10.1016/j.taap.2005.07.011; Rosenberg GA, 1999, PROG CARDIOVASC DIS, V42, P209, DOI 10.1016/S0033-0620(99)70003-4; Rosenberg Gary A, 2007, Neurosurg Focus, V22, pE4; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Schenck LP, 2013, NEUROGASTROENT MOTIL, V25, pe441, DOI 10.1111/nmo.12139; SCHULZ E, 2012, STRESS ANTIOXIDANTS, DOI DOI 10.1089/ARS.2012.4609; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shi HL, 2007, FRONT BIOSCI-LANDMRK, V12, P1318, DOI 10.2741/2150; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Terrisse AD, 2010, J THROMB HAEMOST, V8, P2810, DOI 10.1111/j.1538-7836.2010.04088.x; Thal SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050752; Wind S, 2010, BRIT J PHARMACOL, V161, P885, DOI 10.1111/j.1476-5381.2010.00920.x; Wolfram CR, 2004, THROMB HAEMOSTASIS, V92, P1099, DOI 10.1160/TH04-03-0196; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022; Zehendner CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016760; Zehendner CM, 2009, J CEREBR BLOOD F MET, V29, P1879, DOI 10.1038/jcbfm.2009.103; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	63	67	70	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2013	8	12							e82823	10.1371/journal.pone.0082823	http://dx.doi.org/10.1371/journal.pone.0082823			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WJ	24324834	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566700113
J	Kalantari, S; Rutishauser, D; Samavat, S; Nafar, M; Mahmudieh, L; Rezaei-Tavirani, M; Zubarev, RA				Kalantari, Shiva; Rutishauser, Dorothea; Samavat, Shiva; Nafar, Mohsen; Mahmudieh, Leyla; Rezaei-Tavirani, Mostafa; Zubarev, Roman A.			Urinary Prognostic Biomarkers and Classification of IgA Nephropathy by High Resolution Mass Spectrometry Coupled with Liquid Chromatography	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; APOLIPOPROTEIN A-IV; OXFORD CLASSIFICATION; VALIDATION; COMPLEMENT; PROGRESSION; PREDICT; IDENTIFICATION; ACTIVATION; EXPRESSION	IgA nephropathy is the most common cause of primary glomerulonephritis. There are different pathologic biopsy-based scoring systems in use, but there is no consensus among nephrologists yet regarding the best classification method. Our aim was to test urine proteomics as a non-invasive method for classification of IgA nephropathy. This aim was pursued by discovering novel prognostic protein biomarkers in urine, and linking them to pathogenesis of the disease through known signaling and metabolic pathways. 13 urine samples of the patients with biopsy-proven IgA nephropathy were analyzed via two proteomics approaches: nanoflow LC-MS/MS and GeLC-MS/MS. The results of label-free quantification were subjected to multivariate statistical analysis, which could classify patients into two groups, broadly corresponding to the primary and advance stages. The proteome classification correlated well with biopsy-based scoring systems, especially endocapillary hypercellularity score of the Oxford's classification. Differentially excreted candidate proteins were found as potential prognostic biomarkers: afamin, leucine-rich alpha-2-glycoprotein, ceruloplasmin, alpha-1-microgolbulin, hemopexin, apolipoprotein A-I, complement C3, vitamin D-binding protein, beta-2-microglobulin, and retinol-binding protein 4. Pathway analysis suggested impairment of Extra Cellular Matrix (ECM)-Receptor Interaction pathways as well as activation of complement and coagulation pathway in progression of IgA nephropathy.	[Kalantari, Shiva] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Dept Basic Sci, Tehran, Iran; [Rutishauser, Dorothea; Zubarev, Roman A.] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Rutishauser, Dorothea; Zubarev, Roman A.] SciLifeLab, Stockholm, Sweden; [Samavat, Shiva; Nafar, Mohsen; Mahmudieh, Leyla] Shahid Beheshti Univ Med Sci, Shahid Labbafinejad Med Ctr, Dept Nephrol, Tehran, Iran; [Nafar, Mohsen] Shahid Beheshti Univ Med Sci, Urol & Nephrol Res Ctr, Tehran, Iran; [Rezaei-Tavirani, Mostafa] Shahid Beheshti Univ Med Sci, Fac Paramed Sci, Prote Res Ctr, Tehran, Iran	Shahid Beheshti University Medical Sciences; Karolinska Institutet; SciLifeLab; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Zubarev, RA (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden.	roman.zubarev@ki.se	nafar, mohsen/ABG-4171-2021; Zubarev, Roman A/W-7891-2018; Samavat, Shiva/AAU-4894-2021; Rezaei-Tavirani, Mostafa/I-2407-2017	Zubarev, Roman A/0000-0001-9839-2089; Samavat, Shiva/0000-0001-6707-7844; Kalantari, Shiva/0000-0001-7690-141X; Rutishauser, Dorothea/0000-0003-2303-103X; Rezaei-Tavirani, Mostafa/0000-0003-1767-7475; Nafar, Mohsen/0000-0001-5636-2666	health ministry of Iran	health ministry of Iran	The grant of this study prepared by the Knut and Alice Wallenberg Foundation, VINNOVA Foundation, Alzheimersfonden as well as the Swedish Research council (Roman A. Zubarev, Dorothea Rutishuser). Urology and nephrology research center of Shahid Beheshty medical university (Mohsen Nafar, Shiva Samavat, Leyla Mahmudie) and faculty of paramedical sciences at Shahid Beheshty medical university (Shiva Kalantari, Mostafa Rezaei-Tavirani) supported this study in sample collection and preparation. The health ministry of Iran supported this study by funding of travel related to the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamartine E, 2011, CLIN J AM SOC NEPHRO, V6, P2384, DOI 10.2215/CJN.01170211; Allhorn M, 2002, BLOOD, V99, P1894, DOI 10.1182/blood.V99.6.1894; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Barratt J, 2005, J AM SOC NEPHROL, V16, P2088, DOI 10.1681/ASN.2005020134; Bazzi C, 2003, G Ital Nefrol, V20, P346; Boes E, 2006, J AM SOC NEPHROL, V17, P528, DOI 10.1681/ASN.2005070733; Branten AJW, 2005, J AM SOC NEPHROL, V16, P169, DOI 10.1681/ASN.2004040287; Cattran DC, 2009, KIDNEY INT, V76, P534, DOI 10.1038/ki.2009.243; Chornoguz O, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002980; D'Amico G, 2004, SEMIN NEPHROL, V24, P179, DOI 10.1016/j.semnephrol.2004.01.001; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; GELADI P, 1991, J CHEMOMETR, V5, P97, DOI 10.1002/cem.1180050206; Haas M, 1997, AM J KIDNEY DIS, V29, P829, DOI 10.1016/S0272-6386(97)90456-X; Herzenberg AM, 2011, KIDNEY INT, V80, P310, DOI 10.1038/ki.2011.126; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hsu SIH, 2000, KIDNEY INT, V57, P1818, DOI 10.1046/j.1523-1755.2000.00032.x; Jackson D, 2007, CLIN CANCER RES, V13, P7370, DOI 10.1158/1078-0432.CCR-07-0747; Julian BA, 2007, ELECTROPHORESIS, V28, P4469, DOI 10.1002/elps.200700237; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kistler AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053016; Kronenberg F, 2009, NAT REV NEPHROL, V5, P677, DOI 10.1038/nrneph.2009.173; Lee H, 2012, KOREAN J INTERN MED, V27, P293, DOI 10.3904/kjim.2012.27.3.293; Lee HS, 2005, NEPHROL DIAL TRANSPL, V20, P342, DOI 10.1093/ndt/gfh633; Li Su-min, 2006, Zhongguo Zhong Xi Yi Jie He Za Zhi, V26, P504; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Lingenhel A, 2006, J LIPID RES, V47, P2071, DOI 10.1194/jlr.M600178-JLR200; Luczak M, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-25; Lundberg S, 2012, SCAND J UROL NEPHROL, V46, P148, DOI 10.3109/00365599.2011.644635; Melenhorst WBWH, 2006, KIDNEY INT, V70, P1269, DOI 10.1038/sj.ki.5001753; Nagaraj N, 2011, J PROTEOME RES, V10, P637, DOI 10.1021/pr100835s; Nasr SH, 2012, NEPHROL DIAL TRANSPL, V0, P1; Negi VS, 2000, J RHEUMATOL, V27, P380; Ohashi N, 2009, Minerva Urol Nefrol, V61, P55; Onda K, 2011, BMC NEPHROL, V12, DOI 10.1186/1471-2369-12-64; Raana G, 2009, J PHYSL, V5, P34; Rao PV, 2007, DIABETES CARE, V30, P629, DOI 10.2337/dc06-2056; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Rauta V, 2002, CLIN NEPHROL, V58, P85; Roberts ISD, 2009, KIDNEY INT, V76, P546, DOI 10.1038/ki.2009.168; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; Sampson DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024973; Sethi S, 2012, KIDNEY INT, V82, P465, DOI 10.1038/ki.2012.212; Shi SF, 2011, CLIN J AM SOC NEPHRO, V6, P2175, DOI 10.2215/CJN.11521210; Stella C, 2006, J PROTEOME RES, V5, P2780, DOI 10.1021/pr060265y; Suzuki M, 2007, PEDIATR NEPHROL, V22, P2047, DOI 10.1007/s00467-007-0608-x; Troyanov S, 2011, CLIN J AM SOC NEPHRO, V6, P2335, DOI 10.2215/CJN.08440811; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Varghese SA, 2007, J AM SOC NEPHROL, V18, P913, DOI 10.1681/ASN.2006070767; Vivekanandan-Giri Anuradha, 2011, Int J Proteomics, V2011, P214715, DOI 10.1155/2011/214715; Wang JJ, 1998, NEPHROLOGY, V4, P27, DOI 10.1046/j.1440-1797.1998.d01-2.x; Webb DJ, 1998, LAB INVEST, V78, P939; Wei P, 2001, BIOCHEM BIOPH RES CO, V280, P744, DOI 10.1006/bbrc.2000.4200; WOLD S, 1993, ANAL CHIM ACTA, V277, P239, DOI 10.1016/0003-2670(93)80437-P; WOO KT, 1984, NEPHRON, V37, P78, DOI 10.1159/000183218; Woo KT, 1997, NEPHROLOGY, V3, P31, DOI 10.1111/j.1440-1797.1997.tb00185.x; Zhang QL, 2009, INT UROL NEPHROL, V41, P703, DOI 10.1007/s11255-008-9512-y	58	51	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80830	10.1371/journal.pone.0080830	http://dx.doi.org/10.1371/journal.pone.0080830			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339887	Green Published, Green Submitted, gold			2022-12-27	WOS:000328566100022
J	Smith, AM; Graham, ES; Feng, SX; Oldfield, RL; Bergin, PM; Mee, EW; Faull, RLM; Curtis, MA; Dragunow, M				Smith, Amy M.; Graham, E. Scott; Feng, Sheryl Xia; Oldfield, Robyn L.; Bergin, Peter M.; Mee, Edward W.; Faull, Richard L. M.; Curtis, Maurice A.; Dragunow, Mike			Adult Human Glia, Pericytes and Meningeal Fibroblasts Respond Similarly to IFNy but Not to TGF beta(1) or M-CSF	PLOS ONE			English	Article							CLASS-II TRANSACTIVATOR; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; MAJOR HISTOCOMPATIBILITY COMPLEX; COLONY-STIMULATING FACTOR; CHEMOKINE RECEPTOR EXPRESSION; MHC GENE-EXPRESSION; HLA-DR; TGF-BETA; ALZHEIMERS-DISEASE	The chemokine Interferon gamma-induced protein 10 (IP-10) and human leukocyte antigen (HLA) are widely used indicators of glial activation and neuroinflammation and are up-regulated in many brain disorders. These inflammatory mediators have been widely studied in rodent models of brain disorders, but less work has been undertaken using human brain cells. In this study we investigate the regulation of HLA and IP-10, as well as other cytokines and chemokines, in microglia, astrocytes, pericytes, and meningeal fibroblasts derived from biopsy and autopsy adult human brain, using immunocytochemistry and a Cytometric Bead Array. Interferonc (IFN gamma) increased microglial HLA expression, but contrary to data in rodents, the anti-inflammatory cytokine transforming growth factor beta 1 (TGF beta 1) did not inhibit this increase in HLA, nor did TGF beta 1 affect basal microglial HLA expression or IFN gamma-induced astrocytic HLA expression. In contrast, IFN gamma-induced and basal microglial HLA expression, but not IFN gamma-induced astrocytic HLA expression, were strongly inhibited by macrophage colony stimulating factor (M-CSF). IFN gamma also strongly induced HLA expression in pericytes and meningeal fibroblasts, which do not basally express HLA, and this induction was completely blocked by TGF beta 1, but not affected by M-CSF. In contrast, TGF beta 1 did not block the IFN gamma-induced increase in IP-10 in pericytes and meningeal fibroblasts. These results show that IFN gamma, TGF beta 1 and MCSF have species-and cell type-specific effects on human brain cells that may have implications for their roles in adult human brain inflammation.	[Smith, Amy M.; Graham, E. Scott; Feng, Sheryl Xia; Dragunow, Mike] Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand; [Smith, Amy M.; Dragunow, Mike] Gravida Natl Res Ctr Growth & Dev, Auckland, New Zealand; [Faull, Richard L. M.; Curtis, Maurice A.] Univ Auckland, Dept Anat, Auckland 1, New Zealand; [Smith, Amy M.; Graham, E. Scott; Feng, Sheryl Xia; Faull, Richard L. M.; Curtis, Maurice A.; Dragunow, Mike] Univ Auckland, Ctr Brain Res, Auckland 1, New Zealand; [Oldfield, Robyn L.] Lab Plus, Auckland, New Zealand; [Bergin, Peter M.; Mee, Edward W.] Auckland City Hosp, Auckland, New Zealand	University of Auckland; University of Auckland; University of Auckland; Auckland City Hospital	Dragunow, M (corresponding author), Univ Auckland, Dept Pharmacol & Clin Pharmacol, Auckland 1, New Zealand.	m.dragunow@auckland.ac.nz		Curtis, Maurice/0000-0003-4496-0233; Faull, Richard/0000-0003-3385-9498; Graham, Scott/0000-0002-2925-9126	Gravida - National Centre for Growth and Development; Neurological Foundation of New Zealand; Tertiary Education Commission; Coker Charitable Trust; Hugh Green Foundation; Health Research Council of New Zealand; MRC [G0901113] Funding Source: UKRI; Medical Research Council [G0901113] Funding Source: researchfish	Gravida - National Centre for Growth and Development; Neurological Foundation of New Zealand; Tertiary Education Commission; Coker Charitable Trust; Hugh Green Foundation; Health Research Council of New Zealand(Health Research Council of New Zealand); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was performed with the help of funding from Gravida - National Centre for Growth and Development, Neurological Foundation of New Zealand, Tertiary Education Commission, Coker Charitable Trust, Hugh Green Foundation and the Health Research Council of New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abutbul S, 2012, GLIA, V60, P1160, DOI 10.1002/glia.22343; Adler MW, 2005, AAPS J, V7, pE865, DOI 10.1208/aapsj070484; AKIYAMA H, 1993, ACTA NEUROPATHOL, V85, P628, DOI 10.1007/BF00334673; ALTERMAN RL, 1994, MOL CHEM NEUROPATHOL, V21, P177, DOI 10.1007/BF02815350; ArmendarizBorunda J, 1996, INT J BIOCHEM CELL B, V28, P1107, DOI 10.1016/1357-2725(96)00067-2; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478; BEACH TG, 1995, NEUROSCI LETT, V191, P27, DOI 10.1016/0304-3940(94)11548-1; Biber K, 2002, NEUROSCIENCE, V112, P487, DOI 10.1016/S0306-4522(02)00114-8; Burkert K, 2012, NEUROCHEM INT, V60, P573, DOI 10.1016/j.neuint.2011.09.002; Croitoru-Lamoury J, 2003, GLIA, V41, P354, DOI 10.1002/glia.10181; de Haas AH, 2007, MOL NEUROBIOL, V36, P137, DOI 10.1007/s12035-007-0036-8; Delvig AA, 2002, J LEUKOCYTE BIOL, V72, P163; Dijkstra IM, 2004, J IMMUNOL, V172, P2744, DOI 10.4049/jimmunol.172.5.2744; Dionne KR, 2011, EXP NEUROL, V228, P222, DOI 10.1016/j.expneurol.2011.01.006; Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469; Dragunow M, 2008, NAT REV NEUROSCI, V9, P779, DOI 10.1038/nrn2492; Dragunow M, 2013, BRAIN RES, V1501, P32, DOI 10.1016/j.brainres.2013.01.013; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Flynn G, 2003, J NEUROIMMUNOL, V136, P84, DOI 10.1016/S0165-5728(03)00009-2; Gibbons HA, 2007, J NEUROSCI METH, V166, P89, DOI 10.1016/j.jneumeth.2007.07.005; Gibbons HM, 2011, NEUROBIOL DIS, V41, P96, DOI 10.1016/j.nbd.2010.08.024; Goldberg SH, 2001, NEUROPATH APPL NEURO, V27, P127, DOI 10.1046/j.1365-2990.2001.00312.x; Graeber MB, 2010, SCIENCE, V330, P783, DOI 10.1126/science.1190929; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hashioka S, 2010, J NEUROIMMUNOL, V225, P91, DOI 10.1016/j.jneuroim.2010.04.023; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; Jones LL, 1998, BRAIN RES, V795, P301, DOI 10.1016/S0006-8993(98)00325-4; Khandelwal PJ, 2011, J NEUROIMMUNOL, V238, P1, DOI 10.1016/j.jneuroim.2011.07.002; Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Klein RS, 2005, J VIROL, V79, P11457, DOI 10.1128/JVI.79.17.11457-11466.2005; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Kremlev SG, 2004, J NEUROIMMUNOL, V149, P1, DOI 10.1016/j.jneuroim.2003.11.012; Lambert C, 2008, J IMMUNOL, V181, P8288, DOI 10.4049/jimmunol.181.12.8288; LEE SC, 1993, J IMMUNOL, V150, P594; Lee YJ, 1997, J IMMUNOL, V158, P2065; Li CY, 2011, CURR ALZHEIMER RES, V8, P67; Lopes KO, 2008, GLIA, V56, P1048, DOI 10.1002/glia.20678; Maingat F, 2010, J IMMUNOL, V184, P1566, DOI 10.4049/jimmunol.0902575; Maru SV, 2008, J NEUROIMMUNOL, V199, P35, DOI 10.1016/j.jneuroim.2008.04.029; MCGEER PL, 1988, ACTA NEUROPATHOL, V76, P550, DOI 10.1007/BF00689592; Nakahara H, 2010, ACTA HISTOCHEM CYTOC, V43, P157, DOI 10.1267/ahc.10022; Nandan D, 1997, J IMMUNOL, V158, P1095; Nelson TE, 2004, J NEUROIMMUNOL, V156, P74, DOI 10.1016/j.jneuroim.2004.07.009; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; O'Keefe GM, 1999, EUR J IMMUNOL, V29, P1275, DOI 10.1002/(SICI)1521-4141(199904)29:04<1275::AID-IMMU1275>3.0.CO;2-T; O'Keefe GM, 2002, J NEUROVIROL, V8, P496, DOI 10.1080/13550280290100941; Papavasiliou AK, 1997, NEUROSURGERY, V41, P916, DOI 10.1097/00006123-199710000-00028; PARDRIDGE WM, 1989, J NEUROSCI RES, V23, P337, DOI 10.1002/jnr.490230314; Park TIH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037742; Paul G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035577; Pazmany T, 2006, J NEUROIMMUNOL, V172, P18, DOI 10.1016/j.jneuroim.2005.10.009; Perry VH, 2010, ACTA NEUROPATHOL, V120, P277, DOI 10.1007/s00401-010-0722-x; Piskurich JF, 1999, MOL CELL BIOL, V19, P431; Politis M, 2012, J NEUROL, V259, P1769, DOI 10.1007/s00415-012-6428-3; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Salmaggi A, 2002, J INTERF CYTOK RES, V22, P631, DOI 10.1089/10799900260100114; Santos AN, 1998, INT IMMUNOL, V10, P601, DOI 10.1093/intimm/10.5.601; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schartner JM, 2005, GLIA, V51, P279, DOI 10.1002/glia.20201; Serrano-Pozo A, 2013, AM J PATHOL, V182, P2332, DOI 10.1016/j.ajpath.2013.02.031; Simpson JE, 2000, NEUROPATH APPL NEURO, V26, P133, DOI 10.1046/j.1365-2990.2000.026002133.x; Smith AM, 2010, NEUROSCIENCE, V169, P505, DOI 10.1016/j.neuroscience.2010.04.041; Smith AM, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-85; Smith Amy M, 2013, Methods Mol Biol, V1041, P41, DOI 10.1007/978-1-62703-520-0_6; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Sorensen TL, 2004, CURR NEUROVASC RES, V1, P183, DOI 10.2174/1567202043480143; Streit WJ, 2006, TRENDS NEUROSCI, V29, P506, DOI 10.1016/j.tins.2006.07.001; STYREN SD, 1990, EXP NEUROL, V110, P93, DOI 10.1016/0014-4886(90)90054-V; Sui YJ, 2004, AM J PATHOL, V164, P1557, DOI 10.1016/S0002-9440(10)63714-5; SUZUMURA A, 1993, J IMMUNOL, V151, P2150; Tanuma N, 2006, ACTA NEUROPATHOL, V112, P195, DOI 10.1007/s00401-006-0083-7; Uddin J, 2005, J IMMUNOL, V175, P3273, DOI 10.4049/jimmunol.175.5.3273; ULVESTAD E, 1994, IMMUNOLOGY, V82, P535; Van der Meer P, 2001, J NEUROPATH EXP NEUR, V60, P25, DOI 10.1093/jnen/60.1.25; van Weering HRJ, 2010, BRAIN BEHAV IMMUN, V24, P768, DOI 10.1016/j.bbi.2009.04.007; Vezzani A., 2011, EXPT NEUROLOGY; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Wang XK, 1998, J NEUROCHEM, V71, P1194; Weiss R, 2011, BRAIN BEHAV IMMUN, V25, P1017, DOI 10.1016/j.bbi.2010.11.012; Weng YM, 1998, J BIOL CHEM, V273, P18288, DOI 10.1074/jbc.273.29.18288; Wierzba-Bobrowicz T, 2002, FOLIA NEUROPATHOL, V40, P125; Wu Z, 2005, J NEUROIMMUNOL, V167, P90, DOI 10.1016/j.jneuroim.2005.06.025; Xia MQ, 2000, J NEUROIMMUNOL, V108, P227, DOI 10.1016/S0165-5728(00)00285-X; YONG VW, 1991, J NEUROPATH EXP NEUR, V50, P16, DOI 10.1097/00005072-199101000-00002; Yoo SW, 2013, NEUROBIOL DIS, V58, P249, DOI 10.1016/j.nbd.2013.06.001	88	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e80463	10.1371/journal.pone.0080463	http://dx.doi.org/10.1371/journal.pone.0080463			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339874	Green Submitted, Green Published, gold			2022-12-27	WOS:000328566100012
J	Torres, C; Fonseca, AM; Leander, M; Matos, R; Morais, S; Campos, M; Lima, M				Torres, Claudia; Fonseca, Ana Mafalda; Leander, Magdalena; Matos, Rui; Morais, Sara; Campos, Manuel; Lima, Margarida			Circulating Endothelial Cells in Patients with Venous Thromboembolism and Myeloproliferative Neoplasms	PLOS ONE			English	Article							PROGENITOR CELLS; TISSUE FACTOR; ESSENTIAL THROMBOCYTHEMIA; LEUKOCYTE ADHESION; ANTITHROMBIN-III; RISK-FACTORS; THROMBOSIS; BLOOD; HYDROXYUREA; PATHOPHYSIOLOGY	Background: Circulating endothelial cells (CEC) may be a biomarker of vascular injury and pro-thrombotic tendency, while circulating endothelial progenitor cells (CEP) may be an indicator for angiogenesis and vascular remodelling. However, there is not a universally accepted standardized protocol to identify and quantify these cells and its clinical relevancy remains to be established. Objectives: To quantify CEC and CEP in patients with venous thromboembolism (VTE) and with myeloproliferative neoplasms (MPN), to characterize the CEC for the expression of activation (CD54, CD62E) and procoagulant (CD142) markers and to investigate whether they correlate with other clinical and laboratory data. Patients and Methods: Sixteen patients with VTE, 17 patients with MPN and 20 healthy individuals were studied. The CEC and CEP were quantified and characterized in the blood using flow cytometry, and the demographic, clinical and laboratory data were obtained from hospital records. Results: We found the CEC counts were higher in both patient groups as compared to controls, whereas increased numbers of CEP were found only in patients with MPN. In addition, all disease groups had higher numbers of CD62E+ CEC as compared to controls, whereas only patients with VTE had increased numbers of CD142+ and CD54+ CEC. Moreover, the numbers of total and CD62+ CEC correlated positively with the white blood cells (WBC) counts in both groups of patients, while the numbers of CEP correlated positively with the WBC counts only in patients with MPN. In addition, in patients with VTE a positive correlation was found between the numbers of CD54+ CEC and the antithrombin levels, as well as between the CD142+ CEC counts and the number of thrombotic events. Conclusions: Our study suggests that CEC counts may reveal endothelial injury in patients with VTE and MPN and that CEC may express different activation-related phenotypes depending on the disease status.	[Torres, Claudia; Leander, Magdalena; Lima, Margarida] CHP, HSA, Serv Hematol Clin, Lab Citometria, Oporto, Portugal; [Torres, Claudia; Leander, Magdalena; Morais, Sara; Campos, Manuel; Lima, Margarida] UP, UMIB, ICBAS, Oporto, Portugal; [Fonseca, Ana Mafalda] UBI, CICS, Covilha, Portugal; [Matos, Rui; Morais, Sara; Campos, Manuel] CHP, HSA, Serv Hematol Clin, Seccao Trombose & Hemostase, Oporto, Portugal	Universidade do Porto; Universidade da Beira Interior	Torres, C (corresponding author), CHP, HSA, Serv Hematol Clin, Lab Citometria, Oporto, Portugal.	torres.cb@gmail.com; mmc.lima@clix.pt	Lima, Margarida/S-7466-2016; Fonseca, Ana M/H-3836-2012	Lima, Margarida/0000-0001-9702-5260; Fonseca, Ana M/0000-0003-1118-5525; Morais, Sara/0000-0003-4266-4457	Unidade Multidisciplinar de Investigacao Biomedica, Instituto de Ciencias Biomedicas Abel Salazar, Universidade do Porto(UMIB/ICBAS/UP)	Unidade Multidisciplinar de Investigacao Biomedica, Instituto de Ciencias Biomedicas Abel Salazar, Universidade do Porto(UMIB/ICBAS/UP)	Funding source: Unidade Multidisciplinar de Investigacao Biomedica, Instituto de Ciencias Biomedicas Abel Salazar, Universidade do Porto(UMIB/ICBAS/UP (http://www1.icbas.up.pt/umib/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams V, 2004, ARTERIOSCL THROM VAS, V24, P684, DOI 10.1161/01.ATV.0000124104.23702.a0; Aird WC, 2007, CIRC RES, V100, P174, DOI 10.1161/01.RES.0000255690.03436.ae; Aird WC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006429; Alonci A, 2008, HEMATOL ONCOL, V26, P235, DOI 10.1002/hon.865; Alt E, 2002, THROMB RES, V107, P101, DOI 10.1016/S0049-3848(02)00302-X; Barbui T, 2005, NEW ENGL J MED, V353, P85, DOI 10.1056/NEJMe058093; BEVILACQUA MP, 1993, ANNU REV IMMUNOL, V11, P767, DOI 10.1146/annurev.iy.11.040193.004003; Blann AD, 2006, BMJ-BRIT MED J, V332, P215, DOI 10.1136/bmj.332.7535.215; Blann AD, 2005, THROMB HAEMOSTASIS, V93, P228, DOI 10.1160/TH04-09-0578; Boos CJ, 2008, J THROMB HAEMOST, V6, P1841, DOI 10.1111/j.1538-7836.2008.03148.x; Brun M, 2003, PHARMACOGENOMICS J, V3, P215, DOI 10.1038/sj.tpj.6500176; Carobbio A, 2008, J CLIN ONCOL, V26, P2732, DOI 10.1200/JCO.2007.15.3569; Carobbio A, 2007, BLOOD, V109, P2310, DOI 10.1182/blood-2006-09-046342; Cella G, 2010, THROMB HAEMOSTASIS, V104, P151, DOI 10.1160/TH09-09-0663; Chen JZ, 2004, CLIN SCI, V107, P273, DOI 10.1042/CS20030389; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; Cines DB, 1998, BLOOD, V91, P3527; CORTELAZZO S, 1995, NEW ENGL J MED, V332, P1132, DOI 10.1056/NEJM199504273321704; Cushman M, 2007, SEMIN HEMATOL, V44, P62, DOI 10.1053/j.seminhematol.2007.02.004; Cushman Mary, 2005, Hematology Am Soc Hematol Educ Program, P452; Day SM, 2005, BLOOD, V105, P192, DOI 10.1182/blood-2004-06-2225; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; Elshal MF, 2005, BLOOD, V106, P2923, DOI 10.1182/blood-2005-06-2307; Finazzi G, 2007, BLOOD, V109, P5104, DOI 10.1182/blood-2006-12-038968; Gill M, 2001, CIRC RES, V88, P167; Handgretinger R, 2003, ANN NY ACAD SCI, V996, P141, DOI 10.1111/j.1749-6632.2003.tb03242.x; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hoffmann JN, 2000, AM J PHYSIOL-CELL PH, V279, pC98, DOI 10.1152/ajpcell.2000.279.1.C98; Inthorn D, 1998, SHOCK, V10, P90, DOI 10.1097/00024382-199808000-00002; Johnson C, 2008, HAEMATOLOGICA, V93, P481, DOI 10.3324/haematol.12734; Khan SS, 2005, CYTOM PART B-CLIN CY, V64B, P1, DOI 10.1002/cyto.b.20040; Landolfi R, 2007, BLOOD, V109, P2446, DOI 10.1182/blood-2006-08-042515; Leibundgut EO, 2006, HAEMATOLOGICA, V91, P1465; Loncar R, 2006, THROMB J, V4, DOI 10.1186/1477-9560-4-19; Lopez J, 2004, AM SOC HEMATOLOGY ED, V2004, P439; Lowe GDO, 2005, J THROMB HAEMOST, V3, P1618, DOI 10.1111/j.1538-7836.2005.01416.x; Mancuso P, 2001, BLOOD, V97, P3658, DOI 10.1182/blood.V97.11.3658; Medinger M, 2009, BRIT J HAEMATOL, V146, P150, DOI 10.1111/j.1365-2141.2009.07726.x; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mutin M, 1999, BLOOD, V93, P2951; Mutunga M, 2001, AM J RESP CRIT CARE, V163, P195, DOI 10.1164/ajrccm.163.1.9912036; Nishijima K, 2003, INVEST OPHTH VIS SCI, V44, P332, DOI 10.1167/iovs.02-0493; Ozdogu H, 2007, AM J HEMATOL, V82, P706, DOI 10.1002/ajh.20904; PAWASHE AB, 1994, CIRC RES, V74, P56, DOI 10.1161/01.RES.74.1.56; Pernod G, 2009, J MAL VASCUL, V34, P156, DOI 10.1016/j.jmv.2009.02.005; Poredos R, 2007, INT ANGIOL, V26, P306; Rodriguez-Carrio J, 2012, RHEUMATOLOGY OXFORD; Rosendaal FR, 2009, J THROMB HAEMOST, V7, P301, DOI 10.1111/j.1538-7836.2009.03394.x; Rosendaal FR, 1999, LANCET, V353, P1167, DOI 10.1016/S0140-6736(98)10266-0; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; Silverstein MD, 1998, ARCH INTERN MED, V158, P585, DOI 10.1001/archinte.158.6.585; Steffel J, 2006, CIRCULATION, V113, P722, DOI 10.1161/CIRCULATIONAHA.105.567297; Strijbos MH, 2009, BLOOD CELL MOL DIS, V43, P63, DOI 10.1016/j.bcmd.2009.02.007; Tefferi A, 2009, CANCER-AM CANCER SOC, V115, P3842, DOI 10.1002/cncr.24440; Trelinski J, 2010, INT J HEMATOL, V91, P792, DOI 10.1007/s12185-010-0596-7; Ueno Y, 1997, PROSTAGLANDINS, V53, P279, DOI 10.1016/S0090-6980(97)89601-3; Wadleigh M, 2010, INT J HEMATOL, V91, P174, DOI 10.1007/s12185-010-0529-5; Wassmann S, 2006, CIRC RES, V99, pE74, DOI 10.1161/01.RES.0000246095.90247.d4; Woywodt A, 2004, BLOOD, V103, P3603, DOI 10.1182/blood-2003-10-3479; Wu KK, 1996, ANNU REV MED, V47, P315	61	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2013	8	12							e81574	10.1371/journal.pone.0081574	http://dx.doi.org/10.1371/journal.pone.0081574			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	273WD	24339944	Green Published, gold, Green Submitted			2022-12-27	WOS:000328566100067
J	Sakamoto, K; Katori, Y; Saito, N; Yoshida, S; Aihara, K; Mushiake, H				Sakamoto, Kazuhiro; Katori, Yuichi; Saito, Naohiro; Yoshida, Shun; Aihara, Kazuyuki; Mushiake, Hajime			Increased Firing Irregularity as an Emergent Property of Neural-State Transition in Monkey Prefrontal Cortex	PLOS ONE			English	Article							EARLY-WARNING SIGNALS; WORKING-MEMORY; PERSISTENT ACTIVITY; PYRAMIDAL NEURONS; CORTICAL-NEURONS; CONNECTIVITY; MODEL; SCHIZOPHRENIA; INTERNEURONS; VARIABILITY	Flexible behaviors are organized by complex neural networks in the prefrontal cortex. Recent studies have suggested that such networks exhibit multiple dynamical states, and can switch rapidly from one state to another. In many complex systems such as the brain, the early-warning signals that may predict whether a critical threshold for state transitions is approaching are extremely difficult to detect. We hypothesized that increases in firing irregularity are a crucial measure for predicting state transitions in the underlying neuronal circuits of the prefrontal cortex. We used both experimental and theoretical approaches to test this hypothesis. Experimentally, we analyzed activities of neurons in the prefrontal cortex while monkeys performed a maze task that required them to perform actions to reach a goal. We observed increased firing irregularity before the activity changed to encode goal-to-action information. Theoretically, we constructed theoretical generic neural networks and demonstrated that changes in neuronal gain on functional connectivity resulted in a loss of stability and an altered state of the networks, accompanied by increased firing irregularity. These results suggest that assessing the temporal pattern of neuronal fluctuations provides important clues regarding the state stability of the prefrontal network. We also introduce a novel scheme that the prefrontal cortex functions in a metastable state near the critical point of bifurcation. According to this scheme, firing irregularity in the prefrontal cortex indicates that the system is about to change its state and the flow of information in a flexible manner, which is essential for executive functions. This metastable and/or critical dynamical state of the prefrontal cortex may account for distractibility and loss of flexibility in the prefrontal cortex in major mental illnesses such as schizophrenia.	[Sakamoto, Kazuhiro] Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan; [Katori, Yuichi; Aihara, Kazuyuki] Univ Tokyo, Inst Ind Sci, Tokyo, Japan; [Katori, Yuichi; Aihara, Kazuyuki] Japan Sci & Technol Agcy, Funding Program World Leading Innovat Res & Dev S, Aihara Innovat Math Modelling Project, Tokyo, Japan; [Saito, Naohiro; Yoshida, Shun; Mushiake, Hajime] Tohoku Univ, Sch Med, Dept Physiol, Sendai, Miyagi 980, Japan; [Mushiake, Hajime] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol Program, Tokyo, Japan	Tohoku University; University of Tokyo; Japan Science & Technology Agency (JST); Tohoku University; Japan Science & Technology Agency (JST)	Sakamoto, K (corresponding author), Tohoku Univ, Elect Commun Res Inst, Sendai, Miyagi, Japan.	sakamoto@riec.tohoku.ac.jp		Mushiake, Hajime/0000-0002-5130-4720	Japan Society for the Promotion of Science (JSPS) [22500283, 25730175]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan [22120504, 24120703, 4103]; Creative Interdisciplinary Research Program in Frontier Research Institute for Interdisciplinary Sciences of Tohoku University; Japan Science and Technology Agency (Exploratory Research for Advanced Technology and Core Research for Evolutional Science and Technology); JSPS through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)''	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Creative Interdisciplinary Research Program in Frontier Research Institute for Interdisciplinary Sciences of Tohoku University; Japan Science and Technology Agency (Exploratory Research for Advanced Technology and Core Research for Evolutional Science and Technology)(Japan Science & Technology Agency (JST)); JSPS through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)''	This research was supported by the Japan Society for the Promotion of Science (JSPS) (# 22500283, # 25730175); a Grant-in-Aid for Scientific Research on Innovative Areas "The study on the neural dynamics for understanding communication in terms of complex hetero systems (number 4103)'' of the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (# 22120504, # 24120703); Creative Interdisciplinary Research Program in Frontier Research Institute for Interdisciplinary Sciences of Tohoku University; the Japan Science and Technology Agency (Exploratory Research for Advanced Technology and Core Research for Evolutional Science and Technology); JSPS through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1982, J NEUROPHYSIOL, V48, P217, DOI 10.1152/jn.1982.48.1.217; Arnsten AFT, 2010, TRENDS COGN SCI, V14, P365, DOI 10.1016/j.tics.2010.05.003; Ashby W.R., 1952, DESIGN BRAIN; BADDELEY AD, 1983, PHILOS T ROY SOC B, V302, P311, DOI 10.1098/rstb.1983.0057; Chance FS, 2002, NEURON, V35, P773, DOI 10.1016/S0896-6273(02)00820-6; Chen LN, 2012, SCI REP-UK, V2, DOI 10.1038/srep00342; Cisek P, 2006, J NEUROSCI, V26, P9761, DOI 10.1523/JNEUROSCI.5605-05.2006; Compte A, 2003, J NEUROPHYSIOL, V90, P3441, DOI 10.1152/jn.00949.2002; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Davies RM, 2006, J NEUROPHYSIOL, V96, P906, DOI 10.1152/jn.01030.2005; Deco G, 2009, PROG NEUROBIOL, V88, P1, DOI 10.1016/j.pneurobio.2009.01.006; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Durstewitz D, 2008, EUR J NEUROSCI, V27, P217, DOI 10.1111/j.1460-9568.2007.05976.x; Fellous JM, 2003, NEUROSCIENCE, V122, P811, DOI 10.1016/j.neuroscience.2003.08.027; Fuster JM, 2008, PREFRONTAL CORTEX, 4TH EDITION, P1; Fuster JM, 2000, EXP BRAIN RES, V133, P66, DOI 10.1007/s002210000401; GOLDMANRAKIC PS, 1994, J NEUROPSYCH CLIN N, V6, P348; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Haken H, 2002, BRAIN DYNAMICS INTRO; Haken H., 1978, SYNERGETICS INTRO; Ho N, 2000, J NEUROPHYSIOL, V84, P1488, DOI 10.1152/jn.2000.84.3.1488; Homae F, 2003, NEUROIMAGE, V20, P578, DOI 10.1016/S1053-8119(03)00272-6; Katori Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002266; Lee JH, 2005, J ABNORM PSYCHOL, V114, P599, DOI 10.1037/0021-843X.114.4.599; Lewis DA, 1997, NEUROPSYCHOPHARMACOL, V16, P385, DOI 10.1016/S0893-133X(96)00277-1; Liu R, 2012, SCI REP-UK, V2, DOI 10.1038/srep00813; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; Lundqvist M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000803; Machens CK, 2005, SCIENCE, V307, P1121, DOI 10.1126/science.1104171; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miura K, 2007, J NEUROSCI, V27, P13802, DOI 10.1523/JNEUROSCI.2452-07.2007; Miura K, 2006, NEURAL COMPUT, V18, P2359, DOI 10.1162/neco.2006.18.10.2359; Mushiake H, 2001, COGNITIVE BRAIN RES, V11, P165, DOI 10.1016/S0926-6410(00)00067-7; Mushiake H, 2006, NEURON, V50, P631, DOI 10.1016/j.neuron.2006.03.045; NAKA KI, 1966, J PHYSIOL-LONDON, V185, P587, DOI 10.1113/jphysiol.1966.sp008003; Nicolis G, 1977, SELF ORG NONEQUILIBR; Ohshiro T, 2011, NAT NEUROSCI, V14, P775, DOI 10.1038/nn.2815; Passingham REP, 2012, NEUROBIOLOGY PREFRON; Rao SG, 1999, J NEUROPHYSIOL, V81, P1903, DOI 10.1152/jn.1999.81.4.1903; Renart A, 2007, NEURAL COMPUT, V19, P1, DOI 10.1162/neco.2007.19.1.1; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Saito N, 2005, CEREB CORTEX, V15, P1535, DOI 10.1093/cercor/bhi032; Sakamoto K, 2012, T1553 IEEE SCIS ISIS; Sakamoto K, 2008, CEREB CORTEX, V18, P2036, DOI 10.1093/cercor/bhm234; Salinas E, 2000, J NEUROSCI, V20, P6193, DOI 10.1523/JNEUROSCI.20-16-06193.2000; Scheffer M, 2012, SCIENCE, V338, P344, DOI 10.1126/science.1225244; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SCHONER G, 1988, SCIENCE, V239, P1513, DOI 10.1126/science.3281253; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Shafi M, 2007, NEUROSCIENCE, V146, P1082, DOI 10.1016/j.neuroscience.2006.12.072; Shinomoto S, 2003, NEURAL COMPUT, V15, P2823, DOI 10.1162/089976603322518759; Shinomoto S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000433; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Tanji J, 2007, TRENDS COGN SCI, V11, P528, DOI 10.1016/j.tics.2007.09.007; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; WILSON FAW, 1994, P NATL ACAD SCI USA, V91, P4009, DOI 10.1073/pnas.91.9.4009; Wong KF, 2006, J NEUROSCI, V26, P1314, DOI 10.1523/JNEUROSCI.3733-05.2006	59	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2013	8	12							e80906	10.1371/journal.pone.0080906	http://dx.doi.org/10.1371/journal.pone.0080906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265KD	24349020	Green Published, Green Submitted, gold			2022-12-27	WOS:000327949300055
J	Xu, HY; Yang, NW; Wan, FH				Xu, Hai-Yun; Yang, Nian-Wan; Wan, Fang-Hao			Competitive Interactions between Parasitoids Provide New Insight into Host Suppression	PLOS ONE			English	Article							TABACI BIOTYPE-B; BEMISIA-TABACI; INTRINSIC COMPETITION; ENCARSIA-FORMOSA; LETHAL INTERFERENCE; LARVAL PARASITOIDS; 2 ENDOPARASITOIDS; ERETMOCERUS; DISCRIMINATION; HYMENOPTERA	Understanding the dynamics of potential inter- and intraspecific competition in parasitoid communities is crucial in the screening of efficient parasitoid species and for utilization of the best parasitoid species combinations. In this respect, the host-parasitoid systems, Bemisia tabaci and two parasitoids, Eretmocerus hayati (exotic) and Encarsia sophia (existing) were studied under laboratory conditions to investigate whether interference competition between the exotic and existing species occurs as well as the influence of potential interference competition on the suppression of the host B. tabaci. Studies on interspecific-, intraspecific- and self-interference competition in two parasitoid species were conducted under both rich and limited host resource conditions. Results showed that (1) both parasitoid species negatively affect the progeny production of the other under both rich and limited host resource conditions; (2) both parasitoid species interfered intraspecifically on conspecific parasitized hosts when the available hosts are scarce and; 3) the mortality of B. tabaci induced by parasitoids via parasitism, host-feeding or both parasitism and host-feeding together varied among treatments under different host resource conditions, but showed promise for optimizing control strategies. As a result of our current findings, we suggest a need to investigate the interactions between the two parasitoids on continuous generations.	[Xu, Hai-Yun; Yang, Nian-Wan; Wan, Fang-Hao] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wan, FH (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China.	wanfanghao@caas.cn	Yang, Nianwan/AAH-7371-2019	Yang, Nianwan/0000-0002-6014-3383; Tang, Shihuan/0000-0003-0589-4499	National Natural Science Foundation [30930062]; National Basic Research and Development Program of China [2009CB119200]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research and Development Program of China(National Basic Research Program of China)	The research was financially supported by the National Natural Science Foundation (30930062) and the National Basic Research and Development Program of China (2009CB119200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardeh MJ, 2005, BIOL CONTROL, V33, P74, DOI 10.1016/j.biocontrol.2005.01.006; Bogran CE, 2002, ECOLOGY, V83, P653, DOI 10.1890/0012-9658(2002)083[0653:ICAIPF]2.0.CO;2; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Collier T, 2002, BIOL CONTROL, V23, P254, DOI 10.1006/bcon.2001.1007; Collier TR, 2007, ECOL ENTOMOL, V32, P70, DOI 10.1111/j.1365-2311.2006.00844.x; Collier TR, 2001, OECOLOGIA, V129, P147, DOI 10.1007/s004420100706; COLLIER TR, 1995, ANN ENTOMOL SOC AM, V88, P206, DOI 10.1093/aesa/88.2.206; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; De Moraes CM, 2005, ECOL ENTOMOL, V30, P564, DOI 10.1111/j.0307-6946.2005.00723.x; De Moraes CM, 1999, ECOL ENTOMOL, V24, P402, DOI 10.1046/j.1365-2311.1999.00212.x; De Vis RMJ, 2003, J INSECT BEHAV, V16, P117, DOI 10.1023/A:1022805529942; FORCE DC, 1985, AM NAT, V126, P440, DOI 10.1086/284430; FORCE DC, 1974, SCIENCE, V184, P624, DOI 10.1126/science.184.4137.624; Giron D, 2002, FUNCT ECOL, V16, P750, DOI 10.1046/j.1365-2435.2002.00679.x; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; Goolsby J, 2005, 2 INT S BIOL CONTR A; Goolsby JA, 2005, BIOL CONTROL, V32, P70, DOI 10.1016/j.biocontrol.2004.07.012; Goolsby John A., 2008, V4, P179; Gould Juli, 2008, V4, P191, DOI 10.1007/978-1-4020-6740-2_12; Harvey JA, 2013, ANNU REV ENTOMOL, V58, P333, DOI 10.1146/annurev-ento-120811-153622; Harvey JA, 2009, ENTOMOL EXP APPL, V132, P155, DOI 10.1111/j.1570-7458.2009.00882.x; Huang Jian, 2000, Entomological Journal of East China, V9, P29; Hunter MS, 2001, ANNU REV ENTOMOL, V46, P251, DOI 10.1146/annurev.ento.46.1.251; Hunter MS, 1998, ENTOMOL EXP APPL, V89, P249, DOI 10.1023/A:1003555607725; JERVIS MA, 1986, BIOL REV, V61, P395, DOI 10.1111/j.1469-185X.1986.tb00660.x; [冀禄禄 Ji Lulu], 2012, [中国生物防治学报, Chinese Journal of Biological Control], V28, P303; Khafagi WE, 2008, BIOCONTROL, V53, P427, DOI 10.1007/s10526-007-9078-0; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Luo Chen, 2002, Acta Entomologica Sinica, V45, P759; MACKAUER M, 1990, CRITICAL ISSUES IN BIOLOGICAL CONTROL, P41; Moretti R, 2008, ENTOMOL EXP APPL, V129, P44, DOI 10.1111/j.1570-7458.2008.00745.x; Mucheru OM, 2009, ENTOMOL EXP APPL, V130, P10, DOI 10.1111/j.1570-7458.2008.00788.x; Murdoch WW, 1998, INSECT POPULATIONS IN THEORY AND IN PRACTICE, P167; Oliveira MRV, 2001, CROP PROT, V20, P709, DOI 10.1016/S0261-2194(01)00108-9; Pedata PA, 2002, B ENTOMOL RES, V92, P521, DOI 10.1079/BER2002203; Perring Thomas M., 1996, P3; Polis GA, 1996, AM NAT, V147, P813, DOI 10.1086/285880; PRICE PW, 1972, ECOLOGY, V53, P190, DOI 10.2307/1935729; PRICE PW, 1988, AM NAT, V131, P544, DOI 10.1086/284805; Qio Bao-Li, 2004, Entomological Knowledge, V41, P333; TILLMAN PG, 1992, ENTOMOPHAGA, V37, P439, DOI 10.1007/BF02373117; WALTER GH, 1983, BIOL J LINN SOC, V19, P63, DOI 10.1111/j.1095-8312.1983.tb00777.x; Wan FH, 2009, SCI CHINA SER C, V52, P88, DOI 10.1007/s11427-008-0135-4; Yang NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041189; Yang NW, 2011, BIOL CONTROL, V59, P313, DOI 10.1016/j.biocontrol.2011.07.019; Zang LS, 2008, ENTOMOL EXP APPL, V127, P55, DOI 10.1111/j.1570-7458.2008.00667.x; Zolnerowich G, 1998, P ENTOMOL SOC WASH, V100, P310	47	43	50	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2013	8	11							e82003	10.1371/journal.pone.0082003	http://dx.doi.org/10.1371/journal.pone.0082003			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	261IJ	24339904	Green Published, Green Submitted, gold			2022-12-27	WOS:000327657900066
J	Li, LL; Howell, K; Sands, M; Banahan, M; Frohlich, S; Rowan, SC; Neary, R; Ryan, D; McLoughlin, P				Li, Lili; Howell, Katherine; Sands, Michelle; Banahan, Mark; Frohlich, Stephen; Rowan, Simon C.; Neary, Roisin; Ryan, Donal; McLoughlin, Paul			The alpha and Delta Isoforms of CREB1 Are Required to Maintain Normal Pulmonary Vascular Resistance	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; MUSCLE-CELL-PROLIFERATION; TRANSCRIPTION FACTOR; GENETIC EMPHYSEMA; KEY ROLE; CAMP; ANGIOGENESIS; INHIBITION; EXPRESSION; LUNG	Chronic hypoxia causes pulmonary hypertension associated with structural alterations in pulmonary vessels and sustained vasoconstriction. The transcriptional mechanisms responsible for these distinctive changes are unclear. We have previously reported that CREB1 is activated in the lung in response to alveolar hypoxia but not in other organs. To directly investigate the role of alpha and Delta isoforms of CREB1 in the regulation of pulmonary vascular resistance we examined the responses of mice in which these isoforms of CREB1 had been inactivated by gene mutation, leaving only the beta isoform intact (CREB alpha Delta mice). Here we report that expression of CREB regulated genes was altered in the lungs of CREB alpha Delta mice. CREB alpha Delta mice had greater pulmonary vascular resistance than wild types, both basally in normoxia and following exposure to hypoxic conditions for three weeks. There was no difference in rho kinase mediated vasoconstriction between CREB alpha Delta and wild type mice. Stereological analysis of pulmonary vascular structure showed characteristic wall thickening and lumen reduction in hypoxic wild-type mice, with similar changes observed in CREB alpha Delta. CREB alpha Delta mice had larger lungs with reduced epithelial surface density suggesting increased pulmonary compliance. These findings show that alpha and Delta isoforms of CREB1 regulate homeostatic gene expression in the lung and that normal activity of these isoforms is essential to maintain low pulmonary vascular resistance in both normoxic and hypoxic conditions and to maintain the normal alveolar structure. Interventions that enhance the actions of alpha and Delta isoforms of CREB1 warrant further investigation in hypoxic lung diseases.	[Li, Lili; Howell, Katherine; Sands, Michelle; Banahan, Mark; Frohlich, Stephen; Rowan, Simon C.; Neary, Roisin; McLoughlin, Paul] Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 2, Ireland; [Frohlich, Stephen; Ryan, Donal] St Vincents Univ Hosp, Dept Anaesthesia & Crit Care, Dublin 4, Ireland	University College Dublin; University College Dublin; Saint Vincent's University Hospital	McLoughlin, P (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, Conway Inst, Dublin 2, Ireland.	Paul.mcloughlin@ucd.ie	Rowan, Simon Coyle/AAO-1549-2020; Wang, Chunmei/J-2423-2013	Rowan, Simon Coyle/0000-0002-4103-4421; Wang, Chunmei/0000-0003-4615-0517; McLoughlin, Paul/0000-0001-6200-016X	Health Research Board, Ireland; Science Foundation Ireland; St Vincent's Hospital Anaesthesia Foundation; Medical Research Council [MC_UP_1202/4] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R03CA165122, R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK026743] Funding Source: NIH RePORTER	Health Research Board, Ireland; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); St Vincent's Hospital Anaesthesia Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by funding from the Health Research Board, Ireland (www.hrb.ie), Science Foundation Ireland (www.sfi.ie) and St Vincent's Hospital Anaesthesia Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki F, 2005, AM J RESP CRIT CARE, V172, P713, DOI 10.1164/rccm.200412-1620OC; Beitner-Johnson D, 1998, J BIOL CHEM, V273, P19834, DOI 10.1074/jbc.273.31.19834; Bierer R, 2011, AM J PHYSIOL-LUNG C, V301, pL872, DOI 10.1152/ajplung.00405.2010; Blendy JA, 1996, EMBO J, V15, P1098, DOI 10.1002/j.1460-2075.1996.tb00447.x; Cadogan E, 1999, AM J PHYSIOL-LUNG C, V277, pL616, DOI 10.1152/ajplung.1999.277.3.L616; Cahill E, 2012, EXP PHYSIOL, V97, P796, DOI 10.1113/expphysiol.2012.065474; Cahill E, 2012, CIRCULATION, V125, P920, DOI 10.1161/CIRCULATIONAHA.111.038125; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Comerford KM, 2003, P NATL ACAD SCI USA, V100, P986, DOI 10.1073/pnas.0337412100; Costa M, 2001, EUR J BIOCHEM, V268, P987, DOI 10.1046/j.1432-1327.2001.01957.x; De Cesare D, 2000, PROG NUCLEIC ACID RE, V64, P343, DOI 10.1016/S0079-6603(00)64009-6; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; Dimova E, 2007, THROMB HAEMOSTASIS, V98, P296, DOI 10.1160/TH07-02-0140; Eberhardt W, 2002, KIDNEY INT, V62, P809, DOI 10.1046/j.1523-1755.2002.00538.x; Ebert BL, 1998, MOL CELL BIOL, V18, P4089, DOI 10.1128/MCB.18.7.4089; Fagan KA, 2004, AM J PHYSIOL-LUNG C, V287, pL656, DOI 10.1152/ajplung.00090.2003; Fediuk J, 2012, AM J PHYSIOL-LUNG C, V302, pL13, DOI 10.1152/ajplung.00016.2011; Fonseca C, 2011, AM J RESP CELL MOL, V44, P1, DOI 10.1165/rcmb.2009-0388TR; Frohlich S, 2013, AM J RESP CELL MOL, V48, P271, DOI 10.1165/rcmb.2012-0137TR; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; Garat CV, 2010, J CARDIOVASC PHARM, V55, P469, DOI 10.1097/FJC.0b013e3181d64dbe; Grossmann C, 2010, FASEB J, V24, P2010, DOI 10.1096/fj.09-146985; Hai CM, 2005, J APPL PHYSIOL, V98, P1356, DOI 10.1152/japplphysiol.00834.2004; HAKIM TS, 1982, J APPL PHYSIOL, V53, P1110, DOI 10.1152/jappl.1982.53.5.1110; Hardy CL, 2013, THORAX, V68, P9, DOI 10.1136/thoraxjnl-2011-201128; Hopkins N, 2002, J ANAT, V201, P335, DOI 10.1046/j.1469-7580.2002.00096.x; Howell K, 2003, J PHYSIOL-LONDON, V547, P133, DOI 10.1113/jphysiol.2002.030676; Howell K, 2009, AM J PHYSIOL-LUNG C, V296, pL1042, DOI 10.1152/ajplung.90327.2008; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Hyvelin JM, 2005, CIRC RES, V97, P185, DOI 10.1161/01.RES.0000174287.17953.83; Hyvelin JM, 2004, AM J PHYSIOL-LUNG C, V287, pL673, DOI 10.1152/ajplung.00331.2003; Illi B, 2000, CIRC RES, V86, pE110; Klemm DJ, 2001, J BIOL CHEM, V276, P46132, DOI 10.1074/jbc.M104769200; Klemm DJ, 2011, J CARDIOVASC PHARM, V58, P181, DOI 10.1097/FJC.0b013e31821f2773; Kvietikova I, 1997, KIDNEY INT, V51, P564, DOI 10.1038/ki.1997.80; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Kwapiszewska G, 2012, AM J PATHOL, V181, P2018, DOI 10.1016/j.ajpath.2012.08.028; Leonard MO, 2008, AM J RESP CRIT CARE, V178, P977, DOI 10.1164/rccm.200712-1890OC; Ludbrook J, 1998, CLIN EXP PHARMACOL P, V25, P1032, DOI 10.1111/j.1440-1681.1998.tb02179.x; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; MARTORANA PA, 1990, AM REV RESPIR DIS, V142, P333, DOI 10.1164/ajrccm/142.2.333; MARTORANA PA, 1989, AM REV RESPIR DIS, V139, P226, DOI 10.1164/ajrccm/139.1.226; McLoughlin P, 2011, COMPR PHYSIOL, V1, P1473, DOI 10.1002/cphy.c100034; Meyuhas R, 2008, MOL CANCER RES, V6, P1397, DOI 10.1158/1541-7786.MCR-07-2086; MORI Y, 1993, J BIOL CHEM, V268, P26482; Nagaoka T, 2004, AM J PHYSIOL-LUNG C, V287, pL665, DOI 10.1152/ajplung.00050.2003; Nakayama K, 2013, J BIOL CHEM; Rich S, 2003, CIRCULATION, V108, P2184, DOI 10.1161/01.CIR.0000094397.19932.78; Robertson TP, 2000, BRIT J PHARMACOL, V131, P5, DOI 10.1038/sj.bjp.0703537; Rudolph D, 1998, P NATL ACAD SCI USA, V95, P4481, DOI 10.1073/pnas.95.8.4481; Signorelli S, 2010, CELL PHYSIOL BIOCHEM, V25, P135, DOI 10.1159/000272066; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Taylor CT, 2000, P NATL ACAD SCI USA, V97, P12091, DOI 10.1073/pnas.220211797; Tokunou T, 2003, CIRCULATION, V108, P1246, DOI 10.1161/01.CIR.0000085164.13439.89; West JB, 2004, ANN INTERN MED, V141, P789, DOI 10.7326/0003-4819-141-10-200411160-00010; Winters SJ, 2007, MOL CELL ENDOCRINOL, V271, P45, DOI 10.1016/j.mce.2007.03.006; Yndestad A, 2009, J APPL PHYSIOL, V106, P1356, DOI 10.1152/japplphysiol.90719.2008; Zhang S, 2004, AM J PHYSIOL-CELL PH, V287, pC1192, DOI 10.1152/ajpcell.00158.2004	58	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2013	8	12							e80637	10.1371/journal.pone.0080637	http://dx.doi.org/10.1371/journal.pone.0080637			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VD	24349008	gold, Green Published, Green Submitted			2022-12-27	WOS:000328705200009
J	Hansen, J; Kharecha, P; Sato, M; Masson-Delmotte, V; Ackerman, F; Beerling, DJ; Hearty, PJ; Hoegh-Guldberg, O; Hsu, SL; Parmesan, C; Rockstrom, J; Rohling, EJ; Sachs, J; Smith, P; Steffen, K; Van Susteren, L; von Schuckmann, K; Zachos, JC				Hansen, James; Kharecha, Pushker; Sato, Makiko; Masson-Delmotte, Valerie; Ackerman, Frank; Beerling, David J.; Hearty, Paul J.; Hoegh-Guldberg, Ove; Hsu, Shi-Ling; Parmesan, Camille; Rockstrom, Johan; Rohling, Eelco J.; Sachs, Jeffrey; Smith, Pete; Steffen, Konrad; Van Susteren, Lise; von Schuckmann, Karina; Zachos, James C.			Assessing "Dangerous Climate Change": Required Reduction of Carbon Emissions to Protect Young People, Future Generations and Nature	PLOS ONE			English	Review							RAPID SEA-LEVEL; GREENHOUSE-GAS EMISSIONS; LAND-USE; PROBABILISTIC ASSESSMENT; INTENSE PRECIPITATION; ANTHROPOGENIC CARBON; GLOBAL TEMPERATURE; SOLAR IRRADIANCE; METHANE HYDRATE; CHANGE IMPACTS	We assess climate impacts of global warming using ongoing observations and paleoclimate data. We use Earth's measured energy imbalance, paleoclimate data, and simple representations of the global carbon cycle and temperature to define emission reductions needed to stabilize climate and avoid potentially disastrous impacts on today's young people, future generations, and nature. A cumulative industrial-era limit of similar to 500 GtC fossil fuel emissions and 100 GtC storage in the biosphere and soil would keep climate close to the Holocene range to which humanity and other species are adapted. Cumulative emissions of similar to 1000 GtC, sometimes associated with 2 degrees C global warming, would spur "slow" feedbacks and eventual warming of 3-4 degrees C with disastrous consequences. Rapid emissions reduction is required to restore Earth's energy balance and avoid ocean heat uptake that would practically guarantee irreversible effects. Continuation of high fossil fuel emissions, given current knowledge of the consequences, would be an act of extraordinary witting intergenerational injustice. Responsible policymaking requires a rising price on carbon emissions that would preclude emissions from most remaining coal and unconventional fossil fuels and phase down emissions from conventional fossil fuels.	[Hansen, James; Kharecha, Pushker; Sato, Makiko; Sachs, Jeffrey] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Kharecha, Pushker] NASA, Goddard Inst Space Studies, New York, NY 10025 USA; [Masson-Delmotte, Valerie] CEA CNRS UVSQ, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Ackerman, Frank] Synapse Energy Econ, Cambridge, MA USA; [Beerling, David J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Hearty, Paul J.] Univ N Carolina, Dept Environm Studies, Wilmington, NC 28401 USA; [Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia; [Hsu, Shi-Ling] Florida State Univ, Coll Law, Tallahassee, FL 32306 USA; [Parmesan, Camille] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Parmesan, Camille] Univ Texas Austin, Austin, TX 78712 USA; [Rockstrom, Johan] Stockholm Univ, Stockholm Resilience Ctr, S-10691 Stockholm, Sweden; [Rohling, Eelco J.] Univ Southampton, Sch Ocean & Earth Sci, Southampton, Hants, England; [Rohling, Eelco J.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Smith, Pete] Univ Aberdeen, Aberdeen, Scotland; [Steffen, Konrad] Swiss Fed Res Inst WSL, Swiss Fed Inst Technol, Zurich, Switzerland; [Van Susteren, Lise] Harvard Univ, Sch Publ Hlth, Advisory Board, Ctr Hlth & Global Environm, Boston, MA 02115 USA; [von Schuckmann, Karina] IFREMER, Toulon, France; [Zachos, James C.] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA	Columbia University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Sheffield; University of North Carolina; University of North Carolina Wilmington; University of Queensland; State University System of Florida; Florida State University; University of Plymouth; University of Texas System; University of Texas Austin; Stockholm University; NERC National Oceanography Centre; University of Southampton; Australian National University; University of Aberdeen; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institute for Forest, Snow & Landscape Research; Harvard University; Harvard T.H. Chan School of Public Health; Ifremer; University of California System; University of California Santa Cruz	Hansen, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	jimehansen@gmail.com	Parmesan, Camille/GVT-5674-2022; Zachos, James C/A-7674-2008; Hoegh-Guldberg, Ove/ABA-5420-2020; von Schuckmann, Karina/AAZ-8897-2021; Rohling, Eelco J/B-9736-2008; Masson-Delmotte, Valerie L/G-1995-2011; Beerling, David J/C-2840-2009; Steffen, Konrad/C-6027-2013; Smith, Pete/G-1041-2010; Hanson, Jamie/B-9420-2014	Zachos, James C/0000-0001-8439-1886; Hoegh-Guldberg, Ove/0000-0001-7510-6713; von Schuckmann, Karina/0000-0002-9922-8528; Rohling, Eelco J/0000-0001-5349-2158; Masson-Delmotte, Valerie L/0000-0001-8296-381X; Beerling, David J/0000-0003-1869-4314; Steffen, Konrad/0000-0001-8658-1026; Smith, Pete/0000-0002-3784-1124; Parmesan, Camille/0000-0002-1515-274X; Ackerman, Frank/0000-0002-7940-482X; Hanson, Jamie/0000-0002-0469-8886; Hair, Nicole L./0000-0001-8559-5717; Rockstrom, Johan/0000-0001-8988-2983	NASA; Flora Family Foundation; Jeremy Grantham, ClimateWorks; Energy Foundation; NERC [NE/H004424/1, NE/I009906/1] Funding Source: UKRI; Natural Environment Research Council [NE/I009906/1, NE/H004424/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Flora Family Foundation; Jeremy Grantham, ClimateWorks; Energy Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding came from: NASA Climate Research Funding, Gifts to Columbia University from H. F. ("Gerry") Lenfest, private philanthropist (no web site, but see http://en.wikipedia.org/wiki/H._F._Lenfest), Jim Miller, Lee Wasserman (Rockefeller Family Fund) (http://www.rffund.org/), Flora Family Foundation (http://www.florafamily.org/), Jeremy Grantham, ClimateWorks and the Energy Foundation provided support for Hansen's Climate Science, Awareness and Solutions program at Columbia University to complete this research and publication. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman F, 2012, ECONOMICS-KIEL, V6, DOI 10.5018/economics-ejournal.ja.2012-10; Ackerman F, 2009, CLIMATIC CHANGE, V95, P297, DOI 10.1007/s10584-009-9570-x; Alexander LV, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006290; Alford RA, 2007, NATURE, V447, pE3, DOI 10.1038/nature05940; Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Allen L., 2011, THE WORLDS WATER, V7, P73; Allen MR, 2009, NATURE, V458, P1163, DOI 10.1038/nature08019; Alvarez RA, 2012, P NATL ACAD SCI US; American Physical Society (APS), 2011, DIR AIR CAPT CO2 CHE; [Anonymous], 2012, BP STAT REV WORLD EN; [Anonymous], 2013, ECONOMIST; Archer D, 2007, BIOGEOSCIENCES, V4, P521, DOI 10.5194/bg-4-521-2007; Archer D, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002625; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Barker PM, 2011, J ATMOS OCEAN TECH, V28, P1036, DOI 10.1175/2011JTECHO831.1; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Barriopedro D, 2011, SCIENCE, V332, P220, DOI 10.1126/science.1201224; Beerling DJ, 2011, NAT GEOSCI, V4, P418, DOI 10.1038/ngeo1186; Beerling DJ, 2011, P NATL ACAD SCI USA, V108, P9770, DOI 10.1073/pnas.1102409108; Bentley CR, 1997, SCIENCE, V275, P1077, DOI 10.1126/science.275.5303.1077; BERGER AL, 1978, J ATMOS SCI, V35, P2362, DOI [10.1175/1520-0469(1978)035<2362:LTVODI>2.0.CO;2, 10.1016/0033-5894(78)90064-9]; Berner RA, 2004, PHANEOROZIC CARBON C; Blanchon P, 2009, NATURE, V458, P881, DOI 10.1038/nature07933; Boden T. A., 2011, GLOBAL REGIONAL NATL, DOI [10.3334/CDIAC/00001_V2010, DOI 10.3334/CDIAC/00001_, 10.3334/CDIAC/00001_V2012]; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bond T. C., 2013, J GEOPHYS R IN PRESS; Briffa KR, 2009, INT J CLIMATOL, V29, P1894, DOI 10.1002/joc.1836; Broecker W.S., 1982, TRACERS SEA; Broecker WS, 1990, PALEOCEANOGRAPHY, V5, P469, DOI 10.1029/PA005i004p00469; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Budyko M. I., 1977, CLIMATIC CHANGES, DOI [DOI 10.1029/SP010, 10.1029/SP010]; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; Caldeira K, 2003, NATURE, V425, P365, DOI 10.1038/425365a; Charpentier AD, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/014005; Chen YY, 2013, P NATL ACAD SCI USA, V110, P12936, DOI 10.1073/pnas.1300018110; Cohen AJ, 2005, J TOXICOL ENV HEAL A, V68, P1301, DOI 10.1080/15287390590936166; Copenhagen Accord, 2009, UN FRAM CONV CLIM CH; Dahl-Jensen D, 2013, NATURE, V493, P489, DOI 10.1038/nature11789; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; Dai AG, 2011, WIRES CLIM CHANGE, V2, P45, DOI 10.1002/wcc.81; Davidson DJ, 2013, SCIENCE, V339, P1286, DOI 10.1126/science.1234205; Davis SM, 2011, J CLIMATOL, DOI [10.1175/JCLI-D-1111-00127.00121, DOI 10.1175/JCLI-D-1111-00127.00121]; De Angelis H, 2003, SCIENCE, V299, P1560, DOI 10.1126/science.1077987; De'ath G, 2009, SCIENCE, V323, P116, DOI 10.1126/science.1165283; DeConto RM, 2012, NATURE, V484, P87, DOI 10.1038/nature10929; Di Rosa I, 2007, NATURE, V447, pE4, DOI 10.1038/nature05941; DICKENS GR, 1995, PALEOCEANOGRAPHY, V10, P965, DOI 10.1029/95PA02087; Dutton A, 2012, SCIENCE, V337, P216, DOI 10.1126/science.1205749; Dwyer GS, 2009, PHILOS T R SOC A, V367, P157, DOI 10.1098/rsta.2008.0222; Eby M, 2009, J CLIMATE, V22, P2501, DOI 10.1175/2008JCLI2554.1; EDDY JA, 1976, SCIENCE, V192, P1189, DOI 10.1126/science.192.4245.1189; Energy Information Agency (EIA), 2011, INT EN OUTL; Energy Resources and Conservation Board, 2012, ALB EN RES 2011 SUPP; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Foster GL, 2013, P NATL ACAD SCI USA, V110, P1209, DOI 10.1073/pnas.1216073110; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fritze J. G., 2008, INT J MENT HEALTH SY, V7, P2; Frohlich C, 2006, SPACE SCI REV, V125, P53, DOI 10.1007/s11214-006-9046-5; Frohlich C, 1998, GEOPHYS RES LETT, V25, P4377, DOI 10.1029/1998GL900157; German Advisory Council on Global Change (GAC), 2011, WORLD TRANS SOC CONT; Gleckler PJ, 2006, NATURE, V439, P675, DOI 10.1038/439675a; Gottlieb D, 1996, J GENET PSYCHOL, V157, P104, DOI 10.1080/00221325.1996.9914849; Gregory KB, 2011, ELEMENTS, V7, P181, DOI 10.2113/gselements.7.3.181; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; Groisman PY, 2005, J CLIMATE, V18, P1326, DOI 10.1175/JCLI3339.1; Hanna E, 2013, NATURE, V498, P51, DOI 10.1038/nature12238; Hansen J, 2000, P NATL ACAD SCI USA, V97, P9875, DOI 10.1073/pnas.170278997; Hansen J, 2007, ATMOS CHEM PHYS, V7, P2287, DOI 10.5194/acp-7-2287-2007; Hansen J, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005776; Hansen J, 2004, P NATL ACAD SCI USA, V101, P16109, DOI 10.1073/pnas.0406982101; Hansen J, 2011, ATMOS CHEM PHYS, V11, P13421, DOI 10.5194/acp-11-13421-2011; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hansen J., 2008, Open Atmosphere Science Journal, V2, P217, DOI 10.2174/1874282300802010217; Hansen J, 1997, J GEOPHYS RES-ATMOS, V102, P25679, DOI 10.1029/97JD01495; Hansen JE, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024002; Hansen J.E., 2012, PALEOCLIMATE IMPLICA, P21; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; Hansen J, 2006, P NATL ACAD SCI USA, V103, P14288, DOI 10.1073/pnas.0606291103; Hansen J, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0294; Hansen J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/011006; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hansen James, 2009, STORMS MY GRANDCHILD; Hansen JE, 2005, CLIMATIC CHANGE, V68, P269, DOI 10.1007/s10584-005-4135-0; Harris NL, 2012, SCIENCE, V336, P1573, DOI 10.1126/science.1217962; Hearty PJ, 2007, QUATERNARY SCI REV, V26, P2090, DOI 10.1016/j.quascirev.2007.06.019; Hearty PJ, 2010, PALAEOGEOGR PALAEOCL, V293, P9, DOI 10.1016/j.palaeo.2010.04.026; Hearty PJ, 2001, QUATERNARY SCI REV, V20, P1881, DOI 10.1016/S0277-3791(01)00021-X; Held IM, 2005, P NATL ACAD SCI USA, V102, P17891, DOI 10.1073/pnas.0509057102; Held IM, 2006, J CLIMATE, V19, P5686, DOI 10.1175/JCLI3990.1; Hicks D., 2001, ENVIRON EDUC RES, V7, P413, DOI [10.1080/13504620120081287, DOI 10.1080/13504620120081287]; Hill DJ, 2007, DEEP-TIME PERSPECTIVES ON CLIMATE CHANGE: MARRYING THE SIGNAL FROM COMPUTER MODELS AND BIOLOGICAL PROXIES, P517; Hillel D, 2011, HDB CLIMATE CHANGE A; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Houghton RA, 2003, TELLUS B, V55, P378, DOI 10.1034/j.1600-0889.2003.01450.x; House KZ, 2011, P NATL ACAD SCI USA, V108, P20428, DOI 10.1073/pnas.1012253108; Hsu, 2011, CASE CARBON TAX; Hughes T, 1972, ISCAP B, V1; Huntingford C, 2013, NAT GEOSCI, V6, P268, DOI [10.1038/ngeo1741, 10.1038/NGEO1741]; Intergovernmental Panel on Climate Change, 2013, APPROVED SUMMARY POL; International Energy Agency, 2012, IEA WORLD EN STAT BA, DOI [10.1787/data-00512-en, DOI 10.1787/DATA-00512-EN.ACCESSED]; International Energy Agency, 2012, WORLD EN OUTL 2012; Johanson TB, 2012, SUSTAINBALE FUTURE; Johnson EA, 2008, ANN NY ACAD SCI, V1134, P120, DOI 10.1196/annals.1439.007; Jones GS, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017013; Joos F, 1996, TELLUS B, V48, P397, DOI 10.1034/j.1600-0889.1996.t01-2-00006.x; Jordaan S.M., 2009, ENVIRON RES LETT, V4, P1; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Kargbo DM, 2010, ENVIRON SCI TECHNOL, V44, P5679, DOI 10.1021/es903811p; Kaser G, 2010, P NATL ACAD SCI USA, V107, P20223, DOI 10.1073/pnas.1008162107; Keith DW, 2006, CLIMATIC CHANGE, V74, P17, DOI 10.1007/s10584-005-9026-x; Kelly EN, 2010, P NATL ACAD SCI USA, V107, P16178, DOI 10.1073/pnas.1008754107; KENNETT JP, 1991, NATURE, V353, P225, DOI 10.1038/353225a0; Kharecha PA, 2013, ENVIRON SCI TECHNOL, V47, P4889, DOI 10.1021/es3051197; Kharecha PA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003142; Kohler P, 2010, QUATERNARY SCI REV, V29, P29; Komanoff C, 2011, 5 SECTOR CARBON TAX; Kopp RE, 2009, NATURE, V462, P863, DOI 10.1038/nature08686; Kosaka Y, 2013, NATURE, V501, P403, DOI 10.1038/nature12534; KRAMER D, 2012, PHYS TODAY, V65, P22; Kurek J, 2013, P NATL ACAD SCI USA, V110, P1761, DOI 10.1073/pnas.1217675110; KVENVOLDEN KA, 1993, REV GEOPHYS, V31, P173, DOI 10.1029/93RG00268; Lamb D, 2011, WORLD FORESTS, V8, P1, DOI 10.1007/978-90-481-9870-2; LEAN J, 1995, GEOPHYS RES LETT, V22, P3195, DOI 10.1029/95GL03093; Levi BG, 2008, PHYS TODAY, V61, P16, DOI 10.1063/1.2911164; Levitus S, 2001, SCIENCE, V292, P267, DOI 10.1126/science.1058154; Levitus S, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051106; Lewis SC, 2013, GEOPHYS RES LETT, V40, P3705, DOI 10.1002/grl.50673; Liu J, 2012, CLIM PAST, V8, P1169, DOI 10.5194/cp-8-1169-2012; Lochhead C, 2013, SAN FRANCISO CH 0308; Lu Z, 2011, ATMOS CHEM PHYS, V11, P9839, DOI 10.5194/acp-11-9839-2011; Lunt DJ, 2010, NAT GEOSCI, V3, P60, DOI 10.1038/NGEO706; Lyman JM, 2010, NATURE, V465, P334, DOI 10.1038/nature09043; Mahlstein I, 2013, NAT CLIM CHANGE, V3, P739, DOI [10.1038/NCLIMATE1876, 10.1038/nclimate1876]; Malhi Y, 2010, CURR OPIN ENV SUST, V2, P237, DOI 10.1016/j.cosust.2010.08.002; Marcott SA, 2013, SCIENCE, V339, P1198, DOI 10.1126/science.1228026; Masson-Delmotte V, 2010, QUATERNARY SCI REV, V29, P113, DOI 10.1016/j.quascirev.2009.09.030; Matthews HD, 2009, NATURE, V459, P829, DOI 10.1038/nature08047; Matthews HD, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028685; Max MD, 2003, NATURAL GAS HYDRATE; McAuley SD, 2006, GROUND WATER QUALITY; McCormick BC, 2009, WATER RESOUR RES, V45; McKibben B, 2012, ROLLING STONE   0802; Meehl GA, 2013, GEOPHYS RES LETT, V40, P1789, DOI 10.1002/grl.50361; Meinshausen M, 2009, NATURE, V458, P1158, DOI 10.1038/nature08017; Metz ORDB, 2007, CLIMATE CHANGE 2007; Meyssignac B, 2012, J GEODYN, V58, P96, DOI 10.1016/j.jog.2012.03.005; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Mishchenko MI, 2007, B AM METEOROL SOC, V88, P677, DOI 10.1175/BAMS-88-5-677; Murphy DM, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012105; Murphy DJ, 2011, ANN NY ACAD SCI, V1219, P52, DOI 10.1111/j.1749-6632.2010.05940.x; Naik V, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD005908; Naish TR, 2009, PHILOS T R SOC A, V367, P169, DOI 10.1098/rsta.2008.0223; Negley TL, 2006, HYDROL PROCESS, V20, P3467, DOI 10.1002/hyp.6148; O'Connor FM, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000326; O'Leary MJ, 2013, NATURE GEOSCI, DOI [10.1038/NGEO1890, DOI 10.1038/NGE01890]; O'Sullivan F, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/044030; Olson SL, 2003, P NATL ACAD SCI USA, V100, P12825, DOI 10.1073/pnas.1934576100; Olson SL, 2010, BIOL LETTERS, V6, P807, DOI 10.1098/rsbl.2010.0423; Oppenheimer M, 1998, NATURE, V393, P325, DOI 10.1038/30661; Oreskes N., 2010, MERCHANTS DOUBT; Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108; Pagani M, 2010, NAT GEOSCI, V3, P27, DOI 10.1038/NGEO724; Palmer MA, 2010, SCIENCE, V327, P148, DOI 10.1126/science.1180543; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parry M. L., 2007, CLIMATE CHANGE 2007; Pauwelyn J, 2012, RES HDB ENV; Pelejero C, 2010, TRENDS ECOL EVOL, V25, P332, DOI 10.1016/j.tree.2010.02.002; Petron G, 2013, J GEOPHYS RES, V118; Petron G, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016360; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; Pounds JA, 2007, NATURE, V447, pE5, DOI 10.1038/nature05942; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Pounds JA, 1999, NATURE, V398, P611, DOI 10.1038/19297; Pritchard HD, 2012, NATURE, V484, P502, DOI 10.1038/nature10968; Rabatel A, 2013, CRYOSPHERE, V7, P81, DOI 10.5194/tc-7-81-2013; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Rampal P, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC007110; Randalls S, 2010, WIRES CLIM CHANGE, V1, P598, DOI 10.1002/wcc.62; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Raven J, 2005, OCEAN ACIDIFICATION; Raymo ME, 2011, NAT GEOSCI, V4, P328, DOI [10.1038/ngeo1118, 10.1038/NGEO1118]; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; Ridgwell A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001372; Rignot E, 2011, GEOPHYS RES LETT, V38, DOI DOI 10.1029/2011GL046583; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; Riverkeeper, 2011, FRACTURED COMMUNITIE; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Robock A, 2000, REV GEOPHYS, V38, P191, DOI 10.1029/1998RG000054; Robock A, 2008, B ATOM SCI, V64, P14, DOI 10.1080/00963402.2008.11461140; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Roemmich D, 2009, PROG OCEANOGR, V82, P81, DOI 10.1016/j.pocean.2009.03.004; Rohling EJ, 2008, NAT GEOSCI, V1, P38, DOI 10.1038/ngeo.2007.28; Rohling EJ, 2012, NATURE, V491, P683, DOI 10.1038/nature11574; Rohling EJ, 2012, J CLIMATE, V25, P1635, DOI 10.1175/2011JCLI4078.1; Rooney RC, 2012, P NATL ACAD SCI USA, V109, P4933, DOI 10.1073/pnas.1117693108; Sarmiento JL, 2010, BIOGEOSCIENCES, V7, P2351, DOI 10.5194/bg-7-2351-2010; Schmidt Charles W, 2011, Environ Health Perspect, V119, pA348, DOI 10.1289/ehp.119-a348; Schneider SH, 2005, P NATL ACAD SCI USA, V102, P15728, DOI 10.1073/pnas.0506356102; Seager R, 2012, J CLIMATE, V25, P3355, DOI 10.1175/JCLI-D-11-00363.1; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Searle K, 2010, INT J CLIM CHANG STR, V2, P362, DOI 10.1108/17568691011089891; Seidel DJ, 2008, NAT GEOSCI, V1, P21, DOI 10.1038/ngeo.2007.38; Seimon TA, 2007, GLOBAL CHANGE BIOL, V13, P288, DOI 10.1111/j.1365-2486.2006.01278.x; Shakhova N, 2010, SCIENCE, V327, P1246, DOI 10.1126/science.1182221; Sheffield J, 2012, NATURE, V491, P435, DOI 10.1038/nature11575; Shepherd A, 2012, SCIENCE, V338, P1183, DOI 10.1126/science.1228102; Shepherd J, 2009, GEOENGINEERING CLIMA; Simmons JA, 2008, ECOL APPL, V18, P104, DOI 10.1890/07-1117.1; Smith JB, 2009, P NATL ACAD SCI USA, V106, P4133, DOI 10.1073/pnas.0812355106; Smith P, 2012, GLOBAL CHANGE BIOL, V18, P35, DOI 10.1111/j.1365-2486.2011.02517.x; Smith P, 2010, PHILOS T R SOC B, V365, P2941, DOI 10.1098/rstb.2010.0127; Solomon S., 2007, PHYS SCI BASIS WORKI; Solomon S, 2010, P NATL ACAD SCI USA, V107, P18354, DOI 10.1073/pnas.1006282107; Sorg A, 2012, NAT CLIM CHANGE, V2, P725, DOI [10.1038/NCLIMATE1592, 10.1038/nclimate1592]; Stehfest E, 2009, CLIMATIC CHANGE, V95, P83, DOI 10.1007/s10584-008-9534-6; STERN N, 2007, STERN REV EC CLIMATE; Stocker BD, 2011, BIOGEOSCIENCES, V8, P69, DOI 10.5194/bg-8-69-2011; Stocker TF, 2013, SCIENCE, V339, P280, DOI 10.1126/science.1232468; Stott PA, 2004, NATURE, V432, P610, DOI 10.1038/nature03089; Stroeve JC, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL052676; TAYLOR JD, 1979, PHILOS T ROY SOC B, V286, P47, DOI 10.1098/rstb.1979.0015; Tedesco M, 2012, CRYOSPHERE DISCUSSIO, V6, P4939, DOI DOI 10.5194/TCD-6-4939-2012; Thompson WG, 2011, NAT GEOSCI, V4, P684, DOI [10.1038/ngeo1253, 10.1038/NGEO1253]; Till C.E., 2011, PLENTIFUL ENERGY STO; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tollefson J, 2013, NATURE, V493, P12, DOI 10.1038/493012a; Tollefson J, 2012, NATURE, V482, P139, DOI 10.1038/482139a; United States Department of State, 2011, FIN ENV IMP STAT; US, 2012, ANN EN REV 2011; Vergara W., 2007, EOS T AM GEOPHYS UN, V88, P261, DOI [DOI 10.1029/2007EO250001, 10.1029/2007EO250001]; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; von Schuckmann K, 2011, OCEAN SCI, V7, P783, DOI 10.5194/os-7-783-2011; Walter KM, 2006, NATURE, V443, P71, DOI 10.1038/nature05040; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Wood MC, 2009, ADJUDICATING CLIMATE CHANGE: STATE, NATIONAL, AND INTERNATIONAL APPROACHES, P99, DOI 10.1017/CBO9780511596766.007; Yao TD, 2012, NAT CLIM CHANGE, V2, P663, DOI [10.1038/NCLIMATE1580, 10.1038/nclimate1580]; Yeh S, 2010, ENVIRON SCI TECHNOL, V44, P8766, DOI 10.1021/es1013278; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zeebe RE, 2009, NAT GEOSCI, V2, P576, DOI 10.1038/NGEO578; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	248	358	363	16	414	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2013	8	12							e81648	10.1371/journal.pone.0081648	http://dx.doi.org/10.1371/journal.pone.0081648			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	265JR	24349025	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000327947800051
J	Chuang, MJ; Wu, ST; Tang, SH; Lai, XM; Lai, HC; Hsu, KH; Sun, KH; Sun, GH; Chang, SY; Yu, DS; Hsiao, PW; Huang, SM; Cha, TL				Chuang, Mei-Jen; Wu, Sheng-Tang; Tang, Shou-Hung; Lai, Xiang-Me; Lai, Hsiao-Chu; Hsu, Kai-Hsiang; Sun, Kuang-Hui; Sun, Guang-Huan; Chang, Sun-Yran; Yu, Dah-Shyong; Hsiao, Pei-Wen; Huang, Shih-Ming; Cha, Tai-Lung			The HDAC Inhibitor LBH589 Induces ERK-Dependent Prometaphase Arrest in Prostate Cancer via HDAC6 Inactivation and Down-Regulation	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CHAPERONE FUNCTION; PHOSPHATASE 2A; CELL-DEATH; KINASE; ACTIVATION; ACETYLATION; APOPTOSIS; AURORA; PP1	Histone deacetylase inhibitors (HDACIs) have potent anti-cancer activity in a variety of cancer models. Understanding the molecular mechanisms involved in the therapeutic responsiveness of HDACI is needed before its clinical application. This study aimed to determine if a potent HDACI, LBH589 (Panobinostat), had differential therapeutic responsiveness towards LNCaP and PC-3 prostate cancer (PCa) cells. The former showed prometaphase arrest with subsequent apoptosis upon LBH589 treatment, while the latter was less sensitive and had late G2 arrest. The LBH589 treatment down-regulated HDAC6 and sustained ERK activation, and contributed to prometaphase arrest. Mechanistically, LBH589 inhibited HDAC6 activity, caused its dissociation from protein phosphatase PP1 alpha, and increased 14-3-3. acetylation. Acetylated 14-3-3 zeta released its mask effect on serine 259 of c-Raf and serine 216 of Cdc25C subsequent to de-phosphorylation by PP1 alpha, which contributed to ERK activation. Enhanced ERK activity by LBH589 further down-regulated HDAC6 protein levels and sustained ERK activation by free-forward regulation. The sustained Cdc25C and ERK activation resulted in early M-phase (prometaphase) arrest and subsequent apoptosis in the most sensitive LNCaP cells but not in PC-3 cells. This study provides pre-clinical evidence that HDAC6 may serve as a sensitive therapeutic target in the treatment of prostate cancer with HDACI LBH589 for clinical translation. This study also posits a novel mechanism of HDAC6 participation in regulating the c-Raf-PP1-ERK signaling pathway and contributing to M phase cell-cycle transition.	[Chuang, Mei-Jen; Wu, Sheng-Tang; Tang, Shou-Hung; Sun, Guang-Huan; Chang, Sun-Yran; Yu, Dah-Shyong; Cha, Tai-Lung] Triserv Gen Hosp, Natl Def Med Ctr, Dept Surg, Div Urol, Taipei, Taiwan; [Hsiao, Pei-Wen] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Sun, Kuang-Hui] Natl Yang Ming Univ, Dept Biotechnol & Lab Sci Med, Taipei 112, Taiwan; [Huang, Shih-Ming; Cha, Tai-Lung] Natl Def Med Ctr, Dept Biochem, Taipei 10764, Taiwan; [Chang, Sun-Yran] Taipei City Hosp, Taipei, Taiwan; [Lai, Hsiao-Chu; Hsu, Kai-Hsiang; Cha, Tai-Lung] Natl Def Med Ctr, Dept Microbiol & Immunol, Taipei, Taiwan; [Lai, Xiang-Me; Cha, Tai-Lung] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Defense Medical Center; Taipei City Hospital; National Defense Medical Center; National Defense Medical Center	Cha, TL (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Surg, Div Urol, Taipei, Taiwan.	tlcha@ndmctsgh.edu.tw	Hsiao, Pei-Wen/V-5653-2018; Bee, Mark A./A-9410-2013	Hsiao, Pei-Wen/0000-0002-3589-6754; Bee, Mark A./0000-0002-6770-9730; Chuang, Ming-Feng/0000-0002-7328-2577; Lai, Xiang-Me/0000-0002-1684-502X; Higgs, Dennis/0000-0002-0771-4642	National Science Council [97-2314-B-016-023-MY3, 99-2628-B-016-012-MY3]; Tri-Service General Hospital Research Foundation, Taiwan, ROC [TSGH-C101-009-S02, TSGH-C100-128, TSGH-C99-012-13-S03]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital Research Foundation, Taiwan, ROC	This work was supported by grants from the National Science Council (97-2314-B-016-023-MY3 and 99-2628-B-016-012-MY3) and from the Tri-Service General Hospital Research Foundation (TSGH-C101-009-S02, TSGH-C100-128 and TSGH-C99-012-13-S03), Taiwan, ROC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham D, 2000, J BIOL CHEM, V275, P22300, DOI 10.1074/jbc.M003259200; Adams DG, 2005, J BIOL CHEM, V280, P42644, DOI 10.1074/jbc.M502464200; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Atadja P, 2009, CANCER LETT, V280, P233, DOI 10.1016/j.canlet.2009.02.019; Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Brush MH, 2004, J BIOL CHEM, V279, P7685, DOI 10.1074/jbc.M310997200; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cha TL, 2009, CLIN CANCER RES, V15, P840, DOI 10.1158/1078-0432.CCR-08-1918; Chen CS, 2005, J BIOL CHEM, V280, P38879, DOI 10.1074/jbc.M505733200; Chong H, 2003, CELL SIGNAL, V15, P463, DOI 10.1016/S0898-6568(02)00139-0; Dhillon AS, 2007, CELL CYCLE, V6, P3, DOI 10.4161/cc.6.1.3593; Dhillon AS, 2002, ARCH BIOCHEM BIOPHYS, V404, P3, DOI 10.1016/S0003-9861(02)00244-8; Dougherty MK, 2004, J CELL SCI, V117, P1875, DOI 10.1242/jcs.01171; Fiskus W, 2008, BLOOD, V112, P2896, DOI 10.1182/blood-2007-10-116319; Hollmann CA, 2006, CANCER RES, V66, P3550, DOI 10.1158/0008-5472.CAN-05-2498; Jaumot M, 2001, ONCOGENE, V20, P3949, DOI 10.1038/sj.onc.1204526; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kim YH, 2008, BIOCHEM PHARMACOL, V75, P1946, DOI 10.1016/j.bcp.2008.02.016; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Lai YJ, 2011, MOL CELL BIOL, V31, P912, DOI 10.1128/MCB.00895-10; Lee YJ, 2003, EXP CELL RES, V291, P251, DOI 10.1016/S0014-4827(03)00391-4; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; Margolis SS, 2006, MOL BIOL CELL, V17, P1779, DOI 10.1091/mbc.E05-08-0751; Margolis SS, 2003, EMBO J, V22, P5734, DOI 10.1093/emboj/cdg545; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Park JH, 2008, J MOL MED, V86, P117, DOI 10.1007/s00109-007-0260-8; Puri Pawan, 2011, Spermatogenesis, V1, P354; Qiu L, 2000, MOL BIOL CELL, V11, P2069, DOI 10.1091/mbc.11.6.2069; Rao R, 2012, ADV CANCER RES, V116, P239, DOI 10.1016/B978-0-12-394387-3.00007-0; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Shan B, 2008, J BIOL CHEM, V283, P21065, DOI 10.1074/jbc.M802786200; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tsai CH, 2009, CLIN CANCER RES, V15, P5435, DOI 10.1158/1078-0432.CCR-09-0298; Valenzuela-Fernandez A, 2008, TRENDS CELL BIOL, V18, P291, DOI 10.1016/j.tcb.2008.04.003; Wang RN, 2007, CELL, V128, P1119, DOI 10.1016/j.cell.2006.11.053; Wu JQ, 2009, NAT CELL BIOL, V11, P644, DOI 10.1038/ncb1871; Yang YH, 2008, CANCER RES, V68, P4833, DOI 10.1158/0008-5472.CAN-08-0644; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115	38	35	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 4	2013	8	9							e73401	10.1371/journal.pone.0073401	http://dx.doi.org/10.1371/journal.pone.0073401			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	219OE	24023871	Green Submitted, Green Published, gold			2022-12-27	WOS:000324515600100
J	Conte, M; Vasuri, F; Trisolino, G; Bellavista, E; Santoro, A; Degiovanni, A; Martucci, E; D'Errico-Grigioni, A; Caporossi, D; Capri, M; Maier, AB; Seynnes, O; Barberi, L; Musaro, A; Narici, MV; Franceschi, C; Salvioli, S				Conte, Maria; Vasuri, Francesco; Trisolino, Giovanni; Bellavista, Elena; Santoro, Aurelia; Degiovanni, Alessio; Martucci, Ermanno; D'Errico-Grigioni, Antonia; Caporossi, Daniela; Capri, Miriam; Maier, Andrea B.; Seynnes, Olivier; Barberi, Laura; Musaro, Antonio; Narici, Marco V.; Franceschi, Claudio; Salvioli, Stefano			Increased Plin2 Expression in Human Skeletal Muscle Is Associated with Sarcopenia and Muscle Weakness	PLOS ONE			English	Article							INSULIN SENSITIVITY; FAT INFILTRATION; PERILIPIN 2; APOPTOSIS; STORAGE; P53; OXIDATION; STRENGTH; EXERCISE; PROTEIN	Human aging is associated with a progressive loss of muscle mass and strength and a concomitant fat accumulation in form of inter-muscular adipose tissue, causing skeletal muscle function decline and immobilization. Fat accumulation can also occur as intra-muscular triglycerides (IMTG) deposition in lipid droplets, which are associated with perilipin proteins, such as Perilipin2 (Plin2). It is not known whether Plin2 expression changes with age and if this has consequences on muscle mass and strength. We studied the expression of Plin2 in the vastus lateralis (VL) muscle of both healthy subjects and patients affected by lower limb mobility limitation of different age. We found that Plin2 expression increases with age, this phenomenon being particularly evident in patients. Moreover, Plin2 expression is inversely correlated with quadriceps strength and VL thickness. To investigate the molecular mechanisms underpinning this phenomenon, we focused on IGF-1/p53 network/signalling pathway, involved in muscle physiology. We found that Plin2 expression strongly correlates with increased p53 activation and reduced IGF-1 expression. To confirm these observations made on humans, we studied mice overexpressing muscle-specific IGF-1, which are protected from sarcopenia. These mice resulted almost negative for the expression of Plin2 and p53 at two years of age. We conclude that fat deposition within skeletal muscle in form of Plin2-coated lipid droplets increases with age and is associated with decreased muscle strength and thickness, likely through an IGF-1- and p53-dependent mechanism. The data also suggest that excessive intramuscular fat accumulation could be the initial trigger for p53 activation and consequent loss of muscle mass and strength.	[Conte, Maria; Bellavista, Elena; Santoro, Aurelia; Capri, Miriam; Franceschi, Claudio; Salvioli, Stefano] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Conte, Maria; Bellavista, Elena; Santoro, Aurelia; Capri, Miriam; Franceschi, Claudio; Salvioli, Stefano] Univ Bologna, Interdept Ctr L Galvani CIG, Bologna, Italy; [Vasuri, Francesco; Degiovanni, Alessio; D'Errico-Grigioni, Antonia] Univ Bologna, S Orsola Malpighi Hosp, F Addarii Inst Oncol & Transplant Pathol, Bologna, Italy; [Trisolino, Giovanni; Martucci, Ermanno] Ist Ortoped Rizzoli, Bologna, Italy; [Caporossi, Daniela] Univ Rome Foro Italico, Dept Hlth Sci, Rome, Italy; [Maier, Andrea B.] Leiden Univ, Med Ctr, Dept Gerontol & Geriatr, Leiden, Netherlands; [Seynnes, Olivier] Norwegian Sch Sport Sci, Oslo, Norway; [Barberi, Laura; Musaro, Antonio] Univ Roma La Sapienza, IIM, DAHFMO Unit Histol & Med Embryol, Inst Pasteur Cenci Bolognetti, I-00185 Rome, Italy; [Narici, Marco V.] Univ Nottingham, Sch Grad Entry Med & Hlth, Div Clin Physiol, Derby Royal Hosp, Derby, England	University of Bologna; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; IRCCS Istituto Ortopedico Rizzoli; Foro Italico University of Rome; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Norwegian School of Sport Sciences; Fondazione Cenci Bolognetti; Sapienza University Rome; University of Nottingham	Conte, M (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	m.conte@unibo.it	Salvioli, Stefano/K-6663-2016; Musaro, Antonio/P-2953-2019; Franceschi, Claudio/L-4484-2017; Capri, Miriam/K-4700-2016; Maier, Andrea B./Q-5548-2019; Musarò, Antonio/K-9598-2016; Trisolino, Giovanni/I-3717-2019; Vasuri, Francesco/K-5418-2016; Maier, Andrea/W-7060-2019; Caporossi, Daniela/D-7434-2011; Bakker, Matthew/B-8610-2013	Salvioli, Stefano/0000-0002-6191-1225; Musaro, Antonio/0000-0002-2944-9739; Franceschi, Claudio/0000-0001-9841-6386; Capri, Miriam/0000-0001-9077-0401; Musarò, Antonio/0000-0002-2944-9739; Trisolino, Giovanni/0000-0002-0361-9920; Vasuri, Francesco/0000-0002-1145-6025; Maier, Andrea/0000-0001-7206-1724; Caporossi, Daniela/0000-0001-9628-0665; Salomon, Christine/0000-0003-4976-598X; Bakker, Matthew/0000-0003-0345-0587; D'ERRICO, ANTONIETTA/0000-0003-2747-3732; Santoro, Aurelia/0000-0002-7187-1116; Seynnes, Olivier/0000-0002-1289-246X; Conte, Maria/0000-0002-4621-9898	European Union [223576]; MRC [MR/K00414X/1] Funding Source: UKRI; Medical Research Council [MR/K00414X/1] Funding Source: researchfish	European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement no 223576 (MYOAGE) to CF, MN and AM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimura N, 2004, J BIOL CHEM, V279, P10070, DOI 10.1074/jbc.M308522200; Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Bosma M, 2012, DIABETES, V61, P2679, DOI 10.2337/db11-1402; Boylston WH, 2004, AGING CELL, V3, P283, DOI 10.1111/j.1474-9728.2004.00115.x; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Dirks-Naylor Amie J, 2011, Curr Aging Sci, V4, P269; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Gandolfi G, 2011, MEAT SCI, V88, P631, DOI 10.1016/j.meatsci.2011.02.020; Gjelstad IMF, 2012, ARCH PHYSIOL BIOCHEM, V118, P22, DOI 10.3109/13813455.2011.630009; Goodpaster BH, 2008, J APPL PHYSIOL, V105, P1498, DOI 10.1152/japplphysiol.90425.2008; Ho TC, 2007, CARDIOVASC RES, V76, P213, DOI 10.1016/j.cardiores.2007.06.032; HUSSAIN MA, 1993, J CLIN INVEST, V92, P2249, DOI 10.1172/JCI116828; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Koster A, 2011, J GERONTOL A-BIOL, V66, P888, DOI 10.1093/gerona/glr070; Marcus RL, 2010, J NUTR HEALTH AGING, V14, P362, DOI 10.1007/s12603-010-0081-2; Marcus Robin L, 2012, J Aging Res, V2012, P629637, DOI 10.1155/2012/629637; Minnaard R, 2009, J CLIN ENDOCR METAB, V94, P4077, DOI 10.1210/jc.2009-0352; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Okura T, 2000, EUR J PHARMACOL, V407, P227, DOI 10.1016/S0014-2999(00)00758-5; Pfaffl M.W., 2004, A Z QUANT PCR, P87; Schwarzkopf M., 2008, BASIC APPL MYOL, V18, P131; Scrable H, 2009, EXP GERONTOL, V44, P93, DOI 10.1016/j.exger.2008.05.017; Shaw CS, 2010, ANNU REV NUTR, V30, P13, DOI 10.1146/annurev.nutr.012809.104817; Shaw C, 2009, HISTOCHEM CELL BIOL, V131, P575, DOI 10.1007/s00418-009-0558-4; Shepherd SO, 2013, J PHYSIOL-LONDON, V591, P657, DOI 10.1113/jphysiol.2012.240952; Shepherd SO, 2012, EXP PHYSIOL, V97, P970, DOI 10.1113/expphysiol.2012.064592; Timmers S, 2012, P NATL ACAD SCI USA, V109, P11711, DOI 10.1073/pnas.1206868109; Vasuri F, 2010, BIOCHEM BIOPH RES CO, V397, P301, DOI 10.1016/j.bbrc.2010.05.104; Wang H, 2011, TRENDS ENDOCRIN MET, V22, P197, DOI 10.1016/j.tem.2011.03.008; Wang XQ, 2009, BIOCHEM BIOPH RES CO, V380, P286, DOI 10.1016/j.bbrc.2009.01.060; Wilkes EA, 2009, AM J CLIN NUTR, V90, P1343, DOI 10.3945/ajcn.2009.27543; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	32	59	61	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 15	2013	8	8							e73709	10.1371/journal.pone.0073709	http://dx.doi.org/10.1371/journal.pone.0073709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	204OU	24339897	Green Published, gold			2022-12-27	WOS:000323378000121
J	Li, L; Wang, CM; Calvisi, DF; Evert, M; Pilo, MG; Jiang, LJ; Yuneva, M; Chen, X				Li, Lei; Wang, Chunmei; Calvisi, Diego F.; Evert, Matthias; Pilo, Maria G.; Jiang, Lijie; Yuneva, Mariia; Chen, Xin			SCD1 Expression Is Dispensable for Hepatocarcinogenesis Induced by AKT and Ras Oncogenes in Mice	PLOS ONE			English	Article							STEAROYL-COA DESATURASE-1; FATTY-ACID SYNTHASE; HEPATOCELLULAR-CARCINOMA; COMPLEX 1; CANCER; LIVER; ACTIVATION; HYPERTRIGLYCERIDEMIA; CARCINOGENESIS; INTEGRATION	Increased de novo lipogenesis is one of the major metabolic events in cancer. In human hepatocellular carcinoma (HCC), de novo lipogenesis has been found to be increased and associated with the activation of AKT/mTOR signaling. In mice, overexpression of an activated form of AKT results in increased lipogenesis and hepatic steatosis, ultimately leading to liver tumor development. Hepatocarcinogenesis is dramatically accelerated when AKT is co-expressed with an oncogenic form of N-Ras. SCD1, the major isoform of stearoyl-CoA desaturases, catalyzing the conversion of saturated fatty acids (SFA) into monounsaturated fatty acids (MUFA), is a key enzyme involved in de novo lipogenesis. While many studies demonstrated the requirement of SCD1 for tumor cell growth in vitro, whether SCD1 is necessary for tumor development in vivo has not been previously investigated. Here, we show that genetic ablation of SCD1 neither inhibits lipogenesis and hepatic steatosis in AKT-overexpressing mice nor affects liver tumor development in mice co-expressing AKT and Ras oncogenes. Molecular analysis showed that SCD2 was strongly upregulated in liver tumors from AKT/Ras injected SCD1(-/-) mice. Noticeably, concomitant silencing of SCD1 and SCD2 genes was highly detrimental for the growth of AKT/Ras cells in vitro. Altogether, our study provides the evidence, for the first time, that SCD1 expression is dispensable for AKT/mTOR-dependent hepatic steatosis and AKT/Ras-induced hepatocarcinogenesis in mice. Complete inhibition of stearoyl-CoA desaturase activity may be required to efficiently suppress liver tumor development.	[Li, Lei; Wang, Chunmei; Jiang, Lijie; Chen, Xin] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Li, Lei] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan 430074, Hubei, Peoples R China; [Calvisi, Diego F.; Pilo, Maria G.] Univ Sassari, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Evert, Matthias] Ernst Moritz Arndt Univ Greifswald, Inst Pathol, Greifswald, Germany; [Yuneva, Mariia] Univ Calif San Francisco, GW Hooper Res Fdn, San Francisco, CA 94143 USA; [Chen, Xin] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Huazhong University of Science & Technology; University of Sassari; Ernst Moritz Arndt Universitat Greifswald; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Chen, X (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.	xin.chen@ucsf.edu	Rowan, Simon Coyle/AAO-1549-2020; Wang, Chunmei/J-2423-2013	Rowan, Simon Coyle/0000-0002-4103-4421; Wang, Chunmei/0000-0003-4615-0517; McLoughlin, Paul/0000-0001-6200-016X	NIH [R01CA136606, R03CA165122]; AIRC [IG12139]; National Natural Science Foundation of China [81201553]; Deutsche Forschungsgemeinschaft [EV 168/2-1]; Government of China through China Scholarship Council (CSC) [2010616508]; Medical Research Council [MC_UP_1202/4] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R03CA165122, R01CA136606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059637, P30DK026743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AIRC(Fondazione AIRC per la ricerca sul cancro); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Government of China through China Scholarship Council (CSC); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by grants from NIH R01CA136606, R03CA165122 (to X. C.), AIRC (IG12139 to D. F. C.), National Natural Science Foundation of China (Grant No. 81201553 to Lei Li) and the Deutsche Forschungsgemeinschaft (EV 168/2-1 to M. E.). Lei Li is also supported by the Government of China through China Scholarship Council (CSC) Contract No. 2010616508. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakan I, 2012, CURR OPIN LIPIDOL, V23, P226, DOI 10.1097/MOL.0b013e328352dd03; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Carlson CM, 2005, P NATL ACAD SCI USA, V102, P17059, DOI 10.1073/pnas.0502974102; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Dobrzyn P, 2004, P NATL ACAD SCI USA, V101, P6409, DOI 10.1073/pnas.0401627101; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Fan LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046472; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fritz V, 2010, MOL CANCER THER, V9, P1740, DOI 10.1158/1535-7163.MCT-09-1064; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; Hess D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011394; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Ho C, 2012, HEPATOLOGY, V55, P833, DOI 10.1002/hep.24736; Hodson L, 2013, PROG LIPID RES, V52, P15, DOI 10.1016/j.plipres.2012.08.002; Igal RA, 2010, CARCINOGENESIS, V31, P1509, DOI 10.1093/carcin/bgq131; Lee SA, 2008, HEPATOLOGY, V47, P1200, DOI 10.1002/hep.22169; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Mashima T, 2009, BRIT J CANCER, V100, P1369, DOI 10.1038/sj.bjc.6605007; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Moon YA, 2012, CELL METAB, V15, P240, DOI 10.1016/j.cmet.2011.12.017; Morgan-Lappe SE, 2007, CANCER RES, V67, P4390, DOI 10.1158/0008-5472.CAN-06-4132; MORRISON WR, 1964, J LIPID RES, V5, P600; Ntambi JM, 2004, LIPIDS, V39, P1061, DOI 10.1007/s11745-004-1331-2; Ntambi JM, 2003, CURR OPIN LIPIDOL, V14, P255, DOI 10.1097/00041433-200306000-00005; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Spangenberg HC, 2009, NAT REV GASTRO HEPAT, V6, P423, DOI 10.1038/nrgastro.2009.86; Wuestefeld T, 2013, CELL, V153, P389, DOI 10.1016/j.cell.2013.03.026	34	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 19	2013	8	9							e75104	10.1371/journal.pone.0075104	http://dx.doi.org/10.1371/journal.pone.0075104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	223BC	24349008	Green Published, Green Submitted, gold			2022-12-27	WOS:000324777300066
J	Cho, SI; Gao, SS; Xia, AP; Wang, R; Salles, FT; Raphael, PD; Abaya, H; Wachtel, J; Baek, J; Jacobs, D; Rasband, MN; Oghalai, JS				Cho, Sung-Il; Gao, Simon S.; Xia, Anping; Wang, Rosalie; Salles, Felipe T.; Raphael, Patrick D.; Abaya, Homer; Wachtel, Jacqueline; Baek, Jongmin; Jacobs, David; Rasband, Matthew N.; Oghalai, John S.			Mechanisms of Hearing Loss after Blast Injury to the Ear	PLOS ONE			English	Article							TYMPANIC-MEMBRANE PERFORATION; NERVE DEGENERATION; BRAIN-INJURY; OVERPRESSURE; EXPOSURE; MODEL; VULNERABILITY; SURVIVORS; RECOVERY; AFFERENT	Given the frequent use of improvised explosive devices (IEDs) around the world, the study of traumatic blast injuries is of increasing interest. The ear is the most common organ affected by blast injury because it is the body's most sensitive pressure transducer. We fabricated a blast chamber to re-create blast profiles similar to that of IEDs and used it to develop a reproducible mouse model to study blast-induced hearing loss. The tympanic membrane was perforated in all mice after blast exposure and found to heal spontaneously. Micro-computed tomography demonstrated no evidence for middle ear or otic capsule injuries; however, the healed tympanic membrane was thickened. Auditory brainstem response and distortion product otoacoustic emission threshold shifts were found to be correlated with blast intensity. As well, these threshold shifts were larger than those found in control mice that underwent surgical perforation of their tympanic membranes, indicating cochlear trauma. Histological studies one week and three months after the blast demonstrated no disruption or damage to the intra-cochlear membranes. However, there was loss of outer hair cells (OHCs) within the basal turn of the cochlea and decreased spiral ganglion neurons (SGNs) and afferent nerve synapses. Using our mouse model that recapitulates human IED exposure, our results identify that the mechanisms underlying blast-induced hearing loss does not include gross membranous rupture as is commonly believed. Instead, there is both OHC and SGN loss that produce auditory dysfunction.	[Cho, Sung-Il; Gao, Simon S.; Xia, Anping; Wang, Rosalie; Salles, Felipe T.; Raphael, Patrick D.; Abaya, Homer; Wachtel, Jacqueline; Oghalai, John S.] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; [Cho, Sung-Il] Chosun Univ, Dept Otolaryngol Head & Neck Surg, Kwangju, South Korea; [Gao, Simon S.] Rice Univ, Dept Bioengn, Houston, TX USA; [Baek, Jongmin; Jacobs, David] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Rasband, Matthew N.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Stanford University; Chosun University; Rice University; Stanford University; Baylor College of Medicine	Oghalai, JS (corresponding author), Stanford Univ, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA.	joghalai@stanford.edu		Ryoo, Seung Mok/0000-0002-2436-3311; Rasband, Matthew/0000-0001-8184-2477; Gao, Simon/0000-0002-7020-037X	DoD [W81XWH-11-2-0004 (DM090212)]; NIH [K08 DC006671, P30 DC010363]; Chosun University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K08DC006671, P30DC010363] Funding Source: NIH RePORTER	DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chosun University; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Support came from DoD W81XWH-11-2-0004 (DM090212) and NIH grants K08 DC006671 and P30 DC010363. Sungil Cho was supported by research funds from Chosun University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahroon WA, 1996, J ACOUST SOC AM, V100, P2247, DOI 10.1121/1.417934; Applegate BE, 2011, OPT LETT, V36, P4716, DOI 10.1364/OL.36.004716; Baalman KL, 2012, NEUROTRAUMA IN PRESS; Barden EK, 2012, J AM ACAD AUDIOL, V23, P332, DOI 10.3766/jaaa.23.5.4; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bauman RA, 2009, J NEUROTRAUM, V26, P841, DOI [10.1089/neu.2008.0898, 10.1089/neu.2009-0898]; Cave KM, 2007, MIL MED, V172, P726, DOI 10.7205/MILMED.172.7.726; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Chen ZQ, 2010, J NEUROPHYSIOL, V103, P2581, DOI 10.1152/jn.00018.2010; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Gao SS, 2011, OPT EXPRESS, V19, P15415, DOI 10.1364/OE.19.015415; Garner Jeff, 2007, Anesthesiol Clin, V25, P147; GOLDSTEIN LE, 2012, SCI TRANSL MED, V4; Gondusky JS, 2005, MIL MED, V170, P546, DOI 10.7205/MILMED.170.6.546; Gutierrez de Ceballos J Peral, 2005, Crit Care Med, V33, pS107, DOI 10.1097/01.CCM.0000151072.17826.72; HAMERNIK RP, 1988, J ACOUST SOC AM, V84, P941, DOI 10.1121/1.396663; HAMERNIK RP, 1984, HEARING RES, V16, P143, DOI 10.1016/0378-5955(84)90004-2; HAMERNIK RP, 1984, HEARING RES, V13, P229, DOI 10.1016/0378-5955(84)90077-7; HAMERNIK RP, 1987, J ACOUST SOC AM, V81, P1118, DOI 10.1121/1.394632; Helfer Thomas M, 2005, Am J Audiol, V14, P161, DOI 10.1044/1059-0889(2005/018); Horrocks C L, 2001, J R Army Med Corps, V147, P28; Ibekwe T S, 2009, J Laryngol Otol, V123, pe2, DOI 10.1017/S0022215108003800; Jeong HK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013756; Kujawa SG, 2009, J NEUROSCI, V29, P14077, DOI 10.1523/JNEUROSCI.2845-09.2009; Lang HN, 2006, J NEUROSCI, V26, P3541, DOI 10.1523/JNEUROSCI.2488-05.2006; Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1; Lerut B, 2012, OTOL NEUROTOL, V33, P379, DOI 10.1097/MAO.0b013e318245cea5; LIBERMAN MC, 1990, J COMP NEUROL, V301, P443, DOI 10.1002/cne.903010309; Lin HW, 2011, JARO-J ASSOC RES OTO, V12, P605, DOI 10.1007/s10162-011-0277-0; Liu CC, 2011, JARO-J ASSOC RES OTO, V12, P577, DOI 10.1007/s10162-011-0269-0; Long JB, 2009, J NEUROTRAUM, V26, P827, DOI 10.1089/neu.2008.0748; Masel BS, 2012, J NEUROTRAUMA; Mediavilla Varas Jesus, 2011, Front Neurol, V2, P58, DOI 10.3389/fneur.2011.00058; Ohlemiller KK, 2011, HEARING RES, V272, P13, DOI 10.1016/j.heares.2010.11.006; Ohlemiller KK, 2010, JARO-J ASSOC RES OTO, V11, P605, DOI 10.1007/s10162-010-0228-1; Ohlemiller KK, 2000, HEARING RES, V149, P239, DOI 10.1016/S0378-5955(00)00191-X; PATOW CA, 1994, OTOLARYNG HEAD NECK, V110, P211, DOI 10.1177/019459989411000211; Patterson JH, 1997, TOXICOLOGY, V121, P29, DOI 10.1016/S0300-483X(97)03653-6; PRICE GR, 1979, J ACOUST SOC AM, V66, P456, DOI 10.1121/1.383096; PRICE GR, 1986, J ACOUST SOC AM, V80, P1076, DOI 10.1121/1.393849; PRICE GR, 1989, J ACOUST SOC AM, V86, P2185, DOI 10.1121/1.398479; Qin ZB, 2010, HEARING RES, V263, P93, DOI 10.1016/j.heares.2009.10.002; Radford P, 2011, OTOLARYNG HEAD NECK, V145, P806, DOI 10.1177/0194599811411143; Ritzel DV, 2011, HUM FACT MED PAN S H, P1; Roberto M, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P23; Saliba I, 2011, INT J PEDIATR OTORHI, V75, P527, DOI 10.1016/j.ijporl.2011.01.012; Schulz TY., 2004, HEALTH-LONDON, V20, P18; Sharpnack D.D., 1991, CONVENTIONAL WARFARE, V1, P271; Stuhmiller J. H., 1991, CONVENTIONAL WARFARE, P241; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; [VA Affairs DoV], 2011, VET BEN ADM ANN BEN; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Wang Y, 2002, JARO, V3, P248, DOI 10.1007/s101620020028; White CH, 2009, MAMM GENOME, V20, P207, DOI 10.1007/s00335-009-9178-5; Wightman JM, 2001, ANN EMERG MED, V37, P664, DOI 10.1067/mem.2001.114906; Xia AP, 2010, DIS MODEL MECH, V3, P209, DOI 10.1242/dmm.004135; Xydakis MS, 2007, NEW ENGL J MED, V357, P830, DOI 10.1056/NEJMc076071; Zhang B, 2011, J TRAUMA, V71, P694, DOI 10.1097/TA.0b013e318224595f	59	107	112	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 1	2013	8	7							e67618	10.1371/journal.pone.0067618	http://dx.doi.org/10.1371/journal.pone.0067618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	175ZH	24339927	gold, Green Published			2022-12-27	WOS:000321271900013
J	O'Connor, JW; Gomez, EW				O'Connor, Joseph W.; Gomez, Esther W.			Cell Adhesion and Shape Regulate TGF-Beta1-Induced Epithelial-Myofibroblast Transition via MRTF-A Signaling	PLOS ONE			English	Article							SMOOTH MUSCLE ACTIN; SERUM RESPONSE FACTOR; MESENCHYMAL STEM-CELLS; TGF-BETA; MESSENGER-RNA; TRANSCRIPTION FACTORS; HISTONE ACETYLATION; GRANULATION-TISSUE; TRACTIONAL FORCES; GENE-EXPRESSION	Myofibroblasts, specialized cells that play important roles in wound healing and fibrosis, can develop from epithelial cells through an epithelial-mesenchymal transition (EMT). During EMT, epithelial cells detach from neighboring cells and acquire an elongated, mesenchymal-like morphology. These phenotypic changes are accompanied by changes in gene expression patterns including upregulation of a variety of cytoskeletal associated proteins which contribute to the ability of myofibroblasts to exert large contractile forces. Here, the relationship between cell shape and cytoskeletal tension and the expression of cytoskeletal proteins in transforming growth factor (TGF)-beta 1-induced EMT is determined. We find that culturing cells in conditions which permit cell spreading and increased contractility promotes the increased expression of myofibroblast markers and cytoskeletal associated proteins. In contrast, blocking cell spreading prevents transdifferentiation to the myofibroblast phenotype. Furthermore, we find that cell shape regulates the expression of cytoskeletal proteins by controlling the subcellular localization of myocardin related transcription factor (MRTF)-A. Pharmacological inhibition of cytoskeletal tension or MRTF-A signaling blocks the acquisition of a myofibroblast phenotype in spread cells while overexpression of MRTF-A promotes the expression of cytoskeletal proteins for all cell shapes. These data suggest that cell shape is a critical determinant of myofibroblast development from epithelial cells.	[O'Connor, Joseph W.; Gomez, Esther W.] Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA; [Gomez, Esther W.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Gomez, EW (corresponding author), Penn State Univ, Dept Chem Engn, University Pk, PA 16802 USA.	ewgomez@engr.psu.edu		Gomez, Esther/0000-0003-2082-013X; Perry, Ivan/0000-0002-4965-9792; Kearney, Patricia/0000-0001-9599-3540	Pennsylvania State University	Pennsylvania State University	Funding provided by The Pennsylvania State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford PW, 2011, INTEGR BIOL-UK, V3, P1063, DOI 10.1039/c1ib00061f; Asparuhova MB, 2009, SCAND J MED SCI SPOR, V19, P490, DOI 10.1111/j.1600-0838.2009.00928.x; Baarlink C, 2013, SCIENCE, V340, P864, DOI 10.1126/science.1235038; BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; BENZEEV A, 1984, J CELL BIOL, V99, P1424, DOI 10.1083/jcb.99.4.1424; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Brown AC, 2013, J PATHOL, V229, P25, DOI 10.1002/path.4114; Busche S, 2008, J CELL SCI, V121, P1025, DOI 10.1242/jcs.014456; Cen B, 2003, MOL CELL BIOL, V23, P6597, DOI 10.1128/MCB.23.18.6597-6608.2003; Chan MWC, 2010, J BIOL CHEM, V285, P9273, DOI 10.1074/jbc.M109.075218; Chan MWC, 2009, J CELL SCI, V122, P2769, DOI 10.1242/jcs.044008; Charbonney E, 2011, MOL BIOL CELL, V22, P4472, DOI 10.1091/mbc.E11-04-0335; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cicchini C, 2008, EXP CELL RES, V314, P143, DOI 10.1016/j.yexcr.2007.09.005; Condeelis J, 2005, BIOL CELL, V97, P97; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; Desai RA, 2011, INTEGR BIOL-UK, V3, P560, DOI 10.1039/c0ib00129e; Elberg G, 2008, AM J PHYSIOL-RENAL, V294, pF1116, DOI 10.1152/ajprenal.00142.2007; Engler A, 2004, BIOPHYS J, V86, P617, DOI 10.1016/S0006-3495(04)74140-5; Neira RE, 2012, INT J BIOCHEM CELL B, V44, P2194, DOI 10.1016/j.biocel.2012.08.018; Evelyn CR, 2007, MOL CANCER THER, V6, P2249, DOI 10.1158/1535-7163.MCT-06-0782; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; GABBIANI G, 1971, EXPERIENTIA, V27, P549, DOI 10.1007/BF02147594; Gabbiani G, 1981, Prog Clin Biol Res, V54, P183; Goffin JM, 2006, J CELL BIOL, V172, P259, DOI 10.1083/jcb.200506179; Gomez EW, 2011, METHODS MOL BIOL, V671, P107, DOI 10.1007/978-1-59745-551-0_5; Gomez EW, 2010, J CELL BIOCHEM, V110, P44, DOI 10.1002/jcb.22545; Hautmann MB, 1999, ARTERIOSCL THROM VAS, V19, P2049, DOI 10.1161/01.ATV.19.9.2049; HESKETH JE, 1991, BIOCHEM J, V277, P1; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2010, J BIOMECH, V43, P146, DOI 10.1016/j.jbiomech.2009.09.020; Jain N, 2013, P NATL ACAD SCI USA, V110, P11349, DOI 10.1073/pnas.1300801110; Jung J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074598; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Le Beyec J, 2007, EXP CELL RES, V313, P3066, DOI 10.1016/j.yexcr.2007.04.022; Leight JL, 2012, MOL BIOL CELL, V23, P781, DOI 10.1091/mbc.E11-06-0537; Li Y, 2011, BIOPHYS J, V100, P1902, DOI 10.1016/j.bpj.2011.03.008; Lin JJC, 2009, INT REV CEL MOL BIO, V274, P1, DOI 10.1016/S1937-6448(08)02001-7; Maeda M, 2006, J BIOL CHEM, V281, P59, DOI 10.1074/jbc.M503304200; Mammoto A, 2004, J BIOL CHEM, V279, P26323, DOI 10.1074/jbc.M402725200; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Masszi A, 2004, AM J PATHOL, V165, P1955, DOI 10.1016/S0002-9440(10)63247-6; Masszi A, 2010, J CELL BIOL, V188, P383, DOI 10.1083/jcb.200906155; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McWhorter FY, 2013, P NATL ACAD SCI USA, V110, P17253, DOI 10.1073/pnas.1308887110; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Nelson CM, 2008, J CELL BIOCHEM, V105, P25, DOI 10.1002/jcb.21821; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Parker KK, 2002, FASEB J, V16, DOI 10.1096/fj.02-0038com; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Rape AD, 2011, BIOMATERIALS, V32, P2043, DOI 10.1016/j.biomaterials.2010.11.044; Roca-Cusachs P, 2008, BIOPHYS J, V94, P4984, DOI 10.1529/biophysj.107.116863; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Small EM, 2010, CIRC RES, V107, P294, DOI 10.1161/CIRCRESAHA.110.223172; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vartiainen MK, 2007, SCIENCE, V316, P1749, DOI 10.1126/science.1141084; Versaevel M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1668; Wang N, 2002, CELL MOTIL CYTOSKEL, V52, P97, DOI 10.1002/cm.10037; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Wozniak MA, 2012, CURR BIOL, V22, P2017, DOI 10.1016/j.cub.2012.08.050; Xing L, 2013, TRAFFIC, V14, P2, DOI 10.1111/tra.12004; Zhao XH, 2007, J CELL SCI, V120, P1801, DOI 10.1242/jcs.001586	73	72	72	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 10	2013	8	12							e83188	10.1371/journal.pone.0083188	http://dx.doi.org/10.1371/journal.pone.0083188			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	275VW	24282548	Green Published, gold, Green Submitted			2022-12-27	WOS:000328707400126
J	Welch, JR; Brondizio, ES; Hetrick, SS; Coimbra, CEA				Welch, James R.; Brondizio, Eduardo S.; Hetrick, Scott S.; Coimbra, Carlos E. A., Jr.			Indigenous Burning as Conservation Practice: Neotropical Savanna Recovery amid Agribusiness Deforestation in Central Brazil	PLOS ONE			English	Article							CERRADO VEGETATION; FIRE MANAGEMENT; CLIMATE-CHANGE; MATO-GROSSO; PEOPLES; ABUNDANCE; FORESTS	International efforts to address climate change by reducing tropical deforestation increasingly rely on indigenous reserves as conservation units and indigenous peoples as strategic partners. Considered win-win situations where global conservation measures also contribute to cultural preservation, such alliances also frame indigenous peoples in diverse ecological settings with the responsibility to offset global carbon budgets through fire suppression based on the presumed positive value of non-alteration of tropical landscapes. Anthropogenic fire associated with indigenous ceremonial and collective hunting practices in the Neotropical savannas (cerrado) of Central Brazil is routinely represented in public and scientific conservation discourse as a cause of deforestation and increased CO2 emissions despite a lack of supporting evidence. We evaluate this claim for the Xavante people of Pimentel Barbosa Indigenous Reserve, Brazil. Building upon 23 years of longitudinal interdisciplinary research in the area, we used multi-temporal spatial analyses to compare land cover change under indigenous and agribusiness management over the last four decades (1973-2010) and quantify the contemporary Xavante burning regime contributing to observed patterns based on a four year sample at the end of this sequence (2007-2010). The overall proportion of deforested land remained stable inside the reserve (0.6%) but increased sharply outside (1.5% to 26.0%). Vegetation recovery occurred where reserve boundary adjustments transferred lands previously deforested by agribusiness to indigenous management. Periodic traditional burning by the Xavante had a large spatial distribution but repeated burning in consecutive years was restricted. Our results suggest a need to reassess overreaching conservation narratives about the purported destructiveness of indigenous anthropogenic fire in the cerrado. The real challenge to conservation in the fire-adapted cerrado biome is the long-term sustainability of indigenous lands and other tropical conservation islands increasingly subsumed by agribusiness expansion rather than the localized subsistence practices of indigenous and other traditional peoples.	[Welch, James R.; Coimbra, Carlos E. A., Jr.] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil; [Brondizio, Eduardo S.] Indiana Univ, Dept Anthropol, Bloomington, IN 47405 USA; [Brondizio, Eduardo S.; Hetrick, Scott S.] Indiana Univ, Anthropol Ctr Training & Res Global Environm Chan, Bloomington, IN USA	Fundacao Oswaldo Cruz; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Welch, JR (corresponding author), Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.	welch@ensp.fiocruz.br	Brondizio, Eduardo/R-7643-2019; Welch, James R/B-5042-2013	Welch, James R/0000-0002-9094-5491; Chunco, Amanda/0000-0002-8265-327X; Coimbra Jr., Carlos E. A./0000-0003-4085-1080	Brazilian National School of Public Health (INOVA-ENSP program); Fulbright Commission (Fulbright-Hays DDRAF) [P022A040016]; Brazilian Research Council (CNPq) [475674/2008-1, 403569/2008-7, 500072/2010-8]	Brazilian National School of Public Health (INOVA-ENSP program); Fulbright Commission (Fulbright-Hays DDRAF); Brazilian Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financing was provided by the Brazilian National School of Public Health (INOVA-ENSP program), the Fulbright Commission (Fulbright-Hays DDRAF no. P022A040016), and the Brazilian Research Council (CNPq grants 475674/2008-1, 403569/2008-7, and 500072/2010-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1987, SCIENCE, V235, P1450, DOI 10.1126/science.235.4795.1450; Adeney JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005014; [Anonymous], BIODIVERS BRAS; [Anonymous], 2002, XAVANTE TRANSITION H; [Anonymous], 2011, BIODIVERS BRAS; [Anonymous], 2006, SAVANA DRY FORESTS L; [Anonymous], 2013, HUMAN ENV INTERACTIO; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Birrell K, 2012, J HUM RIGHTS ENVIRON, V3, P196, DOI 10.4337/jhre.2012.03.02; Boer MM, 2009, FOREST ECOL MANAG, V259, P132, DOI 10.1016/j.foreco.2009.10.005; Briani DC, 2004, BIODIVERS CONSERV, V13, P1023, DOI 10.1023/B:BIOC.0000014467.27138.0b; Brondizio ES, 2009, ANNU REV ENV RESOUR, V34, P253, DOI 10.1146/annurev.environ.020708.100707; Cavalcanti Roberto B., 1997, Ornitologia Neotropical, V8, P85; COUTINHO LM, 1990, ECOL STU AN, V84, P82; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; De Castro EA, 1998, J TROP ECOL, V14, P263, DOI 10.1017/S0266467498000212; de Melo MM, 2013, SOC NATUR RESOUR, V26, P478, DOI 10.1080/08941920.2012.713087; Diaz M.d.C.V., 2002, PRECO OCULTO FOGO AM; EITEN G, 1972, BOT REV, V38, P201, DOI 10.1007/BF02859158; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Ferreira JuCnior L.G, 2011, REV BRASILEIRA CARTO, V63, P461; Flowers N. M., 1983, ADAPTIVE RESPONSES N, P357; FRIZZO, 2011, OECOLOGIA AUSTR RIO, V15, P365, DOI DOI 10.4257/0EC0.2011.1502.13; Garfield S, 2001, INDIGENOUS STRUGGLE; Georgescu M, 2013, GEOPHYS RES LETT, V40, P972, DOI 10.1002/grl.50206; GROSS DR, 1979, SCIENCE, V206, P1043, DOI 10.1126/science.206.4422.1043; Hecht S. B., 2009, P143, DOI 10.1007/978-1-4020-9031-8_7; Kassu Milanez F, 2010, AGUA BOA NEWS   1212; Klink C.A., 2002, CERRADOS BRAZIL ECOL, P69, DOI DOI 10.7312/0LIV12042; Klink CA, 2005, CONSERV BIOL, V19, P707, DOI 10.1111/j.1523-1739.2005.00702.x; Leach M, 2012, J PEASANT STUD, V39, P285, DOI 10.1080/03066150.2012.658042; Ledru Marie-Pierre., 2002, CERRADOS BRAZIL ECOL, P33; Leeuwenberg FJ, 2000, BIOL RESOURCE MANAGE, P375; Leite DLP, 2007, THESIS U BRASILIA BR; Leonel M., 2000, ESTUD AV-SAO PAULO, V14, P231, DOI [10.1590/S0103-40142000000300019, DOI 10.1590/S0103-40142000000300019]; McGregor S, 2010, HUM ECOL, V38, P721, DOI 10.1007/s10745-010-9362-y; Miranda H.S., 2002, CERRADOS BRAZIL ECOL, P51, DOI 10.7312/oliv12042-005; Mistry J, 1998, PROG PHYS GEOG, V22, P425, DOI 10.1177/030913339802200401; Mistry J, 2005, HUM ECOL, V33, P365, DOI 10.1007/s10745-005-4143-8; Mittermeier Russell A., 2004, P1; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nascimento LJ, 2013, G1 MATO GROSSO  0820; Nepstad D, 2006, CONSERV BIOL, V20, P65, DOI 10.1111/j.1523-1739.2006.00351.x; Oliveira M, 2001, DIARIO CUIABA   0814; Pereira C. A., 2004, Floresta, V34, P95; Phalan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051759; Pivello VR, 2011, FIRE ECOL, V7, P24, DOI 10.4996/fireecology.0701024; Prada M, 1995, BIOTROPICA, V27, P513, DOI 10.2307/2388965; Prada M, 2004, AUSTRAL ECOL, V29, P568, DOI 10.1111/j.1442-9993.2004.01391.x; Prada M, 2001, MAMMALIA, V65, P55, DOI 10.1515/mamm.2001.65.1.55; Ramos-Neto MB, 2000, ENVIRON MANAGE, V26, P675, DOI 10.1007/s002670010124; Ratter JA, 1997, ANN BOT-LONDON, V80, P223, DOI 10.1006/anbo.1997.0469; Ricketts TH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000331; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Soares R. V., 2002, Floresta, V32, P219; Soares B, 2010, P NATL ACAD SCI USA, V107, P10821, DOI 10.1073/pnas.0913048107; Turnhout E, 2012, NATURE, V488, P454, DOI 10.1038/488454a; United Nations, 2012, 2 SESS PLEN M DET MO; van Dam C, 2011, FORESTS, V2, P394, DOI 10.3390/f2010394; van Wilgen BW, 2010, J APPL ECOL, V47, P631, DOI 10.1111/j.1365-2664.2010.01800.x; VanWey LK, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0168; Villalobos M. P., 2002, THESIS U BRASILIA BR; VITT LJ, 1993, J HERPETOL, V27, P46, DOI 10.2307/1564904; WARMING Eugenius, 1892, LAGOA SANTA BIDRAG B; WELCH J. R., 2013, PRIMEIRA MARGEM RIO; Welch JR, 2009, HUM ECOL, V37, P13, DOI 10.1007/s10745-009-9216-7; Whitehead PJ, 2003, INT J WILDLAND FIRE, V12, P415, DOI 10.1071/WF03027	67	82	98	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 11	2013	8	12							e81226	10.1371/journal.pone.0081226	http://dx.doi.org/10.1371/journal.pone.0081226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	276EG	24349045	Green Submitted, Green Published, gold			2022-12-27	WOS:000328730300022
J	Zhao, Z; Su, TJ; Chesters, D; Wang, SD; Ho, SYW; Zhu, CD; Chen, XL; Zhang, CT				Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Wang, Shi-di; Ho, Simon Y. W.; Zhu, Chao-dong; Chen, Xiao-lin; Zhang, Chun-tian			The Mitochondrial Genome of Elodia flavipalpis Aldrich (Diptera: Tachinidae) and the Evolutionary Timescale of Tachinid Flies	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; DNA CONTROL REGION; TRANSFER-RNA GENE; CALYPTRATAE DIPTERA; MOLECULAR PHYLOGENY; FRUIT-FLY; AGROMYZIDAE; PHYLOGEOGRAPHY; REARRANGEMENT; ORGANIZATION	Tachinid flies are natural enemies of many lepidopteran and coleopteran pests of forests, crops, and fruit trees. In order to address the lack of genetic data in this economically important group, we sequenced the complete mitochondrial genome of the Palaearctic tachinid fly Elodia flavipalpis Aldrich, 1933. Usually found in Northern China and Japan, this species is one of the primary natural enemies of the leaf-roller moths (Tortricidae), which are major pests of various fruit trees. The 14,932-bp mitochondrial genome was typical of Diptera, with 13 protein-coding genes, 22 tRNA genes, and 2 rRNA genes. However, its control region is only 105 bp in length, which is the shortest found so far in flies. In order to estimate dipteran evolutionary relationships, we conducted a phylogenetic analysis of 58 mitochondrial genomes from 23 families. Maximum-likelihood and Bayesian methods supported the monophyly of both Tachinidae and superfamily Oestroidea. Within the subsection Calyptratae, Muscidae was inferred as the sister group to Oestroidea. Within Oestroidea, Calliphoridae and Sarcophagidae formed a sister clade to Oestridae and Tachinidae. Using a Bayesian relaxed clock calibrated with fossil data, we estimated that Tachinidae originated in the middle Eocene.	[Zhao, Zhe; Wang, Shi-di; Zhang, Chun-tian] Shenyang Normal Univ, Liaoning Key Lab Evolut & Biodivers, Shenyang, Liaoning, Peoples R China; [Zhao, Zhe; Su, Tian-juan; Chesters, Douglas; Zhu, Chao-dong; Chen, Xiao-lin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Ho, Simon Y. W.] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	Shenyang Normal University; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Sydney	Zhu, CD (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhucd@ioz.ac.cn; xlchen@ioz.ac.cn; chuntianzhang@yahoo.cn	Su, Tianjuan/AAJ-6290-2021; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Chesters, Douglas/AAF-7926-2019	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	Knowledge Innovation Program of Chinese Academy of Sciences [KSXC2-EW-B-02]; Public Welfare Project from the Ministry of Agriculture, China [201103024]; National Science Foundation, China [30870268, 31172048, J0930004, 31093430, 31272279]; National Special Science and Technology Foundation of China [2012FY111100]; NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	Knowledge Innovation Program of Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Public Welfare Project from the Ministry of Agriculture, China; National Science Foundation, China(National Natural Science Foundation of China (NSFC)); National Special Science and Technology Foundation of China; NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported mainly by a grant from the Knowledge Innovation Program of Chinese Academy of Sciences (grant KSXC2-EW-B-02), Public Welfare Project from the Ministry of Agriculture, China (grant 201103024), and the National Science Foundation, China (grants 30870268, 31172048, J0930004) to Chao-dong Zhu; the National Science Foundation, China (grants 31093430, 31272279) to Chun-tian Zhang; National Special Science and Technology Foundation of China (2012FY111100) to Xiao-lin Chen and Chao-dong Zhu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aldrich JM, 1933, P ENTOMOLOGICAL SOC, V35, P21; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Beckenbach AT, 2012, GENOME BIOL EVOL, V4, P89, DOI 10.1093/gbe/evr131; Beckenbach AT, 2009, GENOME BIOL EVOL, V1, P278, DOI 10.1093/gbe/evp027; Behura SK, 2011, INSECT BIOCHEM MOLEC, V41, P770, DOI 10.1016/j.ibmb.2011.05.006; Boore JL, 2005, METHOD ENZYMOL, V395, P311, DOI 10.1016/S0076-6879(05)95019-2; Cameron SL, 2007, SYST ENTOMOL, V32, P40, DOI 10.1111/j.1365-3113.2006.00355.x; Chao CM, 2009, FAUNA HEBEI PROVINCE, p[1, 555]; Chatterjee S, 2005, GENETICA, V125, P1, DOI 10.1007/s10709-004-6192-0; CLARY DO, 1985, J MOL EVOL, V22, P252, DOI 10.1007/BF02099755; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Griffiths G.C.D., 1972, Series Ent, V8, P1; Grimaldi David, 2005, pi; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han HY, 2000, BIOCHEM SYST ECOL, V28, P501, DOI 10.1016/S0305-1978(99)00097-6; HENNIG W, 1976, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), P1; Jiang ST, 2009, INT J BIOL SCI, V5, P351; Junqueira ACM, 2004, GENE, V339, P7, DOI 10.1016/j.gene.2004.06.031; Krzeminski Wieslaw, 1994, Acta Zoologica Cracoviensia, V37, P95; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Krzywinski J, 2011, MOL PHYLOGENET EVOL, V58, P469, DOI 10.1016/j.ympev.2011.01.003; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lessinger AC, 2000, MED VET ENTOMOL, V14, P71, DOI 10.1046/j.1365-2915.2000.00209.x; Lessinger AC, 2004, GENE, V339, P1, DOI 10.1016/j.gene.2004.06.041; Lessinger AC, 2000, INSECT MOL BIOL, V9, P521, DOI 10.1046/j.1365-2583.2000.00215.x; Lewis DL, 1995, INSECT MOL BIOL, V4, P263, DOI 10.1111/j.1365-2583.1995.tb00032.x; LIU YQ, 2002, FAUNA SINICA INSECT, V27, P315; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsumoto Y, 2009, MED VET ENTOMOL, V23, P47, DOI 10.1111/j.1365-2915.2008.00789.x; McAlpine JF, 1989, MONOGRAPH, V3, P1397; MITCHELL SE, 1993, GENOME, V36, P1058, DOI 10.1139/g93-141; Moreno M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-127; Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nelson LA, 2012, MITOCHONDR DNA, V23, P42, DOI 10.3109/19401736.2011.644042; Nelson LA, 2011, MITOCHONDR DNA, V22, P197, DOI 10.3109/19401736.2011.632896; Nirmala X, 2001, INSECT MOL BIOL, V10, P475, DOI 10.1046/j.0962-1075 .2001.00286.x; O'Hara JE, 2009, ZOOTAXA, P1; O'Hara JE, 2010, WORLD GENERA TACHINI; Oliveira MT, 2006, J MED ENTOMOL, V43, P636, DOI 10.1603/0022-2585(2006)43[636:IATTCR]2.0.CO;2; Oliveira MT, 2007, J MOL EVOL, V64, P519, DOI 10.1007/s00239-006-0099-6; Oliveira MT, 2008, MOL PHYLOGENET EVOL, V48, P850, DOI 10.1016/j.ympev.2008.05.022; PAPE T, 1992, Tijdschrift voor Entomologie, V135, P43; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A., 2007, TRACER V1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P991, DOI 10.1603/0013-8746(2006)99[991:MPOTVP]2.0.CO;2; Shao YJ, 2012, MOL BIOL REP, V39, P11023, DOI 10.1007/s11033-012-2005-1; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh VK, 1998, BIOTECHNIQUES, V24, P318, DOI 10.2144/98242pf02; Spanos L, 2000, INSECT MOL BIOL, V9, P139, DOI 10.1046/j.1365-2583.2000.00165.x; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stireman JO, 2002, SYST ENTOMOL, V27, P409, DOI 10.1046/j.1365-3113.2002.00187.x; Tachi T, 2010, SYST ENTOMOL, V35, P148, DOI 10.1111/j.1365-3113.2009.00497.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Torres TT, 2009, NUCLEIC ACIDS RES, V37, P7509, DOI 10.1093/nar/gkp856; von Tschirnhaus Michael, 2009, Denisia, P171; Wang S., 2009, MOL BIOL REP, V38, P687; Weigl S, 2010, MED VET ENTOMOL, V24, P329, DOI 10.1111/j.1365-2915.2010.00873.x; Wiegmann BM, 2003, SYST BIOL, V52, P745, DOI [10.1080/10635150390250965, 10.1093/sysbio/52.6.745]; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Winkler IS, 2010, J PALEONTOL, V84, P935, DOI 10.1666/09-163.1; Yang F, 2011, GENE, V485, P7, DOI 10.1016/j.gene.2011.05.030; Ye Jun, 2010, Plant Quarantine (Shanghai), V24, P11; Yeates DK, 2007, ZOOTAXA, P565, DOI 10.11646/zootaxa.1668.1.27; Yu DJ, 2007, GENE, V396, P66, DOI 10.1016/j.gene.2007.02.023; Zhao JL, 2011, MOL BIOL REP, V38, P3757, DOI 10.1007/s11033-010-0491-6; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133	71	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2013	8	4							e61814	10.1371/journal.pone.0061814	http://dx.doi.org/10.1371/journal.pone.0061814			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	131QH	23626734	Green Published, Green Submitted, gold			2022-12-27	WOS:000318008400098
J	Zhao, ZG; Zhang, JW; He, J; Zeng, GH				Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua			Clinical Utility of the UPOINT Phenotype System in Chinese Males with Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS): A Prospective Study	PLOS ONE			English	Article							SEXUAL DYSFUNCTION; ERECTILE DYSFUNCTION; SYMPTOM INDEX; MEN; PREVALENCE; CLASSIFICATION; MULTICENTER; MECHANISMS; DISEASE; IMPACT	Background: Recent data showed that a six-domain UPOINT is a flexible and responsive new classification system that has the clinical applicability in CP/CPPS. However, the utility of UPOINT algorithm in men in China with CP/CPPS has not been comprehensively studied. For international validation and adoption, we evaluated this clinical phenotype system for a large cohort of Chinese CP/CPPS patients and correlated it with patient symptoms and erectile dysfunction (ED). We also investigated the addition of an ED domain in regard to symptom correlation. Methods: A total of 389 Chinese males with CP/CPPS were prospectively collected and classified in each domain of the UPOINT system. Symptom severity was measured using the NIH-CPSI and IPSS. The erectile function was evaluated using the IIEF-5. Clinically relevant associations were calculated. Results: The percentage of patients positive for each domain was 54.0%, 42.1%, 41.9%, 20.8%, 26.7%, and 40.4% for the Urinary, Psychosocial, Organ-specific, Infection, Neurological/systemic, and Tenderness, respectively. There were significant correlations between the number of positive UPOINT domains and total NIH-CPSI (r = 0.706, p<0.001), IPSS (r = 0.682, p<0.001) and IIEF-5 scores (r = 0.631, P = 0.007) in Chinese cohort. Except for patients age, symptom duration was associated with a significantly greater number of positive domains (r = 0.638, P = 0.005). After adding an ED domain to create a modified UPOINT system, the correlation between the number of phenotypic domains and symptom severity was improved (0.706 to 0.844, p<0.001). Conclusions: The clinical applicability of using UPOINT phenotyping system has been validated in the Chinese patients with CP/CPPS. In our cohort, the number of positive domains was also correlated with ED symptoms and the significant association between the number of UPOINT domains and NIH-CPSI scores was further refined by adding a domain for ED. Our findings presented here support the utility of using ED as a stand-alone item in the UPOINT domain.	[Zhao, Zhigang; Zhang, Jingwei; He, Jun; Zeng, Guohua] Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Affiliated Hosp 1, Guangdong Prov Key Lab Urol, Dept Urol & Androl,Minimally Invas Surg Ctr, Guangzhou, Guangdong, Peoples R China.	zgzhaodr@yahoo.com.cn	Su, Tianjuan/AAJ-6290-2021; ZHU, Chao-Dong/E-5961-2011; Ho, Simon YW/A-8417-2008; Chesters, Douglas/AAF-7926-2019	ZHU, Chao-Dong/0000-0002-9347-3178; Ho, Simon YW/0000-0002-0361-2307; 	NHLBI NIH HHS [R01 HL97979, R01 HL097979] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Anderson RU, 2006, J UROLOGY, V176, P1534, DOI 10.1016/j.juro.2006.06.010; Bartoletti R, 2007, J UROLOGY, V178, P2411, DOI 10.1016/j.juro.2007.08.046; Calhoun EA, 2004, ARCH INTERN MED, V164, P1231; Chou YH., 2011, INCONT PELVIC FLOOR, V5, P31; Chung SD, 2012, BJU INT, V110, P726, DOI 10.1111/j.1464-410X.2011.10807.x; Collins MM, 2001, J GEN INTERN MED, V16, P656; Davis SNP, 2009, J SEX MARITAL THER, V35, P182, DOI 10.1080/00926230802716310; Eryildirim B, 2010, INT J IMPOT RES, V22, P349, DOI 10.1038/ijir.2010.26; Gonen M, 2005, J ANDROL, V26, P601, DOI 10.2164/jandrol.04159; Hedelin HH, 2009, SCAND J UROL NEPHROL, V43, P373, DOI 10.3109/00365590903164514; Krieger JN, 1999, JAMA-J AM MED ASSOC, V282, P236, DOI 10.1001/jama.282.3.236; Krieger JN, 2002, UROLOGY, V60, P959, DOI 10.1016/S0090-4295(02)01963-5; Lee SWH, 2008, UROLOGY, V71, P79, DOI 10.1016/j.urology.2007.08.043; Liang CZ, 2009, J UROLOGY, V182, P558, DOI 10.1016/j.juro.2009.04.011; Liang CZ, 2004, BJU INT, V93, P568, DOI 10.1111/j.1464-410X.2003.04662.x; Litwin MS, 1999, J UROLOGY, V162, P369, DOI 10.1016/S0022-5347(05)68562-X; Magri V, 2010, J UROLOGY, V184, P2339, DOI 10.1016/j.juro.2010.08.025; Magri Vittorio, 2008, Arch Ital Urol Androl, V80, P172; Muller Alexander, 2006, Curr Urol Rep, V7, P307, DOI 10.1007/s11934-996-0010-4; Perlmutter AE, 2011, INTERNET J UROLOGY, V9, P1, DOI [10.5580/c54, DOI 10.5580/C54]; Pontari MA, 2004, J UROLOGY, V172, P839, DOI 10.1097/01.ju.0000136002.76898.04; Pontari MA, 2008, J UROLOGY, V179, pS61, DOI 10.1016/j.juro.2008.03.139; Propert KJ, 2006, QUAL LIFE RES, V15, P299, DOI 10.1007/s11136-005-1317-1; Propert KJ, 2006, J UROLOGY, V175, P619, DOI 10.1016/S0022-5347(05)00233-8; Rosen RC, 1999, INT J IMPOT RES, V11, P319, DOI 10.1038/sj.ijir.3900472; Samplaski MK, 2011, UROLOGY, V78, P653, DOI 10.1016/j.urology.2011.04.016; Schaeffer AJ, 2006, 6 INT C NEW DEV PROS, P343; Shoskes DA, 2009, PROSTATE CANCER P D, V12, P177, DOI 10.1038/pcan.2008.42; Shoskes DA, 2012, CURR UROL REP, V13, P263, DOI 10.1007/s11934-012-0254-0; Shoskes DA, 2011, J UROLOGY, V186, P907, DOI 10.1016/j.juro.2011.04.063; Shoskes DA, 2010, UROLOGY, V75, P1249, DOI 10.1016/j.urology.2010.01.021; Shoskes DA, 2009, UROLOGY, V73, P538, DOI 10.1016/j.urology.2008.09.074; Sprague AH, 2009, BIOCHEM PHARMACOL, V78, P539, DOI 10.1016/j.bcp.2009.04.029; Tan HM, 2012, J SEX MED, V9, P663, DOI 10.1111/j.1743-6109.2011.02582.x; Trinchieri Alberto, 2007, Arch Ital Urol Androl, V79, P67; Tuncel A, 2006, INT UROL NEPHROL, V38, P583, DOI 10.1007/s11255-006-0087-1; Wagenlehner FME, 2009, EUR UROL, V56, P544, DOI 10.1016/j.eururo.2009.05.046	37	141	147	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 17	2013	8	1							e52044	10.1371/journal.pone.0052044	http://dx.doi.org/10.1371/journal.pone.0052044			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	073JI	23626734	Green Published, gold, Green Submitted			2022-12-27	WOS:000313738900004
J	Williams, O; Gbadero, D; Edowhorhu, G; Brearley, A; Slusher, T; Lund, TC				Williams, Olatundun; Gbadero, Daniel; Edowhorhu, Grace; Brearley, Ann; Slusher, Tina; Lund, Troy C.			Glucose-6-Phosphate Dehydrogenase Deficiency in Nigerian Children	PLOS ONE			English	Article							ANEMIA	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy and in Sub-Saharan Africa, is a significant cause of infection-and drug-induced hemolysis and neonatal jaundice. Our goals were to determine the prevalence of G6PD deficiency among Nigerian children of different ethnic backgrounds and to identify predictors of G6PD deficiency by analyzing vital signs and hematocrit and by asking screening questions about symptoms of hemolysis. We studied 1,122 children (561 males and 561 females) aged 1 month to 15 years. The mean age was 7.4 +/- 3.2 years. Children of Yoruba ethnicity made up the largest group (77.5%) followed by those Igbo descent (10.6%) and those of Igede (10.2%) and Tiv (1.8%) ethnicity. G6PD status was determined using the fluorescent spot method. We found that the overall prevalence of G6PD deficiency was 15.3% (24.1% in males, 6.6% in females). Yoruba children had a higher prevalence (16.9%) than Igede (10.5%), Igbo (10.1%) and Tiv (5.0%) children. The odds of G6PD deficiency were 0.38 times as high in Igbo children compared to Yoruba children (p = 0.0500). The odds for Igede and Tiv children were not significantly different from Yoruba children (p = 0.7528 and 0.9789 respectively). Mean oxygen saturation, heart rate and hematocrit were not significantly different in G6PD deficient and G6PD sufficient children. The odds of being G6PD deficient were 2.1 times higher in children with scleral icterus than those without (p = 0.0351). In conclusion, we determined the prevalence of G6PD deficiency in Nigerian sub-populations. The odds of G6PD deficiency were decreased in Igbo children compared to Yoruba children. There was no association between vital parameters or hematocrit and G6PD deficiency. We found that a history of scleral icterus may increase the odds of G6PD deficiency, but we did not exclude other common causes of icterus such as sickle cell disease or malarial infection.	[Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Div Global Hlth, Minneapolis, MN USA; [Gbadero, Daniel] Bowen Univ, Teaching Hosp, Dept Pediat, Ogbomosho, Nigeria; [Edowhorhu, Grace] Bowen Univ, Teaching Hosp, Dept Lab Med, Ogbomosho, Nigeria; [Brearley, Ann] Univ Minnesota, Biostat Design & Anal Ctr, Clin & Translat Sci Inst, Minneapolis, MN USA; [Lund, Troy C.] Univ Minnesota, Div Blood & Marrow Transplant, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lund, TC (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	lundx072@umn.edu			National Center for Research Resources [UL1TR000114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Biostatistics was made available through grant UL1TR000114 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BIENZLE U, 1975, BLOOD, V46, P591, DOI 10.1182/blood.V46.4.591.591; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Kaplan M, 2011, SEMIN PERINATOL, V35, P155, DOI 10.1053/j.semperi.2011.02.010; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Orimadegun AE, 2011, J INFECT DEV COUNTR, V5, P792, DOI 10.3855/jidc.1837; Peters AL, 2009, J HISTOCHEM CYTOCHEM, V57, P1003, DOI 10.1369/jhc.2009.953828; STEINBERG MH, 1988, BLOOD, V71, P748	10	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68800	10.1371/journal.pone.0068800	http://dx.doi.org/10.1371/journal.pone.0068800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	24349006	Green Submitted, Green Published, gold			2022-12-27	WOS:000321718700041
